data_1mdk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mdk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.306 -0.627 . . . . 1.1000000000000001 109.306 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -155.22 122.91 5.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.143 -0.973 . . . . 2.5 108.892 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -89.61 137.88 31.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 1.6100000000000001 110.371 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.9 mm -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.488 -1.301 . . . . 1.04 107.488 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -108.17 -15.93 14.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.292 -0.88 . . . . 1.97 109.195 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -153.13 158.95 42.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.92000000000000004 109.506 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.27 -29.49 23.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 2.48 109.998 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -58.7 -46.57 87.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 1.05 109.794 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.4 63.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0600000000000001 109.909 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -58.91 -65.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.046 . . . . 0.25 109.806 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -55.91 -45.27 78.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 3.0699999999999998 109.724 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -58.8 -35.55 73.02 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.174 -0.954 . . . . 2.1000000000000001 109.753 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.15 83.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.1 . . . . 1.04 109.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.44 -41.46 98.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.815 . . . . 1.27 109.534 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.85 -45.56 85.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 109.912 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.98 59.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 1.0900000000000001 109.952 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -7.44 29.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 1.0700000000000001 109.782 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.75 -136.09 24.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.137 -1.585 . . . . 0.31 109.137 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -117.01 5.92 12.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.43 -1.041 . . . . 2.21 109.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.72 168.01 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 2.4100000000000001 109.102 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.66 164.51 9.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.158 -1.053 . . . . 1.05 108.158 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 12.1 t -145.1 107.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.993 -1.067 . . . . 1.03 109.672 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.84 136.48 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.178 -1.045 . . . . 1.01 108.178 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 136.7 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.528 -0.732 . . . . 1.02 109.645 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.73 101.78 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.95999999999999996 109.292 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -88.04 79.07 8.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.32000000000000001 108.056 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.3 m -113.36 150.9 31.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.315 0.579 . . . . 1.04 109.487 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.19 130.24 37.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.0600000000000001 108.766 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -66.94 -28.83 68.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 110.809 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -88.47 -8.82 54.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.003 -1.061 . . . . 0.51000000000000001 110.536 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -97.61 128.4 44.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.34000000000000002 109.542 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.14 -55.99 9.63 Favored Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.563 -0.711 . . . . 0.40000000000000002 111.42 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 13.6 Cg_exo -49.94 -35.0 39.27 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.746 1.631 . . . . 0.47999999999999998 111.401 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.96 -1.087 . . . . 0.81000000000000005 109.076 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -58.27 -20.27 41.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 2.46 110.018 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.9 tpt -60.43 -19.73 57.27 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.144 -0.973 . . . . 3.6600000000000001 110.883 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.45 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.2 mt -100.73 4.39 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.998 -1.064 . . . . 1.0700000000000001 111.182 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 6.6 ptpt -64.65 -32.93 7.66 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 120.121 -1.612 . . . . 2.1099999999999999 112.439 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -57.64 -13.71 14.89 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.944 1.016 . . . . 0.29999999999999999 110.245 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -99.82 -67.19 0.86 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.724 -0.843 . . . . 0.37 108.724 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -46.61 -52.87 12.66 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.713 -0.617 . . . . 0.14999999999999999 110.424 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.7 -33.6 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.47999999999999998 109.73 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.0 -41.98 97.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.05 109.851 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 mt -52.25 -15.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.014 . . . . 1.1299999999999999 109.326 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 m -58.27 -33.37 69.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.93000000000000005 109.729 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.11 -18.06 22.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -0.907 . . . . 2.0 110.076 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -91.39 -22.81 20.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.132 -0.98 . . . . 2.6499999999999999 109.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -133.1 69.39 1.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.594 -0.691 . . . . 0.89000000000000001 109.193 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.6 p -67.34 -5.32 13.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.306 -0.871 . . . . 0.93000000000000005 109.114 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.44 5.28 52.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.487 -0.758 . . . . 0.46999999999999997 109.555 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.17 149.46 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.471 -0.768 . . . . 1.03 109.332 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.52 126.25 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.901 -0.777 . . . . 1.05 108.901 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -114.39 134.25 55.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.391 -0.818 . . . . 0.11 109.418 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 mp -116.4 175.11 5.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -0.783 . . . . 1.04 109.247 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -144.31 143.31 30.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.015 -1.106 . . . . 1.3100000000000001 108.015 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.8 t -140.44 142.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.07 -1.019 . . . . 1.02 110.658 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.95 100.77 11.72 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.932 -1.136 . . . . 1.0800000000000001 107.932 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.36 -10.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 111.099 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -102.52 -41.34 6.31 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 111.239 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -94.86 -13.67 25.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.98 -1.075 . . . . 1.1200000000000001 110.061 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.88 48.48 1.62 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.284 -0.885 . . . . 1.01 108.797 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' NE2' ' HE ' ' B' ' 4' ' ' ARG . 96.5 mt-30 -55.22 -13.97 1.53 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.571 -0.705 . . . . 2.7799999999999998 109.592 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.44 -42.42 71.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.246 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.61 -45.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 1.05 108.542 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -34.36 77.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 1.0600000000000001 109.304 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 24.1 m -64.08 -49.49 72.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 1.79 109.332 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.8 -37.06 85.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 2.2000000000000002 109.224 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.71 -3.74 58.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.492 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ALA . 36.1 mt-10 47.0 52.65 11.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 2.3399999999999999 110.279 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.06 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 1.05 108.896 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 54.5 mttp -127.74 6.74 6.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.451 -0.781 . . . . 2.9300000000000002 109.733 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 137.82 17.34 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.057 -1.027 . . . . 1.0600000000000001 108.95 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.3 p -122.04 149.89 55.13 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.362 -0.836 . . . . 0.97999999999999998 109.006 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -76.6 148.07 88.16 Favored 'Cis proline' 0 N--CA 1.484 0.932 0 C-N-CA 124.66 -0.975 . . . . 0.23999999999999999 110.409 -2.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -117.63 115.82 25.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.255 -1.387 . . . . 1.04 107.255 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -93.04 121.68 34.63 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.213 -0.929 . . . . 0.19 108.555 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -119.8 137.88 53.7 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.608 -1.256 . . . . 1.71 107.608 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.5 m-85 -111.44 127.8 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.536 0.684 . . . . 0.13 110.044 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -126.33 157.49 38.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.619 -0.882 . . . . 0.22 108.619 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -155.48 123.84 5.91 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.403 -1.332 . . . . 2.0299999999999998 107.403 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt 56.39 28.38 13.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.764 . . . . 2.1600000000000001 109.89 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.04 87.19 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.98 -1.105 . . . . 0.23000000000000001 110.357 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -115.3 146.48 41.46 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.372 -1.075 . . . . 2.8100000000000001 110.128 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -85.54 140.79 30.36 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.402 -0.811 . . . . 2.2599999999999998 109.222 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 -20.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.396 -0.815 . . . . 1.05 110.289 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.1 46.69 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.454 -1.355 . . . . 0.25 110.378 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -174.18 153.66 2.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.359 -1.083 . . . . 2.04 110.229 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.94 135.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.17999999999999999 109.974 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -106.6 -169.24 1.53 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.238 -0.914 . . . . 0.89000000000000001 108.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 91.87 129.25 4.61 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.806 -1.318 . . . . 0.14000000000000001 109.806 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.87 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -1.097 . . . . 1.0600000000000001 110.297 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.0 t-20 -139.96 74.38 1.46 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 1.98 108.787 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.58 74.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 1.72 110.319 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.06 -30.67 70.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.981 -1.074 . . . . 1.95 109.598 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -67.36 -33.5 75.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 2.5600000000000001 109.254 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 mt -50.82 -35.36 31.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.964 -1.085 . . . . 1.03 108.605 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.98 -57.59 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.836 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.2 88.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 1.04 110.876 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.6 m -66.87 -46.04 76.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 1.04 110.467 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.27 -50.56 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 1.05 109.163 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -61.17 -18.27 57.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 1.6599999999999999 109.652 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.63 -60.69 2.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 2.02 110.134 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.8 mt -91.88 22.1 4.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.463 -0.773 . . . . 1.1399999999999999 110.461 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 1.1799999999999999 109.178 179.357 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.436 ' HE ' ' NE2' ' A' ' 63' ' ' GLN . 7.3 mmt180 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.423 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 2.6 p90 -109.79 -168.54 1.34 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.087 -1.008 . . . . 0.0 110.714 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.02 150.31 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.943 0.877 . . . . 0.0 112.909 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.63 97.11 7.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -83.77 44.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.068 -1.02 . . . . 0.0 110.477 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.17 -136.82 0.15 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.32 28.27 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 118.755 1.278 . . . . 0.0 109.012 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.636 ' H ' ' C ' ' B' ' 9' ' ' GLY . 9.3 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 109.697 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 75.0 t . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.261 0.553 . . . . 1.1000000000000001 109.626 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.99 125.26 7.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.363 -0.836 . . . . 2.5 108.803 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -88.39 134.87 33.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 1.6100000000000001 109.899 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.99 106.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.219 -1.03 . . . . 1.04 108.219 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.63 -8.79 23.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.205 -0.934 . . . . 1.97 109.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.3 p -152.09 150.31 29.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.92000000000000004 109.623 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -51.57 -28.15 13.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 2.48 109.396 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 m -60.7 -43.27 97.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 1.05 109.584 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.35 -26.58 64.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.845 . . . . 1.0600000000000001 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.94 -67.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.25 109.868 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -54.1 -44.33 71.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 3.0699999999999998 109.673 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.44 -37.82 76.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.159 -0.963 . . . . 2.1000000000000001 109.726 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.71 88.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 1.04 109.276 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.7 -41.07 96.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 1.27 109.812 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.95 -38.68 92.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.587 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.08 -16.62 54.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.888 . . . . 1.0900000000000001 109.828 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -6.96 31.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 1.0700000000000001 109.938 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.66 -105.95 1.4 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.837 -1.305 . . . . 0.31 109.837 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.78 3.38 2.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -1.078 . . . . 2.21 109.74 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -70.09 166.82 19.0 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.042 -1.036 . . . . 2.4100000000000001 109.124 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 163.39 11.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.295 -0.878 . . . . 1.05 108.687 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.414 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 13.4 t -146.21 107.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.094 -1.004 . . . . 1.03 109.48 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -103.73 128.5 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.366 -0.833 . . . . 1.01 108.804 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.95 134.81 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.612 -0.68 . . . . 1.02 109.896 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -106.48 101.1 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.177 -0.675 . . . . 0.95999999999999996 109.177 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -84.97 81.17 9.01 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.765 -1.198 . . . . 0.32000000000000001 107.765 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -110.94 -163.06 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.626 0.727 . . . . 1.04 109.514 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 124.81 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.607 -0.886 . . . . 1.0600000000000001 108.607 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.649 ' HG1' ' HZ3' ' A' ' 36' ' ' LYS . 10.0 t -64.69 -25.47 67.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 1.0600000000000001 110.718 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -89.05 -19.45 25.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.972 -1.08 . . . . 0.51000000000000001 110.169 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.84 122.17 34.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.34000000000000002 109.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.63 -57.41 12.74 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 120.929 -0.653 . . . . 0.40000000000000002 111.555 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 22.8 Cg_exo -46.04 -36.88 16.83 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.712 1.608 . . . . 0.47999999999999998 111.645 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.86 -59.54 2.74 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.869 -1.145 . . . . 0.81000000000000005 108.944 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.649 ' HZ3' ' HG1' ' A' ' 30' ' ' THR . 14.6 ttmt -59.47 -15.15 15.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 2.46 110.009 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 tpt -58.24 -20.13 39.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 3.6600000000000001 110.434 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mt -97.27 8.57 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.083 -1.01 . . . . 1.0700000000000001 110.783 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.96 -31.97 5.25 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 120.122 -1.611 . . . . 2.1099999999999999 112.529 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.67 -5.14 11.09 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 CA-C-N 119.968 1.024 . . . . 0.29999999999999999 109.706 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -111.85 -78.45 0.58 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.015 -0.735 . . . . 0.37 109.015 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -41.56 -56.91 2.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.767 -0.583 . . . . 0.14999999999999999 110.688 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.01 -31.48 72.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.47999999999999998 109.871 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 46' ' ' SER . 13.4 m -66.49 -38.77 88.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.853 -1.154 . . . . 1.05 110.235 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.8 mt -49.17 -12.93 0.06 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.879 -1.138 . . . . 1.1299999999999999 109.649 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 44' ' ' SER . 54.9 m -56.75 -31.57 64.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.93000000000000005 109.51 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.25 -17.59 21.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.266 -0.896 . . . . 2.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -91.03 -24.3 20.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.976 -1.077 . . . . 2.6499999999999999 109.85 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -135.49 70.96 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 0.89000000000000001 109.621 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.2 p -66.97 -4.57 9.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.266 -0.896 . . . . 0.93000000000000005 108.714 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.11 -0.37 50.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.736 . . . . 0.46999999999999997 109.823 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.7 149.59 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.729 . . . . 1.03 109.4 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.07 133.57 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.442 -0.786 . . . . 1.05 109.418 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -119.06 131.77 55.98 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.544 -0.723 . . . . 0.11 109.163 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.99 172.81 6.82 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.399 -0.813 . . . . 1.04 108.962 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.99 143.33 31.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.85 138.2 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.168 -0.957 . . . . 1.02 110.288 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.79 102.9 14.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.648 -1.241 . . . . 1.0800000000000001 107.648 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.03 -6.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.233 -0.917 . . . . 1.0600000000000001 111.044 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.08 -44.52 5.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.052 -1.03 . . . . 1.1100000000000001 110.597 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.99 -15.37 24.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.093 -1.004 . . . . 1.1200000000000001 109.776 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.48 44.66 2.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -0.865 . . . . 1.01 109.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -57.06 -10.88 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.7799999999999998 110.216 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 1.4 p30 -69.04 -39.16 79.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.908 -1.12 . . . . 1.1100000000000001 109.149 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.428 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 2.8 t -74.05 -42.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.137 -1.06 . . . . 1.05 108.137 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.2 -37.85 88.87 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.907 -0.775 . . . . 1.0600000000000001 108.907 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 m -64.03 -45.02 90.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 1.79 109.079 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.87 -39.03 93.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 2.2000000000000002 109.427 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.11 0.33 55.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -0.896 . . . . 1.0600000000000001 109.754 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 49.21 56.81 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.905 . . . . 2.3399999999999999 109.951 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.59 135.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 1.05 109.192 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -123.86 -6.86 7.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.604 -0.685 . . . . 2.9300000000000002 109.638 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.494 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.01 136.96 16.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 109.433 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -115.47 150.61 44.9 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.295 -1.002 . . . . 0.97999999999999998 108.295 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.62 148.62 86.86 Favored 'Cis proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.838 -0.901 . . . . 0.23999999999999999 109.838 -2.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -119.26 118.89 32.48 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.145 -1.057 . . . . 1.04 108.145 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -95.76 111.9 23.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.19 108.775 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -114.03 139.39 49.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.601 -1.259 . . . . 1.71 107.601 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.6 m-85 -109.17 133.24 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.54 0.686 . . . . 0.13 110.052 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -126.59 156.62 40.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.488 -0.93 . . . . 0.22 108.488 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -154.73 122.51 5.81 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.633 -1.247 . . . . 2.0299999999999998 107.633 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 56.86 29.67 16.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 2.1600000000000001 109.866 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.4 1.54 90.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.113 -1.041 . . . . 0.23000000000000001 110.741 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -112.67 148.32 34.9 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.155 -1.203 . . . . 2.8100000000000001 110.281 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.478 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -87.19 146.5 25.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 2.2599999999999998 109.523 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.09 -29.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.442 -0.786 . . . . 1.05 110.147 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.43 45.51 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.659 -1.258 . . . . 0.25 110.083 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -172.34 160.99 5.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -1.147 . . . . 2.04 110.77 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.6 133.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.511 -0.743 . . . . 0.17999999999999999 110.18 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -104.23 -170.39 1.76 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.89000000000000001 109.291 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.59 130.19 4.41 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.526 -1.43 . . . . 0.14000000000000001 109.526 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -1.17 . . . . 1.0600000000000001 110.237 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.6 74.76 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.331 -0.989 . . . . 1.98 108.331 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' H ' ' HD2' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.25 -32.45 74.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.72 110.782 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.62 -28.67 69.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.1 -1.0 . . . . 1.95 109.153 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -69.4 -36.38 76.7 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.53 -0.731 . . . . 2.5600000000000001 109.873 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.05 -36.31 60.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.767 -1.208 . . . . 1.03 108.765 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -65.79 -58.15 6.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 2.1499999999999999 109.615 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.5 91.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 1.04 110.485 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.3 m -65.06 -45.26 86.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 1.04 110.212 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.96 -54.35 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.0 -1.062 . . . . 1.05 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -61.46 -16.55 48.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 1.6599999999999999 109.745 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -76.3 -60.45 2.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.902 . . . . 2.02 110.479 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.33 18.18 7.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 1.1399999999999999 110.544 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.265 179.374 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -108.75 -177.49 3.33 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.652 -1.28 . . . . 0.0 110.69 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.03 145.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.038 0.923 . . . . 0.0 113.058 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 m -101.22 93.73 5.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -83.5 44.61 0.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.337 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.02 -132.4 0.07 OUTLIER Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.54 25.15 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 CA-C-N 119.211 1.505 . . . . 0.0 109.274 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.1 t . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.55 -0.537 . . . . 1.1000000000000001 109.55 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.24 5.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.727 -1.212 . . . . 2.5 107.727 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -86.77 141.39 28.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 1.6100000000000001 110.411 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.12 109.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 1.04 108.022 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.97 -14.88 17.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 1.97 109.327 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -154.96 157.61 37.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.92000000000000004 109.843 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 49.7 tttp -51.55 -27.65 11.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 2.48 109.574 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 m -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 1.05 110.005 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.47 -27.26 65.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.687 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.84 -67.61 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.25 109.942 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -54.04 -43.98 70.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.901 . . . . 3.0699999999999998 109.64 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.51 -37.5 78.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.245 -0.909 . . . . 2.1000000000000001 109.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.2 86.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 1.04 109.454 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.31 -43.16 98.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.413 -0.804 . . . . 1.27 109.563 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.27 -42.33 96.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 1.0900000000000001 109.594 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.06 -13.49 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.962 . . . . 1.0900000000000001 109.809 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -6.4 24.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 1.0700000000000001 109.753 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.54 -112.43 4.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.31 109.562 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.43 2.67 2.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -1.103 . . . . 2.21 109.262 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -68.84 167.05 16.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 2.4100000000000001 108.812 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.555 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.67 161.86 11.62 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.099 -1.074 . . . . 1.05 108.099 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.555 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 13.0 t -143.99 105.8 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.968 -1.083 . . . . 1.03 109.451 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 t -102.41 132.19 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.704 -0.85 . . . . 1.01 108.704 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.38 138.54 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.674 -0.641 . . . . 1.02 109.758 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.09 101.57 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.178 -0.675 . . . . 0.95999999999999996 109.178 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -85.09 79.97 9.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.874 -1.158 . . . . 0.32000000000000001 107.874 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.43 149.53 34.05 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.279 0.562 . . . . 1.04 109.789 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.95 128.17 37.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.63 -0.878 . . . . 1.0600000000000001 108.63 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -65.93 -26.65 67.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 1.0600000000000001 110.605 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.43 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 60.4 p-90 -88.53 -13.76 39.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.887 -1.133 . . . . 0.51000000000000001 110.038 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 t -94.34 126.01 39.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.34000000000000002 109.995 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.98 -58.96 8.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.462 -0.655 . . . . 0.40000000000000002 111.462 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.6 Cg_exo -45.12 -33.21 7.8 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.9 1.733 . . . . 0.47999999999999998 111.314 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.41 -61.58 1.96 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.897 -1.127 . . . . 0.81000000000000005 108.626 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -60.89 -15.7 33.66 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.71 -0.619 . . . . 2.46 110.473 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 33' ' ' GLY . 27.9 tpp -60.92 -27.38 68.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.05 -1.031 . . . . 3.6600000000000001 109.991 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mt -96.49 15.63 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.131 -0.981 . . . . 1.0700000000000001 111.023 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.89 -32.75 3.67 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 118.179 -1.408 . . . . 2.1099999999999999 112.224 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -62.9 -4.58 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 CA-C-N 119.758 0.949 . . . . 0.29999999999999999 110.114 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.435 ' O ' ' OG ' ' A' ' 44' ' ' SER . 46.5 m-85 -109.16 -79.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.37 109.025 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.73 -55.8 2.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.632 . . . . 0.14999999999999999 111.082 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.37 -34.7 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.47999999999999998 110.219 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 85.1 p -64.85 -35.42 81.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.637 -1.29 . . . . 1.05 110.012 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.5 mt -50.11 -16.11 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.987 -1.071 . . . . 1.1299999999999999 109.28 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 14.9 m -57.03 -36.48 70.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.93000000000000005 109.706 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -93.16 -15.02 26.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.159 -0.963 . . . . 2.0 110.089 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -91.26 -23.12 20.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.056 -1.027 . . . . 2.6499999999999999 109.196 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -135.88 72.46 1.44 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.531 -0.731 . . . . 0.89000000000000001 109.414 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 93.3 p -67.17 -4.76 11.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.93000000000000005 108.969 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -96.97 -0.37 47.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.46999999999999997 109.9 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.29 147.54 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -0.784 . . . . 1.03 109.223 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 mm -98.77 130.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 1.05 109.36 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -118.11 132.13 56.37 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.486 -0.759 . . . . 0.11 109.142 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.78 171.92 7.29 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.786 -0.82 . . . . 1.04 108.786 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -141.54 137.83 32.29 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.717 -1.216 . . . . 1.3100000000000001 107.717 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 t -136.47 139.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.275 -0.891 . . . . 1.02 110.883 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' ASP . 19.5 t70 -99.99 101.77 12.95 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.745 -0.835 . . . . 1.0800000000000001 108.745 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -60.98 -2.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.879 . . . . 1.0600000000000001 111.017 -179.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.43 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 26.1 m-20 -108.66 -44.44 4.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.061 -1.025 . . . . 1.1100000000000001 110.503 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -95.11 -26.97 15.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.102 -0.999 . . . . 1.1200000000000001 109.21 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.92 40.39 1.51 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.309 -0.997 . . . . 1.01 108.309 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.41 ' O ' ' OG ' ' A' ' 67' ' ' SER . 10.9 pt20 -53.57 -15.87 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.636 -0.665 . . . . 2.7799999999999998 110.121 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -70.26 -36.29 74.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.978 -1.076 . . . . 1.1100000000000001 108.783 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -75.27 -48.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.663 -0.866 . . . . 1.05 108.663 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.72 74.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.801 . . . . 1.0600000000000001 109.161 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 34.1 m -63.16 -48.98 76.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 1.79 109.182 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -64.94 -35.99 82.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.522 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 0.47 55.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.945 . . . . 1.0600000000000001 109.905 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 45.88 50.95 10.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.961 . . . . 2.3399999999999999 110.251 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.82 131.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 1.05 108.904 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -130.52 6.19 4.79 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.376 -0.827 . . . . 2.9300000000000002 110.212 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.46 120.7 6.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.04 -1.037 . . . . 1.0600000000000001 108.731 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.0 p -108.17 150.65 40.74 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.759 -0.83 . . . . 0.97999999999999998 108.759 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.8 141.97 68.83 Favored 'Cis proline' 0 N--CA 1.484 0.919 0 C-N-CA 125.033 -0.82 . . . . 0.23999999999999999 110.105 -1.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 115.66 27.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.973 -1.121 . . . . 1.04 107.973 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -91.47 118.62 30.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.19 108.94 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -117.06 132.95 56.56 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.839 -1.171 . . . . 1.71 107.839 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.0 m-85 -107.84 126.55 52.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.656 -0.653 . . . . 0.13 109.55 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -123.03 158.46 30.5 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.786 -0.82 . . . . 0.22 108.786 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HZ1' ' HZ2' ' A' ' 82' ' ' LYS . 42.8 tttm -154.75 123.07 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.866 -1.531 . . . . 2.0299999999999998 106.866 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HZ2' ' HZ1' ' A' ' 81' ' ' LYS . 25.1 mttm 58.26 28.59 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 2.1600000000000001 109.41 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 2.83 88.8 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.606 -1.397 . . . . 0.23000000000000001 109.606 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.76 145.75 31.68 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.543 -0.975 . . . . 2.8100000000000001 110.334 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -85.6 141.13 30.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 2.2599999999999998 109.357 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.6 -21.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.49 -0.756 . . . . 1.05 110.253 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.04 177.32 48.42 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.485 -1.341 . . . . 0.25 110.178 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -174.27 156.1 2.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -1.121 . . . . 2.04 110.165 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.9 131.15 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.17999999999999999 110.0 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 p -102.57 -166.85 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.192 -0.942 . . . . 0.89000000000000001 108.892 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.98 127.9 3.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.126 -1.59 . . . . 0.14000000000000001 109.126 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.81 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.158 -1.201 . . . . 1.0600000000000001 110.734 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -143.12 77.38 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.136 -1.061 . . . . 1.98 108.136 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -33.34 75.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 1.72 110.484 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.97 -26.57 67.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.98 -1.075 . . . . 1.95 109.185 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -68.97 -36.54 78.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.346 -0.846 . . . . 2.5600000000000001 109.512 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.7 -34.9 60.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.064 . . . . 1.03 108.919 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.0 -57.54 6.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 2.1499999999999999 109.722 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.33 90.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 1.04 110.59 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.0 m -66.86 -45.14 79.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 1.04 110.206 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.49 -51.9 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.932 -1.105 . . . . 1.05 108.631 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.91 -15.34 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.857 . . . . 1.6599999999999999 109.646 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -76.49 -59.72 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 2.02 110.176 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.3 mt -92.32 17.17 10.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 110.404 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.973 -1.08 . . . . 1.1799999999999999 109.382 179.595 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -115.08 -172.56 2.15 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.941 -1.1 . . . . 0.0 110.632 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.95 152.54 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.957 0.884 . . . . 0.0 112.056 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 m -101.25 96.84 7.46 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -82.8 45.48 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.948 . . . . 0.0 109.819 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.679 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.74 -132.66 0.07 OUTLIER Glycine 0 N--CA 1.484 1.894 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.27 21.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 CA-C-N 119.286 1.543 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.679 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.3 t . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.245 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 69.8 t . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.364 0.602 . . . . 1.1000000000000001 109.73 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HZ1' ' CD1' ' A' ' 5' ' ' ILE . 48.4 tttm -154.1 127.8 8.73 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 2.5 108.991 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -87.55 130.99 34.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.912 . . . . 1.6100000000000001 109.592 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CD1' ' HZ1' ' A' ' 3' ' ' LYS . 25.0 mm -114.78 85.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.675 -0.861 . . . . 1.04 108.675 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -95.29 4.43 53.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.979 -1.075 . . . . 1.97 109.551 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 p -150.4 141.48 23.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.92000000000000004 109.889 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -51.57 -31.07 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.823 . . . . 2.48 109.49 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -59.88 -43.93 94.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 1.05 109.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.08 -26.01 63.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 1.0600000000000001 109.828 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.91 -67.39 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.25 110.118 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -53.78 -44.41 70.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 3.0699999999999998 109.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.38 -36.89 76.63 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.269 -0.894 . . . . 2.1000000000000001 109.969 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.36 89.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 1.04 109.484 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -63.77 -45.6 89.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 1.27 110.034 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.19 -41.57 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.048 -1.033 . . . . 1.0900000000000001 109.415 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.42 -13.06 59.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 1.0900000000000001 109.628 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.09 40.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 1.0700000000000001 109.581 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.11 -113.01 4.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.444 -1.462 . . . . 0.31 109.444 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -137.71 2.51 2.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.353 -1.087 . . . . 2.21 109.348 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -69.37 168.08 15.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.4100000000000001 108.702 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.55 165.1 10.58 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.168 -0.958 . . . . 1.05 108.452 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.1 t -145.29 106.31 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.87 -1.144 . . . . 1.03 109.712 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.5 132.25 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.354 -0.841 . . . . 1.01 108.996 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.07 136.75 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.619 -0.676 . . . . 1.02 109.636 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.472 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 14.5 t70 -109.37 102.29 11.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.95999999999999996 109.363 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -85.01 82.48 8.43 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.939 -1.134 . . . . 0.32000000000000001 107.939 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.472 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 57.1 m -114.24 150.05 34.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.822 -0.549 . . . . 1.04 109.734 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.0 123.41 35.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.234 -1.024 . . . . 1.0600000000000001 108.234 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -65.37 -23.25 66.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 110.454 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -89.1 -11.75 43.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.51000000000000001 109.899 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 t -96.97 128.04 43.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.34000000000000002 110.049 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.29 -56.46 11.92 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.631 -0.668 . . . . 0.40000000000000002 111.601 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.4 Cg_exo -47.2 -35.06 19.16 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.829 1.686 . . . . 0.47999999999999998 111.438 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -61.26 2.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.926 -1.109 . . . . 0.81000000000000005 108.832 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.51 -16.86 27.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.421 -0.799 . . . . 2.46 110.102 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.84 -28.44 68.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 3.6600000000000001 110.212 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.457 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 43.3 mt -96.76 18.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.232 -0.918 . . . . 1.0700000000000001 110.485 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.09 -32.05 2.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.53 -1.357 . . . . 2.1099999999999999 112.606 179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -62.69 -3.69 4.8 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.659 0.914 . . . . 0.29999999999999999 109.994 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.3 m-85 -110.2 -76.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.567 -0.708 . . . . 0.37 109.331 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.1 t80 -42.28 -57.2 2.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.433 -0.792 . . . . 0.14999999999999999 110.715 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -66.82 -30.94 71.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.952 . . . . 0.47999999999999998 109.959 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.0 t -64.28 -40.08 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.804 -1.185 . . . . 1.05 109.96 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.8 -16.33 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.054 -1.029 . . . . 1.1299999999999999 109.437 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.419 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 44.9 m -57.38 -31.42 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.93000000000000005 109.869 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -96.57 -19.34 19.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.159 -0.963 . . . . 2.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -91.14 -23.7 20.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.965 -1.085 . . . . 2.6499999999999999 109.8 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' ASN . 39.1 m-85 -131.36 66.99 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.579 -0.7 . . . . 0.89000000000000001 109.181 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -66.5 -3.61 6.62 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 0.93000000000000005 108.79 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -95.4 -1.49 50.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 0.46999999999999997 109.319 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.7 t -115.56 149.11 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.058 -0.719 . . . . 1.03 109.058 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.58 128.76 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 1.05 109.324 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.29 132.31 56.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.532 -0.73 . . . . 0.11 109.181 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -114.08 171.33 7.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.871 -0.789 . . . . 1.04 108.871 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.69 138.38 28.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.066 -1.087 . . . . 1.3100000000000001 108.066 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.6 t -134.6 138.37 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.211 -0.931 . . . . 1.02 110.616 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.99 99.13 9.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.835 -1.172 . . . . 1.0800000000000001 107.835 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.18 -13.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 1.0600000000000001 111.331 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -100.03 -44.58 5.96 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.894 -1.129 . . . . 1.1100000000000001 111.298 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.6 -10.61 39.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.973 -1.08 . . . . 1.1200000000000001 109.718 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.4 2.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.543 -0.91 . . . . 1.01 108.543 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.401 ' O ' ' OG ' ' A' ' 67' ' ' SER . 48.0 mt-30 -55.44 -15.43 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.762 . . . . 2.7799999999999998 110.142 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.6 p30 -69.74 -39.53 76.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.032 -1.042 . . . . 1.1100000000000001 108.995 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.05 -46.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.05 108.777 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.48 -31.99 72.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 1.0600000000000001 108.846 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 40.7 m -64.29 -56.23 15.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 1.79 109.219 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 -31.16 72.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 2.2000000000000002 109.351 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.24 -6.81 57.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 109.296 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' ALA . 27.5 mt-10 45.27 51.6 9.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.383 -0.823 . . . . 2.3399999999999999 110.369 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.49 136.13 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 1.05 109.145 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -130.4 2.34 4.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.442 -0.786 . . . . 2.9300000000000002 109.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.09 126.95 9.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.005 -1.059 . . . . 1.0600000000000001 109.496 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.2 p -111.6 150.54 42.35 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.385 -0.822 . . . . 0.97999999999999998 108.876 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.61 141.42 64.22 Favored 'Cis proline' 0 N--CA 1.486 1.075 0 C-N-CA 125.03 -0.821 . . . . 0.23999999999999999 110.371 -1.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.67 114.26 26.78 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.129 -1.063 . . . . 1.04 108.129 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.61 124.16 34.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.848 -1.157 . . . . 0.19 109.093 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -122.4 133.67 54.63 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.915 -1.142 . . . . 1.71 107.915 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.3 m-85 -107.88 127.81 54.06 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.665 0.745 . . . . 0.13 110.012 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -126.08 155.37 41.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.923 -1.14 . . . . 0.22 107.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -156.25 125.46 6.13 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.205 -1.035 . . . . 2.0299999999999998 108.205 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 56.32 19.22 3.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.573 -0.705 . . . . 2.1600000000000001 109.569 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.464 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.39 1.09 69.39 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.309 -1.116 . . . . 0.23000000000000001 110.309 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.464 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.1 mm-40 -110.33 148.14 32.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.352 -1.087 . . . . 2.8100000000000001 110.272 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -87.89 145.65 25.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 2.2599999999999998 109.36 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.17 -25.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 1.05 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.1 46.25 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.477 -1.344 . . . . 0.25 110.516 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -174.49 154.94 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -1.094 . . . . 2.04 109.967 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.9 p90 -167.76 131.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.17999999999999999 110.455 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -104.53 -170.97 1.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.229 -0.919 . . . . 0.89000000000000001 108.805 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.18 131.96 3.86 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.785 -1.326 . . . . 0.14000000000000001 109.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.29 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -1.129 . . . . 1.0600000000000001 110.609 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.75 66.3 1.35 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.138 -1.06 . . . . 1.98 108.138 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.645 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.0 ptpt -61.04 -38.58 86.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 1.72 110.854 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.23 -28.81 69.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.986 -1.071 . . . . 1.95 109.729 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -70.16 -33.07 71.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.311 -0.868 . . . . 2.5600000000000001 109.592 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.74 -37.98 44.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 1.03 108.63 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.72 -54.85 16.02 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.935 -0.706 . . . . 2.1499999999999999 109.658 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.71 90.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 1.04 110.542 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.7 m -66.5 -46.92 74.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.163 -0.961 . . . . 1.04 110.486 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 -50.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.05 108.975 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -61.62 -17.54 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 1.6599999999999999 109.544 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -77.05 -58.69 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 2.02 110.207 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.78 18.57 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.341 -0.849 . . . . 1.1399999999999999 110.46 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.1799999999999999 109.275 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -128.47 -170.19 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.185 -0.947 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.22 144.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.906 0.86 . . . . 0.0 112.837 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.5 m -101.25 94.64 6.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -83.09 45.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.9 -130.66 0.19 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.17 28.02 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 CA-C-N 119.323 1.562 . . . . 0.0 109.201 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.621 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.7 t . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 60.6 t . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.315 -0.624 . . . . 1.1000000000000001 109.315 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.427 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 53.1 tttm -153.46 121.57 6.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -0.965 . . . . 2.5 109.224 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -89.79 136.06 33.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 1.6100000000000001 110.01 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mm -106.98 113.03 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.843 -1.169 . . . . 1.04 107.843 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.12 -11.04 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 1.97 109.561 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -153.29 155.55 36.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.121 -0.987 . . . . 0.92000000000000004 109.777 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 78.9 tttt -52.44 -31.36 34.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 2.48 109.806 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -57.93 -44.76 87.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.878 -1.139 . . . . 1.05 109.695 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.09 -23.7 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 1.0600000000000001 109.715 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -60.37 -68.39 0.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.25 110.181 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . 0.622 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -54.35 -42.72 70.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 3.0699999999999998 109.279 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.82 -38.36 78.47 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.186 -0.946 . . . . 2.1000000000000001 109.974 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -47.72 84.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 1.04 109.362 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.66 -40.83 97.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.344 -0.848 . . . . 1.27 109.416 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.6 -41.42 96.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 109.869 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.09 58.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 1.0900000000000001 109.945 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 -3.38 9.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 1.0700000000000001 109.625 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -108.85 2.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.47 . . . . 0.31 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -139.7 4.59 2.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.395 -1.062 . . . . 2.21 109.282 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 55.9 mttm -69.95 175.06 4.66 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.124 -0.985 . . . . 2.4100000000000001 109.775 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.69 159.75 31.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.364 -0.976 . . . . 1.05 108.364 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.505 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.0 t -144.73 107.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.763 -1.211 . . . . 1.03 109.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -105.73 131.6 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.643 -0.873 . . . . 1.01 108.643 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 136.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.684 -0.635 . . . . 1.02 109.633 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.96 105.8 15.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.109 -0.7 . . . . 0.95999999999999996 109.109 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.62 79.62 8.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.988 -1.116 . . . . 0.32000000000000001 107.988 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -113.78 150.15 33.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.788 -0.57 . . . . 1.04 109.873 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.81 124.77 36.19 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.403 -0.962 . . . . 1.0600000000000001 108.403 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -66.0 -23.88 66.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 1.0600000000000001 110.367 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -88.62 -13.95 38.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.51000000000000001 110.001 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.19 121.62 37.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.34000000000000002 109.665 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.94 -57.15 20.18 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 121.579 -0.701 . . . . 0.40000000000000002 111.372 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.96 -34.3 16.23 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.863 1.709 . . . . 0.47999999999999998 111.5 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.03 2.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.026 -1.046 . . . . 0.81000000000000005 108.878 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.25 -18.52 49.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.522 -0.736 . . . . 2.46 110.233 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -59.21 -25.3 63.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 3.6600000000000001 110.17 -179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.34 11.94 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.069 -1.019 . . . . 1.0700000000000001 110.476 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.62 -32.24 3.54 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 120.407 -1.433 . . . . 2.1099999999999999 112.726 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.25 -3.98 5.82 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.851 0.982 . . . . 0.29999999999999999 110.318 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -111.96 -75.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.37 109.338 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -43.53 -57.03 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.14999999999999999 110.709 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.09 -31.89 72.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.47999999999999998 110.121 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' SER . 5.8 t -63.45 -39.02 93.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.856 -1.153 . . . . 1.05 110.4 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.6 mt -51.11 -12.78 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.019 -1.051 . . . . 1.1299999999999999 109.646 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' SER . 49.0 m -57.31 -36.95 71.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.93000000000000005 109.64 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -94.91 -16.75 22.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.119 -0.988 . . . . 2.0 110.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -90.33 -23.45 21.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.945 -1.097 . . . . 2.6499999999999999 109.4 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.413 ' C ' ' H ' ' A' ' 51' ' ' ASN . 40.0 m-85 -134.32 69.61 1.46 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.433 -0.792 . . . . 0.89000000000000001 109.219 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -66.51 -3.14 5.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.257 -0.902 . . . . 0.93000000000000005 108.946 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -95.94 0.74 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.544 -0.723 . . . . 0.46999999999999997 109.669 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.8 t -119.43 151.9 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.486 -0.759 . . . . 1.03 109.301 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 mm -101.6 129.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.402 -0.811 . . . . 1.05 109.461 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -116.95 131.0 57.06 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.441 -0.787 . . . . 0.11 109.147 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 mp -113.04 173.1 6.55 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.905 -0.776 . . . . 1.04 108.905 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -143.46 143.65 31.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.034 -1.098 . . . . 1.3100000000000001 108.034 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.59 138.19 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.095 -1.003 . . . . 1.02 110.731 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -99.69 105.01 16.78 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.176 -1.046 . . . . 1.0800000000000001 108.176 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.19 -12.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 1.0600000000000001 111.16 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -100.28 -43.04 6.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.004 -1.06 . . . . 1.1100000000000001 110.733 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.32 -10.5 38.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.925 -1.109 . . . . 1.1200000000000001 109.63 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 47.55 2.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.656 -0.868 . . . . 1.01 108.656 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 11.6 pt20 -56.17 -15.79 4.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.782 . . . . 2.7799999999999998 110.016 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.5 p-10 -70.15 -40.22 74.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.145 -0.972 . . . . 1.1100000000000001 109.253 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 t -73.56 -47.08 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.668 -0.864 . . . . 1.05 108.668 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.42 -35.44 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 1.0600000000000001 108.927 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 34.6 m -64.07 -45.53 88.33 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 1.79 109.229 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.64 -40.8 97.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 2.2000000000000002 109.28 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.8 58.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.178 -0.951 . . . . 1.0600000000000001 109.713 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.2 mm-40 49.08 55.18 9.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 110.112 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.91 133.56 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 1.05 109.153 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -125.72 2.68 7.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.434 -0.791 . . . . 2.9300000000000002 109.837 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.38 127.72 10.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.984 -1.072 . . . . 1.0600000000000001 109.309 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.459 ' O ' ' N ' ' B' ' 8' ' ' GLU . 20.4 p -114.4 150.63 44.12 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.681 -0.859 . . . . 0.97999999999999998 108.681 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.21 142.02 72.14 Favored 'Cis proline' 0 N--CA 1.487 1.131 0 C-N-CA 125.005 -0.831 . . . . 0.23999999999999999 110.98 -1.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -114.68 114.69 25.99 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.595 -1.261 . . . . 1.04 107.595 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -91.54 122.06 33.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.895 -1.128 . . . . 0.19 108.922 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -120.91 136.19 55.01 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.308 -1.367 . . . . 1.71 107.308 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.7 m-85 -108.22 132.89 53.19 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.636 0.731 . . . . 0.13 110.087 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.8 157.15 41.19 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.725 -0.842 . . . . 0.22 108.725 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -156.15 124.94 5.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.647 -1.242 . . . . 2.0299999999999998 107.647 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 56.22 18.71 3.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 2.1600000000000001 109.68 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.527 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.13 -1.11 64.59 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 120.158 -1.02 . . . . 0.23000000000000001 110.767 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.527 HE21 ' C ' ' A' ' 83' ' ' GLY . 31.0 mm-40 -109.7 147.99 32.18 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.091 -1.241 . . . . 2.8100000000000001 110.316 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -85.85 139.72 31.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.92 -0.77 . . . . 2.2599999999999998 108.92 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.3 -6.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 1.05 110.642 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.89 173.72 37.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.398 -1.382 . . . . 0.25 110.454 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -173.4 156.29 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -1.07 . . . . 2.04 110.165 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.61 132.17 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.503 -0.748 . . . . 0.17999999999999999 110.323 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -102.17 -162.92 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.89000000000000001 109.142 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.52 127.62 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.662 -1.375 . . . . 0.14000000000000001 109.662 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.4 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 1.0600000000000001 110.276 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' GLY . 26.3 t-20 -137.19 75.11 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.887 -1.153 . . . . 1.98 107.887 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -65.81 -42.26 90.87 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.812 -0.631 . . . . 1.72 111.316 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.02 -27.09 68.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.919 -1.113 . . . . 1.95 110.052 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -68.84 -32.44 72.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 2.5600000000000001 109.589 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.55 -35.83 61.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.809 -1.182 . . . . 1.03 108.518 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.42 -54.86 16.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 2.1499999999999999 109.479 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.59 89.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.835 . . . . 1.04 110.386 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 m -66.52 -45.09 80.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 1.04 109.784 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.92 -53.01 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.847 . . . . 1.05 109.29 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -60.34 -16.88 39.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 1.6599999999999999 109.467 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.49 -57.3 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 2.02 110.06 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.61 17.38 10.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 1.1399999999999999 110.131 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 1.1799999999999999 109.38 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -113.31 -167.75 1.24 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.271 -0.893 . . . . 0.0 110.975 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.21 148.25 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.92 0.867 . . . . 0.0 112.712 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 m -101.3 94.83 6.14 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 74' ' ' THR . 5.2 pt-20 -83.54 44.71 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.091 -1.006 . . . . 0.0 110.41 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.0 -132.6 0.09 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.52 23.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 CA-C-N 119.404 1.602 . . . . 0.0 109.278 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.662 ' H ' ' C ' ' B' ' 9' ' ' GLY . 48.3 t . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 83.5 t . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.157 -0.683 . . . . 1.1000000000000001 109.157 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -155.12 122.87 5.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.037 -1.039 . . . . 2.5 109.438 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -89.59 138.33 31.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.81 . . . . 1.6100000000000001 109.767 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.59 101.48 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.668 -0.864 . . . . 1.04 108.668 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -97.92 -6.51 32.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.077 -1.015 . . . . 1.97 109.266 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 p -152.73 152.38 31.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.86 . . . . 0.92000000000000004 109.688 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -52.78 -26.45 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.48 110.081 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 m -60.11 -46.15 90.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 1.05 109.995 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.8 63.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 1.0600000000000001 109.809 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.42 -68.45 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.136 -0.977 . . . . 0.25 109.96 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -55.09 -44.0 74.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 3.0699999999999998 109.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.09 -36.28 74.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.243 -0.911 . . . . 2.1000000000000001 110.128 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.02 -46.82 87.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.935 -1.103 . . . . 1.04 109.728 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.46 -50.22 70.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.334 -0.854 . . . . 1.27 109.952 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.57 -40.68 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 1.0900000000000001 109.817 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -16.45 56.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 1.0900000000000001 109.607 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.88 -12.39 61.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 1.0700000000000001 109.643 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 -116.84 4.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.779 -1.328 . . . . 0.31 109.779 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 42.3 t0 -135.23 4.16 3.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.46 -1.024 . . . . 2.21 109.466 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -68.68 169.69 10.74 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.999 -1.063 . . . . 2.4100000000000001 108.737 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 161.31 19.38 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 t -144.22 104.65 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.979 -1.075 . . . . 1.03 109.637 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.69 127.07 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.736 -0.838 . . . . 1.01 108.736 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.45 138.69 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.577 -0.702 . . . . 1.02 109.522 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -110.88 104.77 13.42 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.294 -0.632 . . . . 0.95999999999999996 109.294 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 40.0 m-85 -86.28 80.83 8.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.739 -1.208 . . . . 0.32000000000000001 107.739 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -114.36 149.15 36.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.773 -0.579 . . . . 1.04 109.547 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.58 129.01 37.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.921 . . . . 1.0600000000000001 108.667 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -66.94 -24.85 66.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 1.0600000000000001 110.516 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -87.86 -16.31 34.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.965 -1.084 . . . . 0.51000000000000001 110.018 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.51 130.79 38.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.34000000000000002 110.231 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.433 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.11 -56.36 7.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.556 -0.618 . . . . 0.40000000000000002 111.556 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -47.87 -35.18 23.9 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.587 1.525 . . . . 0.47999999999999998 111.482 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.61 2.29 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.81000000000000005 109.042 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.93 -18.78 47.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.806 . . . . 2.46 109.931 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.7 -16.19 25.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.065 -1.022 . . . . 3.6600000000000001 110.406 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 mt -100.43 8.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.136 -0.978 . . . . 1.0700000000000001 110.292 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.33 -32.94 6.93 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 120.189 -1.569 . . . . 2.1099999999999999 112.002 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -65.24 -3.04 6.68 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 CA-C-N 120.113 1.076 . . . . 0.29999999999999999 109.693 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.45 -79.12 0.58 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.925 -0.769 . . . . 0.37 108.925 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -42.03 -57.02 2.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.581 -0.699 . . . . 0.14999999999999999 110.806 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.432 ' O ' ' OG ' ' A' ' 46' ' ' SER . 5.0 t60 -66.97 -31.05 71.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.932 -1.105 . . . . 0.47999999999999998 110.032 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.4 m -63.89 -39.94 95.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.776 -1.203 . . . . 1.05 110.042 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 mt -51.99 -15.9 0.64 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 1.1299999999999999 109.781 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.531 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 3.9 m -58.6 -31.63 68.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.89 -1.131 . . . . 0.93000000000000005 109.825 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.45 -20.14 19.96 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.015 -1.053 . . . . 2.0 109.911 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -91.72 -21.15 20.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 2.6499999999999999 109.478 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -135.84 67.1 1.48 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.517 -0.739 . . . . 0.89000000000000001 109.083 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.4 p -66.95 -3.28 6.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.212 -0.93 . . . . 0.93000000000000005 109.207 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 23.9 t-20 -95.19 -0.98 52.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.851 . . . . 0.46999999999999997 109.527 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.2 t -116.28 149.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.941 -0.763 . . . . 1.03 108.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.9 mm -99.4 127.78 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 1.05 109.562 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -114.88 128.96 56.6 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.793 -0.817 . . . . 0.11 108.793 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.8 mp -112.29 170.56 8.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.294 -0.879 . . . . 1.04 108.986 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -141.62 141.58 33.43 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.961 -1.126 . . . . 1.3100000000000001 107.961 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.5 t -138.71 136.19 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 1.02 110.389 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.64 105.86 18.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.543 -0.91 . . . . 1.0800000000000001 108.543 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 m -60.91 -7.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.843 . . . . 1.0600000000000001 111.344 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -108.87 -40.46 5.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 1.1100000000000001 111.074 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.88 -18.91 21.48 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.86 -1.15 . . . . 1.1200000000000001 109.318 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.98 47.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.236 -1.024 . . . . 1.01 108.236 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 67' ' ' SER . 16.6 mt-30 -54.98 -18.1 4.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.631 -0.668 . . . . 2.7799999999999998 110.608 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -37.32 77.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.847 -1.158 . . . . 1.1100000000000001 109.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.5 -47.29 40.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.392 -0.817 . . . . 1.05 108.842 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.78 76.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.305 -0.872 . . . . 1.0600000000000001 109.189 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 62.0 m -63.71 -52.02 62.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 1.79 109.31 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.74 -31.92 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 110.069 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.7 -6.73 57.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.138 -0.976 . . . . 1.0600000000000001 110.09 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 46.76 64.99 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.955 . . . . 2.3399999999999999 109.777 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 15.9 t -83.38 136.86 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.351 -0.843 . . . . 1.05 108.979 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.97 -8.54 8.32 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.274 -0.891 . . . . 2.9300000000000002 109.715 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.0 130.83 11.67 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 1.0600000000000001 109.848 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' GLU . 6.0 p -112.15 151.19 43.46 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.376 -0.972 . . . . 0.97999999999999998 108.376 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.05 142.04 71.15 Favored 'Cis proline' 0 N--CA 1.483 0.885 0 C-N-CA 124.752 -0.937 . . . . 0.23999999999999999 110.101 -1.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -113.83 114.22 25.98 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.031 -1.1 . . . . 1.04 108.031 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -90.84 121.92 33.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.016 -1.053 . . . . 0.19 108.659 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.8 mt-30 -121.57 135.89 54.98 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.77 -1.196 . . . . 1.71 107.77 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.5 m-85 -106.7 132.62 52.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.736 . . . . 0.13 110.126 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.55 155.68 38.62 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.313 -0.995 . . . . 0.22 108.313 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -155.63 121.39 5.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.3 -1.371 . . . . 2.0299999999999998 107.3 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.9 mttt 57.44 19.73 5.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.636 -0.665 . . . . 2.1600000000000001 109.551 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.551 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 93.99 -1.07 67.46 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.432 -1.067 . . . . 0.23000000000000001 110.432 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 83' ' ' GLY . 18.9 mm-40 -109.96 147.36 33.61 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.245 -1.15 . . . . 2.8100000000000001 110.35 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -86.98 139.07 30.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 2.2599999999999998 109.4 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.18 -14.87 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.474 -0.766 . . . . 1.05 109.976 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.23 171.89 42.85 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.485 -1.34 . . . . 0.25 110.409 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -172.83 156.42 3.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -1.043 . . . . 2.04 109.961 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.7 p90 -168.91 133.57 1.53 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.626 -0.83 . . . . 0.17999999999999999 110.466 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -102.75 -172.35 2.11 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.489 -0.93 . . . . 0.89000000000000001 108.489 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.8 5.02 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.222 -1.551 . . . . 0.14000000000000001 109.222 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.0 94.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -1.169 . . . . 1.0600000000000001 111.053 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -140.25 75.71 1.52 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.815 -1.18 . . . . 1.98 107.815 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.31 -32.93 73.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.523 -0.735 . . . . 1.72 110.341 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.64 -25.82 67.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.055 -1.028 . . . . 1.95 108.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -69.19 -38.84 78.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 2.5600000000000001 109.465 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.66 -38.09 63.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.863 -1.148 . . . . 1.03 109.106 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.33 -56.48 12.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 2.1499999999999999 109.506 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.8 94.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 1.04 110.429 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.0 m -66.19 -44.85 82.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 1.04 109.807 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.2 mt -58.18 -55.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.065 -1.022 . . . . 1.05 108.33 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.55 -16.53 25.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 1.6599999999999999 109.903 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -76.61 -61.23 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 2.02 110.678 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.6 mt -93.16 15.63 14.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 1.1399999999999999 111.038 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.232 179.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.47 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.7 p90 -111.6 -166.71 1.1 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.626 -1.296 . . . . 0.0 111.068 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.31 151.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.944 0.878 . . . . 0.0 112.308 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.81 96.12 6.86 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.0 pt-20 -83.35 43.16 0.86 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.012 -1.055 . . . . 0.0 110.098 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.73 -133.07 0.07 OUTLIER Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.13 25.36 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 CA-C-N 119.319 1.56 . . . . 0.0 109.346 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.8 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.34 -0.85 . . . . 0.0 109.515 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 79.5 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.39 -0.596 . . . . 1.1000000000000001 109.39 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.454 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 43.9 tttm -155.17 121.32 5.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 2.5 108.972 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.57 135.37 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.853 . . . . 1.6100000000000001 109.534 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 mm -107.99 109.67 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.769 -1.196 . . . . 1.04 107.769 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.28 -7.14 24.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.247 -0.908 . . . . 1.97 110.031 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -153.0 153.81 33.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.047 -1.033 . . . . 0.92000000000000004 109.912 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -52.3 -27.37 14.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.396 -0.815 . . . . 2.48 109.471 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -60.42 -47.4 86.25 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.254 -0.903 . . . . 1.05 109.909 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.47 -24.31 63.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0600000000000001 110.139 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.31 -66.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.015 -1.053 . . . . 0.25 110.139 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -44.93 78.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 3.0699999999999998 109.572 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -58.91 -36.7 75.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.362 -0.836 . . . . 2.1000000000000001 109.9 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' CB ' ' HZ3' ' A' ' 3' ' ' LYS . . . -59.87 -47.85 84.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.94 -1.1 . . . . 1.04 109.194 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.94 -42.1 97.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.464 -0.773 . . . . 1.27 109.713 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.4 -40.97 96.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.136 -0.977 . . . . 1.0900000000000001 109.851 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.65 -16.2 56.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 109.648 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.57 -5.27 18.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 1.0700000000000001 109.578 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.11 -116.26 7.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.31 109.613 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -133.35 5.34 3.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.414 -1.05 . . . . 2.21 109.235 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -70.43 167.72 17.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.186 -0.946 . . . . 2.4100000000000001 108.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.548 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.03 161.35 16.14 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.894 -1.151 . . . . 1.05 107.894 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 14.0 t -143.93 108.8 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 1.03 109.421 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.39 131.36 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.592 -0.892 . . . . 1.01 108.592 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 t -109.06 133.21 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.629 -0.67 . . . . 1.02 109.382 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -106.86 105.33 15.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.92 -0.77 . . . . 0.95999999999999996 108.92 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -87.27 80.33 8.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.757 -1.201 . . . . 0.32000000000000001 107.757 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.5 m -113.22 148.52 35.33 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.283 0.563 . . . . 1.04 109.771 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.48 127.07 37.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.407 -0.96 . . . . 1.0600000000000001 108.407 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -66.06 -25.62 67.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 1.0600000000000001 110.234 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.8 p-90 -89.48 -11.79 41.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.207 -0.933 . . . . 0.51000000000000001 110.17 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.04 128.11 41.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.34000000000000002 109.931 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.79 -58.96 7.57 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 111.166 -0.774 . . . . 0.40000000000000002 111.166 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.4 Cg_exo -47.22 -31.64 12.74 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 121.897 1.731 . . . . 0.47999999999999998 111.184 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.4 -61.28 2.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 108.771 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -59.84 -17.58 37.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 2.46 110.068 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.474 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.992 -1.068 . . . . 3.6600000000000001 110.137 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 88.1 mt -96.07 7.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 1.0700000000000001 111.276 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.71 -35.58 23.49 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 120.309 -1.494 . . . . 2.1099999999999999 111.895 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -61.26 -5.98 5.98 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 CA-C-N 119.842 0.979 . . . . 0.29999999999999999 110.839 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.26 -71.99 0.74 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.987 -0.746 . . . . 0.37 108.987 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -46.37 -57.47 4.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.601 -0.687 . . . . 0.14999999999999999 110.536 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.47 -30.68 71.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.199 -0.938 . . . . 0.47999999999999998 109.771 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.4 m -64.01 -42.1 97.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.979 -1.076 . . . . 1.05 109.774 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.7 mt -50.2 -13.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.929 . . . . 1.1299999999999999 109.365 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 44' ' ' SER . 47.6 m -57.14 -34.52 68.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.93000000000000005 109.647 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.95 -16.9 22.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.273 -0.892 . . . . 2.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -89.59 -41.98 11.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.992 -1.067 . . . . 2.6499999999999999 109.826 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -113.04 70.4 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.424 -0.798 . . . . 0.89000000000000001 109.351 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.7 p -67.14 -5.09 12.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.33 -0.857 . . . . 0.93000000000000005 108.84 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.22 1.22 54.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.778 . . . . 0.46999999999999997 109.657 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.85 151.01 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.785 -0.82 . . . . 1.03 108.785 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mm -100.83 126.51 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.331 -0.855 . . . . 1.05 109.042 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -112.02 129.26 56.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.397 -0.815 . . . . 0.11 108.917 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.4 mp -113.12 172.2 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.729 -0.841 . . . . 1.04 108.729 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.06 142.07 30.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.824 -1.176 . . . . 1.3100000000000001 107.824 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.1 t -139.12 136.6 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.339 -0.851 . . . . 1.02 110.176 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -99.0 109.35 22.12 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.922 -1.14 . . . . 1.0800000000000001 107.922 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.3 m -63.74 -12.98 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.315 -0.865 . . . . 1.0600000000000001 111.104 -178.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.9 -40.21 7.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.064 -1.022 . . . . 1.1100000000000001 111.015 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.6 -14.82 26.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.013 -1.055 . . . . 1.1200000000000001 109.289 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.26 44.4 2.81 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.752 -0.833 . . . . 1.01 108.752 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.57 -14.53 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 2.7799999999999998 109.942 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.07 -38.12 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.021 -1.05 . . . . 1.1100000000000001 108.891 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -74.56 -46.84 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.513 -0.921 . . . . 1.05 108.513 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.67 -35.09 78.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.356 -0.84 . . . . 1.0600000000000001 108.928 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.3 m -64.5 -45.34 87.74 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.273 -0.892 . . . . 1.79 109.034 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -63.73 -41.48 98.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.799 . . . . 2.2000000000000002 109.327 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.02 -4.12 58.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.272 -0.893 . . . . 1.0600000000000001 109.365 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.3 mm-40 50.26 55.07 10.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 2.3399999999999999 110.421 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.4 123.27 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 1.05 108.989 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -114.01 5.31 16.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.402 -0.811 . . . . 2.9300000000000002 109.92 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.552 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.57 148.17 27.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.096 -1.003 . . . . 1.0600000000000001 109.219 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 p -131.48 149.04 72.42 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.616 -0.883 . . . . 0.97999999999999998 108.616 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.45 145.77 78.18 Favored 'Cis proline' 0 C--N 1.322 -0.85 0 C-N-CA 124.664 -0.973 . . . . 0.23999999999999999 110.429 -1.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.8 m -115.7 114.92 25.49 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.622 -1.251 . . . . 1.04 107.622 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -91.26 118.58 30.6 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.433 -0.907 . . . . 0.19 108.573 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -119.94 135.94 54.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.617 -1.253 . . . . 1.71 107.617 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 26.8 m-85 -107.3 132.34 53.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.13 109.699 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -125.0 156.22 38.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.617 -0.883 . . . . 0.22 108.617 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -156.09 121.19 4.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.783 -1.191 . . . . 2.0299999999999998 107.783 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt 55.68 34.26 22.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.693 -0.629 . . . . 2.1600000000000001 110.318 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.39 3.27 88.59 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.092 -1.052 . . . . 0.23000000000000001 110.751 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -114.01 146.58 39.97 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.349 -1.089 . . . . 2.8100000000000001 110.295 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -86.49 144.4 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.718 -0.845 . . . . 2.2599999999999998 108.718 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.03 -20.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.381 -0.825 . . . . 1.05 110.466 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 174.71 47.18 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.301 -1.428 . . . . 0.25 110.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -174.17 156.98 2.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 2.04 110.169 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.91 131.88 1.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.528 -0.732 . . . . 0.17999999999999999 109.683 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 p -103.44 -160.27 0.77 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.051 -1.03 . . . . 0.89000000000000001 108.574 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 79.44 122.11 0.36 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.47 -1.452 . . . . 0.14000000000000001 109.47 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.66 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.122 . . . . 1.0600000000000001 110.601 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -137.47 71.58 1.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.805 -1.183 . . . . 1.98 107.805 178.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -61.62 -39.53 91.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.731 -0.605 . . . . 1.72 111.358 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.55 -25.74 67.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.758 -1.214 . . . . 1.95 109.704 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -69.1 -32.65 72.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 2.5600000000000001 109.575 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.6 mt -51.02 -38.85 53.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 1.03 109.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.11 -53.22 40.67 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.661 -0.816 . . . . 2.1499999999999999 109.288 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.05 90.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 1.04 110.699 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -67.68 -42.94 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 1.04 110.235 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -61.48 -52.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 1.05 108.691 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -61.26 -17.77 55.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.858 . . . . 1.6599999999999999 109.561 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -76.17 -59.36 2.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 2.02 110.043 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.0 mt -92.64 20.42 6.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.385 -0.822 . . . . 1.1399999999999999 110.429 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.988 -1.006 . . . . 1.1799999999999999 109.178 179.361 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -116.1 -173.27 2.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.321 -0.862 . . . . 0.0 110.529 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.11 150.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.992 0.901 . . . . 0.0 112.614 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.32 97.04 7.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -83.47 46.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.98 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.645 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.78 -126.51 0.16 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.69 24.51 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 119.2 1.5 . . . . 0.0 109.603 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.645 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.1 t . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.534 -0.729 . . . . 0.0 110.255 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 60.8 t . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.336 0.588 . . . . 1.1000000000000001 109.882 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 25.9 tptp -154.24 124.92 7.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.25 -0.906 . . . . 2.5 108.823 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -91.71 134.12 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.6100000000000001 109.923 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mm -110.68 109.11 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.034 -1.099 . . . . 1.04 108.034 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.98 -11.13 19.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.3 -0.875 . . . . 1.97 109.811 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -152.89 154.52 35.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.92000000000000004 109.715 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -51.82 -25.79 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 2.48 109.695 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -59.61 -48.61 80.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 1.05 109.767 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.69 63.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0600000000000001 109.9 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.31 -65.56 0.63 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.124 . . . . 0.25 110.011 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -55.51 -46.05 77.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 3.0699999999999998 109.623 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.76 -35.07 72.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 2.1000000000000001 110.027 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.51 90.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.939 -1.101 . . . . 1.04 109.735 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.85 -46.59 87.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 1.27 109.845 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.57 -38.11 89.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 110.089 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.91 -16.52 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 1.0900000000000001 110.073 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -2.76 8.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 1.0700000000000001 109.925 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -114.79 5.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.31 109.555 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -138.42 4.72 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.336 -1.097 . . . . 2.21 109.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.1 168.16 16.17 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.204 -0.935 . . . . 2.4100000000000001 108.748 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.62 162.39 13.11 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.81 -1.181 . . . . 1.05 107.81 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 15.1 t -145.03 109.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.771 -1.206 . . . . 1.03 109.628 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.9 135.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.776 -0.824 . . . . 1.01 108.776 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -110.35 134.58 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 1.02 109.383 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.17 101.16 10.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.697 -0.627 . . . . 0.95999999999999996 109.459 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -87.41 76.56 9.04 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 0.32000000000000001 107.933 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -113.72 148.77 35.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.772 -0.58 . . . . 1.04 109.474 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.46 125.24 36.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.542 -0.91 . . . . 1.0600000000000001 108.542 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -65.18 -23.42 67.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 1.0600000000000001 110.573 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -88.62 -14.76 36.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.053 -1.029 . . . . 0.51000000000000001 109.976 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.64 118.36 32.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.34000000000000002 109.686 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.55 -58.15 16.08 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.717 -0.754 . . . . 0.40000000000000002 111.435 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -47.52 -34.96 21.08 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.806 1.67 . . . . 0.47999999999999998 111.23 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.22 -60.98 2.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.924 -1.11 . . . . 0.81000000000000005 109.208 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -58.98 -17.04 21.24 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.595 -0.691 . . . . 2.46 110.041 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.505 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -58.45 -19.73 39.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 3.6600000000000001 110.523 -178.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.5 mt -96.55 7.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.09 -1.006 . . . . 1.0700000000000001 110.813 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.27 5.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 119.953 -1.717 . . . . 2.1099999999999999 112.645 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -65.16 -7.48 15.68 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 CA-C-N 119.555 0.877 . . . . 0.29999999999999999 110.04 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -109.52 -74.54 0.65 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.845 . . . . 0.37 108.976 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -41.66 -56.63 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.649 -0.657 . . . . 0.14999999999999999 110.931 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -67.0 -31.04 71.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.022 -1.049 . . . . 0.47999999999999998 110.1 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -65.73 -42.57 90.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.839 -1.163 . . . . 1.05 110.534 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -50.39 -17.44 0.47 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.985 -1.072 . . . . 1.1299999999999999 109.99 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -56.8 -27.77 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.93000000000000005 110.051 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -96.1 -22.1 17.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.142 -0.974 . . . . 2.0 110.323 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -90.32 -19.88 23.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 2.6499999999999999 109.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -132.34 72.1 1.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.692 . . . . 0.89000000000000001 109.257 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.2 p -67.87 -5.31 16.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.412 -0.805 . . . . 0.93000000000000005 109.327 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.9 t-20 -96.47 -0.77 48.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.75 . . . . 0.46999999999999997 109.61 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 145.96 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.249 -0.907 . . . . 1.03 109.472 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.35 132.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.529 -0.732 . . . . 1.05 109.371 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.67 130.73 56.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.397 -0.814 . . . . 0.11 109.059 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.2 mp -113.2 172.44 6.94 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.801 -0.814 . . . . 1.04 108.801 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -141.8 143.17 33.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.202 -1.036 . . . . 1.3100000000000001 108.202 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 136.17 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -0.97 . . . . 1.02 110.641 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.38 103.13 15.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.448 -0.945 . . . . 1.0800000000000001 108.448 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.485 ' O ' ' NE ' ' B' ' 4' ' ' ARG . 16.1 m -61.19 -8.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 1.0600000000000001 111.036 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.48 -46.1 5.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 110.856 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -93.12 -14.47 27.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.086 -1.008 . . . . 1.1200000000000001 109.673 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.06 46.18 1.83 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.306 -0.871 . . . . 1.01 109.049 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.07 -15.73 2.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 2.7799999999999998 109.66 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.8 p30 -70.12 -41.11 74.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.112 -0.993 . . . . 1.1100000000000001 109.056 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 t -73.55 -46.28 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.949 . . . . 1.05 108.617 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.8 -36.67 83.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 1.0600000000000001 108.735 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -64.47 -47.67 78.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.79 109.074 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.09 -34.42 78.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 2.2000000000000002 109.599 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.92 -7.14 54.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 1.0600000000000001 109.587 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.4 mt-10 51.11 61.12 3.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 2.3399999999999999 110.21 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 35.0 t -78.61 138.07 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.116 -0.99 . . . . 1.05 108.996 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -123.03 -9.02 8.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.431 -0.793 . . . . 2.9300000000000002 109.546 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.3 135.6 14.96 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.064 -1.022 . . . . 1.0600000000000001 109.66 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 8' ' ' GLU . 2.9 p -114.87 150.6 44.38 Favored Pre-proline 0 N--CA 1.5 2.027 0 N-CA-C 108.117 -1.068 . . . . 0.97999999999999998 108.117 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.37 146.76 83.57 Favored 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 124.877 -0.885 . . . . 0.23999999999999999 110.205 -1.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.84 121.99 42.19 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.429 -0.952 . . . . 1.04 108.429 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -98.82 115.93 29.9 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.395 -0.965 . . . . 0.19 108.395 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.89 141.26 48.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.988 -1.116 . . . . 1.71 107.988 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.5 m-85 -111.17 134.54 52.69 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.49 0.662 . . . . 0.13 110.156 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.37 155.12 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.998 -0.741 . . . . 0.22 108.998 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -154.58 123.18 6.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.91 -1.145 . . . . 2.0299999999999998 107.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt 55.74 30.66 16.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 2.1600000000000001 110.064 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.42 90.52 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.791 -1.195 . . . . 0.23000000000000001 110.621 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -112.83 145.65 40.27 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.248 -1.148 . . . . 2.8100000000000001 110.319 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -86.88 144.8 26.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 2.2599999999999998 108.75 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.68 -23.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.41 -0.806 . . . . 1.05 110.587 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.94 179.34 47.12 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.28 -1.438 . . . . 0.25 110.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.26 158.59 2.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -1.126 . . . . 2.04 110.357 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.98 132.14 1.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.476 -0.765 . . . . 0.17999999999999999 110.195 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.406 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 16.5 p -104.14 -172.95 2.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.191 -0.943 . . . . 0.89000000000000001 108.608 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 130.76 5.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.353 -1.499 . . . . 0.14000000000000001 109.353 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.27 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -1.211 . . . . 1.0600000000000001 110.477 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.88 71.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.815 -1.18 . . . . 1.98 107.815 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.01 -30.51 71.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 1.72 110.294 -178.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.6 -26.85 67.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.787 -1.196 . . . . 1.95 108.998 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -69.08 -34.14 74.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.486 -0.759 . . . . 2.5600000000000001 109.405 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.4 mt -50.92 -37.24 42.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.02 -1.05 . . . . 1.03 108.82 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.23 -57.17 7.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.395 -0.815 . . . . 2.1499999999999999 109.667 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.02 92.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 1.04 110.509 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.5 m -66.84 -44.2 81.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 1.04 110.164 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.87 -52.75 55.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 1.05 108.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.1 -16.66 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 1.6599999999999999 109.977 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.13 -58.28 3.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 2.02 110.484 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.04 14.16 18.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 1.1399999999999999 110.693 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.494 1.764 0 O-C-N 120.863 -1.148 . . . . 1.1799999999999999 109.199 179.22 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' A' ' 59' ' ' VAL . 13.6 mmm180 . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.435 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.1 p90 -109.59 -168.42 1.33 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.274 -0.892 . . . . 0.0 110.525 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.09 146.95 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.717 0.77 . . . . 0.0 112.114 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -101.16 95.45 6.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.1 pt-20 -83.3 42.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.064 -1.023 . . . . 0.0 110.479 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.81 -130.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.81 20.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 CA-C-N 119.139 1.47 . . . . 0.0 109.05 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.67 ' H ' ' C ' ' B' ' 9' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.3 t . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.117 -0.698 . . . . 1.1000000000000001 109.117 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.408 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 26.9 tttp -154.99 121.15 5.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 2.5 109.553 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.417 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 31.6 tt0 -89.54 136.51 32.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 1.6100000000000001 109.579 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -107.04 113.13 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.606 -1.257 . . . . 1.04 107.606 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' OE1' ' NE2' ' A' ' 4' ' ' GLN . 4.1 mm-40 -99.79 -13.32 19.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 1.97 108.933 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 p -154.09 158.78 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.92000000000000004 109.554 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -52.36 -22.97 5.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 2.48 110.037 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -60.93 -51.32 69.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 1.05 110.671 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.26 -22.53 64.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 1.0600000000000001 110.014 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.1 -64.19 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.25 109.791 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -55.75 -46.72 77.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 3.0699999999999998 109.963 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.94 -35.66 71.42 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -46.51 90.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 1.04 109.563 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.26 -44.79 94.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 1.27 109.721 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.51 -36.8 85.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.727 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.03 -18.84 52.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 109.776 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -5.94 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 1.0700000000000001 109.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.68 1.24 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.457 -1.457 . . . . 0.31 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -138.13 0.4 2.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 2.21 109.781 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm -69.89 172.21 8.11 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.033 -1.042 . . . . 2.4100000000000001 109.012 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.582 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.34 164.42 16.12 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.383 -0.823 . . . . 1.05 108.992 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.582 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 20.1 t -145.94 105.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 1.03 109.469 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -103.67 133.73 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.304 -0.872 . . . . 1.01 109.148 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.64 134.07 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.233 -0.654 . . . . 1.02 109.233 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -107.87 104.79 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.117 -0.698 . . . . 0.95999999999999996 109.117 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 57.7 m-85 -86.37 82.33 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.736 -1.209 . . . . 0.32000000000000001 107.736 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -113.72 147.82 37.54 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.443 -0.577 . . . . 1.04 109.443 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.68 124.2 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.485 -0.931 . . . . 1.0600000000000001 108.485 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -65.51 -24.8 67.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.832 . . . . 1.0600000000000001 110.478 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -88.79 -13.57 39.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.1 . . . . 0.51000000000000001 109.926 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.7 116.92 29.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.34000000000000002 109.723 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.67 -55.47 30.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.832 -0.699 . . . . 0.40000000000000002 111.742 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.2 Cg_exo -47.86 -35.23 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.6 1.533 . . . . 0.47999999999999998 111.388 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.57 -60.55 2.32 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.049 -1.032 . . . . 0.81000000000000005 109.194 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.65 -18.07 38.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.748 . . . . 2.46 110.052 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.6 tmt? -58.77 -24.89 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 3.6600000000000001 110.389 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -96.31 13.82 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.873 -1.142 . . . . 1.0700000000000001 110.149 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.72 2.89 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.585 -1.322 . . . . 2.1099999999999999 112.164 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.4 Cg_endo -67.94 7.44 0.6 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 CA-C-N 119.6 0.893 . . . . 0.29999999999999999 110.526 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 39' ' ' LYS . 45.6 m-85 -124.48 -73.7 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.756 -0.831 . . . . 0.37 108.756 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -43.44 -55.76 3.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 0.14999999999999999 110.266 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.85 -27.33 66.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.47999999999999998 109.869 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 46' ' ' SER . 1.4 p -65.13 -44.92 87.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 1.05 110.068 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.8 mt -49.15 -14.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 1.1299999999999999 109.706 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 68.0 m -57.66 -32.14 67.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.993 -1.067 . . . . 0.93000000000000005 109.743 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -94.91 -19.57 20.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.963 . . . . 2.0 110.141 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -91.4 -21.69 20.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.954 -1.091 . . . . 2.6499999999999999 109.584 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -134.2 72.76 1.47 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.502 -0.749 . . . . 0.89000000000000001 109.384 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 p -68.59 -6.9 28.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.383 -0.823 . . . . 0.93000000000000005 109.35 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -96.31 0.92 51.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.352 -0.842 . . . . 0.46999999999999997 109.881 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -112.76 146.35 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.349 -0.982 . . . . 1.03 108.349 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.9 mm -100.42 119.42 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 1.05 109.538 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -108.77 130.04 55.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.786 -0.82 . . . . 0.11 108.786 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.7 mp -111.9 172.82 6.67 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.853 -0.795 . . . . 1.04 108.853 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -142.12 144.12 33.36 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.053 -1.091 . . . . 1.3100000000000001 108.053 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -141.73 142.53 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.111 -0.993 . . . . 1.02 110.858 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' C ' ' H ' ' A' ' 60' ' ' ASP . 21.4 t70 -99.0 96.47 7.84 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.3 m -56.59 -3.06 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 110.833 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' H ' ' C ' ' A' ' 58' ' ' ASP . 37.7 m-20 -105.05 -46.28 4.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.118 -0.989 . . . . 1.1100000000000001 110.991 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.04 -23.56 16.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.106 -0.996 . . . . 1.1200000000000001 110.296 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 64' ' ' ASP . . . -105.32 41.81 1.31 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.12 -0.988 . . . . 1.01 108.967 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 67' ' ' SER . 35.4 tt0 -54.98 -10.84 0.54 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.397 -0.815 . . . . 2.7799999999999998 109.825 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -68.9 -43.62 74.87 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.14 -0.975 . . . . 1.1100000000000001 108.768 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.34 -45.71 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.302 -0.999 . . . . 1.05 108.302 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.79 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.054 -0.721 . . . . 1.0600000000000001 109.054 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 6.6 m -64.0 -54.01 41.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 1.79 109.304 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.2 -33.41 75.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.476 -0.765 . . . . 2.2000000000000002 110.019 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.37 1.2 54.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.069 -1.019 . . . . 1.0600000000000001 109.859 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 67' ' ' SER . 15.0 mp0 45.0 50.46 9.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.278 -0.889 . . . . 2.3399999999999999 110.243 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.34 130.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 1.05 108.91 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.12 7.61 5.07 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.396 -0.815 . . . . 2.9300000000000002 110.024 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.63 134.27 14.58 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.161 -0.962 . . . . 1.0600000000000001 108.93 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 p -119.78 150.24 50.07 Favored Pre-proline 0 N--CA 1.508 2.441 0 O-C-N 121.227 -0.921 . . . . 0.97999999999999998 108.925 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.88 145.22 80.86 Favored 'Cis proline' 0 N--CA 1.486 1.057 0 C-N-CA 124.893 -0.878 . . . . 0.23999999999999999 110.758 -2.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.81 122.03 45.09 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.7 -1.222 . . . . 1.04 107.7 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -99.26 121.08 40.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.19 108.822 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.515 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.1 mt-30 -119.62 135.74 54.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.894 -1.15 . . . . 1.71 107.894 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.7 m-85 -109.93 126.57 54.03 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.461 0.648 . . . . 0.13 109.764 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -126.06 156.93 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.601 -0.888 . . . . 0.22 108.601 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.55 126.09 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.786 -1.19 . . . . 2.0299999999999998 107.786 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 55.05 25.27 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 2.1600000000000001 109.951 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.15 6.51 84.48 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.909 -1.138 . . . . 0.23000000000000001 110.347 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.28 146.78 40.01 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -1.076 . . . . 2.8100000000000001 109.956 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -85.91 143.88 27.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 2.2599999999999998 109.529 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.78 -27.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.423 -0.798 . . . . 1.05 110.315 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.43 177.99 45.57 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.388 -1.387 . . . . 0.25 110.415 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -174.08 154.14 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 2.04 110.299 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.0 p90 -169.05 133.11 1.41 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.516 -0.74 . . . . 0.17999999999999999 109.982 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -105.51 -175.03 2.68 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.136 -0.978 . . . . 0.89000000000000001 108.44 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 98.1 133.83 8.11 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.622 -1.391 . . . . 0.14000000000000001 109.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.24 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 1.0600000000000001 110.136 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.2 t-20 -139.89 72.45 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.466 -0.939 . . . . 1.98 108.466 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.54 -0.725 . . . . 1.72 110.781 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -64.76 -26.6 68.42 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -68.82 -35.46 77.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.435 -0.79 . . . . 2.5600000000000001 109.17 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.4 mt -51.13 -36.11 39.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.017 . . . . 1.03 108.906 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.96 -58.5 5.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 2.1499999999999999 109.34 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.26 90.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 1.04 110.327 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -67.61 -48.11 67.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -0.965 . . . . 1.04 110.31 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mt -62.46 -50.11 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.024 -1.048 . . . . 1.05 108.785 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -59.41 -17.27 29.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.6599999999999999 109.538 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.06 -62.16 1.74 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 2.02 110.009 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.21 21.17 5.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 1.1399999999999999 110.494 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.236 179.585 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.419 ' HG2' HH11 ' B' ' 4' ' ' ARG . 1.1 tpt180 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' B' ' 4' ' ' ARG . 3.6 p90 -108.97 -164.89 0.97 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.757 -1.214 . . . . 0.0 110.821 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.86 149.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.247 -0.908 . . . . 0.0 112.839 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.71 95.53 6.49 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' B' ' 9' ' ' GLY . 7.3 pt-20 -84.01 42.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.024 -1.047 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.08 -133.93 0.05 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.29 21.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.322 -0.841 0 CA-C-N 119.154 1.477 . . . . 0.0 109.649 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.667 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.411 -0.806 . . . . 0.0 109.413 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 72.5 t . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.131 -0.692 . . . . 1.1000000000000001 109.131 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -154.6 122.58 5.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 2.5 109.351 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -89.23 135.97 33.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.325 -0.859 . . . . 1.6100000000000001 109.447 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -106.03 123.16 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.483 -1.302 . . . . 1.04 107.483 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 8.9 mp0 -107.92 -15.2 14.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.25 -0.906 . . . . 1.97 109.627 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.8 p -152.16 159.23 43.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.92000000000000004 109.695 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.32 -30.86 30.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 2.48 109.861 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 9' ' ' THR . 4.1 m -59.53 -44.25 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.078 . . . . 1.05 109.679 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.19 -27.23 64.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 1.0600000000000001 109.775 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.49 -69.0 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.25 110.216 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -55.27 -42.04 73.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 3.0699999999999998 109.61 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -58.99 -36.89 75.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.14 -0.975 . . . . 2.1000000000000001 109.474 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.34 95.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 1.04 109.088 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.6 -47.8 77.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.458 -0.776 . . . . 1.27 109.734 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.04 -37.77 88.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.701 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.52 -16.53 54.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 1.0900000000000001 109.616 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.07 -7.39 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 1.0700000000000001 109.844 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 -111.01 3.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.535 -1.426 . . . . 0.31 109.535 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.64 4.72 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.254 -1.145 . . . . 2.21 109.436 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -70.05 168.02 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 2.4100000000000001 109.193 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.543 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.34 163.59 12.8 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.045 -1.094 . . . . 1.05 108.045 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 9.2 t -145.26 105.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.016 -1.052 . . . . 1.03 109.797 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.18 133.42 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.284 -1.006 . . . . 1.01 108.284 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -110.53 134.58 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 1.02 109.827 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.75 101.36 10.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.08 -0.711 . . . . 0.95999999999999996 109.08 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -86.14 79.23 9.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.566 -1.272 . . . . 0.32000000000000001 107.566 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -113.44 148.61 35.57 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.415 0.626 . . . . 1.04 109.748 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.66 124.23 34.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.131 -1.063 . . . . 1.0600000000000001 108.131 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -64.97 -23.11 67.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 1.0600000000000001 110.484 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -89.84 -13.29 36.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.013 -1.054 . . . . 0.51000000000000001 110.405 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.88 137.78 32.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.34000000000000002 109.886 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.16 -59.15 3.19 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.739 -0.744 . . . . 0.40000000000000002 111.355 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -46.1 -43.41 20.53 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.77 1.647 . . . . 0.47999999999999998 111.766 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.84 -55.19 6.07 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.728 -1.232 . . . . 0.81000000000000005 109.048 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -60.45 -20.66 60.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.413 -0.804 . . . . 2.46 110.225 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLY . 35.6 tpp -59.82 -20.5 57.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 3.6600000000000001 110.557 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 81.8 mt -97.53 11.18 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.992 -1.067 . . . . 1.0700000000000001 111.686 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.78 -34.08 9.83 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.02 -1.675 . . . . 2.1099999999999999 112.63 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.52 -11.86 25.24 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 CA-C-N 119.742 0.944 . . . . 0.29999999999999999 110.803 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -102.76 -68.29 0.84 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.248 -0.908 . . . . 0.37 109.693 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -45.42 -51.31 11.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.422 -0.799 . . . . 0.14999999999999999 110.556 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.83 -34.7 75.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.937 -1.102 . . . . 0.47999999999999998 110.111 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.6 m -60.71 -41.14 94.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 1.05 110.153 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.0 mt -51.4 -15.6 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 1.1299999999999999 109.692 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.412 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 69.2 m -58.15 -31.7 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.93000000000000005 109.902 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -94.84 -20.76 19.18 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.273 -0.892 . . . . 2.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -90.34 -21.52 21.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 2.6499999999999999 109.341 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -133.71 68.54 1.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.577 -0.702 . . . . 0.89000000000000001 109.375 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.3 p -67.45 -5.54 15.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.93000000000000005 108.915 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 24.1 t-20 -95.84 4.0 53.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.46999999999999997 109.646 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -118.76 149.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.212 -0.662 . . . . 1.03 109.212 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -101.94 128.56 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.421 -0.8 . . . . 1.05 109.223 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -115.03 132.01 56.74 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.438 -0.788 . . . . 0.11 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 mp -114.95 173.89 6.26 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.474 -0.766 . . . . 1.04 109.197 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -143.83 144.89 31.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.021 -1.103 . . . . 1.3100000000000001 108.021 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.7 t -141.6 139.63 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.141 -0.975 . . . . 1.02 110.521 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.0 t70 -99.21 100.44 11.55 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.204 -1.035 . . . . 1.0800000000000001 108.204 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -60.67 -1.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.275 -0.891 . . . . 1.0600000000000001 111.482 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 58' ' ' ASP . 13.5 m-20 -113.68 -41.23 3.64 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.13 -0.981 . . . . 1.1100000000000001 111.002 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.0 -13.14 29.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.581 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 50.45 1.79 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 1.01 108.586 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -54.93 -15.23 1.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.522 -0.736 . . . . 2.7799999999999998 109.701 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.62 -39.88 73.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.992 . . . . 1.1100000000000001 109.364 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.75 -47.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.16 -0.963 . . . . 1.05 108.676 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.46 -36.21 83.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 1.0600000000000001 109.288 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -63.35 -44.87 93.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 1.79 108.968 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.59 -44.06 95.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.712 -0.847 . . . . 2.2000000000000002 108.712 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 70' ' ' GLU . . . -89.06 10.45 21.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 1.0600000000000001 109.519 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 66' ' ' ALA . 5.2 pt-20 31.73 56.06 0.3 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.409 0.623 . . . . 2.3399999999999999 111.362 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 13.5 t -79.67 134.32 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 1.05 109.037 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 62.7 mttm -129.66 8.7 5.39 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.47 -0.769 . . . . 2.9300000000000002 109.861 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.45 135.11 15.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.133 -0.98 . . . . 1.0600000000000001 108.902 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.6 p -121.03 149.53 51.38 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.835 . . . . 0.97999999999999998 109.172 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.51 144.17 74.09 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 C-N-CA 124.962 -0.849 . . . . 0.23999999999999999 110.197 -1.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.27 113.22 24.31 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.387 -1.338 . . . . 1.04 107.387 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -89.68 119.92 30.51 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.215 -0.994 . . . . 0.19 108.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -118.92 136.08 54.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.925 -1.139 . . . . 1.71 107.925 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.2 m-85 -110.14 127.0 54.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.381 0.61 . . . . 0.13 109.568 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.98 157.54 35.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.752 -0.833 . . . . 0.22 108.752 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -154.8 123.66 6.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.429 -1.323 . . . . 2.0299999999999998 107.429 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 57.09 27.65 13.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 2.1600000000000001 110.078 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.8 87.94 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.025 -1.083 . . . . 0.23000000000000001 110.427 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -112.98 146.46 39.02 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.357 -1.084 . . . . 2.8100000000000001 110.282 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -85.61 139.52 31.35 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.766 -0.828 . . . . 2.2599999999999998 108.766 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.61 -21.46 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.474 -0.766 . . . . 1.05 110.195 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.94 176.12 47.77 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.498 -1.334 . . . . 0.25 110.397 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.51 159.01 3.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -1.072 . . . . 2.04 110.336 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -169.0 130.84 1.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.466 -0.772 . . . . 0.17999999999999999 109.811 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 p -103.27 -163.73 1.01 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.07 -1.018 . . . . 0.89000000000000001 108.538 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 127.04 1.03 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.19 -1.564 . . . . 0.14000000000000001 109.19 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -1.16 . . . . 1.0600000000000001 110.726 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -137.71 73.77 1.45 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.032 -1.099 . . . . 1.98 108.032 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -35.82 80.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.878 -0.514 . . . . 1.72 110.895 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.52 -27.09 68.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.97 -1.081 . . . . 1.95 109.507 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HZ1' ' HG1' ' A' ' 100' ' ' THR . 49.3 tttm -69.65 -33.7 72.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 2.5600000000000001 109.759 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -49.82 -36.08 25.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.067 -1.021 . . . . 1.03 109.071 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.35 -58.24 5.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.482 -0.761 . . . . 2.1499999999999999 110.025 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.25 77.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.405 -0.809 . . . . 1.04 111.273 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . 0.551 ' HG1' ' HZ1' ' A' ' 96' ' ' LYS . 16.9 m -67.47 -46.76 72.06 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.859 -1.151 . . . . 1.04 110.758 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.25 -52.19 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 1.05 109.46 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -59.71 -17.88 38.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 1.6599999999999999 109.745 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.4 -59.65 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 2.02 110.516 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt -92.93 17.37 10.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 1.1399999999999999 110.561 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.085 . . . . 1.1799999999999999 109.31 179.296 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.414 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 4.3 p90 -130.44 -168.62 2.0 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.8 148.25 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.007 0.908 . . . . 0.0 112.809 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.36 95.08 6.27 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.46 46.44 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.921 -1.112 . . . . 0.0 110.217 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.661 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.01 -130.69 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.06 20.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 CA-C-N 119.322 1.561 . . . . 0.0 109.009 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.661 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.39 -0.819 . . . . 0.0 109.506 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 108.934 -0.765 . . . . 1.1000000000000001 108.934 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -154.28 123.54 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.019 -1.051 . . . . 2.5 109.468 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -90.65 134.4 34.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.835 . . . . 1.6100000000000001 110.087 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.99 114.11 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.724 -1.213 . . . . 1.04 107.724 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.08 -13.68 18.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.962 . . . . 1.97 109.724 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 p -153.72 158.76 41.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.114 -0.991 . . . . 0.92000000000000004 109.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -52.1 -21.36 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.722 . . . . 2.48 109.663 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 21.1 m -61.73 -56.08 23.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 1.05 110.116 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.3 -18.06 64.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 1.0600000000000001 110.262 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.93 -60.85 3.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.068 . . . . 0.25 110.523 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.96 -44.35 97.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.016 . . . . 3.0699999999999998 109.638 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -60.77 -32.58 71.9 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.471 -0.768 . . . . 2.1000000000000001 110.389 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.34 85.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.853 -1.155 . . . . 1.04 109.121 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.09 -43.55 95.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 1.27 109.367 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.71 -40.07 94.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 1.0900000000000001 109.806 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.71 -17.19 54.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 1.0900000000000001 109.85 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.61 26.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 1.0700000000000001 109.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.46 18.22 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.365 -1.494 . . . . 0.31 109.365 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.18 2.68 8.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.553 -0.969 . . . . 2.21 109.627 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -69.35 167.05 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.013 -1.054 . . . . 2.4100000000000001 108.739 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.96 164.29 8.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.196 -1.038 . . . . 1.05 108.196 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.7 t -146.05 106.84 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.957 -1.089 . . . . 1.03 109.525 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -102.49 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.644 -0.873 . . . . 1.01 108.644 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.15 139.13 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.626 -0.671 . . . . 1.02 109.821 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.58 99.63 8.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.632 -0.668 . . . . 0.95999999999999996 109.248 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -85.41 80.59 9.06 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.898 -1.149 . . . . 0.32000000000000001 107.898 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -106.48 -163.6 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 1.04 109.633 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.35 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.573 -0.899 . . . . 1.0600000000000001 108.573 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -64.43 -26.92 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 110.77 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -88.39 -16.54 32.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.979 -1.076 . . . . 0.51000000000000001 110.009 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.25 120.12 35.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 0.34000000000000002 109.809 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -65.03 -52.98 36.58 Favored Glycine 0 N--CA 1.486 1.992 0 O-C-N 121.519 -0.738 . . . . 0.40000000000000002 111.548 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.3 Cg_exo -49.21 -37.04 38.49 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.664 1.576 . . . . 0.47999999999999998 111.386 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.68 1.04 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.884 -1.135 . . . . 0.81000000000000005 108.993 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.12 -15.04 20.11 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.517 -0.74 . . . . 2.46 110.332 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 tpt -59.94 -21.51 61.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 3.6600000000000001 109.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mt -96.93 15.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 1.0700000000000001 110.44 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.53 -31.26 2.93 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.687 -1.258 . . . . 2.1099999999999999 112.153 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.74 -5.52 10.58 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 CA-C-N 119.798 0.963 . . . . 0.29999999999999999 109.799 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 39.1 m-85 -109.72 -78.42 0.59 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.832 -0.803 . . . . 0.37 108.832 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 94.0 t80 -40.46 -58.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.73 -0.606 . . . . 0.14999999999999999 111.083 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.53 -30.9 71.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.03 . . . . 0.47999999999999998 109.939 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.8 t -65.47 -40.48 93.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.91 -1.119 . . . . 1.05 110.28 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.6 mt -50.24 -15.93 0.28 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.99 -1.069 . . . . 1.1299999999999999 109.713 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -57.29 -29.48 63.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.065 -1.022 . . . . 0.93000000000000005 109.917 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.73 -21.04 17.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.0 110.226 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -90.98 -22.19 20.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.994 -1.066 . . . . 2.6499999999999999 109.747 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -133.54 69.78 1.47 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.511 -0.743 . . . . 0.89000000000000001 109.275 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -67.85 -5.95 19.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.465 -0.772 . . . . 0.93000000000000005 109.243 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -94.49 3.78 54.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.46999999999999997 109.457 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.5 t -121.11 145.38 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.701 -0.852 . . . . 1.03 108.701 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -97.86 129.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.242 -0.911 . . . . 1.05 109.422 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -114.73 130.93 56.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.315 -0.866 . . . . 0.11 109.423 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.5 mp -112.61 172.83 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.959 -0.756 . . . . 1.04 108.959 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.89 142.2 30.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.992 -1.114 . . . . 1.3100000000000001 107.992 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.4 t -142.2 136.69 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.121 -0.987 . . . . 1.02 110.774 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -96.99 111.45 23.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.996 -1.113 . . . . 1.0800000000000001 107.996 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.33 -12.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 110.749 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.85 -44.41 6.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.013 -1.055 . . . . 1.1100000000000001 111.021 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -91.93 -15.35 28.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 1.1200000000000001 109.459 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.24 43.05 2.41 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.632 -0.877 . . . . 1.01 108.632 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.14 -15.35 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.415 -0.803 . . . . 2.7799999999999998 109.762 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -40.22 74.35 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.256 -0.903 . . . . 1.1100000000000001 109.002 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.26 -45.77 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.679 -0.86 . . . . 1.05 108.679 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.28 -32.52 73.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 1.0600000000000001 108.956 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -64.03 -48.94 74.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 1.79 109.271 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.08 -38.5 91.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.321 -0.862 . . . . 2.2000000000000002 109.535 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.53 58.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 109.697 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.2 mt-10 46.66 57.74 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 2.3399999999999999 110.284 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.07 132.28 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 1.05 108.916 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.37 2.0 8.41 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.402 -0.811 . . . . 2.9300000000000002 110.244 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.79 131.33 13.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.968 -1.083 . . . . 1.0600000000000001 109.061 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.9 p -116.56 149.72 44.31 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.48 -0.762 . . . . 0.97999999999999998 109.119 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.61 145.91 80.78 Favored 'Cis proline' 0 N--CA 1.487 1.091 0 C-N-CA 124.934 -0.861 . . . . 0.23999999999999999 110.071 -1.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.96 113.42 23.24 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.713 -1.217 . . . . 1.04 107.713 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -87.56 126.78 35.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.881 -1.137 . . . . 0.19 108.939 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -124.33 133.82 53.34 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.702 -1.221 . . . . 1.71 107.702 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.3 m-85 -108.22 127.66 54.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.13 109.619 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -125.69 156.66 38.96 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.714 -0.847 . . . . 0.22 108.714 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -153.86 124.97 7.36 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.558 -1.275 . . . . 2.0299999999999998 107.558 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.7 mttt 56.64 20.15 4.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.569 -0.707 . . . . 2.1600000000000001 109.884 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.38 2.51 70.46 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.319 -1.112 . . . . 0.23000000000000001 110.319 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -110.35 148.12 32.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.258 -1.143 . . . . 2.8100000000000001 110.057 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -85.01 140.43 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.827 . . . . 2.2599999999999998 109.274 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.98 -3.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.461 -0.775 . . . . 1.05 110.176 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.81 170.74 30.17 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.491 -1.338 . . . . 0.25 110.63 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.08 155.52 3.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -1.065 . . . . 2.04 110.134 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.58 131.7 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.17999999999999999 110.439 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.414 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 16.9 p -101.55 -165.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.134 -0.979 . . . . 0.89000000000000001 108.875 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 86.13 131.49 2.85 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.143 -1.583 . . . . 0.14000000000000001 109.143 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.13 96.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -1.166 . . . . 1.0600000000000001 110.837 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -143.06 77.6 1.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.372 -0.973 . . . . 1.98 108.372 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -33.59 76.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.381 -0.825 . . . . 1.72 110.65 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.38 -26.15 67.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.891 -1.131 . . . . 1.95 109.179 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -68.38 -36.49 79.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.81 . . . . 2.5600000000000001 109.257 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.5 mt -52.39 -37.04 55.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.03 108.775 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.85 -58.92 4.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 2.1499999999999999 109.76 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.54 89.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 1.04 110.865 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 m -66.58 -46.85 74.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.087 -1.008 . . . . 1.04 110.467 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.1 -51.95 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 1.05 108.853 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -61.18 -16.47 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 1.6599999999999999 109.688 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.57 -56.2 4.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 2.02 110.342 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.84 13.24 21.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 1.1399999999999999 110.527 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.942 -1.098 . . . . 1.1799999999999999 109.394 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -128.2 -166.81 1.67 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.293 -0.879 . . . . 0.0 110.55 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.9 143.18 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.375 -0.828 . . . . 0.0 112.633 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.78 94.76 6.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.16 46.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 110.134 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.08 -133.83 0.15 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.95 27.73 0.15 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 CA-C-N 119.325 1.563 . . . . 0.0 109.049 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.326 -0.62 . . . . 1.1000000000000001 109.326 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -154.56 125.48 7.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 2.5 109.079 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.39 130.66 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.6100000000000001 109.994 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mm -106.08 112.87 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.768 -1.197 . . . . 1.04 107.768 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.42 -15.12 18.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.139 -0.975 . . . . 1.97 109.641 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 p -154.12 159.87 41.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.92000000000000004 109.698 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 26.7 tttp -51.57 -22.7 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 2.48 109.293 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -60.38 -52.37 65.51 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.895 . . . . 1.05 109.869 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -22.7 63.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 1.0600000000000001 109.889 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.49 -65.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.25 109.708 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -55.04 -45.62 75.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.951 . . . . 3.0699999999999998 109.727 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.62 -36.22 73.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.303 -0.873 . . . . 2.1000000000000001 109.973 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.49 86.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 1.04 109.409 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.04 -46.85 79.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.738 . . . . 1.27 110.02 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.82 -41.2 97.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 110.067 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.88 -17.21 53.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 1.0900000000000001 109.646 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -6.7 27.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 1.0700000000000001 109.566 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 -133.47 24.73 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.434 -1.466 . . . . 0.31 109.434 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.74 6.11 13.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.363 -1.081 . . . . 2.21 109.6 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.66 166.82 19.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.062 -1.024 . . . . 2.4100000000000001 109.252 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.553 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.38 160.71 15.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 1.05 108.494 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.553 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.6 t -144.61 109.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.994 . . . . 1.03 109.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.32 133.85 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.665 -0.865 . . . . 1.01 108.665 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.45 141.95 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.431 -0.793 . . . . 1.02 109.869 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -111.41 99.89 8.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.924 -0.769 . . . . 0.95999999999999996 108.924 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.58 80.04 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.903 -1.147 . . . . 0.32000000000000001 107.903 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -113.3 150.01 33.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.79 -0.569 . . . . 1.04 109.718 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.39 126.4 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.568 -0.901 . . . . 1.0600000000000001 108.568 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -65.98 -25.89 67.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 110.662 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.5 p-90 -87.7 -10.7 50.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.51000000000000001 109.942 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -97.51 127.52 43.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.477 -0.764 . . . . 0.34000000000000002 109.591 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.94 -55.83 10.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.145 -0.782 . . . . 0.40000000000000002 111.145 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.78 -39.64 38.85 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.912 1.742 . . . . 0.47999999999999998 111.605 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -61.84 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.675 -1.266 . . . . 0.81000000000000005 109.243 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -58.98 -20.12 49.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.261 -0.899 . . . . 2.46 109.82 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.7 ttt -60.37 -18.33 49.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 3.6600000000000001 110.249 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -99.64 8.02 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 1.0700000000000001 110.26 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.75 -31.96 5.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.648 -1.283 . . . . 2.1099999999999999 112.453 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.1 Cg_exo -62.03 -7.71 10.37 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.757 0.949 . . . . 0.29999999999999999 109.81 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -106.28 -74.49 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.032 -0.729 . . . . 0.37 109.032 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -44.49 -56.08 4.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.754 . . . . 0.14999999999999999 110.792 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -65.75 -32.04 73.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.113 -0.992 . . . . 0.47999999999999998 109.877 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 t -64.96 -41.45 95.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 1.05 110.049 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.99 -14.64 0.23 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 1.1299999999999999 109.81 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -56.61 -32.37 65.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.038 -1.039 . . . . 0.93000000000000005 109.926 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -95.09 -17.12 22.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 2.0 110.368 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.603 ' HZ1' ' HH ' ' A' ' 49' ' ' TYR . 11.2 tmtt? -91.0 -23.51 20.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.123 -0.986 . . . . 2.6499999999999999 109.187 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.603 ' HH ' ' HZ1' ' A' ' 48' ' ' LYS . 41.5 m-85 -131.5 66.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.556 -0.715 . . . . 0.89000000000000001 109.245 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -66.68 -1.91 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.339 -0.851 . . . . 0.93000000000000005 109.0 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 34.1 t-20 -94.94 -7.38 40.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.424 -0.797 . . . . 0.46999999999999997 109.124 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.4 t -112.65 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.418 -0.801 . . . . 1.03 109.026 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -100.37 125.48 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.052 -0.721 . . . . 1.05 109.052 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -109.09 132.57 53.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.11 108.996 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.7 mp -113.11 169.56 8.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.679 -0.86 . . . . 1.04 108.679 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.01 143.32 34.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.729 -1.212 . . . . 1.3100000000000001 107.729 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.8 t -141.38 138.01 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 1.02 111.045 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.81 96.92 8.9 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.049 -1.093 . . . . 1.0800000000000001 108.049 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 m -54.63 -8.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0600000000000001 111.464 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.46 -44.07 5.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 110.672 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.91 -9.09 41.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.167 -0.958 . . . . 1.1200000000000001 109.323 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.15 43.3 3.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.708 -0.849 . . . . 1.01 108.708 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.92 -15.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.802 . . . . 2.7799999999999998 109.669 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.19 -39.86 74.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 1.1100000000000001 108.913 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.7 t -74.42 -46.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 1.05 108.51 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.96 75.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.868 . . . . 1.0600000000000001 108.96 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -64.29 -47.91 77.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.405 -0.81 . . . . 1.79 109.065 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.53 -36.9 85.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.811 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.36 59.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.156 -0.965 . . . . 1.0600000000000001 110.166 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 49.57 55.81 8.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.05 -1.031 . . . . 2.3399999999999999 109.813 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.5 137.51 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 1.05 109.638 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -128.8 -4.94 5.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 2.9300000000000002 109.465 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.562 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.64 136.39 15.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.968 -1.082 . . . . 1.0600000000000001 110.006 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.3 p -115.58 150.35 44.55 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.362 -0.836 . . . . 0.97999999999999998 108.747 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.66 143.16 73.38 Favored 'Cis proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.842 -0.899 . . . . 0.23999999999999999 110.13 -2.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.27 115.5 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.13 -1.063 . . . . 1.04 108.13 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -91.45 115.42 28.02 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.378 -0.929 . . . . 0.19 108.568 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.23 136.33 53.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.559 -1.274 . . . . 1.71 107.559 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.9 m-85 -107.75 127.38 53.64 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.596 0.713 . . . . 0.13 109.978 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.17 156.97 31.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.376 -0.972 . . . . 0.22 108.376 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HZ1' ' HA ' ' A' ' 22' ' ' LEU . 28.5 tttp -155.97 123.52 5.53 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.501 -1.296 . . . . 2.0299999999999998 107.501 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.1 mttm 57.89 16.54 3.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.495 -0.753 . . . . 2.1600000000000001 109.544 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.545 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 96.82 -1.87 61.68 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.424 -1.07 . . . . 0.23000000000000001 110.424 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.545 HE21 ' C ' ' A' ' 83' ' ' GLY . 17.1 mm-40 -110.04 149.91 29.31 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.154 -1.203 . . . . 2.8100000000000001 110.435 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -85.58 143.72 28.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.685 . . . . 2.2599999999999998 109.456 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.27 -21.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.575 -0.703 . . . . 1.05 110.222 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.94 175.0 45.98 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.652 -1.261 . . . . 0.25 110.003 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -173.79 154.4 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -1.176 . . . . 2.04 110.232 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.5 132.09 1.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 0.17999999999999999 109.772 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -104.23 -162.07 0.87 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.89000000000000001 109.1 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.41 133.82 1.56 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.14000000000000001 109.577 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.71 97.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -1.19 . . . . 1.0600000000000001 110.553 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.517 HD21 ' H ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -141.51 72.36 1.38 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.72 -0.844 . . . . 1.98 108.72 178.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.88 . . . . 1.72 110.431 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.9 -31.29 71.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.025 -1.047 . . . . 1.95 109.467 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.517 ' H ' HD21 ' A' ' 93' ' ' ASN . 43.4 tttp -67.87 -33.63 75.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 2.5600000000000001 109.787 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.2 mt -51.46 -36.03 42.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.992 -1.068 . . . . 1.03 108.646 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.27 -55.74 14.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 2.1499999999999999 109.448 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.38 94.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 1.04 110.946 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -67.3 -45.97 74.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.923 -1.111 . . . . 1.04 110.44 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.71 -51.39 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 1.05 109.037 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -60.01 -18.57 46.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 1.6599999999999999 109.633 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -76.44 -61.98 1.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 2.02 110.276 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 mt -91.68 21.61 4.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 1.1399999999999999 110.534 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.902 -1.124 . . . . 1.1799999999999999 109.315 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 5' ' ' TYR . 2.6 p90 -111.96 -167.68 1.21 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.778 -1.201 . . . . 0.0 110.47 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.34 149.32 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.308 -0.87 . . . . 0.0 112.428 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.67 95.61 6.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.72 47.5 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.807 -1.183 . . . . 0.0 110.061 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.94 -129.98 0.23 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -69.72 25.07 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 41.9 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.533 -0.73 . . . . 0.0 109.555 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.5 t . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.524 -0.547 . . . . 1.1000000000000001 109.524 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -155.13 130.56 9.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.199 -0.938 . . . . 2.5 109.124 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.447 ' NE2' ' OE2' ' A' ' 6' ' ' GLU . 19.3 tt0 -88.69 138.19 31.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.106 -0.996 . . . . 1.6100000000000001 109.752 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.3 93.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.58 -0.896 . . . . 1.04 108.58 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.447 ' OE2' ' NE2' ' A' ' 4' ' ' GLN . 58.1 mt-10 -96.72 -1.01 47.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.014 -1.054 . . . . 1.97 109.538 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.5 p -151.85 147.82 27.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.975 -1.078 . . . . 0.92000000000000004 110.184 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 54.3 tttt -52.43 -29.25 23.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 2.48 109.687 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -60.53 -45.55 93.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.034 -1.041 . . . . 1.05 109.557 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.45 65.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 1.0600000000000001 109.61 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.85 -65.69 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.25 109.534 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -55.66 -46.34 77.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 3.0699999999999998 109.818 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -58.12 -34.49 70.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.094 -1.004 . . . . 2.1000000000000001 109.648 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.09 86.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 1.04 109.0 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.7 -44.64 93.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.369 -0.832 . . . . 1.27 109.387 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.08 -37.98 89.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.049 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.12 53.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 1.0900000000000001 109.492 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.17 61.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 1.0700000000000001 109.544 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 -109.33 2.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.993 -1.243 . . . . 0.31 109.993 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.1 t0 -136.37 -0.46 2.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.384 -1.068 . . . . 2.21 109.32 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.47 163.31 23.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.664 -1.273 . . . . 2.4100000000000001 108.505 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.581 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -62.24 163.63 8.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.115 -1.068 . . . . 1.05 108.115 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.581 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 12.5 t -143.62 108.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.979 -1.076 . . . . 1.03 109.827 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.4 133.54 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.642 -0.873 . . . . 1.01 108.642 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.28 137.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.477 -0.764 . . . . 1.02 109.736 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.84 104.57 13.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.584 -0.698 . . . . 0.95999999999999996 109.207 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -86.86 80.0 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.932 -1.136 . . . . 0.32000000000000001 107.932 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.1 m -114.4 147.74 38.75 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.436 0.636 . . . . 1.04 109.563 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.71 123.1 34.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 1.0600000000000001 108.681 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -65.93 -21.14 66.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 110.319 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.495 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.4 p-90 -88.52 -16.99 31.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.059 . . . . 0.51000000000000001 109.915 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -91.49 136.65 32.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.906 . . . . 0.34000000000000002 110.209 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.28 -58.17 4.78 Favored Glycine 0 N--CA 1.491 2.313 0 O-C-N 121.679 -0.638 . . . . 0.40000000000000002 111.535 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.7 -33.38 31.7 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 C-N-CA 121.597 1.532 . . . . 0.47999999999999998 111.4 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -60.38 2.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.835 -1.166 . . . . 0.81000000000000005 108.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.69 -21.98 55.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 2.46 109.887 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.1 ttm -60.58 -21.4 62.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.201 -0.937 . . . . 3.6600000000000001 110.533 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.08 8.5 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.097 -1.002 . . . . 1.0700000000000001 110.91 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.7 -32.44 5.99 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 117.923 -1.511 . . . . 2.1099999999999999 112.709 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.3 Cg_exo -60.81 -11.61 18.52 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 CA-C-N 119.906 1.002 . . . . 0.29999999999999999 110.267 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.462 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 34.0 m-85 -99.78 -70.3 0.74 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.37 109.527 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -45.01 -51.24 10.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.14999999999999999 110.658 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -67.97 -33.83 75.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.47999999999999998 109.617 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.78 -42.76 99.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 1.05 109.786 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.4 mt -51.9 -19.6 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.073 . . . . 1.1299999999999999 109.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -56.85 -32.92 66.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.93000000000000005 109.275 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.64 -16.86 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 2.0 109.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -90.09 -20.94 22.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 2.6499999999999999 108.959 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.34 71.14 1.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.89000000000000001 109.241 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.3 p -66.89 -4.7 10.04 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.9 . . . . 0.93000000000000005 108.931 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.1 t30 -96.79 1.86 51.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.46999999999999997 109.731 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -119.04 150.35 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.519 -0.738 . . . . 1.03 109.389 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.66 131.68 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.304 -0.872 . . . . 1.05 109.183 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -117.84 132.49 56.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.211 -0.931 . . . . 0.11 109.262 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.21 174.85 5.74 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.374 -0.829 . . . . 1.04 109.039 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -142.69 142.57 32.04 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.084 -1.08 . . . . 1.3100000000000001 108.084 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.6 t -139.74 133.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.109 -0.994 . . . . 1.02 110.447 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.2 t70 -98.72 105.16 17.27 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.107 -1.071 . . . . 1.0800000000000001 108.107 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.6 m -59.33 -4.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.804 . . . . 1.0600000000000001 111.171 -178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.495 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 53.1 m-20 -108.9 -44.22 4.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.216 -0.928 . . . . 1.1100000000000001 110.83 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.57 -10.7 39.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.24 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 47.38 2.19 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.303 -0.999 . . . . 1.01 108.303 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -55.29 -17.45 4.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.668 -0.645 . . . . 2.7799999999999998 109.974 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.5 p-10 -71.54 -38.93 71.0 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.946 . . . . 1.1100000000000001 109.537 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.14 -48.39 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 1.05 108.922 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.03 72.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 1.0600000000000001 109.462 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -64.05 -57.1 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 1.79 109.679 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -63.18 -26.6 68.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2000000000000002 109.825 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.06 -3.16 58.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.115 -0.991 . . . . 1.0600000000000001 109.923 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 47.56 53.09 11.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 2.3399999999999999 110.08 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 22.1 t -79.56 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 1.05 109.402 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -125.17 -1.83 7.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.341 -0.85 . . . . 2.9300000000000002 109.815 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.56 130.98 12.91 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.019 -1.051 . . . . 1.0600000000000001 109.418 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 8' ' ' GLU . 12.0 p -114.99 150.63 44.5 Favored Pre-proline 0 N--CA 1.502 2.143 0 N-CA-C 108.26 -1.015 . . . . 0.97999999999999998 108.26 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.92 144.07 77.53 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 C-N-CA 124.842 -0.899 . . . . 0.23999999999999999 110.615 -1.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.03 113.78 23.66 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.757 -1.201 . . . . 1.04 107.757 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -89.55 122.16 32.45 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.898 -1.126 . . . . 0.19 108.902 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -119.6 135.99 54.56 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.029 -1.1 . . . . 1.71 108.029 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.0 m-85 -109.65 131.87 54.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.13 109.967 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -129.08 157.04 42.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.884 -0.784 . . . . 0.22 108.884 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -154.05 124.86 7.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.601 -1.259 . . . . 2.0299999999999998 107.601 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 mttt 54.28 32.73 16.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.996 . . . . 2.1600000000000001 109.77 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 9.69 86.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.005 -1.238 . . . . 0.23000000000000001 110.005 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.75 144.07 44.07 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.331 -1.099 . . . . 2.8100000000000001 110.363 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -85.53 146.66 26.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 2.2599999999999998 109.27 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.91 -29.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.454 -0.779 . . . . 1.05 109.971 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.58 178.03 44.1 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.5 -1.333 . . . . 0.25 110.477 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -173.6 156.87 3.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 2.04 110.179 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -168.88 134.25 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.17999999999999999 110.563 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -105.83 -171.33 1.88 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.203 -0.935 . . . . 0.89000000000000001 108.889 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 92.88 128.61 4.8 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.788 -1.325 . . . . 0.14000000000000001 109.788 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.87 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -1.12 . . . . 1.0600000000000001 110.31 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' GLY . 14.5 t-20 -140.14 73.24 1.42 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.452 -0.944 . . . . 1.98 108.452 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.462 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -64.65 -31.73 73.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 1.72 110.28 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 23.6 mp0 -66.86 -29.95 69.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.898 -1.126 . . . . 1.95 109.124 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -32.38 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.418 -0.801 . . . . 2.5600000000000001 109.331 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.38 -35.0 36.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 1.03 108.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -68.24 -56.77 7.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.747 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.58 87.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.819 . . . . 1.04 110.668 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 m -67.0 -45.13 78.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 1.04 110.218 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.3 -51.97 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 1.05 109.074 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.3 -15.2 46.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 1.6599999999999999 109.781 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.12 -59.51 2.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 2.02 110.294 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.97 18.49 10.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.393 -0.817 . . . . 1.1399999999999999 110.74 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.895 -1.128 . . . . 1.1799999999999999 109.347 179.582 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.457 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.7 p90 -123.25 -168.5 1.77 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.894 -1.129 . . . . 0.0 111.249 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.22 149.71 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.886 0.851 . . . . 0.0 112.868 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.91 96.95 7.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.0 pt-20 -83.04 46.15 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.041 -1.037 . . . . 0.0 110.639 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.26 -130.24 0.09 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.755 -2.538 . . . . 0.0 106.755 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.6 22.27 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.335 1.568 . . . . 0.0 109.367 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.0 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.759 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.1 t . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.548 -0.538 . . . . 1.1000000000000001 109.548 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -154.8 122.33 5.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 2.5 109.251 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.5 134.83 34.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 1.6100000000000001 110.015 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.06 109.72 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.063 -1.088 . . . . 1.04 108.063 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -101.02 -7.01 23.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.193 -0.942 . . . . 1.97 109.847 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 p -152.35 153.58 33.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.037 -1.039 . . . . 0.92000000000000004 109.926 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 69.4 tttt -52.46 -33.22 43.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.446 -0.784 . . . . 2.48 109.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -59.69 -41.1 89.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 1.05 109.849 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.41 -25.63 63.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 1.0600000000000001 109.78 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.3 -68.31 0.31 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.011 -1.056 . . . . 0.25 110.043 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.91 -41.25 70.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 3.0699999999999998 109.785 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.85 -37.69 80.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 2.1000000000000001 109.504 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.18 91.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 1.04 109.539 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.32 -44.7 94.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.27 109.715 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.71 -41.12 98.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.713 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.1 -14.58 58.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 109.732 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.59 -6.97 28.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 1.0700000000000001 109.847 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -113.81 4.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.578 -1.409 . . . . 0.31 109.578 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.17 5.15 2.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -1.054 . . . . 2.21 109.499 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.24 170.18 12.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.003 -1.061 . . . . 2.4100000000000001 109.097 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 161.51 14.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.932 -1.136 . . . . 1.05 107.932 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.2 t -145.33 106.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.927 -1.108 . . . . 1.03 109.652 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.94 130.3 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.688 -0.856 . . . . 1.01 108.688 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.78 140.13 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.55 -0.719 . . . . 1.02 109.591 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -110.96 99.27 8.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.982 -0.747 . . . . 0.95999999999999996 108.982 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.64 82.98 8.18 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.807 -1.183 . . . . 0.32000000000000001 107.807 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.3 m -109.39 -163.24 0.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.985 -0.746 . . . . 1.04 108.985 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.31 125.13 18.26 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.95 -0.759 . . . . 1.0600000000000001 108.95 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -65.6 -30.68 71.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.68 . . . . 1.0600000000000001 111.331 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.538 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 50.7 p-90 -86.04 -14.18 45.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.748 -1.22 . . . . 0.51000000000000001 109.884 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -94.76 128.58 41.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.34000000000000002 109.657 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.62 -55.79 8.14 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.579 -0.701 . . . . 0.40000000000000002 111.495 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.6 Cg_exo -48.03 -33.58 20.99 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.72 1.613 . . . . 0.47999999999999998 111.45 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.27 -59.75 2.63 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.809 -1.182 . . . . 0.81000000000000005 108.958 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -60.32 -19.22 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 2.46 110.258 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -19.55 52.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.01 . . . . 3.6600000000000001 110.361 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.2 mt -99.45 9.08 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.16 -0.962 . . . . 1.0700000000000001 110.497 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.52 -31.98 4.07 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 120.374 -1.454 . . . . 2.1099999999999999 112.516 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -62.61 -5.0 6.37 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.947 1.017 . . . . 0.29999999999999999 110.049 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 45.5 m-85 -112.39 -75.49 0.61 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.218 -0.66 . . . . 0.37 109.218 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -43.13 -56.8 3.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.14999999999999999 110.551 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -66.94 -32.37 73.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.47999999999999998 110.068 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.5 t -63.18 -40.92 98.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.809 -1.182 . . . . 1.05 110.38 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.4 mt -50.62 -15.32 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.992 -1.067 . . . . 1.1299999999999999 109.532 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.0 m -58.17 -30.77 66.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.066 -1.021 . . . . 0.93000000000000005 109.521 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -96.09 -21.45 17.94 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.272 -0.892 . . . . 2.0 110.156 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -90.43 -21.01 22.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.037 -1.039 . . . . 2.6499999999999999 109.602 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.74 67.6 1.5 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.409 -0.807 . . . . 0.89000000000000001 108.896 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.5 p -66.8 -3.01 5.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.374 -0.829 . . . . 0.93000000000000005 109.088 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.29 -1.23 51.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.443 -0.786 . . . . 0.46999999999999997 109.251 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.26 149.01 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.633 -0.667 . . . . 1.03 109.24 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -99.96 125.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 1.05 109.146 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -112.47 130.96 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.271 -0.893 . . . . 0.11 108.878 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.51 171.58 7.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.736 -0.838 . . . . 1.04 108.736 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -142.82 142.57 31.87 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.836 -1.172 . . . . 1.3100000000000001 107.836 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.0 t -141.12 138.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.152 -0.967 . . . . 1.02 110.758 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.41 105.75 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.443 -0.947 . . . . 1.0800000000000001 108.443 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.402 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 29.1 m -66.94 -4.95 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.376 -0.828 . . . . 1.0600000000000001 110.905 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.538 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 36.8 m-20 -102.72 -42.83 5.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 1.1100000000000001 110.877 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -25.6 15.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.181 -0.949 . . . . 1.1200000000000001 109.362 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.29 43.45 1.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.426 -0.953 . . . . 1.01 108.426 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.559 ' NE2' ' NH1' ' B' ' 4' ' ' ARG . 25.6 mt-30 -53.6 -13.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 2.7799999999999998 110.235 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.1 p-10 -69.85 -40.68 75.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.791 -1.193 . . . . 1.1100000000000001 109.19 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -73.37 -48.07 43.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.234 -0.916 . . . . 1.05 108.584 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -38.19 90.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.528 -0.732 . . . . 1.0600000000000001 109.539 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 61.8 m -64.1 -43.73 94.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 1.79 109.052 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.59 -40.41 96.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 2.2000000000000002 109.228 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.83 -6.27 57.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 1.0600000000000001 109.399 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ALA . 46.7 mt-10 49.31 71.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 2.3399999999999999 110.253 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 42.0 t -79.11 135.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.922 . . . . 1.05 108.978 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -113.64 -12.54 12.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.484 -0.76 . . . . 2.9300000000000002 109.805 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -154.78 137.69 15.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.952 -1.092 . . . . 1.0600000000000001 109.81 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p -115.63 151.27 45.99 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 108.487 -0.931 . . . . 0.97999999999999998 108.487 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -75.73 147.33 87.89 Favored 'Cis proline' 0 N--CA 1.484 0.968 0 C-N-CA 124.651 -0.979 . . . . 0.23999999999999999 109.878 -1.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -116.08 113.34 23.02 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.996 -1.113 . . . . 1.04 107.996 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -89.15 125.1 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.124 -1.03 . . . . 0.19 108.906 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.16 136.71 54.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.895 -1.15 . . . . 1.71 107.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.4 m-85 -109.91 130.18 55.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.707 . . . . 0.13 109.958 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -128.93 157.24 42.17 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.58 -0.896 . . . . 0.22 108.58 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -155.53 122.65 5.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.014 -1.106 . . . . 2.0299999999999998 108.014 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.2 22.57 6.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 2.1600000000000001 109.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 3.55 72.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.194 -1.162 . . . . 0.23000000000000001 110.194 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -110.95 144.95 39.22 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.293 -1.122 . . . . 2.8100000000000001 110.21 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -85.47 139.56 31.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 2.2599999999999998 109.052 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.03 -18.02 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.399 -0.813 . . . . 1.05 110.715 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.92 172.69 45.68 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.25 110.541 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -174.21 150.49 1.53 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 2.04 110.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.02 132.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.818 . . . . 0.17999999999999999 110.189 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 18.8 p -101.98 -160.19 0.77 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.064 -1.023 . . . . 0.89000000000000001 109.066 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.491 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 79.4 129.3 0.67 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.52 -1.432 . . . . 0.14000000000000001 109.52 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.16 93.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 1.0600000000000001 110.205 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.96 75.53 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.819 -1.178 . . . . 1.98 107.819 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.579 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.8 ptpt -63.49 -39.36 94.23 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.818 -0.628 . . . . 1.72 111.275 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.58 -25.97 68.2 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 1.95 109.567 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.21 -34.79 76.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 2.5600000000000001 109.528 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.73 -35.96 64.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.118 . . . . 1.03 108.732 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.7 -58.08 6.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 2.1499999999999999 109.54 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.47 -41.92 90.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 1.04 110.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.2 m -65.81 -45.73 81.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.161 -0.962 . . . . 1.04 110.183 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.48 -53.97 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 1.05 108.822 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.64 -17.64 48.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 1.6599999999999999 109.744 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -75.9 -60.25 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 2.02 110.155 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.64 20.74 6.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.771 . . . . 1.1399999999999999 110.416 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.238 179.473 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.559 ' NH1' ' NE2' ' A' ' 63' ' ' GLN . 7.9 tpt180 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.467 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.1 p90 -128.8 -166.89 1.7 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.013 -1.054 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.55 152.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 122.0 0.905 . . . . 0.0 112.591 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 95.09 6.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -83.16 45.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.78 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -131.98 0.08 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.6 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.251 1.525 . . . . 0.0 109.147 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.652 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.2 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 109.58 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.498 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 76.3 t . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.295 0.569 . . . . 1.1000000000000001 109.902 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.06 125.97 7.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 2.5 109.375 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.13 136.52 33.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.904 . . . . 1.6100000000000001 109.73 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mm -106.3 110.02 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.185 -1.042 . . . . 1.04 108.185 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.87 -9.98 21.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.2 -0.938 . . . . 1.97 109.703 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 p -153.18 152.6 31.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.11 -0.994 . . . . 0.92000000000000004 109.699 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -51.9 -28.0 14.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 2.48 110.021 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -59.14 -44.29 92.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 1.05 109.692 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.32 -24.56 61.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 1.0600000000000001 109.952 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -59.33 -68.64 0.26 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.25 110.328 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.34 -43.2 71.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 3.0699999999999998 109.554 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -59.67 -36.73 77.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.228 -0.92 . . . . 2.1000000000000001 110.085 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.32 86.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.003 . . . . 1.04 109.384 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.29 -43.4 94.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.468 -0.77 . . . . 1.27 109.645 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.76 -40.78 97.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.771 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -14.44 59.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.988 . . . . 1.0900000000000001 110.03 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -10.56 56.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 1.0700000000000001 109.806 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.2 -112.3 3.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.47 -1.452 . . . . 0.31 109.47 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -139.85 3.77 2.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.317 -1.107 . . . . 2.21 109.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -69.61 172.68 7.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 2.4100000000000001 109.032 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.83 161.47 18.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.977 -1.12 . . . . 1.05 107.977 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.509 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.3 t -144.87 104.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.873 -1.142 . . . . 1.03 109.421 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.99 128.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.359 -0.838 . . . . 1.01 108.937 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.77 139.72 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 1.02 109.565 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -112.02 103.49 11.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.95999999999999996 108.903 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.5 m-85 -86.06 80.31 8.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.3 -1.0 . . . . 0.32000000000000001 108.3 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.3 m -113.45 149.4 34.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.652 -0.655 . . . . 1.04 109.597 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.39 129.26 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 1.0600000000000001 109.048 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -67.15 -25.32 66.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.882 . . . . 1.0600000000000001 110.855 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.464 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 54.0 p-90 -88.4 -17.58 30.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.842 -1.161 . . . . 0.51000000000000001 110.351 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.96 123.37 37.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -0.929 . . . . 0.34000000000000002 109.941 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.87 -53.74 32.43 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-O 119.426 -0.652 . . . . 0.40000000000000002 112.002 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -48.32 -36.41 29.95 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.647 1.565 . . . . 0.47999999999999998 111.33 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.76 -60.99 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.81000000000000005 109.137 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -58.28 -18.92 30.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 2.46 109.96 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.9 ttm -58.61 -18.41 29.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 3.6600000000000001 110.581 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 67.1 mt -100.39 9.7 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.167 -0.958 . . . . 1.0700000000000001 110.583 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.74 -32.55 4.39 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.107 -1.621 . . . . 2.1099999999999999 112.598 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -64.09 -6.2 10.87 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 CA-C-N 119.794 0.962 . . . . 0.29999999999999999 109.758 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 32.6 m-85 -110.52 -75.21 0.63 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.544 -0.723 . . . . 0.37 109.384 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -43.02 -57.42 2.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.427 -0.795 . . . . 0.14999999999999999 110.67 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.82 -31.15 71.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.47999999999999998 110.04 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 46' ' ' SER . 3.4 t -64.34 -40.1 95.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.822 -1.174 . . . . 1.05 109.938 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.2 -12.87 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.079 -1.013 . . . . 1.1299999999999999 109.369 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.498 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 20.2 m -58.03 -34.69 70.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.93000000000000005 109.439 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -94.33 -13.17 26.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.312 -0.868 . . . . 2.0 110.084 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -91.65 -32.07 15.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 2.6499999999999999 109.455 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.418 ' C ' ' H ' ' A' ' 51' ' ' ASN . 44.5 m-85 -126.38 71.96 1.3 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.025 -0.732 . . . . 0.89000000000000001 109.025 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.08 -2.59 4.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.292 -0.88 . . . . 0.93000000000000005 108.968 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 49' ' ' TYR . 35.0 t30 -97.01 -1.99 44.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.46999999999999997 109.816 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.74 148.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.508 -0.745 . . . . 1.03 109.586 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.37 124.21 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.993 -0.743 . . . . 1.05 108.993 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.91 133.0 53.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.294 -0.879 . . . . 0.11 108.948 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.08 171.87 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.241 -0.912 . . . . 1.04 108.706 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -141.94 144.24 33.65 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.028 -1.101 . . . . 1.3100000000000001 108.028 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.63 139.26 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.17 -0.956 . . . . 1.02 110.507 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.7 t70 -98.98 101.97 13.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.859 -0.793 . . . . 1.0800000000000001 108.859 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.04 0.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.836 . . . . 1.0600000000000001 110.967 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 58' ' ' ASP . 39.3 m-20 -112.7 -41.08 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.343 -0.848 . . . . 1.1100000000000001 110.655 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -95.5 -21.18 18.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.041 . . . . 1.1200000000000001 109.503 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.48 47.86 1.19 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.25 -1.019 . . . . 1.01 108.25 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' B' ' 4' ' ' ARG . 14.0 mt-30 -54.62 -18.28 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.749 -0.594 . . . . 2.7799999999999998 110.326 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -70.82 -39.41 73.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.917 -1.114 . . . . 1.1100000000000001 109.606 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.44 -47.63 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.149 -0.969 . . . . 1.05 108.836 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.48 78.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 1.0600000000000001 109.461 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -63.47 -52.72 60.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 1.79 109.525 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -64.75 -30.55 71.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 2.2000000000000002 110.027 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.94 2.99 47.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 1.0600000000000001 109.943 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 47.14 50.3 14.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 2.3399999999999999 110.541 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 4.0 t -81.39 128.64 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 1.05 108.773 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -126.28 -2.13 6.94 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.363 -0.835 . . . . 2.9300000000000002 110.434 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.486 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.32 124.68 8.21 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.759 -1.213 . . . . 1.0600000000000001 109.427 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.7 p -106.24 151.3 40.17 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 121.322 -0.861 . . . . 0.97999999999999998 109.185 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.8 140.13 63.45 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.947 -0.855 . . . . 0.23999999999999999 110.066 -2.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.38 111.11 21.73 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.056 -1.09 . . . . 1.04 108.056 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -89.19 118.14 28.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.988 -1.07 . . . . 0.19 109.127 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.461 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.3 mt-30 -117.05 135.55 53.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.332 -1.358 . . . . 1.71 107.332 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.8 m-85 -107.83 128.08 54.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.488 0.661 . . . . 0.13 109.896 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.8 156.95 35.16 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.94 -0.763 . . . . 0.22 108.94 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -155.26 124.35 6.23 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.298 -1.371 . . . . 2.0299999999999998 107.298 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.3 mttt 56.0 32.65 20.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.6 -0.687 . . . . 2.1600000000000001 109.382 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.41 7.19 87.01 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.779 -1.201 . . . . 0.23000000000000001 110.143 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.03 142.6 45.52 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.375 -1.073 . . . . 2.8100000000000001 110.64 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -86.62 140.09 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.838 . . . . 2.2599999999999998 108.947 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.27 -17.39 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.413 -0.805 . . . . 1.05 110.693 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.39 176.56 48.1 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.415 -1.374 . . . . 0.25 110.454 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -174.1 156.46 2.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -1.128 . . . . 2.04 110.296 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.58 129.97 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.17999999999999999 109.982 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 18.4 p -102.83 -162.16 0.9 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.292 -0.88 . . . . 0.89000000000000001 109.234 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 81.55 126.74 0.84 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.964 -1.654 . . . . 0.14000000000000001 108.964 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.88 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.091 -1.241 . . . . 1.0600000000000001 110.043 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -138.32 66.65 1.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.516 -1.29 . . . . 1.98 107.516 178.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.591 ' NZ ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -59.25 -34.11 71.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.824 -0.548 . . . . 1.72 111.023 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.58 -26.03 68.23 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.935 -1.103 . . . . 1.95 109.254 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -71.05 -36.26 72.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.787 . . . . 2.5600000000000001 110.095 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.4 mt -50.8 -33.29 22.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.914 -1.117 . . . . 1.03 109.012 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.38 -57.01 7.37 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.467 -0.893 . . . . 2.1499999999999999 109.539 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.86 95.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 1.04 110.942 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 m -64.94 -45.3 86.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.953 -1.092 . . . . 1.04 109.918 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.63 -53.09 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 1.05 108.681 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.27 -16.23 43.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 1.6599999999999999 109.626 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -62.38 1.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 2.02 109.934 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.25 22.62 3.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 1.1399999999999999 110.162 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.037 -1.04 . . . . 1.1799999999999999 109.295 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' A' ' 63' ' ' GLN . 8.7 tpt180 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.46 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 5.2 p90 -129.95 -167.16 1.77 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.053 -1.029 . . . . 0.0 110.464 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.75 150.58 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.938 0.875 . . . . 0.0 112.522 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.12 93.44 5.47 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -83.79 44.26 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.285 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.73 -130.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.64 20.8 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 119.533 1.667 . . . . 0.0 109.37 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.671 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.3 t . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.525 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.268 -0.642 . . . . 1.1000000000000001 109.268 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -154.15 125.31 7.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 2.5 109.402 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -89.85 136.3 33.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.6100000000000001 109.903 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.86 107.27 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.206 -1.035 . . . . 1.04 108.206 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.57 -8.74 24.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 1.97 109.547 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.07 156.27 38.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.135 -0.978 . . . . 0.92000000000000004 109.829 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -52.99 -30.15 33.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 2.48 110.075 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.5 m -60.27 -44.51 95.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.05 110.313 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -25.14 64.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 1.0600000000000001 109.649 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -60.76 -67.95 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.957 -1.089 . . . . 0.25 109.94 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.55 -44.98 69.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.795 . . . . 3.0699999999999998 109.679 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -58.61 -36.94 74.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.845 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.93 91.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.081 -1.012 . . . . 1.04 109.362 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.14 -46.56 83.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.804 . . . . 1.27 109.774 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.45 -38.71 92.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 109.482 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.88 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.981 . . . . 1.0900000000000001 109.667 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -5.36 18.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 1.0700000000000001 109.588 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 -111.45 3.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.453 -1.459 . . . . 0.31 109.453 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 61.5 t0 -139.06 2.49 2.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.434 -1.039 . . . . 2.21 109.554 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -68.8 171.86 7.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.017 . . . . 2.4100000000000001 109.053 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.518 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.8 162.27 19.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.351 -0.981 . . . . 1.05 108.351 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.518 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.2 t -144.96 107.72 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.874 -1.141 . . . . 1.03 109.855 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.06 132.66 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.805 -0.813 . . . . 1.01 108.805 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.2 140.43 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 1.02 109.598 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -110.59 101.28 9.96 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.247 -0.649 . . . . 0.95999999999999996 109.247 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 42.1 m-85 -85.36 80.14 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.194 -1.039 . . . . 0.32000000000000001 108.194 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -114.19 147.96 38.07 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.228 0.537 . . . . 1.04 109.651 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.59 131.24 37.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.194 -0.941 . . . . 1.0600000000000001 108.853 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -67.67 -28.02 67.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 1.0600000000000001 110.655 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.516 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 59.2 p-90 -87.71 -11.61 47.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.51000000000000001 110.023 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.39 125.29 39.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.34000000000000002 109.864 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -67.81 -54.12 20.04 Favored Glycine 0 N--CA 1.49 2.244 0 CA-C-O 119.491 -0.616 . . . . 0.40000000000000002 112.299 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.83 -43.85 33.63 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.544 1.496 . . . . 0.47999999999999998 111.618 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.96 -55.85 5.66 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.688 -1.257 . . . . 0.81000000000000005 109.056 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.2 -18.23 46.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 2.46 109.809 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.0 ttt -62.82 -22.46 66.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 3.6600000000000001 110.466 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 65.5 mt -98.12 18.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.198 -0.939 . . . . 1.0700000000000001 111.014 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.39 -33.85 3.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.148 -1.595 . . . . 2.1099999999999999 113.091 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.02 -7.71 14.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 CA-C-N 119.469 0.846 . . . . 0.29999999999999999 110.595 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.0 m-85 -105.22 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.315 -0.866 . . . . 0.37 109.803 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.6 t80 -41.94 -52.4 4.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.14999999999999999 110.742 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.403 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.9 t60 -68.73 -34.3 75.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.991 -1.068 . . . . 0.47999999999999998 109.931 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 46' ' ' SER . 4.2 t -60.64 -44.36 96.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.863 -1.148 . . . . 1.05 110.014 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.6 mt -50.43 -16.8 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.978 -1.076 . . . . 1.1299999999999999 109.214 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.1 m -57.06 -33.96 67.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.93000000000000005 109.629 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.14 -18.74 20.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -0.927 . . . . 2.0 110.251 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -90.54 -20.74 22.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.05 . . . . 2.6499999999999999 109.502 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -133.9 66.49 1.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.89000000000000001 109.297 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 p -67.68 -3.37 8.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.93000000000000005 109.251 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.37 0.39 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.395 -0.816 . . . . 0.46999999999999997 109.46 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.7 t -120.77 150.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.872 -0.788 . . . . 1.03 108.872 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.55 132.02 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.191 -0.943 . . . . 1.05 109.659 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.33 131.69 56.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.571 -0.706 . . . . 0.11 109.102 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mp -114.27 174.98 5.68 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.423 -0.798 . . . . 1.04 109.093 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -144.88 146.81 32.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.247 -1.019 . . . . 1.3100000000000001 108.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.03 138.27 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.999 -1.063 . . . . 1.02 110.611 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.0 t70 -100.03 100.88 11.82 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.665 -0.865 . . . . 1.0800000000000001 108.665 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.1 m -59.31 0.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 111.171 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 14.9 m-20 -116.84 -41.87 3.01 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.163 -0.96 . . . . 1.1100000000000001 110.709 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.13 -19.5 20.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.014 -1.054 . . . . 1.1200000000000001 109.279 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.36 46.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.006 -1.109 . . . . 1.01 108.006 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 27.3 mt-30 -55.31 -16.46 3.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.619 -0.676 . . . . 2.7799999999999998 110.533 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.21 -36.78 77.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.765 -1.209 . . . . 1.1100000000000001 109.113 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -73.76 -48.46 39.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.217 -0.927 . . . . 1.05 108.72 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.27 -36.96 85.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.0600000000000001 109.37 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 75.0 m -63.48 -46.49 85.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 1.79 109.198 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -64.55 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 2.2000000000000002 109.284 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.98 -6.29 58.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -0.988 . . . . 1.0600000000000001 109.257 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ALA . 35.3 mt-10 51.61 55.62 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 2.3399999999999999 110.462 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 46.2 t -84.25 124.26 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.262 -0.898 . . . . 1.05 108.999 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.37 6.7 17.36 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.175 -0.953 . . . . 2.9300000000000002 110.219 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.02 146.19 24.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.773 -1.204 . . . . 1.0600000000000001 109.714 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.3 p -127.29 148.88 68.04 Favored Pre-proline 0 N--CA 1.506 2.354 0 N-CA-C 108.284 -1.006 . . . . 0.97999999999999998 108.284 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -80.32 139.99 50.74 Favored 'Cis proline' 0 N--CA 1.487 1.113 0 N-CA-C 110.072 -0.78 . . . . 0.23999999999999999 110.072 -1.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -110.58 110.53 21.27 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.157 -1.053 . . . . 1.04 108.157 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -86.98 115.53 24.43 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.995 -1.082 . . . . 0.19 109.206 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.579 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 32.5 mt-30 -114.2 137.01 52.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.735 -1.209 . . . . 1.71 107.735 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.5 m-85 -109.91 126.33 53.76 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.519 0.676 . . . . 0.13 109.592 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 156.28 35.36 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.452 -0.944 . . . . 0.22 108.452 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.385 -1.339 . . . . 2.0299999999999998 107.385 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 55.01 38.28 30.27 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.433 -0.792 . . . . 2.1600000000000001 109.238 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 6.25 63.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.352 -1.099 . . . . 0.23000000000000001 110.352 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -112.12 145.82 39.12 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.312 -1.111 . . . . 2.8100000000000001 110.541 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -86.19 142.62 28.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 2.2599999999999998 109.279 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.9 -9.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.452 -0.78 . . . . 1.05 110.341 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.4 38.01 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.389 -1.386 . . . . 0.25 110.521 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -173.35 156.69 3.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.411 -1.053 . . . . 2.04 110.06 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.88 131.12 1.27 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.799 . . . . 0.17999999999999999 110.027 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -160.98 0.81 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.16 -0.962 . . . . 0.89000000000000001 109.093 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 82.34 121.07 0.63 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.451 -1.46 . . . . 0.14000000000000001 109.451 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.34 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -1.158 . . . . 1.0600000000000001 110.25 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.38 76.98 1.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.129 -1.063 . . . . 1.98 108.129 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.1 ptpt -64.57 -42.55 95.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.871 -0.518 . . . . 1.72 111.556 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -63.93 -25.72 68.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.739 -1.226 . . . . 1.95 109.978 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -70.55 -32.09 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 2.5600000000000001 109.432 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.1 mt -51.08 -37.54 46.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.064 . . . . 1.03 108.805 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -68.36 -56.33 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.822 -0.751 . . . . 2.1499999999999999 109.975 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.16 75.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 1.04 110.453 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 m -67.68 -45.21 75.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.989 . . . . 1.04 110.0 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.95 -53.44 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 1.05 109.274 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.81 -16.25 26.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 1.6599999999999999 109.839 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -75.97 -60.18 2.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 2.02 109.944 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -92.89 18.77 8.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.398 -0.814 . . . . 1.1399999999999999 110.414 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 109.309 179.507 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 8.3 tpt180 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 4.1 p90 -131.87 -166.59 1.74 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.673 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.42 150.52 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.167 0.984 . . . . 0.0 112.967 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 94.35 5.59 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.21 49.82 1.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.908 -1.12 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -76.28 -128.09 0.28 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -68.7 26.64 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.372 1.586 . . . . 0.0 108.946 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.639 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.6 t . . . . . 0 N--CA 1.487 1.4 0 O-C-N 121.315 -0.865 . . . . 0.0 109.271 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 58.6 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.38 0.61 . . . . 1.1000000000000001 109.743 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.428 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 36.9 tptt -153.99 123.9 6.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 2.5 109.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -90.3 128.51 36.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.186 -0.946 . . . . 1.6100000000000001 109.861 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.63 109.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.871 -1.159 . . . . 1.04 107.871 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -100.23 -8.06 23.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.174 -0.954 . . . . 1.97 110.078 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p -152.06 153.45 34.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.92000000000000004 109.82 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 50.7 tttm -52.23 -26.15 11.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 2.48 109.784 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -60.17 -50.08 75.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 1.05 110.005 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.94 63.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 1.0600000000000001 109.791 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.89 -65.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.25 109.864 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -54.99 -45.35 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 3.0699999999999998 109.733 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.92 -35.79 73.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.222 -0.924 . . . . 2.1000000000000001 109.743 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.78 80.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 1.04 109.099 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.55 -39.84 94.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.746 . . . . 1.27 109.603 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.98 -42.86 97.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 109.756 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.04 57.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.114 -0.991 . . . . 1.0900000000000001 109.613 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.76 -8.42 42.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.155 -0.966 . . . . 1.0700000000000001 109.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.07 -129.39 32.12 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.161 -1.575 . . . . 0.31 109.161 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.97 5.89 12.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.956 . . . . 2.21 109.462 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -69.76 167.33 17.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 2.4100000000000001 109.266 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.457 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 161.47 18.99 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.331 -0.988 . . . . 1.05 108.331 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.457 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.0 t -145.09 107.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 1.03 109.647 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.09 131.73 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.603 -0.888 . . . . 1.01 108.603 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.34 139.57 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.511 -0.743 . . . . 1.02 109.772 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 13.6 t0 -110.44 102.09 10.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -86.1 83.42 7.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.804 -1.184 . . . . 0.32000000000000001 107.804 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.473 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 58.7 m -114.86 152.74 31.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.655 -0.653 . . . . 1.04 109.849 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.4 131.06 38.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.559 -0.904 . . . . 1.0600000000000001 108.559 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -67.46 -30.84 70.66 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 1.0600000000000001 111.119 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 65.9 p-90 -87.64 -5.94 58.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.937 -1.102 . . . . 0.51000000000000001 110.651 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.17 132.97 43.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.34000000000000002 109.691 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -74.83 -54.19 5.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.628 -0.67 . . . . 0.40000000000000002 112.019 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.5 -39.58 45.3 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.413 1.409 . . . . 0.47999999999999998 111.603 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.62 5.61 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.631 -1.293 . . . . 0.81000000000000005 109.003 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -60.4 -20.57 60.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 2.46 110.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.1 tpt -60.13 -22.01 62.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 3.6600000000000001 110.556 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 80.2 mt -96.61 14.21 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 1.0700000000000001 111.69 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.65 -33.3 5.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.042 -1.662 . . . . 2.1099999999999999 112.924 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.99 -9.15 18.11 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.69 0.925 . . . . 0.29999999999999999 110.685 -176.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.71 -70.84 0.77 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.37 109.68 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -43.69 -53.2 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.14999999999999999 110.553 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.43 -34.22 75.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.087 -1.008 . . . . 0.47999999999999998 110.022 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 t -60.97 -40.35 93.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.883 -1.135 . . . . 1.05 110.302 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.2 mt -51.49 -19.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.901 -1.124 . . . . 1.1299999999999999 109.334 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -58.36 -28.99 65.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.93000000000000005 109.815 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -95.23 -22.97 17.46 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.083 -1.011 . . . . 2.0 110.27 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -90.87 -20.2 22.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.045 -1.034 . . . . 2.6499999999999999 109.342 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.49 68.92 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.89000000000000001 109.374 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 97.9 p -67.65 -5.65 16.75 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 0.93000000000000005 109.164 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -94.7 1.52 55.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 0.46999999999999997 109.576 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.79 147.77 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.599 -0.889 . . . . 1.03 108.599 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -99.77 127.61 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 1.05 109.567 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -114.74 132.14 56.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.371 -0.831 . . . . 0.11 109.111 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.47 171.14 7.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.793 . . . . 1.04 108.883 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -143.35 145.63 32.85 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.911 -1.144 . . . . 1.3100000000000001 107.911 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.98 139.18 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.086 -1.009 . . . . 1.02 110.375 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.444 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.9 t70 -97.78 89.71 4.71 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.91 -1.144 . . . . 1.0800000000000001 107.91 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.493 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 27.7 m -53.68 -6.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.595 -0.691 . . . . 1.0600000000000001 111.681 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 46.6 m-20 -104.99 -35.17 7.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 110.49 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.51 -9.49 22.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.123 -0.986 . . . . 1.1200000000000001 110.07 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.17 54.5 1.54 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.199 -0.938 . . . . 1.01 109.433 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 60' ' ' ASP . 3.5 mp0 -54.88 -14.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.3 -0.875 . . . . 2.7799999999999998 110.379 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.7 p-10 -69.41 -44.84 70.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.888 -1.133 . . . . 1.1100000000000001 109.989 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.94 -44.62 57.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.081 -1.012 . . . . 1.05 108.692 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.13 86.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 1.0600000000000001 109.236 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 40.0 m -64.5 -47.2 79.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 1.79 109.586 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.37 -38.12 89.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.662 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -4.34 58.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.242 -0.911 . . . . 1.0600000000000001 109.801 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 47.66 65.88 1.17 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.197 -0.939 . . . . 2.3399999999999999 109.866 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.15 130.09 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 1.05 109.272 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -125.79 -5.6 6.9 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.413 -0.804 . . . . 2.9300000000000002 109.349 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.07 129.68 11.51 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.131 -1.062 . . . . 1.0600000000000001 108.131 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.4 p -124.69 157.45 65.77 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.361 -0.837 . . . . 0.97999999999999998 110.04 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -72.93 138.86 57.93 Favored 'Cis proline' 0 N--CA 1.487 1.119 0 O-C-N 122.856 0.924 . . . . 0.23999999999999999 110.946 0.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -108.23 110.0 21.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.077 -1.083 . . . . 1.04 108.077 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -87.84 118.95 27.71 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.229 -0.989 . . . . 0.19 108.835 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -117.2 139.48 50.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.782 -1.192 . . . . 1.71 107.782 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.5 m-85 -110.92 133.85 53.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.13 110.311 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.75 156.32 43.72 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.393 -0.965 . . . . 0.22 108.393 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -155.55 121.54 5.09 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.202 -1.407 . . . . 2.0299999999999998 107.202 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 55.99 33.63 22.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.545 -0.722 . . . . 2.1600000000000001 109.723 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.27 5.25 87.41 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.044 -1.074 . . . . 0.23000000000000001 110.523 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -112.88 145.37 40.82 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.235 -1.156 . . . . 2.8100000000000001 110.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -85.54 141.69 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -0.915 . . . . 2.2599999999999998 109.338 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.55 -34.28 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.466 -0.771 . . . . 1.05 110.128 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.55 -178.17 40.56 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.537 -1.316 . . . . 0.25 110.326 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.46 157.17 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -1.01 . . . . 2.04 110.215 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.67 130.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.904 -0.718 . . . . 0.17999999999999999 110.064 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -102.7 -159.69 0.74 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.255 -0.903 . . . . 0.89000000000000001 108.917 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.58 120.14 0.42 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.05 -1.62 . . . . 0.14000000000000001 109.05 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.43 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -1.188 . . . . 1.0600000000000001 110.656 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 91' ' ' GLY . 30.3 t-20 -139.34 76.75 1.58 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.131 -1.063 . . . . 1.98 108.131 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -64.79 -40.14 94.76 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.967 -0.56 . . . . 1.72 111.074 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -65.82 -26.44 67.68 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.057 -1.027 . . . . 1.95 109.974 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -68.1 -33.07 73.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 2.5600000000000001 109.284 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.2 mt -50.46 -34.73 25.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.052 -1.03 . . . . 1.03 108.52 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.31 -56.77 8.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 2.1499999999999999 109.597 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.84 86.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 1.04 110.548 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 m -66.91 -47.69 71.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.115 -0.991 . . . . 1.04 110.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.29 -48.81 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 1.05 108.842 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.43 -16.84 57.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 1.6599999999999999 109.443 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -78.17 -58.69 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 2.02 110.435 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.24 19.07 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.823 . . . . 1.1399999999999999 110.415 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.021 -0.99 . . . . 1.1799999999999999 109.389 179.596 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.976 0.417 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.493 ' OH ' ' CG1' ' A' ' 59' ' ' VAL . 1.2 p90 -109.06 -164.18 0.92 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.077 -1.015 . . . . 0.0 110.398 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.04 147.39 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.941 0.876 . . . . 0.0 111.788 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.98 95.04 6.32 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.24 46.32 1.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.805 -1.184 . . . . 0.0 109.991 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.3 -130.99 0.13 Allowed Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.01 23.73 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 CA-C-N 119.372 1.586 . . . . 0.0 108.56 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.658 ' H ' ' C ' ' B' ' 9' ' ' GLY . 29.5 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.959 -0.756 . . . . 1.1000000000000001 108.959 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -155.06 121.81 5.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.072 -1.017 . . . . 2.5 109.16 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -91.74 131.73 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 1.6100000000000001 109.621 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -107.1 108.87 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.821 -1.177 . . . . 1.04 107.821 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.75 -5.35 26.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.162 -0.961 . . . . 1.97 110.209 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -152.03 152.95 33.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 0.92000000000000004 110.076 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 68' ' ' GLU . 21.2 tttp -52.32 -31.5 33.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 2.48 109.713 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -61.2 -43.86 98.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 1.05 110.294 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.68 -24.39 64.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 1.0600000000000001 110.196 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.18 -64.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.25 109.964 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.2 -44.4 83.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 3.0699999999999998 109.67 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -58.2 -36.03 72.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.24 -0.913 . . . . 2.1000000000000001 110.171 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.34 86.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 1.04 109.454 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -63.68 -44.41 93.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -0.795 . . . . 1.27 109.525 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.41 -36.87 85.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0900000000000001 109.322 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.74 -17.88 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.002 . . . . 1.0900000000000001 109.483 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -6.43 27.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 1.0700000000000001 109.919 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.79 -112.43 4.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.722 -1.351 . . . . 0.31 109.722 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 47.4 t0 -137.86 4.38 2.53 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.286 -1.126 . . . . 2.21 109.463 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -71.42 170.17 13.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 2.4100000000000001 109.471 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.02 164.08 13.49 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.105 -1.072 . . . . 1.05 108.105 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 10.8 t -146.46 109.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 1.03 109.809 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 t -105.13 134.26 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.41 -0.959 . . . . 1.01 108.41 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.56 140.0 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 1.02 109.864 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -110.47 103.34 11.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.221 -0.659 . . . . 0.95999999999999996 109.221 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 54.6 m-85 -88.45 79.41 7.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.011 -1.107 . . . . 0.32000000000000001 108.011 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -114.17 149.68 35.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.767 -0.583 . . . . 1.04 109.643 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.47 129.01 37.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.868 . . . . 1.0600000000000001 108.699 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -66.6 -22.86 66.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 1.0600000000000001 110.688 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' A' ' 60' ' ' ASP . 52.9 p-90 -89.17 -21.73 23.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.965 -1.085 . . . . 0.51000000000000001 110.406 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.01 119.78 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.34000000000000002 110.017 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.04 -54.57 35.67 Favored Glycine 0 N--CA 1.489 2.181 0 CA-C-O 119.429 -0.651 . . . . 0.40000000000000002 111.72 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -48.03 -35.44 25.56 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.58 1.52 . . . . 0.47999999999999998 111.406 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.84 1.3 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.083 -1.01 . . . . 0.81000000000000005 109.063 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.98 -17.49 38.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 2.46 109.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpt -59.77 -19.59 51.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -0.974 . . . . 3.6600000000000001 109.997 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.7 10.58 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.11 -0.994 . . . . 1.0700000000000001 110.34 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.26 -33.44 7.91 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 120.714 -1.241 . . . . 2.1099999999999999 112.167 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -61.51 -6.54 7.22 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.078 1.064 . . . . 0.29999999999999999 110.59 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -107.9 -74.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.555 -0.716 . . . . 0.37 109.403 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -45.03 -55.9 5.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.299 -0.876 . . . . 0.14999999999999999 110.707 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -66.07 -31.48 72.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.049 -1.032 . . . . 0.47999999999999998 109.89 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' SER . 2.8 t -64.07 -40.42 96.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.924 -1.11 . . . . 1.05 110.189 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 mt -51.57 -12.6 0.18 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 1.1299999999999999 109.979 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' SER . 27.8 m -56.44 -38.56 71.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.835 -1.165 . . . . 0.93000000000000005 109.566 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.14 -11.18 33.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.305 -0.872 . . . . 2.0 109.875 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.61 -53.26 4.73 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.3 -1.0 . . . . 2.6499999999999999 108.3 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.442 ' C ' ' H ' ' A' ' 51' ' ' ASN . 57.1 m-85 -108.19 72.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.342 -0.849 . . . . 0.89000000000000001 109.789 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 p -66.7 -1.6 3.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.93000000000000005 108.602 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 49' ' ' TYR . 24.6 t-20 -95.3 -4.38 45.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.46999999999999997 109.541 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.2 t -116.75 150.5 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.947 -0.76 . . . . 1.03 108.947 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mm -100.45 132.24 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.421 -0.799 . . . . 1.05 109.088 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.77 134.83 54.79 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.335 -0.853 . . . . 0.11 109.5 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.5 171.36 7.77 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.762 -0.829 . . . . 1.04 108.762 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.06 142.49 30.68 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.946 -1.131 . . . . 1.3100000000000001 107.946 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.3 141.16 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.148 -0.97 . . . . 1.02 110.246 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.1 93.86 6.51 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.819 -1.178 . . . . 1.0800000000000001 107.819 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -54.35 -3.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 1.0600000000000001 111.47 -178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 58' ' ' ASP . 6.2 m-20 -113.15 -37.35 4.78 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 111.231 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -95.42 -16.8 22.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.887 -1.133 . . . . 1.1200000000000001 109.619 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.81 49.92 1.58 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.54 -0.911 . . . . 1.01 108.54 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.458 ' CB ' HH21 ' B' ' 4' ' ' ARG . 8.1 pt20 -54.98 -14.5 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.514 -0.741 . . . . 2.7799999999999998 110.054 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -38.35 73.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.927 -1.108 . . . . 1.1100000000000001 109.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.42 -47.51 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.007 . . . . 1.05 108.644 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.85 78.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.809 . . . . 1.0600000000000001 109.351 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.3 m -64.31 -50.31 68.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 1.79 109.663 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 8' ' ' LYS . 69.5 tt0 -63.47 -33.27 75.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 2.2000000000000002 109.803 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.93 0.41 55.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.094 -1.004 . . . . 1.0600000000000001 109.538 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 48.95 54.19 11.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 110.157 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.28 129.53 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 1.05 109.037 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -122.65 -3.58 8.76 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.465 -0.772 . . . . 2.9300000000000002 109.733 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.58 141.53 21.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.116 -0.99 . . . . 1.0600000000000001 109.451 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 p -121.02 150.31 53.03 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.681 -0.859 . . . . 0.97999999999999998 108.681 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.25 149.8 90.29 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.749 -0.938 . . . . 0.23999999999999999 110.127 -2.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.91 124.77 49.09 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.855 -1.165 . . . . 1.04 107.855 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -102.35 115.7 31.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.269 -1.011 . . . . 0.19 108.269 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 5.2 mt-30 -116.58 139.96 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.012 -1.107 . . . . 1.71 108.012 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -109.54 126.52 53.66 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.48 0.657 . . . . 0.13 110.065 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -123.0 154.78 38.0 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.205 -1.035 . . . . 0.22 108.205 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -155.87 123.76 5.67 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.965 -1.124 . . . . 2.0299999999999998 107.965 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 56.84 20.74 5.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.726 -0.609 . . . . 2.1600000000000001 110.088 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.586 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 94.22 -1.48 67.33 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.074 -1.016 . . . . 0.23000000000000001 110.579 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.586 HE21 ' C ' ' A' ' 83' ' ' GLY . 15.5 mm-40 -110.79 148.02 33.24 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.112 -1.228 . . . . 2.8100000000000001 110.56 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.526 ' CB ' ' HZ1' ' A' ' 85' ' ' LYS . 3.4 ttmp? -86.6 139.98 30.29 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.522 -0.918 . . . . 2.2599999999999998 108.522 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -122.34 -21.44 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.454 -0.779 . . . . 1.05 110.704 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.74 174.92 47.17 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.425 -1.369 . . . . 0.25 110.209 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.75 155.75 2.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -1.14 . . . . 2.04 110.531 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -169.76 135.06 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.685 -0.634 . . . . 0.17999999999999999 109.875 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.408 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 18.8 p -107.2 -178.76 3.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.341 -0.85 . . . . 0.89000000000000001 108.898 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.41 134.0 8.34 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.446 -1.462 . . . . 0.14000000000000001 109.446 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.75 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -1.195 . . . . 1.0600000000000001 110.261 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.82 73.21 1.42 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.936 -1.135 . . . . 1.98 107.936 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -34.86 78.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 1.72 110.84 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.38 -25.03 67.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.991 -1.068 . . . . 1.95 109.354 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -69.1 -38.12 78.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.372 -0.83 . . . . 2.5600000000000001 109.726 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 mt -51.23 -36.51 42.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.919 -1.113 . . . . 1.03 109.077 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.45 -56.63 10.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.851 . . . . 2.1499999999999999 109.573 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.94 86.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 1.04 110.398 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 m -67.47 -47.41 70.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.137 -0.977 . . . . 1.04 109.818 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -60.94 -49.4 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 1.05 108.46 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.55 -17.71 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 1.6599999999999999 109.62 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.2 -60.35 2.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 2.02 109.928 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.11 21.54 5.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.492 -0.755 . . . . 1.1399999999999999 110.307 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 1.1799999999999999 109.197 179.454 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.458 HH21 ' CB ' ' A' ' 63' ' ' GLN . 5.8 mmt180 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -113.17 -171.77 1.93 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.068 -1.02 . . . . 0.0 111.002 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.91 144.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.912 0.863 . . . . 0.0 113.072 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -101.7 93.81 5.52 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.408 ' OE2' ' OG ' ' A' ' 90' ' ' SER . 10.6 pt-20 -85.04 44.7 1.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.07 . . . . 0.0 110.843 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.27 -133.46 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.36 18.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.23 1.515 . . . . 0.0 109.639 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.686 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.3 t . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.467 -0.771 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 t . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.299 -0.63 . . . . 1.1000000000000001 109.299 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.69 119.77 5.83 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.923 -1.139 . . . . 2.5 107.923 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -86.95 144.1 27.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.974 -1.079 . . . . 1.6100000000000001 110.362 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mm -111.05 108.64 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.884 -1.154 . . . . 1.04 107.884 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.65 -12.56 19.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 1.97 109.489 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -153.55 155.12 35.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 0.92000000000000004 109.631 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -51.35 -21.25 2.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 2.48 109.436 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.57 -52.9 62.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 1.05 110.435 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -20.45 63.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 1.0600000000000001 110.275 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.37 -65.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.059 -1.026 . . . . 0.25 110.19 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.37 -45.07 84.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 3.0699999999999998 109.633 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -59.0 -34.44 71.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.985 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.38 81.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.916 -1.115 . . . . 1.04 109.332 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.74 -45.97 84.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.227 -0.921 . . . . 1.27 109.447 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -63.78 -37.41 87.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.466 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.76 -16.93 52.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 1.0900000000000001 109.472 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.78 27.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 1.0700000000000001 109.522 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.38 -111.0 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.742 -1.343 . . . . 0.31 109.742 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -138.1 3.57 2.42 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.391 -1.064 . . . . 2.21 109.349 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.29 169.05 14.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.164 -0.96 . . . . 2.4100000000000001 108.916 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 162.32 12.2 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.035 -1.098 . . . . 1.05 108.035 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -144.18 103.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.831 -1.168 . . . . 1.03 109.628 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.27 129.92 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.563 -0.903 . . . . 1.01 108.563 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.16 141.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -0.762 . . . . 1.02 109.548 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -110.97 99.1 8.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.957 -0.757 . . . . 0.95999999999999996 108.957 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 52.0 m-85 -84.82 81.41 8.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.632 -1.248 . . . . 0.32000000000000001 107.632 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -109.89 -163.87 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.563 0.697 . . . . 1.04 109.147 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.53 119.93 13.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.151 -1.055 . . . . 1.0600000000000001 108.151 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -63.21 -24.02 67.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.565 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -89.64 -14.87 33.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.51000000000000001 110.118 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 t -93.77 133.73 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.34000000000000002 109.706 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -72.77 -57.76 5.21 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 111.337 -0.705 . . . . 0.40000000000000002 111.337 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.5 Cg_exo -49.24 -37.27 39.32 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.779 1.652 . . . . 0.47999999999999998 111.414 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.46 -62.62 1.56 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.857 -1.152 . . . . 0.81000000000000005 109.069 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -59.0 -20.05 49.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 2.46 109.676 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.4 tpt -60.57 -18.04 50.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.322 -0.861 . . . . 3.6600000000000001 109.662 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.51 10.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.289 -0.882 . . . . 1.0700000000000001 110.412 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.59 -32.3 5.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.416 -1.427 . . . . 2.1099999999999999 112.386 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -63.07 -5.09 7.17 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 CA-C-N 119.865 0.988 . . . . 0.29999999999999999 110.29 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.8 -77.51 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.928 -0.767 . . . . 0.37 108.928 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -42.44 -56.63 2.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.14999999999999999 110.998 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -65.73 -33.32 75.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.103 -0.998 . . . . 0.47999999999999998 109.688 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 14.5 m -64.36 -39.89 94.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 1.05 109.997 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -51.85 -16.54 0.72 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.025 -1.047 . . . . 1.1299999999999999 109.72 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -57.01 -29.46 63.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.93000000000000005 109.737 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -95.95 -21.4 18.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 2.0 110.162 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -90.32 -19.7 23.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.053 -1.029 . . . . 2.6499999999999999 109.41 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.15 64.65 1.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.39 -0.819 . . . . 0.89000000000000001 109.209 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 p -66.9 -4.43 9.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.337 -0.852 . . . . 0.93000000000000005 109.027 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -95.05 2.31 55.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.445 -0.784 . . . . 0.46999999999999997 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -119.0 150.03 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.157 -0.683 . . . . 1.03 109.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.79 122.31 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 1.05 108.982 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -109.74 129.84 55.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.254 -0.904 . . . . 0.11 108.969 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.3 mp -112.7 169.63 8.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.336 -0.852 . . . . 1.04 108.807 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -142.06 140.39 32.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.602 -1.259 . . . . 1.3100000000000001 107.602 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.2 136.94 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.898 . . . . 1.02 110.741 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.99 107.68 20.26 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.645 -1.243 . . . . 1.0800000000000001 107.645 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.3 m -65.14 -9.68 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 1.0600000000000001 111.06 -178.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -101.03 -41.69 6.68 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 110.704 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -12.48 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 1.1200000000000001 109.91 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.31 49.63 1.88 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.311 -0.868 . . . . 1.01 108.836 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.08 -17.01 5.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.721 . . . . 2.7799999999999998 109.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.4 p30 -70.33 -41.29 73.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.433 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -74.18 -45.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 1.05 108.674 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.27 79.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.282 -0.886 . . . . 1.0600000000000001 108.779 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -64.04 -44.79 91.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.369 -0.832 . . . . 1.79 109.265 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.59 -39.11 93.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.449 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.71 55.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.186 -0.946 . . . . 1.0600000000000001 109.909 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 47.65 56.21 7.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.06 -1.025 . . . . 2.3399999999999999 109.748 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.9 t -79.52 131.27 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 1.05 109.588 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -128.8 0.96 5.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.385 -0.822 . . . . 2.9300000000000002 109.669 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.0 128.65 10.8 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.966 -1.084 . . . . 1.0600000000000001 108.771 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.476 ' O ' ' N ' ' B' ' 8' ' ' GLU . 11.2 p -114.77 150.43 44.03 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.733 -0.84 . . . . 0.97999999999999998 108.733 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.54 147.47 84.66 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 C-N-CA 124.776 -0.927 . . . . 0.23999999999999999 109.941 -1.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.56 117.42 28.93 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.938 -1.134 . . . . 1.04 107.938 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.78 121.48 33.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.07 -1.019 . . . . 0.19 108.494 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.504 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.1 mt-30 -120.05 136.38 54.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.783 -1.191 . . . . 1.71 107.783 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 32.3 m-85 -108.97 129.43 55.44 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.581 0.705 . . . . 0.13 109.978 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -126.24 156.92 39.52 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.263 -1.014 . . . . 0.22 108.263 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -155.39 120.23 4.79 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.485 -1.302 . . . . 2.0299999999999998 107.485 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt 55.97 29.14 13.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -0.783 . . . . 2.1600000000000001 108.909 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.13 7.8 87.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.896 -1.281 . . . . 0.23000000000000001 109.896 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -112.85 142.41 45.54 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.469 -1.018 . . . . 2.8100000000000001 110.643 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -84.77 141.37 30.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 2.2599999999999998 109.314 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.34 -20.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.426 -0.796 . . . . 1.05 110.452 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.24 172.97 45.53 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.346 -1.407 . . . . 0.25 110.435 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -174.22 150.68 1.54 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.447 -1.031 . . . . 2.04 110.044 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -169.09 133.18 1.41 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.17999999999999999 110.48 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.405 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 17.3 p -103.55 -169.55 1.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.89000000000000001 108.929 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.13 129.88 3.67 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.669 -1.372 . . . . 0.14000000000000001 109.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.87 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -1.16 . . . . 1.0600000000000001 110.602 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -139.46 76.68 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.828 -1.175 . . . . 1.98 107.828 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -32.55 74.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.654 -0.654 . . . . 1.72 110.656 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.66 -28.35 69.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.906 -1.121 . . . . 1.95 109.146 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.71 -35.23 76.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 2.5600000000000001 109.322 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.4 mt -52.07 -38.99 59.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 1.03 108.823 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -57.63 6.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.578 -0.701 . . . . 2.1499999999999999 109.785 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.32 82.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.04 110.494 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.2 m -66.78 -45.79 77.36 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 1.04 110.163 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.68 -52.37 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 1.05 109.214 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -60.52 -18.09 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 1.6599999999999999 109.449 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -77.39 -62.72 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 2.02 110.202 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.33 24.39 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.558 -0.714 . . . . 1.1399999999999999 110.437 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.937 -1.102 . . . . 1.1799999999999999 109.165 179.541 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.45 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.4 p90 -109.55 -168.39 1.32 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.259 -0.901 . . . . 0.0 110.461 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.67 150.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.266 -0.896 . . . . 0.0 112.57 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.9 m -101.4 96.53 7.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.6 pt-20 -83.25 44.76 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 110.279 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.89 -131.43 0.12 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.08 23.98 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.273 1.537 . . . . 0.0 109.129 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.648 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.6 t . . . . . 0 N--CA 1.486 1.348 0 O-C-N 121.354 -0.842 . . . . 0.0 109.335 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 78.9 t . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.3 0.571 . . . . 1.1000000000000001 109.588 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.411 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 33.6 tttt -155.96 123.32 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 2.5 109.224 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -90.45 132.52 35.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 1.6100000000000001 109.645 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -112.51 103.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.548 -0.908 . . . . 1.04 108.548 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -99.19 -4.46 32.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.204 -0.935 . . . . 1.97 109.852 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 p -151.18 148.9 28.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.112 -0.992 . . . . 0.92000000000000004 109.96 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -52.31 -25.59 9.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.319 -0.863 . . . . 2.48 109.552 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.7 m -59.7 -48.92 79.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 1.05 109.34 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -23.62 62.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 1.0600000000000001 109.733 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -58.28 -66.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.25 110.198 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -56.27 -44.62 79.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 3.0699999999999998 109.669 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -58.91 -35.11 72.52 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 109.804 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 1.04 108.898 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.21 -43.52 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.578 -0.702 . . . . 1.27 109.318 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 -38.2 90.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 1.0900000000000001 109.681 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.19 -16.08 55.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 1.0900000000000001 109.909 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.28 50.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 1.0700000000000001 109.889 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 -112.94 4.76 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.31 -1.516 . . . . 0.31 109.31 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -134.71 2.54 3.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.435 -1.038 . . . . 2.21 109.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -70.28 166.87 19.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.044 -1.035 . . . . 2.4100000000000001 108.689 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.585 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.39 163.36 10.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 1.05 108.834 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.585 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.2 t -144.6 107.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 1.03 109.402 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.38 135.5 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.556 -0.905 . . . . 1.01 108.556 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.15 133.44 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 1.02 109.894 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -106.44 102.96 12.31 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.98 -0.748 . . . . 0.95999999999999996 108.98 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -88.45 79.43 7.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.603 -1.258 . . . . 0.32000000000000001 107.603 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -113.3 149.27 34.16 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.225 0.536 . . . . 1.04 109.613 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.89 129.57 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.858 . . . . 1.0600000000000001 109.082 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.45 -23.97 65.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0600000000000001 110.118 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.8 p-90 -89.1 -16.88 30.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.061 -1.024 . . . . 0.51000000000000001 110.176 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.48 124.71 37.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.965 . . . . 0.34000000000000002 110.291 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.76 -57.75 11.67 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.972 -0.851 . . . . 0.40000000000000002 110.972 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -46.18 -36.07 16.19 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 121.908 1.739 . . . . 0.47999999999999998 111.359 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.0 -60.31 2.41 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.672 -1.267 . . . . 0.81000000000000005 108.991 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -59.91 -18.39 44.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.489 -0.757 . . . . 2.46 110.029 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.4 tpt -59.68 -24.77 64.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 3.6600000000000001 110.155 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 72.3 mt -96.91 6.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.142 -0.974 . . . . 1.0700000000000001 111.371 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -62.58 -34.39 14.52 Favored Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 118.194 -1.402 . . . . 2.1099999999999999 111.64 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -62.32 -5.9 7.48 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 CA-C-N 120.009 1.039 . . . . 0.29999999999999999 110.524 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.83 -71.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.37 108.958 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -46.06 -58.5 3.55 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.488 -0.757 . . . . 0.14999999999999999 110.733 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.24 -30.49 71.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.47999999999999998 109.714 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.3 m -63.54 -41.17 98.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.855 -1.153 . . . . 1.05 109.735 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -52.01 -16.92 0.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 1.1299999999999999 109.575 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 66.6 m -56.93 -31.37 64.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.93000000000000005 109.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.92 -19.72 20.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.127 -0.983 . . . . 2.0 109.906 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -90.94 -21.38 21.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 2.6499999999999999 109.774 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.22 67.71 1.5 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.89000000000000001 109.231 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -68.01 -3.97 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.413 -0.805 . . . . 0.93000000000000005 109.322 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.5 t30 -94.94 2.22 55.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 109.719 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.1 t -119.12 152.99 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.811 -0.811 . . . . 1.03 108.811 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 mm -100.44 128.64 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.306 -0.871 . . . . 1.05 108.911 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -114.58 132.9 56.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.407 -0.808 . . . . 0.11 109.144 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.31 169.0 9.47 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.083 -0.71 . . . . 1.04 109.083 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -144.25 141.1 29.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.196 -1.039 . . . . 1.3100000000000001 108.196 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.15 145.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.103 -0.998 . . . . 1.02 110.425 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' A' ' 60' ' ' ASP . 19.2 t70 -101.32 100.92 11.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.219 -1.03 . . . . 1.0800000000000001 108.219 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.09 -3.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 111.287 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 58' ' ' ASP . 27.1 m-20 -108.79 -40.94 4.9 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.203 -0.936 . . . . 1.1100000000000001 111.095 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.21 -23.43 16.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.891 -1.131 . . . . 1.1200000000000001 110.036 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.0 46.34 0.98 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.352 -0.981 . . . . 1.01 108.352 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -53.53 -14.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.731 -0.606 . . . . 2.7799999999999998 109.9 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -71.2 -42.98 68.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.316 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.19 -43.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.143 -0.973 . . . . 1.05 108.696 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -35.55 79.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.453 -0.943 . . . . 1.0600000000000001 108.453 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 m -64.69 -46.98 80.07 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.754 -0.832 . . . . 1.79 108.754 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.57 -39.42 94.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 2.2000000000000002 109.35 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -3.15 58.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 1.0600000000000001 109.603 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 66' ' ' ALA . 52.3 mm-40 47.47 53.01 11.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.873 . . . . 2.3399999999999999 110.352 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.96 136.14 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 1.05 109.413 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -129.88 3.86 4.92 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.476 -0.765 . . . . 2.9300000000000002 109.5 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.505 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 136.26 16.27 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.128 -0.982 . . . . 1.0600000000000001 108.883 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -118.55 150.79 48.76 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.945 -0.761 . . . . 0.97999999999999998 108.945 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.76 145.92 80.39 Favored 'Cis proline' 0 N--CA 1.482 0.848 0 N-CA-C 109.778 -0.893 . . . . 0.23999999999999999 109.778 -1.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.6 112.47 22.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.513 -1.292 . . . . 1.04 107.513 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.56 113.8 26.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.426 -0.91 . . . . 0.19 108.686 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -115.91 138.68 50.95 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.443 -1.317 . . . . 1.71 107.443 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -110.11 127.23 54.77 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.374 0.607 . . . . 0.13 109.756 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -121.45 157.18 31.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.541 -0.911 . . . . 0.22 108.541 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -155.73 123.53 5.65 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.491 -1.3 . . . . 2.0299999999999998 107.491 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt 57.07 17.81 3.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.687 -0.633 . . . . 2.1600000000000001 109.89 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.572 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.72 0.18 62.59 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.416 -1.074 . . . . 0.23000000000000001 110.416 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.572 HE21 ' C ' ' A' ' 83' ' ' GLY . 23.6 mm-40 -111.87 151.1 29.51 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.184 -1.186 . . . . 2.8100000000000001 110.033 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.398 -0.814 . . . . 2.2599999999999998 109.316 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.87 -7.03 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.735 . . . . 1.05 110.542 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.93 167.77 35.29 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.445 -1.36 . . . . 0.25 110.284 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.95 153.2 2.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 2.04 110.604 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 8.2 p90 -169.66 132.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.17999999999999999 109.603 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.7 p -104.23 -162.28 0.88 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.015 -1.053 . . . . 0.89000000000000001 109.183 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.14 137.1 1.08 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.325 -1.51 . . . . 0.14000000000000001 109.325 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.49 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 1.0600000000000001 110.094 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.46 66.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.868 -1.16 . . . . 1.98 107.868 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -62.24 -38.94 91.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.816 -0.552 . . . . 1.72 111.262 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.58 -27.33 68.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.596 -1.315 . . . . 1.95 109.497 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.19 -32.77 73.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 2.5600000000000001 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.9 mt -51.4 -36.88 45.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 1.03 108.687 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.34 -59.64 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.527 -0.733 . . . . 2.1499999999999999 109.848 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.47 81.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 1.04 110.741 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.8 m -67.84 -45.28 75.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 1.04 110.211 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.55 -51.24 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 1.05 109.157 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.71 -17.22 46.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 1.6599999999999999 109.634 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.95 -61.26 1.99 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 2.02 110.015 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.9 21.33 5.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.424 -0.797 . . . . 1.1399999999999999 110.391 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.017 -1.052 . . . . 1.1799999999999999 109.414 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -125.35 -173.97 2.95 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.16 149.72 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.006 0.908 . . . . 0.0 112.496 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.55 95.69 6.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.89 41.59 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.03 -1.044 . . . . 0.0 110.361 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -129.4 0.05 OUTLIER Glycine 0 N--CA 1.485 1.915 0 N-CA-C 106.898 -2.481 . . . . 0.0 106.898 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.71 22.67 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.307 1.553 . . . . 0.0 109.119 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.646 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.546 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 78.3 t . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.41 -0.589 . . . . 1.1000000000000001 109.41 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.473 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 43.7 tttp -151.92 121.54 6.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.234 -0.916 . . . . 2.5 109.073 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -88.29 132.04 34.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 1.6100000000000001 109.709 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.97 107.46 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.228 -1.027 . . . . 1.04 108.228 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.58 -10.33 22.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.201 -0.937 . . . . 1.97 109.646 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 p -153.51 157.49 39.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.92000000000000004 109.95 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -53.02 -30.38 35.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 2.48 109.916 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 m -59.49 -45.1 92.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.05 110.25 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.06 -26.48 64.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.795 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.02 -69.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.973 . . . . 0.25 110.237 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -54.38 -43.16 71.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 3.0699999999999998 109.603 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -59.0 -36.36 74.8 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.171 -0.956 . . . . 2.1000000000000001 109.643 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.63 85.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.032 -1.043 . . . . 1.04 109.013 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.18 -44.49 88.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.735 . . . . 1.27 109.877 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -62.92 -45.73 91.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 1.0900000000000001 109.826 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.95 59.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 109.876 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.79 -10.53 57.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.084 -1.01 . . . . 1.0700000000000001 109.649 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.61 13.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.31 109.612 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' NZ ' ' A' ' 81' ' ' LYS . 46.1 t0 -121.17 2.81 10.4 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.586 -0.949 . . . . 2.21 109.925 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.25 169.98 9.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.902 -1.123 . . . . 2.4100000000000001 109.367 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.53 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.0 162.43 19.36 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.19 -1.041 . . . . 1.05 108.19 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.53 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 4.8 t -145.26 102.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.981 -1.074 . . . . 1.03 109.111 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.42 127.54 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.485 -0.76 . . . . 1.01 109.069 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.0 138.32 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.606 -0.684 . . . . 1.02 109.764 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -108.86 99.46 8.8 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.974 -0.751 . . . . 0.95999999999999996 108.974 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.6 m-85 -82.96 77.26 9.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.794 -1.187 . . . . 0.32000000000000001 107.794 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -103.98 -166.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.574 0.702 . . . . 1.04 109.433 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 127.98 21.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.863 -0.791 . . . . 1.0600000000000001 108.863 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 1.0600000000000001 111.194 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.515 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.7 p-90 -86.74 -11.05 52.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.768 -1.208 . . . . 0.51000000000000001 110.09 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.84 117.38 30.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.34000000000000002 109.981 -179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.63 -55.19 31.32 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 120.865 -0.683 . . . . 0.40000000000000002 111.419 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.1 Cg_exo -49.59 -35.7 38.31 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.814 1.676 . . . . 0.47999999999999998 111.11 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.34 -62.64 1.59 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.951 -1.093 . . . . 0.81000000000000005 109.055 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.62 -16.93 29.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.476 -0.765 . . . . 2.46 110.163 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -61.48 -19.37 61.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.083 -1.011 . . . . 3.6600000000000001 110.222 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 72.2 mt -100.48 13.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 110.718 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.51 -32.1 2.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.469 -1.394 . . . . 2.1099999999999999 112.607 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.7 Cg_exo -63.79 -4.06 6.64 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 119.793 0.962 . . . . 0.29999999999999999 110.268 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 42' ' ' PHE . 42.0 m-85 -110.9 -79.47 0.58 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.404 -0.81 . . . . 0.37 108.907 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.62 -57.12 1.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.566 . . . . 0.14999999999999999 110.79 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.07 -30.72 70.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.47999999999999998 109.834 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 11.2 m -66.76 -38.62 86.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 1.05 110.284 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -49.45 -20.25 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.935 -1.103 . . . . 1.1299999999999999 109.772 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.546 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 39.0 m -56.71 -22.94 38.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.93000000000000005 110.105 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -97.07 -26.46 14.98 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.15 -0.969 . . . . 2.0 110.239 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.13 -17.76 27.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.077 -1.014 . . . . 2.6499999999999999 109.56 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -134.16 70.19 1.45 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.377 -0.827 . . . . 0.89000000000000001 109.39 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.6 p -68.51 -6.23 24.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.423 -0.798 . . . . 0.93000000000000005 109.12 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.2 3.31 54.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.448 -0.782 . . . . 0.46999999999999997 110.052 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.69 148.54 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 1.03 109.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mm -99.23 121.73 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 1.05 108.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.84 128.39 54.86 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.878 . . . . 0.11 108.937 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.7 mp -110.2 170.41 8.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.504 -0.747 . . . . 1.04 109.023 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -140.82 137.93 33.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.634 -1.247 . . . . 1.3100000000000001 107.634 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.69 134.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.913 . . . . 1.02 110.336 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.14 110.31 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.63 -1.248 . . . . 1.0800000000000001 107.63 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.23 -11.35 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 1.0600000000000001 111.346 -178.251 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.515 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 12.1 m-20 -104.76 -38.92 6.51 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 110.793 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.52 -13.62 27.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.693 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.46 49.14 1.94 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.306 -0.998 . . . . 1.01 108.306 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 26.1 mt-30 -56.11 -16.42 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 2.7799999999999998 110.755 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -39.43 76.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.853 -1.154 . . . . 1.1100000000000001 109.304 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.8 -47.12 44.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.201 -0.937 . . . . 1.05 108.84 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.86 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.847 . . . . 1.0600000000000001 109.333 179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 45.0 m -62.78 -50.13 72.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 1.79 109.26 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.54 -32.33 73.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.635 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.98 0.11 56.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.238 -0.913 . . . . 1.0600000000000001 109.816 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 47.41 50.01 15.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 2.3399999999999999 110.097 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.61 131.94 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 1.05 109.064 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -129.12 6.71 5.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.331 -0.855 . . . . 2.9300000000000002 109.661 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 144.29 24.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.402 -0.962 . . . . 1.0600000000000001 108.402 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.442 ' O ' ' OE1' ' B' ' 8' ' ' GLU . 32.5 p -131.01 149.12 72.87 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 108.546 -0.909 . . . . 0.97999999999999998 108.546 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -79.09 142.69 68.3 Favored 'Cis proline' 0 N--CA 1.487 1.134 0 C-N-CA 124.966 -0.848 . . . . 0.23999999999999999 110.219 -1.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.01 111.06 21.52 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 107.862 -1.162 . . . . 1.04 107.862 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.15 116.0 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.822 -1.174 . . . . 0.19 109.541 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.3 mt-30 -115.96 132.12 56.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.207 -1.405 . . . . 1.71 107.207 179.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -105.14 127.51 52.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.13 109.66 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -121.78 155.46 35.24 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.92 -0.77 . . . . 0.22 108.92 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.463 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.8 tttm -154.96 123.65 6.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.737 -1.208 . . . . 2.0299999999999998 107.737 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 55.95 28.88 13.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.529 -0.732 . . . . 2.1600000000000001 109.827 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.07 -0.1 89.49 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.089 -1.053 . . . . 0.23000000000000001 110.815 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -110.98 147.88 33.75 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.144 -1.209 . . . . 2.8100000000000001 110.475 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.56 ' CB ' ' HZ1' ' A' ' 85' ' ' LYS . 3.2 ttmp? -87.87 143.84 26.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 2.2599999999999998 109.339 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.1 m -123.59 -24.0 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.497 -0.752 . . . . 1.05 110.15 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.29 177.18 47.87 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.586 -1.292 . . . . 0.25 109.975 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.19 157.21 3.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 2.04 110.057 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.5 p90 -168.76 131.16 1.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.807 . . . . 0.17999999999999999 110.161 178.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -101.48 -161.16 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.559 -0.904 . . . . 0.89000000000000001 108.559 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' B' ' 8' ' ' GLU . . . 82.43 126.5 0.98 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.104 -1.598 . . . . 0.14000000000000001 109.104 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -1.203 . . . . 1.0600000000000001 110.891 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -142.73 76.61 1.54 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.967 -1.123 . . . . 1.98 107.967 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -32.4 73.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.72 110.774 -178.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.13 -25.23 67.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.93 -1.106 . . . . 1.95 109.372 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -70.86 -37.23 73.09 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.3 -0.875 . . . . 2.5600000000000001 109.852 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.5 mt -52.17 -36.03 50.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 1.03 108.962 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -66.09 -59.21 4.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.431 -0.793 . . . . 2.1499999999999999 110.071 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.53 82.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.04 110.676 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.4 m -67.22 -45.22 77.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.072 -1.017 . . . . 1.04 110.192 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.04 -53.03 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.191 -0.943 . . . . 1.05 109.127 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -59.19 -18.53 37.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 1.6599999999999999 109.471 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.54 -56.56 4.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 2.02 110.08 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -92.96 15.47 14.88 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.495 -0.753 . . . . 1.1399999999999999 110.613 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.872 -1.143 . . . . 1.1799999999999999 109.403 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -109.28 -169.78 1.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.177 -0.952 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.63 150.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-O 122.09 0.948 . . . . 0.0 112.875 -176.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -102.24 96.28 6.87 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -82.88 47.86 1.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 110.131 -179.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -78.16 -125.28 0.35 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 177.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.9 25.67 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.495 1.648 . . . . 0.0 109.54 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.622 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.4 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 95.3 t . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.496 -0.557 . . . . 1.1000000000000001 109.496 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 37.8 tptt -154.5 125.21 7.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.274 -0.891 . . . . 2.5 109.212 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -90.26 131.66 35.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 1.6100000000000001 109.668 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.32 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.403 -0.962 . . . . 1.04 108.403 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.63 -1.33 47.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 1.97 109.791 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -150.99 146.93 26.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.92000000000000004 109.813 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -51.83 -29.5 19.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.34 -0.85 . . . . 2.48 109.831 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -59.04 -45.66 90.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 1.05 109.799 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.44 63.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 109.681 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.99 -66.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.061 -1.024 . . . . 0.25 109.786 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -53.65 -46.09 70.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.207 -0.933 . . . . 3.0699999999999998 109.728 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.98 -35.13 72.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.152 -0.967 . . . . 2.1000000000000001 110.022 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.53 -46.24 90.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.995 -1.065 . . . . 1.04 109.296 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.4 -50.19 68.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 1.27 109.717 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.29 -36.59 84.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.474 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.58 -18.66 47.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -0.927 . . . . 1.0900000000000001 109.682 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.8 23.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 1.0700000000000001 109.73 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 70.97 -116.11 6.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.31 109.642 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.451 ' CG ' ' HZ2' ' A' ' 82' ' ' LYS . 84.1 m-20 -135.22 4.01 3.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.442 -1.034 . . . . 2.21 109.408 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -69.8 170.07 11.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.047 -1.033 . . . . 2.4100000000000001 109.013 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.523 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 159.89 22.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.71 -1.218 . . . . 1.05 107.71 179.574 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.523 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 16.1 t -143.56 108.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.865 -1.147 . . . . 1.03 109.374 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.95 134.47 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.912 -0.773 . . . . 1.01 108.912 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.66 136.08 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.665 -0.647 . . . . 1.02 109.523 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.37 101.95 11.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.017 -0.735 . . . . 0.95999999999999996 109.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -85.25 77.84 9.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.041 -1.096 . . . . 0.32000000000000001 108.041 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -113.92 146.47 40.02 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.16 -0.682 . . . . 1.04 109.16 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.56 130.51 36.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 1.0600000000000001 108.751 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -65.88 -24.57 66.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 1.0600000000000001 110.311 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.427 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 58.5 p-90 -88.54 -17.35 30.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.082 -1.011 . . . . 0.51000000000000001 109.888 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.82 116.18 28.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.34000000000000002 110.135 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.16 -53.14 47.21 Favored Glycine 0 N--CA 1.488 2.123 0 CA-C-O 119.341 -0.699 . . . . 0.40000000000000002 111.854 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.7 Cg_exo -48.38 -38.79 35.13 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.534 1.489 . . . . 0.47999999999999998 111.148 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.4 -59.67 2.64 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.727 -1.233 . . . . 0.81000000000000005 109.015 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.49 -18.63 52.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.739 . . . . 2.46 110.295 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm -57.93 -19.55 30.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.79 -1.194 . . . . 3.6600000000000001 110.257 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 77.4 mt -101.5 15.02 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.136 -0.977 . . . . 1.0700000000000001 110.39 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.75 -32.21 3.43 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.618 -1.301 . . . . 2.1099999999999999 112.56 179.727 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.6 Cg_exo -63.08 -5.21 7.41 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.883 0.994 . . . . 0.29999999999999999 110.165 -178.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.08 -76.73 0.6 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.475 -0.766 . . . . 0.37 109.203 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.14999999999999999 110.787 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.5 -31.52 72.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.93 -1.106 . . . . 0.47999999999999998 110.025 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 46' ' ' SER . 4.5 m -64.64 -38.82 92.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.818 -1.176 . . . . 1.05 110.039 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -50.25 -12.62 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.926 -1.109 . . . . 1.1299999999999999 109.776 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 44' ' ' SER . 19.4 m -56.76 -37.34 70.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.084 -1.01 . . . . 0.93000000000000005 109.665 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -94.97 -13.32 25.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.232 -0.918 . . . . 2.0 110.283 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -27.5 19.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.002 -1.062 . . . . 2.6499999999999999 109.572 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.42 72.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.088 -0.708 . . . . 0.89000000000000001 109.088 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.1 p -67.02 -4.48 9.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.93000000000000005 109.215 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.0 t30 -96.1 -3.17 45.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.46999999999999997 109.829 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.45 150.12 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.452 -0.78 . . . . 1.03 109.603 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.1 130.48 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.534 -0.729 . . . . 1.05 109.412 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -115.03 132.53 56.57 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.554 -0.716 . . . . 0.11 109.192 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.66 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.743 -0.836 . . . . 1.04 108.743 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.68 138.9 32.79 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.44 136.9 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.163 -0.961 . . . . 1.02 110.887 -178.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' A' ' 60' ' ' ASP . 11.4 t70 -98.78 102.78 14.62 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.268 -1.012 . . . . 1.0800000000000001 108.268 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 16.3 m -61.06 -0.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 111.56 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.427 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 18.0 m-20 -115.18 -37.86 3.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.102 -0.999 . . . . 1.1100000000000001 111.053 -178.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -94.96 -14.26 24.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.997 -1.064 . . . . 1.1200000000000001 109.766 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.58 52.84 1.6 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.709 -0.848 . . . . 1.01 108.709 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.93 -19.23 4.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.431 -0.793 . . . . 2.7799999999999998 110.173 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -68.02 -39.57 83.11 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.18 -1.575 . . . . 1.1100000000000001 109.989 -178.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.14 -48.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.955 -1.091 . . . . 1.05 108.736 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.22 90.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 1.0600000000000001 110.336 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.406 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 23.1 t -63.63 -42.19 98.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 1.79 109.581 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.69 -38.81 92.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.126 -0.984 . . . . 2.2000000000000002 109.191 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.9 0.17 56.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 1.0600000000000001 109.872 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 67' ' ' SER . 22.9 mp0 48.15 56.29 7.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 2.3399999999999999 110.222 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 6.9 t -79.14 132.76 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 1.05 108.916 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.481 ' CB ' ' HZ1' ' A' ' 72' ' ' LYS . 9.3 mtmp? -129.77 3.8 4.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.331 -0.856 . . . . 2.9300000000000002 110.358 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 123.17 7.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.975 -1.078 . . . . 1.0600000000000001 109.457 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.5 p -109.47 150.25 40.92 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.322 -0.861 . . . . 0.97999999999999998 109.068 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -77.41 139.55 58.82 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 C-N-CA 124.894 -0.878 . . . . 0.23999999999999999 110.421 -1.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -110.44 112.02 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.797 -1.186 . . . . 1.04 107.797 178.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.62 119.08 29.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.919 -1.113 . . . . 0.19 109.27 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -117.0 132.63 56.65 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.37 -1.344 . . . . 1.71 107.37 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -108.76 123.77 49.53 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.628 0.727 . . . . 0.13 109.471 -178.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -120.86 157.37 29.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.54 -0.911 . . . . 0.22 108.54 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.65 125.98 6.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.855 -1.165 . . . . 2.0299999999999998 107.855 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HZ2' ' CG ' ' A' ' 20' ' ' ASP . 58.4 mttm 56.18 26.15 9.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 2.1600000000000001 109.988 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.99 3.26 90.56 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.947 -1.261 . . . . 0.23000000000000001 109.947 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -111.49 148.06 33.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.517 -0.99 . . . . 2.8100000000000001 109.744 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.66 146.03 26.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 2.2599999999999998 109.692 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.91 -29.77 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -0.752 . . . . 1.05 109.844 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.43 177.91 44.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.529 -1.32 . . . . 0.25 110.472 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.1 pm0 -173.3 154.52 2.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -1.08 . . . . 2.04 110.164 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.98 131.58 1.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.353 -0.842 . . . . 0.17999999999999999 109.924 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -102.98 -158.16 0.65 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.231 -0.918 . . . . 0.89000000000000001 108.895 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.9 126.05 0.7 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.438 -1.465 . . . . 0.14000000000000001 109.438 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.19 94.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.244 . . . . 1.0600000000000001 110.131 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.3 t-20 -139.49 76.59 1.57 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.37 -0.974 . . . . 1.98 108.37 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -63.99 -41.08 97.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.778 -0.576 . . . . 1.72 111.206 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.58 -25.85 68.15 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.051 -1.031 . . . . 1.95 109.785 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -69.35 -33.79 73.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.192 -0.942 . . . . 2.5600000000000001 109.405 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.8 mt -54.77 -35.53 63.9 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.68 -1.208 . . . . 1.03 108.583 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -66.62 -55.96 12.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 2.1499999999999999 109.465 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.73 92.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 1.04 110.419 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -65.81 -46.79 77.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 1.04 110.203 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.28 -49.67 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 1.05 108.676 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -62.59 -17.06 59.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 1.6599999999999999 109.183 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -79.37 -55.51 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 2.02 110.457 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.15 14.13 16.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 1.1399999999999999 110.336 -178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.284 179.632 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.487 ' HH ' ' CG1' ' A' ' 59' ' ' VAL . 5.5 p90 -116.56 -167.79 1.34 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.843 -1.16 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.1 150.71 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.381 -0.825 . . . . 0.0 112.317 -177.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -101.59 95.36 6.4 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.51 45.42 0.96 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.075 -1.015 . . . . 0.0 109.594 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.645 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -133.99 0.08 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.81 25.38 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.79 0 CA-C-N 119.2 1.5 . . . . 0.0 108.773 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.645 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.2 t . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 109.261 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.255 0.55 . . . . 1.1000000000000001 109.722 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -154.01 124.98 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.271 -0.893 . . . . 2.5 109.325 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -89.03 133.74 34.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 1.6100000000000001 109.654 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -105.56 117.01 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.162 -1.051 . . . . 1.04 108.162 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 11.6 mp0 -102.54 -14.67 16.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.156 -0.965 . . . . 1.97 109.508 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 p -152.74 158.63 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.92000000000000004 109.817 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -52.22 -26.71 12.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 2.48 109.703 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -59.89 -48.61 80.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.05 110.018 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.67 62.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 1.0600000000000001 109.765 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.69 -69.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.018 . . . . 0.25 110.039 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -54.23 -43.97 71.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -0.857 . . . . 3.0699999999999998 109.853 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.74 -37.45 76.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.236 -0.915 . . . . 2.1000000000000001 109.743 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.52 95.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.0 -1.063 . . . . 1.04 109.187 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.69 -42.39 95.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 1.27 109.589 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.86 -42.44 97.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.763 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -12.98 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.146 -0.971 . . . . 1.0900000000000001 109.552 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -5.91 25.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 1.0700000000000001 109.653 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.25 -110.76 3.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.369 -1.492 . . . . 0.31 109.369 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.14 5.09 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.335 -1.097 . . . . 2.21 108.98 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -69.8 168.61 14.72 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.094 -1.004 . . . . 2.4100000000000001 108.819 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.49 162.52 12.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.039 -1.097 . . . . 1.05 108.039 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.562 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.8 t -145.46 105.13 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.907 -1.121 . . . . 1.03 109.379 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.0 t -103.73 126.89 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 1.01 108.833 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.59 138.97 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.713 . . . . 1.02 109.527 -179.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.49 104.99 13.45 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.299 -0.63 . . . . 0.95999999999999996 109.299 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.53 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 48.3 m-85 -85.41 81.85 8.56 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.034 -1.099 . . . . 0.32000000000000001 108.034 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -114.53 150.3 35.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.785 -0.572 . . . . 1.04 109.636 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.46 125.3 37.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 1.0600000000000001 108.591 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -66.13 -21.27 66.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.2 -0.937 . . . . 1.0600000000000001 109.96 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.9 p-90 -89.4 -17.64 28.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 0.51000000000000001 109.801 -179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.33 125.59 38.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.34000000000000002 110.136 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -63.98 -58.58 10.41 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 111.316 -0.714 . . . . 0.40000000000000002 111.316 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.26 -34.49 24.75 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.638 1.559 . . . . 0.47999999999999998 111.275 -178.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.5 -63.68 1.32 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.093 -1.005 . . . . 0.81000000000000005 108.929 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -59.67 -17.55 35.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.588 -0.695 . . . . 2.46 110.095 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.2 ttt -61.67 -18.71 60.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 3.6600000000000001 110.155 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.5 mt -98.15 13.87 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.201 -0.937 . . . . 1.0700000000000001 110.244 -178.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.84 -32.05 3.26 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.393 -1.442 . . . . 2.1099999999999999 112.267 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.64 -3.26 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 CA-C-N 119.855 0.984 . . . . 0.29999999999999999 110.119 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.2 m-85 -112.47 -81.13 0.59 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.519 -0.738 . . . . 0.37 109.173 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.6 t80 -41.44 -55.37 2.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.14999999999999999 110.727 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -68.1 -32.02 72.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.854 -1.154 . . . . 0.47999999999999998 109.675 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.3 t -64.42 -41.22 96.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.827 -1.17 . . . . 1.05 110.191 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -49.62 -14.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.885 -1.135 . . . . 1.1299999999999999 109.494 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' SER . 17.2 m -57.45 -34.65 69.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.93000000000000005 109.68 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.05 -17.54 21.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.129 -0.982 . . . . 2.0 110.075 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.6 -21.74 22.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 2.6499999999999999 109.093 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -135.75 72.32 1.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.89000000000000001 109.142 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.1 p -66.94 -4.27 9.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.902 . . . . 0.93000000000000005 109.174 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.38 -3.23 44.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 109.818 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.95 148.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.445 -0.784 . . . . 1.03 109.347 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mm -100.31 129.06 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 1.05 109.553 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.95 129.48 56.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.425 -0.797 . . . . 0.11 109.18 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.3 mp -111.93 175.12 5.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.402 -0.811 . . . . 1.04 108.977 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -143.62 146.1 33.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.204 -1.036 . . . . 1.3100000000000001 108.204 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -142.48 138.43 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.134 -0.979 . . . . 1.02 110.821 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -98.44 104.48 16.51 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.114 -1.069 . . . . 1.0800000000000001 108.114 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.8 m -60.56 -4.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 1.0600000000000001 111.46 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -110.21 -43.04 4.01 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 110.833 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 -12.28 32.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.002 . . . . 1.1200000000000001 109.34 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.44 45.22 2.63 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.764 -0.828 . . . . 1.01 108.764 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.645 HE21 HH11 ' B' ' 4' ' ' ARG . 54.3 mt-30 -56.46 -12.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 2.7799999999999998 110.454 -179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -40.41 75.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.922 -1.111 . . . . 1.1100000000000001 109.266 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.84 -46.71 45.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.907 . . . . 1.05 109.001 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.74 72.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 1.0600000000000001 109.078 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -64.42 -54.57 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 1.79 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.84 -29.05 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 2.2000000000000002 109.599 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.89 -5.7 57.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.226 -0.921 . . . . 1.0600000000000001 109.588 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 47.25 59.39 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 2.3399999999999999 110.2 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.7 t -78.92 136.6 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.145 -0.972 . . . . 1.05 109.061 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -123.46 -7.77 8.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.47 -0.769 . . . . 2.9300000000000002 109.778 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -154.11 132.47 11.98 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.943 -1.098 . . . . 1.0600000000000001 109.945 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.452 ' O ' ' N ' ' B' ' 8' ' ' GLU . 2.9 p -110.79 151.37 42.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.278 -1.008 . . . . 0.97999999999999998 108.278 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -76.59 144.38 78.82 Favored 'Cis proline' 0 N--CA 1.484 0.922 0 C-N-CA 124.747 -0.939 . . . . 0.23999999999999999 110.281 -1.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.9 122.34 46.0 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.529 -0.915 . . . . 1.04 108.529 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -98.21 122.73 41.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.19 109.031 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.53 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.4 mt-30 -120.31 133.35 55.47 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.91 -1.144 . . . . 1.71 107.91 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 17.4 m-85 -107.68 124.82 50.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.13 109.346 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.76 157.42 35.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.891 -0.781 . . . . 0.22 108.891 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -153.85 123.19 6.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.639 -1.245 . . . . 2.0299999999999998 107.639 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 55.72 31.67 17.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 2.1600000000000001 109.284 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.59 6.84 88.87 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.285 -1.126 . . . . 0.23000000000000001 110.285 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -112.01 143.52 42.88 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.35 -1.088 . . . . 2.8100000000000001 110.605 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -84.31 141.94 30.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 109.58 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.99 -9.48 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.52 -0.737 . . . . 1.05 110.528 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.05 168.71 36.01 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.41 -1.376 . . . . 0.25 110.596 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.518 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.0 152.93 2.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -1.08 . . . . 2.04 110.416 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.4 p90 -169.05 134.07 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.17999999999999999 110.267 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.81 -174.33 2.52 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.074 -1.017 . . . . 0.89000000000000001 109.168 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.82 132.11 6.29 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.382 -1.487 . . . . 0.14000000000000001 109.382 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 94.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 1.0600000000000001 110.137 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.31 70.54 1.37 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.822 -1.177 . . . . 1.98 107.822 178.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -33.15 73.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.379 -0.826 . . . . 1.72 110.603 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.04 -27.03 68.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.946 -1.097 . . . . 1.95 109.055 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -71.14 -37.61 72.26 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.546 -0.722 . . . . 2.5600000000000001 110.063 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.28 -36.11 51.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.666 -1.271 . . . . 1.03 108.866 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -66.91 -54.88 17.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 2.1499999999999999 109.457 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.75 93.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 1.04 110.355 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.2 m -65.51 -44.89 85.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.161 -0.962 . . . . 1.04 109.916 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.3 mt -60.43 -52.88 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 1.05 108.764 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -61.76 -16.01 45.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 1.6599999999999999 109.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -77.22 -59.03 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 2.02 110.115 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.04 18.69 7.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.443 -0.786 . . . . 1.1399999999999999 110.246 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 1.1799999999999999 109.404 179.822 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.645 HH11 HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.095 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.464 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.1 p90 -130.23 -167.22 1.78 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.105 -0.997 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.51 148.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.833 0.825 . . . . 0.0 112.357 -177.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 24.1 m -100.89 93.02 5.31 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 74' ' ' THR . 6.2 pt-20 -83.38 43.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.0 -1.062 . . . . 0.0 110.364 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.55 -130.18 0.04 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.08 24.05 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.407 1.604 . . . . 0.0 109.325 178.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.649 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.24 0.543 . . . . 1.1000000000000001 109.681 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -154.24 118.0 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.833 . . . . 2.5 108.886 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.421 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 19.5 tt0 -89.5 134.63 34.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 1.6100000000000001 109.961 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.09 121.24 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.483 -1.302 . . . . 1.04 107.483 178.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 5.8 mp0 -101.98 -16.89 16.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.085 -1.01 . . . . 1.97 109.471 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.6 p -153.13 155.58 37.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.92000000000000004 109.137 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -50.74 -21.77 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 2.48 109.337 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 m -61.5 -47.46 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.989 . . . . 1.05 109.31 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.99 62.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 1.0600000000000001 109.838 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.34 -65.76 0.62 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.25 109.868 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -55.27 -45.09 76.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 3.0699999999999998 109.67 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -58.03 -36.17 72.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.172 -0.955 . . . . 2.1000000000000001 109.594 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.98 90.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 1.04 109.17 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.26 -45.42 84.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.446 -0.784 . . . . 1.27 109.92 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.34 -40.58 97.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 1.0900000000000001 109.886 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -15.38 58.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 1.0900000000000001 109.516 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.97 -7.46 35.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 1.0700000000000001 109.553 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.08 -110.58 3.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.445 . . . . 0.31 109.486 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -138.67 2.98 2.25 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.436 -1.038 . . . . 2.21 109.52 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -70.06 171.71 9.13 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.997 -1.065 . . . . 2.4100000000000001 109.134 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.514 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.06 160.5 20.86 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.468 -0.938 . . . . 1.05 108.468 -179.555 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.514 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.7 t -143.38 104.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.04 . . . . 1.03 109.254 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.19 127.88 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 1.01 108.799 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.66 135.52 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.668 -0.645 . . . . 1.02 109.402 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -107.64 101.43 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.912 -0.773 . . . . 0.95999999999999996 108.912 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -84.82 82.6 8.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.813 -1.181 . . . . 0.32000000000000001 107.813 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -113.38 149.06 34.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.717 -0.615 . . . . 1.04 109.602 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.0 127.25 36.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.517 -0.92 . . . . 1.0600000000000001 108.517 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -66.59 -28.46 68.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.356 -0.84 . . . . 1.0600000000000001 111.081 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -87.55 -10.28 52.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.887 -1.133 . . . . 0.51000000000000001 110.218 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.48 135.97 37.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.34000000000000002 109.532 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.78 -56.9 3.68 Favored Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.501 -0.75 . . . . 0.40000000000000002 112.035 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -46.31 -39.1 21.18 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.673 1.582 . . . . 0.47999999999999998 111.721 -177.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.59 -53.97 7.75 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.73 -1.231 . . . . 0.81000000000000005 108.823 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.87 -19.85 53.69 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.624 -0.672 . . . . 2.46 109.791 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -59.42 -19.15 45.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 3.6600000000000001 110.504 -179.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.25 12.97 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.053 -1.029 . . . . 1.0700000000000001 111.112 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.06 -32.98 4.47 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 119.98 -1.7 . . . . 2.1099999999999999 112.362 179.328 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.1 Cg_exo -66.43 -0.03 3.91 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 CA-C-N 119.571 0.882 . . . . 0.29999999999999999 110.519 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' ' OG ' ' A' ' 44' ' ' SER . 44.4 m-85 -117.64 -74.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.511 -0.743 . . . . 0.37 109.179 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -42.45 -52.57 4.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.66 -0.65 . . . . 0.14999999999999999 110.495 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.11 -32.6 73.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.47999999999999998 109.72 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 59.7 p -62.37 -44.13 97.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.813 -1.179 . . . . 1.05 109.879 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -51.33 -15.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.109 -0.994 . . . . 1.1299999999999999 109.233 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' N ' ' C ' ' A' ' 44' ' ' SER . 28.9 m -57.19 -38.49 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.93000000000000005 109.698 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -94.95 -16.76 22.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.12 -0.987 . . . . 2.0 110.473 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -88.91 -19.81 25.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 2.6499999999999999 109.234 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.66 73.15 1.47 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.513 -0.742 . . . . 0.89000000000000001 109.135 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.46 -5.07 13.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.93000000000000005 109.273 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -96.24 8.32 44.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.46999999999999997 109.713 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.05 148.42 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 1.03 109.454 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -100.2 129.74 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 1.05 109.055 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.79 130.34 56.66 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.485 -0.759 . . . . 0.11 109.446 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.4 mp -114.01 171.41 7.62 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.853 -0.795 . . . . 1.04 108.853 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -143.42 147.78 35.13 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.893 -1.151 . . . . 1.3100000000000001 107.893 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.37 144.55 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.0 -1.062 . . . . 1.02 111.114 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.57 103.17 15.09 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.59 -1.263 . . . . 1.0800000000000001 107.59 178.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.84 -3.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 112.766 -177.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 m-20 -120.45 -33.28 3.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.73 -1.232 . . . . 1.1100000000000001 110.909 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.23 -21.55 18.39 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.782 -1.199 . . . . 1.1200000000000001 108.678 179.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.03 45.63 1.15 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.589 -1.263 . . . . 1.01 107.589 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' NE2' ' N ' ' A' ' 64' ' ' ASP . 3.7 pp0? -52.74 -15.12 0.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.781 -0.574 . . . . 2.7799999999999998 110.767 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' N ' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -70.02 -38.78 76.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.868 -1.145 . . . . 1.1100000000000001 108.89 179.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.65 -47.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 1.05 108.663 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.08 -35.48 80.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 1.0600000000000001 109.129 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -63.49 -46.46 86.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.862 . . . . 1.79 109.03 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.99 -38.42 90.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 2.2000000000000002 109.682 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.37 -6.19 56.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 1.0600000000000001 110.132 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 66' ' ' ALA . 65.3 mt-10 48.8 58.29 5.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.056 -1.027 . . . . 2.3399999999999999 110.192 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.6 t -79.27 135.25 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.114 -0.991 . . . . 1.05 109.089 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -127.36 -1.55 6.29 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.374 -0.829 . . . . 2.9300000000000002 110.063 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 125.15 8.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.999 -1.063 . . . . 1.0600000000000001 108.944 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.483 ' CG2' ' HH ' ' B' ' 5' ' ' TYR . 4.6 p -111.08 152.29 43.61 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.889 -0.782 . . . . 0.97999999999999998 108.889 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.12 143.15 74.53 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 C-N-CA 124.775 -0.927 . . . . 0.23999999999999999 109.948 -2.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -113.34 109.62 19.0 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.235 -1.024 . . . . 1.04 108.235 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.02 117.85 26.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.19 108.778 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -115.72 135.15 54.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.57 -1.27 . . . . 1.71 107.57 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -109.95 127.21 54.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.617 -0.677 . . . . 0.13 109.706 -178.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.47 157.98 35.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.457 -0.942 . . . . 0.22 108.457 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -155.0 123.81 6.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 2.0299999999999998 107.95 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.19 25.39 9.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.591 -0.693 . . . . 2.1600000000000001 109.228 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 85.5 4.0 86.09 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.132 -1.187 . . . . 0.23000000000000001 110.132 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.558 HE21 ' C ' ' A' ' 83' ' ' GLY . 13.8 mm-40 -109.73 145.48 36.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.286 -1.126 . . . . 2.8100000000000001 110.137 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -86.8 141.21 29.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 2.2599999999999998 109.039 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.06 -20.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.486 -0.759 . . . . 1.05 110.323 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 173.15 45.55 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.386 -1.388 . . . . 0.25 110.53 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -174.05 151.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -1.047 . . . . 2.04 109.802 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.05 133.5 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.297 -0.877 . . . . 0.17999999999999999 110.149 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -103.56 -163.39 0.98 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.255 -0.903 . . . . 0.89000000000000001 108.967 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.91 131.61 2.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.361 -1.496 . . . . 0.14000000000000001 109.361 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.53 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -1.213 . . . . 1.0600000000000001 110.852 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.29 78.32 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.772 -1.195 . . . . 1.98 107.772 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.409 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.04 -34.89 79.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 1.72 110.833 -178.494 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.8 -25.78 68.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.879 -1.138 . . . . 1.95 109.23 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -68.85 -37.45 79.14 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 2.5600000000000001 109.404 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.7 mt -52.46 -35.68 53.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.948 -1.095 . . . . 1.03 108.689 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.0 -58.79 4.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 2.1499999999999999 109.584 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.34 83.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 1.04 110.628 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.7 m -66.97 -44.81 79.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.049 -1.032 . . . . 1.04 109.938 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.7 mt -60.99 -52.56 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 1.05 109.128 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -60.8 -17.22 48.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 1.6599999999999999 109.407 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -77.66 -62.54 1.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 2.02 110.3 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.59 23.09 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 1.1399999999999999 110.617 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.996 -1.065 . . . . 1.1799999999999999 109.239 179.562 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.483 ' HH ' ' CG2' ' A' ' 74' ' ' THR . 4.9 p90 -121.61 -167.0 1.45 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.837 -1.164 . . . . 0.0 110.334 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.48 151.11 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 112.018 -177.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 m -101.78 95.42 6.4 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -83.43 45.85 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.937 -1.102 . . . . 0.0 109.966 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.12 -134.68 0.07 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.983 -2.447 . . . . 0.0 106.983 178.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.76 24.39 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 CA-C-N 119.212 1.506 . . . . 0.0 108.441 178.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.663 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.6 t . . . . . 0 N--CA 1.486 1.364 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.8 t . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.499 -0.556 . . . . 1.1000000000000001 109.499 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.36 119.36 5.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.16 -0.962 . . . . 2.5 108.726 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -86.72 139.79 30.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 1.6100000000000001 109.911 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mm -110.03 119.49 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.961 -1.126 . . . . 1.04 107.961 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 6.7 mp0 -105.4 -17.34 14.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -0.898 . . . . 1.97 109.705 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.7 p -151.74 161.39 42.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.035 -1.041 . . . . 0.92000000000000004 110.128 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -53.01 -32.14 44.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.736 . . . . 2.48 109.966 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -59.44 -43.69 93.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 1.05 109.98 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.0 64.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.855 . . . . 1.0600000000000001 109.943 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.69 -63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.25 110.04 -179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 3.0699999999999998 109.638 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -58.7 -35.5 72.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.933 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.39 94.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 1.04 109.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.45 -44.02 97.42 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.853 . . . . 1.27 109.649 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.1 -38.36 90.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.851 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.62 -19.88 44.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 1.0900000000000001 109.646 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -2.9 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 1.0700000000000001 109.74 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 -136.34 32.39 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.211 -1.556 . . . . 0.31 109.211 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m-20 -116.6 5.65 13.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.38 -1.07 . . . . 2.21 109.621 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -70.18 170.92 10.62 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.206 -0.934 . . . . 2.4100000000000001 109.127 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.27 161.7 18.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.855 -1.165 . . . . 1.05 107.855 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.5 t -145.13 105.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.891 -1.131 . . . . 1.03 109.632 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.7 t -103.41 128.81 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.788 -0.819 . . . . 1.01 108.788 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.01 139.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.598 -0.689 . . . . 1.02 109.649 -178.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -109.54 98.42 7.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.293 -0.632 . . . . 0.95999999999999996 109.293 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.0 m-85 -83.42 83.43 7.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.568 -1.271 . . . . 0.32000000000000001 107.568 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 m -110.38 -163.28 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.514 0.673 . . . . 1.04 109.381 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.97 120.26 13.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.341 -0.985 . . . . 1.0600000000000001 108.341 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.0 t -63.57 -25.02 68.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 1.0600000000000001 110.934 -178.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -89.27 -12.79 39.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.931 -1.106 . . . . 0.51000000000000001 110.093 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.6 134.33 39.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.34000000000000002 109.776 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -73.65 -55.5 5.97 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.809 -0.71 . . . . 0.40000000000000002 111.492 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -51.4 -32.83 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.663 1.575 . . . . 0.47999999999999998 111.085 -178.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -62.26 1.71 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.058 -1.026 . . . . 0.81000000000000005 108.905 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -59.72 -21.17 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.77 . . . . 2.46 110.03 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.9 ttm -59.61 -18.24 39.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.97 . . . . 3.6600000000000001 110.296 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 95.6 mt -99.45 7.57 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.951 . . . . 1.0700000000000001 110.722 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -32.2 3.52 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 118.429 -1.308 . . . . 2.1099999999999999 112.519 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_exo -61.22 -6.05 6.02 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 CA-C-N 119.979 1.028 . . . . 0.29999999999999999 109.706 -178.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 39' ' ' LYS . 38.4 m-85 -110.82 -76.29 0.61 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.968 -0.753 . . . . 0.37 108.968 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -42.72 -56.99 2.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.531 -0.73 . . . . 0.14999999999999999 110.726 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.417 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.4 t60 -66.51 -31.79 72.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.007 -1.058 . . . . 0.47999999999999998 110.013 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.6 t -64.33 -40.82 96.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.743 -1.223 . . . . 1.05 110.163 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.51 -14.31 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 1.1299999999999999 109.469 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.52 -38.0 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.078 -1.014 . . . . 0.93000000000000005 109.537 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -93.63 -12.23 29.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 2.0 110.054 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -51.67 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.029 -1.1 . . . . 2.6499999999999999 108.029 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.412 ' C ' ' H ' ' A' ' 51' ' ' ASN . 54.8 m-85 -107.34 75.72 1.04 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.545 -0.722 . . . . 0.89000000000000001 109.607 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.7 p -66.79 -3.68 7.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.93000000000000005 108.618 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 49' ' ' TYR . 8.9 t-20 -95.77 -0.74 50.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.595 -0.69 . . . . 0.46999999999999997 109.372 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.28 147.07 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.362 0.601 . . . . 1.03 109.614 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.22 134.72 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 1.05 109.268 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -121.62 131.3 54.03 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.507 -0.745 . . . . 0.11 109.237 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.89 172.71 6.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.282 -0.886 . . . . 1.04 108.777 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -142.79 138.7 30.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.149 -1.056 . . . . 1.3100000000000001 108.149 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.29 136.74 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.243 -0.91 . . . . 1.02 110.593 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.78 100.69 12.22 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.855 -1.165 . . . . 1.0800000000000001 107.855 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.18 -6.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 1.0600000000000001 110.885 -178.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.43 -42.31 5.49 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.123 -0.986 . . . . 1.1100000000000001 110.712 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -94.28 -12.43 28.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.094 -1.004 . . . . 1.1200000000000001 109.624 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.73 48.67 1.74 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.536 -0.913 . . . . 1.01 108.536 179.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.623 ' CG ' HH12 ' B' ' 4' ' ' ARG . 21.6 mt-30 -56.34 -16.47 5.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 2.7799999999999998 110.321 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -70.49 -39.59 74.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.015 -1.053 . . . . 1.1100000000000001 109.442 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.9 -46.03 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.153 -0.967 . . . . 1.05 108.679 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.357 -0.839 . . . . 1.0600000000000001 109.003 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 56.2 m -64.28 -46.8 82.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 1.79 109.155 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -64.18 -38.09 89.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.761 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.54 -3.36 58.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 109.777 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.75 59.18 4.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 2.3399999999999999 110.002 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 17.2 t -79.22 136.58 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.127 -0.983 . . . . 1.05 109.163 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -128.04 -4.35 5.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.431 -0.793 . . . . 2.9300000000000002 110.019 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 126.8 8.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.014 -1.054 . . . . 1.0600000000000001 109.322 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.6 p -110.76 151.66 43.01 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.746 -0.835 . . . . 0.97999999999999998 108.746 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -76.58 142.77 74.07 Favored 'Cis proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.887 -0.88 . . . . 0.23999999999999999 110.076 -1.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.17 111.63 21.87 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.965 -1.124 . . . . 1.04 107.965 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.99 119.87 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.038 -1.065 . . . . 0.19 109.264 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 41.4 mt-30 -117.05 135.71 53.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.575 -1.268 . . . . 1.71 107.575 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.9 m-85 -109.0 127.45 54.09 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.496 0.665 . . . . 0.13 109.816 -177.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -125.37 156.02 39.41 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.516 -0.92 . . . . 0.22 108.516 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -155.1 123.34 5.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.169 -1.048 . . . . 2.0299999999999998 108.169 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt 54.48 30.61 13.23 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.768 -0.773 . . . . 2.1600000000000001 110.012 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.94 90.52 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.074 -1.06 . . . . 0.23000000000000001 110.48 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -112.46 146.25 38.76 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.312 -1.111 . . . . 2.8100000000000001 110.036 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -86.18 143.63 27.89 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.361 -0.837 . . . . 2.2599999999999998 109.246 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.0 m -126.94 -19.51 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 1.05 110.449 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.58 178.07 47.67 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.305 -1.426 . . . . 0.25 110.524 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -174.11 154.11 2.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -1.061 . . . . 2.04 110.113 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.46 131.18 1.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.17999999999999999 110.171 178.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 17.7 p -102.21 -162.35 0.92 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.246 -0.909 . . . . 0.89000000000000001 108.96 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 81.99 129.82 1.21 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.075 -1.61 . . . . 0.14000000000000001 109.075 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.6 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -1.226 . . . . 1.0600000000000001 110.213 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.23 67.33 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.888 -1.152 . . . . 1.98 107.888 178.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -58.13 -37.45 74.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.837 -0.539 . . . . 1.72 110.652 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.97 -26.54 68.34 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.95 109.611 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -70.3 -33.39 71.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 2.5600000000000001 109.835 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.19 -33.88 54.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.801 -1.187 . . . . 1.03 108.656 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -67.36 -55.6 13.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 2.1499999999999999 109.35 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.8 94.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 1.04 110.648 -179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -65.49 -45.1 84.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.037 -1.039 . . . . 1.04 109.876 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.91 -53.23 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 1.05 108.838 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.44 -16.45 36.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 1.6599999999999999 109.593 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.76 -60.65 2.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 2.02 110.064 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.76 20.79 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 1.1399999999999999 110.16 -178.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.023 -1.048 . . . . 1.1799999999999999 109.317 179.598 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.623 HH12 ' CG ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.444 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.0 p90 -123.42 -167.2 1.57 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.916 -1.115 . . . . 0.0 110.233 179.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 148.98 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.831 0.825 . . . . 0.0 112.154 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -100.88 95.59 6.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.91 43.4 0.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.052 -178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.59 -132.59 0.07 OUTLIER Glycine 0 N--CA 1.484 1.836 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.85 26.51 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 119.328 1.564 . . . . 0.0 109.161 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.8 t . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.789 . . . . 0.0 109.502 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 71.2 t . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.211 0.529 . . . . 1.1000000000000001 109.592 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.422 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 48.5 tttp -154.29 122.33 5.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.949 . . . . 2.5 109.199 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -88.99 139.0 30.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 1.6100000000000001 109.482 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.96 106.99 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.273 -1.01 . . . . 1.04 108.273 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -100.1 -6.81 25.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.017 -1.052 . . . . 1.97 109.616 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -152.61 152.08 31.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -0.968 . . . . 0.92000000000000004 109.601 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -52.04 -28.6 17.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 2.48 109.951 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -60.12 -45.13 94.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 1.05 110.241 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.74 64.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 1.0600000000000001 110.114 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.45 -69.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.25 110.197 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -55.73 -41.37 73.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 3.0699999999999998 109.808 -179.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.78 -38.55 78.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.223 -0.923 . . . . 2.1000000000000001 109.848 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.06 92.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 1.04 109.305 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.38 -45.08 89.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.386 -0.821 . . . . 1.27 109.832 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.95 -40.37 96.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 1.0900000000000001 109.748 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -13.99 59.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 1.0900000000000001 109.734 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -6.92 28.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 1.0700000000000001 109.809 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.88 -111.96 4.14 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.409 . . . . 0.31 109.576 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -138.03 4.32 2.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.39 -1.064 . . . . 2.21 109.268 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -71.03 166.44 21.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 2.4100000000000001 109.153 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.02 161.37 13.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.15 -0.969 . . . . 1.05 108.688 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.57 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.0 t -144.0 106.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.856 -1.153 . . . . 1.03 109.489 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.96 132.64 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.108 -1.071 . . . . 1.01 108.108 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.26 139.37 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.548 -0.72 . . . . 1.02 110.002 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 10.8 t0 -109.33 101.89 10.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.929 -0.767 . . . . 0.95999999999999996 108.929 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -86.35 79.11 9.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.32000000000000001 107.708 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 57.9 m -113.45 149.56 34.06 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.324 0.583 . . . . 1.04 109.745 -179.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.23 128.48 38.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 1.0600000000000001 108.73 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.6 t -66.29 -25.17 66.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 1.0600000000000001 110.241 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.0 p-90 -87.98 -14.34 39.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.033 -1.042 . . . . 0.51000000000000001 109.958 -179.529 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.37 125.88 40.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.34000000000000002 109.487 -179.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.61 -54.13 20.75 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.48 -0.762 . . . . 0.40000000000000002 111.437 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.51 -32.6 21.21 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.912 1.741 . . . . 0.47999999999999998 110.88 -178.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.02 -61.79 1.86 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.81000000000000005 109.057 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -59.8 -17.87 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.537 -0.727 . . . . 2.46 110.033 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.11 -25.75 61.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 3.6600000000000001 110.387 -178.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 90.8 mt -97.54 9.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.123 -0.985 . . . . 1.0700000000000001 110.819 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.93 -32.57 6.86 Favored Pre-proline 0 N--CA 1.484 1.264 0 O-C-N 120.425 -1.422 . . . . 2.1099999999999999 111.846 178.772 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.18 -5.24 7.62 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 119.7 0.929 . . . . 0.29999999999999999 110.102 -177.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -112.37 -71.59 0.75 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.957 -0.757 . . . . 0.37 108.957 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -45.69 -56.76 4.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.14999999999999999 110.457 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.59 -31.97 73.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.47999999999999998 110.044 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 7.0 m -64.18 -38.84 92.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 1.05 110.184 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.9 mt -51.39 -12.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 109.547 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' SER . 67.1 m -57.92 -32.89 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.956 -1.09 . . . . 0.93000000000000005 109.625 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.37 -19.45 19.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.193 -0.942 . . . . 2.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.81 -22.16 21.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 2.6499999999999999 109.525 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -134.26 68.41 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.479 -0.763 . . . . 0.89000000000000001 109.292 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.4 p -67.28 -4.79 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.795 . . . . 0.93000000000000005 109.164 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.51 0.21 52.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.825 . . . . 0.46999999999999997 109.62 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.17 151.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.047 -0.723 . . . . 1.03 109.047 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -101.22 126.5 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 1.05 109.311 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -112.96 130.87 55.97 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.39 -0.819 . . . . 0.11 109.16 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 mp -115.17 173.77 6.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.459 -0.775 . . . . 1.04 109.055 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.29 141.1 28.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -137.17 139.44 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.2 -0.937 . . . . 1.02 110.443 -178.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -99.57 108.07 20.38 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.33 -8.5 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.257 -0.902 . . . . 1.0600000000000001 111.23 -178.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -104.6 -38.67 6.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 110.919 -179.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -95.59 -17.67 21.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.058 . . . . 1.1200000000000001 110.131 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.25 1.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.509 -0.923 . . . . 1.01 108.509 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -54.26 -15.37 1.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.607 -0.683 . . . . 2.7799999999999998 110.237 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.4 -40.28 74.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.905 -1.122 . . . . 1.1100000000000001 109.53 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.09 -47.22 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -0.924 . . . . 1.05 108.729 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.55 -31.21 72.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 109.352 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 15.1 m -63.79 -52.49 60.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 1.79 109.288 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.17 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 2.2000000000000002 109.466 179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.44 -2.69 58.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 1.0600000000000001 109.582 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 67' ' ' SER . 21.3 mp0 43.98 52.09 6.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.825 . . . . 2.3399999999999999 110.083 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -77.99 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 1.05 108.944 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 83.8 mttt -125.58 5.79 7.55 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.531 -0.73 . . . . 2.9300000000000002 109.68 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 138.0 17.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.112 -0.993 . . . . 1.0600000000000001 108.806 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 65.0 p -123.88 149.7 60.38 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 108.865 -0.791 . . . . 0.97999999999999998 108.865 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.02 144.78 76.88 Favored 'Cis proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.959 -0.851 . . . . 0.23999999999999999 110.422 -1.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.21 114.74 26.41 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.576 -1.268 . . . . 1.04 107.576 178.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -90.2 123.93 34.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 0.19 108.747 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -121.87 136.52 54.93 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 1.71 107.676 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.44 124.22 51.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.475 0.655 . . . . 0.13 109.426 -178.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -124.02 155.56 38.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.688 -0.856 . . . . 0.22 108.688 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -155.48 124.36 6.11 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 2.0299999999999998 107.42 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mttt 57.96 25.4 12.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.623 . . . . 2.1600000000000001 109.821 -178.846 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 6.69 86.56 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.219 -1.152 . . . . 0.23000000000000001 110.219 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -114.47 147.93 38.58 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.357 -1.084 . . . . 2.8100000000000001 110.101 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -85.33 141.26 30.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 2.2599999999999998 109.162 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.31 -18.54 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.452 -0.78 . . . . 1.05 110.221 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 171.79 44.89 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.6 -1.286 . . . . 0.25 110.389 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -174.09 151.93 1.79 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.417 -1.049 . . . . 2.04 110.233 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.97 130.91 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.667 0.746 . . . . 0.17999999999999999 110.316 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -101.27 -162.16 0.91 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.035 -1.041 . . . . 0.89000000000000001 108.685 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.1 128.5 1.32 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.249 -1.541 . . . . 0.14000000000000001 109.249 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.87 97.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 1.0600000000000001 110.866 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -141.06 77.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.984 -1.117 . . . . 1.98 107.984 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -64.76 -42.66 94.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.81 -0.556 . . . . 1.72 111.579 -178.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.81 -24.97 67.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.877 -1.139 . . . . 1.95 110.059 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -68.04 -34.48 76.55 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.052 -1.03 . . . . 2.5600000000000001 109.497 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.4 mt -52.08 -34.44 43.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.998 -1.063 . . . . 1.03 109.008 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.31 -57.74 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.77 . . . . 2.1499999999999999 109.49 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.18 86.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 1.04 110.546 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 m -66.98 -45.32 78.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -0.942 . . . . 1.04 109.973 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.51 -52.89 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 1.05 108.79 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 23.5 t-20 -60.62 -16.93 43.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 1.6599999999999999 109.859 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.89 -55.99 5.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.895 . . . . 2.02 110.463 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -94.38 10.75 33.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.329 -0.857 . . . . 1.1399999999999999 110.872 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.269 179.721 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 3.1 p90 -130.0 -176.11 3.83 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.354 -0.842 . . . . 0.0 110.18 179.446 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.38 146.23 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.964 0.888 . . . . 0.0 112.821 -176.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.01 95.78 6.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.15 45.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 110.188 -178.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.24 -132.63 0.1 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 177.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.47 22.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 CA-C-N 118.95 1.375 . . . . 0.0 109.065 178.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.66 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.1 t . . . . . 0 N--CA 1.486 1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.34 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 85.3 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.297 -0.631 . . . . 1.1000000000000001 109.297 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 24.2 tptp -155.02 125.55 6.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.268 -0.895 . . . . 2.5 109.09 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -90.73 135.45 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 1.6100000000000001 109.792 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -110.16 113.92 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.994 -1.113 . . . . 1.04 107.994 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -103.27 -13.05 16.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 1.97 109.657 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.5 p -152.9 156.99 40.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.92000000000000004 109.91 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.8 -32.62 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 2.48 110.163 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -58.95 -44.24 91.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.065 . . . . 1.05 109.492 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.41 64.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 1.0600000000000001 109.448 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.6 -70.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.25 109.996 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -42.56 71.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 3.0699999999999998 109.709 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -58.39 -37.76 75.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.022 -1.049 . . . . 2.1000000000000001 109.278 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.74 93.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 1.04 108.678 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.59 -40.47 97.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.27 109.332 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.87 -42.56 97.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 109.383 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.58 59.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 1.0900000000000001 109.533 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -6.33 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 1.0700000000000001 109.751 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.71 -115.47 6.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.31 109.515 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -136.11 4.88 3.0 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -1.072 . . . . 2.21 109.349 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -71.0 169.14 15.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.246 -0.909 . . . . 2.4100000000000001 109.163 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.26 162.43 14.74 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 1.05 108.088 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.591 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 18.7 t -144.73 109.01 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.826 -1.171 . . . . 1.03 109.397 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.29 132.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.533 -0.914 . . . . 1.01 108.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.75 131.34 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 1.02 109.557 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.76 107.51 18.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.95999999999999996 109.443 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.2 m-85 -88.72 81.36 7.04 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.116 -1.068 . . . . 0.32000000000000001 108.116 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -113.72 152.35 30.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.736 -0.602 . . . . 1.04 109.559 -179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.72 123.16 35.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.721 -0.844 . . . . 1.0600000000000001 108.721 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 t -65.54 -20.87 66.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 1.0600000000000001 109.746 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 50.6 p-90 -89.5 -18.15 27.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.231 -0.918 . . . . 0.51000000000000001 109.934 -179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.6 143.97 25.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.34000000000000002 110.029 -178.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -83.69 -57.23 2.47 Favored Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.684 -0.635 . . . . 0.40000000000000002 111.628 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.3 Cg_exo -47.47 -41.56 29.23 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.85 1.7 . . . . 0.47999999999999998 112.031 -177.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -58.61 3.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.816 -1.178 . . . . 0.81000000000000005 109.02 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.32 -18.58 39.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.553 -0.717 . . . . 2.46 110.232 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 36.8 ttm -59.43 -18.39 38.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 3.6600000000000001 110.309 -179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 67.8 mt -100.35 14.15 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.037 -1.039 . . . . 1.0700000000000001 111.276 -178.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.4 -34.95 12.41 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 117.957 -1.497 . . . . 2.1099999999999999 111.946 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -61.64 -14.81 37.96 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 CA-C-N 119.707 0.931 . . . . 0.29999999999999999 110.877 -175.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.8 -69.36 0.76 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.33 -0.856 . . . . 0.37 109.223 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -44.48 -51.55 8.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.618 -0.677 . . . . 0.14999999999999999 110.725 -179.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -67.57 -35.28 78.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.878 -1.139 . . . . 0.47999999999999998 109.585 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.2 m -60.32 -42.71 96.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.017 -1.052 . . . . 1.05 109.624 -179.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -52.26 -21.72 3.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 1.1299999999999999 109.563 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.5 m -57.3 -32.34 66.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.93000000000000005 109.592 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -94.82 -19.49 20.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.142 -0.974 . . . . 2.0 110.083 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -91.28 -20.82 21.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 2.6499999999999999 109.128 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.43 67.95 1.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.89000000000000001 109.085 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.2 p -67.01 -3.84 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.465 -0.772 . . . . 0.93000000000000005 109.243 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -94.43 -0.52 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.35 -0.844 . . . . 0.46999999999999997 109.475 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.06 149.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.539 -0.726 . . . . 1.03 109.189 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -100.43 128.84 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.225 -0.922 . . . . 1.05 109.058 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -114.63 131.8 56.59 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.413 -0.804 . . . . 0.11 109.173 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mp -115.95 175.29 5.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.543 -0.723 . . . . 1.04 109.179 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -144.07 144.94 31.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.417 -0.957 . . . . 1.3100000000000001 108.417 179.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.26 140.7 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.2 -0.938 . . . . 1.02 110.147 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.44 100.46 11.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.615 -1.254 . . . . 1.0800000000000001 107.615 178.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.14 -12.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.858 . . . . 1.0600000000000001 111.217 -178.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -100.94 -42.81 6.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.85 -1.156 . . . . 1.1100000000000001 111.173 -178.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.1 -10.47 35.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.1200000000000001 109.569 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.63 2.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.511 -0.922 . . . . 1.01 108.511 179.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 41.7 mt-30 -55.82 -14.32 2.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 2.7799999999999998 109.87 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 5.5 p30 -70.44 -40.93 73.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.121 -0.987 . . . . 1.1100000000000001 109.618 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.24 -46.22 45.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 1.05 108.699 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.03 73.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 1.0600000000000001 109.309 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 20.4 m -63.72 -52.35 60.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.79 109.53 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.82 -34.31 77.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 2.2000000000000002 109.237 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.67 57.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.889 . . . . 1.0600000000000001 109.516 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 44.99 50.7 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 2.3399999999999999 109.911 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.12 129.85 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 1.05 109.445 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . 0.449 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 67.9 mttm -129.93 8.86 5.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.502 -0.749 . . . . 2.9300000000000002 109.511 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.04 133.79 14.79 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 1.0600000000000001 108.274 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.8 p -120.38 150.05 51.03 Favored Pre-proline 0 N--CA 1.507 2.424 0 O-C-N 121.205 -0.934 . . . . 0.97999999999999998 108.96 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.72 147.27 83.75 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 O-C-N 122.714 0.849 . . . . 0.23999999999999999 110.539 -1.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.2 m -117.37 116.49 27.3 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.337 -1.357 . . . . 1.04 107.337 178.059 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.06 122.08 35.07 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.312 -0.955 . . . . 0.19 108.653 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.5 mt-30 -119.16 137.4 53.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.729 -1.212 . . . . 1.71 107.729 -179.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 26.3 m-85 -112.03 128.54 56.22 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.423 0.63 . . . . 0.13 110.04 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.09 159.85 32.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.851 -0.796 . . . . 0.22 108.851 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.11 122.81 5.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.748 -1.204 . . . . 2.0299999999999998 107.748 179.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 57.24 24.44 9.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.78 -0.575 . . . . 2.1600000000000001 110.301 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.4 5.0 76.3 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.354 -1.098 . . . . 0.23000000000000001 110.354 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -113.4 146.13 40.01 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.303 -1.116 . . . . 2.8100000000000001 110.236 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -85.98 145.07 27.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 2.2599999999999998 109.363 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -126.54 -15.4 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.51 -0.744 . . . . 1.05 109.762 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.14 -179.14 41.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.584 -1.294 . . . . 0.25 110.581 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.2 161.19 4.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.457 -1.025 . . . . 2.04 110.049 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -169.04 132.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.17999999999999999 110.218 178.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 p -104.58 -170.05 1.71 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.225 -0.922 . . . . 0.89000000000000001 108.759 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 93.97 121.37 3.31 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.536 -1.426 . . . . 0.14000000000000001 109.536 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.44 91.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -1.146 . . . . 1.0600000000000001 110.432 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' GLY . 13.6 t-20 -140.04 78.07 1.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.119 -1.067 . . . . 1.98 108.119 178.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.91 -34.7 78.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.696 -0.627 . . . . 1.72 110.608 -178.861 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.7 -26.07 67.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.816 -1.177 . . . . 1.95 109.187 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -35.41 78.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.425 -0.797 . . . . 2.5600000000000001 109.124 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.6 mt -51.87 -37.69 53.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 1.03 108.783 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.37 -57.6 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 2.1499999999999999 109.896 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.64 83.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 1.04 110.477 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -67.76 -45.22 75.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.074 -1.016 . . . . 1.04 110.29 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.22 -52.56 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.934 . . . . 1.05 109.331 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.26 -17.9 45.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 1.6599999999999999 109.674 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.01 -59.41 2.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.871 . . . . 2.02 110.476 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -93.69 18.96 9.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.348 -0.845 . . . . 1.1399999999999999 110.794 -178.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.494 1.728 0 O-C-N 120.941 -1.099 . . . . 1.1799999999999999 109.303 179.25 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.449 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 3.0 p90 -109.5 -174.59 2.54 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.176 -0.953 . . . . 0.0 110.796 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.1 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 122.191 0.996 . . . . 0.0 112.851 -176.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 61.3 m -101.05 93.75 5.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.1 44.42 1.01 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.102 -0.999 . . . . 0.0 110.904 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.68 -129.98 0.07 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.69 19.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.871 0 CA-C-N 119.447 1.623 . . . . 0.0 109.799 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.668 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 3' ' ' LYS . 44.7 t . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.512 -0.551 . . . . 1.1000000000000001 109.512 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . 0.437 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 44.7 tptt -153.72 122.84 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -0.93 . . . . 2.5 109.116 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -90.05 129.4 36.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 1.6100000000000001 109.462 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -102.05 120.15 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.291 -1.374 . . . . 1.04 107.291 178.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.62 -16.76 14.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.197 -0.939 . . . . 1.97 109.949 -179.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.8 p -152.47 160.15 43.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.056 -1.027 . . . . 0.92000000000000004 109.801 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 35.0 tttp -52.09 -31.39 30.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.439 -0.788 . . . . 2.48 109.639 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -59.96 -47.25 86.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 1.05 110.093 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.72 -27.0 65.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 1.0600000000000001 109.662 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.17 -68.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.25 109.838 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -53.53 -44.44 69.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 3.0699999999999998 109.749 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -58.19 -37.0 73.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 2.1000000000000001 109.619 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.77 92.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 1.04 109.094 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.5 -44.95 89.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.458 -0.776 . . . . 1.27 109.781 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.71 -41.28 99.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 1.0900000000000001 109.686 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -13.6 59.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.467 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -5.71 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 1.0700000000000001 109.722 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 68.23 -114.1 5.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.513 -1.435 . . . . 0.31 109.513 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 81.2 m-20 -136.55 4.07 2.83 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.265 -1.138 . . . . 2.21 109.447 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -69.65 170.09 11.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.072 -1.017 . . . . 2.4100000000000001 108.94 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.547 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.43 163.12 13.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.172 -1.047 . . . . 1.05 108.172 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.547 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.3 t -145.42 104.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.825 -1.172 . . . . 1.03 109.359 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.61 130.41 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 1.01 108.882 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.37 133.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.02 109.644 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -107.04 102.98 12.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.585 -0.697 . . . . 0.95999999999999996 109.448 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.87 82.69 8.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.758 -1.201 . . . . 0.32000000000000001 107.758 179.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.68 148.62 36.01 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.594 -0.692 . . . . 1.04 109.89 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.89 122.74 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.267 -1.012 . . . . 1.0600000000000001 108.267 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -64.95 -22.33 66.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 1.0600000000000001 110.414 -178.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -90.34 -14.2 33.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.13 -0.981 . . . . 0.51000000000000001 110.054 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.23 128.56 40.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.34000000000000002 110.04 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.06 -59.33 7.57 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.894 -0.67 . . . . 0.40000000000000002 111.595 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.5 Cg_exo -46.11 -37.7 18.28 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.805 1.67 . . . . 0.47999999999999998 111.941 -178.169 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.4 -55.6 5.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.714 -1.241 . . . . 0.81000000000000005 108.756 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -60.6 -21.73 62.97 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.655 -0.653 . . . . 2.46 110.045 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.9 tpp -61.44 -18.52 59.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 3.6600000000000001 110.379 -179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.1 mt -99.56 15.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.097 -1.002 . . . . 1.0700000000000001 110.765 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.77 -33.41 3.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.163 -1.586 . . . . 2.1099999999999999 112.452 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -63.14 -3.59 5.13 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.509 0.86 . . . . 0.29999999999999999 110.302 -176.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.456 ' O ' ' OG ' ' A' ' 44' ' ' SER . 49.0 m-85 -110.46 -79.83 0.58 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.45 -0.781 . . . . 0.37 109.08 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 87.6 t80 -40.9 -54.57 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.14999999999999999 111.024 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -66.86 -36.83 83.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.842 -1.162 . . . . 0.47999999999999998 110.064 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 81.8 p -61.34 -38.37 86.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.753 -1.217 . . . . 1.05 110.041 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.88 -14.3 0.37 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 1.1299999999999999 109.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.417 ' N ' ' C ' ' A' ' 44' ' ' SER . 37.1 m -57.76 -36.5 72.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.176 -0.953 . . . . 0.93000000000000005 109.636 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -94.35 -16.42 23.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.21 -0.931 . . . . 2.0 110.166 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.33 -22.83 20.33 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.003 -1.06 . . . . 2.6499999999999999 109.331 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -135.34 66.66 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.415 -0.803 . . . . 0.89000000000000001 109.151 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 p -66.64 -3.03 5.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.337 -0.852 . . . . 0.93000000000000005 109.038 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.95 -2.27 53.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.46999999999999997 109.263 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.64 148.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.055 -0.72 . . . . 1.03 109.055 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.5 125.26 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.414 -0.804 . . . . 1.05 109.338 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -111.21 129.07 56.07 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.355 -0.841 . . . . 0.11 109.365 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.3 173.73 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.444 -0.785 . . . . 1.04 109.078 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.79 147.94 33.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.307 -0.998 . . . . 1.3100000000000001 108.307 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 t -141.74 142.68 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.044 -1.035 . . . . 1.02 110.451 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 60' ' ' ASP . 10.1 t70 -98.78 90.94 4.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.969 -1.123 . . . . 1.0800000000000001 107.969 178.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -52.59 -3.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 1.0600000000000001 111.624 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.502 ' H ' ' C ' ' A' ' 58' ' ' ASP . 30.3 m-20 -110.04 -40.66 4.67 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.034 -1.041 . . . . 1.1100000000000001 110.982 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.61 -19.17 19.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.05 -1.031 . . . . 1.1200000000000001 109.816 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.89 45.52 1.33 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.349 -0.844 . . . . 1.01 108.74 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -53.25 -13.46 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 2.7799999999999998 109.852 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.9 p-10 -71.13 -41.44 70.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 1.1100000000000001 109.459 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -74.08 -45.37 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.181 -0.949 . . . . 1.05 108.802 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -34.14 76.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 108.688 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -64.59 -46.13 84.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 1.79 109.075 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -63.65 -38.48 91.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.349 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.0 58.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 109.874 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 49.6 59.19 4.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 109.743 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 19.5 t -79.13 137.44 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 1.05 109.489 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -130.4 -1.77 4.42 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.452 -0.78 . . . . 2.9300000000000002 109.791 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 127.31 9.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.022 -1.049 . . . . 1.0600000000000001 109.1 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 p -111.04 152.02 43.41 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 108.654 -0.869 . . . . 0.97999999999999998 108.654 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.39 143.98 76.26 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 C-N-CA 124.75 -0.938 . . . . 0.23999999999999999 109.935 -1.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 117.94 32.27 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.666 -0.865 . . . . 1.04 108.666 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -93.26 122.68 35.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.19 108.886 179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -120.19 133.09 55.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.804 -1.184 . . . . 1.71 107.804 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -108.64 126.56 53.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.13 109.716 -178.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -124.05 158.79 31.36 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.512 -0.921 . . . . 0.22 108.512 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -154.93 123.46 6.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.753 -1.203 . . . . 2.0299999999999998 107.753 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.583 ' NZ ' ' NE2' ' A' ' 84' ' ' GLN . 7.3 mtmp? 56.01 27.33 11.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.527 -0.733 . . . . 2.1600000000000001 109.882 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.3 87.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.165 -1.017 . . . . 0.23000000000000001 110.625 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.583 ' NE2' ' NZ ' ' A' ' 82' ' ' LYS . 35.6 mt-30 -109.98 147.48 33.41 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.329 -1.1 . . . . 2.8100000000000001 110.191 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -86.03 142.46 28.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.868 . . . . 2.2599999999999998 109.124 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.35 -17.25 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.528 -0.732 . . . . 1.05 110.358 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 176.14 174.24 42.49 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.455 -1.355 . . . . 0.25 110.351 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -172.9 155.49 3.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.388 -1.066 . . . . 2.04 109.937 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.5 p90 -168.41 133.55 1.73 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.303 -0.873 . . . . 0.17999999999999999 110.342 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -104.07 -171.02 1.86 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.198 -0.939 . . . . 0.89000000000000001 109.03 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.93 5.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.14000000000000001 109.522 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.89 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -1.117 . . . . 1.0600000000000001 110.424 -179.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -139.94 77.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.665 -1.235 . . . . 1.98 107.665 178.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.97 -33.95 76.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 1.72 110.687 -178.525 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -25.61 68.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.012 -1.055 . . . . 1.95 109.148 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -69.07 -37.6 78.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.328 -0.858 . . . . 2.5600000000000001 109.333 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.8 mt -54.19 -35.6 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 1.03 108.634 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -66.1 -58.89 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 2.1499999999999999 109.461 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.0 90.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 1.04 110.494 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 m -65.25 -46.76 79.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.194 -0.941 . . . . 1.04 109.971 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.95 -52.32 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.183 -0.948 . . . . 1.05 108.88 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -61.4 -16.48 46.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 1.6599999999999999 109.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.9 -60.13 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 2.02 109.91 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.3 mt -91.69 20.57 5.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.716 . . . . 1.1399999999999999 110.28 -178.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 1.1799999999999999 109.247 179.782 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.422 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.3 p90 -125.13 -170.82 2.23 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.062 -1.024 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.33 150.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.78 0.8 . . . . 0.0 112.148 -177.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.0 m -101.15 94.23 5.86 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -83.15 44.71 0.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 110.214 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.95 -131.21 0.15 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 177.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -69.64 30.37 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 119.315 1.557 . . . . 0.0 109.215 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.6 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.5 t . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 109.832 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.8 t . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.421 0.629 . . . . 1.1000000000000001 109.432 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -155.56 122.29 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 2.5 109.26 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.81 134.11 34.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.353 -0.842 . . . . 1.6100000000000001 108.992 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.92 108.6 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.363 -0.977 . . . . 1.04 108.363 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.24 -11.21 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 1.97 109.308 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -152.57 153.05 32.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.92000000000000004 109.462 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -52.39 -25.59 10.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.455 -0.778 . . . . 2.48 109.812 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -60.2 -47.34 86.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 1.05 109.797 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -26.21 64.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 109.644 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -59.7 -68.73 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.25 109.821 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.38 -41.39 72.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 3.0699999999999998 109.849 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.0 -38.86 80.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.085 -1.009 . . . . 2.1000000000000001 109.601 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.28 95.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 1.04 109.497 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.66 -46.66 84.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 1.27 110.117 -179.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.23 -43.21 95.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.997 . . . . 1.0900000000000001 109.815 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 -12.8 59.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 109.917 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -8.55 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 1.0700000000000001 109.551 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.99 -117.05 6.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.669 -1.373 . . . . 0.31 109.669 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 8.0 t0 -133.74 4.2 3.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.318 -1.107 . . . . 2.21 109.113 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -68.57 165.6 18.84 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.921 -1.112 . . . . 2.4100000000000001 108.711 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.69 157.84 23.07 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.315 -0.994 . . . . 1.05 108.315 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.459 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 9.3 t -141.98 107.1 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 1.03 109.329 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.62 133.68 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.582 -0.895 . . . . 1.01 108.582 179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.21 133.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 1.02 109.529 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -104.88 102.26 11.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.609 -0.682 . . . . 0.95999999999999996 109.202 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.8 m-85 -86.57 78.96 9.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.805 -1.183 . . . . 0.32000000000000001 107.805 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -106.72 -164.47 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.532 0.682 . . . . 1.04 109.462 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.28 122.74 14.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.412 -0.959 . . . . 1.0600000000000001 108.412 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -63.66 -25.11 68.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.76 . . . . 1.0600000000000001 110.446 -178.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 45.8 p-90 -88.33 -15.5 35.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 0.51000000000000001 110.011 -179.203 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.74 129.08 43.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -0.908 . . . . 0.34000000000000002 109.813 -179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.548 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.89 -54.03 8.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 111.205 -0.758 . . . . 0.40000000000000002 111.205 -178.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.6 Cg_exo -48.54 -34.31 25.99 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.823 1.682 . . . . 0.47999999999999998 111.156 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -58.79 3.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.81000000000000005 109.16 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.8 -21.14 55.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 2.46 109.785 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.484 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.7 tmt? -58.2 -21.23 46.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 3.6600000000000001 109.946 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.3 mt -97.08 2.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.252 -0.905 . . . . 1.0700000000000001 110.224 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.16 -34.72 18.72 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 118.431 -1.308 . . . . 2.1099999999999999 111.084 -179.483 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.5 Cg_endo -63.78 -5.96 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.691 0.926 . . . . 0.29999999999999999 110.561 -177.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 41.9 m-85 -111.1 -73.43 0.68 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.848 -0.797 . . . . 0.37 108.848 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.48 -56.81 4.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.704 -0.623 . . . . 0.14999999999999999 110.471 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.9 -31.9 72.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.47999999999999998 110.083 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 46' ' ' SER . 3.5 t -63.99 -39.72 94.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.014 -1.054 . . . . 1.05 110.092 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 83.2 mt -50.74 -12.98 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.035 -1.04 . . . . 1.1299999999999999 109.782 -179.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 44' ' ' SER . 16.4 m -57.78 -36.78 72.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.93000000000000005 109.636 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -93.85 -17.16 23.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.864 . . . . 2.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -90.65 -23.42 20.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 2.6499999999999999 109.117 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.11 71.8 1.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.696 . . . . 0.89000000000000001 109.125 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -66.84 -3.32 6.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.93000000000000005 108.988 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.7 t-20 -95.74 -0.07 51.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.516 -0.74 . . . . 0.46999999999999997 109.514 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.53 148.66 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.239 -0.913 . . . . 1.03 109.6 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -101.07 123.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.882 -0.784 . . . . 1.05 108.882 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -112.18 132.26 55.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.244 -0.91 . . . . 0.11 109.655 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.9 mp -114.29 172.08 7.23 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.772 -0.825 . . . . 1.04 108.772 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.23 140.77 29.47 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.345 -0.983 . . . . 1.3100000000000001 108.345 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -139.25 138.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.138 -0.976 . . . . 1.02 110.193 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.47 108.68 21.43 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.635 -1.246 . . . . 1.0800000000000001 107.635 177.441 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.14 -10.59 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 1.0600000000000001 111.107 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 10.1 m-20 -103.71 -40.34 6.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 110.756 -178.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -93.88 -14.39 26.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.1200000000000001 109.563 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.36 49.28 1.92 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.79 -0.818 . . . . 1.01 108.79 178.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 67' ' ' SER . 5.6 pt20 -55.95 -11.24 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.432 -0.792 . . . . 2.7799999999999998 110.19 -179.316 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.924 -1.11 . . . . 1.1100000000000001 109.546 -179.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.2 -46.34 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 1.05 108.886 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.85 70.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.822 . . . . 1.0600000000000001 109.258 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 20.1 m -64.21 -58.29 7.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 1.79 109.48 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -62.67 -29.82 70.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 2.2000000000000002 109.537 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.402 ' HB2' HE22 ' A' ' 78' ' ' GLN . . . -88.18 -5.78 58.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.159 -0.963 . . . . 1.0600000000000001 109.544 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 43.58 52.84 6.05 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -0.756 . . . . 2.3399999999999999 110.328 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 17.8 t -77.76 134.79 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 1.05 109.156 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.66 -0.39 8.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.411 -0.806 . . . . 2.9300000000000002 110.194 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.01 133.93 15.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.063 -1.023 . . . . 1.0600000000000001 109.261 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -118.25 150.75 48.27 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.311 -0.868 . . . . 0.97999999999999998 108.934 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -76.13 145.16 81.69 Favored 'Cis proline' 0 C--N 1.319 -0.995 0 C-N-CA 124.555 -1.019 . . . . 0.23999999999999999 110.131 -1.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.48 116.51 28.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.693 -1.225 . . . . 1.04 107.693 178.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -93.66 116.03 28.51 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.363 -0.935 . . . . 0.19 108.603 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 31.8 mt-30 -116.18 139.95 49.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.163 -1.421 . . . . 1.71 107.163 179.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.06 132.22 54.36 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.719 . . . . 0.13 109.856 -176.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -126.93 154.94 43.84 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.327 -0.99 . . . . 0.22 108.327 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -157.02 123.26 4.9 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.632 -1.247 . . . . 2.0299999999999998 107.632 -179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mttp 59.23 25.61 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 2.1600000000000001 110.319 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.85 88.98 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.758 -1.337 . . . . 0.23000000000000001 109.758 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -113.35 147.46 37.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.293 -1.121 . . . . 2.8100000000000001 109.701 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -86.38 141.93 28.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 2.2599999999999998 109.175 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.23 -39.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.408 -0.808 . . . . 1.05 110.091 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.99 37.23 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.911 -1.276 . . . . 0.25 109.911 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.2 pm0 -172.4 156.28 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 2.04 110.147 -179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.3 p90 -169.05 132.26 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.17999999999999999 109.385 178.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 p -103.31 -161.23 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.89000000000000001 108.743 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.05 137.67 2.56 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.492 -1.443 . . . . 0.14000000000000001 109.492 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.89 92.21 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.25 -1.147 . . . . 1.0600000000000001 110.577 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.66 74.82 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.888 -1.153 . . . . 1.98 107.888 177.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.73 -34.16 76.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 1.72 110.495 -177.946 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.5 -26.43 68.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -67.94 -38.41 82.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 2.5600000000000001 109.428 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.7 mt -51.96 -37.68 53.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.958 . . . . 1.03 108.833 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.97 -58.29 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 2.1499999999999999 109.31 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.95 86.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.407 -0.808 . . . . 1.04 110.416 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -67.62 -45.55 75.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.219 -0.925 . . . . 1.04 110.042 -178.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.08 -51.11 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.106 -0.996 . . . . 1.05 108.882 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -61.53 -17.03 53.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 1.6599999999999999 109.488 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.3 -58.98 2.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 2.02 109.65 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.78 20.96 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.423 -0.798 . . . . 1.1399999999999999 110.352 -178.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 1.1799999999999999 109.209 179.373 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.76 -167.64 1.8 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 110.208 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.16 146.79 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 111.934 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.88 97.11 7.75 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.39 45.45 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.749 -179.172 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.68 -130.05 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 177.655 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.81 17.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 118.64 1.22 . . . . 0.0 109.784 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.676 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.2 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.548 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.324 0.583 . . . . 1.1000000000000001 109.802 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -154.39 118.78 4.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.314 -0.866 . . . . 2.5 108.921 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -88.76 135.78 33.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 1.6100000000000001 109.829 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -106.69 113.06 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.615 -1.254 . . . . 1.04 107.615 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -100.07 -11.01 20.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.282 -0.886 . . . . 1.97 109.786 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 p -154.59 158.02 39.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.065 -1.022 . . . . 0.92000000000000004 109.987 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 43.0 tttm -52.33 -23.78 6.44 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 2.48 109.697 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -61.95 -51.03 69.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.012 . . . . 1.05 110.293 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.99 -21.67 64.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 1.0600000000000001 109.952 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.88 -64.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.99 -1.069 . . . . 0.25 109.714 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.62 -46.79 77.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 3.0699999999999998 109.799 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.28 -34.82 70.94 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.273 -0.892 . . . . 2.1000000000000001 110.142 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.93 91.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 1.04 109.624 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.9 -51.76 60.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.54 -0.725 . . . . 1.27 109.646 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.28 -35.99 80.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 109.511 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.63 -16.08 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 1.0900000000000001 109.458 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -20.64 64.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.158 -0.964 . . . . 1.0700000000000001 109.469 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.45 -107.72 2.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.707 -1.357 . . . . 0.31 109.707 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.1 -2.2 1.88 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -1.039 . . . . 2.21 109.553 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -67.33 168.06 11.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.903 -1.123 . . . . 2.4100000000000001 108.817 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.41 163.44 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.077 -1.083 . . . . 1.05 108.077 -179.987 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.4 t -144.39 103.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.869 -1.145 . . . . 1.03 109.648 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -102.9 130.87 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.78 -0.822 . . . . 1.01 108.78 179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.76 135.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 1.02 109.608 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.8 101.64 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.783 -0.821 . . . . 0.95999999999999996 108.783 179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -84.32 80.74 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.884 -1.154 . . . . 0.32000000000000001 107.884 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.0 m -113.7 152.22 30.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.767 -0.583 . . . . 1.04 109.601 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.61 127.13 41.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 1.0600000000000001 109.275 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -67.11 -25.61 66.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.823 . . . . 1.0600000000000001 110.64 -179.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' TRP . . . . . 0.502 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 53.7 p-90 -87.45 -14.83 39.43 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.957 -1.09 . . . . 0.51000000000000001 109.927 -179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 t -93.34 130.92 38.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.34000000000000002 110.018 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -68.9 -59.24 6.1 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.875 -0.678 . . . . 0.40000000000000002 111.48 -179.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -48.86 -35.91 32.4 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.795 1.663 . . . . 0.47999999999999998 111.547 -178.206 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.92 -61.33 2.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.81000000000000005 108.936 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -59.55 -20.27 54.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.561 -0.712 . . . . 2.46 109.986 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.1 ttt -62.09 -19.09 62.6 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.206 -0.934 . . . . 3.6600000000000001 110.341 -179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.28 11.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.197 -0.94 . . . . 1.0700000000000001 110.269 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 4.5 ptmm? -71.42 -27.24 1.0 Allowed Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 120.212 -1.555 . . . . 2.1099999999999999 111.844 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.4 Cg_exo -65.23 -4.39 9.12 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 120.641 1.265 . . . . 0.29999999999999999 109.452 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 44' ' ' SER . 37.5 m-85 -107.68 -79.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.693 -0.855 . . . . 0.37 108.693 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.6 t80 -40.19 -58.13 1.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 0.14999999999999999 111.206 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.39 -33.59 76.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 0.47999999999999998 110.322 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 80.5 p -66.33 -36.81 83.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.633 -1.292 . . . . 1.05 110.409 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.5 mt -50.52 -19.84 0.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.928 -1.107 . . . . 1.1299999999999999 109.535 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 m -56.94 -21.73 32.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.966 -1.083 . . . . 0.93000000000000005 109.977 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -97.22 -26.88 14.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.137 -0.977 . . . . 2.0 110.052 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -90.32 -18.61 25.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.046 -1.034 . . . . 2.6499999999999999 109.412 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' TYR . . . . . 0.406 ' C ' ' H ' ' A' ' 51' ' ' ASN . 39.0 m-85 -133.35 62.44 1.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.528 -0.732 . . . . 0.89000000000000001 109.247 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 p -66.72 -3.01 5.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.364 -0.835 . . . . 0.93000000000000005 108.91 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 49' ' ' TYR . 25.4 t-20 -95.59 1.11 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.418 -0.801 . . . . 0.46999999999999997 109.446 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.73 150.62 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.274 -0.639 . . . . 1.03 109.274 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.6 mm -98.89 123.49 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.426 -0.796 . . . . 1.05 109.078 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -111.24 132.87 54.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.357 -0.839 . . . . 0.11 109.141 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 mp -114.06 167.3 10.78 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.641 -0.874 . . . . 1.04 108.641 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.61 133.97 29.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.353 -1.351 . . . . 1.3100000000000001 107.353 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.3 t -132.32 141.43 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.264 -0.897 . . . . 1.02 110.745 -177.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.56 101.35 12.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.422 -0.955 . . . . 1.0800000000000001 108.422 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.42 -4.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 1.0600000000000001 111.197 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.502 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 38.3 m-20 -107.58 -41.97 4.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.253 -0.905 . . . . 1.1100000000000001 110.554 -178.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.11 -21.8 18.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.348 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.73 43.31 1.35 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.477 -0.935 . . . . 1.01 108.477 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' HH12 ' B' ' 4' ' ' ARG . 2.5 pt20 -53.81 -13.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.529 -0.732 . . . . 2.7799999999999998 110.015 -179.426 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.43 -42.12 71.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 108.981 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.89 -46.02 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.711 -0.848 . . . . 1.05 108.711 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.38 -34.0 76.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 1.0600000000000001 108.989 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 22.4 m -63.63 -48.21 78.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 1.79 108.962 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.94 -36.49 84.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.573 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.34 -7.71 54.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.232 -0.917 . . . . 1.0600000000000001 109.648 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' ALA . 39.4 mt-10 47.72 62.97 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.323 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 t -79.0 137.75 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 1.05 108.918 179.12 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -125.26 -4.48 7.34 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.407 -0.808 . . . . 2.9300000000000002 110.085 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.55 126.55 9.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.91 -1.119 . . . . 1.0600000000000001 109.349 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -110.07 151.87 42.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.54 -0.911 . . . . 0.97999999999999998 108.54 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -77.34 143.34 74.56 Favored 'Cis proline' 0 N--CA 1.483 0.875 0 C-N-CA 124.858 -0.892 . . . . 0.23999999999999999 109.926 -1.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.58 114.7 26.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.421 -0.955 . . . . 1.04 108.421 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -89.08 125.57 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.864 -1.147 . . . . 0.19 108.833 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -122.84 132.23 54.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.825 -1.176 . . . . 1.71 107.825 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.7 m-85 -107.09 129.82 54.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.13 109.911 -178.213 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.61 157.29 42.49 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.22 108.71 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -155.11 127.01 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.265 . . . . 2.0299999999999998 107.586 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 56.0 18.97 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 2.1600000000000001 109.847 -178.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.65 3.08 69.12 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 120.836 -1.165 . . . . 0.23000000000000001 110.447 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.68 147.23 34.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.356 -1.085 . . . . 2.8100000000000001 109.822 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -85.51 144.86 27.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.335 -0.853 . . . . 2.2599999999999998 109.384 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.65 -23.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.461 -0.775 . . . . 1.05 110.264 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.22 174.91 46.61 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.483 -1.342 . . . . 0.25 110.509 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.79 153.41 2.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -1.107 . . . . 2.04 110.094 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.74 132.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.17999999999999999 110.46 179.079 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -103.37 -169.17 1.61 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.19 -0.944 . . . . 0.89000000000000001 109.321 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.66 129.85 3.89 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.858 -1.297 . . . . 0.14000000000000001 109.858 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.97 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.196 -1.179 . . . . 1.0600000000000001 110.365 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 74.82 1.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.109 -1.071 . . . . 1.98 108.109 178.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -34.27 77.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 1.72 110.83 -178.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -64.52 -25.74 68.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.834 -1.166 . . . . 1.95 109.282 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -68.54 -35.97 78.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 2.5600000000000001 109.422 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -51.83 -36.4 47.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 1.03 108.958 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.83 -58.17 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 2.1499999999999999 109.863 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.1 84.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.36 -0.838 . . . . 1.04 110.844 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.9 m -67.18 -47.84 69.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.065 . . . . 1.04 110.273 -178.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.52 -51.09 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 1.05 108.983 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.28 -17.77 31.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 1.6599999999999999 109.605 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -76.46 -62.22 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 110.015 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.09 22.38 4.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.546 -0.721 . . . . 1.1399999999999999 110.518 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.226 179.408 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' B' B ' 4' ' ' ARG . . . . . 0.434 HH12 ' NE2' ' A' ' 63' ' ' GLN . 7.0 tpt180 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 5' ' ' TYR . . . . . 0.456 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 5.1 p90 -131.15 -165.26 1.54 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.099 -1.001 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.35 152.54 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.255 -0.903 . . . . 0.0 112.379 -177.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m -102.02 95.61 6.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.17 46.15 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 110.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 9' ' ' GLY . . . . . 0.645 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.81 -131.44 0.11 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 177.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.62 25.45 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.279 1.539 . . . . 0.0 109.276 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' B' B ' 11' ' ' SER . . . . . 0.645 ' H ' ' C ' ' B' ' 9' ' ' GLY . 20.4 t . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.52 -0.548 . . . . 3.3799999999999999 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.6 t -94.63 161.81 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.298 -0.876 . . . . 1.1000000000000001 109.306 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 3.7 tmtm? -155.22 122.91 5.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.143 -0.973 . . . . 2.5 108.892 179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -89.61 137.88 31.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 1.6100000000000001 110.371 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.9 mm -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.488 -1.301 . . . . 1.04 107.488 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -108.17 -15.93 14.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.292 -0.88 . . . . 1.97 109.195 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -153.13 158.95 42.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.92000000000000004 109.506 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.27 -29.49 23.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 2.48 109.998 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -58.7 -46.57 87.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 1.05 109.794 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.4 63.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 1.0600000000000001 109.909 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -58.91 -65.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.046 . . . . 0.25 109.806 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -55.91 -45.27 78.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 3.0699999999999998 109.724 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -58.8 -35.55 73.02 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.174 -0.954 . . . . 2.1000000000000001 109.753 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.15 83.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.1 . . . . 1.04 109.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.44 -41.46 98.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.815 . . . . 1.27 109.534 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.85 -45.56 85.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 109.912 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.98 59.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 1.0900000000000001 109.952 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -7.44 29.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 1.0700000000000001 109.782 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.75 -136.09 24.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.137 -1.585 . . . . 0.31 109.137 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -117.01 5.92 12.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.43 -1.041 . . . . 2.21 109.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.72 168.01 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 2.4100000000000001 109.102 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.66 164.51 9.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.158 -1.053 . . . . 1.05 108.158 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 12.1 t -145.1 107.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.993 -1.067 . . . . 1.03 109.672 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.84 136.48 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.178 -1.045 . . . . 1.01 108.178 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 136.7 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.528 -0.732 . . . . 1.02 109.645 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.73 101.78 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.95999999999999996 109.292 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -88.04 79.07 8.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.32000000000000001 108.056 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.3 m -113.36 150.9 31.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.315 0.579 . . . . 1.04 109.487 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.19 130.24 37.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 1.0600000000000001 108.766 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -66.94 -28.83 68.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 1.0600000000000001 110.809 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 58.4 p-90 -88.47 -8.82 54.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.003 -1.061 . . . . 0.51000000000000001 110.536 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -97.61 128.4 44.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.34000000000000002 109.542 -179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.14 -55.99 9.63 Favored Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.563 -0.711 . . . . 0.40000000000000002 111.42 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 13.6 Cg_exo -49.94 -35.0 39.27 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.746 1.631 . . . . 0.47999999999999998 111.401 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.96 -1.087 . . . . 0.81000000000000005 109.076 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -58.27 -20.27 41.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 2.46 110.018 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.9 tpt -60.43 -19.73 57.27 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.144 -0.973 . . . . 3.6600000000000001 110.883 -178.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.45 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.2 mt -100.73 4.39 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.998 -1.064 . . . . 1.0700000000000001 111.182 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 6.6 ptpt -64.65 -32.93 7.66 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 120.121 -1.612 . . . . 2.1099999999999999 112.439 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -57.64 -13.71 14.89 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.944 1.016 . . . . 0.29999999999999999 110.245 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -99.82 -67.19 0.86 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.724 -0.843 . . . . 0.37 108.724 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -46.61 -52.87 12.66 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.713 -0.617 . . . . 0.14999999999999999 110.424 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.7 -33.6 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.47999999999999998 109.73 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.0 -41.98 97.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 1.05 109.851 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 mt -52.25 -15.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.014 . . . . 1.1299999999999999 109.326 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 m -58.27 -33.37 69.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.93000000000000005 109.729 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.11 -18.06 22.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -0.907 . . . . 2.0 110.076 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -91.39 -22.81 20.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.132 -0.98 . . . . 2.6499999999999999 109.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -133.1 69.39 1.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.594 -0.691 . . . . 0.89000000000000001 109.193 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.6 p -67.34 -5.32 13.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.306 -0.871 . . . . 0.93000000000000005 109.114 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.44 5.28 52.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.487 -0.758 . . . . 0.46999999999999997 109.555 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.17 149.46 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.471 -0.768 . . . . 1.03 109.332 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.52 126.25 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.901 -0.777 . . . . 1.05 108.901 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -114.39 134.25 55.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.391 -0.818 . . . . 0.11 109.418 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 mp -116.4 175.11 5.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -0.783 . . . . 1.04 109.247 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -144.31 143.31 30.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.015 -1.106 . . . . 1.3100000000000001 108.015 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 55.8 t -140.44 142.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.07 -1.019 . . . . 1.02 110.658 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.95 100.77 11.72 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.932 -1.136 . . . . 1.0800000000000001 107.932 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.36 -10.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 111.099 -178.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -102.52 -41.34 6.31 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 111.239 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -94.86 -13.67 25.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.98 -1.075 . . . . 1.1200000000000001 110.061 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.88 48.48 1.62 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.284 -0.885 . . . . 1.01 108.797 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' NE2' ' HE ' ' B' ' 4' ' ' ARG . 96.5 mt-30 -55.22 -13.97 1.53 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.571 -0.705 . . . . 2.7799999999999998 109.592 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.44 -42.42 71.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.246 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.61 -45.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 1.05 108.542 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -34.36 77.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 1.0600000000000001 109.304 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 24.1 m -64.08 -49.49 72.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 1.79 109.332 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.8 -37.06 85.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 2.2000000000000002 109.224 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.71 -3.74 58.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 109.492 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ALA . 36.1 mt-10 47.0 52.65 11.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 2.3399999999999999 110.279 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.06 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 1.05 108.896 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 54.5 mttp -127.74 6.74 6.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.451 -0.781 . . . . 2.9300000000000002 109.733 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 137.82 17.34 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.057 -1.027 . . . . 1.0600000000000001 108.95 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 74.3 p -122.04 149.89 55.13 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.362 -0.836 . . . . 0.97999999999999998 109.006 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -76.6 148.07 88.16 Favored 'Cis proline' 0 N--CA 1.484 0.932 0 C-N-CA 124.66 -0.975 . . . . 0.23999999999999999 110.409 -2.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -117.63 115.82 25.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.255 -1.387 . . . . 1.04 107.255 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -93.04 121.68 34.63 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.213 -0.929 . . . . 0.19 108.555 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -119.8 137.88 53.7 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.608 -1.256 . . . . 1.71 107.608 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.5 m-85 -111.44 127.8 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.536 0.684 . . . . 0.13 110.044 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -126.33 157.49 38.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.619 -0.882 . . . . 0.22 108.619 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -155.48 123.84 5.91 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.403 -1.332 . . . . 2.0299999999999998 107.403 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt 56.39 28.38 13.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.764 . . . . 2.1600000000000001 109.89 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.04 87.19 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.98 -1.105 . . . . 0.23000000000000001 110.357 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -115.3 146.48 41.46 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.372 -1.075 . . . . 2.8100000000000001 110.128 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -85.54 140.79 30.36 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.402 -0.811 . . . . 2.2599999999999998 109.222 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 -20.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.396 -0.815 . . . . 1.05 110.289 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.1 46.69 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.454 -1.355 . . . . 0.25 110.378 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -174.18 153.66 2.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.359 -1.083 . . . . 2.04 110.229 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.94 135.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.17999999999999999 109.974 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -106.6 -169.24 1.53 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.238 -0.914 . . . . 0.89000000000000001 108.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 91.87 129.25 4.61 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.806 -1.318 . . . . 0.14000000000000001 109.806 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.87 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -1.097 . . . . 1.0600000000000001 110.297 -179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.0 t-20 -139.96 74.38 1.46 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 1.98 108.787 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.23 -32.58 74.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 1.72 110.319 -179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.06 -30.67 70.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.981 -1.074 . . . . 1.95 109.598 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -67.36 -33.5 75.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 2.5600000000000001 109.254 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.1 mt -50.82 -35.36 31.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.964 -1.085 . . . . 1.03 108.605 179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.98 -57.59 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.836 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.2 88.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 1.04 110.876 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.6 m -66.87 -46.04 76.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 1.04 110.467 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.27 -50.56 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 1.05 109.163 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -61.17 -18.27 57.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 1.6599999999999999 109.652 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.63 -60.69 2.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 2.02 110.134 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.8 mt -91.88 22.1 4.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.463 -0.773 . . . . 1.1399999999999999 110.461 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 1.1799999999999999 109.178 179.357 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.0 mtt-85 -118.28 74.36 0.95 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.506 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -130.29 150.72 51.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.448 -0.782 . . . . 0.0 109.022 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.436 ' HE ' ' NE2' ' A' ' 63' ' ' GLN . 7.3 mmt180 -148.0 -102.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.423 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 2.6 p90 -109.79 -168.54 1.34 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.087 -1.008 . . . . 0.0 110.714 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.02 150.31 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.943 0.877 . . . . 0.0 112.909 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.63 97.11 7.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -83.77 44.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.068 -1.02 . . . . 0.0 110.477 -179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.636 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.17 -136.82 0.15 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.32 28.27 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 118.755 1.278 . . . . 0.0 109.012 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.636 ' H ' ' C ' ' B' ' 9' ' ' GLY . 9.3 t -89.24 -31.04 18.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 109.697 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -65.34 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.703 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.566 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.436 -0.579 . . . . 3.3799999999999999 109.436 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 75.0 t -94.77 158.69 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.3 -0.875 . . . . 1.1000000000000001 109.626 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 52.0 tttt -153.99 125.26 7.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.363 -0.836 . . . . 2.5 108.803 179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -88.39 134.87 33.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 1.6100000000000001 109.899 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.99 106.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.219 -1.03 . . . . 1.04 108.219 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.63 -8.79 23.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.205 -0.934 . . . . 1.97 109.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.3 p -152.09 150.31 29.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.92000000000000004 109.623 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -51.57 -28.15 13.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 2.48 109.396 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 m -60.7 -43.27 97.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 1.05 109.584 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.35 -26.58 64.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.845 . . . . 1.0600000000000001 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.94 -67.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.25 109.868 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -54.1 -44.33 71.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 3.0699999999999998 109.673 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.44 -37.82 76.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.159 -0.963 . . . . 2.1000000000000001 109.726 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.71 88.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 1.04 109.276 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -64.7 -41.07 96.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 1.27 109.812 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.95 -38.68 92.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.587 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.08 -16.62 54.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.888 . . . . 1.0900000000000001 109.828 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -6.96 31.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 1.0700000000000001 109.938 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.452 ' H ' ' H2 ' ' A' ' 110' ' ' HOH . . . 65.66 -105.95 1.4 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.837 -1.305 . . . . 0.31 109.837 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.524 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 3.3 m-20 -137.78 3.38 2.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -1.078 . . . . 2.21 109.74 -179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.595 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 77.8 mttt -70.09 166.82 19.0 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.042 -1.036 . . . . 2.4100000000000001 109.124 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.414 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 163.39 11.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.295 -0.878 . . . . 1.05 108.687 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.414 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 13.4 t -146.21 107.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.094 -1.004 . . . . 1.03 109.48 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -103.73 128.5 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.366 -0.833 . . . . 1.01 108.804 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.95 134.81 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.612 -0.68 . . . . 1.02 109.896 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -106.48 101.1 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.177 -0.675 . . . . 0.95999999999999996 109.177 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -84.97 81.17 9.01 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.765 -1.198 . . . . 0.32000000000000001 107.765 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -110.94 -163.06 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.626 0.727 . . . . 1.04 109.514 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 124.81 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.607 -0.886 . . . . 1.0600000000000001 108.607 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.649 ' HG1' ' HZ3' ' A' ' 36' ' ' LYS . 10.0 t -64.69 -25.47 67.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 1.0600000000000001 110.718 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 46.9 p-90 -89.05 -19.45 25.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.972 -1.08 . . . . 0.51000000000000001 110.169 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.84 122.17 34.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.34000000000000002 109.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.63 -57.41 12.74 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 120.929 -0.653 . . . . 0.40000000000000002 111.555 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 22.8 Cg_exo -46.04 -36.88 16.83 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.712 1.608 . . . . 0.47999999999999998 111.645 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.86 -59.54 2.74 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.869 -1.145 . . . . 0.81000000000000005 108.944 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.649 ' HZ3' ' HG1' ' A' ' 30' ' ' THR . 14.6 ttmt -59.47 -15.15 15.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 2.46 110.009 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 tpt -58.24 -20.13 39.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 3.6600000000000001 110.434 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.2 mt -97.27 8.57 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.083 -1.01 . . . . 1.0700000000000001 110.783 -178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.96 -31.97 5.25 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 120.122 -1.611 . . . . 2.1099999999999999 112.529 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.67 -5.14 11.09 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 CA-C-N 119.968 1.024 . . . . 0.29999999999999999 109.706 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -111.85 -78.45 0.58 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.015 -0.735 . . . . 0.37 109.015 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -41.56 -56.91 2.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.767 -0.583 . . . . 0.14999999999999999 110.688 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.01 -31.48 72.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.47999999999999998 109.871 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.48 ' C ' ' H ' ' A' ' 46' ' ' SER . 13.4 m -66.49 -38.77 88.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.853 -1.154 . . . . 1.05 110.235 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.8 mt -49.17 -12.93 0.06 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.879 -1.138 . . . . 1.1299999999999999 109.649 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.48 ' H ' ' C ' ' A' ' 44' ' ' SER . 54.9 m -56.75 -31.57 64.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.93000000000000005 109.51 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.25 -17.59 21.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.266 -0.896 . . . . 2.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -91.03 -24.3 20.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.976 -1.077 . . . . 2.6499999999999999 109.85 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -135.49 70.96 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 0.89000000000000001 109.621 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.2 p -66.97 -4.57 9.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.266 -0.896 . . . . 0.93000000000000005 108.714 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.11 -0.37 50.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.736 . . . . 0.46999999999999997 109.823 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.7 149.59 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.729 . . . . 1.03 109.4 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.07 133.57 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.442 -0.786 . . . . 1.05 109.418 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -119.06 131.77 55.98 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.544 -0.723 . . . . 0.11 109.163 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.4 mp -114.99 172.81 6.82 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.399 -0.813 . . . . 1.04 108.962 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.99 143.33 31.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.85 138.2 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.168 -0.957 . . . . 1.02 110.288 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.79 102.9 14.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.648 -1.241 . . . . 1.0800000000000001 107.648 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.03 -6.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.233 -0.917 . . . . 1.0600000000000001 111.044 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.08 -44.52 5.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.052 -1.03 . . . . 1.1100000000000001 110.597 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.99 -15.37 24.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.093 -1.004 . . . . 1.1200000000000001 109.776 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.48 44.66 2.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -0.865 . . . . 1.01 109.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -57.06 -10.88 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.7799999999999998 110.216 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 65' ' ' VAL . 1.4 p30 -69.04 -39.16 79.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.908 -1.12 . . . . 1.1100000000000001 109.149 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.428 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 2.8 t -74.05 -42.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.137 -1.06 . . . . 1.05 108.137 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.2 -37.85 88.87 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.907 -0.775 . . . . 1.0600000000000001 108.907 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 m -64.03 -45.02 90.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 1.79 109.079 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.87 -39.03 93.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 2.2000000000000002 109.427 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.11 0.33 55.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -0.896 . . . . 1.0600000000000001 109.754 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 49.21 56.81 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.905 . . . . 2.3399999999999999 109.951 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.59 135.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 1.05 109.192 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -123.86 -6.86 7.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.604 -0.685 . . . . 2.9300000000000002 109.638 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.494 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.01 136.96 16.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.149 -0.969 . . . . 1.0600000000000001 109.433 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 9.2 p -115.47 150.61 44.9 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.295 -1.002 . . . . 0.97999999999999998 108.295 178.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.62 148.62 86.86 Favored 'Cis proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.838 -0.901 . . . . 0.23999999999999999 109.838 -2.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.494 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -119.26 118.89 32.48 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.145 -1.057 . . . . 1.04 108.145 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.0 m-85 -95.76 111.9 23.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.19 108.775 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -114.03 139.39 49.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.601 -1.259 . . . . 1.71 107.601 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.6 m-85 -109.17 133.24 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.54 0.686 . . . . 0.13 110.052 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -126.59 156.62 40.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.488 -0.93 . . . . 0.22 108.488 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -154.73 122.51 5.81 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.633 -1.247 . . . . 2.0299999999999998 107.633 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 56.86 29.67 16.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 2.1600000000000001 109.866 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.4 1.54 90.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.113 -1.041 . . . . 0.23000000000000001 110.741 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -112.67 148.32 34.9 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.155 -1.203 . . . . 2.8100000000000001 110.281 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.478 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -87.19 146.5 25.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 2.2599999999999998 109.523 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.09 -29.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.442 -0.786 . . . . 1.05 110.147 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.43 45.51 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.659 -1.258 . . . . 0.25 110.083 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -172.34 160.99 5.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -1.147 . . . . 2.04 110.77 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.6 133.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.511 -0.743 . . . . 0.17999999999999999 110.18 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -104.23 -170.39 1.76 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.89000000000000001 109.291 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.59 130.19 4.41 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.526 -1.43 . . . . 0.14000000000000001 109.526 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.82 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -1.17 . . . . 1.0600000000000001 110.237 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.6 74.76 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.331 -0.989 . . . . 1.98 108.331 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.25 -32.45 74.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.72 110.782 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.62 -28.67 69.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.1 -1.0 . . . . 1.95 109.153 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -69.4 -36.38 76.7 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.53 -0.731 . . . . 2.5600000000000001 109.873 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 58.7 mt -53.05 -36.31 60.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.767 -1.208 . . . . 1.03 108.765 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -65.79 -58.15 6.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 2.1499999999999999 109.615 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.5 91.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 1.04 110.485 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.3 m -65.06 -45.26 86.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 1.04 110.212 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.96 -54.35 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.0 -1.062 . . . . 1.05 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -61.46 -16.55 48.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 1.6599999999999999 109.745 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -76.3 -60.45 2.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.902 . . . . 2.02 110.479 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.33 18.18 7.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 1.1399999999999999 110.544 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.265 179.374 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.4 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 90.6 mtt180 -153.63 66.82 0.75 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.489 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 30.7 m-85 -116.27 150.42 37.61 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.42 -107.79 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.0 109.651 -179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -108.75 -177.49 3.33 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.652 -1.28 . . . . 0.0 110.69 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.03 145.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.038 0.923 . . . . 0.0 113.058 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 m -101.22 93.73 5.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -83.5 44.61 0.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.337 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.02 -132.4 0.07 OUTLIER Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.54 25.15 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 CA-C-N 119.211 1.505 . . . . 0.0 109.274 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t -85.99 -36.87 19.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 37.6 t-80 -86.48 -94.95 0.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.403 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.953 -1.471 . . . . 0.0 109.63 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.595 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.452 ' H2 ' ' H ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.397 -0.594 . . . . 3.3799999999999999 109.397 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 96.1 t -94.62 160.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 1.1000000000000001 109.55 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.75 121.24 5.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.727 -1.212 . . . . 2.5 107.727 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -86.77 141.39 28.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 1.6100000000000001 110.411 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.12 109.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 1.04 108.022 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.97 -14.88 17.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 1.97 109.327 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -154.96 157.61 37.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.92000000000000004 109.843 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 49.7 tttp -51.55 -27.65 11.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 2.48 109.574 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 m -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 1.05 110.005 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.47 -27.26 65.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.687 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.84 -67.61 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.25 109.942 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -54.04 -43.98 70.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.901 . . . . 3.0699999999999998 109.64 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.51 -37.5 78.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.245 -0.909 . . . . 2.1000000000000001 109.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.2 86.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 1.04 109.454 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.31 -43.16 98.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.413 -0.804 . . . . 1.27 109.563 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.27 -42.33 96.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 1.0900000000000001 109.594 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.06 -13.49 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.962 . . . . 1.0900000000000001 109.809 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -6.4 24.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 1.0700000000000001 109.753 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.433 ' H ' ' H1 ' ' A' ' 110' ' ' HOH . . . 70.54 -112.43 4.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.31 109.562 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -139.43 2.67 2.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -1.103 . . . . 2.21 109.262 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 68.2 mttt -68.84 167.05 16.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 2.4100000000000001 108.812 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.555 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.67 161.86 11.62 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.099 -1.074 . . . . 1.05 108.099 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.555 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 13.0 t -143.99 105.8 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.968 -1.083 . . . . 1.03 109.451 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.0 t -102.41 132.19 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.704 -0.85 . . . . 1.01 108.704 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.38 138.54 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.674 -0.641 . . . . 1.02 109.758 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.09 101.57 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.178 -0.675 . . . . 0.95999999999999996 109.178 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -85.09 79.97 9.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.874 -1.158 . . . . 0.32000000000000001 107.874 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.43 149.53 34.05 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.279 0.562 . . . . 1.04 109.789 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.95 128.17 37.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.63 -0.878 . . . . 1.0600000000000001 108.63 179.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -65.93 -26.65 67.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 1.0600000000000001 110.605 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.509 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 60.4 p-90 -88.53 -13.76 39.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.887 -1.133 . . . . 0.51000000000000001 110.038 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.8 t -94.34 126.01 39.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.34000000000000002 109.995 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.98 -58.96 8.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.462 -0.655 . . . . 0.40000000000000002 111.462 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.6 Cg_exo -45.12 -33.21 7.8 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.9 1.733 . . . . 0.47999999999999998 111.314 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.41 -61.58 1.96 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.897 -1.127 . . . . 0.81000000000000005 108.626 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -60.89 -15.7 33.66 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.71 -0.619 . . . . 2.46 110.473 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 33' ' ' GLY . 27.9 tpp -60.92 -27.38 68.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.05 -1.031 . . . . 3.6600000000000001 109.991 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 49.6 mt -96.49 15.63 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.131 -0.981 . . . . 1.0700000000000001 111.023 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.89 -32.75 3.67 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 118.179 -1.408 . . . . 2.1099999999999999 112.224 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -62.9 -4.58 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 CA-C-N 119.758 0.949 . . . . 0.29999999999999999 110.114 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.435 ' O ' ' OG ' ' A' ' 44' ' ' SER . 46.5 m-85 -109.16 -79.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.37 109.025 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.73 -55.8 2.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.632 . . . . 0.14999999999999999 111.082 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.37 -34.7 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.47999999999999998 110.219 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.435 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 85.1 p -64.85 -35.42 81.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.637 -1.29 . . . . 1.05 110.012 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.5 mt -50.11 -16.11 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.987 -1.071 . . . . 1.1299999999999999 109.28 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 14.9 m -57.03 -36.48 70.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.93000000000000005 109.706 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -93.16 -15.02 26.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.159 -0.963 . . . . 2.0 110.089 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -91.26 -23.12 20.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.056 -1.027 . . . . 2.6499999999999999 109.196 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -135.88 72.46 1.44 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.531 -0.731 . . . . 0.89000000000000001 109.414 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 93.3 p -67.17 -4.76 11.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.93000000000000005 108.969 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -96.97 -0.37 47.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.46999999999999997 109.9 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.29 147.54 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -0.784 . . . . 1.03 109.223 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 mm -98.77 130.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 1.05 109.36 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -118.11 132.13 56.37 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.486 -0.759 . . . . 0.11 109.142 179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.78 171.92 7.29 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.786 -0.82 . . . . 1.04 108.786 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -141.54 137.83 32.29 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.717 -1.216 . . . . 1.3100000000000001 107.717 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 t -136.47 139.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.275 -0.891 . . . . 1.02 110.883 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' C ' ' H ' ' A' ' 60' ' ' ASP . 19.5 t70 -99.99 101.77 12.95 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.745 -0.835 . . . . 1.0800000000000001 108.745 179.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.403 ' N ' ' O ' ' A' ' 108' ' ' HOH . 15.6 m -60.98 -2.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.879 . . . . 1.0600000000000001 111.017 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.43 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 26.1 m-20 -108.66 -44.44 4.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.061 -1.025 . . . . 1.1100000000000001 110.503 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -95.11 -26.97 15.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.102 -0.999 . . . . 1.1200000000000001 109.21 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.92 40.39 1.51 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.309 -0.997 . . . . 1.01 108.309 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.41 ' O ' ' OG ' ' A' ' 67' ' ' SER . 10.9 pt20 -53.57 -15.87 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.636 -0.665 . . . . 2.7799999999999998 110.121 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -70.26 -36.29 74.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.978 -1.076 . . . . 1.1100000000000001 108.783 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -75.27 -48.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.663 -0.866 . . . . 1.05 108.663 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.72 74.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.801 . . . . 1.0600000000000001 109.161 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.41 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 34.1 m -63.16 -48.98 76.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 1.79 109.182 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -64.94 -35.99 82.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.522 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 0.47 55.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.945 . . . . 1.0600000000000001 109.905 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 45.88 50.95 10.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.961 . . . . 2.3399999999999999 110.251 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.82 131.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 1.05 108.904 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -130.52 6.19 4.79 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.376 -0.827 . . . . 2.9300000000000002 110.212 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.46 120.7 6.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.04 -1.037 . . . . 1.0600000000000001 108.731 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 25.0 p -108.17 150.65 40.74 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.759 -0.83 . . . . 0.97999999999999998 108.759 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.8 141.97 68.83 Favored 'Cis proline' 0 N--CA 1.484 0.919 0 C-N-CA 125.033 -0.82 . . . . 0.23999999999999999 110.105 -1.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 115.66 27.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.973 -1.121 . . . . 1.04 107.973 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -91.47 118.62 30.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.19 108.94 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -117.06 132.95 56.56 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.839 -1.171 . . . . 1.71 107.839 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.0 m-85 -107.84 126.55 52.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.656 -0.653 . . . . 0.13 109.55 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -123.03 158.46 30.5 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.786 -0.82 . . . . 0.22 108.786 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.468 ' HZ1' ' HZ2' ' A' ' 82' ' ' LYS . 42.8 tttm -154.75 123.07 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.866 -1.531 . . . . 2.0299999999999998 106.866 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' HZ2' ' HZ1' ' A' ' 81' ' ' LYS . 25.1 mttm 58.26 28.59 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 2.1600000000000001 109.41 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 2.83 88.8 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.606 -1.397 . . . . 0.23000000000000001 109.606 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -106.76 145.75 31.68 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.543 -0.975 . . . . 2.8100000000000001 110.334 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -85.6 141.13 30.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 2.2599999999999998 109.357 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.6 -21.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.49 -0.756 . . . . 1.05 110.253 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.04 177.32 48.42 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.485 -1.341 . . . . 0.25 110.178 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -174.27 156.1 2.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -1.121 . . . . 2.04 110.165 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.9 131.15 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.17999999999999999 110.0 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 p -102.57 -166.85 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.192 -0.942 . . . . 0.89000000000000001 108.892 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.98 127.9 3.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.126 -1.59 . . . . 0.14000000000000001 109.126 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.81 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.158 -1.201 . . . . 1.0600000000000001 110.734 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -143.12 77.38 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.136 -1.061 . . . . 1.98 108.136 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -33.34 75.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 1.72 110.484 -178.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.97 -26.57 67.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.98 -1.075 . . . . 1.95 109.185 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -68.97 -36.54 78.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.346 -0.846 . . . . 2.5600000000000001 109.512 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.0 mt -53.7 -34.9 60.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.064 . . . . 1.03 108.919 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.0 -57.54 6.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 2.1499999999999999 109.722 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.33 90.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 1.04 110.59 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.0 m -66.86 -45.14 79.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 1.04 110.206 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.49 -51.9 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.932 -1.105 . . . . 1.05 108.631 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.91 -15.34 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.857 . . . . 1.6599999999999999 109.646 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -76.49 -59.72 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 2.02 110.176 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.3 mt -92.32 17.17 10.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -0.841 . . . . 1.1399999999999999 110.404 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.973 -1.08 . . . . 1.1799999999999999 109.382 179.595 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -119.67 71.67 0.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.495 -0.753 . . . . 0.0 109.165 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.404 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.7 m-85 -134.03 155.38 50.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.485 -0.759 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.564 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -149.61 -95.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.013 . . . . 0.0 109.356 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -115.08 -172.56 2.15 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.941 -1.1 . . . . 0.0 110.632 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.95 152.54 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.957 0.884 . . . . 0.0 112.056 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 m -101.25 96.84 7.46 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.8 pt-20 -82.8 45.48 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.948 . . . . 0.0 109.819 -179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.679 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.74 -132.66 0.07 OUTLIER Glycine 0 N--CA 1.484 1.894 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.27 21.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 CA-C-N 119.286 1.543 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.679 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.3 t -80.86 -49.76 10.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.245 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.543 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 56.4 t-80 -72.43 173.24 9.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.428 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.26 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.571 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.403 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.456 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.433 ' H1 ' ' H ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.412 -0.588 . . . . 3.3799999999999999 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.419 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 69.8 t -94.7 159.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.177 -0.952 . . . . 1.1000000000000001 109.73 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.527 ' HZ1' ' CD1' ' A' ' 5' ' ' ILE . 48.4 tttm -154.1 127.8 8.73 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 2.5 108.991 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -87.55 130.99 34.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.912 . . . . 1.6100000000000001 109.592 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.527 ' CD1' ' HZ1' ' A' ' 3' ' ' LYS . 25.0 mm -114.78 85.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.675 -0.861 . . . . 1.04 108.675 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -95.29 4.43 53.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.979 -1.075 . . . . 1.97 109.551 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 p -150.4 141.48 23.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.92000000000000004 109.889 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -51.57 -31.07 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.823 . . . . 2.48 109.49 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -59.88 -43.93 94.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 1.05 109.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.08 -26.01 63.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 1.0600000000000001 109.828 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.91 -67.39 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.25 110.118 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -53.78 -44.41 70.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 3.0699999999999998 109.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.38 -36.89 76.63 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.269 -0.894 . . . . 2.1000000000000001 109.969 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.36 89.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 1.04 109.484 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -63.77 -45.6 89.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 1.27 110.034 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.19 -41.57 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.048 -1.033 . . . . 1.0900000000000001 109.415 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.42 -13.06 59.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 1.0900000000000001 109.628 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.09 40.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 1.0700000000000001 109.581 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.11 -113.01 4.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.444 -1.462 . . . . 0.31 109.444 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -137.71 2.51 2.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.353 -1.087 . . . . 2.21 109.348 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.0 mttt -69.37 168.08 15.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 2.4100000000000001 108.702 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.49 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.55 165.1 10.58 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.168 -0.958 . . . . 1.05 108.452 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.1 t -145.29 106.31 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.87 -1.144 . . . . 1.03 109.712 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.5 132.25 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.354 -0.841 . . . . 1.01 108.996 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.07 136.75 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.619 -0.676 . . . . 1.02 109.636 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.472 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 14.5 t70 -109.37 102.29 11.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.95999999999999996 109.363 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -85.01 82.48 8.43 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.939 -1.134 . . . . 0.32000000000000001 107.939 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.472 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 57.1 m -114.24 150.05 34.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.822 -0.549 . . . . 1.04 109.734 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.0 123.41 35.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.234 -1.024 . . . . 1.0600000000000001 108.234 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -65.37 -23.25 66.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 110.454 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.0 p-90 -89.1 -11.75 43.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.51000000000000001 109.899 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 t -96.97 128.04 43.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.34000000000000002 110.049 -178.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.431 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.29 -56.46 11.92 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.631 -0.668 . . . . 0.40000000000000002 111.601 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.4 Cg_exo -47.2 -35.06 19.16 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.829 1.686 . . . . 0.47999999999999998 111.438 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -61.26 2.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.926 -1.109 . . . . 0.81000000000000005 108.832 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.51 -16.86 27.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.421 -0.799 . . . . 2.46 110.102 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.84 -28.44 68.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 3.6600000000000001 110.212 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.457 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 43.3 mt -96.76 18.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.232 -0.918 . . . . 1.0700000000000001 110.485 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.09 -32.05 2.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.53 -1.357 . . . . 2.1099999999999999 112.606 179.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -62.69 -3.69 4.8 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.659 0.914 . . . . 0.29999999999999999 109.994 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.645 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.3 m-85 -110.2 -76.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.567 -0.708 . . . . 0.37 109.331 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.1 t80 -42.28 -57.2 2.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.433 -0.792 . . . . 0.14999999999999999 110.715 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -66.82 -30.94 71.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.952 . . . . 0.47999999999999998 109.959 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.0 t -64.28 -40.08 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.804 -1.185 . . . . 1.05 109.96 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.8 -16.33 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.054 -1.029 . . . . 1.1299999999999999 109.437 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.419 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 44.9 m -57.38 -31.42 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.93000000000000005 109.869 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -96.57 -19.34 19.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.159 -0.963 . . . . 2.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -91.14 -23.7 20.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.965 -1.085 . . . . 2.6499999999999999 109.8 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 51' ' ' ASN . 39.1 m-85 -131.36 66.99 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.579 -0.7 . . . . 0.89000000000000001 109.181 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -66.5 -3.61 6.62 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 0.93000000000000005 108.79 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -95.4 -1.49 50.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 0.46999999999999997 109.319 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.7 t -115.56 149.11 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.058 -0.719 . . . . 1.03 109.058 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.58 128.76 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 1.05 109.324 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -115.29 132.31 56.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.532 -0.73 . . . . 0.11 109.181 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -114.08 171.33 7.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.871 -0.789 . . . . 1.04 108.871 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.69 138.38 28.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.066 -1.087 . . . . 1.3100000000000001 108.066 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 80.6 t -134.6 138.37 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.211 -0.931 . . . . 1.02 110.616 -178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.99 99.13 9.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.835 -1.172 . . . . 1.0800000000000001 107.835 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.18 -13.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 1.0600000000000001 111.331 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -100.03 -44.58 5.96 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.894 -1.129 . . . . 1.1100000000000001 111.298 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.6 -10.61 39.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.973 -1.08 . . . . 1.1200000000000001 109.718 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.4 2.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.543 -0.91 . . . . 1.01 108.543 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.401 ' O ' ' OG ' ' A' ' 67' ' ' SER . 48.0 mt-30 -55.44 -15.43 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.762 . . . . 2.7799999999999998 110.142 -179.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.6 p30 -69.74 -39.53 76.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.032 -1.042 . . . . 1.1100000000000001 108.995 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.05 -46.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 1.05 108.777 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.48 -31.99 72.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 1.0600000000000001 108.846 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.401 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 40.7 m -64.29 -56.23 15.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 1.79 109.219 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 -31.16 72.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 2.2000000000000002 109.351 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.24 -6.81 57.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 1.0600000000000001 109.296 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' ALA . 27.5 mt-10 45.27 51.6 9.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.383 -0.823 . . . . 2.3399999999999999 110.369 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.49 136.13 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 1.05 109.145 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -130.4 2.34 4.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.442 -0.786 . . . . 2.9300000000000002 109.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.09 126.95 9.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.005 -1.059 . . . . 1.0600000000000001 109.496 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 72.2 p -111.6 150.54 42.35 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.385 -0.822 . . . . 0.97999999999999998 108.876 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.61 141.42 64.22 Favored 'Cis proline' 0 N--CA 1.486 1.075 0 C-N-CA 125.03 -0.821 . . . . 0.23999999999999999 110.371 -1.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.67 114.26 26.78 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.129 -1.063 . . . . 1.04 108.129 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.61 124.16 34.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.848 -1.157 . . . . 0.19 109.093 179.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 41.4 mt-30 -122.4 133.67 54.63 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.915 -1.142 . . . . 1.71 107.915 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.3 m-85 -107.88 127.81 54.06 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.665 0.745 . . . . 0.13 110.012 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -126.08 155.37 41.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.923 -1.14 . . . . 0.22 107.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -156.25 125.46 6.13 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.205 -1.035 . . . . 2.0299999999999998 108.205 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.619 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 73.4 mttt 56.32 19.22 3.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.573 -0.705 . . . . 2.1600000000000001 109.569 -178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.464 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.39 1.09 69.39 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.309 -1.116 . . . . 0.23000000000000001 110.309 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.464 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.1 mm-40 -110.33 148.14 32.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.352 -1.087 . . . . 2.8100000000000001 110.272 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -87.89 145.65 25.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 2.2599999999999998 109.36 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.17 -25.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 1.05 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.1 46.25 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.477 -1.344 . . . . 0.25 110.516 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -174.49 154.94 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -1.094 . . . . 2.04 109.967 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.9 p90 -167.76 131.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.17999999999999999 110.455 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -104.53 -170.97 1.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.229 -0.919 . . . . 0.89000000000000001 108.805 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.18 131.96 3.86 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.785 -1.326 . . . . 0.14000000000000001 109.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.29 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -1.129 . . . . 1.0600000000000001 110.609 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.75 66.3 1.35 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.138 -1.06 . . . . 1.98 108.138 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.645 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.0 ptpt -61.04 -38.58 86.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 1.72 110.854 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.23 -28.81 69.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.986 -1.071 . . . . 1.95 109.729 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -70.16 -33.07 71.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.311 -0.868 . . . . 2.5600000000000001 109.592 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 26.3 mt -50.74 -37.98 44.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 1.03 108.63 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.72 -54.85 16.02 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.935 -0.706 . . . . 2.1499999999999999 109.658 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.71 90.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 1.04 110.542 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.7 m -66.5 -46.92 74.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.163 -0.961 . . . . 1.04 110.486 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 -50.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 1.05 108.975 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -61.62 -17.54 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 1.6599999999999999 109.544 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -77.05 -58.69 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 2.02 110.207 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.8 mt -91.78 18.57 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.341 -0.849 . . . . 1.1399999999999999 110.46 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.1799999999999999 109.275 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 59.7 mtp180 -140.8 50.81 1.65 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.351 -0.843 . . . . 0.0 108.865 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.482 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.7 m-85 -99.23 164.0 12.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -149.3 -96.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.294 -0.879 . . . . 0.0 109.22 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -128.47 -170.19 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.185 -0.947 . . . . 0.0 110.754 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.8 t -63.22 144.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.906 0.86 . . . . 0.0 112.837 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.5 m -101.25 94.64 6.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -83.09 45.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 110.672 -178.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.621 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.9 -130.66 0.19 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.17 28.02 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 CA-C-N 119.323 1.562 . . . . 0.0 109.201 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.621 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.7 t -96.38 3.42 52.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -163.79 145.64 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.638 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.617 179.825 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.619 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.403 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 mmt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.467 -0.568 . . . . 3.3799999999999999 109.467 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.427 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 60.6 t -94.55 172.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.265 -0.897 . . . . 1.1000000000000001 109.315 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.427 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 53.1 tttm -153.46 121.57 6.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -0.965 . . . . 2.5 109.224 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -89.79 136.06 33.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 1.6100000000000001 110.01 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mm -106.98 113.03 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.843 -1.169 . . . . 1.04 107.843 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.12 -11.04 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 1.97 109.561 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -153.29 155.55 36.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.121 -0.987 . . . . 0.92000000000000004 109.777 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 78.9 tttt -52.44 -31.36 34.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 2.48 109.806 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -57.93 -44.76 87.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.878 -1.139 . . . . 1.05 109.695 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.09 -23.7 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 1.0600000000000001 109.715 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -60.37 -68.39 0.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.25 110.181 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . 0.622 ' NE2' ' H ' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -54.35 -42.72 70.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 3.0699999999999998 109.279 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.82 -38.36 78.47 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.186 -0.946 . . . . 2.1000000000000001 109.974 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -47.72 84.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 1.04 109.362 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.66 -40.83 97.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.344 -0.848 . . . . 1.27 109.416 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.6 -41.42 96.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 109.869 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.09 58.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 1.0900000000000001 109.945 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 -3.38 9.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 1.0700000000000001 109.625 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -108.85 2.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.47 . . . . 0.31 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -139.7 4.59 2.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.395 -1.062 . . . . 2.21 109.282 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 55.9 mttm -69.95 175.06 4.66 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.124 -0.985 . . . . 2.4100000000000001 109.775 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.505 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.69 159.75 31.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.364 -0.976 . . . . 1.05 108.364 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.0 t -144.73 107.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.763 -1.211 . . . . 1.03 109.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -105.73 131.6 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.643 -0.873 . . . . 1.01 108.643 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 136.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.684 -0.635 . . . . 1.02 109.633 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.96 105.8 15.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.109 -0.7 . . . . 0.95999999999999996 109.109 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.62 79.62 8.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.988 -1.116 . . . . 0.32000000000000001 107.988 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -113.78 150.15 33.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.788 -0.57 . . . . 1.04 109.873 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.81 124.77 36.19 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.403 -0.962 . . . . 1.0600000000000001 108.403 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -66.0 -23.88 66.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 1.0600000000000001 110.367 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.538 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 54.3 p-90 -88.62 -13.95 38.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.51000000000000001 110.001 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -95.19 121.62 37.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.34000000000000002 109.665 -179.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.432 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.94 -57.15 20.18 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 121.579 -0.701 . . . . 0.40000000000000002 111.372 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.96 -34.3 16.23 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.863 1.709 . . . . 0.47999999999999998 111.5 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.03 2.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.026 -1.046 . . . . 0.81000000000000005 108.878 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.25 -18.52 49.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.522 -0.736 . . . . 2.46 110.233 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -59.21 -25.3 63.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 3.6600000000000001 110.17 -179.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.7 mt -96.34 11.94 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.069 -1.019 . . . . 1.0700000000000001 110.476 -179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.62 -32.24 3.54 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 120.407 -1.433 . . . . 2.1099999999999999 112.726 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.25 -3.98 5.82 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.851 0.982 . . . . 0.29999999999999999 110.318 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -111.96 -75.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.37 109.338 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -43.53 -57.03 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.14999999999999999 110.709 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.09 -31.89 72.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.47999999999999998 110.121 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' SER . 5.8 t -63.45 -39.02 93.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.856 -1.153 . . . . 1.05 110.4 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.6 mt -51.11 -12.78 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.019 -1.051 . . . . 1.1299999999999999 109.646 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' SER . 49.0 m -57.31 -36.95 71.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.93000000000000005 109.64 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -94.91 -16.75 22.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.119 -0.988 . . . . 2.0 110.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -90.33 -23.45 21.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.945 -1.097 . . . . 2.6499999999999999 109.4 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.413 ' C ' ' H ' ' A' ' 51' ' ' ASN . 40.0 m-85 -134.32 69.61 1.46 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.433 -0.792 . . . . 0.89000000000000001 109.219 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -66.51 -3.14 5.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.257 -0.902 . . . . 0.93000000000000005 108.946 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -95.94 0.74 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.544 -0.723 . . . . 0.46999999999999997 109.669 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.8 t -119.43 151.9 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.486 -0.759 . . . . 1.03 109.301 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 mm -101.6 129.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.402 -0.811 . . . . 1.05 109.461 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -116.95 131.0 57.06 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.441 -0.787 . . . . 0.11 109.147 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 mp -113.04 173.1 6.55 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.905 -0.776 . . . . 1.04 108.905 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -143.46 143.65 31.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.034 -1.098 . . . . 1.3100000000000001 108.034 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.59 138.19 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.095 -1.003 . . . . 1.02 110.731 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -99.69 105.01 16.78 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.176 -1.046 . . . . 1.0800000000000001 108.176 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.19 -12.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 1.0600000000000001 111.16 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.673 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 13.3 m-20 -100.28 -43.04 6.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.004 -1.06 . . . . 1.1100000000000001 110.733 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.32 -10.5 38.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.925 -1.109 . . . . 1.1200000000000001 109.63 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 47.55 2.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.656 -0.868 . . . . 1.01 108.656 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.408 ' O ' ' OG ' ' A' ' 67' ' ' SER . 11.6 pt20 -56.17 -15.79 4.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.782 . . . . 2.7799999999999998 110.016 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.5 p-10 -70.15 -40.22 74.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.145 -0.972 . . . . 1.1100000000000001 109.253 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 t -73.56 -47.08 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.668 -0.864 . . . . 1.05 108.668 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.42 -35.44 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 1.0600000000000001 108.927 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.408 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 34.6 m -64.07 -45.53 88.33 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 1.79 109.229 179.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.64 -40.8 97.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 2.2000000000000002 109.28 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.8 58.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.178 -0.951 . . . . 1.0600000000000001 109.713 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.2 mm-40 49.08 55.18 9.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 110.112 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.91 133.56 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 1.05 109.153 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -125.72 2.68 7.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.434 -0.791 . . . . 2.9300000000000002 109.837 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.38 127.72 10.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.984 -1.072 . . . . 1.0600000000000001 109.309 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.459 ' O ' ' N ' ' B' ' 8' ' ' GLU . 20.4 p -114.4 150.63 44.12 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.681 -0.859 . . . . 0.97999999999999998 108.681 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.21 142.02 72.14 Favored 'Cis proline' 0 N--CA 1.487 1.131 0 C-N-CA 125.005 -0.831 . . . . 0.23999999999999999 110.98 -1.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -114.68 114.69 25.99 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.595 -1.261 . . . . 1.04 107.595 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -91.54 122.06 33.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.895 -1.128 . . . . 0.19 108.922 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -120.91 136.19 55.01 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.308 -1.367 . . . . 1.71 107.308 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.7 m-85 -108.22 132.89 53.19 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.636 0.731 . . . . 0.13 110.087 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.8 157.15 41.19 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.725 -0.842 . . . . 0.22 108.725 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -156.15 124.94 5.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.647 -1.242 . . . . 2.0299999999999998 107.647 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.491 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 82.6 mttt 56.22 18.71 3.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 2.1600000000000001 109.68 -178.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.527 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.13 -1.11 64.59 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 120.158 -1.02 . . . . 0.23000000000000001 110.767 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.527 HE21 ' C ' ' A' ' 83' ' ' GLY . 31.0 mm-40 -109.7 147.99 32.18 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.091 -1.241 . . . . 2.8100000000000001 110.316 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -85.85 139.72 31.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.92 -0.77 . . . . 2.2599999999999998 108.92 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.3 -6.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 1.05 110.642 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.89 173.72 37.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.398 -1.382 . . . . 0.25 110.454 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -173.4 156.29 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -1.07 . . . . 2.04 110.165 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.61 132.17 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.503 -0.748 . . . . 0.17999999999999999 110.323 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -102.17 -162.92 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.89000000000000001 109.142 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.52 127.62 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.662 -1.375 . . . . 0.14000000000000001 109.662 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.4 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 1.0600000000000001 110.276 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' GLY . 26.3 t-20 -137.19 75.11 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.887 -1.153 . . . . 1.98 107.887 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -65.81 -42.26 90.87 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.812 -0.631 . . . . 1.72 111.316 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.02 -27.09 68.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.919 -1.113 . . . . 1.95 110.052 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -68.84 -32.44 72.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 2.5600000000000001 109.589 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 17.3 mt -53.55 -35.83 61.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.809 -1.182 . . . . 1.03 108.518 179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.42 -54.86 16.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 2.1499999999999999 109.479 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.59 89.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.835 . . . . 1.04 110.386 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 m -66.52 -45.09 80.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 1.04 109.784 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.92 -53.01 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.847 . . . . 1.05 109.29 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -60.34 -16.88 39.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 1.6599999999999999 109.467 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.49 -57.3 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 2.02 110.06 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.61 17.38 10.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 1.1399999999999999 110.131 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 1.1799999999999999 109.38 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 19.4 p90 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.538 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 14.7 mmm-85 -127.79 68.56 1.32 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.4 m-85 -118.8 150.55 39.63 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -144.87 -104.48 0.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.377 -0.827 . . . . 0.0 109.139 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -113.31 -167.75 1.24 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.271 -0.893 . . . . 0.0 110.975 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.21 148.25 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.92 0.867 . . . . 0.0 112.712 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 m -101.3 94.83 6.14 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.459 ' N ' ' O ' ' A' ' 74' ' ' THR . 5.2 pt-20 -83.54 44.71 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.091 -1.006 . . . . 0.0 110.41 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.662 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.0 -132.6 0.09 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.52 23.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 CA-C-N 119.404 1.602 . . . . 0.0 109.278 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.662 ' H ' ' C ' ' B' ' 9' ' ' GLY . 48.3 t -87.18 -43.38 12.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.621 ' HD1' ' H ' ' B' ' 13' ' ' GLY . 1.6 t60 -59.38 147.37 36.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.855 . . . . 0.0 109.617 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.621 ' H ' ' HD1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.491 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.673 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.428 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.417 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.432 -0.581 . . . . 3.3799999999999999 109.432 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.531 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 83.5 t -94.38 159.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.161 -0.962 . . . . 1.1000000000000001 109.157 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 25.5 tttt -155.12 122.87 5.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.037 -1.039 . . . . 2.5 109.438 -179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -89.59 138.33 31.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.81 . . . . 1.6100000000000001 109.767 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.59 101.48 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.668 -0.864 . . . . 1.04 108.668 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -97.92 -6.51 32.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.077 -1.015 . . . . 1.97 109.266 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 p -152.73 152.38 31.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.86 . . . . 0.92000000000000004 109.688 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -52.78 -26.45 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 2.48 110.081 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 m -60.11 -46.15 90.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 1.05 109.995 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.8 63.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 1.0600000000000001 109.809 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.42 -68.45 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.136 -0.977 . . . . 0.25 109.96 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -55.09 -44.0 74.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 3.0699999999999998 109.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.09 -36.28 74.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.243 -0.911 . . . . 2.1000000000000001 110.128 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -62.02 -46.82 87.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.935 -1.103 . . . . 1.04 109.728 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.46 -50.22 70.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.334 -0.854 . . . . 1.27 109.952 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.57 -40.68 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 1.0900000000000001 109.817 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -16.45 56.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 1.0900000000000001 109.607 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.88 -12.39 61.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 1.0700000000000001 109.643 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 -116.84 4.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.779 -1.328 . . . . 0.31 109.779 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 42.3 t0 -135.23 4.16 3.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.46 -1.024 . . . . 2.21 109.466 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -68.68 169.69 10.74 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.999 -1.063 . . . . 2.4100000000000001 108.737 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.15 161.31 19.38 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.905 -1.146 . . . . 1.05 107.905 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.4 t -144.22 104.65 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.979 -1.075 . . . . 1.03 109.637 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.69 127.07 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.736 -0.838 . . . . 1.01 108.736 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.45 138.69 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.577 -0.702 . . . . 1.02 109.522 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -110.88 104.77 13.42 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.294 -0.632 . . . . 0.95999999999999996 109.294 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 40.0 m-85 -86.28 80.83 8.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.739 -1.208 . . . . 0.32000000000000001 107.739 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -114.36 149.15 36.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.773 -0.579 . . . . 1.04 109.547 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.58 129.01 37.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.921 . . . . 1.0600000000000001 108.667 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -66.94 -24.85 66.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 1.0600000000000001 110.516 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 52.5 p-90 -87.86 -16.31 34.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.965 -1.084 . . . . 0.51000000000000001 110.018 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.51 130.79 38.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.34000000000000002 110.231 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.433 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.11 -56.36 7.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.556 -0.618 . . . . 0.40000000000000002 111.556 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -47.87 -35.18 23.9 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.587 1.525 . . . . 0.47999999999999998 111.482 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.61 2.29 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.81000000000000005 109.042 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.93 -18.78 47.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.806 . . . . 2.46 109.931 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.7 -16.19 25.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.065 -1.022 . . . . 3.6600000000000001 110.406 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 32.2 mt -100.43 8.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.136 -0.978 . . . . 1.0700000000000001 110.292 -179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.33 -32.94 6.93 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 120.189 -1.569 . . . . 2.1099999999999999 112.002 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -65.24 -3.04 6.68 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 CA-C-N 120.113 1.076 . . . . 0.29999999999999999 109.693 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.45 -79.12 0.58 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.925 -0.769 . . . . 0.37 108.925 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -42.03 -57.02 2.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.581 -0.699 . . . . 0.14999999999999999 110.806 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.432 ' O ' ' OG ' ' A' ' 46' ' ' SER . 5.0 t60 -66.97 -31.05 71.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.932 -1.105 . . . . 0.47999999999999998 110.032 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.449 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 4.4 m -63.89 -39.94 95.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.776 -1.203 . . . . 1.05 110.042 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 mt -51.99 -15.9 0.64 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 1.1299999999999999 109.781 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.531 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 3.9 m -58.6 -31.63 68.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.89 -1.131 . . . . 0.93000000000000005 109.825 -179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.45 -20.14 19.96 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.015 -1.053 . . . . 2.0 109.911 -179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -91.72 -21.15 20.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 2.6499999999999999 109.478 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -135.84 67.1 1.48 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.517 -0.739 . . . . 0.89000000000000001 109.083 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.4 p -66.95 -3.28 6.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.212 -0.93 . . . . 0.93000000000000005 109.207 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 23.9 t-20 -95.19 -0.98 52.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.851 . . . . 0.46999999999999997 109.527 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.2 t -116.28 149.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.941 -0.763 . . . . 1.03 108.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.9 mm -99.4 127.78 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 1.05 109.562 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -114.88 128.96 56.6 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.793 -0.817 . . . . 0.11 108.793 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.8 mp -112.29 170.56 8.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.294 -0.879 . . . . 1.04 108.986 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -141.62 141.58 33.43 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.961 -1.126 . . . . 1.3100000000000001 107.961 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.5 t -138.71 136.19 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 1.02 110.389 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' CG ' ' H1 ' ' A' ' 108' ' ' HOH . 17.0 t70 -98.64 105.86 18.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.543 -0.91 . . . . 1.0800000000000001 108.543 178.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.0 m -60.91 -7.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.843 . . . . 1.0600000000000001 111.344 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -108.87 -40.46 5.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 1.1100000000000001 111.074 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.88 -18.91 21.48 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.86 -1.15 . . . . 1.1200000000000001 109.318 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.98 47.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.236 -1.024 . . . . 1.01 108.236 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.416 ' O ' ' OG ' ' A' ' 67' ' ' SER . 16.6 mt-30 -54.98 -18.1 4.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.631 -0.668 . . . . 2.7799999999999998 110.608 -179.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -37.32 77.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.847 -1.158 . . . . 1.1100000000000001 109.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.5 -47.29 40.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.392 -0.817 . . . . 1.05 108.842 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.78 76.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.305 -0.872 . . . . 1.0600000000000001 109.189 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.416 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 62.0 m -63.71 -52.02 62.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 1.79 109.31 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.74 -31.92 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 110.069 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.7 -6.73 57.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.138 -0.976 . . . . 1.0600000000000001 110.09 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 46.76 64.99 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.955 . . . . 2.3399999999999999 109.777 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 15.9 t -83.38 136.86 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.351 -0.843 . . . . 1.05 108.979 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.97 -8.54 8.32 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.274 -0.891 . . . . 2.9300000000000002 109.715 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.0 130.83 11.67 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 1.0600000000000001 109.848 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.472 ' O ' ' N ' ' B' ' 8' ' ' GLU . 6.0 p -112.15 151.19 43.46 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.376 -0.972 . . . . 0.97999999999999998 108.376 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.05 142.04 71.15 Favored 'Cis proline' 0 N--CA 1.483 0.885 0 C-N-CA 124.752 -0.937 . . . . 0.23999999999999999 110.101 -1.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -113.83 114.22 25.98 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.031 -1.1 . . . . 1.04 108.031 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 81.3 m-85 -90.84 121.92 33.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.016 -1.053 . . . . 0.19 108.659 179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.8 mt-30 -121.57 135.89 54.98 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.77 -1.196 . . . . 1.71 107.77 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.5 m-85 -106.7 132.62 52.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.736 . . . . 0.13 110.126 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.55 155.68 38.62 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.313 -0.995 . . . . 0.22 108.313 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -155.63 121.39 5.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.3 -1.371 . . . . 2.0299999999999998 107.3 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.468 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 68.9 mttt 57.44 19.73 5.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.636 -0.665 . . . . 2.1600000000000001 109.551 -178.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.551 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 93.99 -1.07 67.46 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.432 -1.067 . . . . 0.23000000000000001 110.432 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.551 HE21 ' C ' ' A' ' 83' ' ' GLY . 18.9 mm-40 -109.96 147.36 33.61 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.245 -1.15 . . . . 2.8100000000000001 110.35 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -86.98 139.07 30.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 2.2599999999999998 109.4 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.18 -14.87 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.474 -0.766 . . . . 1.05 109.976 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.23 171.89 42.85 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.485 -1.34 . . . . 0.25 110.409 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -172.83 156.42 3.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -1.043 . . . . 2.04 109.961 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.7 p90 -168.91 133.57 1.53 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.626 -0.83 . . . . 0.17999999999999999 110.466 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -102.75 -172.35 2.11 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.489 -0.93 . . . . 0.89000000000000001 108.489 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.8 5.02 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.222 -1.551 . . . . 0.14000000000000001 109.222 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.0 94.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -1.169 . . . . 1.0600000000000001 111.053 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -140.25 75.71 1.52 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.815 -1.18 . . . . 1.98 107.815 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.31 -32.93 73.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.523 -0.735 . . . . 1.72 110.341 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.64 -25.82 67.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.055 -1.028 . . . . 1.95 108.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -69.19 -38.84 78.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 2.5600000000000001 109.465 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.66 -38.09 63.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.863 -1.148 . . . . 1.03 109.106 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.33 -56.48 12.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 2.1499999999999999 109.506 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.8 94.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 1.04 110.429 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.0 m -66.19 -44.85 82.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 1.04 109.807 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.2 mt -58.18 -55.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.065 -1.022 . . . . 1.05 108.33 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.55 -16.53 25.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 1.6599999999999999 109.903 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -76.61 -61.23 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 2.02 110.678 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.6 mt -93.16 15.63 14.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 1.1399999999999999 111.038 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.232 179.406 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 41.6 t80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.5 mtp180 -144.51 55.61 1.27 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 0.0 109.257 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 3' ' ' PHE . 27.5 m-85 -121.84 157.91 30.07 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.474 -0.767 . . . . 0.0 109.547 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -150.16 -92.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.914 -1.116 . . . . 0.0 110.148 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.47 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.7 p90 -111.6 -166.71 1.1 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.626 -1.296 . . . . 0.0 111.068 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.31 151.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.944 0.878 . . . . 0.0 112.308 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.81 96.12 6.86 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.472 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.0 pt-20 -83.35 43.16 0.86 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.012 -1.055 . . . . 0.0 110.098 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.73 -133.07 0.07 OUTLIER Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.13 25.36 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 CA-C-N 119.319 1.56 . . . . 0.0 109.346 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.8 t -84.12 -40.2 18.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.34 -0.85 . . . . 0.0 109.515 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.6 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 25.7 t-80 -64.46 -132.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.6 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.953 -1.47 . . . . 0.0 109.583 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.468 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.445 ' H1 ' ' CG ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.559 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.313 -0.625 . . . . 3.3799999999999999 109.313 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.454 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 79.5 t -94.72 165.1 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 1.1000000000000001 109.39 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.454 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 43.9 tttm -155.17 121.32 5.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 2.5 108.972 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.57 135.37 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.853 . . . . 1.6100000000000001 109.534 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.5 mm -107.99 109.67 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.769 -1.196 . . . . 1.04 107.769 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.28 -7.14 24.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.247 -0.908 . . . . 1.97 110.031 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -153.0 153.81 33.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.047 -1.033 . . . . 0.92000000000000004 109.912 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -52.3 -27.37 14.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.396 -0.815 . . . . 2.48 109.471 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -60.42 -47.4 86.25 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.254 -0.903 . . . . 1.05 109.909 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.47 -24.31 63.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 1.0600000000000001 110.139 -179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.31 -66.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.015 -1.053 . . . . 0.25 110.139 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -44.93 78.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 3.0699999999999998 109.572 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -58.91 -36.7 75.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.362 -0.836 . . . . 2.1000000000000001 109.9 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' CB ' ' HZ3' ' A' ' 3' ' ' LYS . . . -59.87 -47.85 84.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.94 -1.1 . . . . 1.04 109.194 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.94 -42.1 97.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.464 -0.773 . . . . 1.27 109.713 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.4 -40.97 96.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.136 -0.977 . . . . 1.0900000000000001 109.851 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.65 -16.2 56.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 109.648 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.454 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.57 -5.27 18.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 1.0700000000000001 109.578 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.11 -116.26 7.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.31 109.613 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -133.35 5.34 3.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.414 -1.05 . . . . 2.21 109.235 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 42.6 mttp -70.43 167.72 17.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.186 -0.946 . . . . 2.4100000000000001 108.946 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.548 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.03 161.35 16.14 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.894 -1.151 . . . . 1.05 107.894 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 14.0 t -143.93 108.8 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 1.03 109.421 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.39 131.36 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.592 -0.892 . . . . 1.01 108.592 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 t -109.06 133.21 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.629 -0.67 . . . . 1.02 109.382 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -106.86 105.33 15.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.92 -0.77 . . . . 0.95999999999999996 108.92 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 38.5 m-85 -87.27 80.33 8.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.757 -1.201 . . . . 0.32000000000000001 107.757 179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.5 m -113.22 148.52 35.33 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.283 0.563 . . . . 1.04 109.771 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.48 127.07 37.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.407 -0.96 . . . . 1.0600000000000001 108.407 178.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -66.06 -25.62 67.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 1.0600000000000001 110.234 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.8 p-90 -89.48 -11.79 41.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.207 -0.933 . . . . 0.51000000000000001 110.17 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 4.0 t -95.04 128.11 41.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.34000000000000002 109.931 -179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.79 -58.96 7.57 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 111.166 -0.774 . . . . 0.40000000000000002 111.166 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.4 Cg_exo -47.22 -31.64 12.74 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 121.897 1.731 . . . . 0.47999999999999998 111.184 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.4 -61.28 2.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 108.771 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -59.84 -17.58 37.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 2.46 110.068 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.474 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.992 -1.068 . . . . 3.6600000000000001 110.137 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.462 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 88.1 mt -96.07 7.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 1.0700000000000001 111.276 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.71 -35.58 23.49 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 120.309 -1.494 . . . . 2.1099999999999999 111.895 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -61.26 -5.98 5.98 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 CA-C-N 119.842 0.979 . . . . 0.29999999999999999 110.839 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.26 -71.99 0.74 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.987 -0.746 . . . . 0.37 108.987 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -46.37 -57.47 4.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.601 -0.687 . . . . 0.14999999999999999 110.536 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.47 -30.68 71.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.199 -0.938 . . . . 0.47999999999999998 109.771 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.4 m -64.01 -42.1 97.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.979 -1.076 . . . . 1.05 109.774 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.7 mt -50.2 -13.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.929 . . . . 1.1299999999999999 109.365 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 44' ' ' SER . 47.6 m -57.14 -34.52 68.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.93000000000000005 109.647 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.95 -16.9 22.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.273 -0.892 . . . . 2.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -89.59 -41.98 11.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.992 -1.067 . . . . 2.6499999999999999 109.826 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -113.04 70.4 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.424 -0.798 . . . . 0.89000000000000001 109.351 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.7 p -67.14 -5.09 12.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.33 -0.857 . . . . 0.93000000000000005 108.84 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.22 1.22 54.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.778 . . . . 0.46999999999999997 109.657 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.85 151.01 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.785 -0.82 . . . . 1.03 108.785 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mm -100.83 126.51 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.331 -0.855 . . . . 1.05 109.042 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -112.02 129.26 56.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.397 -0.815 . . . . 0.11 108.917 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.4 mp -113.12 172.2 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.729 -0.841 . . . . 1.04 108.729 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.06 142.07 30.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.824 -1.176 . . . . 1.3100000000000001 107.824 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 98.1 t -139.12 136.6 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.339 -0.851 . . . . 1.02 110.176 -178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.405 ' C ' ' H2 ' ' A' ' 108' ' ' HOH . 8.2 t70 -99.0 109.35 22.12 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.922 -1.14 . . . . 1.0800000000000001 107.922 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.612 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 20.3 m -63.74 -12.98 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.315 -0.865 . . . . 1.0600000000000001 111.104 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.608 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 19.5 m-20 -100.9 -40.21 7.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.064 -1.022 . . . . 1.1100000000000001 111.015 -178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.6 -14.82 26.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.013 -1.055 . . . . 1.1200000000000001 109.289 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.26 44.4 2.81 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.752 -0.833 . . . . 1.01 108.752 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.57 -14.53 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 2.7799999999999998 109.942 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.07 -38.12 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.021 -1.05 . . . . 1.1100000000000001 108.891 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -74.56 -46.84 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.513 -0.921 . . . . 1.05 108.513 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.67 -35.09 78.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.356 -0.84 . . . . 1.0600000000000001 108.928 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.3 m -64.5 -45.34 87.74 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.273 -0.892 . . . . 1.79 109.034 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -63.73 -41.48 98.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.799 . . . . 2.2000000000000002 109.327 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.02 -4.12 58.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.272 -0.893 . . . . 1.0600000000000001 109.365 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.3 mm-40 50.26 55.07 10.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 2.3399999999999999 110.421 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.4 123.27 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 1.05 108.989 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -114.01 5.31 16.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.402 -0.811 . . . . 2.9300000000000002 109.92 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.552 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.57 148.17 27.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.096 -1.003 . . . . 1.0600000000000001 109.219 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 20.7 p -131.48 149.04 72.42 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.616 -0.883 . . . . 0.97999999999999998 108.616 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.45 145.77 78.18 Favored 'Cis proline' 0 C--N 1.322 -0.85 0 C-N-CA 124.664 -0.973 . . . . 0.23999999999999999 110.429 -1.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.8 m -115.7 114.92 25.49 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.622 -1.251 . . . . 1.04 107.622 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -91.26 118.58 30.6 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.433 -0.907 . . . . 0.19 108.573 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -119.94 135.94 54.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.617 -1.253 . . . . 1.71 107.617 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 26.8 m-85 -107.3 132.34 53.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.13 109.699 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -125.0 156.22 38.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.617 -0.883 . . . . 0.22 108.617 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -156.09 121.19 4.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.783 -1.191 . . . . 2.0299999999999998 107.783 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt 55.68 34.26 22.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.693 -0.629 . . . . 2.1600000000000001 110.318 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.39 3.27 88.59 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.092 -1.052 . . . . 0.23000000000000001 110.751 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -114.01 146.58 39.97 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.349 -1.089 . . . . 2.8100000000000001 110.295 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -86.49 144.4 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.718 -0.845 . . . . 2.2599999999999998 108.718 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.03 -20.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.381 -0.825 . . . . 1.05 110.466 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 174.71 47.18 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.301 -1.428 . . . . 0.25 110.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -174.17 156.98 2.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 2.04 110.169 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.91 131.88 1.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.528 -0.732 . . . . 0.17999999999999999 109.683 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 p -103.44 -160.27 0.77 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.051 -1.03 . . . . 0.89000000000000001 108.574 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 79.44 122.11 0.36 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.47 -1.452 . . . . 0.14000000000000001 109.47 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.66 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.122 . . . . 1.0600000000000001 110.601 -179.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -137.47 71.58 1.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.805 -1.183 . . . . 1.98 107.805 178.436 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -61.62 -39.53 91.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.731 -0.605 . . . . 1.72 111.358 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.55 -25.74 67.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.758 -1.214 . . . . 1.95 109.704 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -69.1 -32.65 72.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 2.5600000000000001 109.575 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.6 mt -51.02 -38.85 53.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 1.03 109.131 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.11 -53.22 40.67 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.661 -0.816 . . . . 2.1499999999999999 109.288 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.05 90.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 1.04 110.699 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.4 m -67.68 -42.94 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 1.04 110.235 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -61.48 -52.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 1.05 108.691 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -61.26 -17.77 55.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.858 . . . . 1.6599999999999999 109.561 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -76.17 -59.36 2.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 2.02 110.043 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.0 mt -92.64 20.42 6.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.385 -0.822 . . . . 1.1399999999999999 110.429 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.988 -1.006 . . . . 1.1799999999999999 109.178 179.361 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 58.9 mtp180 -132.46 57.71 1.78 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.785 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.2 m-85 -111.7 158.94 18.71 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -150.17 -99.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.031 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -116.1 -173.27 2.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.321 -0.862 . . . . 0.0 110.529 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.11 150.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.992 0.901 . . . . 0.0 112.614 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.32 97.04 7.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -83.47 46.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.98 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.645 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.78 -126.51 0.16 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.69 24.51 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 119.2 1.5 . . . . 0.0 109.603 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.645 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.1 t -101.33 3.81 41.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.534 -0.729 . . . . 0.0 110.255 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.472 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 76.1 t60 -141.06 173.95 10.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.472 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.429 0 CA-C-O 118.208 -1.329 . . . . 0.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.612 ' H2 ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.454 ' H1 ' ' C ' ' A' ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.494 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.8 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.427 -0.583 . . . . 3.3799999999999999 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.461 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 60.8 t -94.74 172.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 1.1000000000000001 109.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.461 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 25.9 tptp -154.24 124.92 7.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.25 -0.906 . . . . 2.5 108.823 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -91.71 134.12 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 1.6100000000000001 109.923 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mm -110.68 109.11 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.034 -1.099 . . . . 1.04 108.034 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.98 -11.13 19.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.3 -0.875 . . . . 1.97 109.811 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -152.89 154.52 35.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.92000000000000004 109.715 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -51.82 -25.79 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 2.48 109.695 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -59.61 -48.61 80.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 1.05 109.767 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.69 63.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 1.0600000000000001 109.9 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.31 -65.56 0.63 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.124 . . . . 0.25 110.011 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -55.51 -46.05 77.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 3.0699999999999998 109.623 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.76 -35.07 72.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 2.1000000000000001 110.027 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.51 90.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.939 -1.101 . . . . 1.04 109.735 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.85 -46.59 87.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 1.27 109.845 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.57 -38.11 89.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 110.089 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.91 -16.52 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 1.0900000000000001 110.073 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -2.76 8.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 1.0700000000000001 109.925 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -114.79 5.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.31 109.555 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -138.42 4.72 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.336 -1.097 . . . . 2.21 109.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 74.5 mttt -70.1 168.16 16.17 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.204 -0.935 . . . . 2.4100000000000001 108.748 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.62 162.39 13.11 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.81 -1.181 . . . . 1.05 107.81 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 15.1 t -145.03 109.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.771 -1.206 . . . . 1.03 109.628 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.9 135.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.776 -0.824 . . . . 1.01 108.776 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -110.35 134.58 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 1.02 109.383 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.17 101.16 10.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.697 -0.627 . . . . 0.95999999999999996 109.459 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -87.41 76.56 9.04 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 0.32000000000000001 107.933 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -113.72 148.77 35.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.772 -0.58 . . . . 1.04 109.474 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.46 125.24 36.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.542 -0.91 . . . . 1.0600000000000001 108.542 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -65.18 -23.42 67.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 1.0600000000000001 110.573 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.3 p-90 -88.62 -14.76 36.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.053 -1.029 . . . . 0.51000000000000001 109.976 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.64 118.36 32.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.34000000000000002 109.686 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.45 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.55 -58.15 16.08 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.717 -0.754 . . . . 0.40000000000000002 111.435 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.45 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -47.52 -34.96 21.08 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.806 1.67 . . . . 0.47999999999999998 111.23 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.22 -60.98 2.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.924 -1.11 . . . . 0.81000000000000005 109.208 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -58.98 -17.04 21.24 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.595 -0.691 . . . . 2.46 110.041 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.505 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -58.45 -19.73 39.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 3.6600000000000001 110.523 -178.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.5 mt -96.55 7.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.09 -1.006 . . . . 1.0700000000000001 110.813 -178.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.27 5.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 119.953 -1.717 . . . . 2.1099999999999999 112.645 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -65.16 -7.48 15.68 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 CA-C-N 119.555 0.877 . . . . 0.29999999999999999 110.04 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -109.52 -74.54 0.65 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.845 . . . . 0.37 108.976 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -41.66 -56.63 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.649 -0.657 . . . . 0.14999999999999999 110.931 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -67.0 -31.04 71.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.022 -1.049 . . . . 0.47999999999999998 110.1 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -65.73 -42.57 90.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.839 -1.163 . . . . 1.05 110.534 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -50.39 -17.44 0.47 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.985 -1.072 . . . . 1.1299999999999999 109.99 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -56.8 -27.77 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.93000000000000005 110.051 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -96.1 -22.1 17.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.142 -0.974 . . . . 2.0 110.323 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -90.32 -19.88 23.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 2.6499999999999999 109.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -132.34 72.1 1.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.692 . . . . 0.89000000000000001 109.257 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.2 p -67.87 -5.31 16.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.412 -0.805 . . . . 0.93000000000000005 109.327 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.9 t-20 -96.47 -0.77 48.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.75 . . . . 0.46999999999999997 109.61 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 145.96 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.249 -0.907 . . . . 1.03 109.472 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.35 132.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.529 -0.732 . . . . 1.05 109.371 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.2 m-85 -117.67 130.73 56.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.397 -0.814 . . . . 0.11 109.059 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.2 mp -113.2 172.44 6.94 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.801 -0.814 . . . . 1.04 108.801 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -141.8 143.17 33.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.202 -1.036 . . . . 1.3100000000000001 108.202 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 136.17 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -0.97 . . . . 1.02 110.641 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.38 103.13 15.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.448 -0.945 . . . . 1.0800000000000001 108.448 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.485 ' O ' ' NE ' ' B' ' 4' ' ' ARG . 16.1 m -61.19 -8.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 1.0600000000000001 111.036 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.48 -46.1 5.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 110.856 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -93.12 -14.47 27.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.086 -1.008 . . . . 1.1200000000000001 109.673 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.06 46.18 1.83 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.306 -0.871 . . . . 1.01 109.049 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.07 -15.73 2.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 2.7799999999999998 109.66 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.8 p30 -70.12 -41.11 74.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.112 -0.993 . . . . 1.1100000000000001 109.056 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 t -73.55 -46.28 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.949 . . . . 1.05 108.617 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.8 -36.67 83.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 1.0600000000000001 108.735 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -64.47 -47.67 78.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.79 109.074 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.09 -34.42 78.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 2.2000000000000002 109.599 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.92 -7.14 54.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 1.0600000000000001 109.587 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.4 mt-10 51.11 61.12 3.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 2.3399999999999999 110.21 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 35.0 t -78.61 138.07 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.116 -0.99 . . . . 1.05 108.996 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -123.03 -9.02 8.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.431 -0.793 . . . . 2.9300000000000002 109.546 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.473 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.3 135.6 14.96 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.064 -1.022 . . . . 1.0600000000000001 109.66 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.547 ' O ' ' N ' ' B' ' 8' ' ' GLU . 2.9 p -114.87 150.6 44.38 Favored Pre-proline 0 N--CA 1.5 2.027 0 N-CA-C 108.117 -1.068 . . . . 0.97999999999999998 108.117 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.37 146.76 83.57 Favored 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 124.877 -0.885 . . . . 0.23999999999999999 110.205 -1.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.84 121.99 42.19 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.429 -0.952 . . . . 1.04 108.429 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -98.82 115.93 29.9 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.395 -0.965 . . . . 0.19 108.395 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.89 141.26 48.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.988 -1.116 . . . . 1.71 107.988 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.5 m-85 -111.17 134.54 52.69 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.49 0.662 . . . . 0.13 110.156 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.37 155.12 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.998 -0.741 . . . . 0.22 108.998 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -154.58 123.18 6.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.91 -1.145 . . . . 2.0299999999999998 107.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt 55.74 30.66 16.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 2.1600000000000001 110.064 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.42 90.52 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.791 -1.195 . . . . 0.23000000000000001 110.621 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -112.83 145.65 40.27 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.248 -1.148 . . . . 2.8100000000000001 110.319 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -86.88 144.8 26.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 2.2599999999999998 108.75 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.68 -23.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.41 -0.806 . . . . 1.05 110.587 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.94 179.34 47.12 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.28 -1.438 . . . . 0.25 110.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.26 158.59 2.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -1.126 . . . . 2.04 110.357 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.98 132.14 1.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.476 -0.765 . . . . 0.17999999999999999 110.195 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.406 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 16.5 p -104.14 -172.95 2.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.191 -0.943 . . . . 0.89000000000000001 108.608 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 130.76 5.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.353 -1.499 . . . . 0.14000000000000001 109.353 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -59.27 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -1.211 . . . . 1.0600000000000001 110.477 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.88 71.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.815 -1.18 . . . . 1.98 107.815 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.01 -30.51 71.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 1.72 110.294 -178.64 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.6 -26.85 67.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.787 -1.196 . . . . 1.95 108.998 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -69.08 -34.14 74.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.486 -0.759 . . . . 2.5600000000000001 109.405 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.4 mt -50.92 -37.24 42.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.02 -1.05 . . . . 1.03 108.82 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.23 -57.17 7.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.395 -0.815 . . . . 2.1499999999999999 109.667 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.02 92.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 1.04 110.509 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.5 m -66.84 -44.2 81.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 1.04 110.164 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.87 -52.75 55.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 1.05 108.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.1 -16.66 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 1.6599999999999999 109.977 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.13 -58.28 3.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 2.02 110.484 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.04 14.16 18.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 1.1399999999999999 110.693 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.494 1.764 0 O-C-N 120.863 -1.148 . . . . 1.1799999999999999 109.199 179.22 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.564 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -138.49 67.32 1.41 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.451 -0.781 . . . . 0.0 109.537 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.8 m-85 -119.68 142.83 48.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.212 -0.93 . . . . 0.0 108.708 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' A' ' 59' ' ' VAL . 13.6 mmm180 -135.84 -109.23 0.21 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.516 -0.74 . . . . 0.0 109.635 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.435 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.1 p90 -109.59 -168.42 1.33 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.274 -0.892 . . . . 0.0 110.525 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.09 146.95 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.717 0.77 . . . . 0.0 112.114 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -101.16 95.45 6.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.1 pt-20 -83.3 42.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.064 -1.023 . . . . 0.0 110.479 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.67 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.81 -130.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.81 20.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 CA-C-N 119.139 1.47 . . . . 0.0 109.05 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.67 ' H ' ' C ' ' B' ' 9' ' ' GLY . 0.4 OUTLIER -89.01 -31.14 18.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -155.66 152.26 28.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.567 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.544 ' H2 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.565 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.312 0.577 . . . . 3.3799999999999999 109.471 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.478 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 84.3 t -94.36 164.81 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 1.1000000000000001 109.117 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.408 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 26.9 tttp -154.99 121.15 5.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 2.5 109.553 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 31.6 tt0 -89.54 136.51 32.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 1.6100000000000001 109.579 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -107.04 113.13 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.606 -1.257 . . . . 1.04 107.606 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' OE1' ' NE2' ' A' ' 4' ' ' GLN . 4.1 mm-40 -99.79 -13.32 19.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 1.97 108.933 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 p -154.09 158.78 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.92000000000000004 109.554 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -52.36 -22.97 5.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 2.48 110.037 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -60.93 -51.32 69.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 1.05 110.671 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.26 -22.53 64.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 1.0600000000000001 110.014 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.1 -64.19 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.25 109.791 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -55.75 -46.72 77.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 3.0699999999999998 109.963 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.94 -35.66 71.42 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.96 -46.51 90.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 1.04 109.563 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.26 -44.79 94.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 1.27 109.721 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.51 -36.8 85.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.727 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.03 -18.84 52.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 109.776 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.46 -5.94 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 1.0700000000000001 109.633 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.68 1.24 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.457 -1.457 . . . . 0.31 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -138.13 0.4 2.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 2.21 109.781 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HOH . 19.9 mtmm -69.89 172.21 8.11 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.033 -1.042 . . . . 2.4100000000000001 109.012 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.712 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -66.34 164.42 16.12 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.383 -0.823 . . . . 1.05 108.992 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.582 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 20.1 t -145.94 105.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 1.03 109.469 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.7 t -103.67 133.73 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.304 -0.872 . . . . 1.01 109.148 179.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.64 134.07 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.233 -0.654 . . . . 1.02 109.233 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -107.87 104.79 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.117 -0.698 . . . . 0.95999999999999996 109.117 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 57.7 m-85 -86.37 82.33 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.736 -1.209 . . . . 0.32000000000000001 107.736 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -113.72 147.82 37.54 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.443 -0.577 . . . . 1.04 109.443 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.68 124.2 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.485 -0.931 . . . . 1.0600000000000001 108.485 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -65.51 -24.8 67.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.832 . . . . 1.0600000000000001 110.478 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 49.2 p-90 -88.79 -13.57 39.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.1 . . . . 0.51000000000000001 109.926 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.7 116.92 29.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.34000000000000002 109.723 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.67 -55.47 30.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.832 -0.699 . . . . 0.40000000000000002 111.742 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.2 Cg_exo -47.86 -35.23 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.6 1.533 . . . . 0.47999999999999998 111.388 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.57 -60.55 2.32 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.049 -1.032 . . . . 0.81000000000000005 109.194 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.65 -18.07 38.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.748 . . . . 2.46 110.052 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.6 tmt? -58.77 -24.89 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 3.6600000000000001 110.389 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -96.31 13.82 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.873 -1.142 . . . . 1.0700000000000001 110.149 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.72 2.89 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.585 -1.322 . . . . 2.1099999999999999 112.164 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.4 Cg_endo -67.94 7.44 0.6 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 CA-C-N 119.6 0.893 . . . . 0.29999999999999999 110.526 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.483 ' H ' ' C ' ' A' ' 39' ' ' LYS . 45.6 m-85 -124.48 -73.7 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.756 -0.831 . . . . 0.37 108.756 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -43.44 -55.76 3.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 0.14999999999999999 110.266 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.85 -27.33 66.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.47999999999999998 109.869 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 46' ' ' SER . 1.4 p -65.13 -44.92 87.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 1.05 110.068 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.8 mt -49.15 -14.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 1.1299999999999999 109.706 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 68.0 m -57.66 -32.14 67.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.993 -1.067 . . . . 0.93000000000000005 109.743 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -94.91 -19.57 20.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.963 . . . . 2.0 110.141 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -91.4 -21.69 20.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.954 -1.091 . . . . 2.6499999999999999 109.584 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -134.2 72.76 1.47 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.502 -0.749 . . . . 0.89000000000000001 109.384 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 p -68.59 -6.9 28.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.383 -0.823 . . . . 0.93000000000000005 109.35 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -96.31 0.92 51.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.352 -0.842 . . . . 0.46999999999999997 109.881 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.6 t -112.76 146.35 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.349 -0.982 . . . . 1.03 108.349 179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.9 mm -100.42 119.42 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 1.05 109.538 -179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 69.2 m-85 -108.77 130.04 55.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.786 -0.82 . . . . 0.11 108.786 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.7 mp -111.9 172.82 6.67 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.853 -0.795 . . . . 1.04 108.853 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -142.12 144.12 33.36 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.053 -1.091 . . . . 1.3100000000000001 108.053 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -141.73 142.53 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.111 -0.993 . . . . 1.02 110.858 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 21.4 t70 -99.0 96.47 7.84 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.3 m -56.59 -3.06 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 110.833 -178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.682 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 37.7 m-20 -105.05 -46.28 4.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.118 -0.989 . . . . 1.1100000000000001 110.991 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.04 -23.56 16.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.106 -0.996 . . . . 1.1200000000000001 110.296 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' C ' ' H ' ' A' ' 64' ' ' ASP . . . -105.32 41.81 1.31 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.12 -0.988 . . . . 1.01 108.967 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' O ' ' OG ' ' A' ' 67' ' ' SER . 35.4 tt0 -54.98 -10.84 0.54 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.397 -0.815 . . . . 2.7799999999999998 109.825 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.416 ' H ' ' C ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -68.9 -43.62 74.87 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.14 -0.975 . . . . 1.1100000000000001 108.768 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.34 -45.71 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.302 -0.999 . . . . 1.05 108.302 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.79 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.054 -0.721 . . . . 1.0600000000000001 109.054 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 6.6 m -64.0 -54.01 41.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 1.79 109.304 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.2 -33.41 75.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.476 -0.765 . . . . 2.2000000000000002 110.019 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.37 1.2 54.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.069 -1.019 . . . . 1.0600000000000001 109.859 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 67' ' ' SER . 15.0 mp0 45.0 50.46 9.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.278 -0.889 . . . . 2.3399999999999999 110.243 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.34 130.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 1.05 108.91 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.12 7.61 5.07 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.396 -0.815 . . . . 2.9300000000000002 110.024 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.63 134.27 14.58 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.161 -0.962 . . . . 1.0600000000000001 108.93 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.5 p -119.78 150.24 50.07 Favored Pre-proline 0 N--CA 1.508 2.441 0 O-C-N 121.227 -0.921 . . . . 0.97999999999999998 108.925 -179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.88 145.22 80.86 Favored 'Cis proline' 0 N--CA 1.486 1.057 0 C-N-CA 124.893 -0.878 . . . . 0.23999999999999999 110.758 -2.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.504 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.81 122.03 45.09 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.7 -1.222 . . . . 1.04 107.7 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -99.26 121.08 40.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.19 108.822 179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.515 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.1 mt-30 -119.62 135.74 54.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.894 -1.15 . . . . 1.71 107.894 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.7 m-85 -109.93 126.57 54.03 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.461 0.648 . . . . 0.13 109.764 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -126.06 156.93 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.601 -0.888 . . . . 0.22 108.601 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.55 126.09 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.786 -1.19 . . . . 2.0299999999999998 107.786 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 55.05 25.27 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 2.1600000000000001 109.951 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.15 6.51 84.48 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.909 -1.138 . . . . 0.23000000000000001 110.347 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.28 146.78 40.01 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -1.076 . . . . 2.8100000000000001 109.956 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -85.91 143.88 27.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 2.2599999999999998 109.529 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.78 -27.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.423 -0.798 . . . . 1.05 110.315 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.43 177.99 45.57 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.388 -1.387 . . . . 0.25 110.415 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -174.08 154.14 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 2.04 110.299 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.0 p90 -169.05 133.11 1.41 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.516 -0.74 . . . . 0.17999999999999999 109.982 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -105.51 -175.03 2.68 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.136 -0.978 . . . . 0.89000000000000001 108.44 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 98.1 133.83 8.11 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.622 -1.391 . . . . 0.14000000000000001 109.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.24 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 1.0600000000000001 110.136 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.2 t-20 -139.89 72.45 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.466 -0.939 . . . . 1.98 108.466 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.54 -0.725 . . . . 1.72 110.781 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -64.76 -26.6 68.42 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -68.82 -35.46 77.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.435 -0.79 . . . . 2.5600000000000001 109.17 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.4 mt -51.13 -36.11 39.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.017 . . . . 1.03 108.906 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.96 -58.5 5.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 2.1499999999999999 109.34 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.26 90.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 1.04 110.327 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -67.61 -48.11 67.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -0.965 . . . . 1.04 110.31 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mt -62.46 -50.11 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.024 -1.048 . . . . 1.05 108.785 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -59.41 -17.27 29.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.6599999999999999 109.538 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.06 -62.16 1.74 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 2.02 110.009 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.21 21.17 5.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 1.1399999999999999 110.494 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.236 179.585 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.2 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.562 ' CG ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -118.89 83.36 2.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.509 -0.744 . . . . 0.0 109.214 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.8 m-85 -133.03 146.8 52.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.272 -0.892 . . . . 0.0 109.079 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.419 ' HG2' HH11 ' B' ' 4' ' ' ARG . 1.1 tpt180 -147.05 -104.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 109.329 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.408 ' H ' ' HB3' ' B' ' 4' ' ' ARG . 3.6 p90 -108.97 -164.89 0.97 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.757 -1.214 . . . . 0.0 110.821 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.86 149.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.247 -0.908 . . . . 0.0 112.839 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.71 95.53 6.49 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.403 ' O ' ' O ' ' B' ' 9' ' ' GLY . 7.3 pt-20 -84.01 42.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.024 -1.047 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.667 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.08 -133.93 0.05 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.29 21.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.322 -0.841 0 CA-C-N 119.154 1.477 . . . . 0.0 109.649 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.667 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -91.87 -21.02 20.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.411 -0.806 . . . . 0.0 109.413 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.65 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.8 OUTLIER -62.42 -159.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.629 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.65 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.573 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.506 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.682 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.425 ' H1 ' ' C ' ' A' ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.712 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.292 0.568 . . . . 3.3799999999999999 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 72.5 t -94.6 153.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.24 -0.913 . . . . 1.1000000000000001 109.131 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -154.6 122.58 5.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 2.5 109.351 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -89.23 135.97 33.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.325 -0.859 . . . . 1.6100000000000001 109.447 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -106.03 123.16 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.483 -1.302 . . . . 1.04 107.483 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 8.9 mp0 -107.92 -15.2 14.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.25 -0.906 . . . . 1.97 109.627 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.8 p -152.16 159.23 43.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.92000000000000004 109.695 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.32 -30.86 30.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 2.48 109.861 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.406 ' H ' ' HG1' ' A' ' 9' ' ' THR . 4.1 m -59.53 -44.25 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.078 . . . . 1.05 109.679 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.19 -27.23 64.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 1.0600000000000001 109.775 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.49 -69.0 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.25 110.216 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -55.27 -42.04 73.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 3.0699999999999998 109.61 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -58.99 -36.89 75.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.14 -0.975 . . . . 2.1000000000000001 109.474 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.34 95.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 1.04 109.088 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.6 mt -64.6 -47.8 77.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.458 -0.776 . . . . 1.27 109.734 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.04 -37.77 88.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.701 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.52 -16.53 54.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 1.0900000000000001 109.616 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.07 -7.39 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 1.0700000000000001 109.844 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' C ' ' H2 ' ' A' ' 109' ' ' HOH . . . 71.96 -111.01 3.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.535 -1.426 . . . . 0.31 109.535 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.64 4.72 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.254 -1.145 . . . . 2.21 109.436 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -70.05 168.02 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 2.4100000000000001 109.193 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.543 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.34 163.59 12.8 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.045 -1.094 . . . . 1.05 108.045 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 9.2 t -145.26 105.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.016 -1.052 . . . . 1.03 109.797 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.18 133.42 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.284 -1.006 . . . . 1.01 108.284 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -110.53 134.58 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 1.02 109.827 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.75 101.36 10.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.08 -0.711 . . . . 0.95999999999999996 109.08 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.5 m-85 -86.14 79.23 9.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.566 -1.272 . . . . 0.32000000000000001 107.566 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -113.44 148.61 35.57 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.415 0.626 . . . . 1.04 109.748 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.66 124.23 34.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.131 -1.063 . . . . 1.0600000000000001 108.131 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -64.97 -23.11 67.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 1.0600000000000001 110.484 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 56.3 p-90 -89.84 -13.29 36.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.013 -1.054 . . . . 0.51000000000000001 110.405 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.88 137.78 32.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.34000000000000002 109.886 -178.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.444 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.16 -59.15 3.19 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.739 -0.744 . . . . 0.40000000000000002 111.355 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -46.1 -43.41 20.53 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.77 1.647 . . . . 0.47999999999999998 111.766 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.84 -55.19 6.07 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.728 -1.232 . . . . 0.81000000000000005 109.048 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -60.45 -20.66 60.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.413 -0.804 . . . . 2.46 110.225 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLY . 35.6 tpp -59.82 -20.5 57.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 3.6600000000000001 110.557 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.464 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 81.8 mt -97.53 11.18 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.992 -1.067 . . . . 1.0700000000000001 111.686 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.78 -34.08 9.83 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.02 -1.675 . . . . 2.1099999999999999 112.63 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.52 -11.86 25.24 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 CA-C-N 119.742 0.944 . . . . 0.29999999999999999 110.803 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -102.76 -68.29 0.84 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.248 -0.908 . . . . 0.37 109.693 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -45.42 -51.31 11.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.422 -0.799 . . . . 0.14999999999999999 110.556 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.83 -34.7 75.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.937 -1.102 . . . . 0.47999999999999998 110.111 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.6 m -60.71 -41.14 94.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 1.05 110.153 -178.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.0 mt -51.4 -15.6 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 1.1299999999999999 109.692 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.412 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 69.2 m -58.15 -31.7 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.93000000000000005 109.902 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -94.84 -20.76 19.18 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.273 -0.892 . . . . 2.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -90.34 -21.52 21.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 2.6499999999999999 109.341 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -133.71 68.54 1.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.577 -0.702 . . . . 0.89000000000000001 109.375 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.3 p -67.45 -5.54 15.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.93000000000000005 108.915 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 24.1 t-20 -95.84 4.0 53.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.46999999999999997 109.646 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -118.76 149.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.212 -0.662 . . . . 1.03 109.212 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -101.94 128.56 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.421 -0.8 . . . . 1.05 109.223 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -115.03 132.01 56.74 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.438 -0.788 . . . . 0.11 109.176 179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 mp -114.95 173.89 6.26 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.474 -0.766 . . . . 1.04 109.197 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -143.83 144.89 31.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.021 -1.103 . . . . 1.3100000000000001 108.021 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 69.7 t -141.6 139.63 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.141 -0.975 . . . . 1.02 110.521 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.0 t70 -99.21 100.44 11.55 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.204 -1.035 . . . . 1.0800000000000001 108.204 179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' CG2' ' H2 ' ' A' ' 108' ' ' HOH . 23.1 m -60.67 -1.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.275 -0.891 . . . . 1.0600000000000001 111.482 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 58' ' ' ASP . 13.5 m-20 -113.68 -41.23 3.64 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.13 -0.981 . . . . 1.1100000000000001 111.002 -178.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.0 -13.14 29.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.581 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 50.45 1.79 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 1.01 108.586 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -54.93 -15.23 1.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.522 -0.736 . . . . 2.7799999999999998 109.701 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.62 -39.88 73.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.992 . . . . 1.1100000000000001 109.364 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.75 -47.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.16 -0.963 . . . . 1.05 108.676 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.46 -36.21 83.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 1.0600000000000001 109.288 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -63.35 -44.87 93.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 1.79 108.968 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.59 -44.06 95.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.712 -0.847 . . . . 2.2000000000000002 108.712 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 70' ' ' GLU . . . -89.06 10.45 21.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 1.0600000000000001 109.519 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 66' ' ' ALA . 5.2 pt-20 31.73 56.06 0.3 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.409 0.623 . . . . 2.3399999999999999 111.362 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.405 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 13.5 t -79.67 134.32 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 1.05 109.037 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 62.7 mttm -129.66 8.7 5.39 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.47 -0.769 . . . . 2.9300000000000002 109.861 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.45 135.11 15.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.133 -0.98 . . . . 1.0600000000000001 108.902 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.6 p -121.03 149.53 51.38 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.835 . . . . 0.97999999999999998 109.172 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.51 144.17 74.09 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 C-N-CA 124.962 -0.849 . . . . 0.23999999999999999 110.197 -1.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.27 113.22 24.31 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.387 -1.338 . . . . 1.04 107.387 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -89.68 119.92 30.51 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.215 -0.994 . . . . 0.19 108.734 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -118.92 136.08 54.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.925 -1.139 . . . . 1.71 107.925 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.2 m-85 -110.14 127.0 54.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.381 0.61 . . . . 0.13 109.568 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.98 157.54 35.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.752 -0.833 . . . . 0.22 108.752 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -154.8 123.66 6.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.429 -1.323 . . . . 2.0299999999999998 107.429 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 57.09 27.65 13.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 2.1600000000000001 110.078 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.8 87.94 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.025 -1.083 . . . . 0.23000000000000001 110.427 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -112.98 146.46 39.02 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.357 -1.084 . . . . 2.8100000000000001 110.282 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -85.61 139.52 31.35 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.766 -0.828 . . . . 2.2599999999999998 108.766 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.61 -21.46 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.474 -0.766 . . . . 1.05 110.195 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.94 176.12 47.77 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.498 -1.334 . . . . 0.25 110.397 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.51 159.01 3.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -1.072 . . . . 2.04 110.336 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -169.0 130.84 1.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.466 -0.772 . . . . 0.17999999999999999 109.811 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 p -103.27 -163.73 1.01 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.07 -1.018 . . . . 0.89000000000000001 108.538 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 127.04 1.03 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.19 -1.564 . . . . 0.14000000000000001 109.19 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -54.53 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -1.16 . . . . 1.0600000000000001 110.726 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -137.71 73.77 1.45 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.032 -1.099 . . . . 1.98 108.032 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -35.82 80.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.878 -0.514 . . . . 1.72 110.895 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.52 -27.09 68.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.97 -1.081 . . . . 1.95 109.507 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' HZ1' ' HG1' ' A' ' 100' ' ' THR . 49.3 tttm -69.65 -33.7 72.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 2.5600000000000001 109.759 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.8 mt -49.82 -36.08 25.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.067 -1.021 . . . . 1.03 109.071 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.35 -58.24 5.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.482 -0.761 . . . . 2.1499999999999999 110.025 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.25 77.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.405 -0.809 . . . . 1.04 111.273 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . 0.551 ' HG1' ' HZ1' ' A' ' 96' ' ' LYS . 16.9 m -67.47 -46.76 72.06 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.859 -1.151 . . . . 1.04 110.758 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.25 -52.19 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 1.05 109.46 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -59.71 -17.88 38.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 1.6599999999999999 109.745 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.4 -59.65 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 2.02 110.516 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt -92.93 17.37 10.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 1.1399999999999999 110.561 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.085 . . . . 1.1799999999999999 109.31 179.296 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.413 0.625 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.566 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 3.8 mtt-85 -151.02 88.85 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.548 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.8 m-85 -134.56 113.29 11.62 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.244 -0.91 . . . . 0.0 109.186 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.583 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -111.97 -81.05 0.59 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.414 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 4.3 p90 -130.44 -168.62 2.0 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.8 148.25 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.007 0.908 . . . . 0.0 112.809 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.36 95.08 6.27 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.46 46.44 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.921 -1.112 . . . . 0.0 110.217 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.661 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.01 -130.69 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.06 20.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 CA-C-N 119.322 1.561 . . . . 0.0 109.009 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.661 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.1 t -81.1 -51.97 7.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -0.819 . . . . 0.0 109.506 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.457 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 4.6 t60 -81.16 155.95 25.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.457 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.014 -1.436 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.47 ' H2 ' ' CG2' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.415 ' H2 ' ' C ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 mtt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.239 0.542 . . . . 3.3799999999999999 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 39.8 t -94.39 164.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 1.1000000000000001 108.934 179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 78.3 tttt -154.28 123.54 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.019 -1.051 . . . . 2.5 109.468 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -90.65 134.4 34.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.835 . . . . 1.6100000000000001 110.087 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.99 114.11 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.724 -1.213 . . . . 1.04 107.724 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.08 -13.68 18.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.962 . . . . 1.97 109.724 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 p -153.72 158.76 41.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.114 -0.991 . . . . 0.92000000000000004 109.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -52.1 -21.36 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.722 . . . . 2.48 109.663 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 21.1 m -61.73 -56.08 23.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 1.05 110.116 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.3 -18.06 64.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 1.0600000000000001 110.262 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.93 -60.85 3.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.068 . . . . 0.25 110.523 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.96 -44.35 97.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.016 . . . . 3.0699999999999998 109.638 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -60.77 -32.58 71.9 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.471 -0.768 . . . . 2.1000000000000001 110.389 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.34 85.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.853 -1.155 . . . . 1.04 109.121 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.09 -43.55 95.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 1.27 109.367 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.71 -40.07 94.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 1.0900000000000001 109.806 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.71 -17.19 54.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 1.0900000000000001 109.85 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.61 26.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 1.0700000000000001 109.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.46 18.22 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.365 -1.494 . . . . 0.31 109.365 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.18 2.68 8.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.553 -0.969 . . . . 2.21 109.627 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.437 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 74.7 mttt -69.35 167.05 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.013 -1.054 . . . . 2.4100000000000001 108.739 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.642 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -62.96 164.29 8.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.196 -1.038 . . . . 1.05 108.196 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.7 t -146.05 106.84 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.957 -1.089 . . . . 1.03 109.525 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -102.49 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.644 -0.873 . . . . 1.01 108.644 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.15 139.13 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.626 -0.671 . . . . 1.02 109.821 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.58 99.63 8.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.632 -0.668 . . . . 0.95999999999999996 109.248 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -85.41 80.59 9.06 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.898 -1.149 . . . . 0.32000000000000001 107.898 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -106.48 -163.6 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 1.04 109.633 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.35 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.573 -0.899 . . . . 1.0600000000000001 108.573 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -64.43 -26.92 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 110.77 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.3 p-90 -88.39 -16.54 32.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.979 -1.076 . . . . 0.51000000000000001 110.009 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.25 120.12 35.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 0.34000000000000002 109.809 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -65.03 -52.98 36.58 Favored Glycine 0 N--CA 1.486 1.992 0 O-C-N 121.519 -0.738 . . . . 0.40000000000000002 111.548 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.3 Cg_exo -49.21 -37.04 38.49 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.664 1.576 . . . . 0.47999999999999998 111.386 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.68 1.04 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.884 -1.135 . . . . 0.81000000000000005 108.993 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.12 -15.04 20.11 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.517 -0.74 . . . . 2.46 110.332 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 tpt -59.94 -21.51 61.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 3.6600000000000001 109.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 50.1 mt -96.93 15.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 1.0700000000000001 110.44 -178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.53 -31.26 2.93 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.687 -1.258 . . . . 2.1099999999999999 112.153 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.74 -5.52 10.58 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 CA-C-N 119.798 0.963 . . . . 0.29999999999999999 109.799 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 39.1 m-85 -109.72 -78.42 0.59 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.832 -0.803 . . . . 0.37 108.832 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 94.0 t80 -40.46 -58.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.73 -0.606 . . . . 0.14999999999999999 111.083 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.53 -30.9 71.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.03 . . . . 0.47999999999999998 109.939 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.8 t -65.47 -40.48 93.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.91 -1.119 . . . . 1.05 110.28 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.6 mt -50.24 -15.93 0.28 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.99 -1.069 . . . . 1.1299999999999999 109.713 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -57.29 -29.48 63.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.065 -1.022 . . . . 0.93000000000000005 109.917 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.73 -21.04 17.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.0 110.226 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -90.98 -22.19 20.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.994 -1.066 . . . . 2.6499999999999999 109.747 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -133.54 69.78 1.47 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.511 -0.743 . . . . 0.89000000000000001 109.275 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -67.85 -5.95 19.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.465 -0.772 . . . . 0.93000000000000005 109.243 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -94.49 3.78 54.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.46999999999999997 109.457 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.5 t -121.11 145.38 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.701 -0.852 . . . . 1.03 108.701 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -97.86 129.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.242 -0.911 . . . . 1.05 109.422 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -114.73 130.93 56.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.315 -0.866 . . . . 0.11 109.423 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.5 mp -112.61 172.83 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.959 -0.756 . . . . 1.04 108.959 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.89 142.2 30.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.992 -1.114 . . . . 1.3100000000000001 107.992 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.4 t -142.2 136.69 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.121 -0.987 . . . . 1.02 110.774 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.501 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 24.0 t70 -96.99 111.45 23.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.996 -1.113 . . . . 1.0800000000000001 107.996 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 108' ' ' HOH . 16.8 m -65.33 -12.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 1.0600000000000001 110.749 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 10.6 m-20 -97.85 -44.41 6.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.013 -1.055 . . . . 1.1100000000000001 111.021 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -91.93 -15.35 28.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 1.1200000000000001 109.459 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -117.24 43.05 2.41 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.632 -0.877 . . . . 1.01 108.632 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.14 -15.35 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.415 -0.803 . . . . 2.7799999999999998 109.762 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -40.22 74.35 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.256 -0.903 . . . . 1.1100000000000001 109.002 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.26 -45.77 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.679 -0.86 . . . . 1.05 108.679 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.28 -32.52 73.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 1.0600000000000001 108.956 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -64.03 -48.94 74.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 1.79 109.271 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.08 -38.5 91.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.321 -0.862 . . . . 2.2000000000000002 109.535 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.53 58.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 109.697 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.2 mt-10 46.66 57.74 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 2.3399999999999999 110.284 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.07 132.28 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 1.05 108.916 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.37 2.0 8.41 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.402 -0.811 . . . . 2.9300000000000002 110.244 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.79 131.33 13.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.968 -1.083 . . . . 1.0600000000000001 109.061 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 46.9 p -116.56 149.72 44.31 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.48 -0.762 . . . . 0.97999999999999998 109.119 -179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.61 145.91 80.78 Favored 'Cis proline' 0 N--CA 1.487 1.091 0 C-N-CA 124.934 -0.861 . . . . 0.23999999999999999 110.071 -1.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.96 113.42 23.24 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.713 -1.217 . . . . 1.04 107.713 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -87.56 126.78 35.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.881 -1.137 . . . . 0.19 108.939 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -124.33 133.82 53.34 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.702 -1.221 . . . . 1.71 107.702 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.3 m-85 -108.22 127.66 54.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.13 109.619 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -125.69 156.66 38.96 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.714 -0.847 . . . . 0.22 108.714 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -153.86 124.97 7.36 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.558 -1.275 . . . . 2.0299999999999998 107.558 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.7 mttt 56.64 20.15 4.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.569 -0.707 . . . . 2.1600000000000001 109.884 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.38 2.51 70.46 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.319 -1.112 . . . . 0.23000000000000001 110.319 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -110.35 148.12 32.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.258 -1.143 . . . . 2.8100000000000001 110.057 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -85.01 140.43 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.827 . . . . 2.2599999999999998 109.274 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.98 -3.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.461 -0.775 . . . . 1.05 110.176 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.81 170.74 30.17 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.491 -1.338 . . . . 0.25 110.63 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.08 155.52 3.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -1.065 . . . . 2.04 110.134 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.58 131.7 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.17999999999999999 110.439 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.414 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 16.9 p -101.55 -165.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.134 -0.979 . . . . 0.89000000000000001 108.875 179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.414 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 86.13 131.49 2.85 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.143 -1.583 . . . . 0.14000000000000001 109.143 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -61.13 96.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -1.166 . . . . 1.0600000000000001 110.837 -179.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -143.06 77.6 1.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.372 -0.973 . . . . 1.98 108.372 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.78 -33.59 76.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.381 -0.825 . . . . 1.72 110.65 -178.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.38 -26.15 67.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.891 -1.131 . . . . 1.95 109.179 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -68.38 -36.49 79.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.81 . . . . 2.5600000000000001 109.257 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 30.5 mt -52.39 -37.04 55.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 1.03 108.775 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.85 -58.92 4.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 2.1499999999999999 109.76 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.54 89.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 1.04 110.865 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 m -66.58 -46.85 74.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.087 -1.008 . . . . 1.04 110.467 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.1 -51.95 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 1.05 108.853 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -61.18 -16.47 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 1.6599999999999999 109.688 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.57 -56.2 4.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 2.02 110.342 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 22.4 mt -92.84 13.24 21.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 1.1399999999999999 110.527 -178.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.942 -1.098 . . . . 1.1799999999999999 109.394 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.5 mtt-85 -140.86 57.15 1.56 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.262 -0.898 . . . . 0.0 109.165 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.41 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.5 m-85 -97.62 159.74 14.74 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.965 -1.084 . . . . 0.0 109.339 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.69 -97.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.332 -0.855 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -128.2 -166.81 1.67 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.293 -0.879 . . . . 0.0 110.55 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.9 143.18 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.375 -0.828 . . . . 0.0 112.633 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.78 94.76 6.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.16 46.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 110.134 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.08 -133.83 0.15 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.95 27.73 0.15 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 CA-C-N 119.325 1.563 . . . . 0.0 109.049 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -89.5 -17.1 29.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.531 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 20.1 t60 -168.35 176.9 5.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.609 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.531 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.989 -1.45 . . . . 0.0 109.512 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.501 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.437 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.642 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.435 -0.58 . . . . 3.3799999999999999 109.435 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 91.9 t -94.53 158.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.354 -0.841 . . . . 1.1000000000000001 109.326 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -154.56 125.48 7.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 2.5 109.079 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.39 130.66 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 1.6100000000000001 109.994 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mm -106.08 112.87 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.768 -1.197 . . . . 1.04 107.768 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.42 -15.12 18.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.139 -0.975 . . . . 1.97 109.641 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 p -154.12 159.87 41.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.92000000000000004 109.698 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 26.7 tttp -51.57 -22.7 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 2.48 109.293 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -60.38 -52.37 65.51 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.895 . . . . 1.05 109.869 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -22.7 63.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 1.0600000000000001 109.889 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.49 -65.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.25 109.708 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -55.04 -45.62 75.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.951 . . . . 3.0699999999999998 109.727 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.62 -36.22 73.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.303 -0.873 . . . . 2.1000000000000001 109.973 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.49 86.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 1.04 109.409 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.04 -46.85 79.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.738 . . . . 1.27 110.02 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.82 -41.2 97.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 110.067 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.88 -17.21 53.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 1.0900000000000001 109.646 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.417 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.67 -6.7 27.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 1.0700000000000001 109.566 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 -133.47 24.73 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.434 -1.466 . . . . 0.31 109.434 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.74 6.11 13.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.363 -1.081 . . . . 2.21 109.6 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.66 166.82 19.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.062 -1.024 . . . . 2.4100000000000001 109.252 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.66 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -63.38 160.71 15.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 1.05 108.494 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.553 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 21.6 t -144.61 109.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.994 . . . . 1.03 109.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.32 133.85 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.665 -0.865 . . . . 1.01 108.665 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.45 141.95 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.431 -0.793 . . . . 1.02 109.869 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -111.41 99.89 8.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.924 -0.769 . . . . 0.95999999999999996 108.924 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.58 80.04 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.903 -1.147 . . . . 0.32000000000000001 107.903 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -113.3 150.01 33.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.79 -0.569 . . . . 1.04 109.718 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.39 126.4 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.568 -0.901 . . . . 1.0600000000000001 108.568 178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -65.98 -25.89 67.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 1.0600000000000001 110.662 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.5 p-90 -87.7 -10.7 50.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.51000000000000001 109.942 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.0 t -97.51 127.52 43.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.477 -0.764 . . . . 0.34000000000000002 109.591 -178.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.94 -55.83 10.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.145 -0.782 . . . . 0.40000000000000002 111.145 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.498 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.78 -39.64 38.85 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.912 1.742 . . . . 0.47999999999999998 111.605 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -61.84 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.675 -1.266 . . . . 0.81000000000000005 109.243 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -58.98 -20.12 49.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.261 -0.899 . . . . 2.46 109.82 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.7 ttt -60.37 -18.33 49.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 3.6600000000000001 110.249 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.439 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -99.64 8.02 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 1.0700000000000001 110.26 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.75 -31.96 5.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.648 -1.283 . . . . 2.1099999999999999 112.453 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.1 Cg_exo -62.03 -7.71 10.37 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.757 0.949 . . . . 0.29999999999999999 109.81 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -106.28 -74.49 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.032 -0.729 . . . . 0.37 109.032 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -44.49 -56.08 4.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.754 . . . . 0.14999999999999999 110.792 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -65.75 -32.04 73.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.113 -0.992 . . . . 0.47999999999999998 109.877 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 t -64.96 -41.45 95.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 1.05 110.049 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.99 -14.64 0.23 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 1.1299999999999999 109.81 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -56.61 -32.37 65.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.038 -1.039 . . . . 0.93000000000000005 109.926 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -95.09 -17.12 22.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 2.0 110.368 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.603 ' HZ1' ' HH ' ' A' ' 49' ' ' TYR . 11.2 tmtt? -91.0 -23.51 20.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.123 -0.986 . . . . 2.6499999999999999 109.187 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.603 ' HH ' ' HZ1' ' A' ' 48' ' ' LYS . 41.5 m-85 -131.5 66.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.556 -0.715 . . . . 0.89000000000000001 109.245 179.61 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -66.68 -1.91 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.339 -0.851 . . . . 0.93000000000000005 109.0 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 34.1 t-20 -94.94 -7.38 40.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.424 -0.797 . . . . 0.46999999999999997 109.124 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.4 t -112.65 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.418 -0.801 . . . . 1.03 109.026 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -100.37 125.48 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.052 -0.721 . . . . 1.05 109.052 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -109.09 132.57 53.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.11 108.996 179.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.407 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.7 mp -113.11 169.56 8.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.679 -0.86 . . . . 1.04 108.679 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.01 143.32 34.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.729 -1.212 . . . . 1.3100000000000001 107.729 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.8 t -141.38 138.01 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 1.02 111.045 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.81 96.92 8.9 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.049 -1.093 . . . . 1.0800000000000001 108.049 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 m -54.63 -8.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0600000000000001 111.464 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.677 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 17.8 m-20 -103.46 -44.07 5.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 110.672 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.91 -9.09 41.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.167 -0.958 . . . . 1.1200000000000001 109.323 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.15 43.3 3.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.708 -0.849 . . . . 1.01 108.708 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.92 -15.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.802 . . . . 2.7799999999999998 109.669 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.19 -39.86 74.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 1.1100000000000001 108.913 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.7 t -74.42 -46.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 1.05 108.51 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.96 75.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.868 . . . . 1.0600000000000001 108.96 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -64.29 -47.91 77.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.405 -0.81 . . . . 1.79 109.065 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.53 -36.9 85.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.811 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.36 59.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.156 -0.965 . . . . 1.0600000000000001 110.166 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 49.57 55.81 8.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.05 -1.031 . . . . 2.3399999999999999 109.813 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.5 137.51 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 1.05 109.638 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -128.8 -4.94 5.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 2.9300000000000002 109.465 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.562 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.64 136.39 15.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.968 -1.082 . . . . 1.0600000000000001 110.006 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 48.3 p -115.58 150.35 44.55 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.362 -0.836 . . . . 0.97999999999999998 108.747 178.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -77.66 143.16 73.38 Favored 'Cis proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.842 -0.899 . . . . 0.23999999999999999 110.13 -2.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.27 115.5 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.13 -1.063 . . . . 1.04 108.13 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -91.45 115.42 28.02 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.378 -0.929 . . . . 0.19 108.568 179.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.23 136.33 53.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.559 -1.274 . . . . 1.71 107.559 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.431 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 27.9 m-85 -107.75 127.38 53.64 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.596 0.713 . . . . 0.13 109.978 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.17 156.97 31.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.376 -0.972 . . . . 0.22 108.376 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.413 ' HZ1' ' HA ' ' A' ' 22' ' ' LEU . 28.5 tttp -155.97 123.52 5.53 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.501 -1.296 . . . . 2.0299999999999998 107.501 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.1 mttm 57.89 16.54 3.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.495 -0.753 . . . . 2.1600000000000001 109.544 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.545 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 96.82 -1.87 61.68 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.424 -1.07 . . . . 0.23000000000000001 110.424 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.545 HE21 ' C ' ' A' ' 83' ' ' GLY . 17.1 mm-40 -110.04 149.91 29.31 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.154 -1.203 . . . . 2.8100000000000001 110.435 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -85.58 143.72 28.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.685 . . . . 2.2599999999999998 109.456 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.27 -21.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.575 -0.703 . . . . 1.05 110.222 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.94 175.0 45.98 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.652 -1.261 . . . . 0.25 110.003 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -173.79 154.4 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -1.176 . . . . 2.04 110.232 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.5 132.09 1.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 0.17999999999999999 109.772 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -104.23 -162.07 0.87 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.89000000000000001 109.1 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.41 133.82 1.56 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.14000000000000001 109.577 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.71 97.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -1.19 . . . . 1.0600000000000001 110.553 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.517 HD21 ' H ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -141.51 72.36 1.38 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.72 -0.844 . . . . 1.98 108.72 178.219 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.69 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.88 . . . . 1.72 110.431 -179.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.9 -31.29 71.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.025 -1.047 . . . . 1.95 109.467 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.517 ' H ' HD21 ' A' ' 93' ' ' ASN . 43.4 tttp -67.87 -33.63 75.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 2.5600000000000001 109.787 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.2 mt -51.46 -36.03 42.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.992 -1.068 . . . . 1.03 108.646 179.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.27 -55.74 14.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 2.1499999999999999 109.448 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.38 94.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 1.04 110.946 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -67.3 -45.97 74.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.923 -1.111 . . . . 1.04 110.44 -178.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.71 -51.39 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 1.05 109.037 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -60.01 -18.57 46.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 1.6599999999999999 109.633 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -76.44 -61.98 1.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 2.02 110.276 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 mt -91.68 21.61 4.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 1.1399999999999999 110.534 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.902 -1.124 . . . . 1.1799999999999999 109.315 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.563 ' CG ' HH11 ' B' ' 2' ' ' ARG . 3.1 mtt-85 -152.03 64.27 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 109.322 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.8 m-85 -101.89 147.72 26.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.932 -1.105 . . . . 0.0 109.751 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -148.45 -105.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.385 -0.822 . . . . 0.0 108.79 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' B' ' 5' ' ' TYR . 2.6 p90 -111.96 -167.68 1.21 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.778 -1.201 . . . . 0.0 110.47 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -79.34 149.32 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.308 -0.87 . . . . 0.0 112.428 -176.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.67 95.61 6.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -83.72 47.5 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.807 -1.183 . . . . 0.0 110.061 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.94 -129.98 0.23 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -69.72 25.07 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 41.9 t -80.56 -15.94 55.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.533 -0.73 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.523 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 11.4 t-160 -159.02 -116.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.523 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.511 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.677 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.417 ' H1 ' ' C ' ' A' ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.66 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.32 0.581 . . . . 3.3799999999999999 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.5 t -94.73 165.1 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.223 -0.923 . . . . 1.1000000000000001 109.524 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -155.13 130.56 9.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.199 -0.938 . . . . 2.5 109.124 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.447 ' NE2' ' OE2' ' A' ' 6' ' ' GLU . 19.3 tt0 -88.69 138.19 31.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.106 -0.996 . . . . 1.6100000000000001 109.752 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.3 93.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.58 -0.896 . . . . 1.04 108.58 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' OE2' ' NE2' ' A' ' 4' ' ' GLN . 58.1 mt-10 -96.72 -1.01 47.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.014 -1.054 . . . . 1.97 109.538 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.5 p -151.85 147.82 27.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.975 -1.078 . . . . 0.92000000000000004 110.184 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 54.3 tttt -52.43 -29.25 23.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 2.48 109.687 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -60.53 -45.55 93.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.034 -1.041 . . . . 1.05 109.557 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.45 65.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 1.0600000000000001 109.61 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.85 -65.69 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.25 109.534 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -55.66 -46.34 77.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 3.0699999999999998 109.818 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -58.12 -34.49 70.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.094 -1.004 . . . . 2.1000000000000001 109.648 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.09 86.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 1.04 109.0 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.7 -44.64 93.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.369 -0.832 . . . . 1.27 109.387 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.08 -37.98 89.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.049 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.12 53.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 1.0900000000000001 109.492 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.17 61.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 1.0700000000000001 109.544 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 -109.33 2.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.993 -1.243 . . . . 0.31 109.993 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.1 t0 -136.37 -0.46 2.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.384 -1.068 . . . . 2.21 109.32 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.6 mttt -68.47 163.31 23.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.664 -1.273 . . . . 2.4100000000000001 108.505 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.581 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -62.24 163.63 8.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.115 -1.068 . . . . 1.05 108.115 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.581 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 12.5 t -143.62 108.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.979 -1.076 . . . . 1.03 109.827 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.4 133.54 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.642 -0.873 . . . . 1.01 108.642 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.28 137.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.477 -0.764 . . . . 1.02 109.736 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.84 104.57 13.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.584 -0.698 . . . . 0.95999999999999996 109.207 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -86.86 80.0 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.932 -1.136 . . . . 0.32000000000000001 107.932 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.1 m -114.4 147.74 38.75 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.436 0.636 . . . . 1.04 109.563 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.71 123.1 34.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 1.0600000000000001 108.681 179.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -65.93 -21.14 66.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.25 -0.906 . . . . 1.0600000000000001 110.319 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.4 p-90 -88.52 -16.99 31.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.059 . . . . 0.51000000000000001 109.915 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -91.49 136.65 32.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.906 . . . . 0.34000000000000002 110.209 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.419 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.28 -58.17 4.78 Favored Glycine 0 N--CA 1.491 2.313 0 O-C-N 121.679 -0.638 . . . . 0.40000000000000002 111.535 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.7 -33.38 31.7 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 C-N-CA 121.597 1.532 . . . . 0.47999999999999998 111.4 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -60.38 2.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.835 -1.166 . . . . 0.81000000000000005 108.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.69 -21.98 55.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 2.46 109.887 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.1 ttm -60.58 -21.4 62.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.201 -0.937 . . . . 3.6600000000000001 110.533 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 54.0 mt -101.08 8.5 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.097 -1.002 . . . . 1.0700000000000001 110.91 -178.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.7 -32.44 5.99 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 117.923 -1.511 . . . . 2.1099999999999999 112.709 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.3 Cg_exo -60.81 -11.61 18.52 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 CA-C-N 119.906 1.002 . . . . 0.29999999999999999 110.267 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.462 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 34.0 m-85 -99.78 -70.3 0.74 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.37 109.527 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -45.01 -51.24 10.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.14999999999999999 110.658 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -67.97 -33.83 75.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.47999999999999998 109.617 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.78 -42.76 99.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 1.05 109.786 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.4 mt -51.9 -19.6 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.073 . . . . 1.1299999999999999 109.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -56.85 -32.92 66.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.93000000000000005 109.275 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.64 -16.86 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 2.0 109.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -90.09 -20.94 22.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 2.6499999999999999 108.959 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.34 71.14 1.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.89000000000000001 109.241 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.3 p -66.89 -4.7 10.04 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.9 . . . . 0.93000000000000005 108.931 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.1 t30 -96.79 1.86 51.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.46999999999999997 109.731 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -119.04 150.35 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.519 -0.738 . . . . 1.03 109.389 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.66 131.68 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.304 -0.872 . . . . 1.05 109.183 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -117.84 132.49 56.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.211 -0.931 . . . . 0.11 109.262 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.1 mp -114.21 174.85 5.74 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.374 -0.829 . . . . 1.04 109.039 -179.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -142.69 142.57 32.04 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.084 -1.08 . . . . 1.3100000000000001 108.084 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.6 t -139.74 133.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.109 -0.994 . . . . 1.02 110.447 -178.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 60' ' ' ASP . 25.2 t70 -98.72 105.16 17.27 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.107 -1.071 . . . . 1.0800000000000001 108.107 178.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.491 ' N ' ' H1 ' ' A' ' 108' ' ' HOH . 23.6 m -59.33 -4.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.804 . . . . 1.0600000000000001 111.171 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 53.1 m-20 -108.9 -44.22 4.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.216 -0.928 . . . . 1.1100000000000001 110.83 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.57 -10.7 39.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.24 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 47.38 2.19 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.303 -0.999 . . . . 1.01 108.303 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -55.29 -17.45 4.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.668 -0.645 . . . . 2.7799999999999998 109.974 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.5 p-10 -71.54 -38.93 71.0 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.946 . . . . 1.1100000000000001 109.537 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.14 -48.39 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 1.05 108.922 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.03 72.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 1.0600000000000001 109.462 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -64.05 -57.1 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 1.79 109.679 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -63.18 -26.6 68.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2000000000000002 109.825 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.06 -3.16 58.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.115 -0.991 . . . . 1.0600000000000001 109.923 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 47.56 53.09 11.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 2.3399999999999999 110.08 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 22.1 t -79.56 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 1.05 109.402 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -125.17 -1.83 7.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.341 -0.85 . . . . 2.9300000000000002 109.815 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.56 130.98 12.91 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.019 -1.051 . . . . 1.0600000000000001 109.418 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.434 ' O ' ' N ' ' B' ' 8' ' ' GLU . 12.0 p -114.99 150.63 44.5 Favored Pre-proline 0 N--CA 1.502 2.143 0 N-CA-C 108.26 -1.015 . . . . 0.97999999999999998 108.26 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.92 144.07 77.53 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 C-N-CA 124.842 -0.899 . . . . 0.23999999999999999 110.615 -1.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.03 113.78 23.66 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.757 -1.201 . . . . 1.04 107.757 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -89.55 122.16 32.45 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.898 -1.126 . . . . 0.19 108.902 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -119.6 135.99 54.56 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.029 -1.1 . . . . 1.71 108.029 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.0 m-85 -109.65 131.87 54.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.13 109.967 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -129.08 157.04 42.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.884 -0.784 . . . . 0.22 108.884 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -154.05 124.86 7.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.601 -1.259 . . . . 2.0299999999999998 107.601 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 mttt 54.28 32.73 16.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.996 . . . . 2.1600000000000001 109.77 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 9.69 86.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.005 -1.238 . . . . 0.23000000000000001 110.005 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -114.75 144.07 44.07 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.331 -1.099 . . . . 2.8100000000000001 110.363 -179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -85.53 146.66 26.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 2.2599999999999998 109.27 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.91 -29.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.454 -0.779 . . . . 1.05 109.971 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.58 178.03 44.1 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.5 -1.333 . . . . 0.25 110.477 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -173.6 156.87 3.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 2.04 110.179 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -168.88 134.25 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.17999999999999999 110.563 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -105.83 -171.33 1.88 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.203 -0.935 . . . . 0.89000000000000001 108.889 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 92.88 128.61 4.8 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.788 -1.325 . . . . 0.14000000000000001 109.788 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.87 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -1.12 . . . . 1.0600000000000001 110.31 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' GLY . 14.5 t-20 -140.14 73.24 1.42 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.452 -0.944 . . . . 1.98 108.452 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.462 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -64.65 -31.73 73.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 1.72 110.28 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 23.6 mp0 -66.86 -29.95 69.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.898 -1.126 . . . . 1.95 109.124 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -32.38 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.418 -0.801 . . . . 2.5600000000000001 109.331 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 29.0 mt -51.38 -35.0 36.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 1.03 108.421 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -68.24 -56.77 7.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.747 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.58 87.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.819 . . . . 1.04 110.668 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 m -67.0 -45.13 78.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 1.04 110.218 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.3 -51.97 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 1.05 109.074 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.3 -15.2 46.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 1.6599999999999999 109.781 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.12 -59.51 2.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 2.02 110.294 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.97 18.49 10.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.393 -0.817 . . . . 1.1399999999999999 110.74 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.895 -1.128 . . . . 1.1799999999999999 109.347 179.582 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 23.1 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 1.5 mtt-85 -129.12 68.2 1.41 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.2 m-85 -125.35 152.84 44.23 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -150.38 -83.38 0.1 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.083 -1.011 . . . . 0.0 109.771 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.457 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.7 p90 -123.25 -168.5 1.77 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.894 -1.129 . . . . 0.0 111.249 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.3 t -76.22 149.71 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.886 0.851 . . . . 0.0 112.868 -176.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.91 96.95 7.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.0 pt-20 -83.04 46.15 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.041 -1.037 . . . . 0.0 110.639 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.634 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.26 -130.24 0.09 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.755 -2.538 . . . . 0.0 106.755 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.6 22.27 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.335 1.568 . . . . 0.0 109.367 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.634 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.0 t -87.08 -18.5 30.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.759 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.589 ' CD2' ' H ' ' B' ' 13' ' ' GLY . 69.0 t60 -149.92 -126.23 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 109.358 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.589 ' H ' ' CD2' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.491 ' H1 ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.444 -0.576 . . . . 3.3799999999999999 109.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 62.1 t -94.57 162.85 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.194 -0.941 . . . . 1.1000000000000001 109.548 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 14.4 tptm -154.8 122.33 5.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 2.5 109.251 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.5 134.83 34.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 1.6100000000000001 110.015 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.06 109.72 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.063 -1.088 . . . . 1.04 108.063 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -101.02 -7.01 23.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.193 -0.942 . . . . 1.97 109.847 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 p -152.35 153.58 33.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.037 -1.039 . . . . 0.92000000000000004 109.926 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 69.4 tttt -52.46 -33.22 43.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.446 -0.784 . . . . 2.48 109.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -59.69 -41.1 89.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 1.05 109.849 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.41 -25.63 63.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 1.0600000000000001 109.78 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.3 -68.31 0.31 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.011 -1.056 . . . . 0.25 110.043 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.91 -41.25 70.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 3.0699999999999998 109.785 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.85 -37.69 80.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 2.1000000000000001 109.504 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.18 91.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 1.04 109.539 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.32 -44.7 94.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 1.27 109.715 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.71 -41.12 98.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.713 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.1 -14.58 58.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 109.732 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.59 -6.97 28.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 1.0700000000000001 109.847 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -113.81 4.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.578 -1.409 . . . . 0.31 109.578 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.17 5.15 2.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -1.054 . . . . 2.21 109.499 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.24 170.18 12.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.003 -1.061 . . . . 2.4100000000000001 109.097 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 161.51 14.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.932 -1.136 . . . . 1.05 107.932 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.2 t -145.33 106.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.927 -1.108 . . . . 1.03 109.652 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.94 130.3 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.688 -0.856 . . . . 1.01 108.688 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.78 140.13 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.55 -0.719 . . . . 1.02 109.591 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -110.96 99.27 8.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.982 -0.747 . . . . 0.95999999999999996 108.982 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.64 82.98 8.18 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.807 -1.183 . . . . 0.32000000000000001 107.807 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.3 m -109.39 -163.24 0.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.985 -0.746 . . . . 1.04 108.985 -179.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.31 125.13 18.26 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.95 -0.759 . . . . 1.0600000000000001 108.95 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -65.6 -30.68 71.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.68 . . . . 1.0600000000000001 111.331 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.538 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 50.7 p-90 -86.04 -14.18 45.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.748 -1.22 . . . . 0.51000000000000001 109.884 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -94.76 128.58 41.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.34000000000000002 109.657 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.46 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.62 -55.79 8.14 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.579 -0.701 . . . . 0.40000000000000002 111.495 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.6 Cg_exo -48.03 -33.58 20.99 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.72 1.613 . . . . 0.47999999999999998 111.45 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.27 -59.75 2.63 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.809 -1.182 . . . . 0.81000000000000005 108.958 179.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -60.32 -19.22 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 2.46 110.258 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -19.55 52.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.01 . . . . 3.6600000000000001 110.361 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.2 mt -99.45 9.08 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.16 -0.962 . . . . 1.0700000000000001 110.497 -178.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.52 -31.98 4.07 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 120.374 -1.454 . . . . 2.1099999999999999 112.516 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -62.61 -5.0 6.37 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.947 1.017 . . . . 0.29999999999999999 110.049 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.579 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 45.5 m-85 -112.39 -75.49 0.61 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.218 -0.66 . . . . 0.37 109.218 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -43.13 -56.8 3.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.14999999999999999 110.551 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -66.94 -32.37 73.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.47999999999999998 110.068 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.5 t -63.18 -40.92 98.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.809 -1.182 . . . . 1.05 110.38 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.4 mt -50.62 -15.32 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.992 -1.067 . . . . 1.1299999999999999 109.532 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.0 m -58.17 -30.77 66.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.066 -1.021 . . . . 0.93000000000000005 109.521 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -96.09 -21.45 17.94 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.272 -0.892 . . . . 2.0 110.156 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -90.43 -21.01 22.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.037 -1.039 . . . . 2.6499999999999999 109.602 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.74 67.6 1.5 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.409 -0.807 . . . . 0.89000000000000001 108.896 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.5 p -66.8 -3.01 5.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.374 -0.829 . . . . 0.93000000000000005 109.088 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.29 -1.23 51.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.443 -0.786 . . . . 0.46999999999999997 109.251 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.26 149.01 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.633 -0.667 . . . . 1.03 109.24 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -99.96 125.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 1.05 109.146 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -112.47 130.96 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.271 -0.893 . . . . 0.11 108.878 179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.8 mp -112.51 171.58 7.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.736 -0.838 . . . . 1.04 108.736 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -142.82 142.57 31.87 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.836 -1.172 . . . . 1.3100000000000001 107.836 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.0 t -141.12 138.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.152 -0.967 . . . . 1.02 110.758 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.41 105.75 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.443 -0.947 . . . . 1.0800000000000001 108.443 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.402 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 29.1 m -66.94 -4.95 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.376 -0.828 . . . . 1.0600000000000001 110.905 -178.755 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.538 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 36.8 m-20 -102.72 -42.83 5.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 1.1100000000000001 110.877 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -25.6 15.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.181 -0.949 . . . . 1.1200000000000001 109.362 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.29 43.45 1.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.426 -0.953 . . . . 1.01 108.426 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.559 ' NE2' ' NH1' ' B' ' 4' ' ' ARG . 25.6 mt-30 -53.6 -13.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 2.7799999999999998 110.235 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.1 p-10 -69.85 -40.68 75.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.791 -1.193 . . . . 1.1100000000000001 109.19 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -73.37 -48.07 43.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.234 -0.916 . . . . 1.05 108.584 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -38.19 90.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.528 -0.732 . . . . 1.0600000000000001 109.539 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 61.8 m -64.1 -43.73 94.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 1.79 109.052 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.59 -40.41 96.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 2.2000000000000002 109.228 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.83 -6.27 57.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 1.0600000000000001 109.399 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ALA . 46.7 mt-10 49.31 71.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 2.3399999999999999 110.253 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 42.0 t -79.11 135.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.922 . . . . 1.05 108.978 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -113.64 -12.54 12.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.484 -0.76 . . . . 2.9300000000000002 109.805 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -154.78 137.69 15.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.952 -1.092 . . . . 1.0600000000000001 109.81 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.7 p -115.63 151.27 45.99 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 108.487 -0.931 . . . . 0.97999999999999998 108.487 179.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -75.73 147.33 87.89 Favored 'Cis proline' 0 N--CA 1.484 0.968 0 C-N-CA 124.651 -0.979 . . . . 0.23999999999999999 109.878 -1.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -116.08 113.34 23.02 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.996 -1.113 . . . . 1.04 107.996 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -89.15 125.1 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.124 -1.03 . . . . 0.19 108.906 179.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.16 136.71 54.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.895 -1.15 . . . . 1.71 107.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.4 m-85 -109.91 130.18 55.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.707 . . . . 0.13 109.958 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -128.93 157.24 42.17 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.58 -0.896 . . . . 0.22 108.58 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -155.53 122.65 5.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.014 -1.106 . . . . 2.0299999999999998 108.014 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.592 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 43.8 mtmt 56.2 22.57 6.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 2.1600000000000001 109.808 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 3.55 72.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.194 -1.162 . . . . 0.23000000000000001 110.194 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -110.95 144.95 39.22 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.293 -1.122 . . . . 2.8100000000000001 110.21 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -85.47 139.56 31.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 2.2599999999999998 109.052 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.03 -18.02 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.399 -0.813 . . . . 1.05 110.715 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.92 172.69 45.68 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.25 110.541 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -174.21 150.49 1.53 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 2.04 110.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.02 132.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.818 . . . . 0.17999999999999999 110.189 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 18.8 p -101.98 -160.19 0.77 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.064 -1.023 . . . . 0.89000000000000001 109.066 179.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.491 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 79.4 129.3 0.67 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.52 -1.432 . . . . 0.14000000000000001 109.52 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.16 93.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 1.0600000000000001 110.205 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.96 75.53 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.819 -1.178 . . . . 1.98 107.819 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.579 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.8 ptpt -63.49 -39.36 94.23 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.818 -0.628 . . . . 1.72 111.275 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.58 -25.97 68.2 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 1.95 109.567 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.21 -34.79 76.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 2.5600000000000001 109.528 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.8 mt -54.73 -35.96 64.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.118 . . . . 1.03 108.732 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.7 -58.08 6.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 2.1499999999999999 109.54 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.47 -41.92 90.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 1.04 110.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.2 m -65.81 -45.73 81.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.161 -0.962 . . . . 1.04 110.183 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.48 -53.97 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 1.05 108.822 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.64 -17.64 48.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 1.6599999999999999 109.744 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -75.9 -60.25 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 2.02 110.155 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.64 20.74 6.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.771 . . . . 1.1399999999999999 110.416 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.238 179.473 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.8 p90 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.419 ' HB3' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -133.59 67.48 1.52 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.402 -0.811 . . . . 0.0 109.455 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -139.26 154.08 47.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.559 ' NH1' ' NE2' ' A' ' 63' ' ' GLN . 7.9 tpt180 -150.28 -79.94 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.092 -1.005 . . . . 0.0 109.701 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.467 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.1 p90 -128.8 -166.89 1.7 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.013 -1.054 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.55 152.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 122.0 0.905 . . . . 0.0 112.591 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 95.09 6.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -83.16 45.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.78 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.652 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -131.98 0.08 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.6 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.251 1.525 . . . . 0.0 109.147 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.652 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.2 t -83.54 -30.84 26.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -160.82 -68.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 117.998 -1.445 . . . . 0.0 109.569 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.592 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mtt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 3.3799999999999999 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.498 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 76.3 t -94.88 160.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.273 -0.892 . . . . 1.1000000000000001 109.902 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -155.06 125.97 7.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 2.5 109.375 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.13 136.52 33.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.904 . . . . 1.6100000000000001 109.73 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mm -106.3 110.02 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.185 -1.042 . . . . 1.04 108.185 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.87 -9.98 21.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.2 -0.938 . . . . 1.97 109.703 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 p -153.18 152.6 31.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.11 -0.994 . . . . 0.92000000000000004 109.699 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -51.9 -28.0 14.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 2.48 110.021 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -59.14 -44.29 92.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 1.05 109.692 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.32 -24.56 61.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 1.0600000000000001 109.952 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -59.33 -68.64 0.26 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.25 110.328 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.34 -43.2 71.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 3.0699999999999998 109.554 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -59.67 -36.73 77.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.228 -0.92 . . . . 2.1000000000000001 110.085 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.32 86.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.003 . . . . 1.04 109.384 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.29 -43.4 94.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.468 -0.77 . . . . 1.27 109.645 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.76 -40.78 97.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.771 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -14.44 59.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.988 . . . . 1.0900000000000001 110.03 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -10.56 56.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 1.0700000000000001 109.806 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.2 -112.3 3.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.47 -1.452 . . . . 0.31 109.47 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -139.85 3.77 2.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.317 -1.107 . . . . 2.21 109.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -69.61 172.68 7.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 2.4100000000000001 109.032 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.509 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.83 161.47 18.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.977 -1.12 . . . . 1.05 107.977 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.509 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.3 t -144.87 104.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.873 -1.142 . . . . 1.03 109.421 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.99 128.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.359 -0.838 . . . . 1.01 108.937 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.77 139.72 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 1.02 109.565 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -112.02 103.49 11.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.95999999999999996 108.903 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.5 m-85 -86.06 80.31 8.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.3 -1.0 . . . . 0.32000000000000001 108.3 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.3 m -113.45 149.4 34.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.652 -0.655 . . . . 1.04 109.597 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.39 129.26 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 1.0600000000000001 109.048 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -67.15 -25.32 66.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.882 . . . . 1.0600000000000001 110.855 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 54.0 p-90 -88.4 -17.58 30.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.842 -1.161 . . . . 0.51000000000000001 110.351 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.96 123.37 37.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -0.929 . . . . 0.34000000000000002 109.941 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.435 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.87 -53.74 32.43 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-O 119.426 -0.652 . . . . 0.40000000000000002 112.002 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -48.32 -36.41 29.95 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.647 1.565 . . . . 0.47999999999999998 111.33 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.76 -60.99 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.81000000000000005 109.137 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -58.28 -18.92 30.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 2.46 109.96 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.9 ttm -58.61 -18.41 29.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 3.6600000000000001 110.581 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.508 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 67.1 mt -100.39 9.7 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.167 -0.958 . . . . 1.0700000000000001 110.583 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.74 -32.55 4.39 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.107 -1.621 . . . . 2.1099999999999999 112.598 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -64.09 -6.2 10.87 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 CA-C-N 119.794 0.962 . . . . 0.29999999999999999 109.758 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 32.6 m-85 -110.52 -75.21 0.63 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.544 -0.723 . . . . 0.37 109.384 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -43.02 -57.42 2.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.427 -0.795 . . . . 0.14999999999999999 110.67 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.82 -31.15 71.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.47999999999999998 110.04 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 46' ' ' SER . 3.4 t -64.34 -40.1 95.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.822 -1.174 . . . . 1.05 109.938 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.2 -12.87 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.079 -1.013 . . . . 1.1299999999999999 109.369 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.498 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 20.2 m -58.03 -34.69 70.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.93000000000000005 109.439 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -94.33 -13.17 26.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.312 -0.868 . . . . 2.0 110.084 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -91.65 -32.07 15.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 2.6499999999999999 109.455 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.418 ' C ' ' H ' ' A' ' 51' ' ' ASN . 44.5 m-85 -126.38 71.96 1.3 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.025 -0.732 . . . . 0.89000000000000001 109.025 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.08 -2.59 4.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.292 -0.88 . . . . 0.93000000000000005 108.968 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.418 ' H ' ' C ' ' A' ' 49' ' ' TYR . 35.0 t30 -97.01 -1.99 44.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.46999999999999997 109.816 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.74 148.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.508 -0.745 . . . . 1.03 109.586 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.37 124.21 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.993 -0.743 . . . . 1.05 108.993 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -109.91 133.0 53.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.294 -0.879 . . . . 0.11 108.948 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.4 mp -115.08 171.87 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.241 -0.912 . . . . 1.04 108.706 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -141.94 144.24 33.65 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.028 -1.101 . . . . 1.3100000000000001 108.028 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.63 139.26 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.17 -0.956 . . . . 1.02 110.507 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.7 t70 -98.98 101.97 13.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.859 -0.793 . . . . 1.0800000000000001 108.859 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.04 0.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.836 . . . . 1.0600000000000001 110.967 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.512 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 39.3 m-20 -112.7 -41.08 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.343 -0.848 . . . . 1.1100000000000001 110.655 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -95.5 -21.18 18.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.041 . . . . 1.1200000000000001 109.503 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.48 47.86 1.19 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.25 -1.019 . . . . 1.01 108.25 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' B' ' 4' ' ' ARG . 14.0 mt-30 -54.62 -18.28 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.749 -0.594 . . . . 2.7799999999999998 110.326 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -70.82 -39.41 73.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.917 -1.114 . . . . 1.1100000000000001 109.606 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.44 -47.63 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.149 -0.969 . . . . 1.05 108.836 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.48 78.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 1.0600000000000001 109.461 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -63.47 -52.72 60.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 1.79 109.525 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -64.75 -30.55 71.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 2.2000000000000002 110.027 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.94 2.99 47.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 1.0600000000000001 109.943 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 47.14 50.3 14.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 2.3399999999999999 110.541 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 4.0 t -81.39 128.64 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 1.05 108.773 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -126.28 -2.13 6.94 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.363 -0.835 . . . . 2.9300000000000002 110.434 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.486 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.32 124.68 8.21 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.759 -1.213 . . . . 1.0600000000000001 109.427 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 23.7 p -106.24 151.3 40.17 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 121.322 -0.861 . . . . 0.97999999999999998 109.185 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.8 140.13 63.45 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.947 -0.855 . . . . 0.23999999999999999 110.066 -2.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.38 111.11 21.73 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.056 -1.09 . . . . 1.04 108.056 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -89.19 118.14 28.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.988 -1.07 . . . . 0.19 109.127 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.3 mt-30 -117.05 135.55 53.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.332 -1.358 . . . . 1.71 107.332 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.8 m-85 -107.83 128.08 54.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.488 0.661 . . . . 0.13 109.896 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.8 156.95 35.16 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.94 -0.763 . . . . 0.22 108.94 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -155.26 124.35 6.23 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.298 -1.371 . . . . 2.0299999999999998 107.298 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.3 mttt 56.0 32.65 20.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.6 -0.687 . . . . 2.1600000000000001 109.382 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.41 7.19 87.01 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.779 -1.201 . . . . 0.23000000000000001 110.143 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.03 142.6 45.52 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.375 -1.073 . . . . 2.8100000000000001 110.64 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -86.62 140.09 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.838 . . . . 2.2599999999999998 108.947 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.27 -17.39 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.413 -0.805 . . . . 1.05 110.693 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.39 176.56 48.1 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.415 -1.374 . . . . 0.25 110.454 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -174.1 156.46 2.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -1.128 . . . . 2.04 110.296 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.58 129.97 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.17999999999999999 109.982 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 18.4 p -102.83 -162.16 0.9 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.292 -0.88 . . . . 0.89000000000000001 109.234 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.435 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 81.55 126.74 0.84 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.964 -1.654 . . . . 0.14000000000000001 108.964 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -53.88 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.091 -1.241 . . . . 1.0600000000000001 110.043 -179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -138.32 66.65 1.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.516 -1.29 . . . . 1.98 107.516 178.712 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.591 ' NZ ' ' CD1' ' A' ' 41' ' ' PHE . 0.0 OUTLIER -59.25 -34.11 71.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.824 -0.548 . . . . 1.72 111.023 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.58 -26.03 68.23 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.935 -1.103 . . . . 1.95 109.254 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -71.05 -36.26 72.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.787 . . . . 2.5600000000000001 110.095 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 15.4 mt -50.8 -33.29 22.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.914 -1.117 . . . . 1.03 109.012 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.38 -57.01 7.37 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.467 -0.893 . . . . 2.1499999999999999 109.539 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.86 95.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 1.04 110.942 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 m -64.94 -45.3 86.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.953 -1.092 . . . . 1.04 109.918 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.63 -53.09 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 1.05 108.681 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.27 -16.23 43.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 1.6599999999999999 109.626 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -62.38 1.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 2.02 109.934 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.25 22.62 3.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 1.1399999999999999 110.162 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.037 -1.04 . . . . 1.1799999999999999 109.295 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.8 mtp180 -141.44 71.67 1.37 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.21 -0.931 . . . . 0.0 109.146 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -133.73 156.24 48.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.411 -0.806 . . . . 0.0 109.146 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' A' ' 63' ' ' GLN . 8.7 tpt180 -147.49 -81.59 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.013 -1.054 . . . . 0.0 109.612 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.46 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 5.2 p90 -129.95 -167.16 1.77 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.053 -1.029 . . . . 0.0 110.464 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -73.75 150.58 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.938 0.875 . . . . 0.0 112.522 -177.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.12 93.44 5.47 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -83.79 44.26 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.285 -178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.671 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.73 -130.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.64 20.8 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 119.533 1.667 . . . . 0.0 109.37 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.671 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.3 t -87.83 -29.14 21.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.525 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -76.57 155.74 33.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.566 179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.512 ' H2 ' ' N ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.563 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.463 -0.569 . . . . 3.3799999999999999 109.463 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.7 t -94.58 163.28 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 1.1000000000000001 109.268 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -154.15 125.31 7.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 2.5 109.402 179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -89.85 136.3 33.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 1.6100000000000001 109.903 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.86 107.27 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.206 -1.035 . . . . 1.04 108.206 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.57 -8.74 24.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 1.97 109.547 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.07 156.27 38.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.135 -0.978 . . . . 0.92000000000000004 109.829 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -52.99 -30.15 33.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 2.48 110.075 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.5 m -60.27 -44.51 95.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 1.05 110.313 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -25.14 64.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 1.0600000000000001 109.649 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -60.76 -67.95 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.957 -1.089 . . . . 0.25 109.94 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.55 -44.98 69.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.795 . . . . 3.0699999999999998 109.679 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -58.61 -36.94 74.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.845 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.93 91.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.081 -1.012 . . . . 1.04 109.362 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.14 -46.56 83.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.804 . . . . 1.27 109.774 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.45 -38.71 92.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 109.482 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.88 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.981 . . . . 1.0900000000000001 109.667 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -5.36 18.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 1.0700000000000001 109.588 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 -111.45 3.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.453 -1.459 . . . . 0.31 109.453 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 61.5 t0 -139.06 2.49 2.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.434 -1.039 . . . . 2.21 109.554 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 109' ' ' HOH . 83.8 mttt -68.8 171.86 7.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.017 . . . . 2.4100000000000001 109.053 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.518 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.8 162.27 19.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.351 -0.981 . . . . 1.05 108.351 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.518 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.2 t -144.96 107.72 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.874 -1.141 . . . . 1.03 109.855 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.5 t -104.06 132.66 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.805 -0.813 . . . . 1.01 108.805 179.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.2 140.43 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 1.02 109.598 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -110.59 101.28 9.96 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.247 -0.649 . . . . 0.95999999999999996 109.247 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 42.1 m-85 -85.36 80.14 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.194 -1.039 . . . . 0.32000000000000001 108.194 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -114.19 147.96 38.07 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.228 0.537 . . . . 1.04 109.651 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.59 131.24 37.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.194 -0.941 . . . . 1.0600000000000001 108.853 179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -67.67 -28.02 67.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 1.0600000000000001 110.655 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.521 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.2 p-90 -87.71 -11.61 47.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.51000000000000001 110.023 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.39 125.29 39.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.34000000000000002 109.864 -179.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -67.81 -54.12 20.04 Favored Glycine 0 N--CA 1.49 2.244 0 CA-C-O 119.491 -0.616 . . . . 0.40000000000000002 112.299 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.83 -43.85 33.63 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.544 1.496 . . . . 0.47999999999999998 111.618 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.96 -55.85 5.66 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.688 -1.257 . . . . 0.81000000000000005 109.056 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.2 -18.23 46.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 2.46 109.809 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.0 ttt -62.82 -22.46 66.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 3.6600000000000001 110.466 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.429 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 65.5 mt -98.12 18.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.198 -0.939 . . . . 1.0700000000000001 111.014 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.39 -33.85 3.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.148 -1.595 . . . . 2.1099999999999999 113.091 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.02 -7.71 14.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 CA-C-N 119.469 0.846 . . . . 0.29999999999999999 110.595 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.626 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.0 m-85 -105.22 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.315 -0.866 . . . . 0.37 109.803 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.6 t80 -41.94 -52.4 4.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.14999999999999999 110.742 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.403 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.9 t60 -68.73 -34.3 75.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.991 -1.068 . . . . 0.47999999999999998 109.931 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 46' ' ' SER . 4.2 t -60.64 -44.36 96.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.863 -1.148 . . . . 1.05 110.014 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.6 mt -50.43 -16.8 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.978 -1.076 . . . . 1.1299999999999999 109.214 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.1 m -57.06 -33.96 67.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.93000000000000005 109.629 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.14 -18.74 20.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -0.927 . . . . 2.0 110.251 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -90.54 -20.74 22.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.05 . . . . 2.6499999999999999 109.502 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -133.9 66.49 1.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.89000000000000001 109.297 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 p -67.68 -3.37 8.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.93000000000000005 109.251 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.37 0.39 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.395 -0.816 . . . . 0.46999999999999997 109.46 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.7 t -120.77 150.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.872 -0.788 . . . . 1.03 108.872 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.55 132.02 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.191 -0.943 . . . . 1.05 109.659 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -117.33 131.69 56.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.571 -0.706 . . . . 0.11 109.102 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.0 mp -114.27 174.98 5.68 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.423 -0.798 . . . . 1.04 109.093 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -144.88 146.81 32.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.247 -1.019 . . . . 1.3100000000000001 108.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.03 138.27 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.999 -1.063 . . . . 1.02 110.611 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.477 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.0 t70 -100.03 100.88 11.82 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.665 -0.865 . . . . 1.0800000000000001 108.665 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 108' ' ' HOH . 25.1 m -59.31 0.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 1.0600000000000001 111.171 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 14.9 m-20 -116.84 -41.87 3.01 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.163 -0.96 . . . . 1.1100000000000001 110.709 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.13 -19.5 20.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.014 -1.054 . . . . 1.1200000000000001 109.279 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.36 46.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.006 -1.109 . . . . 1.01 108.006 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 27.3 mt-30 -55.31 -16.46 3.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.619 -0.676 . . . . 2.7799999999999998 110.533 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.21 -36.78 77.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.765 -1.209 . . . . 1.1100000000000001 109.113 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -73.76 -48.46 39.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.217 -0.927 . . . . 1.05 108.72 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.27 -36.96 85.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 1.0600000000000001 109.37 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 75.0 m -63.48 -46.49 85.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 1.79 109.198 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -64.55 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 2.2000000000000002 109.284 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.98 -6.29 58.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -0.988 . . . . 1.0600000000000001 109.257 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ALA . 35.3 mt-10 51.61 55.62 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 2.3399999999999999 110.462 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 46.2 t -84.25 124.26 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.262 -0.898 . . . . 1.05 108.999 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.37 6.7 17.36 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.175 -0.953 . . . . 2.9300000000000002 110.219 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.02 146.19 24.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.773 -1.204 . . . . 1.0600000000000001 109.714 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.3 p -127.29 148.88 68.04 Favored Pre-proline 0 N--CA 1.506 2.354 0 N-CA-C 108.284 -1.006 . . . . 0.97999999999999998 108.284 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 12.1 Cg_endo -80.32 139.99 50.74 Favored 'Cis proline' 0 N--CA 1.487 1.113 0 N-CA-C 110.072 -0.78 . . . . 0.23999999999999999 110.072 -1.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -110.58 110.53 21.27 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.157 -1.053 . . . . 1.04 108.157 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -86.98 115.53 24.43 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.995 -1.082 . . . . 0.19 109.206 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.579 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 32.5 mt-30 -114.2 137.01 52.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.735 -1.209 . . . . 1.71 107.735 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.5 m-85 -109.91 126.33 53.76 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.519 0.676 . . . . 0.13 109.592 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 156.28 35.36 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.452 -0.944 . . . . 0.22 108.452 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.385 -1.339 . . . . 2.0299999999999998 107.385 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.411 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 37.4 mtmt 55.01 38.28 30.27 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.433 -0.792 . . . . 2.1600000000000001 109.238 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 6.25 63.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.352 -1.099 . . . . 0.23000000000000001 110.352 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -112.12 145.82 39.12 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.312 -1.111 . . . . 2.8100000000000001 110.541 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -86.19 142.62 28.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 2.2599999999999998 109.279 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.9 -9.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.452 -0.78 . . . . 1.05 110.341 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.4 38.01 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.389 -1.386 . . . . 0.25 110.521 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -173.35 156.69 3.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.411 -1.053 . . . . 2.04 110.06 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.88 131.12 1.27 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.799 . . . . 0.17999999999999999 110.027 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -160.98 0.81 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.16 -0.962 . . . . 0.89000000000000001 109.093 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 82.34 121.07 0.63 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.451 -1.46 . . . . 0.14000000000000001 109.451 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.34 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -1.158 . . . . 1.0600000000000001 110.25 -179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.38 76.98 1.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.129 -1.063 . . . . 1.98 108.129 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.626 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.1 ptpt -64.57 -42.55 95.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.871 -0.518 . . . . 1.72 111.556 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -63.93 -25.72 68.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.739 -1.226 . . . . 1.95 109.978 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -70.55 -32.09 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 2.5600000000000001 109.432 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 34.1 mt -51.08 -37.54 46.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.064 . . . . 1.03 108.805 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -68.36 -56.33 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.822 -0.751 . . . . 2.1499999999999999 109.975 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.16 75.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 1.04 110.453 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 11.9 m -67.68 -45.21 75.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.989 . . . . 1.04 110.0 -179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.95 -53.44 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 1.05 109.274 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.81 -16.25 26.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 1.6599999999999999 109.839 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -75.97 -60.18 2.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 2.02 109.944 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -92.89 18.77 8.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.398 -0.814 . . . . 1.1399999999999999 110.414 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 109.309 179.507 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.521 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 56.1 mtp180 -136.88 70.64 1.41 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.6 m-85 -130.97 156.18 45.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 8.3 tpt180 -150.13 -79.71 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.053 -1.029 . . . . 0.0 109.417 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 4.1 p90 -131.87 -166.59 1.74 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.673 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.42 150.52 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.167 0.984 . . . . 0.0 112.967 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 94.35 5.59 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.21 49.82 1.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.908 -1.12 . . . . 0.0 109.944 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.639 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -76.28 -128.09 0.28 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -68.7 26.64 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.372 1.586 . . . . 0.0 108.946 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.639 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.6 t -81.49 -20.09 40.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.315 -0.865 . . . . 0.0 109.271 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -159.23 141.34 13.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.387 -0.821 . . . . 0.0 109.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.034 -1.425 . . . . 0.0 109.589 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.411 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.418 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.43 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.302 -0.629 . . . . 3.3799999999999999 109.302 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.428 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 58.6 t -94.75 171.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 1.1000000000000001 109.743 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.428 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 36.9 tptt -153.99 123.9 6.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 2.5 109.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -90.3 128.51 36.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.186 -0.946 . . . . 1.6100000000000001 109.861 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.63 109.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.871 -1.159 . . . . 1.04 107.871 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -100.23 -8.06 23.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.174 -0.954 . . . . 1.97 110.078 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p -152.06 153.45 34.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.92000000000000004 109.82 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 50.7 tttm -52.23 -26.15 11.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 2.48 109.784 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -60.17 -50.08 75.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 1.05 110.005 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.94 63.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 1.0600000000000001 109.791 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.89 -65.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.25 109.864 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -54.99 -45.35 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 3.0699999999999998 109.733 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.92 -35.79 73.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.222 -0.924 . . . . 2.1000000000000001 109.743 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.78 80.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 1.04 109.099 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.55 -39.84 94.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.746 . . . . 1.27 109.603 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.98 -42.86 97.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 109.756 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.04 57.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.114 -0.991 . . . . 1.0900000000000001 109.613 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.422 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.76 -8.42 42.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.155 -0.966 . . . . 1.0700000000000001 109.523 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' N ' ' H1 ' ' A' ' 110' ' ' HOH . . . 66.07 -129.39 32.12 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.161 -1.575 . . . . 0.31 109.161 -179.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.97 5.89 12.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.956 . . . . 2.21 109.462 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' HOH . 45.8 mttp -69.76 167.33 17.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 2.4100000000000001 109.266 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.457 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 161.47 18.99 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.331 -0.988 . . . . 1.05 108.331 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.0 t -145.09 107.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 1.03 109.647 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.09 131.73 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.603 -0.888 . . . . 1.01 108.603 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.34 139.57 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.511 -0.743 . . . . 1.02 109.772 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.473 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 13.6 t0 -110.44 102.09 10.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -86.1 83.42 7.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.804 -1.184 . . . . 0.32000000000000001 107.804 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.473 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 58.7 m -114.86 152.74 31.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.655 -0.653 . . . . 1.04 109.849 -179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -93.4 131.06 38.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.559 -0.904 . . . . 1.0600000000000001 108.559 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -67.46 -30.84 70.66 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 1.0600000000000001 111.119 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 65.9 p-90 -87.64 -5.94 58.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.937 -1.102 . . . . 0.51000000000000001 110.651 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -98.17 132.97 43.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.34000000000000002 109.691 -179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -74.83 -54.19 5.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.628 -0.67 . . . . 0.40000000000000002 112.019 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.5 -39.58 45.3 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.413 1.409 . . . . 0.47999999999999998 111.603 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.62 5.61 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.631 -1.293 . . . . 0.81000000000000005 109.003 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -60.4 -20.57 60.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 2.46 110.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.1 tpt -60.13 -22.01 62.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 3.6600000000000001 110.556 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.479 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 80.2 mt -96.61 14.21 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 1.0700000000000001 111.69 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.65 -33.3 5.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.042 -1.662 . . . . 2.1099999999999999 112.924 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.99 -9.15 18.11 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.69 0.925 . . . . 0.29999999999999999 110.685 -176.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.71 -70.84 0.77 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.37 109.68 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -43.69 -53.2 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.14999999999999999 110.553 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.43 -34.22 75.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.087 -1.008 . . . . 0.47999999999999998 110.022 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 t -60.97 -40.35 93.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.883 -1.135 . . . . 1.05 110.302 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.2 mt -51.49 -19.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.901 -1.124 . . . . 1.1299999999999999 109.334 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -58.36 -28.99 65.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.93000000000000005 109.815 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -95.23 -22.97 17.46 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.083 -1.011 . . . . 2.0 110.27 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -90.87 -20.2 22.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.045 -1.034 . . . . 2.6499999999999999 109.342 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.49 68.92 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.89000000000000001 109.374 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 97.9 p -67.65 -5.65 16.75 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 0.93000000000000005 109.164 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -94.7 1.52 55.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 0.46999999999999997 109.576 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.79 147.77 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.599 -0.889 . . . . 1.03 108.599 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -99.77 127.61 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 1.05 109.567 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -114.74 132.14 56.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.371 -0.831 . . . . 0.11 109.111 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mp -114.47 171.14 7.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.793 . . . . 1.04 108.883 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -143.35 145.63 32.85 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.911 -1.144 . . . . 1.3100000000000001 107.911 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.98 139.18 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.086 -1.009 . . . . 1.02 110.375 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.509 ' CG ' HH21 ' B' ' 2' ' ' ARG . 9.9 t70 -97.78 89.71 4.71 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.91 -1.144 . . . . 1.0800000000000001 107.91 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.493 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 27.7 m -53.68 -6.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.595 -0.691 . . . . 1.0600000000000001 111.681 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.749 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 46.6 m-20 -104.99 -35.17 7.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 110.49 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.51 -9.49 22.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.123 -0.986 . . . . 1.1200000000000001 110.07 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.17 54.5 1.54 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.199 -0.938 . . . . 1.01 109.433 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 60' ' ' ASP . 3.5 mp0 -54.88 -14.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.3 -0.875 . . . . 2.7799999999999998 110.379 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.7 p-10 -69.41 -44.84 70.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.888 -1.133 . . . . 1.1100000000000001 109.989 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.94 -44.62 57.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.081 -1.012 . . . . 1.05 108.692 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.13 86.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 1.0600000000000001 109.236 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 40.0 m -64.5 -47.2 79.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 1.79 109.586 -179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.37 -38.12 89.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.662 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -4.34 58.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.242 -0.911 . . . . 1.0600000000000001 109.801 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 47.66 65.88 1.17 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.197 -0.939 . . . . 2.3399999999999999 109.866 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.15 130.09 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 1.05 109.272 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -125.79 -5.6 6.9 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.413 -0.804 . . . . 2.9300000000000002 109.349 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.447 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.07 129.68 11.51 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.131 -1.062 . . . . 1.0600000000000001 108.131 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.4 p -124.69 157.45 65.77 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.361 -0.837 . . . . 0.97999999999999998 110.04 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -72.93 138.86 57.93 Favored 'Cis proline' 0 N--CA 1.487 1.119 0 O-C-N 122.856 0.924 . . . . 0.23999999999999999 110.946 0.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -108.23 110.0 21.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.077 -1.083 . . . . 1.04 108.077 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -87.84 118.95 27.71 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.229 -0.989 . . . . 0.19 108.835 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -117.2 139.48 50.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.782 -1.192 . . . . 1.71 107.782 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.5 m-85 -110.92 133.85 53.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.13 110.311 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.75 156.32 43.72 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.393 -0.965 . . . . 0.22 108.393 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -155.55 121.54 5.09 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.202 -1.407 . . . . 2.0299999999999998 107.202 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 55.99 33.63 22.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.545 -0.722 . . . . 2.1600000000000001 109.723 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.27 5.25 87.41 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.044 -1.074 . . . . 0.23000000000000001 110.523 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -112.88 145.37 40.82 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.235 -1.156 . . . . 2.8100000000000001 110.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -85.54 141.69 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -0.915 . . . . 2.2599999999999998 109.338 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.55 -34.28 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.466 -0.771 . . . . 1.05 110.128 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.55 -178.17 40.56 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.537 -1.316 . . . . 0.25 110.326 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.46 157.17 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -1.01 . . . . 2.04 110.215 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.67 130.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.904 -0.718 . . . . 0.17999999999999999 110.064 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -102.7 -159.69 0.74 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.255 -0.903 . . . . 0.89000000000000001 108.917 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.58 120.14 0.42 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.05 -1.62 . . . . 0.14000000000000001 109.05 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -48.43 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -1.188 . . . . 1.0600000000000001 110.656 -179.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 91' ' ' GLY . 30.3 t-20 -139.34 76.75 1.58 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.131 -1.063 . . . . 1.98 108.131 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 3.9 ptpp? -64.79 -40.14 94.76 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.967 -0.56 . . . . 1.72 111.074 -178.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -65.82 -26.44 67.68 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.057 -1.027 . . . . 1.95 109.974 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -68.1 -33.07 73.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 2.5600000000000001 109.284 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 38.2 mt -50.46 -34.73 25.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.052 -1.03 . . . . 1.03 108.52 179.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.31 -56.77 8.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 2.1499999999999999 109.597 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.84 86.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 1.04 110.548 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.3 m -66.91 -47.69 71.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.115 -0.991 . . . . 1.04 110.361 -178.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.29 -48.81 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 1.05 108.842 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 50.6 t-20 -62.43 -16.84 57.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 1.6599999999999999 109.443 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -78.17 -58.69 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 2.02 110.435 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.24 19.07 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.823 . . . . 1.1399999999999999 110.415 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.5 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.021 -0.99 . . . . 1.1799999999999999 109.389 179.596 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 32.8 p90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.54 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 56.0 mtp180 -142.39 60.39 1.45 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.128 -0.983 . . . . 0.0 109.621 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.48 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.6 m-85 -116.51 159.81 21.53 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.264 -0.898 . . . . 0.0 108.867 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -150.78 -104.12 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.078 . . . . 0.0 110.649 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.493 ' OH ' ' CG1' ' A' ' 59' ' ' VAL . 1.2 p90 -109.06 -164.18 0.92 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.077 -1.015 . . . . 0.0 110.398 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.04 147.39 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.941 0.876 . . . . 0.0 111.788 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.98 95.04 6.32 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -83.24 46.32 1.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.805 -1.184 . . . . 0.0 109.991 -179.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.658 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.3 -130.99 0.13 Allowed Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.01 23.73 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 CA-C-N 119.372 1.586 . . . . 0.0 108.56 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.658 ' H ' ' C ' ' B' ' 9' ' ' GLY . 29.5 t -93.26 -11.11 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 0.0 109.876 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -134.71 123.04 23.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.749 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.437 ' H1 ' ' C ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.518 ' H1 ' ' N ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.339 0.59 . . . . 3.3799999999999999 109.426 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -94.22 163.45 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 1.1000000000000001 108.959 179.685 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 22.7 tptm -155.06 121.81 5.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.072 -1.017 . . . . 2.5 109.16 -179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -91.74 131.73 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 1.6100000000000001 109.621 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -107.1 108.87 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.821 -1.177 . . . . 1.04 107.821 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.75 -5.35 26.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.162 -0.961 . . . . 1.97 110.209 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -152.03 152.95 33.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 0.92000000000000004 110.076 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.448 ' HZ3' ' CD ' ' A' ' 68' ' ' GLU . 21.2 tttp -52.32 -31.5 33.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 2.48 109.713 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -61.2 -43.86 98.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 1.05 110.294 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.68 -24.39 64.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 1.0600000000000001 110.196 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.18 -64.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.25 109.964 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.2 -44.4 83.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 3.0699999999999998 109.67 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -58.2 -36.03 72.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.24 -0.913 . . . . 2.1000000000000001 110.171 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.34 86.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 1.04 109.454 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.7 mt -63.68 -44.41 93.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -0.795 . . . . 1.27 109.525 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.41 -36.87 85.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0900000000000001 109.322 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.74 -17.88 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.002 . . . . 1.0900000000000001 109.483 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -6.43 27.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 1.0700000000000001 109.919 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.626 ' N ' ' H2 ' ' A' ' 110' ' ' HOH . . . 71.79 -112.43 4.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.722 -1.351 . . . . 0.31 109.722 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 47.4 t0 -137.86 4.38 2.53 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.286 -1.126 . . . . 2.21 109.463 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -71.42 170.17 13.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 2.4100000000000001 109.471 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.521 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.02 164.08 13.49 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.105 -1.072 . . . . 1.05 108.105 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 10.8 t -146.46 109.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 1.03 109.809 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 t -105.13 134.26 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.41 -0.959 . . . . 1.01 108.41 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.56 140.0 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 1.02 109.864 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -110.47 103.34 11.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.221 -0.659 . . . . 0.95999999999999996 109.221 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 54.6 m-85 -88.45 79.41 7.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.011 -1.107 . . . . 0.32000000000000001 108.011 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -114.17 149.68 35.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.767 -0.583 . . . . 1.04 109.643 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.47 129.01 37.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.868 . . . . 1.0600000000000001 108.699 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -66.6 -22.86 66.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 1.0600000000000001 110.688 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.551 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 52.9 p-90 -89.17 -21.73 23.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.965 -1.085 . . . . 0.51000000000000001 110.406 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.01 119.78 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.34000000000000002 110.017 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.04 -54.57 35.67 Favored Glycine 0 N--CA 1.489 2.181 0 CA-C-O 119.429 -0.651 . . . . 0.40000000000000002 111.72 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -48.03 -35.44 25.56 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.58 1.52 . . . . 0.47999999999999998 111.406 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.84 1.3 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.083 -1.01 . . . . 0.81000000000000005 109.063 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.98 -17.49 38.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 2.46 109.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpt -59.77 -19.59 51.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -0.974 . . . . 3.6600000000000001 109.997 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 mt -99.7 10.58 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.11 -0.994 . . . . 1.0700000000000001 110.34 -178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.26 -33.44 7.91 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 120.714 -1.241 . . . . 2.1099999999999999 112.167 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -61.51 -6.54 7.22 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.078 1.064 . . . . 0.29999999999999999 110.59 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -107.9 -74.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.555 -0.716 . . . . 0.37 109.403 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -45.03 -55.9 5.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.299 -0.876 . . . . 0.14999999999999999 110.707 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -66.07 -31.48 72.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.049 -1.032 . . . . 0.47999999999999998 109.89 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 46' ' ' SER . 2.8 t -64.07 -40.42 96.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.924 -1.11 . . . . 1.05 110.189 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 mt -51.57 -12.6 0.18 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 1.1299999999999999 109.979 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.414 ' H ' ' C ' ' A' ' 44' ' ' SER . 27.8 m -56.44 -38.56 71.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.835 -1.165 . . . . 0.93000000000000005 109.566 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.14 -11.18 33.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.305 -0.872 . . . . 2.0 109.875 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.61 -53.26 4.73 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.3 -1.0 . . . . 2.6499999999999999 108.3 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.442 ' C ' ' H ' ' A' ' 51' ' ' ASN . 57.1 m-85 -108.19 72.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.342 -0.849 . . . . 0.89000000000000001 109.789 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 p -66.7 -1.6 3.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.93000000000000005 108.602 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.442 ' H ' ' C ' ' A' ' 49' ' ' TYR . 24.6 t-20 -95.3 -4.38 45.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.46999999999999997 109.541 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.2 t -116.75 150.5 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.947 -0.76 . . . . 1.03 108.947 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mm -100.45 132.24 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.421 -0.799 . . . . 1.05 109.088 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -114.77 134.83 54.79 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.335 -0.853 . . . . 0.11 109.5 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.4 mp -115.5 171.36 7.77 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.762 -0.829 . . . . 1.04 108.762 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.06 142.49 30.68 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.946 -1.131 . . . . 1.3100000000000001 107.946 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.3 141.16 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.148 -0.97 . . . . 1.02 110.246 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.473 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.1 93.86 6.51 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.819 -1.178 . . . . 1.0800000000000001 107.819 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.616 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 10.5 m -54.35 -3.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 1.0600000000000001 111.47 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 58' ' ' ASP . 6.2 m-20 -113.15 -37.35 4.78 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 111.231 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -95.42 -16.8 22.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.887 -1.133 . . . . 1.1200000000000001 109.619 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.81 49.92 1.58 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.54 -0.911 . . . . 1.01 108.54 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.458 ' CB ' HH21 ' B' ' 4' ' ' ARG . 8.1 pt20 -54.98 -14.5 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.514 -0.741 . . . . 2.7799999999999998 110.054 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -38.35 73.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.927 -1.108 . . . . 1.1100000000000001 109.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.42 -47.51 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.007 . . . . 1.05 108.644 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.85 78.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.809 . . . . 1.0600000000000001 109.351 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.3 m -64.31 -50.31 68.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 1.79 109.663 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.448 ' CD ' ' HZ3' ' A' ' 8' ' ' LYS . 69.5 tt0 -63.47 -33.27 75.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 2.2000000000000002 109.803 -179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.93 0.41 55.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.094 -1.004 . . . . 1.0600000000000001 109.538 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 48.95 54.19 11.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 110.157 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.28 129.53 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 1.05 109.037 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -122.65 -3.58 8.76 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.465 -0.772 . . . . 2.9300000000000002 109.733 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.451 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.58 141.53 21.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.116 -0.99 . . . . 1.0600000000000001 109.451 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 10.4 p -121.02 150.31 53.03 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.681 -0.859 . . . . 0.97999999999999998 108.681 179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.25 149.8 90.29 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.749 -0.938 . . . . 0.23999999999999999 110.127 -2.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.451 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.91 124.77 49.09 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.855 -1.165 . . . . 1.04 107.855 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -102.35 115.7 31.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.269 -1.011 . . . . 0.19 108.269 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 5.2 mt-30 -116.58 139.96 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.012 -1.107 . . . . 1.71 108.012 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -109.54 126.52 53.66 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.48 0.657 . . . . 0.13 110.065 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -123.0 154.78 38.0 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.205 -1.035 . . . . 0.22 108.205 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -155.87 123.76 5.67 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.965 -1.124 . . . . 2.0299999999999998 107.965 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 56.84 20.74 5.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.726 -0.609 . . . . 2.1600000000000001 110.088 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.586 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 94.22 -1.48 67.33 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.074 -1.016 . . . . 0.23000000000000001 110.579 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.586 HE21 ' C ' ' A' ' 83' ' ' GLY . 15.5 mm-40 -110.79 148.02 33.24 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.112 -1.228 . . . . 2.8100000000000001 110.56 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.526 ' CB ' ' HZ1' ' A' ' 85' ' ' LYS . 3.4 ttmp? -86.6 139.98 30.29 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.522 -0.918 . . . . 2.2599999999999998 108.522 178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -122.34 -21.44 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.454 -0.779 . . . . 1.05 110.704 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.74 174.92 47.17 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.425 -1.369 . . . . 0.25 110.209 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.75 155.75 2.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -1.14 . . . . 2.04 110.531 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -169.76 135.06 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.685 -0.634 . . . . 0.17999999999999999 109.875 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.408 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 18.8 p -107.2 -178.76 3.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.341 -0.85 . . . . 0.89000000000000001 108.898 179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.41 134.0 8.34 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.446 -1.462 . . . . 0.14000000000000001 109.446 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.75 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -1.195 . . . . 1.0600000000000001 110.261 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.82 73.21 1.42 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.936 -1.135 . . . . 1.98 107.936 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.01 -34.86 78.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 1.72 110.84 -178.565 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.38 -25.03 67.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.991 -1.068 . . . . 1.95 109.354 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -69.1 -38.12 78.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.372 -0.83 . . . . 2.5600000000000001 109.726 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 42.6 mt -51.23 -36.51 42.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.919 -1.113 . . . . 1.03 109.077 -179.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.45 -56.63 10.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.851 . . . . 2.1499999999999999 109.573 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.94 86.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 1.04 110.398 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 m -67.47 -47.41 70.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.137 -0.977 . . . . 1.04 109.818 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -60.94 -49.4 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 1.05 108.46 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.55 -17.71 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 1.6599999999999999 109.62 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.2 -60.35 2.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 2.02 109.928 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.11 21.54 5.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.492 -0.755 . . . . 1.1399999999999999 110.307 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 1.1799999999999999 109.197 179.454 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.588 ' CE2' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -140.7 89.03 2.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.338 -0.851 . . . . 0.0 108.909 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' B' ' 1' ' ' PHE . 43.2 m-85 -99.6 163.52 12.46 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.129 -0.982 . . . . 0.0 109.518 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.458 HH21 ' CB ' ' A' ' 63' ' ' GLN . 5.8 mmt180 -150.33 -101.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 108.805 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.4 p90 -113.17 -171.77 1.93 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.068 -1.02 . . . . 0.0 111.002 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -64.91 144.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.912 0.863 . . . . 0.0 113.072 -176.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -101.7 93.81 5.52 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.408 ' OE2' ' OG ' ' A' ' 90' ' ' SER . 10.6 pt-20 -85.04 44.7 1.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.07 . . . . 0.0 110.843 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.27 -133.46 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.36 18.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.23 1.515 . . . . 0.0 109.639 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.686 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.3 t -83.74 -25.32 30.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.467 -0.771 . . . . 0.0 109.66 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.617 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.7 OUTLIER -74.38 -128.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.617 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.536 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.616 ' H2 ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.401 ' H1 ' ' N ' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.626 ' H2 ' ' N ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.251 0.548 . . . . 3.3799999999999999 109.545 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 33.0 t -94.71 169.2 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 1.1000000000000001 109.299 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -152.69 119.77 5.83 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.923 -1.139 . . . . 2.5 107.923 179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -86.95 144.1 27.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.974 -1.079 . . . . 1.6100000000000001 110.362 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mm -111.05 108.64 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.884 -1.154 . . . . 1.04 107.884 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.65 -12.56 19.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 1.97 109.489 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -153.55 155.12 35.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 0.92000000000000004 109.631 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -51.35 -21.25 2.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 2.48 109.436 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.57 -52.9 62.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 1.05 110.435 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -20.45 63.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 1.0600000000000001 110.275 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.37 -65.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.059 -1.026 . . . . 0.25 110.19 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.37 -45.07 84.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 3.0699999999999998 109.633 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -59.0 -34.44 71.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.985 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.38 81.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.916 -1.115 . . . . 1.04 109.332 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.74 -45.97 84.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.227 -0.921 . . . . 1.27 109.447 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -63.78 -37.41 87.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.466 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.76 -16.93 52.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 1.0900000000000001 109.472 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.78 27.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 1.0700000000000001 109.522 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.38 -111.0 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.742 -1.343 . . . . 0.31 109.742 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -138.1 3.57 2.42 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.391 -1.064 . . . . 2.21 109.349 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.623 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 76.9 mttt -70.29 169.05 14.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.164 -0.96 . . . . 2.4100000000000001 108.916 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 162.32 12.2 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.035 -1.098 . . . . 1.05 108.035 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -144.18 103.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.831 -1.168 . . . . 1.03 109.628 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.27 129.92 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.563 -0.903 . . . . 1.01 108.563 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.16 141.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -0.762 . . . . 1.02 109.548 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -110.97 99.1 8.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.957 -0.757 . . . . 0.95999999999999996 108.957 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 52.0 m-85 -84.82 81.41 8.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.632 -1.248 . . . . 0.32000000000000001 107.632 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -109.89 -163.87 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.563 0.697 . . . . 1.04 109.147 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.53 119.93 13.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.151 -1.055 . . . . 1.0600000000000001 108.151 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -63.21 -24.02 67.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 1.0600000000000001 110.565 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.7 p-90 -89.64 -14.87 33.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.51000000000000001 110.118 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 t -93.77 133.73 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.34000000000000002 109.706 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -72.77 -57.76 5.21 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 111.337 -0.705 . . . . 0.40000000000000002 111.337 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.5 Cg_exo -49.24 -37.27 39.32 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.779 1.652 . . . . 0.47999999999999998 111.414 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.46 -62.62 1.56 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.857 -1.152 . . . . 0.81000000000000005 109.069 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -59.0 -20.05 49.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 2.46 109.676 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.465 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.4 tpt -60.57 -18.04 50.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.322 -0.861 . . . . 3.6600000000000001 109.662 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.6 mt -100.51 10.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.289 -0.882 . . . . 1.0700000000000001 110.412 -178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.59 -32.3 5.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.416 -1.427 . . . . 2.1099999999999999 112.386 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -63.07 -5.09 7.17 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 CA-C-N 119.865 0.988 . . . . 0.29999999999999999 110.29 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.8 -77.51 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.928 -0.767 . . . . 0.37 108.928 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -42.44 -56.63 2.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.14999999999999999 110.998 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -65.73 -33.32 75.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.103 -0.998 . . . . 0.47999999999999998 109.688 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 14.5 m -64.36 -39.89 94.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 1.05 109.997 179.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -51.85 -16.54 0.72 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.025 -1.047 . . . . 1.1299999999999999 109.72 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -57.01 -29.46 63.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.93000000000000005 109.737 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -95.95 -21.4 18.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 2.0 110.162 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -90.32 -19.7 23.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.053 -1.029 . . . . 2.6499999999999999 109.41 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.15 64.65 1.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.39 -0.819 . . . . 0.89000000000000001 109.209 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 p -66.9 -4.43 9.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.337 -0.852 . . . . 0.93000000000000005 109.027 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -95.05 2.31 55.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.445 -0.784 . . . . 0.46999999999999997 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -119.0 150.03 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.157 -0.683 . . . . 1.03 109.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.79 122.31 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 1.05 108.982 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -109.74 129.84 55.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.254 -0.904 . . . . 0.11 108.969 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.3 mp -112.7 169.63 8.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.336 -0.852 . . . . 1.04 108.807 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -142.06 140.39 32.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.602 -1.259 . . . . 1.3100000000000001 107.602 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.2 136.94 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.898 . . . . 1.02 110.741 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.99 107.68 20.26 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.645 -1.243 . . . . 1.0800000000000001 107.645 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.621 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 23.3 m -65.14 -9.68 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 1.0600000000000001 111.06 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.725 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 31.1 m-20 -101.03 -41.69 6.68 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 110.704 -179.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -12.48 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 1.1200000000000001 109.91 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.31 49.63 1.88 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.311 -0.868 . . . . 1.01 108.836 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.08 -17.01 5.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.721 . . . . 2.7799999999999998 109.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.4 p30 -70.33 -41.29 73.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.433 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -74.18 -45.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 1.05 108.674 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.27 79.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.282 -0.886 . . . . 1.0600000000000001 108.779 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -64.04 -44.79 91.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.369 -0.832 . . . . 1.79 109.265 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.59 -39.11 93.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.449 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.71 55.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.186 -0.946 . . . . 1.0600000000000001 109.909 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 47.65 56.21 7.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.06 -1.025 . . . . 2.3399999999999999 109.748 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.9 t -79.52 131.27 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 1.05 109.588 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -128.8 0.96 5.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.385 -0.822 . . . . 2.9300000000000002 109.669 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.0 128.65 10.8 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.966 -1.084 . . . . 1.0600000000000001 108.771 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.476 ' O ' ' N ' ' B' ' 8' ' ' GLU . 11.2 p -114.77 150.43 44.03 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.733 -0.84 . . . . 0.97999999999999998 108.733 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -77.54 147.47 84.66 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 C-N-CA 124.776 -0.927 . . . . 0.23999999999999999 109.941 -1.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.512 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.56 117.42 28.93 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.938 -1.134 . . . . 1.04 107.938 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -91.78 121.48 33.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.07 -1.019 . . . . 0.19 108.494 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.504 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.1 mt-30 -120.05 136.38 54.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.783 -1.191 . . . . 1.71 107.783 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.415 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 32.3 m-85 -108.97 129.43 55.44 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.581 0.705 . . . . 0.13 109.978 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -126.24 156.92 39.52 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.263 -1.014 . . . . 0.22 108.263 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -155.39 120.23 4.79 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.485 -1.302 . . . . 2.0299999999999998 107.485 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.65 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 44.6 mtmt 55.97 29.14 13.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -0.783 . . . . 2.1600000000000001 108.909 -178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.13 7.8 87.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.896 -1.281 . . . . 0.23000000000000001 109.896 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -112.85 142.41 45.54 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.469 -1.018 . . . . 2.8100000000000001 110.643 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -84.77 141.37 30.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 2.2599999999999998 109.314 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.34 -20.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.426 -0.796 . . . . 1.05 110.452 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.24 172.97 45.53 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.346 -1.407 . . . . 0.25 110.435 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -174.22 150.68 1.54 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.447 -1.031 . . . . 2.04 110.044 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -169.09 133.18 1.41 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.17999999999999999 110.48 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.405 ' OG ' ' OE2' ' B' ' 8' ' ' GLU . 17.3 p -103.55 -169.55 1.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.89000000000000001 108.929 179.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.13 129.88 3.67 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.669 -1.372 . . . . 0.14000000000000001 109.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.87 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -1.16 . . . . 1.0600000000000001 110.602 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -139.46 76.68 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.828 -1.175 . . . . 1.98 107.828 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.34 -32.55 74.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.654 -0.654 . . . . 1.72 110.656 -178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.66 -28.35 69.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.906 -1.121 . . . . 1.95 109.146 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.71 -35.23 76.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 2.5600000000000001 109.322 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 41.4 mt -52.07 -38.99 59.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 1.03 108.823 179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -57.63 6.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.578 -0.701 . . . . 2.1499999999999999 109.785 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.32 82.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.04 110.494 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.2 m -66.78 -45.79 77.36 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 1.04 110.163 -179.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.68 -52.37 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 1.05 109.214 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -60.52 -18.09 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 1.6599999999999999 109.449 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -77.39 -62.72 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 2.02 110.202 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.33 24.39 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.558 -0.714 . . . . 1.1399999999999999 110.437 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.937 -1.102 . . . . 1.1799999999999999 109.165 179.541 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.4 p90 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 90.1 mtt180 -146.68 71.22 1.23 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.195 -0.941 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.5 m-85 -118.65 143.66 46.68 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.536 -0.728 . . . . 0.0 109.208 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -138.65 -105.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.45 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 2.4 p90 -109.55 -168.39 1.32 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.259 -0.901 . . . . 0.0 110.461 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.67 150.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.266 -0.896 . . . . 0.0 112.57 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.9 m -101.4 96.53 7.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.476 ' N ' ' O ' ' A' ' 74' ' ' THR . 3.6 pt-20 -83.25 44.76 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 110.279 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.89 -131.43 0.12 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.08 23.98 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.273 1.537 . . . . 0.0 109.129 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.648 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.6 t -84.99 -50.72 7.24 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.354 -0.842 . . . . 0.0 109.335 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -92.23 102.57 15.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.378 -0.827 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.984 -1.454 . . . . 0.0 109.558 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.65 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.725 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.623 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.598 ' N ' ' SD ' ' A' ' 1' ' ' MET . 4.1 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.273 -0.639 . . . . 3.3799999999999999 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 78.9 t -94.52 162.28 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.169 -0.957 . . . . 1.1000000000000001 109.588 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.411 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 33.6 tttt -155.96 123.32 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 2.5 109.224 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -90.45 132.52 35.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 1.6100000000000001 109.645 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -112.51 103.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.548 -0.908 . . . . 1.04 108.548 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -99.19 -4.46 32.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.204 -0.935 . . . . 1.97 109.852 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 p -151.18 148.9 28.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.112 -0.992 . . . . 0.92000000000000004 109.96 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -52.31 -25.59 9.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.319 -0.863 . . . . 2.48 109.552 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.7 m -59.7 -48.92 79.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 1.05 109.34 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -23.62 62.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 1.0600000000000001 109.733 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -58.28 -66.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.25 110.198 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -56.27 -44.62 79.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 3.0699999999999998 109.669 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -58.91 -35.11 72.52 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 109.804 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 1.04 108.898 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.21 -43.52 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.578 -0.702 . . . . 1.27 109.318 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 -38.2 90.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 1.0900000000000001 109.681 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.19 -16.08 55.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 1.0900000000000001 109.909 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.28 50.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 1.0700000000000001 109.889 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 -112.94 4.76 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.31 -1.516 . . . . 0.31 109.31 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.565 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 19.2 t70 -134.71 2.54 3.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.435 -1.038 . . . . 2.21 109.305 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 76.3 mttt -70.28 166.87 19.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.044 -1.035 . . . . 2.4100000000000001 108.689 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.585 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.39 163.36 10.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 1.05 108.834 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.585 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.2 t -144.6 107.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 1.03 109.402 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.38 135.5 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.556 -0.905 . . . . 1.01 108.556 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.15 133.44 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 1.02 109.894 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -106.44 102.96 12.31 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.98 -0.748 . . . . 0.95999999999999996 108.98 179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -88.45 79.43 7.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.603 -1.258 . . . . 0.32000000000000001 107.603 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.0 m -113.3 149.27 34.16 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.225 0.536 . . . . 1.04 109.613 -179.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.89 129.57 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.858 . . . . 1.0600000000000001 109.082 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.45 -23.97 65.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 1.0600000000000001 110.118 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.542 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.8 p-90 -89.1 -16.88 30.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.061 -1.024 . . . . 0.51000000000000001 110.176 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.48 124.71 37.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.965 . . . . 0.34000000000000002 110.291 -178.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.76 -57.75 11.67 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.972 -0.851 . . . . 0.40000000000000002 110.972 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -46.18 -36.07 16.19 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 121.908 1.739 . . . . 0.47999999999999998 111.359 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.0 -60.31 2.41 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.672 -1.267 . . . . 0.81000000000000005 108.991 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -59.91 -18.39 44.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.489 -0.757 . . . . 2.46 110.029 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.4 tpt -59.68 -24.77 64.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 3.6600000000000001 110.155 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.425 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 72.3 mt -96.91 6.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.142 -0.974 . . . . 1.0700000000000001 111.371 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -62.58 -34.39 14.52 Favored Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 118.194 -1.402 . . . . 2.1099999999999999 111.64 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -62.32 -5.9 7.48 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 CA-C-N 120.009 1.039 . . . . 0.29999999999999999 110.524 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.83 -71.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.37 108.958 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -46.06 -58.5 3.55 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.488 -0.757 . . . . 0.14999999999999999 110.733 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.24 -30.49 71.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.47999999999999998 109.714 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.3 m -63.54 -41.17 98.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.855 -1.153 . . . . 1.05 109.735 179.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -52.01 -16.92 0.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 1.1299999999999999 109.575 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 66.6 m -56.93 -31.37 64.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.93000000000000005 109.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.92 -19.72 20.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.127 -0.983 . . . . 2.0 109.906 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -90.94 -21.38 21.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 2.6499999999999999 109.774 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.22 67.71 1.5 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.89000000000000001 109.231 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -68.01 -3.97 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.413 -0.805 . . . . 0.93000000000000005 109.322 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.5 t30 -94.94 2.22 55.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 109.719 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.1 t -119.12 152.99 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.811 -0.811 . . . . 1.03 108.811 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 mm -100.44 128.64 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.306 -0.871 . . . . 1.05 108.911 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -114.58 132.9 56.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.407 -0.808 . . . . 0.11 109.144 -179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.31 169.0 9.47 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.083 -0.71 . . . . 1.04 109.083 -179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -144.25 141.1 29.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.196 -1.039 . . . . 1.3100000000000001 108.196 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.15 145.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.103 -0.998 . . . . 1.02 110.425 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' CG ' HH21 ' B' ' 2' ' ' ARG . 19.2 t70 -101.32 100.92 11.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.219 -1.03 . . . . 1.0800000000000001 108.219 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.09 -3.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 111.287 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' H ' ' C ' ' A' ' 58' ' ' ASP . 27.1 m-20 -108.79 -40.94 4.9 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.203 -0.936 . . . . 1.1100000000000001 111.095 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.21 -23.43 16.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.891 -1.131 . . . . 1.1200000000000001 110.036 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.0 46.34 0.98 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.352 -0.981 . . . . 1.01 108.352 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -53.53 -14.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.731 -0.606 . . . . 2.7799999999999998 109.9 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -71.2 -42.98 68.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.316 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.19 -43.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.143 -0.973 . . . . 1.05 108.696 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -35.55 79.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.453 -0.943 . . . . 1.0600000000000001 108.453 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 m -64.69 -46.98 80.07 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.754 -0.832 . . . . 1.79 108.754 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.57 -39.42 94.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 2.2000000000000002 109.35 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -3.15 58.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 1.0600000000000001 109.603 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 66' ' ' ALA . 52.3 mm-40 47.47 53.01 11.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.873 . . . . 2.3399999999999999 110.352 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.96 136.14 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 1.05 109.413 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -129.88 3.86 4.92 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.476 -0.765 . . . . 2.9300000000000002 109.5 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.505 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 136.26 16.27 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.128 -0.982 . . . . 1.0600000000000001 108.883 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 41.1 p -118.55 150.79 48.76 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.945 -0.761 . . . . 0.97999999999999998 108.945 179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.76 145.92 80.39 Favored 'Cis proline' 0 N--CA 1.482 0.848 0 N-CA-C 109.778 -0.893 . . . . 0.23999999999999999 109.778 -1.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.6 112.47 22.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.513 -1.292 . . . . 1.04 107.513 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.0 m-85 -92.56 113.8 26.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.426 -0.91 . . . . 0.19 108.686 179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -115.91 138.68 50.95 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.443 -1.317 . . . . 1.71 107.443 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -110.11 127.23 54.77 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.374 0.607 . . . . 0.13 109.756 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -121.45 157.18 31.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.541 -0.911 . . . . 0.22 108.541 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -155.73 123.53 5.65 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.491 -1.3 . . . . 2.0299999999999998 107.491 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt 57.07 17.81 3.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.687 -0.633 . . . . 2.1600000000000001 109.89 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.572 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.72 0.18 62.59 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.416 -1.074 . . . . 0.23000000000000001 110.416 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.572 HE21 ' C ' ' A' ' 83' ' ' GLY . 23.6 mm-40 -111.87 151.1 29.51 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.184 -1.186 . . . . 2.8100000000000001 110.033 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.398 -0.814 . . . . 2.2599999999999998 109.316 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.87 -7.03 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.735 . . . . 1.05 110.542 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.93 167.77 35.29 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.445 -1.36 . . . . 0.25 110.284 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.95 153.2 2.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 2.04 110.604 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 8.2 p90 -169.66 132.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.17999999999999999 109.603 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.7 p -104.23 -162.28 0.88 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.015 -1.053 . . . . 0.89000000000000001 109.183 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.14 137.1 1.08 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.325 -1.51 . . . . 0.14000000000000001 109.325 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.49 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 1.0600000000000001 110.094 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.46 66.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.868 -1.16 . . . . 1.98 107.868 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -62.24 -38.94 91.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.816 -0.552 . . . . 1.72 111.262 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.58 -27.33 68.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.596 -1.315 . . . . 1.95 109.497 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.19 -32.77 73.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 2.5600000000000001 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 27.9 mt -51.4 -36.88 45.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 1.03 108.687 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.34 -59.64 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.527 -0.733 . . . . 2.1499999999999999 109.848 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.47 81.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 1.04 110.741 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.8 m -67.84 -45.28 75.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 1.04 110.211 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.55 -51.24 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 1.05 109.157 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.71 -17.22 46.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 1.6599999999999999 109.634 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.95 -61.26 1.99 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 2.02 110.015 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.9 21.33 5.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.424 -0.797 . . . . 1.1399999999999999 110.391 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.017 -1.052 . . . . 1.1799999999999999 109.414 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.6 p90 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 47.4 mtp180 -142.76 57.77 1.43 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.224 -0.923 . . . . 0.0 109.308 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.47 160.24 22.07 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.598 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.54 -86.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.408 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -125.35 -173.97 2.95 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.16 149.72 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.006 0.908 . . . . 0.0 112.496 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.55 95.69 6.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -83.89 41.59 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.03 -1.044 . . . . 0.0 110.361 -179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.646 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -129.4 0.05 OUTLIER Glycine 0 N--CA 1.485 1.915 0 N-CA-C 106.898 -2.481 . . . . 0.0 106.898 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.71 22.67 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.307 1.553 . . . . 0.0 109.119 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.646 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t -101.82 11.39 38.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -154.75 123.75 6.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 109.46 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 CA-C-O 117.951 -1.472 . . . . 0.0 109.494 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.565 ' H1 ' ' N ' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.445 -0.576 . . . . 3.3799999999999999 109.445 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.546 ' CG2' ' HG ' ' A' ' 46' ' ' SER . 78.3 t -94.68 168.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.262 -0.899 . . . . 1.1000000000000001 109.41 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.473 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 43.7 tttp -151.92 121.54 6.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.234 -0.916 . . . . 2.5 109.073 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -88.29 132.04 34.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 1.6100000000000001 109.709 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.97 107.46 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.228 -1.027 . . . . 1.04 108.228 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.58 -10.33 22.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.201 -0.937 . . . . 1.97 109.646 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 p -153.51 157.49 39.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.92000000000000004 109.95 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -53.02 -30.38 35.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 2.48 109.916 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 m -59.49 -45.1 92.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 1.05 110.25 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.06 -26.48 64.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 1.0600000000000001 109.795 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.02 -69.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.973 . . . . 0.25 110.237 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -54.38 -43.16 71.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 3.0699999999999998 109.603 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -59.0 -36.36 74.8 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.171 -0.956 . . . . 2.1000000000000001 109.643 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.0 -47.63 85.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.032 -1.043 . . . . 1.04 109.013 179.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.18 -44.49 88.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.735 . . . . 1.27 109.877 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -62.92 -45.73 91.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 1.0900000000000001 109.826 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.95 59.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 1.0900000000000001 109.876 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.79 -10.53 57.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.084 -1.01 . . . . 1.0700000000000001 109.649 -179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.486 ' N ' ' H1 ' ' A' ' 110' ' ' HOH . . . 71.72 -127.61 13.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.31 109.612 179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.463 ' OD1' ' NZ ' ' A' ' 81' ' ' LYS . 46.1 t0 -121.17 2.81 10.4 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.586 -0.949 . . . . 2.21 109.925 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 109' ' ' HOH . 46.9 mttp -68.25 169.98 9.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.902 -1.123 . . . . 2.4100000000000001 109.367 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.718 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -66.0 162.43 19.36 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.19 -1.041 . . . . 1.05 108.19 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.53 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 4.8 t -145.26 102.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.981 -1.074 . . . . 1.03 109.111 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -101.42 127.54 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.485 -0.76 . . . . 1.01 109.069 179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.0 138.32 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.606 -0.684 . . . . 1.02 109.764 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -108.86 99.46 8.8 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.974 -0.751 . . . . 0.95999999999999996 108.974 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.6 m-85 -82.96 77.26 9.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.794 -1.187 . . . . 0.32000000000000001 107.794 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -103.98 -166.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.574 0.702 . . . . 1.04 109.433 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 127.98 21.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.863 -0.791 . . . . 1.0600000000000001 108.863 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 1.0600000000000001 111.194 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.552 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 59.7 p-90 -86.74 -11.05 52.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.768 -1.208 . . . . 0.51000000000000001 110.09 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.84 117.38 30.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.34000000000000002 109.981 -179.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.437 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -60.63 -55.19 31.32 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 120.865 -0.683 . . . . 0.40000000000000002 111.419 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.436 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.1 Cg_exo -49.59 -35.7 38.31 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.814 1.676 . . . . 0.47999999999999998 111.11 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.34 -62.64 1.59 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.951 -1.093 . . . . 0.81000000000000005 109.055 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.62 -16.93 29.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.476 -0.765 . . . . 2.46 110.163 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -61.48 -19.37 61.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.083 -1.011 . . . . 3.6600000000000001 110.222 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.401 ' O ' ' CG2' ' A' ' 38' ' ' ILE . 72.2 mt -100.48 13.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.244 -0.91 . . . . 1.0700000000000001 110.718 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.51 -32.1 2.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.469 -1.394 . . . . 2.1099999999999999 112.607 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.7 Cg_exo -63.79 -4.06 6.64 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 119.793 0.962 . . . . 0.29999999999999999 110.268 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 42' ' ' PHE . 42.0 m-85 -110.9 -79.47 0.58 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.404 -0.81 . . . . 0.37 108.907 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.62 -57.12 1.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.566 . . . . 0.14999999999999999 110.79 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.07 -30.72 70.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.47999999999999998 109.834 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 11.2 m -66.76 -38.62 86.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 1.05 110.284 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -49.45 -20.25 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.935 -1.103 . . . . 1.1299999999999999 109.772 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.546 ' HG ' ' CG2' ' A' ' 2' ' ' VAL . 39.0 m -56.71 -22.94 38.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.93000000000000005 110.105 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -97.07 -26.46 14.98 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.15 -0.969 . . . . 2.0 110.239 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.13 -17.76 27.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.077 -1.014 . . . . 2.6499999999999999 109.56 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -134.16 70.19 1.45 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.377 -0.827 . . . . 0.89000000000000001 109.39 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.6 p -68.51 -6.23 24.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.423 -0.798 . . . . 0.93000000000000005 109.12 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.2 3.31 54.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.448 -0.782 . . . . 0.46999999999999997 110.052 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.69 148.54 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 1.03 109.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.8 mm -99.23 121.73 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 1.05 108.983 179.897 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 81.4 m-85 -108.84 128.39 54.86 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.878 . . . . 0.11 108.937 179.841 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 6.7 mp -110.2 170.41 8.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.504 -0.747 . . . . 1.04 109.023 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -140.82 137.93 33.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.634 -1.247 . . . . 1.3100000000000001 107.634 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.69 134.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.913 . . . . 1.02 110.336 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.14 110.31 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.63 -1.248 . . . . 1.0800000000000001 107.63 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.649 ' N ' ' H2 ' ' A' ' 108' ' ' HOH . 17.6 m -66.23 -11.35 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 1.0600000000000001 111.346 -178.251 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.671 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 12.1 m-20 -104.76 -38.92 6.51 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 110.793 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.52 -13.62 27.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.693 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.46 49.14 1.94 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.306 -0.998 . . . . 1.01 108.306 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 26.1 mt-30 -56.11 -16.42 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 2.7799999999999998 110.755 -179.17 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -39.43 76.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.853 -1.154 . . . . 1.1100000000000001 109.304 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.8 -47.12 44.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.201 -0.937 . . . . 1.05 108.84 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.86 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.847 . . . . 1.0600000000000001 109.333 179.488 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 45.0 m -62.78 -50.13 72.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 1.79 109.26 -179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.54 -32.33 73.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.635 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.98 0.11 56.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.238 -0.913 . . . . 1.0600000000000001 109.816 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 47.41 50.01 15.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 2.3399999999999999 110.097 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.61 131.94 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 1.05 109.064 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -129.12 6.71 5.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.331 -0.855 . . . . 2.9300000000000002 109.661 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 144.29 24.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.402 -0.962 . . . . 1.0600000000000001 108.402 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.442 ' O ' ' OE1' ' B' ' 8' ' ' GLU . 32.5 p -131.01 149.12 72.87 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 108.546 -0.909 . . . . 0.97999999999999998 108.546 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.4 Cg_endo -79.09 142.69 68.3 Favored 'Cis proline' 0 N--CA 1.487 1.134 0 C-N-CA 124.966 -0.848 . . . . 0.23999999999999999 110.219 -1.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.01 111.06 21.52 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 107.862 -1.162 . . . . 1.04 107.862 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -86.15 116.0 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.822 -1.174 . . . . 0.19 109.541 -179.947 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.3 mt-30 -115.96 132.12 56.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.207 -1.405 . . . . 1.71 107.207 179.325 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -105.14 127.51 52.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.13 109.66 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -121.78 155.46 35.24 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.92 -0.77 . . . . 0.22 108.92 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.463 ' NZ ' ' OD1' ' A' ' 20' ' ' ASP . 48.8 tttm -154.96 123.65 6.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.737 -1.208 . . . . 2.0299999999999998 107.737 -179.842 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 55.95 28.88 13.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.529 -0.732 . . . . 2.1600000000000001 109.827 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.07 -0.1 89.49 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.089 -1.053 . . . . 0.23000000000000001 110.815 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -110.98 147.88 33.75 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.144 -1.209 . . . . 2.8100000000000001 110.475 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.56 ' CB ' ' HZ1' ' A' ' 85' ' ' LYS . 3.2 ttmp? -87.87 143.84 26.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 2.2599999999999998 109.339 179.413 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.1 m -123.59 -24.0 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.497 -0.752 . . . . 1.05 110.15 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.29 177.18 47.87 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.586 -1.292 . . . . 0.25 109.975 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.19 157.21 3.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 2.04 110.057 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.5 p90 -168.76 131.16 1.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.807 . . . . 0.17999999999999999 110.161 178.958 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -101.48 -161.16 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.559 -0.904 . . . . 0.89000000000000001 108.559 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' B' ' 8' ' ' GLU . . . 82.43 126.5 0.98 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.104 -1.598 . . . . 0.14000000000000001 109.104 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.09 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -1.203 . . . . 1.0600000000000001 110.891 -179.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -142.73 76.61 1.54 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.967 -1.123 . . . . 1.98 107.967 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -32.4 73.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.72 110.774 -178.56 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.13 -25.23 67.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.93 -1.106 . . . . 1.95 109.372 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -70.86 -37.23 73.09 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.3 -0.875 . . . . 2.5600000000000001 109.852 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.5 mt -52.17 -36.03 50.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 1.03 108.962 -179.698 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -66.09 -59.21 4.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.431 -0.793 . . . . 2.1499999999999999 110.071 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.53 82.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 1.04 110.676 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.4 m -67.22 -45.22 77.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.072 -1.017 . . . . 1.04 110.192 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.04 -53.03 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.191 -0.943 . . . . 1.05 109.127 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -59.19 -18.53 37.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 1.6599999999999999 109.471 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.54 -56.56 4.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 2.02 110.08 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -92.96 15.47 14.88 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.495 -0.753 . . . . 1.1399999999999999 110.613 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.872 -1.143 . . . . 1.1799999999999999 109.403 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 50.9 p90 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 58.9 mtm180 -154.28 74.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.228 -0.92 . . . . 0.0 109.233 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.552 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.5 m-85 -122.27 152.21 40.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.627 -0.67 . . . . 0.0 109.386 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.1 -103.58 0.11 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 2.6 p90 -109.28 -169.78 1.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.177 -0.952 . . . . 0.0 110.973 -179.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.63 150.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-O 122.09 0.948 . . . . 0.0 112.875 -176.778 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -102.24 96.28 6.87 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -82.88 47.86 1.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 110.131 -179.51 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -78.16 -125.28 0.35 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 177.936 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.9 25.67 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.495 1.648 . . . . 0.0 109.54 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.622 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.4 t -87.52 -24.43 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -78.53 143.9 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 CA-C-O 117.996 -1.447 . . . . 0.0 109.523 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.671 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.457 ' H2 ' ' C ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.486 ' H1 ' ' N ' ' A' ' 19' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.718 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.36 0.6 . . . . 3.3799999999999999 109.449 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.401 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 95.3 t -94.76 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 1.1000000000000001 109.496 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.401 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 37.8 tptt -154.5 125.21 7.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.274 -0.891 . . . . 2.5 109.212 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -90.26 131.66 35.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 1.6100000000000001 109.668 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.32 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.403 -0.962 . . . . 1.04 108.403 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.63 -1.33 47.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 1.97 109.791 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -150.99 146.93 26.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.92000000000000004 109.813 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -51.83 -29.5 19.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.34 -0.85 . . . . 2.48 109.831 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -59.04 -45.66 90.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 1.05 109.799 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.44 63.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 1.0600000000000001 109.681 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.99 -66.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.061 -1.024 . . . . 0.25 109.786 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -53.65 -46.09 70.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.207 -0.933 . . . . 3.0699999999999998 109.728 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.98 -35.13 72.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.152 -0.967 . . . . 2.1000000000000001 110.022 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.53 -46.24 90.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.995 -1.065 . . . . 1.04 109.296 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.4 -50.19 68.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 1.27 109.717 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.486 ' C ' ' H1 ' ' A' ' 110' ' ' HOH . 9.2 t70 -63.29 -36.59 84.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.474 -179.822 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.58 -18.66 47.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -0.927 . . . . 1.0900000000000001 109.682 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.8 23.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 1.0700000000000001 109.73 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 70.97 -116.11 6.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.31 109.642 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.601 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 84.1 m-20 -135.22 4.01 3.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.442 -1.034 . . . . 2.21 109.408 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.629 ' N ' ' H2 ' ' A' ' 109' ' ' HOH . 39.0 mttp -69.8 170.07 11.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.047 -1.033 . . . . 2.4100000000000001 109.013 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.523 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 159.89 22.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.71 -1.218 . . . . 1.05 107.71 179.574 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.523 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 16.1 t -143.56 108.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.865 -1.147 . . . . 1.03 109.374 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -103.95 134.47 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.912 -0.773 . . . . 1.01 108.912 179.77 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.66 136.08 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.665 -0.647 . . . . 1.02 109.523 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.37 101.95 11.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.017 -0.735 . . . . 0.95999999999999996 109.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -85.25 77.84 9.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.041 -1.096 . . . . 0.32000000000000001 108.041 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -113.92 146.47 40.02 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.16 -0.682 . . . . 1.04 109.16 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.56 130.51 36.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 1.0600000000000001 108.751 179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -65.88 -24.57 66.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 1.0600000000000001 110.311 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 58.5 p-90 -88.54 -17.35 30.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.082 -1.011 . . . . 0.51000000000000001 109.888 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.82 116.18 28.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.34000000000000002 110.135 -178.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -61.16 -53.14 47.21 Favored Glycine 0 N--CA 1.488 2.123 0 CA-C-O 119.341 -0.699 . . . . 0.40000000000000002 111.854 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.456 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.7 Cg_exo -48.38 -38.79 35.13 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.534 1.489 . . . . 0.47999999999999998 111.148 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.4 -59.67 2.64 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.727 -1.233 . . . . 0.81000000000000005 109.015 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.49 -18.63 52.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.739 . . . . 2.46 110.295 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm -57.93 -19.55 30.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.79 -1.194 . . . . 3.6600000000000001 110.257 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.446 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 77.4 mt -101.5 15.02 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.136 -0.977 . . . . 1.0700000000000001 110.39 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.75 -32.21 3.43 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.618 -1.301 . . . . 2.1099999999999999 112.56 179.727 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.6 Cg_exo -63.08 -5.21 7.41 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.883 0.994 . . . . 0.29999999999999999 110.165 -178.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.08 -76.73 0.6 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.475 -0.766 . . . . 0.37 109.203 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.14999999999999999 110.787 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.5 -31.52 72.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.93 -1.106 . . . . 0.47999999999999998 110.025 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 46' ' ' SER . 4.5 m -64.64 -38.82 92.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.818 -1.176 . . . . 1.05 110.039 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -50.25 -12.62 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.926 -1.109 . . . . 1.1299999999999999 109.776 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 44' ' ' SER . 19.4 m -56.76 -37.34 70.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.084 -1.01 . . . . 0.93000000000000005 109.665 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -94.97 -13.32 25.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.232 -0.918 . . . . 2.0 110.283 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -27.5 19.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.002 -1.062 . . . . 2.6499999999999999 109.572 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.42 72.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.088 -0.708 . . . . 0.89000000000000001 109.088 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.1 p -67.02 -4.48 9.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.93000000000000005 109.215 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.0 t30 -96.1 -3.17 45.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.46999999999999997 109.829 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.45 150.12 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.452 -0.78 . . . . 1.03 109.603 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.1 130.48 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.534 -0.729 . . . . 1.05 109.412 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.7 m-85 -115.03 132.53 56.57 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.554 -0.716 . . . . 0.11 109.192 179.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.2 mp -113.66 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.743 -0.836 . . . . 1.04 108.743 -179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.68 138.9 32.79 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.44 136.9 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.163 -0.961 . . . . 1.02 110.887 -178.335 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' H ' ' H2 ' ' A' ' 107' ' ' HOH . 11.4 t70 -98.78 102.78 14.62 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.268 -1.012 . . . . 1.0800000000000001 108.268 178.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.487 ' CG1' ' HH ' ' B' ' 5' ' ' TYR . 16.3 m -61.06 -0.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 111.56 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.427 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 18.0 m-20 -115.18 -37.86 3.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.102 -0.999 . . . . 1.1100000000000001 111.053 -178.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -94.96 -14.26 24.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.997 -1.064 . . . . 1.1200000000000001 109.766 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.58 52.84 1.6 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.709 -0.848 . . . . 1.01 108.709 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.93 -19.23 4.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.431 -0.793 . . . . 2.7799999999999998 110.173 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -68.02 -39.57 83.11 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.18 -1.575 . . . . 1.1100000000000001 109.989 -178.863 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.14 -48.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.955 -1.091 . . . . 1.05 108.736 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.22 90.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 1.0600000000000001 110.336 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.406 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 23.1 t -63.63 -42.19 98.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 1.79 109.581 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.69 -38.81 92.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.126 -0.984 . . . . 2.2000000000000002 109.191 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.9 0.17 56.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 1.0600000000000001 109.872 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 67' ' ' SER . 22.9 mp0 48.15 56.29 7.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 2.3399999999999999 110.222 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 6.9 t -79.14 132.76 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 1.05 108.916 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.481 ' CB ' ' HZ1' ' A' ' 72' ' ' LYS . 9.3 mtmp? -129.77 3.8 4.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.331 -0.856 . . . . 2.9300000000000002 110.358 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 123.17 7.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.975 -1.078 . . . . 1.0600000000000001 109.457 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 37.5 p -109.47 150.25 40.92 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.322 -0.861 . . . . 0.97999999999999998 109.068 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -77.41 139.55 58.82 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 C-N-CA 124.894 -0.878 . . . . 0.23999999999999999 110.421 -1.651 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -110.44 112.02 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.797 -1.186 . . . . 1.04 107.797 178.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -89.62 119.08 29.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.919 -1.113 . . . . 0.19 109.27 179.87 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -117.0 132.63 56.65 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.37 -1.344 . . . . 1.71 107.37 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -108.76 123.77 49.53 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.628 0.727 . . . . 0.13 109.471 -178.234 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -120.86 157.37 29.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.54 -0.911 . . . . 0.22 108.54 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.65 125.98 6.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.855 -1.165 . . . . 2.0299999999999998 107.855 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.451 ' HZ2' ' CG ' ' A' ' 20' ' ' ASP . 58.4 mttm 56.18 26.15 9.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 2.1600000000000001 109.988 -179.154 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.99 3.26 90.56 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.947 -1.261 . . . . 0.23000000000000001 109.947 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -111.49 148.06 33.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.517 -0.99 . . . . 2.8100000000000001 109.744 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.66 146.03 26.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 2.2599999999999998 109.692 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.91 -29.77 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -0.752 . . . . 1.05 109.844 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.43 177.91 44.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.529 -1.32 . . . . 0.25 110.472 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.1 pm0 -173.3 154.52 2.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -1.08 . . . . 2.04 110.164 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.98 131.58 1.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.353 -0.842 . . . . 0.17999999999999999 109.924 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -102.98 -158.16 0.65 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.231 -0.918 . . . . 0.89000000000000001 108.895 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.9 126.05 0.7 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.438 -1.465 . . . . 0.14000000000000001 109.438 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.19 94.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.244 . . . . 1.0600000000000001 110.131 -179.475 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.3 t-20 -139.49 76.59 1.57 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.37 -0.974 . . . . 1.98 108.37 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -63.99 -41.08 97.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.778 -0.576 . . . . 1.72 111.206 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.58 -25.85 68.15 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.051 -1.031 . . . . 1.95 109.785 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -69.35 -33.79 73.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.192 -0.942 . . . . 2.5600000000000001 109.405 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.8 mt -54.77 -35.53 63.9 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.68 -1.208 . . . . 1.03 108.583 179.715 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -66.62 -55.96 12.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 2.1499999999999999 109.465 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.73 92.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 1.04 110.419 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -65.81 -46.79 77.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 1.04 110.203 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.28 -49.67 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 1.05 108.676 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -62.59 -17.06 59.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 1.6599999999999999 109.183 179.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -79.37 -55.51 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 2.02 110.457 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -92.15 14.13 16.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 1.1399999999999999 110.336 -178.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.284 179.632 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.9 p90 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.533 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 57.8 mtp180 -139.78 73.55 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.225 -0.922 . . . . 0.0 109.316 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.468 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 42.2 m-85 -136.39 148.95 48.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.295 -0.878 . . . . 0.0 109.281 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -143.9 -87.77 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.146 -0.971 . . . . 0.0 109.734 179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.487 ' HH ' ' CG1' ' A' ' 59' ' ' VAL . 5.5 p90 -116.56 -167.79 1.34 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.843 -1.16 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.1 150.71 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.381 -0.825 . . . . 0.0 112.317 -177.437 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -101.59 95.36 6.4 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -82.51 45.42 0.96 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.075 -1.015 . . . . 0.0 109.594 -179.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.645 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -133.99 0.08 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.81 25.38 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.79 0 CA-C-N 119.2 1.5 . . . . 0.0 108.773 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.645 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.2 t -88.04 -53.41 4.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 109.261 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.549 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 25.7 t-80 -93.25 -173.19 3.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.549 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.95 -1.472 . . . . 0.0 109.532 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.427 ' H2 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.402 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.629 ' H2 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.486 ' H1 ' ' C ' ' A' ' 16' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.287 0.565 . . . . 3.3799999999999999 109.501 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.1 t -94.85 172.07 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 1.1000000000000001 109.722 -179.701 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 76.4 tttt -154.01 124.98 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.271 -0.893 . . . . 2.5 109.325 179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -89.03 133.74 34.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 1.6100000000000001 109.654 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -105.56 117.01 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.162 -1.051 . . . . 1.04 108.162 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 11.6 mp0 -102.54 -14.67 16.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.156 -0.965 . . . . 1.97 109.508 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 p -152.74 158.63 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.92000000000000004 109.817 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -52.22 -26.71 12.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 2.48 109.703 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -59.89 -48.61 80.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 1.05 110.018 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.67 62.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 1.0600000000000001 109.765 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.69 -69.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.018 . . . . 0.25 110.039 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -54.23 -43.97 71.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -0.857 . . . . 3.0699999999999998 109.853 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.74 -37.45 76.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.236 -0.915 . . . . 2.1000000000000001 109.743 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.52 95.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.0 -1.063 . . . . 1.04 109.187 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.69 -42.39 95.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 1.27 109.589 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.86 -42.44 97.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.763 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -12.98 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.146 -0.971 . . . . 1.0900000000000001 109.552 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -5.91 25.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 1.0700000000000001 109.653 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.25 -110.76 3.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.369 -1.492 . . . . 0.31 109.369 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.58 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 0.0 OUTLIER -140.14 5.09 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.335 -1.097 . . . . 2.21 108.98 179.897 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 71.1 mttt -69.8 168.61 14.72 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.094 -1.004 . . . . 2.4100000000000001 108.819 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.562 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.49 162.52 12.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.039 -1.097 . . . . 1.05 108.039 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.562 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 8.8 t -145.46 105.13 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.907 -1.121 . . . . 1.03 109.379 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.0 t -103.73 126.89 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 1.01 108.833 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.59 138.97 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.713 . . . . 1.02 109.527 -179.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.49 104.99 13.45 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.299 -0.63 . . . . 0.95999999999999996 109.299 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.53 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 48.3 m-85 -85.41 81.85 8.56 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.034 -1.099 . . . . 0.32000000000000001 108.034 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -114.53 150.3 35.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.785 -0.572 . . . . 1.04 109.636 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.46 125.3 37.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 1.0600000000000001 108.591 179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -66.13 -21.27 66.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.2 -0.937 . . . . 1.0600000000000001 109.96 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 56.9 p-90 -89.4 -17.64 28.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 0.51000000000000001 109.801 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -93.33 125.59 38.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.34000000000000002 110.136 -178.588 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -63.98 -58.58 10.41 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 111.316 -0.714 . . . . 0.40000000000000002 111.316 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.26 -34.49 24.75 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.638 1.559 . . . . 0.47999999999999998 111.275 -178.34 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.5 -63.68 1.32 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.093 -1.005 . . . . 0.81000000000000005 108.929 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -59.67 -17.55 35.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.588 -0.695 . . . . 2.46 110.095 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.2 ttt -61.67 -18.71 60.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 3.6600000000000001 110.155 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 29.5 mt -98.15 13.87 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.201 -0.937 . . . . 1.0700000000000001 110.244 -178.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.84 -32.05 3.26 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.393 -1.442 . . . . 2.1099999999999999 112.267 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.64 -3.26 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 CA-C-N 119.855 0.984 . . . . 0.29999999999999999 110.119 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.2 m-85 -112.47 -81.13 0.59 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.519 -0.738 . . . . 0.37 109.173 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.6 t80 -41.44 -55.37 2.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.14999999999999999 110.727 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -68.1 -32.02 72.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.854 -1.154 . . . . 0.47999999999999998 109.675 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.3 t -64.42 -41.22 96.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.827 -1.17 . . . . 1.05 110.191 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -49.62 -14.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.885 -1.135 . . . . 1.1299999999999999 109.494 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' SER . 17.2 m -57.45 -34.65 69.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.93000000000000005 109.68 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.05 -17.54 21.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.129 -0.982 . . . . 2.0 110.075 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.6 -21.74 22.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 2.6499999999999999 109.093 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -135.75 72.32 1.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.89000000000000001 109.142 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.1 p -66.94 -4.27 9.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.902 . . . . 0.93000000000000005 109.174 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.38 -3.23 44.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.46999999999999997 109.818 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.95 148.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.445 -0.784 . . . . 1.03 109.347 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mm -100.31 129.06 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 1.05 109.553 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -116.95 129.48 56.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.425 -0.797 . . . . 0.11 109.18 179.696 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.401 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.3 mp -111.93 175.12 5.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.402 -0.811 . . . . 1.04 108.977 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -143.62 146.1 33.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.204 -1.036 . . . . 1.3100000000000001 108.204 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -142.48 138.43 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.134 -0.979 . . . . 1.02 110.821 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -98.44 104.48 16.51 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.114 -1.069 . . . . 1.0800000000000001 108.114 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.8 m -60.56 -4.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 1.0600000000000001 111.46 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -110.21 -43.04 4.01 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 110.833 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 -12.28 32.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.002 . . . . 1.1200000000000001 109.34 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.44 45.22 2.63 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.764 -0.828 . . . . 1.01 108.764 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.645 HE21 HH11 ' B' ' 4' ' ' ARG . 54.3 mt-30 -56.46 -12.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 2.7799999999999998 110.454 -179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -40.41 75.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.922 -1.111 . . . . 1.1100000000000001 109.266 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.84 -46.71 45.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.907 . . . . 1.05 109.001 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.74 72.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 1.0600000000000001 109.078 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -64.42 -54.57 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 1.79 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.84 -29.05 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 2.2000000000000002 109.599 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.89 -5.7 57.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.226 -0.921 . . . . 1.0600000000000001 109.588 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 47.25 59.39 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 2.3399999999999999 110.2 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.7 t -78.92 136.6 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.145 -0.972 . . . . 1.05 109.061 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -123.46 -7.77 8.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.47 -0.769 . . . . 2.9300000000000002 109.778 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -154.11 132.47 11.98 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.943 -1.098 . . . . 1.0600000000000001 109.945 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.452 ' O ' ' N ' ' B' ' 8' ' ' GLU . 2.9 p -110.79 151.37 42.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.278 -1.008 . . . . 0.97999999999999998 108.278 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -76.59 144.38 78.82 Favored 'Cis proline' 0 N--CA 1.484 0.922 0 C-N-CA 124.747 -0.939 . . . . 0.23999999999999999 110.281 -1.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.9 122.34 46.0 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.529 -0.915 . . . . 1.04 108.529 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 76.8 m-85 -98.21 122.73 41.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.19 109.031 179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.53 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.4 mt-30 -120.31 133.35 55.47 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.91 -1.144 . . . . 1.71 107.91 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 17.4 m-85 -107.68 124.82 50.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.13 109.346 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.76 157.42 35.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.891 -0.781 . . . . 0.22 108.891 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -153.85 123.19 6.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.639 -1.245 . . . . 2.0299999999999998 107.639 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.542 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 31.4 mtmt 55.72 31.67 17.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 2.1600000000000001 109.284 -178.605 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.59 6.84 88.87 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.285 -1.126 . . . . 0.23000000000000001 110.285 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -112.01 143.52 42.88 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.35 -1.088 . . . . 2.8100000000000001 110.605 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -84.31 141.94 30.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 2.2599999999999998 109.58 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.99 -9.48 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.52 -0.737 . . . . 1.05 110.528 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.05 168.71 36.01 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.41 -1.376 . . . . 0.25 110.596 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.0 152.93 2.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -1.08 . . . . 2.04 110.416 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.4 p90 -169.05 134.07 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.17999999999999999 110.267 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.81 -174.33 2.52 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.074 -1.017 . . . . 0.89000000000000001 109.168 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.82 132.11 6.29 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.382 -1.487 . . . . 0.14000000000000001 109.382 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -58.91 94.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 1.0600000000000001 110.137 -179.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.31 70.54 1.37 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.822 -1.177 . . . . 1.98 107.822 178.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.77 -33.15 73.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.379 -0.826 . . . . 1.72 110.603 -178.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.04 -27.03 68.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.946 -1.097 . . . . 1.95 109.055 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -71.14 -37.61 72.26 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.546 -0.722 . . . . 2.5600000000000001 110.063 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.0 mt -52.28 -36.11 51.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.666 -1.271 . . . . 1.03 108.866 -179.808 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -66.91 -54.88 17.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 2.1499999999999999 109.457 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.75 93.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 1.04 110.355 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.2 m -65.51 -44.89 85.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.161 -0.962 . . . . 1.04 109.916 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.3 mt -60.43 -52.88 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 1.05 108.764 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -61.76 -16.01 45.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 1.6599999999999999 109.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -77.22 -59.03 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 2.02 110.115 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.04 18.69 7.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.443 -0.786 . . . . 1.1399999999999999 110.246 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 1.1799999999999999 109.404 179.822 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.523 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 91.7 mtt180 -150.67 60.9 0.94 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.498 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 41.7 m-85 -106.07 149.67 26.5 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.645 HH11 HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -137.3 -84.54 0.33 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.537 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.464 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.1 p90 -130.23 -167.22 1.78 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.105 -0.997 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.51 148.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.833 0.825 . . . . 0.0 112.357 -177.055 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 24.1 m -100.89 93.02 5.31 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . 0.452 ' N ' ' O ' ' A' ' 74' ' ' THR . 6.2 pt-20 -83.38 43.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.0 -1.062 . . . . 0.0 110.364 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.642 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.55 -130.18 0.04 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.08 24.05 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.407 1.604 . . . . 0.0 109.325 178.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.642 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t -91.97 -13.15 31.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.649 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -157.62 129.81 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.653 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.572 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.542 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.58 ' H1 ' ' N ' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.483 -0.562 . . . . 3.3799999999999999 109.483 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -97.22 154.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.27 -0.894 . . . . 1.1000000000000001 109.681 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -154.24 118.0 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.833 . . . . 2.5 108.886 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 19.5 tt0 -89.5 134.63 34.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 1.6100000000000001 109.961 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.3 mm -105.09 121.24 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.483 -1.302 . . . . 1.04 107.483 178.669 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 5.8 mp0 -101.98 -16.89 16.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.085 -1.01 . . . . 1.97 109.471 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.6 p -153.13 155.58 37.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.92000000000000004 109.137 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -50.74 -21.77 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 2.48 109.337 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 m -61.5 -47.46 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.989 . . . . 1.05 109.31 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.85 -22.99 62.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 1.0600000000000001 109.838 -179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.34 -65.76 0.62 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.25 109.868 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -55.27 -45.09 76.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 3.0699999999999998 109.67 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -58.03 -36.17 72.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.172 -0.955 . . . . 2.1000000000000001 109.594 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.76 -45.98 90.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 1.04 109.17 179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.26 -45.42 84.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.446 -0.784 . . . . 1.27 109.92 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.34 -40.58 97.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 1.0900000000000001 109.886 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -15.38 58.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 1.0900000000000001 109.516 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.97 -7.46 35.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 1.0700000000000001 109.553 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.08 -110.58 3.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.445 . . . . 0.31 109.486 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -138.67 2.98 2.25 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.436 -1.038 . . . . 2.21 109.52 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 84.4 mttt -70.06 171.71 9.13 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.997 -1.065 . . . . 2.4100000000000001 109.134 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.596 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -65.06 160.5 20.86 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.468 -0.938 . . . . 1.05 108.468 -179.555 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.514 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 3.7 t -143.38 104.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.04 . . . . 1.03 109.254 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.19 127.88 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 1.01 108.799 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.66 135.52 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.668 -0.645 . . . . 1.02 109.402 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -107.64 101.43 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.912 -0.773 . . . . 0.95999999999999996 108.912 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -84.82 82.6 8.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.813 -1.181 . . . . 0.32000000000000001 107.813 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -113.38 149.06 34.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.717 -0.615 . . . . 1.04 109.602 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.0 127.25 36.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.517 -0.92 . . . . 1.0600000000000001 108.517 179.421 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -66.59 -28.46 68.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.356 -0.84 . . . . 1.0600000000000001 111.081 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.542 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 62.1 p-90 -87.55 -10.28 52.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.887 -1.133 . . . . 0.51000000000000001 110.218 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -96.48 135.97 37.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.34000000000000002 109.532 -179.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.78 -56.9 3.68 Favored Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.501 -0.75 . . . . 0.40000000000000002 112.035 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.439 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -46.31 -39.1 21.18 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.673 1.582 . . . . 0.47999999999999998 111.721 -177.904 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.59 -53.97 7.75 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.73 -1.231 . . . . 0.81000000000000005 108.823 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.87 -19.85 53.69 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.624 -0.672 . . . . 2.46 109.791 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -59.42 -19.15 45.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 3.6600000000000001 110.504 -179.056 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.25 12.97 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.053 -1.029 . . . . 1.0700000000000001 111.112 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.06 -32.98 4.47 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 119.98 -1.7 . . . . 2.1099999999999999 112.362 179.328 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.1 Cg_exo -66.43 -0.03 3.91 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 CA-C-N 119.571 0.882 . . . . 0.29999999999999999 110.519 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.427 ' O ' ' OG ' ' A' ' 44' ' ' SER . 44.4 m-85 -117.64 -74.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.511 -0.743 . . . . 0.37 109.179 179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -42.45 -52.57 4.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.66 -0.65 . . . . 0.14999999999999999 110.495 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.11 -32.6 73.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.47999999999999998 109.72 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 59.7 p -62.37 -44.13 97.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.813 -1.179 . . . . 1.05 109.879 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -51.33 -15.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.109 -0.994 . . . . 1.1299999999999999 109.233 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' N ' ' C ' ' A' ' 44' ' ' SER . 28.9 m -57.19 -38.49 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.93000000000000005 109.698 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -94.95 -16.76 22.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.12 -0.987 . . . . 2.0 110.473 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -88.91 -19.81 25.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 2.6499999999999999 109.234 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.66 73.15 1.47 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.513 -0.742 . . . . 0.89000000000000001 109.135 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.46 -5.07 13.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.93000000000000005 109.273 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -96.24 8.32 44.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.46999999999999997 109.713 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.05 148.42 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 1.03 109.454 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -100.2 129.74 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 1.05 109.055 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -116.79 130.34 56.66 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.485 -0.759 . . . . 0.11 109.446 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 8.4 mp -114.01 171.41 7.62 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.853 -0.795 . . . . 1.04 108.853 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -143.42 147.78 35.13 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.893 -1.151 . . . . 1.3100000000000001 107.893 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.37 144.55 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.0 -1.062 . . . . 1.02 111.114 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.57 103.17 15.09 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.59 -1.263 . . . . 1.0800000000000001 107.59 178.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -64.84 -3.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 1.0600000000000001 112.766 -177.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.6 m-20 -120.45 -33.28 3.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.73 -1.232 . . . . 1.1100000000000001 110.909 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.23 -21.55 18.39 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.782 -1.199 . . . . 1.1200000000000001 108.678 179.174 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.03 45.63 1.15 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.589 -1.263 . . . . 1.01 107.589 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' NE2' ' N ' ' A' ' 64' ' ' ASP . 3.7 pp0? -52.74 -15.12 0.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.781 -0.574 . . . . 2.7799999999999998 110.767 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' N ' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -70.02 -38.78 76.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.868 -1.145 . . . . 1.1100000000000001 108.89 179.867 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.65 -47.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 1.05 108.663 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.08 -35.48 80.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 1.0600000000000001 109.129 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -63.49 -46.46 86.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.862 . . . . 1.79 109.03 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.99 -38.42 90.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 2.2000000000000002 109.682 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.37 -6.19 56.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 1.0600000000000001 110.132 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 66' ' ' ALA . 65.3 mt-10 48.8 58.29 5.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.056 -1.027 . . . . 2.3399999999999999 110.192 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.6 t -79.27 135.25 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.114 -0.991 . . . . 1.05 109.089 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -127.36 -1.55 6.29 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.374 -0.829 . . . . 2.9300000000000002 110.063 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.482 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 125.15 8.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.999 -1.063 . . . . 1.0600000000000001 108.944 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.483 ' CG2' ' HH ' ' B' ' 5' ' ' TYR . 4.6 p -111.08 152.29 43.61 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.889 -0.782 . . . . 0.97999999999999998 108.889 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.12 143.15 74.53 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 C-N-CA 124.775 -0.927 . . . . 0.23999999999999999 109.948 -2.095 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.482 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -113.34 109.62 19.0 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.235 -1.024 . . . . 1.04 108.235 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -87.02 117.85 26.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.19 108.778 179.759 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -115.72 135.15 54.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.57 -1.27 . . . . 1.71 107.57 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -109.95 127.21 54.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.617 -0.677 . . . . 0.13 109.706 -178.05 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.47 157.98 35.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.457 -0.942 . . . . 0.22 108.457 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -155.0 123.81 6.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 2.0299999999999998 107.95 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.656 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 7.9 mtmp? 56.19 25.39 9.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.591 -0.693 . . . . 2.1600000000000001 109.228 -179.022 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 85.5 4.0 86.09 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.132 -1.187 . . . . 0.23000000000000001 110.132 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.558 HE21 ' C ' ' A' ' 83' ' ' GLY . 13.8 mm-40 -109.73 145.48 36.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.286 -1.126 . . . . 2.8100000000000001 110.137 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -86.8 141.21 29.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 2.2599999999999998 109.039 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.06 -20.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.486 -0.759 . . . . 1.05 110.323 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 173.15 45.55 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.386 -1.388 . . . . 0.25 110.53 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -174.05 151.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -1.047 . . . . 2.04 109.802 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.05 133.5 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.297 -0.877 . . . . 0.17999999999999999 110.149 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -103.56 -163.39 0.98 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.255 -0.903 . . . . 0.89000000000000001 108.967 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.91 131.61 2.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.361 -1.496 . . . . 0.14000000000000001 109.361 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -60.53 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -1.213 . . . . 1.0600000000000001 110.852 -179.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.29 78.32 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.772 -1.195 . . . . 1.98 107.772 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.409 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.04 -34.89 79.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 1.72 110.833 -178.494 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.8 -25.78 68.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.879 -1.138 . . . . 1.95 109.23 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -68.85 -37.45 79.14 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 2.5600000000000001 109.404 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.7 mt -52.46 -35.68 53.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.948 -1.095 . . . . 1.03 108.689 179.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.0 -58.79 4.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 2.1499999999999999 109.584 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.34 83.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 1.04 110.628 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.7 m -66.97 -44.81 79.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.049 -1.032 . . . . 1.04 109.938 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.7 mt -60.99 -52.56 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 1.05 109.128 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -60.8 -17.22 48.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 1.6599999999999999 109.407 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -77.66 -62.54 1.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 2.02 110.3 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.59 23.09 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 1.1399999999999999 110.617 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.996 -1.065 . . . . 1.1799999999999999 109.239 179.562 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -152.86 65.08 0.79 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.046 -1.034 . . . . 0.0 109.577 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.542 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.9 m-85 -123.87 162.16 23.86 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.624 -0.673 . . . . 0.0 109.244 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -150.25 -90.25 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.082 -1.011 . . . . 0.0 109.549 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.483 ' HH ' ' CG2' ' A' ' 74' ' ' THR . 4.9 p90 -121.61 -167.0 1.45 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.837 -1.164 . . . . 0.0 110.334 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.48 151.11 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 112.018 -177.292 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 m -101.78 95.42 6.4 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -83.43 45.85 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.937 -1.102 . . . . 0.0 109.966 -179.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.663 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.12 -134.68 0.07 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.983 -2.447 . . . . 0.0 106.983 178.155 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.76 24.39 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 CA-C-N 119.212 1.506 . . . . 0.0 108.441 178.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.663 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.6 t -81.73 -41.98 20.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.411 ' ND1' ' C ' ' B' ' 12' ' ' HIS . 0.3 OUTLIER -69.42 94.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.794 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.552 179.93 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.656 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.596 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.419 -0.585 . . . . 3.3799999999999999 109.419 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.8 t -94.76 168.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 1.1000000000000001 109.499 -179.874 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -153.36 119.36 5.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.16 -0.962 . . . . 2.5 108.726 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -86.72 139.79 30.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 1.6100000000000001 109.911 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mm -110.03 119.49 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.961 -1.126 . . . . 1.04 107.961 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 6.7 mp0 -105.4 -17.34 14.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -0.898 . . . . 1.97 109.705 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.7 p -151.74 161.39 42.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.035 -1.041 . . . . 0.92000000000000004 110.128 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -53.01 -32.14 44.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.736 . . . . 2.48 109.966 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -59.44 -43.69 93.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 1.05 109.98 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.0 64.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.855 . . . . 1.0600000000000001 109.943 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.69 -63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.25 110.04 -179.52 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 3.0699999999999998 109.638 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -58.7 -35.5 72.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.933 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.39 94.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 1.04 109.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.45 -44.02 97.42 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.853 . . . . 1.27 109.649 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.1 -38.36 90.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.851 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.62 -19.88 44.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 1.0900000000000001 109.646 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -2.9 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 1.0700000000000001 109.74 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 -136.34 32.39 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.211 -1.556 . . . . 0.31 109.211 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m-20 -116.6 5.65 13.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.38 -1.07 . . . . 2.21 109.621 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 88.0 mttt -70.18 170.92 10.62 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.206 -0.934 . . . . 2.4100000000000001 109.127 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.558 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.27 161.7 18.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.855 -1.165 . . . . 1.05 107.855 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.558 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 5.5 t -145.13 105.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.891 -1.131 . . . . 1.03 109.632 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.7 t -103.41 128.81 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.788 -0.819 . . . . 1.01 108.788 179.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.01 139.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.598 -0.689 . . . . 1.02 109.649 -178.909 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -109.54 98.42 7.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.293 -0.632 . . . . 0.95999999999999996 109.293 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.0 m-85 -83.42 83.43 7.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.568 -1.271 . . . . 0.32000000000000001 107.568 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 m -110.38 -163.28 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.514 0.673 . . . . 1.04 109.381 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.97 120.26 13.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.341 -0.985 . . . . 1.0600000000000001 108.341 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.0 t -63.57 -25.02 68.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 1.0600000000000001 110.934 -178.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 58.0 p-90 -89.27 -12.79 39.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.931 -1.106 . . . . 0.51000000000000001 110.093 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.6 134.33 39.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.34000000000000002 109.776 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' ' CD ' ' A' ' 34' ' ' PRO . . . -73.65 -55.5 5.97 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.809 -0.71 . . . . 0.40000000000000002 111.492 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' CD ' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -51.4 -32.83 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.663 1.575 . . . . 0.47999999999999998 111.085 -178.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -62.26 1.71 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.058 -1.026 . . . . 0.81000000000000005 108.905 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -59.72 -21.17 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.77 . . . . 2.46 110.03 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.9 ttm -59.61 -18.24 39.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.97 . . . . 3.6600000000000001 110.296 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.469 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 95.6 mt -99.45 7.57 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.951 . . . . 1.0700000000000001 110.722 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -32.2 3.52 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 118.429 -1.308 . . . . 2.1099999999999999 112.519 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_exo -61.22 -6.05 6.02 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 CA-C-N 119.979 1.028 . . . . 0.29999999999999999 109.706 -178.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.419 ' H ' ' C ' ' A' ' 39' ' ' LYS . 38.4 m-85 -110.82 -76.29 0.61 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.968 -0.753 . . . . 0.37 108.968 179.273 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -42.72 -56.99 2.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.531 -0.73 . . . . 0.14999999999999999 110.726 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.417 ' O ' ' OG ' ' A' ' 46' ' ' SER . 4.4 t60 -66.51 -31.79 72.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.007 -1.058 . . . . 0.47999999999999998 110.013 -179.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.6 t -64.33 -40.82 96.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.743 -1.223 . . . . 1.05 110.163 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.51 -14.31 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 1.1299999999999999 109.469 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.52 -38.0 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.078 -1.014 . . . . 0.93000000000000005 109.537 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -93.63 -12.23 29.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 2.0 110.054 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -51.67 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.029 -1.1 . . . . 2.6499999999999999 108.029 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.412 ' C ' ' H ' ' A' ' 51' ' ' ASN . 54.8 m-85 -107.34 75.72 1.04 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.545 -0.722 . . . . 0.89000000000000001 109.607 179.481 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.7 p -66.79 -3.68 7.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.93000000000000005 108.618 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.412 ' H ' ' C ' ' A' ' 49' ' ' TYR . 8.9 t-20 -95.77 -0.74 50.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.595 -0.69 . . . . 0.46999999999999997 109.372 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.28 147.07 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.362 0.601 . . . . 1.03 109.614 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.22 134.72 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 1.05 109.268 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -121.62 131.3 54.03 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.507 -0.745 . . . . 0.11 109.237 179.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 mp -112.89 172.71 6.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.282 -0.886 . . . . 1.04 108.777 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -142.79 138.7 30.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.149 -1.056 . . . . 1.3100000000000001 108.149 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.29 136.74 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.243 -0.91 . . . . 1.02 110.593 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.407 ' H ' ' H1 ' ' A' ' 107' ' ' HOH . 13.2 t70 -96.78 100.69 12.22 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.855 -1.165 . . . . 1.0800000000000001 107.855 178.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.18 -6.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 1.0600000000000001 110.885 -178.393 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.43 -42.31 5.49 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.123 -0.986 . . . . 1.1100000000000001 110.712 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -94.28 -12.43 28.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.094 -1.004 . . . . 1.1200000000000001 109.624 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.73 48.67 1.74 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.536 -0.913 . . . . 1.01 108.536 179.093 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.623 ' CG ' HH12 ' B' ' 4' ' ' ARG . 21.6 mt-30 -56.34 -16.47 5.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 2.7799999999999998 110.321 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -70.49 -39.59 74.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.015 -1.053 . . . . 1.1100000000000001 109.442 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.9 -46.03 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.153 -0.967 . . . . 1.05 108.679 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.357 -0.839 . . . . 1.0600000000000001 109.003 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 56.2 m -64.28 -46.8 82.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 1.79 109.155 179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -64.18 -38.09 89.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.761 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.54 -3.36 58.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 1.0600000000000001 109.777 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.75 59.18 4.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 2.3399999999999999 110.002 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 17.2 t -79.22 136.58 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.127 -0.983 . . . . 1.05 109.163 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -128.04 -4.35 5.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.431 -0.793 . . . . 2.9300000000000002 110.019 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 126.8 8.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.014 -1.054 . . . . 1.0600000000000001 109.322 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 12.6 p -110.76 151.66 43.01 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.746 -0.835 . . . . 0.97999999999999998 108.746 -179.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -76.58 142.77 74.07 Favored 'Cis proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.887 -0.88 . . . . 0.23999999999999999 110.076 -1.743 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.477 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.17 111.63 21.87 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.965 -1.124 . . . . 1.04 107.965 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -86.99 119.87 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.038 -1.065 . . . . 0.19 109.264 -179.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 41.4 mt-30 -117.05 135.71 53.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.575 -1.268 . . . . 1.71 107.575 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.425 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.9 m-85 -109.0 127.45 54.09 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.496 0.665 . . . . 0.13 109.816 -177.763 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -125.37 156.02 39.41 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.516 -0.92 . . . . 0.22 108.516 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -155.1 123.34 5.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.169 -1.048 . . . . 2.0299999999999998 108.169 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt 54.48 30.61 13.23 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.768 -0.773 . . . . 2.1600000000000001 110.012 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.94 90.52 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.074 -1.06 . . . . 0.23000000000000001 110.48 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -112.46 146.25 38.76 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.312 -1.111 . . . . 2.8100000000000001 110.036 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -86.18 143.63 27.89 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.361 -0.837 . . . . 2.2599999999999998 109.246 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.0 m -126.94 -19.51 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 1.05 110.449 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.58 178.07 47.67 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.305 -1.426 . . . . 0.25 110.524 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -174.11 154.11 2.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -1.061 . . . . 2.04 110.113 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.46 131.18 1.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.17999999999999999 110.171 178.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.521 ' HG ' ' N ' ' A' ' 91' ' ' GLY . 17.7 p -102.21 -162.35 0.92 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.246 -0.909 . . . . 0.89000000000000001 108.96 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.521 ' N ' ' HG ' ' A' ' 90' ' ' SER . . . 81.99 129.82 1.21 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.075 -1.61 . . . . 0.14000000000000001 109.075 -179.967 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.6 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -1.226 . . . . 1.0600000000000001 110.213 -179.201 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.23 67.33 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.888 -1.152 . . . . 1.98 107.888 178.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -58.13 -37.45 74.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.837 -0.539 . . . . 1.72 110.652 -178.797 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.97 -26.54 68.34 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.95 109.611 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -70.3 -33.39 71.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 2.5600000000000001 109.835 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 14.5 mt -53.19 -33.88 54.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.801 -1.187 . . . . 1.03 108.656 179.869 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -67.36 -55.6 13.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 2.1499999999999999 109.35 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.8 94.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 1.04 110.648 -179.356 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -65.49 -45.1 84.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.037 -1.039 . . . . 1.04 109.876 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.91 -53.23 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 1.05 108.838 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.44 -16.45 36.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 1.6599999999999999 109.593 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.76 -60.65 2.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 2.02 110.064 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.76 20.79 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 1.1399999999999999 110.16 -178.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.023 -1.048 . . . . 1.1799999999999999 109.317 179.598 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' B' ' 1' ' ' PHE . 11.4 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -115.02 68.26 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.343 -0.848 . . . . 0.0 108.894 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.3 m-85 -113.49 156.15 24.06 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.084 -1.01 . . . . 0.0 108.983 179.443 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.623 HH12 ' CG ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -150.23 -92.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 109.077 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.444 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.0 p90 -123.42 -167.2 1.57 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.916 -1.115 . . . . 0.0 110.233 179.431 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 148.98 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.831 0.825 . . . . 0.0 112.154 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -100.88 95.59 6.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.248 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -82.91 43.4 0.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.052 -178.761 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.59 -132.59 0.07 OUTLIER Glycine 0 N--CA 1.484 1.836 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.85 26.51 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 119.328 1.564 . . . . 0.0 109.161 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.8 t -90.72 -23.46 20.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.789 . . . . 0.0 109.502 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.16 131.31 41.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.985 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . 0.407 ' H1 ' ' H ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.451 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 mmm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.369 -0.604 . . . . 3.3799999999999999 109.369 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.422 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 71.2 t -94.68 168.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.26 -0.9 . . . . 1.1000000000000001 109.592 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.422 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 48.5 tttp -154.29 122.33 5.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.949 . . . . 2.5 109.199 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -88.99 139.0 30.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 1.6100000000000001 109.482 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.96 106.99 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.273 -1.01 . . . . 1.04 108.273 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -100.1 -6.81 25.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.017 -1.052 . . . . 1.97 109.616 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -152.61 152.08 31.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -0.968 . . . . 0.92000000000000004 109.601 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -52.04 -28.6 17.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 2.48 109.951 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -60.12 -45.13 94.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 1.05 110.241 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.74 64.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 1.0600000000000001 110.114 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.45 -69.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.25 110.197 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -55.73 -41.37 73.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 3.0699999999999998 109.808 -179.349 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.78 -38.55 78.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.223 -0.923 . . . . 2.1000000000000001 109.848 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.87 -46.06 92.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 1.04 109.305 179.975 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.38 -45.08 89.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.386 -0.821 . . . . 1.27 109.832 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.95 -40.37 96.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 1.0900000000000001 109.748 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -13.99 59.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 1.0900000000000001 109.734 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.425 ' C ' ' H1 ' ' A' ' 109' ' ' HOH . . . -68.56 -6.92 28.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 1.0700000000000001 109.809 -179.86 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.88 -111.96 4.14 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.409 . . . . 0.31 109.576 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -138.03 4.32 2.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.39 -1.064 . . . . 2.21 109.268 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -71.03 166.44 21.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 2.4100000000000001 109.153 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.57 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.02 161.37 13.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.15 -0.969 . . . . 1.05 108.688 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.0 t -144.0 106.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.856 -1.153 . . . . 1.03 109.489 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.96 132.64 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.108 -1.071 . . . . 1.01 108.108 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.26 139.37 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.548 -0.72 . . . . 1.02 110.002 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.449 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 10.8 t0 -109.33 101.89 10.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.929 -0.767 . . . . 0.95999999999999996 108.929 179.328 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -86.35 79.11 9.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.32000000000000001 107.708 179.299 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.449 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 57.9 m -113.45 149.56 34.06 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.324 0.583 . . . . 1.04 109.745 -179.153 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.23 128.48 38.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 1.0600000000000001 108.73 179.295 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.6 t -66.29 -25.17 66.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 1.0600000000000001 110.241 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 55.0 p-90 -87.98 -14.34 39.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.033 -1.042 . . . . 0.51000000000000001 109.958 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.37 125.88 40.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.34000000000000002 109.487 -179.198 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.61 -54.13 20.75 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.48 -0.762 . . . . 0.40000000000000002 111.437 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.51 -32.6 21.21 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.912 1.741 . . . . 0.47999999999999998 110.88 -178.186 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.02 -61.79 1.86 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.81000000000000005 109.057 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -59.8 -17.87 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.537 -0.727 . . . . 2.46 110.033 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.11 -25.75 61.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 3.6600000000000001 110.387 -178.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 90.8 mt -97.54 9.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.123 -0.985 . . . . 1.0700000000000001 110.819 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.93 -32.57 6.86 Favored Pre-proline 0 N--CA 1.484 1.264 0 O-C-N 120.425 -1.422 . . . . 2.1099999999999999 111.846 178.772 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.18 -5.24 7.62 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 119.7 0.929 . . . . 0.29999999999999999 110.102 -177.505 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -112.37 -71.59 0.75 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.957 -0.757 . . . . 0.37 108.957 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -45.69 -56.76 4.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.14999999999999999 110.457 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.59 -31.97 73.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.47999999999999998 110.044 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.453 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 7.0 m -64.18 -38.84 92.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 1.05 110.184 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.9 mt -51.39 -12.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 1.1299999999999999 109.547 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 44' ' ' SER . 67.1 m -57.92 -32.89 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.956 -1.09 . . . . 0.93000000000000005 109.625 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.37 -19.45 19.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.193 -0.942 . . . . 2.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.81 -22.16 21.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 2.6499999999999999 109.525 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -134.26 68.41 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.479 -0.763 . . . . 0.89000000000000001 109.292 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.4 p -67.28 -4.79 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.795 . . . . 0.93000000000000005 109.164 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.51 0.21 52.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.825 . . . . 0.46999999999999997 109.62 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.17 151.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.047 -0.723 . . . . 1.03 109.047 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -101.22 126.5 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 1.05 109.311 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -112.96 130.87 55.97 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.39 -0.819 . . . . 0.11 109.16 179.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 9.0 mp -115.17 173.77 6.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.459 -0.775 . . . . 1.04 109.055 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.29 141.1 28.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 76.9 t -137.17 139.44 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.2 -0.937 . . . . 1.02 110.443 -178.514 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HH21 ' B' ' 2' ' ' ARG . 7.1 t70 -99.57 108.07 20.38 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.3 m -68.33 -8.5 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.257 -0.902 . . . . 1.0600000000000001 111.23 -178.563 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.668 ' H ' ' H2 ' ' A' ' 108' ' ' HOH . 7.0 m-20 -104.6 -38.67 6.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 110.919 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -95.59 -17.67 21.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.058 . . . . 1.1200000000000001 110.131 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.25 1.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.509 -0.923 . . . . 1.01 108.509 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -54.26 -15.37 1.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.607 -0.683 . . . . 2.7799999999999998 110.237 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.4 -40.28 74.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.905 -1.122 . . . . 1.1100000000000001 109.53 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.09 -47.22 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -0.924 . . . . 1.05 108.729 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.55 -31.21 72.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 1.0600000000000001 109.352 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 15.1 m -63.79 -52.49 60.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 1.79 109.288 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.17 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 2.2000000000000002 109.466 179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.44 -2.69 58.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 1.0600000000000001 109.582 -179.892 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 67' ' ' SER . 21.3 mp0 43.98 52.09 6.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.825 . . . . 2.3399999999999999 110.083 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -77.99 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 1.05 108.944 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 83.8 mttt -125.58 5.79 7.55 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.531 -0.73 . . . . 2.9300000000000002 109.68 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 138.0 17.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.112 -0.993 . . . . 1.0600000000000001 108.806 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 65.0 p -123.88 149.7 60.38 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 108.865 -0.791 . . . . 0.97999999999999998 108.865 179.218 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.02 144.78 76.88 Favored 'Cis proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.959 -0.851 . . . . 0.23999999999999999 110.422 -1.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.21 114.74 26.41 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.576 -1.268 . . . . 1.04 107.576 178.31 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -90.2 123.93 34.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 0.19 108.747 179.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -121.87 136.52 54.93 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 1.71 107.676 -179.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.44 124.22 51.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.475 0.655 . . . . 0.13 109.426 -178.526 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -124.02 155.56 38.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.688 -0.856 . . . . 0.22 108.688 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -155.48 124.36 6.11 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 2.0299999999999998 107.42 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.579 ' H ' ' H2 ' ' A' ' 106' ' ' HOH . 70.9 mttt 57.96 25.4 12.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.623 . . . . 2.1600000000000001 109.821 -178.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 6.69 86.56 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.219 -1.152 . . . . 0.23000000000000001 110.219 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -114.47 147.93 38.58 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.357 -1.084 . . . . 2.8100000000000001 110.101 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -85.33 141.26 30.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 2.2599999999999998 109.162 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.31 -18.54 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.452 -0.78 . . . . 1.05 110.221 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 171.79 44.89 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.6 -1.286 . . . . 0.25 110.389 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -174.09 151.93 1.79 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.417 -1.049 . . . . 2.04 110.233 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.97 130.91 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.667 0.746 . . . . 0.17999999999999999 110.316 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -101.27 -162.16 0.91 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.035 -1.041 . . . . 0.89000000000000001 108.685 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.1 128.5 1.32 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.249 -1.541 . . . . 0.14000000000000001 109.249 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.87 97.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 1.0600000000000001 110.866 -179.157 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -141.06 77.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.984 -1.117 . . . . 1.98 107.984 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -64.76 -42.66 94.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.81 -0.556 . . . . 1.72 111.579 -178.414 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.81 -24.97 67.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.877 -1.139 . . . . 1.95 110.059 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -68.04 -34.48 76.55 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.052 -1.03 . . . . 2.5600000000000001 109.497 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 39.4 mt -52.08 -34.44 43.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.998 -1.063 . . . . 1.03 109.008 -179.939 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.31 -57.74 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.77 . . . . 2.1499999999999999 109.49 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.18 86.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 1.04 110.546 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 m -66.98 -45.32 78.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -0.942 . . . . 1.04 109.973 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.51 -52.89 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 1.05 108.79 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 23.5 t-20 -60.62 -16.93 43.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 1.6599999999999999 109.859 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.89 -55.99 5.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.895 . . . . 2.02 110.463 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -94.38 10.75 33.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.329 -0.857 . . . . 1.1399999999999999 110.872 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.269 179.721 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.1 t80 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.528 HH21 ' CG ' ' A' ' 58' ' ' ASP . 58.5 mtp180 -137.64 56.78 1.75 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.461 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 43.3 m-85 -106.4 158.38 16.93 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.412 -0.805 . . . . 0.0 109.402 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.585 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -149.83 -84.23 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.166 -0.959 . . . . 0.0 108.611 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.439 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 3.1 p90 -130.0 -176.11 3.83 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.354 -0.842 . . . . 0.0 110.18 179.446 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.38 146.23 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.964 0.888 . . . . 0.0 112.821 -176.99 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.01 95.78 6.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.15 45.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 110.188 -178.797 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.66 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.24 -132.63 0.1 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 177.959 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.47 22.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 CA-C-N 118.95 1.375 . . . . 0.0 109.065 178.62 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.66 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.1 t -84.82 -49.7 8.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.44 122.94 25.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.992 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . 0.579 ' H2 ' ' H ' ' A' ' 82' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.668 ' H2 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.425 ' H1 ' ' C ' ' A' ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.463 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 mmm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.423 -0.584 . . . . 3.3799999999999999 109.423 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG1' ' N ' ' A' ' 3' ' ' LYS . 85.3 t -94.58 165.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.212 -0.93 . . . . 1.1000000000000001 109.297 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.412 ' N ' ' CG1' ' A' ' 2' ' ' VAL . 24.2 tptp -155.02 125.55 6.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.268 -0.895 . . . . 2.5 109.09 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -90.73 135.45 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 1.6100000000000001 109.792 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -110.16 113.92 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.994 -1.113 . . . . 1.04 107.994 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -103.27 -13.05 16.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 1.97 109.657 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.5 p -152.9 156.99 40.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.92000000000000004 109.91 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.8 -32.62 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 2.48 110.163 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -58.95 -44.24 91.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.065 . . . . 1.05 109.492 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.41 64.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 1.0600000000000001 109.448 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.6 -70.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.25 109.996 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -42.56 71.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 3.0699999999999998 109.709 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -58.39 -37.76 75.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.022 -1.049 . . . . 2.1000000000000001 109.278 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.74 93.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 1.04 108.678 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.59 -40.47 97.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 1.27 109.332 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.87 -42.56 97.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 109.383 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.58 59.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 1.0900000000000001 109.533 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -6.33 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 1.0700000000000001 109.751 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.71 -115.47 6.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.31 109.515 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -136.11 4.88 3.0 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -1.072 . . . . 2.21 109.349 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.507 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 13.5 mttp -71.0 169.14 15.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.246 -0.909 . . . . 2.4100000000000001 109.163 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.591 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.26 162.43 14.74 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 1.05 108.088 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.591 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 18.7 t -144.73 109.01 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.826 -1.171 . . . . 1.03 109.397 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.29 132.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.533 -0.914 . . . . 1.01 108.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.75 131.34 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 1.02 109.557 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.76 107.51 18.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.95999999999999996 109.443 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.2 m-85 -88.72 81.36 7.04 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.116 -1.068 . . . . 0.32000000000000001 108.116 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -113.72 152.35 30.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.736 -0.602 . . . . 1.04 109.559 -179.548 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -92.72 123.16 35.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.721 -0.844 . . . . 1.0600000000000001 108.721 179.541 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.2 t -65.54 -20.87 66.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 1.0600000000000001 109.746 -179.632 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.6 p-90 -89.5 -18.15 27.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.231 -0.918 . . . . 0.51000000000000001 109.934 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.6 143.97 25.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.34000000000000002 110.029 -178.81 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.442 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -83.69 -57.23 2.47 Favored Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.684 -0.635 . . . . 0.40000000000000002 111.628 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.442 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.3 Cg_exo -47.47 -41.56 29.23 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.85 1.7 . . . . 0.47999999999999998 112.031 -177.686 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -58.61 3.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.816 -1.178 . . . . 0.81000000000000005 109.02 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.32 -18.58 39.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.553 -0.717 . . . . 2.46 110.232 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 36.8 ttm -59.43 -18.39 38.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 3.6600000000000001 110.309 -179.189 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.44 ' CG2' ' O ' ' A' ' 38' ' ' ILE . 67.8 mt -100.35 14.15 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.037 -1.039 . . . . 1.0700000000000001 111.276 -178.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.4 -34.95 12.41 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 117.957 -1.497 . . . . 2.1099999999999999 111.946 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -61.64 -14.81 37.96 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 CA-C-N 119.707 0.931 . . . . 0.29999999999999999 110.877 -175.215 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.8 -69.36 0.76 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.33 -0.856 . . . . 0.37 109.223 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -44.48 -51.55 8.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.618 -0.677 . . . . 0.14999999999999999 110.725 -179.054 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -67.57 -35.28 78.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.878 -1.139 . . . . 0.47999999999999998 109.585 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.431 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 3.2 m -60.32 -42.71 96.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.017 -1.052 . . . . 1.05 109.624 -179.33 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -52.26 -21.72 3.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 1.1299999999999999 109.563 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.5 m -57.3 -32.34 66.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.93000000000000005 109.592 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -94.82 -19.49 20.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.142 -0.974 . . . . 2.0 110.083 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -91.28 -20.82 21.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 2.6499999999999999 109.128 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.43 67.95 1.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.89000000000000001 109.085 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.2 p -67.01 -3.84 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.465 -0.772 . . . . 0.93000000000000005 109.243 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -94.43 -0.52 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.35 -0.844 . . . . 0.46999999999999997 109.475 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.06 149.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.539 -0.726 . . . . 1.03 109.189 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -100.43 128.84 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.225 -0.922 . . . . 1.05 109.058 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 84.5 m-85 -114.63 131.8 56.59 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.413 -0.804 . . . . 0.11 109.173 179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.5 mp -115.95 175.29 5.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.543 -0.723 . . . . 1.04 109.179 -179.288 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -144.07 144.94 31.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.417 -0.957 . . . . 1.3100000000000001 108.417 179.481 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.4 t -140.26 140.7 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.2 -0.938 . . . . 1.02 110.147 -178.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -99.44 100.46 11.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.615 -1.254 . . . . 1.0800000000000001 107.615 178.16 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.14 -12.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.858 . . . . 1.0600000000000001 111.217 -178.362 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -100.94 -42.81 6.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.85 -1.156 . . . . 1.1100000000000001 111.173 -178.708 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.419 ' CB ' HH21 ' B' ' 2' ' ' ARG . 2.5 t70 -93.1 -10.47 35.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.1200000000000001 109.569 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.63 2.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.511 -0.922 . . . . 1.01 108.511 179.366 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.407 ' O ' ' OG ' ' A' ' 67' ' ' SER . 41.7 mt-30 -55.82 -14.32 2.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 2.7799999999999998 109.87 -179.732 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 5.5 p30 -70.44 -40.93 73.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.121 -0.987 . . . . 1.1100000000000001 109.618 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.24 -46.22 45.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 1.05 108.699 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.03 73.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 1.0600000000000001 109.309 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 20.4 m -63.72 -52.35 60.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.79 109.53 -179.85 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.82 -34.31 77.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 2.2000000000000002 109.237 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.67 57.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.889 . . . . 1.0600000000000001 109.516 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 44.99 50.7 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 2.3399999999999999 109.911 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.12 129.85 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 1.05 109.445 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 67.9 mttm -129.93 8.86 5.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.502 -0.749 . . . . 2.9300000000000002 109.511 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.513 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.04 133.79 14.79 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 1.0600000000000001 108.274 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 33.8 p -120.38 150.05 51.03 Favored Pre-proline 0 N--CA 1.507 2.424 0 O-C-N 121.205 -0.934 . . . . 0.97999999999999998 108.96 179.422 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.72 147.27 83.75 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 O-C-N 122.714 0.849 . . . . 0.23999999999999999 110.539 -1.82 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.513 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.2 m -117.37 116.49 27.3 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.337 -1.357 . . . . 1.04 107.337 178.059 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -93.06 122.08 35.07 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.312 -0.955 . . . . 0.19 108.653 179.862 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.5 mt-30 -119.16 137.4 53.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.729 -1.212 . . . . 1.71 107.729 -179.738 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 26.3 m-85 -112.03 128.54 56.22 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.423 0.63 . . . . 0.13 110.04 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.09 159.85 32.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.851 -0.796 . . . . 0.22 108.851 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.11 122.81 5.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.748 -1.204 . . . . 2.0299999999999998 107.748 179.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 57.24 24.44 9.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.78 -0.575 . . . . 2.1600000000000001 110.301 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.4 5.0 76.3 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.354 -1.098 . . . . 0.23000000000000001 110.354 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -113.4 146.13 40.01 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.303 -1.116 . . . . 2.8100000000000001 110.236 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -85.98 145.07 27.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 2.2599999999999998 109.363 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -126.54 -15.4 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.51 -0.744 . . . . 1.05 109.762 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.14 -179.14 41.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.584 -1.294 . . . . 0.25 110.581 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.2 161.19 4.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.457 -1.025 . . . . 2.04 110.049 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -169.04 132.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.17999999999999999 110.218 178.755 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 p -104.58 -170.05 1.71 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.225 -0.922 . . . . 0.89000000000000001 108.759 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 93.97 121.37 3.31 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.536 -1.426 . . . . 0.14000000000000001 109.536 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -51.44 91.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -1.146 . . . . 1.0600000000000001 110.432 -179.372 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' GLY . 13.6 t-20 -140.04 78.07 1.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.119 -1.067 . . . . 1.98 108.119 178.605 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.444 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.91 -34.7 78.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.696 -0.627 . . . . 1.72 110.608 -178.861 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.7 -26.07 67.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.816 -1.177 . . . . 1.95 109.187 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.66 -35.41 78.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.425 -0.797 . . . . 2.5600000000000001 109.124 179.548 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 44.6 mt -51.87 -37.69 53.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 1.03 108.783 179.758 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.37 -57.6 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 2.1499999999999999 109.896 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.64 83.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 1.04 110.477 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -67.76 -45.22 75.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.074 -1.016 . . . . 1.04 110.29 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.22 -52.56 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.934 . . . . 1.05 109.331 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.26 -17.9 45.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 1.6599999999999999 109.674 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.01 -59.41 2.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.871 . . . . 2.02 110.476 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -93.69 18.96 9.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.348 -0.845 . . . . 1.1399999999999999 110.794 -178.123 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.494 1.728 0 O-C-N 120.941 -1.099 . . . . 1.1799999999999999 109.303 179.25 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 22.8 mtp180 -141.39 52.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 0.0 109.006 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.531 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.6 m-85 -103.8 156.23 17.98 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.218 -0.927 . . . . 0.0 109.972 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -150.75 -101.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.449 ' CD2' ' C ' ' A' ' 72' ' ' LYS . 3.0 p90 -109.5 -174.59 2.54 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.176 -0.953 . . . . 0.0 110.796 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.1 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 122.191 0.996 . . . . 0.0 112.851 -176.935 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 61.3 m -101.05 93.75 5.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.521 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -84.1 44.42 1.01 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.102 -0.999 . . . . 0.0 110.904 -178.645 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.668 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.68 -129.98 0.07 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.69 19.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.871 0 CA-C-N 119.447 1.623 . . . . 0.0 109.799 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.668 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t -82.13 -3.24 54.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.532 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 36.9 t-80 -160.2 177.17 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.532 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.385 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.511 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.507 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' SD ' ' A' ' 1' ' ' MET . 2.7 ppp? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.347 0.594 . . . . 3.3799999999999999 109.458 . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.437 ' CG1' ' H ' ' A' ' 3' ' ' LYS . 44.7 t -96.91 173.23 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.264 -0.898 . . . . 1.1000000000000001 109.512 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . 0.437 ' H ' ' CG1' ' A' ' 2' ' ' VAL . 44.7 tptt -153.72 122.84 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -0.93 . . . . 2.5 109.116 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -90.05 129.4 36.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 1.6100000000000001 109.462 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -102.05 120.15 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.291 -1.374 . . . . 1.04 107.291 178.897 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.62 -16.76 14.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.197 -0.939 . . . . 1.97 109.949 -179.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.8 p -152.47 160.15 43.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.056 -1.027 . . . . 0.92000000000000004 109.801 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 35.0 tttp -52.09 -31.39 30.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.439 -0.788 . . . . 2.48 109.639 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -59.96 -47.25 86.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 1.05 110.093 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.72 -27.0 65.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 1.0600000000000001 109.662 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.17 -68.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.25 109.838 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -53.53 -44.44 69.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 3.0699999999999998 109.749 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -58.19 -37.0 73.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 2.1000000000000001 109.619 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.77 92.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 1.04 109.094 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.5 -44.95 89.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.458 -0.776 . . . . 1.27 109.781 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.415 ' C ' ' H1 ' ' A' ' 110' ' ' HOH . 26.0 t0 -62.71 -41.28 99.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 1.0900000000000001 109.686 -179.614 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -13.6 59.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.467 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -5.71 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 1.0700000000000001 109.722 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 68.23 -114.1 5.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.513 -1.435 . . . . 0.31 109.513 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.563 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 81.2 m-20 -136.55 4.07 2.83 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.265 -1.138 . . . . 2.21 109.447 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.617 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 80.5 mttt -69.65 170.09 11.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.072 -1.017 . . . . 2.4100000000000001 108.94 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.547 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.43 163.12 13.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.172 -1.047 . . . . 1.05 108.172 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.547 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 11.3 t -145.42 104.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.825 -1.172 . . . . 1.03 109.359 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.7 t -101.61 130.41 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 1.01 108.882 179.713 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.37 133.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 1.02 109.644 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -107.04 102.98 12.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.585 -0.697 . . . . 0.95999999999999996 109.448 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -84.87 82.69 8.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.758 -1.201 . . . . 0.32000000000000001 107.758 179.099 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.68 148.62 36.01 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.594 -0.692 . . . . 1.04 109.89 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.89 122.74 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.267 -1.012 . . . . 1.0600000000000001 108.267 178.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -64.95 -22.33 66.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 1.0600000000000001 110.414 -178.978 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.604 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 55.5 p-90 -90.34 -14.2 33.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.13 -0.981 . . . . 0.51000000000000001 110.054 -179.4 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.23 128.56 40.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.34000000000000002 110.04 -178.591 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.406 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.06 -59.33 7.57 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.894 -0.67 . . . . 0.40000000000000002 111.595 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.5 Cg_exo -46.11 -37.7 18.28 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.805 1.67 . . . . 0.47999999999999998 111.941 -178.169 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.4 -55.6 5.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.714 -1.241 . . . . 0.81000000000000005 108.756 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -60.6 -21.73 62.97 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.655 -0.653 . . . . 2.46 110.045 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.9 tpp -61.44 -18.52 59.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 3.6600000000000001 110.379 -179.324 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.1 mt -99.56 15.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.097 -1.002 . . . . 1.0700000000000001 110.765 -178.457 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.77 -33.41 3.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.163 -1.586 . . . . 2.1099999999999999 112.452 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -63.14 -3.59 5.13 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.509 0.86 . . . . 0.29999999999999999 110.302 -176.708 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.456 ' O ' ' OG ' ' A' ' 44' ' ' SER . 49.0 m-85 -110.46 -79.83 0.58 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.45 -0.781 . . . . 0.37 109.08 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 87.6 t80 -40.9 -54.57 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.14999999999999999 111.024 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -66.86 -36.83 83.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.842 -1.162 . . . . 0.47999999999999998 110.064 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 81.8 p -61.34 -38.37 86.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.753 -1.217 . . . . 1.05 110.041 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.88 -14.3 0.37 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 1.1299999999999999 109.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.417 ' N ' ' C ' ' A' ' 44' ' ' SER . 37.1 m -57.76 -36.5 72.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.176 -0.953 . . . . 0.93000000000000005 109.636 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -94.35 -16.42 23.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.21 -0.931 . . . . 2.0 110.166 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.33 -22.83 20.33 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.003 -1.06 . . . . 2.6499999999999999 109.331 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -135.34 66.66 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.415 -0.803 . . . . 0.89000000000000001 109.151 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 p -66.64 -3.03 5.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.337 -0.852 . . . . 0.93000000000000005 109.038 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.95 -2.27 53.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.46999999999999997 109.263 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.64 148.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.055 -0.72 . . . . 1.03 109.055 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.5 125.26 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.414 -0.804 . . . . 1.05 109.338 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 75.4 m-85 -111.21 129.07 56.07 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.355 -0.841 . . . . 0.11 109.365 179.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.3 173.73 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.444 -0.785 . . . . 1.04 109.078 -179.934 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.79 147.94 33.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.307 -0.998 . . . . 1.3100000000000001 108.307 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 11.0 t -141.74 142.68 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.044 -1.035 . . . . 1.02 110.451 -178.799 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.502 ' C ' ' H ' ' A' ' 60' ' ' ASP . 10.1 t70 -98.78 90.94 4.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.969 -1.123 . . . . 1.0800000000000001 107.969 178.564 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -52.59 -3.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 1.0600000000000001 111.624 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.65 ' H ' ' H1 ' ' A' ' 108' ' ' HOH . 30.3 m-20 -110.04 -40.66 4.67 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.034 -1.041 . . . . 1.1100000000000001 110.982 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.61 -19.17 19.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.05 -1.031 . . . . 1.1200000000000001 109.816 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.89 45.52 1.33 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.349 -0.844 . . . . 1.01 108.74 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -53.25 -13.46 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 2.7799999999999998 109.852 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.9 p-10 -71.13 -41.44 70.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 1.1100000000000001 109.459 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -74.08 -45.37 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.181 -0.949 . . . . 1.05 108.802 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -34.14 76.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 1.0600000000000001 108.688 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -64.59 -46.13 84.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 1.79 109.075 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -63.65 -38.48 91.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.349 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.0 58.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.909 . . . . 1.0600000000000001 109.874 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 49.6 59.19 4.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 109.743 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 19.5 t -79.13 137.44 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 1.05 109.489 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -130.4 -1.77 4.42 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.452 -0.78 . . . . 2.9300000000000002 109.791 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.455 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.42 127.31 9.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.022 -1.049 . . . . 1.0600000000000001 109.1 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 3.3 p -111.04 152.02 43.41 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 108.654 -0.869 . . . . 0.97999999999999998 108.654 -179.994 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.39 143.98 76.26 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 C-N-CA 124.75 -0.938 . . . . 0.23999999999999999 109.935 -1.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 117.94 32.27 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.666 -0.865 . . . . 1.04 108.666 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -93.26 122.68 35.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.19 108.886 179.368 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -120.19 133.09 55.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.804 -1.184 . . . . 1.71 107.804 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -108.64 126.56 53.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.13 109.716 -178.066 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -124.05 158.79 31.36 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.512 -0.921 . . . . 0.22 108.512 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -154.93 123.46 6.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.753 -1.203 . . . . 2.0299999999999998 107.753 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.583 ' NZ ' ' NE2' ' A' ' 84' ' ' GLN . 7.3 mtmp? 56.01 27.33 11.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.527 -0.733 . . . . 2.1600000000000001 109.882 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.3 87.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.165 -1.017 . . . . 0.23000000000000001 110.625 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.583 ' NE2' ' NZ ' ' A' ' 82' ' ' LYS . 35.6 mt-30 -109.98 147.48 33.41 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.329 -1.1 . . . . 2.8100000000000001 110.191 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -86.03 142.46 28.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.868 . . . . 2.2599999999999998 109.124 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.35 -17.25 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.528 -0.732 . . . . 1.05 110.358 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 176.14 174.24 42.49 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.455 -1.355 . . . . 0.25 110.351 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -172.9 155.49 3.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.388 -1.066 . . . . 2.04 109.937 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.5 p90 -168.41 133.55 1.73 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.303 -0.873 . . . . 0.17999999999999999 110.342 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -104.07 -171.02 1.86 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.198 -0.939 . . . . 0.89000000000000001 109.03 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.93 5.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.14000000000000001 109.522 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -57.89 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -1.117 . . . . 1.0600000000000001 110.424 -179.537 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -139.94 77.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.665 -1.235 . . . . 1.98 107.665 178.203 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.422 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.97 -33.95 76.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 1.72 110.687 -178.525 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -25.61 68.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.012 -1.055 . . . . 1.95 109.148 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -69.07 -37.6 78.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.328 -0.858 . . . . 2.5600000000000001 109.333 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 13.8 mt -54.19 -35.6 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 1.03 108.634 179.871 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -66.1 -58.89 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 2.1499999999999999 109.461 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.0 90.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 1.04 110.494 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 m -65.25 -46.76 79.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.194 -0.941 . . . . 1.04 109.971 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.95 -52.32 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.183 -0.948 . . . . 1.05 108.88 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -61.4 -16.48 46.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 1.6599999999999999 109.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.9 -60.13 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 2.02 109.91 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.3 mt -91.69 20.57 5.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.716 . . . . 1.1399999999999999 110.28 -178.891 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 1.1799999999999999 109.247 179.782 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.9 p90 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.557 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.8 mtt-85 -152.92 78.99 1.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -0.977 . . . . 0.0 109.215 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.604 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.8 m-85 -126.2 148.05 49.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.385 -0.822 . . . . 0.0 108.876 179.435 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.588 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.36 -86.17 0.11 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 -179.771 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.422 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 3.3 p90 -125.13 -170.82 2.23 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.062 -1.024 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -72.33 150.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.78 0.8 . . . . 0.0 112.148 -177.431 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.0 m -101.15 94.23 5.86 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.72 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -83.15 44.71 0.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 110.214 -178.915 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.6 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.95 -131.21 0.15 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 177.764 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -69.64 30.37 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 119.315 1.557 . . . . 0.0 109.215 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.6 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.5 t -94.23 -23.83 17.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.615 ' HD1' ' N ' ' B' ' 13' ' ' GLY . 10.2 t-80 60.81 139.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.469 -0.769 . . . . 0.0 109.551 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.615 ' N ' ' HD1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.65 ' H1 ' ' H ' ' A' ' 60' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.617 ' H1 ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . 0.415 ' H1 ' ' C ' ' A' ' 16' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.43 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' N ' ' SD ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.346 -0.613 . . . . 3.3799999999999999 109.346 . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 58.8 t -94.56 159.89 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 1.1000000000000001 109.432 -179.897 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 43.0 tptt -155.56 122.29 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 2.5 109.26 179.973 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.81 134.11 34.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.353 -0.842 . . . . 1.6100000000000001 108.992 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.92 108.6 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.363 -0.977 . . . . 1.04 108.363 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.24 -11.21 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 1.97 109.308 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -152.57 153.05 32.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.92000000000000004 109.462 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -52.39 -25.59 10.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.455 -0.778 . . . . 2.48 109.812 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -60.2 -47.34 86.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 1.05 109.797 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -26.21 64.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 1.0600000000000001 109.644 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -59.7 -68.73 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.25 109.821 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.38 -41.39 72.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 3.0699999999999998 109.849 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.0 -38.86 80.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.085 -1.009 . . . . 2.1000000000000001 109.601 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.28 95.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 1.04 109.497 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.66 -46.66 84.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 1.27 110.117 -179.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.23 -43.21 95.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.997 . . . . 1.0900000000000001 109.815 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 -12.8 59.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 1.0900000000000001 109.917 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -8.55 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 1.0700000000000001 109.551 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.99 -117.05 6.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.669 -1.373 . . . . 0.31 109.669 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.467 ' N ' ' H1 ' ' A' ' 109' ' ' HOH . 8.0 t0 -133.74 4.2 3.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.318 -1.107 . . . . 2.21 109.113 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -68.57 165.6 18.84 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.921 -1.112 . . . . 2.4100000000000001 108.711 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' CD2' ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.69 157.84 23.07 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.315 -0.994 . . . . 1.05 108.315 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.459 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 9.3 t -141.98 107.1 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 1.03 109.329 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.62 133.68 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.582 -0.895 . . . . 1.01 108.582 179.237 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.21 133.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 1.02 109.529 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -104.88 102.26 11.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.609 -0.682 . . . . 0.95999999999999996 109.202 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.8 m-85 -86.57 78.96 9.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.805 -1.183 . . . . 0.32000000000000001 107.805 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -106.72 -164.47 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.532 0.682 . . . . 1.04 109.462 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.28 122.74 14.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.412 -0.959 . . . . 1.0600000000000001 108.412 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -63.66 -25.11 68.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.76 . . . . 1.0600000000000001 110.446 -178.154 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 45.8 p-90 -88.33 -15.5 35.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 0.51000000000000001 110.011 -179.203 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.74 129.08 43.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -0.908 . . . . 0.34000000000000002 109.813 -179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.548 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.89 -54.03 8.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 111.205 -0.758 . . . . 0.40000000000000002 111.205 -178.869 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.6 Cg_exo -48.54 -34.31 25.99 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.823 1.682 . . . . 0.47999999999999998 111.156 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -58.79 3.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.81000000000000005 109.16 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.8 -21.14 55.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 2.46 109.785 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.484 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.7 tmt? -58.2 -21.23 46.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 3.6600000000000001 109.946 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.3 mt -97.08 2.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.252 -0.905 . . . . 1.0700000000000001 110.224 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.16 -34.72 18.72 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 118.431 -1.308 . . . . 2.1099999999999999 111.084 -179.483 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.5 Cg_endo -63.78 -5.96 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.691 0.926 . . . . 0.29999999999999999 110.561 -177.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.434 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 41.9 m-85 -111.1 -73.43 0.68 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.848 -0.797 . . . . 0.37 108.848 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.48 -56.81 4.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.704 -0.623 . . . . 0.14999999999999999 110.471 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.9 -31.9 72.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.47999999999999998 110.083 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.443 ' C ' ' H ' ' A' ' 46' ' ' SER . 3.5 t -63.99 -39.72 94.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.014 -1.054 . . . . 1.05 110.092 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 83.2 mt -50.74 -12.98 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.035 -1.04 . . . . 1.1299999999999999 109.782 -179.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.443 ' H ' ' C ' ' A' ' 44' ' ' SER . 16.4 m -57.78 -36.78 72.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.93000000000000005 109.636 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -93.85 -17.16 23.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.864 . . . . 2.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -90.65 -23.42 20.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 2.6499999999999999 109.117 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.11 71.8 1.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.696 . . . . 0.89000000000000001 109.125 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -66.84 -3.32 6.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.93000000000000005 108.988 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.7 t-20 -95.74 -0.07 51.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.516 -0.74 . . . . 0.46999999999999997 109.514 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.53 148.66 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.239 -0.913 . . . . 1.03 109.6 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -101.07 123.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.882 -0.784 . . . . 1.05 108.882 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -112.18 132.26 55.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.244 -0.91 . . . . 0.11 109.655 -179.563 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.415 ' N ' ' CD1' ' A' ' 55' ' ' LEU . 7.9 mp -114.29 172.08 7.23 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.772 -0.825 . . . . 1.04 108.772 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.23 140.77 29.47 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.345 -0.983 . . . . 1.3100000000000001 108.345 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -139.25 138.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.138 -0.976 . . . . 1.02 110.193 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.4 ' CG ' ' H1 ' ' A' ' 108' ' ' HOH . 7.4 t70 -98.47 108.68 21.43 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.635 -1.246 . . . . 1.0800000000000001 107.635 177.441 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.14 -10.59 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 1.0600000000000001 111.107 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 10.1 m-20 -103.71 -40.34 6.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 110.756 -178.686 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -93.88 -14.39 26.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.1200000000000001 109.563 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.36 49.28 1.92 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.79 -0.818 . . . . 1.01 108.79 178.72 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.4 ' O ' ' OG ' ' A' ' 67' ' ' SER . 5.6 pt20 -55.95 -11.24 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.432 -0.792 . . . . 2.7799999999999998 110.19 -179.316 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.924 -1.11 . . . . 1.1100000000000001 109.546 -179.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.2 -46.34 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 1.05 108.886 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.85 70.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.822 . . . . 1.0600000000000001 109.258 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 20.1 m -64.21 -58.29 7.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 1.79 109.48 -179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -62.67 -29.82 70.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 2.2000000000000002 109.537 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.402 ' HB2' HE22 ' A' ' 78' ' ' GLN . . . -88.18 -5.78 58.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.159 -0.963 . . . . 1.0600000000000001 109.544 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 43.58 52.84 6.05 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -0.756 . . . . 2.3399999999999999 110.328 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 17.8 t -77.76 134.79 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 1.05 109.156 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.66 -0.39 8.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.411 -0.806 . . . . 2.9300000000000002 110.194 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.01 133.93 15.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.063 -1.023 . . . . 1.0600000000000001 109.261 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 21.8 p -118.25 150.75 48.27 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.311 -0.868 . . . . 0.97999999999999998 108.934 179.96 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -76.13 145.16 81.69 Favored 'Cis proline' 0 C--N 1.319 -0.995 0 C-N-CA 124.555 -1.019 . . . . 0.23999999999999999 110.131 -1.849 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.48 116.51 28.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.693 -1.225 . . . . 1.04 107.693 178.018 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -93.66 116.03 28.51 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.363 -0.935 . . . . 0.19 108.603 179.773 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 31.8 mt-30 -116.18 139.95 49.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.163 -1.421 . . . . 1.71 107.163 179.321 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.06 132.22 54.36 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.719 . . . . 0.13 109.856 -176.938 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -126.93 154.94 43.84 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.327 -0.99 . . . . 0.22 108.327 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 tttp -157.02 123.26 4.9 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.632 -1.247 . . . . 2.0299999999999998 107.632 -179.642 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mttp 59.23 25.61 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 2.1600000000000001 110.319 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.85 88.98 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.758 -1.337 . . . . 0.23000000000000001 109.758 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -113.35 147.46 37.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.293 -1.121 . . . . 2.8100000000000001 109.701 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -86.38 141.93 28.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 2.2599999999999998 109.175 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 27.9 m -118.23 -39.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.408 -0.808 . . . . 1.05 110.091 -178.927 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -165.07 -176.99 37.23 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.911 -1.276 . . . . 0.25 109.911 -179.793 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.2 pm0 -172.4 156.28 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 2.04 110.147 -179.537 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.3 p90 -169.05 132.26 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.17999999999999999 109.385 178.355 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 p -103.31 -161.23 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.89000000000000001 108.743 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.05 137.67 2.56 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.492 -1.443 . . . . 0.14000000000000001 109.492 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -65.89 92.21 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.25 -1.147 . . . . 1.0600000000000001 110.577 -179.262 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.66 74.82 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.888 -1.153 . . . . 1.98 107.888 177.881 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.73 -34.16 76.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 1.72 110.495 -177.946 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.5 -26.43 68.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -67.94 -38.41 82.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 2.5600000000000001 109.428 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 19.7 mt -51.96 -37.68 53.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.958 . . . . 1.03 108.833 179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.97 -58.29 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 2.1499999999999999 109.31 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.95 86.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.407 -0.808 . . . . 1.04 110.416 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -67.62 -45.55 75.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.219 -0.925 . . . . 1.04 110.042 -178.767 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.08 -51.11 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.106 -0.996 . . . . 1.05 108.882 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -61.53 -17.03 53.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 1.6599999999999999 109.488 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.3 -58.98 2.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 2.02 109.65 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.78 20.96 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.423 -0.798 . . . . 1.1399999999999999 110.352 -178.576 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 1.1799999999999999 109.209 179.373 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 50.6 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.58 ' CB ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -144.92 75.17 1.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.104 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.478 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.5 m-85 -124.34 119.82 30.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.275 -0.891 . . . . 0.0 108.926 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.56 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -108.13 -86.13 0.51 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 -178.879 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -128.76 -167.64 1.8 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 110.208 179.65 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.16 146.79 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 111.934 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.88 97.11 7.75 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -83.39 45.45 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.749 -179.172 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.676 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.68 -130.05 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 177.655 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.81 17.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 118.64 1.22 . . . . 0.0 109.784 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.676 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.2 t -79.32 -30.61 42.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.515 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 14.8 t60 -68.19 171.37 7.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.407 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.515 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . 0.4 ' H1 ' ' CG ' ' A' ' 58' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.467 ' H1 ' ' N ' ' A' ' 20' ' ' ASP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.063 -0.717 . . . . 3.3799999999999999 109.063 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.57 151.85 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.17 -0.956 . . . . 1.1000000000000001 109.802 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -154.39 118.78 4.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.314 -0.866 . . . . 2.5 108.921 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -88.76 135.78 33.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 1.6100000000000001 109.829 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -106.69 113.06 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.615 -1.254 . . . . 1.04 107.615 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -100.07 -11.01 20.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.282 -0.886 . . . . 1.97 109.786 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 p -154.59 158.02 39.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.065 -1.022 . . . . 0.92000000000000004 109.987 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 43.0 tttm -52.33 -23.78 6.44 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 2.48 109.697 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -61.95 -51.03 69.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.012 . . . . 1.05 110.293 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.99 -21.67 64.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 1.0600000000000001 109.952 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.88 -64.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.99 -1.069 . . . . 0.25 109.714 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.62 -46.79 77.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 3.0699999999999998 109.799 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.28 -34.82 70.94 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.273 -0.892 . . . . 2.1000000000000001 110.142 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.62 -45.93 91.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 1.04 109.624 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.9 -51.76 60.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.54 -0.725 . . . . 1.27 109.646 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.28 -35.99 80.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 109.511 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.63 -16.08 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 1.0900000000000001 109.458 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.421 ' CB ' ' H2 ' ' A' ' 109' ' ' HOH . . . -68.46 -20.64 64.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.158 -0.964 . . . . 1.0700000000000001 109.469 179.947 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.45 -107.72 2.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.707 -1.357 . . . . 0.31 109.707 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.1 -2.2 1.88 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -1.039 . . . . 2.21 109.553 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -67.33 168.06 11.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.903 -1.123 . . . . 2.4100000000000001 108.817 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.609 ' H ' ' H2 ' ' A' ' 111' ' ' HOH . 0.4 OUTLIER -64.41 163.44 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.077 -1.083 . . . . 1.05 108.077 -179.987 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' H ' ' CD2' ' A' ' 22' ' ' LEU . 6.4 t -144.39 103.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.869 -1.145 . . . . 1.03 109.648 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 5.7 t -102.9 130.87 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.78 -0.822 . . . . 1.01 108.78 179.348 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.76 135.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 1.02 109.608 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.8 101.64 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.783 -0.821 . . . . 0.95999999999999996 108.783 179.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -84.32 80.74 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.884 -1.154 . . . . 0.32000000000000001 107.884 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.0 m -113.7 152.22 30.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.767 -0.583 . . . . 1.04 109.601 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.61 127.13 41.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 1.0600000000000001 109.275 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -67.11 -25.61 66.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.823 . . . . 1.0600000000000001 110.64 -179.294 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 53.7 p-90 -87.45 -14.83 39.43 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.957 -1.09 . . . . 0.51000000000000001 109.927 -179.298 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 t -93.34 130.92 38.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.34000000000000002 110.018 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.413 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -68.9 -59.24 6.1 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.875 -0.678 . . . . 0.40000000000000002 111.48 -179.338 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -48.86 -35.91 32.4 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.795 1.663 . . . . 0.47999999999999998 111.547 -178.206 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.92 -61.33 2.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.81000000000000005 108.936 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -59.55 -20.27 54.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.561 -0.712 . . . . 2.46 109.986 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.1 ttt -62.09 -19.09 62.6 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.206 -0.934 . . . . 3.6600000000000001 110.341 -179.17 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.4 mt -100.28 11.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.197 -0.94 . . . . 1.0700000000000001 110.269 -179.076 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 4.5 ptmm? -71.42 -27.24 1.0 Allowed Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 120.212 -1.555 . . . . 2.1099999999999999 111.844 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.4 Cg_exo -65.23 -4.39 9.12 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 120.641 1.265 . . . . 0.29999999999999999 109.452 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . 0.44 ' O ' ' OG ' ' A' ' 44' ' ' SER . 37.5 m-85 -107.68 -79.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.693 -0.855 . . . . 0.37 108.693 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.6 t80 -40.19 -58.13 1.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 0.14999999999999999 111.206 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.39 -33.59 76.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 0.47999999999999998 110.322 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 41' ' ' PHE . 80.5 p -66.33 -36.81 83.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.633 -1.292 . . . . 1.05 110.409 179.65 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.5 mt -50.52 -19.84 0.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.928 -1.107 . . . . 1.1299999999999999 109.535 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 m -56.94 -21.73 32.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.966 -1.083 . . . . 0.93000000000000005 109.977 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -97.22 -26.88 14.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.137 -0.977 . . . . 2.0 110.052 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -90.32 -18.61 25.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.046 -1.034 . . . . 2.6499999999999999 109.412 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' TYR . . . . . 0.406 ' C ' ' H ' ' A' ' 51' ' ' ASN . 39.0 m-85 -133.35 62.44 1.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.528 -0.732 . . . . 0.89000000000000001 109.247 -179.998 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 p -66.72 -3.01 5.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.364 -0.835 . . . . 0.93000000000000005 108.91 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 49' ' ' TYR . 25.4 t-20 -95.59 1.11 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.418 -0.801 . . . . 0.46999999999999997 109.446 179.899 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.73 150.62 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.274 -0.639 . . . . 1.03 109.274 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.6 mm -98.89 123.49 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.426 -0.796 . . . . 1.05 109.078 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -111.24 132.87 54.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.357 -0.839 . . . . 0.11 109.141 179.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.9 mp -114.06 167.3 10.78 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.641 -0.874 . . . . 1.04 108.641 179.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.61 133.97 29.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.353 -1.351 . . . . 1.3100000000000001 107.353 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.3 t -132.32 141.43 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.264 -0.897 . . . . 1.02 110.745 -177.862 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.56 101.35 12.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.422 -0.955 . . . . 1.0800000000000001 108.422 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.4 m -61.42 -4.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 1.0600000000000001 111.197 -178.884 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.502 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 38.3 m-20 -107.58 -41.97 4.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.253 -0.905 . . . . 1.1100000000000001 110.554 -178.663 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.11 -21.8 18.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.348 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.73 43.31 1.35 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.477 -0.935 . . . . 1.01 108.477 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.434 ' NE2' HH12 ' B' ' 4' ' ' ARG . 2.5 pt20 -53.81 -13.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.529 -0.732 . . . . 2.7799999999999998 110.015 -179.426 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.43 -42.12 71.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 108.981 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.89 -46.02 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.711 -0.848 . . . . 1.05 108.711 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.38 -34.0 76.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 1.0600000000000001 108.989 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 22.4 m -63.63 -48.21 78.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 1.79 108.962 179.748 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.94 -36.49 84.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.573 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.34 -7.71 54.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.232 -0.917 . . . . 1.0600000000000001 109.648 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' ALA . 39.4 mt-10 47.72 62.97 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.323 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 t -79.0 137.75 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 1.05 108.918 179.12 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -125.26 -4.48 7.34 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.407 -0.808 . . . . 2.9300000000000002 110.085 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.453 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.55 126.55 9.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.91 -1.119 . . . . 1.0600000000000001 109.349 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 6.8 p -110.07 151.87 42.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.54 -0.911 . . . . 0.97999999999999998 108.54 -179.707 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -77.34 143.34 74.56 Favored 'Cis proline' 0 N--CA 1.483 0.875 0 C-N-CA 124.858 -0.892 . . . . 0.23999999999999999 109.926 -1.982 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.58 114.7 26.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.421 -0.955 . . . . 1.04 108.421 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -89.08 125.57 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.864 -1.147 . . . . 0.19 108.833 179.551 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -122.84 132.23 54.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.825 -1.176 . . . . 1.71 107.825 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.429 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.7 m-85 -107.09 129.82 54.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.13 109.911 -178.213 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.61 157.29 42.49 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.22 108.71 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -155.11 127.01 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.265 . . . . 2.0299999999999998 107.586 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 56.0 18.97 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 2.1600000000000001 109.847 -178.808 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.65 3.08 69.12 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 120.836 -1.165 . . . . 0.23000000000000001 110.447 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.68 147.23 34.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.356 -1.085 . . . . 2.8100000000000001 109.822 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -85.51 144.86 27.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.335 -0.853 . . . . 2.2599999999999998 109.384 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.65 -23.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.461 -0.775 . . . . 1.05 110.264 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.22 174.91 46.61 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.483 -1.342 . . . . 0.25 110.509 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.79 153.41 2.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -1.107 . . . . 2.04 110.094 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.74 132.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.17999999999999999 110.46 179.079 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -103.37 -169.17 1.61 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.19 -0.944 . . . . 0.89000000000000001 109.321 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.66 129.85 3.89 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.858 -1.297 . . . . 0.14000000000000001 109.858 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -55.97 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.196 -1.179 . . . . 1.0600000000000001 110.365 -179.819 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 74.82 1.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.109 -1.071 . . . . 1.98 108.109 178.486 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -34.27 77.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 1.72 110.83 -178.601 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -64.52 -25.74 68.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.834 -1.166 . . . . 1.95 109.282 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -68.54 -35.97 78.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 2.5600000000000001 109.422 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 28.6 mt -51.83 -36.4 47.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 1.03 108.958 179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.83 -58.17 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 2.1499999999999999 109.863 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.1 84.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.36 -0.838 . . . . 1.04 110.844 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 15.9 m -67.18 -47.84 69.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.065 . . . . 1.04 110.273 -178.905 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.52 -51.09 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 1.05 108.983 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.28 -17.77 31.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 1.6599999999999999 109.605 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -76.46 -62.22 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 110.015 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.09 22.38 4.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.546 -0.721 . . . . 1.1399999999999999 110.518 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.226 179.408 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.537 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 mtt-85 -135.25 79.64 1.8 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.35 -0.844 . . . . 0.0 109.278 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 3' ' ' PHE . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -136.38 153.59 51.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.189 -0.944 . . . . 0.0 109.745 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 4' ' ' ARG . . . . . 0.434 HH12 ' NE2' ' A' ' 63' ' ' GLN . 7.0 tpt180 -150.47 -79.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 109.23 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 5' ' ' TYR . . . . . 0.456 ' OH ' ' CG1' ' A' ' 71' ' ' VAL . 5.1 p90 -131.15 -165.26 1.54 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.099 -1.001 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.35 152.54 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.255 -0.903 . . . . 0.0 112.379 -177.157 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m -102.02 95.61 6.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -83.17 46.15 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 110.058 -179.511 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 9' ' ' GLY . . . . . 0.645 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.81 -131.44 0.11 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 177.94 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.62 25.45 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.279 1.539 . . . . 0.0 109.276 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' B' B ' 11' ' ' SER . . . . . 0.645 ' H ' ' C ' ' B' ' 9' ' ' GLY . 20.4 t -84.2 -39.63 19.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 12' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 10.4 t-160 -170.76 -97.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 109' ' ' HOH . . . . . 0.421 ' H2 ' ' CB ' ' A' ' 18' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 111' ' ' HOH . . . . . 0.609 ' H2 ' ' H ' ' A' ' 22' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.6 t . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.306 -0.627 . . . . 0.29999999999999999 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' N ' HG12 ' A' ' 2' ' ' VAL . 3.7 tmtm? -155.22 122.91 5.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.143 -0.973 . . . . 1.97 108.892 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -89.61 137.88 31.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.97999999999999998 110.371 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.9 mm -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.488 -1.301 . . . . 0.19 107.488 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -108.17 -15.93 14.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.292 -0.88 . . . . 1.97 109.195 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -153.13 158.95 42.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.23000000000000001 109.506 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.27 -29.49 23.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 1.8999999999999999 109.998 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -58.7 -46.57 87.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.25 109.794 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.4 63.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.20000000000000001 109.909 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -58.91 -65.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.046 . . . . 0.20999999999999999 109.806 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -55.91 -45.27 78.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 2.4700000000000002 109.724 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -58.8 -35.55 73.02 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.174 -0.954 . . . . 2.1000000000000001 109.753 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.15 83.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.1 . . . . 0.20000000000000001 109.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.44 -41.46 98.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.815 . . . . 0.62 109.534 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.85 -45.56 85.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 109.912 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.98 59.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.29999999999999999 109.952 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -7.44 29.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.23999999999999999 109.782 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.75 -136.09 24.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.137 -1.585 . . . . 0.28000000000000003 109.137 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -117.01 5.92 12.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.43 -1.041 . . . . 2.21 109.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.72 168.01 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 1.8999999999999999 109.102 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.66 164.51 9.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.158 -1.053 . . . . 0.17000000000000001 108.158 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.1 t -145.1 107.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.993 -1.067 . . . . 0.12 109.672 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.84 136.48 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.178 -1.045 . . . . 0.089999999999999997 108.178 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 136.7 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.528 -0.732 . . . . 0.17000000000000001 109.645 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.73 101.78 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.95999999999999996 109.292 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 57' ' ' VAL . 40.7 m-85 -88.04 79.07 8.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.23999999999999999 108.056 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.3 m -113.36 150.9 31.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.315 0.579 . . . . 1.03 109.487 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.19 130.24 37.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.26000000000000001 108.766 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -66.94 -28.83 68.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.32000000000000001 110.809 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -88.47 -8.82 54.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.003 -1.061 . . . . 0.44 110.536 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.61 128.4 44.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.32000000000000001 109.542 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.14 -55.99 9.63 Favored Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.563 -0.711 . . . . 0.35999999999999999 111.42 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 13.6 Cg_exo -49.94 -35.0 39.27 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.746 1.631 . . . . 0.44 111.401 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.96 -1.087 . . . . 0.81000000000000005 109.076 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -58.27 -20.27 41.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.9199999999999999 110.018 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.43 -19.73 57.27 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.144 -0.973 . . . . 3.1299999999999999 110.883 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.527 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.2 mt -100.73 4.39 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.998 -1.064 . . . . 0.28000000000000003 111.182 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 6.6 ptpt -64.65 -32.93 7.66 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 120.121 -1.612 . . . . 1.6200000000000001 112.439 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -57.64 -13.71 14.89 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.944 1.016 . . . . 0.25 110.245 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -99.82 -67.19 0.86 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.724 -0.843 . . . . 0.29999999999999999 108.724 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -46.61 -52.87 12.66 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.713 -0.617 . . . . 0.13 110.424 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -67.7 -33.6 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.40999999999999998 109.73 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.0 -41.98 97.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 0.96999999999999997 109.851 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 mt -52.25 -15.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.014 . . . . 0.5 109.326 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 m -58.27 -33.37 69.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.51000000000000001 109.729 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.11 -18.06 22.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -0.907 . . . . 2.0 110.076 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -91.39 -22.81 20.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.132 -0.98 . . . . 2.1600000000000001 109.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -133.1 69.39 1.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.594 -0.691 . . . . 0.23999999999999999 109.193 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.6 p -67.34 -5.32 13.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.306 -0.871 . . . . 0.17000000000000001 109.114 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.44 5.28 52.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.487 -0.758 . . . . 0.34000000000000002 109.555 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.17 149.46 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.471 -0.768 . . . . 0.12 109.332 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.52 126.25 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.901 -0.777 . . . . 0.17000000000000001 108.901 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 55' ' ' LEU . 85.5 m-85 -114.39 134.25 55.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.391 -0.818 . . . . 0.11 109.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -116.4 175.11 5.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -0.783 . . . . 0.12 109.247 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -144.31 143.31 30.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.015 -1.106 . . . . 1.3100000000000001 108.015 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 27' ' ' PHE . 55.8 t -140.44 142.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.07 -1.019 . . . . 0.14000000000000001 110.658 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.95 100.77 11.72 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.932 -1.136 . . . . 1.0800000000000001 107.932 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.2 m -60.36 -10.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.27000000000000002 111.099 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -102.52 -41.34 6.31 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 111.239 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -94.86 -13.67 25.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.98 -1.075 . . . . 1.1200000000000001 110.061 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.88 48.48 1.62 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.284 -0.885 . . . . 0.17000000000000001 108.797 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.22 -13.97 1.53 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.571 -0.705 . . . . 2.2200000000000002 109.592 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.44 -42.42 71.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.246 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.61 -45.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.19 108.542 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -34.36 77.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.22 109.304 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.1 m -64.08 -49.49 72.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 1.29 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.8 -37.06 85.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 2.2000000000000002 109.224 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.71 -3.74 58.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.33000000000000002 109.492 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ALA . 36.1 mt-10 47.0 52.65 11.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 2.3399999999999999 110.279 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.06 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.28000000000000003 108.896 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 54.5 mttp -127.74 6.74 6.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.451 -0.781 . . . . 2.3999999999999999 109.733 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 137.82 17.34 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.057 -1.027 . . . . 0.22 108.95 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.475 HG23 ' CE2' ' B' ' 5' ' ' TYR . 74.3 p -122.04 149.89 55.13 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.362 -0.836 . . . . 0.22 109.006 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.1 Cg_endo -76.6 148.07 88.16 Favored 'Cis proline' 0 N--CA 1.484 0.932 0 C-N-CA 124.66 -0.975 . . . . 0.20000000000000001 110.409 -2.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -117.63 115.82 25.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.255 -1.387 . . . . 0.17999999999999999 107.255 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.6 m-85 -93.04 121.68 34.63 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.213 -0.929 . . . . 0.14999999999999999 108.555 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -119.8 137.88 53.7 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.608 -1.256 . . . . 1.03 107.608 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.5 m-85 -111.44 127.8 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.536 0.684 . . . . 0.11 110.044 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -126.33 157.49 38.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.619 -0.882 . . . . 0.17000000000000001 108.619 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -155.48 123.84 5.91 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt 56.39 28.38 13.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.764 . . . . 1.6699999999999999 109.89 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.04 87.19 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.98 -1.105 . . . . 0.22 110.357 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -115.3 146.48 41.46 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.372 -1.075 . . . . 2.0800000000000001 110.128 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -85.54 140.79 30.36 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.402 -0.811 . . . . 1.7 109.222 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 -20.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.396 -0.815 . . . . 0.26000000000000001 110.289 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.1 46.69 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.454 -1.355 . . . . 0.17999999999999999 110.378 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -174.18 153.66 2.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.359 -1.083 . . . . 2.04 110.229 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.94 135.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.14000000000000001 109.974 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -106.6 -169.24 1.53 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.238 -0.914 . . . . 0.17000000000000001 108.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 91.87 129.25 4.61 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -1.097 . . . . 0.20000000000000001 110.297 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.0 t-20 -139.96 74.38 1.46 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 1.1499999999999999 108.787 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -65.23 -32.58 74.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 1.1899999999999999 110.319 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.06 -30.67 70.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.981 -1.074 . . . . 1.95 109.598 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -67.36 -33.5 75.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 2.0499999999999998 109.254 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.1 mt -50.82 -35.36 31.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.964 -1.085 . . . . 0.14999999999999999 108.605 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.98 -57.59 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.836 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.2 88.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.14999999999999999 110.876 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.6 m -66.87 -46.04 76.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.13 110.467 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.27 -50.56 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.17999999999999999 109.163 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -61.17 -18.27 57.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 1.03 109.652 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.63 -60.69 2.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 2.02 110.134 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.8 mt -91.88 22.1 4.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.463 -0.773 . . . . 0.34999999999999998 110.461 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 1.1799999999999999 109.178 179.357 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.79 -168.54 1.34 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.087 -1.008 . . . . 0.0 110.714 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.02 150.31 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.943 0.877 . . . . 0.0 112.909 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.63 97.11 7.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.427 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.77 44.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.068 -1.02 . . . . 0.0 110.477 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.17 -136.82 0.15 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.32 28.27 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 118.755 1.278 . . . . 0.0 109.012 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 9.3 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 109.697 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 3' ' ' LYS . 75.0 t . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.261 0.553 . . . . 0.29999999999999999 109.626 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.0 tttt -153.99 125.26 7.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.363 -0.836 . . . . 1.97 108.803 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -88.39 134.87 33.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.97999999999999998 109.899 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.99 106.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.219 -1.03 . . . . 0.19 108.219 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.63 -8.79 23.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.205 -0.934 . . . . 1.97 109.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.3 p -152.09 150.31 29.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.23000000000000001 109.623 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -51.57 -28.15 13.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 1.8999999999999999 109.396 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 m -60.7 -43.27 97.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.25 109.584 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.35 -26.58 64.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.845 . . . . 0.20000000000000001 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.94 -67.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.20999999999999999 109.868 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -54.1 -44.33 71.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 2.4700000000000002 109.673 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.44 -37.82 76.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.159 -0.963 . . . . 2.1000000000000001 109.726 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.71 88.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.20000000000000001 109.276 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.0 mt -64.7 -41.07 96.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.62 109.812 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.95 -38.68 92.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.587 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.08 -16.62 54.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.888 . . . . 0.29999999999999999 109.828 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -6.96 31.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.23999999999999999 109.938 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.66 -105.95 1.4 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.837 -1.305 . . . . 0.28000000000000003 109.837 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.78 3.38 2.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -1.078 . . . . 2.21 109.74 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -70.09 166.82 19.0 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.042 -1.036 . . . . 1.8999999999999999 109.124 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 163.39 11.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.295 -0.878 . . . . 0.17000000000000001 108.687 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.4 t -146.21 107.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.094 -1.004 . . . . 0.12 109.48 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -103.73 128.5 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.366 -0.833 . . . . 0.089999999999999997 108.804 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.95 134.81 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.612 -0.68 . . . . 0.17000000000000001 109.896 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -106.48 101.1 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.177 -0.675 . . . . 0.95999999999999996 109.177 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' THR . 50.5 m-85 -84.97 81.17 9.01 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.765 -1.198 . . . . 0.23999999999999999 107.765 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -110.94 -163.06 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.626 0.727 . . . . 1.03 109.514 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 124.81 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.607 -0.886 . . . . 0.26000000000000001 108.607 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -64.69 -25.47 67.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.32000000000000001 110.718 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -89.05 -19.45 25.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.972 -1.08 . . . . 0.44 110.169 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.84 122.17 34.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.32000000000000001 109.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.63 -57.41 12.74 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 120.929 -0.653 . . . . 0.35999999999999999 111.555 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 22.8 Cg_exo -46.04 -36.88 16.83 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.712 1.608 . . . . 0.44 111.645 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.86 -59.54 2.74 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.869 -1.145 . . . . 0.81000000000000005 108.944 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -59.47 -15.15 15.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 1.9199999999999999 110.009 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 tpt -58.24 -20.13 39.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 3.1299999999999999 110.434 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 38' ' ' ILE . 49.2 mt -97.27 8.57 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.083 -1.01 . . . . 0.28000000000000003 110.783 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.96 -31.97 5.25 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 120.122 -1.611 . . . . 1.6200000000000001 112.529 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.67 -5.14 11.09 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 CA-C-N 119.968 1.024 . . . . 0.25 109.706 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -111.85 -78.45 0.58 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.015 -0.735 . . . . 0.29999999999999999 109.015 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -41.56 -56.91 2.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.767 -0.583 . . . . 0.13 110.688 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.01 -31.48 72.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.40999999999999998 109.871 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 46' ' ' SER . 13.4 m -66.49 -38.77 88.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.853 -1.154 . . . . 0.96999999999999997 110.235 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.8 mt -49.17 -12.93 0.06 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.879 -1.138 . . . . 0.5 109.649 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' SER . 54.9 m -56.75 -31.57 64.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.51000000000000001 109.51 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.25 -17.59 21.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.266 -0.896 . . . . 2.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -91.03 -24.3 20.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.976 -1.077 . . . . 2.1600000000000001 109.85 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -135.49 70.96 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 0.23999999999999999 109.621 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.2 p -66.97 -4.57 9.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.266 -0.896 . . . . 0.17000000000000001 108.714 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -96.11 -0.37 50.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.736 . . . . 0.34000000000000002 109.823 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.7 149.59 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.729 . . . . 0.12 109.4 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.07 133.57 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.442 -0.786 . . . . 0.17000000000000001 109.418 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -119.06 131.77 55.98 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.544 -0.723 . . . . 0.11 109.163 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.99 172.81 6.82 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.399 -0.813 . . . . 0.12 108.962 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.99 143.33 31.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.85 138.2 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.168 -0.957 . . . . 0.14000000000000001 110.288 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.79 102.9 14.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.648 -1.241 . . . . 1.0800000000000001 107.648 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.03 -6.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.233 -0.917 . . . . 0.27000000000000002 111.044 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.08 -44.52 5.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.052 -1.03 . . . . 1.1100000000000001 110.597 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.99 -15.37 24.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.093 -1.004 . . . . 1.1200000000000001 109.776 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.48 44.66 2.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -0.865 . . . . 0.17000000000000001 109.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -57.06 -10.88 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.2200000000000002 110.216 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.6 ' OD1' HG23 ' A' ' 65' ' ' VAL . 1.4 p30 -69.04 -39.16 79.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.908 -1.12 . . . . 1.1100000000000001 109.149 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.8 t -74.05 -42.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.137 -1.06 . . . . 0.19 108.137 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.2 -37.85 88.87 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.907 -0.775 . . . . 0.22 108.907 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 m -64.03 -45.02 90.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 1.29 109.079 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.87 -39.03 93.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 2.2000000000000002 109.427 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.11 0.33 55.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -0.896 . . . . 0.33000000000000002 109.754 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 49.21 56.81 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.905 . . . . 2.3399999999999999 109.951 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.59 135.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.28000000000000003 109.192 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -123.86 -6.86 7.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.604 -0.685 . . . . 2.3999999999999999 109.638 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.01 136.96 16.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.149 -0.969 . . . . 0.22 109.433 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.2 p -115.47 150.61 44.9 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.62 148.62 86.86 Favored 'Cis proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.838 -0.901 . . . . 0.20000000000000001 109.838 -2.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -119.26 118.89 32.48 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.145 -1.057 . . . . 0.17999999999999999 108.145 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.0 m-85 -95.76 111.9 23.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.14999999999999999 108.775 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -114.03 139.39 49.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.601 -1.259 . . . . 1.03 107.601 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.6 m-85 -109.17 133.24 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.54 0.686 . . . . 0.11 110.052 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -126.59 156.62 40.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.488 -0.93 . . . . 0.17000000000000001 108.488 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -154.73 122.51 5.81 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.633 -1.247 . . . . 1.48 107.633 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 56.86 29.67 16.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 1.6699999999999999 109.866 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.4 1.54 90.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.113 -1.041 . . . . 0.22 110.741 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -112.67 148.32 34.9 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.155 -1.203 . . . . 2.0800000000000001 110.281 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.478 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -87.19 146.5 25.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 1.7 109.523 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.09 -29.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.442 -0.786 . . . . 0.26000000000000001 110.147 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.43 45.51 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.659 -1.258 . . . . 0.17999999999999999 110.083 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -172.34 160.99 5.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -1.147 . . . . 2.04 110.77 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.6 133.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.511 -0.743 . . . . 0.14000000000000001 110.18 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -104.23 -170.39 1.76 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.17000000000000001 109.291 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.59 130.19 4.41 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.526 -1.43 . . . . 0.13 109.526 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.82 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -1.17 . . . . 0.20000000000000001 110.237 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -141.6 74.76 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.331 -0.989 . . . . 1.1499999999999999 108.331 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.25 -32.45 74.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.1899999999999999 110.782 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.62 -28.67 69.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.1 -1.0 . . . . 1.95 109.153 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -69.4 -36.38 76.7 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.53 -0.731 . . . . 2.0499999999999998 109.873 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 77' ' ' PHE . 58.7 mt -53.05 -36.31 60.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.767 -1.208 . . . . 0.14999999999999999 108.765 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -65.79 -58.15 6.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 2.1499999999999999 109.615 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.5 91.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.14999999999999999 110.485 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.3 m -65.06 -45.26 86.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 0.13 110.212 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.96 -54.35 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.0 -1.062 . . . . 0.17999999999999999 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -61.46 -16.55 48.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 1.03 109.745 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -76.3 -60.45 2.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.902 . . . . 2.02 110.479 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.33 18.18 7.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 0.34999999999999998 110.544 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.265 179.374 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -108.75 -177.49 3.33 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.652 -1.28 . . . . 0.0 110.69 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.03 145.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.038 0.923 . . . . 0.0 113.058 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 m -101.22 93.73 5.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.553 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.5 44.61 0.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.337 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.02 -132.4 0.07 OUTLIER Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.54 25.15 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 CA-C-N 119.211 1.505 . . . . 0.0 109.274 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 96.1 t . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.55 -0.537 . . . . 0.29999999999999999 109.55 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -154.75 121.24 5.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.727 -1.212 . . . . 1.97 107.727 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -86.77 141.39 28.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.97999999999999998 110.411 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.12 109.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.19 108.022 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.97 -14.88 17.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 1.97 109.327 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -154.96 157.61 37.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.23000000000000001 109.843 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 49.7 tttp -51.55 -27.65 11.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 1.8999999999999999 109.574 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 m -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.25 110.005 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.47 -27.26 65.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.20000000000000001 109.687 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.84 -67.61 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.20999999999999999 109.942 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -54.04 -43.98 70.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.901 . . . . 2.4700000000000002 109.64 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.51 -37.5 78.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.245 -0.909 . . . . 2.1000000000000001 109.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.2 86.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.20000000000000001 109.454 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.31 -43.16 98.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.413 -0.804 . . . . 0.62 109.563 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.27 -42.33 96.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 1.0900000000000001 109.594 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.06 -13.49 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.962 . . . . 0.29999999999999999 109.809 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -6.4 24.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.23999999999999999 109.753 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.54 -112.43 4.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.28000000000000003 109.562 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB2' ' HZ2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -139.43 2.67 2.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -1.103 . . . . 2.21 109.262 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -68.84 167.05 16.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 1.8999999999999999 108.812 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.67 161.86 11.62 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.099 -1.074 . . . . 0.17000000000000001 108.099 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -143.99 105.8 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.968 -1.083 . . . . 0.12 109.451 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.0 t -102.41 132.19 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.704 -0.85 . . . . 0.089999999999999997 108.704 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.38 138.54 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.674 -0.641 . . . . 0.17000000000000001 109.758 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.09 101.57 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.178 -0.675 . . . . 0.95999999999999996 109.178 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -85.09 79.97 9.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.874 -1.158 . . . . 0.23999999999999999 107.874 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.43 149.53 34.05 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.279 0.562 . . . . 1.03 109.789 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.95 128.17 37.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.63 -0.878 . . . . 0.26000000000000001 108.63 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -65.93 -26.65 67.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.32000000000000001 110.605 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.441 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 60.4 p-90 -88.53 -13.76 39.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.887 -1.133 . . . . 0.44 110.038 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -94.34 126.01 39.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.32000000000000001 109.995 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.98 -58.96 8.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.462 -0.655 . . . . 0.35999999999999999 111.462 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.6 Cg_exo -45.12 -33.21 7.8 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.9 1.733 . . . . 0.44 111.314 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.41 -61.58 1.96 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.897 -1.127 . . . . 0.81000000000000005 108.626 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -60.89 -15.7 33.66 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.71 -0.619 . . . . 1.9199999999999999 110.473 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 33' ' ' GLY . 27.9 tpp -60.92 -27.38 68.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.05 -1.031 . . . . 3.1299999999999999 109.991 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . 49.6 mt -96.49 15.63 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.131 -0.981 . . . . 0.28000000000000003 111.023 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.89 -32.75 3.67 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 118.179 -1.408 . . . . 1.6200000000000001 112.224 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -62.9 -4.58 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 CA-C-N 119.758 0.949 . . . . 0.25 110.114 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 46.5 m-85 -109.16 -79.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.29999999999999999 109.025 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.73 -55.8 2.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.632 . . . . 0.13 111.082 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.37 -34.7 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.40999999999999998 110.219 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 85.1 p -64.85 -35.42 81.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.637 -1.29 . . . . 0.96999999999999997 110.012 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.5 mt -50.11 -16.11 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.987 -1.071 . . . . 0.5 109.28 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 14.9 m -57.03 -36.48 70.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.51000000000000001 109.706 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -93.16 -15.02 26.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.159 -0.963 . . . . 2.0 110.089 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -91.26 -23.12 20.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.056 -1.027 . . . . 2.1600000000000001 109.196 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -135.88 72.46 1.44 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.531 -0.731 . . . . 0.23999999999999999 109.414 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 93.3 p -67.17 -4.76 11.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.17000000000000001 108.969 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -96.97 -0.37 47.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.34000000000000002 109.9 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.29 147.54 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -0.784 . . . . 0.12 109.223 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 mm -98.77 130.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.17000000000000001 109.36 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.548 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -118.11 132.13 56.37 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.486 -0.759 . . . . 0.11 109.142 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.78 171.92 7.29 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.786 -0.82 . . . . 0.12 108.786 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -141.54 137.83 32.29 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.717 -1.216 . . . . 1.3100000000000001 107.717 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 t -136.47 139.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.275 -0.891 . . . . 0.14000000000000001 110.883 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.99 101.77 12.95 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.745 -0.835 . . . . 1.0800000000000001 108.745 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 59' ' ' VAL . 15.6 m -60.98 -2.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.879 . . . . 0.27000000000000002 111.017 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.441 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 26.1 m-20 -108.66 -44.44 4.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.061 -1.025 . . . . 1.1100000000000001 110.503 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -95.11 -26.97 15.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.102 -0.999 . . . . 1.1200000000000001 109.21 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.92 40.39 1.51 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.309 -0.997 . . . . 0.17000000000000001 108.309 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -53.57 -15.87 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.636 -0.665 . . . . 2.2200000000000002 110.121 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -70.26 -36.29 74.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.978 -1.076 . . . . 1.1100000000000001 108.783 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -75.27 -48.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.663 -0.866 . . . . 0.19 108.663 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.72 74.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.801 . . . . 0.22 109.161 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 m -63.16 -48.98 76.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 1.29 109.182 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -64.94 -35.99 82.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.522 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 0.47 55.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.945 . . . . 0.33000000000000002 109.905 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 45.88 50.95 10.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.961 . . . . 2.3399999999999999 110.251 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.82 131.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.28000000000000003 108.904 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -130.52 6.19 4.79 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.376 -0.827 . . . . 2.3999999999999999 110.212 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.46 120.7 6.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.04 -1.037 . . . . 0.22 108.731 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.632 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.0 p -108.17 150.65 40.74 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.759 -0.83 . . . . 0.22 108.759 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.8 141.97 68.83 Favored 'Cis proline' 0 N--CA 1.484 0.919 0 C-N-CA 125.033 -0.82 . . . . 0.20000000000000001 110.105 -1.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 115.66 27.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.973 -1.121 . . . . 0.17999999999999999 107.973 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -91.47 118.62 30.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.14999999999999999 108.94 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -117.06 132.95 56.56 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.0 m-85 -107.84 126.55 52.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.656 -0.653 . . . . 0.11 109.55 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -123.03 158.46 30.5 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.786 -0.82 . . . . 0.17000000000000001 108.786 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -154.75 123.07 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.866 -1.531 . . . . 1.48 106.866 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 20' ' ' ASP . 25.1 mttm 58.26 28.59 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 1.6699999999999999 109.41 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 2.83 88.8 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.606 -1.397 . . . . 0.22 109.606 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -106.76 145.75 31.68 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.543 -0.975 . . . . 2.0800000000000001 110.334 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -85.6 141.13 30.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 1.7 109.357 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.6 -21.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.49 -0.756 . . . . 0.26000000000000001 110.253 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.04 177.32 48.42 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.485 -1.341 . . . . 0.17999999999999999 110.178 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -174.27 156.1 2.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -1.121 . . . . 2.04 110.165 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.9 131.15 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.14000000000000001 110.0 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 p -102.57 -166.85 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.192 -0.942 . . . . 0.17000000000000001 108.892 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.98 127.9 3.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.126 -1.59 . . . . 0.13 109.126 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.532 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.81 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.158 -1.201 . . . . 0.20000000000000001 110.734 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -143.12 77.38 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.136 -1.061 . . . . 1.1499999999999999 108.136 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.34 75.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 1.1899999999999999 110.484 -178.733 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.97 -26.57 67.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.98 -1.075 . . . . 1.95 109.185 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -68.97 -36.54 78.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.346 -0.846 . . . . 2.0499999999999998 109.512 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 77' ' ' PHE . 15.0 mt -53.7 -34.9 60.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.064 . . . . 0.14999999999999999 108.919 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.0 -57.54 6.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 2.1499999999999999 109.722 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.33 90.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.14999999999999999 110.59 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.0 m -66.86 -45.14 79.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.13 110.206 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.49 -51.9 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.932 -1.105 . . . . 0.17999999999999999 108.631 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -61.91 -15.34 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.857 . . . . 1.03 109.646 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -76.49 -59.72 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 2.02 110.176 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.3 mt -92.32 17.17 10.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -0.841 . . . . 0.34999999999999998 110.404 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.973 -1.08 . . . . 1.1799999999999999 109.382 179.595 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.632 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -115.08 -172.56 2.15 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.941 -1.1 . . . . 0.0 110.632 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.95 152.54 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.957 0.884 . . . . 0.0 112.056 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 m -101.25 96.84 7.46 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.574 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.8 45.48 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.948 . . . . 0.0 109.819 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.74 -132.66 0.07 OUTLIER Glycine 0 N--CA 1.484 1.894 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.27 21.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 CA-C-N 119.286 1.543 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.648 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.3 t . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.245 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 3' ' ' LYS . 69.8 t . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.364 0.602 . . . . 0.29999999999999999 109.73 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.515 ' HZ2' ' CD1' ' A' ' 5' ' ' ILE . 48.4 tttm -154.1 127.8 8.73 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 1.97 108.991 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -87.55 130.99 34.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.912 . . . . 0.97999999999999998 109.592 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.515 ' CD1' ' HZ2' ' A' ' 3' ' ' LYS . 25.0 mm -114.78 85.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.675 -0.861 . . . . 0.19 108.675 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -95.29 4.43 53.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.979 -1.075 . . . . 1.97 109.551 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 p -150.4 141.48 23.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.23000000000000001 109.889 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -51.57 -31.07 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.823 . . . . 1.8999999999999999 109.49 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -59.88 -43.93 94.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.25 109.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.08 -26.01 63.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.20000000000000001 109.828 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.91 -67.39 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.20999999999999999 110.118 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -53.78 -44.41 70.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 2.4700000000000002 109.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.38 -36.89 76.63 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.269 -0.894 . . . . 2.1000000000000001 109.969 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.36 89.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.20000000000000001 109.484 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -63.77 -45.6 89.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 0.62 110.034 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.19 -41.57 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.048 -1.033 . . . . 1.0900000000000001 109.415 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.42 -13.06 59.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.29999999999999999 109.628 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.09 40.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 0.23999999999999999 109.581 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.11 -113.01 4.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.444 -1.462 . . . . 0.28000000000000003 109.444 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -137.71 2.51 2.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.353 -1.087 . . . . 2.21 109.348 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -69.37 168.08 15.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 1.8999999999999999 108.702 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.581 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.55 165.1 10.58 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.168 -0.958 . . . . 0.17000000000000001 108.452 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.581 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.1 t -145.29 106.31 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.87 -1.144 . . . . 0.12 109.712 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.5 132.25 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.354 -0.841 . . . . 0.089999999999999997 108.996 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.07 136.75 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.619 -0.676 . . . . 0.17000000000000001 109.636 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.37 102.29 11.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.95999999999999996 109.363 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.8 m-85 -85.01 82.48 8.43 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.939 -1.134 . . . . 0.23999999999999999 107.939 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -114.24 150.05 34.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.822 -0.549 . . . . 1.03 109.734 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.0 123.41 35.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.234 -1.024 . . . . 0.26000000000000001 108.234 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -65.37 -23.25 66.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.32000000000000001 110.454 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -89.1 -11.75 43.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.44 109.899 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -96.97 128.04 43.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.32000000000000001 110.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.29 -56.46 11.92 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.631 -0.668 . . . . 0.35999999999999999 111.601 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.4 Cg_exo -47.2 -35.06 19.16 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.829 1.686 . . . . 0.44 111.438 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -61.26 2.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.926 -1.109 . . . . 0.81000000000000005 108.832 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.51 -16.86 27.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.421 -0.799 . . . . 1.9199999999999999 110.102 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.84 -28.44 68.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 3.1299999999999999 110.212 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' HG22 ' A' ' 38' ' ' ILE . 43.3 mt -96.76 18.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.232 -0.918 . . . . 0.28000000000000003 110.485 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.09 -32.05 2.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.53 -1.357 . . . . 1.6200000000000001 112.606 179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -62.69 -3.69 4.8 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.659 0.914 . . . . 0.25 109.994 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.3 m-85 -110.2 -76.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.567 -0.708 . . . . 0.29999999999999999 109.331 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.1 t80 -42.28 -57.2 2.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.433 -0.792 . . . . 0.13 110.715 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -66.82 -30.94 71.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.952 . . . . 0.40999999999999998 109.959 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.0 t -64.28 -40.08 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.804 -1.185 . . . . 0.96999999999999997 109.96 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.8 -16.33 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.054 -1.029 . . . . 0.5 109.437 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 44' ' ' SER . 44.9 m -57.38 -31.42 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.51000000000000001 109.869 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -96.57 -19.34 19.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.159 -0.963 . . . . 2.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -91.14 -23.7 20.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.965 -1.085 . . . . 2.1600000000000001 109.8 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -131.36 66.99 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.579 -0.7 . . . . 0.23999999999999999 109.181 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -66.5 -3.61 6.62 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 0.17000000000000001 108.79 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -95.4 -1.49 50.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 0.34000000000000002 109.319 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.7 t -115.56 149.11 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.058 -0.719 . . . . 0.12 109.058 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.58 128.76 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.17000000000000001 109.324 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.1 m-85 -115.29 132.31 56.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.532 -0.73 . . . . 0.11 109.181 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.08 171.33 7.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.871 -0.789 . . . . 0.12 108.871 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.69 138.38 28.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.066 -1.087 . . . . 1.3100000000000001 108.066 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 27' ' ' PHE . 80.6 t -134.6 138.37 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.211 -0.931 . . . . 0.14000000000000001 110.616 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.99 99.13 9.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.835 -1.172 . . . . 1.0800000000000001 107.835 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.18 -13.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.27000000000000002 111.331 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -100.03 -44.58 5.96 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.894 -1.129 . . . . 1.1100000000000001 111.298 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.6 -10.61 39.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.973 -1.08 . . . . 1.1200000000000001 109.718 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.4 2.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.543 -0.91 . . . . 0.17000000000000001 108.543 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -55.44 -15.43 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.762 . . . . 2.2200000000000002 110.142 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.6 p30 -69.74 -39.53 76.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.032 -1.042 . . . . 1.1100000000000001 108.995 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.05 -46.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.19 108.777 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.48 -31.99 72.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.22 108.846 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.7 m -64.29 -56.23 15.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 1.29 109.219 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 -31.16 72.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 2.2000000000000002 109.351 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.24 -6.81 57.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.33000000000000002 109.296 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' ALA . 27.5 mt-10 45.27 51.6 9.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.383 -0.823 . . . . 2.3399999999999999 110.369 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.49 136.13 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.28000000000000003 109.145 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -130.4 2.34 4.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.442 -0.786 . . . . 2.3999999999999999 109.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.09 126.95 9.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.005 -1.059 . . . . 0.22 109.496 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.583 HG23 ' CE2' ' B' ' 5' ' ' TYR . 72.2 p -111.6 150.54 42.35 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.385 -0.822 . . . . 0.22 108.876 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.61 141.42 64.22 Favored 'Cis proline' 0 N--CA 1.486 1.075 0 C-N-CA 125.03 -0.821 . . . . 0.20000000000000001 110.371 -1.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.67 114.26 26.78 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.129 -1.063 . . . . 0.17999999999999999 108.129 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.6 m-85 -89.61 124.16 34.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.848 -1.157 . . . . 0.14999999999999999 109.093 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.447 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.4 mt-30 -122.4 133.67 54.63 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.915 -1.142 . . . . 1.03 107.915 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.3 m-85 -107.88 127.81 54.06 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.665 0.745 . . . . 0.11 110.012 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -126.08 155.37 41.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.923 -1.14 . . . . 0.17000000000000001 107.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.7 tttp -156.25 125.46 6.13 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 56.32 19.22 3.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.573 -0.705 . . . . 1.6699999999999999 109.569 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.39 1.09 69.39 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.309 -1.116 . . . . 0.22 110.309 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -110.33 148.14 32.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.352 -1.087 . . . . 2.0800000000000001 110.272 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -87.89 145.65 25.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 1.7 109.36 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.17 -25.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 0.26000000000000001 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.1 46.25 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.477 -1.344 . . . . 0.17999999999999999 110.516 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -174.49 154.94 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -1.094 . . . . 2.04 109.967 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.9 p90 -167.76 131.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.14000000000000001 110.455 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -104.53 -170.97 1.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.229 -0.919 . . . . 0.17000000000000001 108.805 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.18 131.96 3.86 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.785 -1.326 . . . . 0.13 109.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.29 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -1.129 . . . . 0.20000000000000001 110.609 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.75 66.3 1.35 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.138 -1.06 . . . . 1.1499999999999999 108.138 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.0 ptpt -61.04 -38.58 86.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 1.1899999999999999 110.854 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.23 -28.81 69.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.986 -1.071 . . . . 1.95 109.729 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -70.16 -33.07 71.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.311 -0.868 . . . . 2.0499999999999998 109.592 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.3 mt -50.74 -37.98 44.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.14999999999999999 108.63 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.72 -54.85 16.02 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.935 -0.706 . . . . 2.1499999999999999 109.658 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.71 90.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.14999999999999999 110.542 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.7 m -66.5 -46.92 74.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.163 -0.961 . . . . 0.13 110.486 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 -50.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.17999999999999999 108.975 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -61.62 -17.54 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 1.03 109.544 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -77.05 -58.69 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 2.02 110.207 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.8 mt -91.78 18.57 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.341 -0.849 . . . . 0.34999999999999998 110.46 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.1799999999999999 109.275 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.583 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.47 -170.19 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.185 -0.947 . . . . 0.0 110.754 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.8 t -63.22 144.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.906 0.86 . . . . 0.0 112.837 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.5 m -101.25 94.64 6.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.512 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.09 45.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 110.672 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.9 -130.66 0.19 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.17 28.02 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 CA-C-N 119.323 1.562 . . . . 0.0 109.201 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.585 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.7 t . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.6 t . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.315 -0.624 . . . . 0.29999999999999999 109.315 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.624 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 tttm -153.46 121.57 6.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -0.965 . . . . 1.97 109.224 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -89.79 136.06 33.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.97999999999999998 110.01 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mm -106.98 113.03 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.843 -1.169 . . . . 0.19 107.843 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.12 -11.04 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 1.97 109.561 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -153.29 155.55 36.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.121 -0.987 . . . . 0.23000000000000001 109.777 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.528 ' HG2' HE22 ' A' ' 12' ' ' GLN . 78.9 tttt -52.44 -31.36 34.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 1.8999999999999999 109.806 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -57.93 -44.76 87.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.878 -1.139 . . . . 0.25 109.695 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.09 -23.7 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.20000000000000001 109.715 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -60.37 -68.39 0.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.20999999999999999 110.181 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . 0.528 HE22 ' HG2' ' A' ' 8' ' ' LYS . 1.2 pm0 -54.35 -42.72 70.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 2.4700000000000002 109.279 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.82 -38.36 78.47 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.186 -0.946 . . . . 2.1000000000000001 109.974 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -47.72 84.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.20000000000000001 109.362 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.66 -40.83 97.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.344 -0.848 . . . . 0.62 109.416 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.6 -41.42 96.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 109.869 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.09 58.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.29999999999999999 109.945 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 -3.38 9.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.23999999999999999 109.625 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -108.85 2.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.47 . . . . 0.28000000000000003 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -139.7 4.59 2.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.395 -1.062 . . . . 2.21 109.282 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 55.9 mttm -69.95 175.06 4.66 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.124 -0.985 . . . . 1.8999999999999999 109.775 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.69 159.75 31.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.364 -0.976 . . . . 0.17000000000000001 108.364 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.0 t -144.73 107.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.763 -1.211 . . . . 0.12 109.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -105.73 131.6 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.643 -0.873 . . . . 0.089999999999999997 108.643 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 136.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.684 -0.635 . . . . 0.17000000000000001 109.633 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.96 105.8 15.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.109 -0.7 . . . . 0.95999999999999996 109.109 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.62 79.62 8.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.988 -1.116 . . . . 0.23999999999999999 107.988 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -113.78 150.15 33.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.788 -0.57 . . . . 1.03 109.873 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.81 124.77 36.19 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.403 -0.962 . . . . 0.26000000000000001 108.403 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -66.0 -23.88 66.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.32000000000000001 110.367 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -88.62 -13.95 38.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.44 110.001 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.19 121.62 37.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.32000000000000001 109.665 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.94 -57.15 20.18 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 121.579 -0.701 . . . . 0.35999999999999999 111.372 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.96 -34.3 16.23 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.863 1.709 . . . . 0.44 111.5 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.03 2.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.026 -1.046 . . . . 0.81000000000000005 108.878 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.25 -18.52 49.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.522 -0.736 . . . . 1.9199999999999999 110.233 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -59.21 -25.3 63.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 3.1299999999999999 110.17 -179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.7 mt -96.34 11.94 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.069 -1.019 . . . . 0.28000000000000003 110.476 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.62 -32.24 3.54 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 120.407 -1.433 . . . . 1.6200000000000001 112.726 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.25 -3.98 5.82 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.851 0.982 . . . . 0.25 110.318 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -111.96 -75.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.29999999999999999 109.338 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -43.53 -57.03 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.13 110.709 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.09 -31.89 72.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.40999999999999998 110.121 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 t -63.45 -39.02 93.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.856 -1.153 . . . . 0.96999999999999997 110.4 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.6 mt -51.11 -12.78 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.019 -1.051 . . . . 0.5 109.646 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.436 ' N ' ' C ' ' A' ' 44' ' ' SER . 49.0 m -57.31 -36.95 71.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.51000000000000001 109.64 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -94.91 -16.75 22.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.119 -0.988 . . . . 2.0 110.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -90.33 -23.45 21.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.945 -1.097 . . . . 2.1600000000000001 109.4 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -134.32 69.61 1.46 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.433 -0.792 . . . . 0.23999999999999999 109.219 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -66.51 -3.14 5.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.257 -0.902 . . . . 0.17000000000000001 108.946 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -95.94 0.74 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.544 -0.723 . . . . 0.34000000000000002 109.669 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.8 t -119.43 151.9 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.486 -0.759 . . . . 0.12 109.301 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 mm -101.6 129.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.402 -0.811 . . . . 0.17000000000000001 109.461 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.1 m-85 -116.95 131.0 57.06 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.441 -0.787 . . . . 0.11 109.147 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -113.04 173.1 6.55 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.905 -0.776 . . . . 0.12 108.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -143.46 143.65 31.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.034 -1.098 . . . . 1.3100000000000001 108.034 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.59 138.19 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.095 -1.003 . . . . 0.14000000000000001 110.731 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -99.69 105.01 16.78 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.176 -1.046 . . . . 1.0800000000000001 108.176 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.19 -12.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.27000000000000002 111.16 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -100.28 -43.04 6.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.004 -1.06 . . . . 1.1100000000000001 110.733 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.32 -10.5 38.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.925 -1.109 . . . . 1.1200000000000001 109.63 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 47.55 2.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.656 -0.868 . . . . 0.17000000000000001 108.656 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -56.17 -15.79 4.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.782 . . . . 2.2200000000000002 110.016 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.5 p-10 -70.15 -40.22 74.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.145 -0.972 . . . . 1.1100000000000001 109.253 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 t -73.56 -47.08 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.42 -35.44 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.22 108.927 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 m -64.07 -45.53 88.33 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 1.29 109.229 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.64 -40.8 97.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 2.2000000000000002 109.28 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.8 58.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.178 -0.951 . . . . 0.33000000000000002 109.713 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.2 mm-40 49.08 55.18 9.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 110.112 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.91 133.56 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 109.153 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -125.72 2.68 7.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.434 -0.791 . . . . 2.3999999999999999 109.837 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.38 127.72 10.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.984 -1.072 . . . . 0.22 109.309 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.4 p -114.4 150.63 44.12 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -76.21 142.02 72.14 Favored 'Cis proline' 0 N--CA 1.487 1.131 0 C-N-CA 125.005 -0.831 . . . . 0.20000000000000001 110.98 -1.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -114.68 114.69 25.99 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.595 -1.261 . . . . 0.17999999999999999 107.595 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.9 m-85 -91.54 122.06 33.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.895 -1.128 . . . . 0.14999999999999999 108.922 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -120.91 136.19 55.01 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.308 -1.367 . . . . 1.03 107.308 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.7 m-85 -108.22 132.89 53.19 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.636 0.731 . . . . 0.11 110.087 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.8 157.15 41.19 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.725 -0.842 . . . . 0.17000000000000001 108.725 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -156.15 124.94 5.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.647 -1.242 . . . . 1.48 107.647 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 56.22 18.71 3.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 1.6699999999999999 109.68 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.13 -1.11 64.59 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 120.158 -1.02 . . . . 0.22 110.767 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -109.7 147.99 32.18 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.091 -1.241 . . . . 2.0800000000000001 110.316 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -85.85 139.72 31.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.92 -0.77 . . . . 1.7 108.92 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.3 -6.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.26000000000000001 110.642 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.89 173.72 37.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.398 -1.382 . . . . 0.17999999999999999 110.454 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -173.4 156.29 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -1.07 . . . . 2.04 110.165 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.61 132.17 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.503 -0.748 . . . . 0.14000000000000001 110.323 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -102.17 -162.92 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.17000000000000001 109.142 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.52 127.62 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.662 -1.375 . . . . 0.13 109.662 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.4 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.20000000000000001 110.276 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' GLY . 26.3 t-20 -137.19 75.11 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.887 -1.153 . . . . 1.1499999999999999 107.887 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -65.81 -42.26 90.87 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.812 -0.631 . . . . 1.1899999999999999 111.316 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.02 -27.09 68.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.919 -1.113 . . . . 1.95 110.052 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -68.84 -32.44 72.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 2.0499999999999998 109.589 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.3 mt -53.55 -35.83 61.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.809 -1.182 . . . . 0.14999999999999999 108.518 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.42 -54.86 16.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 2.1499999999999999 109.479 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.59 89.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.835 . . . . 0.14999999999999999 110.386 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 m -66.52 -45.09 80.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.13 109.784 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.92 -53.01 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.847 . . . . 0.17999999999999999 109.29 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -60.34 -16.88 39.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 1.03 109.467 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.49 -57.3 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 2.02 110.06 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.61 17.38 10.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.34999999999999998 110.131 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 1.1799999999999999 109.38 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.8 p90 -113.31 -167.75 1.24 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.271 -0.893 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.21 148.25 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.92 0.867 . . . . 0.0 112.712 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 m -101.3 94.83 6.14 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.502 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -83.54 44.71 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.091 -1.006 . . . . 0.0 110.41 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.0 -132.6 0.09 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.52 23.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 CA-C-N 119.404 1.602 . . . . 0.0 109.278 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.631 ' H ' ' C ' ' B' ' 9' ' ' GLY . 48.3 t . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.5 t . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.157 -0.683 . . . . 0.29999999999999999 109.157 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.5 tttt -155.12 122.87 5.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.037 -1.039 . . . . 1.97 109.438 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -89.59 138.33 31.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.81 . . . . 0.97999999999999998 109.767 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.59 101.48 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -97.92 -6.51 32.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.077 -1.015 . . . . 1.97 109.266 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 p -152.73 152.38 31.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.86 . . . . 0.23000000000000001 109.688 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -52.78 -26.45 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 1.8999999999999999 110.081 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 m -60.11 -46.15 90.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 0.25 109.995 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.8 63.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.20000000000000001 109.809 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.42 -68.45 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.136 -0.977 . . . . 0.20999999999999999 109.96 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -55.09 -44.0 74.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 2.4700000000000002 109.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.09 -36.28 74.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.243 -0.911 . . . . 2.1000000000000001 110.128 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.02 -46.82 87.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.935 -1.103 . . . . 0.20000000000000001 109.728 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.46 -50.22 70.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.334 -0.854 . . . . 0.62 109.952 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.57 -40.68 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 1.0900000000000001 109.817 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -16.45 56.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.29999999999999999 109.607 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.88 -12.39 61.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.23999999999999999 109.643 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 -116.84 4.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.779 -1.328 . . . . 0.28000000000000003 109.779 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 42.3 t0 -135.23 4.16 3.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.46 -1.024 . . . . 2.21 109.466 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -68.68 169.69 10.74 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.999 -1.063 . . . . 1.8999999999999999 108.737 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.15 161.31 19.38 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.905 -1.146 . . . . 0.17000000000000001 107.905 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.442 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.22 104.65 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.979 -1.075 . . . . 0.12 109.637 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.69 127.07 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.736 -0.838 . . . . 0.089999999999999997 108.736 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.45 138.69 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.577 -0.702 . . . . 0.17000000000000001 109.522 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -110.88 104.77 13.42 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.294 -0.632 . . . . 0.95999999999999996 109.294 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 40.0 m-85 -86.28 80.83 8.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.739 -1.208 . . . . 0.23999999999999999 107.739 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -114.36 149.15 36.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.773 -0.579 . . . . 1.03 109.547 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.58 129.01 37.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.921 . . . . 0.26000000000000001 108.667 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -66.94 -24.85 66.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.32000000000000001 110.516 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -87.86 -16.31 34.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.965 -1.084 . . . . 0.44 110.018 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.51 130.79 38.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.32000000000000001 110.231 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.11 -56.36 7.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.556 -0.618 . . . . 0.35999999999999999 111.556 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -47.87 -35.18 23.9 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.587 1.525 . . . . 0.44 111.482 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.61 2.29 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.81000000000000005 109.042 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.93 -18.78 47.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.806 . . . . 1.9199999999999999 109.931 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.7 -16.19 25.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.065 -1.022 . . . . 3.1299999999999999 110.406 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 38' ' ' ILE . 32.2 mt -100.43 8.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.136 -0.978 . . . . 0.28000000000000003 110.292 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.33 -32.94 6.93 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 120.189 -1.569 . . . . 1.6200000000000001 112.002 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -65.24 -3.04 6.68 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 CA-C-N 120.113 1.076 . . . . 0.25 109.693 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.45 -79.12 0.58 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.925 -0.769 . . . . 0.29999999999999999 108.925 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -42.03 -57.02 2.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.581 -0.699 . . . . 0.13 110.806 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.97 -31.05 71.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.932 -1.105 . . . . 0.40999999999999998 110.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -63.89 -39.94 95.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.776 -1.203 . . . . 0.96999999999999997 110.042 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 mt -51.99 -15.9 0.64 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.5 109.781 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -58.6 -31.63 68.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.89 -1.131 . . . . 0.51000000000000001 109.825 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 3.3 mp0 -94.45 -20.14 19.96 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.015 -1.053 . . . . 2.0 109.911 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -91.72 -21.15 20.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 2.1600000000000001 109.478 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -135.84 67.1 1.48 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.517 -0.739 . . . . 0.23999999999999999 109.083 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.4 p -66.95 -3.28 6.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.212 -0.93 . . . . 0.17000000000000001 109.207 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 23.9 t-20 -95.19 -0.98 52.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.851 . . . . 0.34000000000000002 109.527 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.2 t -116.28 149.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.941 -0.763 . . . . 0.12 108.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.9 mm -99.4 127.78 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 0.17000000000000001 109.562 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.541 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -114.88 128.96 56.6 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.793 -0.817 . . . . 0.11 108.793 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.29 170.56 8.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.294 -0.879 . . . . 0.12 108.986 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -141.62 141.58 33.43 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.961 -1.126 . . . . 1.3100000000000001 107.961 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.5 t -138.71 136.19 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.14000000000000001 110.389 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.64 105.86 18.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.543 -0.91 . . . . 1.0800000000000001 108.543 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.54 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.0 m -60.91 -7.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.843 . . . . 0.27000000000000002 111.344 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -108.87 -40.46 5.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 1.1100000000000001 111.074 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.88 -18.91 21.48 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.86 -1.15 . . . . 1.1200000000000001 109.318 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.98 47.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.236 -1.024 . . . . 0.17000000000000001 108.236 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.98 -18.1 4.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.631 -0.668 . . . . 2.2200000000000002 110.608 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -37.32 77.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.847 -1.158 . . . . 1.1100000000000001 109.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.5 -47.29 40.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.392 -0.817 . . . . 0.19 108.842 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.78 76.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.305 -0.872 . . . . 0.22 109.189 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -63.71 -52.02 62.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 1.29 109.31 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.74 -31.92 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 110.069 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.7 -6.73 57.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.138 -0.976 . . . . 0.33000000000000002 110.09 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 46.76 64.99 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.955 . . . . 2.3399999999999999 109.777 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 15.9 t -83.38 136.86 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.351 -0.843 . . . . 0.28000000000000003 108.979 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.97 -8.54 8.32 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.274 -0.891 . . . . 2.3999999999999999 109.715 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.0 130.83 11.67 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.22 109.848 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.724 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.0 p -112.15 151.19 43.46 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.376 -0.972 . . . . 0.22 108.376 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.05 142.04 71.15 Favored 'Cis proline' 0 N--CA 1.483 0.885 0 C-N-CA 124.752 -0.937 . . . . 0.20000000000000001 110.101 -1.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -113.83 114.22 25.98 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.031 -1.1 . . . . 0.17999999999999999 108.031 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -90.84 121.92 33.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 108.659 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.8 mt-30 -121.57 135.89 54.98 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.77 -1.196 . . . . 1.03 107.77 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.5 m-85 -106.7 132.62 52.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.736 . . . . 0.11 110.126 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.55 155.68 38.62 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.313 -0.995 . . . . 0.17000000000000001 108.313 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -155.63 121.39 5.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.3 -1.371 . . . . 1.48 107.3 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.9 mttt 57.44 19.73 5.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.636 -0.665 . . . . 1.6699999999999999 109.551 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.07 67.46 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.432 -1.067 . . . . 0.22 110.432 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -109.96 147.36 33.61 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.245 -1.15 . . . . 2.0800000000000001 110.35 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -86.98 139.07 30.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 1.7 109.4 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.18 -14.87 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.474 -0.766 . . . . 0.26000000000000001 109.976 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.23 171.89 42.85 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.485 -1.34 . . . . 0.17999999999999999 110.409 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -172.83 156.42 3.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -1.043 . . . . 2.04 109.961 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.7 p90 -168.91 133.57 1.53 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.626 -0.83 . . . . 0.14000000000000001 110.466 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -102.75 -172.35 2.11 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.489 -0.93 . . . . 0.17000000000000001 108.489 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.8 5.02 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.222 -1.551 . . . . 0.13 109.222 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.0 94.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -1.169 . . . . 0.20000000000000001 111.053 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -140.25 75.71 1.52 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.815 -1.18 . . . . 1.1499999999999999 107.815 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.502 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.31 -32.93 73.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.523 -0.735 . . . . 1.1899999999999999 110.341 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.64 -25.82 67.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.055 -1.028 . . . . 1.95 108.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -69.19 -38.84 78.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 2.0499999999999998 109.465 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.1 mt -53.66 -38.09 63.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.863 -1.148 . . . . 0.14999999999999999 109.106 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.33 -56.48 12.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 2.1499999999999999 109.506 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.8 94.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.14999999999999999 110.429 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 42.0 m -66.19 -44.85 82.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 0.13 109.807 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.2 mt -58.18 -55.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.065 -1.022 . . . . 0.17999999999999999 108.33 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.55 -16.53 25.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 1.03 109.903 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -76.61 -61.23 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 2.02 110.678 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.6 mt -93.16 15.63 14.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.34999999999999998 111.038 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.232 179.406 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.724 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.7 p90 -111.6 -166.71 1.1 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.626 -1.296 . . . . 0.0 111.068 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.31 151.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.944 0.878 . . . . 0.0 112.308 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.81 96.12 6.86 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.578 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.35 43.16 0.86 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.012 -1.055 . . . . 0.0 110.098 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.73 -133.07 0.07 OUTLIER Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.13 25.36 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 CA-C-N 119.319 1.56 . . . . 0.0 109.346 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.8 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.34 -0.85 . . . . 0.0 109.515 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.5 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.39 -0.596 . . . . 0.29999999999999999 109.39 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.9 tttm -155.17 121.32 5.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 1.97 108.972 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.57 135.37 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.853 . . . . 0.97999999999999998 109.534 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 10' ' ' ALA . 13.5 mm -107.99 109.67 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.769 -1.196 . . . . 0.19 107.769 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.28 -7.14 24.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.247 -0.908 . . . . 1.97 110.031 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -153.0 153.81 33.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.047 -1.033 . . . . 0.23000000000000001 109.912 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -52.3 -27.37 14.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.396 -0.815 . . . . 1.8999999999999999 109.471 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -60.42 -47.4 86.25 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.254 -0.903 . . . . 0.25 109.909 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -69.47 -24.31 63.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.20000000000000001 110.139 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.31 -66.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.015 -1.053 . . . . 0.20999999999999999 110.139 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.89 -44.93 78.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 2.4700000000000002 109.572 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -58.91 -36.7 75.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.362 -0.836 . . . . 2.1000000000000001 109.9 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.85 84.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.94 -1.1 . . . . 0.20000000000000001 109.194 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.94 -42.1 97.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.464 -0.773 . . . . 0.62 109.713 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.4 -40.97 96.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.136 -0.977 . . . . 1.0900000000000001 109.851 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.65 -16.2 56.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.29999999999999999 109.648 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.57 -5.27 18.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.23999999999999999 109.578 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.11 -116.26 7.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.28000000000000003 109.613 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -133.35 5.34 3.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.414 -1.05 . . . . 2.21 109.235 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -70.43 167.72 17.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.186 -0.946 . . . . 1.8999999999999999 108.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.03 161.35 16.14 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.894 -1.151 . . . . 0.17000000000000001 107.894 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.649 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -143.93 108.8 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 0.12 109.421 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.39 131.36 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.592 -0.892 . . . . 0.089999999999999997 108.592 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 t -109.06 133.21 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.629 -0.67 . . . . 0.17000000000000001 109.382 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -106.86 105.33 15.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.92 -0.77 . . . . 0.95999999999999996 108.92 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE2' HG11 ' A' ' 57' ' ' VAL . 38.5 m-85 -87.27 80.33 8.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.757 -1.201 . . . . 0.23999999999999999 107.757 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.5 m -113.22 148.52 35.33 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.283 0.563 . . . . 1.03 109.771 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.48 127.07 37.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.407 -0.96 . . . . 0.26000000000000001 108.407 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -66.06 -25.62 67.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.32000000000000001 110.234 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.8 p-90 -89.48 -11.79 41.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.207 -0.933 . . . . 0.44 110.17 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.0 t -95.04 128.11 41.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.32000000000000001 109.931 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.79 -58.96 7.57 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 111.166 -0.774 . . . . 0.35999999999999999 111.166 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.4 Cg_exo -47.22 -31.64 12.74 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 121.897 1.731 . . . . 0.44 111.184 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.4 -61.28 2.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 108.771 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -59.84 -17.58 37.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 1.9199999999999999 110.068 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.474 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.992 -1.068 . . . . 3.1299999999999999 110.137 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.668 ' O ' HG22 ' A' ' 38' ' ' ILE . 88.1 mt -96.07 7.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.28000000000000003 111.276 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.71 -35.58 23.49 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 120.309 -1.494 . . . . 1.6200000000000001 111.895 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -61.26 -5.98 5.98 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 CA-C-N 119.842 0.979 . . . . 0.25 110.839 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.26 -71.99 0.74 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.987 -0.746 . . . . 0.29999999999999999 108.987 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -46.37 -57.47 4.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.601 -0.687 . . . . 0.13 110.536 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.47 -30.68 71.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.199 -0.938 . . . . 0.40999999999999998 109.771 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.438 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.4 m -64.01 -42.1 97.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.979 -1.076 . . . . 0.96999999999999997 109.774 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.7 mt -50.2 -13.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.929 . . . . 0.5 109.365 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 44' ' ' SER . 47.6 m -57.14 -34.52 68.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.51000000000000001 109.647 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.95 -16.9 22.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.273 -0.892 . . . . 2.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -89.59 -41.98 11.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.992 -1.067 . . . . 2.1600000000000001 109.826 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -113.04 70.4 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.424 -0.798 . . . . 0.23999999999999999 109.351 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.7 p -67.14 -5.09 12.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.33 -0.857 . . . . 0.17000000000000001 108.84 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.22 1.22 54.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.778 . . . . 0.34000000000000002 109.657 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.85 151.01 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.785 -0.82 . . . . 0.12 108.785 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mm -100.83 126.51 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.331 -0.855 . . . . 0.17000000000000001 109.042 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' C ' HD12 ' A' ' 55' ' ' LEU . 70.4 m-85 -112.02 129.26 56.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.397 -0.815 . . . . 0.11 108.917 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -113.12 172.2 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.729 -0.841 . . . . 0.12 108.729 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.06 142.07 30.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.824 -1.176 . . . . 1.3100000000000001 107.824 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 98.1 t -139.12 136.6 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.339 -0.851 . . . . 0.14000000000000001 110.176 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -99.0 109.35 22.12 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.922 -1.14 . . . . 1.0800000000000001 107.922 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.452 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.3 m -63.74 -12.98 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.315 -0.865 . . . . 0.27000000000000002 111.104 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.9 -40.21 7.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.064 -1.022 . . . . 1.1100000000000001 111.015 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.6 -14.82 26.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.013 -1.055 . . . . 1.1200000000000001 109.289 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.26 44.4 2.81 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.752 -0.833 . . . . 0.17000000000000001 108.752 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.57 -14.53 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 2.2200000000000002 109.942 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.07 -38.12 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.021 -1.05 . . . . 1.1100000000000001 108.891 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -74.56 -46.84 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.513 -0.921 . . . . 0.19 108.513 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.67 -35.09 78.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.356 -0.84 . . . . 0.22 108.928 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.3 m -64.5 -45.34 87.74 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.273 -0.892 . . . . 1.29 109.034 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -63.73 -41.48 98.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.799 . . . . 2.2000000000000002 109.327 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.02 -4.12 58.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.272 -0.893 . . . . 0.33000000000000002 109.365 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.3 mm-40 50.26 55.07 10.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 2.3399999999999999 110.421 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.4 123.27 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.28000000000000003 108.989 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -114.01 5.31 16.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.402 -0.811 . . . . 2.3999999999999999 109.92 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.552 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.57 148.17 27.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.096 -1.003 . . . . 0.22 109.219 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.54 HG23 ' HE2' ' B' ' 5' ' ' TYR . 20.7 p -131.48 149.04 72.42 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.616 -0.883 . . . . 0.22 108.616 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.45 145.77 78.18 Favored 'Cis proline' 0 C--N 1.322 -0.85 0 C-N-CA 124.664 -0.973 . . . . 0.20000000000000001 110.429 -1.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.8 m -115.7 114.92 25.49 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.622 -1.251 . . . . 0.17999999999999999 107.622 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.2 m-85 -91.26 118.58 30.6 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.433 -0.907 . . . . 0.14999999999999999 108.573 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -119.94 135.94 54.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.617 -1.253 . . . . 1.03 107.617 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 100' ' ' THR . 26.8 m-85 -107.3 132.34 53.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.11 109.699 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -125.0 156.22 38.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.617 -0.883 . . . . 0.17000000000000001 108.617 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -156.09 121.19 4.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.783 -1.191 . . . . 1.48 107.783 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt 55.68 34.26 22.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.693 -0.629 . . . . 1.6699999999999999 110.318 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.39 3.27 88.59 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.092 -1.052 . . . . 0.22 110.751 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -114.01 146.58 39.97 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.349 -1.089 . . . . 2.0800000000000001 110.295 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -86.49 144.4 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.718 -0.845 . . . . 1.7 108.718 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.03 -20.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.381 -0.825 . . . . 0.26000000000000001 110.466 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 174.71 47.18 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.301 -1.428 . . . . 0.17999999999999999 110.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -174.17 156.98 2.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 2.04 110.169 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.91 131.88 1.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.528 -0.732 . . . . 0.14000000000000001 109.683 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 p -103.44 -160.27 0.77 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.051 -1.03 . . . . 0.17000000000000001 108.574 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 79.44 122.11 0.36 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.47 -1.452 . . . . 0.13 109.47 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.66 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.122 . . . . 0.20000000000000001 110.601 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.2 t-20 -137.47 71.58 1.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.805 -1.183 . . . . 1.1499999999999999 107.805 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -61.62 -39.53 91.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.731 -0.605 . . . . 1.1899999999999999 111.358 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.55 -25.74 67.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.758 -1.214 . . . . 1.95 109.704 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -69.1 -32.65 72.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 2.0499999999999998 109.575 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.6 mt -51.02 -38.85 53.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.14999999999999999 109.131 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.11 -53.22 40.67 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.661 -0.816 . . . . 2.1499999999999999 109.288 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.05 90.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.14999999999999999 110.699 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.448 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.4 m -67.68 -42.94 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.13 110.235 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -61.48 -52.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.17999999999999999 108.691 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -61.26 -17.77 55.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.858 . . . . 1.03 109.561 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -76.17 -59.36 2.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 2.02 110.043 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.0 mt -92.64 20.42 6.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.385 -0.822 . . . . 0.34999999999999998 110.429 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.988 -1.006 . . . . 1.1799999999999999 109.178 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.54 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -116.1 -173.27 2.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.321 -0.862 . . . . 0.0 110.529 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.11 150.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.992 0.901 . . . . 0.0 112.614 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.32 97.04 7.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -83.47 46.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.98 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.78 -126.51 0.16 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.69 24.51 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 119.2 1.5 . . . . 0.0 109.603 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.619 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.1 t . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.534 -0.729 . . . . 0.0 110.255 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.8 t . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.336 0.588 . . . . 0.29999999999999999 109.882 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.9 tptp -154.24 124.92 7.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.25 -0.906 . . . . 1.97 108.823 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -91.71 134.12 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.97999999999999998 109.923 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mm -110.68 109.11 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.034 -1.099 . . . . 0.19 108.034 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.98 -11.13 19.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.3 -0.875 . . . . 1.97 109.811 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -152.89 154.52 35.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.23000000000000001 109.715 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -51.82 -25.79 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 1.8999999999999999 109.695 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -59.61 -48.61 80.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.25 109.767 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.69 63.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 0.20000000000000001 109.9 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.31 -65.56 0.63 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.124 . . . . 0.20999999999999999 110.011 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -55.51 -46.05 77.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 2.4700000000000002 109.623 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.76 -35.07 72.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 2.1000000000000001 110.027 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.51 90.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.939 -1.101 . . . . 0.20000000000000001 109.735 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.85 -46.59 87.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.62 109.845 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.57 -38.11 89.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 110.089 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.91 -16.52 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.29999999999999999 110.073 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -2.76 8.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 0.23999999999999999 109.925 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -114.79 5.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.28000000000000003 109.555 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -138.42 4.72 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.336 -1.097 . . . . 2.21 109.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.1 168.16 16.17 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.204 -0.935 . . . . 1.8999999999999999 108.748 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.62 162.39 13.11 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.81 -1.181 . . . . 0.17000000000000001 107.81 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.1 t -145.03 109.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.771 -1.206 . . . . 0.12 109.628 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.9 t -102.9 135.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.776 -0.824 . . . . 0.089999999999999997 108.776 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -110.35 134.58 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.17000000000000001 109.383 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.17 101.16 10.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.697 -0.627 . . . . 0.95999999999999996 109.459 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -87.41 76.56 9.04 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 0.23999999999999999 107.933 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -113.72 148.77 35.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.772 -0.58 . . . . 1.03 109.474 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.46 125.24 36.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.542 -0.91 . . . . 0.26000000000000001 108.542 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -65.18 -23.42 67.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.32000000000000001 110.573 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -88.62 -14.76 36.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.053 -1.029 . . . . 0.44 109.976 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.64 118.36 32.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 109.686 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.55 -58.15 16.08 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.717 -0.754 . . . . 0.35999999999999999 111.435 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -47.52 -34.96 21.08 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.806 1.67 . . . . 0.44 111.23 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.22 -60.98 2.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.924 -1.11 . . . . 0.81000000000000005 109.208 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -58.98 -17.04 21.24 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.595 -0.691 . . . . 1.9199999999999999 110.041 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.505 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -58.45 -19.73 39.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 3.1299999999999999 110.523 -178.759 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 38' ' ' ILE . 63.5 mt -96.55 7.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.09 -1.006 . . . . 0.28000000000000003 110.813 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.27 5.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 119.953 -1.717 . . . . 1.6200000000000001 112.645 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -65.16 -7.48 15.68 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 CA-C-N 119.555 0.877 . . . . 0.25 110.04 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -109.52 -74.54 0.65 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.845 . . . . 0.29999999999999999 108.976 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -41.66 -56.63 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.649 -0.657 . . . . 0.13 110.931 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -67.0 -31.04 71.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.022 -1.049 . . . . 0.40999999999999998 110.1 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -65.73 -42.57 90.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.839 -1.163 . . . . 0.96999999999999997 110.534 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -50.39 -17.44 0.47 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.985 -1.072 . . . . 0.5 109.99 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -56.8 -27.77 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.51000000000000001 110.051 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -96.1 -22.1 17.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.142 -0.974 . . . . 2.0 110.323 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -90.32 -19.88 23.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 2.1600000000000001 109.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -132.34 72.1 1.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.692 . . . . 0.23999999999999999 109.257 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.2 p -67.87 -5.31 16.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.412 -0.805 . . . . 0.17000000000000001 109.327 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.9 t-20 -96.47 -0.77 48.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.75 . . . . 0.34000000000000002 109.61 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 145.96 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.249 -0.907 . . . . 0.12 109.472 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.35 132.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.529 -0.732 . . . . 0.17000000000000001 109.371 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.544 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -117.67 130.73 56.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.397 -0.814 . . . . 0.11 109.059 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.2 mp -113.2 172.44 6.94 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.801 -0.814 . . . . 0.12 108.801 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -141.8 143.17 33.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.202 -1.036 . . . . 1.3100000000000001 108.202 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 136.17 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -0.97 . . . . 0.14000000000000001 110.641 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.38 103.13 15.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.448 -0.945 . . . . 1.0800000000000001 108.448 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.485 ' O ' ' NE ' ' B' ' 4' ' ' ARG . 16.1 m -61.19 -8.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.27000000000000002 111.036 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.48 -46.1 5.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 110.856 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -93.12 -14.47 27.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.086 -1.008 . . . . 1.1200000000000001 109.673 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.06 46.18 1.83 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.306 -0.871 . . . . 0.17000000000000001 109.049 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.07 -15.73 2.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 2.2200000000000002 109.66 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.8 p30 -70.12 -41.11 74.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.112 -0.993 . . . . 1.1100000000000001 109.056 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 t -73.55 -46.28 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.949 . . . . 0.19 108.617 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.8 -36.67 83.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.22 108.735 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -64.47 -47.67 78.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.29 109.074 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.09 -34.42 78.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 2.2000000000000002 109.599 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.92 -7.14 54.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.33000000000000002 109.587 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.4 mt-10 51.11 61.12 3.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 2.3399999999999999 110.21 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 35.0 t -78.61 138.07 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.116 -0.99 . . . . 0.28000000000000003 108.996 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -123.03 -9.02 8.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.431 -0.793 . . . . 2.3999999999999999 109.546 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.3 135.6 14.96 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.064 -1.022 . . . . 0.22 109.66 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -114.87 150.6 44.38 Favored Pre-proline 0 N--CA 1.5 2.027 0 N-CA-C 108.117 -1.068 . . . . 0.22 108.117 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.37 146.76 83.57 Favored 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 124.877 -0.885 . . . . 0.20000000000000001 110.205 -1.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.84 121.99 42.19 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.429 -0.952 . . . . 0.17999999999999999 108.429 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CD1' HD21 ' A' ' 97' ' ' LEU . 71.3 m-85 -98.82 115.93 29.9 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.395 -0.965 . . . . 0.14999999999999999 108.395 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.89 141.26 48.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.988 -1.116 . . . . 1.03 107.988 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.5 m-85 -111.17 134.54 52.69 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.49 0.662 . . . . 0.11 110.156 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.37 155.12 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.998 -0.741 . . . . 0.17000000000000001 108.998 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -154.58 123.18 6.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.91 -1.145 . . . . 1.48 107.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt 55.74 30.66 16.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 1.6699999999999999 110.064 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.42 90.52 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.791 -1.195 . . . . 0.22 110.621 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -112.83 145.65 40.27 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.248 -1.148 . . . . 2.0800000000000001 110.319 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -86.88 144.8 26.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 1.7 108.75 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.68 -23.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.41 -0.806 . . . . 0.26000000000000001 110.587 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.94 179.34 47.12 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.28 -1.438 . . . . 0.17999999999999999 110.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.26 158.59 2.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -1.126 . . . . 2.04 110.357 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.98 132.14 1.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.476 -0.765 . . . . 0.14000000000000001 110.195 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 p -104.14 -172.95 2.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.191 -0.943 . . . . 0.17000000000000001 108.608 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 130.76 5.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.353 -1.499 . . . . 0.13 109.353 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.27 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -1.211 . . . . 0.20000000000000001 110.477 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -139.88 71.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.815 -1.18 . . . . 1.1499999999999999 107.815 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.01 -30.51 71.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 1.1899999999999999 110.294 -178.64 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.6 -26.85 67.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.787 -1.196 . . . . 1.95 108.998 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -69.08 -34.14 74.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.486 -0.759 . . . . 2.0499999999999998 109.405 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -50.92 -37.24 42.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.02 -1.05 . . . . 0.14999999999999999 108.82 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.23 -57.17 7.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.395 -0.815 . . . . 2.1499999999999999 109.667 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.02 92.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.14999999999999999 110.509 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.5 m -66.84 -44.2 81.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.13 110.164 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.87 -52.75 55.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.17999999999999999 108.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.1 -16.66 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 1.03 109.977 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.13 -58.28 3.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 2.02 110.484 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.04 14.16 18.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.34999999999999998 110.693 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.494 1.764 0 O-C-N 120.863 -1.148 . . . . 1.1799999999999999 109.199 179.22 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' A' ' 59' ' ' VAL . 13.6 mmm180 . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.693 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -109.59 -168.42 1.33 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.274 -0.892 . . . . 0.0 110.525 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.09 146.95 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.717 0.77 . . . . 0.0 112.114 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -101.16 95.45 6.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.1 pt-20 -83.3 42.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.064 -1.023 . . . . 0.0 110.479 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.81 -130.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.81 20.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 CA-C-N 119.139 1.47 . . . . 0.0 109.05 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.653 ' H ' ' C ' ' B' ' 9' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 3' ' ' LYS . 84.3 t . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.117 -0.698 . . . . 0.29999999999999999 109.117 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.9 tttp -154.99 121.15 5.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.97 109.553 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.417 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 31.6 tt0 -89.54 136.51 32.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.97999999999999998 109.579 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -107.04 113.13 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.606 -1.257 . . . . 0.19 107.606 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' OE1' ' NE2' ' A' ' 4' ' ' GLN . 4.1 mm-40 -99.79 -13.32 19.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 1.97 108.933 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 p -154.09 158.78 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.23000000000000001 109.554 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -52.36 -22.97 5.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 1.8999999999999999 110.037 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -60.93 -51.32 69.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.25 110.671 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.26 -22.53 64.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.20000000000000001 110.014 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.1 -64.19 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.20999999999999999 109.791 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -55.75 -46.72 77.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 2.4700000000000002 109.963 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.94 -35.66 71.42 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.96 -46.51 90.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.20000000000000001 109.563 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.26 -44.79 94.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 0.62 109.721 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.51 -36.8 85.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.727 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.03 -18.84 52.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.29999999999999999 109.776 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -5.94 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.23999999999999999 109.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.68 1.24 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.457 -1.457 . . . . 0.28000000000000003 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -138.13 0.4 2.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 2.21 109.781 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm -69.89 172.21 8.11 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.033 -1.042 . . . . 1.8999999999999999 109.012 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.34 164.42 16.12 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.383 -0.823 . . . . 0.17000000000000001 108.992 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 20.1 t -145.94 105.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.12 109.469 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.7 t -103.67 133.73 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.304 -0.872 . . . . 0.089999999999999997 109.148 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.64 134.07 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.233 -0.654 . . . . 0.17000000000000001 109.233 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -107.87 104.79 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.117 -0.698 . . . . 0.95999999999999996 109.117 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 57.7 m-85 -86.37 82.33 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.736 -1.209 . . . . 0.23999999999999999 107.736 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -113.72 147.82 37.54 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.68 124.2 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.485 -0.931 . . . . 0.26000000000000001 108.485 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -65.51 -24.8 67.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.832 . . . . 0.32000000000000001 110.478 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -88.79 -13.57 39.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.1 . . . . 0.44 109.926 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.7 116.92 29.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.32000000000000001 109.723 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.67 -55.47 30.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.832 -0.699 . . . . 0.35999999999999999 111.742 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.2 Cg_exo -47.86 -35.23 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.6 1.533 . . . . 0.44 111.388 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.57 -60.55 2.32 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.049 -1.032 . . . . 0.81000000000000005 109.194 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.65 -18.07 38.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.748 . . . . 1.9199999999999999 110.052 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.6 tmt? -58.77 -24.89 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 3.1299999999999999 110.389 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -96.31 13.82 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.873 -1.142 . . . . 0.28000000000000003 110.149 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.72 2.89 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.585 -1.322 . . . . 1.6200000000000001 112.164 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.4 Cg_endo -67.94 7.44 0.6 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 CA-C-N 119.6 0.893 . . . . 0.25 110.526 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' LYS . 45.6 m-85 -124.48 -73.7 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.756 -0.831 . . . . 0.29999999999999999 108.756 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -43.44 -55.76 3.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 0.13 110.266 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.85 -27.33 66.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.40999999999999998 109.869 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 46' ' ' SER . 1.4 p -65.13 -44.92 87.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.96999999999999997 110.068 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.8 mt -49.15 -14.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.5 109.706 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 68.0 m -57.66 -32.14 67.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.993 -1.067 . . . . 0.51000000000000001 109.743 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -94.91 -19.57 20.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.963 . . . . 2.0 110.141 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -91.4 -21.69 20.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.954 -1.091 . . . . 2.1600000000000001 109.584 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -134.2 72.76 1.47 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.502 -0.749 . . . . 0.23999999999999999 109.384 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 p -68.59 -6.9 28.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.383 -0.823 . . . . 0.17000000000000001 109.35 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -96.31 0.92 51.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.352 -0.842 . . . . 0.34000000000000002 109.881 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' C ' HD13 ' A' ' 53' ' ' ILE . 98.6 t -112.76 146.35 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.349 -0.982 . . . . 0.12 108.349 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' C ' ' A' ' 52' ' ' VAL . 4.9 mm -100.42 119.42 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.17000000000000001 109.538 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.571 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -108.77 130.04 55.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.786 -0.82 . . . . 0.11 108.786 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -111.9 172.82 6.67 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -142.12 144.12 33.36 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.053 -1.091 . . . . 1.3100000000000001 108.053 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -141.73 142.53 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.111 -0.993 . . . . 0.14000000000000001 110.858 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 21.4 t70 -99.0 96.47 7.84 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 74' ' ' THR . 10.3 m -56.59 -3.06 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.27000000000000002 110.833 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 37.7 m-20 -105.05 -46.28 4.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.118 -0.989 . . . . 1.1100000000000001 110.991 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.04 -23.56 16.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.106 -0.996 . . . . 1.1200000000000001 110.296 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' N ' ' A' ' 64' ' ' ASP . . . -105.32 41.81 1.31 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.12 -0.988 . . . . 0.17000000000000001 108.967 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 35.4 tt0 -54.98 -10.84 0.54 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.397 -0.815 . . . . 2.2200000000000002 109.825 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -68.9 -43.62 74.87 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.14 -0.975 . . . . 1.1100000000000001 108.768 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.34 -45.71 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.302 -0.999 . . . . 0.19 108.302 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.79 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 6.6 m -64.0 -54.01 41.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 1.29 109.304 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.2 -33.41 75.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.476 -0.765 . . . . 2.2000000000000002 110.019 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.37 1.2 54.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.069 -1.019 . . . . 0.33000000000000002 109.859 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 67' ' ' SER . 15.0 mp0 45.0 50.46 9.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.278 -0.889 . . . . 2.3399999999999999 110.243 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.34 130.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.28000000000000003 108.91 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.12 7.61 5.07 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.396 -0.815 . . . . 2.3999999999999999 110.024 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.63 134.27 14.58 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.161 -0.962 . . . . 0.22 108.93 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.574 HG23 ' HE1' ' B' ' 5' ' ' TYR . 23.5 p -119.78 150.24 50.07 Favored Pre-proline 0 N--CA 1.508 2.441 0 O-C-N 121.227 -0.921 . . . . 0.22 108.925 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -76.88 145.22 80.86 Favored 'Cis proline' 0 N--CA 1.486 1.057 0 C-N-CA 124.893 -0.878 . . . . 0.20000000000000001 110.758 -2.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.81 122.03 45.09 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.7 -1.222 . . . . 0.17999999999999999 107.7 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.5 m-85 -99.26 121.08 40.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.14999999999999999 108.822 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.515 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.1 mt-30 -119.62 135.74 54.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.894 -1.15 . . . . 1.03 107.894 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.7 m-85 -109.93 126.57 54.03 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.461 0.648 . . . . 0.11 109.764 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -126.06 156.93 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.601 -0.888 . . . . 0.17000000000000001 108.601 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.55 126.09 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.786 -1.19 . . . . 1.48 107.786 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 55.05 25.27 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 1.6699999999999999 109.951 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.15 6.51 84.48 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.909 -1.138 . . . . 0.22 110.347 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.28 146.78 40.01 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -1.076 . . . . 2.0800000000000001 109.956 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -85.91 143.88 27.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.7 109.529 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.78 -27.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.423 -0.798 . . . . 0.26000000000000001 110.315 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.43 177.99 45.57 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.388 -1.387 . . . . 0.17999999999999999 110.415 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -174.08 154.14 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 2.04 110.299 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.0 p90 -169.05 133.11 1.41 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.516 -0.74 . . . . 0.14000000000000001 109.982 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -105.51 -175.03 2.68 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.136 -0.978 . . . . 0.17000000000000001 108.44 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 98.1 133.83 8.11 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.622 -1.391 . . . . 0.13 109.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.24 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.20000000000000001 110.136 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.2 t-20 -139.89 72.45 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.466 -0.939 . . . . 1.1499999999999999 108.466 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.54 -0.725 . . . . 1.1899999999999999 110.781 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -64.76 -26.6 68.42 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -68.82 -35.46 77.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.435 -0.79 . . . . 2.0499999999999998 109.17 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.4 mt -51.13 -36.11 39.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.017 . . . . 0.14999999999999999 108.906 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.96 -58.5 5.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 2.1499999999999999 109.34 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.26 90.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.14999999999999999 110.327 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -67.61 -48.11 67.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -0.965 . . . . 0.13 110.31 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mt -62.46 -50.11 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.024 -1.048 . . . . 0.17999999999999999 108.785 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -59.41 -17.27 29.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.03 109.538 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.06 -62.16 1.74 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 2.02 110.009 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.21 21.17 5.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.34999999999999998 110.494 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.236 179.585 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.432 ' HG2' HH11 ' B' ' 4' ' ' ARG . 1.1 tpt180 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -108.97 -164.89 0.97 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.757 -1.214 . . . . 0.0 110.821 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.86 149.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.247 -0.908 . . . . 0.0 112.839 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.71 95.53 6.49 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.407 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 7.3 pt-20 -84.01 42.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.024 -1.047 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.08 -133.93 0.05 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.29 21.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.322 -0.841 0 CA-C-N 119.154 1.477 . . . . 0.0 109.649 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.411 -0.806 . . . . 0.0 109.413 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 72.5 t . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.131 -0.692 . . . . 0.29999999999999999 109.131 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -154.6 122.58 5.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 1.97 109.351 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -89.23 135.97 33.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.325 -0.859 . . . . 0.97999999999999998 109.447 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -106.03 123.16 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 8.9 mp0 -107.92 -15.2 14.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.25 -0.906 . . . . 1.97 109.627 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.8 p -152.16 159.23 43.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.23000000000000001 109.695 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.32 -30.86 30.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 1.8999999999999999 109.861 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -59.53 -44.25 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.078 . . . . 0.25 109.679 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.19 -27.23 64.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.20000000000000001 109.775 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.49 -69.0 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.20999999999999999 110.216 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -55.27 -42.04 73.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 2.4700000000000002 109.61 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -58.99 -36.89 75.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.14 -0.975 . . . . 2.1000000000000001 109.474 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.34 95.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.20000000000000001 109.088 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 13.6 mt -64.6 -47.8 77.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.458 -0.776 . . . . 0.62 109.734 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.04 -37.77 88.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.701 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.52 -16.53 54.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.29999999999999999 109.616 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.07 -7.39 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.23999999999999999 109.844 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 -111.01 3.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.535 -1.426 . . . . 0.28000000000000003 109.535 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.64 4.72 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.254 -1.145 . . . . 2.21 109.436 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -70.05 168.02 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 1.8999999999999999 109.193 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.34 163.59 12.8 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.045 -1.094 . . . . 0.17000000000000001 108.045 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.2 t -145.26 105.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.016 -1.052 . . . . 0.12 109.797 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.18 133.42 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.284 -1.006 . . . . 0.089999999999999997 108.284 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -110.53 134.58 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.17000000000000001 109.827 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.75 101.36 10.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.08 -0.711 . . . . 0.95999999999999996 109.08 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 57' ' ' VAL . 43.5 m-85 -86.14 79.23 9.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.566 -1.272 . . . . 0.23999999999999999 107.566 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -113.44 148.61 35.57 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.415 0.626 . . . . 1.03 109.748 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.66 124.23 34.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.131 -1.063 . . . . 0.26000000000000001 108.131 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -64.97 -23.11 67.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 0.32000000000000001 110.484 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -89.84 -13.29 36.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.013 -1.054 . . . . 0.44 110.405 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.88 137.78 32.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.32000000000000001 109.886 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.16 -59.15 3.19 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.739 -0.744 . . . . 0.35999999999999999 111.355 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -46.1 -43.41 20.53 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.77 1.647 . . . . 0.44 111.766 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.84 -55.19 6.07 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.728 -1.232 . . . . 0.81000000000000005 109.048 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -60.45 -20.66 60.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.413 -0.804 . . . . 1.9199999999999999 110.225 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLY . 35.6 tpp -59.82 -20.5 57.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 3.1299999999999999 110.557 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.709 ' O ' HG22 ' A' ' 38' ' ' ILE . 81.8 mt -97.53 11.18 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.992 -1.067 . . . . 0.28000000000000003 111.686 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.78 -34.08 9.83 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.02 -1.675 . . . . 1.6200000000000001 112.63 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.52 -11.86 25.24 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 CA-C-N 119.742 0.944 . . . . 0.25 110.803 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -102.76 -68.29 0.84 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.248 -0.908 . . . . 0.29999999999999999 109.693 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -45.42 -51.31 11.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.422 -0.799 . . . . 0.13 110.556 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.83 -34.7 75.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.937 -1.102 . . . . 0.40999999999999998 110.111 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 -41.14 94.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.96999999999999997 110.153 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.0 mt -51.4 -15.6 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.5 109.692 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.412 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 69.2 m -58.15 -31.7 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.51000000000000001 109.902 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -94.84 -20.76 19.18 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.273 -0.892 . . . . 2.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -90.34 -21.52 21.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 2.1600000000000001 109.341 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -133.71 68.54 1.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.577 -0.702 . . . . 0.23999999999999999 109.375 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.3 p -67.45 -5.54 15.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.17000000000000001 108.915 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 24.1 t-20 -95.84 4.0 53.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.34000000000000002 109.646 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -118.76 149.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.212 -0.662 . . . . 0.12 109.212 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -101.94 128.56 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.421 -0.8 . . . . 0.17000000000000001 109.223 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.4 m-85 -115.03 132.01 56.74 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.438 -0.788 . . . . 0.11 109.176 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.95 173.89 6.26 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.474 -0.766 . . . . 0.12 109.197 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -143.83 144.89 31.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.021 -1.103 . . . . 1.3100000000000001 108.021 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 27' ' ' PHE . 69.7 t -141.6 139.63 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.141 -0.975 . . . . 0.14000000000000001 110.521 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.21 100.44 11.55 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.204 -1.035 . . . . 1.0800000000000001 108.204 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -60.67 -1.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.275 -0.891 . . . . 0.27000000000000002 111.482 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.68 -41.23 3.64 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.13 -0.981 . . . . 1.1100000000000001 111.002 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.0 -13.14 29.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.581 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 50.45 1.79 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.17000000000000001 108.586 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -54.93 -15.23 1.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.522 -0.736 . . . . 2.2200000000000002 109.701 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.62 -39.88 73.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.992 . . . . 1.1100000000000001 109.364 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.75 -47.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.16 -0.963 . . . . 0.19 108.676 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.46 -36.21 83.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.22 109.288 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -63.35 -44.87 93.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 1.29 108.968 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.59 -44.06 95.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.712 -0.847 . . . . 2.2000000000000002 108.712 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 70' ' ' GLU . . . -89.06 10.45 21.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.33000000000000002 109.519 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 66' ' ' ALA . 5.2 pt-20 31.73 56.06 0.3 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.409 0.623 . . . . 2.3399999999999999 111.362 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 t -79.67 134.32 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.28000000000000003 109.037 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 62.7 mttm -129.66 8.7 5.39 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.47 -0.769 . . . . 2.3999999999999999 109.861 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.45 135.11 15.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.133 -0.98 . . . . 0.22 108.902 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.519 HG23 ' CE2' ' B' ' 5' ' ' TYR . 70.6 p -121.03 149.53 51.38 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.835 . . . . 0.22 109.172 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.51 144.17 74.09 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 C-N-CA 124.962 -0.849 . . . . 0.20000000000000001 110.197 -1.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.27 113.22 24.31 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.387 -1.338 . . . . 0.17999999999999999 107.387 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.1 m-85 -89.68 119.92 30.51 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.215 -0.994 . . . . 0.14999999999999999 108.734 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -118.92 136.08 54.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.925 -1.139 . . . . 1.03 107.925 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.2 m-85 -110.14 127.0 54.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.381 0.61 . . . . 0.11 109.568 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.98 157.54 35.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.752 -0.833 . . . . 0.17000000000000001 108.752 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -154.8 123.66 6.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 57.09 27.65 13.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 1.6699999999999999 110.078 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.8 87.94 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.025 -1.083 . . . . 0.22 110.427 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -112.98 146.46 39.02 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.357 -1.084 . . . . 2.0800000000000001 110.282 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -85.61 139.52 31.35 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.766 -0.828 . . . . 1.7 108.766 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.61 -21.46 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.474 -0.766 . . . . 0.26000000000000001 110.195 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.94 176.12 47.77 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.498 -1.334 . . . . 0.17999999999999999 110.397 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.51 159.01 3.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -1.072 . . . . 2.04 110.336 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -169.0 130.84 1.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.466 -0.772 . . . . 0.14000000000000001 109.811 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 p -103.27 -163.73 1.01 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.07 -1.018 . . . . 0.17000000000000001 108.538 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 127.04 1.03 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.19 -1.564 . . . . 0.13 109.19 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.497 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.53 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -1.16 . . . . 0.20000000000000001 110.726 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -137.71 73.77 1.45 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.032 -1.099 . . . . 1.1499999999999999 108.032 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -35.82 80.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.878 -0.514 . . . . 1.1899999999999999 110.895 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.52 -27.09 68.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.97 -1.081 . . . . 1.95 109.507 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -69.65 -33.7 72.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 2.0499999999999998 109.759 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.8 mt -49.82 -36.08 25.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.067 -1.021 . . . . 0.14999999999999999 109.071 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.35 -58.24 5.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.482 -0.761 . . . . 2.1499999999999999 110.025 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.25 77.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.405 -0.809 . . . . 0.14999999999999999 111.273 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.458 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.9 m -67.47 -46.76 72.06 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.859 -1.151 . . . . 0.13 110.758 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.25 -52.19 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.17999999999999999 109.46 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -59.71 -17.88 38.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 1.03 109.745 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.4 -59.65 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 2.02 110.516 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt -92.93 17.37 10.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.34999999999999998 110.561 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.085 . . . . 1.1799999999999999 109.31 179.296 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -130.44 -168.62 2.0 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.8 148.25 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.007 0.908 . . . . 0.0 112.809 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.36 95.08 6.27 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.46 46.44 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.921 -1.112 . . . . 0.0 110.217 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.01 -130.69 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.06 20.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 CA-C-N 119.322 1.561 . . . . 0.0 109.009 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.39 -0.819 . . . . 0.0 109.506 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 39.8 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 108.934 -0.765 . . . . 0.29999999999999999 108.934 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.3 tttt -154.28 123.54 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.019 -1.051 . . . . 1.97 109.468 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -90.65 134.4 34.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.835 . . . . 0.97999999999999998 110.087 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.99 114.11 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.724 -1.213 . . . . 0.19 107.724 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.08 -13.68 18.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.962 . . . . 1.97 109.724 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 p -153.72 158.76 41.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.114 -0.991 . . . . 0.23000000000000001 109.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -52.1 -21.36 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.722 . . . . 1.8999999999999999 109.663 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 21.1 m -61.73 -56.08 23.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.25 110.116 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.3 -18.06 64.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.20000000000000001 110.262 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.93 -60.85 3.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.068 . . . . 0.20999999999999999 110.523 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.96 -44.35 97.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.016 . . . . 2.4700000000000002 109.638 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -60.77 -32.58 71.9 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.471 -0.768 . . . . 2.1000000000000001 110.389 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.34 85.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.853 -1.155 . . . . 0.20000000000000001 109.121 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.09 -43.55 95.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.62 109.367 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.71 -40.07 94.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 1.0900000000000001 109.806 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.71 -17.19 54.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.29999999999999999 109.85 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.61 26.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.23999999999999999 109.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.46 18.22 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.365 -1.494 . . . . 0.28000000000000003 109.365 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.18 2.68 8.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.553 -0.969 . . . . 2.21 109.627 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -69.35 167.05 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.013 -1.054 . . . . 1.8999999999999999 108.739 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.96 164.29 8.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.196 -1.038 . . . . 0.17000000000000001 108.196 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.7 t -146.05 106.84 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.957 -1.089 . . . . 0.12 109.525 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.49 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.644 -0.873 . . . . 0.089999999999999997 108.644 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.15 139.13 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.626 -0.671 . . . . 0.17000000000000001 109.821 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.58 99.63 8.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.632 -0.668 . . . . 0.95999999999999996 109.248 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -85.41 80.59 9.06 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.898 -1.149 . . . . 0.23999999999999999 107.898 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -106.48 -163.6 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 1.03 109.633 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.35 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.573 -0.899 . . . . 0.26000000000000001 108.573 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -64.43 -26.92 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.32000000000000001 110.77 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -88.39 -16.54 32.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.979 -1.076 . . . . 0.44 110.009 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.25 120.12 35.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 0.32000000000000001 109.809 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.03 -52.98 36.58 Favored Glycine 0 N--CA 1.486 1.992 0 O-C-N 121.519 -0.738 . . . . 0.35999999999999999 111.548 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.3 Cg_exo -49.21 -37.04 38.49 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.664 1.576 . . . . 0.44 111.386 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.68 1.04 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.884 -1.135 . . . . 0.81000000000000005 108.993 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.12 -15.04 20.11 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.517 -0.74 . . . . 1.9199999999999999 110.332 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 tpt -59.94 -21.51 61.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 3.1299999999999999 109.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 38' ' ' ILE . 50.1 mt -96.93 15.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 110.44 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.53 -31.26 2.93 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.687 -1.258 . . . . 1.6200000000000001 112.153 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.74 -5.52 10.58 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 CA-C-N 119.798 0.963 . . . . 0.25 109.799 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 39.1 m-85 -109.72 -78.42 0.59 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.832 -0.803 . . . . 0.29999999999999999 108.832 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 94.0 t80 -40.46 -58.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.73 -0.606 . . . . 0.13 111.083 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.53 -30.9 71.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.03 . . . . 0.40999999999999998 109.939 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.8 t -65.47 -40.48 93.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.91 -1.119 . . . . 0.96999999999999997 110.28 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.6 mt -50.24 -15.93 0.28 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.99 -1.069 . . . . 0.5 109.713 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -57.29 -29.48 63.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.065 -1.022 . . . . 0.51000000000000001 109.917 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.73 -21.04 17.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.0 110.226 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -90.98 -22.19 20.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.994 -1.066 . . . . 2.1600000000000001 109.747 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -133.54 69.78 1.47 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.511 -0.743 . . . . 0.23999999999999999 109.275 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -67.85 -5.95 19.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.465 -0.772 . . . . 0.17000000000000001 109.243 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -94.49 3.78 54.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.34000000000000002 109.457 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.5 t -121.11 145.38 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.701 -0.852 . . . . 0.12 108.701 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -97.86 129.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.242 -0.911 . . . . 0.17000000000000001 109.422 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -114.73 130.93 56.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.315 -0.866 . . . . 0.11 109.423 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.61 172.83 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.959 -0.756 . . . . 0.12 108.959 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.89 142.2 30.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.992 -1.114 . . . . 1.3100000000000001 107.992 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.4 t -142.2 136.69 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.121 -0.987 . . . . 0.14000000000000001 110.774 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 24.0 t70 -96.99 111.45 23.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.996 -1.113 . . . . 1.0800000000000001 107.996 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.33 -12.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.27000000000000002 110.749 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.85 -44.41 6.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.013 -1.055 . . . . 1.1100000000000001 111.021 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -91.93 -15.35 28.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 1.1200000000000001 109.459 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -117.24 43.05 2.41 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.632 -0.877 . . . . 0.17000000000000001 108.632 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.14 -15.35 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.415 -0.803 . . . . 2.2200000000000002 109.762 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -40.22 74.35 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.256 -0.903 . . . . 1.1100000000000001 109.002 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.26 -45.77 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.679 -0.86 . . . . 0.19 108.679 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.28 -32.52 73.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.22 108.956 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -64.03 -48.94 74.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 1.29 109.271 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.08 -38.5 91.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.321 -0.862 . . . . 2.2000000000000002 109.535 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.53 58.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.212 -0.93 . . . . 0.33000000000000002 109.697 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.2 mt-10 46.66 57.74 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 2.3399999999999999 110.284 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.07 132.28 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.28000000000000003 108.916 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.37 2.0 8.41 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.402 -0.811 . . . . 2.3999999999999999 110.244 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.79 131.33 13.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.968 -1.083 . . . . 0.22 109.061 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 46.9 p -116.56 149.72 44.31 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.48 -0.762 . . . . 0.22 109.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.61 145.91 80.78 Favored 'Cis proline' 0 N--CA 1.487 1.091 0 C-N-CA 124.934 -0.861 . . . . 0.20000000000000001 110.071 -1.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.96 113.42 23.24 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.713 -1.217 . . . . 0.17999999999999999 107.713 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -87.56 126.78 35.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.881 -1.137 . . . . 0.14999999999999999 108.939 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -124.33 133.82 53.34 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.702 -1.221 . . . . 1.03 107.702 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' CD2' HG22 ' A' ' 24' ' ' VAL . 25.3 m-85 -108.22 127.66 54.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.11 109.619 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -125.69 156.66 38.96 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.714 -0.847 . . . . 0.17000000000000001 108.714 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -153.86 124.97 7.36 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.558 -1.275 . . . . 1.48 107.558 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.7 mttt 56.64 20.15 4.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.569 -0.707 . . . . 1.6699999999999999 109.884 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.38 2.51 70.46 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.319 -1.112 . . . . 0.22 110.319 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -110.35 148.12 32.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.258 -1.143 . . . . 2.0800000000000001 110.057 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -85.01 140.43 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.827 . . . . 1.7 109.274 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.98 -3.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.461 -0.775 . . . . 0.26000000000000001 110.176 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.81 170.74 30.17 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.491 -1.338 . . . . 0.17999999999999999 110.63 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.08 155.52 3.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -1.065 . . . . 2.04 110.134 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.58 131.7 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.14000000000000001 110.439 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.9 p -101.55 -165.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.134 -0.979 . . . . 0.17000000000000001 108.875 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.13 131.49 2.85 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.143 -1.583 . . . . 0.13 109.143 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -61.13 96.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -1.166 . . . . 0.20000000000000001 110.837 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -143.06 77.6 1.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.372 -0.973 . . . . 1.1499999999999999 108.372 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.78 -33.59 76.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.381 -0.825 . . . . 1.1899999999999999 110.65 -178.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.38 -26.15 67.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.891 -1.131 . . . . 1.95 109.179 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -68.38 -36.49 79.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.81 . . . . 2.0499999999999998 109.257 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.5 mt -52.39 -37.04 55.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.14999999999999999 108.775 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.85 -58.92 4.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 2.1499999999999999 109.76 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.54 89.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.14999999999999999 110.865 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 m -66.58 -46.85 74.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.087 -1.008 . . . . 0.13 110.467 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.1 -51.95 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.17999999999999999 108.853 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -61.18 -16.47 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 1.03 109.688 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.57 -56.2 4.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 2.02 110.342 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 22' ' ' LEU . 22.4 mt -92.84 13.24 21.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.34999999999999998 110.527 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.942 -1.098 . . . . 1.1799999999999999 109.394 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -128.2 -166.81 1.67 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.293 -0.879 . . . . 0.0 110.55 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.9 143.18 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.375 -0.828 . . . . 0.0 112.633 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.78 94.76 6.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.16 46.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 110.134 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.08 -133.83 0.15 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.95 27.73 0.15 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 CA-C-N 119.325 1.563 . . . . 0.0 109.049 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 3' ' ' LYS . 91.9 t . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.326 -0.62 . . . . 0.29999999999999999 109.326 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.4 tttm -154.56 125.48 7.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 1.97 109.079 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.39 130.66 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.97999999999999998 109.994 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mm -106.08 112.87 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.768 -1.197 . . . . 0.19 107.768 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.42 -15.12 18.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.139 -0.975 . . . . 1.97 109.641 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 p -154.12 159.87 41.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.23000000000000001 109.698 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 26.7 tttp -51.57 -22.7 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 1.8999999999999999 109.293 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -60.38 -52.37 65.51 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.895 . . . . 0.25 109.869 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -22.7 63.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.20000000000000001 109.889 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.49 -65.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.20999999999999999 109.708 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -55.04 -45.62 75.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.951 . . . . 2.4700000000000002 109.727 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.62 -36.22 73.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.303 -0.873 . . . . 2.1000000000000001 109.973 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.49 86.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 0.20000000000000001 109.409 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.04 -46.85 79.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.738 . . . . 0.62 110.02 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.82 -41.2 97.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 110.067 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.88 -17.21 53.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.29999999999999999 109.646 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -6.7 27.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.23999999999999999 109.566 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 -133.47 24.73 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.434 -1.466 . . . . 0.28000000000000003 109.434 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.74 6.11 13.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.363 -1.081 . . . . 2.21 109.6 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.66 166.82 19.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.062 -1.024 . . . . 1.8999999999999999 109.252 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.38 160.71 15.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 0.17000000000000001 108.494 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.619 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.6 t -144.61 109.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.994 . . . . 0.12 109.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.32 133.85 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.665 -0.865 . . . . 0.089999999999999997 108.665 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.45 141.95 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.431 -0.793 . . . . 0.17000000000000001 109.869 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -111.41 99.89 8.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.924 -0.769 . . . . 0.95999999999999996 108.924 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.58 80.04 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.903 -1.147 . . . . 0.23999999999999999 107.903 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -113.3 150.01 33.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.79 -0.569 . . . . 1.03 109.718 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.39 126.4 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.568 -0.901 . . . . 0.26000000000000001 108.568 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -65.98 -25.89 67.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32000000000000001 110.662 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 50.5 p-90 -87.7 -10.7 50.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.44 109.942 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -97.51 127.52 43.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.477 -0.764 . . . . 0.32000000000000001 109.591 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.94 -55.83 10.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.145 -0.782 . . . . 0.35999999999999999 111.145 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.78 -39.64 38.85 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.912 1.742 . . . . 0.44 111.605 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -61.84 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.675 -1.266 . . . . 0.81000000000000005 109.243 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -58.98 -20.12 49.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.261 -0.899 . . . . 1.9199999999999999 109.82 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.7 ttt -60.37 -18.33 49.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 3.1299999999999999 110.249 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.473 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -99.64 8.02 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.26 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.75 -31.96 5.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.648 -1.283 . . . . 1.6200000000000001 112.453 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.1 Cg_exo -62.03 -7.71 10.37 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.757 0.949 . . . . 0.25 109.81 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -106.28 -74.49 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.032 -0.729 . . . . 0.29999999999999999 109.032 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -44.49 -56.08 4.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.754 . . . . 0.13 110.792 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.75 -32.04 73.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.113 -0.992 . . . . 0.40999999999999998 109.877 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 t -64.96 -41.45 95.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.96999999999999997 110.049 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.99 -14.64 0.23 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.5 109.81 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -56.61 -32.37 65.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.038 -1.039 . . . . 0.51000000000000001 109.926 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -95.09 -17.12 22.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 2.0 110.368 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -91.0 -23.51 20.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.123 -0.986 . . . . 2.1600000000000001 109.187 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.5 66.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.556 -0.715 . . . . 0.23999999999999999 109.245 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -66.68 -1.91 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.339 -0.851 . . . . 0.17000000000000001 109.0 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 34.1 t-20 -94.94 -7.38 40.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.424 -0.797 . . . . 0.34000000000000002 109.124 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.4 t -112.65 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.418 -0.801 . . . . 0.12 109.026 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -100.37 125.48 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.052 -0.721 . . . . 0.17000000000000001 109.052 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.585 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.6 m-85 -109.09 132.57 53.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.11 108.996 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -113.11 169.56 8.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.679 -0.86 . . . . 0.12 108.679 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.01 143.32 34.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.729 -1.212 . . . . 1.3100000000000001 107.729 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.8 t -141.38 138.01 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.14000000000000001 111.045 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.81 96.92 8.9 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.049 -1.093 . . . . 1.0800000000000001 108.049 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 m -54.63 -8.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.27000000000000002 111.464 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.46 -44.07 5.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 110.672 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.91 -9.09 41.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.167 -0.958 . . . . 1.1200000000000001 109.323 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.15 43.3 3.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.708 -0.849 . . . . 0.17000000000000001 108.708 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.92 -15.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.802 . . . . 2.2200000000000002 109.669 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.19 -39.86 74.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 1.1100000000000001 108.913 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.7 t -74.42 -46.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.19 108.51 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.96 75.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.868 . . . . 0.22 108.96 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -64.29 -47.91 77.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.405 -0.81 . . . . 1.29 109.065 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.53 -36.9 85.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.811 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.36 59.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.156 -0.965 . . . . 0.33000000000000002 110.166 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 49.57 55.81 8.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.05 -1.031 . . . . 2.3399999999999999 109.813 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.5 137.51 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.28000000000000003 109.638 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -128.8 -4.94 5.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 2.3999999999999999 109.465 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.562 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.64 136.39 15.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.968 -1.082 . . . . 0.22 110.006 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.606 HG23 ' CE2' ' B' ' 5' ' ' TYR . 48.3 p -115.58 150.35 44.55 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.362 -0.836 . . . . 0.22 108.747 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.66 143.16 73.38 Favored 'Cis proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.842 -0.899 . . . . 0.20000000000000001 110.13 -2.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.27 115.5 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.13 -1.063 . . . . 0.17999999999999999 108.13 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.495 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.7 m-85 -91.45 115.42 28.02 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.378 -0.929 . . . . 0.14999999999999999 108.568 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.23 136.33 53.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.559 -1.274 . . . . 1.03 107.559 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 100' ' ' THR . 27.9 m-85 -107.75 127.38 53.64 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.596 0.713 . . . . 0.11 109.978 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.17 156.97 31.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.376 -0.972 . . . . 0.17000000000000001 108.376 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -155.97 123.52 5.53 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.501 -1.296 . . . . 1.48 107.501 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.1 mttm 57.89 16.54 3.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.495 -0.753 . . . . 1.6699999999999999 109.544 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.87 61.68 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.424 -1.07 . . . . 0.22 110.424 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -110.04 149.91 29.31 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.154 -1.203 . . . . 2.0800000000000001 110.435 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -85.58 143.72 28.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.685 . . . . 1.7 109.456 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.27 -21.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.575 -0.703 . . . . 0.26000000000000001 110.222 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.94 175.0 45.98 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.652 -1.261 . . . . 0.17999999999999999 110.003 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -173.79 154.4 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -1.176 . . . . 2.04 110.232 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.5 132.09 1.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 0.14000000000000001 109.772 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -104.23 -162.07 0.87 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.17000000000000001 109.1 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.41 133.82 1.56 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.13 109.577 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.71 97.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -1.19 . . . . 0.20000000000000001 110.553 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -141.51 72.36 1.38 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.72 -0.844 . . . . 1.1499999999999999 108.72 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.69 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.88 . . . . 1.1899999999999999 110.431 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.9 -31.29 71.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.025 -1.047 . . . . 1.95 109.467 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -67.87 -33.63 75.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 2.0499999999999998 109.787 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.2 mt -51.46 -36.03 42.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.992 -1.068 . . . . 0.14999999999999999 108.646 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.27 -55.74 14.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 2.1499999999999999 109.448 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.38 94.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.14999999999999999 110.946 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.454 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 19.4 m -67.3 -45.97 74.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.923 -1.111 . . . . 0.13 110.44 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.71 -51.39 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.17999999999999999 109.037 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -60.01 -18.57 46.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 1.03 109.633 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -76.44 -61.98 1.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 2.02 110.276 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 mt -91.68 21.61 4.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.34999999999999998 110.534 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.902 -1.124 . . . . 1.1799999999999999 109.315 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.606 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -111.96 -167.68 1.21 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.778 -1.201 . . . . 0.0 110.47 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.34 149.32 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.308 -0.87 . . . . 0.0 112.428 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.67 95.61 6.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.414 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.72 47.5 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.807 -1.183 . . . . 0.0 110.061 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.94 -129.98 0.23 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -69.72 25.07 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.609 ' H ' ' C ' ' B' ' 9' ' ' GLY . 41.9 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.533 -0.73 . . . . 0.0 109.555 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.5 t . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.524 -0.547 . . . . 0.29999999999999999 109.524 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 74.9 tttt -155.13 130.56 9.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.199 -0.938 . . . . 1.97 109.124 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -88.69 138.19 31.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.106 -0.996 . . . . 0.97999999999999998 109.752 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.3 93.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.58 -0.896 . . . . 0.19 108.58 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -96.72 -1.01 47.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.014 -1.054 . . . . 1.97 109.538 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.5 p -151.85 147.82 27.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.975 -1.078 . . . . 0.23000000000000001 110.184 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 54.3 tttt -52.43 -29.25 23.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 1.8999999999999999 109.687 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -60.53 -45.55 93.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.034 -1.041 . . . . 0.25 109.557 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.45 65.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.20000000000000001 109.61 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.85 -65.69 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.20999999999999999 109.534 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -55.66 -46.34 77.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 2.4700000000000002 109.818 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -58.12 -34.49 70.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.094 -1.004 . . . . 2.1000000000000001 109.648 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.09 86.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.20000000000000001 109.0 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.7 -44.64 93.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.369 -0.832 . . . . 0.62 109.387 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.08 -37.98 89.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.049 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.12 53.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.29999999999999999 109.492 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.17 61.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.23999999999999999 109.544 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 -109.33 2.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.993 -1.243 . . . . 0.28000000000000003 109.993 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.1 t0 -136.37 -0.46 2.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.384 -1.068 . . . . 2.21 109.32 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.47 163.31 23.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.664 -1.273 . . . . 1.8999999999999999 108.505 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -62.24 163.63 8.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.115 -1.068 . . . . 0.17000000000000001 108.115 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.5 t -143.62 108.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.979 -1.076 . . . . 0.12 109.827 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.4 133.54 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.642 -0.873 . . . . 0.089999999999999997 108.642 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.28 137.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.477 -0.764 . . . . 0.17000000000000001 109.736 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.84 104.57 13.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.584 -0.698 . . . . 0.95999999999999996 109.207 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.438 ' CE2' HG11 ' A' ' 57' ' ' VAL . 37.5 m-85 -86.86 80.0 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.932 -1.136 . . . . 0.23999999999999999 107.932 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.1 m -114.4 147.74 38.75 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.436 0.636 . . . . 1.03 109.563 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -91.71 123.1 34.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.26000000000000001 108.681 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -65.93 -21.14 66.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.25 -0.906 . . . . 0.32000000000000001 110.319 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.495 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.4 p-90 -88.52 -16.99 31.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.059 . . . . 0.44 109.915 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -91.49 136.65 32.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.906 . . . . 0.32000000000000001 110.209 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.28 -58.17 4.78 Favored Glycine 0 N--CA 1.491 2.313 0 O-C-N 121.679 -0.638 . . . . 0.35999999999999999 111.535 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.7 -33.38 31.7 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 C-N-CA 121.597 1.532 . . . . 0.44 111.4 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -60.38 2.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.835 -1.166 . . . . 0.81000000000000005 108.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.69 -21.98 55.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 1.9199999999999999 109.887 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.1 ttm -60.58 -21.4 62.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.201 -0.937 . . . . 3.1299999999999999 110.533 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 38' ' ' ILE . 54.0 mt -101.08 8.5 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.097 -1.002 . . . . 0.28000000000000003 110.91 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.7 -32.44 5.99 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 117.923 -1.511 . . . . 1.6200000000000001 112.709 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.3 Cg_exo -60.81 -11.61 18.52 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 CA-C-N 119.906 1.002 . . . . 0.25 110.267 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.78 -70.3 0.74 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.29999999999999999 109.527 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -45.01 -51.24 10.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.13 110.658 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.97 -33.83 75.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.40999999999999998 109.617 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.78 -42.76 99.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 0.96999999999999997 109.786 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.4 mt -51.9 -19.6 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.073 . . . . 0.5 109.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -56.85 -32.92 66.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.51000000000000001 109.275 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.64 -16.86 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 2.0 109.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -90.09 -20.94 22.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 2.1600000000000001 108.959 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.34 71.14 1.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.23999999999999999 109.241 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.3 p -66.89 -4.7 10.04 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.9 . . . . 0.17000000000000001 108.931 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.79 1.86 51.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.34000000000000002 109.731 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -119.04 150.35 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.519 -0.738 . . . . 0.12 109.389 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.66 131.68 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.304 -0.872 . . . . 0.17000000000000001 109.183 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 86.4 m-85 -117.84 132.49 56.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.211 -0.931 . . . . 0.11 109.262 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -114.21 174.85 5.74 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.374 -0.829 . . . . 0.12 109.039 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -142.69 142.57 32.04 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.084 -1.08 . . . . 1.3100000000000001 108.084 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 27' ' ' PHE . 44.6 t -139.74 133.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.109 -0.994 . . . . 0.14000000000000001 110.447 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.72 105.16 17.27 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.107 -1.071 . . . . 1.0800000000000001 108.107 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.6 m -59.33 -4.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.804 . . . . 0.27000000000000002 111.171 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.495 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 53.1 m-20 -108.9 -44.22 4.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.216 -0.928 . . . . 1.1100000000000001 110.83 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.57 -10.7 39.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.24 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 47.38 2.19 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.303 -0.999 . . . . 0.17000000000000001 108.303 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -55.29 -17.45 4.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.668 -0.645 . . . . 2.2200000000000002 109.974 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.5 p-10 -71.54 -38.93 71.0 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.946 . . . . 1.1100000000000001 109.537 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.14 -48.39 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.19 108.922 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.03 72.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.22 109.462 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -64.05 -57.1 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 1.29 109.679 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -63.18 -26.6 68.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2000000000000002 109.825 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.06 -3.16 58.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.115 -0.991 . . . . 0.33000000000000002 109.923 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 47.56 53.09 11.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 2.3399999999999999 110.08 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 22.1 t -79.56 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.28000000000000003 109.402 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -125.17 -1.83 7.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.341 -0.85 . . . . 2.3999999999999999 109.815 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.56 130.98 12.91 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.019 -1.051 . . . . 0.22 109.418 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.0 p -114.99 150.63 44.5 Favored Pre-proline 0 N--CA 1.502 2.143 0 N-CA-C 108.26 -1.015 . . . . 0.22 108.26 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.92 144.07 77.53 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 C-N-CA 124.842 -0.899 . . . . 0.20000000000000001 110.615 -1.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.03 113.78 23.66 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.757 -1.201 . . . . 0.17999999999999999 107.757 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.3 m-85 -89.55 122.16 32.45 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.898 -1.126 . . . . 0.14999999999999999 108.902 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -119.6 135.99 54.56 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.029 -1.1 . . . . 1.03 108.029 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.0 m-85 -109.65 131.87 54.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.11 109.967 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -129.08 157.04 42.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.884 -0.784 . . . . 0.17000000000000001 108.884 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -154.05 124.86 7.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.601 -1.259 . . . . 1.48 107.601 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 mttt 54.28 32.73 16.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.996 . . . . 1.6699999999999999 109.77 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 9.69 86.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.005 -1.238 . . . . 0.22 110.005 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -114.75 144.07 44.07 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.331 -1.099 . . . . 2.0800000000000001 110.363 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -85.53 146.66 26.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 1.7 109.27 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.91 -29.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.454 -0.779 . . . . 0.26000000000000001 109.971 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.58 178.03 44.1 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.5 -1.333 . . . . 0.17999999999999999 110.477 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -173.6 156.87 3.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 2.04 110.179 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -168.88 134.25 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.14000000000000001 110.563 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -105.83 -171.33 1.88 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.203 -0.935 . . . . 0.17000000000000001 108.889 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 92.88 128.61 4.8 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -1.12 . . . . 0.20000000000000001 110.31 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' GLY . 14.5 t-20 -140.14 73.24 1.42 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.452 -0.944 . . . . 1.1499999999999999 108.452 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.65 -31.73 73.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 1.1899999999999999 110.28 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 23.6 mp0 -66.86 -29.95 69.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.898 -1.126 . . . . 1.95 109.124 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -32.38 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.418 -0.801 . . . . 2.0499999999999998 109.331 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.0 mt -51.38 -35.0 36.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.14999999999999999 108.421 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -68.24 -56.77 7.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.747 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.58 87.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.819 . . . . 0.14999999999999999 110.668 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 m -67.0 -45.13 78.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.13 110.218 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.3 -51.97 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.17999999999999999 109.074 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.3 -15.2 46.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 1.03 109.781 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.12 -59.51 2.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 2.02 110.294 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.97 18.49 10.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.393 -0.817 . . . . 0.34999999999999998 110.74 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.895 -1.128 . . . . 1.1799999999999999 109.347 179.582 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -123.25 -168.5 1.77 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.894 -1.129 . . . . 0.0 111.249 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.3 t -76.22 149.71 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.886 0.851 . . . . 0.0 112.868 -176.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.91 96.95 7.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.457 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.04 46.15 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.041 -1.037 . . . . 0.0 110.639 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.26 -130.24 0.09 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.755 -2.538 . . . . 0.0 106.755 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.6 22.27 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.335 1.568 . . . . 0.0 109.367 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.0 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.759 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 62.1 t . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.548 -0.538 . . . . 0.29999999999999999 109.548 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 14.4 tptm -154.8 122.33 5.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.97 109.251 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.5 134.83 34.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.97999999999999998 110.015 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.06 109.72 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.063 -1.088 . . . . 0.19 108.063 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -101.02 -7.01 23.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.193 -0.942 . . . . 1.97 109.847 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 p -152.35 153.58 33.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.037 -1.039 . . . . 0.23000000000000001 109.926 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 69.4 tttt -52.46 -33.22 43.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -59.69 -41.1 89.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 0.25 109.849 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.41 -25.63 63.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.20000000000000001 109.78 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.3 -68.31 0.31 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.011 -1.056 . . . . 0.20999999999999999 110.043 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.91 -41.25 70.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 2.4700000000000002 109.785 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.85 -37.69 80.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 2.1000000000000001 109.504 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.18 91.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.20000000000000001 109.539 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.32 -44.7 94.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 0.62 109.715 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.71 -41.12 98.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.713 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.1 -14.58 58.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.29999999999999999 109.732 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.59 -6.97 28.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.23999999999999999 109.847 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -113.81 4.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.578 -1.409 . . . . 0.28000000000000003 109.578 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.17 5.15 2.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -1.054 . . . . 2.21 109.499 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.24 170.18 12.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.003 -1.061 . . . . 1.8999999999999999 109.097 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 161.51 14.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.932 -1.136 . . . . 0.17000000000000001 107.932 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -145.33 106.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.927 -1.108 . . . . 0.12 109.652 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.94 130.3 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.688 -0.856 . . . . 0.089999999999999997 108.688 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.78 140.13 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.55 -0.719 . . . . 0.17000000000000001 109.591 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -110.96 99.27 8.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.982 -0.747 . . . . 0.95999999999999996 108.982 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.64 82.98 8.18 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.807 -1.183 . . . . 0.23999999999999999 107.807 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 41.3 m -109.39 -163.24 0.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.985 -0.746 . . . . 1.03 108.985 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.31 125.13 18.26 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.95 -0.759 . . . . 0.26000000000000001 108.95 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -65.6 -30.68 71.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.68 . . . . 0.32000000000000001 111.331 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.585 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 50.7 p-90 -86.04 -14.18 45.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.748 -1.22 . . . . 0.44 109.884 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -94.76 128.58 41.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.32000000000000001 109.657 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.62 -55.79 8.14 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.579 -0.701 . . . . 0.35999999999999999 111.495 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.6 Cg_exo -48.03 -33.58 20.99 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.72 1.613 . . . . 0.44 111.45 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -76.27 -59.75 2.63 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.809 -1.182 . . . . 0.81000000000000005 108.958 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -60.32 -19.22 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 1.9199999999999999 110.258 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -19.55 52.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.01 . . . . 3.1299999999999999 110.361 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.2 mt -99.45 9.08 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.16 -0.962 . . . . 0.28000000000000003 110.497 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.52 -31.98 4.07 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 120.374 -1.454 . . . . 1.6200000000000001 112.516 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -62.61 -5.0 6.37 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.947 1.017 . . . . 0.25 110.049 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 45.5 m-85 -112.39 -75.49 0.61 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.218 -0.66 . . . . 0.29999999999999999 109.218 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -43.13 -56.8 3.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.13 110.551 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.94 -32.37 73.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.40999999999999998 110.068 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.5 t -63.18 -40.92 98.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.809 -1.182 . . . . 0.96999999999999997 110.38 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.4 mt -50.62 -15.32 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.992 -1.067 . . . . 0.5 109.532 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.0 m -58.17 -30.77 66.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.066 -1.021 . . . . 0.51000000000000001 109.521 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -96.09 -21.45 17.94 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.272 -0.892 . . . . 2.0 110.156 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -90.43 -21.01 22.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.037 -1.039 . . . . 2.1600000000000001 109.602 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.74 67.6 1.5 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.409 -0.807 . . . . 0.23999999999999999 108.896 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.5 p -66.8 -3.01 5.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.374 -0.829 . . . . 0.17000000000000001 109.088 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.29 -1.23 51.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.443 -0.786 . . . . 0.34000000000000002 109.251 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.26 149.01 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.633 -0.667 . . . . 0.12 109.24 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -99.96 125.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.17000000000000001 109.146 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -112.47 130.96 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.271 -0.893 . . . . 0.11 108.878 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.51 171.58 7.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.736 -0.838 . . . . 0.12 108.736 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -142.82 142.57 31.87 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.836 -1.172 . . . . 1.3100000000000001 107.836 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.0 t -141.12 138.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.152 -0.967 . . . . 0.14000000000000001 110.758 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.41 105.75 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.443 -0.947 . . . . 1.0800000000000001 108.443 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.94 -4.95 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.376 -0.828 . . . . 0.27000000000000002 110.905 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.585 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 36.8 m-20 -102.72 -42.83 5.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 1.1100000000000001 110.877 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -25.6 15.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.181 -0.949 . . . . 1.1200000000000001 109.362 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.29 43.45 1.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.426 -0.953 . . . . 0.17000000000000001 108.426 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.409 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 87.3 mt-30 -53.6 -13.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 2.2200000000000002 110.235 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.1 p-10 -69.85 -40.68 75.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.791 -1.193 . . . . 1.1100000000000001 109.19 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -73.37 -48.07 43.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.234 -0.916 . . . . 0.19 108.584 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -38.19 90.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.528 -0.732 . . . . 0.22 109.539 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 61.8 m -64.1 -43.73 94.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 1.29 109.052 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.59 -40.41 96.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 2.2000000000000002 109.228 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.83 -6.27 57.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.33000000000000002 109.399 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ALA . 46.7 mt-10 49.31 71.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 2.3399999999999999 110.253 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 42.0 t -79.11 135.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.922 . . . . 0.28000000000000003 108.978 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -113.64 -12.54 12.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.484 -0.76 . . . . 2.3999999999999999 109.805 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.78 137.69 15.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.952 -1.092 . . . . 0.22 109.81 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.733 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.7 p -115.63 151.27 45.99 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 108.487 -0.931 . . . . 0.22 108.487 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -75.73 147.33 87.89 Favored 'Cis proline' 0 N--CA 1.484 0.968 0 C-N-CA 124.651 -0.979 . . . . 0.20000000000000001 109.878 -1.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -116.08 113.34 23.02 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.996 -1.113 . . . . 0.17999999999999999 107.996 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.1 m-85 -89.15 125.1 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.124 -1.03 . . . . 0.14999999999999999 108.906 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.16 136.71 54.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.895 -1.15 . . . . 1.03 107.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.4 m-85 -109.91 130.18 55.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.707 . . . . 0.11 109.958 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -128.93 157.24 42.17 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.58 -0.896 . . . . 0.17000000000000001 108.58 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -155.53 122.65 5.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.014 -1.106 . . . . 1.48 108.014 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.2 22.57 6.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 1.6699999999999999 109.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 3.55 72.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.194 -1.162 . . . . 0.22 110.194 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -110.95 144.95 39.22 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.293 -1.122 . . . . 2.0800000000000001 110.21 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -85.47 139.56 31.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 1.7 109.052 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.03 -18.02 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.399 -0.813 . . . . 0.26000000000000001 110.715 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.92 172.69 45.68 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.17999999999999999 110.541 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -174.21 150.49 1.53 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 2.04 110.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.02 132.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.818 . . . . 0.14000000000000001 110.189 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -101.98 -160.19 0.77 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.064 -1.023 . . . . 0.17000000000000001 109.066 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 129.3 0.67 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.52 -1.432 . . . . 0.13 109.52 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.16 93.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.20000000000000001 110.205 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.96 75.53 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.819 -1.178 . . . . 1.1499999999999999 107.819 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.528 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.8 ptpt -63.49 -39.36 94.23 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.818 -0.628 . . . . 1.1899999999999999 111.275 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.58 -25.97 68.2 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 1.95 109.567 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.21 -34.79 76.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 2.0499999999999998 109.528 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.8 mt -54.73 -35.96 64.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.118 . . . . 0.14999999999999999 108.732 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.7 -58.08 6.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 2.1499999999999999 109.54 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.47 -41.92 90.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.14999999999999999 110.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.2 m -65.81 -45.73 81.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.161 -0.962 . . . . 0.13 110.183 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.48 -53.97 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.17999999999999999 108.822 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -17.64 48.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 1.03 109.744 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -75.9 -60.25 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 2.02 110.155 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.64 20.74 6.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.771 . . . . 0.34999999999999998 110.416 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.238 179.473 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.409 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 7.9 tpt180 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.8 -166.89 1.7 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.013 -1.054 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.55 152.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 122.0 0.905 . . . . 0.0 112.591 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 95.09 6.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.16 45.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.78 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -131.98 0.08 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.6 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.251 1.525 . . . . 0.0 109.147 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.2 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 109.58 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.3 t . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.295 0.569 . . . . 0.29999999999999999 109.902 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.4 tttt -155.06 125.97 7.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 1.97 109.375 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.13 136.52 33.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.904 . . . . 0.97999999999999998 109.73 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mm -106.3 110.02 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.185 -1.042 . . . . 0.19 108.185 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.87 -9.98 21.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.2 -0.938 . . . . 1.97 109.703 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 p -153.18 152.6 31.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.11 -0.994 . . . . 0.23000000000000001 109.699 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -51.9 -28.0 14.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 1.8999999999999999 110.021 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -59.14 -44.29 92.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.25 109.692 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.32 -24.56 61.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.20000000000000001 109.952 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -59.33 -68.64 0.26 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.20999999999999999 110.328 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.34 -43.2 71.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 2.4700000000000002 109.554 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -59.67 -36.73 77.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.228 -0.92 . . . . 2.1000000000000001 110.085 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.32 86.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.003 . . . . 0.20000000000000001 109.384 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.29 -43.4 94.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.468 -0.77 . . . . 0.62 109.645 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.76 -40.78 97.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.771 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -14.44 59.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.988 . . . . 0.29999999999999999 110.03 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -10.56 56.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.23999999999999999 109.806 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.2 -112.3 3.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.47 -1.452 . . . . 0.28000000000000003 109.47 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -139.85 3.77 2.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.317 -1.107 . . . . 2.21 109.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -69.61 172.68 7.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 1.8999999999999999 109.032 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.83 161.47 18.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.977 -1.12 . . . . 0.17000000000000001 107.977 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.3 t -144.87 104.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.873 -1.142 . . . . 0.12 109.421 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.99 128.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.359 -0.838 . . . . 0.089999999999999997 108.937 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.77 139.72 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.17000000000000001 109.565 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -112.02 103.49 11.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.95999999999999996 108.903 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.5 m-85 -86.06 80.31 8.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.3 -1.0 . . . . 0.23999999999999999 108.3 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.3 m -113.45 149.4 34.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.652 -0.655 . . . . 1.03 109.597 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.39 129.26 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.26000000000000001 109.048 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -67.15 -25.32 66.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.882 . . . . 0.32000000000000001 110.855 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.464 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 54.0 p-90 -88.4 -17.58 30.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.842 -1.161 . . . . 0.44 110.351 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.96 123.37 37.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -0.929 . . . . 0.32000000000000001 109.941 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.87 -53.74 32.43 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-O 119.426 -0.652 . . . . 0.35999999999999999 112.002 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -48.32 -36.41 29.95 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.647 1.565 . . . . 0.44 111.33 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.76 -60.99 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.81000000000000005 109.137 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -58.28 -18.92 30.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 1.9199999999999999 109.96 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.9 ttm -58.61 -18.41 29.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 3.1299999999999999 110.581 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 38' ' ' ILE . 67.1 mt -100.39 9.7 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 110.583 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.74 -32.55 4.39 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.107 -1.621 . . . . 1.6200000000000001 112.598 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -64.09 -6.2 10.87 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 CA-C-N 119.794 0.962 . . . . 0.25 109.758 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 32.6 m-85 -110.52 -75.21 0.63 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.544 -0.723 . . . . 0.29999999999999999 109.384 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -43.02 -57.42 2.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.427 -0.795 . . . . 0.13 110.67 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.82 -31.15 71.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.40999999999999998 110.04 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' SER . 3.4 t -64.34 -40.1 95.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.822 -1.174 . . . . 0.96999999999999997 109.938 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.2 -12.87 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.079 -1.013 . . . . 0.5 109.369 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.03 -34.69 70.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.51000000000000001 109.439 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -94.33 -13.17 26.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.312 -0.868 . . . . 2.0 110.084 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -91.65 -32.07 15.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 2.1600000000000001 109.455 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -126.38 71.96 1.3 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.025 -0.732 . . . . 0.23999999999999999 109.025 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.08 -2.59 4.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.292 -0.88 . . . . 0.17000000000000001 108.968 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 35.0 t30 -97.01 -1.99 44.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.34000000000000002 109.816 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.74 148.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.508 -0.745 . . . . 0.12 109.586 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.37 124.21 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.993 -0.743 . . . . 0.17000000000000001 108.993 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.7 m-85 -109.91 133.0 53.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.294 -0.879 . . . . 0.11 108.948 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -115.08 171.87 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.241 -0.912 . . . . 0.12 108.706 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -141.94 144.24 33.65 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.028 -1.101 . . . . 1.3100000000000001 108.028 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.63 139.26 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.17 -0.956 . . . . 0.14000000000000001 110.507 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.7 t70 -98.98 101.97 13.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.859 -0.793 . . . . 1.0800000000000001 108.859 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.04 0.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.836 . . . . 0.27000000000000002 110.967 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.464 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 39.3 m-20 -112.7 -41.08 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.343 -0.848 . . . . 1.1100000000000001 110.655 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -95.5 -21.18 18.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.041 . . . . 1.1200000000000001 109.503 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.48 47.86 1.19 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.25 -1.019 . . . . 0.17000000000000001 108.25 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' B' ' 4' ' ' ARG . 69.1 mt-30 -54.62 -18.28 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.749 -0.594 . . . . 2.2200000000000002 110.326 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -70.82 -39.41 73.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.917 -1.114 . . . . 1.1100000000000001 109.606 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.44 -47.63 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.149 -0.969 . . . . 0.19 108.836 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.48 78.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.22 109.461 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -63.47 -52.72 60.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 1.29 109.525 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -64.75 -30.55 71.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 2.2000000000000002 110.027 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.94 2.99 47.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.33000000000000002 109.943 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 47.14 50.3 14.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 2.3399999999999999 110.541 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 4.0 t -81.39 128.64 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.28000000000000003 108.773 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -126.28 -2.13 6.94 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.363 -0.835 . . . . 2.3999999999999999 110.434 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.32 124.68 8.21 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.759 -1.213 . . . . 0.22 109.427 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.7 p -106.24 151.3 40.17 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 121.322 -0.861 . . . . 0.22 109.185 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.8 140.13 63.45 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.947 -0.855 . . . . 0.20000000000000001 110.066 -2.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.38 111.11 21.73 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.056 -1.09 . . . . 0.17999999999999999 108.056 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.5 m-85 -89.19 118.14 28.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.988 -1.07 . . . . 0.14999999999999999 109.127 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.461 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.3 mt-30 -117.05 135.55 53.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.332 -1.358 . . . . 1.03 107.332 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.8 m-85 -107.83 128.08 54.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.488 0.661 . . . . 0.11 109.896 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.8 156.95 35.16 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.94 -0.763 . . . . 0.17000000000000001 108.94 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -155.26 124.35 6.23 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.298 -1.371 . . . . 1.48 107.298 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.3 mttt 56.0 32.65 20.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.6 -0.687 . . . . 1.6699999999999999 109.382 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.41 7.19 87.01 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.779 -1.201 . . . . 0.22 110.143 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.03 142.6 45.52 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.375 -1.073 . . . . 2.0800000000000001 110.64 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -86.62 140.09 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.838 . . . . 1.7 108.947 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.27 -17.39 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.413 -0.805 . . . . 0.26000000000000001 110.693 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.39 176.56 48.1 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.415 -1.374 . . . . 0.17999999999999999 110.454 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -174.1 156.46 2.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -1.128 . . . . 2.04 110.296 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.58 129.97 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.14000000000000001 109.982 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -102.83 -162.16 0.9 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.292 -0.88 . . . . 0.17000000000000001 109.234 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.55 126.74 0.84 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.964 -1.654 . . . . 0.13 108.964 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.88 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.091 -1.241 . . . . 0.20000000000000001 110.043 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.32 66.65 1.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.516 -1.29 . . . . 1.1499999999999999 107.516 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.25 -34.11 71.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.824 -0.548 . . . . 1.1899999999999999 111.023 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.58 -26.03 68.23 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.935 -1.103 . . . . 1.95 109.254 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -71.05 -36.26 72.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.787 . . . . 2.0499999999999998 110.095 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.4 mt -50.8 -33.29 22.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.914 -1.117 . . . . 0.14999999999999999 109.012 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.38 -57.01 7.37 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.467 -0.893 . . . . 2.1499999999999999 109.539 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.86 95.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.14999999999999999 110.942 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 m -64.94 -45.3 86.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.953 -1.092 . . . . 0.13 109.918 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.63 -53.09 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.17999999999999999 108.681 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.27 -16.23 43.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 1.03 109.626 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -62.38 1.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 2.02 109.934 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.25 22.62 3.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.34999999999999998 110.162 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.037 -1.04 . . . . 1.1799999999999999 109.295 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' A' ' 63' ' ' GLN . 8.7 tpt180 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.2 p90 -129.95 -167.16 1.77 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.053 -1.029 . . . . 0.0 110.464 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -73.75 150.58 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.938 0.875 . . . . 0.0 112.522 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.12 93.44 5.47 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.7 pt-20 -83.79 44.26 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.285 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.73 -130.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.64 20.8 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 119.533 1.667 . . . . 0.0 109.37 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.3 t . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.525 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.7 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.268 -0.642 . . . . 0.29999999999999999 109.268 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 54.6 tttp -154.15 125.31 7.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 1.97 109.402 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -89.85 136.3 33.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.97999999999999998 109.903 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.86 107.27 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.206 -1.035 . . . . 0.19 108.206 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.57 -8.74 24.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 1.97 109.547 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.07 156.27 38.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.135 -0.978 . . . . 0.23000000000000001 109.829 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -52.99 -30.15 33.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.8999999999999999 110.075 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.5 m -60.27 -44.51 95.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.25 110.313 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -25.14 64.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.20000000000000001 109.649 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -60.76 -67.95 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.957 -1.089 . . . . 0.20999999999999999 109.94 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.55 -44.98 69.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.795 . . . . 2.4700000000000002 109.679 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -58.61 -36.94 74.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.845 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.93 91.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.081 -1.012 . . . . 0.20000000000000001 109.362 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.14 -46.56 83.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.804 . . . . 0.62 109.774 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.45 -38.71 92.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 109.482 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.88 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.981 . . . . 0.29999999999999999 109.667 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -5.36 18.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.23999999999999999 109.588 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 -111.45 3.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.453 -1.459 . . . . 0.28000000000000003 109.453 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 61.5 t0 -139.06 2.49 2.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.434 -1.039 . . . . 2.21 109.554 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -68.8 171.86 7.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.017 . . . . 1.8999999999999999 109.053 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.8 162.27 19.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.351 -0.981 . . . . 0.17000000000000001 108.351 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.571 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -144.96 107.72 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.874 -1.141 . . . . 0.12 109.855 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -104.06 132.66 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.805 -0.813 . . . . 0.089999999999999997 108.805 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.2 140.43 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.17000000000000001 109.598 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -110.59 101.28 9.96 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.247 -0.649 . . . . 0.95999999999999996 109.247 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 42.1 m-85 -85.36 80.14 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.194 -1.039 . . . . 0.23999999999999999 108.194 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -114.19 147.96 38.07 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.228 0.537 . . . . 1.03 109.651 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.59 131.24 37.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.194 -0.941 . . . . 0.26000000000000001 108.853 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -67.67 -28.02 67.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.32000000000000001 110.655 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.535 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.2 p-90 -87.71 -11.61 47.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.44 110.023 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.39 125.29 39.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.32000000000000001 109.864 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -67.81 -54.12 20.04 Favored Glycine 0 N--CA 1.49 2.244 0 CA-C-O 119.491 -0.616 . . . . 0.35999999999999999 112.299 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.83 -43.85 33.63 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.544 1.496 . . . . 0.44 111.618 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.96 -55.85 5.66 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.688 -1.257 . . . . 0.81000000000000005 109.056 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.2 -18.23 46.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 1.9199999999999999 109.809 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.0 ttt -62.82 -22.46 66.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 3.1299999999999999 110.466 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 38' ' ' ILE . 65.5 mt -98.12 18.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.198 -0.939 . . . . 0.28000000000000003 111.014 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.39 -33.85 3.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.148 -1.595 . . . . 1.6200000000000001 113.091 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.02 -7.71 14.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 CA-C-N 119.469 0.846 . . . . 0.25 110.595 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.0 m-85 -105.22 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.315 -0.866 . . . . 0.29999999999999999 109.803 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.6 t80 -41.94 -52.4 4.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.13 110.742 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.73 -34.3 75.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.991 -1.068 . . . . 0.40999999999999998 109.931 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 46' ' ' SER . 4.2 t -60.64 -44.36 96.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.863 -1.148 . . . . 0.96999999999999997 110.014 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.6 mt -50.43 -16.8 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.978 -1.076 . . . . 0.5 109.214 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.1 m -57.06 -33.96 67.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.51000000000000001 109.629 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.14 -18.74 20.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -0.927 . . . . 2.0 110.251 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -90.54 -20.74 22.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.05 . . . . 2.1600000000000001 109.502 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -133.9 66.49 1.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.23999999999999999 109.297 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 p -67.68 -3.37 8.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.17000000000000001 109.251 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.37 0.39 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.395 -0.816 . . . . 0.34000000000000002 109.46 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.7 t -120.77 150.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.872 -0.788 . . . . 0.12 108.872 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.55 132.02 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.191 -0.943 . . . . 0.17000000000000001 109.659 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.1 m-85 -117.33 131.69 56.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.571 -0.706 . . . . 0.11 109.102 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -114.27 174.98 5.68 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.423 -0.798 . . . . 0.12 109.093 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -144.88 146.81 32.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.247 -1.019 . . . . 1.3100000000000001 108.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.03 138.27 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.999 -1.063 . . . . 0.14000000000000001 110.611 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.0 t70 -100.03 100.88 11.82 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.665 -0.865 . . . . 1.0800000000000001 108.665 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.1 m -59.31 0.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 111.171 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.535 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 14.9 m-20 -116.84 -41.87 3.01 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.163 -0.96 . . . . 1.1100000000000001 110.709 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.13 -19.5 20.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.014 -1.054 . . . . 1.1200000000000001 109.279 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.36 46.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.006 -1.109 . . . . 0.17000000000000001 108.006 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 27.3 mt-30 -55.31 -16.46 3.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.619 -0.676 . . . . 2.2200000000000002 110.533 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.21 -36.78 77.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.765 -1.209 . . . . 1.1100000000000001 109.113 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -73.76 -48.46 39.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.217 -0.927 . . . . 0.19 108.72 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.27 -36.96 85.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.22 109.37 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -63.48 -46.49 85.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 1.29 109.198 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -64.55 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 2.2000000000000002 109.284 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.98 -6.29 58.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -0.988 . . . . 0.33000000000000002 109.257 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ALA . 35.3 mt-10 51.61 55.62 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 2.3399999999999999 110.462 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 46.2 t -84.25 124.26 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.262 -0.898 . . . . 0.28000000000000003 108.999 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.37 6.7 17.36 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.175 -0.953 . . . . 2.3999999999999999 110.219 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.02 146.19 24.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.773 -1.204 . . . . 0.22 109.714 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.3 p -127.29 148.88 68.04 Favored Pre-proline 0 N--CA 1.506 2.354 0 N-CA-C 108.284 -1.006 . . . . 0.22 108.284 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.528 ' HG3' HD12 ' A' ' 38' ' ' ILE . 12.1 Cg_endo -80.32 139.99 50.74 Favored 'Cis proline' 0 N--CA 1.487 1.113 0 N-CA-C 110.072 -0.78 . . . . 0.20000000000000001 110.072 -1.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -110.58 110.53 21.27 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.157 -1.053 . . . . 0.17999999999999999 108.157 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.832 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.3 m-85 -86.98 115.53 24.43 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.995 -1.082 . . . . 0.14999999999999999 109.206 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.579 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 32.5 mt-30 -114.2 137.01 52.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.735 -1.209 . . . . 1.03 107.735 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.5 m-85 -109.91 126.33 53.76 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.519 0.676 . . . . 0.11 109.592 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 156.28 35.36 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.452 -0.944 . . . . 0.17000000000000001 108.452 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.385 -1.339 . . . . 1.48 107.385 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 55.01 38.28 30.27 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.433 -0.792 . . . . 1.6699999999999999 109.238 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 6.25 63.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.352 -1.099 . . . . 0.22 110.352 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -112.12 145.82 39.12 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.312 -1.111 . . . . 2.0800000000000001 110.541 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -86.19 142.62 28.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 1.7 109.279 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.9 -9.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.452 -0.78 . . . . 0.26000000000000001 110.341 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.4 38.01 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.389 -1.386 . . . . 0.17999999999999999 110.521 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -173.35 156.69 3.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.411 -1.053 . . . . 2.04 110.06 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.88 131.12 1.27 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.799 . . . . 0.14000000000000001 110.027 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -160.98 0.81 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.16 -0.962 . . . . 0.17000000000000001 109.093 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 82.34 121.07 0.63 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.451 -1.46 . . . . 0.13 109.451 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.544 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.34 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -1.158 . . . . 0.20000000000000001 110.25 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.38 76.98 1.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.129 -1.063 . . . . 1.1499999999999999 108.129 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.1 ptpt -64.57 -42.55 95.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.871 -0.518 . . . . 1.1899999999999999 111.556 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -63.93 -25.72 68.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.739 -1.226 . . . . 1.95 109.978 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -70.55 -32.09 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 2.0499999999999998 109.432 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 77' ' ' PHE . 34.1 mt -51.08 -37.54 46.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.064 . . . . 0.14999999999999999 108.805 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -68.36 -56.33 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.822 -0.751 . . . . 2.1499999999999999 109.975 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.16 75.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.14999999999999999 110.453 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 m -67.68 -45.21 75.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.989 . . . . 0.13 110.0 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.95 -53.44 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.17999999999999999 109.274 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.81 -16.25 26.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 1.03 109.839 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -75.97 -60.18 2.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 2.02 109.944 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -92.89 18.77 8.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.398 -0.814 . . . . 0.34999999999999998 110.414 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 109.309 179.507 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 8.3 tpt180 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 4.1 p90 -131.87 -166.59 1.74 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.673 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.42 150.52 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.167 0.984 . . . . 0.0 112.967 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 94.35 5.59 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.4 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.21 49.82 1.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.908 -1.12 . . . . 0.0 109.944 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.605 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -76.28 -128.09 0.28 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -68.7 26.64 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.372 1.586 . . . . 0.0 108.946 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.605 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.6 t . . . . . 0 N--CA 1.487 1.4 0 O-C-N 121.315 -0.865 . . . . 0.0 109.271 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.6 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.38 0.61 . . . . 0.29999999999999999 109.743 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.613 ' N ' HG12 ' A' ' 2' ' ' VAL . 36.9 tptt -153.99 123.9 6.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 1.97 109.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -90.3 128.51 36.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.186 -0.946 . . . . 0.97999999999999998 109.861 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.63 109.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.871 -1.159 . . . . 0.19 107.871 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -100.23 -8.06 23.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.174 -0.954 . . . . 1.97 110.078 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p -152.06 153.45 34.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.23000000000000001 109.82 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 50.7 tttm -52.23 -26.15 11.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 1.8999999999999999 109.784 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -60.17 -50.08 75.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.25 110.005 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.94 63.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.20000000000000001 109.791 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.89 -65.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.20999999999999999 109.864 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -54.99 -45.35 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 2.4700000000000002 109.733 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.92 -35.79 73.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.222 -0.924 . . . . 2.1000000000000001 109.743 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.78 80.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.20000000000000001 109.099 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.8 mt -64.55 -39.84 94.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.746 . . . . 0.62 109.603 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.98 -42.86 97.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 109.756 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.04 57.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.114 -0.991 . . . . 0.29999999999999999 109.613 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.76 -8.42 42.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.155 -0.966 . . . . 0.23999999999999999 109.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.07 -129.39 32.12 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.161 -1.575 . . . . 0.28000000000000003 109.161 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.97 5.89 12.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.956 . . . . 2.21 109.462 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -69.76 167.33 17.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 1.8999999999999999 109.266 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 161.47 18.99 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.331 -0.988 . . . . 0.17000000000000001 108.331 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.622 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.0 t -145.09 107.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.12 109.647 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.09 131.73 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.603 -0.888 . . . . 0.089999999999999997 108.603 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.34 139.57 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.511 -0.743 . . . . 0.17000000000000001 109.772 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -110.44 102.09 10.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -86.1 83.42 7.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.804 -1.184 . . . . 0.23999999999999999 107.804 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -114.86 152.74 31.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.655 -0.653 . . . . 1.03 109.849 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -93.4 131.06 38.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.559 -0.904 . . . . 0.26000000000000001 108.559 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -67.46 -30.84 70.66 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.32000000000000001 111.119 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 65.9 p-90 -87.64 -5.94 58.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.937 -1.102 . . . . 0.44 110.651 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -98.17 132.97 43.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.32000000000000001 109.691 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -74.83 -54.19 5.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.628 -0.67 . . . . 0.35999999999999999 112.019 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.5 -39.58 45.3 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.413 1.409 . . . . 0.44 111.603 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.62 5.61 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.631 -1.293 . . . . 0.81000000000000005 109.003 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -60.4 -20.57 60.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 1.9199999999999999 110.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.1 tpt -60.13 -22.01 62.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 3.1299999999999999 110.556 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.706 ' O ' HG22 ' A' ' 38' ' ' ILE . 80.2 mt -96.61 14.21 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.28000000000000003 111.69 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.65 -33.3 5.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.042 -1.662 . . . . 1.6200000000000001 112.924 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.99 -9.15 18.11 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.69 0.925 . . . . 0.25 110.685 -176.185 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.71 -70.84 0.77 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.29999999999999999 109.68 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -43.69 -53.2 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.13 110.553 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -68.43 -34.22 75.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.087 -1.008 . . . . 0.40999999999999998 110.022 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 t -60.97 -40.35 93.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.883 -1.135 . . . . 0.96999999999999997 110.302 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.2 mt -51.49 -19.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.901 -1.124 . . . . 0.5 109.334 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -58.36 -28.99 65.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.51000000000000001 109.815 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -95.23 -22.97 17.46 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.083 -1.011 . . . . 2.0 110.27 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -90.87 -20.2 22.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.045 -1.034 . . . . 2.1600000000000001 109.342 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.49 68.92 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.23999999999999999 109.374 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 97.9 p -67.65 -5.65 16.75 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 0.17000000000000001 109.164 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -94.7 1.52 55.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 0.34000000000000002 109.576 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.79 147.77 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.599 -0.889 . . . . 0.12 108.599 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -99.77 127.61 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.17000000000000001 109.567 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -114.74 132.14 56.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.371 -0.831 . . . . 0.11 109.111 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.47 171.14 7.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.793 . . . . 0.12 108.883 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -143.35 145.63 32.85 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.911 -1.144 . . . . 1.3100000000000001 107.911 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.98 139.18 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.086 -1.009 . . . . 0.14000000000000001 110.375 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.9 t70 -97.78 89.71 4.71 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.91 -1.144 . . . . 1.0800000000000001 107.91 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.674 HG11 ' OH ' ' B' ' 5' ' ' TYR . 27.7 m -53.68 -6.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.595 -0.691 . . . . 0.27000000000000002 111.681 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 46.6 m-20 -104.99 -35.17 7.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 110.49 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.51 -9.49 22.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.123 -0.986 . . . . 1.1200000000000001 110.07 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.17 54.5 1.54 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.199 -0.938 . . . . 0.17000000000000001 109.433 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 60' ' ' ASP . 3.5 mp0 -54.88 -14.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.3 -0.875 . . . . 2.2200000000000002 110.379 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.7 p-10 -69.41 -44.84 70.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.888 -1.133 . . . . 1.1100000000000001 109.989 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.94 -44.62 57.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.081 -1.012 . . . . 0.19 108.692 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.13 86.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.22 109.236 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.0 m -64.5 -47.2 79.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 1.29 109.586 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.37 -38.12 89.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.662 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -4.34 58.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.242 -0.911 . . . . 0.33000000000000002 109.801 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 47.66 65.88 1.17 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.197 -0.939 . . . . 2.3399999999999999 109.866 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.15 130.09 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 0.28000000000000003 109.272 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -125.79 -5.6 6.9 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.413 -0.804 . . . . 2.3999999999999999 109.349 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.724 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.07 129.68 11.51 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.131 -1.062 . . . . 0.22 108.131 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.4 p -124.69 157.45 65.77 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.361 -0.837 . . . . 0.22 110.04 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -72.93 138.86 57.93 Favored 'Cis proline' 0 N--CA 1.487 1.119 0 O-C-N 122.856 0.924 . . . . 0.20000000000000001 110.946 0.164 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -108.23 110.0 21.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.077 -1.083 . . . . 0.17999999999999999 108.077 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.531 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -87.84 118.95 27.71 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.229 -0.989 . . . . 0.14999999999999999 108.835 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -117.2 139.48 50.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.782 -1.192 . . . . 1.03 107.782 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 24.5 m-85 -110.92 133.85 53.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.11 110.311 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.75 156.32 43.72 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.393 -0.965 . . . . 0.17000000000000001 108.393 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -155.55 121.54 5.09 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.202 -1.407 . . . . 1.48 107.202 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 55.99 33.63 22.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.545 -0.722 . . . . 1.6699999999999999 109.723 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.27 5.25 87.41 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.044 -1.074 . . . . 0.22 110.523 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -112.88 145.37 40.82 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.235 -1.156 . . . . 2.0800000000000001 110.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -85.54 141.69 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -0.915 . . . . 1.7 109.338 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.55 -34.28 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.466 -0.771 . . . . 0.26000000000000001 110.128 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.55 -178.17 40.56 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.537 -1.316 . . . . 0.17999999999999999 110.326 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.46 157.17 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -1.01 . . . . 2.04 110.215 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.67 130.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.904 -0.718 . . . . 0.14000000000000001 110.064 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -102.7 -159.69 0.74 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 108.917 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.58 120.14 0.42 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.05 -1.62 . . . . 0.13 109.05 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.43 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -1.188 . . . . 0.20000000000000001 110.656 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 91' ' ' GLY . 30.3 t-20 -139.34 76.75 1.58 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.131 -1.063 . . . . 1.1499999999999999 108.131 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 3.9 ptpp? -64.79 -40.14 94.76 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.967 -0.56 . . . . 1.1899999999999999 111.074 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -65.82 -26.44 67.68 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.057 -1.027 . . . . 1.95 109.974 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -68.1 -33.07 73.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 2.0499999999999998 109.284 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.531 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.2 mt -50.46 -34.73 25.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.052 -1.03 . . . . 0.14999999999999999 108.52 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.31 -56.77 8.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 2.1499999999999999 109.597 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.84 86.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.14999999999999999 110.548 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 m -66.91 -47.69 71.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.115 -0.991 . . . . 0.13 110.361 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.29 -48.81 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.17999999999999999 108.842 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 50.6 t-20 -62.43 -16.84 57.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 1.03 109.443 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -78.17 -58.69 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 2.02 110.435 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.24 19.07 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.823 . . . . 0.34999999999999998 110.415 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 102' ' ' ASN . 6.5 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.021 -0.99 . . . . 1.1799999999999999 109.389 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.976 0.417 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.674 ' OH ' HG11 ' A' ' 59' ' ' VAL . 1.2 p90 -109.06 -164.18 0.92 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.077 -1.015 . . . . 0.0 110.398 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.04 147.39 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.941 0.876 . . . . 0.0 111.788 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.98 95.04 6.32 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.724 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.24 46.32 1.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.805 -1.184 . . . . 0.0 109.991 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.3 -130.99 0.13 Allowed Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.01 23.73 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 CA-C-N 119.372 1.586 . . . . 0.0 108.56 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.611 ' H ' ' C ' ' B' ' 9' ' ' GLY . 29.5 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 3' ' ' LYS . 25.8 t . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.959 -0.756 . . . . 0.29999999999999999 108.959 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' VAL . 22.7 tptm -155.06 121.81 5.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.072 -1.017 . . . . 1.97 109.16 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -91.74 131.73 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.97999999999999998 109.621 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -107.1 108.87 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.821 -1.177 . . . . 0.19 107.821 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.75 -5.35 26.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.162 -0.961 . . . . 1.97 110.209 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -152.03 152.95 33.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 0.23000000000000001 110.076 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -52.32 -31.5 33.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 1.8999999999999999 109.713 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -61.2 -43.86 98.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.25 110.294 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.68 -24.39 64.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.20000000000000001 110.196 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.18 -64.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.20999999999999999 109.964 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -57.2 -44.4 83.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 2.4700000000000002 109.67 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -58.2 -36.03 72.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.24 -0.913 . . . . 2.1000000000000001 110.171 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.34 86.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.20000000000000001 109.454 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.7 mt -63.68 -44.41 93.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -0.795 . . . . 0.62 109.525 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.41 -36.87 85.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0900000000000001 109.322 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.74 -17.88 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.002 . . . . 0.29999999999999999 109.483 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -6.43 27.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.23999999999999999 109.919 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.79 -112.43 4.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.722 -1.351 . . . . 0.28000000000000003 109.722 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 47.4 t0 -137.86 4.38 2.53 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.286 -1.126 . . . . 2.21 109.463 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -71.42 170.17 13.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 1.8999999999999999 109.471 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.02 164.08 13.49 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.105 -1.072 . . . . 0.17000000000000001 108.105 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.632 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.8 t -146.46 109.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.12 109.809 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 t -105.13 134.26 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.41 -0.959 . . . . 0.089999999999999997 108.41 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.56 140.0 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.17000000000000001 109.864 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -110.47 103.34 11.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.221 -0.659 . . . . 0.95999999999999996 109.221 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 54.6 m-85 -88.45 79.41 7.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.011 -1.107 . . . . 0.23999999999999999 108.011 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -114.17 149.68 35.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.767 -0.583 . . . . 1.03 109.643 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.47 129.01 37.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.868 . . . . 0.26000000000000001 108.699 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -66.6 -22.86 66.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.32000000000000001 110.688 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' A' ' 60' ' ' ASP . 52.9 p-90 -89.17 -21.73 23.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.965 -1.085 . . . . 0.44 110.406 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.01 119.78 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.32000000000000001 110.017 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.04 -54.57 35.67 Favored Glycine 0 N--CA 1.489 2.181 0 CA-C-O 119.429 -0.651 . . . . 0.35999999999999999 111.72 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -48.03 -35.44 25.56 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.58 1.52 . . . . 0.44 111.406 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.84 1.3 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.083 -1.01 . . . . 0.81000000000000005 109.063 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.98 -17.49 38.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 1.9199999999999999 109.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpt -59.77 -19.59 51.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -0.974 . . . . 3.1299999999999999 109.997 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.436 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.8 mt -99.7 10.58 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.11 -0.994 . . . . 0.28000000000000003 110.34 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.26 -33.44 7.91 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 120.714 -1.241 . . . . 1.6200000000000001 112.167 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -61.51 -6.54 7.22 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.078 1.064 . . . . 0.25 110.59 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -107.9 -74.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.555 -0.716 . . . . 0.29999999999999999 109.403 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -45.03 -55.9 5.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.299 -0.876 . . . . 0.13 110.707 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.07 -31.48 72.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.049 -1.032 . . . . 0.40999999999999998 109.89 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -64.07 -40.42 96.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.924 -1.11 . . . . 0.96999999999999997 110.189 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 mt -51.57 -12.6 0.18 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.5 109.979 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' SER . 27.8 m -56.44 -38.56 71.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.835 -1.165 . . . . 0.51000000000000001 109.566 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.14 -11.18 33.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.305 -0.872 . . . . 2.0 109.875 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.61 -53.26 4.73 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.3 -1.0 . . . . 2.1600000000000001 108.3 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.19 72.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.342 -0.849 . . . . 0.23999999999999999 109.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 p -66.7 -1.6 3.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.17000000000000001 108.602 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -95.3 -4.38 45.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.34000000000000002 109.541 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.2 t -116.75 150.5 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.947 -0.76 . . . . 0.12 108.947 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mm -100.45 132.24 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.421 -0.799 . . . . 0.17000000000000001 109.088 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.58 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.6 m-85 -114.77 134.83 54.79 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.335 -0.853 . . . . 0.11 109.5 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -115.5 171.36 7.77 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.762 -0.829 . . . . 0.12 108.762 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.06 142.49 30.68 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.946 -1.131 . . . . 1.3100000000000001 107.946 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.3 141.16 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.148 -0.97 . . . . 0.14000000000000001 110.246 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.1 93.86 6.51 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.819 -1.178 . . . . 1.0800000000000001 107.819 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 74' ' ' THR . 10.5 m -54.35 -3.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.27000000000000002 111.47 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 6.2 m-20 -113.15 -37.35 4.78 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 111.231 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -95.42 -16.8 22.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.887 -1.133 . . . . 1.1200000000000001 109.619 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.81 49.92 1.58 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.54 -0.911 . . . . 0.17000000000000001 108.54 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.471 ' CB ' HH21 ' B' ' 4' ' ' ARG . 8.1 pt20 -54.98 -14.5 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.514 -0.741 . . . . 2.2200000000000002 110.054 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -38.35 73.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.927 -1.108 . . . . 1.1100000000000001 109.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.42 -47.51 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.007 . . . . 0.19 108.644 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.85 78.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.809 . . . . 0.22 109.351 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.3 m -64.31 -50.31 68.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 1.29 109.663 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -63.47 -33.27 75.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 2.2000000000000002 109.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.93 0.41 55.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.094 -1.004 . . . . 0.33000000000000002 109.538 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 48.95 54.19 11.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 110.157 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.28 129.53 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.28000000000000003 109.037 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -122.65 -3.58 8.76 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.465 -0.772 . . . . 2.3999999999999999 109.733 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.58 141.53 21.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.116 -0.99 . . . . 0.22 109.451 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.62 HG23 ' CE2' ' B' ' 5' ' ' TYR . 10.4 p -121.02 150.31 53.03 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.25 149.8 90.29 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.749 -0.938 . . . . 0.20000000000000001 110.127 -2.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.91 124.77 49.09 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.855 -1.165 . . . . 0.17999999999999999 107.855 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.79 ' CD1' HD21 ' A' ' 97' ' ' LEU . 75.3 m-85 -102.35 115.7 31.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.269 -1.011 . . . . 0.14999999999999999 108.269 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 5.2 mt-30 -116.58 139.96 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.012 -1.107 . . . . 1.03 108.012 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -109.54 126.52 53.66 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.48 0.657 . . . . 0.11 110.065 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -123.0 154.78 38.0 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.205 -1.035 . . . . 0.17000000000000001 108.205 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -155.87 123.76 5.67 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.965 -1.124 . . . . 1.48 107.965 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 56.84 20.74 5.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.726 -0.609 . . . . 1.6699999999999999 110.088 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.22 -1.48 67.33 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.074 -1.016 . . . . 0.22 110.579 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -110.79 148.02 33.24 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.112 -1.228 . . . . 2.0800000000000001 110.56 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -86.6 139.98 30.29 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.522 -0.918 . . . . 1.7 108.522 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -122.34 -21.44 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.454 -0.779 . . . . 0.26000000000000001 110.704 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.74 174.92 47.17 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.425 -1.369 . . . . 0.17999999999999999 110.209 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.75 155.75 2.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -1.14 . . . . 2.04 110.531 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -169.76 135.06 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.685 -0.634 . . . . 0.14000000000000001 109.875 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -107.2 -178.76 3.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 108.898 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.41 134.0 8.34 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.446 -1.462 . . . . 0.13 109.446 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.516 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.75 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -1.195 . . . . 0.20000000000000001 110.261 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -138.82 73.21 1.42 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.936 -1.135 . . . . 1.1499999999999999 107.936 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -34.86 78.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 1.1899999999999999 110.84 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.38 -25.03 67.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.991 -1.068 . . . . 1.95 109.354 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -69.1 -38.12 78.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.372 -0.83 . . . . 2.0499999999999998 109.726 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 77' ' ' PHE . 42.6 mt -51.23 -36.51 42.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.919 -1.113 . . . . 0.14999999999999999 109.077 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.45 -56.63 10.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.851 . . . . 2.1499999999999999 109.573 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.94 86.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.14999999999999999 110.398 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 m -67.47 -47.41 70.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.137 -0.977 . . . . 0.13 109.818 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -60.94 -49.4 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.17999999999999999 108.46 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.55 -17.71 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 1.03 109.62 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.2 -60.35 2.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 2.02 109.928 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.11 21.54 5.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.492 -0.755 . . . . 0.34999999999999998 110.307 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 1.1799999999999999 109.197 179.454 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.471 HH21 ' CB ' ' A' ' 63' ' ' GLN . 5.8 mmt180 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.62 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -113.17 -171.77 1.93 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.068 -1.02 . . . . 0.0 111.002 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.4 t -64.91 144.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.912 0.863 . . . . 0.0 113.072 -176.471 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -101.7 93.81 5.52 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.412 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 10.6 pt-20 -85.04 44.7 1.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.07 . . . . 0.0 110.843 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.27 -133.46 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.36 18.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.23 1.515 . . . . 0.0 109.639 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.655 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.3 t . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.467 -0.771 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.0 t . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.299 -0.63 . . . . 0.29999999999999999 109.299 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -152.69 119.77 5.83 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.923 -1.139 . . . . 1.97 107.923 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -86.95 144.1 27.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.974 -1.079 . . . . 0.97999999999999998 110.362 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mm -111.05 108.64 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.884 -1.154 . . . . 0.19 107.884 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.65 -12.56 19.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 1.97 109.489 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -153.55 155.12 35.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 0.23000000000000001 109.631 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -51.35 -21.25 2.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 1.8999999999999999 109.436 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.57 -52.9 62.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 0.25 110.435 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -20.45 63.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.20000000000000001 110.275 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.37 -65.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.059 -1.026 . . . . 0.20999999999999999 110.19 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.37 -45.07 84.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 2.4700000000000002 109.633 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -59.0 -34.44 71.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.985 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.38 81.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.916 -1.115 . . . . 0.20000000000000001 109.332 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.74 -45.97 84.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.227 -0.921 . . . . 0.62 109.447 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -63.78 -37.41 87.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.466 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.76 -16.93 52.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.29999999999999999 109.472 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.78 27.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.23999999999999999 109.522 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.38 -111.0 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.742 -1.343 . . . . 0.28000000000000003 109.742 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -138.1 3.57 2.42 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.391 -1.064 . . . . 2.21 109.349 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.29 169.05 14.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.164 -0.96 . . . . 1.8999999999999999 108.916 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 162.32 12.2 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.035 -1.098 . . . . 0.17000000000000001 108.035 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -144.18 103.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.831 -1.168 . . . . 0.12 109.628 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.27 129.92 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.563 -0.903 . . . . 0.089999999999999997 108.563 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.16 141.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -0.762 . . . . 0.17000000000000001 109.548 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -110.97 99.1 8.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.957 -0.757 . . . . 0.95999999999999996 108.957 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 52.0 m-85 -84.82 81.41 8.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.632 -1.248 . . . . 0.23999999999999999 107.632 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -109.89 -163.87 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.563 0.697 . . . . 1.03 109.147 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.53 119.93 13.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.151 -1.055 . . . . 0.26000000000000001 108.151 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -63.21 -24.02 67.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.32000000000000001 110.565 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -89.64 -14.87 33.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.44 110.118 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 t -93.77 133.73 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.32000000000000001 109.706 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.448 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.77 -57.76 5.21 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 111.337 -0.705 . . . . 0.35999999999999999 111.337 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.5 Cg_exo -49.24 -37.27 39.32 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.779 1.652 . . . . 0.44 111.414 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.46 -62.62 1.56 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.857 -1.152 . . . . 0.81000000000000005 109.069 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -59.0 -20.05 49.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 1.9199999999999999 109.676 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.4 tpt -60.57 -18.04 50.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.322 -0.861 . . . . 3.1299999999999999 109.662 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -100.51 10.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.289 -0.882 . . . . 0.28000000000000003 110.412 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.59 -32.3 5.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.416 -1.427 . . . . 1.6200000000000001 112.386 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -63.07 -5.09 7.17 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 CA-C-N 119.865 0.988 . . . . 0.25 110.29 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.8 -77.51 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.928 -0.767 . . . . 0.29999999999999999 108.928 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -42.44 -56.63 2.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.13 110.998 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.73 -33.32 75.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.103 -0.998 . . . . 0.40999999999999998 109.688 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 m -64.36 -39.89 94.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 0.96999999999999997 109.997 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -51.85 -16.54 0.72 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.025 -1.047 . . . . 0.5 109.72 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -57.01 -29.46 63.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.51000000000000001 109.737 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -95.95 -21.4 18.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 2.0 110.162 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -90.32 -19.7 23.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.053 -1.029 . . . . 2.1600000000000001 109.41 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.15 64.65 1.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.39 -0.819 . . . . 0.23999999999999999 109.209 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 p -66.9 -4.43 9.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.337 -0.852 . . . . 0.17000000000000001 109.027 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -95.05 2.31 55.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.445 -0.784 . . . . 0.34000000000000002 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -119.0 150.03 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.157 -0.683 . . . . 0.12 109.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.79 122.31 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.17000000000000001 108.982 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -109.74 129.84 55.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.254 -0.904 . . . . 0.11 108.969 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.7 169.63 8.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.336 -0.852 . . . . 0.12 108.807 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -142.06 140.39 32.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.602 -1.259 . . . . 1.3100000000000001 107.602 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.2 136.94 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.898 . . . . 0.14000000000000001 110.741 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.99 107.68 20.26 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.645 -1.243 . . . . 1.0800000000000001 107.645 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.3 m -65.14 -9.68 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.27000000000000002 111.06 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -101.03 -41.69 6.68 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 110.704 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -12.48 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 1.1200000000000001 109.91 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.31 49.63 1.88 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.311 -0.868 . . . . 0.17000000000000001 108.836 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.08 -17.01 5.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.721 . . . . 2.2200000000000002 109.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.4 p30 -70.33 -41.29 73.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.433 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -74.18 -45.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.19 108.674 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.27 79.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.282 -0.886 . . . . 0.22 108.779 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -64.04 -44.79 91.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.369 -0.832 . . . . 1.29 109.265 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.59 -39.11 93.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.449 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.71 55.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.186 -0.946 . . . . 0.33000000000000002 109.909 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 47.65 56.21 7.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.06 -1.025 . . . . 2.3399999999999999 109.748 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.9 t -79.52 131.27 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.28000000000000003 109.588 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -128.8 0.96 5.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.385 -0.822 . . . . 2.3999999999999999 109.669 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.0 128.65 10.8 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.966 -1.084 . . . . 0.22 108.771 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.666 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.2 p -114.77 150.43 44.03 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.733 -0.84 . . . . 0.22 108.733 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.54 147.47 84.66 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 C-N-CA 124.776 -0.927 . . . . 0.20000000000000001 109.941 -1.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.56 117.42 28.93 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.938 -1.134 . . . . 0.17999999999999999 107.938 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.6 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.2 m-85 -91.78 121.48 33.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.07 -1.019 . . . . 0.14999999999999999 108.494 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.504 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.1 mt-30 -120.05 136.38 54.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.783 -1.191 . . . . 1.03 107.783 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 32.3 m-85 -108.97 129.43 55.44 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.581 0.705 . . . . 0.11 109.978 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -126.24 156.92 39.52 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.263 -1.014 . . . . 0.17000000000000001 108.263 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -155.39 120.23 4.79 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.485 -1.302 . . . . 1.48 107.485 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt 55.97 29.14 13.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -0.783 . . . . 1.6699999999999999 108.909 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.13 7.8 87.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.896 -1.281 . . . . 0.22 109.896 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -112.85 142.41 45.54 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.469 -1.018 . . . . 2.0800000000000001 110.643 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -84.77 141.37 30.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 1.7 109.314 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.34 -20.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.426 -0.796 . . . . 0.26000000000000001 110.452 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.24 172.97 45.53 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.346 -1.407 . . . . 0.17999999999999999 110.435 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -174.22 150.68 1.54 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.447 -1.031 . . . . 2.04 110.044 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -169.09 133.18 1.41 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.14000000000000001 110.48 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.55 -169.55 1.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.17000000000000001 108.929 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.13 129.88 3.67 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.669 -1.372 . . . . 0.13 109.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.87 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -1.16 . . . . 0.20000000000000001 110.602 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -139.46 76.68 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.828 -1.175 . . . . 1.1499999999999999 107.828 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.34 -32.55 74.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.654 -0.654 . . . . 1.1899999999999999 110.656 -178.671 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.66 -28.35 69.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.906 -1.121 . . . . 1.95 109.146 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.71 -35.23 76.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 2.0499999999999998 109.322 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.4 mt -52.07 -38.99 59.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.14999999999999999 108.823 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -57.63 6.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.578 -0.701 . . . . 2.1499999999999999 109.785 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.32 82.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.14999999999999999 110.494 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.2 m -66.78 -45.79 77.36 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.13 110.163 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.68 -52.37 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.17999999999999999 109.214 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -60.52 -18.09 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 1.03 109.449 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -77.39 -62.72 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 2.02 110.202 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.33 24.39 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.558 -0.714 . . . . 0.34999999999999998 110.437 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.937 -1.102 . . . . 1.1799999999999999 109.165 179.541 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -109.55 -168.39 1.32 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.259 -0.901 . . . . 0.0 110.461 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.67 150.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.266 -0.896 . . . . 0.0 112.57 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.9 m -101.4 96.53 7.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.595 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.25 44.76 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 110.279 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.89 -131.43 0.12 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.08 23.98 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.273 1.537 . . . . 0.0 109.129 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.622 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.6 t . . . . . 0 N--CA 1.486 1.348 0 O-C-N 121.354 -0.842 . . . . 0.0 109.335 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.9 t . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.3 0.571 . . . . 0.29999999999999999 109.588 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' N ' HG12 ' A' ' 2' ' ' VAL . 33.6 tttt -155.96 123.32 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 1.97 109.224 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -90.45 132.52 35.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.97999999999999998 109.645 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -112.51 103.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.548 -0.908 . . . . 0.19 108.548 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -99.19 -4.46 32.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.204 -0.935 . . . . 1.97 109.852 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 p -151.18 148.9 28.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.112 -0.992 . . . . 0.23000000000000001 109.96 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -52.31 -25.59 9.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.319 -0.863 . . . . 1.8999999999999999 109.552 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.7 m -59.7 -48.92 79.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.25 109.34 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -23.62 62.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.20000000000000001 109.733 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -58.28 -66.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.20999999999999999 110.198 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.27 -44.62 79.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 2.4700000000000002 109.669 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -58.91 -35.11 72.52 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 109.804 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.20000000000000001 108.898 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.21 -43.52 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.578 -0.702 . . . . 0.62 109.318 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 -38.2 90.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 1.0900000000000001 109.681 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.19 -16.08 55.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.29999999999999999 109.909 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.28 50.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.23999999999999999 109.889 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 -112.94 4.76 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.31 -1.516 . . . . 0.28000000000000003 109.31 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -134.71 2.54 3.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.435 -1.038 . . . . 2.21 109.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -70.28 166.87 19.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.044 -1.035 . . . . 1.8999999999999999 108.689 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.39 163.36 10.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.17000000000000001 108.834 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.2 t -144.6 107.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 0.12 109.402 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.38 135.5 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.556 -0.905 . . . . 0.089999999999999997 108.556 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.15 133.44 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.17000000000000001 109.894 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 9.4 t70 -106.44 102.96 12.31 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.98 -0.748 . . . . 0.95999999999999996 108.98 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -88.45 79.43 7.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.603 -1.258 . . . . 0.23999999999999999 107.603 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.416 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 67.0 m -113.3 149.27 34.16 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.225 0.536 . . . . 1.03 109.613 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.89 129.57 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.858 . . . . 0.26000000000000001 109.082 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.45 -23.97 65.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 0.32000000000000001 110.118 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.407 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 53.8 p-90 -89.1 -16.88 30.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.061 -1.024 . . . . 0.44 110.176 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.48 124.71 37.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.965 . . . . 0.32000000000000001 110.291 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.76 -57.75 11.67 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.972 -0.851 . . . . 0.35999999999999999 110.972 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -46.18 -36.07 16.19 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 121.908 1.739 . . . . 0.44 111.359 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.0 -60.31 2.41 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.672 -1.267 . . . . 0.81000000000000005 108.991 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -59.91 -18.39 44.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.489 -0.757 . . . . 1.9199999999999999 110.029 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.4 tpt -59.68 -24.77 64.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 3.1299999999999999 110.155 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 38' ' ' ILE . 72.3 mt -96.91 6.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.142 -0.974 . . . . 0.28000000000000003 111.371 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -62.58 -34.39 14.52 Favored Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 118.194 -1.402 . . . . 1.6200000000000001 111.64 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -62.32 -5.9 7.48 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 CA-C-N 120.009 1.039 . . . . 0.25 110.524 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.83 -71.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.29999999999999999 108.958 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -46.06 -58.5 3.55 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.488 -0.757 . . . . 0.13 110.733 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.24 -30.49 71.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.40999999999999998 109.714 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 m -63.54 -41.17 98.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.855 -1.153 . . . . 0.96999999999999997 109.735 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -52.01 -16.92 0.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.5 109.575 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 66.6 m -56.93 -31.37 64.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.51000000000000001 109.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.92 -19.72 20.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.127 -0.983 . . . . 2.0 109.906 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -90.94 -21.38 21.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 2.1600000000000001 109.774 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.22 67.71 1.5 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.23999999999999999 109.231 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -68.01 -3.97 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.413 -0.805 . . . . 0.17000000000000001 109.322 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -94.94 2.22 55.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.34000000000000002 109.719 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.1 t -119.12 152.99 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.811 -0.811 . . . . 0.12 108.811 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 mm -100.44 128.64 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.306 -0.871 . . . . 0.17000000000000001 108.911 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.603 ' C ' HD12 ' A' ' 55' ' ' LEU . 65.0 m-85 -114.58 132.9 56.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.407 -0.808 . . . . 0.11 109.144 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -115.31 169.0 9.47 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.083 -0.71 . . . . 0.12 109.083 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -144.25 141.1 29.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.196 -1.039 . . . . 1.3100000000000001 108.196 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.15 145.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.103 -0.998 . . . . 0.14000000000000001 110.425 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.32 100.92 11.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.219 -1.03 . . . . 1.0800000000000001 108.219 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.09 -3.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.246 -0.909 . . . . 0.27000000000000002 111.287 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 27.1 m-20 -108.79 -40.94 4.9 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.203 -0.936 . . . . 1.1100000000000001 111.095 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.21 -23.43 16.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.891 -1.131 . . . . 1.1200000000000001 110.036 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.0 46.34 0.98 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.352 -0.981 . . . . 0.17000000000000001 108.352 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -53.53 -14.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.731 -0.606 . . . . 2.2200000000000002 109.9 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -71.2 -42.98 68.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.316 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.19 -43.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.143 -0.973 . . . . 0.19 108.696 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -35.55 79.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 m -64.69 -46.98 80.07 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.754 -0.832 . . . . 1.29 108.754 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.57 -39.42 94.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 2.2000000000000002 109.35 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -3.15 58.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 0.33000000000000002 109.603 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 66' ' ' ALA . 52.3 mm-40 47.47 53.01 11.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.873 . . . . 2.3399999999999999 110.352 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.96 136.14 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.28000000000000003 109.413 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -129.88 3.86 4.92 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.476 -0.765 . . . . 2.3999999999999999 109.5 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 136.26 16.27 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.128 -0.982 . . . . 0.22 108.883 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.521 HG23 ' CE2' ' B' ' 5' ' ' TYR . 41.1 p -118.55 150.79 48.76 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.945 -0.761 . . . . 0.22 108.945 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.76 145.92 80.39 Favored 'Cis proline' 0 N--CA 1.482 0.848 0 N-CA-C 109.778 -0.893 . . . . 0.20000000000000001 109.778 -1.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.6 112.47 22.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.513 -1.292 . . . . 0.17999999999999999 107.513 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -92.56 113.8 26.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.426 -0.91 . . . . 0.14999999999999999 108.686 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -115.91 138.68 50.95 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.443 -1.317 . . . . 1.03 107.443 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -110.11 127.23 54.77 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.374 0.607 . . . . 0.11 109.756 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -121.45 157.18 31.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.541 -0.911 . . . . 0.17000000000000001 108.541 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -155.73 123.53 5.65 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.491 -1.3 . . . . 1.48 107.491 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt 57.07 17.81 3.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.687 -0.633 . . . . 1.6699999999999999 109.89 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.72 0.18 62.59 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.416 -1.074 . . . . 0.22 110.416 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -111.87 151.1 29.51 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.184 -1.186 . . . . 2.0800000000000001 110.033 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.398 -0.814 . . . . 1.7 109.316 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.87 -7.03 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.735 . . . . 0.26000000000000001 110.542 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.93 167.77 35.29 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.445 -1.36 . . . . 0.17999999999999999 110.284 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.95 153.2 2.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 2.04 110.604 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 8.2 p90 -169.66 132.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.14000000000000001 109.603 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.7 p -104.23 -162.28 0.88 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.015 -1.053 . . . . 0.17000000000000001 109.183 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.14 137.1 1.08 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.325 -1.51 . . . . 0.13 109.325 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.49 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.20000000000000001 110.094 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -137.46 66.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.868 -1.16 . . . . 1.1499999999999999 107.868 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -62.24 -38.94 91.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.816 -0.552 . . . . 1.1899999999999999 111.262 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.58 -27.33 68.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.596 -1.315 . . . . 1.95 109.497 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.19 -32.77 73.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 2.0499999999999998 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.9 mt -51.4 -36.88 45.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.14999999999999999 108.687 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.34 -59.64 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.527 -0.733 . . . . 2.1499999999999999 109.848 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.47 81.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.14999999999999999 110.741 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.8 m -67.84 -45.28 75.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.13 110.211 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.55 -51.24 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.17999999999999999 109.157 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.71 -17.22 46.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 1.03 109.634 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.95 -61.26 1.99 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 2.02 110.015 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.9 21.33 5.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.424 -0.797 . . . . 0.34999999999999998 110.391 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.017 -1.052 . . . . 1.1799999999999999 109.414 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.606 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -125.35 -173.97 2.95 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.16 149.72 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.006 0.908 . . . . 0.0 112.496 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.55 95.69 6.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -83.89 41.59 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.03 -1.044 . . . . 0.0 110.361 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -129.4 0.05 OUTLIER Glycine 0 N--CA 1.485 1.915 0 N-CA-C 106.898 -2.481 . . . . 0.0 106.898 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.71 22.67 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.307 1.553 . . . . 0.0 109.119 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.3 t . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.41 -0.589 . . . . 0.29999999999999999 109.41 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.618 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.7 tttp -151.92 121.54 6.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.234 -0.916 . . . . 1.97 109.073 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -88.29 132.04 34.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.97999999999999998 109.709 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.97 107.46 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.228 -1.027 . . . . 0.19 108.228 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.58 -10.33 22.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.201 -0.937 . . . . 1.97 109.646 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 p -153.51 157.49 39.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.23000000000000001 109.95 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -53.02 -30.38 35.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 1.8999999999999999 109.916 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 m -59.49 -45.1 92.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.25 110.25 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.06 -26.48 64.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.20000000000000001 109.795 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.02 -69.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.973 . . . . 0.20999999999999999 110.237 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -54.38 -43.16 71.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 2.4700000000000002 109.603 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -59.0 -36.36 74.8 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.171 -0.956 . . . . 2.1000000000000001 109.643 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.0 -47.63 85.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.032 -1.043 . . . . 0.20000000000000001 109.013 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.18 -44.49 88.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.735 . . . . 0.62 109.877 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -62.92 -45.73 91.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 1.0900000000000001 109.826 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.95 59.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.29999999999999999 109.876 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.79 -10.53 57.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.084 -1.01 . . . . 0.23999999999999999 109.649 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.61 13.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.28000000000000003 109.612 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 46.1 t0 -121.17 2.81 10.4 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.586 -0.949 . . . . 2.21 109.925 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.25 169.98 9.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.902 -1.123 . . . . 1.8999999999999999 109.367 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.0 162.43 19.36 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.19 -1.041 . . . . 0.17000000000000001 108.19 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.8 t -145.26 102.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.981 -1.074 . . . . 0.12 109.111 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' CE2' ' A' ' 79' ' ' PHE . 3.1 t -101.42 127.54 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.485 -0.76 . . . . 0.089999999999999997 109.069 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.0 138.32 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.606 -0.684 . . . . 0.17000000000000001 109.764 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -108.86 99.46 8.8 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.974 -0.751 . . . . 0.95999999999999996 108.974 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.6 m-85 -82.96 77.26 9.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.794 -1.187 . . . . 0.23999999999999999 107.794 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -103.98 -166.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.574 0.702 . . . . 1.03 109.433 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 127.98 21.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.863 -0.791 . . . . 0.26000000000000001 108.863 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.32000000000000001 111.194 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.557 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.7 p-90 -86.74 -11.05 52.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.768 -1.208 . . . . 0.44 110.09 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.84 117.38 30.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.32000000000000001 109.981 -179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.63 -55.19 31.32 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 120.865 -0.683 . . . . 0.35999999999999999 111.419 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.1 Cg_exo -49.59 -35.7 38.31 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.814 1.676 . . . . 0.44 111.11 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.34 -62.64 1.59 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.951 -1.093 . . . . 0.81000000000000005 109.055 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.62 -16.93 29.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.476 -0.765 . . . . 1.9199999999999999 110.163 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -61.48 -19.37 61.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.083 -1.011 . . . . 3.1299999999999999 110.222 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 38' ' ' ILE . 72.2 mt -100.48 13.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.244 -0.91 . . . . 0.28000000000000003 110.718 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.51 -32.1 2.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.469 -1.394 . . . . 1.6200000000000001 112.607 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.7 Cg_exo -63.79 -4.06 6.64 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 119.793 0.962 . . . . 0.25 110.268 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 42' ' ' PHE . 42.0 m-85 -110.9 -79.47 0.58 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.404 -0.81 . . . . 0.29999999999999999 108.907 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.62 -57.12 1.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.566 . . . . 0.13 110.79 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.07 -30.72 70.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.40999999999999998 109.834 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 11.2 m -66.76 -38.62 86.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.96999999999999997 110.284 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -49.45 -20.25 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.935 -1.103 . . . . 0.5 109.772 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -56.71 -22.94 38.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.51000000000000001 110.105 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -97.07 -26.46 14.98 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.15 -0.969 . . . . 2.0 110.239 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.13 -17.76 27.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.077 -1.014 . . . . 2.1600000000000001 109.56 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -134.16 70.19 1.45 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.377 -0.827 . . . . 0.23999999999999999 109.39 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.6 p -68.51 -6.23 24.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.423 -0.798 . . . . 0.17000000000000001 109.12 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.2 3.31 54.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.448 -0.782 . . . . 0.34000000000000002 110.052 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.69 148.54 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.12 109.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.8 mm -99.23 121.73 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17000000000000001 108.983 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' C ' HD12 ' A' ' 55' ' ' LEU . 81.4 m-85 -108.84 128.39 54.86 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.878 . . . . 0.11 108.937 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.7 mp -110.2 170.41 8.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.504 -0.747 . . . . 0.12 109.023 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -140.82 137.93 33.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.634 -1.247 . . . . 1.3100000000000001 107.634 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.69 134.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.913 . . . . 0.14000000000000001 110.336 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.14 110.31 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.63 -1.248 . . . . 1.0800000000000001 107.63 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.23 -11.35 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.27000000000000002 111.346 -178.251 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.557 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 12.1 m-20 -104.76 -38.92 6.51 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 110.793 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.52 -13.62 27.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.693 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.46 49.14 1.94 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.306 -0.998 . . . . 0.17000000000000001 108.306 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.11 -16.42 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 2.2200000000000002 110.755 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -39.43 76.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.853 -1.154 . . . . 1.1100000000000001 109.304 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.8 -47.12 44.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.201 -0.937 . . . . 0.19 108.84 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.86 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.847 . . . . 0.22 109.333 179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.0 m -62.78 -50.13 72.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 1.29 109.26 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.54 -32.33 73.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.635 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.98 0.11 56.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.238 -0.913 . . . . 0.33000000000000002 109.816 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 47.41 50.01 15.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 2.3399999999999999 110.097 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.61 131.94 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 109.064 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -129.12 6.71 5.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.331 -0.855 . . . . 2.3999999999999999 109.661 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 144.29 24.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.497 HG23 ' CE2' ' B' ' 5' ' ' TYR . 32.5 p -131.01 149.12 72.87 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 108.546 -0.909 . . . . 0.22 108.546 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.4 Cg_endo -79.09 142.69 68.3 Favored 'Cis proline' 0 N--CA 1.487 1.134 0 C-N-CA 124.966 -0.848 . . . . 0.20000000000000001 110.219 -1.312 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.01 111.06 21.52 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 107.862 -1.162 . . . . 0.17999999999999999 107.862 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 97' ' ' LEU . 88.7 m-85 -86.15 116.0 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.822 -1.174 . . . . 0.14999999999999999 109.541 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.3 mt-30 -115.96 132.12 56.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.325 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -105.14 127.51 52.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.11 109.66 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -121.78 155.46 35.24 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.92 -0.77 . . . . 0.17000000000000001 108.92 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -154.96 123.65 6.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.737 -1.208 . . . . 1.48 107.737 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 55.95 28.88 13.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.529 -0.732 . . . . 1.6699999999999999 109.827 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.07 -0.1 89.49 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.089 -1.053 . . . . 0.22 110.815 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -110.98 147.88 33.75 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.144 -1.209 . . . . 2.0800000000000001 110.475 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -87.87 143.84 26.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 1.7 109.339 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.1 m -123.59 -24.0 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.497 -0.752 . . . . 0.26000000000000001 110.15 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.29 177.18 47.87 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.586 -1.292 . . . . 0.17999999999999999 109.975 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.19 157.21 3.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 2.04 110.057 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.5 p90 -168.76 131.16 1.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.807 . . . . 0.14000000000000001 110.161 178.958 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -101.48 -161.16 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.559 -0.904 . . . . 0.17000000000000001 108.559 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' B' ' 8' ' ' GLU . . . 82.43 126.5 0.98 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.104 -1.598 . . . . 0.13 109.104 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.09 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -1.203 . . . . 0.20000000000000001 110.891 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -142.73 76.61 1.54 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.967 -1.123 . . . . 1.1499999999999999 107.967 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -32.4 73.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.1899999999999999 110.774 -178.56 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.13 -25.23 67.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.93 -1.106 . . . . 1.95 109.372 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -70.86 -37.23 73.09 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.3 -0.875 . . . . 2.0499999999999998 109.852 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.5 mt -52.17 -36.03 50.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.14999999999999999 108.962 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -66.09 -59.21 4.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.431 -0.793 . . . . 2.1499999999999999 110.071 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.53 82.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.14999999999999999 110.676 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.4 m -67.22 -45.22 77.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.072 -1.017 . . . . 0.13 110.192 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.04 -53.03 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.191 -0.943 . . . . 0.17999999999999999 109.127 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -59.19 -18.53 37.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 1.03 109.471 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.54 -56.56 4.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 2.02 110.08 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -92.96 15.47 14.88 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.495 -0.753 . . . . 0.34999999999999998 110.613 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.872 -1.143 . . . . 1.1799999999999999 109.403 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.497 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.28 -169.78 1.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.177 -0.952 . . . . 0.0 110.973 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.63 150.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-O 122.09 0.948 . . . . 0.0 112.875 -176.778 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -102.24 96.28 6.87 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -82.88 47.86 1.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 110.131 -179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -78.16 -125.28 0.35 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 177.936 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.9 25.67 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.495 1.648 . . . . 0.0 109.54 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.4 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 3' ' ' LYS . 95.3 t . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.496 -0.557 . . . . 0.29999999999999999 109.496 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 tptt -154.5 125.21 7.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.274 -0.891 . . . . 1.97 109.212 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -90.26 131.66 35.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.97999999999999998 109.668 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.32 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.403 -0.962 . . . . 0.19 108.403 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.63 -1.33 47.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 1.97 109.791 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -150.99 146.93 26.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.23000000000000001 109.813 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -51.83 -29.5 19.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.34 -0.85 . . . . 1.8999999999999999 109.831 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -59.04 -45.66 90.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.25 109.799 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.44 63.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.20000000000000001 109.681 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.99 -66.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.061 -1.024 . . . . 0.20999999999999999 109.786 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -53.65 -46.09 70.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.207 -0.933 . . . . 2.4700000000000002 109.728 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.98 -35.13 72.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.152 -0.967 . . . . 2.1000000000000001 110.022 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.53 -46.24 90.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.995 -1.065 . . . . 0.20000000000000001 109.296 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.4 -50.19 68.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.62 109.717 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.29 -36.59 84.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.474 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.58 -18.66 47.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -0.927 . . . . 0.29999999999999999 109.682 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.8 23.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.23999999999999999 109.73 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 70.97 -116.11 6.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.28000000000000003 109.642 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 84.1 m-20 -135.22 4.01 3.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.442 -1.034 . . . . 2.21 109.408 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -69.8 170.07 11.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.047 -1.033 . . . . 1.8999999999999999 109.013 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 159.89 22.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.71 -1.218 . . . . 0.17000000000000001 107.71 179.574 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.697 ' H ' HD23 ' A' ' 22' ' ' LEU . 16.1 t -143.56 108.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.865 -1.147 . . . . 0.12 109.374 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.95 134.47 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.912 -0.773 . . . . 0.089999999999999997 108.912 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.66 136.08 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.665 -0.647 . . . . 0.17000000000000001 109.523 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.37 101.95 11.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.017 -0.735 . . . . 0.95999999999999996 109.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -85.25 77.84 9.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.041 -1.096 . . . . 0.23999999999999999 108.041 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -113.92 146.47 40.02 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.16 -0.682 . . . . 1.03 109.16 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.56 130.51 36.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.26000000000000001 108.751 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -65.88 -24.57 66.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.32000000000000001 110.311 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 58.5 p-90 -88.54 -17.35 30.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.082 -1.011 . . . . 0.44 109.888 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.82 116.18 28.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.32000000000000001 110.135 -178.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.16 -53.14 47.21 Favored Glycine 0 N--CA 1.488 2.123 0 CA-C-O 119.341 -0.699 . . . . 0.35999999999999999 111.854 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.7 Cg_exo -48.38 -38.79 35.13 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.534 1.489 . . . . 0.44 111.148 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.4 -59.67 2.64 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.727 -1.233 . . . . 0.81000000000000005 109.015 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.49 -18.63 52.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.739 . . . . 1.9199999999999999 110.295 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm -57.93 -19.55 30.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.79 -1.194 . . . . 3.1299999999999999 110.257 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.688 ' O ' HG22 ' A' ' 38' ' ' ILE . 77.4 mt -101.5 15.02 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.136 -0.977 . . . . 0.28000000000000003 110.39 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.75 -32.21 3.43 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.618 -1.301 . . . . 1.6200000000000001 112.56 179.727 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.6 Cg_exo -63.08 -5.21 7.41 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.883 0.994 . . . . 0.25 110.165 -178.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.08 -76.73 0.6 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.475 -0.766 . . . . 0.29999999999999999 109.203 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.13 110.787 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.5 -31.52 72.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.93 -1.106 . . . . 0.40999999999999998 110.025 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.5 m -64.64 -38.82 92.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.818 -1.176 . . . . 0.96999999999999997 110.039 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -50.25 -12.62 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.926 -1.109 . . . . 0.5 109.776 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' SER . 19.4 m -56.76 -37.34 70.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.084 -1.01 . . . . 0.51000000000000001 109.665 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -94.97 -13.32 25.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.232 -0.918 . . . . 2.0 110.283 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -27.5 19.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.002 -1.062 . . . . 2.1600000000000001 109.572 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.42 72.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.088 -0.708 . . . . 0.23999999999999999 109.088 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.1 p -67.02 -4.48 9.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.17000000000000001 109.215 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -96.1 -3.17 45.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.34000000000000002 109.829 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.45 150.12 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.452 -0.78 . . . . 0.12 109.603 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.1 130.48 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.534 -0.729 . . . . 0.17000000000000001 109.412 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -115.03 132.53 56.57 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.554 -0.716 . . . . 0.11 109.192 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.66 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.743 -0.836 . . . . 0.12 108.743 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.68 138.9 32.79 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.44 136.9 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.163 -0.961 . . . . 0.14000000000000001 110.887 -178.335 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -98.78 102.78 14.62 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.268 -1.012 . . . . 1.0800000000000001 108.268 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.3 m -61.06 -0.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.27000000000000002 111.56 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 18.0 m-20 -115.18 -37.86 3.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.102 -0.999 . . . . 1.1100000000000001 111.053 -178.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -94.96 -14.26 24.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.997 -1.064 . . . . 1.1200000000000001 109.766 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.58 52.84 1.6 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.709 -0.848 . . . . 0.17000000000000001 108.709 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -53.93 -19.23 4.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.431 -0.793 . . . . 2.2200000000000002 110.173 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -68.02 -39.57 83.11 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.18 -1.575 . . . . 1.1100000000000001 109.989 -178.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.14 -48.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.955 -1.091 . . . . 0.19 108.736 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.22 90.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.22 110.336 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.428 ' HA ' HH22 ' B' ' 4' ' ' ARG . 23.1 t -63.63 -42.19 98.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 1.29 109.581 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.69 -38.81 92.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.126 -0.984 . . . . 2.2000000000000002 109.191 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.9 0.17 56.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.33000000000000002 109.872 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 67' ' ' SER . 22.9 mp0 48.15 56.29 7.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 2.3399999999999999 110.222 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 6.9 t -79.14 132.76 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.28000000000000003 108.916 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 9.3 mtmp? -129.77 3.8 4.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.331 -0.856 . . . . 2.3999999999999999 110.358 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 123.17 7.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.975 -1.078 . . . . 0.22 109.457 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.667 HG23 ' CE2' ' B' ' 5' ' ' TYR . 37.5 p -109.47 150.25 40.92 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.322 -0.861 . . . . 0.22 109.068 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -77.41 139.55 58.82 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 C-N-CA 124.894 -0.878 . . . . 0.20000000000000001 110.421 -1.651 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -110.44 112.02 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.797 -1.186 . . . . 0.17999999999999999 107.797 178.68 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 97' ' ' LEU . 91.9 m-85 -89.62 119.08 29.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.919 -1.113 . . . . 0.14999999999999999 109.27 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -117.0 132.63 56.65 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.37 -1.344 . . . . 1.03 107.37 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -108.76 123.77 49.53 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.628 0.727 . . . . 0.11 109.471 -178.234 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -120.86 157.37 29.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.54 -0.911 . . . . 0.17000000000000001 108.54 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.65 125.98 6.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.855 -1.165 . . . . 1.48 107.855 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm 56.18 26.15 9.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 1.6699999999999999 109.988 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.99 3.26 90.56 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.947 -1.261 . . . . 0.22 109.947 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -111.49 148.06 33.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.517 -0.99 . . . . 2.0800000000000001 109.744 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.66 146.03 26.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 1.7 109.692 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.91 -29.77 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -0.752 . . . . 0.26000000000000001 109.844 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.43 177.91 44.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.529 -1.32 . . . . 0.17999999999999999 110.472 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.1 pm0 -173.3 154.52 2.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -1.08 . . . . 2.04 110.164 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.98 131.58 1.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.353 -0.842 . . . . 0.14000000000000001 109.924 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -102.98 -158.16 0.65 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 108.895 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.9 126.05 0.7 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.438 -1.465 . . . . 0.13 109.438 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.19 94.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.244 . . . . 0.20000000000000001 110.131 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.3 t-20 -139.49 76.59 1.57 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.37 -0.974 . . . . 1.1499999999999999 108.37 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -63.99 -41.08 97.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.778 -0.576 . . . . 1.1899999999999999 111.206 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.58 -25.85 68.15 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.051 -1.031 . . . . 1.95 109.785 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -69.35 -33.79 73.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.192 -0.942 . . . . 2.0499999999999998 109.405 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.8 mt -54.77 -35.53 63.9 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.68 -1.208 . . . . 0.14999999999999999 108.583 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -66.62 -55.96 12.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 2.1499999999999999 109.465 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.73 92.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.14999999999999999 110.419 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -65.81 -46.79 77.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.13 110.203 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.28 -49.67 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.17999999999999999 108.676 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' HG12 ' A' ' 105' ' ' VAL . 55.8 t30 -62.59 -17.06 59.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 1.03 109.183 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -79.37 -55.51 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 2.02 110.457 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 22' ' ' LEU . 27.2 mt -92.15 14.13 16.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.34999999999999998 110.336 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.284 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.428 HH22 ' HA ' ' A' ' 67' ' ' SER . 7.0 ttt180 . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.667 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.5 p90 -116.56 -167.79 1.34 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.843 -1.16 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.1 150.71 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.381 -0.825 . . . . 0.0 112.317 -177.437 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -101.59 95.36 6.4 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.412 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -82.51 45.42 0.96 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.075 -1.015 . . . . 0.0 109.594 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -133.99 0.08 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.81 25.38 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.79 0 CA-C-N 119.2 1.5 . . . . 0.0 108.773 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.2 t . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 109.261 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 31.1 t . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.255 0.55 . . . . 0.29999999999999999 109.722 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 76.4 tttt -154.01 124.98 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.271 -0.893 . . . . 1.97 109.325 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -89.03 133.74 34.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.97999999999999998 109.654 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -105.56 117.01 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.162 -1.051 . . . . 0.19 108.162 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 11.6 mp0 -102.54 -14.67 16.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.156 -0.965 . . . . 1.97 109.508 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 p -152.74 158.63 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.23000000000000001 109.817 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -52.22 -26.71 12.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 1.8999999999999999 109.703 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -59.89 -48.61 80.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.25 110.018 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.67 62.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.20000000000000001 109.765 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.69 -69.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.018 . . . . 0.20999999999999999 110.039 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -54.23 -43.97 71.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -0.857 . . . . 2.4700000000000002 109.853 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.74 -37.45 76.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.236 -0.915 . . . . 2.1000000000000001 109.743 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.52 95.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.0 -1.063 . . . . 0.20000000000000001 109.187 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.69 -42.39 95.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.62 109.589 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.86 -42.44 97.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.763 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -12.98 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.146 -0.971 . . . . 0.29999999999999999 109.552 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -5.91 25.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.23999999999999999 109.653 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.25 -110.76 3.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.369 -1.492 . . . . 0.28000000000000003 109.369 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.14 5.09 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.335 -1.097 . . . . 2.21 108.98 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -69.8 168.61 14.72 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.094 -1.004 . . . . 1.8999999999999999 108.819 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.49 162.52 12.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.039 -1.097 . . . . 0.17000000000000001 108.039 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.46 105.13 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.907 -1.121 . . . . 0.12 109.379 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.0 t -103.73 126.89 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.089999999999999997 108.833 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.59 138.97 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.713 . . . . 0.17000000000000001 109.527 -179.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.49 104.99 13.45 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.299 -0.63 . . . . 0.95999999999999996 109.299 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.53 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 48.3 m-85 -85.41 81.85 8.56 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.034 -1.099 . . . . 0.23999999999999999 108.034 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -114.53 150.3 35.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.785 -0.572 . . . . 1.03 109.636 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -92.46 125.3 37.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.26000000000000001 108.591 179.102 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -66.13 -21.27 66.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.2 -0.937 . . . . 0.32000000000000001 109.96 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.497 ' NE1' ' HB1' ' A' ' 29' ' ' ALA . 56.9 p-90 -89.4 -17.64 28.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 0.44 109.801 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.33 125.59 38.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.32000000000000001 110.136 -178.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -63.98 -58.58 10.41 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 111.316 -0.714 . . . . 0.35999999999999999 111.316 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.26 -34.49 24.75 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.638 1.559 . . . . 0.44 111.275 -178.34 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.5 -63.68 1.32 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.093 -1.005 . . . . 0.81000000000000005 108.929 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -59.67 -17.55 35.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.588 -0.695 . . . . 1.9199999999999999 110.095 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.2 ttt -61.67 -18.71 60.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 3.1299999999999999 110.155 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 75' ' ' PRO . 29.5 mt -98.15 13.87 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.201 -0.937 . . . . 0.28000000000000003 110.244 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.84 -32.05 3.26 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.393 -1.442 . . . . 1.6200000000000001 112.267 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.64 -3.26 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 CA-C-N 119.855 0.984 . . . . 0.25 110.119 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.2 m-85 -112.47 -81.13 0.59 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.519 -0.738 . . . . 0.29999999999999999 109.173 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.6 t80 -41.44 -55.37 2.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.13 110.727 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.1 -32.02 72.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.854 -1.154 . . . . 0.40999999999999998 109.675 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.3 t -64.42 -41.22 96.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.827 -1.17 . . . . 0.96999999999999997 110.191 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -49.62 -14.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.885 -1.135 . . . . 0.5 109.494 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' SER . 17.2 m -57.45 -34.65 69.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.51000000000000001 109.68 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.05 -17.54 21.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.129 -0.982 . . . . 2.0 110.075 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.6 -21.74 22.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 2.1600000000000001 109.093 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -135.75 72.32 1.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.23999999999999999 109.142 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.1 p -66.94 -4.27 9.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.902 . . . . 0.17000000000000001 109.174 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.38 -3.23 44.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34000000000000002 109.818 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.95 148.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.445 -0.784 . . . . 0.12 109.347 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mm -100.31 129.06 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.17000000000000001 109.553 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -116.95 129.48 56.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.425 -0.797 . . . . 0.11 109.18 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -111.93 175.12 5.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.402 -0.811 . . . . 0.12 108.977 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -143.62 146.1 33.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.204 -1.036 . . . . 1.3100000000000001 108.204 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -142.48 138.43 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.134 -0.979 . . . . 0.14000000000000001 110.821 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -98.44 104.48 16.51 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.114 -1.069 . . . . 1.0800000000000001 108.114 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.8 m -60.56 -4.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.27000000000000002 111.46 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -110.21 -43.04 4.01 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 110.833 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 -12.28 32.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.002 . . . . 1.1200000000000001 109.34 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.44 45.22 2.63 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.764 -0.828 . . . . 0.17000000000000001 108.764 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.414 ' CG ' HH12 ' B' ' 4' ' ' ARG . 26.5 mt-30 -56.46 -12.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 2.2200000000000002 110.454 -179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -40.41 75.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.922 -1.111 . . . . 1.1100000000000001 109.266 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.84 -46.71 45.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.907 . . . . 0.19 109.001 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.74 72.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.22 109.078 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -64.42 -54.57 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 1.29 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.84 -29.05 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 2.2000000000000002 109.599 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.89 -5.7 57.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.226 -0.921 . . . . 0.33000000000000002 109.588 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 47.25 59.39 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 2.3399999999999999 110.2 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.7 t -78.92 136.6 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.145 -0.972 . . . . 0.28000000000000003 109.061 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -123.46 -7.77 8.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.47 -0.769 . . . . 2.3999999999999999 109.778 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.11 132.47 11.98 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.943 -1.098 . . . . 0.22 109.945 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.73 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -110.79 151.37 42.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.278 -1.008 . . . . 0.22 108.278 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -76.59 144.38 78.82 Favored 'Cis proline' 0 N--CA 1.484 0.922 0 C-N-CA 124.747 -0.939 . . . . 0.20000000000000001 110.281 -1.993 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.9 122.34 46.0 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.529 -0.915 . . . . 0.17999999999999999 108.529 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -98.21 122.73 41.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.14999999999999999 109.031 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.53 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.4 mt-30 -120.31 133.35 55.47 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.91 -1.144 . . . . 1.03 107.91 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 24' ' ' VAL . 17.4 m-85 -107.68 124.82 50.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.11 109.346 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.76 157.42 35.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.891 -0.781 . . . . 0.17000000000000001 108.891 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -153.85 123.19 6.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.639 -1.245 . . . . 1.48 107.639 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 55.72 31.67 17.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.6699999999999999 109.284 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.59 6.84 88.87 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.285 -1.126 . . . . 0.22 110.285 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -112.01 143.52 42.88 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.35 -1.088 . . . . 2.0800000000000001 110.605 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -84.31 141.94 30.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 1.7 109.58 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.99 -9.48 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.52 -0.737 . . . . 0.26000000000000001 110.528 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.05 168.71 36.01 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.41 -1.376 . . . . 0.17999999999999999 110.596 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.518 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.0 152.93 2.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -1.08 . . . . 2.04 110.416 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.4 p90 -169.05 134.07 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.14000000000000001 110.267 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.81 -174.33 2.52 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.074 -1.017 . . . . 0.17000000000000001 109.168 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.82 132.11 6.29 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.382 -1.487 . . . . 0.13 109.382 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.91 94.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.20000000000000001 110.137 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -139.31 70.54 1.37 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.822 -1.177 . . . . 1.1499999999999999 107.822 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.77 -33.15 73.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.379 -0.826 . . . . 1.1899999999999999 110.603 -178.511 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.04 -27.03 68.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.946 -1.097 . . . . 1.95 109.055 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -71.14 -37.61 72.26 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.546 -0.722 . . . . 2.0499999999999998 110.063 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.0 mt -52.28 -36.11 51.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.666 -1.271 . . . . 0.14999999999999999 108.866 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -66.91 -54.88 17.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 2.1499999999999999 109.457 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.75 93.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.14999999999999999 110.355 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.2 m -65.51 -44.89 85.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.161 -0.962 . . . . 0.13 109.916 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.3 mt -60.43 -52.88 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.17999999999999999 108.764 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -61.76 -16.01 45.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 1.03 109.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -77.22 -59.03 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 2.02 110.115 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.04 18.69 7.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.443 -0.786 . . . . 0.34999999999999998 110.246 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 1.1799999999999999 109.404 179.822 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.095 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.73 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.23 -167.22 1.78 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.105 -0.997 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.51 148.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.833 0.825 . . . . 0.0 112.357 -177.055 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 24.1 m -100.89 93.02 5.31 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.49 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 6.2 pt-20 -83.38 43.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.0 -1.062 . . . . 0.0 110.364 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.55 -130.18 0.04 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.08 24.05 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.407 1.604 . . . . 0.0 109.325 178.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.649 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.24 0.543 . . . . 0.29999999999999999 109.681 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -154.24 118.0 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.833 . . . . 1.97 108.886 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.421 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 19.5 tt0 -89.5 134.63 34.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.97999999999999998 109.961 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.3 mm -105.09 121.24 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 5.8 mp0 -101.98 -16.89 16.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.085 -1.01 . . . . 1.97 109.471 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.6 p -153.13 155.58 37.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.23000000000000001 109.137 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -50.74 -21.77 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 1.8999999999999999 109.337 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 m -61.5 -47.46 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.989 . . . . 0.25 109.31 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.85 -22.99 62.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.20000000000000001 109.838 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.34 -65.76 0.62 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.20999999999999999 109.868 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -55.27 -45.09 76.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 2.4700000000000002 109.67 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -58.03 -36.17 72.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.172 -0.955 . . . . 2.1000000000000001 109.594 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -59.76 -45.98 90.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 0.20000000000000001 109.17 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.26 -45.42 84.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.446 -0.784 . . . . 0.62 109.92 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.34 -40.58 97.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 1.0900000000000001 109.886 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -15.38 58.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.29999999999999999 109.516 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.97 -7.46 35.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.23999999999999999 109.553 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.08 -110.58 3.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.445 . . . . 0.28000000000000003 109.486 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -138.67 2.98 2.25 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.436 -1.038 . . . . 2.21 109.52 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -70.06 171.71 9.13 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.997 -1.065 . . . . 1.8999999999999999 109.134 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.06 160.5 20.86 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.468 -0.938 . . . . 0.17000000000000001 108.468 -179.555 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.639 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.7 t -143.38 104.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.04 . . . . 0.12 109.254 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.19 127.88 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.089999999999999997 108.799 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.66 135.52 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.668 -0.645 . . . . 0.17000000000000001 109.402 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -107.64 101.43 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.912 -0.773 . . . . 0.95999999999999996 108.912 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -84.82 82.6 8.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.813 -1.181 . . . . 0.23999999999999999 107.813 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -113.38 149.06 34.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.717 -0.615 . . . . 1.03 109.602 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.0 127.25 36.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.517 -0.92 . . . . 0.26000000000000001 108.517 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -66.59 -28.46 68.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.356 -0.84 . . . . 0.32000000000000001 111.081 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -87.55 -10.28 52.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.887 -1.133 . . . . 0.44 110.218 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.48 135.97 37.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.32000000000000001 109.532 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.78 -56.9 3.68 Favored Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.501 -0.75 . . . . 0.35999999999999999 112.035 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -46.31 -39.1 21.18 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.673 1.582 . . . . 0.44 111.721 -177.904 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.59 -53.97 7.75 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.73 -1.231 . . . . 0.81000000000000005 108.823 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.87 -19.85 53.69 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.624 -0.672 . . . . 1.9199999999999999 109.791 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -59.42 -19.15 45.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 3.1299999999999999 110.504 -179.056 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.25 12.97 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.053 -1.029 . . . . 0.28000000000000003 111.112 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.06 -32.98 4.47 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 119.98 -1.7 . . . . 1.6200000000000001 112.362 179.328 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.1 Cg_exo -66.43 -0.03 3.91 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 CA-C-N 119.571 0.882 . . . . 0.25 110.519 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.64 -74.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.511 -0.743 . . . . 0.29999999999999999 109.179 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -42.45 -52.57 4.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.66 -0.65 . . . . 0.13 110.495 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.11 -32.6 73.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.40999999999999998 109.72 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 46' ' ' SER . 59.7 p -62.37 -44.13 97.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.813 -1.179 . . . . 0.96999999999999997 109.879 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -51.33 -15.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.109 -0.994 . . . . 0.5 109.233 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.411 ' N ' ' C ' ' A' ' 44' ' ' SER . 28.9 m -57.19 -38.49 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.51000000000000001 109.698 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -94.95 -16.76 22.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.12 -0.987 . . . . 2.0 110.473 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -88.91 -19.81 25.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 2.1600000000000001 109.234 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.66 73.15 1.47 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.513 -0.742 . . . . 0.23999999999999999 109.135 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.46 -5.07 13.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.17000000000000001 109.273 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -96.24 8.32 44.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.34000000000000002 109.713 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.05 148.42 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.12 109.454 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -100.2 129.74 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.17000000000000001 109.055 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.8 m-85 -116.79 130.34 56.66 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.485 -0.759 . . . . 0.11 109.446 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.01 171.41 7.62 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -143.42 147.78 35.13 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.893 -1.151 . . . . 1.3100000000000001 107.893 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.37 144.55 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.0 -1.062 . . . . 0.14000000000000001 111.114 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.57 103.17 15.09 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.59 -1.263 . . . . 1.0800000000000001 107.59 178.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.657 HG21 HG21 ' A' ' 74' ' ' THR . 2.3 m -64.84 -3.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.27000000000000002 112.766 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 59' ' ' VAL . 1.6 m-20 -120.45 -33.28 3.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.73 -1.232 . . . . 1.1100000000000001 110.909 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.23 -21.55 18.39 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.782 -1.199 . . . . 1.1200000000000001 108.678 179.174 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.03 45.63 1.15 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.589 -1.263 . . . . 0.17000000000000001 107.589 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -15.12 0.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.781 -0.574 . . . . 2.2200000000000002 110.767 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -38.78 76.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.868 -1.145 . . . . 1.1100000000000001 108.89 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.65 -47.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.19 108.663 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.08 -35.48 80.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.22 109.129 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -63.49 -46.46 86.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.862 . . . . 1.29 109.03 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.99 -38.42 90.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 2.2000000000000002 109.682 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.37 -6.19 56.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.33000000000000002 110.132 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 66' ' ' ALA . 65.3 mt-10 48.8 58.29 5.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.056 -1.027 . . . . 2.3399999999999999 110.192 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.6 t -79.27 135.25 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.114 -0.991 . . . . 0.28000000000000003 109.089 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -127.36 -1.55 6.29 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.374 -0.829 . . . . 2.3999999999999999 110.063 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 125.15 8.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.999 -1.063 . . . . 0.22 108.944 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.72 HG23 ' CE2' ' B' ' 5' ' ' TYR . 4.6 p -111.08 152.29 43.61 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.889 -0.782 . . . . 0.22 108.889 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.12 143.15 74.53 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 C-N-CA 124.775 -0.927 . . . . 0.20000000000000001 109.948 -2.095 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -113.34 109.62 19.0 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.235 -1.024 . . . . 0.17999999999999999 108.235 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.1 m-85 -87.02 117.85 26.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.14999999999999999 108.778 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -115.72 135.15 54.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.57 -1.27 . . . . 1.03 107.57 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -109.95 127.21 54.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.617 -0.677 . . . . 0.11 109.706 -178.05 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.47 157.98 35.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.457 -0.942 . . . . 0.17000000000000001 108.457 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -155.0 123.81 6.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.48 107.95 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.19 25.39 9.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.591 -0.693 . . . . 1.6699999999999999 109.228 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.0 86.09 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.132 -1.187 . . . . 0.22 110.132 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -109.73 145.48 36.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.286 -1.126 . . . . 2.0800000000000001 110.137 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -86.8 141.21 29.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 1.7 109.039 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.06 -20.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.486 -0.759 . . . . 0.26000000000000001 110.323 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 173.15 45.55 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.386 -1.388 . . . . 0.17999999999999999 110.53 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -174.05 151.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -1.047 . . . . 2.04 109.802 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.05 133.5 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.297 -0.877 . . . . 0.14000000000000001 110.149 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -103.56 -163.39 0.98 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 108.967 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.91 131.61 2.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.361 -1.496 . . . . 0.13 109.361 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.495 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.53 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -1.213 . . . . 0.20000000000000001 110.852 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.29 78.32 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.772 -1.195 . . . . 1.1499999999999999 107.772 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.04 -34.89 79.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 1.1899999999999999 110.833 -178.494 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.8 -25.78 68.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.879 -1.138 . . . . 1.95 109.23 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -68.85 -37.45 79.14 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 2.0499999999999998 109.404 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.7 mt -52.46 -35.68 53.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.948 -1.095 . . . . 0.14999999999999999 108.689 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.0 -58.79 4.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 2.1499999999999999 109.584 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.34 83.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.14999999999999999 110.628 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.7 m -66.97 -44.81 79.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.049 -1.032 . . . . 0.13 109.938 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.7 mt -60.99 -52.56 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.17999999999999999 109.128 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -60.8 -17.22 48.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 1.03 109.407 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -77.66 -62.54 1.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 2.02 110.3 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.59 23.09 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 0.34999999999999998 110.617 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.996 -1.065 . . . . 1.1799999999999999 109.239 179.562 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.72 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -121.61 -167.0 1.45 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.837 -1.164 . . . . 0.0 110.334 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.48 151.11 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 112.018 -177.292 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 m -101.78 95.42 6.4 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.424 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.9 pt-20 -83.43 45.85 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.937 -1.102 . . . . 0.0 109.966 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.12 -134.68 0.07 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.983 -2.447 . . . . 0.0 106.983 178.155 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.76 24.39 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 CA-C-N 119.212 1.506 . . . . 0.0 108.441 178.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.6 t . . . . . 0 N--CA 1.486 1.364 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 19.8 t . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.499 -0.556 . . . . 0.29999999999999999 109.499 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -153.36 119.36 5.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.16 -0.962 . . . . 1.97 108.726 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -86.72 139.79 30.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.97999999999999998 109.911 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mm -110.03 119.49 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.961 -1.126 . . . . 0.19 107.961 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 6.7 mp0 -105.4 -17.34 14.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -0.898 . . . . 1.97 109.705 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.7 p -151.74 161.39 42.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.035 -1.041 . . . . 0.23000000000000001 110.128 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -53.01 -32.14 44.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.736 . . . . 1.8999999999999999 109.966 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -59.44 -43.69 93.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.25 109.98 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.0 64.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.855 . . . . 0.20000000000000001 109.943 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.69 -63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.20999999999999999 110.04 -179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 2.4700000000000002 109.638 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -58.7 -35.5 72.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.933 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.39 94.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.20000000000000001 109.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.45 -44.02 97.42 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.853 . . . . 0.62 109.649 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.1 -38.36 90.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.851 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.62 -19.88 44.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.29999999999999999 109.646 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -2.9 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.23999999999999999 109.74 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 -136.34 32.39 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.211 -1.556 . . . . 0.28000000000000003 109.211 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m-20 -116.6 5.65 13.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.38 -1.07 . . . . 2.21 109.621 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -70.18 170.92 10.62 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.206 -0.934 . . . . 1.8999999999999999 109.127 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.27 161.7 18.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.855 -1.165 . . . . 0.17000000000000001 107.855 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.633 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -145.13 105.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.891 -1.131 . . . . 0.12 109.632 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.7 t -103.41 128.81 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.788 -0.819 . . . . 0.089999999999999997 108.788 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.01 139.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.598 -0.689 . . . . 0.17000000000000001 109.649 -178.909 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -109.54 98.42 7.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.293 -0.632 . . . . 0.95999999999999996 109.293 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.0 m-85 -83.42 83.43 7.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.568 -1.271 . . . . 0.23999999999999999 107.568 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 m -110.38 -163.28 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.514 0.673 . . . . 1.03 109.381 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.97 120.26 13.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.341 -0.985 . . . . 0.26000000000000001 108.341 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.0 t -63.57 -25.02 68.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.32000000000000001 110.934 -178.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -89.27 -12.79 39.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.931 -1.106 . . . . 0.44 110.093 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.6 134.33 39.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.32000000000000001 109.776 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.65 -55.5 5.97 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.809 -0.71 . . . . 0.35999999999999999 111.492 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -51.4 -32.83 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.663 1.575 . . . . 0.44 111.085 -178.274 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -62.26 1.71 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.058 -1.026 . . . . 0.81000000000000005 108.905 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -59.72 -21.17 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.77 . . . . 1.9199999999999999 110.03 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.9 ttm -59.61 -18.24 39.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.97 . . . . 3.1299999999999999 110.296 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' HG22 ' A' ' 38' ' ' ILE . 95.6 mt -99.45 7.57 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.951 . . . . 0.28000000000000003 110.722 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -32.2 3.52 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 118.429 -1.308 . . . . 1.6200000000000001 112.519 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_exo -61.22 -6.05 6.02 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 CA-C-N 119.979 1.028 . . . . 0.25 109.706 -178.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -110.82 -76.29 0.61 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.968 -0.753 . . . . 0.29999999999999999 108.968 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -42.72 -56.99 2.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.531 -0.73 . . . . 0.13 110.726 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -66.51 -31.79 72.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.007 -1.058 . . . . 0.40999999999999998 110.013 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.6 t -64.33 -40.82 96.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.743 -1.223 . . . . 0.96999999999999997 110.163 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.51 -14.31 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.5 109.469 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.52 -38.0 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.078 -1.014 . . . . 0.51000000000000001 109.537 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -93.63 -12.23 29.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 2.0 110.054 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -51.67 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.029 -1.1 . . . . 2.1600000000000001 108.029 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -107.34 75.72 1.04 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.545 -0.722 . . . . 0.23999999999999999 109.607 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.7 p -66.79 -3.68 7.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.17000000000000001 108.618 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -95.77 -0.74 50.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.595 -0.69 . . . . 0.34000000000000002 109.372 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.28 147.07 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.362 0.601 . . . . 0.12 109.614 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.22 134.72 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.17000000000000001 109.268 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.3 m-85 -121.62 131.3 54.03 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.507 -0.745 . . . . 0.11 109.237 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.89 172.71 6.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.282 -0.886 . . . . 0.12 108.777 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -142.79 138.7 30.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.149 -1.056 . . . . 1.3100000000000001 108.149 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.29 136.74 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.243 -0.91 . . . . 0.14000000000000001 110.593 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.78 100.69 12.22 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.855 -1.165 . . . . 1.0800000000000001 107.855 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.18 -6.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.27000000000000002 110.885 -178.393 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.43 -42.31 5.49 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.123 -0.986 . . . . 1.1100000000000001 110.712 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -94.28 -12.43 28.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.094 -1.004 . . . . 1.1200000000000001 109.624 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.73 48.67 1.74 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.536 -0.913 . . . . 0.17000000000000001 108.536 179.093 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.641 ' CG ' HH12 ' B' ' 4' ' ' ARG . 5.7 mt-30 -56.34 -16.47 5.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 2.2200000000000002 110.321 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -70.49 -39.59 74.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.015 -1.053 . . . . 1.1100000000000001 109.442 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.9 -46.03 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.153 -0.967 . . . . 0.19 108.679 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.357 -0.839 . . . . 0.22 109.003 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -64.28 -46.8 82.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 1.29 109.155 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -64.18 -38.09 89.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.761 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.54 -3.36 58.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 109.777 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.75 59.18 4.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 2.3399999999999999 110.002 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 17.2 t -79.22 136.58 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.127 -0.983 . . . . 0.28000000000000003 109.163 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -128.04 -4.35 5.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.431 -0.793 . . . . 2.3999999999999999 110.019 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.85 126.8 8.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.014 -1.054 . . . . 0.22 109.322 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.6 p -110.76 151.66 43.01 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.746 -0.835 . . . . 0.22 108.746 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.58 142.77 74.07 Favored 'Cis proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.887 -0.88 . . . . 0.20000000000000001 110.076 -1.743 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.17 111.63 21.87 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.965 -1.124 . . . . 0.17999999999999999 107.965 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.7 m-85 -86.99 119.87 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.038 -1.065 . . . . 0.14999999999999999 109.264 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 41.4 mt-30 -117.05 135.71 53.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.575 -1.268 . . . . 1.03 107.575 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 19.9 m-85 -109.0 127.45 54.09 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.496 0.665 . . . . 0.11 109.816 -177.763 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -125.37 156.02 39.41 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.516 -0.92 . . . . 0.17000000000000001 108.516 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -155.1 123.34 5.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.169 -1.048 . . . . 1.48 108.169 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt 54.48 30.61 13.23 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.768 -0.773 . . . . 1.6699999999999999 110.012 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.94 90.52 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.074 -1.06 . . . . 0.22 110.48 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -112.46 146.25 38.76 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.312 -1.111 . . . . 2.0800000000000001 110.036 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -86.18 143.63 27.89 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.361 -0.837 . . . . 1.7 109.246 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.0 m -126.94 -19.51 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.26000000000000001 110.449 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.58 178.07 47.67 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.305 -1.426 . . . . 0.17999999999999999 110.524 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -174.11 154.11 2.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -1.061 . . . . 2.04 110.113 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.46 131.18 1.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.14000000000000001 110.171 178.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 p -102.21 -162.35 0.92 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.246 -0.909 . . . . 0.17000000000000001 108.96 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 129.82 1.21 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.075 -1.61 . . . . 0.13 109.075 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.561 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.6 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -1.226 . . . . 0.20000000000000001 110.213 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.23 67.33 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.888 -1.152 . . . . 1.1499999999999999 107.888 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 12.4 ptpt -58.13 -37.45 74.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.837 -0.539 . . . . 1.1899999999999999 110.652 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.97 -26.54 68.34 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.95 109.611 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -70.3 -33.39 71.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 2.0499999999999998 109.835 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.5 mt -53.19 -33.88 54.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.801 -1.187 . . . . 0.14999999999999999 108.656 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -67.36 -55.6 13.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 2.1499999999999999 109.35 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.8 94.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.14999999999999999 110.648 -179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -65.49 -45.1 84.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.037 -1.039 . . . . 0.13 109.876 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.91 -53.23 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.17999999999999999 108.838 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.44 -16.45 36.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 1.03 109.593 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.76 -60.65 2.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 2.02 110.064 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.76 20.79 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.34999999999999998 110.16 -178.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.023 -1.048 . . . . 1.1799999999999999 109.317 179.598 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.641 HH12 ' CG ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.719 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -123.42 -167.2 1.57 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.916 -1.115 . . . . 0.0 110.233 179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 148.98 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.831 0.825 . . . . 0.0 112.154 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -100.88 95.59 6.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.248 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -82.91 43.4 0.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.052 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.59 -132.59 0.07 OUTLIER Glycine 0 N--CA 1.484 1.836 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.85 26.51 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 119.328 1.564 . . . . 0.0 109.161 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.8 t . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.789 . . . . 0.0 109.502 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 3' ' ' LYS . 71.2 t . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.211 0.529 . . . . 0.29999999999999999 109.592 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.5 tttp -154.29 122.33 5.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.949 . . . . 1.97 109.199 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -88.99 139.0 30.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.97999999999999998 109.482 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.96 106.99 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.273 -1.01 . . . . 0.19 108.273 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -100.1 -6.81 25.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.017 -1.052 . . . . 1.97 109.616 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -152.61 152.08 31.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -0.968 . . . . 0.23000000000000001 109.601 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -52.04 -28.6 17.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 1.8999999999999999 109.951 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -60.12 -45.13 94.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.25 110.241 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.74 64.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.20000000000000001 110.114 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.45 -69.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.20999999999999999 110.197 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -55.73 -41.37 73.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 2.4700000000000002 109.808 -179.349 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.78 -38.55 78.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.223 -0.923 . . . . 2.1000000000000001 109.848 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.87 -46.06 92.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.20000000000000001 109.305 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.38 -45.08 89.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.386 -0.821 . . . . 0.62 109.832 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.95 -40.37 96.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 1.0900000000000001 109.748 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -13.99 59.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.29999999999999999 109.734 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -6.92 28.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.23999999999999999 109.809 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.88 -111.96 4.14 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.409 . . . . 0.28000000000000003 109.576 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -138.03 4.32 2.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.39 -1.064 . . . . 2.21 109.268 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -71.03 166.44 21.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 1.8999999999999999 109.153 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.02 161.37 13.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.15 -0.969 . . . . 0.17000000000000001 108.688 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.0 t -144.0 106.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.856 -1.153 . . . . 0.12 109.489 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.96 132.64 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.108 -1.071 . . . . 0.089999999999999997 108.108 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.26 139.37 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.548 -0.72 . . . . 0.17000000000000001 110.002 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -109.33 101.89 10.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.929 -0.767 . . . . 0.95999999999999996 108.929 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 57' ' ' VAL . 41.1 m-85 -86.35 79.11 9.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.23999999999999999 107.708 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -113.45 149.56 34.06 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.324 0.583 . . . . 1.03 109.745 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.23 128.48 38.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.26000000000000001 108.73 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.6 t -66.29 -25.17 66.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.32000000000000001 110.241 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.414 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.0 p-90 -87.98 -14.34 39.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.033 -1.042 . . . . 0.44 109.958 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.37 125.88 40.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.32000000000000001 109.487 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.61 -54.13 20.75 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.48 -0.762 . . . . 0.35999999999999999 111.437 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.51 -32.6 21.21 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.912 1.741 . . . . 0.44 110.88 -178.186 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.02 -61.79 1.86 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.81000000000000005 109.057 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -59.8 -17.87 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.537 -0.727 . . . . 1.9199999999999999 110.033 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.11 -25.75 61.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 3.1299999999999999 110.387 -178.957 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 38' ' ' ILE . 90.8 mt -97.54 9.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.123 -0.985 . . . . 0.28000000000000003 110.819 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.93 -32.57 6.86 Favored Pre-proline 0 N--CA 1.484 1.264 0 O-C-N 120.425 -1.422 . . . . 1.6200000000000001 111.846 178.772 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.18 -5.24 7.62 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 119.7 0.929 . . . . 0.25 110.102 -177.505 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -112.37 -71.59 0.75 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.957 -0.757 . . . . 0.29999999999999999 108.957 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -45.69 -56.76 4.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.13 110.457 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.59 -31.97 73.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.044 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -64.18 -38.84 92.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.96999999999999997 110.184 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.9 mt -51.39 -12.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 0.5 109.547 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 44' ' ' SER . 67.1 m -57.92 -32.89 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.956 -1.09 . . . . 0.51000000000000001 109.625 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.37 -19.45 19.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.193 -0.942 . . . . 2.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.81 -22.16 21.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 2.1600000000000001 109.525 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -134.26 68.41 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.479 -0.763 . . . . 0.23999999999999999 109.292 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.4 p -67.28 -4.79 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.795 . . . . 0.17000000000000001 109.164 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.51 0.21 52.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.825 . . . . 0.34000000000000002 109.62 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.17 151.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.047 -0.723 . . . . 0.12 109.047 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -101.22 126.5 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 0.17000000000000001 109.311 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.8 m-85 -112.96 130.87 55.97 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.39 -0.819 . . . . 0.11 109.16 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -115.17 173.77 6.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.459 -0.775 . . . . 0.12 109.055 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.29 141.1 28.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 27' ' ' PHE . 76.9 t -137.17 139.44 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.2 -0.937 . . . . 0.14000000000000001 110.443 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -99.57 108.07 20.38 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.407 HG11 ' OH ' ' B' ' 5' ' ' TYR . 33.3 m -68.33 -8.5 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.257 -0.902 . . . . 0.27000000000000002 111.23 -178.563 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.414 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -104.6 -38.67 6.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 110.919 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -95.59 -17.67 21.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.058 . . . . 1.1200000000000001 110.131 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.25 1.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.509 -0.923 . . . . 0.17000000000000001 108.509 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -54.26 -15.37 1.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.607 -0.683 . . . . 2.2200000000000002 110.237 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.4 -40.28 74.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.905 -1.122 . . . . 1.1100000000000001 109.53 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.09 -47.22 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -0.924 . . . . 0.19 108.729 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.55 -31.21 72.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.22 109.352 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 15.1 m -63.79 -52.49 60.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 1.29 109.288 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.17 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 2.2000000000000002 109.466 179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.44 -2.69 58.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.33000000000000002 109.582 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 67' ' ' SER . 21.3 mp0 43.98 52.09 6.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.825 . . . . 2.3399999999999999 110.083 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -77.99 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.28000000000000003 108.944 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 83.8 mttt -125.58 5.79 7.55 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.531 -0.73 . . . . 2.3999999999999999 109.68 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 138.0 17.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.112 -0.993 . . . . 0.22 108.806 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.482 HG23 ' CE2' ' B' ' 5' ' ' TYR . 65.0 p -123.88 149.7 60.38 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 108.865 -0.791 . . . . 0.22 108.865 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.02 144.78 76.88 Favored 'Cis proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.959 -0.851 . . . . 0.20000000000000001 110.422 -1.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.21 114.74 26.41 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.576 -1.268 . . . . 0.17999999999999999 107.576 178.31 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.719 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.7 m-85 -90.2 123.93 34.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 0.14999999999999999 108.747 179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.414 HE22 ' HB1' ' A' ' 69' ' ' ALA . 34.0 mt-30 -121.87 136.52 54.93 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 1.03 107.676 -179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.44 124.22 51.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.475 0.655 . . . . 0.11 109.426 -178.526 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -124.02 155.56 38.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.688 -0.856 . . . . 0.17000000000000001 108.688 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -155.48 124.36 6.11 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 1.48 107.42 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mttt 57.96 25.4 12.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.623 . . . . 1.6699999999999999 109.821 -178.846 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 6.69 86.56 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.219 -1.152 . . . . 0.22 110.219 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -114.47 147.93 38.58 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.357 -1.084 . . . . 2.0800000000000001 110.101 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -85.33 141.26 30.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 1.7 109.162 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.31 -18.54 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.452 -0.78 . . . . 0.26000000000000001 110.221 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 171.79 44.89 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.6 -1.286 . . . . 0.17999999999999999 110.389 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -174.09 151.93 1.79 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.417 -1.049 . . . . 2.04 110.233 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.97 130.91 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.667 0.746 . . . . 0.14000000000000001 110.316 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -101.27 -162.16 0.91 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.035 -1.041 . . . . 0.17000000000000001 108.685 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.1 128.5 1.32 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.249 -1.541 . . . . 0.13 109.249 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.87 97.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.20000000000000001 110.866 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -141.06 77.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.984 -1.117 . . . . 1.1499999999999999 107.984 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -64.76 -42.66 94.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.81 -0.556 . . . . 1.1899999999999999 111.579 -178.414 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.81 -24.97 67.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.877 -1.139 . . . . 1.95 110.059 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -68.04 -34.48 76.55 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.052 -1.03 . . . . 2.0499999999999998 109.497 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.4 mt -52.08 -34.44 43.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.998 -1.063 . . . . 0.14999999999999999 109.008 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.31 -57.74 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.77 . . . . 2.1499999999999999 109.49 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.18 86.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.14999999999999999 110.546 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 m -66.98 -45.32 78.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -0.942 . . . . 0.13 109.973 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.51 -52.89 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.17999999999999999 108.79 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 23.5 t-20 -60.62 -16.93 43.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 1.03 109.859 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.89 -55.99 5.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.895 . . . . 2.02 110.463 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -94.38 10.75 33.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.329 -0.857 . . . . 0.34999999999999998 110.872 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.269 179.721 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.482 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.0 -176.11 3.83 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.354 -0.842 . . . . 0.0 110.18 179.446 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.38 146.23 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.964 0.888 . . . . 0.0 112.821 -176.99 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.01 95.78 6.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.15 45.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 110.188 -178.797 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.24 -132.63 0.1 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 177.959 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.47 22.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 CA-C-N 118.95 1.375 . . . . 0.0 109.065 178.62 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.1 t . . . . . 0 N--CA 1.486 1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.34 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 3' ' ' LYS . 85.3 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.297 -0.631 . . . . 0.29999999999999999 109.297 . . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.2 tptp -155.02 125.55 6.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.268 -0.895 . . . . 1.97 109.09 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -90.73 135.45 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.97999999999999998 109.792 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -110.16 113.92 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.994 -1.113 . . . . 0.19 107.994 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -103.27 -13.05 16.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 1.97 109.657 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.5 p -152.9 156.99 40.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.23000000000000001 109.91 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.8 -32.62 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 1.8999999999999999 110.163 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -58.95 -44.24 91.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.065 . . . . 0.25 109.492 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.41 64.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.20000000000000001 109.448 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.6 -70.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.20999999999999999 109.996 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -54.58 -42.56 71.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 2.4700000000000002 109.709 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -58.39 -37.76 75.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.022 -1.049 . . . . 2.1000000000000001 109.278 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.74 93.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.20000000000000001 108.678 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.59 -40.47 97.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 0.62 109.332 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.87 -42.56 97.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 109.383 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.58 59.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.29999999999999999 109.533 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -6.33 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.23999999999999999 109.751 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.71 -115.47 6.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.28000000000000003 109.515 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -136.11 4.88 3.0 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -1.072 . . . . 2.21 109.349 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -71.0 169.14 15.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.246 -0.909 . . . . 1.8999999999999999 109.163 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.26 162.43 14.74 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.17000000000000001 108.088 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 18.7 t -144.73 109.01 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.826 -1.171 . . . . 0.12 109.397 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.29 132.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.533 -0.914 . . . . 0.089999999999999997 108.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.75 131.34 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.17000000000000001 109.557 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.76 107.51 18.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.95999999999999996 109.443 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.2 m-85 -88.72 81.36 7.04 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.116 -1.068 . . . . 0.23999999999999999 108.116 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -113.72 152.35 30.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.736 -0.602 . . . . 1.03 109.559 -179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -92.72 123.16 35.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.721 -0.844 . . . . 0.26000000000000001 108.721 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 58' ' ' ASP . 7.2 t -65.54 -20.87 66.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.32000000000000001 109.746 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.479 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 50.6 p-90 -89.5 -18.15 27.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.231 -0.918 . . . . 0.44 109.934 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.6 143.97 25.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.32000000000000001 110.029 -178.81 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -83.69 -57.23 2.47 Favored Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.684 -0.635 . . . . 0.35999999999999999 111.628 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.3 Cg_exo -47.47 -41.56 29.23 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.85 1.7 . . . . 0.44 112.031 -177.686 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -58.61 3.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.816 -1.178 . . . . 0.81000000000000005 109.02 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.32 -18.58 39.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.553 -0.717 . . . . 1.9199999999999999 110.232 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 36.8 ttm -59.43 -18.39 38.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 3.1299999999999999 110.309 -179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 38' ' ' ILE . 67.8 mt -100.35 14.15 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.037 -1.039 . . . . 0.28000000000000003 111.276 -178.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.4 -34.95 12.41 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 117.957 -1.497 . . . . 1.6200000000000001 111.946 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -61.64 -14.81 37.96 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 CA-C-N 119.707 0.931 . . . . 0.25 110.877 -175.215 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.8 -69.36 0.76 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.33 -0.856 . . . . 0.29999999999999999 109.223 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -44.48 -51.55 8.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.618 -0.677 . . . . 0.13 110.725 -179.054 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -67.57 -35.28 78.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.878 -1.139 . . . . 0.40999999999999998 109.585 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -60.32 -42.71 96.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.017 -1.052 . . . . 0.96999999999999997 109.624 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -52.26 -21.72 3.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.5 109.563 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.5 m -57.3 -32.34 66.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.51000000000000001 109.592 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -94.82 -19.49 20.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.142 -0.974 . . . . 2.0 110.083 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -91.28 -20.82 21.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 2.1600000000000001 109.128 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.43 67.95 1.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.23999999999999999 109.085 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.2 p -67.01 -3.84 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.465 -0.772 . . . . 0.17000000000000001 109.243 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -94.43 -0.52 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.35 -0.844 . . . . 0.34000000000000002 109.475 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.06 149.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.539 -0.726 . . . . 0.12 109.189 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -100.43 128.84 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.225 -0.922 . . . . 0.17000000000000001 109.058 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.5 m-85 -114.63 131.8 56.59 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.413 -0.804 . . . . 0.11 109.173 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.5 mp -115.95 175.29 5.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.543 -0.723 . . . . 0.12 109.179 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -144.07 144.94 31.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.417 -0.957 . . . . 1.3100000000000001 108.417 179.481 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.4 t -140.26 140.7 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.2 -0.938 . . . . 0.14000000000000001 110.147 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' A' ' 30' ' ' THR . 8.1 t70 -99.44 100.46 11.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.615 -1.254 . . . . 1.0800000000000001 107.615 178.16 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.14 -12.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.858 . . . . 0.27000000000000002 111.217 -178.362 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -100.94 -42.81 6.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.85 -1.156 . . . . 1.1100000000000001 111.173 -178.708 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.1 -10.47 35.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.1200000000000001 109.569 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.63 2.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.511 -0.922 . . . . 0.17000000000000001 108.511 179.366 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -55.82 -14.32 2.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 2.2200000000000002 109.87 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 5.5 p30 -70.44 -40.93 73.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.121 -0.987 . . . . 1.1100000000000001 109.618 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.24 -46.22 45.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.19 108.699 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.03 73.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.22 109.309 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m -63.72 -52.35 60.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.29 109.53 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.82 -34.31 77.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 2.2000000000000002 109.237 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.67 57.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.889 . . . . 0.33000000000000002 109.516 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 44.99 50.7 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 2.3399999999999999 109.911 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.12 129.85 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 109.445 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.449 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 67.9 mttm -129.93 8.86 5.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.502 -0.749 . . . . 2.3999999999999999 109.511 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.04 133.79 14.79 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.22 108.274 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.555 HG23 ' CE2' ' B' ' 5' ' ' TYR . 33.8 p -120.38 150.05 51.03 Favored Pre-proline 0 N--CA 1.507 2.424 0 O-C-N 121.205 -0.934 . . . . 0.22 108.96 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.72 147.27 83.75 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 O-C-N 122.714 0.849 . . . . 0.20000000000000001 110.539 -1.82 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.2 m -117.37 116.49 27.3 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.337 -1.357 . . . . 0.17999999999999999 107.337 178.059 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.1 m-85 -93.06 122.08 35.07 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.312 -0.955 . . . . 0.14999999999999999 108.653 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.5 mt-30 -119.16 137.4 53.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.729 -1.212 . . . . 1.03 107.729 -179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 26.3 m-85 -112.03 128.54 56.22 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.423 0.63 . . . . 0.11 110.04 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.09 159.85 32.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.851 -0.796 . . . . 0.17000000000000001 108.851 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.11 122.81 5.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 179.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 57.24 24.44 9.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.78 -0.575 . . . . 1.6699999999999999 110.301 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.4 5.0 76.3 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.354 -1.098 . . . . 0.22 110.354 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -113.4 146.13 40.01 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.303 -1.116 . . . . 2.0800000000000001 110.236 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -85.98 145.07 27.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 1.7 109.363 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -126.54 -15.4 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.51 -0.744 . . . . 0.26000000000000001 109.762 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.14 -179.14 41.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.584 -1.294 . . . . 0.17999999999999999 110.581 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.2 161.19 4.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.457 -1.025 . . . . 2.04 110.049 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -169.04 132.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.14000000000000001 110.218 178.755 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 p -104.58 -170.05 1.71 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.225 -0.922 . . . . 0.17000000000000001 108.759 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 91' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 93.97 121.37 3.31 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.536 -1.426 . . . . 0.13 109.536 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.548 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.44 91.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -1.146 . . . . 0.20000000000000001 110.432 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' GLY . 13.6 t-20 -140.04 78.07 1.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.119 -1.067 . . . . 1.1499999999999999 108.119 178.605 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.91 -34.7 78.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.696 -0.627 . . . . 1.1899999999999999 110.608 -178.861 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.7 -26.07 67.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.816 -1.177 . . . . 1.95 109.187 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.66 -35.41 78.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.425 -0.797 . . . . 2.0499999999999998 109.124 179.548 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.628 HD21 ' CD1' ' A' ' 77' ' ' PHE . 44.6 mt -51.87 -37.69 53.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.14999999999999999 108.783 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.37 -57.6 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 2.1499999999999999 109.896 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.64 83.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.14999999999999999 110.477 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -67.76 -45.22 75.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.074 -1.016 . . . . 0.13 110.29 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.22 -52.56 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.934 . . . . 0.17999999999999999 109.331 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.26 -17.9 45.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 1.03 109.674 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.01 -59.41 2.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.871 . . . . 2.02 110.476 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -93.69 18.96 9.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.348 -0.845 . . . . 0.34999999999999998 110.794 -178.123 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' OXT' HG22 ' A' ' 105' ' ' VAL . 8.3 p . . . . . 0 N--CA 1.494 1.728 0 O-C-N 120.941 -1.099 . . . . 1.1799999999999999 109.303 179.25 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -109.5 -174.59 2.54 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.176 -0.953 . . . . 0.0 110.796 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.1 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 122.191 0.996 . . . . 0.0 112.851 -176.935 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 61.3 m -101.05 93.75 5.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.521 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.674 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.0 pt-20 -84.1 44.42 1.01 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.102 -0.999 . . . . 0.0 110.904 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.68 -129.98 0.07 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.69 19.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.871 0 CA-C-N 119.447 1.623 . . . . 0.0 109.799 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 3' ' ' LYS . 44.7 t . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.512 -0.551 . . . . 0.29999999999999999 109.512 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.627 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.7 tptt -153.72 122.84 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -0.93 . . . . 1.97 109.116 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -90.05 129.4 36.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.97999999999999998 109.462 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -102.05 120.15 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.291 -1.374 . . . . 0.19 107.291 178.897 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.62 -16.76 14.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.197 -0.939 . . . . 1.97 109.949 -179.277 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.8 p -152.47 160.15 43.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.056 -1.027 . . . . 0.23000000000000001 109.801 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 35.0 tttp -52.09 -31.39 30.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.439 -0.788 . . . . 1.8999999999999999 109.639 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -59.96 -47.25 86.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.25 110.093 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.72 -27.0 65.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.20000000000000001 109.662 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.17 -68.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.20999999999999999 109.838 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -53.53 -44.44 69.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 2.4700000000000002 109.749 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -58.19 -37.0 73.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 2.1000000000000001 109.619 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.77 92.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.20000000000000001 109.094 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.5 -44.95 89.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.458 -0.776 . . . . 0.62 109.781 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.71 -41.28 99.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 1.0900000000000001 109.686 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -13.6 59.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.29999999999999999 109.467 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -5.71 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.23999999999999999 109.722 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 68.23 -114.1 5.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.513 -1.435 . . . . 0.28000000000000003 109.513 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 81.2 m-20 -136.55 4.07 2.83 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.265 -1.138 . . . . 2.21 109.447 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -69.65 170.09 11.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.072 -1.017 . . . . 1.8999999999999999 108.94 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.43 163.12 13.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.172 -1.047 . . . . 0.17000000000000001 108.172 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.3 t -145.42 104.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.825 -1.172 . . . . 0.12 109.359 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.7 t -101.61 130.41 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.089999999999999997 108.882 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.37 133.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 0.17000000000000001 109.644 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -107.04 102.98 12.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.585 -0.697 . . . . 0.95999999999999996 109.448 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 57' ' ' VAL . 51.0 m-85 -84.87 82.69 8.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.758 -1.201 . . . . 0.23999999999999999 107.758 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.68 148.62 36.01 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.594 -0.692 . . . . 1.03 109.89 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.89 122.74 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.267 -1.012 . . . . 0.26000000000000001 108.267 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -64.95 -22.33 66.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.32000000000000001 110.414 -178.978 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -90.34 -14.2 33.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.13 -0.981 . . . . 0.44 110.054 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -94.23 128.56 40.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.32000000000000001 110.04 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.06 -59.33 7.57 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.894 -0.67 . . . . 0.35999999999999999 111.595 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.5 Cg_exo -46.11 -37.7 18.28 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.805 1.67 . . . . 0.44 111.941 -178.169 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.4 -55.6 5.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.714 -1.241 . . . . 0.81000000000000005 108.756 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -60.6 -21.73 62.97 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.655 -0.653 . . . . 1.9199999999999999 110.045 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.9 tpp -61.44 -18.52 59.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 3.1299999999999999 110.379 -179.324 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -99.56 15.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.097 -1.002 . . . . 0.28000000000000003 110.765 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.77 -33.41 3.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.163 -1.586 . . . . 1.6200000000000001 112.452 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -63.14 -3.59 5.13 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.509 0.86 . . . . 0.25 110.302 -176.708 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.0 m-85 -110.46 -79.83 0.58 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.45 -0.781 . . . . 0.29999999999999999 109.08 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 87.6 t80 -40.9 -54.57 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.13 111.024 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -66.86 -36.83 83.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.842 -1.162 . . . . 0.40999999999999998 110.064 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.417 ' C ' ' N ' ' A' ' 46' ' ' SER . 81.8 p -61.34 -38.37 86.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.753 -1.217 . . . . 0.96999999999999997 110.041 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.88 -14.3 0.37 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.5 109.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.417 ' N ' ' C ' ' A' ' 44' ' ' SER . 37.1 m -57.76 -36.5 72.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.176 -0.953 . . . . 0.51000000000000001 109.636 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -94.35 -16.42 23.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.21 -0.931 . . . . 2.0 110.166 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.33 -22.83 20.33 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.003 -1.06 . . . . 2.1600000000000001 109.331 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -135.34 66.66 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.415 -0.803 . . . . 0.23999999999999999 109.151 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 p -66.64 -3.03 5.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.337 -0.852 . . . . 0.17000000000000001 109.038 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.95 -2.27 53.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.34000000000000002 109.263 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.64 148.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.055 -0.72 . . . . 0.12 109.055 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.5 125.26 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.414 -0.804 . . . . 0.17000000000000001 109.338 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -111.21 129.07 56.07 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.355 -0.841 . . . . 0.11 109.365 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -111.3 173.73 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.444 -0.785 . . . . 0.12 109.078 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.79 147.94 33.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.307 -0.998 . . . . 1.3100000000000001 108.307 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 27' ' ' PHE . 11.0 t -141.74 142.68 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.044 -1.035 . . . . 0.14000000000000001 110.451 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 60' ' ' ASP . 10.1 t70 -98.78 90.94 4.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.969 -1.123 . . . . 1.0800000000000001 107.969 178.564 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -52.59 -3.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 0.27000000000000002 111.624 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 58' ' ' ASP . 30.3 m-20 -110.04 -40.66 4.67 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.034 -1.041 . . . . 1.1100000000000001 110.982 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.61 -19.17 19.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.05 -1.031 . . . . 1.1200000000000001 109.816 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.89 45.52 1.33 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.349 -0.844 . . . . 0.17000000000000001 108.74 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -53.25 -13.46 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 2.2200000000000002 109.852 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.9 p-10 -71.13 -41.44 70.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 1.1100000000000001 109.459 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -74.08 -45.37 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.181 -0.949 . . . . 0.19 108.802 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -34.14 76.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.22 108.688 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -64.59 -46.13 84.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 1.29 109.075 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -63.65 -38.48 91.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.349 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.0 58.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.909 . . . . 0.33000000000000002 109.874 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 49.6 59.19 4.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 109.743 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 19.5 t -79.13 137.44 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.28000000000000003 109.489 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -130.4 -1.77 4.42 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.452 -0.78 . . . . 2.3999999999999999 109.791 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.639 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.42 127.31 9.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.022 -1.049 . . . . 0.22 109.1 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.706 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.3 p -111.04 152.02 43.41 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 108.654 -0.869 . . . . 0.22 108.654 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.39 143.98 76.26 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 C-N-CA 124.75 -0.938 . . . . 0.20000000000000001 109.935 -1.847 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 117.94 32.27 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.666 -0.865 . . . . 0.17999999999999999 108.666 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.2 m-85 -93.26 122.68 35.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.14999999999999999 108.886 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -120.19 133.09 55.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.804 -1.184 . . . . 1.03 107.804 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -108.64 126.56 53.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.11 109.716 -178.066 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -124.05 158.79 31.36 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.512 -0.921 . . . . 0.17000000000000001 108.512 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -154.93 123.46 6.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.753 -1.203 . . . . 1.48 107.753 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 84' ' ' GLN . 7.3 mtmp? 56.01 27.33 11.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.527 -0.733 . . . . 1.6699999999999999 109.882 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.3 87.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.165 -1.017 . . . . 0.22 110.625 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.432 ' OE1' ' NZ ' ' A' ' 82' ' ' LYS . 55.0 mt-30 -109.98 147.48 33.41 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.329 -1.1 . . . . 2.0800000000000001 110.191 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -86.03 142.46 28.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.868 . . . . 1.7 109.124 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.35 -17.25 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.528 -0.732 . . . . 0.26000000000000001 110.358 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 176.14 174.24 42.49 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.455 -1.355 . . . . 0.17999999999999999 110.351 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -172.9 155.49 3.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.388 -1.066 . . . . 2.04 109.937 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.5 p90 -168.41 133.55 1.73 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.303 -0.873 . . . . 0.14000000000000001 110.342 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -104.07 -171.02 1.86 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.198 -0.939 . . . . 0.17000000000000001 109.03 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.93 5.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.13 109.522 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.89 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -1.117 . . . . 0.20000000000000001 110.424 -179.537 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -139.94 77.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.665 -1.235 . . . . 1.1499999999999999 107.665 178.203 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.97 -33.95 76.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 1.1899999999999999 110.687 -178.525 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -25.61 68.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.012 -1.055 . . . . 1.95 109.148 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -69.07 -37.6 78.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.328 -0.858 . . . . 2.0499999999999998 109.333 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 77' ' ' PHE . 13.8 mt -54.19 -35.6 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.14999999999999999 108.634 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -66.1 -58.89 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 2.1499999999999999 109.461 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.0 90.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.14999999999999999 110.494 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 m -65.25 -46.76 79.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.194 -0.941 . . . . 0.13 109.971 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.95 -52.32 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.183 -0.948 . . . . 0.17999999999999999 108.88 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -61.4 -16.48 46.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 1.03 109.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.9 -60.13 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 2.02 109.91 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.3 mt -91.69 20.57 5.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.716 . . . . 0.34999999999999998 110.28 -178.891 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 1.1799999999999999 109.247 179.782 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -125.13 -170.82 2.23 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.062 -1.024 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.417 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -72.33 150.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.78 0.8 . . . . 0.0 112.148 -177.431 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.0 m -101.15 94.23 5.86 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.72 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.639 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.15 44.71 0.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 110.214 -178.915 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.95 -131.21 0.15 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 177.764 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -69.64 30.37 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 119.315 1.557 . . . . 0.0 109.215 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.568 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.5 t . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 109.832 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.8 t . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.421 0.629 . . . . 0.29999999999999999 109.432 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.0 tptt -155.56 122.29 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 1.97 109.26 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.81 134.11 34.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.353 -0.842 . . . . 0.97999999999999998 108.992 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.92 108.6 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.363 -0.977 . . . . 0.19 108.363 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.24 -11.21 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 1.97 109.308 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -152.57 153.05 32.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.23000000000000001 109.462 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -52.39 -25.59 10.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.455 -0.778 . . . . 1.8999999999999999 109.812 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -60.2 -47.34 86.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.25 109.797 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -26.21 64.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.20000000000000001 109.644 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -59.7 -68.73 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.20999999999999999 109.821 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.38 -41.39 72.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 2.4700000000000002 109.849 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.0 -38.86 80.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.085 -1.009 . . . . 2.1000000000000001 109.601 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.28 95.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.20000000000000001 109.497 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.66 -46.66 84.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.62 110.117 -179.68 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.23 -43.21 95.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.997 . . . . 1.0900000000000001 109.815 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 -12.8 59.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.29999999999999999 109.917 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -8.55 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.23999999999999999 109.551 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.99 -117.05 6.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.669 -1.373 . . . . 0.28000000000000003 109.669 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 8.0 t0 -133.74 4.2 3.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.318 -1.107 . . . . 2.21 109.113 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -68.57 165.6 18.84 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.921 -1.112 . . . . 1.8999999999999999 108.711 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.69 157.84 23.07 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.315 -0.994 . . . . 0.17000000000000001 108.315 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.588 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.3 t -141.98 107.1 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.12 109.329 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.62 133.68 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.582 -0.895 . . . . 0.089999999999999997 108.582 179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.21 133.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.17000000000000001 109.529 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -104.88 102.26 11.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.609 -0.682 . . . . 0.95999999999999996 109.202 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.57 78.96 9.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.805 -1.183 . . . . 0.23999999999999999 107.805 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -106.72 -164.47 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.532 0.682 . . . . 1.03 109.462 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.28 122.74 14.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.412 -0.959 . . . . 0.26000000000000001 108.412 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -63.66 -25.11 68.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.76 . . . . 0.32000000000000001 110.446 -178.154 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 45.8 p-90 -88.33 -15.5 35.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 0.44 110.011 -179.203 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.74 129.08 43.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -0.908 . . . . 0.32000000000000001 109.813 -179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.89 -54.03 8.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 111.205 -0.758 . . . . 0.35999999999999999 111.205 -178.869 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.6 Cg_exo -48.54 -34.31 25.99 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.823 1.682 . . . . 0.44 111.156 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -58.79 3.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.81000000000000005 109.16 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.8 -21.14 55.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 1.9199999999999999 109.785 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.484 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.7 tmt? -58.2 -21.23 46.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 3.1299999999999999 109.946 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.3 mt -97.08 2.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.252 -0.905 . . . . 0.28000000000000003 110.224 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.16 -34.72 18.72 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 118.431 -1.308 . . . . 1.6200000000000001 111.084 -179.483 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.5 Cg_endo -63.78 -5.96 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.691 0.926 . . . . 0.25 110.561 -177.572 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.446 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 41.9 m-85 -111.1 -73.43 0.68 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.848 -0.797 . . . . 0.29999999999999999 108.848 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.48 -56.81 4.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.704 -0.623 . . . . 0.13 110.471 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.9 -31.9 72.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.40999999999999998 110.083 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.5 t -63.99 -39.72 94.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.014 -1.054 . . . . 0.96999999999999997 110.092 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 83.2 mt -50.74 -12.98 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.035 -1.04 . . . . 0.5 109.782 -179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.432 ' N ' ' C ' ' A' ' 44' ' ' SER . 16.4 m -57.78 -36.78 72.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.51000000000000001 109.636 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -93.85 -17.16 23.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.864 . . . . 2.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -90.65 -23.42 20.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 2.1600000000000001 109.117 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.11 71.8 1.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.696 . . . . 0.23999999999999999 109.125 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -66.84 -3.32 6.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.17000000000000001 108.988 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.615 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 0.4 OUTLIER -95.74 -0.07 51.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.516 -0.74 . . . . 0.34000000000000002 109.514 -179.673 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.53 148.66 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.239 -0.913 . . . . 0.12 109.6 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -101.07 123.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.882 -0.784 . . . . 0.17000000000000001 108.882 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -112.18 132.26 55.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.244 -0.91 . . . . 0.11 109.655 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -114.29 172.08 7.23 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.772 -0.825 . . . . 0.12 108.772 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.23 140.77 29.47 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.345 -0.983 . . . . 1.3100000000000001 108.345 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -139.25 138.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.138 -0.976 . . . . 0.14000000000000001 110.193 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.47 108.68 21.43 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.635 -1.246 . . . . 1.0800000000000001 107.635 177.441 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.14 -10.59 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.27000000000000002 111.107 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 10.1 m-20 -103.71 -40.34 6.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 110.756 -178.686 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -93.88 -14.39 26.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.1200000000000001 109.563 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.36 49.28 1.92 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.79 -0.818 . . . . 0.17000000000000001 108.79 178.72 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -55.95 -11.24 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.432 -0.792 . . . . 2.2200000000000002 110.19 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.924 -1.11 . . . . 1.1100000000000001 109.546 -179.447 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.2 -46.34 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.19 108.886 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.85 70.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.822 . . . . 0.22 109.258 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -64.21 -58.29 7.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 1.29 109.48 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -62.67 -29.82 70.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 2.2000000000000002 109.537 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.78 58.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.159 -0.963 . . . . 0.33000000000000002 109.544 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 43.58 52.84 6.05 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -0.756 . . . . 2.3399999999999999 110.328 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 17.8 t -77.76 134.79 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.28000000000000003 109.156 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.66 -0.39 8.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.411 -0.806 . . . . 2.3999999999999999 110.194 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.01 133.93 15.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.063 -1.023 . . . . 0.22 109.261 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.69 HG23 ' CE2' ' B' ' 5' ' ' TYR . 21.8 p -118.25 150.75 48.27 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.311 -0.868 . . . . 0.22 108.934 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' CG ' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.13 145.16 81.69 Favored 'Cis proline' 0 C--N 1.319 -0.995 0 C-N-CA 124.555 -1.019 . . . . 0.20000000000000001 110.131 -1.849 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.48 116.51 28.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.693 -1.225 . . . . 0.17999999999999999 107.693 178.018 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.8 m-85 -93.66 116.03 28.51 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.363 -0.935 . . . . 0.14999999999999999 108.603 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -116.18 139.95 49.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.163 -1.421 . . . . 1.03 107.163 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.06 132.22 54.36 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.719 . . . . 0.11 109.856 -176.938 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -126.93 154.94 43.84 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.327 -0.99 . . . . 0.17000000000000001 108.327 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.444 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 33.3 tttp -157.02 123.26 4.9 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.632 -1.247 . . . . 1.48 107.632 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mttp 59.23 25.61 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 1.6699999999999999 110.319 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.85 88.98 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.758 -1.337 . . . . 0.22 109.758 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -113.35 147.46 37.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.293 -1.121 . . . . 2.0800000000000001 109.701 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -86.38 141.93 28.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 1.7 109.175 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 87' ' ' GLY . 27.9 m -118.23 -39.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.408 -0.808 . . . . 0.26000000000000001 110.091 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -165.07 -176.99 37.23 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.911 -1.276 . . . . 0.17999999999999999 109.911 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.2 pm0 -172.4 156.28 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 2.04 110.147 -179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.3 p90 -169.05 132.26 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.14000000000000001 109.385 178.355 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 p -103.31 -161.23 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 108.743 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.05 137.67 2.56 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.492 -1.443 . . . . 0.13 109.492 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -65.89 92.21 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.25 -1.147 . . . . 0.20000000000000001 110.577 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -137.66 74.82 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.888 -1.153 . . . . 1.1499999999999999 107.888 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.49 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.73 -34.16 76.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 1.1899999999999999 110.495 -177.946 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.5 -26.43 68.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -67.94 -38.41 82.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 2.0499999999999998 109.428 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.7 mt -51.96 -37.68 53.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.958 . . . . 0.14999999999999999 108.833 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.97 -58.29 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 2.1499999999999999 109.31 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.95 86.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.407 -0.808 . . . . 0.14999999999999999 110.416 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -67.62 -45.55 75.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.219 -0.925 . . . . 0.13 110.042 -178.767 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.08 -51.11 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.106 -0.996 . . . . 0.17999999999999999 108.882 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -61.53 -17.03 53.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 1.03 109.488 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.3 -58.98 2.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 2.02 109.65 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.78 20.96 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.423 -0.798 . . . . 0.34999999999999998 110.352 -178.576 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 1.1799999999999999 109.209 179.373 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' B' B ' 4' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -128.76 -167.64 1.8 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 110.208 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.16 146.79 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 111.934 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.88 97.11 7.75 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -83.39 45.45 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.749 -179.172 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.68 -130.05 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 177.655 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.81 17.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 118.64 1.22 . . . . 0.0 109.784 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.2 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.548 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.324 0.583 . . . . 0.29999999999999999 109.802 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -154.39 118.78 4.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.314 -0.866 . . . . 1.97 108.921 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -88.76 135.78 33.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.97999999999999998 109.829 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -106.69 113.06 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.615 -1.254 . . . . 0.19 107.615 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -100.07 -11.01 20.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.282 -0.886 . . . . 1.97 109.786 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 p -154.59 158.02 39.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.065 -1.022 . . . . 0.23000000000000001 109.987 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 43.0 tttm -52.33 -23.78 6.44 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.697 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -61.95 -51.03 69.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.012 . . . . 0.25 110.293 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.99 -21.67 64.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.20000000000000001 109.952 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.88 -64.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.99 -1.069 . . . . 0.20999999999999999 109.714 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.62 -46.79 77.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 2.4700000000000002 109.799 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.28 -34.82 70.94 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.273 -0.892 . . . . 2.1000000000000001 110.142 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.62 -45.93 91.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.20000000000000001 109.624 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.9 -51.76 60.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.54 -0.725 . . . . 0.62 109.646 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.28 -35.99 80.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 109.511 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.63 -16.08 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.29999999999999999 109.458 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -20.64 64.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.158 -0.964 . . . . 0.23999999999999999 109.469 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.45 -107.72 2.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.707 -1.357 . . . . 0.28000000000000003 109.707 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.1 -2.2 1.88 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -1.039 . . . . 2.21 109.553 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -67.33 168.06 11.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.903 -1.123 . . . . 1.8999999999999999 108.817 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.41 163.44 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.077 -1.083 . . . . 0.17000000000000001 108.077 -179.987 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.636 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.39 103.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.869 -1.145 . . . . 0.12 109.648 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.9 130.87 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.78 -0.822 . . . . 0.089999999999999997 108.78 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.76 135.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 0.17000000000000001 109.608 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.8 101.64 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.783 -0.821 . . . . 0.95999999999999996 108.783 179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -84.32 80.74 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.884 -1.154 . . . . 0.23999999999999999 107.884 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.0 m -113.7 152.22 30.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.767 -0.583 . . . . 1.03 109.601 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.61 127.13 41.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.26000000000000001 109.275 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -67.11 -25.61 66.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.823 . . . . 0.32000000000000001 110.64 -179.294 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' TRP . . . . . 0.546 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 53.7 p-90 -87.45 -14.83 39.43 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.957 -1.09 . . . . 0.44 109.927 -179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 t -93.34 130.92 38.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.32000000000000001 110.018 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.9 -59.24 6.1 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.875 -0.678 . . . . 0.35999999999999999 111.48 -179.338 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -48.86 -35.91 32.4 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.795 1.663 . . . . 0.44 111.547 -178.206 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.92 -61.33 2.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.81000000000000005 108.936 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -59.55 -20.27 54.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.561 -0.712 . . . . 1.9199999999999999 109.986 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.1 ttt -62.09 -19.09 62.6 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.206 -0.934 . . . . 3.1299999999999999 110.341 -179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -100.28 11.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.197 -0.94 . . . . 0.28000000000000003 110.269 -179.076 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 4.5 ptmm? -71.42 -27.24 1.0 Allowed Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 120.212 -1.555 . . . . 1.6200000000000001 111.844 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.4 Cg_exo -65.23 -4.39 9.12 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 120.641 1.265 . . . . 0.25 109.452 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -107.68 -79.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.693 -0.855 . . . . 0.29999999999999999 108.693 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.6 t80 -40.19 -58.13 1.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 0.13 111.206 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.39 -33.59 76.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 0.40999999999999998 110.322 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.5 p -66.33 -36.81 83.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.633 -1.292 . . . . 0.96999999999999997 110.409 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.5 mt -50.52 -19.84 0.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.928 -1.107 . . . . 0.5 109.535 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 m -56.94 -21.73 32.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.966 -1.083 . . . . 0.51000000000000001 109.977 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -97.22 -26.88 14.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.137 -0.977 . . . . 2.0 110.052 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -90.32 -18.61 25.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.046 -1.034 . . . . 2.1600000000000001 109.412 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.35 62.44 1.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.528 -0.732 . . . . 0.23999999999999999 109.247 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 p -66.72 -3.01 5.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.364 -0.835 . . . . 0.17000000000000001 108.91 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -95.59 1.11 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.418 -0.801 . . . . 0.34000000000000002 109.446 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.73 150.62 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.274 -0.639 . . . . 0.12 109.274 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.6 mm -98.89 123.49 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.426 -0.796 . . . . 0.17000000000000001 109.078 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.3 m-85 -111.24 132.87 54.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.357 -0.839 . . . . 0.11 109.141 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.06 167.3 10.78 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.641 -0.874 . . . . 0.12 108.641 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.61 133.97 29.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.353 -1.351 . . . . 1.3100000000000001 107.353 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.3 t -132.32 141.43 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.264 -0.897 . . . . 0.14000000000000001 110.745 -177.862 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.56 101.35 12.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.422 -0.955 . . . . 1.0800000000000001 108.422 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 74' ' ' THR . 16.4 m -61.42 -4.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.27000000000000002 111.197 -178.884 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 38.3 m-20 -107.58 -41.97 4.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.253 -0.905 . . . . 1.1100000000000001 110.554 -178.663 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.11 -21.8 18.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.348 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.73 43.31 1.35 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.477 -0.935 . . . . 0.17000000000000001 108.477 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -53.81 -13.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.529 -0.732 . . . . 2.2200000000000002 110.015 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.43 -42.12 71.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 108.981 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.89 -46.02 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.711 -0.848 . . . . 0.19 108.711 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.38 -34.0 76.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.22 108.989 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 m -63.63 -48.21 78.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 1.29 108.962 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.94 -36.49 84.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.573 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.34 -7.71 54.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.232 -0.917 . . . . 0.33000000000000002 109.648 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' ALA . 39.4 mt-10 47.72 62.97 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.323 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 t -79.0 137.75 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.28000000000000003 108.918 179.12 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -125.26 -4.48 7.34 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.407 -0.808 . . . . 2.3999999999999999 110.085 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.55 126.55 9.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.91 -1.119 . . . . 0.22 109.349 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.752 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.8 p -110.07 151.87 42.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.54 -0.911 . . . . 0.22 108.54 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -77.34 143.34 74.56 Favored 'Cis proline' 0 N--CA 1.483 0.875 0 C-N-CA 124.858 -0.892 . . . . 0.20000000000000001 109.926 -1.982 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.58 114.7 26.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.421 -0.955 . . . . 0.17999999999999999 108.421 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -89.08 125.57 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.864 -1.147 . . . . 0.14999999999999999 108.833 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -122.84 132.23 54.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.825 -1.176 . . . . 1.03 107.825 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.7 m-85 -107.09 129.82 54.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.11 109.911 -178.213 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.61 157.29 42.49 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.17000000000000001 108.71 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -155.11 127.01 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.265 . . . . 1.48 107.586 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 56.0 18.97 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 1.6699999999999999 109.847 -178.808 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.65 3.08 69.12 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 120.836 -1.165 . . . . 0.22 110.447 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.68 147.23 34.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.356 -1.085 . . . . 2.0800000000000001 109.822 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -85.51 144.86 27.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.335 -0.853 . . . . 1.7 109.384 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.65 -23.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.461 -0.775 . . . . 0.26000000000000001 110.264 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.22 174.91 46.61 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.483 -1.342 . . . . 0.17999999999999999 110.509 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.79 153.41 2.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -1.107 . . . . 2.04 110.094 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.74 132.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.14000000000000001 110.46 179.079 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -103.37 -169.17 1.61 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.19 -0.944 . . . . 0.17000000000000001 109.321 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.66 129.85 3.89 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 92' ' ' ALA . . . . . 0.487 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.97 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.196 -1.179 . . . . 0.20000000000000001 110.365 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -141.13 74.82 1.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.109 -1.071 . . . . 1.1499999999999999 108.109 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -34.27 77.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 1.1899999999999999 110.83 -178.601 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -64.52 -25.74 68.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.834 -1.166 . . . . 1.95 109.282 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -68.54 -35.97 78.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 2.0499999999999998 109.422 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.6 mt -51.83 -36.4 47.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.14999999999999999 108.958 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.83 -58.17 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 2.1499999999999999 109.863 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.1 84.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.36 -0.838 . . . . 0.14999999999999999 110.844 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.9 m -67.18 -47.84 69.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.065 . . . . 0.13 110.273 -178.905 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.52 -51.09 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.17999999999999999 108.983 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.28 -17.77 31.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 1.03 109.605 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -76.46 -62.22 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 110.015 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.09 22.38 4.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.546 -0.721 . . . . 0.34999999999999998 110.518 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.226 179.408 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' B' B ' 5' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.1 p90 -131.15 -165.26 1.54 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.099 -1.001 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 6' ' ' VAL . . . . . 0.406 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -80.35 152.54 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.255 -0.903 . . . . 0.0 112.379 -177.157 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m -102.02 95.61 6.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.779 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 8' ' ' GLU . . . . . 0.654 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.9 pt-20 -83.17 46.15 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 110.058 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.81 -131.44 0.11 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 177.94 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.62 25.45 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.279 1.539 . . . . 0.0 109.276 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 20.4 t . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.52 -0.548 . . . . 2.8900000000000001 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.6 t -94.63 161.81 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.298 -0.876 . . . . 0.29999999999999999 109.306 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' N ' HG12 ' A' ' 2' ' ' VAL . 3.7 tmtm? -155.22 122.91 5.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.143 -0.973 . . . . 1.97 108.892 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -89.61 137.88 31.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.97999999999999998 110.371 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.9 mm -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.488 -1.301 . . . . 0.19 107.488 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -108.17 -15.93 14.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.292 -0.88 . . . . 1.97 109.195 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -153.13 158.95 42.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.23000000000000001 109.506 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.27 -29.49 23.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 1.8999999999999999 109.998 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -58.7 -46.57 87.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.25 109.794 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.4 63.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.20000000000000001 109.909 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -58.91 -65.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.046 . . . . 0.20999999999999999 109.806 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -55.91 -45.27 78.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 2.4700000000000002 109.724 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -58.8 -35.55 73.02 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.174 -0.954 . . . . 2.1000000000000001 109.753 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.15 83.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.1 . . . . 0.20000000000000001 109.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.44 -41.46 98.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.815 . . . . 0.62 109.534 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.85 -45.56 85.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 1.0900000000000001 109.912 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.98 59.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.29999999999999999 109.952 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -7.44 29.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.23999999999999999 109.782 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.75 -136.09 24.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.137 -1.585 . . . . 0.28000000000000003 109.137 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -117.01 5.92 12.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.43 -1.041 . . . . 2.21 109.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.72 168.01 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 1.8999999999999999 109.102 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.66 164.51 9.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.158 -1.053 . . . . 0.17000000000000001 108.158 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.1 t -145.1 107.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.993 -1.067 . . . . 0.12 109.672 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.84 136.48 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.178 -1.045 . . . . 0.089999999999999997 108.178 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 136.7 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.528 -0.732 . . . . 0.17000000000000001 109.645 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.73 101.78 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.95999999999999996 109.292 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 57' ' ' VAL . 40.7 m-85 -88.04 79.07 8.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.23999999999999999 108.056 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.3 m -113.36 150.9 31.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.315 0.579 . . . . 1.03 109.487 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.19 130.24 37.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.26000000000000001 108.766 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -66.94 -28.83 68.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.32000000000000001 110.809 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 58.4 p-90 -88.47 -8.82 54.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.003 -1.061 . . . . 0.44 110.536 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.61 128.4 44.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.32000000000000001 109.542 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.14 -55.99 9.63 Favored Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.563 -0.711 . . . . 0.35999999999999999 111.42 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 13.6 Cg_exo -49.94 -35.0 39.27 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.746 1.631 . . . . 0.44 111.401 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.96 -1.087 . . . . 0.81000000000000005 109.076 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -58.27 -20.27 41.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.9199999999999999 110.018 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.43 -19.73 57.27 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.144 -0.973 . . . . 3.1299999999999999 110.883 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.527 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.2 mt -100.73 4.39 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.998 -1.064 . . . . 0.28000000000000003 111.182 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 6.6 ptpt -64.65 -32.93 7.66 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 120.121 -1.612 . . . . 1.6200000000000001 112.439 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -57.64 -13.71 14.89 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.944 1.016 . . . . 0.25 110.245 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -99.82 -67.19 0.86 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.724 -0.843 . . . . 0.29999999999999999 108.724 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -46.61 -52.87 12.66 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.713 -0.617 . . . . 0.13 110.424 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -67.7 -33.6 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.40999999999999998 109.73 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.0 -41.98 97.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 0.96999999999999997 109.851 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 mt -52.25 -15.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.014 . . . . 0.5 109.326 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 m -58.27 -33.37 69.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.51000000000000001 109.729 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.11 -18.06 22.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -0.907 . . . . 2.0 110.076 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -91.39 -22.81 20.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.132 -0.98 . . . . 2.1600000000000001 109.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -133.1 69.39 1.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.594 -0.691 . . . . 0.23999999999999999 109.193 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.6 p -67.34 -5.32 13.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.306 -0.871 . . . . 0.17000000000000001 109.114 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -95.44 5.28 52.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.487 -0.758 . . . . 0.34000000000000002 109.555 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.17 149.46 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.471 -0.768 . . . . 0.12 109.332 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.52 126.25 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.901 -0.777 . . . . 0.17000000000000001 108.901 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 55' ' ' LEU . 85.5 m-85 -114.39 134.25 55.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.391 -0.818 . . . . 0.11 109.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -116.4 175.11 5.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -0.783 . . . . 0.12 109.247 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -144.31 143.31 30.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.015 -1.106 . . . . 1.3100000000000001 108.015 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 27' ' ' PHE . 55.8 t -140.44 142.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.07 -1.019 . . . . 0.14000000000000001 110.658 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.95 100.77 11.72 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.932 -1.136 . . . . 1.0800000000000001 107.932 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.2 m -60.36 -10.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.27000000000000002 111.099 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -102.52 -41.34 6.31 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 111.239 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' HB2' HH12 ' B' ' 2' ' ' ARG . 6.7 t70 -94.86 -13.67 25.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.98 -1.075 . . . . 1.1200000000000001 110.061 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.88 48.48 1.62 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.284 -0.885 . . . . 0.17000000000000001 108.797 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -55.22 -13.97 1.53 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.571 -0.705 . . . . 2.2200000000000002 109.592 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.44 -42.42 71.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.1100000000000001 109.246 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.61 -45.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.19 108.542 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -34.36 77.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.22 109.304 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.1 m -64.08 -49.49 72.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 1.29 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.8 -37.06 85.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 2.2000000000000002 109.224 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.71 -3.74 58.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.33000000000000002 109.492 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ALA . 36.1 mt-10 47.0 52.65 11.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 2.3399999999999999 110.279 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.06 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.28000000000000003 108.896 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 54.5 mttp -127.74 6.74 6.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.451 -0.781 . . . . 2.3999999999999999 109.733 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 137.82 17.34 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.057 -1.027 . . . . 0.22 108.95 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.475 HG23 ' CE2' ' B' ' 5' ' ' TYR . 74.3 p -122.04 149.89 55.13 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.362 -0.836 . . . . 0.22 109.006 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.1 Cg_endo -76.6 148.07 88.16 Favored 'Cis proline' 0 N--CA 1.484 0.932 0 C-N-CA 124.66 -0.975 . . . . 0.20000000000000001 110.409 -2.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -117.63 115.82 25.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.255 -1.387 . . . . 0.17999999999999999 107.255 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.6 m-85 -93.04 121.68 34.63 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.213 -0.929 . . . . 0.14999999999999999 108.555 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -119.8 137.88 53.7 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.608 -1.256 . . . . 1.03 107.608 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.433 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 28.5 m-85 -111.44 127.8 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.536 0.684 . . . . 0.11 110.044 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -126.33 157.49 38.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.619 -0.882 . . . . 0.17000000000000001 108.619 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -155.48 123.84 5.91 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt 56.39 28.38 13.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.764 . . . . 1.6699999999999999 109.89 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.04 87.19 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.98 -1.105 . . . . 0.22 110.357 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -115.3 146.48 41.46 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.372 -1.075 . . . . 2.0800000000000001 110.128 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -85.54 140.79 30.36 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.402 -0.811 . . . . 1.7 109.222 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 -20.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.396 -0.815 . . . . 0.26000000000000001 110.289 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.1 46.69 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.454 -1.355 . . . . 0.17999999999999999 110.378 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -174.18 153.66 2.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.359 -1.083 . . . . 2.04 110.229 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.94 135.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.14000000000000001 109.974 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -106.6 -169.24 1.53 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.238 -0.914 . . . . 0.17000000000000001 108.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 91.87 129.25 4.61 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -1.097 . . . . 0.20000000000000001 110.297 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.0 t-20 -139.96 74.38 1.46 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 1.1499999999999999 108.787 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -65.23 -32.58 74.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 1.1899999999999999 110.319 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.06 -30.67 70.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.981 -1.074 . . . . 1.95 109.598 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -67.36 -33.5 75.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 2.0499999999999998 109.254 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.1 mt -50.82 -35.36 31.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.964 -1.085 . . . . 0.14999999999999999 108.605 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.98 -57.59 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.836 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.2 88.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.14999999999999999 110.876 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.6 m -66.87 -46.04 76.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.13 110.467 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.27 -50.56 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.17999999999999999 109.163 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -61.17 -18.27 57.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 1.03 109.652 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.63 -60.69 2.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 2.02 110.134 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.8 mt -91.88 22.1 4.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.463 -0.773 . . . . 0.34999999999999998 110.461 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 1.1799999999999999 109.178 179.357 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.0 mtt-85 -118.28 74.36 0.95 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.506 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -130.29 150.72 51.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.448 -0.782 . . . . 0.0 109.022 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.3 mmt180 -148.0 -102.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.79 -168.54 1.34 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.087 -1.008 . . . . 0.0 110.714 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.02 150.31 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.943 0.877 . . . . 0.0 112.909 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.63 97.11 7.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.427 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.77 44.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.068 -1.02 . . . . 0.0 110.477 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.17 -136.82 0.15 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.32 28.27 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 118.755 1.278 . . . . 0.0 109.012 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 9.3 t -89.24 -31.04 18.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 109.697 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -65.34 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.703 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.436 -0.579 . . . . 2.8900000000000001 109.436 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 3' ' ' LYS . 75.0 t -94.77 158.69 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.3 -0.875 . . . . 0.29999999999999999 109.626 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.0 tttt -153.99 125.26 7.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.363 -0.836 . . . . 1.97 108.803 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -88.39 134.87 33.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.97999999999999998 109.899 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.99 106.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.219 -1.03 . . . . 0.19 108.219 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.63 -8.79 23.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.205 -0.934 . . . . 1.97 109.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.3 p -152.09 150.31 29.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.23000000000000001 109.623 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -51.57 -28.15 13.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 1.8999999999999999 109.396 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 m -60.7 -43.27 97.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.25 109.584 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.35 -26.58 64.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.845 . . . . 0.20000000000000001 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.94 -67.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.20999999999999999 109.868 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -54.1 -44.33 71.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 2.4700000000000002 109.673 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.44 -37.82 76.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.159 -0.963 . . . . 2.1000000000000001 109.726 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.71 88.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.20000000000000001 109.276 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.0 mt -64.7 -41.07 96.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.62 109.812 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.95 -38.68 92.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.587 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.08 -16.62 54.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.888 . . . . 0.29999999999999999 109.828 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -6.96 31.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.23999999999999999 109.938 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.66 -105.95 1.4 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.837 -1.305 . . . . 0.28000000000000003 109.837 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.78 3.38 2.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -1.078 . . . . 2.21 109.74 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 109' ' ' HOH . 77.8 mttt -70.09 166.82 19.0 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.042 -1.036 . . . . 1.8999999999999999 109.124 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 163.39 11.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.295 -0.878 . . . . 0.17000000000000001 108.687 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.4 t -146.21 107.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.094 -1.004 . . . . 0.12 109.48 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -103.73 128.5 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.366 -0.833 . . . . 0.089999999999999997 108.804 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.95 134.81 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.612 -0.68 . . . . 0.17000000000000001 109.896 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -106.48 101.1 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.177 -0.675 . . . . 0.95999999999999996 109.177 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' THR . 50.5 m-85 -84.97 81.17 9.01 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.765 -1.198 . . . . 0.23999999999999999 107.765 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -110.94 -163.06 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.626 0.727 . . . . 1.03 109.514 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 124.81 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.607 -0.886 . . . . 0.26000000000000001 108.607 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -64.69 -25.47 67.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.32000000000000001 110.718 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 46.9 p-90 -89.05 -19.45 25.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.972 -1.08 . . . . 0.44 110.169 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.84 122.17 34.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.32000000000000001 109.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.63 -57.41 12.74 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 120.929 -0.653 . . . . 0.35999999999999999 111.555 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 22.8 Cg_exo -46.04 -36.88 16.83 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.712 1.608 . . . . 0.44 111.645 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.86 -59.54 2.74 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.869 -1.145 . . . . 0.81000000000000005 108.944 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -59.47 -15.15 15.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 1.9199999999999999 110.009 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 tpt -58.24 -20.13 39.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 3.1299999999999999 110.434 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.584 ' O ' HG22 ' A' ' 38' ' ' ILE . 49.2 mt -97.27 8.57 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.083 -1.01 . . . . 0.28000000000000003 110.783 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.96 -31.97 5.25 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 120.122 -1.611 . . . . 1.6200000000000001 112.529 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.67 -5.14 11.09 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 CA-C-N 119.968 1.024 . . . . 0.25 109.706 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -111.85 -78.45 0.58 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.015 -0.735 . . . . 0.29999999999999999 109.015 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -41.56 -56.91 2.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.767 -0.583 . . . . 0.13 110.688 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.01 -31.48 72.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.40999999999999998 109.871 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 46' ' ' SER . 13.4 m -66.49 -38.77 88.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.853 -1.154 . . . . 0.96999999999999997 110.235 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.8 mt -49.17 -12.93 0.06 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.879 -1.138 . . . . 0.5 109.649 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' SER . 54.9 m -56.75 -31.57 64.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.51000000000000001 109.51 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.25 -17.59 21.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.266 -0.896 . . . . 2.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -91.03 -24.3 20.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.976 -1.077 . . . . 2.1600000000000001 109.85 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -135.49 70.96 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 0.23999999999999999 109.621 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.2 p -66.97 -4.57 9.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.266 -0.896 . . . . 0.17000000000000001 108.714 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -96.11 -0.37 50.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.736 . . . . 0.34000000000000002 109.823 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.7 149.59 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.729 . . . . 0.12 109.4 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.07 133.57 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.442 -0.786 . . . . 0.17000000000000001 109.418 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -119.06 131.77 55.98 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.544 -0.723 . . . . 0.11 109.163 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.99 172.81 6.82 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.399 -0.813 . . . . 0.12 108.962 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.99 143.33 31.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.162 -1.051 . . . . 1.3100000000000001 108.162 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.85 138.2 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.168 -0.957 . . . . 0.14000000000000001 110.288 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.79 102.9 14.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.648 -1.241 . . . . 1.0800000000000001 107.648 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.03 -6.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.233 -0.917 . . . . 0.27000000000000002 111.044 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.08 -44.52 5.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.052 -1.03 . . . . 1.1100000000000001 110.597 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.99 -15.37 24.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.093 -1.004 . . . . 1.1200000000000001 109.776 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.48 44.66 2.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -0.865 . . . . 0.17000000000000001 109.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -57.06 -10.88 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.2200000000000002 110.216 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.6 ' OD1' HG23 ' A' ' 65' ' ' VAL . 1.4 p30 -69.04 -39.16 79.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.908 -1.12 . . . . 1.1100000000000001 109.149 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.8 t -74.05 -42.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.137 -1.06 . . . . 0.19 108.137 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.2 -37.85 88.87 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.907 -0.775 . . . . 0.22 108.907 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 m -64.03 -45.02 90.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 1.29 109.079 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.87 -39.03 93.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 2.2000000000000002 109.427 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.11 0.33 55.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -0.896 . . . . 0.33000000000000002 109.754 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 49.21 56.81 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.905 . . . . 2.3399999999999999 109.951 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.59 135.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.28000000000000003 109.192 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -123.86 -6.86 7.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.604 -0.685 . . . . 2.3999999999999999 109.638 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.01 136.96 16.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.149 -0.969 . . . . 0.22 109.433 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.2 p -115.47 150.61 44.9 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.62 148.62 86.86 Favored 'Cis proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.838 -0.901 . . . . 0.20000000000000001 109.838 -2.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -119.26 118.89 32.48 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.145 -1.057 . . . . 0.17999999999999999 108.145 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.0 m-85 -95.76 111.9 23.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.14999999999999999 108.775 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -114.03 139.39 49.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.601 -1.259 . . . . 1.03 107.601 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.6 m-85 -109.17 133.24 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.54 0.686 . . . . 0.11 110.052 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -126.59 156.62 40.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.488 -0.93 . . . . 0.17000000000000001 108.488 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -154.73 122.51 5.81 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.633 -1.247 . . . . 1.48 107.633 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 56.86 29.67 16.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 1.6699999999999999 109.866 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.4 1.54 90.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.113 -1.041 . . . . 0.22 110.741 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -112.67 148.32 34.9 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.155 -1.203 . . . . 2.0800000000000001 110.281 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.478 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -87.19 146.5 25.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 1.7 109.523 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.09 -29.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.442 -0.786 . . . . 0.26000000000000001 110.147 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.43 45.51 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.659 -1.258 . . . . 0.17999999999999999 110.083 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -172.34 160.99 5.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -1.147 . . . . 2.04 110.77 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -169.6 133.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.511 -0.743 . . . . 0.14000000000000001 110.18 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -104.23 -170.39 1.76 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.17000000000000001 109.291 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.59 130.19 4.41 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.526 -1.43 . . . . 0.13 109.526 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.82 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -1.17 . . . . 0.20000000000000001 110.237 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -141.6 74.76 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.331 -0.989 . . . . 1.1499999999999999 108.331 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.25 -32.45 74.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.1899999999999999 110.782 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.62 -28.67 69.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.1 -1.0 . . . . 1.95 109.153 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -69.4 -36.38 76.7 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.53 -0.731 . . . . 2.0499999999999998 109.873 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 77' ' ' PHE . 58.7 mt -53.05 -36.31 60.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.767 -1.208 . . . . 0.14999999999999999 108.765 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -65.79 -58.15 6.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 2.1499999999999999 109.615 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.5 91.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.14999999999999999 110.485 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.3 m -65.06 -45.26 86.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 0.13 110.212 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.96 -54.35 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.0 -1.062 . . . . 0.17999999999999999 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -61.46 -16.55 48.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 1.03 109.745 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -76.3 -60.45 2.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.902 . . . . 2.02 110.479 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.33 18.18 7.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 0.34999999999999998 110.544 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.265 179.374 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.4 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 90.6 mtt180 -153.63 66.82 0.75 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.489 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 30.7 m-85 -116.27 150.42 37.61 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.9 OUTLIER -147.42 -107.79 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.0 109.651 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -108.75 -177.49 3.33 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.652 -1.28 . . . . 0.0 110.69 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.03 145.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.038 0.923 . . . . 0.0 113.058 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 m -101.22 93.73 5.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.553 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.5 44.61 0.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.337 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.02 -132.4 0.07 OUTLIER Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.54 25.15 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 CA-C-N 119.211 1.505 . . . . 0.0 109.274 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t -85.99 -36.87 19.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 37.6 t-80 -86.48 -94.95 0.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.403 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.953 -1.471 . . . . 0.0 109.63 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.397 -0.594 . . . . 2.8900000000000001 109.397 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 96.1 t -94.62 160.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.29999999999999999 109.55 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -154.75 121.24 5.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.727 -1.212 . . . . 1.97 107.727 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -86.77 141.39 28.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.97999999999999998 110.411 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.12 109.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.19 108.022 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.97 -14.88 17.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 1.97 109.327 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -154.96 157.61 37.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.23000000000000001 109.843 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 49.7 tttp -51.55 -27.65 11.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 1.8999999999999999 109.574 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 m -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.25 110.005 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.47 -27.26 65.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.20000000000000001 109.687 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.84 -67.61 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.20999999999999999 109.942 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -54.04 -43.98 70.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.901 . . . . 2.4700000000000002 109.64 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.51 -37.5 78.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.245 -0.909 . . . . 2.1000000000000001 109.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.2 86.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.20000000000000001 109.454 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.31 -43.16 98.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.413 -0.804 . . . . 0.62 109.563 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.27 -42.33 96.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 1.0900000000000001 109.594 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.06 -13.49 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.962 . . . . 0.29999999999999999 109.809 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -6.4 24.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.23999999999999999 109.753 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.54 -112.43 4.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.28000000000000003 109.562 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB2' ' HZ2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -139.43 2.67 2.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -1.103 . . . . 2.21 109.262 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 109' ' ' HOH . 68.2 mttt -68.84 167.05 16.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 1.8999999999999999 108.812 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.67 161.86 11.62 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.099 -1.074 . . . . 0.17000000000000001 108.099 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -143.99 105.8 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.968 -1.083 . . . . 0.12 109.451 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.0 t -102.41 132.19 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.704 -0.85 . . . . 0.089999999999999997 108.704 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.38 138.54 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.674 -0.641 . . . . 0.17000000000000001 109.758 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.09 101.57 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.178 -0.675 . . . . 0.95999999999999996 109.178 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -85.09 79.97 9.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.874 -1.158 . . . . 0.23999999999999999 107.874 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.43 149.53 34.05 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.279 0.562 . . . . 1.03 109.789 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.95 128.17 37.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.63 -0.878 . . . . 0.26000000000000001 108.63 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -65.93 -26.65 67.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.32000000000000001 110.605 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.509 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 60.4 p-90 -88.53 -13.76 39.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.887 -1.133 . . . . 0.44 110.038 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -94.34 126.01 39.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.32000000000000001 109.995 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.98 -58.96 8.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.462 -0.655 . . . . 0.35999999999999999 111.462 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.6 Cg_exo -45.12 -33.21 7.8 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.9 1.733 . . . . 0.44 111.314 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.41 -61.58 1.96 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.897 -1.127 . . . . 0.81000000000000005 108.626 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -60.89 -15.7 33.66 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.71 -0.619 . . . . 1.9199999999999999 110.473 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 33' ' ' GLY . 27.9 tpp -60.92 -27.38 68.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.05 -1.031 . . . . 3.1299999999999999 109.991 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.601 ' O ' HG22 ' A' ' 38' ' ' ILE . 49.6 mt -96.49 15.63 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.131 -0.981 . . . . 0.28000000000000003 111.023 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.89 -32.75 3.67 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 118.179 -1.408 . . . . 1.6200000000000001 112.224 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -62.9 -4.58 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 CA-C-N 119.758 0.949 . . . . 0.25 110.114 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 46.5 m-85 -109.16 -79.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.29999999999999999 109.025 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.73 -55.8 2.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.632 . . . . 0.13 111.082 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.37 -34.7 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.40999999999999998 110.219 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 85.1 p -64.85 -35.42 81.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.637 -1.29 . . . . 0.96999999999999997 110.012 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.5 mt -50.11 -16.11 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.987 -1.071 . . . . 0.5 109.28 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 14.9 m -57.03 -36.48 70.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.51000000000000001 109.706 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -93.16 -15.02 26.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.159 -0.963 . . . . 2.0 110.089 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -91.26 -23.12 20.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.056 -1.027 . . . . 2.1600000000000001 109.196 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -135.88 72.46 1.44 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.531 -0.731 . . . . 0.23999999999999999 109.414 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 93.3 p -67.17 -4.76 11.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.17000000000000001 108.969 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -96.97 -0.37 47.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.34000000000000002 109.9 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.29 147.54 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -0.784 . . . . 0.12 109.223 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 mm -98.77 130.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.17000000000000001 109.36 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -118.11 132.13 56.37 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.486 -0.759 . . . . 0.11 109.142 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.78 171.92 7.29 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.786 -0.82 . . . . 0.12 108.786 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -141.54 137.83 32.29 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.717 -1.216 . . . . 1.3100000000000001 107.717 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 t -136.47 139.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.275 -0.891 . . . . 0.14000000000000001 110.883 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.99 101.77 12.95 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.745 -0.835 . . . . 1.0800000000000001 108.745 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 59' ' ' VAL . 15.6 m -60.98 -2.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.879 . . . . 0.27000000000000002 111.017 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.441 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 26.1 m-20 -108.66 -44.44 4.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.061 -1.025 . . . . 1.1100000000000001 110.503 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -95.11 -26.97 15.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.102 -0.999 . . . . 1.1200000000000001 109.21 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.92 40.39 1.51 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.309 -0.997 . . . . 0.17000000000000001 108.309 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -53.57 -15.87 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.636 -0.665 . . . . 2.2200000000000002 110.121 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -70.26 -36.29 74.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.978 -1.076 . . . . 1.1100000000000001 108.783 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -75.27 -48.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.663 -0.866 . . . . 0.19 108.663 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.72 74.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.801 . . . . 0.22 109.161 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 m -63.16 -48.98 76.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 1.29 109.182 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -64.94 -35.99 82.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 2.2000000000000002 109.522 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 0.47 55.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.945 . . . . 0.33000000000000002 109.905 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 45.88 50.95 10.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.961 . . . . 2.3399999999999999 110.251 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.82 131.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.28000000000000003 108.904 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -130.52 6.19 4.79 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.376 -0.827 . . . . 2.3999999999999999 110.212 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.46 120.7 6.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.04 -1.037 . . . . 0.22 108.731 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.632 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.0 p -108.17 150.65 40.74 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.759 -0.83 . . . . 0.22 108.759 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.8 141.97 68.83 Favored 'Cis proline' 0 N--CA 1.484 0.919 0 C-N-CA 125.033 -0.82 . . . . 0.20000000000000001 110.105 -1.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 115.66 27.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.973 -1.121 . . . . 0.17999999999999999 107.973 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -91.47 118.62 30.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.14999999999999999 108.94 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -117.06 132.95 56.56 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.0 m-85 -107.84 126.55 52.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.656 -0.653 . . . . 0.11 109.55 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -123.03 158.46 30.5 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.786 -0.82 . . . . 0.17000000000000001 108.786 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -154.75 123.07 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.866 -1.531 . . . . 1.48 106.866 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 20' ' ' ASP . 25.1 mttm 58.26 28.59 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 1.6699999999999999 109.41 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 2.83 88.8 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.606 -1.397 . . . . 0.22 109.606 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.6 mm-40 -106.76 145.75 31.68 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.543 -0.975 . . . . 2.0800000000000001 110.334 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -85.6 141.13 30.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 1.7 109.357 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.6 -21.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.49 -0.756 . . . . 0.26000000000000001 110.253 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.04 177.32 48.42 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.485 -1.341 . . . . 0.17999999999999999 110.178 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -174.27 156.1 2.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -1.121 . . . . 2.04 110.165 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -168.9 131.15 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.14000000000000001 110.0 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 p -102.57 -166.85 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.192 -0.942 . . . . 0.17000000000000001 108.892 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.98 127.9 3.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.126 -1.59 . . . . 0.13 109.126 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.532 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.81 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.158 -1.201 . . . . 0.20000000000000001 110.734 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -143.12 77.38 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.136 -1.061 . . . . 1.1499999999999999 108.136 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.34 75.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 1.1899999999999999 110.484 -178.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.97 -26.57 67.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.98 -1.075 . . . . 1.95 109.185 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -68.97 -36.54 78.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.346 -0.846 . . . . 2.0499999999999998 109.512 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 77' ' ' PHE . 15.0 mt -53.7 -34.9 60.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.064 . . . . 0.14999999999999999 108.919 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.0 -57.54 6.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 2.1499999999999999 109.722 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.33 90.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.14999999999999999 110.59 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.0 m -66.86 -45.14 79.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.13 110.206 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.49 -51.9 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.932 -1.105 . . . . 0.17999999999999999 108.631 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.48 ' O ' ' ND2' ' A' ' 102' ' ' ASN . 0.2 OUTLIER -61.91 -15.34 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.857 . . . . 1.03 109.646 179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -76.49 -59.72 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 2.02 110.176 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.3 mt -92.32 17.17 10.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -0.841 . . . . 0.34999999999999998 110.404 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.973 -1.08 . . . . 1.1799999999999999 109.382 179.595 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -119.67 71.67 0.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.495 -0.753 . . . . 0.0 109.165 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.404 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.7 m-85 -134.03 155.38 50.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.485 -0.759 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.577 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -149.61 -95.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.013 . . . . 0.0 109.356 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.632 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -115.08 -172.56 2.15 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.941 -1.1 . . . . 0.0 110.632 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.95 152.54 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.957 0.884 . . . . 0.0 112.056 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 m -101.25 96.84 7.46 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.574 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.8 45.48 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.948 . . . . 0.0 109.819 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.74 -132.66 0.07 OUTLIER Glycine 0 N--CA 1.484 1.894 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.27 21.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 CA-C-N 119.286 1.543 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.648 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.3 t -80.86 -49.76 10.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.245 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.543 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 56.4 t-80 -72.43 173.24 9.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.428 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.26 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.571 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.403 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.412 -0.588 . . . . 2.8900000000000001 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 3' ' ' LYS . 69.8 t -94.7 159.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.177 -0.952 . . . . 0.29999999999999999 109.73 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.515 ' HZ2' ' CD1' ' A' ' 5' ' ' ILE . 48.4 tttm -154.1 127.8 8.73 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 1.97 108.991 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -87.55 130.99 34.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.912 . . . . 0.97999999999999998 109.592 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.515 ' CD1' ' HZ2' ' A' ' 3' ' ' LYS . 25.0 mm -114.78 85.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.675 -0.861 . . . . 0.19 108.675 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -95.29 4.43 53.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.979 -1.075 . . . . 1.97 109.551 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 p -150.4 141.48 23.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.23000000000000001 109.889 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -51.57 -31.07 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.823 . . . . 1.8999999999999999 109.49 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -59.88 -43.93 94.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.25 109.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.08 -26.01 63.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.20000000000000001 109.828 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.91 -67.39 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.20999999999999999 110.118 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -53.78 -44.41 70.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 2.4700000000000002 109.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.38 -36.89 76.63 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.269 -0.894 . . . . 2.1000000000000001 109.969 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.36 89.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.20000000000000001 109.484 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -63.77 -45.6 89.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 0.62 110.034 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.19 -41.57 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.048 -1.033 . . . . 1.0900000000000001 109.415 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.42 -13.06 59.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.29999999999999999 109.628 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.09 40.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 0.23999999999999999 109.581 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.11 -113.01 4.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.444 -1.462 . . . . 0.28000000000000003 109.444 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -137.71 2.51 2.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.353 -1.087 . . . . 2.21 109.348 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.0 mttt -69.37 168.08 15.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 1.8999999999999999 108.702 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.581 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.55 165.1 10.58 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.168 -0.958 . . . . 0.17000000000000001 108.452 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.581 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.1 t -145.29 106.31 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.87 -1.144 . . . . 0.12 109.712 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.5 132.25 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.354 -0.841 . . . . 0.089999999999999997 108.996 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.07 136.75 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.619 -0.676 . . . . 0.17000000000000001 109.636 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.37 102.29 11.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.95999999999999996 109.363 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.8 m-85 -85.01 82.48 8.43 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.939 -1.134 . . . . 0.23999999999999999 107.939 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -114.24 150.05 34.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.822 -0.549 . . . . 1.03 109.734 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.0 123.41 35.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.234 -1.024 . . . . 0.26000000000000001 108.234 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -65.37 -23.25 66.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.32000000000000001 110.454 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.0 p-90 -89.1 -11.75 43.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.44 109.899 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -96.97 128.04 43.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.32000000000000001 110.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.29 -56.46 11.92 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.631 -0.668 . . . . 0.35999999999999999 111.601 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.4 Cg_exo -47.2 -35.06 19.16 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.829 1.686 . . . . 0.44 111.438 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -61.26 2.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.926 -1.109 . . . . 0.81000000000000005 108.832 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.51 -16.86 27.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.421 -0.799 . . . . 1.9199999999999999 110.102 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.481 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.84 -28.44 68.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 3.1299999999999999 110.212 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' HG22 ' A' ' 38' ' ' ILE . 43.3 mt -96.76 18.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.232 -0.918 . . . . 0.28000000000000003 110.485 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.09 -32.05 2.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.53 -1.357 . . . . 1.6200000000000001 112.606 179.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -62.69 -3.69 4.8 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.659 0.914 . . . . 0.25 109.994 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.3 m-85 -110.2 -76.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.567 -0.708 . . . . 0.29999999999999999 109.331 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.1 t80 -42.28 -57.2 2.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.433 -0.792 . . . . 0.13 110.715 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -66.82 -30.94 71.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.952 . . . . 0.40999999999999998 109.959 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.0 t -64.28 -40.08 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.804 -1.185 . . . . 0.96999999999999997 109.96 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.8 -16.33 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.054 -1.029 . . . . 0.5 109.437 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 44' ' ' SER . 44.9 m -57.38 -31.42 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.51000000000000001 109.869 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -96.57 -19.34 19.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.159 -0.963 . . . . 2.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -91.14 -23.7 20.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.965 -1.085 . . . . 2.1600000000000001 109.8 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -131.36 66.99 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.579 -0.7 . . . . 0.23999999999999999 109.181 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -66.5 -3.61 6.62 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 0.17000000000000001 108.79 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -95.4 -1.49 50.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 0.34000000000000002 109.319 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.7 t -115.56 149.11 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.058 -0.719 . . . . 0.12 109.058 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.58 128.76 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.17000000000000001 109.324 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.1 m-85 -115.29 132.31 56.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.532 -0.73 . . . . 0.11 109.181 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.08 171.33 7.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.871 -0.789 . . . . 0.12 108.871 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.69 138.38 28.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.066 -1.087 . . . . 1.3100000000000001 108.066 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 27' ' ' PHE . 80.6 t -134.6 138.37 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.211 -0.931 . . . . 0.14000000000000001 110.616 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.99 99.13 9.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.835 -1.172 . . . . 1.0800000000000001 107.835 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.18 -13.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.27000000000000002 111.331 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -100.03 -44.58 5.96 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.894 -1.129 . . . . 1.1100000000000001 111.298 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.6 -10.61 39.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.973 -1.08 . . . . 1.1200000000000001 109.718 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.4 2.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.543 -0.91 . . . . 0.17000000000000001 108.543 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -55.44 -15.43 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.762 . . . . 2.2200000000000002 110.142 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.6 p30 -69.74 -39.53 76.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.032 -1.042 . . . . 1.1100000000000001 108.995 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.05 -46.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.19 108.777 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.48 -31.99 72.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.22 108.846 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.7 m -64.29 -56.23 15.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 1.29 109.219 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 -31.16 72.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 2.2000000000000002 109.351 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.24 -6.81 57.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.33000000000000002 109.296 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' ALA . 27.5 mt-10 45.27 51.6 9.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.383 -0.823 . . . . 2.3399999999999999 110.369 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.49 136.13 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.28000000000000003 109.145 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -130.4 2.34 4.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.442 -0.786 . . . . 2.3999999999999999 109.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.09 126.95 9.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.005 -1.059 . . . . 0.22 109.496 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.583 HG23 ' CE2' ' B' ' 5' ' ' TYR . 72.2 p -111.6 150.54 42.35 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.385 -0.822 . . . . 0.22 108.876 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.61 141.42 64.22 Favored 'Cis proline' 0 N--CA 1.486 1.075 0 C-N-CA 125.03 -0.821 . . . . 0.20000000000000001 110.371 -1.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.67 114.26 26.78 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.129 -1.063 . . . . 0.17999999999999999 108.129 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.6 m-85 -89.61 124.16 34.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.848 -1.157 . . . . 0.14999999999999999 109.093 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.447 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.4 mt-30 -122.4 133.67 54.63 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.915 -1.142 . . . . 1.03 107.915 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 24.3 m-85 -107.88 127.81 54.06 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.665 0.745 . . . . 0.11 110.012 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -126.08 155.37 41.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.923 -1.14 . . . . 0.17000000000000001 107.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.7 tttp -156.25 125.46 6.13 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 56.32 19.22 3.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.573 -0.705 . . . . 1.6699999999999999 109.569 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.39 1.09 69.39 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.309 -1.116 . . . . 0.22 110.309 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.2 mm100 -110.33 148.14 32.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.352 -1.087 . . . . 2.0800000000000001 110.272 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -87.89 145.65 25.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 1.7 109.36 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.17 -25.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 0.26000000000000001 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.1 46.25 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.477 -1.344 . . . . 0.17999999999999999 110.516 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -174.49 154.94 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -1.094 . . . . 2.04 109.967 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.9 p90 -167.76 131.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.14000000000000001 110.455 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -104.53 -170.97 1.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.229 -0.919 . . . . 0.17000000000000001 108.805 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.18 131.96 3.86 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.785 -1.326 . . . . 0.13 109.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.29 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -1.129 . . . . 0.20000000000000001 110.609 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -141.75 66.3 1.35 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.138 -1.06 . . . . 1.1499999999999999 108.138 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.0 ptpt -61.04 -38.58 86.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 1.1899999999999999 110.854 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.23 -28.81 69.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.986 -1.071 . . . . 1.95 109.729 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -70.16 -33.07 71.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.311 -0.868 . . . . 2.0499999999999998 109.592 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.3 mt -50.74 -37.98 44.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.14999999999999999 108.63 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.72 -54.85 16.02 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.935 -0.706 . . . . 2.1499999999999999 109.658 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.71 90.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.14999999999999999 110.542 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.7 m -66.5 -46.92 74.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.163 -0.961 . . . . 0.13 110.486 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 -50.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.17999999999999999 108.975 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -61.62 -17.54 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 1.03 109.544 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -77.05 -58.69 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 2.02 110.207 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.8 mt -91.78 18.57 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.341 -0.849 . . . . 0.34999999999999998 110.46 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.1799999999999999 109.275 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 59.7 mtp180 -140.8 50.81 1.65 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.351 -0.843 . . . . 0.0 108.865 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.482 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.7 m-85 -99.23 164.0 12.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -149.3 -96.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.294 -0.879 . . . . 0.0 109.22 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.583 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.47 -170.19 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.185 -0.947 . . . . 0.0 110.754 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.8 t -63.22 144.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.906 0.86 . . . . 0.0 112.837 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.5 m -101.25 94.64 6.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.512 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.09 45.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 110.672 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.9 -130.66 0.19 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.17 28.02 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 CA-C-N 119.323 1.562 . . . . 0.0 109.201 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.585 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.7 t -96.38 3.42 52.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -163.79 145.64 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.638 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.617 179.825 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.403 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 mmt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.467 -0.568 . . . . 2.8900000000000001 109.467 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.6 t -94.55 172.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.265 -0.897 . . . . 0.29999999999999999 109.315 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.624 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 tttm -153.46 121.57 6.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -0.965 . . . . 1.97 109.224 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -89.79 136.06 33.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.97999999999999998 110.01 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mm -106.98 113.03 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.843 -1.169 . . . . 0.19 107.843 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.12 -11.04 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 1.97 109.561 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -153.29 155.55 36.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.121 -0.987 . . . . 0.23000000000000001 109.777 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.528 ' HG2' HE22 ' A' ' 12' ' ' GLN . 78.9 tttt -52.44 -31.36 34.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 1.8999999999999999 109.806 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -57.93 -44.76 87.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.878 -1.139 . . . . 0.25 109.695 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.09 -23.7 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.20000000000000001 109.715 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -60.37 -68.39 0.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.20999999999999999 110.181 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.528 HE22 ' HG2' ' A' ' 8' ' ' LYS . 1.2 pm0 -54.35 -42.72 70.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 2.4700000000000002 109.279 -179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.82 -38.36 78.47 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.186 -0.946 . . . . 2.1000000000000001 109.974 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -47.72 84.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.20000000000000001 109.362 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.66 -40.83 97.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.344 -0.848 . . . . 0.62 109.416 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.6 -41.42 96.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 1.0900000000000001 109.869 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.09 58.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.29999999999999999 109.945 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 -3.38 9.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.23999999999999999 109.625 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -108.85 2.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.47 . . . . 0.28000000000000003 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -139.7 4.59 2.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.395 -1.062 . . . . 2.21 109.282 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 55.9 mttm -69.95 175.06 4.66 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.124 -0.985 . . . . 1.8999999999999999 109.775 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.69 159.75 31.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.364 -0.976 . . . . 0.17000000000000001 108.364 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.0 t -144.73 107.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.763 -1.211 . . . . 0.12 109.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -105.73 131.6 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.643 -0.873 . . . . 0.089999999999999997 108.643 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 136.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.684 -0.635 . . . . 0.17000000000000001 109.633 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.96 105.8 15.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.109 -0.7 . . . . 0.95999999999999996 109.109 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.62 79.62 8.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.988 -1.116 . . . . 0.23999999999999999 107.988 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -113.78 150.15 33.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.788 -0.57 . . . . 1.03 109.873 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.81 124.77 36.19 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.403 -0.962 . . . . 0.26000000000000001 108.403 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -66.0 -23.88 66.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.32000000000000001 110.367 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.538 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 54.3 p-90 -88.62 -13.95 38.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.44 110.001 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.19 121.62 37.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.32000000000000001 109.665 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.94 -57.15 20.18 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 121.579 -0.701 . . . . 0.35999999999999999 111.372 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.96 -34.3 16.23 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.863 1.709 . . . . 0.44 111.5 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.03 2.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.026 -1.046 . . . . 0.81000000000000005 108.878 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.25 -18.52 49.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.522 -0.736 . . . . 1.9199999999999999 110.233 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.508 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -59.21 -25.3 63.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 3.1299999999999999 110.17 -179.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.7 mt -96.34 11.94 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.069 -1.019 . . . . 0.28000000000000003 110.476 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.62 -32.24 3.54 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 120.407 -1.433 . . . . 1.6200000000000001 112.726 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.25 -3.98 5.82 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.851 0.982 . . . . 0.25 110.318 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -111.96 -75.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.29999999999999999 109.338 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -43.53 -57.03 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.13 110.709 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -67.09 -31.89 72.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.40999999999999998 110.121 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 t -63.45 -39.02 93.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.856 -1.153 . . . . 0.96999999999999997 110.4 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.6 mt -51.11 -12.78 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.019 -1.051 . . . . 0.5 109.646 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.436 ' N ' ' C ' ' A' ' 44' ' ' SER . 49.0 m -57.31 -36.95 71.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.51000000000000001 109.64 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -94.91 -16.75 22.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.119 -0.988 . . . . 2.0 110.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -90.33 -23.45 21.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.945 -1.097 . . . . 2.1600000000000001 109.4 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -134.32 69.61 1.46 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.433 -0.792 . . . . 0.23999999999999999 109.219 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -66.51 -3.14 5.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.257 -0.902 . . . . 0.17000000000000001 108.946 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -95.94 0.74 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.544 -0.723 . . . . 0.34000000000000002 109.669 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.8 t -119.43 151.9 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.486 -0.759 . . . . 0.12 109.301 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 mm -101.6 129.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.402 -0.811 . . . . 0.17000000000000001 109.461 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.1 m-85 -116.95 131.0 57.06 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.441 -0.787 . . . . 0.11 109.147 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -113.04 173.1 6.55 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.905 -0.776 . . . . 0.12 108.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -143.46 143.65 31.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.034 -1.098 . . . . 1.3100000000000001 108.034 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.59 138.19 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.095 -1.003 . . . . 0.14000000000000001 110.731 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -99.69 105.01 16.78 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.176 -1.046 . . . . 1.0800000000000001 108.176 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.19 -12.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.27000000000000002 111.16 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -100.28 -43.04 6.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.004 -1.06 . . . . 1.1100000000000001 110.733 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.32 -10.5 38.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.925 -1.109 . . . . 1.1200000000000001 109.63 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 47.55 2.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.656 -0.868 . . . . 0.17000000000000001 108.656 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -56.17 -15.79 4.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.782 . . . . 2.2200000000000002 110.016 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.5 p-10 -70.15 -40.22 74.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.145 -0.972 . . . . 1.1100000000000001 109.253 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 t -73.56 -47.08 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.42 -35.44 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.22 108.927 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 m -64.07 -45.53 88.33 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 1.29 109.229 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.64 -40.8 97.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 2.2000000000000002 109.28 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.8 58.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.178 -0.951 . . . . 0.33000000000000002 109.713 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.2 mm-40 49.08 55.18 9.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 110.112 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.91 133.56 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.28000000000000003 109.153 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -125.72 2.68 7.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.434 -0.791 . . . . 2.3999999999999999 109.837 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.38 127.72 10.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.984 -1.072 . . . . 0.22 109.309 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.4 p -114.4 150.63 44.12 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -76.21 142.02 72.14 Favored 'Cis proline' 0 N--CA 1.487 1.131 0 C-N-CA 125.005 -0.831 . . . . 0.20000000000000001 110.98 -1.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -114.68 114.69 25.99 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.595 -1.261 . . . . 0.17999999999999999 107.595 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.9 m-85 -91.54 122.06 33.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.895 -1.128 . . . . 0.14999999999999999 108.922 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -120.91 136.19 55.01 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.308 -1.367 . . . . 1.03 107.308 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.7 m-85 -108.22 132.89 53.19 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.636 0.731 . . . . 0.11 110.087 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.8 157.15 41.19 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.725 -0.842 . . . . 0.17000000000000001 108.725 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -156.15 124.94 5.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.647 -1.242 . . . . 1.48 107.647 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 56.22 18.71 3.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 1.6699999999999999 109.68 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.13 -1.11 64.59 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 120.158 -1.02 . . . . 0.22 110.767 179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.0 mm100 -109.7 147.99 32.18 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.091 -1.241 . . . . 2.0800000000000001 110.316 -179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -85.85 139.72 31.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.92 -0.77 . . . . 1.7 108.92 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.3 -6.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.26000000000000001 110.642 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.89 173.72 37.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.398 -1.382 . . . . 0.17999999999999999 110.454 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -173.4 156.29 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -1.07 . . . . 2.04 110.165 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.3 p90 -168.61 132.17 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.503 -0.748 . . . . 0.14000000000000001 110.323 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -102.17 -162.92 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.17000000000000001 109.142 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.52 127.62 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.662 -1.375 . . . . 0.13 109.662 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.4 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.20000000000000001 110.276 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' GLY . 26.3 t-20 -137.19 75.11 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.887 -1.153 . . . . 1.1499999999999999 107.887 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -65.81 -42.26 90.87 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.812 -0.631 . . . . 1.1899999999999999 111.316 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.02 -27.09 68.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.919 -1.113 . . . . 1.95 110.052 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -68.84 -32.44 72.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 2.0499999999999998 109.589 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.3 mt -53.55 -35.83 61.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.809 -1.182 . . . . 0.14999999999999999 108.518 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.42 -54.86 16.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 2.1499999999999999 109.479 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.59 89.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.835 . . . . 0.14999999999999999 110.386 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 m -66.52 -45.09 80.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.13 109.784 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.92 -53.01 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.847 . . . . 0.17999999999999999 109.29 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -60.34 -16.88 39.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 1.03 109.467 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.49 -57.3 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 2.02 110.06 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.61 17.38 10.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.34999999999999998 110.131 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 1.1799999999999999 109.38 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 19.4 p90 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.538 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 14.7 mmm-85 -127.79 68.56 1.32 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.4 m-85 -118.8 150.55 39.63 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -144.87 -104.48 0.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.377 -0.827 . . . . 0.0 109.139 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.8 p90 -113.31 -167.75 1.24 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.271 -0.893 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.21 148.25 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.92 0.867 . . . . 0.0 112.712 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 m -101.3 94.83 6.14 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.502 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -83.54 44.71 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.091 -1.006 . . . . 0.0 110.41 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.0 -132.6 0.09 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.52 23.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 CA-C-N 119.404 1.602 . . . . 0.0 109.278 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.631 ' H ' ' C ' ' B' ' 9' ' ' GLY . 48.3 t -87.18 -43.38 12.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.474 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 1.6 t60 -59.38 147.37 36.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.855 . . . . 0.0 109.617 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.474 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.428 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.432 -0.581 . . . . 2.8900000000000001 109.432 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.5 t -94.38 159.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.161 -0.962 . . . . 0.29999999999999999 109.157 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.5 tttt -155.12 122.87 5.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.037 -1.039 . . . . 1.97 109.438 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -89.59 138.33 31.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.81 . . . . 0.97999999999999998 109.767 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.59 101.48 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -97.92 -6.51 32.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.077 -1.015 . . . . 1.97 109.266 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 p -152.73 152.38 31.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.86 . . . . 0.23000000000000001 109.688 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -52.78 -26.45 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 1.8999999999999999 110.081 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 m -60.11 -46.15 90.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 0.25 109.995 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.8 63.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.20000000000000001 109.809 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.42 -68.45 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.136 -0.977 . . . . 0.20999999999999999 109.96 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -55.09 -44.0 74.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 2.4700000000000002 109.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.09 -36.28 74.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.243 -0.911 . . . . 2.1000000000000001 110.128 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.02 -46.82 87.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.935 -1.103 . . . . 0.20000000000000001 109.728 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.46 -50.22 70.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.334 -0.854 . . . . 0.62 109.952 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.57 -40.68 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 1.0900000000000001 109.817 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -16.45 56.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.29999999999999999 109.607 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.88 -12.39 61.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.23999999999999999 109.643 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 -116.84 4.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.779 -1.328 . . . . 0.28000000000000003 109.779 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 42.3 t0 -135.23 4.16 3.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.46 -1.024 . . . . 2.21 109.466 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -68.68 169.69 10.74 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.999 -1.063 . . . . 1.8999999999999999 108.737 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.15 161.31 19.38 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.905 -1.146 . . . . 0.17000000000000001 107.905 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.442 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.22 104.65 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.979 -1.075 . . . . 0.12 109.637 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.69 127.07 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.736 -0.838 . . . . 0.089999999999999997 108.736 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.45 138.69 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.577 -0.702 . . . . 0.17000000000000001 109.522 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -110.88 104.77 13.42 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.294 -0.632 . . . . 0.95999999999999996 109.294 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 40.0 m-85 -86.28 80.83 8.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.739 -1.208 . . . . 0.23999999999999999 107.739 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -114.36 149.15 36.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.773 -0.579 . . . . 1.03 109.547 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.58 129.01 37.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.921 . . . . 0.26000000000000001 108.667 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -66.94 -24.85 66.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.32000000000000001 110.516 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 52.5 p-90 -87.86 -16.31 34.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.965 -1.084 . . . . 0.44 110.018 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.51 130.79 38.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.32000000000000001 110.231 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.11 -56.36 7.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.556 -0.618 . . . . 0.35999999999999999 111.556 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -47.87 -35.18 23.9 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.587 1.525 . . . . 0.44 111.482 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.61 2.29 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.81000000000000005 109.042 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.93 -18.78 47.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.806 . . . . 1.9199999999999999 109.931 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.7 -16.19 25.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.065 -1.022 . . . . 3.1299999999999999 110.406 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.494 ' O ' HG22 ' A' ' 38' ' ' ILE . 32.2 mt -100.43 8.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.136 -0.978 . . . . 0.28000000000000003 110.292 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.33 -32.94 6.93 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 120.189 -1.569 . . . . 1.6200000000000001 112.002 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -65.24 -3.04 6.68 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 CA-C-N 120.113 1.076 . . . . 0.25 109.693 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.45 -79.12 0.58 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.925 -0.769 . . . . 0.29999999999999999 108.925 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -42.03 -57.02 2.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.581 -0.699 . . . . 0.13 110.806 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.97 -31.05 71.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.932 -1.105 . . . . 0.40999999999999998 110.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -63.89 -39.94 95.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.776 -1.203 . . . . 0.96999999999999997 110.042 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 mt -51.99 -15.9 0.64 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.5 109.781 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -58.6 -31.63 68.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.89 -1.131 . . . . 0.51000000000000001 109.825 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 47' ' ' GLU . 3.3 mp0 -94.45 -20.14 19.96 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.015 -1.053 . . . . 2.0 109.911 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -91.72 -21.15 20.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 2.1600000000000001 109.478 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -135.84 67.1 1.48 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.517 -0.739 . . . . 0.23999999999999999 109.083 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.4 p -66.95 -3.28 6.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.212 -0.93 . . . . 0.17000000000000001 109.207 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 23.9 t-20 -95.19 -0.98 52.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.851 . . . . 0.34000000000000002 109.527 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.2 t -116.28 149.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.941 -0.763 . . . . 0.12 108.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.9 mm -99.4 127.78 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 0.17000000000000001 109.562 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.541 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -114.88 128.96 56.6 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.793 -0.817 . . . . 0.11 108.793 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.29 170.56 8.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.294 -0.879 . . . . 0.12 108.986 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -141.62 141.58 33.43 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.961 -1.126 . . . . 1.3100000000000001 107.961 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.5 t -138.71 136.19 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.14000000000000001 110.389 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.64 105.86 18.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.543 -0.91 . . . . 1.0800000000000001 108.543 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.54 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.0 m -60.91 -7.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.843 . . . . 0.27000000000000002 111.344 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -108.87 -40.46 5.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 1.1100000000000001 111.074 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.88 -18.91 21.48 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.86 -1.15 . . . . 1.1200000000000001 109.318 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.98 47.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.236 -1.024 . . . . 0.17000000000000001 108.236 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 76.2 mt-30 -54.98 -18.1 4.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.631 -0.668 . . . . 2.2200000000000002 110.608 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -37.32 77.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.847 -1.158 . . . . 1.1100000000000001 109.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.5 -47.29 40.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.392 -0.817 . . . . 0.19 108.842 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.78 76.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.305 -0.872 . . . . 0.22 109.189 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -63.71 -52.02 62.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 1.29 109.31 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.74 -31.92 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.84 . . . . 2.2000000000000002 110.069 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.7 -6.73 57.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.138 -0.976 . . . . 0.33000000000000002 110.09 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 46.76 64.99 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.955 . . . . 2.3399999999999999 109.777 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 15.9 t -83.38 136.86 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.351 -0.843 . . . . 0.28000000000000003 108.979 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.97 -8.54 8.32 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.274 -0.891 . . . . 2.3999999999999999 109.715 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.0 130.83 11.67 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.22 109.848 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.724 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.0 p -112.15 151.19 43.46 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.376 -0.972 . . . . 0.22 108.376 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.05 142.04 71.15 Favored 'Cis proline' 0 N--CA 1.483 0.885 0 C-N-CA 124.752 -0.937 . . . . 0.20000000000000001 110.101 -1.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -113.83 114.22 25.98 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.031 -1.1 . . . . 0.17999999999999999 108.031 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -90.84 121.92 33.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.016 -1.053 . . . . 0.14999999999999999 108.659 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.8 mt-30 -121.57 135.89 54.98 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.77 -1.196 . . . . 1.03 107.77 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.5 m-85 -106.7 132.62 52.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.736 . . . . 0.11 110.126 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.55 155.68 38.62 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.313 -0.995 . . . . 0.17000000000000001 108.313 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -155.63 121.39 5.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.3 -1.371 . . . . 1.48 107.3 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.9 mttt 57.44 19.73 5.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.636 -0.665 . . . . 1.6699999999999999 109.551 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 93.99 -1.07 67.46 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.432 -1.067 . . . . 0.22 110.432 179.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.6 mm100 -109.96 147.36 33.61 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.245 -1.15 . . . . 2.0800000000000001 110.35 -179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -86.98 139.07 30.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 1.7 109.4 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.18 -14.87 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.474 -0.766 . . . . 0.26000000000000001 109.976 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.23 171.89 42.85 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.485 -1.34 . . . . 0.17999999999999999 110.409 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -172.83 156.42 3.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -1.043 . . . . 2.04 109.961 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.7 p90 -168.91 133.57 1.53 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.626 -0.83 . . . . 0.14000000000000001 110.466 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -102.75 -172.35 2.11 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.489 -0.93 . . . . 0.17000000000000001 108.489 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.8 5.02 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.222 -1.551 . . . . 0.13 109.222 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.0 94.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -1.169 . . . . 0.20000000000000001 111.053 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -140.25 75.71 1.52 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.815 -1.18 . . . . 1.1499999999999999 107.815 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.502 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.31 -32.93 73.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.523 -0.735 . . . . 1.1899999999999999 110.341 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.64 -25.82 67.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.055 -1.028 . . . . 1.95 108.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -69.19 -38.84 78.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 2.0499999999999998 109.465 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.1 mt -53.66 -38.09 63.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.863 -1.148 . . . . 0.14999999999999999 109.106 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.33 -56.48 12.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 2.1499999999999999 109.506 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.8 94.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.14999999999999999 110.429 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 42.0 m -66.19 -44.85 82.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 0.13 109.807 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.2 mt -58.18 -55.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.065 -1.022 . . . . 0.17999999999999999 108.33 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.55 -16.53 25.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 1.03 109.903 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -76.61 -61.23 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 2.02 110.678 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.6 mt -93.16 15.63 14.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.34999999999999998 111.038 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.232 179.406 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 41.6 t80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.5 mtp180 -144.51 55.61 1.27 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 0.0 109.257 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 3' ' ' PHE . 27.5 m-85 -121.84 157.91 30.07 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.474 -0.767 . . . . 0.0 109.547 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -150.16 -92.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.914 -1.116 . . . . 0.0 110.148 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.724 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.7 p90 -111.6 -166.71 1.1 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.626 -1.296 . . . . 0.0 111.068 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.31 151.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.944 0.878 . . . . 0.0 112.308 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.81 96.12 6.86 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.578 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.35 43.16 0.86 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.012 -1.055 . . . . 0.0 110.098 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.73 -133.07 0.07 OUTLIER Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.13 25.36 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 CA-C-N 119.319 1.56 . . . . 0.0 109.346 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.8 t -84.12 -40.2 18.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.34 -0.85 . . . . 0.0 109.515 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 25.7 t-80 -64.46 -132.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.953 -1.47 . . . . 0.0 109.583 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.313 -0.625 . . . . 2.8900000000000001 109.313 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.5 t -94.72 165.1 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.29999999999999999 109.39 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.9 tttm -155.17 121.32 5.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 1.97 108.972 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.57 135.37 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.853 . . . . 0.97999999999999998 109.534 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 10' ' ' ALA . 13.5 mm -107.99 109.67 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.769 -1.196 . . . . 0.19 107.769 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.28 -7.14 24.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.247 -0.908 . . . . 1.97 110.031 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -153.0 153.81 33.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.047 -1.033 . . . . 0.23000000000000001 109.912 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -52.3 -27.37 14.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.396 -0.815 . . . . 1.8999999999999999 109.471 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -60.42 -47.4 86.25 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.254 -0.903 . . . . 0.25 109.909 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -69.47 -24.31 63.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.20000000000000001 110.139 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.31 -66.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.015 -1.053 . . . . 0.20999999999999999 110.139 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -55.89 -44.93 78.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 2.4700000000000002 109.572 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -58.91 -36.7 75.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.362 -0.836 . . . . 2.1000000000000001 109.9 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.85 84.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.94 -1.1 . . . . 0.20000000000000001 109.194 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.94 -42.1 97.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.464 -0.773 . . . . 0.62 109.713 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.4 -40.97 96.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.136 -0.977 . . . . 1.0900000000000001 109.851 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.65 -16.2 56.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.29999999999999999 109.648 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.57 -5.27 18.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.23999999999999999 109.578 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.11 -116.26 7.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.28000000000000003 109.613 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -133.35 5.34 3.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.414 -1.05 . . . . 2.21 109.235 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 42.6 mttp -70.43 167.72 17.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.186 -0.946 . . . . 1.8999999999999999 108.946 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.03 161.35 16.14 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.894 -1.151 . . . . 0.17000000000000001 107.894 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.649 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -143.93 108.8 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 0.12 109.421 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.39 131.36 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.592 -0.892 . . . . 0.089999999999999997 108.592 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 t -109.06 133.21 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.629 -0.67 . . . . 0.17000000000000001 109.382 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -106.86 105.33 15.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.92 -0.77 . . . . 0.95999999999999996 108.92 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE2' HG11 ' A' ' 57' ' ' VAL . 38.5 m-85 -87.27 80.33 8.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.757 -1.201 . . . . 0.23999999999999999 107.757 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.5 m -113.22 148.52 35.33 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.283 0.563 . . . . 1.03 109.771 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.48 127.07 37.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.407 -0.96 . . . . 0.26000000000000001 108.407 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -66.06 -25.62 67.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.32000000000000001 110.234 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.8 p-90 -89.48 -11.79 41.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.207 -0.933 . . . . 0.44 110.17 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.0 t -95.04 128.11 41.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.32000000000000001 109.931 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.79 -58.96 7.57 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 111.166 -0.774 . . . . 0.35999999999999999 111.166 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.4 Cg_exo -47.22 -31.64 12.74 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 121.897 1.731 . . . . 0.44 111.184 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.4 -61.28 2.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.06 -1.025 . . . . 0.81000000000000005 108.771 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -59.84 -17.58 37.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 1.9199999999999999 110.068 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.474 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.992 -1.068 . . . . 3.1299999999999999 110.137 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.668 ' O ' HG22 ' A' ' 38' ' ' ILE . 88.1 mt -96.07 7.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.28000000000000003 111.276 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.71 -35.58 23.49 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 120.309 -1.494 . . . . 1.6200000000000001 111.895 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -61.26 -5.98 5.98 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 CA-C-N 119.842 0.979 . . . . 0.25 110.839 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.26 -71.99 0.74 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.987 -0.746 . . . . 0.29999999999999999 108.987 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -46.37 -57.47 4.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.601 -0.687 . . . . 0.13 110.536 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.47 -30.68 71.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.199 -0.938 . . . . 0.40999999999999998 109.771 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.438 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.4 m -64.01 -42.1 97.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.979 -1.076 . . . . 0.96999999999999997 109.774 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.7 mt -50.2 -13.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.929 . . . . 0.5 109.365 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 44' ' ' SER . 47.6 m -57.14 -34.52 68.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.51000000000000001 109.647 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.95 -16.9 22.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.273 -0.892 . . . . 2.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -89.59 -41.98 11.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.992 -1.067 . . . . 2.1600000000000001 109.826 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -113.04 70.4 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.424 -0.798 . . . . 0.23999999999999999 109.351 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.7 p -67.14 -5.09 12.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.33 -0.857 . . . . 0.17000000000000001 108.84 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.22 1.22 54.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.778 . . . . 0.34000000000000002 109.657 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.85 151.01 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.785 -0.82 . . . . 0.12 108.785 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mm -100.83 126.51 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.331 -0.855 . . . . 0.17000000000000001 109.042 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' C ' HD12 ' A' ' 55' ' ' LEU . 70.4 m-85 -112.02 129.26 56.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.397 -0.815 . . . . 0.11 108.917 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -113.12 172.2 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.729 -0.841 . . . . 0.12 108.729 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.06 142.07 30.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.824 -1.176 . . . . 1.3100000000000001 107.824 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 98.1 t -139.12 136.6 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.339 -0.851 . . . . 0.14000000000000001 110.176 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -99.0 109.35 22.12 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.922 -1.14 . . . . 1.0800000000000001 107.922 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.3 m -63.74 -12.98 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.315 -0.865 . . . . 0.27000000000000002 111.104 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.9 -40.21 7.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.064 -1.022 . . . . 1.1100000000000001 111.015 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.6 -14.82 26.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.013 -1.055 . . . . 1.1200000000000001 109.289 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.26 44.4 2.81 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.752 -0.833 . . . . 0.17000000000000001 108.752 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.57 -14.53 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 2.2200000000000002 109.942 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.07 -38.12 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.021 -1.05 . . . . 1.1100000000000001 108.891 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -74.56 -46.84 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.513 -0.921 . . . . 0.19 108.513 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.67 -35.09 78.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.356 -0.84 . . . . 0.22 108.928 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.3 m -64.5 -45.34 87.74 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.273 -0.892 . . . . 1.29 109.034 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -63.73 -41.48 98.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.799 . . . . 2.2000000000000002 109.327 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.02 -4.12 58.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.272 -0.893 . . . . 0.33000000000000002 109.365 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.3 mm-40 50.26 55.07 10.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 2.3399999999999999 110.421 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.4 123.27 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.28000000000000003 108.989 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -114.01 5.31 16.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.402 -0.811 . . . . 2.3999999999999999 109.92 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.552 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.57 148.17 27.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.096 -1.003 . . . . 0.22 109.219 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.54 HG23 ' HE2' ' B' ' 5' ' ' TYR . 20.7 p -131.48 149.04 72.42 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.616 -0.883 . . . . 0.22 108.616 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.45 145.77 78.18 Favored 'Cis proline' 0 C--N 1.322 -0.85 0 C-N-CA 124.664 -0.973 . . . . 0.20000000000000001 110.429 -1.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.8 m -115.7 114.92 25.49 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.622 -1.251 . . . . 0.17999999999999999 107.622 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.2 m-85 -91.26 118.58 30.6 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.433 -0.907 . . . . 0.14999999999999999 108.573 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -119.94 135.94 54.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.617 -1.253 . . . . 1.03 107.617 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 100' ' ' THR . 26.8 m-85 -107.3 132.34 53.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.11 109.699 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -125.0 156.22 38.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.617 -0.883 . . . . 0.17000000000000001 108.617 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -156.09 121.19 4.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.783 -1.191 . . . . 1.48 107.783 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt 55.68 34.26 22.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.693 -0.629 . . . . 1.6699999999999999 110.318 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.39 3.27 88.59 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.092 -1.052 . . . . 0.22 110.751 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 79.5 mt-30 -114.01 146.58 39.97 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.349 -1.089 . . . . 2.0800000000000001 110.295 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -86.49 144.4 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.718 -0.845 . . . . 1.7 108.718 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.03 -20.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.381 -0.825 . . . . 0.26000000000000001 110.466 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 174.71 47.18 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.301 -1.428 . . . . 0.17999999999999999 110.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -174.17 156.98 2.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 2.04 110.169 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -168.91 131.88 1.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.528 -0.732 . . . . 0.14000000000000001 109.683 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 p -103.44 -160.27 0.77 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.051 -1.03 . . . . 0.17000000000000001 108.574 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 79.44 122.11 0.36 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.47 -1.452 . . . . 0.13 109.47 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.66 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.122 . . . . 0.20000000000000001 110.601 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.2 t-20 -137.47 71.58 1.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.805 -1.183 . . . . 1.1499999999999999 107.805 178.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -61.62 -39.53 91.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.731 -0.605 . . . . 1.1899999999999999 111.358 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.55 -25.74 67.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.758 -1.214 . . . . 1.95 109.704 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -69.1 -32.65 72.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 2.0499999999999998 109.575 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.6 mt -51.02 -38.85 53.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.14999999999999999 109.131 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.11 -53.22 40.67 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.661 -0.816 . . . . 2.1499999999999999 109.288 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.05 90.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.14999999999999999 110.699 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.448 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.4 m -67.68 -42.94 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.13 110.235 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -61.48 -52.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.17999999999999999 108.691 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' O ' HG12 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -61.26 -17.77 55.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.858 . . . . 1.03 109.561 -179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -76.17 -59.36 2.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 2.02 110.043 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.0 mt -92.64 20.42 6.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.385 -0.822 . . . . 0.34999999999999998 110.429 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.988 -1.006 . . . . 1.1799999999999999 109.178 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 58.9 mtp180 -132.46 57.71 1.78 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.785 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.2 m-85 -111.7 158.94 18.71 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -150.17 -99.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.031 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.54 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -116.1 -173.27 2.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.321 -0.862 . . . . 0.0 110.529 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.11 150.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.992 0.901 . . . . 0.0 112.614 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.32 97.04 7.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -83.47 46.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.98 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.78 -126.51 0.16 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.69 24.51 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 119.2 1.5 . . . . 0.0 109.603 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.619 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.1 t -101.33 3.81 41.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.534 -0.729 . . . . 0.0 110.255 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.443 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 76.1 t60 -141.06 173.95 10.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.429 0 CA-C-O 118.208 -1.329 . . . . 0.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.8 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.427 -0.583 . . . . 2.8900000000000001 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.8 t -94.74 172.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.29999999999999999 109.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.9 tptp -154.24 124.92 7.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.25 -0.906 . . . . 1.97 108.823 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -91.71 134.12 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.97999999999999998 109.923 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mm -110.68 109.11 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.034 -1.099 . . . . 0.19 108.034 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.98 -11.13 19.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.3 -0.875 . . . . 1.97 109.811 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -152.89 154.52 35.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.23000000000000001 109.715 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -51.82 -25.79 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 1.8999999999999999 109.695 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -59.61 -48.61 80.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.25 109.767 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.69 63.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 0.20000000000000001 109.9 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.31 -65.56 0.63 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.124 . . . . 0.20999999999999999 110.011 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -55.51 -46.05 77.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 2.4700000000000002 109.623 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.76 -35.07 72.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 2.1000000000000001 110.027 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.51 90.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.939 -1.101 . . . . 0.20000000000000001 109.735 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.85 -46.59 87.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.62 109.845 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.57 -38.11 89.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 110.089 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.91 -16.52 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.29999999999999999 110.073 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -2.76 8.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 0.23999999999999999 109.925 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -114.79 5.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.28000000000000003 109.555 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -138.42 4.72 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.336 -1.097 . . . . 2.21 109.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.5 mttt -70.1 168.16 16.17 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.204 -0.935 . . . . 1.8999999999999999 108.748 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.62 162.39 13.11 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.81 -1.181 . . . . 0.17000000000000001 107.81 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.1 t -145.03 109.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.771 -1.206 . . . . 0.12 109.628 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.9 t -102.9 135.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.776 -0.824 . . . . 0.089999999999999997 108.776 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -110.35 134.58 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.17000000000000001 109.383 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.17 101.16 10.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.697 -0.627 . . . . 0.95999999999999996 109.459 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -87.41 76.56 9.04 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 0.23999999999999999 107.933 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -113.72 148.77 35.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.772 -0.58 . . . . 1.03 109.474 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.46 125.24 36.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.542 -0.91 . . . . 0.26000000000000001 108.542 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -65.18 -23.42 67.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.32000000000000001 110.573 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.3 p-90 -88.62 -14.76 36.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.053 -1.029 . . . . 0.44 109.976 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.64 118.36 32.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.32000000000000001 109.686 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.55 -58.15 16.08 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.717 -0.754 . . . . 0.35999999999999999 111.435 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -47.52 -34.96 21.08 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.806 1.67 . . . . 0.44 111.23 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.22 -60.98 2.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.924 -1.11 . . . . 0.81000000000000005 109.208 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -58.98 -17.04 21.24 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.595 -0.691 . . . . 1.9199999999999999 110.041 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.505 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -58.45 -19.73 39.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 3.1299999999999999 110.523 -178.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.615 ' O ' HG22 ' A' ' 38' ' ' ILE . 63.5 mt -96.55 7.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.09 -1.006 . . . . 0.28000000000000003 110.813 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.27 5.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 119.953 -1.717 . . . . 1.6200000000000001 112.645 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -65.16 -7.48 15.68 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 CA-C-N 119.555 0.877 . . . . 0.25 110.04 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -109.52 -74.54 0.65 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.845 . . . . 0.29999999999999999 108.976 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -41.66 -56.63 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.649 -0.657 . . . . 0.13 110.931 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -67.0 -31.04 71.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.022 -1.049 . . . . 0.40999999999999998 110.1 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -65.73 -42.57 90.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.839 -1.163 . . . . 0.96999999999999997 110.534 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -50.39 -17.44 0.47 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.985 -1.072 . . . . 0.5 109.99 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -56.8 -27.77 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.51000000000000001 110.051 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -96.1 -22.1 17.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.142 -0.974 . . . . 2.0 110.323 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -90.32 -19.88 23.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 2.1600000000000001 109.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -132.34 72.1 1.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.692 . . . . 0.23999999999999999 109.257 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.2 p -67.87 -5.31 16.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.412 -0.805 . . . . 0.17000000000000001 109.327 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 20.9 t-20 -96.47 -0.77 48.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.75 . . . . 0.34000000000000002 109.61 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 145.96 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.249 -0.907 . . . . 0.12 109.472 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.35 132.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.529 -0.732 . . . . 0.17000000000000001 109.371 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -117.67 130.73 56.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.397 -0.814 . . . . 0.11 109.059 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.2 mp -113.2 172.44 6.94 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.801 -0.814 . . . . 0.12 108.801 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -141.8 143.17 33.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.202 -1.036 . . . . 1.3100000000000001 108.202 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 136.17 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -0.97 . . . . 0.14000000000000001 110.641 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.38 103.13 15.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.448 -0.945 . . . . 1.0800000000000001 108.448 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.485 ' O ' ' NE ' ' B' ' 4' ' ' ARG . 16.1 m -61.19 -8.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.27000000000000002 111.036 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.48 -46.1 5.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.119 -0.988 . . . . 1.1100000000000001 110.856 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -93.12 -14.47 27.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.086 -1.008 . . . . 1.1200000000000001 109.673 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.06 46.18 1.83 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.306 -0.871 . . . . 0.17000000000000001 109.049 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.07 -15.73 2.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 2.2200000000000002 109.66 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.8 p30 -70.12 -41.11 74.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.112 -0.993 . . . . 1.1100000000000001 109.056 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 t -73.55 -46.28 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.949 . . . . 0.19 108.617 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.8 -36.67 83.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.22 108.735 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -64.47 -47.67 78.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.29 109.074 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.09 -34.42 78.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 2.2000000000000002 109.599 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.92 -7.14 54.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.33000000000000002 109.587 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.4 mt-10 51.11 61.12 3.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 2.3399999999999999 110.21 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 35.0 t -78.61 138.07 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.116 -0.99 . . . . 0.28000000000000003 108.996 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -123.03 -9.02 8.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.431 -0.793 . . . . 2.3999999999999999 109.546 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.3 135.6 14.96 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.064 -1.022 . . . . 0.22 109.66 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -114.87 150.6 44.38 Favored Pre-proline 0 N--CA 1.5 2.027 0 N-CA-C 108.117 -1.068 . . . . 0.22 108.117 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.37 146.76 83.57 Favored 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 124.877 -0.885 . . . . 0.20000000000000001 110.205 -1.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.84 121.99 42.19 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.429 -0.952 . . . . 0.17999999999999999 108.429 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CD1' HD21 ' A' ' 97' ' ' LEU . 71.3 m-85 -98.82 115.93 29.9 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.395 -0.965 . . . . 0.14999999999999999 108.395 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.89 141.26 48.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.988 -1.116 . . . . 1.03 107.988 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 25.5 m-85 -111.17 134.54 52.69 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.49 0.662 . . . . 0.11 110.156 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.37 155.12 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.998 -0.741 . . . . 0.17000000000000001 108.998 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -154.58 123.18 6.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.91 -1.145 . . . . 1.48 107.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt 55.74 30.66 16.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 1.6699999999999999 110.064 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.42 90.52 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.791 -1.195 . . . . 0.22 110.621 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -112.83 145.65 40.27 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.248 -1.148 . . . . 2.0800000000000001 110.319 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -86.88 144.8 26.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 1.7 108.75 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.68 -23.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.41 -0.806 . . . . 0.26000000000000001 110.587 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.94 179.34 47.12 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.28 -1.438 . . . . 0.17999999999999999 110.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.26 158.59 2.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -1.126 . . . . 2.04 110.357 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.98 132.14 1.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.476 -0.765 . . . . 0.14000000000000001 110.195 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 p -104.14 -172.95 2.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.191 -0.943 . . . . 0.17000000000000001 108.608 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 130.76 5.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.353 -1.499 . . . . 0.13 109.353 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.27 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -1.211 . . . . 0.20000000000000001 110.477 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -139.88 71.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.815 -1.18 . . . . 1.1499999999999999 107.815 178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.01 -30.51 71.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 1.1899999999999999 110.294 -178.64 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.6 -26.85 67.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.787 -1.196 . . . . 1.95 108.998 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -69.08 -34.14 74.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.486 -0.759 . . . . 2.0499999999999998 109.405 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -50.92 -37.24 42.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.02 -1.05 . . . . 0.14999999999999999 108.82 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.23 -57.17 7.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.395 -0.815 . . . . 2.1499999999999999 109.667 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.02 92.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.14999999999999999 110.509 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.5 m -66.84 -44.2 81.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.13 110.164 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.87 -52.75 55.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.17999999999999999 108.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.1 -16.66 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 1.03 109.977 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.13 -58.28 3.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 2.02 110.484 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.04 14.16 18.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.34999999999999998 110.693 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.494 1.764 0 O-C-N 120.863 -1.148 . . . . 1.1799999999999999 109.199 179.22 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.564 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -138.49 67.32 1.41 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.451 -0.781 . . . . 0.0 109.537 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.8 m-85 -119.68 142.83 48.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.212 -0.93 . . . . 0.0 108.708 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' A' ' 59' ' ' VAL . 13.6 mmm180 -135.84 -109.23 0.21 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.516 -0.74 . . . . 0.0 109.635 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.693 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -109.59 -168.42 1.33 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.274 -0.892 . . . . 0.0 110.525 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.09 146.95 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.717 0.77 . . . . 0.0 112.114 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -101.16 95.45 6.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.1 pt-20 -83.3 42.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.064 -1.023 . . . . 0.0 110.479 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.81 -130.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.81 20.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 CA-C-N 119.139 1.47 . . . . 0.0 109.05 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.653 ' H ' ' C ' ' B' ' 9' ' ' GLY . 0.4 OUTLIER -89.01 -31.14 18.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 48.6 t-80 -155.66 152.26 28.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.567 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.312 0.577 . . . . 2.8900000000000001 109.471 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 3' ' ' LYS . 84.3 t -94.36 164.81 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.29999999999999999 109.117 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.9 tttp -154.99 121.15 5.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.97 109.553 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 31.6 tt0 -89.54 136.51 32.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.97999999999999998 109.579 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -107.04 113.13 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.606 -1.257 . . . . 0.19 107.606 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' OE1' ' NE2' ' A' ' 4' ' ' GLN . 4.1 mm-40 -99.79 -13.32 19.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 1.97 108.933 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 p -154.09 158.78 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.23000000000000001 109.554 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -52.36 -22.97 5.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 1.8999999999999999 110.037 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -60.93 -51.32 69.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.25 110.671 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.26 -22.53 64.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.20000000000000001 110.014 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.1 -64.19 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.20999999999999999 109.791 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -55.75 -46.72 77.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 2.4700000000000002 109.963 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.94 -35.66 71.42 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.196 -0.94 . . . . 2.1000000000000001 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.96 -46.51 90.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.20000000000000001 109.563 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.26 -44.79 94.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 0.62 109.721 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.51 -36.8 85.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 1.0900000000000001 109.727 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.03 -18.84 52.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.29999999999999999 109.776 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -5.94 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.23999999999999999 109.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.68 1.24 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.457 -1.457 . . . . 0.28000000000000003 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -138.13 0.4 2.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 2.21 109.781 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HOH . 19.9 mtmm -69.89 172.21 8.11 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.033 -1.042 . . . . 1.8999999999999999 109.012 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.34 164.42 16.12 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.383 -0.823 . . . . 0.17000000000000001 108.992 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 20.1 t -145.94 105.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.12 109.469 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.7 t -103.67 133.73 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.304 -0.872 . . . . 0.089999999999999997 109.148 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.64 134.07 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.233 -0.654 . . . . 0.17000000000000001 109.233 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -107.87 104.79 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.117 -0.698 . . . . 0.95999999999999996 109.117 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 57.7 m-85 -86.37 82.33 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.736 -1.209 . . . . 0.23999999999999999 107.736 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -113.72 147.82 37.54 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.68 124.2 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.485 -0.931 . . . . 0.26000000000000001 108.485 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -65.51 -24.8 67.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.832 . . . . 0.32000000000000001 110.478 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 49.2 p-90 -88.79 -13.57 39.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.1 . . . . 0.44 109.926 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.7 116.92 29.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.32000000000000001 109.723 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.67 -55.47 30.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.832 -0.699 . . . . 0.35999999999999999 111.742 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.2 Cg_exo -47.86 -35.23 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.6 1.533 . . . . 0.44 111.388 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.57 -60.55 2.32 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.049 -1.032 . . . . 0.81000000000000005 109.194 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.65 -18.07 38.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.748 . . . . 1.9199999999999999 110.052 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.502 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.6 tmt? -58.77 -24.89 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 3.1299999999999999 110.389 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -96.31 13.82 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.873 -1.142 . . . . 0.28000000000000003 110.149 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.72 2.89 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.585 -1.322 . . . . 1.6200000000000001 112.164 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.4 Cg_endo -67.94 7.44 0.6 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 CA-C-N 119.6 0.893 . . . . 0.25 110.526 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' LYS . 45.6 m-85 -124.48 -73.7 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.756 -0.831 . . . . 0.29999999999999999 108.756 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -43.44 -55.76 3.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 0.13 110.266 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.85 -27.33 66.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.40999999999999998 109.869 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 46' ' ' SER . 1.4 p -65.13 -44.92 87.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.96999999999999997 110.068 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.8 mt -49.15 -14.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.5 109.706 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 68.0 m -57.66 -32.14 67.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.993 -1.067 . . . . 0.51000000000000001 109.743 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -94.91 -19.57 20.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.963 . . . . 2.0 110.141 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -91.4 -21.69 20.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.954 -1.091 . . . . 2.1600000000000001 109.584 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -134.2 72.76 1.47 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.502 -0.749 . . . . 0.23999999999999999 109.384 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 p -68.59 -6.9 28.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.383 -0.823 . . . . 0.17000000000000001 109.35 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -96.31 0.92 51.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.352 -0.842 . . . . 0.34000000000000002 109.881 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' C ' HD13 ' A' ' 53' ' ' ILE . 98.6 t -112.76 146.35 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.349 -0.982 . . . . 0.12 108.349 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' C ' ' A' ' 52' ' ' VAL . 4.9 mm -100.42 119.42 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.17000000000000001 109.538 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.571 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -108.77 130.04 55.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.786 -0.82 . . . . 0.11 108.786 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -111.9 172.82 6.67 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -142.12 144.12 33.36 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.053 -1.091 . . . . 1.3100000000000001 108.053 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -141.73 142.53 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.111 -0.993 . . . . 0.14000000000000001 110.858 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 21.4 t70 -99.0 96.47 7.84 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.488 -0.93 . . . . 1.0800000000000001 108.488 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 74' ' ' THR . 10.3 m -56.59 -3.06 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.27000000000000002 110.833 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 37.7 m-20 -105.05 -46.28 4.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.118 -0.989 . . . . 1.1100000000000001 110.991 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.4 OUTLIER -97.04 -23.56 16.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.106 -0.996 . . . . 1.1200000000000001 110.296 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' N ' ' A' ' 64' ' ' ASP . . . -105.32 41.81 1.31 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.12 -0.988 . . . . 0.17000000000000001 108.967 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 35.4 tt0 -54.98 -10.84 0.54 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.397 -0.815 . . . . 2.2200000000000002 109.825 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -68.9 -43.62 74.87 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.14 -0.975 . . . . 1.1100000000000001 108.768 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.34 -45.71 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.302 -0.999 . . . . 0.19 108.302 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.79 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 6.6 m -64.0 -54.01 41.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 1.29 109.304 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.2 -33.41 75.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.476 -0.765 . . . . 2.2000000000000002 110.019 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.37 1.2 54.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.069 -1.019 . . . . 0.33000000000000002 109.859 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 67' ' ' SER . 15.0 mp0 45.0 50.46 9.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.278 -0.889 . . . . 2.3399999999999999 110.243 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.34 130.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.28000000000000003 108.91 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.12 7.61 5.07 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.396 -0.815 . . . . 2.3999999999999999 110.024 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.63 134.27 14.58 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.161 -0.962 . . . . 0.22 108.93 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.574 HG23 ' HE1' ' B' ' 5' ' ' TYR . 23.5 p -119.78 150.24 50.07 Favored Pre-proline 0 N--CA 1.508 2.441 0 O-C-N 121.227 -0.921 . . . . 0.22 108.925 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -76.88 145.22 80.86 Favored 'Cis proline' 0 N--CA 1.486 1.057 0 C-N-CA 124.893 -0.878 . . . . 0.20000000000000001 110.758 -2.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.81 122.03 45.09 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.7 -1.222 . . . . 0.17999999999999999 107.7 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.5 m-85 -99.26 121.08 40.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.14999999999999999 108.822 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.515 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.1 mt-30 -119.62 135.74 54.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.894 -1.15 . . . . 1.03 107.894 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.7 m-85 -109.93 126.57 54.03 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.461 0.648 . . . . 0.11 109.764 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -126.06 156.93 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.601 -0.888 . . . . 0.17000000000000001 108.601 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.55 126.09 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.786 -1.19 . . . . 1.48 107.786 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 55.05 25.27 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 1.6699999999999999 109.951 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.15 6.51 84.48 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.909 -1.138 . . . . 0.22 110.347 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.28 146.78 40.01 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -1.076 . . . . 2.0800000000000001 109.956 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -85.91 143.88 27.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.7 109.529 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.78 -27.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.423 -0.798 . . . . 0.26000000000000001 110.315 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.43 177.99 45.57 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.388 -1.387 . . . . 0.17999999999999999 110.415 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -174.08 154.14 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 2.04 110.299 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.0 p90 -169.05 133.11 1.41 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.516 -0.74 . . . . 0.14000000000000001 109.982 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -105.51 -175.03 2.68 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.136 -0.978 . . . . 0.17000000000000001 108.44 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 98.1 133.83 8.11 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.622 -1.391 . . . . 0.13 109.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.24 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.20000000000000001 110.136 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.2 t-20 -139.89 72.45 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.466 -0.939 . . . . 1.1499999999999999 108.466 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.54 -0.725 . . . . 1.1899999999999999 110.781 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -64.76 -26.6 68.42 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -68.82 -35.46 77.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.435 -0.79 . . . . 2.0499999999999998 109.17 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.4 mt -51.13 -36.11 39.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.017 . . . . 0.14999999999999999 108.906 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.96 -58.5 5.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 2.1499999999999999 109.34 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.26 90.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.14999999999999999 110.327 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -67.61 -48.11 67.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -0.965 . . . . 0.13 110.31 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mt -62.46 -50.11 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.024 -1.048 . . . . 0.17999999999999999 108.785 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -59.41 -17.27 29.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.03 109.538 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.06 -62.16 1.74 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 2.02 110.009 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.21 21.17 5.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.34999999999999998 110.494 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.236 179.585 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.2 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.57 ' CG ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -118.89 83.36 2.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.509 -0.744 . . . . 0.0 109.214 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.8 m-85 -133.03 146.8 52.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.272 -0.892 . . . . 0.0 109.079 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.432 ' HG2' HH11 ' B' ' 4' ' ' ARG . 1.1 tpt180 -147.05 -104.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 109.329 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -108.97 -164.89 0.97 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.757 -1.214 . . . . 0.0 110.821 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.86 149.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.247 -0.908 . . . . 0.0 112.839 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.71 95.53 6.49 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.407 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 7.3 pt-20 -84.01 42.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.024 -1.047 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.08 -133.93 0.05 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.29 21.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.322 -0.841 0 CA-C-N 119.154 1.477 . . . . 0.0 109.649 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -91.87 -21.02 20.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.411 -0.806 . . . . 0.0 109.413 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.609 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.8 OUTLIER -62.42 -159.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.629 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.609 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.573 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.42 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.292 0.568 . . . . 2.8900000000000001 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 72.5 t -94.6 153.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.24 -0.913 . . . . 0.29999999999999999 109.131 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -154.6 122.58 5.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 1.97 109.351 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -89.23 135.97 33.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.325 -0.859 . . . . 0.97999999999999998 109.447 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -106.03 123.16 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 8.9 mp0 -107.92 -15.2 14.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.25 -0.906 . . . . 1.97 109.627 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.8 p -152.16 159.23 43.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.23000000000000001 109.695 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.32 -30.86 30.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 1.8999999999999999 109.861 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -59.53 -44.25 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.078 . . . . 0.25 109.679 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.19 -27.23 64.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.20000000000000001 109.775 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.49 -69.0 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.20999999999999999 110.216 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -55.27 -42.04 73.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 2.4700000000000002 109.61 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -58.99 -36.89 75.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.14 -0.975 . . . . 2.1000000000000001 109.474 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.34 95.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.20000000000000001 109.088 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 13.6 mt -64.6 -47.8 77.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.458 -0.776 . . . . 0.62 109.734 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.04 -37.77 88.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 1.0900000000000001 109.701 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.52 -16.53 54.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.29999999999999999 109.616 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.07 -7.39 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.23999999999999999 109.844 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 -111.01 3.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.535 -1.426 . . . . 0.28000000000000003 109.535 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.64 4.72 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.254 -1.145 . . . . 2.21 109.436 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -70.05 168.02 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 1.8999999999999999 109.193 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.34 163.59 12.8 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.045 -1.094 . . . . 0.17000000000000001 108.045 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.2 t -145.26 105.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.016 -1.052 . . . . 0.12 109.797 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.18 133.42 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.284 -1.006 . . . . 0.089999999999999997 108.284 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -110.53 134.58 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.17000000000000001 109.827 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.75 101.36 10.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.08 -0.711 . . . . 0.95999999999999996 109.08 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 57' ' ' VAL . 43.5 m-85 -86.14 79.23 9.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.566 -1.272 . . . . 0.23999999999999999 107.566 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -113.44 148.61 35.57 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.415 0.626 . . . . 1.03 109.748 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.66 124.23 34.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.131 -1.063 . . . . 0.26000000000000001 108.131 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -64.97 -23.11 67.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 0.32000000000000001 110.484 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 56.3 p-90 -89.84 -13.29 36.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.013 -1.054 . . . . 0.44 110.405 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.88 137.78 32.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.32000000000000001 109.886 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.16 -59.15 3.19 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.739 -0.744 . . . . 0.35999999999999999 111.355 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -46.1 -43.41 20.53 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.77 1.647 . . . . 0.44 111.766 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.84 -55.19 6.07 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.728 -1.232 . . . . 0.81000000000000005 109.048 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -60.45 -20.66 60.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.413 -0.804 . . . . 1.9199999999999999 110.225 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLY . 35.6 tpp -59.82 -20.5 57.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 3.1299999999999999 110.557 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.709 ' O ' HG22 ' A' ' 38' ' ' ILE . 81.8 mt -97.53 11.18 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.992 -1.067 . . . . 0.28000000000000003 111.686 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.78 -34.08 9.83 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.02 -1.675 . . . . 1.6200000000000001 112.63 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.52 -11.86 25.24 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 CA-C-N 119.742 0.944 . . . . 0.25 110.803 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -102.76 -68.29 0.84 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.248 -0.908 . . . . 0.29999999999999999 109.693 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -45.42 -51.31 11.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.422 -0.799 . . . . 0.13 110.556 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.83 -34.7 75.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.937 -1.102 . . . . 0.40999999999999998 110.111 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 -41.14 94.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.96999999999999997 110.153 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.0 mt -51.4 -15.6 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.5 109.692 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.412 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 69.2 m -58.15 -31.7 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.51000000000000001 109.902 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -94.84 -20.76 19.18 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.273 -0.892 . . . . 2.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -90.34 -21.52 21.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 2.1600000000000001 109.341 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -133.71 68.54 1.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.577 -0.702 . . . . 0.23999999999999999 109.375 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.3 p -67.45 -5.54 15.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.17000000000000001 108.915 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.405 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 24.1 t-20 -95.84 4.0 53.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.34000000000000002 109.646 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -118.76 149.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.212 -0.662 . . . . 0.12 109.212 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -101.94 128.56 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.421 -0.8 . . . . 0.17000000000000001 109.223 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.4 m-85 -115.03 132.01 56.74 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.438 -0.788 . . . . 0.11 109.176 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.95 173.89 6.26 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.474 -0.766 . . . . 0.12 109.197 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -143.83 144.89 31.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.021 -1.103 . . . . 1.3100000000000001 108.021 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 27' ' ' PHE . 69.7 t -141.6 139.63 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.141 -0.975 . . . . 0.14000000000000001 110.521 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.21 100.44 11.55 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.204 -1.035 . . . . 1.0800000000000001 108.204 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -60.67 -1.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.275 -0.891 . . . . 0.27000000000000002 111.482 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.68 -41.23 3.64 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.13 -0.981 . . . . 1.1100000000000001 111.002 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.0 -13.14 29.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.025 -1.047 . . . . 1.1200000000000001 109.581 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 50.45 1.79 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.17000000000000001 108.586 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -54.93 -15.23 1.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.522 -0.736 . . . . 2.2200000000000002 109.701 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.62 -39.88 73.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.992 . . . . 1.1100000000000001 109.364 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.75 -47.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.16 -0.963 . . . . 0.19 108.676 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.46 -36.21 83.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.22 109.288 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -63.35 -44.87 93.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 1.29 108.968 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.59 -44.06 95.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.712 -0.847 . . . . 2.2000000000000002 108.712 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 70' ' ' GLU . . . -89.06 10.45 21.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.33000000000000002 109.519 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 66' ' ' ALA . 5.2 pt-20 31.73 56.06 0.3 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.409 0.623 . . . . 2.3399999999999999 111.362 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 t -79.67 134.32 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.28000000000000003 109.037 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 62.7 mttm -129.66 8.7 5.39 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.47 -0.769 . . . . 2.3999999999999999 109.861 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.45 135.11 15.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.133 -0.98 . . . . 0.22 108.902 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.519 HG23 ' CE2' ' B' ' 5' ' ' TYR . 70.6 p -121.03 149.53 51.38 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.835 . . . . 0.22 109.172 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.51 144.17 74.09 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 C-N-CA 124.962 -0.849 . . . . 0.20000000000000001 110.197 -1.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.27 113.22 24.31 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.387 -1.338 . . . . 0.17999999999999999 107.387 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.1 m-85 -89.68 119.92 30.51 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.215 -0.994 . . . . 0.14999999999999999 108.734 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -118.92 136.08 54.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.925 -1.139 . . . . 1.03 107.925 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.2 m-85 -110.14 127.0 54.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.381 0.61 . . . . 0.11 109.568 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.98 157.54 35.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.752 -0.833 . . . . 0.17000000000000001 108.752 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -154.8 123.66 6.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 57.09 27.65 13.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 1.6699999999999999 110.078 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.8 87.94 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.025 -1.083 . . . . 0.22 110.427 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -112.98 146.46 39.02 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.357 -1.084 . . . . 2.0800000000000001 110.282 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -85.61 139.52 31.35 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.766 -0.828 . . . . 1.7 108.766 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.61 -21.46 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.474 -0.766 . . . . 0.26000000000000001 110.195 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.94 176.12 47.77 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.498 -1.334 . . . . 0.17999999999999999 110.397 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.51 159.01 3.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -1.072 . . . . 2.04 110.336 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.4 p90 -169.0 130.84 1.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.466 -0.772 . . . . 0.14000000000000001 109.811 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 p -103.27 -163.73 1.01 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.07 -1.018 . . . . 0.17000000000000001 108.538 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 127.04 1.03 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.19 -1.564 . . . . 0.13 109.19 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.497 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.53 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -1.16 . . . . 0.20000000000000001 110.726 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -137.71 73.77 1.45 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.032 -1.099 . . . . 1.1499999999999999 108.032 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -35.82 80.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.878 -0.514 . . . . 1.1899999999999999 110.895 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.52 -27.09 68.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.97 -1.081 . . . . 1.95 109.507 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -69.65 -33.7 72.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 2.0499999999999998 109.759 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.8 mt -49.82 -36.08 25.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.067 -1.021 . . . . 0.14999999999999999 109.071 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.35 -58.24 5.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.482 -0.761 . . . . 2.1499999999999999 110.025 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.25 77.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.405 -0.809 . . . . 0.14999999999999999 111.273 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.458 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.9 m -67.47 -46.76 72.06 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.859 -1.151 . . . . 0.13 110.758 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.25 -52.19 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.17999999999999999 109.46 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -59.71 -17.88 38.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 1.03 109.745 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.4 -59.65 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 2.02 110.516 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt -92.93 17.37 10.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.34999999999999998 110.561 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.085 . . . . 1.1799999999999999 109.31 179.296 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.413 0.625 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.566 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 3.8 mtt-85 -151.02 88.85 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.548 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.8 m-85 -134.56 113.29 11.62 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.244 -0.91 . . . . 0.0 109.186 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.591 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -111.97 -81.05 0.59 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -130.44 -168.62 2.0 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.8 148.25 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.007 0.908 . . . . 0.0 112.809 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.36 95.08 6.27 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.46 46.44 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.921 -1.112 . . . . 0.0 110.217 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.01 -130.69 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.06 20.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 CA-C-N 119.322 1.561 . . . . 0.0 109.009 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.1 t -81.1 -51.97 7.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -0.819 . . . . 0.0 109.506 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.457 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 4.6 t60 -81.16 155.95 25.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.457 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.014 -1.436 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 mtt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.239 0.542 . . . . 2.8900000000000001 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 39.8 t -94.39 164.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.29999999999999999 108.934 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.3 tttt -154.28 123.54 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.019 -1.051 . . . . 1.97 109.468 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -90.65 134.4 34.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.835 . . . . 0.97999999999999998 110.087 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.99 114.11 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.724 -1.213 . . . . 0.19 107.724 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.08 -13.68 18.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.962 . . . . 1.97 109.724 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 p -153.72 158.76 41.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.114 -0.991 . . . . 0.23000000000000001 109.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -52.1 -21.36 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.722 . . . . 1.8999999999999999 109.663 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 21.1 m -61.73 -56.08 23.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.25 110.116 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.3 -18.06 64.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.20000000000000001 110.262 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.93 -60.85 3.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.068 . . . . 0.20999999999999999 110.523 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -60.96 -44.35 97.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.016 . . . . 2.4700000000000002 109.638 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -60.77 -32.58 71.9 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.471 -0.768 . . . . 2.1000000000000001 110.389 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.34 85.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.853 -1.155 . . . . 0.20000000000000001 109.121 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.09 -43.55 95.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.62 109.367 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.71 -40.07 94.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 1.0900000000000001 109.806 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.71 -17.19 54.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.29999999999999999 109.85 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.61 26.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.23999999999999999 109.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.46 18.22 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.365 -1.494 . . . . 0.28000000000000003 109.365 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.18 2.68 8.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.553 -0.969 . . . . 2.21 109.627 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.7 mttt -69.35 167.05 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.013 -1.054 . . . . 1.8999999999999999 108.739 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.96 164.29 8.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.196 -1.038 . . . . 0.17000000000000001 108.196 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.7 t -146.05 106.84 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.957 -1.089 . . . . 0.12 109.525 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.49 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.644 -0.873 . . . . 0.089999999999999997 108.644 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.15 139.13 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.626 -0.671 . . . . 0.17000000000000001 109.821 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.58 99.63 8.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.632 -0.668 . . . . 0.95999999999999996 109.248 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -85.41 80.59 9.06 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.898 -1.149 . . . . 0.23999999999999999 107.898 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -106.48 -163.6 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 1.03 109.633 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.35 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.573 -0.899 . . . . 0.26000000000000001 108.573 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -64.43 -26.92 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.32000000000000001 110.77 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.3 p-90 -88.39 -16.54 32.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.979 -1.076 . . . . 0.44 110.009 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.25 120.12 35.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 0.32000000000000001 109.809 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.03 -52.98 36.58 Favored Glycine 0 N--CA 1.486 1.992 0 O-C-N 121.519 -0.738 . . . . 0.35999999999999999 111.548 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.3 Cg_exo -49.21 -37.04 38.49 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.664 1.576 . . . . 0.44 111.386 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.68 1.04 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.884 -1.135 . . . . 0.81000000000000005 108.993 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.12 -15.04 20.11 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.517 -0.74 . . . . 1.9199999999999999 110.332 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 tpt -59.94 -21.51 61.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 3.1299999999999999 109.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.555 ' O ' HG22 ' A' ' 38' ' ' ILE . 50.1 mt -96.93 15.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 110.44 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.53 -31.26 2.93 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.687 -1.258 . . . . 1.6200000000000001 112.153 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.74 -5.52 10.58 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 CA-C-N 119.798 0.963 . . . . 0.25 109.799 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 39.1 m-85 -109.72 -78.42 0.59 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.832 -0.803 . . . . 0.29999999999999999 108.832 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 94.0 t80 -40.46 -58.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.73 -0.606 . . . . 0.13 111.083 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.53 -30.9 71.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.03 . . . . 0.40999999999999998 109.939 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.8 t -65.47 -40.48 93.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.91 -1.119 . . . . 0.96999999999999997 110.28 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.6 mt -50.24 -15.93 0.28 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.99 -1.069 . . . . 0.5 109.713 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -57.29 -29.48 63.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.065 -1.022 . . . . 0.51000000000000001 109.917 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.73 -21.04 17.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.0 110.226 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -90.98 -22.19 20.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.994 -1.066 . . . . 2.1600000000000001 109.747 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -133.54 69.78 1.47 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.511 -0.743 . . . . 0.23999999999999999 109.275 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -67.85 -5.95 19.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.465 -0.772 . . . . 0.17000000000000001 109.243 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -94.49 3.78 54.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.34000000000000002 109.457 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.5 t -121.11 145.38 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.701 -0.852 . . . . 0.12 108.701 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -97.86 129.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.242 -0.911 . . . . 0.17000000000000001 109.422 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -114.73 130.93 56.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.315 -0.866 . . . . 0.11 109.423 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.61 172.83 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.959 -0.756 . . . . 0.12 108.959 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.89 142.2 30.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.992 -1.114 . . . . 1.3100000000000001 107.992 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.4 t -142.2 136.69 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.121 -0.987 . . . . 0.14000000000000001 110.774 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 24.0 t70 -96.99 111.45 23.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.996 -1.113 . . . . 1.0800000000000001 107.996 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 108' ' ' HOH . 16.8 m -65.33 -12.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.27000000000000002 110.749 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 10.6 m-20 -97.85 -44.41 6.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.013 -1.055 . . . . 1.1100000000000001 111.021 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -91.93 -15.35 28.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 1.1200000000000001 109.459 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -117.24 43.05 2.41 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.632 -0.877 . . . . 0.17000000000000001 108.632 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.14 -15.35 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.415 -0.803 . . . . 2.2200000000000002 109.762 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -40.22 74.35 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.256 -0.903 . . . . 1.1100000000000001 109.002 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.26 -45.77 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.679 -0.86 . . . . 0.19 108.679 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.28 -32.52 73.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.22 108.956 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -64.03 -48.94 74.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 1.29 109.271 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.08 -38.5 91.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.321 -0.862 . . . . 2.2000000000000002 109.535 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.53 58.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.212 -0.93 . . . . 0.33000000000000002 109.697 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.2 mt-10 46.66 57.74 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 2.3399999999999999 110.284 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.07 132.28 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.28000000000000003 108.916 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.37 2.0 8.41 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.402 -0.811 . . . . 2.3999999999999999 110.244 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.79 131.33 13.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.968 -1.083 . . . . 0.22 109.061 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 46.9 p -116.56 149.72 44.31 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.48 -0.762 . . . . 0.22 109.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.61 145.91 80.78 Favored 'Cis proline' 0 N--CA 1.487 1.091 0 C-N-CA 124.934 -0.861 . . . . 0.20000000000000001 110.071 -1.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.96 113.42 23.24 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.713 -1.217 . . . . 0.17999999999999999 107.713 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -87.56 126.78 35.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.881 -1.137 . . . . 0.14999999999999999 108.939 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -124.33 133.82 53.34 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.702 -1.221 . . . . 1.03 107.702 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' CD2' HG22 ' A' ' 24' ' ' VAL . 25.3 m-85 -108.22 127.66 54.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.11 109.619 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -125.69 156.66 38.96 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.714 -0.847 . . . . 0.17000000000000001 108.714 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -153.86 124.97 7.36 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.558 -1.275 . . . . 1.48 107.558 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.7 mttt 56.64 20.15 4.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.569 -0.707 . . . . 1.6699999999999999 109.884 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.38 2.51 70.46 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.319 -1.112 . . . . 0.22 110.319 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -110.35 148.12 32.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.258 -1.143 . . . . 2.0800000000000001 110.057 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -85.01 140.43 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.827 . . . . 1.7 109.274 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.98 -3.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.461 -0.775 . . . . 0.26000000000000001 110.176 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.81 170.74 30.17 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.491 -1.338 . . . . 0.17999999999999999 110.63 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.511 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.08 155.52 3.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -1.065 . . . . 2.04 110.134 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.6 p90 -168.58 131.7 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.14000000000000001 110.439 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.9 p -101.55 -165.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.134 -0.979 . . . . 0.17000000000000001 108.875 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.13 131.49 2.85 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.143 -1.583 . . . . 0.13 109.143 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -61.13 96.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -1.166 . . . . 0.20000000000000001 110.837 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -143.06 77.6 1.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.372 -0.973 . . . . 1.1499999999999999 108.372 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.78 -33.59 76.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.381 -0.825 . . . . 1.1899999999999999 110.65 -178.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.38 -26.15 67.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.891 -1.131 . . . . 1.95 109.179 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -68.38 -36.49 79.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.81 . . . . 2.0499999999999998 109.257 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.5 mt -52.39 -37.04 55.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.14999999999999999 108.775 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.85 -58.92 4.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 2.1499999999999999 109.76 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.54 89.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.14999999999999999 110.865 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 m -66.58 -46.85 74.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.087 -1.008 . . . . 0.13 110.467 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.1 -51.95 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.17999999999999999 108.853 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -61.18 -16.47 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 1.03 109.688 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.57 -56.2 4.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 2.02 110.342 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 22' ' ' LEU . 22.4 mt -92.84 13.24 21.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.34999999999999998 110.527 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.942 -1.098 . . . . 1.1799999999999999 109.394 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.5 mtt-85 -140.86 57.15 1.56 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.262 -0.898 . . . . 0.0 109.165 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.41 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.5 m-85 -97.62 159.74 14.74 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.965 -1.084 . . . . 0.0 109.339 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.69 -97.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.332 -0.855 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -128.2 -166.81 1.67 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.293 -0.879 . . . . 0.0 110.55 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.9 143.18 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.375 -0.828 . . . . 0.0 112.633 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.78 94.76 6.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.16 46.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 110.134 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.08 -133.83 0.15 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.95 27.73 0.15 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 CA-C-N 119.325 1.563 . . . . 0.0 109.049 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -89.5 -17.1 29.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 20.1 t60 -168.35 176.9 5.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.609 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.989 -1.45 . . . . 0.0 109.512 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.428 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.435 -0.58 . . . . 2.8900000000000001 109.435 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 3' ' ' LYS . 91.9 t -94.53 158.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.354 -0.841 . . . . 0.29999999999999999 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.4 tttm -154.56 125.48 7.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 1.97 109.079 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.39 130.66 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.97999999999999998 109.994 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mm -106.08 112.87 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.768 -1.197 . . . . 0.19 107.768 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.42 -15.12 18.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.139 -0.975 . . . . 1.97 109.641 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 p -154.12 159.87 41.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.23000000000000001 109.698 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 26.7 tttp -51.57 -22.7 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 1.8999999999999999 109.293 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -60.38 -52.37 65.51 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.895 . . . . 0.25 109.869 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -22.7 63.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.20000000000000001 109.889 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.49 -65.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.20999999999999999 109.708 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -55.04 -45.62 75.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.951 . . . . 2.4700000000000002 109.727 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.62 -36.22 73.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.303 -0.873 . . . . 2.1000000000000001 109.973 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.49 86.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 0.20000000000000001 109.409 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.04 -46.85 79.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.738 . . . . 0.62 110.02 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.82 -41.2 97.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 110.067 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.88 -17.21 53.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.29999999999999999 109.646 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -6.7 27.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.23999999999999999 109.566 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 -133.47 24.73 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.434 -1.466 . . . . 0.28000000000000003 109.434 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.74 6.11 13.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.363 -1.081 . . . . 2.21 109.6 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.66 166.82 19.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.062 -1.024 . . . . 1.8999999999999999 109.252 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.38 160.71 15.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 0.17000000000000001 108.494 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.619 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.6 t -144.61 109.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.994 . . . . 0.12 109.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.32 133.85 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.665 -0.865 . . . . 0.089999999999999997 108.665 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.45 141.95 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.431 -0.793 . . . . 0.17000000000000001 109.869 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -111.41 99.89 8.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.924 -0.769 . . . . 0.95999999999999996 108.924 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.58 80.04 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.903 -1.147 . . . . 0.23999999999999999 107.903 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -113.3 150.01 33.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.79 -0.569 . . . . 1.03 109.718 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.39 126.4 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.568 -0.901 . . . . 0.26000000000000001 108.568 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -65.98 -25.89 67.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32000000000000001 110.662 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.5 p-90 -87.7 -10.7 50.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.44 109.942 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -97.51 127.52 43.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.477 -0.764 . . . . 0.32000000000000001 109.591 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.94 -55.83 10.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.145 -0.782 . . . . 0.35999999999999999 111.145 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.78 -39.64 38.85 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.912 1.742 . . . . 0.44 111.605 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -61.84 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.675 -1.266 . . . . 0.81000000000000005 109.243 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -58.98 -20.12 49.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.261 -0.899 . . . . 1.9199999999999999 109.82 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.7 ttt -60.37 -18.33 49.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 3.1299999999999999 110.249 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.473 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -99.64 8.02 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 110.26 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.75 -31.96 5.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.648 -1.283 . . . . 1.6200000000000001 112.453 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.1 Cg_exo -62.03 -7.71 10.37 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.757 0.949 . . . . 0.25 109.81 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -106.28 -74.49 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.032 -0.729 . . . . 0.29999999999999999 109.032 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -44.49 -56.08 4.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.754 . . . . 0.13 110.792 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.75 -32.04 73.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.113 -0.992 . . . . 0.40999999999999998 109.877 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 t -64.96 -41.45 95.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.96999999999999997 110.049 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.99 -14.64 0.23 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.5 109.81 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -56.61 -32.37 65.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.038 -1.039 . . . . 0.51000000000000001 109.926 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -95.09 -17.12 22.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 2.0 110.368 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -91.0 -23.51 20.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.123 -0.986 . . . . 2.1600000000000001 109.187 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.5 66.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.556 -0.715 . . . . 0.23999999999999999 109.245 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -66.68 -1.91 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.339 -0.851 . . . . 0.17000000000000001 109.0 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.494 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 34.1 t-20 -94.94 -7.38 40.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.424 -0.797 . . . . 0.34000000000000002 109.124 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.4 t -112.65 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.418 -0.801 . . . . 0.12 109.026 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -100.37 125.48 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.052 -0.721 . . . . 0.17000000000000001 109.052 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.585 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.6 m-85 -109.09 132.57 53.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.11 108.996 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -113.11 169.56 8.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.679 -0.86 . . . . 0.12 108.679 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.01 143.32 34.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.729 -1.212 . . . . 1.3100000000000001 107.729 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.8 t -141.38 138.01 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.14000000000000001 111.045 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.81 96.92 8.9 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.049 -1.093 . . . . 1.0800000000000001 108.049 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 m -54.63 -8.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.27000000000000002 111.464 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.46 -44.07 5.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 110.672 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.91 -9.09 41.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.167 -0.958 . . . . 1.1200000000000001 109.323 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.15 43.3 3.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.708 -0.849 . . . . 0.17000000000000001 108.708 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.92 -15.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.802 . . . . 2.2200000000000002 109.669 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.19 -39.86 74.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 1.1100000000000001 108.913 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.7 t -74.42 -46.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.19 108.51 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.96 75.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.868 . . . . 0.22 108.96 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -64.29 -47.91 77.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.405 -0.81 . . . . 1.29 109.065 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.53 -36.9 85.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 2.2000000000000002 109.811 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.36 59.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.156 -0.965 . . . . 0.33000000000000002 110.166 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 49.57 55.81 8.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.05 -1.031 . . . . 2.3399999999999999 109.813 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.5 137.51 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.28000000000000003 109.638 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -128.8 -4.94 5.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 2.3999999999999999 109.465 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.562 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.64 136.39 15.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.968 -1.082 . . . . 0.22 110.006 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.606 HG23 ' CE2' ' B' ' 5' ' ' TYR . 48.3 p -115.58 150.35 44.55 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.362 -0.836 . . . . 0.22 108.747 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.66 143.16 73.38 Favored 'Cis proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.842 -0.899 . . . . 0.20000000000000001 110.13 -2.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.27 115.5 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.13 -1.063 . . . . 0.17999999999999999 108.13 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.495 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.7 m-85 -91.45 115.42 28.02 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.378 -0.929 . . . . 0.14999999999999999 108.568 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.23 136.33 53.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.559 -1.274 . . . . 1.03 107.559 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 100' ' ' THR . 27.9 m-85 -107.75 127.38 53.64 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.596 0.713 . . . . 0.11 109.978 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.17 156.97 31.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.376 -0.972 . . . . 0.17000000000000001 108.376 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -155.97 123.52 5.53 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.501 -1.296 . . . . 1.48 107.501 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.1 mttm 57.89 16.54 3.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.495 -0.753 . . . . 1.6699999999999999 109.544 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.82 -1.87 61.68 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.424 -1.07 . . . . 0.22 110.424 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -110.04 149.91 29.31 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.154 -1.203 . . . . 2.0800000000000001 110.435 -179.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -85.58 143.72 28.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.685 . . . . 1.7 109.456 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.27 -21.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.575 -0.703 . . . . 0.26000000000000001 110.222 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.94 175.0 45.98 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.652 -1.261 . . . . 0.17999999999999999 110.003 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -173.79 154.4 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -1.176 . . . . 2.04 110.232 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -169.5 132.09 1.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 0.14000000000000001 109.772 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -104.23 -162.07 0.87 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.17000000000000001 109.1 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.41 133.82 1.56 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.13 109.577 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.71 97.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -1.19 . . . . 0.20000000000000001 110.553 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -141.51 72.36 1.38 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.72 -0.844 . . . . 1.1499999999999999 108.72 178.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.69 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.88 . . . . 1.1899999999999999 110.431 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.9 -31.29 71.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.025 -1.047 . . . . 1.95 109.467 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 43.4 tttp -67.87 -33.63 75.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 2.0499999999999998 109.787 -179.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.2 mt -51.46 -36.03 42.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.992 -1.068 . . . . 0.14999999999999999 108.646 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.27 -55.74 14.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 2.1499999999999999 109.448 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.38 94.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.14999999999999999 110.946 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.454 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 19.4 m -67.3 -45.97 74.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.923 -1.111 . . . . 0.13 110.44 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.71 -51.39 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.17999999999999999 109.037 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -60.01 -18.57 46.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 1.03 109.633 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -76.44 -61.98 1.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 2.02 110.276 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 mt -91.68 21.61 4.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.34999999999999998 110.534 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.902 -1.124 . . . . 1.1799999999999999 109.315 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' B' ' 2' ' ' ARG . 3.1 mtt-85 -152.03 64.27 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 109.322 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.8 m-85 -101.89 147.72 26.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.932 -1.105 . . . . 0.0 109.751 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -148.45 -105.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.385 -0.822 . . . . 0.0 108.79 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.606 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -111.96 -167.68 1.21 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.778 -1.201 . . . . 0.0 110.47 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.34 149.32 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.308 -0.87 . . . . 0.0 112.428 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.67 95.61 6.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.414 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.72 47.5 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.807 -1.183 . . . . 0.0 110.061 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.94 -129.98 0.23 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -69.72 25.07 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.609 ' H ' ' C ' ' B' ' 9' ' ' GLY . 41.9 t -80.56 -15.94 55.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.533 -0.73 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.488 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 11.4 t-160 -159.02 -116.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.488 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.511 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.32 0.581 . . . . 2.8900000000000001 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.5 t -94.73 165.1 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.223 -0.923 . . . . 0.29999999999999999 109.524 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 74.9 tttt -155.13 130.56 9.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.199 -0.938 . . . . 1.97 109.124 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -88.69 138.19 31.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.106 -0.996 . . . . 0.97999999999999998 109.752 -179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.3 93.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.58 -0.896 . . . . 0.19 108.58 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -96.72 -1.01 47.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.014 -1.054 . . . . 1.97 109.538 -179.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.5 p -151.85 147.82 27.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.975 -1.078 . . . . 0.23000000000000001 110.184 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 54.3 tttt -52.43 -29.25 23.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 1.8999999999999999 109.687 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -60.53 -45.55 93.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.034 -1.041 . . . . 0.25 109.557 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.45 65.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.20000000000000001 109.61 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.85 -65.69 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.20999999999999999 109.534 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -55.66 -46.34 77.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 2.4700000000000002 109.818 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -58.12 -34.49 70.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.094 -1.004 . . . . 2.1000000000000001 109.648 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.09 86.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.20000000000000001 109.0 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.7 -44.64 93.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.369 -0.832 . . . . 0.62 109.387 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.08 -37.98 89.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 1.0900000000000001 109.049 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.12 53.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.29999999999999999 109.492 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.17 61.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.23999999999999999 109.544 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 -109.33 2.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.993 -1.243 . . . . 0.28000000000000003 109.993 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.1 t0 -136.37 -0.46 2.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.384 -1.068 . . . . 2.21 109.32 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.6 mttt -68.47 163.31 23.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.664 -1.273 . . . . 1.8999999999999999 108.505 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -62.24 163.63 8.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.115 -1.068 . . . . 0.17000000000000001 108.115 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.5 t -143.62 108.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.979 -1.076 . . . . 0.12 109.827 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.4 133.54 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.642 -0.873 . . . . 0.089999999999999997 108.642 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.28 137.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.477 -0.764 . . . . 0.17000000000000001 109.736 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.84 104.57 13.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.584 -0.698 . . . . 0.95999999999999996 109.207 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.438 ' CE2' HG11 ' A' ' 57' ' ' VAL . 37.5 m-85 -86.86 80.0 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.932 -1.136 . . . . 0.23999999999999999 107.932 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.1 m -114.4 147.74 38.75 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.436 0.636 . . . . 1.03 109.563 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -91.71 123.1 34.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.26000000000000001 108.681 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -65.93 -21.14 66.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.25 -0.906 . . . . 0.32000000000000001 110.319 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.4 p-90 -88.52 -16.99 31.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.059 . . . . 0.44 109.915 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -91.49 136.65 32.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.906 . . . . 0.32000000000000001 110.209 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.28 -58.17 4.78 Favored Glycine 0 N--CA 1.491 2.313 0 O-C-N 121.679 -0.638 . . . . 0.35999999999999999 111.535 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.7 -33.38 31.7 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 C-N-CA 121.597 1.532 . . . . 0.44 111.4 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -60.38 2.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.835 -1.166 . . . . 0.81000000000000005 108.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.69 -21.98 55.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 1.9199999999999999 109.887 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.1 ttm -60.58 -21.4 62.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.201 -0.937 . . . . 3.1299999999999999 110.533 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.578 ' O ' HG22 ' A' ' 38' ' ' ILE . 54.0 mt -101.08 8.5 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.097 -1.002 . . . . 0.28000000000000003 110.91 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.7 -32.44 5.99 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 117.923 -1.511 . . . . 1.6200000000000001 112.709 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.3 Cg_exo -60.81 -11.61 18.52 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 CA-C-N 119.906 1.002 . . . . 0.25 110.267 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.78 -70.3 0.74 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.29999999999999999 109.527 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -45.01 -51.24 10.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.13 110.658 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.7 t-80 -67.97 -33.83 75.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.40999999999999998 109.617 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.78 -42.76 99.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 0.96999999999999997 109.786 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.4 mt -51.9 -19.6 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.073 . . . . 0.5 109.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -56.85 -32.92 66.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.51000000000000001 109.275 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.64 -16.86 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 2.0 109.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -90.09 -20.94 22.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 2.1600000000000001 108.959 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.34 71.14 1.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.23999999999999999 109.241 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.3 p -66.89 -4.7 10.04 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.9 . . . . 0.17000000000000001 108.931 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.79 1.86 51.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.34000000000000002 109.731 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -119.04 150.35 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.519 -0.738 . . . . 0.12 109.389 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.66 131.68 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.304 -0.872 . . . . 0.17000000000000001 109.183 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 86.4 m-85 -117.84 132.49 56.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.211 -0.931 . . . . 0.11 109.262 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -114.21 174.85 5.74 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.374 -0.829 . . . . 0.12 109.039 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -142.69 142.57 32.04 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.084 -1.08 . . . . 1.3100000000000001 108.084 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 27' ' ' PHE . 44.6 t -139.74 133.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.109 -0.994 . . . . 0.14000000000000001 110.447 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.72 105.16 17.27 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.107 -1.071 . . . . 1.0800000000000001 108.107 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.6 m -59.33 -4.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.804 . . . . 0.27000000000000002 111.171 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 53.1 m-20 -108.9 -44.22 4.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.216 -0.928 . . . . 1.1100000000000001 110.83 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' HB2' HH12 ' B' ' 2' ' ' ARG . 1.8 t70 -91.57 -10.7 39.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.24 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 47.38 2.19 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.303 -0.999 . . . . 0.17000000000000001 108.303 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -55.29 -17.45 4.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.668 -0.645 . . . . 2.2200000000000002 109.974 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.5 p-10 -71.54 -38.93 71.0 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.946 . . . . 1.1100000000000001 109.537 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.14 -48.39 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.19 108.922 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.03 72.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.22 109.462 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -64.05 -57.1 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 1.29 109.679 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -63.18 -26.6 68.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2000000000000002 109.825 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.06 -3.16 58.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.115 -0.991 . . . . 0.33000000000000002 109.923 -179.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 47.56 53.09 11.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 2.3399999999999999 110.08 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 22.1 t -79.56 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.28000000000000003 109.402 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -125.17 -1.83 7.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.341 -0.85 . . . . 2.3999999999999999 109.815 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.56 130.98 12.91 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.019 -1.051 . . . . 0.22 109.418 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.0 p -114.99 150.63 44.5 Favored Pre-proline 0 N--CA 1.502 2.143 0 N-CA-C 108.26 -1.015 . . . . 0.22 108.26 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.92 144.07 77.53 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 C-N-CA 124.842 -0.899 . . . . 0.20000000000000001 110.615 -1.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.03 113.78 23.66 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.757 -1.201 . . . . 0.17999999999999999 107.757 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.3 m-85 -89.55 122.16 32.45 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.898 -1.126 . . . . 0.14999999999999999 108.902 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -119.6 135.99 54.56 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.029 -1.1 . . . . 1.03 108.029 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.0 m-85 -109.65 131.87 54.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.11 109.967 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -129.08 157.04 42.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.884 -0.784 . . . . 0.17000000000000001 108.884 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -154.05 124.86 7.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.601 -1.259 . . . . 1.48 107.601 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 mttt 54.28 32.73 16.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.996 . . . . 1.6699999999999999 109.77 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 9.69 86.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.005 -1.238 . . . . 0.22 110.005 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.2 mm-40 -114.75 144.07 44.07 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.331 -1.099 . . . . 2.0800000000000001 110.363 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -85.53 146.66 26.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 1.7 109.27 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.91 -29.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.454 -0.779 . . . . 0.26000000000000001 109.971 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.58 178.03 44.1 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.5 -1.333 . . . . 0.17999999999999999 110.477 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -173.6 156.87 3.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 2.04 110.179 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.0 p90 -168.88 134.25 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.14000000000000001 110.563 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -105.83 -171.33 1.88 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.203 -0.935 . . . . 0.17000000000000001 108.889 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 92.88 128.61 4.8 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -1.12 . . . . 0.20000000000000001 110.31 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' GLY . 14.5 t-20 -140.14 73.24 1.42 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.452 -0.944 . . . . 1.1499999999999999 108.452 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.65 -31.73 73.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 1.1899999999999999 110.28 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.517 ' H ' ' CD ' ' A' ' 95' ' ' GLU . 23.6 mp0 -66.86 -29.95 69.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.898 -1.126 . . . . 1.95 109.124 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -32.38 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.418 -0.801 . . . . 2.0499999999999998 109.331 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.0 mt -51.38 -35.0 36.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.14999999999999999 108.421 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -68.24 -56.77 7.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.687 . . . . 2.1499999999999999 109.747 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.58 87.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.819 . . . . 0.14999999999999999 110.668 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 m -67.0 -45.13 78.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.13 110.218 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.3 -51.97 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.17999999999999999 109.074 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.3 -15.2 46.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 1.03 109.781 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.12 -59.51 2.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 2.02 110.294 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.97 18.49 10.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.393 -0.817 . . . . 0.34999999999999998 110.74 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.895 -1.128 . . . . 1.1799999999999999 109.347 179.582 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 23.1 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 1.5 mtt-85 -129.12 68.2 1.41 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.2 m-85 -125.35 152.84 44.23 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -150.38 -83.38 0.1 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.083 -1.011 . . . . 0.0 109.771 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -123.25 -168.5 1.77 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.894 -1.129 . . . . 0.0 111.249 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.3 t -76.22 149.71 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.886 0.851 . . . . 0.0 112.868 -176.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.91 96.95 7.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.457 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.04 46.15 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.041 -1.037 . . . . 0.0 110.639 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.26 -130.24 0.09 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.755 -2.538 . . . . 0.0 106.755 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.6 22.27 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.335 1.568 . . . . 0.0 109.367 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.0 t -87.08 -18.5 30.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.759 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.498 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 32.9 t-80 -149.92 -126.23 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 109.358 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.498 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.444 -0.576 . . . . 2.8900000000000001 109.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 62.1 t -94.57 162.85 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.194 -0.941 . . . . 0.29999999999999999 109.548 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 14.4 tptm -154.8 122.33 5.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.97 109.251 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.5 134.83 34.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.97999999999999998 110.015 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.06 109.72 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.063 -1.088 . . . . 0.19 108.063 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -101.02 -7.01 23.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.193 -0.942 . . . . 1.97 109.847 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 p -152.35 153.58 33.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.037 -1.039 . . . . 0.23000000000000001 109.926 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 69.4 tttt -52.46 -33.22 43.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -59.69 -41.1 89.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 0.25 109.849 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.41 -25.63 63.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.20000000000000001 109.78 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.3 -68.31 0.31 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.011 -1.056 . . . . 0.20999999999999999 110.043 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.91 -41.25 70.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 2.4700000000000002 109.785 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.85 -37.69 80.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 2.1000000000000001 109.504 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.18 91.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.20000000000000001 109.539 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.32 -44.7 94.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 0.62 109.715 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.71 -41.12 98.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 1.0900000000000001 109.713 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.1 -14.58 58.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.29999999999999999 109.732 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.59 -6.97 28.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.23999999999999999 109.847 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -113.81 4.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.578 -1.409 . . . . 0.28000000000000003 109.578 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.17 5.15 2.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -1.054 . . . . 2.21 109.499 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.24 170.18 12.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.003 -1.061 . . . . 1.8999999999999999 109.097 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 161.51 14.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.932 -1.136 . . . . 0.17000000000000001 107.932 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -145.33 106.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.927 -1.108 . . . . 0.12 109.652 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.94 130.3 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.688 -0.856 . . . . 0.089999999999999997 108.688 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.78 140.13 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.55 -0.719 . . . . 0.17000000000000001 109.591 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -110.96 99.27 8.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.982 -0.747 . . . . 0.95999999999999996 108.982 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.64 82.98 8.18 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.807 -1.183 . . . . 0.23999999999999999 107.807 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 41.3 m -109.39 -163.24 0.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.985 -0.746 . . . . 1.03 108.985 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.31 125.13 18.26 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.95 -0.759 . . . . 0.26000000000000001 108.95 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -65.6 -30.68 71.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.68 . . . . 0.32000000000000001 111.331 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.585 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 50.7 p-90 -86.04 -14.18 45.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.748 -1.22 . . . . 0.44 109.884 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -94.76 128.58 41.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.32000000000000001 109.657 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.62 -55.79 8.14 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.579 -0.701 . . . . 0.35999999999999999 111.495 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.6 Cg_exo -48.03 -33.58 20.99 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.72 1.613 . . . . 0.44 111.45 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -76.27 -59.75 2.63 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.809 -1.182 . . . . 0.81000000000000005 108.958 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -60.32 -19.22 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 1.9199999999999999 110.258 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -19.55 52.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.01 . . . . 3.1299999999999999 110.361 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.2 mt -99.45 9.08 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.16 -0.962 . . . . 0.28000000000000003 110.497 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.52 -31.98 4.07 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 120.374 -1.454 . . . . 1.6200000000000001 112.516 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -62.61 -5.0 6.37 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.947 1.017 . . . . 0.25 110.049 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 45.5 m-85 -112.39 -75.49 0.61 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.218 -0.66 . . . . 0.29999999999999999 109.218 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -43.13 -56.8 3.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.13 110.551 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.94 -32.37 73.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.40999999999999998 110.068 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.5 t -63.18 -40.92 98.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.809 -1.182 . . . . 0.96999999999999997 110.38 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.4 mt -50.62 -15.32 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.992 -1.067 . . . . 0.5 109.532 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.0 m -58.17 -30.77 66.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.066 -1.021 . . . . 0.51000000000000001 109.521 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -96.09 -21.45 17.94 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.272 -0.892 . . . . 2.0 110.156 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -90.43 -21.01 22.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.037 -1.039 . . . . 2.1600000000000001 109.602 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.74 67.6 1.5 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.409 -0.807 . . . . 0.23999999999999999 108.896 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.5 p -66.8 -3.01 5.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.374 -0.829 . . . . 0.17000000000000001 109.088 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.29 -1.23 51.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.443 -0.786 . . . . 0.34000000000000002 109.251 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.26 149.01 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.633 -0.667 . . . . 0.12 109.24 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -99.96 125.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.17000000000000001 109.146 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -112.47 130.96 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.271 -0.893 . . . . 0.11 108.878 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.51 171.58 7.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.736 -0.838 . . . . 0.12 108.736 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -142.82 142.57 31.87 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.836 -1.172 . . . . 1.3100000000000001 107.836 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.0 t -141.12 138.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.152 -0.967 . . . . 0.14000000000000001 110.758 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.41 105.75 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.443 -0.947 . . . . 1.0800000000000001 108.443 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.94 -4.95 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.376 -0.828 . . . . 0.27000000000000002 110.905 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.585 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 36.8 m-20 -102.72 -42.83 5.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 1.1100000000000001 110.877 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -25.6 15.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.181 -0.949 . . . . 1.1200000000000001 109.362 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.29 43.45 1.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.426 -0.953 . . . . 0.17000000000000001 108.426 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.409 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 87.3 mt-30 -53.6 -13.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 2.2200000000000002 110.235 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.1 p-10 -69.85 -40.68 75.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.791 -1.193 . . . . 1.1100000000000001 109.19 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -73.37 -48.07 43.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.234 -0.916 . . . . 0.19 108.584 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -38.19 90.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.528 -0.732 . . . . 0.22 109.539 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 61.8 m -64.1 -43.73 94.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 1.29 109.052 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.59 -40.41 96.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 2.2000000000000002 109.228 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.83 -6.27 57.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.33000000000000002 109.399 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ALA . 46.7 mt-10 49.31 71.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 2.3399999999999999 110.253 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 42.0 t -79.11 135.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.922 . . . . 0.28000000000000003 108.978 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -113.64 -12.54 12.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.484 -0.76 . . . . 2.3999999999999999 109.805 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.78 137.69 15.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.952 -1.092 . . . . 0.22 109.81 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.733 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.7 p -115.63 151.27 45.99 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 108.487 -0.931 . . . . 0.22 108.487 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -75.73 147.33 87.89 Favored 'Cis proline' 0 N--CA 1.484 0.968 0 C-N-CA 124.651 -0.979 . . . . 0.20000000000000001 109.878 -1.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -116.08 113.34 23.02 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.996 -1.113 . . . . 0.17999999999999999 107.996 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.1 m-85 -89.15 125.1 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.124 -1.03 . . . . 0.14999999999999999 108.906 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.16 136.71 54.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.895 -1.15 . . . . 1.03 107.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 23.4 m-85 -109.91 130.18 55.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.707 . . . . 0.11 109.958 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -128.93 157.24 42.17 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.58 -0.896 . . . . 0.17000000000000001 108.58 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -155.53 122.65 5.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.014 -1.106 . . . . 1.48 108.014 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.2 22.57 6.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 1.6699999999999999 109.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 3.55 72.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.194 -1.162 . . . . 0.22 110.194 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -110.95 144.95 39.22 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.293 -1.122 . . . . 2.0800000000000001 110.21 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -85.47 139.56 31.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 1.7 109.052 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.03 -18.02 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.399 -0.813 . . . . 0.26000000000000001 110.715 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.92 172.69 45.68 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.17999999999999999 110.541 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -174.21 150.49 1.53 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 2.04 110.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.0 p90 -169.02 132.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.818 . . . . 0.14000000000000001 110.189 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -101.98 -160.19 0.77 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.064 -1.023 . . . . 0.17000000000000001 109.066 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 129.3 0.67 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.52 -1.432 . . . . 0.13 109.52 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.16 93.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.20000000000000001 110.205 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.96 75.53 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.819 -1.178 . . . . 1.1499999999999999 107.819 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.528 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.8 ptpt -63.49 -39.36 94.23 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.818 -0.628 . . . . 1.1899999999999999 111.275 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.58 -25.97 68.2 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 1.95 109.567 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.21 -34.79 76.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 2.0499999999999998 109.528 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.8 mt -54.73 -35.96 64.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.118 . . . . 0.14999999999999999 108.732 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.7 -58.08 6.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 2.1499999999999999 109.54 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.47 -41.92 90.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.14999999999999999 110.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.2 m -65.81 -45.73 81.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.161 -0.962 . . . . 0.13 110.183 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.48 -53.97 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.17999999999999999 108.822 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.64 -17.64 48.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 1.03 109.744 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -75.9 -60.25 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 2.02 110.155 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.64 20.74 6.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.771 . . . . 0.34999999999999998 110.416 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.1799999999999999 109.238 179.473 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.8 p90 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.442 ' HB3' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -133.59 67.48 1.52 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.402 -0.811 . . . . 0.0 109.455 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -139.26 154.08 47.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.409 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 7.9 tpt180 -150.28 -79.94 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.092 -1.005 . . . . 0.0 109.701 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.8 -166.89 1.7 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.013 -1.054 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.55 152.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 122.0 0.905 . . . . 0.0 112.591 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 95.09 6.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.16 45.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.78 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -131.98 0.08 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.6 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.251 1.525 . . . . 0.0 109.147 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.2 t -83.54 -30.84 26.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -160.82 -68.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 117.998 -1.445 . . . . 0.0 109.569 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mtt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 2.8900000000000001 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.3 t -94.88 160.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.273 -0.892 . . . . 0.29999999999999999 109.902 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.4 tttt -155.06 125.97 7.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 1.97 109.375 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.13 136.52 33.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.904 . . . . 0.97999999999999998 109.73 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mm -106.3 110.02 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.185 -1.042 . . . . 0.19 108.185 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.87 -9.98 21.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.2 -0.938 . . . . 1.97 109.703 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 p -153.18 152.6 31.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.11 -0.994 . . . . 0.23000000000000001 109.699 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -51.9 -28.0 14.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 1.8999999999999999 110.021 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -59.14 -44.29 92.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.25 109.692 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.32 -24.56 61.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.20000000000000001 109.952 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -59.33 -68.64 0.26 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.20999999999999999 110.328 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.34 -43.2 71.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 2.4700000000000002 109.554 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -59.67 -36.73 77.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.228 -0.92 . . . . 2.1000000000000001 110.085 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.32 86.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.003 . . . . 0.20000000000000001 109.384 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.29 -43.4 94.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.468 -0.77 . . . . 0.62 109.645 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.76 -40.78 97.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 1.0900000000000001 109.771 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -14.44 59.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.988 . . . . 0.29999999999999999 110.03 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -10.56 56.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.23999999999999999 109.806 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.2 -112.3 3.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.47 -1.452 . . . . 0.28000000000000003 109.47 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -139.85 3.77 2.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.317 -1.107 . . . . 2.21 109.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -69.61 172.68 7.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 1.8999999999999999 109.032 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.83 161.47 18.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.977 -1.12 . . . . 0.17000000000000001 107.977 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.3 t -144.87 104.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.873 -1.142 . . . . 0.12 109.421 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.99 128.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.359 -0.838 . . . . 0.089999999999999997 108.937 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.77 139.72 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.17000000000000001 109.565 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -112.02 103.49 11.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.95999999999999996 108.903 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.5 m-85 -86.06 80.31 8.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.3 -1.0 . . . . 0.23999999999999999 108.3 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.3 m -113.45 149.4 34.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.652 -0.655 . . . . 1.03 109.597 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.39 129.26 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.26000000000000001 109.048 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -67.15 -25.32 66.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.882 . . . . 0.32000000000000001 110.855 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 54.0 p-90 -88.4 -17.58 30.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.842 -1.161 . . . . 0.44 110.351 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.96 123.37 37.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -0.929 . . . . 0.32000000000000001 109.941 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.87 -53.74 32.43 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-O 119.426 -0.652 . . . . 0.35999999999999999 112.002 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -48.32 -36.41 29.95 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.647 1.565 . . . . 0.44 111.33 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.76 -60.99 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.81000000000000005 109.137 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -58.28 -18.92 30.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 1.9199999999999999 109.96 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.9 ttm -58.61 -18.41 29.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 3.1299999999999999 110.581 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.644 ' O ' HG22 ' A' ' 38' ' ' ILE . 67.1 mt -100.39 9.7 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 110.583 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.74 -32.55 4.39 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.107 -1.621 . . . . 1.6200000000000001 112.598 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -64.09 -6.2 10.87 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 CA-C-N 119.794 0.962 . . . . 0.25 109.758 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 32.6 m-85 -110.52 -75.21 0.63 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.544 -0.723 . . . . 0.29999999999999999 109.384 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -43.02 -57.42 2.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.427 -0.795 . . . . 0.13 110.67 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.82 -31.15 71.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.40999999999999998 110.04 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' SER . 3.4 t -64.34 -40.1 95.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.822 -1.174 . . . . 0.96999999999999997 109.938 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.2 -12.87 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.079 -1.013 . . . . 0.5 109.369 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.03 -34.69 70.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.51000000000000001 109.439 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -94.33 -13.17 26.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.312 -0.868 . . . . 2.0 110.084 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -91.65 -32.07 15.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 2.1600000000000001 109.455 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -126.38 71.96 1.3 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.025 -0.732 . . . . 0.23999999999999999 109.025 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.08 -2.59 4.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.292 -0.88 . . . . 0.17000000000000001 108.968 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 35.0 t30 -97.01 -1.99 44.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.34000000000000002 109.816 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.74 148.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.508 -0.745 . . . . 0.12 109.586 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.37 124.21 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.993 -0.743 . . . . 0.17000000000000001 108.993 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.7 m-85 -109.91 133.0 53.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.294 -0.879 . . . . 0.11 108.948 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -115.08 171.87 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.241 -0.912 . . . . 0.12 108.706 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -141.94 144.24 33.65 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.028 -1.101 . . . . 1.3100000000000001 108.028 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.63 139.26 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.17 -0.956 . . . . 0.14000000000000001 110.507 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.7 t70 -98.98 101.97 13.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.859 -0.793 . . . . 1.0800000000000001 108.859 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.04 0.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.836 . . . . 0.27000000000000002 110.967 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.464 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 39.3 m-20 -112.7 -41.08 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.343 -0.848 . . . . 1.1100000000000001 110.655 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -95.5 -21.18 18.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.041 . . . . 1.1200000000000001 109.503 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.48 47.86 1.19 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.25 -1.019 . . . . 0.17000000000000001 108.25 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' B' ' 4' ' ' ARG . 69.1 mt-30 -54.62 -18.28 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.749 -0.594 . . . . 2.2200000000000002 110.326 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.2 p30 -70.82 -39.41 73.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.917 -1.114 . . . . 1.1100000000000001 109.606 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.44 -47.63 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.149 -0.969 . . . . 0.19 108.836 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.48 78.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.22 109.461 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -63.47 -52.72 60.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 1.29 109.525 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -64.75 -30.55 71.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 2.2000000000000002 110.027 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.94 2.99 47.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.33000000000000002 109.943 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 47.14 50.3 14.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 2.3399999999999999 110.541 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 4.0 t -81.39 128.64 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.28000000000000003 108.773 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -126.28 -2.13 6.94 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.363 -0.835 . . . . 2.3999999999999999 110.434 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.32 124.68 8.21 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.759 -1.213 . . . . 0.22 109.427 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.7 p -106.24 151.3 40.17 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 121.322 -0.861 . . . . 0.22 109.185 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.8 140.13 63.45 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.947 -0.855 . . . . 0.20000000000000001 110.066 -2.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.38 111.11 21.73 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.056 -1.09 . . . . 0.17999999999999999 108.056 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.5 m-85 -89.19 118.14 28.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.988 -1.07 . . . . 0.14999999999999999 109.127 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.3 mt-30 -117.05 135.55 53.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.332 -1.358 . . . . 1.03 107.332 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.8 m-85 -107.83 128.08 54.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.488 0.661 . . . . 0.11 109.896 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.8 156.95 35.16 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.94 -0.763 . . . . 0.17000000000000001 108.94 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -155.26 124.35 6.23 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.298 -1.371 . . . . 1.48 107.298 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.3 mttt 56.0 32.65 20.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.6 -0.687 . . . . 1.6699999999999999 109.382 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.41 7.19 87.01 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.779 -1.201 . . . . 0.22 110.143 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.8 mm-40 -113.03 142.6 45.52 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.375 -1.073 . . . . 2.0800000000000001 110.64 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -86.62 140.09 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.838 . . . . 1.7 108.947 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.27 -17.39 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.413 -0.805 . . . . 0.26000000000000001 110.693 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.39 176.56 48.1 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.415 -1.374 . . . . 0.17999999999999999 110.454 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -174.1 156.46 2.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -1.128 . . . . 2.04 110.296 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.553 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.58 129.97 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.14000000000000001 109.982 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -102.83 -162.16 0.9 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.292 -0.88 . . . . 0.17000000000000001 109.234 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.55 126.74 0.84 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.964 -1.654 . . . . 0.13 108.964 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.88 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.091 -1.241 . . . . 0.20000000000000001 110.043 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.32 66.65 1.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.516 -1.29 . . . . 1.1499999999999999 107.516 178.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.25 -34.11 71.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.824 -0.548 . . . . 1.1899999999999999 111.023 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.58 -26.03 68.23 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.935 -1.103 . . . . 1.95 109.254 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -71.05 -36.26 72.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.787 . . . . 2.0499999999999998 110.095 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.4 mt -50.8 -33.29 22.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.914 -1.117 . . . . 0.14999999999999999 109.012 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.38 -57.01 7.37 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.467 -0.893 . . . . 2.1499999999999999 109.539 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.86 95.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.14999999999999999 110.942 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 m -64.94 -45.3 86.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.953 -1.092 . . . . 0.13 109.918 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.63 -53.09 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.17999999999999999 108.681 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.27 -16.23 43.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 1.03 109.626 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -62.38 1.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 2.02 109.934 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.25 22.62 3.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.34999999999999998 110.162 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.037 -1.04 . . . . 1.1799999999999999 109.295 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.8 mtp180 -141.44 71.67 1.37 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.21 -0.931 . . . . 0.0 109.146 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -133.73 156.24 48.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.411 -0.806 . . . . 0.0 109.146 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' A' ' 63' ' ' GLN . 8.7 tpt180 -147.49 -81.59 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.013 -1.054 . . . . 0.0 109.612 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.2 p90 -129.95 -167.16 1.77 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.053 -1.029 . . . . 0.0 110.464 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -73.75 150.58 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.938 0.875 . . . . 0.0 112.522 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.12 93.44 5.47 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.7 pt-20 -83.79 44.26 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.285 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.73 -130.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.64 20.8 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 119.533 1.667 . . . . 0.0 109.37 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.3 t -87.83 -29.14 21.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.525 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -76.57 155.74 33.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.566 179.996 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.463 -0.569 . . . . 2.8900000000000001 109.463 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.7 t -94.58 163.28 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.29999999999999999 109.268 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 54.6 tttp -154.15 125.31 7.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 1.97 109.402 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -89.85 136.3 33.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.97999999999999998 109.903 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.86 107.27 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.206 -1.035 . . . . 0.19 108.206 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.57 -8.74 24.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 1.97 109.547 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.07 156.27 38.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.135 -0.978 . . . . 0.23000000000000001 109.829 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -52.99 -30.15 33.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.8999999999999999 110.075 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.5 m -60.27 -44.51 95.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.25 110.313 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -25.14 64.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.20000000000000001 109.649 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -60.76 -67.95 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.957 -1.089 . . . . 0.20999999999999999 109.94 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.55 -44.98 69.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.795 . . . . 2.4700000000000002 109.679 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -58.61 -36.94 74.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.947 . . . . 2.1000000000000001 109.845 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.93 91.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.081 -1.012 . . . . 0.20000000000000001 109.362 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.14 -46.56 83.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.804 . . . . 0.62 109.774 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.45 -38.71 92.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 1.0900000000000001 109.482 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.88 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.981 . . . . 0.29999999999999999 109.667 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -5.36 18.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.23999999999999999 109.588 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 -111.45 3.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.453 -1.459 . . . . 0.28000000000000003 109.453 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 61.5 t0 -139.06 2.49 2.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.434 -1.039 . . . . 2.21 109.554 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 109' ' ' HOH . 83.8 mttt -68.8 171.86 7.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.017 . . . . 1.8999999999999999 109.053 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.8 162.27 19.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.351 -0.981 . . . . 0.17000000000000001 108.351 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.571 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -144.96 107.72 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.874 -1.141 . . . . 0.12 109.855 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -104.06 132.66 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.805 -0.813 . . . . 0.089999999999999997 108.805 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.2 140.43 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.17000000000000001 109.598 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -110.59 101.28 9.96 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.247 -0.649 . . . . 0.95999999999999996 109.247 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 42.1 m-85 -85.36 80.14 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.194 -1.039 . . . . 0.23999999999999999 108.194 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -114.19 147.96 38.07 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.228 0.537 . . . . 1.03 109.651 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.59 131.24 37.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.194 -0.941 . . . . 0.26000000000000001 108.853 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -67.67 -28.02 67.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.32000000000000001 110.655 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.2 p-90 -87.71 -11.61 47.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.44 110.023 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.39 125.29 39.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.32000000000000001 109.864 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -67.81 -54.12 20.04 Favored Glycine 0 N--CA 1.49 2.244 0 CA-C-O 119.491 -0.616 . . . . 0.35999999999999999 112.299 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.83 -43.85 33.63 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.544 1.496 . . . . 0.44 111.618 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.96 -55.85 5.66 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.688 -1.257 . . . . 0.81000000000000005 109.056 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.2 -18.23 46.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 1.9199999999999999 109.809 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.0 ttt -62.82 -22.46 66.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 3.1299999999999999 110.466 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.655 ' O ' HG22 ' A' ' 38' ' ' ILE . 65.5 mt -98.12 18.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.198 -0.939 . . . . 0.28000000000000003 111.014 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.39 -33.85 3.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.148 -1.595 . . . . 1.6200000000000001 113.091 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.02 -7.71 14.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 CA-C-N 119.469 0.846 . . . . 0.25 110.595 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.0 m-85 -105.22 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.315 -0.866 . . . . 0.29999999999999999 109.803 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.6 t80 -41.94 -52.4 4.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.13 110.742 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -68.73 -34.3 75.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.991 -1.068 . . . . 0.40999999999999998 109.931 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 46' ' ' SER . 4.2 t -60.64 -44.36 96.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.863 -1.148 . . . . 0.96999999999999997 110.014 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.6 mt -50.43 -16.8 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.978 -1.076 . . . . 0.5 109.214 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.1 m -57.06 -33.96 67.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.51000000000000001 109.629 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.14 -18.74 20.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -0.927 . . . . 2.0 110.251 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -90.54 -20.74 22.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.05 . . . . 2.1600000000000001 109.502 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -133.9 66.49 1.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.23999999999999999 109.297 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 p -67.68 -3.37 8.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.17000000000000001 109.251 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.37 0.39 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.395 -0.816 . . . . 0.34000000000000002 109.46 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.7 t -120.77 150.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.872 -0.788 . . . . 0.12 108.872 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.55 132.02 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.191 -0.943 . . . . 0.17000000000000001 109.659 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.1 m-85 -117.33 131.69 56.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.571 -0.706 . . . . 0.11 109.102 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -114.27 174.98 5.68 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.423 -0.798 . . . . 0.12 109.093 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -144.88 146.81 32.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.247 -1.019 . . . . 1.3100000000000001 108.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.03 138.27 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.999 -1.063 . . . . 0.14000000000000001 110.611 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.0 t70 -100.03 100.88 11.82 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.665 -0.865 . . . . 1.0800000000000001 108.665 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 108' ' ' HOH . 25.1 m -59.31 0.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 111.171 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.535 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 14.9 m-20 -116.84 -41.87 3.01 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.163 -0.96 . . . . 1.1100000000000001 110.709 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.13 -19.5 20.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.014 -1.054 . . . . 1.1200000000000001 109.279 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.36 46.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.006 -1.109 . . . . 0.17000000000000001 108.006 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 27.3 mt-30 -55.31 -16.46 3.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.619 -0.676 . . . . 2.2200000000000002 110.533 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.21 -36.78 77.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.765 -1.209 . . . . 1.1100000000000001 109.113 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -73.76 -48.46 39.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.217 -0.927 . . . . 0.19 108.72 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.27 -36.96 85.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.22 109.37 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -63.48 -46.49 85.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 1.29 109.198 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -64.55 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 2.2000000000000002 109.284 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.98 -6.29 58.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -0.988 . . . . 0.33000000000000002 109.257 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ALA . 35.3 mt-10 51.61 55.62 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 2.3399999999999999 110.462 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 46.2 t -84.25 124.26 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.262 -0.898 . . . . 0.28000000000000003 108.999 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.37 6.7 17.36 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.175 -0.953 . . . . 2.3999999999999999 110.219 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.02 146.19 24.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.773 -1.204 . . . . 0.22 109.714 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.3 p -127.29 148.88 68.04 Favored Pre-proline 0 N--CA 1.506 2.354 0 N-CA-C 108.284 -1.006 . . . . 0.22 108.284 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.528 ' HG3' HD12 ' A' ' 38' ' ' ILE . 12.1 Cg_endo -80.32 139.99 50.74 Favored 'Cis proline' 0 N--CA 1.487 1.113 0 N-CA-C 110.072 -0.78 . . . . 0.20000000000000001 110.072 -1.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -110.58 110.53 21.27 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.157 -1.053 . . . . 0.17999999999999999 108.157 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.832 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.3 m-85 -86.98 115.53 24.43 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.995 -1.082 . . . . 0.14999999999999999 109.206 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.579 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 32.5 mt-30 -114.2 137.01 52.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.735 -1.209 . . . . 1.03 107.735 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 19.5 m-85 -109.91 126.33 53.76 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.519 0.676 . . . . 0.11 109.592 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 156.28 35.36 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.452 -0.944 . . . . 0.17000000000000001 108.452 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.385 -1.339 . . . . 1.48 107.385 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 55.01 38.28 30.27 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.433 -0.792 . . . . 1.6699999999999999 109.238 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 6.25 63.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.352 -1.099 . . . . 0.22 110.352 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.2 mm-40 -112.12 145.82 39.12 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.312 -1.111 . . . . 2.0800000000000001 110.541 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -86.19 142.62 28.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 1.7 109.279 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.9 -9.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.452 -0.78 . . . . 0.26000000000000001 110.341 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.4 38.01 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.389 -1.386 . . . . 0.17999999999999999 110.521 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -173.35 156.69 3.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.411 -1.053 . . . . 2.04 110.06 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.88 131.12 1.27 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.799 . . . . 0.14000000000000001 110.027 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -160.98 0.81 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.16 -0.962 . . . . 0.17000000000000001 109.093 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 82.34 121.07 0.63 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.451 -1.46 . . . . 0.13 109.451 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.544 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.34 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -1.158 . . . . 0.20000000000000001 110.25 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.38 76.98 1.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.129 -1.063 . . . . 1.1499999999999999 108.129 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.1 ptpt -64.57 -42.55 95.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.871 -0.518 . . . . 1.1899999999999999 111.556 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -63.93 -25.72 68.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.739 -1.226 . . . . 1.95 109.978 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -70.55 -32.09 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 2.0499999999999998 109.432 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 77' ' ' PHE . 34.1 mt -51.08 -37.54 46.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.064 . . . . 0.14999999999999999 108.805 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -68.36 -56.33 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.822 -0.751 . . . . 2.1499999999999999 109.975 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.16 75.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.14999999999999999 110.453 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 m -67.68 -45.21 75.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.989 . . . . 0.13 110.0 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.95 -53.44 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.17999999999999999 109.274 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.81 -16.25 26.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 1.03 109.839 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -75.97 -60.18 2.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 2.02 109.944 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -92.89 18.77 8.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.398 -0.814 . . . . 0.34999999999999998 110.414 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.957 -1.089 . . . . 1.1799999999999999 109.309 179.507 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.521 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 56.1 mtp180 -136.88 70.64 1.41 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.6 m-85 -130.97 156.18 45.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 8.3 tpt180 -150.13 -79.71 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.053 -1.029 . . . . 0.0 109.417 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 4.1 p90 -131.87 -166.59 1.74 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.673 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.42 150.52 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.167 0.984 . . . . 0.0 112.967 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 94.35 5.59 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.4 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.21 49.82 1.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.908 -1.12 . . . . 0.0 109.944 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.605 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -76.28 -128.09 0.28 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -68.7 26.64 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.372 1.586 . . . . 0.0 108.946 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.605 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.6 t -81.49 -20.09 40.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.315 -0.865 . . . . 0.0 109.271 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -159.23 141.34 13.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.387 -0.821 . . . . 0.0 109.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.034 -1.425 . . . . 0.0 109.589 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.412 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.43 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.302 -0.629 . . . . 2.8900000000000001 109.302 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.6 t -94.75 171.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.29999999999999999 109.743 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' N ' HG12 ' A' ' 2' ' ' VAL . 36.9 tptt -153.99 123.9 6.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 1.97 109.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -90.3 128.51 36.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.186 -0.946 . . . . 0.97999999999999998 109.861 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.63 109.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.871 -1.159 . . . . 0.19 107.871 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -100.23 -8.06 23.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.174 -0.954 . . . . 1.97 110.078 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p -152.06 153.45 34.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.23000000000000001 109.82 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 50.7 tttm -52.23 -26.15 11.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 1.8999999999999999 109.784 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -60.17 -50.08 75.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.25 110.005 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.94 63.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.20000000000000001 109.791 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.89 -65.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.20999999999999999 109.864 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -54.99 -45.35 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 2.4700000000000002 109.733 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.92 -35.79 73.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.222 -0.924 . . . . 2.1000000000000001 109.743 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.78 80.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.20000000000000001 109.099 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.8 mt -64.55 -39.84 94.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.746 . . . . 0.62 109.603 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.98 -42.86 97.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 1.0900000000000001 109.756 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.04 57.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.114 -0.991 . . . . 0.29999999999999999 109.613 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.76 -8.42 42.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.155 -0.966 . . . . 0.23999999999999999 109.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.07 -129.39 32.12 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.161 -1.575 . . . . 0.28000000000000003 109.161 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.97 5.89 12.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.956 . . . . 2.21 109.462 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' HOH . 45.8 mttp -69.76 167.33 17.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 1.8999999999999999 109.266 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 161.47 18.99 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.331 -0.988 . . . . 0.17000000000000001 108.331 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.622 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.0 t -145.09 107.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.12 109.647 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.09 131.73 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.603 -0.888 . . . . 0.089999999999999997 108.603 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.34 139.57 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.511 -0.743 . . . . 0.17000000000000001 109.772 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -110.44 102.09 10.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.164 -0.68 . . . . 0.95999999999999996 109.164 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -86.1 83.42 7.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.804 -1.184 . . . . 0.23999999999999999 107.804 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -114.86 152.74 31.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.655 -0.653 . . . . 1.03 109.849 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -93.4 131.06 38.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.559 -0.904 . . . . 0.26000000000000001 108.559 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -67.46 -30.84 70.66 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.32000000000000001 111.119 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 65.9 p-90 -87.64 -5.94 58.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.937 -1.102 . . . . 0.44 110.651 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -98.17 132.97 43.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.32000000000000001 109.691 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -74.83 -54.19 5.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.628 -0.67 . . . . 0.35999999999999999 112.019 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.5 -39.58 45.3 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.413 1.409 . . . . 0.44 111.603 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.62 5.61 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.631 -1.293 . . . . 0.81000000000000005 109.003 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -60.4 -20.57 60.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 1.9199999999999999 110.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.1 tpt -60.13 -22.01 62.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 3.1299999999999999 110.556 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.706 ' O ' HG22 ' A' ' 38' ' ' ILE . 80.2 mt -96.61 14.21 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.28000000000000003 111.69 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.65 -33.3 5.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.042 -1.662 . . . . 1.6200000000000001 112.924 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.99 -9.15 18.11 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.69 0.925 . . . . 0.25 110.685 -176.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.71 -70.84 0.77 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.29999999999999999 109.68 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -43.69 -53.2 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.13 110.553 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -68.43 -34.22 75.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.087 -1.008 . . . . 0.40999999999999998 110.022 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 t -60.97 -40.35 93.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.883 -1.135 . . . . 0.96999999999999997 110.302 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.2 mt -51.49 -19.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.901 -1.124 . . . . 0.5 109.334 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -58.36 -28.99 65.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.51000000000000001 109.815 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -95.23 -22.97 17.46 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.083 -1.011 . . . . 2.0 110.27 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -90.87 -20.2 22.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.045 -1.034 . . . . 2.1600000000000001 109.342 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.49 68.92 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.23999999999999999 109.374 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 97.9 p -67.65 -5.65 16.75 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 0.17000000000000001 109.164 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -94.7 1.52 55.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 0.34000000000000002 109.576 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.79 147.77 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.599 -0.889 . . . . 0.12 108.599 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -99.77 127.61 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.17000000000000001 109.567 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -114.74 132.14 56.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.371 -0.831 . . . . 0.11 109.111 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.47 171.14 7.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.793 . . . . 0.12 108.883 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -143.35 145.63 32.85 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.911 -1.144 . . . . 1.3100000000000001 107.911 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.98 139.18 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.086 -1.009 . . . . 0.14000000000000001 110.375 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HH21 ' B' ' 2' ' ' ARG . 9.9 t70 -97.78 89.71 4.71 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.91 -1.144 . . . . 1.0800000000000001 107.91 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.674 HG11 ' OH ' ' B' ' 5' ' ' TYR . 27.7 m -53.68 -6.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.595 -0.691 . . . . 0.27000000000000002 111.681 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.523 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 46.6 m-20 -104.99 -35.17 7.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.073 -1.017 . . . . 1.1100000000000001 110.49 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.51 -9.49 22.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.123 -0.986 . . . . 1.1200000000000001 110.07 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.17 54.5 1.54 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.199 -0.938 . . . . 0.17000000000000001 109.433 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 60' ' ' ASP . 3.5 mp0 -54.88 -14.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.3 -0.875 . . . . 2.2200000000000002 110.379 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.7 p-10 -69.41 -44.84 70.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.888 -1.133 . . . . 1.1100000000000001 109.989 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.94 -44.62 57.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.081 -1.012 . . . . 0.19 108.692 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.13 86.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.22 109.236 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.0 m -64.5 -47.2 79.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 1.29 109.586 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.37 -38.12 89.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.662 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -4.34 58.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.242 -0.911 . . . . 0.33000000000000002 109.801 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 47.66 65.88 1.17 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.197 -0.939 . . . . 2.3399999999999999 109.866 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.15 130.09 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 0.28000000000000003 109.272 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -125.79 -5.6 6.9 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.413 -0.804 . . . . 2.3999999999999999 109.349 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.724 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.07 129.68 11.51 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.131 -1.062 . . . . 0.22 108.131 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.4 p -124.69 157.45 65.77 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.361 -0.837 . . . . 0.22 110.04 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -72.93 138.86 57.93 Favored 'Cis proline' 0 N--CA 1.487 1.119 0 O-C-N 122.856 0.924 . . . . 0.20000000000000001 110.946 0.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -108.23 110.0 21.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.077 -1.083 . . . . 0.17999999999999999 108.077 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.531 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -87.84 118.95 27.71 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.229 -0.989 . . . . 0.14999999999999999 108.835 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -117.2 139.48 50.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.782 -1.192 . . . . 1.03 107.782 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 24.5 m-85 -110.92 133.85 53.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.11 110.311 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.75 156.32 43.72 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.393 -0.965 . . . . 0.17000000000000001 108.393 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -155.55 121.54 5.09 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.202 -1.407 . . . . 1.48 107.202 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 55.99 33.63 22.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.545 -0.722 . . . . 1.6699999999999999 109.723 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.27 5.25 87.41 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.044 -1.074 . . . . 0.22 110.523 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -112.88 145.37 40.82 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.235 -1.156 . . . . 2.0800000000000001 110.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -85.54 141.69 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -0.915 . . . . 1.7 109.338 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.55 -34.28 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.466 -0.771 . . . . 0.26000000000000001 110.128 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.55 -178.17 40.56 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.537 -1.316 . . . . 0.17999999999999999 110.326 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.46 157.17 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -1.01 . . . . 2.04 110.215 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.1 p90 -168.67 130.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.904 -0.718 . . . . 0.14000000000000001 110.064 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -102.7 -159.69 0.74 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 108.917 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.58 120.14 0.42 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.05 -1.62 . . . . 0.13 109.05 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.43 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -1.188 . . . . 0.20000000000000001 110.656 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 91' ' ' GLY . 30.3 t-20 -139.34 76.75 1.58 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.131 -1.063 . . . . 1.1499999999999999 108.131 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 3.9 ptpp? -64.79 -40.14 94.76 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.967 -0.56 . . . . 1.1899999999999999 111.074 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -65.82 -26.44 67.68 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.057 -1.027 . . . . 1.95 109.974 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -68.1 -33.07 73.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 2.0499999999999998 109.284 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.531 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.2 mt -50.46 -34.73 25.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.052 -1.03 . . . . 0.14999999999999999 108.52 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.31 -56.77 8.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 2.1499999999999999 109.597 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.84 86.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.14999999999999999 110.548 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 m -66.91 -47.69 71.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.115 -0.991 . . . . 0.13 110.361 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.29 -48.81 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.17999999999999999 108.842 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 50.6 t-20 -62.43 -16.84 57.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 1.03 109.443 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -78.17 -58.69 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 2.02 110.435 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.24 19.07 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.823 . . . . 0.34999999999999998 110.415 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 102' ' ' ASN . 6.5 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.021 -0.99 . . . . 1.1799999999999999 109.389 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 32.8 p90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.54 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 56.0 mtp180 -142.39 60.39 1.45 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.128 -0.983 . . . . 0.0 109.621 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.48 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.6 m-85 -116.51 159.81 21.53 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.264 -0.898 . . . . 0.0 108.867 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -150.78 -104.12 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.078 . . . . 0.0 110.649 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.674 ' OH ' HG11 ' A' ' 59' ' ' VAL . 1.2 p90 -109.06 -164.18 0.92 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.077 -1.015 . . . . 0.0 110.398 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.04 147.39 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.941 0.876 . . . . 0.0 111.788 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.98 95.04 6.32 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.724 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.24 46.32 1.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.805 -1.184 . . . . 0.0 109.991 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.3 -130.99 0.13 Allowed Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.01 23.73 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 CA-C-N 119.372 1.586 . . . . 0.0 108.56 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.611 ' H ' ' C ' ' B' ' 9' ' ' GLY . 29.5 t -93.26 -11.11 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 0.0 109.876 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -134.71 123.04 23.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.415 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.339 0.59 . . . . 2.8900000000000001 109.426 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 3' ' ' LYS . 25.8 t -94.22 163.45 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.29999999999999999 108.959 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' VAL . 22.7 tptm -155.06 121.81 5.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.072 -1.017 . . . . 1.97 109.16 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -91.74 131.73 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.97999999999999998 109.621 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -107.1 108.87 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.821 -1.177 . . . . 0.19 107.821 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.75 -5.35 26.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.162 -0.961 . . . . 1.97 110.209 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -152.03 152.95 33.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 0.23000000000000001 110.076 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -52.32 -31.5 33.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 1.8999999999999999 109.713 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -61.2 -43.86 98.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.25 110.294 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.68 -24.39 64.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.20000000000000001 110.196 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.18 -64.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.20999999999999999 109.964 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 74.4 mm-40 -57.2 -44.4 83.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 2.4700000000000002 109.67 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -58.2 -36.03 72.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.24 -0.913 . . . . 2.1000000000000001 110.171 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.34 86.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.20000000000000001 109.454 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.7 mt -63.68 -44.41 93.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -0.795 . . . . 0.62 109.525 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.41 -36.87 85.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.0900000000000001 109.322 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.74 -17.88 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.002 . . . . 0.29999999999999999 109.483 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -6.43 27.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.23999999999999999 109.919 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.79 -112.43 4.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.722 -1.351 . . . . 0.28000000000000003 109.722 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 47.4 t0 -137.86 4.38 2.53 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.286 -1.126 . . . . 2.21 109.463 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -71.42 170.17 13.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 1.8999999999999999 109.471 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.02 164.08 13.49 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.105 -1.072 . . . . 0.17000000000000001 108.105 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.632 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.8 t -146.46 109.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.12 109.809 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 t -105.13 134.26 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.41 -0.959 . . . . 0.089999999999999997 108.41 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.56 140.0 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.17000000000000001 109.864 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -110.47 103.34 11.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.221 -0.659 . . . . 0.95999999999999996 109.221 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 54.6 m-85 -88.45 79.41 7.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.011 -1.107 . . . . 0.23999999999999999 108.011 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -114.17 149.68 35.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.767 -0.583 . . . . 1.03 109.643 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.47 129.01 37.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.868 . . . . 0.26000000000000001 108.699 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -66.6 -22.86 66.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.32000000000000001 110.688 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.551 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 52.9 p-90 -89.17 -21.73 23.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.965 -1.085 . . . . 0.44 110.406 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.01 119.78 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.32000000000000001 110.017 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.04 -54.57 35.67 Favored Glycine 0 N--CA 1.489 2.181 0 CA-C-O 119.429 -0.651 . . . . 0.35999999999999999 111.72 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -48.03 -35.44 25.56 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.58 1.52 . . . . 0.44 111.406 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.84 1.3 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.083 -1.01 . . . . 0.81000000000000005 109.063 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.98 -17.49 38.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 1.9199999999999999 109.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpt -59.77 -19.59 51.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -0.974 . . . . 3.1299999999999999 109.997 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.436 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.8 mt -99.7 10.58 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.11 -0.994 . . . . 0.28000000000000003 110.34 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.26 -33.44 7.91 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 120.714 -1.241 . . . . 1.6200000000000001 112.167 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -61.51 -6.54 7.22 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.078 1.064 . . . . 0.25 110.59 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -107.9 -74.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.555 -0.716 . . . . 0.29999999999999999 109.403 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -45.03 -55.9 5.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.299 -0.876 . . . . 0.13 110.707 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.07 -31.48 72.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.049 -1.032 . . . . 0.40999999999999998 109.89 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -64.07 -40.42 96.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.924 -1.11 . . . . 0.96999999999999997 110.189 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 mt -51.57 -12.6 0.18 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.5 109.979 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' SER . 27.8 m -56.44 -38.56 71.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.835 -1.165 . . . . 0.51000000000000001 109.566 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.14 -11.18 33.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.305 -0.872 . . . . 2.0 109.875 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.61 -53.26 4.73 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.3 -1.0 . . . . 2.1600000000000001 108.3 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.19 72.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.342 -0.849 . . . . 0.23999999999999999 109.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 p -66.7 -1.6 3.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.17000000000000001 108.602 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -95.3 -4.38 45.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.34000000000000002 109.541 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.2 t -116.75 150.5 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.947 -0.76 . . . . 0.12 108.947 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mm -100.45 132.24 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.421 -0.799 . . . . 0.17000000000000001 109.088 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.58 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.6 m-85 -114.77 134.83 54.79 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.335 -0.853 . . . . 0.11 109.5 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -115.5 171.36 7.77 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.762 -0.829 . . . . 0.12 108.762 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.06 142.49 30.68 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.946 -1.131 . . . . 1.3100000000000001 107.946 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.3 141.16 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.148 -0.97 . . . . 0.14000000000000001 110.246 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.1 93.86 6.51 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.819 -1.178 . . . . 1.0800000000000001 107.819 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 74' ' ' THR . 10.5 m -54.35 -3.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.27000000000000002 111.47 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 6.2 m-20 -113.15 -37.35 4.78 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 111.231 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -95.42 -16.8 22.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.887 -1.133 . . . . 1.1200000000000001 109.619 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.81 49.92 1.58 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.54 -0.911 . . . . 0.17000000000000001 108.54 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.471 ' CB ' HH21 ' B' ' 4' ' ' ARG . 8.1 pt20 -54.98 -14.5 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.514 -0.741 . . . . 2.2200000000000002 110.054 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -38.35 73.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.927 -1.108 . . . . 1.1100000000000001 109.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.42 -47.51 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.007 . . . . 0.19 108.644 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.85 78.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.809 . . . . 0.22 109.351 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.3 m -64.31 -50.31 68.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 1.29 109.663 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -63.47 -33.27 75.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 2.2000000000000002 109.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.93 0.41 55.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.094 -1.004 . . . . 0.33000000000000002 109.538 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 48.95 54.19 11.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 2.3399999999999999 110.157 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.28 129.53 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.28000000000000003 109.037 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -122.65 -3.58 8.76 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.465 -0.772 . . . . 2.3999999999999999 109.733 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.58 141.53 21.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.116 -0.99 . . . . 0.22 109.451 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.62 HG23 ' CE2' ' B' ' 5' ' ' TYR . 10.4 p -121.02 150.31 53.03 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.25 149.8 90.29 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.749 -0.938 . . . . 0.20000000000000001 110.127 -2.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.91 124.77 49.09 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.855 -1.165 . . . . 0.17999999999999999 107.855 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.79 ' CD1' HD21 ' A' ' 97' ' ' LEU . 75.3 m-85 -102.35 115.7 31.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.269 -1.011 . . . . 0.14999999999999999 108.269 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 5.2 mt-30 -116.58 139.96 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.012 -1.107 . . . . 1.03 108.012 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -109.54 126.52 53.66 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.48 0.657 . . . . 0.11 110.065 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -123.0 154.78 38.0 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.205 -1.035 . . . . 0.17000000000000001 108.205 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -155.87 123.76 5.67 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.965 -1.124 . . . . 1.48 107.965 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 56.84 20.74 5.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.726 -0.609 . . . . 1.6699999999999999 110.088 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 94.22 -1.48 67.33 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.074 -1.016 . . . . 0.22 110.579 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -110.79 148.02 33.24 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.112 -1.228 . . . . 2.0800000000000001 110.56 -179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -86.6 139.98 30.29 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.522 -0.918 . . . . 1.7 108.522 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -122.34 -21.44 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.454 -0.779 . . . . 0.26000000000000001 110.704 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.74 174.92 47.17 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.425 -1.369 . . . . 0.17999999999999999 110.209 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.75 155.75 2.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -1.14 . . . . 2.04 110.531 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.5 p90 -169.76 135.06 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.685 -0.634 . . . . 0.14000000000000001 109.875 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -107.2 -178.76 3.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.341 -0.85 . . . . 0.17000000000000001 108.898 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.41 134.0 8.34 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.446 -1.462 . . . . 0.13 109.446 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.516 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.75 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -1.195 . . . . 0.20000000000000001 110.261 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -138.82 73.21 1.42 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.936 -1.135 . . . . 1.1499999999999999 107.936 178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -34.86 78.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 1.1899999999999999 110.84 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.38 -25.03 67.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.991 -1.068 . . . . 1.95 109.354 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -69.1 -38.12 78.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.372 -0.83 . . . . 2.0499999999999998 109.726 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 77' ' ' PHE . 42.6 mt -51.23 -36.51 42.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.919 -1.113 . . . . 0.14999999999999999 109.077 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.45 -56.63 10.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.851 . . . . 2.1499999999999999 109.573 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.94 86.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.14999999999999999 110.398 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 m -67.47 -47.41 70.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.137 -0.977 . . . . 0.13 109.818 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -60.94 -49.4 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.17999999999999999 108.46 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.55 -17.71 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 1.03 109.62 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.2 -60.35 2.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 2.02 109.928 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.11 21.54 5.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.492 -0.755 . . . . 0.34999999999999998 110.307 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 1.1799999999999999 109.197 179.454 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.588 ' CE2' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -140.7 89.03 2.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.338 -0.851 . . . . 0.0 108.909 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' B' ' 1' ' ' PHE . 43.2 m-85 -99.6 163.52 12.46 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.129 -0.982 . . . . 0.0 109.518 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.471 HH21 ' CB ' ' A' ' 63' ' ' GLN . 5.8 mmt180 -150.33 -101.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 108.805 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.62 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -113.17 -171.77 1.93 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.068 -1.02 . . . . 0.0 111.002 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.4 t -64.91 144.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.912 0.863 . . . . 0.0 113.072 -176.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -101.7 93.81 5.52 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.412 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 10.6 pt-20 -85.04 44.7 1.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.07 . . . . 0.0 110.843 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.27 -133.46 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.36 18.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.23 1.515 . . . . 0.0 109.639 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.655 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.3 t -83.74 -25.32 30.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.467 -0.771 . . . . 0.0 109.66 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.572 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.7 OUTLIER -74.38 -128.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.572 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.536 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.251 0.548 . . . . 2.8900000000000001 109.545 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.0 t -94.71 169.2 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.29999999999999999 109.299 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -152.69 119.77 5.83 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.923 -1.139 . . . . 1.97 107.923 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -86.95 144.1 27.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.974 -1.079 . . . . 0.97999999999999998 110.362 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mm -111.05 108.64 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.884 -1.154 . . . . 0.19 107.884 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.65 -12.56 19.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 1.97 109.489 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -153.55 155.12 35.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 0.23000000000000001 109.631 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -51.35 -21.25 2.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 1.8999999999999999 109.436 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.57 -52.9 62.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 0.25 110.435 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -20.45 63.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.20000000000000001 110.275 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.37 -65.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.059 -1.026 . . . . 0.20999999999999999 110.19 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.37 -45.07 84.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 2.4700000000000002 109.633 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -59.0 -34.44 71.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.214 -0.929 . . . . 2.1000000000000001 109.985 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.38 81.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.916 -1.115 . . . . 0.20000000000000001 109.332 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.74 -45.97 84.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.227 -0.921 . . . . 0.62 109.447 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -63.78 -37.41 87.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 1.0900000000000001 109.466 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.76 -16.93 52.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.29999999999999999 109.472 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.78 27.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.23999999999999999 109.522 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.38 -111.0 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.742 -1.343 . . . . 0.28000000000000003 109.742 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -138.1 3.57 2.42 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.391 -1.064 . . . . 2.21 109.349 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' HOH . 76.9 mttt -70.29 169.05 14.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.164 -0.96 . . . . 1.8999999999999999 108.916 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 162.32 12.2 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.035 -1.098 . . . . 0.17000000000000001 108.035 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -144.18 103.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.831 -1.168 . . . . 0.12 109.628 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.27 129.92 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.563 -0.903 . . . . 0.089999999999999997 108.563 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.16 141.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -0.762 . . . . 0.17000000000000001 109.548 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -110.97 99.1 8.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.957 -0.757 . . . . 0.95999999999999996 108.957 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 52.0 m-85 -84.82 81.41 8.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.632 -1.248 . . . . 0.23999999999999999 107.632 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -109.89 -163.87 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.563 0.697 . . . . 1.03 109.147 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.53 119.93 13.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.151 -1.055 . . . . 0.26000000000000001 108.151 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -63.21 -24.02 67.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.32000000000000001 110.565 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.7 p-90 -89.64 -14.87 33.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.44 110.118 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 t -93.77 133.73 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.32000000000000001 109.706 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.448 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.77 -57.76 5.21 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 111.337 -0.705 . . . . 0.35999999999999999 111.337 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.5 Cg_exo -49.24 -37.27 39.32 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.779 1.652 . . . . 0.44 111.414 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.46 -62.62 1.56 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.857 -1.152 . . . . 0.81000000000000005 109.069 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -59.0 -20.05 49.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 1.9199999999999999 109.676 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.4 tpt -60.57 -18.04 50.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.322 -0.861 . . . . 3.1299999999999999 109.662 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -100.51 10.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.289 -0.882 . . . . 0.28000000000000003 110.412 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.59 -32.3 5.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.416 -1.427 . . . . 1.6200000000000001 112.386 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -63.07 -5.09 7.17 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 CA-C-N 119.865 0.988 . . . . 0.25 110.29 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.8 -77.51 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.928 -0.767 . . . . 0.29999999999999999 108.928 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -42.44 -56.63 2.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.13 110.998 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -65.73 -33.32 75.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.103 -0.998 . . . . 0.40999999999999998 109.688 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 m -64.36 -39.89 94.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 0.96999999999999997 109.997 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -51.85 -16.54 0.72 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.025 -1.047 . . . . 0.5 109.72 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -57.01 -29.46 63.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.51000000000000001 109.737 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -95.95 -21.4 18.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 2.0 110.162 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -90.32 -19.7 23.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.053 -1.029 . . . . 2.1600000000000001 109.41 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.15 64.65 1.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.39 -0.819 . . . . 0.23999999999999999 109.209 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 p -66.9 -4.43 9.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.337 -0.852 . . . . 0.17000000000000001 109.027 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -95.05 2.31 55.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.445 -0.784 . . . . 0.34000000000000002 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -119.0 150.03 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.157 -0.683 . . . . 0.12 109.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.79 122.31 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.17000000000000001 108.982 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -109.74 129.84 55.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.254 -0.904 . . . . 0.11 108.969 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.7 169.63 8.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.336 -0.852 . . . . 0.12 108.807 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -142.06 140.39 32.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.602 -1.259 . . . . 1.3100000000000001 107.602 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.2 136.94 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.898 . . . . 0.14000000000000001 110.741 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.99 107.68 20.26 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.645 -1.243 . . . . 1.0800000000000001 107.645 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.3 m -65.14 -9.68 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.27000000000000002 111.06 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -101.03 -41.69 6.68 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.013 -1.054 . . . . 1.1100000000000001 110.704 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -12.48 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 1.1200000000000001 109.91 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.31 49.63 1.88 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.311 -0.868 . . . . 0.17000000000000001 108.836 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.08 -17.01 5.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.721 . . . . 2.2200000000000002 109.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.4 p30 -70.33 -41.29 73.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.004 . . . . 1.1100000000000001 109.433 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -74.18 -45.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.19 108.674 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.27 79.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.282 -0.886 . . . . 0.22 108.779 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -64.04 -44.79 91.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.369 -0.832 . . . . 1.29 109.265 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.59 -39.11 93.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.449 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.71 55.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.186 -0.946 . . . . 0.33000000000000002 109.909 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 47.65 56.21 7.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.06 -1.025 . . . . 2.3399999999999999 109.748 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.9 t -79.52 131.27 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.28000000000000003 109.588 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -128.8 0.96 5.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.385 -0.822 . . . . 2.3999999999999999 109.669 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.0 128.65 10.8 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.966 -1.084 . . . . 0.22 108.771 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.666 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.2 p -114.77 150.43 44.03 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.733 -0.84 . . . . 0.22 108.733 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.54 147.47 84.66 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 C-N-CA 124.776 -0.927 . . . . 0.20000000000000001 109.941 -1.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.56 117.42 28.93 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.938 -1.134 . . . . 0.17999999999999999 107.938 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.6 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.2 m-85 -91.78 121.48 33.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.07 -1.019 . . . . 0.14999999999999999 108.494 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.504 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.1 mt-30 -120.05 136.38 54.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.783 -1.191 . . . . 1.03 107.783 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 32.3 m-85 -108.97 129.43 55.44 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.581 0.705 . . . . 0.11 109.978 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -126.24 156.92 39.52 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.263 -1.014 . . . . 0.17000000000000001 108.263 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -155.39 120.23 4.79 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.485 -1.302 . . . . 1.48 107.485 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt 55.97 29.14 13.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -0.783 . . . . 1.6699999999999999 108.909 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.13 7.8 87.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.896 -1.281 . . . . 0.22 109.896 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 34.7 mm-40 -112.85 142.41 45.54 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.469 -1.018 . . . . 2.0800000000000001 110.643 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -84.77 141.37 30.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 1.7 109.314 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.34 -20.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.426 -0.796 . . . . 0.26000000000000001 110.452 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.24 172.97 45.53 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.346 -1.407 . . . . 0.17999999999999999 110.435 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -174.22 150.68 1.54 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.447 -1.031 . . . . 2.04 110.044 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.9 p90 -169.09 133.18 1.41 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.14000000000000001 110.48 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.55 -169.55 1.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.17000000000000001 108.929 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.13 129.88 3.67 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.669 -1.372 . . . . 0.13 109.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.87 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -1.16 . . . . 0.20000000000000001 110.602 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -139.46 76.68 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.828 -1.175 . . . . 1.1499999999999999 107.828 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.34 -32.55 74.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.654 -0.654 . . . . 1.1899999999999999 110.656 -178.671 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.66 -28.35 69.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.906 -1.121 . . . . 1.95 109.146 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.71 -35.23 76.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 2.0499999999999998 109.322 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.4 mt -52.07 -38.99 59.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.14999999999999999 108.823 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -57.63 6.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.578 -0.701 . . . . 2.1499999999999999 109.785 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.32 82.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.14999999999999999 110.494 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.2 m -66.78 -45.79 77.36 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.13 110.163 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.68 -52.37 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.17999999999999999 109.214 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -60.52 -18.09 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 1.03 109.449 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -77.39 -62.72 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 2.02 110.202 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.33 24.39 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.558 -0.714 . . . . 0.34999999999999998 110.437 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.937 -1.102 . . . . 1.1799999999999999 109.165 179.541 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.4 p90 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 90.1 mtt180 -146.68 71.22 1.23 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.195 -0.941 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.5 m-85 -118.65 143.66 46.68 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.536 -0.728 . . . . 0.0 109.208 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -138.65 -105.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -109.55 -168.39 1.32 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.259 -0.901 . . . . 0.0 110.461 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.67 150.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.266 -0.896 . . . . 0.0 112.57 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.9 m -101.4 96.53 7.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.595 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.25 44.76 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 110.279 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.89 -131.43 0.12 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.08 23.98 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.273 1.537 . . . . 0.0 109.129 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.622 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.6 t -84.99 -50.72 7.24 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.354 -0.842 . . . . 0.0 109.335 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -92.23 102.57 15.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.378 -0.827 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.984 -1.454 . . . . 0.0 109.558 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.553 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.1 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.273 -0.639 . . . . 2.8900000000000001 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.9 t -94.52 162.28 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.169 -0.957 . . . . 0.29999999999999999 109.588 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' N ' HG12 ' A' ' 2' ' ' VAL . 33.6 tttt -155.96 123.32 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 1.97 109.224 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -90.45 132.52 35.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.97999999999999998 109.645 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -112.51 103.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.548 -0.908 . . . . 0.19 108.548 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -99.19 -4.46 32.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.204 -0.935 . . . . 1.97 109.852 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 p -151.18 148.9 28.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.112 -0.992 . . . . 0.23000000000000001 109.96 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -52.31 -25.59 9.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.319 -0.863 . . . . 1.8999999999999999 109.552 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.7 m -59.7 -48.92 79.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.25 109.34 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -23.62 62.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.20000000000000001 109.733 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -58.28 -66.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.20999999999999999 110.198 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.2 mt-30 -56.27 -44.62 79.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 2.4700000000000002 109.669 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -58.91 -35.11 72.52 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 2.1000000000000001 109.804 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.20000000000000001 108.898 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.21 -43.52 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.578 -0.702 . . . . 0.62 109.318 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 -38.2 90.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 1.0900000000000001 109.681 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.19 -16.08 55.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.29999999999999999 109.909 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.28 50.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.23999999999999999 109.889 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 -112.94 4.76 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.31 -1.516 . . . . 0.28000000000000003 109.31 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -134.71 2.54 3.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.435 -1.038 . . . . 2.21 109.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 76.3 mttt -70.28 166.87 19.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.044 -1.035 . . . . 1.8999999999999999 108.689 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.39 163.36 10.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.17000000000000001 108.834 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.2 t -144.6 107.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 0.12 109.402 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.38 135.5 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.556 -0.905 . . . . 0.089999999999999997 108.556 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.15 133.44 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.17000000000000001 109.894 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 9.4 t70 -106.44 102.96 12.31 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.98 -0.748 . . . . 0.95999999999999996 108.98 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -88.45 79.43 7.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.603 -1.258 . . . . 0.23999999999999999 107.603 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 67.0 m -113.3 149.27 34.16 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.225 0.536 . . . . 1.03 109.613 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.89 129.57 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.858 . . . . 0.26000000000000001 109.082 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.45 -23.97 65.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 0.32000000000000001 110.118 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.542 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.8 p-90 -89.1 -16.88 30.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.061 -1.024 . . . . 0.44 110.176 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.48 124.71 37.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.965 . . . . 0.32000000000000001 110.291 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.76 -57.75 11.67 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.972 -0.851 . . . . 0.35999999999999999 110.972 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -46.18 -36.07 16.19 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 121.908 1.739 . . . . 0.44 111.359 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.0 -60.31 2.41 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.672 -1.267 . . . . 0.81000000000000005 108.991 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -59.91 -18.39 44.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.489 -0.757 . . . . 1.9199999999999999 110.029 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.4 tpt -59.68 -24.77 64.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 3.1299999999999999 110.155 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.662 ' O ' HG22 ' A' ' 38' ' ' ILE . 72.3 mt -96.91 6.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.142 -0.974 . . . . 0.28000000000000003 111.371 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -62.58 -34.39 14.52 Favored Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 118.194 -1.402 . . . . 1.6200000000000001 111.64 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -62.32 -5.9 7.48 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 CA-C-N 120.009 1.039 . . . . 0.25 110.524 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.83 -71.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.29999999999999999 108.958 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -46.06 -58.5 3.55 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.488 -0.757 . . . . 0.13 110.733 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -65.24 -30.49 71.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.40999999999999998 109.714 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 m -63.54 -41.17 98.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.855 -1.153 . . . . 0.96999999999999997 109.735 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -52.01 -16.92 0.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.5 109.575 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 66.6 m -56.93 -31.37 64.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.51000000000000001 109.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.92 -19.72 20.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.127 -0.983 . . . . 2.0 109.906 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -90.94 -21.38 21.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 2.1600000000000001 109.774 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.22 67.71 1.5 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.23999999999999999 109.231 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -68.01 -3.97 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.413 -0.805 . . . . 0.17000000000000001 109.322 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -94.94 2.22 55.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.34000000000000002 109.719 -179.687 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.1 t -119.12 152.99 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.811 -0.811 . . . . 0.12 108.811 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 mm -100.44 128.64 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.306 -0.871 . . . . 0.17000000000000001 108.911 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.603 ' C ' HD12 ' A' ' 55' ' ' LEU . 65.0 m-85 -114.58 132.9 56.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.407 -0.808 . . . . 0.11 109.144 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -115.31 169.0 9.47 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.083 -0.71 . . . . 0.12 109.083 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -144.25 141.1 29.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.196 -1.039 . . . . 1.3100000000000001 108.196 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.15 145.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.103 -0.998 . . . . 0.14000000000000001 110.425 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' CG ' HH21 ' B' ' 2' ' ' ARG . 19.2 t70 -101.32 100.92 11.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.219 -1.03 . . . . 1.0800000000000001 108.219 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.09 -3.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.246 -0.909 . . . . 0.27000000000000002 111.287 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 27.1 m-20 -108.79 -40.94 4.9 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.203 -0.936 . . . . 1.1100000000000001 111.095 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.21 -23.43 16.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.891 -1.131 . . . . 1.1200000000000001 110.036 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.0 46.34 0.98 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.352 -0.981 . . . . 0.17000000000000001 108.352 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -53.53 -14.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.731 -0.606 . . . . 2.2200000000000002 109.9 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -71.2 -42.98 68.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 109.316 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.19 -43.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.143 -0.973 . . . . 0.19 108.696 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -35.55 79.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 m -64.69 -46.98 80.07 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.754 -0.832 . . . . 1.29 108.754 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.57 -39.42 94.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 2.2000000000000002 109.35 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -3.15 58.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 0.33000000000000002 109.603 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 66' ' ' ALA . 52.3 mm-40 47.47 53.01 11.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.873 . . . . 2.3399999999999999 110.352 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.96 136.14 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.28000000000000003 109.413 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -129.88 3.86 4.92 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.476 -0.765 . . . . 2.3999999999999999 109.5 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 136.26 16.27 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.128 -0.982 . . . . 0.22 108.883 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.521 HG23 ' CE2' ' B' ' 5' ' ' TYR . 41.1 p -118.55 150.79 48.76 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.945 -0.761 . . . . 0.22 108.945 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.76 145.92 80.39 Favored 'Cis proline' 0 N--CA 1.482 0.848 0 N-CA-C 109.778 -0.893 . . . . 0.20000000000000001 109.778 -1.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.6 112.47 22.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.513 -1.292 . . . . 0.17999999999999999 107.513 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -92.56 113.8 26.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.426 -0.91 . . . . 0.14999999999999999 108.686 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -115.91 138.68 50.95 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.443 -1.317 . . . . 1.03 107.443 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 21.3 m-85 -110.11 127.23 54.77 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.374 0.607 . . . . 0.11 109.756 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -121.45 157.18 31.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.541 -0.911 . . . . 0.17000000000000001 108.541 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -155.73 123.53 5.65 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.491 -1.3 . . . . 1.48 107.491 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt 57.07 17.81 3.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.687 -0.633 . . . . 1.6699999999999999 109.89 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.72 0.18 62.59 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.416 -1.074 . . . . 0.22 110.416 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.3 mm100 -111.87 151.1 29.51 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.184 -1.186 . . . . 2.0800000000000001 110.033 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.398 -0.814 . . . . 1.7 109.316 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.87 -7.03 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.735 . . . . 0.26000000000000001 110.542 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.93 167.77 35.29 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.445 -1.36 . . . . 0.17999999999999999 110.284 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.95 153.2 2.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 2.04 110.604 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 8.2 p90 -169.66 132.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.14000000000000001 109.603 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.7 p -104.23 -162.28 0.88 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.015 -1.053 . . . . 0.17000000000000001 109.183 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.14 137.1 1.08 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.325 -1.51 . . . . 0.13 109.325 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.49 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.20000000000000001 110.094 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -137.46 66.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.868 -1.16 . . . . 1.1499999999999999 107.868 178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -62.24 -38.94 91.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.816 -0.552 . . . . 1.1899999999999999 111.262 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.58 -27.33 68.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.596 -1.315 . . . . 1.95 109.497 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.19 -32.77 73.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 2.0499999999999998 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.9 mt -51.4 -36.88 45.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.14999999999999999 108.687 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.34 -59.64 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.527 -0.733 . . . . 2.1499999999999999 109.848 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.47 81.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.14999999999999999 110.741 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.8 m -67.84 -45.28 75.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.13 110.211 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.55 -51.24 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.17999999999999999 109.157 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.71 -17.22 46.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 1.03 109.634 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.95 -61.26 1.99 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 2.02 110.015 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.9 21.33 5.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.424 -0.797 . . . . 0.34999999999999998 110.391 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.017 -1.052 . . . . 1.1799999999999999 109.414 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.6 p90 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 47.4 mtp180 -142.76 57.77 1.43 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.224 -0.923 . . . . 0.0 109.308 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.47 160.24 22.07 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.606 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.54 -86.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.408 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -125.35 -173.97 2.95 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.16 149.72 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.006 0.908 . . . . 0.0 112.496 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.55 95.69 6.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -83.89 41.59 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.03 -1.044 . . . . 0.0 110.361 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -129.4 0.05 OUTLIER Glycine 0 N--CA 1.485 1.915 0 N-CA-C 106.898 -2.481 . . . . 0.0 106.898 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.71 22.67 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.307 1.553 . . . . 0.0 109.119 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t -101.82 11.39 38.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -154.75 123.75 6.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 109.46 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 CA-C-O 117.951 -1.472 . . . . 0.0 109.494 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.445 -0.576 . . . . 2.8900000000000001 109.445 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.3 t -94.68 168.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.262 -0.899 . . . . 0.29999999999999999 109.41 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.618 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.7 tttp -151.92 121.54 6.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.234 -0.916 . . . . 1.97 109.073 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -88.29 132.04 34.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.97999999999999998 109.709 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.97 107.46 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.228 -1.027 . . . . 0.19 108.228 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.58 -10.33 22.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.201 -0.937 . . . . 1.97 109.646 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 p -153.51 157.49 39.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.23000000000000001 109.95 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -53.02 -30.38 35.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 1.8999999999999999 109.916 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 m -59.49 -45.1 92.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.25 110.25 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.06 -26.48 64.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.20000000000000001 109.795 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.02 -69.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.973 . . . . 0.20999999999999999 110.237 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 71.7 mm-40 -54.38 -43.16 71.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 2.4700000000000002 109.603 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -59.0 -36.36 74.8 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.171 -0.956 . . . . 2.1000000000000001 109.643 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.0 -47.63 85.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.032 -1.043 . . . . 0.20000000000000001 109.013 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.18 -44.49 88.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.735 . . . . 0.62 109.877 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -62.92 -45.73 91.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 1.0900000000000001 109.826 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.95 59.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.29999999999999999 109.876 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.79 -10.53 57.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.084 -1.01 . . . . 0.23999999999999999 109.649 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.61 13.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.28000000000000003 109.612 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 46.1 t0 -121.17 2.81 10.4 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.586 -0.949 . . . . 2.21 109.925 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 109' ' ' HOH . 46.9 mttp -68.25 169.98 9.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.902 -1.123 . . . . 1.8999999999999999 109.367 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.0 162.43 19.36 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.19 -1.041 . . . . 0.17000000000000001 108.19 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.8 t -145.26 102.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.981 -1.074 . . . . 0.12 109.111 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' CE2' ' A' ' 79' ' ' PHE . 3.1 t -101.42 127.54 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.485 -0.76 . . . . 0.089999999999999997 109.069 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.0 138.32 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.606 -0.684 . . . . 0.17000000000000001 109.764 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -108.86 99.46 8.8 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.974 -0.751 . . . . 0.95999999999999996 108.974 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.6 m-85 -82.96 77.26 9.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.794 -1.187 . . . . 0.23999999999999999 107.794 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -103.98 -166.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.574 0.702 . . . . 1.03 109.433 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 127.98 21.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.863 -0.791 . . . . 0.26000000000000001 108.863 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.32000000000000001 111.194 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.557 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.7 p-90 -86.74 -11.05 52.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.768 -1.208 . . . . 0.44 110.09 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.84 117.38 30.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.32000000000000001 109.981 -179.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.63 -55.19 31.32 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 120.865 -0.683 . . . . 0.35999999999999999 111.419 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.1 Cg_exo -49.59 -35.7 38.31 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.814 1.676 . . . . 0.44 111.11 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.34 -62.64 1.59 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.951 -1.093 . . . . 0.81000000000000005 109.055 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.62 -16.93 29.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.476 -0.765 . . . . 1.9199999999999999 110.163 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -61.48 -19.37 61.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.083 -1.011 . . . . 3.1299999999999999 110.222 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.649 ' O ' HG22 ' A' ' 38' ' ' ILE . 72.2 mt -100.48 13.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.244 -0.91 . . . . 0.28000000000000003 110.718 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.51 -32.1 2.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.469 -1.394 . . . . 1.6200000000000001 112.607 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.7 Cg_exo -63.79 -4.06 6.64 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 119.793 0.962 . . . . 0.25 110.268 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 42' ' ' PHE . 42.0 m-85 -110.9 -79.47 0.58 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.404 -0.81 . . . . 0.29999999999999999 108.907 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.62 -57.12 1.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.566 . . . . 0.13 110.79 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.07 -30.72 70.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.40999999999999998 109.834 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 11.2 m -66.76 -38.62 86.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.96999999999999997 110.284 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -49.45 -20.25 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.935 -1.103 . . . . 0.5 109.772 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -56.71 -22.94 38.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.51000000000000001 110.105 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -97.07 -26.46 14.98 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.15 -0.969 . . . . 2.0 110.239 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.13 -17.76 27.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.077 -1.014 . . . . 2.1600000000000001 109.56 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -134.16 70.19 1.45 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.377 -0.827 . . . . 0.23999999999999999 109.39 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.6 p -68.51 -6.23 24.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.423 -0.798 . . . . 0.17000000000000001 109.12 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.2 3.31 54.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.448 -0.782 . . . . 0.34000000000000002 110.052 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.69 148.54 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.12 109.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.419 HD13 ' N ' ' A' ' 53' ' ' ILE . 4.8 mm -99.23 121.73 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17000000000000001 108.983 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' C ' HD12 ' A' ' 55' ' ' LEU . 81.4 m-85 -108.84 128.39 54.86 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.878 . . . . 0.11 108.937 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.7 mp -110.2 170.41 8.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.504 -0.747 . . . . 0.12 109.023 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -140.82 137.93 33.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.634 -1.247 . . . . 1.3100000000000001 107.634 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.69 134.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.913 . . . . 0.14000000000000001 110.336 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.14 110.31 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.63 -1.248 . . . . 1.0800000000000001 107.63 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.23 -11.35 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.27000000000000002 111.346 -178.251 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.557 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 12.1 m-20 -104.76 -38.92 6.51 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.022 -1.049 . . . . 1.1100000000000001 110.793 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB2' HH11 ' B' ' 2' ' ' ARG . 14.8 t70 -93.52 -13.62 27.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.908 -1.12 . . . . 1.1200000000000001 109.693 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.46 49.14 1.94 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.306 -0.998 . . . . 0.17000000000000001 108.306 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 86.7 mt-30 -56.11 -16.42 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 2.2200000000000002 110.755 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -39.43 76.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.853 -1.154 . . . . 1.1100000000000001 109.304 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.8 -47.12 44.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.201 -0.937 . . . . 0.19 108.84 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.86 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.847 . . . . 0.22 109.333 179.488 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.0 m -62.78 -50.13 72.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 1.29 109.26 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.54 -32.33 73.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 2.2000000000000002 109.635 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.98 0.11 56.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.238 -0.913 . . . . 0.33000000000000002 109.816 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 47.41 50.01 15.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 2.3399999999999999 110.097 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.61 131.94 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 109.064 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -129.12 6.71 5.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.331 -0.855 . . . . 2.3999999999999999 109.661 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 144.29 24.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.497 HG23 ' CE2' ' B' ' 5' ' ' TYR . 32.5 p -131.01 149.12 72.87 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 108.546 -0.909 . . . . 0.22 108.546 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.4 Cg_endo -79.09 142.69 68.3 Favored 'Cis proline' 0 N--CA 1.487 1.134 0 C-N-CA 124.966 -0.848 . . . . 0.20000000000000001 110.219 -1.312 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.01 111.06 21.52 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 107.862 -1.162 . . . . 0.17999999999999999 107.862 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 97' ' ' LEU . 88.7 m-85 -86.15 116.0 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.822 -1.174 . . . . 0.14999999999999999 109.541 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.3 mt-30 -115.96 132.12 56.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.325 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -105.14 127.51 52.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.11 109.66 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -121.78 155.46 35.24 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.92 -0.77 . . . . 0.17000000000000001 108.92 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -154.96 123.65 6.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.737 -1.208 . . . . 1.48 107.737 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 55.95 28.88 13.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.529 -0.732 . . . . 1.6699999999999999 109.827 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.07 -0.1 89.49 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.089 -1.053 . . . . 0.22 110.815 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -110.98 147.88 33.75 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.144 -1.209 . . . . 2.0800000000000001 110.475 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -87.87 143.84 26.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 1.7 109.339 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.1 m -123.59 -24.0 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.497 -0.752 . . . . 0.26000000000000001 110.15 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.29 177.18 47.87 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.586 -1.292 . . . . 0.17999999999999999 109.975 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.19 157.21 3.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 2.04 110.057 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 6.5 p90 -168.76 131.16 1.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.807 . . . . 0.14000000000000001 110.161 178.958 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -101.48 -161.16 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.559 -0.904 . . . . 0.17000000000000001 108.559 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' B' ' 8' ' ' GLU . . . 82.43 126.5 0.98 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.104 -1.598 . . . . 0.13 109.104 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.09 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -1.203 . . . . 0.20000000000000001 110.891 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -142.73 76.61 1.54 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.967 -1.123 . . . . 1.1499999999999999 107.967 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -32.4 73.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.1899999999999999 110.774 -178.56 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.13 -25.23 67.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.93 -1.106 . . . . 1.95 109.372 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -70.86 -37.23 73.09 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.3 -0.875 . . . . 2.0499999999999998 109.852 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.5 mt -52.17 -36.03 50.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.14999999999999999 108.962 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -66.09 -59.21 4.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.431 -0.793 . . . . 2.1499999999999999 110.071 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.53 82.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.14999999999999999 110.676 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.4 m -67.22 -45.22 77.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.072 -1.017 . . . . 0.13 110.192 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.04 -53.03 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.191 -0.943 . . . . 0.17999999999999999 109.127 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -59.19 -18.53 37.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 1.03 109.471 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.54 -56.56 4.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 2.02 110.08 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -92.96 15.47 14.88 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.495 -0.753 . . . . 0.34999999999999998 110.613 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.872 -1.143 . . . . 1.1799999999999999 109.403 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 50.9 p90 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 58.9 mtm180 -154.28 74.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.228 -0.92 . . . . 0.0 109.233 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.552 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.5 m-85 -122.27 152.21 40.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.627 -0.67 . . . . 0.0 109.386 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.1 -103.58 0.11 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.497 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.28 -169.78 1.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.177 -0.952 . . . . 0.0 110.973 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.63 150.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-O 122.09 0.948 . . . . 0.0 112.875 -176.778 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -102.24 96.28 6.87 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -82.88 47.86 1.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 110.131 -179.51 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -78.16 -125.28 0.35 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 177.936 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.9 25.67 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.495 1.648 . . . . 0.0 109.54 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.4 t -87.52 -24.43 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -78.53 143.9 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 CA-C-O 117.996 -1.447 . . . . 0.0 109.523 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.36 0.6 . . . . 2.8900000000000001 109.449 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 3' ' ' LYS . 95.3 t -94.76 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.29999999999999999 109.496 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 tptt -154.5 125.21 7.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.274 -0.891 . . . . 1.97 109.212 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -90.26 131.66 35.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.97999999999999998 109.668 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.32 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.403 -0.962 . . . . 0.19 108.403 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.63 -1.33 47.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 1.97 109.791 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -150.99 146.93 26.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.23000000000000001 109.813 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -51.83 -29.5 19.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.34 -0.85 . . . . 1.8999999999999999 109.831 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -59.04 -45.66 90.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.25 109.799 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.44 63.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.20000000000000001 109.681 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.99 -66.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.061 -1.024 . . . . 0.20999999999999999 109.786 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -53.65 -46.09 70.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.207 -0.933 . . . . 2.4700000000000002 109.728 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.98 -35.13 72.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.152 -0.967 . . . . 2.1000000000000001 110.022 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.53 -46.24 90.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.995 -1.065 . . . . 0.20000000000000001 109.296 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.4 -50.19 68.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.62 109.717 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.29 -36.59 84.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 1.0900000000000001 109.474 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.58 -18.66 47.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -0.927 . . . . 0.29999999999999999 109.682 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.8 23.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.23999999999999999 109.73 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 70.97 -116.11 6.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.28000000000000003 109.642 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 84.1 m-20 -135.22 4.01 3.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.442 -1.034 . . . . 2.21 109.408 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' HOH . 39.0 mttp -69.8 170.07 11.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.047 -1.033 . . . . 1.8999999999999999 109.013 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 159.89 22.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.71 -1.218 . . . . 0.17000000000000001 107.71 179.574 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.697 ' H ' HD23 ' A' ' 22' ' ' LEU . 16.1 t -143.56 108.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.865 -1.147 . . . . 0.12 109.374 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.95 134.47 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.912 -0.773 . . . . 0.089999999999999997 108.912 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.66 136.08 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.665 -0.647 . . . . 0.17000000000000001 109.523 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.37 101.95 11.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.017 -0.735 . . . . 0.95999999999999996 109.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -85.25 77.84 9.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.041 -1.096 . . . . 0.23999999999999999 108.041 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -113.92 146.47 40.02 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.16 -0.682 . . . . 1.03 109.16 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.56 130.51 36.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.26000000000000001 108.751 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -65.88 -24.57 66.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.32000000000000001 110.311 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 58.5 p-90 -88.54 -17.35 30.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.082 -1.011 . . . . 0.44 109.888 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.82 116.18 28.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.32000000000000001 110.135 -178.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.16 -53.14 47.21 Favored Glycine 0 N--CA 1.488 2.123 0 CA-C-O 119.341 -0.699 . . . . 0.35999999999999999 111.854 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.7 Cg_exo -48.38 -38.79 35.13 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.534 1.489 . . . . 0.44 111.148 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.4 -59.67 2.64 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.727 -1.233 . . . . 0.81000000000000005 109.015 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.49 -18.63 52.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.739 . . . . 1.9199999999999999 110.295 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm -57.93 -19.55 30.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.79 -1.194 . . . . 3.1299999999999999 110.257 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.688 ' O ' HG22 ' A' ' 38' ' ' ILE . 77.4 mt -101.5 15.02 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.136 -0.977 . . . . 0.28000000000000003 110.39 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.75 -32.21 3.43 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.618 -1.301 . . . . 1.6200000000000001 112.56 179.727 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.6 Cg_exo -63.08 -5.21 7.41 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.883 0.994 . . . . 0.25 110.165 -178.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.08 -76.73 0.6 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.475 -0.766 . . . . 0.29999999999999999 109.203 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.13 110.787 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.5 -31.52 72.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.93 -1.106 . . . . 0.40999999999999998 110.025 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.5 m -64.64 -38.82 92.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.818 -1.176 . . . . 0.96999999999999997 110.039 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -50.25 -12.62 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.926 -1.109 . . . . 0.5 109.776 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' SER . 19.4 m -56.76 -37.34 70.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.084 -1.01 . . . . 0.51000000000000001 109.665 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -94.97 -13.32 25.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.232 -0.918 . . . . 2.0 110.283 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -27.5 19.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.002 -1.062 . . . . 2.1600000000000001 109.572 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.42 72.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.088 -0.708 . . . . 0.23999999999999999 109.088 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.1 p -67.02 -4.48 9.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.17000000000000001 109.215 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -96.1 -3.17 45.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.34000000000000002 109.829 -179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.45 150.12 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.452 -0.78 . . . . 0.12 109.603 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.1 130.48 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.534 -0.729 . . . . 0.17000000000000001 109.412 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -115.03 132.53 56.57 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.554 -0.716 . . . . 0.11 109.192 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.66 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.743 -0.836 . . . . 0.12 108.743 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.68 138.9 32.79 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.688 -1.227 . . . . 1.3100000000000001 107.688 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.44 136.9 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.163 -0.961 . . . . 0.14000000000000001 110.887 -178.335 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -98.78 102.78 14.62 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.268 -1.012 . . . . 1.0800000000000001 108.268 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.3 m -61.06 -0.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.27000000000000002 111.56 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 18.0 m-20 -115.18 -37.86 3.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.102 -0.999 . . . . 1.1100000000000001 111.053 -178.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -94.96 -14.26 24.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.997 -1.064 . . . . 1.1200000000000001 109.766 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.58 52.84 1.6 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.709 -0.848 . . . . 0.17000000000000001 108.709 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -53.93 -19.23 4.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.431 -0.793 . . . . 2.2200000000000002 110.173 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.1 p30 -68.02 -39.57 83.11 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.18 -1.575 . . . . 1.1100000000000001 109.989 -178.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.14 -48.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.955 -1.091 . . . . 0.19 108.736 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.22 90.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.22 110.336 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.428 ' HA ' HH22 ' B' ' 4' ' ' ARG . 23.1 t -63.63 -42.19 98.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 1.29 109.581 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.69 -38.81 92.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.126 -0.984 . . . . 2.2000000000000002 109.191 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.9 0.17 56.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.33000000000000002 109.872 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 67' ' ' SER . 22.9 mp0 48.15 56.29 7.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 2.3399999999999999 110.222 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 6.9 t -79.14 132.76 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.28000000000000003 108.916 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 9.3 mtmp? -129.77 3.8 4.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.331 -0.856 . . . . 2.3999999999999999 110.358 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 123.17 7.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.975 -1.078 . . . . 0.22 109.457 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.667 HG23 ' CE2' ' B' ' 5' ' ' TYR . 37.5 p -109.47 150.25 40.92 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.322 -0.861 . . . . 0.22 109.068 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -77.41 139.55 58.82 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 C-N-CA 124.894 -0.878 . . . . 0.20000000000000001 110.421 -1.651 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -110.44 112.02 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.797 -1.186 . . . . 0.17999999999999999 107.797 178.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 97' ' ' LEU . 91.9 m-85 -89.62 119.08 29.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.919 -1.113 . . . . 0.14999999999999999 109.27 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -117.0 132.63 56.65 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.37 -1.344 . . . . 1.03 107.37 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.8 m-85 -108.76 123.77 49.53 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.628 0.727 . . . . 0.11 109.471 -178.234 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -120.86 157.37 29.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.54 -0.911 . . . . 0.17000000000000001 108.54 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.65 125.98 6.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.855 -1.165 . . . . 1.48 107.855 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm 56.18 26.15 9.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 1.6699999999999999 109.988 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.99 3.26 90.56 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.947 -1.261 . . . . 0.22 109.947 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -111.49 148.06 33.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.517 -0.99 . . . . 2.0800000000000001 109.744 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.66 146.03 26.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 1.7 109.692 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.91 -29.77 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -0.752 . . . . 0.26000000000000001 109.844 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.43 177.91 44.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.529 -1.32 . . . . 0.17999999999999999 110.472 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.1 pm0 -173.3 154.52 2.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -1.08 . . . . 2.04 110.164 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.1 p90 -168.98 131.58 1.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.353 -0.842 . . . . 0.14000000000000001 109.924 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -102.98 -158.16 0.65 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.231 -0.918 . . . . 0.17000000000000001 108.895 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.9 126.05 0.7 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.438 -1.465 . . . . 0.13 109.438 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.19 94.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.244 . . . . 0.20000000000000001 110.131 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.3 t-20 -139.49 76.59 1.57 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.37 -0.974 . . . . 1.1499999999999999 108.37 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -63.99 -41.08 97.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.778 -0.576 . . . . 1.1899999999999999 111.206 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.58 -25.85 68.15 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.051 -1.031 . . . . 1.95 109.785 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -69.35 -33.79 73.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.192 -0.942 . . . . 2.0499999999999998 109.405 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.8 mt -54.77 -35.53 63.9 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.68 -1.208 . . . . 0.14999999999999999 108.583 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -66.62 -55.96 12.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 2.1499999999999999 109.465 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.73 92.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.14999999999999999 110.419 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -65.81 -46.79 77.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.13 110.203 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.28 -49.67 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.17999999999999999 108.676 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' HG12 ' A' ' 105' ' ' VAL . 55.8 t30 -62.59 -17.06 59.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 1.03 109.183 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -79.37 -55.51 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 2.02 110.457 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 22' ' ' LEU . 27.2 mt -92.15 14.13 16.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.34999999999999998 110.336 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.962 -1.086 . . . . 1.1799999999999999 109.284 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.9 p90 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.533 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 57.8 mtp180 -139.78 73.55 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.225 -0.922 . . . . 0.0 109.316 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.468 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 42.2 m-85 -136.39 148.95 48.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.295 -0.878 . . . . 0.0 109.281 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.428 HH22 ' HA ' ' A' ' 67' ' ' SER . 7.0 ttt180 -143.9 -87.77 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.146 -0.971 . . . . 0.0 109.734 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.667 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.5 p90 -116.56 -167.79 1.34 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.843 -1.16 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.1 150.71 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.381 -0.825 . . . . 0.0 112.317 -177.437 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -101.59 95.36 6.4 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.412 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -82.51 45.42 0.96 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.075 -1.015 . . . . 0.0 109.594 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -133.99 0.08 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.81 25.38 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.79 0 CA-C-N 119.2 1.5 . . . . 0.0 108.773 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.2 t -88.04 -53.41 4.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 109.261 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.513 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 25.7 t-80 -93.25 -173.19 3.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.95 -1.472 . . . . 0.0 109.532 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 108' ' ' HOH . . . . . 0.402 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.287 0.565 . . . . 2.8900000000000001 109.501 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 31.1 t -94.85 172.07 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.29999999999999999 109.722 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 76.4 tttt -154.01 124.98 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.271 -0.893 . . . . 1.97 109.325 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -89.03 133.74 34.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.97999999999999998 109.654 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -105.56 117.01 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.162 -1.051 . . . . 0.19 108.162 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 11.6 mp0 -102.54 -14.67 16.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.156 -0.965 . . . . 1.97 109.508 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 p -152.74 158.63 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.23000000000000001 109.817 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -52.22 -26.71 12.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 1.8999999999999999 109.703 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -59.89 -48.61 80.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.25 110.018 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.67 62.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.20000000000000001 109.765 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.69 -69.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.018 . . . . 0.20999999999999999 110.039 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -54.23 -43.97 71.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -0.857 . . . . 2.4700000000000002 109.853 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.74 -37.45 76.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.236 -0.915 . . . . 2.1000000000000001 109.743 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.52 95.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.0 -1.063 . . . . 0.20000000000000001 109.187 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.69 -42.39 95.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.62 109.589 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.86 -42.44 97.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 1.0900000000000001 109.763 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -12.98 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.146 -0.971 . . . . 0.29999999999999999 109.552 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -5.91 25.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.23999999999999999 109.653 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.25 -110.76 3.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.369 -1.492 . . . . 0.28000000000000003 109.369 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.14 5.09 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.335 -1.097 . . . . 2.21 108.98 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 71.1 mttt -69.8 168.61 14.72 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.094 -1.004 . . . . 1.8999999999999999 108.819 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.49 162.52 12.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.039 -1.097 . . . . 0.17000000000000001 108.039 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.46 105.13 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.907 -1.121 . . . . 0.12 109.379 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.0 t -103.73 126.89 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.089999999999999997 108.833 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.59 138.97 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.713 . . . . 0.17000000000000001 109.527 -179.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.49 104.99 13.45 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.299 -0.63 . . . . 0.95999999999999996 109.299 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.53 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 48.3 m-85 -85.41 81.85 8.56 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.034 -1.099 . . . . 0.23999999999999999 108.034 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -114.53 150.3 35.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.785 -0.572 . . . . 1.03 109.636 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -92.46 125.3 37.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.26000000000000001 108.591 179.102 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -66.13 -21.27 66.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.2 -0.937 . . . . 0.32000000000000001 109.96 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 56.9 p-90 -89.4 -17.64 28.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 0.44 109.801 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.33 125.59 38.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.32000000000000001 110.136 -178.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -63.98 -58.58 10.41 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 111.316 -0.714 . . . . 0.35999999999999999 111.316 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.26 -34.49 24.75 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.638 1.559 . . . . 0.44 111.275 -178.34 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.5 -63.68 1.32 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.093 -1.005 . . . . 0.81000000000000005 108.929 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -59.67 -17.55 35.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.588 -0.695 . . . . 1.9199999999999999 110.095 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.2 ttt -61.67 -18.71 60.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 3.1299999999999999 110.155 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 75' ' ' PRO . 29.5 mt -98.15 13.87 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.201 -0.937 . . . . 0.28000000000000003 110.244 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.84 -32.05 3.26 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.393 -1.442 . . . . 1.6200000000000001 112.267 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.64 -3.26 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 CA-C-N 119.855 0.984 . . . . 0.25 110.119 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.2 m-85 -112.47 -81.13 0.59 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.519 -0.738 . . . . 0.29999999999999999 109.173 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.6 t80 -41.44 -55.37 2.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.13 110.727 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.2 t-80 -68.1 -32.02 72.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.854 -1.154 . . . . 0.40999999999999998 109.675 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.3 t -64.42 -41.22 96.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.827 -1.17 . . . . 0.96999999999999997 110.191 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -49.62 -14.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.885 -1.135 . . . . 0.5 109.494 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' SER . 17.2 m -57.45 -34.65 69.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.51000000000000001 109.68 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.05 -17.54 21.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.129 -0.982 . . . . 2.0 110.075 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.6 -21.74 22.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 2.1600000000000001 109.093 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -135.75 72.32 1.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.23999999999999999 109.142 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.1 p -66.94 -4.27 9.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.902 . . . . 0.17000000000000001 109.174 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -96.38 -3.23 44.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34000000000000002 109.818 -179.698 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.95 148.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.445 -0.784 . . . . 0.12 109.347 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mm -100.31 129.06 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.17000000000000001 109.553 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -116.95 129.48 56.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.425 -0.797 . . . . 0.11 109.18 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -111.93 175.12 5.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.402 -0.811 . . . . 0.12 108.977 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -143.62 146.1 33.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.204 -1.036 . . . . 1.3100000000000001 108.204 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -142.48 138.43 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.134 -0.979 . . . . 0.14000000000000001 110.821 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -98.44 104.48 16.51 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.114 -1.069 . . . . 1.0800000000000001 108.114 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.8 m -60.56 -4.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.27000000000000002 111.46 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -110.21 -43.04 4.01 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.067 -1.02 . . . . 1.1100000000000001 110.833 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 -12.28 32.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.002 . . . . 1.1200000000000001 109.34 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.44 45.22 2.63 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.764 -0.828 . . . . 0.17000000000000001 108.764 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.414 ' CG ' HH12 ' B' ' 4' ' ' ARG . 26.5 mt-30 -56.46 -12.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 2.2200000000000002 110.454 -179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -40.41 75.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.922 -1.111 . . . . 1.1100000000000001 109.266 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.84 -46.71 45.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.907 . . . . 0.19 109.001 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.74 72.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.22 109.078 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -64.42 -54.57 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 1.29 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.84 -29.05 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 2.2000000000000002 109.599 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.89 -5.7 57.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.226 -0.921 . . . . 0.33000000000000002 109.588 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 47.25 59.39 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 2.3399999999999999 110.2 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.7 t -78.92 136.6 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.145 -0.972 . . . . 0.28000000000000003 109.061 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -123.46 -7.77 8.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.47 -0.769 . . . . 2.3999999999999999 109.778 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.11 132.47 11.98 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.943 -1.098 . . . . 0.22 109.945 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.73 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -110.79 151.37 42.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.278 -1.008 . . . . 0.22 108.278 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -76.59 144.38 78.82 Favored 'Cis proline' 0 N--CA 1.484 0.922 0 C-N-CA 124.747 -0.939 . . . . 0.20000000000000001 110.281 -1.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.9 122.34 46.0 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.529 -0.915 . . . . 0.17999999999999999 108.529 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -98.21 122.73 41.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.14999999999999999 109.031 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.53 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.4 mt-30 -120.31 133.35 55.47 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.91 -1.144 . . . . 1.03 107.91 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 24' ' ' VAL . 17.4 m-85 -107.68 124.82 50.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.11 109.346 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.76 157.42 35.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.891 -0.781 . . . . 0.17000000000000001 108.891 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -153.85 123.19 6.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.639 -1.245 . . . . 1.48 107.639 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 55.72 31.67 17.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.6699999999999999 109.284 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.59 6.84 88.87 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.285 -1.126 . . . . 0.22 110.285 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -112.01 143.52 42.88 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.35 -1.088 . . . . 2.0800000000000001 110.605 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -84.31 141.94 30.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 1.7 109.58 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.99 -9.48 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.52 -0.737 . . . . 0.26000000000000001 110.528 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.05 168.71 36.01 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.41 -1.376 . . . . 0.17999999999999999 110.596 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.0 152.93 2.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -1.08 . . . . 2.04 110.416 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 5.4 p90 -169.05 134.07 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.14000000000000001 110.267 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.81 -174.33 2.52 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.074 -1.017 . . . . 0.17000000000000001 109.168 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.82 132.11 6.29 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.382 -1.487 . . . . 0.13 109.382 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.91 94.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.20000000000000001 110.137 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -139.31 70.54 1.37 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.822 -1.177 . . . . 1.1499999999999999 107.822 178.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.77 -33.15 73.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.379 -0.826 . . . . 1.1899999999999999 110.603 -178.511 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.04 -27.03 68.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.946 -1.097 . . . . 1.95 109.055 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -71.14 -37.61 72.26 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.546 -0.722 . . . . 2.0499999999999998 110.063 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.0 mt -52.28 -36.11 51.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.666 -1.271 . . . . 0.14999999999999999 108.866 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -66.91 -54.88 17.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 2.1499999999999999 109.457 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.75 93.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.14999999999999999 110.355 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.2 m -65.51 -44.89 85.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.161 -0.962 . . . . 0.13 109.916 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.3 mt -60.43 -52.88 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.17999999999999999 108.764 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -61.76 -16.01 45.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 1.03 109.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -77.22 -59.03 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 2.02 110.115 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.04 18.69 7.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.443 -0.786 . . . . 0.34999999999999998 110.246 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 1.1799999999999999 109.404 179.822 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.523 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 91.7 mtt180 -150.67 60.9 0.94 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.498 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 41.7 m-85 -106.07 149.67 26.5 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.578 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -137.3 -84.54 0.33 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.537 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.73 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.23 -167.22 1.78 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.105 -0.997 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.51 148.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.833 0.825 . . . . 0.0 112.357 -177.055 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 24.1 m -100.89 93.02 5.31 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.49 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 6.2 pt-20 -83.38 43.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.0 -1.062 . . . . 0.0 110.364 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.55 -130.18 0.04 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.08 24.05 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.407 1.604 . . . . 0.0 109.325 178.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t -91.97 -13.15 31.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.649 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -157.62 129.81 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.653 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.572 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.483 -0.562 . . . . 2.8900000000000001 109.483 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -97.22 154.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.27 -0.894 . . . . 0.29999999999999999 109.681 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -154.24 118.0 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.833 . . . . 1.97 108.886 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 19.5 tt0 -89.5 134.63 34.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.97999999999999998 109.961 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.3 mm -105.09 121.24 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 5.8 mp0 -101.98 -16.89 16.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.085 -1.01 . . . . 1.97 109.471 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.6 p -153.13 155.58 37.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.23000000000000001 109.137 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -50.74 -21.77 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 1.8999999999999999 109.337 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 m -61.5 -47.46 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.989 . . . . 0.25 109.31 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.85 -22.99 62.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.20000000000000001 109.838 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.34 -65.76 0.62 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.20999999999999999 109.868 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -55.27 -45.09 76.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 2.4700000000000002 109.67 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -58.03 -36.17 72.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.172 -0.955 . . . . 2.1000000000000001 109.594 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -59.76 -45.98 90.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 0.20000000000000001 109.17 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.26 -45.42 84.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.446 -0.784 . . . . 0.62 109.92 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.34 -40.58 97.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 1.0900000000000001 109.886 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -15.38 58.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.29999999999999999 109.516 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.97 -7.46 35.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.23999999999999999 109.553 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.08 -110.58 3.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.445 . . . . 0.28000000000000003 109.486 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -138.67 2.98 2.25 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.436 -1.038 . . . . 2.21 109.52 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 84.4 mttt -70.06 171.71 9.13 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.997 -1.065 . . . . 1.8999999999999999 109.134 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.06 160.5 20.86 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.468 -0.938 . . . . 0.17000000000000001 108.468 -179.555 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.639 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.7 t -143.38 104.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.04 . . . . 0.12 109.254 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.19 127.88 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.089999999999999997 108.799 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.66 135.52 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.668 -0.645 . . . . 0.17000000000000001 109.402 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -107.64 101.43 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.912 -0.773 . . . . 0.95999999999999996 108.912 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -84.82 82.6 8.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.813 -1.181 . . . . 0.23999999999999999 107.813 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -113.38 149.06 34.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.717 -0.615 . . . . 1.03 109.602 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.0 127.25 36.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.517 -0.92 . . . . 0.26000000000000001 108.517 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -66.59 -28.46 68.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.356 -0.84 . . . . 0.32000000000000001 111.081 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.542 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 62.1 p-90 -87.55 -10.28 52.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.887 -1.133 . . . . 0.44 110.218 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.48 135.97 37.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.32000000000000001 109.532 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.78 -56.9 3.68 Favored Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.501 -0.75 . . . . 0.35999999999999999 112.035 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -46.31 -39.1 21.18 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.673 1.582 . . . . 0.44 111.721 -177.904 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.59 -53.97 7.75 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.73 -1.231 . . . . 0.81000000000000005 108.823 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.87 -19.85 53.69 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.624 -0.672 . . . . 1.9199999999999999 109.791 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.504 ' O ' ' SD ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -59.42 -19.15 45.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 3.1299999999999999 110.504 -179.056 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.25 12.97 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.053 -1.029 . . . . 0.28000000000000003 111.112 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.06 -32.98 4.47 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 119.98 -1.7 . . . . 1.6200000000000001 112.362 179.328 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.1 Cg_exo -66.43 -0.03 3.91 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 CA-C-N 119.571 0.882 . . . . 0.25 110.519 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.64 -74.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.511 -0.743 . . . . 0.29999999999999999 109.179 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -42.45 -52.57 4.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.66 -0.65 . . . . 0.13 110.495 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.11 -32.6 73.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.40999999999999998 109.72 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 46' ' ' SER . 59.7 p -62.37 -44.13 97.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.813 -1.179 . . . . 0.96999999999999997 109.879 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -51.33 -15.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.109 -0.994 . . . . 0.5 109.233 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.411 ' N ' ' C ' ' A' ' 44' ' ' SER . 28.9 m -57.19 -38.49 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.51000000000000001 109.698 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -94.95 -16.76 22.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.12 -0.987 . . . . 2.0 110.473 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -88.91 -19.81 25.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 2.1600000000000001 109.234 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.66 73.15 1.47 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.513 -0.742 . . . . 0.23999999999999999 109.135 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.46 -5.07 13.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.17000000000000001 109.273 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -96.24 8.32 44.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.34000000000000002 109.713 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.05 148.42 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.12 109.454 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -100.2 129.74 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.17000000000000001 109.055 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.8 m-85 -116.79 130.34 56.66 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.485 -0.759 . . . . 0.11 109.446 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.01 171.41 7.62 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -143.42 147.78 35.13 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.893 -1.151 . . . . 1.3100000000000001 107.893 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.37 144.55 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.0 -1.062 . . . . 0.14000000000000001 111.114 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.57 103.17 15.09 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.59 -1.263 . . . . 1.0800000000000001 107.59 178.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.657 HG21 HG21 ' A' ' 74' ' ' THR . 2.3 m -64.84 -3.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.27000000000000002 112.766 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 59' ' ' VAL . 1.6 m-20 -120.45 -33.28 3.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.73 -1.232 . . . . 1.1100000000000001 110.909 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.23 -21.55 18.39 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.782 -1.199 . . . . 1.1200000000000001 108.678 179.174 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.03 45.63 1.15 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.589 -1.263 . . . . 0.17000000000000001 107.589 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.74 -15.12 0.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.781 -0.574 . . . . 2.2200000000000002 110.767 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.02 -38.78 76.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.868 -1.145 . . . . 1.1100000000000001 108.89 179.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.65 -47.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.19 108.663 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.08 -35.48 80.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.22 109.129 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -63.49 -46.46 86.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.862 . . . . 1.29 109.03 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.99 -38.42 90.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 2.2000000000000002 109.682 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.37 -6.19 56.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.33000000000000002 110.132 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 66' ' ' ALA . 65.3 mt-10 48.8 58.29 5.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.056 -1.027 . . . . 2.3399999999999999 110.192 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.6 t -79.27 135.25 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.114 -0.991 . . . . 0.28000000000000003 109.089 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -127.36 -1.55 6.29 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.374 -0.829 . . . . 2.3999999999999999 110.063 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 125.15 8.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.999 -1.063 . . . . 0.22 108.944 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.72 HG23 ' CE2' ' B' ' 5' ' ' TYR . 4.6 p -111.08 152.29 43.61 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.889 -0.782 . . . . 0.22 108.889 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.12 143.15 74.53 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 C-N-CA 124.775 -0.927 . . . . 0.20000000000000001 109.948 -2.095 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -113.34 109.62 19.0 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.235 -1.024 . . . . 0.17999999999999999 108.235 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.1 m-85 -87.02 117.85 26.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.14999999999999999 108.778 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -115.72 135.15 54.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.57 -1.27 . . . . 1.03 107.57 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 20.3 m-85 -109.95 127.21 54.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.617 -0.677 . . . . 0.11 109.706 -178.05 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.47 157.98 35.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.457 -0.942 . . . . 0.17000000000000001 108.457 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -155.0 123.81 6.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.48 107.95 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.19 25.39 9.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.591 -0.693 . . . . 1.6699999999999999 109.228 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.5 4.0 86.09 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.132 -1.187 . . . . 0.22 110.132 179.326 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -109.73 145.48 36.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.286 -1.126 . . . . 2.0800000000000001 110.137 -179.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -86.8 141.21 29.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 1.7 109.039 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.06 -20.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.486 -0.759 . . . . 0.26000000000000001 110.323 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 173.15 45.55 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.386 -1.388 . . . . 0.17999999999999999 110.53 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -174.05 151.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -1.047 . . . . 2.04 109.802 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.4 p90 -169.05 133.5 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.297 -0.877 . . . . 0.14000000000000001 110.149 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -103.56 -163.39 0.98 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 108.967 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.91 131.61 2.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.361 -1.496 . . . . 0.13 109.361 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.495 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.53 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -1.213 . . . . 0.20000000000000001 110.852 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.29 78.32 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.772 -1.195 . . . . 1.1499999999999999 107.772 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.488 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.04 -34.89 79.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 1.1899999999999999 110.833 -178.494 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.8 -25.78 68.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.879 -1.138 . . . . 1.95 109.23 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -68.85 -37.45 79.14 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 2.0499999999999998 109.404 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.7 mt -52.46 -35.68 53.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.948 -1.095 . . . . 0.14999999999999999 108.689 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.0 -58.79 4.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 2.1499999999999999 109.584 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.34 83.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.14999999999999999 110.628 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.7 m -66.97 -44.81 79.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.049 -1.032 . . . . 0.13 109.938 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.7 mt -60.99 -52.56 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.17999999999999999 109.128 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -60.8 -17.22 48.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 1.03 109.407 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -77.66 -62.54 1.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 2.02 110.3 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.59 23.09 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 0.34999999999999998 110.617 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.996 -1.065 . . . . 1.1799999999999999 109.239 179.562 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -152.86 65.08 0.79 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.046 -1.034 . . . . 0.0 109.577 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.542 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.9 m-85 -123.87 162.16 23.86 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.624 -0.673 . . . . 0.0 109.244 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -150.25 -90.25 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.082 -1.011 . . . . 0.0 109.549 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.72 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -121.61 -167.0 1.45 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.837 -1.164 . . . . 0.0 110.334 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.48 151.11 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 112.018 -177.292 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 m -101.78 95.42 6.4 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.424 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.9 pt-20 -83.43 45.85 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.937 -1.102 . . . . 0.0 109.966 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.12 -134.68 0.07 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.983 -2.447 . . . . 0.0 106.983 178.155 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.76 24.39 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 CA-C-N 119.212 1.506 . . . . 0.0 108.441 178.127 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.6 t -81.73 -41.98 20.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.411 ' ND1' ' C ' ' B' ' 12' ' ' HIS . 0.3 OUTLIER -69.42 94.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.794 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.552 179.93 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.419 -0.585 . . . . 2.8900000000000001 109.419 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 19.8 t -94.76 168.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.29999999999999999 109.499 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -153.36 119.36 5.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.16 -0.962 . . . . 1.97 108.726 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -86.72 139.79 30.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.97999999999999998 109.911 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mm -110.03 119.49 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.961 -1.126 . . . . 0.19 107.961 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' CD ' ' N ' ' A' ' 6' ' ' GLU . 6.7 mp0 -105.4 -17.34 14.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -0.898 . . . . 1.97 109.705 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.7 p -151.74 161.39 42.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.035 -1.041 . . . . 0.23000000000000001 110.128 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -53.01 -32.14 44.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.736 . . . . 1.8999999999999999 109.966 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -59.44 -43.69 93.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.25 109.98 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.0 64.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.855 . . . . 0.20000000000000001 109.943 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.69 -63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.20999999999999999 110.04 -179.52 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 2.4700000000000002 109.638 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -58.7 -35.5 72.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.257 -0.902 . . . . 2.1000000000000001 109.933 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.39 94.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.20000000000000001 109.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.45 -44.02 97.42 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.853 . . . . 0.62 109.649 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.1 -38.36 90.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 1.0900000000000001 109.851 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.62 -19.88 44.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.29999999999999999 109.646 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -2.9 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.23999999999999999 109.74 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 -136.34 32.39 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.211 -1.556 . . . . 0.28000000000000003 109.211 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m-20 -116.6 5.65 13.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.38 -1.07 . . . . 2.21 109.621 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 88.0 mttt -70.18 170.92 10.62 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.206 -0.934 . . . . 1.8999999999999999 109.127 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.27 161.7 18.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.855 -1.165 . . . . 0.17000000000000001 107.855 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.633 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -145.13 105.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.891 -1.131 . . . . 0.12 109.632 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.7 t -103.41 128.81 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.788 -0.819 . . . . 0.089999999999999997 108.788 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.01 139.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.598 -0.689 . . . . 0.17000000000000001 109.649 -178.909 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -109.54 98.42 7.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.293 -0.632 . . . . 0.95999999999999996 109.293 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.0 m-85 -83.42 83.43 7.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.568 -1.271 . . . . 0.23999999999999999 107.568 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 m -110.38 -163.28 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.514 0.673 . . . . 1.03 109.381 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.97 120.26 13.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.341 -0.985 . . . . 0.26000000000000001 108.341 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.0 t -63.57 -25.02 68.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.32000000000000001 110.934 -178.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 58.0 p-90 -89.27 -12.79 39.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.931 -1.106 . . . . 0.44 110.093 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.6 134.33 39.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.32000000000000001 109.776 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.65 -55.5 5.97 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.809 -0.71 . . . . 0.35999999999999999 111.492 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -51.4 -32.83 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.663 1.575 . . . . 0.44 111.085 -178.274 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -62.26 1.71 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.058 -1.026 . . . . 0.81000000000000005 108.905 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -59.72 -21.17 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.77 . . . . 1.9199999999999999 110.03 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.9 ttm -59.61 -18.24 39.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.97 . . . . 3.1299999999999999 110.296 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.677 ' O ' HG22 ' A' ' 38' ' ' ILE . 95.6 mt -99.45 7.57 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.951 . . . . 0.28000000000000003 110.722 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -32.2 3.52 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 118.429 -1.308 . . . . 1.6200000000000001 112.519 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_exo -61.22 -6.05 6.02 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 CA-C-N 119.979 1.028 . . . . 0.25 109.706 -178.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -110.82 -76.29 0.61 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.968 -0.753 . . . . 0.29999999999999999 108.968 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -42.72 -56.99 2.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.531 -0.73 . . . . 0.13 110.726 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -66.51 -31.79 72.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.007 -1.058 . . . . 0.40999999999999998 110.013 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.6 t -64.33 -40.82 96.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.743 -1.223 . . . . 0.96999999999999997 110.163 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.51 -14.31 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.5 109.469 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.52 -38.0 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.078 -1.014 . . . . 0.51000000000000001 109.537 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -93.63 -12.23 29.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 2.0 110.054 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -51.67 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.029 -1.1 . . . . 2.1600000000000001 108.029 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -107.34 75.72 1.04 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.545 -0.722 . . . . 0.23999999999999999 109.607 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.7 p -66.79 -3.68 7.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.17000000000000001 108.618 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -95.77 -0.74 50.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.595 -0.69 . . . . 0.34000000000000002 109.372 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.28 147.07 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.362 0.601 . . . . 0.12 109.614 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.22 134.72 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.17000000000000001 109.268 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.3 m-85 -121.62 131.3 54.03 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.507 -0.745 . . . . 0.11 109.237 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.89 172.71 6.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.282 -0.886 . . . . 0.12 108.777 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -142.79 138.7 30.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.149 -1.056 . . . . 1.3100000000000001 108.149 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.29 136.74 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.243 -0.91 . . . . 0.14000000000000001 110.593 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.78 100.69 12.22 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.855 -1.165 . . . . 1.0800000000000001 107.855 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.18 -6.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.27000000000000002 110.885 -178.393 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.43 -42.31 5.49 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.123 -0.986 . . . . 1.1100000000000001 110.712 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -94.28 -12.43 28.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.094 -1.004 . . . . 1.1200000000000001 109.624 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.73 48.67 1.74 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.536 -0.913 . . . . 0.17000000000000001 108.536 179.093 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.641 ' CG ' HH12 ' B' ' 4' ' ' ARG . 5.7 mt-30 -56.34 -16.47 5.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 2.2200000000000002 110.321 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 4.3 p30 -70.49 -39.59 74.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.015 -1.053 . . . . 1.1100000000000001 109.442 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.9 -46.03 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.153 -0.967 . . . . 0.19 108.679 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.357 -0.839 . . . . 0.22 109.003 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -64.28 -46.8 82.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 1.29 109.155 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -64.18 -38.09 89.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 2.2000000000000002 109.761 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.54 -3.36 58.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 109.777 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.75 59.18 4.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 2.3399999999999999 110.002 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 17.2 t -79.22 136.58 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.127 -0.983 . . . . 0.28000000000000003 109.163 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -128.04 -4.35 5.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.431 -0.793 . . . . 2.3999999999999999 110.019 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.85 126.8 8.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.014 -1.054 . . . . 0.22 109.322 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.6 p -110.76 151.66 43.01 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.746 -0.835 . . . . 0.22 108.746 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.58 142.77 74.07 Favored 'Cis proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.887 -0.88 . . . . 0.20000000000000001 110.076 -1.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.17 111.63 21.87 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.965 -1.124 . . . . 0.17999999999999999 107.965 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.7 m-85 -86.99 119.87 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.038 -1.065 . . . . 0.14999999999999999 109.264 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 41.4 mt-30 -117.05 135.71 53.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.575 -1.268 . . . . 1.03 107.575 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 19.9 m-85 -109.0 127.45 54.09 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.496 0.665 . . . . 0.11 109.816 -177.763 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -125.37 156.02 39.41 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.516 -0.92 . . . . 0.17000000000000001 108.516 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -155.1 123.34 5.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.169 -1.048 . . . . 1.48 108.169 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt 54.48 30.61 13.23 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.768 -0.773 . . . . 1.6699999999999999 110.012 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.94 90.52 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.074 -1.06 . . . . 0.22 110.48 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -112.46 146.25 38.76 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.312 -1.111 . . . . 2.0800000000000001 110.036 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -86.18 143.63 27.89 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.361 -0.837 . . . . 1.7 109.246 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.0 m -126.94 -19.51 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.26000000000000001 110.449 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.58 178.07 47.67 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.305 -1.426 . . . . 0.17999999999999999 110.524 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -174.11 154.11 2.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -1.061 . . . . 2.04 110.113 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.5 p90 -168.46 131.18 1.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.14000000000000001 110.171 178.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 p -102.21 -162.35 0.92 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.246 -0.909 . . . . 0.17000000000000001 108.96 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 129.82 1.21 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.075 -1.61 . . . . 0.13 109.075 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.561 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.6 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -1.226 . . . . 0.20000000000000001 110.213 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -140.23 67.33 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.888 -1.152 . . . . 1.1499999999999999 107.888 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 12.4 ptpt -58.13 -37.45 74.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.837 -0.539 . . . . 1.1899999999999999 110.652 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.97 -26.54 68.34 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.95 109.611 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -70.3 -33.39 71.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 2.0499999999999998 109.835 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.5 mt -53.19 -33.88 54.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.801 -1.187 . . . . 0.14999999999999999 108.656 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -67.36 -55.6 13.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 2.1499999999999999 109.35 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.8 94.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.14999999999999999 110.648 -179.356 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -65.49 -45.1 84.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.037 -1.039 . . . . 0.13 109.876 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.91 -53.23 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.17999999999999999 108.838 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.44 -16.45 36.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 1.03 109.593 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.76 -60.65 2.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 2.02 110.064 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.76 20.79 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.34999999999999998 110.16 -178.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.023 -1.048 . . . . 1.1799999999999999 109.317 179.598 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' B' B ' 1' ' ' PHE . . . . . 0.454 ' C ' ' CD1' ' B' ' 1' ' ' PHE . 11.4 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -115.02 68.26 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.343 -0.848 . . . . 0.0 108.894 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.3 m-85 -113.49 156.15 24.06 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.084 -1.01 . . . . 0.0 108.983 179.443 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.641 HH12 ' CG ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -150.23 -92.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 109.077 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.719 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -123.42 -167.2 1.57 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.916 -1.115 . . . . 0.0 110.233 179.431 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 148.98 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.831 0.825 . . . . 0.0 112.154 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -100.88 95.59 6.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.248 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -82.91 43.4 0.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.052 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.59 -132.59 0.07 OUTLIER Glycine 0 N--CA 1.484 1.836 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.85 26.51 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 119.328 1.564 . . . . 0.0 109.161 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.8 t -90.72 -23.46 20.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.789 . . . . 0.0 109.502 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.16 131.31 41.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.985 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 mmm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.369 -0.604 . . . . 2.8900000000000001 109.369 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 3' ' ' LYS . 71.2 t -94.68 168.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.26 -0.9 . . . . 0.29999999999999999 109.592 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.5 tttp -154.29 122.33 5.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.949 . . . . 1.97 109.199 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -88.99 139.0 30.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.97999999999999998 109.482 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.96 106.99 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.273 -1.01 . . . . 0.19 108.273 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -100.1 -6.81 25.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.017 -1.052 . . . . 1.97 109.616 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -152.61 152.08 31.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -0.968 . . . . 0.23000000000000001 109.601 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -52.04 -28.6 17.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 1.8999999999999999 109.951 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -60.12 -45.13 94.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.25 110.241 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.74 64.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.20000000000000001 110.114 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.45 -69.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.20999999999999999 110.197 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -55.73 -41.37 73.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 2.4700000000000002 109.808 -179.349 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.78 -38.55 78.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.223 -0.923 . . . . 2.1000000000000001 109.848 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.87 -46.06 92.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.20000000000000001 109.305 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.38 -45.08 89.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.386 -0.821 . . . . 0.62 109.832 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.95 -40.37 96.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 1.0900000000000001 109.748 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -13.99 59.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.29999999999999999 109.734 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -6.92 28.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.23999999999999999 109.809 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.88 -111.96 4.14 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.409 . . . . 0.28000000000000003 109.576 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -138.03 4.32 2.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.39 -1.064 . . . . 2.21 109.268 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -71.03 166.44 21.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 1.8999999999999999 109.153 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.02 161.37 13.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.15 -0.969 . . . . 0.17000000000000001 108.688 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.0 t -144.0 106.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.856 -1.153 . . . . 0.12 109.489 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.96 132.64 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.108 -1.071 . . . . 0.089999999999999997 108.108 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.26 139.37 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.548 -0.72 . . . . 0.17000000000000001 110.002 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -109.33 101.89 10.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.929 -0.767 . . . . 0.95999999999999996 108.929 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 57' ' ' VAL . 41.1 m-85 -86.35 79.11 9.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.23999999999999999 107.708 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -113.45 149.56 34.06 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.324 0.583 . . . . 1.03 109.745 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.23 128.48 38.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.26000000000000001 108.73 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.6 t -66.29 -25.17 66.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.32000000000000001 110.241 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 55.0 p-90 -87.98 -14.34 39.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.033 -1.042 . . . . 0.44 109.958 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.37 125.88 40.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.32000000000000001 109.487 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.61 -54.13 20.75 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.48 -0.762 . . . . 0.35999999999999999 111.437 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.51 -32.6 21.21 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.912 1.741 . . . . 0.44 110.88 -178.186 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.02 -61.79 1.86 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.81000000000000005 109.057 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -59.8 -17.87 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.537 -0.727 . . . . 1.9199999999999999 110.033 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.11 -25.75 61.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 3.1299999999999999 110.387 -178.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.664 ' O ' HG22 ' A' ' 38' ' ' ILE . 90.8 mt -97.54 9.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.123 -0.985 . . . . 0.28000000000000003 110.819 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.93 -32.57 6.86 Favored Pre-proline 0 N--CA 1.484 1.264 0 O-C-N 120.425 -1.422 . . . . 1.6200000000000001 111.846 178.772 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.18 -5.24 7.62 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 119.7 0.929 . . . . 0.25 110.102 -177.505 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -112.37 -71.59 0.75 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.957 -0.757 . . . . 0.29999999999999999 108.957 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -45.69 -56.76 4.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.13 110.457 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -66.59 -31.97 73.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.40999999999999998 110.044 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -64.18 -38.84 92.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.96999999999999997 110.184 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.9 mt -51.39 -12.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 0.5 109.547 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 44' ' ' SER . 67.1 m -57.92 -32.89 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.956 -1.09 . . . . 0.51000000000000001 109.625 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.37 -19.45 19.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.193 -0.942 . . . . 2.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.81 -22.16 21.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 2.1600000000000001 109.525 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -134.26 68.41 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.479 -0.763 . . . . 0.23999999999999999 109.292 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.4 p -67.28 -4.79 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.795 . . . . 0.17000000000000001 109.164 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.51 0.21 52.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.825 . . . . 0.34000000000000002 109.62 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.17 151.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.047 -0.723 . . . . 0.12 109.047 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -101.22 126.5 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 0.17000000000000001 109.311 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.8 m-85 -112.96 130.87 55.97 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.39 -0.819 . . . . 0.11 109.16 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -115.17 173.77 6.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.459 -0.775 . . . . 0.12 109.055 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.29 141.1 28.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.03 -1.1 . . . . 1.3100000000000001 108.03 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 27' ' ' PHE . 76.9 t -137.17 139.44 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.2 -0.937 . . . . 0.14000000000000001 110.443 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.544 ' CG ' HH21 ' B' ' 2' ' ' ARG . 7.1 t70 -99.57 108.07 20.38 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.089 -1.078 . . . . 1.0800000000000001 108.089 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.407 HG11 ' OH ' ' B' ' 5' ' ' TYR . 33.3 m -68.33 -8.5 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.257 -0.902 . . . . 0.27000000000000002 111.23 -178.563 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.414 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -104.6 -38.67 6.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 110.919 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -95.59 -17.67 21.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.058 . . . . 1.1200000000000001 110.131 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.25 1.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.509 -0.923 . . . . 0.17000000000000001 108.509 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -54.26 -15.37 1.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.607 -0.683 . . . . 2.2200000000000002 110.237 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 3.3 p30 -70.4 -40.28 74.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.905 -1.122 . . . . 1.1100000000000001 109.53 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.09 -47.22 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -0.924 . . . . 0.19 108.729 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.55 -31.21 72.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.22 109.352 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 15.1 m -63.79 -52.49 60.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 1.29 109.288 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.17 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 2.2000000000000002 109.466 179.892 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.44 -2.69 58.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.33000000000000002 109.582 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 67' ' ' SER . 21.3 mp0 43.98 52.09 6.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.825 . . . . 2.3399999999999999 110.083 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -77.99 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.28000000000000003 108.944 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 83.8 mttt -125.58 5.79 7.55 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.531 -0.73 . . . . 2.3999999999999999 109.68 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 138.0 17.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.112 -0.993 . . . . 0.22 108.806 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.482 HG23 ' CE2' ' B' ' 5' ' ' TYR . 65.0 p -123.88 149.7 60.38 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 108.865 -0.791 . . . . 0.22 108.865 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.02 144.78 76.88 Favored 'Cis proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.959 -0.851 . . . . 0.20000000000000001 110.422 -1.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.21 114.74 26.41 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.576 -1.268 . . . . 0.17999999999999999 107.576 178.31 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.719 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.7 m-85 -90.2 123.93 34.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 0.14999999999999999 108.747 179.808 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.414 HE22 ' HB1' ' A' ' 69' ' ' ALA . 34.0 mt-30 -121.87 136.52 54.93 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 1.03 107.676 -179.832 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.44 124.22 51.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.475 0.655 . . . . 0.11 109.426 -178.526 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -124.02 155.56 38.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.688 -0.856 . . . . 0.17000000000000001 108.688 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -155.48 124.36 6.11 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 1.48 107.42 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mttt 57.96 25.4 12.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.623 . . . . 1.6699999999999999 109.821 -178.846 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 6.69 86.56 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.219 -1.152 . . . . 0.22 110.219 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 82.8 mt-30 -114.47 147.93 38.58 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.357 -1.084 . . . . 2.0800000000000001 110.101 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -85.33 141.26 30.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 1.7 109.162 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.31 -18.54 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.452 -0.78 . . . . 0.26000000000000001 110.221 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 171.79 44.89 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.6 -1.286 . . . . 0.17999999999999999 110.389 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -174.09 151.93 1.79 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.417 -1.049 . . . . 2.04 110.233 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.97 130.91 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.667 0.746 . . . . 0.14000000000000001 110.316 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -101.27 -162.16 0.91 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.035 -1.041 . . . . 0.17000000000000001 108.685 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.1 128.5 1.32 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.249 -1.541 . . . . 0.13 109.249 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.87 97.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.20000000000000001 110.866 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -141.06 77.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.984 -1.117 . . . . 1.1499999999999999 107.984 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -64.76 -42.66 94.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.81 -0.556 . . . . 1.1899999999999999 111.579 -178.414 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.81 -24.97 67.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.877 -1.139 . . . . 1.95 110.059 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -68.04 -34.48 76.55 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.052 -1.03 . . . . 2.0499999999999998 109.497 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.4 mt -52.08 -34.44 43.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.998 -1.063 . . . . 0.14999999999999999 109.008 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.31 -57.74 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.77 . . . . 2.1499999999999999 109.49 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.18 86.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.14999999999999999 110.546 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 m -66.98 -45.32 78.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -0.942 . . . . 0.13 109.973 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.51 -52.89 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.17999999999999999 108.79 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' O ' ' OD1' ' A' ' 102' ' ' ASN . 23.5 t-20 -60.62 -16.93 43.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 1.03 109.859 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.89 -55.99 5.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.895 . . . . 2.02 110.463 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -94.38 10.75 33.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.329 -0.857 . . . . 0.34999999999999998 110.872 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.704 -1.248 . . . . 1.1799999999999999 109.269 179.721 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.1 t80 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.544 HH21 ' CG ' ' A' ' 58' ' ' ASP . 58.5 mtp180 -137.64 56.78 1.75 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.461 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 43.3 m-85 -106.4 158.38 16.93 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.412 -0.805 . . . . 0.0 109.402 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.596 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -149.83 -84.23 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.166 -0.959 . . . . 0.0 108.611 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.482 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.0 -176.11 3.83 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.354 -0.842 . . . . 0.0 110.18 179.446 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.38 146.23 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.964 0.888 . . . . 0.0 112.821 -176.99 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.01 95.78 6.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.15 45.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 110.188 -178.797 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.24 -132.63 0.1 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 177.959 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.47 22.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 CA-C-N 118.95 1.375 . . . . 0.0 109.065 178.62 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.1 t -84.82 -49.7 8.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.44 122.94 25.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.992 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 mmm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.423 -0.584 . . . . 2.8900000000000001 109.423 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 3' ' ' LYS . 85.3 t -94.58 165.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.212 -0.93 . . . . 0.29999999999999999 109.297 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.2 tptp -155.02 125.55 6.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.268 -0.895 . . . . 1.97 109.09 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -90.73 135.45 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.97999999999999998 109.792 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -110.16 113.92 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.994 -1.113 . . . . 0.19 107.994 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -103.27 -13.05 16.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 1.97 109.657 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.5 p -152.9 156.99 40.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.23000000000000001 109.91 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.8 -32.62 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 1.8999999999999999 110.163 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -58.95 -44.24 91.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.065 . . . . 0.25 109.492 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.41 64.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.20000000000000001 109.448 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.6 -70.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.20999999999999999 109.996 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -54.58 -42.56 71.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 2.4700000000000002 109.709 -179.247 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -58.39 -37.76 75.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.022 -1.049 . . . . 2.1000000000000001 109.278 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.74 93.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.20000000000000001 108.678 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.59 -40.47 97.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 0.62 109.332 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.87 -42.56 97.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 1.0900000000000001 109.383 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.58 59.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.29999999999999999 109.533 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -6.33 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.23999999999999999 109.751 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.71 -115.47 6.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.28000000000000003 109.515 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -136.11 4.88 3.0 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -1.072 . . . . 2.21 109.349 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' HOH . 13.5 mttp -71.0 169.14 15.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.246 -0.909 . . . . 1.8999999999999999 109.163 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.26 162.43 14.74 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.17000000000000001 108.088 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 18.7 t -144.73 109.01 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.826 -1.171 . . . . 0.12 109.397 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.29 132.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.533 -0.914 . . . . 0.089999999999999997 108.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.75 131.34 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.17000000000000001 109.557 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.76 107.51 18.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.95999999999999996 109.443 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.2 m-85 -88.72 81.36 7.04 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.116 -1.068 . . . . 0.23999999999999999 108.116 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -113.72 152.35 30.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.736 -0.602 . . . . 1.03 109.559 -179.548 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -92.72 123.16 35.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.721 -0.844 . . . . 0.26000000000000001 108.721 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 58' ' ' ASP . 7.2 t -65.54 -20.87 66.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.32000000000000001 109.746 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.6 p-90 -89.5 -18.15 27.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.231 -0.918 . . . . 0.44 109.934 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.6 143.97 25.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.32000000000000001 110.029 -178.81 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -83.69 -57.23 2.47 Favored Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.684 -0.635 . . . . 0.35999999999999999 111.628 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.3 Cg_exo -47.47 -41.56 29.23 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.85 1.7 . . . . 0.44 112.031 -177.686 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -58.61 3.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.816 -1.178 . . . . 0.81000000000000005 109.02 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.32 -18.58 39.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.553 -0.717 . . . . 1.9199999999999999 110.232 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 36.8 ttm -59.43 -18.39 38.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 3.1299999999999999 110.309 -179.189 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.652 ' O ' HG22 ' A' ' 38' ' ' ILE . 67.8 mt -100.35 14.15 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.037 -1.039 . . . . 0.28000000000000003 111.276 -178.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.4 -34.95 12.41 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 117.957 -1.497 . . . . 1.6200000000000001 111.946 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -61.64 -14.81 37.96 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 CA-C-N 119.707 0.931 . . . . 0.25 110.877 -175.215 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.8 -69.36 0.76 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.33 -0.856 . . . . 0.29999999999999999 109.223 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -44.48 -51.55 8.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.618 -0.677 . . . . 0.13 110.725 -179.054 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -67.57 -35.28 78.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.878 -1.139 . . . . 0.40999999999999998 109.585 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -60.32 -42.71 96.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.017 -1.052 . . . . 0.96999999999999997 109.624 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -52.26 -21.72 3.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.5 109.563 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.5 m -57.3 -32.34 66.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.51000000000000001 109.592 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -94.82 -19.49 20.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.142 -0.974 . . . . 2.0 110.083 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -91.28 -20.82 21.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 2.1600000000000001 109.128 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.43 67.95 1.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.23999999999999999 109.085 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.2 p -67.01 -3.84 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.465 -0.772 . . . . 0.17000000000000001 109.243 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -94.43 -0.52 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.35 -0.844 . . . . 0.34000000000000002 109.475 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.06 149.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.539 -0.726 . . . . 0.12 109.189 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -100.43 128.84 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.225 -0.922 . . . . 0.17000000000000001 109.058 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.5 m-85 -114.63 131.8 56.59 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.413 -0.804 . . . . 0.11 109.173 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.5 mp -115.95 175.29 5.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.543 -0.723 . . . . 0.12 109.179 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -144.07 144.94 31.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.417 -0.957 . . . . 1.3100000000000001 108.417 179.481 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.4 t -140.26 140.7 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.2 -0.938 . . . . 0.14000000000000001 110.147 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' A' ' 30' ' ' THR . 8.1 t70 -99.44 100.46 11.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.615 -1.254 . . . . 1.0800000000000001 107.615 178.16 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.14 -12.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.858 . . . . 0.27000000000000002 111.217 -178.362 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -100.94 -42.81 6.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.85 -1.156 . . . . 1.1100000000000001 111.173 -178.708 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' CB ' HH21 ' B' ' 2' ' ' ARG . 2.5 t70 -93.1 -10.47 35.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.1200000000000001 109.569 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.63 2.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.511 -0.922 . . . . 0.17000000000000001 108.511 179.366 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -55.82 -14.32 2.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 2.2200000000000002 109.87 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 5.5 p30 -70.44 -40.93 73.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.121 -0.987 . . . . 1.1100000000000001 109.618 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.24 -46.22 45.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.19 108.699 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.03 73.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.22 109.309 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m -63.72 -52.35 60.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.29 109.53 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.82 -34.31 77.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 2.2000000000000002 109.237 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.67 57.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.889 . . . . 0.33000000000000002 109.516 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 44.99 50.7 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 2.3399999999999999 109.911 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.12 129.85 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.28000000000000003 109.445 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 67.9 mttm -129.93 8.86 5.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.502 -0.749 . . . . 2.3999999999999999 109.511 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.04 133.79 14.79 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.22 108.274 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.555 HG23 ' CE2' ' B' ' 5' ' ' TYR . 33.8 p -120.38 150.05 51.03 Favored Pre-proline 0 N--CA 1.507 2.424 0 O-C-N 121.205 -0.934 . . . . 0.22 108.96 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.72 147.27 83.75 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 O-C-N 122.714 0.849 . . . . 0.20000000000000001 110.539 -1.82 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.2 m -117.37 116.49 27.3 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.337 -1.357 . . . . 0.17999999999999999 107.337 178.059 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.1 m-85 -93.06 122.08 35.07 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.312 -0.955 . . . . 0.14999999999999999 108.653 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.5 mt-30 -119.16 137.4 53.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.729 -1.212 . . . . 1.03 107.729 -179.738 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 26.3 m-85 -112.03 128.54 56.22 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.423 0.63 . . . . 0.11 110.04 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.09 159.85 32.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.851 -0.796 . . . . 0.17000000000000001 108.851 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.11 122.81 5.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 179.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 57.24 24.44 9.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.78 -0.575 . . . . 1.6699999999999999 110.301 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.4 5.0 76.3 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.354 -1.098 . . . . 0.22 110.354 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -113.4 146.13 40.01 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.303 -1.116 . . . . 2.0800000000000001 110.236 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -85.98 145.07 27.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 1.7 109.363 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -126.54 -15.4 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.51 -0.744 . . . . 0.26000000000000001 109.762 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.14 -179.14 41.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.584 -1.294 . . . . 0.17999999999999999 110.581 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.2 161.19 4.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.457 -1.025 . . . . 2.04 110.049 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 2.8 p90 -169.04 132.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.14000000000000001 110.218 178.755 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 p -104.58 -170.05 1.71 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.225 -0.922 . . . . 0.17000000000000001 108.759 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 91' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 93.97 121.37 3.31 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.536 -1.426 . . . . 0.13 109.536 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.548 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.44 91.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -1.146 . . . . 0.20000000000000001 110.432 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' GLY . 13.6 t-20 -140.04 78.07 1.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.119 -1.067 . . . . 1.1499999999999999 108.119 178.605 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.91 -34.7 78.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.696 -0.627 . . . . 1.1899999999999999 110.608 -178.861 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.7 -26.07 67.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.816 -1.177 . . . . 1.95 109.187 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HZ3' ' HB2' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.66 -35.41 78.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.425 -0.797 . . . . 2.0499999999999998 109.124 179.548 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.628 HD21 ' CD1' ' A' ' 77' ' ' PHE . 44.6 mt -51.87 -37.69 53.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.14999999999999999 108.783 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.37 -57.6 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 2.1499999999999999 109.896 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.64 83.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.14999999999999999 110.477 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -67.76 -45.22 75.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.074 -1.016 . . . . 0.13 110.29 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.22 -52.56 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.934 . . . . 0.17999999999999999 109.331 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.26 -17.9 45.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 1.03 109.674 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.01 -59.41 2.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.871 . . . . 2.02 110.476 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -93.69 18.96 9.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.348 -0.845 . . . . 0.34999999999999998 110.794 -178.123 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' OXT' HG22 ' A' ' 105' ' ' VAL . 8.3 p . . . . . 0 N--CA 1.494 1.728 0 O-C-N 120.941 -1.099 . . . . 1.1799999999999999 109.303 179.25 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 22.8 mtp180 -141.39 52.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 0.0 109.006 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.531 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.6 m-85 -103.8 156.23 17.98 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.218 -0.927 . . . . 0.0 109.972 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -150.75 -101.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -109.5 -174.59 2.54 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.176 -0.953 . . . . 0.0 110.796 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.1 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 122.191 0.996 . . . . 0.0 112.851 -176.935 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 61.3 m -101.05 93.75 5.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.521 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.674 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.0 pt-20 -84.1 44.42 1.01 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.102 -0.999 . . . . 0.0 110.904 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.68 -129.98 0.07 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.69 19.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.871 0 CA-C-N 119.447 1.623 . . . . 0.0 109.799 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t -82.13 -3.24 54.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.501 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 36.9 t-80 -160.2 177.17 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.385 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.511 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.401 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.499 ' O ' ' SD ' ' A' ' 1' ' ' MET . 2.7 ppp? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.347 0.594 . . . . 2.8900000000000001 109.458 . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 3' ' ' LYS . 44.7 t -96.91 173.23 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.264 -0.898 . . . . 0.29999999999999999 109.512 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.627 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.7 tptt -153.72 122.84 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -0.93 . . . . 1.97 109.116 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -90.05 129.4 36.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.97999999999999998 109.462 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -102.05 120.15 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.291 -1.374 . . . . 0.19 107.291 178.897 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.62 -16.76 14.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.197 -0.939 . . . . 1.97 109.949 -179.277 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.8 p -152.47 160.15 43.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.056 -1.027 . . . . 0.23000000000000001 109.801 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 35.0 tttp -52.09 -31.39 30.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.439 -0.788 . . . . 1.8999999999999999 109.639 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -59.96 -47.25 86.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.25 110.093 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.72 -27.0 65.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.20000000000000001 109.662 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.17 -68.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.20999999999999999 109.838 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -53.53 -44.44 69.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 2.4700000000000002 109.749 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -58.19 -37.0 73.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 2.1000000000000001 109.619 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.77 92.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.20000000000000001 109.094 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.5 -44.95 89.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.458 -0.776 . . . . 0.62 109.781 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.71 -41.28 99.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 1.0900000000000001 109.686 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -13.6 59.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.29999999999999999 109.467 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -5.71 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.23999999999999999 109.722 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 68.23 -114.1 5.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.513 -1.435 . . . . 0.28000000000000003 109.513 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 81.2 m-20 -136.55 4.07 2.83 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.265 -1.138 . . . . 2.21 109.447 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 109' ' ' HOH . 80.5 mttt -69.65 170.09 11.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.072 -1.017 . . . . 1.8999999999999999 108.94 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.43 163.12 13.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.172 -1.047 . . . . 0.17000000000000001 108.172 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.3 t -145.42 104.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.825 -1.172 . . . . 0.12 109.359 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.7 t -101.61 130.41 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.089999999999999997 108.882 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.37 133.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 0.17000000000000001 109.644 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -107.04 102.98 12.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.585 -0.697 . . . . 0.95999999999999996 109.448 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 57' ' ' VAL . 51.0 m-85 -84.87 82.69 8.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.758 -1.201 . . . . 0.23999999999999999 107.758 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.68 148.62 36.01 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.594 -0.692 . . . . 1.03 109.89 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.89 122.74 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.267 -1.012 . . . . 0.26000000000000001 108.267 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -64.95 -22.33 66.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.32000000000000001 110.414 -178.978 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.604 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 55.5 p-90 -90.34 -14.2 33.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.13 -0.981 . . . . 0.44 110.054 -179.4 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -94.23 128.56 40.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.32000000000000001 110.04 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.06 -59.33 7.57 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.894 -0.67 . . . . 0.35999999999999999 111.595 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.5 Cg_exo -46.11 -37.7 18.28 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.805 1.67 . . . . 0.44 111.941 -178.169 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.4 -55.6 5.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.714 -1.241 . . . . 0.81000000000000005 108.756 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -60.6 -21.73 62.97 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.655 -0.653 . . . . 1.9199999999999999 110.045 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.9 tpp -61.44 -18.52 59.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 3.1299999999999999 110.379 -179.324 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -99.56 15.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.097 -1.002 . . . . 0.28000000000000003 110.765 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.77 -33.41 3.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.163 -1.586 . . . . 1.6200000000000001 112.452 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -63.14 -3.59 5.13 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.509 0.86 . . . . 0.25 110.302 -176.708 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.0 m-85 -110.46 -79.83 0.58 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.45 -0.781 . . . . 0.29999999999999999 109.08 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 87.6 t80 -40.9 -54.57 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.13 111.024 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -66.86 -36.83 83.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.842 -1.162 . . . . 0.40999999999999998 110.064 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.417 ' C ' ' N ' ' A' ' 46' ' ' SER . 81.8 p -61.34 -38.37 86.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.753 -1.217 . . . . 0.96999999999999997 110.041 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.88 -14.3 0.37 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.5 109.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.417 ' N ' ' C ' ' A' ' 44' ' ' SER . 37.1 m -57.76 -36.5 72.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.176 -0.953 . . . . 0.51000000000000001 109.636 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -94.35 -16.42 23.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.21 -0.931 . . . . 2.0 110.166 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.33 -22.83 20.33 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.003 -1.06 . . . . 2.1600000000000001 109.331 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -135.34 66.66 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.415 -0.803 . . . . 0.23999999999999999 109.151 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 p -66.64 -3.03 5.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.337 -0.852 . . . . 0.17000000000000001 109.038 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.95 -2.27 53.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.34000000000000002 109.263 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.64 148.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.055 -0.72 . . . . 0.12 109.055 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.5 125.26 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.414 -0.804 . . . . 0.17000000000000001 109.338 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -111.21 129.07 56.07 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.355 -0.841 . . . . 0.11 109.365 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -111.3 173.73 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.444 -0.785 . . . . 0.12 109.078 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.79 147.94 33.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.307 -0.998 . . . . 1.3100000000000001 108.307 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 27' ' ' PHE . 11.0 t -141.74 142.68 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.044 -1.035 . . . . 0.14000000000000001 110.451 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 60' ' ' ASP . 10.1 t70 -98.78 90.94 4.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.969 -1.123 . . . . 1.0800000000000001 107.969 178.564 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -52.59 -3.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 0.27000000000000002 111.624 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 58' ' ' ASP . 30.3 m-20 -110.04 -40.66 4.67 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.034 -1.041 . . . . 1.1100000000000001 110.982 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.61 -19.17 19.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.05 -1.031 . . . . 1.1200000000000001 109.816 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.89 45.52 1.33 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.349 -0.844 . . . . 0.17000000000000001 108.74 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -53.25 -13.46 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 2.2200000000000002 109.852 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.9 p-10 -71.13 -41.44 70.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 1.1100000000000001 109.459 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -74.08 -45.37 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.181 -0.949 . . . . 0.19 108.802 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -34.14 76.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.22 108.688 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -64.59 -46.13 84.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 1.29 109.075 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -63.65 -38.48 91.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 2.2000000000000002 109.349 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.0 58.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.909 . . . . 0.33000000000000002 109.874 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 49.6 59.19 4.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 2.3399999999999999 109.743 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 19.5 t -79.13 137.44 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.28000000000000003 109.489 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -130.4 -1.77 4.42 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.452 -0.78 . . . . 2.3999999999999999 109.791 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.639 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.42 127.31 9.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.022 -1.049 . . . . 0.22 109.1 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.706 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.3 p -111.04 152.02 43.41 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 108.654 -0.869 . . . . 0.22 108.654 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.39 143.98 76.26 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 C-N-CA 124.75 -0.938 . . . . 0.20000000000000001 109.935 -1.847 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 117.94 32.27 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.666 -0.865 . . . . 0.17999999999999999 108.666 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.2 m-85 -93.26 122.68 35.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.14999999999999999 108.886 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -120.19 133.09 55.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.804 -1.184 . . . . 1.03 107.804 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 18.1 m-85 -108.64 126.56 53.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.11 109.716 -178.066 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -124.05 158.79 31.36 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.512 -0.921 . . . . 0.17000000000000001 108.512 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -154.93 123.46 6.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.753 -1.203 . . . . 1.48 107.753 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.432 ' NZ ' ' OE1' ' A' ' 84' ' ' GLN . 7.3 mtmp? 56.01 27.33 11.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.527 -0.733 . . . . 1.6699999999999999 109.882 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.3 87.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.165 -1.017 . . . . 0.22 110.625 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.432 ' OE1' ' NZ ' ' A' ' 82' ' ' LYS . 55.0 mt-30 -109.98 147.48 33.41 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.329 -1.1 . . . . 2.0800000000000001 110.191 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' CB ' ' NZ ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -86.03 142.46 28.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.868 . . . . 1.7 109.124 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.35 -17.25 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.528 -0.732 . . . . 0.26000000000000001 110.358 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 176.14 174.24 42.49 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.455 -1.355 . . . . 0.17999999999999999 110.351 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -172.9 155.49 3.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.388 -1.066 . . . . 2.04 109.937 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 4.5 p90 -168.41 133.55 1.73 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.303 -0.873 . . . . 0.14000000000000001 110.342 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -104.07 -171.02 1.86 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.198 -0.939 . . . . 0.17000000000000001 109.03 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.93 5.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.13 109.522 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.89 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -1.117 . . . . 0.20000000000000001 110.424 -179.537 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -139.94 77.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.665 -1.235 . . . . 1.1499999999999999 107.665 178.203 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.97 -33.95 76.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 1.1899999999999999 110.687 -178.525 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -25.61 68.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.012 -1.055 . . . . 1.95 109.148 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -69.07 -37.6 78.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.328 -0.858 . . . . 2.0499999999999998 109.333 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 77' ' ' PHE . 13.8 mt -54.19 -35.6 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.14999999999999999 108.634 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -66.1 -58.89 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 2.1499999999999999 109.461 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.0 90.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.14999999999999999 110.494 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 m -65.25 -46.76 79.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.194 -0.941 . . . . 0.13 109.971 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.95 -52.32 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.183 -0.948 . . . . 0.17999999999999999 108.88 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -61.4 -16.48 46.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 1.03 109.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.9 -60.13 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 2.02 109.91 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.3 mt -91.69 20.57 5.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.716 . . . . 0.34999999999999998 110.28 -178.891 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 1.1799999999999999 109.247 179.782 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.9 p90 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' B' ' 2' ' ' ARG . 2.8 mtt-85 -152.92 78.99 1.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -0.977 . . . . 0.0 109.215 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.604 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.8 m-85 -126.2 148.05 49.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.385 -0.822 . . . . 0.0 108.876 179.435 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.595 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.36 -86.17 0.11 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 -179.771 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -125.13 -170.82 2.23 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.062 -1.024 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.417 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -72.33 150.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.78 0.8 . . . . 0.0 112.148 -177.431 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.0 m -101.15 94.23 5.86 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.72 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.639 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.15 44.71 0.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 110.214 -178.915 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.95 -131.21 0.15 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 177.764 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -69.64 30.37 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 119.315 1.557 . . . . 0.0 109.215 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.568 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.5 t -94.23 -23.83 17.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' B' ' 11' ' ' SER . 10.2 t-80 60.81 139.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.469 -0.769 . . . . 0.0 109.551 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.909 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 109' ' ' HOH . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.346 -0.613 . . . . 2.8900000000000001 109.346 . . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.8 t -94.56 159.89 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.29999999999999999 109.432 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.0 tptt -155.56 122.29 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 1.97 109.26 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.81 134.11 34.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.353 -0.842 . . . . 0.97999999999999998 108.992 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.92 108.6 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.363 -0.977 . . . . 0.19 108.363 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.24 -11.21 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 1.97 109.308 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -152.57 153.05 32.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.23000000000000001 109.462 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -52.39 -25.59 10.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.455 -0.778 . . . . 1.8999999999999999 109.812 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -60.2 -47.34 86.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.25 109.797 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -26.21 64.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.20000000000000001 109.644 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -59.7 -68.73 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.20999999999999999 109.821 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -55.38 -41.39 72.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 2.4700000000000002 109.849 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.0 -38.86 80.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.085 -1.009 . . . . 2.1000000000000001 109.601 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.28 95.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.20000000000000001 109.497 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.66 -46.66 84.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.62 110.117 -179.68 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.23 -43.21 95.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.997 . . . . 1.0900000000000001 109.815 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 -12.8 59.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.29999999999999999 109.917 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -8.55 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.23999999999999999 109.551 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.99 -117.05 6.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.669 -1.373 . . . . 0.28000000000000003 109.669 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 8.0 t0 -133.74 4.2 3.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.318 -1.107 . . . . 2.21 109.113 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -68.57 165.6 18.84 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.921 -1.112 . . . . 1.8999999999999999 108.711 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.69 157.84 23.07 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.315 -0.994 . . . . 0.17000000000000001 108.315 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.588 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.3 t -141.98 107.1 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.12 109.329 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.62 133.68 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.582 -0.895 . . . . 0.089999999999999997 108.582 179.237 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.21 133.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.17000000000000001 109.529 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -104.88 102.26 11.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.609 -0.682 . . . . 0.95999999999999996 109.202 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.57 78.96 9.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.805 -1.183 . . . . 0.23999999999999999 107.805 179.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -106.72 -164.47 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.532 0.682 . . . . 1.03 109.462 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.28 122.74 14.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.412 -0.959 . . . . 0.26000000000000001 108.412 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -63.66 -25.11 68.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.76 . . . . 0.32000000000000001 110.446 -178.154 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 45.8 p-90 -88.33 -15.5 35.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 0.44 110.011 -179.203 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.74 129.08 43.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -0.908 . . . . 0.32000000000000001 109.813 -179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.89 -54.03 8.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 111.205 -0.758 . . . . 0.35999999999999999 111.205 -178.869 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.6 Cg_exo -48.54 -34.31 25.99 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.823 1.682 . . . . 0.44 111.156 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -58.79 3.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.81000000000000005 109.16 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.8 -21.14 55.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 1.9199999999999999 109.785 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.484 ' O ' ' SD ' ' A' ' 37' ' ' MET . 1.7 tmt? -58.2 -21.23 46.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 3.1299999999999999 109.946 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.3 mt -97.08 2.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.252 -0.905 . . . . 0.28000000000000003 110.224 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.16 -34.72 18.72 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 118.431 -1.308 . . . . 1.6200000000000001 111.084 -179.483 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.5 Cg_endo -63.78 -5.96 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.691 0.926 . . . . 0.25 110.561 -177.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.446 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 41.9 m-85 -111.1 -73.43 0.68 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.848 -0.797 . . . . 0.29999999999999999 108.848 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.48 -56.81 4.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.704 -0.623 . . . . 0.13 110.471 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -66.9 -31.9 72.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.40999999999999998 110.083 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.5 t -63.99 -39.72 94.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.014 -1.054 . . . . 0.96999999999999997 110.092 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 83.2 mt -50.74 -12.98 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.035 -1.04 . . . . 0.5 109.782 -179.254 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.432 ' N ' ' C ' ' A' ' 44' ' ' SER . 16.4 m -57.78 -36.78 72.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.51000000000000001 109.636 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -93.85 -17.16 23.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.864 . . . . 2.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -90.65 -23.42 20.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 2.1600000000000001 109.117 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.11 71.8 1.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.696 . . . . 0.23999999999999999 109.125 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -66.84 -3.32 6.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.17000000000000001 108.988 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 21.7 t-20 -95.74 -0.07 51.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.516 -0.74 . . . . 0.34000000000000002 109.514 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.53 148.66 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.239 -0.913 . . . . 0.12 109.6 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -101.07 123.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.882 -0.784 . . . . 0.17000000000000001 108.882 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -112.18 132.26 55.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.244 -0.91 . . . . 0.11 109.655 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -114.29 172.08 7.23 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.772 -0.825 . . . . 0.12 108.772 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.23 140.77 29.47 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.345 -0.983 . . . . 1.3100000000000001 108.345 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -139.25 138.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.138 -0.976 . . . . 0.14000000000000001 110.193 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.47 108.68 21.43 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.635 -1.246 . . . . 1.0800000000000001 107.635 177.441 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.14 -10.59 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.27000000000000002 111.107 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 10.1 m-20 -103.71 -40.34 6.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.089 -1.007 . . . . 1.1100000000000001 110.756 -178.686 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -93.88 -14.39 26.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.1200000000000001 109.563 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.36 49.28 1.92 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.79 -0.818 . . . . 0.17000000000000001 108.79 178.72 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -55.95 -11.24 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.432 -0.792 . . . . 2.2200000000000002 110.19 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.924 -1.11 . . . . 1.1100000000000001 109.546 -179.447 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.2 -46.34 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.19 108.886 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.85 70.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.822 . . . . 0.22 109.258 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -64.21 -58.29 7.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 1.29 109.48 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -62.67 -29.82 70.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 2.2000000000000002 109.537 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.18 -5.78 58.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.159 -0.963 . . . . 0.33000000000000002 109.544 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 43.58 52.84 6.05 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -0.756 . . . . 2.3399999999999999 110.328 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 17.8 t -77.76 134.79 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.28000000000000003 109.156 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.66 -0.39 8.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.411 -0.806 . . . . 2.3999999999999999 110.194 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.01 133.93 15.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.063 -1.023 . . . . 0.22 109.261 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.69 HG23 ' CE2' ' B' ' 5' ' ' TYR . 21.8 p -118.25 150.75 48.27 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.311 -0.868 . . . . 0.22 108.934 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' CG ' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.13 145.16 81.69 Favored 'Cis proline' 0 C--N 1.319 -0.995 0 C-N-CA 124.555 -1.019 . . . . 0.20000000000000001 110.131 -1.849 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.48 116.51 28.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.693 -1.225 . . . . 0.17999999999999999 107.693 178.018 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.8 m-85 -93.66 116.03 28.51 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.363 -0.935 . . . . 0.14999999999999999 108.603 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.2 mt-30 -116.18 139.95 49.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.163 -1.421 . . . . 1.03 107.163 179.321 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' N ' ' CD1' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.06 132.22 54.36 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.719 . . . . 0.11 109.856 -176.938 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -126.93 154.94 43.84 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.327 -0.99 . . . . 0.17000000000000001 108.327 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.444 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 33.3 tttp -157.02 123.26 4.9 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.632 -1.247 . . . . 1.48 107.632 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mttp 59.23 25.61 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 1.6699999999999999 110.319 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.85 88.98 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.758 -1.337 . . . . 0.22 109.758 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -113.35 147.46 37.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.293 -1.121 . . . . 2.0800000000000001 109.701 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -86.38 141.93 28.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 1.7 109.175 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 87' ' ' GLY . 27.9 m -118.23 -39.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.408 -0.808 . . . . 0.26000000000000001 110.091 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -165.07 -176.99 37.23 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.911 -1.276 . . . . 0.17999999999999999 109.911 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' CD ' ' N ' ' A' ' 88' ' ' GLU . 1.2 pm0 -172.4 156.28 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 2.04 110.147 -179.537 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.3 p90 -169.05 132.26 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.14000000000000001 109.385 178.355 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 p -103.31 -161.23 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 108.743 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.05 137.67 2.56 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.492 -1.443 . . . . 0.13 109.492 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -65.89 92.21 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.25 -1.147 . . . . 0.20000000000000001 110.577 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -137.66 74.82 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.888 -1.153 . . . . 1.1499999999999999 107.888 177.881 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.49 ' CD ' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.73 -34.16 76.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 1.1899999999999999 110.495 -177.946 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.5 -26.43 68.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -67.94 -38.41 82.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 2.0499999999999998 109.428 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.7 mt -51.96 -37.68 53.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.958 . . . . 0.14999999999999999 108.833 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.97 -58.29 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 2.1499999999999999 109.31 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.95 86.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.407 -0.808 . . . . 0.14999999999999999 110.416 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -67.62 -45.55 75.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.219 -0.925 . . . . 0.13 110.042 -178.767 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.08 -51.11 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.106 -0.996 . . . . 0.17999999999999999 108.882 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -61.53 -17.03 53.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 1.03 109.488 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.3 -58.98 2.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 2.02 109.65 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.78 20.96 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.423 -0.798 . . . . 0.34999999999999998 110.352 -178.576 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 1.1799999999999999 109.209 179.373 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 50.6 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.599 ' CB ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -144.92 75.17 1.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.104 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.478 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.5 m-85 -124.34 119.82 30.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.275 -0.891 . . . . 0.0 108.926 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 4' ' ' ARG . . . . . 0.57 HH11 ' CG ' ' B' ' 4' ' ' ARG . 0.0 OUTLIER -108.13 -86.13 0.51 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 -178.879 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -128.76 -167.64 1.8 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 110.208 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.16 146.79 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 111.934 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.88 97.11 7.75 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -83.39 45.45 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.749 -179.172 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.68 -130.05 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 177.655 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.81 17.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 118.64 1.22 . . . . 0.0 109.784 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.2 t -79.32 -30.61 42.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.515 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 14.8 t60 -68.19 171.37 7.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.407 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.515 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.063 -0.717 . . . . 2.8900000000000001 109.063 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.57 151.85 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.17 -0.956 . . . . 0.29999999999999999 109.802 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -154.39 118.78 4.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.314 -0.866 . . . . 1.97 108.921 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -88.76 135.78 33.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.97999999999999998 109.829 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -106.69 113.06 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.615 -1.254 . . . . 0.19 107.615 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -100.07 -11.01 20.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.282 -0.886 . . . . 1.97 109.786 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 p -154.59 158.02 39.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.065 -1.022 . . . . 0.23000000000000001 109.987 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 43.0 tttm -52.33 -23.78 6.44 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 1.8999999999999999 109.697 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -61.95 -51.03 69.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.012 . . . . 0.25 110.293 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.99 -21.67 64.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.20000000000000001 109.952 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.88 -64.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.99 -1.069 . . . . 0.20999999999999999 109.714 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.62 -46.79 77.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 2.4700000000000002 109.799 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.28 -34.82 70.94 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.273 -0.892 . . . . 2.1000000000000001 110.142 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.62 -45.93 91.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.20000000000000001 109.624 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.9 -51.76 60.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.54 -0.725 . . . . 0.62 109.646 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.28 -35.99 80.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 1.0900000000000001 109.511 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.63 -16.08 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.29999999999999999 109.458 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -20.64 64.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.158 -0.964 . . . . 0.23999999999999999 109.469 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.45 -107.72 2.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.707 -1.357 . . . . 0.28000000000000003 109.707 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.1 -2.2 1.88 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -1.039 . . . . 2.21 109.553 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -67.33 168.06 11.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.903 -1.123 . . . . 1.8999999999999999 108.817 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.41 163.44 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.077 -1.083 . . . . 0.17000000000000001 108.077 -179.987 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.636 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.39 103.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.869 -1.145 . . . . 0.12 109.648 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.9 130.87 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.78 -0.822 . . . . 0.089999999999999997 108.78 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.76 135.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 0.17000000000000001 109.608 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.8 101.64 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.783 -0.821 . . . . 0.95999999999999996 108.783 179.406 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -84.32 80.74 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.884 -1.154 . . . . 0.23999999999999999 107.884 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.0 m -113.7 152.22 30.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.767 -0.583 . . . . 1.03 109.601 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.61 127.13 41.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.26000000000000001 109.275 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -67.11 -25.61 66.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.823 . . . . 0.32000000000000001 110.64 -179.294 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 53.7 p-90 -87.45 -14.83 39.43 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.957 -1.09 . . . . 0.44 109.927 -179.298 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 t -93.34 130.92 38.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.32000000000000001 110.018 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.9 -59.24 6.1 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.875 -0.678 . . . . 0.35999999999999999 111.48 -179.338 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -48.86 -35.91 32.4 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.795 1.663 . . . . 0.44 111.547 -178.206 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.92 -61.33 2.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.81000000000000005 108.936 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -59.55 -20.27 54.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.561 -0.712 . . . . 1.9199999999999999 109.986 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.1 ttt -62.09 -19.09 62.6 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.206 -0.934 . . . . 3.1299999999999999 110.341 -179.17 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -100.28 11.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.197 -0.94 . . . . 0.28000000000000003 110.269 -179.076 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 4.5 ptmm? -71.42 -27.24 1.0 Allowed Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 120.212 -1.555 . . . . 1.6200000000000001 111.844 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.4 Cg_exo -65.23 -4.39 9.12 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 120.641 1.265 . . . . 0.25 109.452 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -107.68 -79.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.693 -0.855 . . . . 0.29999999999999999 108.693 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.6 t80 -40.19 -58.13 1.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 0.13 111.206 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.39 -33.59 76.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 0.40999999999999998 110.322 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.5 p -66.33 -36.81 83.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.633 -1.292 . . . . 0.96999999999999997 110.409 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.5 mt -50.52 -19.84 0.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.928 -1.107 . . . . 0.5 109.535 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 m -56.94 -21.73 32.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.966 -1.083 . . . . 0.51000000000000001 109.977 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -97.22 -26.88 14.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.137 -0.977 . . . . 2.0 110.052 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -90.32 -18.61 25.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.046 -1.034 . . . . 2.1600000000000001 109.412 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.35 62.44 1.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.528 -0.732 . . . . 0.23999999999999999 109.247 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 p -66.72 -3.01 5.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.364 -0.835 . . . . 0.17000000000000001 108.91 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -95.59 1.11 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.418 -0.801 . . . . 0.34000000000000002 109.446 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.73 150.62 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.274 -0.639 . . . . 0.12 109.274 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.6 mm -98.89 123.49 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.426 -0.796 . . . . 0.17000000000000001 109.078 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.3 m-85 -111.24 132.87 54.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.357 -0.839 . . . . 0.11 109.141 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.06 167.3 10.78 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.641 -0.874 . . . . 0.12 108.641 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.61 133.97 29.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.353 -1.351 . . . . 1.3100000000000001 107.353 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.3 t -132.32 141.43 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.264 -0.897 . . . . 0.14000000000000001 110.745 -177.862 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.56 101.35 12.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.422 -0.955 . . . . 1.0800000000000001 108.422 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 74' ' ' THR . 16.4 m -61.42 -4.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.27000000000000002 111.197 -178.884 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 38.3 m-20 -107.58 -41.97 4.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.253 -0.905 . . . . 1.1100000000000001 110.554 -178.663 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.11 -21.8 18.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.0 . . . . 1.1200000000000001 109.348 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.73 43.31 1.35 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.477 -0.935 . . . . 0.17000000000000001 108.477 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -53.81 -13.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.529 -0.732 . . . . 2.2200000000000002 110.015 -179.426 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.43 -42.12 71.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.992 -1.067 . . . . 1.1100000000000001 108.981 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.89 -46.02 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.711 -0.848 . . . . 0.19 108.711 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.38 -34.0 76.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.22 108.989 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 m -63.63 -48.21 78.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 1.29 108.962 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.94 -36.49 84.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 2.2000000000000002 109.573 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.34 -7.71 54.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.232 -0.917 . . . . 0.33000000000000002 109.648 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' ALA . 39.4 mt-10 47.72 62.97 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 2.3399999999999999 110.323 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 t -79.0 137.75 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.28000000000000003 108.918 179.12 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -125.26 -4.48 7.34 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.407 -0.808 . . . . 2.3999999999999999 110.085 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.55 126.55 9.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.91 -1.119 . . . . 0.22 109.349 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.752 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.8 p -110.07 151.87 42.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.54 -0.911 . . . . 0.22 108.54 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -77.34 143.34 74.56 Favored 'Cis proline' 0 N--CA 1.483 0.875 0 C-N-CA 124.858 -0.892 . . . . 0.20000000000000001 109.926 -1.982 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.58 114.7 26.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.421 -0.955 . . . . 0.17999999999999999 108.421 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -89.08 125.57 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.864 -1.147 . . . . 0.14999999999999999 108.833 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -122.84 132.23 54.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.825 -1.176 . . . . 1.03 107.825 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.7 m-85 -107.09 129.82 54.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.11 109.911 -178.213 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.61 157.29 42.49 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.17000000000000001 108.71 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -155.11 127.01 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.265 . . . . 1.48 107.586 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 56.0 18.97 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 1.6699999999999999 109.847 -178.808 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.65 3.08 69.12 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 120.836 -1.165 . . . . 0.22 110.447 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.68 147.23 34.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.356 -1.085 . . . . 2.0800000000000001 109.822 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -85.51 144.86 27.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.335 -0.853 . . . . 1.7 109.384 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.65 -23.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.461 -0.775 . . . . 0.26000000000000001 110.264 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.22 174.91 46.61 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.483 -1.342 . . . . 0.17999999999999999 110.509 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.79 153.41 2.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -1.107 . . . . 2.04 110.094 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' O ' ' CD1' ' A' ' 89' ' ' PHE . 3.7 p90 -168.74 132.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.14000000000000001 110.46 179.079 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -103.37 -169.17 1.61 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.19 -0.944 . . . . 0.17000000000000001 109.321 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.66 129.85 3.89 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 92' ' ' ALA . . . . . 0.487 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.97 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.196 -1.179 . . . . 0.20000000000000001 110.365 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -141.13 74.82 1.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.109 -1.071 . . . . 1.1499999999999999 108.109 178.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -34.27 77.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 1.1899999999999999 110.83 -178.601 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -64.52 -25.74 68.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.834 -1.166 . . . . 1.95 109.282 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -68.54 -35.97 78.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 2.0499999999999998 109.422 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.6 mt -51.83 -36.4 47.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.14999999999999999 108.958 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.83 -58.17 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 2.1499999999999999 109.863 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.1 84.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.36 -0.838 . . . . 0.14999999999999999 110.844 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.9 m -67.18 -47.84 69.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.065 . . . . 0.13 110.273 -178.905 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.52 -51.09 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.17999999999999999 108.983 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.28 -17.77 31.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 1.03 109.605 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -76.46 -62.22 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 110.015 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.09 22.38 4.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.546 -0.721 . . . . 0.34999999999999998 110.518 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.884 -1.135 . . . . 1.1799999999999999 109.226 179.408 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.537 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 mtt-85 -135.25 79.64 1.8 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.35 -0.844 . . . . 0.0 109.278 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 3' ' ' PHE . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -136.38 153.59 51.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.189 -0.944 . . . . 0.0 109.745 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -150.47 -79.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 109.23 179.321 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 5' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.1 p90 -131.15 -165.26 1.54 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.099 -1.001 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 6' ' ' VAL . . . . . 0.406 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -80.35 152.54 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.255 -0.903 . . . . 0.0 112.379 -177.157 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m -102.02 95.61 6.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.779 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 8' ' ' GLU . . . . . 0.654 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.9 pt-20 -83.17 46.15 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 110.058 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.81 -131.44 0.11 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 177.94 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.62 25.45 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.279 1.539 . . . . 0.0 109.276 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 20.4 t -84.2 -39.63 19.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 12' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 10.4 t-160 -170.76 -97.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' B' B ' 13' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.6 t . . . . . 0 N--CA 1.495 1.787 0 N-CA-C 109.306 -0.627 . . . . 0.3 109.306 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.46 ' N ' HG12 ' A' ' 2' ' ' VAL . 3.7 tmtm? -155.22 122.91 5.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.143 -0.973 . . . . 1.97 108.892 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -89.61 137.88 31.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.98 110.371 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.9 mm -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.488 -1.301 . . . . 0.19 107.488 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -108.17 -15.93 14.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.292 -0.88 . . . . 1.97 109.195 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -153.13 158.95 42.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.23 109.506 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.27 -29.49 23.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 1.9 109.998 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -58.7 -46.57 87.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.25 109.794 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.4 63.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.2 109.909 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -58.91 -65.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.046 . . . . 0.21 109.806 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -55.91 -45.27 78.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 2.47 109.724 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -58.8 -35.55 73.02 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.174 -0.954 . . . . 2.1 109.753 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.15 83.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.1 . . . . 0.2 109.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.44 -41.46 98.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.815 . . . . 0.62 109.534 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.85 -45.56 85.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 1.09 109.912 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.98 59.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.3 109.952 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -7.44 29.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.24 109.782 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.75 -136.09 24.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.137 -1.585 . . . . 0.28 109.137 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -117.01 5.92 12.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.43 -1.041 . . . . 2.21 109.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.72 168.01 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 1.9 109.102 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.66 164.51 9.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.158 -1.053 . . . . 0.17 108.158 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.1 t -145.1 107.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.993 -1.067 . . . . 0.12 109.672 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.84 136.48 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.178 -1.045 . . . . 0.09 108.178 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 136.7 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.528 -0.732 . . . . 0.17 109.645 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.73 101.78 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.96 109.292 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 57' ' ' VAL . 40.7 m-85 -88.04 79.07 8.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.24 108.056 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.3 m -113.36 150.9 31.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.315 0.579 . . . . 1.03 109.487 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.19 130.24 37.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.26 108.766 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -66.94 -28.83 68.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.32 110.809 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.4 p-90 -88.47 -8.82 54.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.003 -1.061 . . . . 0.44 110.536 -178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.61 128.4 44.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.32 109.542 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.14 -55.99 9.63 Favored Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.563 -0.711 . . . . 0.36 111.42 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 13.6 Cg_exo -49.94 -35.0 39.27 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.746 1.631 . . . . 0.44 111.401 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.96 -1.087 . . . . 0.81 109.076 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -58.27 -20.27 41.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.92 110.018 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.43 -19.73 57.27 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.144 -0.973 . . . . 3.13 110.883 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.527 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.2 mt -100.73 4.39 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.998 -1.064 . . . . 0.28 111.182 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 6.6 ptpt -64.65 -32.93 7.66 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 120.121 -1.612 . . . . 1.62 112.439 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -57.64 -13.71 14.89 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.944 1.016 . . . . 0.25 110.245 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -99.82 -67.19 0.86 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.724 -0.843 . . . . 0.3 108.724 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -46.61 -52.87 12.66 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.713 -0.617 . . . . 0.13 110.424 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.7 -33.6 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.41 109.73 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.0 -41.98 97.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 0.97 109.851 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 mt -52.25 -15.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.014 . . . . 0.5 109.326 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 m -58.27 -33.37 69.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.51 109.729 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.11 -18.06 22.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -0.907 . . . . 2.0 110.076 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -91.39 -22.81 20.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.132 -0.98 . . . . 2.16 109.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -133.1 69.39 1.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.594 -0.691 . . . . 0.24 109.193 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.6 p -67.34 -5.32 13.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.306 -0.871 . . . . 0.17 109.114 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.44 5.28 52.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.487 -0.758 . . . . 0.34 109.555 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.17 149.46 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.471 -0.768 . . . . 0.12 109.332 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.52 126.25 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.901 -0.777 . . . . 0.17 108.901 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 55' ' ' LEU . 85.5 m-85 -114.39 134.25 55.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.391 -0.818 . . . . 0.11 109.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -116.4 175.11 5.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -0.783 . . . . 0.12 109.247 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -144.31 143.31 30.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.015 -1.106 . . . . 1.31 108.015 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 27' ' ' PHE . 55.8 t -140.44 142.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.07 -1.019 . . . . 0.14 110.658 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.95 100.77 11.72 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.932 -1.136 . . . . 1.08 107.932 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.2 m -60.36 -10.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.27 111.099 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -102.52 -41.34 6.31 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.991 -1.068 . . . . 1.11 111.239 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -94.86 -13.67 25.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.98 -1.075 . . . . 1.12 110.061 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.88 48.48 1.62 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.284 -0.885 . . . . 0.17 108.797 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.472 ' NE2' ' HE ' ' B' ' 4' ' ' ARG . 96.5 mt-30 -55.22 -13.97 1.53 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.571 -0.705 . . . . 2.22 109.592 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.44 -42.42 71.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.11 109.246 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.61 -45.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.19 108.542 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -34.36 77.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.22 109.304 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.1 m -64.08 -49.49 72.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 1.29 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.8 -37.06 85.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 2.2 109.224 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.71 -3.74 58.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.33 109.492 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ALA . 36.1 mt-10 47.0 52.65 11.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 2.34 110.279 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.06 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.28 108.896 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.423 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 54.5 mttp -127.74 6.74 6.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.451 -0.781 . . . . 2.4 109.733 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 137.82 17.34 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.057 -1.027 . . . . 0.22 108.95 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.475 HG23 ' CE2' ' B' ' 5' ' ' TYR . 74.3 p -122.04 149.89 55.13 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.362 -0.836 . . . . 0.22 109.006 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.1 Cg_endo -76.6 148.07 88.16 Favored 'Cis proline' 0 N--CA 1.484 0.932 0 C-N-CA 124.66 -0.975 . . . . 0.2 110.409 -2.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -117.63 115.82 25.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.255 -1.387 . . . . 0.18 107.255 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.6 m-85 -93.04 121.68 34.63 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.213 -0.929 . . . . 0.15 108.555 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -119.8 137.88 53.7 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.608 -1.256 . . . . 1.03 107.608 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.5 m-85 -111.44 127.8 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.536 0.684 . . . . 0.11 110.044 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -126.33 157.49 38.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.619 -0.882 . . . . 0.17 108.619 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -155.48 123.84 5.91 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt 56.39 28.38 13.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.764 . . . . 1.67 109.89 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.04 87.19 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.98 -1.105 . . . . 0.22 110.357 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -115.3 146.48 41.46 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.372 -1.075 . . . . 2.08 110.128 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -85.54 140.79 30.36 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.402 -0.811 . . . . 1.7 109.222 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 -20.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.396 -0.815 . . . . 0.26 110.289 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.1 46.69 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.454 -1.355 . . . . 0.18 110.378 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -174.18 153.66 2.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.359 -1.083 . . . . 2.04 110.229 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.0 p90 -169.94 135.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.14 109.974 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -106.6 -169.24 1.53 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.238 -0.914 . . . . 0.17 108.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 91.87 129.25 4.61 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -1.097 . . . . 0.2 110.297 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.0 t-20 -139.96 74.38 1.46 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 1.15 108.787 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -65.23 -32.58 74.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 1.19 110.319 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.06 -30.67 70.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.981 -1.074 . . . . 1.95 109.598 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -67.36 -33.5 75.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 2.05 109.254 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.1 mt -50.82 -35.36 31.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.964 -1.085 . . . . 0.15 108.605 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.98 -57.59 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.687 . . . . 2.15 109.836 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.2 88.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.15 110.876 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.6 m -66.87 -46.04 76.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.13 110.467 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.27 -50.56 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.18 109.163 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -61.17 -18.27 57.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 1.03 109.652 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.63 -60.69 2.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 2.02 110.134 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.8 mt -91.88 22.1 4.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.463 -0.773 . . . . 0.35 110.461 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 1.18 109.178 179.357 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.472 ' HE ' ' NE2' ' A' ' 63' ' ' GLN . 7.3 mmt180 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.79 -168.54 1.34 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.087 -1.008 . . . . 0.0 110.714 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.02 150.31 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.943 0.877 . . . . 0.0 112.909 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.63 97.11 7.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.427 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.77 44.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.068 -1.02 . . . . 0.0 110.477 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.17 -136.82 0.15 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.32 28.27 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 118.755 1.278 . . . . 0.0 109.012 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 9.3 t . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 109.697 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 3' ' ' LYS . 75.0 t . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.261 0.553 . . . . 0.3 109.626 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.0 tttt -153.99 125.26 7.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.363 -0.836 . . . . 1.97 108.803 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -88.39 134.87 33.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.98 109.899 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.99 106.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.219 -1.03 . . . . 0.19 108.219 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.63 -8.79 23.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.205 -0.934 . . . . 1.97 109.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.3 p -152.09 150.31 29.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.23 109.623 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -51.57 -28.15 13.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 1.9 109.396 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 m -60.7 -43.27 97.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.25 109.584 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.35 -26.58 64.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.845 . . . . 0.2 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.94 -67.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.21 109.868 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -54.1 -44.33 71.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 2.47 109.673 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.44 -37.82 76.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.159 -0.963 . . . . 2.1 109.726 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.71 88.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.2 109.276 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.0 mt -64.7 -41.07 96.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.62 109.812 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.95 -38.68 92.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.09 109.587 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.08 -16.62 54.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.888 . . . . 0.3 109.828 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -6.96 31.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.24 109.938 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.66 -105.95 1.4 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.837 -1.305 . . . . 0.28 109.837 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.78 3.38 2.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -1.078 . . . . 2.21 109.74 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -70.09 166.82 19.0 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.042 -1.036 . . . . 1.9 109.124 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 163.39 11.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.295 -0.878 . . . . 0.17 108.687 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.543 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.4 t -146.21 107.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.094 -1.004 . . . . 0.12 109.48 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -103.73 128.5 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.366 -0.833 . . . . 0.09 108.804 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.95 134.81 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.612 -0.68 . . . . 0.17 109.896 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -106.48 101.1 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.177 -0.675 . . . . 0.96 109.177 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' THR . 50.5 m-85 -84.97 81.17 9.01 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.765 -1.198 . . . . 0.24 107.765 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -110.94 -163.06 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.626 0.727 . . . . 1.03 109.514 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 124.81 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.607 -0.886 . . . . 0.26 108.607 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -64.69 -25.47 67.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.32 110.718 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.9 p-90 -89.05 -19.45 25.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.972 -1.08 . . . . 0.44 110.169 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.84 122.17 34.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.32 109.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.63 -57.41 12.74 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 120.929 -0.653 . . . . 0.36 111.555 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 22.8 Cg_exo -46.04 -36.88 16.83 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.712 1.608 . . . . 0.44 111.645 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.86 -59.54 2.74 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.869 -1.145 . . . . 0.81 108.944 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -59.47 -15.15 15.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 1.92 110.009 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 tpt -58.24 -20.13 39.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 3.13 110.434 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 38' ' ' ILE . 49.2 mt -97.27 8.57 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.083 -1.01 . . . . 0.28 110.783 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.96 -31.97 5.25 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 120.122 -1.611 . . . . 1.62 112.529 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.67 -5.14 11.09 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 CA-C-N 119.968 1.024 . . . . 0.25 109.706 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -111.85 -78.45 0.58 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.015 -0.735 . . . . 0.3 109.015 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -41.56 -56.91 2.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.767 -0.583 . . . . 0.13 110.688 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.01 -31.48 72.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.41 109.871 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 46' ' ' SER . 13.4 m -66.49 -38.77 88.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.853 -1.154 . . . . 0.97 110.235 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.8 mt -49.17 -12.93 0.06 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.879 -1.138 . . . . 0.5 109.649 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' SER . 54.9 m -56.75 -31.57 64.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.51 109.51 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.25 -17.59 21.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.266 -0.896 . . . . 2.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -91.03 -24.3 20.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.976 -1.077 . . . . 2.16 109.85 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -135.49 70.96 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 0.24 109.621 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.2 p -66.97 -4.57 9.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.266 -0.896 . . . . 0.17 108.714 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.11 -0.37 50.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.736 . . . . 0.34 109.823 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.7 149.59 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.729 . . . . 0.12 109.4 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.07 133.57 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.442 -0.786 . . . . 0.17 109.418 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -119.06 131.77 55.98 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.544 -0.723 . . . . 0.11 109.163 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.99 172.81 6.82 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.399 -0.813 . . . . 0.12 108.962 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.99 143.33 31.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.162 -1.051 . . . . 1.31 108.162 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.85 138.2 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.168 -0.957 . . . . 0.14 110.288 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.79 102.9 14.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.648 -1.241 . . . . 1.08 107.648 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.03 -6.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.233 -0.917 . . . . 0.27 111.044 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.08 -44.52 5.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.052 -1.03 . . . . 1.11 110.597 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.99 -15.37 24.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.093 -1.004 . . . . 1.12 109.776 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.48 44.66 2.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -0.865 . . . . 0.17 109.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -57.06 -10.88 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.22 110.216 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.6 ' OD1' HG23 ' A' ' 65' ' ' VAL . 1.4 p30 -69.04 -39.16 79.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.908 -1.12 . . . . 1.11 109.149 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.8 t -74.05 -42.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.137 -1.06 . . . . 0.19 108.137 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.2 -37.85 88.87 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.907 -0.775 . . . . 0.22 108.907 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 m -64.03 -45.02 90.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 1.29 109.079 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.87 -39.03 93.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 2.2 109.427 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.11 0.33 55.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -0.896 . . . . 0.33 109.754 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 49.21 56.81 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.905 . . . . 2.34 109.951 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.59 135.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.28 109.192 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -123.86 -6.86 7.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.604 -0.685 . . . . 2.4 109.638 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.01 136.96 16.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.149 -0.969 . . . . 0.22 109.433 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.2 p -115.47 150.61 44.9 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.62 148.62 86.86 Favored 'Cis proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.838 -0.901 . . . . 0.2 109.838 -2.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -119.26 118.89 32.48 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.145 -1.057 . . . . 0.18 108.145 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.0 m-85 -95.76 111.9 23.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.15 108.775 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -114.03 139.39 49.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.601 -1.259 . . . . 1.03 107.601 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.6 m-85 -109.17 133.24 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.54 0.686 . . . . 0.11 110.052 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -126.59 156.62 40.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.488 -0.93 . . . . 0.17 108.488 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -154.73 122.51 5.81 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.633 -1.247 . . . . 1.48 107.633 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 56.86 29.67 16.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 1.67 109.866 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.4 1.54 90.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.113 -1.041 . . . . 0.22 110.741 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -112.67 148.32 34.9 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.155 -1.203 . . . . 2.08 110.281 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.478 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -87.19 146.5 25.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 1.7 109.523 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.09 -29.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.442 -0.786 . . . . 0.26 110.147 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.43 45.51 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.659 -1.258 . . . . 0.18 110.083 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -172.34 160.99 5.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -1.147 . . . . 2.04 110.77 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -169.6 133.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.511 -0.743 . . . . 0.14 110.18 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -104.23 -170.39 1.76 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.17 109.291 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.59 130.19 4.41 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.526 -1.43 . . . . 0.13 109.526 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.82 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -1.17 . . . . 0.2 110.237 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.6 74.76 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.331 -0.989 . . . . 1.15 108.331 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.25 -32.45 74.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.19 110.782 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.62 -28.67 69.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.1 -1.0 . . . . 1.95 109.153 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -69.4 -36.38 76.7 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.53 -0.731 . . . . 2.05 109.873 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 77' ' ' PHE . 58.7 mt -53.05 -36.31 60.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.767 -1.208 . . . . 0.15 108.765 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -65.79 -58.15 6.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 2.15 109.615 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.5 91.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.15 110.485 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.3 m -65.06 -45.26 86.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 0.13 110.212 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.96 -54.35 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.0 -1.062 . . . . 0.18 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -61.46 -16.55 48.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 1.03 109.745 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -76.3 -60.45 2.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.902 . . . . 2.02 110.479 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.33 18.18 7.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 0.35 110.544 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 1.18 109.265 179.374 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.742 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -108.75 -177.49 3.33 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.652 -1.28 . . . . 0.0 110.69 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.03 145.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.038 0.923 . . . . 0.0 113.058 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 m -101.22 93.73 5.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.553 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.5 44.61 0.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.337 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.02 -132.4 0.07 OUTLIER Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.54 25.15 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 CA-C-N 119.211 1.505 . . . . 0.0 109.274 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 96.1 t . . . . . 0 N--CA 1.495 1.776 0 N-CA-C 109.55 -0.537 . . . . 0.3 109.55 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -154.75 121.24 5.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.727 -1.212 . . . . 1.97 107.727 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -86.77 141.39 28.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.98 110.411 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.12 109.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.19 108.022 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.97 -14.88 17.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 1.97 109.327 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -154.96 157.61 37.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.23 109.843 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 49.7 tttp -51.55 -27.65 11.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 1.9 109.574 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 m -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.25 110.005 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.47 -27.26 65.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.2 109.687 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.84 -67.61 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.21 109.942 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -54.04 -43.98 70.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.901 . . . . 2.47 109.64 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.51 -37.5 78.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.245 -0.909 . . . . 2.1 109.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.2 86.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.2 109.454 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.31 -43.16 98.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.413 -0.804 . . . . 0.62 109.563 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.27 -42.33 96.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 1.09 109.594 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.06 -13.49 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.962 . . . . 0.3 109.809 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -6.4 24.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.24 109.753 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.54 -112.43 4.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.28 109.562 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB2' ' HZ2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -139.43 2.67 2.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -1.103 . . . . 2.21 109.262 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -68.84 167.05 16.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 1.9 108.812 179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.67 161.86 11.62 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.099 -1.074 . . . . 0.17 108.099 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.669 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -143.99 105.8 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.968 -1.083 . . . . 0.12 109.451 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.0 t -102.41 132.19 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.704 -0.85 . . . . 0.09 108.704 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.38 138.54 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.674 -0.641 . . . . 0.17 109.758 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.09 101.57 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.178 -0.675 . . . . 0.96 109.178 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -85.09 79.97 9.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.874 -1.158 . . . . 0.24 107.874 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.43 149.53 34.05 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.279 0.562 . . . . 1.03 109.789 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.95 128.17 37.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.63 -0.878 . . . . 0.26 108.63 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -65.93 -26.65 67.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.32 110.605 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.441 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 60.4 p-90 -88.53 -13.76 39.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.887 -1.133 . . . . 0.44 110.038 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -94.34 126.01 39.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.32 109.995 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.98 -58.96 8.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.462 -0.655 . . . . 0.36 111.462 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.6 Cg_exo -45.12 -33.21 7.8 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.9 1.733 . . . . 0.44 111.314 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.41 -61.58 1.96 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.897 -1.127 . . . . 0.81 108.626 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -60.89 -15.7 33.66 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.71 -0.619 . . . . 1.92 110.473 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 33' ' ' GLY . 27.9 tpp -60.92 -27.38 68.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.05 -1.031 . . . . 3.13 109.991 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 38' ' ' ILE . 49.6 mt -96.49 15.63 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.131 -0.981 . . . . 0.28 111.023 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.89 -32.75 3.67 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 118.179 -1.408 . . . . 1.62 112.224 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -62.9 -4.58 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 CA-C-N 119.758 0.949 . . . . 0.25 110.114 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 46.5 m-85 -109.16 -79.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.3 109.025 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.73 -55.8 2.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.632 . . . . 0.13 111.082 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.37 -34.7 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.41 110.219 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 85.1 p -64.85 -35.42 81.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.637 -1.29 . . . . 0.97 110.012 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.5 mt -50.11 -16.11 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.987 -1.071 . . . . 0.5 109.28 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 14.9 m -57.03 -36.48 70.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.51 109.706 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -93.16 -15.02 26.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.159 -0.963 . . . . 2.0 110.089 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -91.26 -23.12 20.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.056 -1.027 . . . . 2.16 109.196 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -135.88 72.46 1.44 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.531 -0.731 . . . . 0.24 109.414 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 93.3 p -67.17 -4.76 11.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.17 108.969 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -96.97 -0.37 47.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.34 109.9 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.29 147.54 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -0.784 . . . . 0.12 109.223 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 mm -98.77 130.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.17 109.36 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.548 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -118.11 132.13 56.37 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.486 -0.759 . . . . 0.11 109.142 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.78 171.92 7.29 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.786 -0.82 . . . . 0.12 108.786 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -141.54 137.83 32.29 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.717 -1.216 . . . . 1.31 107.717 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 t -136.47 139.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.275 -0.891 . . . . 0.14 110.883 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.99 101.77 12.95 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.745 -0.835 . . . . 1.08 108.745 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 59' ' ' VAL . 15.6 m -60.98 -2.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.879 . . . . 0.27 111.017 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.441 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 26.1 m-20 -108.66 -44.44 4.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.061 -1.025 . . . . 1.11 110.503 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -95.11 -26.97 15.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.102 -0.999 . . . . 1.12 109.21 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.92 40.39 1.51 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.309 -0.997 . . . . 0.17 108.309 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -53.57 -15.87 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.636 -0.665 . . . . 2.22 110.121 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -70.26 -36.29 74.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.978 -1.076 . . . . 1.11 108.783 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -75.27 -48.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.663 -0.866 . . . . 0.19 108.663 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.72 74.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.801 . . . . 0.22 109.161 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 m -63.16 -48.98 76.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 1.29 109.182 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -64.94 -35.99 82.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 2.2 109.522 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 0.47 55.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.945 . . . . 0.33 109.905 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 45.88 50.95 10.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.961 . . . . 2.34 110.251 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.82 131.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.28 108.904 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -130.52 6.19 4.79 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.376 -0.827 . . . . 2.4 110.212 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.46 120.7 6.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.04 -1.037 . . . . 0.22 108.731 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.632 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.0 p -108.17 150.65 40.74 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.759 -0.83 . . . . 0.22 108.759 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.8 141.97 68.83 Favored 'Cis proline' 0 N--CA 1.484 0.919 0 C-N-CA 125.033 -0.82 . . . . 0.2 110.105 -1.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 115.66 27.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.973 -1.121 . . . . 0.18 107.973 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -91.47 118.62 30.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.15 108.94 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -117.06 132.95 56.56 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.0 m-85 -107.84 126.55 52.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.656 -0.653 . . . . 0.11 109.55 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -123.03 158.46 30.5 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.786 -0.82 . . . . 0.17 108.786 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -154.75 123.07 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.866 -1.531 . . . . 1.48 106.866 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 20' ' ' ASP . 25.1 mttm 58.26 28.59 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 1.67 109.41 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 2.83 88.8 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.606 -1.397 . . . . 0.22 109.606 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.413 ' CA ' HE21 ' A' ' 84' ' ' GLN . 0.7 OUTLIER -106.76 145.75 31.68 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.543 -0.975 . . . . 2.08 110.334 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -85.6 141.13 30.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 1.7 109.357 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.6 -21.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.49 -0.756 . . . . 0.26 110.253 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.04 177.32 48.42 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.485 -1.341 . . . . 0.18 110.178 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -174.27 156.1 2.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -1.121 . . . . 2.04 110.165 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.4 p90 -168.9 131.15 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.14 110.0 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 p -102.57 -166.85 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.192 -0.942 . . . . 0.17 108.892 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.98 127.9 3.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.126 -1.59 . . . . 0.13 109.126 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.532 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.81 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.158 -1.201 . . . . 0.2 110.734 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -143.12 77.38 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.136 -1.061 . . . . 1.15 108.136 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.34 75.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 1.19 110.484 -178.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.97 -26.57 67.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.98 -1.075 . . . . 1.95 109.185 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -68.97 -36.54 78.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.346 -0.846 . . . . 2.05 109.512 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 77' ' ' PHE . 15.0 mt -53.7 -34.9 60.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.064 . . . . 0.15 108.919 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.0 -57.54 6.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 2.15 109.722 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.33 90.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.15 110.59 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.0 m -66.86 -45.14 79.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.13 110.206 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.49 -51.9 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.932 -1.105 . . . . 0.18 108.631 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.91 -15.34 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.857 . . . . 1.03 109.646 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -76.49 -59.72 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 2.02 110.176 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.3 mt -92.32 17.17 10.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -0.841 . . . . 0.35 110.404 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.973 -1.08 . . . . 1.18 109.382 179.595 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.761 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.632 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -115.08 -172.56 2.15 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.941 -1.1 . . . . 0.0 110.632 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.95 152.54 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.957 0.884 . . . . 0.0 112.056 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 m -101.25 96.84 7.46 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.574 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.8 45.48 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.948 . . . . 0.0 109.819 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.74 -132.66 0.07 OUTLIER Glycine 0 N--CA 1.484 1.894 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.27 21.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 CA-C-N 119.286 1.543 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.648 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.3 t . . . . . 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.245 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 3' ' ' LYS . 69.8 t . . . . . 0 N--CA 1.495 1.818 0 CA-C-O 121.364 0.602 . . . . 0.3 109.73 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.515 ' HZ2' ' CD1' ' A' ' 5' ' ' ILE . 48.4 tttm -154.1 127.8 8.73 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 1.97 108.991 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -87.55 130.99 34.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.912 . . . . 0.98 109.592 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.515 ' CD1' ' HZ2' ' A' ' 3' ' ' LYS . 25.0 mm -114.78 85.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.675 -0.861 . . . . 0.19 108.675 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -95.29 4.43 53.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.979 -1.075 . . . . 1.97 109.551 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 p -150.4 141.48 23.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.23 109.889 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -51.57 -31.07 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.823 . . . . 1.9 109.49 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -59.88 -43.93 94.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.25 109.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.08 -26.01 63.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.2 109.828 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.91 -67.39 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.21 110.118 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -53.78 -44.41 70.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 2.47 109.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.38 -36.89 76.63 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.269 -0.894 . . . . 2.1 109.969 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.36 89.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.2 109.484 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -63.77 -45.6 89.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 0.62 110.034 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.19 -41.57 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.048 -1.033 . . . . 1.09 109.415 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.42 -13.06 59.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.3 109.628 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.09 40.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 0.24 109.581 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.11 -113.01 4.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.444 -1.462 . . . . 0.28 109.444 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -137.71 2.51 2.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.353 -1.087 . . . . 2.21 109.348 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -69.37 168.08 15.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 1.9 108.702 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.581 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.55 165.1 10.58 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.168 -0.958 . . . . 0.17 108.452 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.581 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.1 t -145.29 106.31 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.87 -1.144 . . . . 0.12 109.712 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.5 132.25 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.354 -0.841 . . . . 0.09 108.996 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.07 136.75 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.619 -0.676 . . . . 0.17 109.636 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.37 102.29 11.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.96 109.363 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.8 m-85 -85.01 82.48 8.43 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.939 -1.134 . . . . 0.24 107.939 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -114.24 150.05 34.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.822 -0.549 . . . . 1.03 109.734 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.0 123.41 35.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.234 -1.024 . . . . 0.26 108.234 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -65.37 -23.25 66.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.32 110.454 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.0 p-90 -89.1 -11.75 43.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.44 109.899 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -96.97 128.04 43.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.32 110.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.29 -56.46 11.92 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.631 -0.668 . . . . 0.36 111.601 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.4 Cg_exo -47.2 -35.06 19.16 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.829 1.686 . . . . 0.44 111.438 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -61.26 2.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.926 -1.109 . . . . 0.81 108.832 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.51 -16.86 27.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.421 -0.799 . . . . 1.92 110.102 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.84 -28.44 68.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 3.13 110.212 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 38' ' ' ILE . 43.3 mt -96.76 18.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.232 -0.918 . . . . 0.28 110.485 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.09 -32.05 2.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.53 -1.357 . . . . 1.62 112.606 179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -62.69 -3.69 4.8 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.659 0.914 . . . . 0.25 109.994 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.3 m-85 -110.2 -76.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.567 -0.708 . . . . 0.3 109.331 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.1 t80 -42.28 -57.2 2.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.433 -0.792 . . . . 0.13 110.715 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -66.82 -30.94 71.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.952 . . . . 0.41 109.959 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.0 t -64.28 -40.08 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.804 -1.185 . . . . 0.97 109.96 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.8 -16.33 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.054 -1.029 . . . . 0.5 109.437 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 44' ' ' SER . 44.9 m -57.38 -31.42 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.51 109.869 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -96.57 -19.34 19.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.159 -0.963 . . . . 2.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -91.14 -23.7 20.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.965 -1.085 . . . . 2.16 109.8 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -131.36 66.99 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.579 -0.7 . . . . 0.24 109.181 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -66.5 -3.61 6.62 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 0.17 108.79 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -95.4 -1.49 50.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 0.34 109.319 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.7 t -115.56 149.11 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.058 -0.719 . . . . 0.12 109.058 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.58 128.76 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.17 109.324 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.1 m-85 -115.29 132.31 56.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.532 -0.73 . . . . 0.11 109.181 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.08 171.33 7.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.871 -0.789 . . . . 0.12 108.871 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.69 138.38 28.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.066 -1.087 . . . . 1.31 108.066 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 27' ' ' PHE . 80.6 t -134.6 138.37 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.211 -0.931 . . . . 0.14 110.616 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.99 99.13 9.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.835 -1.172 . . . . 1.08 107.835 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.18 -13.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.27 111.331 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -100.03 -44.58 5.96 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.894 -1.129 . . . . 1.11 111.298 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.6 -10.61 39.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.973 -1.08 . . . . 1.12 109.718 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.4 2.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.543 -0.91 . . . . 0.17 108.543 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -55.44 -15.43 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.762 . . . . 2.22 110.142 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.6 p30 -69.74 -39.53 76.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.032 -1.042 . . . . 1.11 108.995 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.05 -46.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.19 108.777 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.48 -31.99 72.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.22 108.846 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.7 m -64.29 -56.23 15.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 1.29 109.219 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 -31.16 72.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 2.2 109.351 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.24 -6.81 57.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.33 109.296 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' ALA . 27.5 mt-10 45.27 51.6 9.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.383 -0.823 . . . . 2.34 110.369 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.49 136.13 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.28 109.145 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -130.4 2.34 4.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.442 -0.786 . . . . 2.4 109.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.09 126.95 9.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.005 -1.059 . . . . 0.22 109.496 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.583 HG23 ' CE2' ' B' ' 5' ' ' TYR . 72.2 p -111.6 150.54 42.35 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.385 -0.822 . . . . 0.22 108.876 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.61 141.42 64.22 Favored 'Cis proline' 0 N--CA 1.486 1.075 0 C-N-CA 125.03 -0.821 . . . . 0.2 110.371 -1.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.67 114.26 26.78 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.129 -1.063 . . . . 0.18 108.129 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.6 m-85 -89.61 124.16 34.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.848 -1.157 . . . . 0.15 109.093 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.447 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.4 mt-30 -122.4 133.67 54.63 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.915 -1.142 . . . . 1.03 107.915 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 24.3 m-85 -107.88 127.81 54.06 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.665 0.745 . . . . 0.11 110.012 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -126.08 155.37 41.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.923 -1.14 . . . . 0.17 107.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.7 tttp -156.25 125.46 6.13 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 56.32 19.22 3.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.573 -0.705 . . . . 1.67 109.569 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.482 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.39 1.09 69.39 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.309 -1.116 . . . . 0.22 110.309 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.1 mm-40 -110.33 148.14 32.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.352 -1.087 . . . . 2.08 110.272 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -87.89 145.65 25.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 1.7 109.36 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.17 -25.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 0.26 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.1 46.25 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.477 -1.344 . . . . 0.18 110.516 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -174.49 154.94 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -1.094 . . . . 2.04 109.967 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.9 p90 -167.76 131.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.14 110.455 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -104.53 -170.97 1.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.229 -0.919 . . . . 0.17 108.805 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.18 131.96 3.86 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.785 -1.326 . . . . 0.13 109.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.29 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -1.129 . . . . 0.2 110.609 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.75 66.3 1.35 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.138 -1.06 . . . . 1.15 108.138 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.543 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.0 ptpt -61.04 -38.58 86.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 1.19 110.854 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.23 -28.81 69.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.986 -1.071 . . . . 1.95 109.729 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -70.16 -33.07 71.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.311 -0.868 . . . . 2.05 109.592 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.3 mt -50.74 -37.98 44.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.15 108.63 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.72 -54.85 16.02 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.935 -0.706 . . . . 2.15 109.658 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.71 90.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.15 110.542 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.7 m -66.5 -46.92 74.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.163 -0.961 . . . . 0.13 110.486 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 -50.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.18 108.975 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -61.62 -17.54 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 1.03 109.544 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -77.05 -58.69 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 2.02 110.207 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.8 mt -91.78 18.57 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.341 -0.849 . . . . 0.35 110.46 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.18 109.275 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.583 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.47 -170.19 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.185 -0.947 . . . . 0.0 110.754 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.8 t -63.22 144.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.906 0.86 . . . . 0.0 112.837 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.5 m -101.25 94.64 6.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.512 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.09 45.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 110.672 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.9 -130.66 0.19 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.17 28.02 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 CA-C-N 119.323 1.562 . . . . 0.0 109.201 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.585 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.7 t . . . . . 0 N--CA 1.493 1.714 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.6 t . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.315 -0.624 . . . . 0.3 109.315 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.624 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 tttm -153.46 121.57 6.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -0.965 . . . . 1.97 109.224 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -89.79 136.06 33.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.98 110.01 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mm -106.98 113.03 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.843 -1.169 . . . . 0.19 107.843 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.12 -11.04 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 1.97 109.561 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -153.29 155.55 36.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.121 -0.987 . . . . 0.23 109.777 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 78.9 tttt -52.44 -31.36 34.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 1.9 109.806 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -57.93 -44.76 87.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.878 -1.139 . . . . 0.25 109.695 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.09 -23.7 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.2 109.715 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -60.37 -68.39 0.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.21 110.181 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . 0.683 ' H ' ' NE2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -54.35 -42.72 70.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 2.47 109.279 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.82 -38.36 78.47 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.186 -0.946 . . . . 2.1 109.974 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -47.72 84.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.2 109.362 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.66 -40.83 97.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.344 -0.848 . . . . 0.62 109.416 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.6 -41.42 96.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 1.09 109.869 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.09 58.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.3 109.945 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 -3.38 9.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.24 109.625 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -108.85 2.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.47 . . . . 0.28 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -139.7 4.59 2.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.395 -1.062 . . . . 2.21 109.282 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 55.9 mttm -69.95 175.06 4.66 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.124 -0.985 . . . . 1.9 109.775 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.69 159.75 31.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.364 -0.976 . . . . 0.17 108.364 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.0 t -144.73 107.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.763 -1.211 . . . . 0.12 109.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -105.73 131.6 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.643 -0.873 . . . . 0.09 108.643 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 136.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.684 -0.635 . . . . 0.17 109.633 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.96 105.8 15.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.109 -0.7 . . . . 0.96 109.109 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.62 79.62 8.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.988 -1.116 . . . . 0.24 107.988 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -113.78 150.15 33.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.788 -0.57 . . . . 1.03 109.873 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.81 124.77 36.19 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.403 -0.962 . . . . 0.26 108.403 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -66.0 -23.88 66.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.32 110.367 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 54.3 p-90 -88.62 -13.95 38.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.44 110.001 -179.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.19 121.62 37.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.32 109.665 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.94 -57.15 20.18 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 121.579 -0.701 . . . . 0.36 111.372 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.96 -34.3 16.23 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.863 1.709 . . . . 0.44 111.5 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.03 2.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.026 -1.046 . . . . 0.81 108.878 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.25 -18.52 49.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.522 -0.736 . . . . 1.92 110.233 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -59.21 -25.3 63.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 3.13 110.17 -179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.7 mt -96.34 11.94 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.069 -1.019 . . . . 0.28 110.476 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.62 -32.24 3.54 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 120.407 -1.433 . . . . 1.62 112.726 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.25 -3.98 5.82 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.851 0.982 . . . . 0.25 110.318 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -111.96 -75.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.3 109.338 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -43.53 -57.03 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.13 110.709 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.09 -31.89 72.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.41 110.121 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 t -63.45 -39.02 93.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.856 -1.153 . . . . 0.97 110.4 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.6 mt -51.11 -12.78 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.019 -1.051 . . . . 0.5 109.646 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.436 ' N ' ' C ' ' A' ' 44' ' ' SER . 49.0 m -57.31 -36.95 71.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.51 109.64 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -94.91 -16.75 22.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.119 -0.988 . . . . 2.0 110.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -90.33 -23.45 21.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.945 -1.097 . . . . 2.16 109.4 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -134.32 69.61 1.46 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.433 -0.792 . . . . 0.24 109.219 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -66.51 -3.14 5.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.257 -0.902 . . . . 0.17 108.946 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -95.94 0.74 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.544 -0.723 . . . . 0.34 109.669 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.8 t -119.43 151.9 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.486 -0.759 . . . . 0.12 109.301 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 mm -101.6 129.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.402 -0.811 . . . . 0.17 109.461 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.1 m-85 -116.95 131.0 57.06 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.441 -0.787 . . . . 0.11 109.147 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -113.04 173.1 6.55 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.905 -0.776 . . . . 0.12 108.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -143.46 143.65 31.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.034 -1.098 . . . . 1.31 108.034 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.59 138.19 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.095 -1.003 . . . . 0.14 110.731 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -99.69 105.01 16.78 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.176 -1.046 . . . . 1.08 108.176 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.19 -12.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.27 111.16 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -100.28 -43.04 6.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.004 -1.06 . . . . 1.11 110.733 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.32 -10.5 38.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.925 -1.109 . . . . 1.12 109.63 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 47.55 2.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.656 -0.868 . . . . 0.17 108.656 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -56.17 -15.79 4.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.782 . . . . 2.22 110.016 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.5 p-10 -70.15 -40.22 74.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.145 -0.972 . . . . 1.11 109.253 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 t -73.56 -47.08 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.42 -35.44 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.22 108.927 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 m -64.07 -45.53 88.33 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 1.29 109.229 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.64 -40.8 97.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 2.2 109.28 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.8 58.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.178 -0.951 . . . . 0.33 109.713 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.2 mm-40 49.08 55.18 9.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 2.34 110.112 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.91 133.56 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.28 109.153 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -125.72 2.68 7.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.434 -0.791 . . . . 2.4 109.837 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.38 127.72 10.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.984 -1.072 . . . . 0.22 109.309 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.4 p -114.4 150.63 44.12 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -76.21 142.02 72.14 Favored 'Cis proline' 0 N--CA 1.487 1.131 0 C-N-CA 125.005 -0.831 . . . . 0.2 110.98 -1.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -114.68 114.69 25.99 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.595 -1.261 . . . . 0.18 107.595 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.9 m-85 -91.54 122.06 33.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.895 -1.128 . . . . 0.15 108.922 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -120.91 136.19 55.01 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.308 -1.367 . . . . 1.03 107.308 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -108.22 132.89 53.19 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.636 0.731 . . . . 0.11 110.087 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.8 157.15 41.19 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.725 -0.842 . . . . 0.17 108.725 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -156.15 124.94 5.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.647 -1.242 . . . . 1.48 107.647 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 56.22 18.71 3.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 1.67 109.68 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.557 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.13 -1.11 64.59 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 120.158 -1.02 . . . . 0.22 110.767 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.557 HE21 ' C ' ' A' ' 83' ' ' GLY . 31.0 mm-40 -109.7 147.99 32.18 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.091 -1.241 . . . . 2.08 110.316 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -85.85 139.72 31.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.92 -0.77 . . . . 1.7 108.92 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.3 -6.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.26 110.642 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.89 173.72 37.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.398 -1.382 . . . . 0.18 110.454 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -173.4 156.29 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -1.07 . . . . 2.04 110.165 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -168.61 132.17 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.503 -0.748 . . . . 0.14 110.323 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -102.17 -162.92 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.17 109.142 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.52 127.62 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.662 -1.375 . . . . 0.13 109.662 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.4 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.2 110.276 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' GLY . 26.3 t-20 -137.19 75.11 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.887 -1.153 . . . . 1.15 107.887 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -65.81 -42.26 90.87 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.812 -0.631 . . . . 1.19 111.316 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.02 -27.09 68.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.919 -1.113 . . . . 1.95 110.052 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -68.84 -32.44 72.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 2.05 109.589 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.3 mt -53.55 -35.83 61.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.809 -1.182 . . . . 0.15 108.518 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.42 -54.86 16.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 2.15 109.479 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.59 89.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.835 . . . . 0.15 110.386 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 m -66.52 -45.09 80.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.13 109.784 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.92 -53.01 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.847 . . . . 0.18 109.29 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -60.34 -16.88 39.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 1.03 109.467 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.49 -57.3 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 2.02 110.06 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.61 17.38 10.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.35 110.131 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 1.18 109.38 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 . . . . . 0 N--CA 1.496 1.838 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.8 p90 -113.31 -167.75 1.24 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.271 -0.893 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.21 148.25 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.92 0.867 . . . . 0.0 112.712 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 m -101.3 94.83 6.14 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.502 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -83.54 44.71 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.091 -1.006 . . . . 0.0 110.41 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.0 -132.6 0.09 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.52 23.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 CA-C-N 119.404 1.602 . . . . 0.0 109.278 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.631 ' H ' ' C ' ' B' ' 9' ' ' GLY . 48.3 t . . . . . 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.5 t . . . . . 0 N--CA 1.494 1.728 0 N-CA-C 109.157 -0.683 . . . . 0.3 109.157 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.5 tttt -155.12 122.87 5.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.037 -1.039 . . . . 1.97 109.438 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -89.59 138.33 31.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.81 . . . . 0.98 109.767 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.59 101.48 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -97.92 -6.51 32.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.077 -1.015 . . . . 1.97 109.266 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 p -152.73 152.38 31.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.86 . . . . 0.23 109.688 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -52.78 -26.45 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 1.9 110.081 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 m -60.11 -46.15 90.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 0.25 109.995 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.8 63.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.2 109.809 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.42 -68.45 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.136 -0.977 . . . . 0.21 109.96 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -55.09 -44.0 74.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 2.47 109.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.09 -36.28 74.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.243 -0.911 . . . . 2.1 110.128 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.02 -46.82 87.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.935 -1.103 . . . . 0.2 109.728 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.46 -50.22 70.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.334 -0.854 . . . . 0.62 109.952 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.57 -40.68 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 1.09 109.817 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -16.45 56.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.3 109.607 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.88 -12.39 61.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.24 109.643 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 -116.84 4.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.779 -1.328 . . . . 0.28 109.779 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 42.3 t0 -135.23 4.16 3.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.46 -1.024 . . . . 2.21 109.466 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -68.68 169.69 10.74 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.999 -1.063 . . . . 1.9 108.737 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.15 161.31 19.38 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.905 -1.146 . . . . 0.17 107.905 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.442 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.22 104.65 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.979 -1.075 . . . . 0.12 109.637 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.69 127.07 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.736 -0.838 . . . . 0.09 108.736 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.45 138.69 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.577 -0.702 . . . . 0.17 109.522 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -110.88 104.77 13.42 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.294 -0.632 . . . . 0.96 109.294 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 40.0 m-85 -86.28 80.83 8.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.739 -1.208 . . . . 0.24 107.739 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -114.36 149.15 36.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.773 -0.579 . . . . 1.03 109.547 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.58 129.01 37.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.921 . . . . 0.26 108.667 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -66.94 -24.85 66.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.32 110.516 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 52.5 p-90 -87.86 -16.31 34.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.965 -1.084 . . . . 0.44 110.018 -179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.51 130.79 38.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.32 110.231 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.11 -56.36 7.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.556 -0.618 . . . . 0.36 111.556 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -47.87 -35.18 23.9 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.587 1.525 . . . . 0.44 111.482 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.61 2.29 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.81 109.042 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.93 -18.78 47.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.806 . . . . 1.92 109.931 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.7 -16.19 25.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.065 -1.022 . . . . 3.13 110.406 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 38' ' ' ILE . 32.2 mt -100.43 8.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.136 -0.978 . . . . 0.28 110.292 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.33 -32.94 6.93 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 120.189 -1.569 . . . . 1.62 112.002 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -65.24 -3.04 6.68 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 CA-C-N 120.113 1.076 . . . . 0.25 109.693 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.45 -79.12 0.58 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.925 -0.769 . . . . 0.3 108.925 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -42.03 -57.02 2.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.581 -0.699 . . . . 0.13 110.806 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.97 -31.05 71.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.932 -1.105 . . . . 0.41 110.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -63.89 -39.94 95.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.776 -1.203 . . . . 0.97 110.042 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 mt -51.99 -15.9 0.64 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.5 109.781 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -58.6 -31.63 68.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.89 -1.131 . . . . 0.51 109.825 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 3.3 mp0 -94.45 -20.14 19.96 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.015 -1.053 . . . . 2.0 109.911 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -91.72 -21.15 20.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 2.16 109.478 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -135.84 67.1 1.48 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.517 -0.739 . . . . 0.24 109.083 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.4 p -66.95 -3.28 6.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.212 -0.93 . . . . 0.17 109.207 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 23.9 t-20 -95.19 -0.98 52.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.851 . . . . 0.34 109.527 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.2 t -116.28 149.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.941 -0.763 . . . . 0.12 108.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.9 mm -99.4 127.78 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 0.17 109.562 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.541 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -114.88 128.96 56.6 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.793 -0.817 . . . . 0.11 108.793 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.29 170.56 8.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.294 -0.879 . . . . 0.12 108.986 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -141.62 141.58 33.43 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.961 -1.126 . . . . 1.31 107.961 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.5 t -138.71 136.19 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.14 110.389 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.64 105.86 18.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.543 -0.91 . . . . 1.08 108.543 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.54 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.0 m -60.91 -7.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.843 . . . . 0.27 111.344 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -108.87 -40.46 5.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 1.11 111.074 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.88 -18.91 21.48 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.86 -1.15 . . . . 1.12 109.318 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.98 47.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.236 -1.024 . . . . 0.17 108.236 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -54.98 -18.1 4.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.631 -0.668 . . . . 2.22 110.608 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -37.32 77.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.847 -1.158 . . . . 1.11 109.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.5 -47.29 40.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.392 -0.817 . . . . 0.19 108.842 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.78 76.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.305 -0.872 . . . . 0.22 109.189 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -63.71 -52.02 62.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 1.29 109.31 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.74 -31.92 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.84 . . . . 2.2 110.069 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.7 -6.73 57.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.138 -0.976 . . . . 0.33 110.09 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 46.76 64.99 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.955 . . . . 2.34 109.777 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 15.9 t -83.38 136.86 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.351 -0.843 . . . . 0.28 108.979 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.97 -8.54 8.32 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.274 -0.891 . . . . 2.4 109.715 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.0 130.83 11.67 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.22 109.848 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.724 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.0 p -112.15 151.19 43.46 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.376 -0.972 . . . . 0.22 108.376 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.05 142.04 71.15 Favored 'Cis proline' 0 N--CA 1.483 0.885 0 C-N-CA 124.752 -0.937 . . . . 0.2 110.101 -1.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -113.83 114.22 25.98 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.031 -1.1 . . . . 0.18 108.031 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -90.84 121.92 33.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.016 -1.053 . . . . 0.15 108.659 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.425 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.8 mt-30 -121.57 135.89 54.98 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.77 -1.196 . . . . 1.03 107.77 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.5 m-85 -106.7 132.62 52.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.736 . . . . 0.11 110.126 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.55 155.68 38.62 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.313 -0.995 . . . . 0.17 108.313 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -155.63 121.39 5.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.3 -1.371 . . . . 1.48 107.3 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.9 mttt 57.44 19.73 5.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.636 -0.665 . . . . 1.67 109.551 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.585 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 93.99 -1.07 67.46 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.432 -1.067 . . . . 0.22 110.432 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.585 HE21 ' C ' ' A' ' 83' ' ' GLY . 18.9 mm-40 -109.96 147.36 33.61 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.245 -1.15 . . . . 2.08 110.35 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -86.98 139.07 30.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 1.7 109.4 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.18 -14.87 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.474 -0.766 . . . . 0.26 109.976 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.23 171.89 42.85 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.485 -1.34 . . . . 0.18 110.409 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -172.83 156.42 3.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -1.043 . . . . 2.04 109.961 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.7 p90 -168.91 133.57 1.53 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.626 -0.83 . . . . 0.14 110.466 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -102.75 -172.35 2.11 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.489 -0.93 . . . . 0.17 108.489 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.8 5.02 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.222 -1.551 . . . . 0.13 109.222 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.0 94.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -1.169 . . . . 0.2 111.053 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -140.25 75.71 1.52 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.815 -1.18 . . . . 1.15 107.815 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.502 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.31 -32.93 73.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.523 -0.735 . . . . 1.19 110.341 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.64 -25.82 67.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.055 -1.028 . . . . 1.95 108.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -69.19 -38.84 78.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 2.05 109.465 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.1 mt -53.66 -38.09 63.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.863 -1.148 . . . . 0.15 109.106 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.33 -56.48 12.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 2.15 109.506 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.8 94.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.15 110.429 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 42.0 m -66.19 -44.85 82.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 0.13 109.807 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.2 mt -58.18 -55.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.065 -1.022 . . . . 0.18 108.33 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.55 -16.53 25.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 1.03 109.903 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -76.61 -61.23 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 2.02 110.678 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.6 mt -93.16 15.63 14.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.35 111.038 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.704 -1.248 . . . . 1.18 109.232 179.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 110.148 -0.315 . . . . 0.0 110.148 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.724 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.7 p90 -111.6 -166.71 1.1 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.626 -1.296 . . . . 0.0 111.068 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.31 151.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.944 0.878 . . . . 0.0 112.308 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.81 96.12 6.86 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.578 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.35 43.16 0.86 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.012 -1.055 . . . . 0.0 110.098 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.73 -133.07 0.07 OUTLIER Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.13 25.36 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 CA-C-N 119.319 1.56 . . . . 0.0 109.346 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.8 t . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.34 -0.85 . . . . 0.0 109.515 -179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.5 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 109.39 -0.596 . . . . 0.3 109.39 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.9 tttm -155.17 121.32 5.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 1.97 108.972 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.57 135.37 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.853 . . . . 0.98 109.534 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 10' ' ' ALA . 13.5 mm -107.99 109.67 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.769 -1.196 . . . . 0.19 107.769 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.28 -7.14 24.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.247 -0.908 . . . . 1.97 110.031 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -153.0 153.81 33.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.047 -1.033 . . . . 0.23 109.912 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -52.3 -27.37 14.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.396 -0.815 . . . . 1.9 109.471 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -60.42 -47.4 86.25 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.254 -0.903 . . . . 0.25 109.909 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -69.47 -24.31 63.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.2 110.139 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.31 -66.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.015 -1.053 . . . . 0.21 110.139 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -44.93 78.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 2.47 109.572 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -58.91 -36.7 75.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.362 -0.836 . . . . 2.1 109.9 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.85 84.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.94 -1.1 . . . . 0.2 109.194 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.94 -42.1 97.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.464 -0.773 . . . . 0.62 109.713 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.4 -40.97 96.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.136 -0.977 . . . . 1.09 109.851 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.65 -16.2 56.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.3 109.648 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.57 -5.27 18.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.24 109.578 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.11 -116.26 7.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.28 109.613 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -133.35 5.34 3.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.414 -1.05 . . . . 2.21 109.235 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.6 mttp -70.43 167.72 17.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.186 -0.946 . . . . 1.9 108.946 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.03 161.35 16.14 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.894 -1.151 . . . . 0.17 107.894 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.649 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -143.93 108.8 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 0.12 109.421 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.39 131.36 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.592 -0.892 . . . . 0.09 108.592 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 t -109.06 133.21 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.629 -0.67 . . . . 0.17 109.382 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -106.86 105.33 15.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.92 -0.77 . . . . 0.96 108.92 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE2' HG11 ' A' ' 57' ' ' VAL . 38.5 m-85 -87.27 80.33 8.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.757 -1.201 . . . . 0.24 107.757 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.5 m -113.22 148.52 35.33 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.283 0.563 . . . . 1.03 109.771 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.48 127.07 37.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.407 -0.96 . . . . 0.26 108.407 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -66.06 -25.62 67.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.32 110.234 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 53.8 p-90 -89.48 -11.79 41.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.207 -0.933 . . . . 0.44 110.17 -179.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.0 t -95.04 128.11 41.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.32 109.931 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.79 -58.96 7.57 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 111.166 -0.774 . . . . 0.36 111.166 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.4 Cg_exo -47.22 -31.64 12.74 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 121.897 1.731 . . . . 0.44 111.184 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.4 -61.28 2.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.06 -1.025 . . . . 0.81 108.771 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -59.84 -17.58 37.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 1.92 110.068 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.992 -1.068 . . . . 3.13 110.137 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 38' ' ' ILE . 88.1 mt -96.07 7.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.28 111.276 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.71 -35.58 23.49 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 120.309 -1.494 . . . . 1.62 111.895 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -61.26 -5.98 5.98 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 CA-C-N 119.842 0.979 . . . . 0.25 110.839 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.26 -71.99 0.74 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.987 -0.746 . . . . 0.3 108.987 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -46.37 -57.47 4.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.601 -0.687 . . . . 0.13 110.536 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.47 -30.68 71.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.199 -0.938 . . . . 0.41 109.771 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.438 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.4 m -64.01 -42.1 97.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.979 -1.076 . . . . 0.97 109.774 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.7 mt -50.2 -13.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.929 . . . . 0.5 109.365 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 44' ' ' SER . 47.6 m -57.14 -34.52 68.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.51 109.647 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.95 -16.9 22.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.273 -0.892 . . . . 2.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -89.59 -41.98 11.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.992 -1.067 . . . . 2.16 109.826 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -113.04 70.4 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.424 -0.798 . . . . 0.24 109.351 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.7 p -67.14 -5.09 12.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.33 -0.857 . . . . 0.17 108.84 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.22 1.22 54.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.778 . . . . 0.34 109.657 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.85 151.01 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.785 -0.82 . . . . 0.12 108.785 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mm -100.83 126.51 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.331 -0.855 . . . . 0.17 109.042 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.556 ' C ' HD12 ' A' ' 55' ' ' LEU . 70.4 m-85 -112.02 129.26 56.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.397 -0.815 . . . . 0.11 108.917 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -113.12 172.2 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.729 -0.841 . . . . 0.12 108.729 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.06 142.07 30.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.824 -1.176 . . . . 1.31 107.824 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 98.1 t -139.12 136.6 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.339 -0.851 . . . . 0.14 110.176 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -99.0 109.35 22.12 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.922 -1.14 . . . . 1.08 107.922 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.452 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.3 m -63.74 -12.98 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.315 -0.865 . . . . 0.27 111.104 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.9 -40.21 7.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.064 -1.022 . . . . 1.11 111.015 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.6 -14.82 26.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.013 -1.055 . . . . 1.12 109.289 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.26 44.4 2.81 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.752 -0.833 . . . . 0.17 108.752 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.57 -14.53 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 2.22 109.942 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.07 -38.12 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.021 -1.05 . . . . 1.11 108.891 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -74.56 -46.84 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.513 -0.921 . . . . 0.19 108.513 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.67 -35.09 78.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.356 -0.84 . . . . 0.22 108.928 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.3 m -64.5 -45.34 87.74 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.273 -0.892 . . . . 1.29 109.034 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -63.73 -41.48 98.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.799 . . . . 2.2 109.327 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.02 -4.12 58.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.272 -0.893 . . . . 0.33 109.365 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.3 mm-40 50.26 55.07 10.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 2.34 110.421 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.4 123.27 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.28 108.989 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -114.01 5.31 16.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.402 -0.811 . . . . 2.4 109.92 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.552 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.57 148.17 27.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.096 -1.003 . . . . 0.22 109.219 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.54 HG23 ' HE2' ' B' ' 5' ' ' TYR . 20.7 p -131.48 149.04 72.42 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.616 -0.883 . . . . 0.22 108.616 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.45 145.77 78.18 Favored 'Cis proline' 0 C--N 1.322 -0.85 0 C-N-CA 124.664 -0.973 . . . . 0.2 110.429 -1.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.8 m -115.7 114.92 25.49 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.622 -1.251 . . . . 0.18 107.622 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.2 m-85 -91.26 118.58 30.6 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.433 -0.907 . . . . 0.15 108.573 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -119.94 135.94 54.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.617 -1.253 . . . . 1.03 107.617 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 100' ' ' THR . 26.8 m-85 -107.3 132.34 53.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.11 109.699 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -125.0 156.22 38.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.617 -0.883 . . . . 0.17 108.617 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -156.09 121.19 4.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.783 -1.191 . . . . 1.48 107.783 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt 55.68 34.26 22.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.693 -0.629 . . . . 1.67 110.318 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.39 3.27 88.59 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.092 -1.052 . . . . 0.22 110.751 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -114.01 146.58 39.97 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.349 -1.089 . . . . 2.08 110.295 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -86.49 144.4 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.718 -0.845 . . . . 1.7 108.718 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.03 -20.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.381 -0.825 . . . . 0.26 110.466 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 174.71 47.18 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.301 -1.428 . . . . 0.18 110.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -174.17 156.98 2.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 2.04 110.169 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.9 p90 -168.91 131.88 1.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.528 -0.732 . . . . 0.14 109.683 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 p -103.44 -160.27 0.77 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.051 -1.03 . . . . 0.17 108.574 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 79.44 122.11 0.36 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.47 -1.452 . . . . 0.13 109.47 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.66 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.122 . . . . 0.2 110.601 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -137.47 71.58 1.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.805 -1.183 . . . . 1.15 107.805 178.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -61.62 -39.53 91.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.731 -0.605 . . . . 1.19 111.358 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.55 -25.74 67.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.758 -1.214 . . . . 1.95 109.704 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -69.1 -32.65 72.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 2.05 109.575 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.6 mt -51.02 -38.85 53.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.15 109.131 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.11 -53.22 40.67 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.661 -0.816 . . . . 2.15 109.288 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.05 90.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.15 110.699 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.448 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.4 m -67.68 -42.94 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.13 110.235 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -61.48 -52.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.18 108.691 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.408 ' O ' HG12 ' A' ' 105' ' ' VAL . 14.0 t-20 -61.26 -17.77 55.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.858 . . . . 1.03 109.561 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -76.17 -59.36 2.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 2.02 110.043 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.0 mt -92.64 20.42 6.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.385 -0.822 . . . . 0.35 110.429 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.988 -1.006 . . . . 1.18 109.178 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.54 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -116.1 -173.27 2.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.321 -0.862 . . . . 0.0 110.529 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.11 150.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.992 0.901 . . . . 0.0 112.614 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.32 97.04 7.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -83.47 46.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.98 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.78 -126.51 0.16 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.69 24.51 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 119.2 1.5 . . . . 0.0 109.603 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.619 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.1 t . . . . . 0 N--CA 1.495 1.806 0 O-C-N 121.534 -0.729 . . . . 0.0 110.255 -178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.8 t . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 121.336 0.588 . . . . 0.3 109.882 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.9 tptp -154.24 124.92 7.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.25 -0.906 . . . . 1.97 108.823 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -91.71 134.12 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.98 109.923 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mm -110.68 109.11 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.034 -1.099 . . . . 0.19 108.034 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.98 -11.13 19.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.3 -0.875 . . . . 1.97 109.811 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -152.89 154.52 35.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.23 109.715 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -51.82 -25.79 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 1.9 109.695 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -59.61 -48.61 80.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.25 109.767 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.69 63.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 0.2 109.9 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.31 -65.56 0.63 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.124 . . . . 0.21 110.011 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -55.51 -46.05 77.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 2.47 109.623 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.76 -35.07 72.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 2.1 110.027 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.51 90.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.939 -1.101 . . . . 0.2 109.735 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.85 -46.59 87.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.62 109.845 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.57 -38.11 89.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.09 110.089 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.91 -16.52 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.3 110.073 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -2.76 8.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 0.24 109.925 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -114.79 5.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.28 109.555 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -138.42 4.72 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.336 -1.097 . . . . 2.21 109.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.1 168.16 16.17 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.204 -0.935 . . . . 1.9 108.748 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.62 162.39 13.11 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.81 -1.181 . . . . 0.17 107.81 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.1 t -145.03 109.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.771 -1.206 . . . . 0.12 109.628 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.9 t -102.9 135.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.776 -0.824 . . . . 0.09 108.776 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -110.35 134.58 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.17 109.383 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.17 101.16 10.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.697 -0.627 . . . . 0.96 109.459 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -87.41 76.56 9.04 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 0.24 107.933 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -113.72 148.77 35.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.772 -0.58 . . . . 1.03 109.474 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.46 125.24 36.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.542 -0.91 . . . . 0.26 108.542 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -65.18 -23.42 67.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.32 110.573 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -88.62 -14.76 36.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.053 -1.029 . . . . 0.44 109.976 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.64 118.36 32.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.32 109.686 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.55 -58.15 16.08 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.717 -0.754 . . . . 0.36 111.435 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -47.52 -34.96 21.08 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.806 1.67 . . . . 0.44 111.23 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.22 -60.98 2.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.924 -1.11 . . . . 0.81 109.208 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -58.98 -17.04 21.24 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.595 -0.691 . . . . 1.92 110.041 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -58.45 -19.73 39.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 3.13 110.523 -178.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 38' ' ' ILE . 63.5 mt -96.55 7.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.09 -1.006 . . . . 0.28 110.813 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.27 5.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 119.953 -1.717 . . . . 1.62 112.645 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -65.16 -7.48 15.68 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 CA-C-N 119.555 0.877 . . . . 0.25 110.04 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -109.52 -74.54 0.65 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.845 . . . . 0.3 108.976 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -41.66 -56.63 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.649 -0.657 . . . . 0.13 110.931 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -67.0 -31.04 71.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.022 -1.049 . . . . 0.41 110.1 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -65.73 -42.57 90.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.839 -1.163 . . . . 0.97 110.534 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -50.39 -17.44 0.47 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.985 -1.072 . . . . 0.5 109.99 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -56.8 -27.77 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.51 110.051 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -96.1 -22.1 17.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.142 -0.974 . . . . 2.0 110.323 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -90.32 -19.88 23.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 2.16 109.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -132.34 72.1 1.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.692 . . . . 0.24 109.257 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.2 p -67.87 -5.31 16.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.412 -0.805 . . . . 0.17 109.327 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 20.9 t-20 -96.47 -0.77 48.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.75 . . . . 0.34 109.61 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 145.96 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.249 -0.907 . . . . 0.12 109.472 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.35 132.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.529 -0.732 . . . . 0.17 109.371 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.544 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -117.67 130.73 56.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.397 -0.814 . . . . 0.11 109.059 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.2 mp -113.2 172.44 6.94 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.801 -0.814 . . . . 0.12 108.801 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -141.8 143.17 33.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.202 -1.036 . . . . 1.31 108.202 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 136.17 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -0.97 . . . . 0.14 110.641 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.38 103.13 15.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.448 -0.945 . . . . 1.08 108.448 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.485 ' O ' ' NE ' ' B' ' 4' ' ' ARG . 16.1 m -61.19 -8.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.27 111.036 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.48 -46.1 5.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.119 -0.988 . . . . 1.11 110.856 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -93.12 -14.47 27.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.086 -1.008 . . . . 1.12 109.673 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.06 46.18 1.83 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.306 -0.871 . . . . 0.17 109.049 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.07 -15.73 2.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 2.22 109.66 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -70.12 -41.11 74.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.112 -0.993 . . . . 1.11 109.056 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 t -73.55 -46.28 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.949 . . . . 0.19 108.617 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.8 -36.67 83.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.22 108.735 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -64.47 -47.67 78.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.29 109.074 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.09 -34.42 78.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 2.2 109.599 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.92 -7.14 54.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.33 109.587 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.4 mt-10 51.11 61.12 3.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 2.34 110.21 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 35.0 t -78.61 138.07 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.116 -0.99 . . . . 0.28 108.996 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -123.03 -9.02 8.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.431 -0.793 . . . . 2.4 109.546 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.3 135.6 14.96 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.064 -1.022 . . . . 0.22 109.66 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -114.87 150.6 44.38 Favored Pre-proline 0 N--CA 1.5 2.027 0 N-CA-C 108.117 -1.068 . . . . 0.22 108.117 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.4 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.37 146.76 83.57 Favored 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 124.877 -0.885 . . . . 0.2 110.205 -1.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.84 121.99 42.19 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.429 -0.952 . . . . 0.18 108.429 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CD1' HD21 ' A' ' 97' ' ' LEU . 71.3 m-85 -98.82 115.93 29.9 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.395 -0.965 . . . . 0.15 108.395 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.89 141.26 48.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.988 -1.116 . . . . 1.03 107.988 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 25.5 m-85 -111.17 134.54 52.69 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.49 0.662 . . . . 0.11 110.156 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.37 155.12 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.998 -0.741 . . . . 0.17 108.998 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -154.58 123.18 6.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.91 -1.145 . . . . 1.48 107.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt 55.74 30.66 16.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 1.67 110.064 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.42 90.52 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.791 -1.195 . . . . 0.22 110.621 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -112.83 145.65 40.27 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.248 -1.148 . . . . 2.08 110.319 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -86.88 144.8 26.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 1.7 108.75 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.68 -23.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.41 -0.806 . . . . 0.26 110.587 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.94 179.34 47.12 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.28 -1.438 . . . . 0.18 110.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.26 158.59 2.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -1.126 . . . . 2.04 110.357 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.6 p90 -168.98 132.14 1.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.476 -0.765 . . . . 0.14 110.195 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 p -104.14 -172.95 2.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.191 -0.943 . . . . 0.17 108.608 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 130.76 5.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.353 -1.499 . . . . 0.13 109.353 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.27 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -1.211 . . . . 0.2 110.477 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.88 71.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.815 -1.18 . . . . 1.15 107.815 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.01 -30.51 71.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 1.19 110.294 -178.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.6 -26.85 67.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.787 -1.196 . . . . 1.95 108.998 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -69.08 -34.14 74.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.486 -0.759 . . . . 2.05 109.405 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.448 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -50.92 -37.24 42.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.02 -1.05 . . . . 0.15 108.82 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.23 -57.17 7.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.395 -0.815 . . . . 2.15 109.667 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.02 92.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.15 110.509 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.5 m -66.84 -44.2 81.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.13 110.164 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.87 -52.75 55.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.18 108.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.1 -16.66 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 1.03 109.977 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.13 -58.28 3.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 2.02 110.484 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.04 14.16 18.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.35 110.693 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.494 1.764 0 O-C-N 120.863 -1.148 . . . . 1.18 109.199 179.22 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' A' ' 59' ' ' VAL . 13.6 mmm180 . . . . . 0 N--CA 1.498 1.932 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.693 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -109.59 -168.42 1.33 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.274 -0.892 . . . . 0.0 110.525 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.09 146.95 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.717 0.77 . . . . 0.0 112.114 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -101.16 95.45 6.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.1 pt-20 -83.3 42.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.064 -1.023 . . . . 0.0 110.479 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.81 -130.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.81 20.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 CA-C-N 119.139 1.47 . . . . 0.0 109.05 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.653 ' H ' ' C ' ' B' ' 9' ' ' GLY . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 3' ' ' LYS . 84.3 t . . . . . 0 N--CA 1.495 1.793 0 N-CA-C 109.117 -0.698 . . . . 0.3 109.117 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.9 tttp -154.99 121.15 5.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.97 109.553 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.417 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 31.6 tt0 -89.54 136.51 32.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.98 109.579 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -107.04 113.13 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.606 -1.257 . . . . 0.19 107.606 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.417 ' OE1' ' NE2' ' A' ' 4' ' ' GLN . 4.1 mm-40 -99.79 -13.32 19.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 1.97 108.933 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 p -154.09 158.78 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.23 109.554 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -52.36 -22.97 5.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 1.9 110.037 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -60.93 -51.32 69.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.25 110.671 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.26 -22.53 64.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.2 110.014 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.1 -64.19 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.21 109.791 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -55.75 -46.72 77.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 2.47 109.963 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.94 -35.66 71.42 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.196 -0.94 . . . . 2.1 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.96 -46.51 90.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.2 109.563 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.26 -44.79 94.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 0.62 109.721 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.51 -36.8 85.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 1.09 109.727 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.03 -18.84 52.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.3 109.776 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -5.94 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.24 109.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.68 1.24 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.457 -1.457 . . . . 0.28 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -138.13 0.4 2.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 2.21 109.781 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 mtmm -69.89 172.21 8.11 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.033 -1.042 . . . . 1.9 109.012 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.34 164.42 16.12 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.383 -0.823 . . . . 0.17 108.992 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 20.1 t -145.94 105.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.12 109.469 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.7 t -103.67 133.73 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.304 -0.872 . . . . 0.09 109.148 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.64 134.07 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.233 -0.654 . . . . 0.17 109.233 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -107.87 104.79 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.117 -0.698 . . . . 0.96 109.117 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 57.7 m-85 -86.37 82.33 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.736 -1.209 . . . . 0.24 107.736 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -113.72 147.82 37.54 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.68 124.2 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.485 -0.931 . . . . 0.26 108.485 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -65.51 -24.8 67.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.832 . . . . 0.32 110.478 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 49.2 p-90 -88.79 -13.57 39.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.1 . . . . 0.44 109.926 -179.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.7 116.92 29.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.32 109.723 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.67 -55.47 30.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.832 -0.699 . . . . 0.36 111.742 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.2 Cg_exo -47.86 -35.23 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.6 1.533 . . . . 0.44 111.388 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.57 -60.55 2.32 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.049 -1.032 . . . . 0.81 109.194 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.65 -18.07 38.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.748 . . . . 1.92 110.052 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.502 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.6 tmt? -58.77 -24.89 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 3.13 110.389 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -96.31 13.82 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.873 -1.142 . . . . 0.28 110.149 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.72 2.89 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.585 -1.322 . . . . 1.62 112.164 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.4 Cg_endo -67.94 7.44 0.6 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 CA-C-N 119.6 0.893 . . . . 0.25 110.526 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' LYS . 45.6 m-85 -124.48 -73.7 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.756 -0.831 . . . . 0.3 108.756 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -43.44 -55.76 3.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 0.13 110.266 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.85 -27.33 66.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.41 109.869 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 46' ' ' SER . 1.4 p -65.13 -44.92 87.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.97 110.068 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.8 mt -49.15 -14.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.5 109.706 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 68.0 m -57.66 -32.14 67.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.993 -1.067 . . . . 0.51 109.743 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -94.91 -19.57 20.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.963 . . . . 2.0 110.141 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -91.4 -21.69 20.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.954 -1.091 . . . . 2.16 109.584 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -134.2 72.76 1.47 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.502 -0.749 . . . . 0.24 109.384 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 p -68.59 -6.9 28.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.383 -0.823 . . . . 0.17 109.35 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -96.31 0.92 51.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.352 -0.842 . . . . 0.34 109.881 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.402 ' C ' HD13 ' A' ' 53' ' ' ILE . 98.6 t -112.76 146.35 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.349 -0.982 . . . . 0.12 108.349 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' C ' ' A' ' 52' ' ' VAL . 4.9 mm -100.42 119.42 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.17 109.538 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.571 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -108.77 130.04 55.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.786 -0.82 . . . . 0.11 108.786 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -111.9 172.82 6.67 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -142.12 144.12 33.36 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.053 -1.091 . . . . 1.31 108.053 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -141.73 142.53 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.111 -0.993 . . . . 0.14 110.858 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 21.4 t70 -99.0 96.47 7.84 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.488 -0.93 . . . . 1.08 108.488 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 74' ' ' THR . 10.3 m -56.59 -3.06 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.27 110.833 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 37.7 m-20 -105.05 -46.28 4.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.118 -0.989 . . . . 1.11 110.991 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -97.04 -23.56 16.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.106 -0.996 . . . . 1.12 110.296 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' N ' ' A' ' 64' ' ' ASP . . . -105.32 41.81 1.31 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.12 -0.988 . . . . 0.17 108.967 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 35.4 tt0 -54.98 -10.84 0.54 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.397 -0.815 . . . . 2.22 109.825 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -68.9 -43.62 74.87 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.14 -0.975 . . . . 1.11 108.768 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.34 -45.71 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.302 -0.999 . . . . 0.19 108.302 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.79 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 6.6 m -64.0 -54.01 41.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 1.29 109.304 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.2 -33.41 75.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.476 -0.765 . . . . 2.2 110.019 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.37 1.2 54.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.069 -1.019 . . . . 0.33 109.859 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 67' ' ' SER . 15.0 mp0 45.0 50.46 9.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.278 -0.889 . . . . 2.34 110.243 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.34 130.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.28 108.91 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.12 7.61 5.07 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.396 -0.815 . . . . 2.4 110.024 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.63 134.27 14.58 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.161 -0.962 . . . . 0.22 108.93 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.574 HG23 ' HE1' ' B' ' 5' ' ' TYR . 23.5 p -119.78 150.24 50.07 Favored Pre-proline 0 N--CA 1.508 2.441 0 O-C-N 121.227 -0.921 . . . . 0.22 108.925 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -76.88 145.22 80.86 Favored 'Cis proline' 0 N--CA 1.486 1.057 0 C-N-CA 124.893 -0.878 . . . . 0.2 110.758 -2.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.81 122.03 45.09 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.7 -1.222 . . . . 0.18 107.7 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.5 m-85 -99.26 121.08 40.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.15 108.822 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.515 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.1 mt-30 -119.62 135.74 54.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.894 -1.15 . . . . 1.03 107.894 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.7 m-85 -109.93 126.57 54.03 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.461 0.648 . . . . 0.11 109.764 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -126.06 156.93 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.601 -0.888 . . . . 0.17 108.601 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.55 126.09 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.786 -1.19 . . . . 1.48 107.786 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 55.05 25.27 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 1.67 109.951 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.15 6.51 84.48 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.909 -1.138 . . . . 0.22 110.347 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.28 146.78 40.01 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -1.076 . . . . 2.08 109.956 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -85.91 143.88 27.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.7 109.529 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.78 -27.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.423 -0.798 . . . . 0.26 110.315 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.43 177.99 45.57 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.388 -1.387 . . . . 0.18 110.415 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -174.08 154.14 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 2.04 110.299 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.0 p90 -169.05 133.11 1.41 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.516 -0.74 . . . . 0.14 109.982 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -105.51 -175.03 2.68 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.136 -0.978 . . . . 0.17 108.44 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 98.1 133.83 8.11 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.622 -1.391 . . . . 0.13 109.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.24 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.2 110.136 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.2 t-20 -139.89 72.45 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.466 -0.939 . . . . 1.15 108.466 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.54 -0.725 . . . . 1.19 110.781 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -64.76 -26.6 68.42 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -68.82 -35.46 77.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.435 -0.79 . . . . 2.05 109.17 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.4 mt -51.13 -36.11 39.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.017 . . . . 0.15 108.906 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.96 -58.5 5.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 2.15 109.34 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.26 90.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.15 110.327 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -67.61 -48.11 67.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -0.965 . . . . 0.13 110.31 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mt -62.46 -50.11 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.024 -1.048 . . . . 0.18 108.785 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -59.41 -17.27 29.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.03 109.538 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.06 -62.16 1.74 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 2.02 110.009 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.21 21.17 5.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.35 110.494 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.962 -1.086 . . . . 1.18 109.236 179.585 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' B' ' 4' ' ' ARG . 1.1 tpt180 . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -108.97 -164.89 0.97 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.757 -1.214 . . . . 0.0 110.821 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.86 149.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.247 -0.908 . . . . 0.0 112.839 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.71 95.53 6.49 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.407 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 7.3 pt-20 -84.01 42.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.024 -1.047 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.08 -133.93 0.05 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.29 21.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.322 -0.841 0 CA-C-N 119.154 1.477 . . . . 0.0 109.649 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.411 -0.806 . . . . 0.0 109.413 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 72.5 t . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.131 -0.692 . . . . 0.3 109.131 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -154.6 122.58 5.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 1.97 109.351 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -89.23 135.97 33.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.325 -0.859 . . . . 0.98 109.447 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -106.03 123.16 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 8.9 mp0 -107.92 -15.2 14.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.25 -0.906 . . . . 1.97 109.627 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.8 p -152.16 159.23 43.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.23 109.695 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.32 -30.86 30.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 1.9 109.861 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -59.53 -44.25 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.078 . . . . 0.25 109.679 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.19 -27.23 64.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.2 109.775 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.49 -69.0 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.21 110.216 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -55.27 -42.04 73.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 2.47 109.61 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -58.99 -36.89 75.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.14 -0.975 . . . . 2.1 109.474 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.34 95.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.2 109.088 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 13.6 mt -64.6 -47.8 77.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.458 -0.776 . . . . 0.62 109.734 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.04 -37.77 88.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 1.09 109.701 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.52 -16.53 54.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.3 109.616 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.07 -7.39 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.24 109.844 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 -111.01 3.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.535 -1.426 . . . . 0.28 109.535 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.64 4.72 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.254 -1.145 . . . . 2.21 109.436 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -70.05 168.02 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 1.9 109.193 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.34 163.59 12.8 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.045 -1.094 . . . . 0.17 108.045 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.2 t -145.26 105.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.016 -1.052 . . . . 0.12 109.797 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.18 133.42 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.284 -1.006 . . . . 0.09 108.284 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -110.53 134.58 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.17 109.827 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.75 101.36 10.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.08 -0.711 . . . . 0.96 109.08 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 57' ' ' VAL . 43.5 m-85 -86.14 79.23 9.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.566 -1.272 . . . . 0.24 107.566 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -113.44 148.61 35.57 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.415 0.626 . . . . 1.03 109.748 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.66 124.23 34.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.131 -1.063 . . . . 0.26 108.131 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -64.97 -23.11 67.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 0.32 110.484 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 56.3 p-90 -89.84 -13.29 36.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.013 -1.054 . . . . 0.44 110.405 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.88 137.78 32.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.32 109.886 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.16 -59.15 3.19 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.739 -0.744 . . . . 0.36 111.355 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -46.1 -43.41 20.53 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.77 1.647 . . . . 0.44 111.766 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.84 -55.19 6.07 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.728 -1.232 . . . . 0.81 109.048 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -60.45 -20.66 60.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.413 -0.804 . . . . 1.92 110.225 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLY . 35.6 tpp -59.82 -20.5 57.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 3.13 110.557 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 38' ' ' ILE . 81.8 mt -97.53 11.18 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.992 -1.067 . . . . 0.28 111.686 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.78 -34.08 9.83 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.02 -1.675 . . . . 1.62 112.63 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.52 -11.86 25.24 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 CA-C-N 119.742 0.944 . . . . 0.25 110.803 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -102.76 -68.29 0.84 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.248 -0.908 . . . . 0.3 109.693 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -45.42 -51.31 11.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.422 -0.799 . . . . 0.13 110.556 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.83 -34.7 75.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.937 -1.102 . . . . 0.41 110.111 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 -41.14 94.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.97 110.153 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.0 mt -51.4 -15.6 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.5 109.692 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.412 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 69.2 m -58.15 -31.7 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.51 109.902 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -94.84 -20.76 19.18 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.273 -0.892 . . . . 2.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -90.34 -21.52 21.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 2.16 109.341 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -133.71 68.54 1.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.577 -0.702 . . . . 0.24 109.375 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.3 p -67.45 -5.54 15.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.17 108.915 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 24.1 t-20 -95.84 4.0 53.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.34 109.646 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -118.76 149.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.212 -0.662 . . . . 0.12 109.212 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -101.94 128.56 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.421 -0.8 . . . . 0.17 109.223 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.4 m-85 -115.03 132.01 56.74 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.438 -0.788 . . . . 0.11 109.176 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.95 173.89 6.26 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.474 -0.766 . . . . 0.12 109.197 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -143.83 144.89 31.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.021 -1.103 . . . . 1.31 108.021 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 27' ' ' PHE . 69.7 t -141.6 139.63 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.141 -0.975 . . . . 0.14 110.521 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.21 100.44 11.55 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.204 -1.035 . . . . 1.08 108.204 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -60.67 -1.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.275 -0.891 . . . . 0.27 111.482 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.68 -41.23 3.64 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.13 -0.981 . . . . 1.11 111.002 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.0 -13.14 29.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.025 -1.047 . . . . 1.12 109.581 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 50.45 1.79 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.17 108.586 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -54.93 -15.23 1.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.522 -0.736 . . . . 2.22 109.701 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.3 p30 -70.62 -39.88 73.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.992 . . . . 1.11 109.364 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.75 -47.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.16 -0.963 . . . . 0.19 108.676 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.46 -36.21 83.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.22 109.288 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -63.35 -44.87 93.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 1.29 108.968 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.59 -44.06 95.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.712 -0.847 . . . . 2.2 108.712 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 70' ' ' GLU . . . -89.06 10.45 21.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.33 109.519 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 66' ' ' ALA . 5.2 pt-20 31.73 56.06 0.3 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.409 0.623 . . . . 2.34 111.362 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 t -79.67 134.32 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.28 109.037 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.414 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 62.7 mttm -129.66 8.7 5.39 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.47 -0.769 . . . . 2.4 109.861 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.45 135.11 15.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.133 -0.98 . . . . 0.22 108.902 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.519 HG23 ' CE2' ' B' ' 5' ' ' TYR . 70.6 p -121.03 149.53 51.38 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.835 . . . . 0.22 109.172 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.51 144.17 74.09 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 C-N-CA 124.962 -0.849 . . . . 0.2 110.197 -1.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.27 113.22 24.31 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.387 -1.338 . . . . 0.18 107.387 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.1 m-85 -89.68 119.92 30.51 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.215 -0.994 . . . . 0.15 108.734 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -118.92 136.08 54.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.925 -1.139 . . . . 1.03 107.925 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.2 m-85 -110.14 127.0 54.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.381 0.61 . . . . 0.11 109.568 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.98 157.54 35.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.752 -0.833 . . . . 0.17 108.752 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -154.8 123.66 6.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 57.09 27.65 13.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 1.67 110.078 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.8 87.94 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.025 -1.083 . . . . 0.22 110.427 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -112.98 146.46 39.02 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.357 -1.084 . . . . 2.08 110.282 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -85.61 139.52 31.35 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.766 -0.828 . . . . 1.7 108.766 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.61 -21.46 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.474 -0.766 . . . . 0.26 110.195 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.94 176.12 47.77 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.498 -1.334 . . . . 0.18 110.397 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.51 159.01 3.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -1.072 . . . . 2.04 110.336 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.4 p90 -169.0 130.84 1.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.466 -0.772 . . . . 0.14 109.811 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 p -103.27 -163.73 1.01 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.07 -1.018 . . . . 0.17 108.538 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 127.04 1.03 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.19 -1.564 . . . . 0.13 109.19 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.497 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.53 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -1.16 . . . . 0.2 110.726 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -137.71 73.77 1.45 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.032 -1.099 . . . . 1.15 108.032 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -35.82 80.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.878 -0.514 . . . . 1.19 110.895 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.52 -27.09 68.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.97 -1.081 . . . . 1.95 109.507 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -69.65 -33.7 72.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 2.05 109.759 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.8 mt -49.82 -36.08 25.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.067 -1.021 . . . . 0.15 109.071 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.35 -58.24 5.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.482 -0.761 . . . . 2.15 110.025 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.25 77.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.405 -0.809 . . . . 0.15 111.273 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.458 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.9 m -67.47 -46.76 72.06 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.859 -1.151 . . . . 0.13 110.758 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.25 -52.19 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.18 109.46 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -59.71 -17.88 38.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 1.03 109.745 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.4 -59.65 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 2.02 110.516 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt -92.93 17.37 10.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.35 110.561 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.085 . . . . 1.18 109.31 179.296 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -130.44 -168.62 2.0 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.8 148.25 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.007 0.908 . . . . 0.0 112.809 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.36 95.08 6.27 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.46 46.44 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.921 -1.112 . . . . 0.0 110.217 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.01 -130.69 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.06 20.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 CA-C-N 119.322 1.561 . . . . 0.0 109.009 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.487 1.384 0 O-C-N 121.39 -0.819 . . . . 0.0 109.506 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 39.8 t . . . . . 0 N--CA 1.496 1.833 0 N-CA-C 108.934 -0.765 . . . . 0.3 108.934 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.3 tttt -154.28 123.54 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.019 -1.051 . . . . 1.97 109.468 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -90.65 134.4 34.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.835 . . . . 0.98 110.087 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.99 114.11 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.724 -1.213 . . . . 0.19 107.724 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.08 -13.68 18.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.962 . . . . 1.97 109.724 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 p -153.72 158.76 41.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.114 -0.991 . . . . 0.23 109.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -52.1 -21.36 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.722 . . . . 1.9 109.663 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 21.1 m -61.73 -56.08 23.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.25 110.116 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.3 -18.06 64.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.2 110.262 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.93 -60.85 3.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.068 . . . . 0.21 110.523 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.96 -44.35 97.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.016 . . . . 2.47 109.638 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -60.77 -32.58 71.9 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.471 -0.768 . . . . 2.1 110.389 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.34 85.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.853 -1.155 . . . . 0.2 109.121 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.09 -43.55 95.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.62 109.367 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.71 -40.07 94.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 1.09 109.806 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.71 -17.19 54.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.3 109.85 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.61 26.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.24 109.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.46 18.22 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.365 -1.494 . . . . 0.28 109.365 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.18 2.68 8.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.553 -0.969 . . . . 2.21 109.627 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.7 mttt -69.35 167.05 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.013 -1.054 . . . . 1.9 108.739 179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.96 164.29 8.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.196 -1.038 . . . . 0.17 108.196 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.7 t -146.05 106.84 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.957 -1.089 . . . . 0.12 109.525 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.49 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.644 -0.873 . . . . 0.09 108.644 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.15 139.13 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.626 -0.671 . . . . 0.17 109.821 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.58 99.63 8.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.632 -0.668 . . . . 0.96 109.248 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -85.41 80.59 9.06 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.898 -1.149 . . . . 0.24 107.898 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -106.48 -163.6 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 1.03 109.633 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.35 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.573 -0.899 . . . . 0.26 108.573 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -64.43 -26.92 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.32 110.77 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 59.3 p-90 -88.39 -16.54 32.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.979 -1.076 . . . . 0.44 110.009 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.25 120.12 35.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 0.32 109.809 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.03 -52.98 36.58 Favored Glycine 0 N--CA 1.486 1.992 0 O-C-N 121.519 -0.738 . . . . 0.36 111.548 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.3 Cg_exo -49.21 -37.04 38.49 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.664 1.576 . . . . 0.44 111.386 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.68 1.04 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.884 -1.135 . . . . 0.81 108.993 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.12 -15.04 20.11 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.517 -0.74 . . . . 1.92 110.332 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 tpt -59.94 -21.51 61.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 3.13 109.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 38' ' ' ILE . 50.1 mt -96.93 15.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.28 110.44 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.53 -31.26 2.93 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.687 -1.258 . . . . 1.62 112.153 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.74 -5.52 10.58 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 CA-C-N 119.798 0.963 . . . . 0.25 109.799 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 39.1 m-85 -109.72 -78.42 0.59 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.832 -0.803 . . . . 0.3 108.832 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 94.0 t80 -40.46 -58.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.73 -0.606 . . . . 0.13 111.083 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.53 -30.9 71.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.03 . . . . 0.41 109.939 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.8 t -65.47 -40.48 93.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.91 -1.119 . . . . 0.97 110.28 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.6 mt -50.24 -15.93 0.28 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.99 -1.069 . . . . 0.5 109.713 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -57.29 -29.48 63.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.065 -1.022 . . . . 0.51 109.917 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.73 -21.04 17.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.0 110.226 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -90.98 -22.19 20.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.994 -1.066 . . . . 2.16 109.747 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -133.54 69.78 1.47 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.511 -0.743 . . . . 0.24 109.275 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -67.85 -5.95 19.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.465 -0.772 . . . . 0.17 109.243 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -94.49 3.78 54.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.34 109.457 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.5 t -121.11 145.38 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.701 -0.852 . . . . 0.12 108.701 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -97.86 129.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.242 -0.911 . . . . 0.17 109.422 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -114.73 130.93 56.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.315 -0.866 . . . . 0.11 109.423 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.61 172.83 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.959 -0.756 . . . . 0.12 108.959 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.89 142.2 30.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.992 -1.114 . . . . 1.31 107.992 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.4 t -142.2 136.69 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.121 -0.987 . . . . 0.14 110.774 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 24.0 t70 -96.99 111.45 23.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.996 -1.113 . . . . 1.08 107.996 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 16.8 m -65.33 -12.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.27 110.749 -178.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -97.85 -44.41 6.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.013 -1.055 . . . . 1.11 111.021 -178.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -91.93 -15.35 28.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 1.12 109.459 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -117.24 43.05 2.41 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.632 -0.877 . . . . 0.17 108.632 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.14 -15.35 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.415 -0.803 . . . . 2.22 109.762 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -40.22 74.35 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.256 -0.903 . . . . 1.11 109.002 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.26 -45.77 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.679 -0.86 . . . . 0.19 108.679 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.28 -32.52 73.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.22 108.956 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -64.03 -48.94 74.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 1.29 109.271 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.08 -38.5 91.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.321 -0.862 . . . . 2.2 109.535 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.53 58.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.212 -0.93 . . . . 0.33 109.697 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.2 mt-10 46.66 57.74 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 2.34 110.284 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.07 132.28 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.28 108.916 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.37 2.0 8.41 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.402 -0.811 . . . . 2.4 110.244 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.79 131.33 13.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.968 -1.083 . . . . 0.22 109.061 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 46.9 p -116.56 149.72 44.31 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.48 -0.762 . . . . 0.22 109.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.61 145.91 80.78 Favored 'Cis proline' 0 N--CA 1.487 1.091 0 C-N-CA 124.934 -0.861 . . . . 0.2 110.071 -1.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.96 113.42 23.24 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.713 -1.217 . . . . 0.18 107.713 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -87.56 126.78 35.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.881 -1.137 . . . . 0.15 108.939 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -124.33 133.82 53.34 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.702 -1.221 . . . . 1.03 107.702 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' CD2' HG22 ' A' ' 24' ' ' VAL . 25.3 m-85 -108.22 127.66 54.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.11 109.619 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -125.69 156.66 38.96 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.714 -0.847 . . . . 0.17 108.714 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -153.86 124.97 7.36 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.558 -1.275 . . . . 1.48 107.558 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.7 mttt 56.64 20.15 4.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.569 -0.707 . . . . 1.67 109.884 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.38 2.51 70.46 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.319 -1.112 . . . . 0.22 110.319 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -110.35 148.12 32.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.258 -1.143 . . . . 2.08 110.057 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -85.01 140.43 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.827 . . . . 1.7 109.274 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.98 -3.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.461 -0.775 . . . . 0.26 110.176 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.81 170.74 30.17 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.491 -1.338 . . . . 0.18 110.63 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.08 155.52 3.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -1.065 . . . . 2.04 110.134 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.6 p90 -168.58 131.7 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.14 110.439 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.9 p -101.55 -165.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.134 -0.979 . . . . 0.17 108.875 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.13 131.49 2.85 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.143 -1.583 . . . . 0.13 109.143 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -61.13 96.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -1.166 . . . . 0.2 110.837 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -143.06 77.6 1.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.372 -0.973 . . . . 1.15 108.372 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.78 -33.59 76.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.381 -0.825 . . . . 1.19 110.65 -178.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.38 -26.15 67.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.891 -1.131 . . . . 1.95 109.179 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -68.38 -36.49 79.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.81 . . . . 2.05 109.257 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.5 mt -52.39 -37.04 55.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.15 108.775 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.85 -58.92 4.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 2.15 109.76 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.54 89.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.15 110.865 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 m -66.58 -46.85 74.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.087 -1.008 . . . . 0.13 110.467 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.1 -51.95 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.18 108.853 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -61.18 -16.47 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 1.03 109.688 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.57 -56.2 4.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 2.02 110.342 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 22' ' ' LEU . 22.4 mt -92.84 13.24 21.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.35 110.527 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.942 -1.098 . . . . 1.18 109.394 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -128.2 -166.81 1.67 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.293 -0.879 . . . . 0.0 110.55 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.9 143.18 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.375 -0.828 . . . . 0.0 112.633 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.78 94.76 6.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.16 46.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 110.134 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.08 -133.83 0.15 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.95 27.73 0.15 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 CA-C-N 119.325 1.563 . . . . 0.0 109.049 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 3' ' ' LYS . 91.9 t . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 109.326 -0.62 . . . . 0.3 109.326 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.44 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.4 tttm -154.56 125.48 7.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 1.97 109.079 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.39 130.66 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.98 109.994 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mm -106.08 112.87 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.768 -1.197 . . . . 0.19 107.768 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.42 -15.12 18.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.139 -0.975 . . . . 1.97 109.641 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 p -154.12 159.87 41.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.23 109.698 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.493 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 26.7 tttp -51.57 -22.7 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 1.9 109.293 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -60.38 -52.37 65.51 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.895 . . . . 0.25 109.869 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -22.7 63.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.2 109.889 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.49 -65.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.21 109.708 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -55.04 -45.62 75.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.951 . . . . 2.47 109.727 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.62 -36.22 73.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.303 -0.873 . . . . 2.1 109.973 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.49 86.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 0.2 109.409 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.04 -46.85 79.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.738 . . . . 0.62 110.02 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.82 -41.2 97.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 1.09 110.067 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.88 -17.21 53.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.3 109.646 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -6.7 27.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.24 109.566 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 -133.47 24.73 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.434 -1.466 . . . . 0.28 109.434 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.74 6.11 13.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.363 -1.081 . . . . 2.21 109.6 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.66 166.82 19.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.062 -1.024 . . . . 1.9 109.252 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.38 160.71 15.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 0.17 108.494 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.619 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.6 t -144.61 109.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.994 . . . . 0.12 109.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.32 133.85 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.665 -0.865 . . . . 0.09 108.665 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.45 141.95 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.431 -0.793 . . . . 0.17 109.869 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -111.41 99.89 8.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.924 -0.769 . . . . 0.96 108.924 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.58 80.04 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.903 -1.147 . . . . 0.24 107.903 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -113.3 150.01 33.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.79 -0.569 . . . . 1.03 109.718 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.39 126.4 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.568 -0.901 . . . . 0.26 108.568 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -65.98 -25.89 67.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32 110.662 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.428 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 50.5 p-90 -87.7 -10.7 50.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.44 109.942 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -97.51 127.52 43.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.477 -0.764 . . . . 0.32 109.591 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.94 -55.83 10.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.145 -0.782 . . . . 0.36 111.145 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.78 -39.64 38.85 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.912 1.742 . . . . 0.44 111.605 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -61.84 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.675 -1.266 . . . . 0.81 109.243 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -58.98 -20.12 49.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.261 -0.899 . . . . 1.92 109.82 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.7 ttt -60.37 -18.33 49.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 3.13 110.249 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.473 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -99.64 8.02 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.28 110.26 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.75 -31.96 5.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.648 -1.283 . . . . 1.62 112.453 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.1 Cg_exo -62.03 -7.71 10.37 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.757 0.949 . . . . 0.25 109.81 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -106.28 -74.49 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.032 -0.729 . . . . 0.3 109.032 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -44.49 -56.08 4.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.754 . . . . 0.13 110.792 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -65.75 -32.04 73.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.113 -0.992 . . . . 0.41 109.877 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 t -64.96 -41.45 95.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.97 110.049 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.99 -14.64 0.23 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.5 109.81 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -56.61 -32.37 65.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.038 -1.039 . . . . 0.51 109.926 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -95.09 -17.12 22.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 2.0 110.368 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -91.0 -23.51 20.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.123 -0.986 . . . . 2.16 109.187 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.5 66.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.556 -0.715 . . . . 0.24 109.245 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -66.68 -1.91 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.339 -0.851 . . . . 0.17 109.0 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 34.1 t-20 -94.94 -7.38 40.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.424 -0.797 . . . . 0.34 109.124 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.4 t -112.65 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.418 -0.801 . . . . 0.12 109.026 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -100.37 125.48 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.052 -0.721 . . . . 0.17 109.052 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.585 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.6 m-85 -109.09 132.57 53.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.11 108.996 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -113.11 169.56 8.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.679 -0.86 . . . . 0.12 108.679 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.01 143.32 34.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.729 -1.212 . . . . 1.31 107.729 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.8 t -141.38 138.01 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.14 111.045 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.81 96.92 8.9 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.049 -1.093 . . . . 1.08 108.049 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 m -54.63 -8.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.27 111.464 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.46 -44.07 5.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 1.11 110.672 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.91 -9.09 41.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.167 -0.958 . . . . 1.12 109.323 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.15 43.3 3.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.708 -0.849 . . . . 0.17 108.708 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.92 -15.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.802 . . . . 2.22 109.669 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.19 -39.86 74.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 1.11 108.913 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.7 t -74.42 -46.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.19 108.51 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.96 75.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.868 . . . . 0.22 108.96 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -64.29 -47.91 77.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.405 -0.81 . . . . 1.29 109.065 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.53 -36.9 85.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 2.2 109.811 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.36 59.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.156 -0.965 . . . . 0.33 110.166 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 49.57 55.81 8.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.05 -1.031 . . . . 2.34 109.813 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.5 137.51 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.28 109.638 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -128.8 -4.94 5.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 2.4 109.465 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.562 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.64 136.39 15.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.968 -1.082 . . . . 0.22 110.006 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.606 HG23 ' CE2' ' B' ' 5' ' ' TYR . 48.3 p -115.58 150.35 44.55 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.362 -0.836 . . . . 0.22 108.747 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.66 143.16 73.38 Favored 'Cis proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.842 -0.899 . . . . 0.2 110.13 -2.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.27 115.5 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.13 -1.063 . . . . 0.18 108.13 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.495 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.7 m-85 -91.45 115.42 28.02 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.378 -0.929 . . . . 0.15 108.568 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.23 136.33 53.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.559 -1.274 . . . . 1.03 107.559 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 100' ' ' THR . 27.9 m-85 -107.75 127.38 53.64 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.596 0.713 . . . . 0.11 109.978 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.17 156.97 31.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.376 -0.972 . . . . 0.17 108.376 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -155.97 123.52 5.53 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.501 -1.296 . . . . 1.48 107.501 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.1 mttm 57.89 16.54 3.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.495 -0.753 . . . . 1.67 109.544 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.581 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 96.82 -1.87 61.68 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.424 -1.07 . . . . 0.22 110.424 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.581 HE21 ' C ' ' A' ' 83' ' ' GLY . 17.1 mm-40 -110.04 149.91 29.31 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.154 -1.203 . . . . 2.08 110.435 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -85.58 143.72 28.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.685 . . . . 1.7 109.456 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.27 -21.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.575 -0.703 . . . . 0.26 110.222 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.94 175.0 45.98 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.652 -1.261 . . . . 0.18 110.003 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -173.79 154.4 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -1.176 . . . . 2.04 110.232 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.0 p90 -169.5 132.09 1.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 0.14 109.772 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -104.23 -162.07 0.87 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.17 109.1 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.41 133.82 1.56 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.13 109.577 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.71 97.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -1.19 . . . . 0.2 110.553 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -141.51 72.36 1.38 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.72 -0.844 . . . . 1.15 108.72 178.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.69 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.88 . . . . 1.19 110.431 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.9 -31.29 71.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.025 -1.047 . . . . 1.95 109.467 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.551 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 43.4 tttp -67.87 -33.63 75.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 2.05 109.787 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.2 mt -51.46 -36.03 42.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.992 -1.068 . . . . 0.15 108.646 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.27 -55.74 14.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 2.15 109.448 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.38 94.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.15 110.946 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.454 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 19.4 m -67.3 -45.97 74.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.923 -1.111 . . . . 0.13 110.44 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.71 -51.39 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.18 109.037 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -60.01 -18.57 46.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 1.03 109.633 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -76.44 -61.98 1.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 2.02 110.276 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 mt -91.68 21.61 4.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.35 110.534 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.902 -1.124 . . . . 1.18 109.315 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.606 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -111.96 -167.68 1.21 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.778 -1.201 . . . . 0.0 110.47 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.34 149.32 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.308 -0.87 . . . . 0.0 112.428 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.67 95.61 6.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.414 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.72 47.5 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.807 -1.183 . . . . 0.0 110.061 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.94 -129.98 0.23 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -69.72 25.07 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.609 ' H ' ' C ' ' B' ' 9' ' ' GLY . 41.9 t . . . . . 0 N--CA 1.492 1.657 0 O-C-N 121.533 -0.73 . . . . 0.0 109.555 -179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.5 t . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 109.524 -0.547 . . . . 0.3 109.524 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 74.9 tttt -155.13 130.56 9.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.199 -0.938 . . . . 1.97 109.124 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.447 ' NE2' ' OE2' ' A' ' 6' ' ' GLU . 19.3 tt0 -88.69 138.19 31.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.106 -0.996 . . . . 0.98 109.752 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.3 93.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.58 -0.896 . . . . 0.19 108.58 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.447 ' OE2' ' NE2' ' A' ' 4' ' ' GLN . 58.1 mt-10 -96.72 -1.01 47.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.014 -1.054 . . . . 1.97 109.538 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.5 p -151.85 147.82 27.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.975 -1.078 . . . . 0.23 110.184 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 54.3 tttt -52.43 -29.25 23.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 1.9 109.687 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -60.53 -45.55 93.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.034 -1.041 . . . . 0.25 109.557 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.45 65.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.2 109.61 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.85 -65.69 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.21 109.534 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -55.66 -46.34 77.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 2.47 109.818 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -58.12 -34.49 70.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.094 -1.004 . . . . 2.1 109.648 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.09 86.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.2 109.0 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.7 -44.64 93.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.369 -0.832 . . . . 0.62 109.387 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.08 -37.98 89.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 1.09 109.049 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.12 53.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.3 109.492 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.17 61.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.24 109.544 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 -109.33 2.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.993 -1.243 . . . . 0.28 109.993 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.1 t0 -136.37 -0.46 2.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.384 -1.068 . . . . 2.21 109.32 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mttt -68.47 163.31 23.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.664 -1.273 . . . . 1.9 108.505 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -62.24 163.63 8.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.115 -1.068 . . . . 0.17 108.115 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.5 t -143.62 108.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.979 -1.076 . . . . 0.12 109.827 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.4 133.54 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.642 -0.873 . . . . 0.09 108.642 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.28 137.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.477 -0.764 . . . . 0.17 109.736 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.84 104.57 13.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.584 -0.698 . . . . 0.96 109.207 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.438 ' CE2' HG11 ' A' ' 57' ' ' VAL . 37.5 m-85 -86.86 80.0 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.932 -1.136 . . . . 0.24 107.932 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.1 m -114.4 147.74 38.75 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.436 0.636 . . . . 1.03 109.563 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -91.71 123.1 34.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.26 108.681 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -65.93 -21.14 66.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.25 -0.906 . . . . 0.32 110.319 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.495 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 56.4 p-90 -88.52 -16.99 31.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.059 . . . . 0.44 109.915 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -91.49 136.65 32.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.906 . . . . 0.32 110.209 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.28 -58.17 4.78 Favored Glycine 0 N--CA 1.491 2.313 0 O-C-N 121.679 -0.638 . . . . 0.36 111.535 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.7 -33.38 31.7 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 C-N-CA 121.597 1.532 . . . . 0.44 111.4 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -60.38 2.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.835 -1.166 . . . . 0.81 108.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.69 -21.98 55.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 1.92 109.887 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.1 ttm -60.58 -21.4 62.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.201 -0.937 . . . . 3.13 110.533 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 38' ' ' ILE . 54.0 mt -101.08 8.5 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.097 -1.002 . . . . 0.28 110.91 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.7 -32.44 5.99 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 117.923 -1.511 . . . . 1.62 112.709 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.3 Cg_exo -60.81 -11.61 18.52 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 CA-C-N 119.906 1.002 . . . . 0.25 110.267 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.78 -70.3 0.74 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.3 109.527 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -45.01 -51.24 10.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.13 110.658 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -67.97 -33.83 75.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.41 109.617 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.78 -42.76 99.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 0.97 109.786 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.4 mt -51.9 -19.6 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.073 . . . . 0.5 109.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -56.85 -32.92 66.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.51 109.275 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.64 -16.86 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 2.0 109.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -90.09 -20.94 22.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 2.16 108.959 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.34 71.14 1.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.24 109.241 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.3 p -66.89 -4.7 10.04 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.9 . . . . 0.17 108.931 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.1 t30 -96.79 1.86 51.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.34 109.731 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -119.04 150.35 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.519 -0.738 . . . . 0.12 109.389 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.66 131.68 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.304 -0.872 . . . . 0.17 109.183 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 86.4 m-85 -117.84 132.49 56.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.211 -0.931 . . . . 0.11 109.262 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -114.21 174.85 5.74 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.374 -0.829 . . . . 0.12 109.039 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -142.69 142.57 32.04 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.084 -1.08 . . . . 1.31 108.084 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 27' ' ' PHE . 44.6 t -139.74 133.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.109 -0.994 . . . . 0.14 110.447 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.72 105.16 17.27 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.107 -1.071 . . . . 1.08 108.107 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.6 m -59.33 -4.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.804 . . . . 0.27 111.171 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.495 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 53.1 m-20 -108.9 -44.22 4.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.216 -0.928 . . . . 1.11 110.83 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -91.57 -10.7 39.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.908 -1.12 . . . . 1.12 109.24 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 47.38 2.19 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.303 -0.999 . . . . 0.17 108.303 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -55.29 -17.45 4.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.668 -0.645 . . . . 2.22 109.974 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.5 p-10 -71.54 -38.93 71.0 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.946 . . . . 1.11 109.537 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.14 -48.39 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.19 108.922 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.03 72.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.22 109.462 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -64.05 -57.1 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 1.29 109.679 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -63.18 -26.6 68.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2 109.825 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -89.06 -3.16 58.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.115 -0.991 . . . . 0.33 109.923 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 47.56 53.09 11.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 2.34 110.08 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.457 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 22.1 t -79.56 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.28 109.402 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -125.17 -1.83 7.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.341 -0.85 . . . . 2.4 109.815 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.56 130.98 12.91 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.019 -1.051 . . . . 0.22 109.418 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.0 p -114.99 150.63 44.5 Favored Pre-proline 0 N--CA 1.502 2.143 0 N-CA-C 108.26 -1.015 . . . . 0.22 108.26 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.92 144.07 77.53 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 C-N-CA 124.842 -0.899 . . . . 0.2 110.615 -1.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.03 113.78 23.66 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.757 -1.201 . . . . 0.18 107.757 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.3 m-85 -89.55 122.16 32.45 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.898 -1.126 . . . . 0.15 108.902 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.445 HE22 ' HB1' ' A' ' 69' ' ' ALA . 33.5 mt-30 -119.6 135.99 54.56 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.029 -1.1 . . . . 1.03 108.029 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.0 m-85 -109.65 131.87 54.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.11 109.967 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -129.08 157.04 42.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.884 -0.784 . . . . 0.17 108.884 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -154.05 124.86 7.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.601 -1.259 . . . . 1.48 107.601 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 mttt 54.28 32.73 16.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.996 . . . . 1.67 109.77 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 9.69 86.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.005 -1.238 . . . . 0.22 110.005 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.4 ' CA ' HE21 ' A' ' 84' ' ' GLN . 0.9 OUTLIER -114.75 144.07 44.07 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.331 -1.099 . . . . 2.08 110.363 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -85.53 146.66 26.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 1.7 109.27 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.91 -29.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.454 -0.779 . . . . 0.26 109.971 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.58 178.03 44.1 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.5 -1.333 . . . . 0.18 110.477 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -173.6 156.87 3.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 2.04 110.179 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.0 p90 -168.88 134.25 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.14 110.563 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -105.83 -171.33 1.88 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.203 -0.935 . . . . 0.17 108.889 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 92.88 128.61 4.8 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -1.12 . . . . 0.2 110.31 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' GLY . 14.5 t-20 -140.14 73.24 1.42 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.452 -0.944 . . . . 1.15 108.452 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.65 -31.73 73.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 1.19 110.28 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 23.6 mp0 -66.86 -29.95 69.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.898 -1.126 . . . . 1.95 109.124 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -32.38 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.418 -0.801 . . . . 2.05 109.331 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.0 mt -51.38 -35.0 36.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.15 108.421 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -68.24 -56.77 7.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.687 . . . . 2.15 109.747 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.58 87.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.819 . . . . 0.15 110.668 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 m -67.0 -45.13 78.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.13 110.218 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.3 -51.97 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.18 109.074 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.3 -15.2 46.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 1.03 109.781 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.12 -59.51 2.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 2.02 110.294 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.97 18.49 10.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.393 -0.817 . . . . 0.35 110.74 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.895 -1.128 . . . . 1.18 109.347 179.582 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -123.25 -168.5 1.77 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.894 -1.129 . . . . 0.0 111.249 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.3 t -76.22 149.71 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.886 0.851 . . . . 0.0 112.868 -176.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.91 96.95 7.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.457 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.04 46.15 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.041 -1.037 . . . . 0.0 110.639 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.26 -130.24 0.09 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.755 -2.538 . . . . 0.0 106.755 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.6 22.27 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.335 1.568 . . . . 0.0 109.367 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.0 t . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.759 -179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 62.1 t . . . . . 0 N--CA 1.495 1.8 0 N-CA-C 109.548 -0.538 . . . . 0.3 109.548 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 14.4 tptm -154.8 122.33 5.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.97 109.251 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.5 134.83 34.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.98 110.015 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.06 109.72 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.063 -1.088 . . . . 0.19 108.063 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -101.02 -7.01 23.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.193 -0.942 . . . . 1.97 109.847 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 p -152.35 153.58 33.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.037 -1.039 . . . . 0.23 109.926 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.437 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 69.4 tttt -52.46 -33.22 43.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.446 -0.784 . . . . 1.9 109.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -59.69 -41.1 89.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 0.25 109.849 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.41 -25.63 63.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.2 109.78 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.3 -68.31 0.31 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.011 -1.056 . . . . 0.21 110.043 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.91 -41.25 70.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 2.47 109.785 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.85 -37.69 80.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 2.1 109.504 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.18 91.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.2 109.539 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.32 -44.7 94.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 0.62 109.715 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.71 -41.12 98.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 1.09 109.713 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.1 -14.58 58.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.3 109.732 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.59 -6.97 28.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.24 109.847 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -113.81 4.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.578 -1.409 . . . . 0.28 109.578 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.17 5.15 2.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -1.054 . . . . 2.21 109.499 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.24 170.18 12.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.003 -1.061 . . . . 1.9 109.097 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 161.51 14.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.932 -1.136 . . . . 0.17 107.932 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -145.33 106.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.927 -1.108 . . . . 0.12 109.652 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.94 130.3 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.688 -0.856 . . . . 0.09 108.688 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.78 140.13 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.55 -0.719 . . . . 0.17 109.591 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -110.96 99.27 8.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.982 -0.747 . . . . 0.96 108.982 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.64 82.98 8.18 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.807 -1.183 . . . . 0.24 107.807 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 41.3 m -109.39 -163.24 0.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.985 -0.746 . . . . 1.03 108.985 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.31 125.13 18.26 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.95 -0.759 . . . . 0.26 108.95 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -65.6 -30.68 71.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.68 . . . . 0.32 111.331 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.585 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 50.7 p-90 -86.04 -14.18 45.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.748 -1.22 . . . . 0.44 109.884 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -94.76 128.58 41.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.32 109.657 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.62 -55.79 8.14 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.579 -0.701 . . . . 0.36 111.495 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.6 Cg_exo -48.03 -33.58 20.99 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.72 1.613 . . . . 0.44 111.45 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -76.27 -59.75 2.63 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.809 -1.182 . . . . 0.81 108.958 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -60.32 -19.22 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 1.92 110.258 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -19.55 52.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.01 . . . . 3.13 110.361 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.2 mt -99.45 9.08 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.16 -0.962 . . . . 0.28 110.497 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.52 -31.98 4.07 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 120.374 -1.454 . . . . 1.62 112.516 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -62.61 -5.0 6.37 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.947 1.017 . . . . 0.25 110.049 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 45.5 m-85 -112.39 -75.49 0.61 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.218 -0.66 . . . . 0.3 109.218 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -43.13 -56.8 3.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.13 110.551 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -66.94 -32.37 73.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.41 110.068 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.5 t -63.18 -40.92 98.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.809 -1.182 . . . . 0.97 110.38 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.4 mt -50.62 -15.32 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.992 -1.067 . . . . 0.5 109.532 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.0 m -58.17 -30.77 66.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.066 -1.021 . . . . 0.51 109.521 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -96.09 -21.45 17.94 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.272 -0.892 . . . . 2.0 110.156 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -90.43 -21.01 22.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.037 -1.039 . . . . 2.16 109.602 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.74 67.6 1.5 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.409 -0.807 . . . . 0.24 108.896 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.5 p -66.8 -3.01 5.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.374 -0.829 . . . . 0.17 109.088 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.29 -1.23 51.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.443 -0.786 . . . . 0.34 109.251 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.26 149.01 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.633 -0.667 . . . . 0.12 109.24 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -99.96 125.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.17 109.146 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -112.47 130.96 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.271 -0.893 . . . . 0.11 108.878 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.51 171.58 7.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.736 -0.838 . . . . 0.12 108.736 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -142.82 142.57 31.87 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.836 -1.172 . . . . 1.31 107.836 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.0 t -141.12 138.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.152 -0.967 . . . . 0.14 110.758 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.41 105.75 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.443 -0.947 . . . . 1.08 108.443 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.94 -4.95 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.376 -0.828 . . . . 0.27 110.905 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.585 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 36.8 m-20 -102.72 -42.83 5.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 1.11 110.877 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -25.6 15.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.181 -0.949 . . . . 1.12 109.362 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.29 43.45 1.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.426 -0.953 . . . . 0.17 108.426 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.559 ' NE2' ' NH1' ' B' ' 4' ' ' ARG . 25.6 mt-30 -53.6 -13.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 2.22 110.235 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.1 p-10 -69.85 -40.68 75.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.791 -1.193 . . . . 1.11 109.19 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -73.37 -48.07 43.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.234 -0.916 . . . . 0.19 108.584 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -38.19 90.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.528 -0.732 . . . . 0.22 109.539 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 61.8 m -64.1 -43.73 94.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 1.29 109.052 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.59 -40.41 96.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 2.2 109.228 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.83 -6.27 57.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.33 109.399 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ALA . 46.7 mt-10 49.31 71.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 2.34 110.253 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 42.0 t -79.11 135.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.922 . . . . 0.28 108.978 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -113.64 -12.54 12.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.484 -0.76 . . . . 2.4 109.805 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.78 137.69 15.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.952 -1.092 . . . . 0.22 109.81 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.733 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.7 p -115.63 151.27 45.99 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 108.487 -0.931 . . . . 0.22 108.487 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -75.73 147.33 87.89 Favored 'Cis proline' 0 N--CA 1.484 0.968 0 C-N-CA 124.651 -0.979 . . . . 0.2 109.878 -1.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -116.08 113.34 23.02 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.996 -1.113 . . . . 0.18 107.996 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.1 m-85 -89.15 125.1 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.124 -1.03 . . . . 0.15 108.906 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.16 136.71 54.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.895 -1.15 . . . . 1.03 107.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.4 m-85 -109.91 130.18 55.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.707 . . . . 0.11 109.958 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -128.93 157.24 42.17 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.58 -0.896 . . . . 0.17 108.58 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -155.53 122.65 5.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.014 -1.106 . . . . 1.48 108.014 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.2 22.57 6.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 1.67 109.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 3.55 72.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.194 -1.162 . . . . 0.22 110.194 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -110.95 144.95 39.22 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.293 -1.122 . . . . 2.08 110.21 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -85.47 139.56 31.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 1.7 109.052 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.03 -18.02 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.399 -0.813 . . . . 0.26 110.715 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.92 172.69 45.68 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.18 110.541 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -174.21 150.49 1.53 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 2.04 110.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.0 p90 -169.02 132.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.818 . . . . 0.14 110.189 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -101.98 -160.19 0.77 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.064 -1.023 . . . . 0.17 109.066 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 129.3 0.67 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.52 -1.432 . . . . 0.13 109.52 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.16 93.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.2 110.205 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.96 75.53 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.819 -1.178 . . . . 1.15 107.819 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.528 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.8 ptpt -63.49 -39.36 94.23 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.818 -0.628 . . . . 1.19 111.275 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.58 -25.97 68.2 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 1.95 109.567 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.21 -34.79 76.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 2.05 109.528 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.8 mt -54.73 -35.96 64.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.118 . . . . 0.15 108.732 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.7 -58.08 6.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 2.15 109.54 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.47 -41.92 90.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.15 110.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.2 m -65.81 -45.73 81.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.161 -0.962 . . . . 0.13 110.183 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.48 -53.97 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.18 108.822 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.64 -17.64 48.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 1.03 109.744 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -75.9 -60.25 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 2.02 110.155 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.64 20.74 6.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.771 . . . . 0.35 110.416 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.18 109.238 179.473 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.559 ' NH1' ' NE2' ' A' ' 63' ' ' GLN . 7.9 tpt180 . . . . . 0 N--CA 1.495 1.809 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.8 -166.89 1.7 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.013 -1.054 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.55 152.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 122.0 0.905 . . . . 0.0 112.591 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 95.09 6.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.16 45.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.78 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -131.98 0.08 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.6 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.251 1.525 . . . . 0.0 109.147 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.2 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 109.58 -179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.3 t . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.295 0.569 . . . . 0.3 109.902 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.4 tttt -155.06 125.97 7.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 1.97 109.375 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.13 136.52 33.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.904 . . . . 0.98 109.73 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mm -106.3 110.02 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.185 -1.042 . . . . 0.19 108.185 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.87 -9.98 21.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.2 -0.938 . . . . 1.97 109.703 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 p -153.18 152.6 31.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.11 -0.994 . . . . 0.23 109.699 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -51.9 -28.0 14.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 1.9 110.021 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -59.14 -44.29 92.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.25 109.692 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.32 -24.56 61.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.2 109.952 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -59.33 -68.64 0.26 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.21 110.328 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.34 -43.2 71.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 2.47 109.554 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -59.67 -36.73 77.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.228 -0.92 . . . . 2.1 110.085 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.32 86.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.003 . . . . 0.2 109.384 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.29 -43.4 94.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.468 -0.77 . . . . 0.62 109.645 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.76 -40.78 97.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 1.09 109.771 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -14.44 59.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.988 . . . . 0.3 110.03 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -10.56 56.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.24 109.806 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.2 -112.3 3.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.47 -1.452 . . . . 0.28 109.47 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -139.85 3.77 2.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.317 -1.107 . . . . 2.21 109.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -69.61 172.68 7.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 1.9 109.032 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.83 161.47 18.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.977 -1.12 . . . . 0.17 107.977 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.3 t -144.87 104.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.873 -1.142 . . . . 0.12 109.421 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.99 128.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.359 -0.838 . . . . 0.09 108.937 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.77 139.72 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.17 109.565 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -112.02 103.49 11.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.96 108.903 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.5 m-85 -86.06 80.31 8.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.3 -1.0 . . . . 0.24 108.3 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.3 m -113.45 149.4 34.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.652 -0.655 . . . . 1.03 109.597 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.39 129.26 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.26 109.048 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -67.15 -25.32 66.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.882 . . . . 0.32 110.855 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.464 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 54.0 p-90 -88.4 -17.58 30.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.842 -1.161 . . . . 0.44 110.351 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.96 123.37 37.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -0.929 . . . . 0.32 109.941 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.87 -53.74 32.43 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-O 119.426 -0.652 . . . . 0.36 112.002 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -48.32 -36.41 29.95 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.647 1.565 . . . . 0.44 111.33 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.76 -60.99 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.81 109.137 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -58.28 -18.92 30.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 1.92 109.96 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.9 ttm -58.61 -18.41 29.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 3.13 110.581 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 38' ' ' ILE . 67.1 mt -100.39 9.7 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.167 -0.958 . . . . 0.28 110.583 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.74 -32.55 4.39 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.107 -1.621 . . . . 1.62 112.598 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -64.09 -6.2 10.87 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 CA-C-N 119.794 0.962 . . . . 0.25 109.758 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 32.6 m-85 -110.52 -75.21 0.63 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.544 -0.723 . . . . 0.3 109.384 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -43.02 -57.42 2.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.427 -0.795 . . . . 0.13 110.67 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.82 -31.15 71.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.41 110.04 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' SER . 3.4 t -64.34 -40.1 95.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.822 -1.174 . . . . 0.97 109.938 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.2 -12.87 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.079 -1.013 . . . . 0.5 109.369 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.03 -34.69 70.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.51 109.439 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -94.33 -13.17 26.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.312 -0.868 . . . . 2.0 110.084 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -91.65 -32.07 15.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 2.16 109.455 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -126.38 71.96 1.3 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.025 -0.732 . . . . 0.24 109.025 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.08 -2.59 4.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.292 -0.88 . . . . 0.17 108.968 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 35.0 t30 -97.01 -1.99 44.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.34 109.816 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.74 148.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.508 -0.745 . . . . 0.12 109.586 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.37 124.21 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.993 -0.743 . . . . 0.17 108.993 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.7 m-85 -109.91 133.0 53.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.294 -0.879 . . . . 0.11 108.948 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -115.08 171.87 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.241 -0.912 . . . . 0.12 108.706 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -141.94 144.24 33.65 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.028 -1.101 . . . . 1.31 108.028 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.63 139.26 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.17 -0.956 . . . . 0.14 110.507 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.7 t70 -98.98 101.97 13.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.859 -0.793 . . . . 1.08 108.859 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.04 0.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.836 . . . . 0.27 110.967 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.464 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 39.3 m-20 -112.7 -41.08 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.343 -0.848 . . . . 1.11 110.655 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -95.5 -21.18 18.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.041 . . . . 1.12 109.503 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.48 47.86 1.19 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.25 -1.019 . . . . 0.17 108.25 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' B' ' 4' ' ' ARG . 14.0 mt-30 -54.62 -18.28 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.749 -0.594 . . . . 2.22 110.326 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.2 p30 -70.82 -39.41 73.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.917 -1.114 . . . . 1.11 109.606 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.44 -47.63 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.149 -0.969 . . . . 0.19 108.836 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.48 78.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.22 109.461 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -63.47 -52.72 60.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 1.29 109.525 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -64.75 -30.55 71.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 2.2 110.027 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.94 2.99 47.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.33 109.943 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 47.14 50.3 14.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 2.34 110.541 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 4.0 t -81.39 128.64 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.28 108.773 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -126.28 -2.13 6.94 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.363 -0.835 . . . . 2.4 110.434 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.32 124.68 8.21 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.759 -1.213 . . . . 0.22 109.427 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.7 p -106.24 151.3 40.17 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 121.322 -0.861 . . . . 0.22 109.185 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.8 140.13 63.45 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.947 -0.855 . . . . 0.2 110.066 -2.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.38 111.11 21.73 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.056 -1.09 . . . . 0.18 108.056 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.5 m-85 -89.19 118.14 28.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.988 -1.07 . . . . 0.15 109.127 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.461 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.3 mt-30 -117.05 135.55 53.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.332 -1.358 . . . . 1.03 107.332 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 18.8 m-85 -107.83 128.08 54.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.488 0.661 . . . . 0.11 109.896 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.8 156.95 35.16 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.94 -0.763 . . . . 0.17 108.94 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -155.26 124.35 6.23 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.298 -1.371 . . . . 1.48 107.298 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.3 mttt 56.0 32.65 20.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.6 -0.687 . . . . 1.67 109.382 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.41 7.19 87.01 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.779 -1.201 . . . . 0.22 110.143 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.03 142.6 45.52 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.375 -1.073 . . . . 2.08 110.64 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -86.62 140.09 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.838 . . . . 1.7 108.947 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.27 -17.39 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.413 -0.805 . . . . 0.26 110.693 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.39 176.56 48.1 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.415 -1.374 . . . . 0.18 110.454 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -174.1 156.46 2.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -1.128 . . . . 2.04 110.296 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.1 p90 -168.58 129.97 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.14 109.982 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -102.83 -162.16 0.9 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.292 -0.88 . . . . 0.17 109.234 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.55 126.74 0.84 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.964 -1.654 . . . . 0.13 108.964 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.88 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.091 -1.241 . . . . 0.2 110.043 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -138.32 66.65 1.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.516 -1.29 . . . . 1.15 107.516 178.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.25 -34.11 71.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.824 -0.548 . . . . 1.19 111.023 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.58 -26.03 68.23 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.935 -1.103 . . . . 1.95 109.254 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -71.05 -36.26 72.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.787 . . . . 2.05 110.095 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.4 mt -50.8 -33.29 22.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.914 -1.117 . . . . 0.15 109.012 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.38 -57.01 7.37 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.467 -0.893 . . . . 2.15 109.539 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.86 95.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.15 110.942 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 m -64.94 -45.3 86.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.953 -1.092 . . . . 0.13 109.918 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.63 -53.09 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.18 108.681 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.27 -16.23 43.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 1.03 109.626 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -62.38 1.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 2.02 109.934 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.25 22.62 3.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.35 110.162 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.037 -1.04 . . . . 1.18 109.295 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' A' ' 63' ' ' GLN . 8.7 tpt180 . . . . . 0 N--CA 1.496 1.83 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.2 p90 -129.95 -167.16 1.77 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.053 -1.029 . . . . 0.0 110.464 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -73.75 150.58 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.938 0.875 . . . . 0.0 112.522 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.12 93.44 5.47 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.7 pt-20 -83.79 44.26 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.285 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.73 -130.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.64 20.8 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 119.533 1.667 . . . . 0.0 109.37 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.3 t . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.525 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.7 t . . . . . 0 N--CA 1.494 1.744 0 N-CA-C 109.268 -0.642 . . . . 0.3 109.268 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 54.6 tttp -154.15 125.31 7.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 1.97 109.402 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -89.85 136.3 33.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.98 109.903 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.86 107.27 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.206 -1.035 . . . . 0.19 108.206 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.57 -8.74 24.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 1.97 109.547 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.07 156.27 38.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.135 -0.978 . . . . 0.23 109.829 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -52.99 -30.15 33.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.9 110.075 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.5 m -60.27 -44.51 95.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.25 110.313 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -25.14 64.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.2 109.649 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -60.76 -67.95 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.957 -1.089 . . . . 0.21 109.94 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.55 -44.98 69.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.795 . . . . 2.47 109.679 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -58.61 -36.94 74.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.947 . . . . 2.1 109.845 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.93 91.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.081 -1.012 . . . . 0.2 109.362 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.14 -46.56 83.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.804 . . . . 0.62 109.774 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.45 -38.71 92.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 1.09 109.482 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.88 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.981 . . . . 0.3 109.667 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -5.36 18.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.24 109.588 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 -111.45 3.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.453 -1.459 . . . . 0.28 109.453 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 61.5 t0 -139.06 2.49 2.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.434 -1.039 . . . . 2.21 109.554 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -68.8 171.86 7.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.017 . . . . 1.9 109.053 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.8 162.27 19.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.351 -0.981 . . . . 0.17 108.351 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.571 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -144.96 107.72 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.874 -1.141 . . . . 0.12 109.855 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -104.06 132.66 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.805 -0.813 . . . . 0.09 108.805 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.2 140.43 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.17 109.598 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -110.59 101.28 9.96 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.247 -0.649 . . . . 0.96 109.247 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 42.1 m-85 -85.36 80.14 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.194 -1.039 . . . . 0.24 108.194 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -114.19 147.96 38.07 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.228 0.537 . . . . 1.03 109.651 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.59 131.24 37.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.194 -0.941 . . . . 0.26 108.853 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -67.67 -28.02 67.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.32 110.655 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.535 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.2 p-90 -87.71 -11.61 47.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.44 110.023 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.39 125.29 39.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.32 109.864 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -67.81 -54.12 20.04 Favored Glycine 0 N--CA 1.49 2.244 0 CA-C-O 119.491 -0.616 . . . . 0.36 112.299 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.83 -43.85 33.63 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.544 1.496 . . . . 0.44 111.618 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.96 -55.85 5.66 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.688 -1.257 . . . . 0.81 109.056 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.2 -18.23 46.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 1.92 109.809 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.0 ttt -62.82 -22.46 66.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 3.13 110.466 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' ILE . 65.5 mt -98.12 18.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.198 -0.939 . . . . 0.28 111.014 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.39 -33.85 3.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.148 -1.595 . . . . 1.62 113.091 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.02 -7.71 14.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 CA-C-N 119.469 0.846 . . . . 0.25 110.595 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.0 m-85 -105.22 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.315 -0.866 . . . . 0.3 109.803 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.6 t80 -41.94 -52.4 4.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.13 110.742 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -68.73 -34.3 75.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.991 -1.068 . . . . 0.41 109.931 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 46' ' ' SER . 4.2 t -60.64 -44.36 96.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.863 -1.148 . . . . 0.97 110.014 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.6 mt -50.43 -16.8 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.978 -1.076 . . . . 0.5 109.214 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.1 m -57.06 -33.96 67.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.51 109.629 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.14 -18.74 20.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -0.927 . . . . 2.0 110.251 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -90.54 -20.74 22.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.05 . . . . 2.16 109.502 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -133.9 66.49 1.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.24 109.297 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 p -67.68 -3.37 8.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.17 109.251 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.37 0.39 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.395 -0.816 . . . . 0.34 109.46 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.7 t -120.77 150.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.872 -0.788 . . . . 0.12 108.872 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.55 132.02 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.191 -0.943 . . . . 0.17 109.659 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.1 m-85 -117.33 131.69 56.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.571 -0.706 . . . . 0.11 109.102 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -114.27 174.98 5.68 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.423 -0.798 . . . . 0.12 109.093 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -144.88 146.81 32.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.247 -1.019 . . . . 1.31 108.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.03 138.27 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.999 -1.063 . . . . 0.14 110.611 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.0 t70 -100.03 100.88 11.82 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.665 -0.865 . . . . 1.08 108.665 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 25.1 m -59.31 0.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.27 111.171 -179.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.535 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 14.9 m-20 -116.84 -41.87 3.01 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.163 -0.96 . . . . 1.11 110.709 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.13 -19.5 20.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.014 -1.054 . . . . 1.12 109.279 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.36 46.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.006 -1.109 . . . . 0.17 108.006 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 27.3 mt-30 -55.31 -16.46 3.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.619 -0.676 . . . . 2.22 110.533 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.21 -36.78 77.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.765 -1.209 . . . . 1.11 109.113 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -73.76 -48.46 39.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.217 -0.927 . . . . 0.19 108.72 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.27 -36.96 85.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.22 109.37 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -63.48 -46.49 85.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 1.29 109.198 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -64.55 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 2.2 109.284 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.98 -6.29 58.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -0.988 . . . . 0.33 109.257 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ALA . 35.3 mt-10 51.61 55.62 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 2.34 110.462 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 46.2 t -84.25 124.26 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.262 -0.898 . . . . 0.28 108.999 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.37 6.7 17.36 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.175 -0.953 . . . . 2.4 110.219 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.02 146.19 24.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.773 -1.204 . . . . 0.22 109.714 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.3 p -127.29 148.88 68.04 Favored Pre-proline 0 N--CA 1.506 2.354 0 N-CA-C 108.284 -1.006 . . . . 0.22 108.284 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.528 ' HG3' HD12 ' A' ' 38' ' ' ILE . 12.1 Cg_endo -80.32 139.99 50.74 Favored 'Cis proline' 0 N--CA 1.487 1.113 0 N-CA-C 110.072 -0.78 . . . . 0.2 110.072 -1.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -110.58 110.53 21.27 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.157 -1.053 . . . . 0.18 108.157 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.832 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.3 m-85 -86.98 115.53 24.43 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.995 -1.082 . . . . 0.15 109.206 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.579 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 32.5 mt-30 -114.2 137.01 52.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.735 -1.209 . . . . 1.03 107.735 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.5 m-85 -109.91 126.33 53.76 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.519 0.676 . . . . 0.11 109.592 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 156.28 35.36 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.452 -0.944 . . . . 0.17 108.452 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.385 -1.339 . . . . 1.48 107.385 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 55.01 38.28 30.27 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.433 -0.792 . . . . 1.67 109.238 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 6.25 63.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.352 -1.099 . . . . 0.22 110.352 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -112.12 145.82 39.12 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.312 -1.111 . . . . 2.08 110.541 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -86.19 142.62 28.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 1.7 109.279 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.9 -9.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.452 -0.78 . . . . 0.26 110.341 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.4 38.01 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.389 -1.386 . . . . 0.18 110.521 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -173.35 156.69 3.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.411 -1.053 . . . . 2.04 110.06 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.1 p90 -168.88 131.12 1.27 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.799 . . . . 0.14 110.027 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -160.98 0.81 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.16 -0.962 . . . . 0.17 109.093 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 82.34 121.07 0.63 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.451 -1.46 . . . . 0.13 109.451 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.544 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.34 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -1.158 . . . . 0.2 110.25 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.38 76.98 1.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.129 -1.063 . . . . 1.15 108.129 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.1 ptpt -64.57 -42.55 95.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.871 -0.518 . . . . 1.19 111.556 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -63.93 -25.72 68.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.739 -1.226 . . . . 1.95 109.978 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -70.55 -32.09 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 2.05 109.432 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 77' ' ' PHE . 34.1 mt -51.08 -37.54 46.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.064 . . . . 0.15 108.805 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -68.36 -56.33 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.822 -0.751 . . . . 2.15 109.975 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.16 75.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.15 110.453 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 m -67.68 -45.21 75.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.989 . . . . 0.13 110.0 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.95 -53.44 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.18 109.274 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.81 -16.25 26.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 1.03 109.839 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -75.97 -60.18 2.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 2.02 109.944 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -92.89 18.77 8.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.398 -0.814 . . . . 0.35 110.414 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.957 -1.089 . . . . 1.18 109.309 179.507 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 8.3 tpt180 . . . . . 0 N--CA 1.496 1.849 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 4.1 p90 -131.87 -166.59 1.74 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.673 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.42 150.52 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.167 0.984 . . . . 0.0 112.967 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 94.35 5.59 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.4 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.21 49.82 1.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.908 -1.12 . . . . 0.0 109.944 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.605 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -76.28 -128.09 0.28 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -68.7 26.64 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.372 1.586 . . . . 0.0 108.946 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.605 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.6 t . . . . . 0 N--CA 1.487 1.4 0 O-C-N 121.315 -0.865 . . . . 0.0 109.271 -179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.6 t . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 121.38 0.61 . . . . 0.3 109.743 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.613 ' N ' HG12 ' A' ' 2' ' ' VAL . 36.9 tptt -153.99 123.9 6.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 1.97 109.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -90.3 128.51 36.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.186 -0.946 . . . . 0.98 109.861 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.63 109.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.871 -1.159 . . . . 0.19 107.871 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -100.23 -8.06 23.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.174 -0.954 . . . . 1.97 110.078 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p -152.06 153.45 34.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.23 109.82 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.412 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 50.7 tttm -52.23 -26.15 11.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 1.9 109.784 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -60.17 -50.08 75.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.25 110.005 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.94 63.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.2 109.791 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.89 -65.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.21 109.864 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -54.99 -45.35 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 2.47 109.733 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.92 -35.79 73.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.222 -0.924 . . . . 2.1 109.743 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.78 80.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.2 109.099 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.8 mt -64.55 -39.84 94.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.746 . . . . 0.62 109.603 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.98 -42.86 97.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 1.09 109.756 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.04 57.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.114 -0.991 . . . . 0.3 109.613 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.76 -8.42 42.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.155 -0.966 . . . . 0.24 109.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.07 -129.39 32.12 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.161 -1.575 . . . . 0.28 109.161 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.97 5.89 12.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.956 . . . . 2.21 109.462 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.8 mttp -69.76 167.33 17.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 1.9 109.266 179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 161.47 18.99 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.331 -0.988 . . . . 0.17 108.331 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.622 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.0 t -145.09 107.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.12 109.647 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.09 131.73 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.603 -0.888 . . . . 0.09 108.603 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.34 139.57 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.511 -0.743 . . . . 0.17 109.772 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -110.44 102.09 10.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.164 -0.68 . . . . 0.96 109.164 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -86.1 83.42 7.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.804 -1.184 . . . . 0.24 107.804 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -114.86 152.74 31.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.655 -0.653 . . . . 1.03 109.849 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -93.4 131.06 38.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.559 -0.904 . . . . 0.26 108.559 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -67.46 -30.84 70.66 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.32 111.119 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.486 ' NE1' ' OD2' ' A' ' 60' ' ' ASP . 65.9 p-90 -87.64 -5.94 58.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.937 -1.102 . . . . 0.44 110.651 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -98.17 132.97 43.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.32 109.691 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -74.83 -54.19 5.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.628 -0.67 . . . . 0.36 112.019 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.5 -39.58 45.3 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.413 1.409 . . . . 0.44 111.603 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.62 5.61 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.631 -1.293 . . . . 0.81 109.003 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -60.4 -20.57 60.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 1.92 110.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.1 tpt -60.13 -22.01 62.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 3.13 110.556 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 38' ' ' ILE . 80.2 mt -96.61 14.21 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.28 111.69 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.65 -33.3 5.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.042 -1.662 . . . . 1.62 112.924 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.99 -9.15 18.11 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.69 0.925 . . . . 0.25 110.685 -176.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.71 -70.84 0.77 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.3 109.68 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -43.69 -53.2 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.13 110.553 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.43 -34.22 75.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.087 -1.008 . . . . 0.41 110.022 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 t -60.97 -40.35 93.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.883 -1.135 . . . . 0.97 110.302 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.2 mt -51.49 -19.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.901 -1.124 . . . . 0.5 109.334 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -58.36 -28.99 65.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.51 109.815 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -95.23 -22.97 17.46 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.083 -1.011 . . . . 2.0 110.27 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -90.87 -20.2 22.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.045 -1.034 . . . . 2.16 109.342 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.49 68.92 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.24 109.374 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 97.9 p -67.65 -5.65 16.75 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 0.17 109.164 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -94.7 1.52 55.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 0.34 109.576 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.79 147.77 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.599 -0.889 . . . . 0.12 108.599 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -99.77 127.61 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.17 109.567 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -114.74 132.14 56.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.371 -0.831 . . . . 0.11 109.111 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.47 171.14 7.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.793 . . . . 0.12 108.883 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -143.35 145.63 32.85 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.911 -1.144 . . . . 1.31 107.911 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.98 139.18 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.086 -1.009 . . . . 0.14 110.375 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.9 t70 -97.78 89.71 4.71 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.91 -1.144 . . . . 1.08 107.91 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.674 HG11 ' OH ' ' B' ' 5' ' ' TYR . 27.7 m -53.68 -6.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.595 -0.691 . . . . 0.27 111.681 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.523 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 46.6 m-20 -104.99 -35.17 7.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.073 -1.017 . . . . 1.11 110.49 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.51 -9.49 22.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.123 -0.986 . . . . 1.12 110.07 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.17 54.5 1.54 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.199 -0.938 . . . . 0.17 109.433 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 60' ' ' ASP . 3.5 mp0 -54.88 -14.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.3 -0.875 . . . . 2.22 110.379 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.7 p-10 -69.41 -44.84 70.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.888 -1.133 . . . . 1.11 109.989 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.94 -44.62 57.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.081 -1.012 . . . . 0.19 108.692 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.13 86.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.22 109.236 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.0 m -64.5 -47.2 79.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 1.29 109.586 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.37 -38.12 89.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 2.2 109.662 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -4.34 58.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.242 -0.911 . . . . 0.33 109.801 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 47.66 65.88 1.17 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.197 -0.939 . . . . 2.34 109.866 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.15 130.09 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 0.28 109.272 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -125.79 -5.6 6.9 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.413 -0.804 . . . . 2.4 109.349 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.724 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.07 129.68 11.51 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.131 -1.062 . . . . 0.22 108.131 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.4 p -124.69 157.45 65.77 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.361 -0.837 . . . . 0.22 110.04 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -72.93 138.86 57.93 Favored 'Cis proline' 0 N--CA 1.487 1.119 0 O-C-N 122.856 0.924 . . . . 0.2 110.946 0.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -108.23 110.0 21.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.077 -1.083 . . . . 0.18 108.077 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.531 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -87.84 118.95 27.71 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.229 -0.989 . . . . 0.15 108.835 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -117.2 139.48 50.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.782 -1.192 . . . . 1.03 107.782 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 24.5 m-85 -110.92 133.85 53.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.11 110.311 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.75 156.32 43.72 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.393 -0.965 . . . . 0.17 108.393 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -155.55 121.54 5.09 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.202 -1.407 . . . . 1.48 107.202 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 55.99 33.63 22.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.545 -0.722 . . . . 1.67 109.723 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.27 5.25 87.41 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.044 -1.074 . . . . 0.22 110.523 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -112.88 145.37 40.82 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.235 -1.156 . . . . 2.08 110.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -85.54 141.69 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -0.915 . . . . 1.7 109.338 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.55 -34.28 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.466 -0.771 . . . . 0.26 110.128 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.55 -178.17 40.56 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.537 -1.316 . . . . 0.18 110.326 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.46 157.17 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -1.01 . . . . 2.04 110.215 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.1 p90 -168.67 130.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.904 -0.718 . . . . 0.14 110.064 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -102.7 -159.69 0.74 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.255 -0.903 . . . . 0.17 108.917 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.58 120.14 0.42 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.05 -1.62 . . . . 0.13 109.05 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.43 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -1.188 . . . . 0.2 110.656 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 91' ' ' GLY . 30.3 t-20 -139.34 76.75 1.58 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.131 -1.063 . . . . 1.15 108.131 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 3.9 ptpp? -64.79 -40.14 94.76 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.967 -0.56 . . . . 1.19 111.074 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -65.82 -26.44 67.68 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.057 -1.027 . . . . 1.95 109.974 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -68.1 -33.07 73.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 2.05 109.284 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.531 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.2 mt -50.46 -34.73 25.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.052 -1.03 . . . . 0.15 108.52 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.31 -56.77 8.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 2.15 109.597 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.84 86.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.15 110.548 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 m -66.91 -47.69 71.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.115 -0.991 . . . . 0.13 110.361 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.29 -48.81 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.18 108.842 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 50.6 t-20 -62.43 -16.84 57.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 1.03 109.443 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -78.17 -58.69 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 2.02 110.435 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.24 19.07 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.823 . . . . 0.35 110.415 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 102' ' ' ASN . 6.5 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.021 -0.99 . . . . 1.18 109.389 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.976 0.417 . . . . 0.0 110.649 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.674 ' OH ' HG11 ' A' ' 59' ' ' VAL . 1.2 p90 -109.06 -164.18 0.92 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.077 -1.015 . . . . 0.0 110.398 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.04 147.39 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.941 0.876 . . . . 0.0 111.788 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.98 95.04 6.32 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.724 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.24 46.32 1.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.805 -1.184 . . . . 0.0 109.991 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.3 -130.99 0.13 Allowed Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.01 23.73 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 CA-C-N 119.372 1.586 . . . . 0.0 108.56 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.611 ' H ' ' C ' ' B' ' 9' ' ' GLY . 29.5 t . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 0.0 109.876 -179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 3' ' ' LYS . 25.8 t . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 108.959 -0.756 . . . . 0.3 108.959 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' VAL . 22.7 tptm -155.06 121.81 5.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.072 -1.017 . . . . 1.97 109.16 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -91.74 131.73 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.98 109.621 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -107.1 108.87 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.821 -1.177 . . . . 0.19 107.821 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.75 -5.35 26.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.162 -0.961 . . . . 1.97 110.209 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -152.03 152.95 33.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 0.23 110.076 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -52.32 -31.5 33.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 1.9 109.713 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -61.2 -43.86 98.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.25 110.294 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.68 -24.39 64.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.2 110.196 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.18 -64.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.21 109.964 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.2 -44.4 83.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 2.47 109.67 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -58.2 -36.03 72.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.24 -0.913 . . . . 2.1 110.171 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.34 86.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.2 109.454 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.7 mt -63.68 -44.41 93.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -0.795 . . . . 0.62 109.525 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.41 -36.87 85.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.09 109.322 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.74 -17.88 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.002 . . . . 0.3 109.483 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -6.43 27.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.24 109.919 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.79 -112.43 4.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.722 -1.351 . . . . 0.28 109.722 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 47.4 t0 -137.86 4.38 2.53 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.286 -1.126 . . . . 2.21 109.463 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -71.42 170.17 13.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 1.9 109.471 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.02 164.08 13.49 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.105 -1.072 . . . . 0.17 108.105 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.632 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.8 t -146.46 109.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.12 109.809 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 t -105.13 134.26 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.41 -0.959 . . . . 0.09 108.41 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.56 140.0 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.17 109.864 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -110.47 103.34 11.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.221 -0.659 . . . . 0.96 109.221 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 54.6 m-85 -88.45 79.41 7.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.011 -1.107 . . . . 0.24 108.011 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -114.17 149.68 35.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.767 -0.583 . . . . 1.03 109.643 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.47 129.01 37.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.868 . . . . 0.26 108.699 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -66.6 -22.86 66.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.32 110.688 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.443 ' CD1' ' OD2' ' A' ' 60' ' ' ASP . 52.9 p-90 -89.17 -21.73 23.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.965 -1.085 . . . . 0.44 110.406 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.01 119.78 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.32 110.017 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.04 -54.57 35.67 Favored Glycine 0 N--CA 1.489 2.181 0 CA-C-O 119.429 -0.651 . . . . 0.36 111.72 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -48.03 -35.44 25.56 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.58 1.52 . . . . 0.44 111.406 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.84 1.3 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.083 -1.01 . . . . 0.81 109.063 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.98 -17.49 38.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 1.92 109.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpt -59.77 -19.59 51.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -0.974 . . . . 3.13 109.997 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.436 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.8 mt -99.7 10.58 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.11 -0.994 . . . . 0.28 110.34 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.26 -33.44 7.91 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 120.714 -1.241 . . . . 1.62 112.167 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -61.51 -6.54 7.22 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.078 1.064 . . . . 0.25 110.59 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -107.9 -74.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.555 -0.716 . . . . 0.3 109.403 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -45.03 -55.9 5.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.299 -0.876 . . . . 0.13 110.707 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -66.07 -31.48 72.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.049 -1.032 . . . . 0.41 109.89 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -64.07 -40.42 96.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.924 -1.11 . . . . 0.97 110.189 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 mt -51.57 -12.6 0.18 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.5 109.979 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' SER . 27.8 m -56.44 -38.56 71.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.835 -1.165 . . . . 0.51 109.566 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.14 -11.18 33.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.305 -0.872 . . . . 2.0 109.875 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.61 -53.26 4.73 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.3 -1.0 . . . . 2.16 108.3 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.19 72.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.342 -0.849 . . . . 0.24 109.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 p -66.7 -1.6 3.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.17 108.602 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -95.3 -4.38 45.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.34 109.541 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.2 t -116.75 150.5 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.947 -0.76 . . . . 0.12 108.947 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mm -100.45 132.24 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.421 -0.799 . . . . 0.17 109.088 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.58 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.6 m-85 -114.77 134.83 54.79 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.335 -0.853 . . . . 0.11 109.5 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -115.5 171.36 7.77 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.762 -0.829 . . . . 0.12 108.762 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.06 142.49 30.68 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.946 -1.131 . . . . 1.31 107.946 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.3 141.16 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.148 -0.97 . . . . 0.14 110.246 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.1 93.86 6.51 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.819 -1.178 . . . . 1.08 107.819 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 74' ' ' THR . 10.5 m -54.35 -3.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.27 111.47 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 6.2 m-20 -113.15 -37.35 4.78 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.067 -1.02 . . . . 1.11 111.231 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -95.42 -16.8 22.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.887 -1.133 . . . . 1.12 109.619 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.81 49.92 1.58 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.54 -0.911 . . . . 0.17 108.54 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.471 ' CB ' HH21 ' B' ' 4' ' ' ARG . 8.1 pt20 -54.98 -14.5 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.514 -0.741 . . . . 2.22 110.054 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -38.35 73.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.927 -1.108 . . . . 1.11 109.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.42 -47.51 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.007 . . . . 0.19 108.644 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.85 78.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.809 . . . . 0.22 109.351 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.3 m -64.31 -50.31 68.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 1.29 109.663 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -63.47 -33.27 75.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 2.2 109.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.93 0.41 55.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.094 -1.004 . . . . 0.33 109.538 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 48.95 54.19 11.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 2.34 110.157 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.28 129.53 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.28 109.037 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -122.65 -3.58 8.76 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.465 -0.772 . . . . 2.4 109.733 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.58 141.53 21.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.116 -0.99 . . . . 0.22 109.451 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.62 HG23 ' CE2' ' B' ' 5' ' ' TYR . 10.4 p -121.02 150.31 53.03 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.25 149.8 90.29 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.749 -0.938 . . . . 0.2 110.127 -2.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.91 124.77 49.09 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.855 -1.165 . . . . 0.18 107.855 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.79 ' CD1' HD21 ' A' ' 97' ' ' LEU . 75.3 m-85 -102.35 115.7 31.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.269 -1.011 . . . . 0.15 108.269 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 5.2 mt-30 -116.58 139.96 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.012 -1.107 . . . . 1.03 108.012 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.1 m-85 -109.54 126.52 53.66 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.48 0.657 . . . . 0.11 110.065 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -123.0 154.78 38.0 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.205 -1.035 . . . . 0.17 108.205 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -155.87 123.76 5.67 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.965 -1.124 . . . . 1.48 107.965 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 56.84 20.74 5.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.726 -0.609 . . . . 1.67 110.088 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.624 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 94.22 -1.48 67.33 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.074 -1.016 . . . . 0.22 110.579 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.624 HE21 ' C ' ' A' ' 83' ' ' GLY . 15.5 mm-40 -110.79 148.02 33.24 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.112 -1.228 . . . . 2.08 110.56 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -86.6 139.98 30.29 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.522 -0.918 . . . . 1.7 108.522 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -122.34 -21.44 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.454 -0.779 . . . . 0.26 110.704 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.74 174.92 47.17 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.425 -1.369 . . . . 0.18 110.209 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.75 155.75 2.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -1.14 . . . . 2.04 110.531 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.5 p90 -169.76 135.06 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.685 -0.634 . . . . 0.14 109.875 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -107.2 -178.76 3.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.341 -0.85 . . . . 0.17 108.898 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.41 134.0 8.34 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.446 -1.462 . . . . 0.13 109.446 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.516 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.75 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -1.195 . . . . 0.2 110.261 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.82 73.21 1.42 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.936 -1.135 . . . . 1.15 107.936 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -34.86 78.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 1.19 110.84 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.38 -25.03 67.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.991 -1.068 . . . . 1.95 109.354 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -69.1 -38.12 78.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.372 -0.83 . . . . 2.05 109.726 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 77' ' ' PHE . 42.6 mt -51.23 -36.51 42.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.919 -1.113 . . . . 0.15 109.077 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.45 -56.63 10.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.851 . . . . 2.15 109.573 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.94 86.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.15 110.398 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 m -67.47 -47.41 70.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.137 -0.977 . . . . 0.13 109.818 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -60.94 -49.4 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.18 108.46 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.55 -17.71 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 1.03 109.62 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.2 -60.35 2.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 2.02 109.928 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.11 21.54 5.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.492 -0.755 . . . . 0.35 110.307 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 1.18 109.197 179.454 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.471 HH21 ' CB ' ' A' ' 63' ' ' GLN . 5.8 mmt180 . . . . . 0 N--CA 1.494 1.747 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.62 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -113.17 -171.77 1.93 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.068 -1.02 . . . . 0.0 111.002 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.4 t -64.91 144.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.912 0.863 . . . . 0.0 113.072 -176.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -101.7 93.81 5.52 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.412 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 10.6 pt-20 -85.04 44.7 1.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.07 . . . . 0.0 110.843 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.27 -133.46 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.36 18.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.23 1.515 . . . . 0.0 109.639 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.655 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.3 t . . . . . 0 N--CA 1.488 1.471 0 O-C-N 121.467 -0.771 . . . . 0.0 109.66 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.0 t . . . . . 0 N--CA 1.495 1.782 0 N-CA-C 109.299 -0.63 . . . . 0.3 109.299 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -152.69 119.77 5.83 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.923 -1.139 . . . . 1.97 107.923 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -86.95 144.1 27.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.974 -1.079 . . . . 0.98 110.362 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mm -111.05 108.64 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.884 -1.154 . . . . 0.19 107.884 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.65 -12.56 19.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 1.97 109.489 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -153.55 155.12 35.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 0.23 109.631 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -51.35 -21.25 2.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 1.9 109.436 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.57 -52.9 62.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 0.25 110.435 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -20.45 63.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.2 110.275 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.37 -65.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.059 -1.026 . . . . 0.21 110.19 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.37 -45.07 84.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 2.47 109.633 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -59.0 -34.44 71.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.214 -0.929 . . . . 2.1 109.985 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.38 81.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.916 -1.115 . . . . 0.2 109.332 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.74 -45.97 84.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.227 -0.921 . . . . 0.62 109.447 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -63.78 -37.41 87.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 1.09 109.466 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.76 -16.93 52.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.3 109.472 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.78 27.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.24 109.522 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.38 -111.0 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.742 -1.343 . . . . 0.28 109.742 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -138.1 3.57 2.42 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.391 -1.064 . . . . 2.21 109.349 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.29 169.05 14.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.164 -0.96 . . . . 1.9 108.916 179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 162.32 12.2 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.035 -1.098 . . . . 0.17 108.035 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -144.18 103.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.831 -1.168 . . . . 0.12 109.628 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.27 129.92 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.563 -0.903 . . . . 0.09 108.563 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.16 141.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -0.762 . . . . 0.17 109.548 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -110.97 99.1 8.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.957 -0.757 . . . . 0.96 108.957 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 52.0 m-85 -84.82 81.41 8.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.632 -1.248 . . . . 0.24 107.632 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -109.89 -163.87 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.563 0.697 . . . . 1.03 109.147 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.53 119.93 13.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.151 -1.055 . . . . 0.26 108.151 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -63.21 -24.02 67.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.32 110.565 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 46.7 p-90 -89.64 -14.87 33.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.44 110.118 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 t -93.77 133.73 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.32 109.706 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.448 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.77 -57.76 5.21 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 111.337 -0.705 . . . . 0.36 111.337 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.5 Cg_exo -49.24 -37.27 39.32 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.779 1.652 . . . . 0.44 111.414 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.46 -62.62 1.56 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.857 -1.152 . . . . 0.81 109.069 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -59.0 -20.05 49.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 1.92 109.676 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.4 tpt -60.57 -18.04 50.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.322 -0.861 . . . . 3.13 109.662 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -100.51 10.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.289 -0.882 . . . . 0.28 110.412 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.59 -32.3 5.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.416 -1.427 . . . . 1.62 112.386 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -63.07 -5.09 7.17 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 CA-C-N 119.865 0.988 . . . . 0.25 110.29 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.8 -77.51 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.928 -0.767 . . . . 0.3 108.928 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -42.44 -56.63 2.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.13 110.998 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -65.73 -33.32 75.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.103 -0.998 . . . . 0.41 109.688 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 m -64.36 -39.89 94.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 0.97 109.997 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -51.85 -16.54 0.72 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.025 -1.047 . . . . 0.5 109.72 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -57.01 -29.46 63.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.51 109.737 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -95.95 -21.4 18.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 2.0 110.162 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -90.32 -19.7 23.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.053 -1.029 . . . . 2.16 109.41 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.15 64.65 1.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.39 -0.819 . . . . 0.24 109.209 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 p -66.9 -4.43 9.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.337 -0.852 . . . . 0.17 109.027 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -95.05 2.31 55.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.445 -0.784 . . . . 0.34 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -119.0 150.03 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.157 -0.683 . . . . 0.12 109.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.79 122.31 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.17 108.982 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -109.74 129.84 55.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.254 -0.904 . . . . 0.11 108.969 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.7 169.63 8.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.336 -0.852 . . . . 0.12 108.807 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -142.06 140.39 32.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.602 -1.259 . . . . 1.31 107.602 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.2 136.94 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.898 . . . . 0.14 110.741 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.99 107.68 20.26 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.645 -1.243 . . . . 1.08 107.645 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.3 m -65.14 -9.68 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.27 111.06 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -101.03 -41.69 6.68 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.013 -1.054 . . . . 1.11 110.704 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -12.48 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 1.12 109.91 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.31 49.63 1.88 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.311 -0.868 . . . . 0.17 108.836 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.08 -17.01 5.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.721 . . . . 2.22 109.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.4 p30 -70.33 -41.29 73.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.004 . . . . 1.11 109.433 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -74.18 -45.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.19 108.674 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.27 79.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.282 -0.886 . . . . 0.22 108.779 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -64.04 -44.79 91.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.369 -0.832 . . . . 1.29 109.265 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.59 -39.11 93.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 2.2 109.449 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.71 55.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.186 -0.946 . . . . 0.33 109.909 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 47.65 56.21 7.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.06 -1.025 . . . . 2.34 109.748 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.9 t -79.52 131.27 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.28 109.588 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -128.8 0.96 5.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.385 -0.822 . . . . 2.4 109.669 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.0 128.65 10.8 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.966 -1.084 . . . . 0.22 108.771 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.666 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.2 p -114.77 150.43 44.03 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.733 -0.84 . . . . 0.22 108.733 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.54 147.47 84.66 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 C-N-CA 124.776 -0.927 . . . . 0.2 109.941 -1.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.56 117.42 28.93 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.938 -1.134 . . . . 0.18 107.938 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.6 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.2 m-85 -91.78 121.48 33.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.07 -1.019 . . . . 0.15 108.494 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.504 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.1 mt-30 -120.05 136.38 54.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.783 -1.191 . . . . 1.03 107.783 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 32.3 m-85 -108.97 129.43 55.44 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.581 0.705 . . . . 0.11 109.978 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -126.24 156.92 39.52 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.263 -1.014 . . . . 0.17 108.263 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -155.39 120.23 4.79 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.485 -1.302 . . . . 1.48 107.485 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt 55.97 29.14 13.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -0.783 . . . . 1.67 108.909 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.13 7.8 87.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.896 -1.281 . . . . 0.22 109.896 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -112.85 142.41 45.54 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.469 -1.018 . . . . 2.08 110.643 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -84.77 141.37 30.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 1.7 109.314 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.34 -20.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.426 -0.796 . . . . 0.26 110.452 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.24 172.97 45.53 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.346 -1.407 . . . . 0.18 110.435 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -174.22 150.68 1.54 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.447 -1.031 . . . . 2.04 110.044 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.9 p90 -169.09 133.18 1.41 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.14 110.48 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.55 -169.55 1.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.17 108.929 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.13 129.88 3.67 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.669 -1.372 . . . . 0.13 109.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.87 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -1.16 . . . . 0.2 110.602 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -139.46 76.68 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.828 -1.175 . . . . 1.15 107.828 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.471 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.34 -32.55 74.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.654 -0.654 . . . . 1.19 110.656 -178.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.66 -28.35 69.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.906 -1.121 . . . . 1.95 109.146 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.71 -35.23 76.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 2.05 109.322 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.4 mt -52.07 -38.99 59.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.15 108.823 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -57.63 6.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.578 -0.701 . . . . 2.15 109.785 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.32 82.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.15 110.494 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.2 m -66.78 -45.79 77.36 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.13 110.163 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.68 -52.37 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.18 109.214 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -60.52 -18.09 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 1.03 109.449 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -77.39 -62.72 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 2.02 110.202 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.33 24.39 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.558 -0.714 . . . . 0.35 110.437 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.937 -1.102 . . . . 1.18 109.165 179.541 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 . . . . . 0 N--CA 1.495 1.819 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -109.55 -168.39 1.32 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.259 -0.901 . . . . 0.0 110.461 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.67 150.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.266 -0.896 . . . . 0.0 112.57 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.9 m -101.4 96.53 7.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.595 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.25 44.76 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 110.279 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.89 -131.43 0.12 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.08 23.98 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.273 1.537 . . . . 0.0 109.129 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.622 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.6 t . . . . . 0 N--CA 1.486 1.348 0 O-C-N 121.354 -0.842 . . . . 0.0 109.335 -179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.9 t . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.3 0.571 . . . . 0.3 109.588 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.526 ' N ' HG12 ' A' ' 2' ' ' VAL . 33.6 tttt -155.96 123.32 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 1.97 109.224 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -90.45 132.52 35.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.98 109.645 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -112.51 103.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.548 -0.908 . . . . 0.19 108.548 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -99.19 -4.46 32.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.204 -0.935 . . . . 1.97 109.852 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 p -151.18 148.9 28.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.112 -0.992 . . . . 0.23 109.96 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -52.31 -25.59 9.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.319 -0.863 . . . . 1.9 109.552 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.7 m -59.7 -48.92 79.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.25 109.34 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -23.62 62.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.2 109.733 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -58.28 -66.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.21 110.198 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -56.27 -44.62 79.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 2.47 109.669 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -58.91 -35.11 72.52 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 2.1 109.804 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.2 108.898 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.21 -43.52 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.578 -0.702 . . . . 0.62 109.318 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 -38.2 90.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 1.09 109.681 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.19 -16.08 55.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.3 109.909 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.28 50.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.24 109.889 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 -112.94 4.76 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.31 -1.516 . . . . 0.28 109.31 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -134.71 2.54 3.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.435 -1.038 . . . . 2.21 109.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.3 mttt -70.28 166.87 19.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.044 -1.035 . . . . 1.9 108.689 179.275 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.39 163.36 10.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.17 108.834 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.2 t -144.6 107.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 0.12 109.402 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.38 135.5 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.556 -0.905 . . . . 0.09 108.556 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.15 133.44 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.17 109.894 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 9.4 t70 -106.44 102.96 12.31 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.98 -0.748 . . . . 0.96 108.98 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -88.45 79.43 7.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.603 -1.258 . . . . 0.24 107.603 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.416 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 67.0 m -113.3 149.27 34.16 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.225 0.536 . . . . 1.03 109.613 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.89 129.57 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.858 . . . . 0.26 109.082 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.45 -23.97 65.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 0.32 110.118 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.407 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 53.8 p-90 -89.1 -16.88 30.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.061 -1.024 . . . . 0.44 110.176 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.48 124.71 37.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.965 . . . . 0.32 110.291 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.76 -57.75 11.67 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.972 -0.851 . . . . 0.36 110.972 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -46.18 -36.07 16.19 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 121.908 1.739 . . . . 0.44 111.359 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.0 -60.31 2.41 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.672 -1.267 . . . . 0.81 108.991 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -59.91 -18.39 44.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.489 -0.757 . . . . 1.92 110.029 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.4 tpt -59.68 -24.77 64.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 3.13 110.155 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 38' ' ' ILE . 72.3 mt -96.91 6.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.142 -0.974 . . . . 0.28 111.371 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -62.58 -34.39 14.52 Favored Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 118.194 -1.402 . . . . 1.62 111.64 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -62.32 -5.9 7.48 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 CA-C-N 120.009 1.039 . . . . 0.25 110.524 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.83 -71.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.3 108.958 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -46.06 -58.5 3.55 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.488 -0.757 . . . . 0.13 110.733 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.24 -30.49 71.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.41 109.714 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 m -63.54 -41.17 98.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.855 -1.153 . . . . 0.97 109.735 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -52.01 -16.92 0.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.5 109.575 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 66.6 m -56.93 -31.37 64.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.51 109.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.92 -19.72 20.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.127 -0.983 . . . . 2.0 109.906 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -90.94 -21.38 21.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 2.16 109.774 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.22 67.71 1.5 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.24 109.231 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -68.01 -3.97 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.413 -0.805 . . . . 0.17 109.322 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.5 t30 -94.94 2.22 55.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.34 109.719 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.1 t -119.12 152.99 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.811 -0.811 . . . . 0.12 108.811 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 mm -100.44 128.64 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.306 -0.871 . . . . 0.17 108.911 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.603 ' C ' HD12 ' A' ' 55' ' ' LEU . 65.0 m-85 -114.58 132.9 56.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.407 -0.808 . . . . 0.11 109.144 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -115.31 169.0 9.47 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.083 -0.71 . . . . 0.12 109.083 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -144.25 141.1 29.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.196 -1.039 . . . . 1.31 108.196 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.15 145.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.103 -0.998 . . . . 0.14 110.425 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -101.32 100.92 11.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.219 -1.03 . . . . 1.08 108.219 178.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.09 -3.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.246 -0.909 . . . . 0.27 111.287 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 27.1 m-20 -108.79 -40.94 4.9 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.203 -0.936 . . . . 1.11 111.095 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.21 -23.43 16.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.891 -1.131 . . . . 1.12 110.036 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.0 46.34 0.98 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.352 -0.981 . . . . 0.17 108.352 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -53.53 -14.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.731 -0.606 . . . . 2.22 109.9 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -71.2 -42.98 68.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.062 -1.024 . . . . 1.11 109.316 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.19 -43.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.143 -0.973 . . . . 0.19 108.696 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -35.55 79.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 m -64.69 -46.98 80.07 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.754 -0.832 . . . . 1.29 108.754 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.57 -39.42 94.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 2.2 109.35 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -3.15 58.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 0.33 109.603 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 66' ' ' ALA . 52.3 mm-40 47.47 53.01 11.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.873 . . . . 2.34 110.352 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.96 136.14 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.28 109.413 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -129.88 3.86 4.92 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.476 -0.765 . . . . 2.4 109.5 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 136.26 16.27 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.128 -0.982 . . . . 0.22 108.883 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.521 HG23 ' CE2' ' B' ' 5' ' ' TYR . 41.1 p -118.55 150.79 48.76 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.945 -0.761 . . . . 0.22 108.945 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.76 145.92 80.39 Favored 'Cis proline' 0 N--CA 1.482 0.848 0 N-CA-C 109.778 -0.893 . . . . 0.2 109.778 -1.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.6 112.47 22.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.513 -1.292 . . . . 0.18 107.513 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -92.56 113.8 26.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.426 -0.91 . . . . 0.15 108.686 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -115.91 138.68 50.95 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.443 -1.317 . . . . 1.03 107.443 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.3 m-85 -110.11 127.23 54.77 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.374 0.607 . . . . 0.11 109.756 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -121.45 157.18 31.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.541 -0.911 . . . . 0.17 108.541 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -155.73 123.53 5.65 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.491 -1.3 . . . . 1.48 107.491 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt 57.07 17.81 3.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.687 -0.633 . . . . 1.67 109.89 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.609 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.72 0.18 62.59 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.416 -1.074 . . . . 0.22 110.416 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.609 HE21 ' C ' ' A' ' 83' ' ' GLY . 23.6 mm-40 -111.87 151.1 29.51 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.184 -1.186 . . . . 2.08 110.033 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.398 -0.814 . . . . 1.7 109.316 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.87 -7.03 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.735 . . . . 0.26 110.542 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.93 167.77 35.29 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.445 -1.36 . . . . 0.18 110.284 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.95 153.2 2.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 2.04 110.604 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 8.2 p90 -169.66 132.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.14 109.603 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.7 p -104.23 -162.28 0.88 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.015 -1.053 . . . . 0.17 109.183 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.14 137.1 1.08 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.325 -1.51 . . . . 0.13 109.325 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.49 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.2 110.094 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.46 66.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.868 -1.16 . . . . 1.15 107.868 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -62.24 -38.94 91.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.816 -0.552 . . . . 1.19 111.262 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.58 -27.33 68.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.596 -1.315 . . . . 1.95 109.497 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.19 -32.77 73.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 2.05 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.9 mt -51.4 -36.88 45.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.15 108.687 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.34 -59.64 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.527 -0.733 . . . . 2.15 109.848 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.47 81.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.15 110.741 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.8 m -67.84 -45.28 75.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.13 110.211 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.55 -51.24 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.18 109.157 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.71 -17.22 46.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 1.03 109.634 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.95 -61.26 1.99 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 2.02 110.015 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.9 21.33 5.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.424 -0.797 . . . . 0.35 110.391 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.017 -1.052 . . . . 1.18 109.414 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -125.35 -173.97 2.95 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.16 149.72 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.006 0.908 . . . . 0.0 112.496 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.55 95.69 6.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -83.89 41.59 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.03 -1.044 . . . . 0.0 110.361 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -129.4 0.05 OUTLIER Glycine 0 N--CA 1.485 1.915 0 N-CA-C 106.898 -2.481 . . . . 0.0 106.898 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.71 22.67 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.307 1.553 . . . . 0.0 109.119 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t . . . . . 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.125 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.3 t . . . . . 0 N--CA 1.494 1.755 0 N-CA-C 109.41 -0.589 . . . . 0.3 109.41 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.618 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.7 tttp -151.92 121.54 6.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.234 -0.916 . . . . 1.97 109.073 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -88.29 132.04 34.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.98 109.709 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.97 107.46 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.228 -1.027 . . . . 0.19 108.228 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.58 -10.33 22.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.201 -0.937 . . . . 1.97 109.646 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 p -153.51 157.49 39.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.23 109.95 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -53.02 -30.38 35.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 1.9 109.916 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 m -59.49 -45.1 92.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.25 110.25 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.06 -26.48 64.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.2 109.795 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.02 -69.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.973 . . . . 0.21 110.237 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -54.38 -43.16 71.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 2.47 109.603 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -59.0 -36.36 74.8 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.171 -0.956 . . . . 2.1 109.643 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.0 -47.63 85.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.032 -1.043 . . . . 0.2 109.013 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.18 -44.49 88.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.735 . . . . 0.62 109.877 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -62.92 -45.73 91.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 1.09 109.826 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.95 59.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.3 109.876 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.79 -10.53 57.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.084 -1.01 . . . . 0.24 109.649 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.61 13.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.28 109.612 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 46.1 t0 -121.17 2.81 10.4 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.586 -0.949 . . . . 2.21 109.925 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 46.9 mttp -68.25 169.98 9.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.902 -1.123 . . . . 1.9 109.367 179.899 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.0 162.43 19.36 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.19 -1.041 . . . . 0.17 108.19 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.8 t -145.26 102.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.981 -1.074 . . . . 0.12 109.111 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' CE2' ' A' ' 79' ' ' PHE . 3.1 t -101.42 127.54 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.485 -0.76 . . . . 0.09 109.069 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.0 138.32 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.606 -0.684 . . . . 0.17 109.764 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -108.86 99.46 8.8 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.974 -0.751 . . . . 0.96 108.974 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.6 m-85 -82.96 77.26 9.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.794 -1.187 . . . . 0.24 107.794 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -103.98 -166.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.574 0.702 . . . . 1.03 109.433 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 127.98 21.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.863 -0.791 . . . . 0.26 108.863 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.32 111.194 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.557 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.7 p-90 -86.74 -11.05 52.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.768 -1.208 . . . . 0.44 110.09 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.84 117.38 30.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.32 109.981 -179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.63 -55.19 31.32 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 120.865 -0.683 . . . . 0.36 111.419 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.1 Cg_exo -49.59 -35.7 38.31 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.814 1.676 . . . . 0.44 111.11 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.34 -62.64 1.59 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.951 -1.093 . . . . 0.81 109.055 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.62 -16.93 29.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.476 -0.765 . . . . 1.92 110.163 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -61.48 -19.37 61.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.083 -1.011 . . . . 3.13 110.222 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 38' ' ' ILE . 72.2 mt -100.48 13.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.244 -0.91 . . . . 0.28 110.718 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.51 -32.1 2.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.469 -1.394 . . . . 1.62 112.607 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.7 Cg_exo -63.79 -4.06 6.64 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 119.793 0.962 . . . . 0.25 110.268 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 42' ' ' PHE . 42.0 m-85 -110.9 -79.47 0.58 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.404 -0.81 . . . . 0.3 108.907 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.62 -57.12 1.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.566 . . . . 0.13 110.79 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.07 -30.72 70.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.41 109.834 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 11.2 m -66.76 -38.62 86.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.97 110.284 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -49.45 -20.25 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.935 -1.103 . . . . 0.5 109.772 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -56.71 -22.94 38.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.51 110.105 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -97.07 -26.46 14.98 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.15 -0.969 . . . . 2.0 110.239 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.13 -17.76 27.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.077 -1.014 . . . . 2.16 109.56 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -134.16 70.19 1.45 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.377 -0.827 . . . . 0.24 109.39 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.6 p -68.51 -6.23 24.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.423 -0.798 . . . . 0.17 109.12 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.2 3.31 54.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.448 -0.782 . . . . 0.34 110.052 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.69 148.54 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.12 109.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.419 ' N ' HD13 ' A' ' 53' ' ' ILE . 4.8 mm -99.23 121.73 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17 108.983 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.497 ' C ' HD12 ' A' ' 55' ' ' LEU . 81.4 m-85 -108.84 128.39 54.86 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.878 . . . . 0.11 108.937 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.7 mp -110.2 170.41 8.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.504 -0.747 . . . . 0.12 109.023 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -140.82 137.93 33.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.634 -1.247 . . . . 1.31 107.634 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.69 134.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.913 . . . . 0.14 110.336 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.14 110.31 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.63 -1.248 . . . . 1.08 107.63 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.23 -11.35 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.27 111.346 -178.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.557 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 12.1 m-20 -104.76 -38.92 6.51 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.022 -1.049 . . . . 1.11 110.793 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -93.52 -13.62 27.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.908 -1.12 . . . . 1.12 109.693 -179.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.46 49.14 1.94 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.306 -0.998 . . . . 0.17 108.306 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -56.11 -16.42 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 2.22 110.755 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -39.43 76.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.853 -1.154 . . . . 1.11 109.304 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.8 -47.12 44.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.201 -0.937 . . . . 0.19 108.84 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.86 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.847 . . . . 0.22 109.333 179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.0 m -62.78 -50.13 72.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 1.29 109.26 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.54 -32.33 73.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 2.2 109.635 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.98 0.11 56.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.238 -0.913 . . . . 0.33 109.816 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 47.41 50.01 15.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 2.34 110.097 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.61 131.94 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.28 109.064 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -129.12 6.71 5.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.331 -0.855 . . . . 2.4 109.661 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 144.29 24.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.497 HG23 ' CE2' ' B' ' 5' ' ' TYR . 32.5 p -131.01 149.12 72.87 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 108.546 -0.909 . . . . 0.22 108.546 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.4 Cg_endo -79.09 142.69 68.3 Favored 'Cis proline' 0 N--CA 1.487 1.134 0 C-N-CA 124.966 -0.848 . . . . 0.2 110.219 -1.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.01 111.06 21.52 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 107.862 -1.162 . . . . 0.18 107.862 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 97' ' ' LEU . 88.7 m-85 -86.15 116.0 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.822 -1.174 . . . . 0.15 109.541 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.443 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.3 mt-30 -115.96 132.12 56.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.8 m-85 -105.14 127.51 52.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.11 109.66 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -121.78 155.46 35.24 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.92 -0.77 . . . . 0.17 108.92 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -154.96 123.65 6.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.737 -1.208 . . . . 1.48 107.737 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 55.95 28.88 13.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.529 -0.732 . . . . 1.67 109.827 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.07 -0.1 89.49 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.089 -1.053 . . . . 0.22 110.815 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -110.98 147.88 33.75 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.144 -1.209 . . . . 2.08 110.475 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -87.87 143.84 26.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 1.7 109.339 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.1 m -123.59 -24.0 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.497 -0.752 . . . . 0.26 110.15 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.29 177.18 47.87 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.586 -1.292 . . . . 0.18 109.975 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.19 157.21 3.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 2.04 110.057 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.5 p90 -168.76 131.16 1.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.807 . . . . 0.14 110.161 178.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -101.48 -161.16 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.559 -0.904 . . . . 0.17 108.559 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' B' ' 8' ' ' GLU . . . 82.43 126.5 0.98 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.104 -1.598 . . . . 0.13 109.104 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.09 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -1.203 . . . . 0.2 110.891 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -142.73 76.61 1.54 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.967 -1.123 . . . . 1.15 107.967 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -32.4 73.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.19 110.774 -178.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.13 -25.23 67.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.93 -1.106 . . . . 1.95 109.372 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -70.86 -37.23 73.09 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.3 -0.875 . . . . 2.05 109.852 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.5 mt -52.17 -36.03 50.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.15 108.962 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -66.09 -59.21 4.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.431 -0.793 . . . . 2.15 110.071 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.53 82.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.15 110.676 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.4 m -67.22 -45.22 77.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.072 -1.017 . . . . 0.13 110.192 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.04 -53.03 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.191 -0.943 . . . . 0.18 109.127 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -59.19 -18.53 37.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 1.03 109.471 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.54 -56.56 4.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 2.02 110.08 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -92.96 15.47 14.88 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.495 -0.753 . . . . 0.35 110.613 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.872 -1.143 . . . . 1.18 109.403 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.802 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.497 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.28 -169.78 1.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.177 -0.952 . . . . 0.0 110.973 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.63 150.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-O 122.09 0.948 . . . . 0.0 112.875 -176.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -102.24 96.28 6.87 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -82.88 47.86 1.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 110.131 -179.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -78.16 -125.28 0.35 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 177.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.9 25.67 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.495 1.648 . . . . 0.0 109.54 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.4 t . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 -179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 3' ' ' LYS . 95.3 t . . . . . 0 N--CA 1.492 1.655 0 N-CA-C 109.496 -0.557 . . . . 0.3 109.496 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.535 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 tptt -154.5 125.21 7.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.274 -0.891 . . . . 1.97 109.212 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -90.26 131.66 35.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.98 109.668 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.32 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.403 -0.962 . . . . 0.19 108.403 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.63 -1.33 47.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 1.97 109.791 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -150.99 146.93 26.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.23 109.813 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -51.83 -29.5 19.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.34 -0.85 . . . . 1.9 109.831 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -59.04 -45.66 90.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.25 109.799 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.44 63.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.2 109.681 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.99 -66.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.061 -1.024 . . . . 0.21 109.786 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -53.65 -46.09 70.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.207 -0.933 . . . . 2.47 109.728 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.98 -35.13 72.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.152 -0.967 . . . . 2.1 110.022 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.53 -46.24 90.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.995 -1.065 . . . . 0.2 109.296 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.4 -50.19 68.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.62 109.717 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.29 -36.59 84.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 1.09 109.474 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.58 -18.66 47.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -0.927 . . . . 0.3 109.682 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.8 23.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.24 109.73 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 70.97 -116.11 6.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.28 109.642 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 84.1 m-20 -135.22 4.01 3.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.442 -1.034 . . . . 2.21 109.408 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 39.0 mttp -69.8 170.07 11.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.047 -1.033 . . . . 1.9 109.013 179.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 159.89 22.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.71 -1.218 . . . . 0.17 107.71 179.574 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.697 ' H ' HD23 ' A' ' 22' ' ' LEU . 16.1 t -143.56 108.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.865 -1.147 . . . . 0.12 109.374 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.95 134.47 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.912 -0.773 . . . . 0.09 108.912 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.66 136.08 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.665 -0.647 . . . . 0.17 109.523 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.37 101.95 11.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.017 -0.735 . . . . 0.96 109.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -85.25 77.84 9.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.041 -1.096 . . . . 0.24 108.041 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -113.92 146.47 40.02 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.16 -0.682 . . . . 1.03 109.16 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.56 130.51 36.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.26 108.751 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -65.88 -24.57 66.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.32 110.311 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.473 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 58.5 p-90 -88.54 -17.35 30.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.082 -1.011 . . . . 0.44 109.888 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.82 116.18 28.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.32 110.135 -178.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.16 -53.14 47.21 Favored Glycine 0 N--CA 1.488 2.123 0 CA-C-O 119.341 -0.699 . . . . 0.36 111.854 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.7 Cg_exo -48.38 -38.79 35.13 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.534 1.489 . . . . 0.44 111.148 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.4 -59.67 2.64 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.727 -1.233 . . . . 0.81 109.015 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.49 -18.63 52.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.739 . . . . 1.92 110.295 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm -57.93 -19.55 30.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.79 -1.194 . . . . 3.13 110.257 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 38' ' ' ILE . 77.4 mt -101.5 15.02 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.136 -0.977 . . . . 0.28 110.39 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.75 -32.21 3.43 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.618 -1.301 . . . . 1.62 112.56 179.727 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.6 Cg_exo -63.08 -5.21 7.41 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.883 0.994 . . . . 0.25 110.165 -178.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.08 -76.73 0.6 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.475 -0.766 . . . . 0.3 109.203 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.13 110.787 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.5 -31.52 72.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.93 -1.106 . . . . 0.41 110.025 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.5 m -64.64 -38.82 92.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.818 -1.176 . . . . 0.97 110.039 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -50.25 -12.62 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.926 -1.109 . . . . 0.5 109.776 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' SER . 19.4 m -56.76 -37.34 70.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.084 -1.01 . . . . 0.51 109.665 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -94.97 -13.32 25.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.232 -0.918 . . . . 2.0 110.283 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -27.5 19.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.002 -1.062 . . . . 2.16 109.572 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.42 72.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.088 -0.708 . . . . 0.24 109.088 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.1 p -67.02 -4.48 9.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.17 109.215 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.0 t30 -96.1 -3.17 45.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.34 109.829 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.45 150.12 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.452 -0.78 . . . . 0.12 109.603 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.1 130.48 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.534 -0.729 . . . . 0.17 109.412 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -115.03 132.53 56.57 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.554 -0.716 . . . . 0.11 109.192 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.66 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.743 -0.836 . . . . 0.12 108.743 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.68 138.9 32.79 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.688 -1.227 . . . . 1.31 107.688 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.44 136.9 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.163 -0.961 . . . . 0.14 110.887 -178.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -98.78 102.78 14.62 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.268 -1.012 . . . . 1.08 108.268 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.3 m -61.06 -0.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.27 111.56 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 18.0 m-20 -115.18 -37.86 3.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.102 -0.999 . . . . 1.11 111.053 -178.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -94.96 -14.26 24.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.997 -1.064 . . . . 1.12 109.766 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.58 52.84 1.6 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.709 -0.848 . . . . 0.17 108.709 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.93 -19.23 4.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.431 -0.793 . . . . 2.22 110.173 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.1 p30 -68.02 -39.57 83.11 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.18 -1.575 . . . . 1.11 109.989 -178.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.14 -48.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.955 -1.091 . . . . 0.19 108.736 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.22 90.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.22 110.336 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.428 ' HA ' HH22 ' B' ' 4' ' ' ARG . 23.1 t -63.63 -42.19 98.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 1.29 109.581 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.69 -38.81 92.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.126 -0.984 . . . . 2.2 109.191 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.9 0.17 56.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.33 109.872 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 67' ' ' SER . 22.9 mp0 48.15 56.29 7.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 2.34 110.222 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 6.9 t -79.14 132.76 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.28 108.916 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.427 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 9.3 mtmp? -129.77 3.8 4.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.331 -0.856 . . . . 2.4 110.358 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 123.17 7.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.975 -1.078 . . . . 0.22 109.457 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.667 HG23 ' CE2' ' B' ' 5' ' ' TYR . 37.5 p -109.47 150.25 40.92 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.322 -0.861 . . . . 0.22 109.068 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -77.41 139.55 58.82 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 C-N-CA 124.894 -0.878 . . . . 0.2 110.421 -1.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -110.44 112.02 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.797 -1.186 . . . . 0.18 107.797 178.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 97' ' ' LEU . 91.9 m-85 -89.62 119.08 29.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.919 -1.113 . . . . 0.15 109.27 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -117.0 132.63 56.65 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.37 -1.344 . . . . 1.03 107.37 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.8 m-85 -108.76 123.77 49.53 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.628 0.727 . . . . 0.11 109.471 -178.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -120.86 157.37 29.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.54 -0.911 . . . . 0.17 108.54 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.65 125.98 6.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.855 -1.165 . . . . 1.48 107.855 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm 56.18 26.15 9.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 1.67 109.988 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.99 3.26 90.56 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.947 -1.261 . . . . 0.22 109.947 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -111.49 148.06 33.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.517 -0.99 . . . . 2.08 109.744 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.66 146.03 26.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 1.7 109.692 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.91 -29.77 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -0.752 . . . . 0.26 109.844 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.43 177.91 44.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.529 -1.32 . . . . 0.18 110.472 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.498 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.1 pm0 -173.3 154.52 2.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -1.08 . . . . 2.04 110.164 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -168.98 131.58 1.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.353 -0.842 . . . . 0.14 109.924 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -102.98 -158.16 0.65 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.231 -0.918 . . . . 0.17 108.895 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.9 126.05 0.7 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.438 -1.465 . . . . 0.13 109.438 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.19 94.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.244 . . . . 0.2 110.131 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.3 t-20 -139.49 76.59 1.57 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.37 -0.974 . . . . 1.15 108.37 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -63.99 -41.08 97.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.778 -0.576 . . . . 1.19 111.206 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.58 -25.85 68.15 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.051 -1.031 . . . . 1.95 109.785 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -69.35 -33.79 73.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.192 -0.942 . . . . 2.05 109.405 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.8 mt -54.77 -35.53 63.9 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.68 -1.208 . . . . 0.15 108.583 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -66.62 -55.96 12.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 2.15 109.465 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.73 92.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.15 110.419 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -65.81 -46.79 77.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.13 110.203 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.28 -49.67 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.18 108.676 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' HG12 ' A' ' 105' ' ' VAL . 55.8 t30 -62.59 -17.06 59.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 1.03 109.183 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -79.37 -55.51 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 2.02 110.457 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 22' ' ' LEU . 27.2 mt -92.15 14.13 16.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.35 110.336 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.962 -1.086 . . . . 1.18 109.284 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.428 HH22 ' HA ' ' A' ' 67' ' ' SER . 7.0 ttt180 . . . . . 0 N--CA 1.496 1.859 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.667 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.5 p90 -116.56 -167.79 1.34 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.843 -1.16 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.1 150.71 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.381 -0.825 . . . . 0.0 112.317 -177.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -101.59 95.36 6.4 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.412 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -82.51 45.42 0.96 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.075 -1.015 . . . . 0.0 109.594 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -133.99 0.08 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.81 25.38 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.79 0 CA-C-N 119.2 1.5 . . . . 0.0 108.773 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.2 t . . . . . 0 N--CA 1.489 1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 109.261 -179.791 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 31.1 t . . . . . 0 N--CA 1.494 1.753 0 CA-C-O 121.255 0.55 . . . . 0.3 109.722 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 76.4 tttt -154.01 124.98 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.271 -0.893 . . . . 1.97 109.325 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -89.03 133.74 34.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.98 109.654 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -105.56 117.01 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.162 -1.051 . . . . 0.19 108.162 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.48 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 11.6 mp0 -102.54 -14.67 16.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.156 -0.965 . . . . 1.97 109.508 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 p -152.74 158.63 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.23 109.817 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -52.22 -26.71 12.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 1.9 109.703 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -59.89 -48.61 80.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.25 110.018 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.67 62.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.2 109.765 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.69 -69.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.018 . . . . 0.21 110.039 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -54.23 -43.97 71.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -0.857 . . . . 2.47 109.853 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.74 -37.45 76.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.236 -0.915 . . . . 2.1 109.743 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.52 95.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.0 -1.063 . . . . 0.2 109.187 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.69 -42.39 95.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.62 109.589 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.86 -42.44 97.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 1.09 109.763 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -12.98 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.146 -0.971 . . . . 0.3 109.552 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -5.91 25.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.24 109.653 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.25 -110.76 3.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.369 -1.492 . . . . 0.28 109.369 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.14 5.09 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.335 -1.097 . . . . 2.21 108.98 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 71.1 mttt -69.8 168.61 14.72 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.094 -1.004 . . . . 1.9 108.819 179.419 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.49 162.52 12.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.039 -1.097 . . . . 0.17 108.039 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.46 105.13 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.907 -1.121 . . . . 0.12 109.379 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.0 t -103.73 126.89 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.09 108.833 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.59 138.97 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.713 . . . . 0.17 109.527 -179.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.49 104.99 13.45 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.299 -0.63 . . . . 0.96 109.299 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.53 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 48.3 m-85 -85.41 81.85 8.56 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.034 -1.099 . . . . 0.24 108.034 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -114.53 150.3 35.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.785 -0.572 . . . . 1.03 109.636 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -92.46 125.3 37.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.26 108.591 179.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -66.13 -21.27 66.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.2 -0.937 . . . . 0.32 109.96 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.497 ' NE1' ' HB1' ' A' ' 29' ' ' ALA . 56.9 p-90 -89.4 -17.64 28.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 0.44 109.801 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.33 125.59 38.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.32 110.136 -178.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -63.98 -58.58 10.41 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 111.316 -0.714 . . . . 0.36 111.316 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.26 -34.49 24.75 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.638 1.559 . . . . 0.44 111.275 -178.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.5 -63.68 1.32 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.093 -1.005 . . . . 0.81 108.929 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -59.67 -17.55 35.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.588 -0.695 . . . . 1.92 110.095 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.2 ttt -61.67 -18.71 60.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 3.13 110.155 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 75' ' ' PRO . 29.5 mt -98.15 13.87 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.201 -0.937 . . . . 0.28 110.244 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.84 -32.05 3.26 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.393 -1.442 . . . . 1.62 112.267 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.64 -3.26 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 CA-C-N 119.855 0.984 . . . . 0.25 110.119 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.2 m-85 -112.47 -81.13 0.59 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.519 -0.738 . . . . 0.3 109.173 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.6 t80 -41.44 -55.37 2.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.13 110.727 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -68.1 -32.02 72.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.854 -1.154 . . . . 0.41 109.675 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.3 t -64.42 -41.22 96.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.827 -1.17 . . . . 0.97 110.191 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -49.62 -14.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.885 -1.135 . . . . 0.5 109.494 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' SER . 17.2 m -57.45 -34.65 69.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.51 109.68 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.05 -17.54 21.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.129 -0.982 . . . . 2.0 110.075 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.6 -21.74 22.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 2.16 109.093 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -135.75 72.32 1.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.24 109.142 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.1 p -66.94 -4.27 9.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.902 . . . . 0.17 109.174 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.38 -3.23 44.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34 109.818 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.95 148.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.445 -0.784 . . . . 0.12 109.347 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mm -100.31 129.06 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.17 109.553 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -116.95 129.48 56.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.425 -0.797 . . . . 0.11 109.18 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -111.93 175.12 5.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.402 -0.811 . . . . 0.12 108.977 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -143.62 146.1 33.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.204 -1.036 . . . . 1.31 108.204 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -142.48 138.43 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.134 -0.979 . . . . 0.14 110.821 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -98.44 104.48 16.51 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.114 -1.069 . . . . 1.08 108.114 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.8 m -60.56 -4.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.27 111.46 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -110.21 -43.04 4.01 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.067 -1.02 . . . . 1.11 110.833 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 -12.28 32.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.002 . . . . 1.12 109.34 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.44 45.22 2.63 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.764 -0.828 . . . . 0.17 108.764 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.682 HE21 HH11 ' B' ' 4' ' ' ARG . 54.3 mt-30 -56.46 -12.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 2.22 110.454 -179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -40.41 75.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.922 -1.111 . . . . 1.11 109.266 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.84 -46.71 45.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.907 . . . . 0.19 109.001 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.74 72.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.22 109.078 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -64.42 -54.57 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 1.29 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.84 -29.05 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 2.2 109.599 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.89 -5.7 57.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.226 -0.921 . . . . 0.33 109.588 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 47.25 59.39 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 2.34 110.2 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.7 t -78.92 136.6 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.145 -0.972 . . . . 0.28 109.061 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -123.46 -7.77 8.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.47 -0.769 . . . . 2.4 109.778 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.11 132.47 11.98 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.943 -1.098 . . . . 0.22 109.945 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.73 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -110.79 151.37 42.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.278 -1.008 . . . . 0.22 108.278 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -76.59 144.38 78.82 Favored 'Cis proline' 0 N--CA 1.484 0.922 0 C-N-CA 124.747 -0.939 . . . . 0.2 110.281 -1.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.9 122.34 46.0 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.529 -0.915 . . . . 0.18 108.529 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -98.21 122.73 41.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.15 109.031 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.53 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.4 mt-30 -120.31 133.35 55.47 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.91 -1.144 . . . . 1.03 107.91 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 24' ' ' VAL . 17.4 m-85 -107.68 124.82 50.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.11 109.346 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.76 157.42 35.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.891 -0.781 . . . . 0.17 108.891 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -153.85 123.19 6.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.639 -1.245 . . . . 1.48 107.639 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 55.72 31.67 17.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.67 109.284 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.59 6.84 88.87 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.285 -1.126 . . . . 0.22 110.285 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -112.01 143.52 42.88 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.35 -1.088 . . . . 2.08 110.605 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -84.31 141.94 30.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 1.7 109.58 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.99 -9.48 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.52 -0.737 . . . . 0.26 110.528 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.05 168.71 36.01 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.41 -1.376 . . . . 0.18 110.596 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.0 152.93 2.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -1.08 . . . . 2.04 110.416 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.4 p90 -169.05 134.07 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.14 110.267 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.81 -174.33 2.52 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.074 -1.017 . . . . 0.17 109.168 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.82 132.11 6.29 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.382 -1.487 . . . . 0.13 109.382 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.91 94.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.2 110.137 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.31 70.54 1.37 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.822 -1.177 . . . . 1.15 107.822 178.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.77 -33.15 73.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.379 -0.826 . . . . 1.19 110.603 -178.511 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.04 -27.03 68.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.946 -1.097 . . . . 1.95 109.055 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -71.14 -37.61 72.26 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.546 -0.722 . . . . 2.05 110.063 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.0 mt -52.28 -36.11 51.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.666 -1.271 . . . . 0.15 108.866 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -66.91 -54.88 17.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 2.15 109.457 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.75 93.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.15 110.355 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.2 m -65.51 -44.89 85.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.161 -0.962 . . . . 0.13 109.916 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.3 mt -60.43 -52.88 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.18 108.764 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -61.76 -16.01 45.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 1.03 109.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -77.22 -59.03 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 2.02 110.115 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.04 18.69 7.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.443 -0.786 . . . . 0.35 110.246 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 1.18 109.404 179.822 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.682 HH11 HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.501 2.095 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.73 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.23 -167.22 1.78 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.105 -0.997 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.51 148.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.833 0.825 . . . . 0.0 112.357 -177.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 24.1 m -100.89 93.02 5.31 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.49 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 6.2 pt-20 -83.38 43.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.0 -1.062 . . . . 0.0 110.364 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.55 -130.18 0.04 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.08 24.05 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.407 1.604 . . . . 0.0 109.325 178.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.649 -179.699 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.24 0.543 . . . . 0.3 109.681 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -154.24 118.0 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.833 . . . . 1.97 108.886 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.421 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 19.5 tt0 -89.5 134.63 34.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.98 109.961 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.3 mm -105.09 121.24 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 5.8 mp0 -101.98 -16.89 16.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.085 -1.01 . . . . 1.97 109.471 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.6 p -153.13 155.58 37.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.23 109.137 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -50.74 -21.77 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 1.9 109.337 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 m -61.5 -47.46 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.989 . . . . 0.25 109.31 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.85 -22.99 62.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.2 109.838 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.34 -65.76 0.62 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.21 109.868 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -55.27 -45.09 76.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 2.47 109.67 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -58.03 -36.17 72.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.172 -0.955 . . . . 2.1 109.594 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -59.76 -45.98 90.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 0.2 109.17 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.26 -45.42 84.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.446 -0.784 . . . . 0.62 109.92 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.34 -40.58 97.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 1.09 109.886 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -15.38 58.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.3 109.516 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.97 -7.46 35.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.24 109.553 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.08 -110.58 3.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.445 . . . . 0.28 109.486 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -138.67 2.98 2.25 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.436 -1.038 . . . . 2.21 109.52 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 84.4 mttt -70.06 171.71 9.13 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.997 -1.065 . . . . 1.9 109.134 179.591 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.06 160.5 20.86 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.468 -0.938 . . . . 0.17 108.468 -179.555 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.639 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.7 t -143.38 104.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.04 . . . . 0.12 109.254 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.19 127.88 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.09 108.799 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.66 135.52 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.668 -0.645 . . . . 0.17 109.402 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -107.64 101.43 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.912 -0.773 . . . . 0.96 108.912 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -84.82 82.6 8.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.813 -1.181 . . . . 0.24 107.813 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -113.38 149.06 34.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.717 -0.615 . . . . 1.03 109.602 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.0 127.25 36.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.517 -0.92 . . . . 0.26 108.517 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -66.59 -28.46 68.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.356 -0.84 . . . . 0.32 111.081 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 62.1 p-90 -87.55 -10.28 52.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.887 -1.133 . . . . 0.44 110.218 -179.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.48 135.97 37.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.32 109.532 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.78 -56.9 3.68 Favored Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.501 -0.75 . . . . 0.36 112.035 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -46.31 -39.1 21.18 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.673 1.582 . . . . 0.44 111.721 -177.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.59 -53.97 7.75 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.73 -1.231 . . . . 0.81 108.823 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.87 -19.85 53.69 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.624 -0.672 . . . . 1.92 109.791 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -59.42 -19.15 45.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 3.13 110.504 -179.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.25 12.97 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.053 -1.029 . . . . 0.28 111.112 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.06 -32.98 4.47 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 119.98 -1.7 . . . . 1.62 112.362 179.328 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.1 Cg_exo -66.43 -0.03 3.91 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 CA-C-N 119.571 0.882 . . . . 0.25 110.519 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.64 -74.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.511 -0.743 . . . . 0.3 109.179 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -42.45 -52.57 4.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.66 -0.65 . . . . 0.13 110.495 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.11 -32.6 73.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.41 109.72 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 46' ' ' SER . 59.7 p -62.37 -44.13 97.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.813 -1.179 . . . . 0.97 109.879 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -51.33 -15.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.109 -0.994 . . . . 0.5 109.233 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.411 ' N ' ' C ' ' A' ' 44' ' ' SER . 28.9 m -57.19 -38.49 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.51 109.698 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -94.95 -16.76 22.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.12 -0.987 . . . . 2.0 110.473 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -88.91 -19.81 25.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 2.16 109.234 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.66 73.15 1.47 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.513 -0.742 . . . . 0.24 109.135 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.46 -5.07 13.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.17 109.273 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -96.24 8.32 44.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.34 109.713 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.05 148.42 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.12 109.454 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -100.2 129.74 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.17 109.055 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.8 m-85 -116.79 130.34 56.66 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.485 -0.759 . . . . 0.11 109.446 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.01 171.41 7.62 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -143.42 147.78 35.13 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.893 -1.151 . . . . 1.31 107.893 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.37 144.55 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.0 -1.062 . . . . 0.14 111.114 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.57 103.17 15.09 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.59 -1.263 . . . . 1.08 107.59 178.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.657 HG21 HG21 ' A' ' 74' ' ' THR . 2.3 m -64.84 -3.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.27 112.766 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 59' ' ' VAL . 1.6 m-20 -120.45 -33.28 3.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.73 -1.232 . . . . 1.11 110.909 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.23 -21.55 18.39 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.782 -1.199 . . . . 1.12 108.678 179.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.03 45.63 1.15 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.589 -1.263 . . . . 0.17 107.589 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.466 ' NE2' ' N ' ' A' ' 64' ' ' ASP . 3.7 pp0? -52.74 -15.12 0.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.781 -0.574 . . . . 2.22 110.767 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' N ' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -70.02 -38.78 76.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.868 -1.145 . . . . 1.11 108.89 179.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.65 -47.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.19 108.663 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.08 -35.48 80.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.22 109.129 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -63.49 -46.46 86.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.862 . . . . 1.29 109.03 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.99 -38.42 90.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 2.2 109.682 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.37 -6.19 56.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.33 110.132 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 66' ' ' ALA . 65.3 mt-10 48.8 58.29 5.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.056 -1.027 . . . . 2.34 110.192 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.6 t -79.27 135.25 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.114 -0.991 . . . . 0.28 109.089 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -127.36 -1.55 6.29 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.374 -0.829 . . . . 2.4 110.063 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 125.15 8.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.999 -1.063 . . . . 0.22 108.944 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.72 HG23 ' CE2' ' B' ' 5' ' ' TYR . 4.6 p -111.08 152.29 43.61 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.889 -0.782 . . . . 0.22 108.889 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.12 143.15 74.53 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 C-N-CA 124.775 -0.927 . . . . 0.2 109.948 -2.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -113.34 109.62 19.0 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.235 -1.024 . . . . 0.18 108.235 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.1 m-85 -87.02 117.85 26.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.15 108.778 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -115.72 135.15 54.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.57 -1.27 . . . . 1.03 107.57 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.3 m-85 -109.95 127.21 54.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.617 -0.677 . . . . 0.11 109.706 -178.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.47 157.98 35.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.457 -0.942 . . . . 0.17 108.457 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -155.0 123.81 6.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.48 107.95 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.19 25.39 9.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.591 -0.693 . . . . 1.67 109.228 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.596 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 85.5 4.0 86.09 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.132 -1.187 . . . . 0.22 110.132 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.596 HE21 ' C ' ' A' ' 83' ' ' GLY . 13.8 mm-40 -109.73 145.48 36.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.286 -1.126 . . . . 2.08 110.137 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -86.8 141.21 29.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 1.7 109.039 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.06 -20.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.486 -0.759 . . . . 0.26 110.323 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 173.15 45.55 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.386 -1.388 . . . . 0.18 110.53 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -174.05 151.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -1.047 . . . . 2.04 109.802 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -169.05 133.5 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.297 -0.877 . . . . 0.14 110.149 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -103.56 -163.39 0.98 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.255 -0.903 . . . . 0.17 108.967 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.91 131.61 2.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.361 -1.496 . . . . 0.13 109.361 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.495 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.53 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -1.213 . . . . 0.2 110.852 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.29 78.32 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.772 -1.195 . . . . 1.15 107.772 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.488 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.04 -34.89 79.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 1.19 110.833 -178.494 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.8 -25.78 68.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.879 -1.138 . . . . 1.95 109.23 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -68.85 -37.45 79.14 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 2.05 109.404 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.7 mt -52.46 -35.68 53.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.948 -1.095 . . . . 0.15 108.689 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.0 -58.79 4.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 2.15 109.584 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.34 83.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.15 110.628 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.7 m -66.97 -44.81 79.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.049 -1.032 . . . . 0.13 109.938 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.7 mt -60.99 -52.56 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.18 109.128 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -60.8 -17.22 48.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 1.03 109.407 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -77.66 -62.54 1.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 2.02 110.3 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.59 23.09 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 0.35 110.617 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.996 -1.065 . . . . 1.18 109.239 179.562 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.72 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -121.61 -167.0 1.45 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.837 -1.164 . . . . 0.0 110.334 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.48 151.11 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 112.018 -177.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 m -101.78 95.42 6.4 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.424 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.9 pt-20 -83.43 45.85 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.937 -1.102 . . . . 0.0 109.966 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.12 -134.68 0.07 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.983 -2.447 . . . . 0.0 106.983 178.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.76 24.39 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 CA-C-N 119.212 1.506 . . . . 0.0 108.441 178.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.6 t . . . . . 0 N--CA 1.486 1.364 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 19.8 t . . . . . 0 N--CA 1.495 1.785 0 N-CA-C 109.499 -0.556 . . . . 0.3 109.499 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -153.36 119.36 5.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.16 -0.962 . . . . 1.97 108.726 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -86.72 139.79 30.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.98 109.911 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mm -110.03 119.49 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.961 -1.126 . . . . 0.19 107.961 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 6.7 mp0 -105.4 -17.34 14.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -0.898 . . . . 1.97 109.705 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.7 p -151.74 161.39 42.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.035 -1.041 . . . . 0.23 110.128 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -53.01 -32.14 44.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.736 . . . . 1.9 109.966 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -59.44 -43.69 93.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.25 109.98 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.0 64.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.855 . . . . 0.2 109.943 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.69 -63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.21 110.04 -179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 2.47 109.638 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -58.7 -35.5 72.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.257 -0.902 . . . . 2.1 109.933 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.39 94.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.2 109.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.45 -44.02 97.42 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.853 . . . . 0.62 109.649 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.1 -38.36 90.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 1.09 109.851 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.62 -19.88 44.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.3 109.646 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -2.9 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.24 109.74 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 -136.34 32.39 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.211 -1.556 . . . . 0.28 109.211 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m-20 -116.6 5.65 13.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.38 -1.07 . . . . 2.21 109.621 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -70.18 170.92 10.62 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.206 -0.934 . . . . 1.9 109.127 179.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.27 161.7 18.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.855 -1.165 . . . . 0.17 107.855 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.633 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -145.13 105.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.891 -1.131 . . . . 0.12 109.632 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.7 t -103.41 128.81 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.788 -0.819 . . . . 0.09 108.788 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.01 139.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.598 -0.689 . . . . 0.17 109.649 -178.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -109.54 98.42 7.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.293 -0.632 . . . . 0.96 109.293 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.0 m-85 -83.42 83.43 7.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.568 -1.271 . . . . 0.24 107.568 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 m -110.38 -163.28 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.514 0.673 . . . . 1.03 109.381 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.97 120.26 13.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.341 -0.985 . . . . 0.26 108.341 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.0 t -63.57 -25.02 68.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.32 110.934 -178.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -89.27 -12.79 39.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.931 -1.106 . . . . 0.44 110.093 -179.369 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.6 134.33 39.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.32 109.776 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.65 -55.5 5.97 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.809 -0.71 . . . . 0.36 111.492 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -51.4 -32.83 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.663 1.575 . . . . 0.44 111.085 -178.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -62.26 1.71 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.058 -1.026 . . . . 0.81 108.905 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -59.72 -21.17 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.77 . . . . 1.92 110.03 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.9 ttm -59.61 -18.24 39.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.97 . . . . 3.13 110.296 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 38' ' ' ILE . 95.6 mt -99.45 7.57 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.951 . . . . 0.28 110.722 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -32.2 3.52 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 118.429 -1.308 . . . . 1.62 112.519 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_exo -61.22 -6.05 6.02 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 CA-C-N 119.979 1.028 . . . . 0.25 109.706 -178.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -110.82 -76.29 0.61 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.968 -0.753 . . . . 0.3 108.968 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -42.72 -56.99 2.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.531 -0.73 . . . . 0.13 110.726 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.51 -31.79 72.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.007 -1.058 . . . . 0.41 110.013 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.6 t -64.33 -40.82 96.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.743 -1.223 . . . . 0.97 110.163 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.51 -14.31 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.5 109.469 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.52 -38.0 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.078 -1.014 . . . . 0.51 109.537 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -93.63 -12.23 29.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 2.0 110.054 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -51.67 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.029 -1.1 . . . . 2.16 108.029 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -107.34 75.72 1.04 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.545 -0.722 . . . . 0.24 109.607 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.7 p -66.79 -3.68 7.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.17 108.618 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -95.77 -0.74 50.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.595 -0.69 . . . . 0.34 109.372 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.28 147.07 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.362 0.601 . . . . 0.12 109.614 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.22 134.72 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.17 109.268 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.3 m-85 -121.62 131.3 54.03 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.507 -0.745 . . . . 0.11 109.237 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.89 172.71 6.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.282 -0.886 . . . . 0.12 108.777 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -142.79 138.7 30.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.149 -1.056 . . . . 1.31 108.149 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.29 136.74 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.243 -0.91 . . . . 0.14 110.593 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.78 100.69 12.22 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.855 -1.165 . . . . 1.08 107.855 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.18 -6.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.27 110.885 -178.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.43 -42.31 5.49 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.123 -0.986 . . . . 1.11 110.712 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -94.28 -12.43 28.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.094 -1.004 . . . . 1.12 109.624 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.73 48.67 1.74 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.536 -0.913 . . . . 0.17 108.536 179.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.641 ' CG ' HH12 ' B' ' 4' ' ' ARG . 21.6 mt-30 -56.34 -16.47 5.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 2.22 110.321 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.3 p30 -70.49 -39.59 74.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.015 -1.053 . . . . 1.11 109.442 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.9 -46.03 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.153 -0.967 . . . . 0.19 108.679 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.357 -0.839 . . . . 0.22 109.003 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -64.28 -46.8 82.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 1.29 109.155 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -64.18 -38.09 89.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 2.2 109.761 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.54 -3.36 58.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.33 109.777 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.75 59.18 4.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 2.34 110.002 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 17.2 t -79.22 136.58 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.127 -0.983 . . . . 0.28 109.163 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -128.04 -4.35 5.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.431 -0.793 . . . . 2.4 110.019 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.85 126.8 8.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.014 -1.054 . . . . 0.22 109.322 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.6 p -110.76 151.66 43.01 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.746 -0.835 . . . . 0.22 108.746 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.58 142.77 74.07 Favored 'Cis proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.887 -0.88 . . . . 0.2 110.076 -1.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.17 111.63 21.87 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.965 -1.124 . . . . 0.18 107.965 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.7 m-85 -86.99 119.87 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.038 -1.065 . . . . 0.15 109.264 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 41.4 mt-30 -117.05 135.71 53.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.575 -1.268 . . . . 1.03 107.575 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 19.9 m-85 -109.0 127.45 54.09 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.496 0.665 . . . . 0.11 109.816 -177.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -125.37 156.02 39.41 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.516 -0.92 . . . . 0.17 108.516 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -155.1 123.34 5.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.169 -1.048 . . . . 1.48 108.169 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt 54.48 30.61 13.23 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.768 -0.773 . . . . 1.67 110.012 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.94 90.52 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.074 -1.06 . . . . 0.22 110.48 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -112.46 146.25 38.76 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.312 -1.111 . . . . 2.08 110.036 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -86.18 143.63 27.89 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.361 -0.837 . . . . 1.7 109.246 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.0 m -126.94 -19.51 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.26 110.449 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.58 178.07 47.67 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.305 -1.426 . . . . 0.18 110.524 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -174.11 154.11 2.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -1.061 . . . . 2.04 110.113 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.5 p90 -168.46 131.18 1.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.14 110.171 178.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 p -102.21 -162.35 0.92 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.246 -0.909 . . . . 0.17 108.96 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 129.82 1.21 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.075 -1.61 . . . . 0.13 109.075 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.561 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.6 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -1.226 . . . . 0.2 110.213 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.23 67.33 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.888 -1.152 . . . . 1.15 107.888 178.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 12.4 ptpt -58.13 -37.45 74.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.837 -0.539 . . . . 1.19 110.652 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.97 -26.54 68.34 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.95 109.611 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -70.3 -33.39 71.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 2.05 109.835 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.5 mt -53.19 -33.88 54.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.801 -1.187 . . . . 0.15 108.656 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -67.36 -55.6 13.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 2.15 109.35 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.8 94.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.15 110.648 -179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -65.49 -45.1 84.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.037 -1.039 . . . . 0.13 109.876 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.91 -53.23 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.18 108.838 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.44 -16.45 36.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 1.03 109.593 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.76 -60.65 2.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 2.02 110.064 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.76 20.79 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.35 110.16 -178.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.023 -1.048 . . . . 1.18 109.317 179.598 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.641 HH12 ' CG ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.705 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.719 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -123.42 -167.2 1.57 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.916 -1.115 . . . . 0.0 110.233 179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 148.98 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.831 0.825 . . . . 0.0 112.154 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -100.88 95.59 6.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -82.91 43.4 0.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.052 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.59 -132.59 0.07 OUTLIER Glycine 0 N--CA 1.484 1.836 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.85 26.51 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 119.328 1.564 . . . . 0.0 109.161 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.8 t . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.789 . . . . 0.0 109.502 -179.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 3' ' ' LYS . 71.2 t . . . . . 0 N--CA 1.495 1.801 0 CA-C-O 121.211 0.529 . . . . 0.3 109.592 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.5 tttp -154.29 122.33 5.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.949 . . . . 1.97 109.199 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -88.99 139.0 30.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.98 109.482 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.96 106.99 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.273 -1.01 . . . . 0.19 108.273 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -100.1 -6.81 25.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.017 -1.052 . . . . 1.97 109.616 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -152.61 152.08 31.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -0.968 . . . . 0.23 109.601 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -52.04 -28.6 17.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 1.9 109.951 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -60.12 -45.13 94.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.25 110.241 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.74 64.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.2 110.114 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.45 -69.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.21 110.197 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -55.73 -41.37 73.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 2.47 109.808 -179.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.78 -38.55 78.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.223 -0.923 . . . . 2.1 109.848 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.87 -46.06 92.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.2 109.305 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.38 -45.08 89.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.386 -0.821 . . . . 0.62 109.832 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.95 -40.37 96.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 1.09 109.748 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -13.99 59.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.3 109.734 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -6.92 28.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.24 109.809 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.88 -111.96 4.14 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.409 . . . . 0.28 109.576 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -138.03 4.32 2.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.39 -1.064 . . . . 2.21 109.268 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -71.03 166.44 21.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 1.9 109.153 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.02 161.37 13.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.15 -0.969 . . . . 0.17 108.688 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.0 t -144.0 106.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.856 -1.153 . . . . 0.12 109.489 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.96 132.64 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.108 -1.071 . . . . 0.09 108.108 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.26 139.37 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.548 -0.72 . . . . 0.17 110.002 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -109.33 101.89 10.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.929 -0.767 . . . . 0.96 108.929 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 57' ' ' VAL . 41.1 m-85 -86.35 79.11 9.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.24 107.708 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -113.45 149.56 34.06 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.324 0.583 . . . . 1.03 109.745 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.23 128.48 38.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.26 108.73 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.6 t -66.29 -25.17 66.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.32 110.241 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.414 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 55.0 p-90 -87.98 -14.34 39.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.033 -1.042 . . . . 0.44 109.958 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.37 125.88 40.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.32 109.487 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.61 -54.13 20.75 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.48 -0.762 . . . . 0.36 111.437 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.51 -32.6 21.21 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.912 1.741 . . . . 0.44 110.88 -178.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.02 -61.79 1.86 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.81 109.057 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -59.8 -17.87 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.537 -0.727 . . . . 1.92 110.033 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.11 -25.75 61.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 3.13 110.387 -178.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 38' ' ' ILE . 90.8 mt -97.54 9.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.123 -0.985 . . . . 0.28 110.819 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.93 -32.57 6.86 Favored Pre-proline 0 N--CA 1.484 1.264 0 O-C-N 120.425 -1.422 . . . . 1.62 111.846 178.772 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.18 -5.24 7.62 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 119.7 0.929 . . . . 0.25 110.102 -177.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -112.37 -71.59 0.75 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.957 -0.757 . . . . 0.3 108.957 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -45.69 -56.76 4.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.13 110.457 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.59 -31.97 73.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.41 110.044 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -64.18 -38.84 92.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.97 110.184 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.9 mt -51.39 -12.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 0.5 109.547 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 44' ' ' SER . 67.1 m -57.92 -32.89 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.956 -1.09 . . . . 0.51 109.625 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.37 -19.45 19.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.193 -0.942 . . . . 2.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.81 -22.16 21.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 2.16 109.525 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -134.26 68.41 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.479 -0.763 . . . . 0.24 109.292 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.4 p -67.28 -4.79 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.795 . . . . 0.17 109.164 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.51 0.21 52.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.825 . . . . 0.34 109.62 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.17 151.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.047 -0.723 . . . . 0.12 109.047 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -101.22 126.5 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 0.17 109.311 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.617 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.8 m-85 -112.96 130.87 55.97 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.39 -0.819 . . . . 0.11 109.16 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -115.17 173.77 6.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.459 -0.775 . . . . 0.12 109.055 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.29 141.1 28.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.03 -1.1 . . . . 1.31 108.03 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 27' ' ' PHE . 76.9 t -137.17 139.44 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.2 -0.937 . . . . 0.14 110.443 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -99.57 108.07 20.38 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.089 -1.078 . . . . 1.08 108.089 178.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.407 HG11 ' OH ' ' B' ' 5' ' ' TYR . 33.3 m -68.33 -8.5 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.257 -0.902 . . . . 0.27 111.23 -178.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.414 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -104.6 -38.67 6.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.992 -1.067 . . . . 1.11 110.919 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -95.59 -17.67 21.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.058 . . . . 1.12 110.131 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.25 1.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.509 -0.923 . . . . 0.17 108.509 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -54.26 -15.37 1.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.607 -0.683 . . . . 2.22 110.237 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.3 p30 -70.4 -40.28 74.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.905 -1.122 . . . . 1.11 109.53 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.09 -47.22 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -0.924 . . . . 0.19 108.729 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.55 -31.21 72.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.22 109.352 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 15.1 m -63.79 -52.49 60.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 1.29 109.288 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.17 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 2.2 109.466 179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.44 -2.69 58.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.33 109.582 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 67' ' ' SER . 21.3 mp0 43.98 52.09 6.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.825 . . . . 2.34 110.083 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -77.99 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.28 108.944 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.439 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 83.8 mttt -125.58 5.79 7.55 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.531 -0.73 . . . . 2.4 109.68 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 138.0 17.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.112 -0.993 . . . . 0.22 108.806 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.482 HG23 ' CE2' ' B' ' 5' ' ' TYR . 65.0 p -123.88 149.7 60.38 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 108.865 -0.791 . . . . 0.22 108.865 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.02 144.78 76.88 Favored 'Cis proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.959 -0.851 . . . . 0.2 110.422 -1.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.21 114.74 26.41 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.576 -1.268 . . . . 0.18 107.576 178.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.719 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.7 m-85 -90.2 123.93 34.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 0.15 108.747 179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.414 HE22 ' HB1' ' A' ' 69' ' ' ALA . 34.0 mt-30 -121.87 136.52 54.93 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 1.03 107.676 -179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.44 124.22 51.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.475 0.655 . . . . 0.11 109.426 -178.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -124.02 155.56 38.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.688 -0.856 . . . . 0.17 108.688 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -155.48 124.36 6.11 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 1.48 107.42 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mttt 57.96 25.4 12.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.623 . . . . 1.67 109.821 -178.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 6.69 86.56 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.219 -1.152 . . . . 0.22 110.219 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -114.47 147.93 38.58 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.357 -1.084 . . . . 2.08 110.101 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -85.33 141.26 30.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 1.7 109.162 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.31 -18.54 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.452 -0.78 . . . . 0.26 110.221 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 171.79 44.89 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.6 -1.286 . . . . 0.18 110.389 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -174.09 151.93 1.79 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.417 -1.049 . . . . 2.04 110.233 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.7 p90 -168.97 130.91 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.667 0.746 . . . . 0.14 110.316 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -101.27 -162.16 0.91 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.035 -1.041 . . . . 0.17 108.685 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.1 128.5 1.32 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.249 -1.541 . . . . 0.13 109.249 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.87 97.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.2 110.866 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -141.06 77.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.984 -1.117 . . . . 1.15 107.984 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -64.76 -42.66 94.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.81 -0.556 . . . . 1.19 111.579 -178.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.81 -24.97 67.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.877 -1.139 . . . . 1.95 110.059 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -68.04 -34.48 76.55 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.052 -1.03 . . . . 2.05 109.497 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.4 mt -52.08 -34.44 43.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.998 -1.063 . . . . 0.15 109.008 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.31 -57.74 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.77 . . . . 2.15 109.49 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.18 86.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.15 110.546 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 m -66.98 -45.32 78.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -0.942 . . . . 0.13 109.973 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.51 -52.89 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.18 108.79 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 102' ' ' ASN . 23.5 t-20 -60.62 -16.93 43.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 1.03 109.859 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.89 -55.99 5.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.895 . . . . 2.02 110.463 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -94.38 10.75 33.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.329 -0.857 . . . . 0.35 110.872 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.704 -1.248 . . . . 1.18 109.269 179.721 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.482 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.0 -176.11 3.83 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.354 -0.842 . . . . 0.0 110.18 179.446 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.38 146.23 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.964 0.888 . . . . 0.0 112.821 -176.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.01 95.78 6.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.15 45.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 110.188 -178.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.24 -132.63 0.1 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 177.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.47 22.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 CA-C-N 118.95 1.375 . . . . 0.0 109.065 178.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.1 t . . . . . 0 N--CA 1.486 1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.34 -179.735 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 3' ' ' LYS . 85.3 t . . . . . 0 N--CA 1.495 1.805 0 N-CA-C 109.297 -0.631 . . . . 0.3 109.297 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.2 tptp -155.02 125.55 6.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.268 -0.895 . . . . 1.97 109.09 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -90.73 135.45 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.98 109.792 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -110.16 113.92 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.994 -1.113 . . . . 0.19 107.994 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -103.27 -13.05 16.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 1.97 109.657 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.5 p -152.9 156.99 40.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.23 109.91 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.8 -32.62 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 1.9 110.163 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -58.95 -44.24 91.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.065 . . . . 0.25 109.492 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.41 64.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.2 109.448 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.6 -70.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.21 109.996 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -42.56 71.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 2.47 109.709 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -58.39 -37.76 75.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.022 -1.049 . . . . 2.1 109.278 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.74 93.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.2 108.678 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.59 -40.47 97.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 0.62 109.332 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.87 -42.56 97.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 1.09 109.383 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.58 59.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.3 109.533 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -6.33 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.24 109.751 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.71 -115.47 6.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.28 109.515 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -136.11 4.88 3.0 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -1.072 . . . . 2.21 109.349 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.5 mttp -71.0 169.14 15.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.246 -0.909 . . . . 1.9 109.163 179.638 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.26 162.43 14.74 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.17 108.088 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 18.7 t -144.73 109.01 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.826 -1.171 . . . . 0.12 109.397 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.29 132.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.533 -0.914 . . . . 0.09 108.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.75 131.34 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.17 109.557 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.76 107.51 18.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.96 109.443 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.2 m-85 -88.72 81.36 7.04 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.116 -1.068 . . . . 0.24 108.116 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -113.72 152.35 30.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.736 -0.602 . . . . 1.03 109.559 -179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -92.72 123.16 35.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.721 -0.844 . . . . 0.26 108.721 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 58' ' ' ASP . 7.2 t -65.54 -20.87 66.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.32 109.746 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.479 ' CD1' ' HB1' ' A' ' 29' ' ' ALA . 50.6 p-90 -89.5 -18.15 27.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.231 -0.918 . . . . 0.44 109.934 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.6 143.97 25.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.32 110.029 -178.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -83.69 -57.23 2.47 Favored Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.684 -0.635 . . . . 0.36 111.628 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.3 Cg_exo -47.47 -41.56 29.23 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.85 1.7 . . . . 0.44 112.031 -177.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -58.61 3.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.816 -1.178 . . . . 0.81 109.02 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.32 -18.58 39.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.553 -0.717 . . . . 1.92 110.232 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 36.8 ttm -59.43 -18.39 38.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 3.13 110.309 -179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 38' ' ' ILE . 67.8 mt -100.35 14.15 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.037 -1.039 . . . . 0.28 111.276 -178.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.4 -34.95 12.41 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 117.957 -1.497 . . . . 1.62 111.946 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -61.64 -14.81 37.96 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 CA-C-N 119.707 0.931 . . . . 0.25 110.877 -175.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.8 -69.36 0.76 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.33 -0.856 . . . . 0.3 109.223 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -44.48 -51.55 8.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.618 -0.677 . . . . 0.13 110.725 -179.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -67.57 -35.28 78.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.878 -1.139 . . . . 0.41 109.585 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -60.32 -42.71 96.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.017 -1.052 . . . . 0.97 109.624 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -52.26 -21.72 3.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.5 109.563 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.5 m -57.3 -32.34 66.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.51 109.592 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -94.82 -19.49 20.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.142 -0.974 . . . . 2.0 110.083 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -91.28 -20.82 21.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 2.16 109.128 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.43 67.95 1.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.24 109.085 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.2 p -67.01 -3.84 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.465 -0.772 . . . . 0.17 109.243 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -94.43 -0.52 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.35 -0.844 . . . . 0.34 109.475 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.06 149.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.539 -0.726 . . . . 0.12 109.189 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -100.43 128.84 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.225 -0.922 . . . . 0.17 109.058 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.636 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.5 m-85 -114.63 131.8 56.59 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.413 -0.804 . . . . 0.11 109.173 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.5 mp -115.95 175.29 5.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.543 -0.723 . . . . 0.12 109.179 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -144.07 144.94 31.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.417 -0.957 . . . . 1.31 108.417 179.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.4 t -140.26 140.7 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.2 -0.938 . . . . 0.14 110.147 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' A' ' 30' ' ' THR . 8.1 t70 -99.44 100.46 11.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.615 -1.254 . . . . 1.08 107.615 178.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.14 -12.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.858 . . . . 0.27 111.217 -178.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -100.94 -42.81 6.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.85 -1.156 . . . . 1.11 111.173 -178.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.1 -10.47 35.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.12 109.569 -179.206 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.63 2.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.511 -0.922 . . . . 0.17 108.511 179.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -55.82 -14.32 2.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 2.22 109.87 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 5.5 p30 -70.44 -40.93 73.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.121 -0.987 . . . . 1.11 109.618 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.24 -46.22 45.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.19 108.699 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.03 73.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.22 109.309 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m -63.72 -52.35 60.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.29 109.53 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.82 -34.31 77.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 2.2 109.237 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.67 57.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.889 . . . . 0.33 109.516 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 44.99 50.7 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 2.34 109.911 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.12 129.85 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.28 109.445 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.449 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 67.9 mttm -129.93 8.86 5.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.502 -0.749 . . . . 2.4 109.511 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.04 133.79 14.79 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.22 108.274 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.555 HG23 ' CE2' ' B' ' 5' ' ' TYR . 33.8 p -120.38 150.05 51.03 Favored Pre-proline 0 N--CA 1.507 2.424 0 O-C-N 121.205 -0.934 . . . . 0.22 108.96 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.72 147.27 83.75 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 O-C-N 122.714 0.849 . . . . 0.2 110.539 -1.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.2 m -117.37 116.49 27.3 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.337 -1.357 . . . . 0.18 107.337 178.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.1 m-85 -93.06 122.08 35.07 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.312 -0.955 . . . . 0.15 108.653 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.501 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.5 mt-30 -119.16 137.4 53.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.729 -1.212 . . . . 1.03 107.729 -179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 26.3 m-85 -112.03 128.54 56.22 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.423 0.63 . . . . 0.11 110.04 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.09 159.85 32.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.851 -0.796 . . . . 0.17 108.851 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.11 122.81 5.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 179.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 57.24 24.44 9.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.78 -0.575 . . . . 1.67 110.301 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.4 5.0 76.3 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.354 -1.098 . . . . 0.22 110.354 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -113.4 146.13 40.01 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.303 -1.116 . . . . 2.08 110.236 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -85.98 145.07 27.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 1.7 109.363 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -126.54 -15.4 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.51 -0.744 . . . . 0.26 109.762 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.14 -179.14 41.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.584 -1.294 . . . . 0.18 110.581 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.2 161.19 4.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.457 -1.025 . . . . 2.04 110.049 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.8 p90 -169.04 132.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.14 110.218 178.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 p -104.58 -170.05 1.71 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.225 -0.922 . . . . 0.17 108.759 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 93.97 121.37 3.31 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.536 -1.426 . . . . 0.13 109.536 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.548 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.44 91.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -1.146 . . . . 0.2 110.432 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' GLY . 13.6 t-20 -140.04 78.07 1.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.119 -1.067 . . . . 1.15 108.119 178.605 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.91 -34.7 78.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.696 -0.627 . . . . 1.19 110.608 -178.861 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.7 -26.07 67.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.816 -1.177 . . . . 1.95 109.187 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HB2' ' HZ3' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.66 -35.41 78.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.425 -0.797 . . . . 2.05 109.124 179.548 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.628 HD21 ' CD1' ' A' ' 77' ' ' PHE . 44.6 mt -51.87 -37.69 53.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.15 108.783 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.37 -57.6 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 2.15 109.896 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.64 83.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.15 110.477 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -67.76 -45.22 75.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.074 -1.016 . . . . 0.13 110.29 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.22 -52.56 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.934 . . . . 0.18 109.331 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.26 -17.9 45.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 1.03 109.674 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.01 -59.41 2.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.871 . . . . 2.02 110.476 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -93.69 18.96 9.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.348 -0.845 . . . . 0.35 110.794 -178.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.412 ' OXT' HG22 ' A' ' 105' ' ' VAL . 8.3 p . . . . . 0 N--CA 1.494 1.728 0 O-C-N 120.941 -1.099 . . . . 1.18 109.303 179.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -109.5 -174.59 2.54 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.176 -0.953 . . . . 0.0 110.796 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.1 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 122.191 0.996 . . . . 0.0 112.851 -176.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 61.3 m -101.05 93.75 5.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.674 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.0 pt-20 -84.1 44.42 1.01 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.102 -0.999 . . . . 0.0 110.904 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.68 -129.98 0.07 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.69 19.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.871 0 CA-C-N 119.447 1.623 . . . . 0.0 109.799 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.712 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 3' ' ' LYS . 44.7 t . . . . . 0 N--CA 1.495 1.81 0 N-CA-C 109.512 -0.551 . . . . 0.3 109.512 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.627 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.7 tptt -153.72 122.84 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -0.93 . . . . 1.97 109.116 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -90.05 129.4 36.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.98 109.462 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -102.05 120.15 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.291 -1.374 . . . . 0.19 107.291 178.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.62 -16.76 14.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.197 -0.939 . . . . 1.97 109.949 -179.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.8 p -152.47 160.15 43.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.056 -1.027 . . . . 0.23 109.801 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 35.0 tttp -52.09 -31.39 30.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.439 -0.788 . . . . 1.9 109.639 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -59.96 -47.25 86.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.25 110.093 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.72 -27.0 65.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.2 109.662 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.17 -68.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.21 109.838 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -53.53 -44.44 69.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 2.47 109.749 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -58.19 -37.0 73.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 2.1 109.619 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.77 92.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.2 109.094 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.5 -44.95 89.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.458 -0.776 . . . . 0.62 109.781 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.71 -41.28 99.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 1.09 109.686 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -13.6 59.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.3 109.467 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -5.71 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.24 109.722 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 68.23 -114.1 5.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.513 -1.435 . . . . 0.28 109.513 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 81.2 m-20 -136.55 4.07 2.83 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.265 -1.138 . . . . 2.21 109.447 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -69.65 170.09 11.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.072 -1.017 . . . . 1.9 108.94 179.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.43 163.12 13.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.172 -1.047 . . . . 0.17 108.172 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.3 t -145.42 104.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.825 -1.172 . . . . 0.12 109.359 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.7 t -101.61 130.41 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.09 108.882 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.37 133.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 0.17 109.644 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -107.04 102.98 12.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.585 -0.697 . . . . 0.96 109.448 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 57' ' ' VAL . 51.0 m-85 -84.87 82.69 8.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.758 -1.201 . . . . 0.24 107.758 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.68 148.62 36.01 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.594 -0.692 . . . . 1.03 109.89 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.89 122.74 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.267 -1.012 . . . . 0.26 108.267 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -64.95 -22.33 66.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.32 110.414 -178.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -90.34 -14.2 33.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.13 -0.981 . . . . 0.44 110.054 -179.4 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -94.23 128.56 40.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.32 110.04 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.06 -59.33 7.57 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.894 -0.67 . . . . 0.36 111.595 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.5 Cg_exo -46.11 -37.7 18.28 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.805 1.67 . . . . 0.44 111.941 -178.169 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.4 -55.6 5.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.714 -1.241 . . . . 0.81 108.756 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -60.6 -21.73 62.97 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.655 -0.653 . . . . 1.92 110.045 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.9 tpp -61.44 -18.52 59.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 3.13 110.379 -179.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -99.56 15.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.097 -1.002 . . . . 0.28 110.765 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.77 -33.41 3.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.163 -1.586 . . . . 1.62 112.452 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -63.14 -3.59 5.13 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.509 0.86 . . . . 0.25 110.302 -176.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.0 m-85 -110.46 -79.83 0.58 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.45 -0.781 . . . . 0.3 109.08 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 87.6 t80 -40.9 -54.57 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.13 111.024 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -66.86 -36.83 83.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.842 -1.162 . . . . 0.41 110.064 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.417 ' C ' ' N ' ' A' ' 46' ' ' SER . 81.8 p -61.34 -38.37 86.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.753 -1.217 . . . . 0.97 110.041 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.88 -14.3 0.37 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.5 109.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.417 ' N ' ' C ' ' A' ' 44' ' ' SER . 37.1 m -57.76 -36.5 72.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.176 -0.953 . . . . 0.51 109.636 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -94.35 -16.42 23.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.21 -0.931 . . . . 2.0 110.166 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.33 -22.83 20.33 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.003 -1.06 . . . . 2.16 109.331 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -135.34 66.66 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.415 -0.803 . . . . 0.24 109.151 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 p -66.64 -3.03 5.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.337 -0.852 . . . . 0.17 109.038 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.95 -2.27 53.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.34 109.263 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.64 148.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.055 -0.72 . . . . 0.12 109.055 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.5 125.26 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.414 -0.804 . . . . 0.17 109.338 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -111.21 129.07 56.07 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.355 -0.841 . . . . 0.11 109.365 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -111.3 173.73 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.444 -0.785 . . . . 0.12 109.078 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.79 147.94 33.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.307 -0.998 . . . . 1.31 108.307 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 27' ' ' PHE . 11.0 t -141.74 142.68 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.044 -1.035 . . . . 0.14 110.451 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 60' ' ' ASP . 10.1 t70 -98.78 90.94 4.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.969 -1.123 . . . . 1.08 107.969 178.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -52.59 -3.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 0.27 111.624 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 58' ' ' ASP . 30.3 m-20 -110.04 -40.66 4.67 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.034 -1.041 . . . . 1.11 110.982 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.61 -19.17 19.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.05 -1.031 . . . . 1.12 109.816 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.89 45.52 1.33 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.349 -0.844 . . . . 0.17 108.74 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -53.25 -13.46 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 2.22 109.852 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.9 p-10 -71.13 -41.44 70.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 1.11 109.459 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -74.08 -45.37 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.181 -0.949 . . . . 0.19 108.802 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -34.14 76.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.22 108.688 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -64.59 -46.13 84.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 1.29 109.075 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -63.65 -38.48 91.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 2.2 109.349 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.0 58.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.909 . . . . 0.33 109.874 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 49.6 59.19 4.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 2.34 109.743 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 19.5 t -79.13 137.44 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.28 109.489 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -130.4 -1.77 4.42 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.452 -0.78 . . . . 2.4 109.791 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.639 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.42 127.31 9.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.022 -1.049 . . . . 0.22 109.1 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.706 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.3 p -111.04 152.02 43.41 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 108.654 -0.869 . . . . 0.22 108.654 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.39 143.98 76.26 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 C-N-CA 124.75 -0.938 . . . . 0.2 109.935 -1.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 117.94 32.27 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.666 -0.865 . . . . 0.18 108.666 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.2 m-85 -93.26 122.68 35.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.15 108.886 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -120.19 133.09 55.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.804 -1.184 . . . . 1.03 107.804 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 18.1 m-85 -108.64 126.56 53.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.11 109.716 -178.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -124.05 158.79 31.36 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.512 -0.921 . . . . 0.17 108.512 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -154.93 123.46 6.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.753 -1.203 . . . . 1.48 107.753 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.583 ' NZ ' ' NE2' ' A' ' 84' ' ' GLN . 7.3 mtmp? 56.01 27.33 11.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.527 -0.733 . . . . 1.67 109.882 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.3 87.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.165 -1.017 . . . . 0.22 110.625 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.583 ' NE2' ' NZ ' ' A' ' 82' ' ' LYS . 35.6 mt-30 -109.98 147.48 33.41 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.329 -1.1 . . . . 2.08 110.191 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.442 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -86.03 142.46 28.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.868 . . . . 1.7 109.124 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.35 -17.25 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.528 -0.732 . . . . 0.26 110.358 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 176.14 174.24 42.49 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.455 -1.355 . . . . 0.18 110.351 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -172.9 155.49 3.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.388 -1.066 . . . . 2.04 109.937 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.5 p90 -168.41 133.55 1.73 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.303 -0.873 . . . . 0.14 110.342 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -104.07 -171.02 1.86 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.198 -0.939 . . . . 0.17 109.03 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.93 5.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.13 109.522 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.89 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -1.117 . . . . 0.2 110.424 -179.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -139.94 77.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.665 -1.235 . . . . 1.15 107.665 178.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.97 -33.95 76.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 1.19 110.687 -178.525 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -25.61 68.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.012 -1.055 . . . . 1.95 109.148 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -69.07 -37.6 78.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.328 -0.858 . . . . 2.05 109.333 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 77' ' ' PHE . 13.8 mt -54.19 -35.6 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.15 108.634 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -66.1 -58.89 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 2.15 109.461 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.0 90.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.15 110.494 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 m -65.25 -46.76 79.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.194 -0.941 . . . . 0.13 109.971 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.95 -52.32 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.183 -0.948 . . . . 0.18 108.88 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -61.4 -16.48 46.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 1.03 109.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.9 -60.13 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 2.02 109.91 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.3 mt -91.69 20.57 5.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.716 . . . . 0.35 110.28 -178.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 1.18 109.247 179.782 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.924 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -125.13 -170.82 2.23 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.062 -1.024 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.417 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -72.33 150.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.78 0.8 . . . . 0.0 112.148 -177.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.0 m -101.15 94.23 5.86 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.639 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.15 44.71 0.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 110.214 -178.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.95 -131.21 0.15 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 177.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -69.64 30.37 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 119.315 1.557 . . . . 0.0 109.215 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.568 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.5 t . . . . . 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 109.832 -179.551 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.8 t . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 121.421 0.629 . . . . 0.3 109.432 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.0 tptt -155.56 122.29 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 1.97 109.26 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.81 134.11 34.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.353 -0.842 . . . . 0.98 108.992 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.92 108.6 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.363 -0.977 . . . . 0.19 108.363 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.24 -11.21 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 1.97 109.308 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -152.57 153.05 32.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.23 109.462 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -52.39 -25.59 10.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.455 -0.778 . . . . 1.9 109.812 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -60.2 -47.34 86.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.25 109.797 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -26.21 64.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.2 109.644 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -59.7 -68.73 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.21 109.821 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.38 -41.39 72.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 2.47 109.849 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.0 -38.86 80.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.085 -1.009 . . . . 2.1 109.601 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.28 95.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.2 109.497 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.66 -46.66 84.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.62 110.117 -179.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.23 -43.21 95.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.997 . . . . 1.09 109.815 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 -12.8 59.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.3 109.917 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -8.55 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.24 109.551 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.99 -117.05 6.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.669 -1.373 . . . . 0.28 109.669 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 8.0 t0 -133.74 4.2 3.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.318 -1.107 . . . . 2.21 109.113 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -68.57 165.6 18.84 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.921 -1.112 . . . . 1.9 108.711 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.69 157.84 23.07 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.315 -0.994 . . . . 0.17 108.315 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.588 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.3 t -141.98 107.1 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.12 109.329 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.62 133.68 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.582 -0.895 . . . . 0.09 108.582 179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.21 133.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.17 109.529 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -104.88 102.26 11.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.609 -0.682 . . . . 0.96 109.202 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.463 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.8 m-85 -86.57 78.96 9.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.805 -1.183 . . . . 0.24 107.805 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -106.72 -164.47 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.532 0.682 . . . . 1.03 109.462 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.28 122.74 14.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.412 -0.959 . . . . 0.26 108.412 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -63.66 -25.11 68.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.76 . . . . 0.32 110.446 -178.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . . . . . . . . . 45.8 p-90 -88.33 -15.5 35.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 0.44 110.011 -179.203 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.74 129.08 43.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -0.908 . . . . 0.32 109.813 -179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.89 -54.03 8.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 111.205 -0.758 . . . . 0.36 111.205 -178.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.6 Cg_exo -48.54 -34.31 25.99 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.823 1.682 . . . . 0.44 111.156 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -58.79 3.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.81 109.16 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.8 -21.14 55.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 1.92 109.785 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.7 tmt? -58.2 -21.23 46.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 3.13 109.946 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.3 mt -97.08 2.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.252 -0.905 . . . . 0.28 110.224 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.16 -34.72 18.72 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 118.431 -1.308 . . . . 1.62 111.084 -179.483 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.5 Cg_endo -63.78 -5.96 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.691 0.926 . . . . 0.25 110.561 -177.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.446 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 41.9 m-85 -111.1 -73.43 0.68 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.848 -0.797 . . . . 0.3 108.848 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.48 -56.81 4.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.704 -0.623 . . . . 0.13 110.471 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.9 -31.9 72.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.41 110.083 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.5 t -63.99 -39.72 94.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.014 -1.054 . . . . 0.97 110.092 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 83.2 mt -50.74 -12.98 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.035 -1.04 . . . . 0.5 109.782 -179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.432 ' N ' ' C ' ' A' ' 44' ' ' SER . 16.4 m -57.78 -36.78 72.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.51 109.636 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -93.85 -17.16 23.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.864 . . . . 2.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -90.65 -23.42 20.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 2.16 109.117 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.11 71.8 1.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.696 . . . . 0.24 109.125 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -66.84 -3.32 6.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.17 108.988 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 21.7 t-20 -95.74 -0.07 51.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.516 -0.74 . . . . 0.34 109.514 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.53 148.66 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.239 -0.913 . . . . 0.12 109.6 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -101.07 123.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.882 -0.784 . . . . 0.17 108.882 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -112.18 132.26 55.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.244 -0.91 . . . . 0.11 109.655 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -114.29 172.08 7.23 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.772 -0.825 . . . . 0.12 108.772 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.23 140.77 29.47 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.345 -0.983 . . . . 1.31 108.345 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -139.25 138.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.138 -0.976 . . . . 0.14 110.193 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.47 108.68 21.43 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.635 -1.246 . . . . 1.08 107.635 177.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.14 -10.59 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.27 111.107 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 10.1 m-20 -103.71 -40.34 6.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.089 -1.007 . . . . 1.11 110.756 -178.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -93.88 -14.39 26.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.12 109.563 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.36 49.28 1.92 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.79 -0.818 . . . . 0.17 108.79 178.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -55.95 -11.24 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.432 -0.792 . . . . 2.22 110.19 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.924 -1.11 . . . . 1.11 109.546 -179.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.2 -46.34 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.19 108.886 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.85 70.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.822 . . . . 0.22 109.258 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -64.21 -58.29 7.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 1.29 109.48 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -62.67 -29.82 70.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 2.2 109.537 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.18 -5.78 58.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.159 -0.963 . . . . 0.33 109.544 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 43.58 52.84 6.05 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -0.756 . . . . 2.34 110.328 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 17.8 t -77.76 134.79 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.28 109.156 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.66 -0.39 8.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.411 -0.806 . . . . 2.4 110.194 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.594 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.01 133.93 15.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.063 -1.023 . . . . 0.22 109.261 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.69 HG23 ' CE2' ' B' ' 5' ' ' TYR . 21.8 p -118.25 150.75 48.27 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.311 -0.868 . . . . 0.22 108.934 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.412 ' CG ' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.13 145.16 81.69 Favored 'Cis proline' 0 C--N 1.319 -0.995 0 C-N-CA 124.555 -1.019 . . . . 0.2 110.131 -1.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.48 116.51 28.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.693 -1.225 . . . . 0.18 107.693 178.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.8 m-85 -93.66 116.03 28.51 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.363 -0.935 . . . . 0.15 108.603 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.463 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 31.8 mt-30 -116.18 139.95 49.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.163 -1.421 . . . . 1.03 107.163 179.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.06 132.22 54.36 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.719 . . . . 0.11 109.856 -176.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -126.93 154.94 43.84 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.327 -0.99 . . . . 0.17 108.327 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.444 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 33.3 tttp -157.02 123.26 4.9 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.632 -1.247 . . . . 1.48 107.632 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mttp 59.23 25.61 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 1.67 110.319 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.85 88.98 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.758 -1.337 . . . . 0.22 109.758 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -113.35 147.46 37.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.293 -1.121 . . . . 2.08 109.701 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -86.38 141.93 28.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 1.7 109.175 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 87' ' ' GLY . 27.9 m -118.23 -39.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.408 -0.808 . . . . 0.26 110.091 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -165.07 -176.99 37.23 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.911 -1.276 . . . . 0.18 109.911 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.2 pm0 -172.4 156.28 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 2.04 110.147 -179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.3 p90 -169.05 132.26 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.14 109.385 178.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 p -103.31 -161.23 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.17 108.743 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.05 137.67 2.56 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.492 -1.443 . . . . 0.13 109.492 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -65.89 92.21 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.25 -1.147 . . . . 0.2 110.577 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.66 74.82 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.888 -1.153 . . . . 1.15 107.888 177.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.49 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.73 -34.16 76.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 1.19 110.495 -177.946 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.5 -26.43 68.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -67.94 -38.41 82.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 2.05 109.428 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.7 mt -51.96 -37.68 53.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.958 . . . . 0.15 108.833 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.97 -58.29 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 2.15 109.31 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.95 86.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.407 -0.808 . . . . 0.15 110.416 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -67.62 -45.55 75.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.219 -0.925 . . . . 0.13 110.042 -178.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.08 -51.11 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.106 -0.996 . . . . 0.18 108.882 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -61.53 -17.03 53.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 1.03 109.488 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.3 -58.98 2.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 2.02 109.65 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.78 20.96 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.423 -0.798 . . . . 0.35 110.352 -178.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 1.18 109.209 179.373 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.57 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -128.76 -167.64 1.8 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 110.208 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.16 146.79 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 111.934 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.88 97.11 7.75 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -83.39 45.45 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.749 -179.172 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.68 -130.05 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 177.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.81 17.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 118.64 1.22 . . . . 0.0 109.784 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.2 t . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.548 -179.921 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t . . . . . 0 N--CA 1.496 1.828 0 CA-C-O 121.324 0.583 . . . . 0.3 109.802 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -154.39 118.78 4.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.314 -0.866 . . . . 1.97 108.921 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -88.76 135.78 33.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.98 109.829 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -106.69 113.06 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.615 -1.254 . . . . 0.19 107.615 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -100.07 -11.01 20.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.282 -0.886 . . . . 1.97 109.786 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 p -154.59 158.02 39.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.065 -1.022 . . . . 0.23 109.987 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LYS . . . . . 0.436 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 43.0 tttm -52.33 -23.78 6.44 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 1.9 109.697 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -61.95 -51.03 69.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.012 . . . . 0.25 110.293 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.99 -21.67 64.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.2 109.952 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.88 -64.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.99 -1.069 . . . . 0.21 109.714 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.62 -46.79 77.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 2.47 109.799 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.28 -34.82 70.94 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.273 -0.892 . . . . 2.1 110.142 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.62 -45.93 91.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.2 109.624 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.9 -51.76 60.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.54 -0.725 . . . . 0.62 109.646 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.28 -35.99 80.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 1.09 109.511 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.63 -16.08 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.3 109.458 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -20.64 64.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.158 -0.964 . . . . 0.24 109.469 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.45 -107.72 2.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.707 -1.357 . . . . 0.28 109.707 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.1 -2.2 1.88 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -1.039 . . . . 2.21 109.553 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -67.33 168.06 11.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.903 -1.123 . . . . 1.9 108.817 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.41 163.44 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.077 -1.083 . . . . 0.17 108.077 -179.987 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.636 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.39 103.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.869 -1.145 . . . . 0.12 109.648 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.9 130.87 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.78 -0.822 . . . . 0.09 108.78 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.76 135.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 0.17 109.608 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.8 101.64 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.783 -0.821 . . . . 0.96 108.783 179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -84.32 80.74 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.884 -1.154 . . . . 0.24 107.884 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.0 m -113.7 152.22 30.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.767 -0.583 . . . . 1.03 109.601 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.61 127.13 41.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.26 109.275 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -67.11 -25.61 66.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.823 . . . . 0.32 110.64 -179.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' TRP . . . . . 0.546 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 53.7 p-90 -87.45 -14.83 39.43 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.957 -1.09 . . . . 0.44 109.927 -179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 t -93.34 130.92 38.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.32 110.018 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.9 -59.24 6.1 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.875 -0.678 . . . . 0.36 111.48 -179.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -48.86 -35.91 32.4 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.795 1.663 . . . . 0.44 111.547 -178.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.92 -61.33 2.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.81 108.936 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -59.55 -20.27 54.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.561 -0.712 . . . . 1.92 109.986 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.1 ttt -62.09 -19.09 62.6 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.206 -0.934 . . . . 3.13 110.341 -179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -100.28 11.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.197 -0.94 . . . . 0.28 110.269 -179.076 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 4.5 ptmm? -71.42 -27.24 1.0 Allowed Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 120.212 -1.555 . . . . 1.62 111.844 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.4 Cg_exo -65.23 -4.39 9.12 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 120.641 1.265 . . . . 0.25 109.452 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -107.68 -79.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.693 -0.855 . . . . 0.3 108.693 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.6 t80 -40.19 -58.13 1.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 0.13 111.206 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.39 -33.59 76.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 0.41 110.322 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.5 p -66.33 -36.81 83.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.633 -1.292 . . . . 0.97 110.409 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.5 mt -50.52 -19.84 0.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.928 -1.107 . . . . 0.5 109.535 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 m -56.94 -21.73 32.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.966 -1.083 . . . . 0.51 109.977 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -97.22 -26.88 14.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.137 -0.977 . . . . 2.0 110.052 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -90.32 -18.61 25.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.046 -1.034 . . . . 2.16 109.412 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.35 62.44 1.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.528 -0.732 . . . . 0.24 109.247 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 p -66.72 -3.01 5.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.364 -0.835 . . . . 0.17 108.91 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -95.59 1.11 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.418 -0.801 . . . . 0.34 109.446 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.73 150.62 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.274 -0.639 . . . . 0.12 109.274 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.6 mm -98.89 123.49 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.426 -0.796 . . . . 0.17 109.078 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.3 m-85 -111.24 132.87 54.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.357 -0.839 . . . . 0.11 109.141 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.06 167.3 10.78 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.641 -0.874 . . . . 0.12 108.641 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.61 133.97 29.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.353 -1.351 . . . . 1.31 107.353 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.3 t -132.32 141.43 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.264 -0.897 . . . . 0.14 110.745 -177.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.56 101.35 12.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.422 -0.955 . . . . 1.08 108.422 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 74' ' ' THR . 16.4 m -61.42 -4.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.27 111.197 -178.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.546 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 38.3 m-20 -107.58 -41.97 4.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.253 -0.905 . . . . 1.11 110.554 -178.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.11 -21.8 18.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.0 . . . . 1.12 109.348 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.73 43.31 1.35 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.477 -0.935 . . . . 0.17 108.477 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.443 ' NE2' HH12 ' B' ' 4' ' ' ARG . 2.5 pt20 -53.81 -13.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.529 -0.732 . . . . 2.22 110.015 -179.426 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.43 -42.12 71.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.992 -1.067 . . . . 1.11 108.981 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.89 -46.02 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.711 -0.848 . . . . 0.19 108.711 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.38 -34.0 76.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.22 108.989 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 m -63.63 -48.21 78.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 1.29 108.962 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.94 -36.49 84.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 2.2 109.573 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.34 -7.71 54.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.232 -0.917 . . . . 0.33 109.648 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' ALA . 39.4 mt-10 47.72 62.97 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 2.34 110.323 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 t -79.0 137.75 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.28 108.918 179.12 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -125.26 -4.48 7.34 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.407 -0.808 . . . . 2.4 110.085 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.55 126.55 9.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.91 -1.119 . . . . 0.22 109.349 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.752 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.8 p -110.07 151.87 42.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.54 -0.911 . . . . 0.22 108.54 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -77.34 143.34 74.56 Favored 'Cis proline' 0 N--CA 1.483 0.875 0 C-N-CA 124.858 -0.892 . . . . 0.2 109.926 -1.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.58 114.7 26.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.421 -0.955 . . . . 0.18 108.421 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -89.08 125.57 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.864 -1.147 . . . . 0.15 108.833 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -122.84 132.23 54.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.825 -1.176 . . . . 1.03 107.825 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.7 m-85 -107.09 129.82 54.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.11 109.911 -178.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.61 157.29 42.49 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.17 108.71 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -155.11 127.01 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.265 . . . . 1.48 107.586 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 56.0 18.97 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 1.67 109.847 -178.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.65 3.08 69.12 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 120.836 -1.165 . . . . 0.22 110.447 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.68 147.23 34.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.356 -1.085 . . . . 2.08 109.822 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -85.51 144.86 27.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.335 -0.853 . . . . 1.7 109.384 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.65 -23.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.461 -0.775 . . . . 0.26 110.264 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.22 174.91 46.61 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.483 -1.342 . . . . 0.18 110.509 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.79 153.41 2.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -1.107 . . . . 2.04 110.094 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.7 p90 -168.74 132.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.14 110.46 179.079 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -103.37 -169.17 1.61 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.19 -0.944 . . . . 0.17 109.321 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.66 129.85 3.89 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 92' ' ' ALA . . . . . 0.487 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.97 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.196 -1.179 . . . . 0.2 110.365 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 74.82 1.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.109 -1.071 . . . . 1.15 108.109 178.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -34.27 77.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 1.19 110.83 -178.601 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -64.52 -25.74 68.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.834 -1.166 . . . . 1.95 109.282 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -68.54 -35.97 78.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 2.05 109.422 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.6 mt -51.83 -36.4 47.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.15 108.958 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.83 -58.17 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 2.15 109.863 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.1 84.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.36 -0.838 . . . . 0.15 110.844 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.9 m -67.18 -47.84 69.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.065 . . . . 0.13 110.273 -178.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.52 -51.09 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.18 108.983 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.28 -17.77 31.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 1.03 109.605 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -76.46 -62.22 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 110.015 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.09 22.38 4.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.546 -0.721 . . . . 0.35 110.518 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.884 -1.135 . . . . 1.18 109.226 179.408 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' B' B ' 4' ' ' ARG . . . . . 0.443 HH12 ' NE2' ' A' ' 63' ' ' GLN . 7.0 tpt180 . . . . . 0 N--CA 1.493 1.699 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 5' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.1 p90 -131.15 -165.26 1.54 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.099 -1.001 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 6' ' ' VAL . . . . . 0.406 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -80.35 152.54 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.255 -0.903 . . . . 0.0 112.379 -177.157 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m -102.02 95.61 6.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 8' ' ' GLU . . . . . 0.654 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.9 pt-20 -83.17 46.15 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 110.058 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.81 -131.44 0.11 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 177.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.62 25.45 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.279 1.539 . . . . 0.0 109.276 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 20.4 t . . . . . 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.4 mtm . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.52 -0.548 . . . . 2.89 109.52 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.46 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.6 t -94.63 161.81 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.298 -0.876 . . . . 0.3 109.306 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.46 ' N ' HG12 ' A' ' 2' ' ' VAL . 3.7 tmtm? -155.22 122.91 5.68 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.143 -0.973 . . . . 1.97 108.892 179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -89.61 137.88 31.94 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.08 -1.012 . . . . 0.98 110.371 -179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.9 mm -104.89 125.3 59.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 107.488 -1.301 . . . . 0.19 107.488 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -108.17 -15.93 14.38 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.292 -0.88 . . . . 1.97 109.195 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -153.13 158.95 42.6 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.24 -0.912 . . . . 0.23 109.506 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 41.1 tttm -52.27 -29.49 23.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 1.9 109.998 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -58.7 -46.57 87.0 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.033 -1.042 . . . . 0.25 109.794 -179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -25.4 63.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.294 -0.879 . . . . 0.2 109.909 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -58.91 -65.46 0.66 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.027 -1.046 . . . . 0.21 109.806 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 33.0 mt-30 -55.91 -45.27 78.72 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.319 -0.863 . . . . 2.47 109.724 -179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.6 mt-10 -58.8 -35.55 73.02 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.174 -0.954 . . . . 2.1 109.753 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -48.15 83.07 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.939 -1.1 . . . . 0.2 109.135 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.0 mt -63.44 -41.46 98.65 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.397 -0.815 . . . . 0.62 109.534 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -64.85 -45.56 85.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.167 -0.958 . . . . 1.09 109.912 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.51 -12.98 59.85 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.186 -0.946 . . . . 0.3 109.952 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.15 -7.44 29.9 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.16 -0.963 . . . . 0.24 109.782 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.75 -136.09 24.02 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.137 -1.585 . . . . 0.28 109.137 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -117.01 5.92 12.89 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.43 -1.041 . . . . 2.21 109.503 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -70.72 168.01 17.51 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.173 -0.955 . . . . 1.9 109.102 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.66 164.51 9.61 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.158 -1.053 . . . . 0.17 108.158 179.698 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.1 t -145.1 107.0 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 120.993 -1.067 . . . . 0.12 109.672 179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.0 t -102.84 136.48 35.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 N-CA-C 108.178 -1.045 . . . . 0.09 108.178 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -113.41 136.7 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.528 -0.732 . . . . 0.17 109.645 -179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 36.2 t0 -106.73 101.78 11.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.606 -0.684 . . . . 0.96 109.292 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.44 ' CE2' HG11 ' A' ' 57' ' ' VAL . 40.7 m-85 -88.04 79.07 8.07 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.056 -1.09 . . . . 0.24 108.056 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.3 m -113.36 150.9 31.96 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 121.315 0.579 . . . . 1.03 109.487 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.461 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.19 130.24 37.1 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.249 -0.907 . . . . 0.26 108.766 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 t -66.94 -28.83 68.61 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.292 -0.88 . . . . 0.32 110.809 -179.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 58.4 p-90 -88.47 -8.82 54.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.003 -1.061 . . . . 0.44 110.536 -178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.461 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -97.61 128.4 44.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.312 -0.867 . . . . 0.32 109.542 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -69.14 -55.99 9.63 Favored Glycine 0 N--CA 1.487 2.072 0 O-C-N 121.563 -0.711 . . . . 0.36 111.42 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 13.6 Cg_exo -49.94 -35.0 39.27 Favored 'Trans proline' 0 C--N 1.317 -1.125 0 C-N-CA 121.746 1.631 . . . . 0.44 111.401 -178.226 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.71 -64.29 1.15 Allowed 'General case' 0 C--N 1.299 -1.616 0 O-C-N 120.96 -1.087 . . . . 0.81 109.076 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -58.27 -20.27 41.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.92 110.018 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.9 tpt -60.43 -19.73 57.27 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.144 -0.973 . . . . 3.13 110.883 -178.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.527 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.2 mt -100.73 4.39 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 O-C-N 120.998 -1.064 . . . . 0.28 111.182 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.584 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 6.6 ptpt -64.65 -32.93 7.66 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 120.121 -1.612 . . . . 1.62 112.439 179.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.584 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -57.64 -13.71 14.89 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.944 1.016 . . . . 0.25 110.245 -177.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -99.82 -67.19 0.86 Allowed 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.724 -0.843 . . . . 0.3 108.724 179.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -46.61 -52.87 12.66 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.713 -0.617 . . . . 0.13 110.424 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.1 t60 -67.7 -33.6 75.23 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.069 -1.019 . . . . 0.41 109.73 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.0 -41.98 97.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.913 -1.117 . . . . 0.97 109.851 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.6 mt -52.25 -15.61 0.64 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.077 -1.014 . . . . 0.5 109.326 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.3 m -58.27 -33.37 69.33 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.51 109.729 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -94.11 -18.06 22.17 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.249 -0.907 . . . . 2.0 110.076 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 45.7 tttm -91.39 -22.81 20.29 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.132 -0.98 . . . . 2.16 109.066 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -133.1 69.39 1.48 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.594 -0.691 . . . . 0.24 109.193 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 85.6 p -67.34 -5.32 13.88 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.306 -0.871 . . . . 0.17 109.114 179.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.3 t30 -95.44 5.28 52.0 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.487 -0.758 . . . . 0.34 109.555 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.8 t -119.17 149.46 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.471 -0.768 . . . . 0.12 109.332 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.0 mm -101.52 126.25 55.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 N-CA-C 108.901 -0.777 . . . . 0.17 108.901 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.621 ' C ' HD12 ' A' ' 55' ' ' LEU . 85.5 m-85 -114.39 134.25 55.12 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.391 -0.818 . . . . 0.11 109.418 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.621 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -116.4 175.11 5.71 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.447 -0.783 . . . . 0.12 109.247 -179.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -144.31 143.31 30.93 Favored 'General case' 0 N--CA 1.495 1.825 0 N-CA-C 108.015 -1.106 . . . . 1.31 108.015 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.44 HG11 ' CE2' ' A' ' 27' ' ' PHE . 55.8 t -140.44 142.73 30.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.087 0 O-C-N 121.07 -1.019 . . . . 0.14 110.658 -178.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -99.95 100.77 11.72 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.932 -1.136 . . . . 1.08 107.932 178.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.426 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.2 m -60.36 -10.41 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.212 -0.93 . . . . 0.27 111.099 -178.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -102.52 -41.34 6.31 Favored 'General case' 0 N--CA 1.501 2.102 0 O-C-N 120.991 -1.068 . . . . 1.11 111.239 -178.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.442 ' HB2' HH12 ' B' ' 2' ' ' ARG . 6.7 t70 -94.86 -13.67 25.29 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.98 -1.075 . . . . 1.12 110.061 -178.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.88 48.48 1.62 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.284 -0.885 . . . . 0.17 108.797 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.472 ' NE2' ' HE ' ' B' ' 4' ' ' ARG . 96.5 mt-30 -55.22 -13.97 1.53 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.571 -0.705 . . . . 2.22 109.592 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -70.44 -42.42 71.56 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.201 -0.937 . . . . 1.11 109.246 -179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.7 t -73.61 -45.79 49.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.19 108.542 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -34.36 77.74 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.419 -0.801 . . . . 0.22 109.304 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 24.1 m -64.08 -49.49 72.07 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.306 -0.871 . . . . 1.29 109.332 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.1 tp10 -62.8 -37.06 85.2 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.312 -0.867 . . . . 2.2 109.224 179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.71 -3.74 58.7 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.25 -0.906 . . . . 0.33 109.492 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 66' ' ' ALA . 36.1 mt-10 47.0 52.65 11.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.319 -0.863 . . . . 2.34 110.279 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 24.4 t -79.06 132.68 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.142 -0.974 . . . . 0.28 108.896 179.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.423 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 54.5 mttp -127.74 6.74 6.16 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.451 -0.781 . . . . 2.4 109.733 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.541 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.7 137.82 17.34 Favored 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.057 -1.027 . . . . 0.22 108.95 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.475 HG23 ' CE2' ' B' ' 5' ' ' TYR . 74.3 p -122.04 149.89 55.13 Favored Pre-proline 0 N--CA 1.501 2.096 0 O-C-N 121.362 -0.836 . . . . 0.22 109.006 178.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.527 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.1 Cg_endo -76.6 148.07 88.16 Favored 'Cis proline' 0 N--CA 1.484 0.932 0 C-N-CA 124.66 -0.975 . . . . 0.2 110.409 -2.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.541 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -117.63 115.82 25.84 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.255 -1.387 . . . . 0.18 107.255 178.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.468 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.6 m-85 -93.04 121.68 34.63 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.213 -0.929 . . . . 0.15 108.555 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.4 mt-30 -119.8 137.88 53.7 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.608 -1.256 . . . . 1.03 107.608 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.433 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 28.5 m-85 -111.44 127.8 55.79 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 121.536 0.684 . . . . 0.11 110.044 -178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.4 m-85 -126.33 157.49 38.28 Favored 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.619 -0.882 . . . . 0.17 108.619 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.8 tttm -155.48 123.84 5.91 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.403 -1.332 . . . . 1.48 107.403 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.9 mtmt 56.39 28.38 13.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.477 -0.764 . . . . 1.67 109.89 -178.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.9 8.04 87.19 Favored Glycine 0 N--CA 1.494 2.501 0 C-N-CA 119.98 -1.105 . . . . 0.22 110.357 179.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.2 mt-30 -115.3 146.48 41.46 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.372 -1.075 . . . . 2.08 110.128 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.404 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -85.54 140.79 30.36 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.402 -0.811 . . . . 1.7 109.222 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 18.0 m -126.86 -20.32 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.396 -0.815 . . . . 0.26 110.289 -179.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.96 174.1 46.69 Favored Glycine 0 N--CA 1.496 2.633 0 C-N-CA 119.454 -1.355 . . . . 0.18 110.378 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -174.18 153.66 2.07 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.359 -1.083 . . . . 2.04 110.229 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.496 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.0 p90 -169.94 135.25 1.39 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.447 -0.783 . . . . 0.14 109.974 179.036 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 p -106.6 -169.24 1.53 Allowed 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.238 -0.914 . . . . 0.17 108.757 179.592 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 91.87 129.25 4.61 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 109.806 -1.318 . . . . 0.13 109.806 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.467 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 91.88 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.335 -1.097 . . . . 0.2 110.297 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.429 ' N ' ' O ' ' A' ' 91' ' ' GLY . 24.0 t-20 -139.96 74.38 1.46 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.279 -0.888 . . . . 1.15 108.787 178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -65.23 -32.58 74.33 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.482 -0.761 . . . . 1.19 110.319 -179.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -67.06 -30.67 70.79 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.981 -1.074 . . . . 1.95 109.598 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -67.36 -33.5 75.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.16 -0.962 . . . . 2.05 109.254 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.468 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.1 mt -50.82 -35.36 31.84 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.964 -1.085 . . . . 0.15 108.605 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -66.98 -57.59 6.59 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.6 -0.687 . . . . 2.15 109.836 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.01 -40.2 88.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.394 -0.816 . . . . 0.15 110.876 -179.218 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 64.6 m -66.87 -46.04 76.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.156 -0.965 . . . . 0.13 110.467 -178.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -62.27 -50.56 79.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.143 -0.973 . . . . 0.18 109.163 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.2 t30 -61.17 -18.27 57.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 1.03 109.652 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.2 tp10 -77.63 -60.69 2.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 2.02 110.134 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 48.8 mt -91.88 22.1 4.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.463 -0.773 . . . . 0.35 110.461 -178.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.491 1.614 0 O-C-N 120.981 -1.074 . . . . 1.18 109.178 179.357 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.1 p90 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.524 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.0 mtt-85 -118.28 74.36 0.95 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.563 -0.711 . . . . 0.0 109.36 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.506 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -130.29 150.72 51.41 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.448 -0.782 . . . . 0.0 109.022 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.472 ' HE ' ' NE2' ' A' ' 63' ' ' GLN . 7.3 mmt180 -148.0 -102.66 0.09 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.199 -0.938 . . . . 0.0 109.074 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.475 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.79 -168.54 1.34 Allowed 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.087 -1.008 . . . . 0.0 110.714 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -77.02 150.31 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.943 0.877 . . . . 0.0 112.909 -176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.63 97.11 7.57 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.427 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.77 44.34 0.98 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.068 -1.02 . . . . 0.0 110.477 -179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.17 -136.82 0.15 Allowed Glycine 0 N--CA 1.485 1.932 0 N-CA-C 106.87 -2.492 . . . . 0.0 106.87 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.32 28.27 0.12 Allowed 'Trans proline' 0 C--N 1.32 -0.928 0 CA-C-N 118.755 1.278 . . . . 0.0 109.012 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 9.3 t -89.24 -31.04 18.08 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.35 -0.844 . . . . 0.0 109.697 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 36.7 t-80 -65.34 -80.77 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.0 109.703 -179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -179.729 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.453 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.583 0 N-CA-C 109.436 -0.579 . . . . 2.89 109.436 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.445 HG12 ' N ' ' A' ' 3' ' ' LYS . 75.0 t -94.77 158.69 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.3 -0.875 . . . . 0.3 109.626 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.445 ' N ' HG12 ' A' ' 2' ' ' VAL . 52.0 tttt -153.99 125.26 7.42 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.363 -0.836 . . . . 1.97 108.803 179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -88.39 134.87 33.71 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.299 -0.876 . . . . 0.98 109.899 -179.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.9 mm -107.99 106.99 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 N-CA-C 108.219 -1.03 . . . . 0.19 108.219 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -99.63 -8.79 23.96 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.205 -0.934 . . . . 1.97 109.648 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 87.3 p -152.09 150.31 29.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.199 -0.938 . . . . 0.23 109.623 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -51.57 -28.15 13.13 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.402 -0.811 . . . . 1.9 109.396 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 77.3 m -60.7 -43.27 97.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.25 109.584 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.35 -26.58 64.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.347 -0.845 . . . . 0.2 109.572 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -59.94 -67.9 0.34 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.113 -0.992 . . . . 0.21 109.868 -179.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -54.1 -44.33 71.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 2.47 109.673 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 42.7 mm-40 -58.44 -37.82 76.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.159 -0.963 . . . . 2.1 109.726 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.91 -46.71 88.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.102 -0.999 . . . . 0.2 109.276 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.0 mt -64.7 -41.07 96.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.42 -0.8 . . . . 0.62 109.812 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -62.95 -38.68 92.04 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.25 -0.906 . . . . 1.09 109.587 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.08 -16.62 54.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.28 -0.888 . . . . 0.3 109.828 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.1 -6.96 31.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.24 109.938 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.66 -105.95 1.4 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.837 -1.305 . . . . 0.28 109.837 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -137.78 3.38 2.48 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.367 -1.078 . . . . 2.21 109.74 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' N ' ' O ' ' A' ' 109' ' ' HOH . 77.8 mttt -70.09 166.82 19.0 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.042 -1.036 . . . . 1.9 109.124 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.543 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 163.39 11.58 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.295 -0.878 . . . . 0.17 108.687 -179.681 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.543 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.4 t -146.21 107.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.094 -1.004 . . . . 0.12 109.48 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.2 t -103.73 128.5 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.366 -0.833 . . . . 0.09 108.804 179.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -107.95 134.81 48.63 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.612 -0.68 . . . . 0.17 109.896 -178.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -106.48 101.1 10.59 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.177 -0.675 . . . . 0.96 109.177 179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.445 ' O ' HG22 ' A' ' 74' ' ' THR . 50.5 m-85 -84.97 81.17 9.01 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 107.765 -1.198 . . . . 0.24 107.765 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -110.94 -163.06 0.82 Allowed 'General case' 0 N--CA 1.493 1.684 0 CA-C-O 121.626 0.727 . . . . 1.03 109.514 -179.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.6 124.81 17.54 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 108.607 -0.886 . . . . 0.26 108.607 179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 t -64.69 -25.47 67.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 0.32 110.718 -178.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.582 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 46.9 p-90 -89.05 -19.45 25.6 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.972 -1.08 . . . . 0.44 110.169 -179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -92.84 122.17 34.95 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -0.956 . . . . 0.32 109.512 -178.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.468 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.63 -57.41 12.74 Favored Glycine 0 N--CA 1.488 2.159 0 C-N-CA 120.929 -0.653 . . . . 0.36 111.555 -179.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.468 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 22.8 Cg_exo -46.04 -36.88 16.83 Favored 'Trans proline' 0 C--N 1.32 -0.95 0 C-N-CA 121.712 1.608 . . . . 0.44 111.645 -177.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.86 -59.54 2.74 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.869 -1.145 . . . . 0.81 108.944 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.6 ttmt -59.47 -15.15 15.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.524 -0.735 . . . . 1.92 110.009 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 4.7 tpt -58.24 -20.13 39.51 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.124 -0.985 . . . . 3.13 110.434 -179.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.584 HG22 ' O ' ' A' ' 38' ' ' ILE . 49.2 mt -97.27 8.57 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.083 -1.01 . . . . 0.28 110.783 -178.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.599 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.96 -31.97 5.25 Favored Pre-proline 0 N--CA 1.486 1.374 0 O-C-N 120.122 -1.611 . . . . 1.62 112.529 -179.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.599 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.8 Cg_exo -65.67 -5.14 11.09 Favored 'Trans proline' 0 C--N 1.321 -0.903 0 CA-C-N 119.968 1.024 . . . . 0.25 109.706 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 50.4 m-85 -111.85 -78.45 0.58 Allowed 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 109.015 -0.735 . . . . 0.3 109.015 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -41.56 -56.91 2.42 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.767 -0.583 . . . . 0.13 110.688 -179.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -67.01 -31.48 72.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.05 -1.031 . . . . 0.41 109.871 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 46' ' ' SER . 13.4 m -66.49 -38.77 88.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.853 -1.154 . . . . 0.97 110.235 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 69.8 mt -49.17 -12.93 0.06 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.879 -1.138 . . . . 0.5 109.649 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.478 ' N ' ' O ' ' A' ' 44' ' ' SER . 54.9 m -56.75 -31.57 64.71 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.134 -0.979 . . . . 0.51 109.51 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.25 -17.59 21.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.266 -0.896 . . . . 2.0 110.166 -179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.2 tttp -91.03 -24.3 20.1 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.976 -1.077 . . . . 2.16 109.85 -179.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 51.6 m-85 -135.49 70.96 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.393 -0.817 . . . . 0.24 109.621 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.2 p -66.97 -4.57 9.93 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.266 -0.896 . . . . 0.17 108.714 179.217 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.487 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.11 -0.37 50.31 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.523 -0.736 . . . . 0.34 109.823 -179.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 98.7 t -117.7 149.59 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.533 -0.729 . . . . 0.12 109.4 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -99.07 133.57 41.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.442 -0.786 . . . . 0.17 109.418 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.578 ' C ' HD12 ' A' ' 55' ' ' LEU . 72.9 m-85 -119.06 131.77 55.98 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.544 -0.723 . . . . 0.11 109.163 179.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.99 172.81 6.82 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.399 -0.813 . . . . 0.12 108.962 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -143.99 143.33 31.17 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.162 -1.051 . . . . 1.31 108.162 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.5 t -139.85 138.2 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 121.168 -0.957 . . . . 0.14 110.288 -178.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -98.79 102.9 14.79 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 107.648 -1.241 . . . . 1.08 107.648 178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 20.5 m -62.03 -6.3 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.233 -0.917 . . . . 0.27 111.044 -178.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -103.08 -44.52 5.19 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.052 -1.03 . . . . 1.11 110.597 -179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -93.99 -15.37 24.93 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.093 -1.004 . . . . 1.12 109.776 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.48 44.66 2.77 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.316 -0.865 . . . . 0.17 109.251 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -57.06 -10.88 1.28 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.314 -0.866 . . . . 2.22 110.216 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.6 ' OD1' HG23 ' A' ' 65' ' ' VAL . 1.4 p30 -69.04 -39.16 79.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.908 -1.12 . . . . 1.11 109.149 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.6 HG23 ' OD1' ' A' ' 64' ' ' ASP . 2.8 t -74.05 -42.28 52.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.137 -1.06 . . . . 0.19 108.137 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.2 -37.85 88.87 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.907 -0.775 . . . . 0.22 108.907 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 m -64.03 -45.02 90.76 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.379 -0.826 . . . . 1.29 109.079 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.87 -39.03 93.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.386 -0.821 . . . . 2.2 109.427 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.11 0.33 55.45 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.267 -0.896 . . . . 0.33 109.754 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 69.8 mt-10 49.21 56.81 7.23 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.253 -0.905 . . . . 2.34 109.951 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.6 t -78.59 135.43 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.079 -1.013 . . . . 0.28 109.192 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 78.6 mttt -123.86 -6.86 7.89 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.604 -0.685 . . . . 2.4 109.638 -179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.553 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.01 136.96 16.27 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.149 -0.969 . . . . 0.22 109.433 -179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.664 HG23 ' CE2' ' B' ' 5' ' ' TYR . 9.2 p -115.47 150.61 44.9 Favored Pre-proline 0 N--CA 1.501 2.085 0 N-CA-C 108.295 -1.002 . . . . 0.22 108.295 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -77.62 148.62 86.86 Favored 'Cis proline' 0 N--CA 1.484 0.957 0 C-N-CA 124.838 -0.901 . . . . 0.2 109.838 -2.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.481 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -119.26 118.89 32.48 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 108.145 -1.057 . . . . 0.18 108.145 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.739 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.0 m-85 -95.76 111.9 23.75 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.275 -0.891 . . . . 0.15 108.775 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -114.03 139.39 49.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 107.601 -1.259 . . . . 1.03 107.601 179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.6 m-85 -109.17 133.24 53.27 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.54 0.686 . . . . 0.11 110.052 -177.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -126.59 156.62 40.62 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.488 -0.93 . . . . 0.17 108.488 179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.9 tttm -154.73 122.51 5.81 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.633 -1.247 . . . . 1.48 107.633 -179.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 46.0 mtmt 56.86 29.67 16.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.534 -0.729 . . . . 1.67 109.866 -179.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.4 1.54 90.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 120.113 -1.041 . . . . 0.22 110.741 178.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.0 mt-30 -112.67 148.32 34.9 Favored 'General case' 0 N--CA 1.504 2.256 0 O-C-N 121.155 -1.203 . . . . 2.08 110.281 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.478 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 2.6 ttmp? -87.19 146.5 25.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.322 -0.861 . . . . 1.7 109.523 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.4 m -127.09 -29.5 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.118 0 O-C-N 121.442 -0.786 . . . . 0.26 110.147 -179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.62 176.43 45.51 Favored Glycine 0 N--CA 1.497 2.731 0 C-N-CA 119.659 -1.258 . . . . 0.18 110.083 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -172.34 160.99 5.13 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.251 -1.147 . . . . 2.04 110.77 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.512 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -169.6 133.86 1.34 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.511 -0.743 . . . . 0.14 110.18 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.3 p -104.23 -170.39 1.76 Allowed 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.247 -0.908 . . . . 0.17 109.291 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 90.59 130.19 4.41 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.526 -1.43 . . . . 0.13 109.526 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.82 96.37 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.211 -1.17 . . . . 0.2 110.237 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.6 74.76 1.47 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 108.331 -0.989 . . . . 1.15 108.331 178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.25 -32.45 74.05 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.278 -0.889 . . . . 1.19 110.782 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -65.62 -28.67 69.29 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.1 -1.0 . . . . 1.95 109.153 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 29.6 ttmt -69.4 -36.38 76.7 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.53 -0.731 . . . . 2.05 109.873 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.739 HD21 ' CD1' ' A' ' 77' ' ' PHE . 58.7 mt -53.05 -36.31 60.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.767 -1.208 . . . . 0.15 108.765 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -65.79 -58.15 6.32 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.551 -0.718 . . . . 2.15 109.615 -179.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.5 91.67 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.271 -0.893 . . . . 0.15 110.485 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 24.3 m -65.06 -45.26 86.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.147 -0.971 . . . . 0.13 110.212 -179.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 37.9 mt -58.96 -54.35 35.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.0 -1.062 . . . . 0.18 108.655 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 43.0 t-20 -61.46 -16.55 48.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 1.03 109.745 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -76.3 -60.45 2.33 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.256 -0.902 . . . . 2.02 110.479 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 34.5 mt -91.33 18.18 7.45 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.342 -0.849 . . . . 0.35 110.544 -178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 120.924 -1.11 . . . . 1.18 109.265 179.374 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.4 p90 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 90.6 mtt180 -153.63 66.82 0.75 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.133 -0.979 . . . . 0.0 109.862 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.489 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 30.7 m-85 -116.27 150.42 37.61 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.411 HH11 ' HG2' ' B' ' 4' ' ' ARG . 0.9 OUTLIER -147.42 -107.79 0.09 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.122 -0.986 . . . . 0.0 109.651 -179.445 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.664 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -108.75 -177.49 3.33 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.652 -1.28 . . . . 0.0 110.69 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.1 t -61.03 145.98 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 122.038 0.923 . . . . 0.0 113.058 -176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 m -101.22 93.73 5.59 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.553 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.5 44.61 0.98 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.995 -1.066 . . . . 0.0 110.337 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.02 -132.4 0.07 OUTLIER Glycine 0 N--CA 1.485 1.956 0 N-CA-C 106.877 -2.489 . . . . 0.0 106.877 178.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.54 25.15 0.12 Allowed 'Trans proline' 0 C--N 1.322 -0.816 0 CA-C-N 119.211 1.505 . . . . 0.0 109.274 178.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.7 t -85.99 -36.87 19.52 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.321 -0.862 . . . . 0.0 109.614 -179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.403 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 37.6 t-80 -86.48 -94.95 0.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 109.582 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.403 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.363 0 CA-C-O 117.953 -1.471 . . . . 0.0 109.63 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.425 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 37.9 mtm . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.397 -0.594 . . . . 2.89 109.397 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 96.1 t -94.62 160.89 2.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.277 -0.889 . . . . 0.3 109.55 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.1 OUTLIER -154.75 121.24 5.37 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 107.727 -1.212 . . . . 1.97 107.727 179.781 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 25.7 tt0 -86.77 141.39 28.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.98 110.411 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.1 mm -110.12 109.55 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 N-CA-C 108.022 -1.103 . . . . 0.19 108.022 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 -100.97 -14.88 17.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.244 -0.91 . . . . 1.97 109.327 -179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 80.2 p -154.96 157.61 37.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.892 . . . . 0.23 109.843 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.403 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 49.7 tttp -51.55 -27.65 11.51 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.34 -0.85 . . . . 1.9 109.574 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.3 m -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 0.25 110.005 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.47 -27.26 65.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.2 109.687 -179.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -59.84 -67.61 0.37 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.138 -0.976 . . . . 0.21 109.942 -179.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 18.9 mt-30 -54.04 -43.98 70.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.258 -0.901 . . . . 2.47 109.64 -179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -59.51 -37.5 78.48 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.245 -0.909 . . . . 2.1 109.983 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.03 -47.2 86.81 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.059 -1.026 . . . . 0.2 109.454 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -63.31 -43.16 98.63 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.413 -0.804 . . . . 0.62 109.563 179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -64.27 -42.33 96.48 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.239 -0.913 . . . . 1.09 109.594 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.06 -13.49 59.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.162 -0.962 . . . . 0.3 109.809 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.35 -6.4 24.11 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.201 -0.937 . . . . 0.24 109.753 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.54 -112.43 4.29 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.562 -1.415 . . . . 0.28 109.562 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.474 ' HB2' ' HZ2' ' A' ' 82' ' ' LYS . 0.0 OUTLIER -139.43 2.67 2.06 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -1.103 . . . . 2.21 109.262 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.418 ' N ' ' O ' ' A' ' 109' ' ' HOH . 68.2 mttt -68.84 167.05 16.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.046 -1.034 . . . . 1.9 108.812 179.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.669 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.67 161.86 11.62 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.099 -1.074 . . . . 0.17 108.099 -179.91 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.669 ' H ' HD23 ' A' ' 22' ' ' LEU . 13.0 t -143.99 105.8 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.968 -1.083 . . . . 0.12 109.451 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CD2' ' A' ' 79' ' ' PHE . 7.0 t -102.41 132.19 48.98 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 N-CA-C 108.704 -0.85 . . . . 0.09 108.704 179.482 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -109.38 138.54 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.674 -0.641 . . . . 0.17 109.758 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -109.09 101.57 10.62 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 109.178 -0.675 . . . . 0.96 109.178 179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.5 m-85 -85.09 79.97 9.42 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 107.874 -1.158 . . . . 0.24 107.874 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.43 149.53 34.05 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 121.279 0.562 . . . . 1.03 109.789 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.42 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.95 128.17 37.69 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.63 -0.878 . . . . 0.26 108.63 179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 t -65.93 -26.65 67.69 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.321 -0.862 . . . . 0.32 110.605 -178.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.509 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 60.4 p-90 -88.53 -13.76 39.37 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.887 -1.133 . . . . 0.44 110.038 -179.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.42 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.8 t -94.34 126.01 39.34 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.289 -0.882 . . . . 0.32 109.995 -179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.449 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.98 -58.96 8.04 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 111.462 -0.655 . . . . 0.36 111.462 -179.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 24.6 Cg_exo -45.12 -33.21 7.8 Favored 'Trans proline' 0 C--N 1.319 -0.987 0 C-N-CA 121.9 1.733 . . . . 0.44 111.314 -178.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.41 -61.58 1.96 Allowed 'General case' 0 C--N 1.299 -1.598 0 O-C-N 120.897 -1.127 . . . . 0.81 108.626 179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -60.89 -15.7 33.66 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.71 -0.619 . . . . 1.92 110.473 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.429 ' N ' ' O ' ' A' ' 33' ' ' GLY . 27.9 tpp -60.92 -27.38 68.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.05 -1.031 . . . . 3.13 109.991 -179.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 38' ' ' ILE . 49.6 mt -96.49 15.63 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.131 -0.981 . . . . 0.28 111.023 -178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.603 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.89 -32.75 3.67 Favored Pre-proline 0 C--N 1.306 -1.304 0 C-N-CA 118.179 -1.408 . . . . 1.62 112.224 179.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.603 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -62.9 -4.58 6.2 Favored 'Trans proline' 0 C--O 1.214 -0.697 0 CA-C-N 119.758 0.949 . . . . 0.25 110.114 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 46.5 m-85 -109.16 -79.87 0.58 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.45 -0.781 . . . . 0.3 109.025 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.73 -55.8 2.31 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.688 -0.632 . . . . 0.13 111.082 -179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.37 -34.7 78.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.056 . . . . 0.41 110.219 -179.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.42 ' C ' ' N ' ' A' ' 46' ' ' SER . 85.1 p -64.85 -35.42 81.07 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.637 -1.29 . . . . 0.97 110.012 179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 96.5 mt -50.11 -16.11 0.27 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.987 -1.071 . . . . 0.5 109.28 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.42 ' N ' ' C ' ' A' ' 44' ' ' SER . 14.9 m -57.03 -36.48 70.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.215 -0.928 . . . . 0.51 109.706 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.1 mm-40 -93.16 -15.02 26.43 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.159 -0.963 . . . . 2.0 110.089 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 51.3 tttm -91.26 -23.12 20.27 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.056 -1.027 . . . . 2.16 109.196 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.2 m-85 -135.88 72.46 1.44 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.531 -0.731 . . . . 0.24 109.414 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 93.3 p -67.17 -4.76 11.14 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.256 -0.903 . . . . 0.17 108.969 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -96.97 -0.37 47.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.408 -0.808 . . . . 0.34 109.9 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.8 t -116.29 147.54 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 O-C-N 121.445 -0.784 . . . . 0.12 109.223 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.2 mm -98.77 130.7 47.24 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.258 -0.901 . . . . 0.17 109.36 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.548 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -118.11 132.13 56.37 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.486 -0.759 . . . . 0.11 109.142 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.548 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.78 171.92 7.29 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 108.786 -0.82 . . . . 0.12 108.786 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 54.1 tt0 -141.54 137.83 32.29 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 107.717 -1.216 . . . . 1.31 107.717 179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.7 t -136.47 139.93 44.31 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.989 0 O-C-N 121.275 -0.891 . . . . 0.14 110.883 -177.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -99.99 101.77 12.95 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.745 -0.835 . . . . 1.08 108.745 179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.406 ' H ' HG22 ' A' ' 59' ' ' VAL . 15.6 m -60.98 -2.25 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.293 -0.879 . . . . 0.27 111.017 -179.05 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.441 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 26.1 m-20 -108.66 -44.44 4.05 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.061 -1.025 . . . . 1.11 110.503 -178.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -95.11 -26.97 15.81 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.102 -0.999 . . . . 1.12 109.21 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -104.92 40.39 1.51 Allowed 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.309 -0.997 . . . . 0.17 108.309 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -53.57 -15.87 1.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.636 -0.665 . . . . 2.22 110.121 -179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.403 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.0 OUTLIER -70.26 -36.29 74.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.978 -1.076 . . . . 1.11 108.783 179.584 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 14.3 t -75.27 -48.9 29.62 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 N-CA-C 108.663 -0.866 . . . . 0.19 108.663 179.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.06 -32.72 74.15 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.418 -0.801 . . . . 0.22 109.161 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.1 m -63.16 -48.98 76.15 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 1.29 109.182 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 14.3 tm-20 -64.94 -35.99 82.94 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.325 -0.859 . . . . 2.2 109.522 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.62 0.47 55.6 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.189 -0.945 . . . . 0.33 109.905 -179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 45.88 50.95 10.93 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.163 -0.961 . . . . 2.34 110.251 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.0 t -79.82 131.35 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.158 -0.964 . . . . 0.28 108.904 179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mttm -130.52 6.19 4.79 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.376 -0.827 . . . . 2.4 110.212 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.574 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -151.46 120.7 6.78 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.04 -1.037 . . . . 0.22 108.731 179.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.632 HG23 ' CE2' ' B' ' 5' ' ' TYR . 25.0 p -108.17 150.65 40.74 Favored Pre-proline 0 N--CA 1.502 2.132 0 N-CA-C 108.759 -0.83 . . . . 0.22 108.759 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -77.8 141.97 68.83 Favored 'Cis proline' 0 N--CA 1.484 0.919 0 C-N-CA 125.033 -0.82 . . . . 0.2 110.105 -1.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 115.66 27.5 Favored 'General case' 0 N--CA 1.501 2.103 0 N-CA-C 107.973 -1.121 . . . . 0.18 107.973 178.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.461 ' CE1' HD21 ' A' ' 97' ' ' LEU . 78.7 m-85 -91.47 118.62 30.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.041 -1.037 . . . . 0.15 108.94 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.0 mt-30 -117.06 132.95 56.56 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.839 -1.171 . . . . 1.03 107.839 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.485 ' CD2' HG22 ' A' ' 24' ' ' VAL . 18.0 m-85 -107.84 126.55 52.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.656 -0.653 . . . . 0.11 109.55 -178.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 65.0 m-85 -123.03 158.46 30.5 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 108.786 -0.82 . . . . 0.17 108.786 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -154.75 123.07 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 106.866 -1.531 . . . . 1.48 106.866 179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.474 ' HZ2' ' HB2' ' A' ' 20' ' ' ASP . 25.1 mttm 58.26 28.59 16.83 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.409 -0.807 . . . . 1.67 109.41 -178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.77 2.83 88.8 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.606 -1.397 . . . . 0.22 109.606 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.413 ' CA ' HE21 ' A' ' 84' ' ' GLN . 0.7 OUTLIER -106.76 145.75 31.68 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.543 -0.975 . . . . 2.08 110.334 -179.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -85.6 141.13 30.04 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.368 -0.832 . . . . 1.7 109.357 179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.6 -21.25 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 O-C-N 121.49 -0.756 . . . . 0.26 110.253 -179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -179.04 177.32 48.42 Favored Glycine 0 N--CA 1.494 2.544 0 C-N-CA 119.485 -1.341 . . . . 0.18 110.178 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -174.27 156.1 2.51 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.294 -1.121 . . . . 2.04 110.165 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.54 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.4 p90 -168.9 131.15 1.27 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.376 -0.828 . . . . 0.14 110.0 178.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 p -102.57 -166.85 1.32 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.192 -0.942 . . . . 0.17 108.892 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.98 127.9 3.1 Favored Glycine 0 N--CA 1.494 2.522 0 N-CA-C 109.126 -1.59 . . . . 0.13 109.126 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.532 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.81 96.98 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.158 -1.201 . . . . 0.2 110.734 -178.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.5 t-20 -143.12 77.38 1.56 Allowed 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 108.136 -1.061 . . . . 1.15 108.136 178.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.473 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.28 -33.34 75.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.404 -0.81 . . . . 1.19 110.484 -178.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -65.97 -26.57 67.63 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.98 -1.075 . . . . 1.95 109.185 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 30.8 ttmt -68.97 -36.54 78.01 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.346 -0.846 . . . . 2.05 109.512 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.461 HD21 ' CE1' ' A' ' 77' ' ' PHE . 15.0 mt -53.7 -34.9 60.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.064 . . . . 0.15 108.919 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -67.0 -57.54 6.68 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.219 -0.925 . . . . 2.15 109.722 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.33 90.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.314 -0.866 . . . . 0.15 110.59 -179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.0 m -66.86 -45.14 79.06 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.132 -0.98 . . . . 0.13 110.206 -178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.0 mt -60.49 -51.9 67.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 120.932 -1.105 . . . . 0.18 108.631 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.91 -15.34 42.21 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.328 -0.857 . . . . 1.03 109.646 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -76.49 -59.72 2.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.251 -0.906 . . . . 2.02 110.176 -179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 41.3 mt -92.32 17.17 10.18 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.355 -0.841 . . . . 0.35 110.404 -178.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.493 1.696 0 O-C-N 120.973 -1.08 . . . . 1.18 109.382 179.595 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.1 p90 . . . . . 0 N--CA 1.491 1.597 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.509 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.5 OUTLIER -119.67 71.67 0.89 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.495 -0.753 . . . . 0.0 109.165 -179.623 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.404 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.7 m-85 -134.03 155.38 50.1 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.485 -0.759 . . . . 0.0 109.198 -179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.577 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -149.61 -95.06 0.07 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.078 -1.013 . . . . 0.0 109.356 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.632 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -115.08 -172.56 2.15 Favored 'General case' 0 N--CA 1.504 2.255 0 O-C-N 120.941 -1.1 . . . . 0.0 110.632 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.95 152.54 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 CA-C-O 121.957 0.884 . . . . 0.0 112.056 -177.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.1 m -101.25 96.84 7.46 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 177.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.574 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 1.8 pt-20 -82.8 45.48 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.184 -0.948 . . . . 0.0 109.819 -179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.648 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.74 -132.66 0.07 OUTLIER Glycine 0 N--CA 1.484 1.894 0 N-CA-C 107.022 -2.431 . . . . 0.0 107.022 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -65.27 21.94 0.08 OUTLIER 'Trans proline' 0 C--N 1.321 -0.917 0 CA-C-N 119.286 1.543 . . . . 0.0 109.473 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.648 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.3 t -80.86 -49.76 10.65 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.245 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.543 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 56.4 t-80 -72.43 173.24 9.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.28 -0.887 . . . . 0.0 109.428 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.543 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.26 0 CA-C-O 118.039 -1.423 . . . . 0.0 109.571 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.403 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.418 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.1 mtt . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 109.412 -0.588 . . . . 2.89 109.412 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 3' ' ' LYS . 69.8 t -94.7 159.71 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.177 -0.952 . . . . 0.3 109.73 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.515 ' HZ2' ' CD1' ' A' ' 5' ' ' ILE . 48.4 tttm -154.1 127.8 8.73 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.289 -0.882 . . . . 1.97 108.991 179.462 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.3 tt0 -87.55 130.99 34.53 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.24 -0.912 . . . . 0.98 109.592 -179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.515 ' CD1' ' HZ2' ' A' ' 3' ' ' LYS . 25.0 mm -114.78 85.99 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.675 -0.861 . . . . 0.19 108.675 179.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -95.29 4.43 53.48 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.979 -1.075 . . . . 1.97 109.551 -179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.3 p -150.4 141.48 23.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.057 -1.027 . . . . 0.23 109.889 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.1 tttm -51.57 -31.07 23.17 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.384 -0.823 . . . . 1.9 109.49 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.1 m -59.88 -43.93 94.5 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.271 -0.893 . . . . 0.25 109.903 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.08 -26.01 63.8 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.317 -0.864 . . . . 0.2 109.828 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -59.91 -67.39 0.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.188 -0.945 . . . . 0.21 110.118 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 16.7 mm100 -53.78 -44.41 70.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.108 -0.995 . . . . 2.47 109.559 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 74.0 mt-10 -59.38 -36.89 76.63 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.269 -0.894 . . . . 2.1 109.969 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.11 -46.36 89.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.103 -0.998 . . . . 0.2 109.484 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.7 mt -63.77 -45.6 89.05 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.335 -0.853 . . . . 0.62 110.034 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.19 -41.57 99.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.048 -1.033 . . . . 1.09 109.415 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.42 -13.06 59.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.214 -0.929 . . . . 0.3 109.628 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.86 -8.09 40.62 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.122 -0.986 . . . . 0.24 109.581 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.11 -113.01 4.48 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.444 -1.462 . . . . 0.28 109.444 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -137.71 2.51 2.43 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.353 -1.087 . . . . 2.21 109.348 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.0 mttt -69.37 168.08 15.15 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.183 -0.948 . . . . 1.9 108.702 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.581 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.55 165.1 10.58 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.168 -0.958 . . . . 0.17 108.452 -179.655 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.581 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.1 t -145.29 106.31 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 120.87 -1.144 . . . . 0.12 109.712 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.9 t -103.5 132.25 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.354 -0.841 . . . . 0.09 108.996 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.07 136.75 45.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.95 0 O-C-N 121.619 -0.676 . . . . 0.17 109.636 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -109.37 102.29 11.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.541 -0.725 . . . . 0.96 109.363 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CE2' HG11 ' A' ' 57' ' ' VAL . 44.8 m-85 -85.01 82.48 8.43 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.939 -1.134 . . . . 0.24 107.939 179.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.1 m -114.24 150.05 34.93 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.822 -0.549 . . . . 1.03 109.734 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.435 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.0 123.41 35.34 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.234 -1.024 . . . . 0.26 108.234 178.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.3 t -65.37 -23.25 66.93 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.26 -0.9 . . . . 0.32 110.454 -178.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.0 p-90 -89.1 -11.75 43.11 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.06 -1.025 . . . . 0.44 109.899 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.435 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -96.97 128.04 43.55 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.327 -0.858 . . . . 0.32 110.049 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.453 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.29 -56.46 11.92 Favored Glycine 0 N--CA 1.49 2.252 0 O-C-N 121.631 -0.668 . . . . 0.36 111.601 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.453 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.4 Cg_exo -47.2 -35.06 19.16 Favored 'Trans proline' 0 C--N 1.318 -1.073 0 C-N-CA 121.829 1.686 . . . . 0.44 111.438 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -61.26 2.04 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.926 -1.109 . . . . 0.81 108.832 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -59.51 -16.86 27.34 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.421 -0.799 . . . . 1.92 110.102 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.481 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.5 tmt? -60.84 -28.44 68.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.156 -0.965 . . . . 3.13 110.212 -179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 38' ' ' ILE . 43.3 mt -96.76 18.02 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.232 -0.918 . . . . 0.28 110.485 -179.051 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.605 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -71.09 -32.05 2.22 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.53 -1.357 . . . . 1.62 112.606 179.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.605 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.0 Cg_exo -62.69 -3.69 4.8 Favored 'Trans proline' 0 C--O 1.214 -0.693 0 CA-C-N 119.659 0.914 . . . . 0.25 109.994 -178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.543 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 38.3 m-85 -110.2 -76.86 0.6 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.567 -0.708 . . . . 0.3 109.331 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.4 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.1 t80 -42.28 -57.2 2.65 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.433 -0.792 . . . . 0.13 110.715 -179.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -66.82 -30.94 71.26 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.176 -0.952 . . . . 0.41 109.959 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.418 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.0 t -64.28 -40.08 95.22 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.804 -1.185 . . . . 0.97 109.96 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.6 mt -49.8 -16.33 0.25 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.054 -1.029 . . . . 0.5 109.437 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.418 ' N ' ' C ' ' A' ' 44' ' ' SER . 44.9 m -57.38 -31.42 65.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.146 -0.971 . . . . 0.51 109.869 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -96.57 -19.34 19.14 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.159 -0.963 . . . . 2.0 110.425 -179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 39.2 tttp -91.14 -23.7 20.19 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.965 -1.085 . . . . 2.16 109.8 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -131.36 66.99 1.53 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.579 -0.7 . . . . 0.24 109.181 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 88.2 p -66.5 -3.61 6.62 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.332 -0.855 . . . . 0.17 108.79 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -95.4 -1.49 50.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.447 -0.783 . . . . 0.34 109.319 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 88.7 t -115.56 149.11 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 109.058 -0.719 . . . . 0.12 109.058 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.3 mm -98.58 128.76 49.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.42 -0.8 . . . . 0.17 109.324 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.552 ' C ' HD12 ' A' ' 55' ' ' LEU . 71.1 m-85 -115.29 132.31 56.65 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.532 -0.73 . . . . 0.11 109.181 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.552 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -114.08 171.33 7.67 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.871 -0.789 . . . . 0.12 108.871 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -143.69 138.38 28.87 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 108.066 -1.087 . . . . 1.31 108.066 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.406 HG11 ' CE2' ' A' ' 27' ' ' PHE . 80.6 t -134.6 138.37 49.67 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.211 -0.931 . . . . 0.14 110.616 -178.537 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -100.99 99.13 9.54 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.835 -1.172 . . . . 1.08 107.835 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.3 m -54.18 -13.41 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 0.27 111.331 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -100.03 -44.58 5.96 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.894 -1.129 . . . . 1.11 111.298 -178.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -91.6 -10.61 39.86 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.973 -1.08 . . . . 1.12 109.718 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.27 46.4 2.37 Favored 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.543 -0.91 . . . . 0.17 108.543 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 48.0 mt-30 -55.44 -15.43 2.68 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.48 -0.762 . . . . 2.22 110.142 -179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.6 p30 -69.74 -39.53 76.72 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.032 -1.042 . . . . 1.11 108.995 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.6 t -74.05 -46.57 45.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.263 -0.898 . . . . 0.19 108.777 179.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.48 -31.99 72.81 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.349 -0.844 . . . . 0.22 108.846 179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.7 m -64.29 -56.23 15.97 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.361 -0.837 . . . . 1.29 109.219 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -63.43 -31.16 72.25 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 2.2 109.351 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.447 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.24 -6.81 57.59 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.26 -0.9 . . . . 0.33 109.296 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.435 ' N ' ' O ' ' A' ' 66' ' ' ALA . 27.5 mt-10 45.27 51.6 9.21 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.383 -0.823 . . . . 2.34 110.369 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.5 t -79.49 136.13 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.153 -0.967 . . . . 0.28 109.145 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.1 mttt -130.4 2.34 4.61 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.442 -0.786 . . . . 2.4 109.764 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.512 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.09 126.95 9.61 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.005 -1.059 . . . . 0.22 109.496 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.583 HG23 ' CE2' ' B' ' 5' ' ' TYR . 72.2 p -111.6 150.54 42.35 Favored Pre-proline 0 N--CA 1.505 2.278 0 O-C-N 121.385 -0.822 . . . . 0.22 108.876 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -78.61 141.42 64.22 Favored 'Cis proline' 0 N--CA 1.486 1.075 0 C-N-CA 125.03 -0.821 . . . . 0.2 110.371 -1.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.67 114.26 26.78 Favored 'General case' 0 N--CA 1.503 2.194 0 N-CA-C 108.129 -1.063 . . . . 0.18 108.129 178.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.6 m-85 -89.61 124.16 34.31 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.848 -1.157 . . . . 0.15 109.093 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.447 HE22 ' HB1' ' A' ' 69' ' ' ALA . 41.4 mt-30 -122.4 133.67 54.63 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.915 -1.142 . . . . 1.03 107.915 -179.478 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.426 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 24.3 m-85 -107.88 127.81 54.06 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.665 0.745 . . . . 0.11 110.012 -178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 77.3 m-85 -126.08 155.37 41.69 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 107.923 -1.14 . . . . 0.17 107.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 35.7 tttp -156.25 125.46 6.13 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.205 -1.035 . . . . 1.48 108.205 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 73.4 mttt 56.32 19.22 3.83 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.573 -0.705 . . . . 1.67 109.569 -178.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.482 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 92.39 1.09 69.39 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 110.309 -1.116 . . . . 0.22 110.309 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.482 HE21 ' C ' ' A' ' 83' ' ' GLY . 40.1 mm-40 -110.33 148.14 32.53 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.352 -1.087 . . . . 2.08 110.272 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -87.89 145.65 25.95 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.455 -0.778 . . . . 1.7 109.36 179.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 25.1 m -128.17 -25.1 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 O-C-N 121.395 -0.816 . . . . 0.26 110.23 -179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.72 179.1 46.25 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 119.477 -1.344 . . . . 0.18 110.516 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -174.49 154.94 2.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.341 -1.094 . . . . 2.04 109.967 179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.9 p90 -167.76 131.7 1.74 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.26 -0.9 . . . . 0.14 110.455 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -104.53 -170.97 1.84 Allowed 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.229 -0.919 . . . . 0.17 108.805 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.18 131.96 3.86 Favored Glycine 0 N--CA 1.494 2.536 0 N-CA-C 109.785 -1.326 . . . . 0.13 109.785 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -52.29 97.73 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -1.129 . . . . 0.2 110.609 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -141.75 66.3 1.35 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.138 -1.06 . . . . 1.15 108.138 178.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.543 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.0 ptpt -61.04 -38.58 86.63 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.683 -0.635 . . . . 1.19 110.854 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 28.8 mm-40 -65.23 -28.81 69.62 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.986 -1.071 . . . . 1.95 109.729 -179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.6 ttmm -70.16 -33.07 71.32 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.311 -0.868 . . . . 2.05 109.592 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 26.3 mt -50.74 -37.98 44.96 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.764 -1.21 . . . . 0.15 108.63 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -67.72 -54.85 16.02 Favored 'General case' 0 C--N 1.299 -1.596 0 C-N-CA 119.935 -0.706 . . . . 2.15 109.658 -179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.6 -41.71 90.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.429 -0.794 . . . . 0.15 110.542 -179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 32.7 m -66.5 -46.92 74.66 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.163 -0.961 . . . . 0.13 110.486 -178.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.8 mt -60.88 -50.51 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 0.18 108.975 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 55.5 t-20 -61.62 -17.54 55.68 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.234 -0.916 . . . . 1.03 109.544 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -77.05 -58.69 3.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.839 . . . . 2.02 110.207 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.449 ' HB2' HD11 ' A' ' 22' ' ' LEU . 24.8 mt -91.78 18.57 7.47 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.341 -0.849 . . . . 0.35 110.46 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.49 1.535 0 O-C-N 120.977 -1.077 . . . . 1.18 109.275 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 35.9 t80 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.535 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 59.7 mtp180 -140.8 50.81 1.65 Allowed 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.351 -0.843 . . . . 0.0 108.865 179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.482 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.7 m-85 -99.23 164.0 12.32 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.26 -0.9 . . . . 0.0 109.341 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 3.7 mmt180 -149.3 -96.77 0.07 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.294 -0.879 . . . . 0.0 109.22 -179.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.583 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.47 -170.19 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.185 -0.947 . . . . 0.0 110.754 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.401 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.8 t -63.22 144.75 14.24 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 CA-C-O 121.906 0.86 . . . . 0.0 112.837 -177.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.5 m -101.25 94.64 6.05 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 176.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.512 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.3 pt-20 -83.09 45.48 1.02 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.942 -1.099 . . . . 0.0 110.672 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.585 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -73.9 -130.66 0.19 Allowed Glycine 0 N--CA 1.482 1.763 0 N-CA-C 106.269 -2.732 . . . . 0.0 106.269 177.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -68.17 28.02 0.14 Allowed 'Trans proline' 0 C--N 1.32 -0.943 0 CA-C-N 119.323 1.562 . . . . 0.0 109.201 178.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.585 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.7 t -96.38 3.42 52.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.339 -0.85 . . . . 0.0 109.456 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 32.9 t60 -163.79 145.64 9.25 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.275 -0.891 . . . . 0.0 109.638 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.319 0 CA-C-O 117.949 -1.473 . . . . 0.0 109.617 179.825 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.403 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 10.1 mmt . . . . . 0 N--CA 1.491 1.602 0 N-CA-C 109.467 -0.568 . . . . 2.89 109.467 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.624 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.6 t -94.55 172.24 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.265 -0.897 . . . . 0.3 109.315 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.624 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.1 tttm -153.46 121.57 6.14 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.156 -0.965 . . . . 1.97 109.224 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -89.79 136.06 33.26 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.852 . . . . 0.98 110.01 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.6 mm -106.98 113.03 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 N-CA-C 107.843 -1.169 . . . . 0.19 107.843 178.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -101.12 -11.04 19.91 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.263 -0.898 . . . . 1.97 109.561 -179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -153.29 155.55 36.73 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.121 -0.987 . . . . 0.23 109.777 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.484 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 78.9 tttt -52.44 -31.36 34.21 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 1.9 109.806 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 m -57.93 -44.76 87.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.878 -1.139 . . . . 0.25 109.695 -179.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -71.09 -23.7 62.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.204 -0.935 . . . . 0.2 109.715 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -60.37 -68.39 0.3 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 0.21 110.181 -179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.683 ' H ' ' NE2' ' A' ' 12' ' ' GLN . 0.0 OUTLIER -54.35 -42.72 70.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.22 -0.925 . . . . 2.47 109.279 -179.372 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 18.1 mm-40 -58.82 -38.36 78.47 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.186 -0.946 . . . . 2.1 109.974 -179.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.24 -47.72 84.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.124 -0.985 . . . . 0.2 109.362 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.9 mt -63.66 -40.83 97.81 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.344 -0.848 . . . . 0.62 109.416 179.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -64.6 -41.42 96.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.269 -0.894 . . . . 1.09 109.869 -179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.95 -15.09 58.77 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.16 -0.963 . . . . 0.3 109.945 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -67.94 -3.38 9.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.163 -0.961 . . . . 0.24 109.625 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.59 -108.85 2.59 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.426 -1.47 . . . . 0.28 109.426 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -139.7 4.59 2.14 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.395 -1.062 . . . . 2.21 109.282 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.532 ' NZ ' ' OD1' ' A' ' 51' ' ' ASN . 55.9 mttm -69.95 175.06 4.66 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.124 -0.985 . . . . 1.9 109.775 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -68.69 159.75 31.55 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 108.364 -0.976 . . . . 0.17 108.364 179.864 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.646 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.0 t -144.73 107.11 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.763 -1.211 . . . . 0.12 109.671 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.407 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.8 t -105.73 131.6 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.952 0 N-CA-C 108.643 -0.873 . . . . 0.09 108.643 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.76 136.8 44.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 121.684 -0.635 . . . . 0.17 109.633 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -108.96 105.8 15.49 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.109 -0.7 . . . . 0.96 109.109 179.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -86.62 79.62 8.84 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 107.988 -1.116 . . . . 0.24 107.988 179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.6 m -113.78 150.15 33.87 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.788 -0.57 . . . . 1.03 109.873 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.422 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.81 124.77 36.19 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.403 -0.962 . . . . 0.26 108.403 178.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.0 t -66.0 -23.88 66.66 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.198 -0.939 . . . . 0.32 110.367 -179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.538 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 54.3 p-90 -88.62 -13.95 38.67 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.007 -1.058 . . . . 0.44 110.001 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.422 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -95.19 121.62 37.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.28 -0.887 . . . . 0.32 109.665 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.94 -57.15 20.18 Favored Glycine 0 N--CA 1.488 2.16 0 O-C-N 121.579 -0.701 . . . . 0.36 111.372 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.1 Cg_exo -46.96 -34.3 16.23 Favored 'Trans proline' 0 C--N 1.322 -0.836 0 C-N-CA 121.863 1.709 . . . . 0.44 111.5 -178.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.9 -59.03 2.95 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.026 -1.046 . . . . 0.81 108.878 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -60.25 -18.52 49.44 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.522 -0.736 . . . . 1.92 110.233 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.508 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.6 OUTLIER -59.21 -25.3 63.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.152 -0.968 . . . . 3.13 110.17 -179.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.427 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.7 mt -96.34 11.94 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 O-C-N 121.069 -1.019 . . . . 0.28 110.476 -179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.606 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.62 -32.24 3.54 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 120.407 -1.433 . . . . 1.62 112.726 179.856 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.606 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -63.25 -3.98 5.82 Favored 'Trans proline' 0 C--O 1.214 -0.712 0 CA-C-N 119.851 0.982 . . . . 0.25 110.318 -177.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -111.96 -75.64 0.61 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.557 -0.714 . . . . 0.3 109.338 179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -43.53 -57.03 3.32 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.444 -0.785 . . . . 0.13 110.709 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -67.09 -31.89 72.69 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.134 -0.979 . . . . 0.41 110.121 -179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.436 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.8 t -63.45 -39.02 93.36 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.856 -1.153 . . . . 0.97 110.4 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.6 mt -51.11 -12.78 0.13 Allowed 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.019 -1.051 . . . . 0.5 109.646 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.436 ' N ' ' C ' ' A' ' 44' ' ' SER . 49.0 m -57.31 -36.95 71.73 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.067 -1.021 . . . . 0.51 109.64 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.0 mm-40 -94.91 -16.75 22.6 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.119 -0.988 . . . . 2.0 110.464 -179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.6 tttp -90.33 -23.45 21.13 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 120.945 -1.097 . . . . 2.16 109.4 -179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.0 m-85 -134.32 69.61 1.46 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.433 -0.792 . . . . 0.24 109.219 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 79.8 p -66.51 -3.14 5.61 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.257 -0.902 . . . . 0.17 108.946 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -95.94 0.74 52.25 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.544 -0.723 . . . . 0.34 109.669 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 71.8 t -119.43 151.9 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 O-C-N 121.486 -0.759 . . . . 0.12 109.301 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.9 mm -101.6 129.26 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.402 -0.811 . . . . 0.17 109.461 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.1 m-85 -116.95 131.0 57.06 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.441 -0.787 . . . . 0.11 109.147 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -113.04 173.1 6.55 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 108.905 -0.776 . . . . 0.12 108.905 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -143.46 143.65 31.67 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 108.034 -1.098 . . . . 1.31 108.034 179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.59 138.19 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.095 -1.003 . . . . 0.14 110.731 -178.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -99.69 105.01 16.78 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 108.176 -1.046 . . . . 1.08 108.176 178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.9 m -60.19 -12.53 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.314 -0.866 . . . . 0.27 111.16 -178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -100.28 -43.04 6.41 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 121.004 -1.06 . . . . 1.11 110.733 -178.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.32 -10.5 38.07 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.925 -1.109 . . . . 1.12 109.63 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.4 47.55 2.17 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.656 -0.868 . . . . 0.17 108.656 179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -56.17 -15.79 4.28 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.448 -0.782 . . . . 2.22 110.016 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.484 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.5 p-10 -70.15 -40.22 74.88 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.145 -0.972 . . . . 1.11 109.253 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.4 t -73.56 -47.08 46.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.454 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.462 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.42 -35.44 80.42 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.317 -0.864 . . . . 0.22 108.927 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 34.6 m -64.07 -45.53 88.33 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.354 -0.841 . . . . 1.29 109.229 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -63.64 -40.8 97.79 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.322 -0.861 . . . . 2.2 109.28 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -4.8 58.65 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.178 -0.951 . . . . 0.33 109.713 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.2 mm-40 49.08 55.18 9.69 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.16 -0.963 . . . . 2.34 110.112 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 26.4 t -77.91 133.56 30.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.242 -0.911 . . . . 0.28 109.153 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -125.72 2.68 7.48 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.434 -0.791 . . . . 2.4 109.837 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.38 127.72 10.63 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.984 -1.072 . . . . 0.22 109.309 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.626 HG23 ' CE2' ' B' ' 5' ' ' TYR . 20.4 p -114.4 150.63 44.12 Favored Pre-proline 0 N--CA 1.502 2.127 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.427 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.7 Cg_endo -76.21 142.02 72.14 Favored 'Cis proline' 0 N--CA 1.487 1.131 0 C-N-CA 125.005 -0.831 . . . . 0.2 110.98 -1.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.528 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -114.68 114.69 25.99 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 107.595 -1.261 . . . . 0.18 107.595 178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.482 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.9 m-85 -91.54 122.06 33.79 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.895 -1.128 . . . . 0.15 108.922 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -120.91 136.19 55.01 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.308 -1.367 . . . . 1.03 107.308 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.7 m-85 -108.22 132.89 53.19 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 121.636 0.731 . . . . 0.11 110.087 -177.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -127.8 157.15 41.19 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.725 -0.842 . . . . 0.17 108.725 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 68.2 tttt -156.15 124.94 5.96 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 107.647 -1.242 . . . . 1.48 107.647 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 82.6 mttt 56.22 18.71 3.44 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.532 -0.73 . . . . 1.67 109.68 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.557 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.13 -1.11 64.59 Favored Glycine 0 N--CA 1.497 2.729 0 C-N-CA 120.158 -1.02 . . . . 0.22 110.767 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.557 HE21 ' C ' ' A' ' 83' ' ' GLY . 31.0 mm-40 -109.7 147.99 32.18 Favored 'General case' 0 N--CA 1.506 2.345 0 O-C-N 121.091 -1.241 . . . . 2.08 110.316 -179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -85.85 139.72 31.03 Favored 'General case' 0 N--CA 1.492 1.654 0 N-CA-C 108.92 -0.77 . . . . 1.7 108.92 179.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.8 m -125.3 -6.03 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 121.406 -0.809 . . . . 0.26 110.642 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.89 173.72 37.56 Favored Glycine 0 N--CA 1.496 2.671 0 C-N-CA 119.398 -1.382 . . . . 0.18 110.454 179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 19.8 pt-20 -173.4 156.29 3.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.381 -1.07 . . . . 2.04 110.165 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.3 p90 -168.61 132.17 1.48 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.503 -0.748 . . . . 0.14 110.323 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -102.17 -162.92 0.96 Allowed 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.116 -0.99 . . . . 0.17 109.142 179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.424 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.52 127.62 0.9 Allowed Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.662 -1.375 . . . . 0.13 109.662 179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.4 94.4 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -1.1 . . . . 0.2 110.276 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.424 ' N ' ' O ' ' A' ' 91' ' ' GLY . 26.3 t-20 -137.19 75.11 1.51 Allowed 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.887 -1.153 . . . . 1.15 107.887 178.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.5 ptpp? -65.81 -42.26 90.87 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-N 115.812 -0.631 . . . . 1.19 111.316 -178.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -65.02 -27.09 68.57 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.919 -1.113 . . . . 1.95 110.052 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 10.0 ttmm -68.84 -32.44 72.13 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.203 -0.936 . . . . 2.05 109.589 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.482 HD21 ' CD1' ' A' ' 77' ' ' PHE . 17.3 mt -53.55 -35.83 61.17 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.809 -1.182 . . . . 0.15 108.518 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -67.42 -54.86 16.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.4 -0.812 . . . . 2.15 109.479 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.38 -41.59 89.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.365 -0.835 . . . . 0.15 110.386 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.4 m -66.52 -45.09 80.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.164 -0.96 . . . . 0.13 109.784 -179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -61.92 -53.01 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.344 -0.847 . . . . 0.18 109.29 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 35.1 t30 -60.34 -16.88 39.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -0.96 . . . . 1.03 109.467 -179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -77.49 -57.3 3.9 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.326 -0.859 . . . . 2.02 110.06 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 25.4 mt -92.61 17.38 10.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.488 -0.757 . . . . 0.35 110.131 -178.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 1.18 109.38 179.681 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 19.4 p90 . . . . . 0 N--CA 1.49 1.56 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.538 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 14.7 mmm-85 -127.79 68.56 1.32 Allowed 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.385 -0.822 . . . . 0.0 109.276 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.4 m-85 -118.8 150.55 39.63 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.54 -0.725 . . . . 0.0 109.53 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 2.6 mmt180 -144.87 -104.48 0.11 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.377 -0.827 . . . . 0.0 109.139 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.626 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.8 p90 -113.31 -167.75 1.24 Allowed 'General case' 0 N--CA 1.504 2.25 0 O-C-N 121.271 -0.893 . . . . 0.0 110.975 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.21 148.25 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-O 121.92 0.867 . . . . 0.0 112.712 -176.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 20.5 m -101.3 94.83 6.14 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 177.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.502 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.2 pt-20 -83.54 44.71 0.99 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.091 -1.006 . . . . 0.0 110.41 -178.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.631 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.0 -132.6 0.09 OUTLIER Glycine 0 N--CA 1.487 2.079 0 N-CA-C 106.972 -2.451 . . . . 0.0 106.972 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.52 23.43 0.1 OUTLIER 'Trans proline' 0 CA--C 1.541 0.839 0 CA-C-N 119.404 1.602 . . . . 0.0 109.278 178.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.631 ' H ' ' C ' ' B' ' 9' ' ' GLY . 48.3 t -87.18 -43.38 12.28 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.379 -0.825 . . . . 0.0 109.274 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.474 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 1.6 t60 -59.38 147.37 36.45 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.333 -0.855 . . . . 0.0 109.617 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.474 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.243 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.563 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.428 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.552 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.432 -0.581 . . . . 2.89 109.432 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 3' ' ' LYS . 83.5 t -94.38 159.98 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.161 -0.962 . . . . 0.3 109.157 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.495 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.5 tttt -155.12 122.87 5.72 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.037 -1.039 . . . . 1.97 109.438 -179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -89.59 138.33 31.56 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.403 -0.81 . . . . 0.98 109.767 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.59 101.48 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 108.668 -0.864 . . . . 0.19 108.668 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -97.92 -6.51 32.11 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.077 -1.015 . . . . 1.97 109.266 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.5 p -152.73 152.38 31.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.86 . . . . 0.23 109.688 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.6 tttm -52.78 -26.45 14.35 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.426 -0.796 . . . . 1.9 110.081 -179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 m -60.11 -46.15 90.57 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.954 -1.091 . . . . 0.25 109.995 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.93 -25.8 63.84 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.2 109.809 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -59.42 -68.45 0.28 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.136 -0.977 . . . . 0.21 109.96 -179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 34.2 mt-30 -55.09 -44.0 74.5 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.392 -0.817 . . . . 2.47 109.78 -179.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -59.09 -36.28 74.85 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.243 -0.911 . . . . 2.1 110.128 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -62.02 -46.82 87.53 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.935 -1.103 . . . . 0.2 109.728 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -63.46 -50.22 70.59 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.334 -0.854 . . . . 0.62 109.952 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.57 -40.68 97.6 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.243 -0.911 . . . . 1.09 109.817 -179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.36 -16.45 56.25 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.176 -0.953 . . . . 0.3 109.607 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.88 -12.39 61.53 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.15 -0.969 . . . . 0.24 109.643 -179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 78.35 -116.84 4.5 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.779 -1.328 . . . . 0.28 109.779 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.406 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 42.3 t0 -135.23 4.16 3.17 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.46 -1.024 . . . . 2.21 109.466 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -68.68 169.69 10.74 Favored 'General case' 0 N--CA 1.486 1.35 0 O-C-N 120.999 -1.063 . . . . 1.9 108.737 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.442 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.15 161.31 19.38 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.905 -1.146 . . . . 0.17 107.905 179.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.442 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.4 t -144.22 104.65 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.979 -1.075 . . . . 0.12 109.637 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.464 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.4 t -101.69 127.07 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 N-CA-C 108.736 -0.838 . . . . 0.09 108.736 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -105.45 138.69 29.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.577 -0.702 . . . . 0.17 109.522 -179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -110.88 104.77 13.42 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 109.294 -0.632 . . . . 0.96 109.294 179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.425 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 40.0 m-85 -86.28 80.83 8.6 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.739 -1.208 . . . . 0.24 107.739 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.8 m -114.36 149.15 36.53 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.773 -0.579 . . . . 1.03 109.547 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.58 129.01 37.62 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.226 -0.921 . . . . 0.26 108.667 179.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -66.94 -24.85 66.12 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.18 -0.95 . . . . 0.32 110.516 -179.242 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.519 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 52.5 p-90 -87.86 -16.31 34.34 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.965 -1.084 . . . . 0.44 110.018 -179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.1 t -92.51 130.79 38.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.209 -0.932 . . . . 0.32 110.231 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.454 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.11 -56.36 7.07 Favored Glycine 0 N--CA 1.488 2.166 0 N-CA-C 111.556 -0.618 . . . . 0.36 111.556 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -47.87 -35.18 23.9 Favored 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.587 1.525 . . . . 0.44 111.482 -178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.05 -60.61 2.29 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.886 -1.134 . . . . 0.81 109.042 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 22.9 tttp -59.93 -18.78 47.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.411 -0.806 . . . . 1.92 109.931 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 23.0 ttt -59.7 -16.19 25.19 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.065 -1.022 . . . . 3.13 110.406 -179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.494 HG22 ' O ' ' A' ' 38' ' ' ILE . 32.2 mt -100.43 8.25 8.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.043 0 O-C-N 121.136 -0.978 . . . . 0.28 110.292 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.33 -32.94 6.93 Favored Pre-proline 0 C--N 1.304 -1.374 0 O-C-N 120.189 -1.569 . . . . 1.62 112.002 -179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.6 Cg_exo -65.24 -3.04 6.68 Favored 'Trans proline' 0 C--N 1.324 -0.729 0 CA-C-N 120.113 1.076 . . . . 0.25 109.693 -178.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 48.2 m-85 -111.45 -79.12 0.58 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.925 -0.769 . . . . 0.3 108.925 179.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.4 t80 -42.03 -57.02 2.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.581 -0.699 . . . . 0.13 110.806 -179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.0 t60 -66.97 -31.05 71.36 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.932 -1.105 . . . . 0.41 110.032 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.4 m -63.89 -39.94 95.35 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.776 -1.203 . . . . 0.97 110.042 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.3 mt -51.99 -15.9 0.64 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.914 -1.116 . . . . 0.5 109.781 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 3.9 m -58.6 -31.63 68.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.89 -1.131 . . . . 0.51 109.825 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' CD ' ' H ' ' A' ' 47' ' ' GLU . 3.3 mp0 -94.45 -20.14 19.96 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.015 -1.053 . . . . 2.0 109.911 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 44.7 tttm -91.72 -21.15 20.89 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.343 -0.848 . . . . 2.16 109.478 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -135.84 67.1 1.48 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.517 -0.739 . . . . 0.24 109.083 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 64.4 p -66.95 -3.28 6.67 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.212 -0.93 . . . . 0.17 109.207 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.402 ' O ' ' OD1' ' A' ' 51' ' ' ASN . 23.9 t-20 -95.19 -0.98 52.66 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.339 -0.851 . . . . 0.34 109.527 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 97.2 t -116.28 149.34 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 N-CA-C 108.941 -0.763 . . . . 0.12 108.941 179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.9 mm -99.4 127.78 51.81 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 0.17 109.562 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.541 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -114.88 128.96 56.6 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 108.793 -0.817 . . . . 0.11 108.793 179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.541 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.29 170.56 8.08 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.294 -0.879 . . . . 0.12 108.986 -179.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -141.62 141.58 33.43 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.961 -1.126 . . . . 1.31 107.961 179.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 38.5 t -138.71 136.19 43.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.23 -0.919 . . . . 0.14 110.389 -178.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -98.64 105.86 18.06 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 108.543 -0.91 . . . . 1.08 108.543 178.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.54 HG11 ' OH ' ' B' ' 5' ' ' TYR . 13.0 m -60.91 -7.15 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.352 -0.843 . . . . 0.27 111.344 -178.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 26.6 m-20 -108.87 -40.46 5.02 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.122 -0.986 . . . . 1.11 111.074 -178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -93.88 -18.91 21.48 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.86 -1.15 . . . . 1.12 109.318 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.98 47.87 1.41 Allowed 'General case' 0 N--CA 1.499 1.997 0 N-CA-C 108.236 -1.024 . . . . 0.17 108.236 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 16.6 mt-30 -54.98 -18.1 4.61 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.631 -0.668 . . . . 2.22 110.608 -179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.43 -37.32 77.36 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.847 -1.158 . . . . 1.11 109.009 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.8 t -74.5 -47.29 40.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.392 -0.817 . . . . 0.19 108.842 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.53 -33.78 76.34 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.305 -0.872 . . . . 0.22 109.189 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 62.0 m -63.71 -52.02 62.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.306 -0.871 . . . . 1.29 109.31 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.74 -31.92 73.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.355 -0.84 . . . . 2.2 110.069 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.7 -6.73 57.26 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.138 -0.976 . . . . 0.33 110.09 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 46.76 64.99 1.33 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.173 -0.955 . . . . 2.34 109.777 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.47 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 15.9 t -83.38 136.86 21.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.351 -0.843 . . . . 0.28 108.979 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.7 mptp? -122.97 -8.54 8.32 Favored 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.274 -0.891 . . . . 2.4 109.715 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.578 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.0 130.83 11.67 Favored 'General case' 0 N--CA 1.502 2.153 0 O-C-N 120.763 -1.21 . . . . 0.22 109.848 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.724 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.0 p -112.15 151.19 43.46 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.376 -0.972 . . . . 0.22 108.376 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.425 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.05 142.04 71.15 Favored 'Cis proline' 0 N--CA 1.483 0.885 0 C-N-CA 124.752 -0.937 . . . . 0.2 110.101 -1.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -113.83 114.22 25.98 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 108.031 -1.1 . . . . 0.18 108.031 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.492 ' CD1' HD21 ' A' ' 97' ' ' LEU . 81.3 m-85 -90.84 121.92 33.11 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.016 -1.053 . . . . 0.15 108.659 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.425 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.8 mt-30 -121.57 135.89 54.98 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.77 -1.196 . . . . 1.03 107.77 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.464 ' CD2' HG22 ' A' ' 24' ' ' VAL . 21.5 m-85 -106.7 132.62 52.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.523 -0.736 . . . . 0.11 110.126 -178.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 46.9 m-85 -124.55 155.68 38.62 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.313 -0.995 . . . . 0.17 108.313 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.1 tttm -155.63 121.39 5.01 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 107.3 -1.371 . . . . 1.48 107.3 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 68.9 mttt 57.44 19.73 5.43 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.636 -0.665 . . . . 1.67 109.551 -178.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.585 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 93.99 -1.07 67.46 Favored Glycine 0 N--CA 1.495 2.59 0 N-CA-C 110.432 -1.067 . . . . 0.22 110.432 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.585 HE21 ' C ' ' A' ' 83' ' ' GLY . 18.9 mm-40 -109.96 147.36 33.61 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.245 -1.15 . . . . 2.08 110.35 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.5 ttmp? -86.98 139.07 30.96 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.561 -0.712 . . . . 1.7 109.4 179.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.7 m -122.18 -14.87 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 121.474 -0.766 . . . . 0.26 109.976 -179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 179.23 171.89 42.85 Favored Glycine 0 N--CA 1.494 2.545 0 C-N-CA 119.485 -1.34 . . . . 0.18 110.409 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.505 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -172.83 156.42 3.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.428 -1.043 . . . . 2.04 109.961 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.7 p90 -168.91 133.57 1.53 Allowed 'General case' 0 C--N 1.305 -1.354 0 C-N-CA 119.626 -0.83 . . . . 0.14 110.466 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -102.75 -172.35 2.11 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 108.489 -0.93 . . . . 0.17 108.489 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.8 5.02 Favored Glycine 0 N--CA 1.498 2.77 0 N-CA-C 109.222 -1.551 . . . . 0.13 109.222 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.0 94.01 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.214 -1.169 . . . . 0.2 111.053 -179.008 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -140.25 75.71 1.52 Allowed 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.815 -1.18 . . . . 1.15 107.815 178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.502 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.31 -32.93 73.74 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.523 -0.735 . . . . 1.19 110.341 -178.694 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -65.64 -25.82 67.54 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.055 -1.028 . . . . 1.95 108.898 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 24.8 ttmt -69.19 -38.84 78.86 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.489 -0.757 . . . . 2.05 109.465 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.492 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.1 mt -53.66 -38.09 63.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.863 -1.148 . . . . 0.15 109.106 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -65.33 -56.48 12.37 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.209 -0.932 . . . . 2.15 109.506 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.29 -41.8 94.16 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.467 -0.771 . . . . 0.15 110.429 -179.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.4 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 42.0 m -66.19 -44.85 82.75 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 0.13 109.807 -179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 41.2 mt -58.18 -55.73 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.065 -1.022 . . . . 0.18 108.33 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -59.55 -16.53 25.61 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.282 -0.886 . . . . 1.03 109.903 179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -76.61 -61.23 2.03 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.203 -0.936 . . . . 2.02 110.678 -179.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 42.6 mt -93.16 15.63 14.86 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.318 -0.864 . . . . 0.35 111.038 -178.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.494 1.736 0 O-C-N 120.704 -1.248 . . . . 1.18 109.232 179.406 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 41.6 t80 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.519 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.5 mtp180 -144.51 55.61 1.27 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.283 -0.886 . . . . 0.0 109.257 -179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' B' ' 3' ' ' PHE . 27.5 m-85 -121.84 157.91 30.07 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.474 -0.767 . . . . 0.0 109.547 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 14.1 ttt180 -150.16 -92.36 0.07 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 120.914 -1.116 . . . . 0.0 110.148 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.724 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.7 p90 -111.6 -166.71 1.1 Allowed 'General case' 0 N--CA 1.511 2.604 0 O-C-N 120.626 -1.296 . . . . 0.0 111.068 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.31 151.91 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 CA-C-O 121.944 0.878 . . . . 0.0 112.308 -177.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.4 m -101.81 96.12 6.86 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.578 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.35 43.16 0.86 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.012 -1.055 . . . . 0.0 110.098 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.73 -133.07 0.07 OUTLIER Glycine 0 N--CA 1.484 1.849 0 N-CA-C 106.95 -2.46 . . . . 0.0 106.95 177.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.13 25.36 0.11 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 CA-C-N 119.319 1.56 . . . . 0.0 109.346 178.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.8 t -84.12 -40.2 18.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.34 -0.85 . . . . 0.0 109.515 -179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.586 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 25.7 t-80 -64.46 -132.88 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.193 -0.942 . . . . 0.0 109.565 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.586 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.953 -1.47 . . . . 0.0 109.583 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.7 mpt? . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.313 -0.625 . . . . 2.89 109.313 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 79.5 t -94.72 165.1 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.383 -0.823 . . . . 0.3 109.39 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.9 tttm -155.17 121.32 5.2 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.375 -0.828 . . . . 1.97 108.972 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -89.57 135.37 33.64 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -0.853 . . . . 0.98 109.534 -179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.441 HG23 ' HB3' ' A' ' 10' ' ' ALA . 13.5 mm -107.99 109.67 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 107.769 -1.196 . . . . 0.19 107.769 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -100.28 -7.14 24.91 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.247 -0.908 . . . . 1.97 110.031 -179.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.7 p -153.0 153.81 33.67 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.047 -1.033 . . . . 0.23 109.912 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -52.3 -27.37 14.96 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.396 -0.815 . . . . 1.9 109.471 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.5 m -60.42 -47.4 86.25 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.254 -0.903 . . . . 0.25 109.909 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.441 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -69.47 -24.31 63.77 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.276 -0.89 . . . . 0.2 110.139 -179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -58.31 -66.42 0.49 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.015 -1.053 . . . . 0.21 110.139 -179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.89 -44.93 78.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.333 -0.854 . . . . 2.47 109.572 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 -58.91 -36.7 75.14 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.362 -0.836 . . . . 2.1 109.9 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -59.87 -47.85 84.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.94 -1.1 . . . . 0.2 109.194 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -63.94 -42.1 97.44 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.464 -0.773 . . . . 0.62 109.713 179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -64.4 -40.97 96.84 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.136 -0.977 . . . . 1.09 109.851 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.65 -16.2 56.2 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.129 -0.982 . . . . 0.3 109.648 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.57 -5.27 18.85 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.148 -0.97 . . . . 0.24 109.578 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.11 -116.26 7.93 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.613 -1.395 . . . . 0.28 109.613 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -133.35 5.34 3.76 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.414 -1.05 . . . . 2.21 109.235 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 109' ' ' HOH . 42.6 mttp -70.43 167.72 17.67 Favored 'General case' 0 C--N 1.306 -1.314 0 O-C-N 121.186 -0.946 . . . . 1.9 108.946 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.03 161.35 16.14 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 107.894 -1.151 . . . . 0.17 107.894 179.68 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.649 ' H ' HD23 ' A' ' 22' ' ' LEU . 14.0 t -143.93 108.8 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.078 -1.014 . . . . 0.12 109.421 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.7 t -103.39 131.36 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 N-CA-C 108.592 -0.892 . . . . 0.09 108.592 179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.8 t -109.06 133.21 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.629 -0.67 . . . . 0.17 109.382 -179.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -106.86 105.33 15.3 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.92 -0.77 . . . . 0.96 108.92 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.419 ' CE2' HG11 ' A' ' 57' ' ' VAL . 38.5 m-85 -87.27 80.33 8.26 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 107.757 -1.201 . . . . 0.24 107.757 179.538 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.5 m -113.22 148.52 35.33 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.283 0.563 . . . . 1.03 109.771 -179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.468 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.48 127.07 37.83 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.407 -0.96 . . . . 0.26 108.407 178.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -66.06 -25.62 67.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.28 -0.887 . . . . 0.32 110.234 -179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.484 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.8 p-90 -89.48 -11.79 41.97 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.207 -0.933 . . . . 0.44 110.17 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 4.0 t -95.04 128.11 41.62 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.133 -0.979 . . . . 0.32 109.931 -179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.486 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.79 -58.96 7.57 Favored Glycine 0 N--CA 1.487 2.036 0 N-CA-C 111.166 -0.774 . . . . 0.36 111.166 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.4 Cg_exo -47.22 -31.64 12.74 Favored 'Trans proline' 0 C--N 1.32 -0.967 0 C-N-CA 121.897 1.731 . . . . 0.44 111.184 -178.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.4 -61.28 2.06 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.06 -1.025 . . . . 0.81 108.771 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 51.1 tttm -59.84 -17.58 37.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.469 -0.769 . . . . 1.92 110.068 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.474 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -58.6 -28.71 65.85 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.992 -1.068 . . . . 3.13 110.137 -179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.668 HG22 ' O ' ' A' ' 38' ' ' ILE . 88.1 mt -96.07 7.67 7.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 121.163 -0.961 . . . . 0.28 111.276 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.568 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.71 -35.58 23.49 Favored Pre-proline 0 C--N 1.303 -1.415 0 O-C-N 120.309 -1.494 . . . . 1.62 111.895 179.511 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.568 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -61.26 -5.98 5.98 Favored 'Trans proline' 0 C--O 1.213 -0.753 0 CA-C-N 119.842 0.979 . . . . 0.25 110.839 -176.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.3 m-85 -109.26 -71.99 0.74 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 108.987 -0.746 . . . . 0.3 108.987 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -46.37 -57.47 4.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.601 -0.687 . . . . 0.13 110.536 -179.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.0 t60 -65.47 -30.68 71.49 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.199 -0.938 . . . . 0.41 109.771 -179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.438 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.4 m -64.01 -42.1 97.27 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.979 -1.076 . . . . 0.97 109.774 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.7 mt -50.2 -13.97 0.14 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.213 -0.929 . . . . 0.5 109.365 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.438 ' N ' ' C ' ' A' ' 44' ' ' SER . 47.6 m -57.14 -34.52 68.49 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.202 -0.936 . . . . 0.51 109.647 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -94.95 -16.9 22.45 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.273 -0.892 . . . . 2.0 110.49 -179.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -89.59 -41.98 11.67 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.992 -1.067 . . . . 2.16 109.826 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -113.04 70.4 0.71 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.424 -0.798 . . . . 0.24 109.351 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 94.7 p -67.14 -5.09 12.0 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.33 -0.857 . . . . 0.17 108.84 179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -95.22 1.22 54.59 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.456 -0.778 . . . . 0.34 109.657 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 89.2 t -118.85 151.01 21.05 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 N-CA-C 108.785 -0.82 . . . . 0.12 108.785 179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.7 mm -100.83 126.51 54.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.331 -0.855 . . . . 0.17 109.042 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.556 ' C ' HD12 ' A' ' 55' ' ' LEU . 70.4 m-85 -112.02 129.26 56.26 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.397 -0.815 . . . . 0.11 108.917 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.556 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -113.12 172.2 7.08 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.729 -0.841 . . . . 0.12 108.729 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -144.06 142.07 30.43 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.824 -1.176 . . . . 1.31 107.824 179.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG11 ' CE2' ' A' ' 27' ' ' PHE . 98.1 t -139.12 136.6 42.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 121.339 -0.851 . . . . 0.14 110.176 -178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -99.0 109.35 22.12 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.922 -1.14 . . . . 1.08 107.922 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.452 HG11 ' OH ' ' B' ' 5' ' ' TYR . 20.3 m -63.74 -12.98 12.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.315 -0.865 . . . . 0.27 111.104 -178.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -100.9 -40.21 7.39 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.064 -1.022 . . . . 1.11 111.015 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.6 -14.82 26.04 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.013 -1.055 . . . . 1.12 109.289 -179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.26 44.4 2.81 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.752 -0.833 . . . . 0.17 108.752 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -55.57 -14.53 2.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 2.22 109.942 -179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.07 -38.12 75.65 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.021 -1.05 . . . . 1.11 108.891 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 17.0 t -74.56 -46.84 41.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 108.513 -0.921 . . . . 0.19 108.513 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.67 -35.09 78.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.356 -0.84 . . . . 0.22 108.928 179.435 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 58.3 m -64.5 -45.34 87.74 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.273 -0.892 . . . . 1.29 109.034 179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.7 tp10 -63.73 -41.48 98.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.421 -0.799 . . . . 2.2 109.327 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.02 -4.12 58.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.272 -0.893 . . . . 0.33 109.365 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.489 ' N ' ' O ' ' A' ' 66' ' ' ALA . 62.3 mm-40 50.26 55.07 10.03 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 2.34 110.421 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.5 t -80.4 123.27 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.054 -1.029 . . . . 0.28 108.989 179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -114.01 5.31 16.05 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.402 -0.811 . . . . 2.4 109.92 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.552 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.57 148.17 27.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.096 -1.003 . . . . 0.22 109.219 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.54 HG23 ' HE2' ' B' ' 5' ' ' TYR . 20.7 p -131.48 149.04 72.42 Favored Pre-proline 0 N--CA 1.499 2.005 0 N-CA-C 108.616 -0.883 . . . . 0.22 108.616 178.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -78.45 145.77 78.18 Favored 'Cis proline' 0 C--N 1.322 -0.85 0 C-N-CA 124.664 -0.973 . . . . 0.2 110.429 -1.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.552 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.8 m -115.7 114.92 25.49 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 107.622 -1.251 . . . . 0.18 107.622 177.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.562 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.2 m-85 -91.26 118.58 30.6 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.433 -0.907 . . . . 0.15 108.573 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -119.94 135.94 54.71 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.617 -1.253 . . . . 1.03 107.617 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CZ ' HG21 ' A' ' 100' ' ' THR . 26.8 m-85 -107.3 132.34 53.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.62 -0.675 . . . . 0.11 109.699 -178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.3 m-85 -125.0 156.22 38.45 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 108.617 -0.883 . . . . 0.17 108.617 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -156.09 121.19 4.74 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 107.783 -1.191 . . . . 1.48 107.783 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt 55.68 34.26 22.95 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.693 -0.629 . . . . 1.67 110.318 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.39 3.27 88.59 Favored Glycine 0 N--CA 1.492 2.418 0 C-N-CA 120.092 -1.052 . . . . 0.22 110.751 178.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -114.01 146.58 39.97 Favored 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.349 -1.089 . . . . 2.08 110.295 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.6 ttmt -86.49 144.4 27.28 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.718 -0.845 . . . . 1.7 108.718 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.3 m -128.03 -20.4 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.985 0 O-C-N 121.381 -0.825 . . . . 0.26 110.466 -178.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.49 174.71 47.18 Favored Glycine 0 N--CA 1.494 2.559 0 C-N-CA 119.301 -1.428 . . . . 0.18 110.13 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -174.17 156.98 2.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.306 -1.114 . . . . 2.04 110.169 -179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.9 p90 -168.91 131.88 1.34 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.528 -0.732 . . . . 0.14 109.683 178.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.7 p -103.44 -160.27 0.77 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.051 -1.03 . . . . 0.17 108.574 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.445 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 79.44 122.11 0.36 Allowed Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.47 -1.452 . . . . 0.13 109.47 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.512 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.66 94.59 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -1.122 . . . . 0.2 110.601 -179.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.445 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -137.47 71.58 1.4 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 107.805 -1.183 . . . . 1.15 107.805 178.436 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.401 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 5.8 ptpp? -61.62 -39.53 91.61 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.731 -0.605 . . . . 1.19 111.358 -178.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -65.55 -25.74 67.57 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.758 -1.214 . . . . 1.95 109.704 -178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 40.5 tttp -69.1 -32.65 72.21 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.196 -0.94 . . . . 2.05 109.575 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.562 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.6 mt -51.02 -38.85 53.88 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.232 -0.918 . . . . 0.15 109.131 179.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -66.11 -53.22 40.67 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.661 -0.816 . . . . 2.15 109.288 -179.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.42 -42.05 90.94 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.415 -0.803 . . . . 0.15 110.699 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.448 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 22.4 m -67.68 -42.94 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.028 -1.045 . . . . 0.13 110.235 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.4 mt -61.48 -52.21 63.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.009 -1.057 . . . . 0.18 108.691 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.408 ' O ' HG12 ' A' ' 105' ' ' VAL . 14.0 t-20 -61.26 -17.77 55.1 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.326 -0.858 . . . . 1.03 109.561 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -76.17 -59.36 2.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.249 -0.907 . . . . 2.02 110.043 -179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 64.0 mt -92.64 20.42 6.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.385 -0.822 . . . . 0.35 110.429 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.408 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 117.988 -1.006 . . . . 1.18 109.178 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.7 t80 . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.484 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 58.9 mtp180 -132.46 57.71 1.78 Allowed 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.443 -0.785 . . . . 0.0 109.334 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.471 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.2 m-85 -111.7 158.94 18.71 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.362 -0.836 . . . . 0.0 109.499 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -150.17 -99.28 0.07 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.321 -0.862 . . . . 0.0 109.031 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.54 ' HE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -116.1 -173.27 2.33 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.321 -0.862 . . . . 0.0 110.529 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.11 150.06 6.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 CA-C-O 121.992 0.901 . . . . 0.0 112.614 -176.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.32 97.04 7.58 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 -83.47 46.57 1.16 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.98 -179.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.619 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.78 -126.51 0.16 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 107.143 -2.383 . . . . 0.0 107.143 178.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.69 24.51 0.1 Allowed 'Trans proline' 0 C--N 1.323 -0.765 0 CA-C-N 119.2 1.5 . . . . 0.0 109.603 178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.619 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.1 t -101.33 3.81 41.0 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.534 -0.729 . . . . 0.0 110.255 -178.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.443 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 76.1 t60 -141.06 173.95 10.99 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.135 -0.978 . . . . 0.0 109.509 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.443 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.429 0 CA-C-O 118.208 -1.329 . . . . 0.0 109.789 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.404 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.8 mtt . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.427 -0.583 . . . . 2.89 109.427 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.638 HG12 ' N ' ' A' ' 3' ' ' LYS . 60.8 t -94.74 172.82 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.361 -0.837 . . . . 0.3 109.882 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.638 ' N ' HG12 ' A' ' 2' ' ' VAL . 25.9 tptp -154.24 124.92 7.09 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.25 -0.906 . . . . 1.97 108.823 179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -91.71 134.12 35.0 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.297 -0.877 . . . . 0.98 109.923 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.0 mm -110.68 109.11 27.26 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 N-CA-C 108.034 -1.099 . . . . 0.19 108.034 178.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -100.98 -11.13 19.95 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.3 -0.875 . . . . 1.97 109.811 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.5 p -152.89 154.52 35.24 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.144 -0.973 . . . . 0.23 109.715 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -51.82 -25.79 8.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.477 -0.765 . . . . 1.9 109.695 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.2 m -59.61 -48.61 80.98 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.19 -0.944 . . . . 0.25 109.767 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.14 -25.69 63.59 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.341 -0.85 . . . . 0.2 109.9 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.8 t80 -58.31 -65.56 0.63 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.902 -1.124 . . . . 0.21 110.011 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -55.51 -46.05 77.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.161 -0.962 . . . . 2.47 109.623 -179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -58.76 -35.07 72.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.217 -0.927 . . . . 2.1 110.027 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.29 -46.51 90.01 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.939 -1.101 . . . . 0.2 109.735 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.5 mt -62.85 -46.59 87.18 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.316 -0.865 . . . . 0.62 109.845 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -64.57 -38.11 89.88 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.317 -0.864 . . . . 1.09 110.089 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.91 -16.52 53.36 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.0 -1.063 . . . . 0.3 110.073 -179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -2.76 8.49 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.059 -1.026 . . . . 0.24 109.925 -179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.94 -114.79 5.77 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.555 -1.418 . . . . 0.28 109.555 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -138.42 4.72 2.43 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.336 -1.097 . . . . 2.21 109.465 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.412 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.5 mttt -70.1 168.16 16.17 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.204 -0.935 . . . . 1.9 108.748 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.62 162.39 13.11 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 107.81 -1.181 . . . . 0.17 107.81 179.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 15.1 t -145.03 109.84 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 120.771 -1.206 . . . . 0.12 109.628 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.445 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.9 t -102.9 135.62 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 N-CA-C 108.776 -0.824 . . . . 0.09 108.776 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 9.0 t -110.35 134.58 52.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.578 -0.701 . . . . 0.17 109.383 -179.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.6 t0 -105.17 101.16 10.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.697 -0.627 . . . . 0.96 109.459 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -87.41 76.56 9.04 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.933 -1.136 . . . . 0.24 107.933 179.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -113.72 148.77 35.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.772 -0.58 . . . . 1.03 109.474 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.46 125.24 36.14 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.542 -0.91 . . . . 0.26 108.542 178.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.4 t -65.18 -23.42 67.09 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.438 -0.789 . . . . 0.32 110.573 -178.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.564 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.3 p-90 -88.62 -14.76 36.7 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.053 -1.029 . . . . 0.44 109.976 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.9 t -95.64 118.36 32.18 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.343 -0.848 . . . . 0.32 109.686 -178.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.55 -58.15 16.08 Favored Glycine 0 N--CA 1.489 2.216 0 C-N-CA 120.717 -0.754 . . . . 0.36 111.435 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.4 Cg_exo -47.52 -34.96 21.08 Favored 'Trans proline' 0 C--N 1.316 -1.151 0 C-N-CA 121.806 1.67 . . . . 0.44 111.23 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.22 -60.98 2.14 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.924 -1.11 . . . . 0.81 109.208 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -58.98 -17.04 21.24 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.595 -0.691 . . . . 1.92 110.041 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.505 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.7 OUTLIER -58.45 -19.73 39.17 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.166 -0.959 . . . . 3.13 110.523 -178.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.615 HG22 ' O ' ' A' ' 38' ' ' ILE . 63.5 mt -96.55 7.2 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 121.09 -1.006 . . . . 0.28 110.813 -178.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.628 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.71 -32.27 5.8 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 119.953 -1.717 . . . . 1.62 112.645 -179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.628 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.4 Cg_exo -65.16 -7.48 15.68 Favored 'Trans proline' 0 C--N 1.319 -1.025 0 CA-C-N 119.555 0.877 . . . . 0.25 110.04 -178.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -109.52 -74.54 0.65 Allowed 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.347 -0.845 . . . . 0.3 108.976 179.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 87.2 t80 -41.66 -56.63 2.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.649 -0.657 . . . . 0.13 110.931 -179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -67.0 -31.04 71.34 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.022 -1.049 . . . . 0.41 110.1 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 12.0 t -65.73 -42.57 90.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.839 -1.163 . . . . 0.97 110.534 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 36.1 mt -50.39 -17.44 0.47 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.985 -1.072 . . . . 0.5 109.99 -179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 73.4 m -56.8 -27.77 60.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.989 -1.069 . . . . 0.51 110.051 -179.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -96.1 -22.1 17.54 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.142 -0.974 . . . . 2.0 110.323 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -90.32 -19.88 23.55 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.966 -1.084 . . . . 2.16 109.491 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -132.34 72.1 1.49 Allowed 'General case' 0 N--CA 1.497 1.92 0 O-C-N 121.594 -0.692 . . . . 0.24 109.257 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 60.2 p -67.87 -5.31 16.1 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.412 -0.805 . . . . 0.17 109.327 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.456 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 20.9 t-20 -96.47 -0.77 48.57 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.499 -0.75 . . . . 0.34 109.61 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.5 t -117.01 145.96 22.06 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.249 -0.907 . . . . 0.12 109.472 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -99.35 132.36 44.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.529 -0.732 . . . . 0.17 109.371 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.544 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.2 m-85 -117.67 130.73 56.53 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.397 -0.814 . . . . 0.11 109.059 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.544 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.2 mp -113.2 172.44 6.94 Favored 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 108.801 -0.814 . . . . 0.12 108.801 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -141.8 143.17 33.3 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 108.202 -1.036 . . . . 1.31 108.202 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.1 t -142.27 136.17 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.148 -0.97 . . . . 0.14 110.641 -178.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -97.38 103.13 15.03 Favored 'General case' 0 N--CA 1.496 1.852 0 N-CA-C 108.448 -0.945 . . . . 1.08 108.448 178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.485 ' O ' ' NE ' ' B' ' 4' ' ' ARG . 16.1 m -61.19 -8.04 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.302 -0.874 . . . . 0.27 111.036 -178.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -100.48 -46.1 5.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.119 -0.988 . . . . 1.11 110.856 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -93.12 -14.47 27.19 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.086 -1.008 . . . . 1.12 109.673 -178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -118.06 46.18 1.83 Allowed 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.306 -0.871 . . . . 0.17 109.049 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -55.07 -15.73 2.37 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 2.22 109.66 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.8 p30 -70.12 -41.11 74.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.112 -0.993 . . . . 1.11 109.056 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.2 t -73.55 -46.28 48.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.181 -0.949 . . . . 0.19 108.617 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.8 -36.67 83.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.312 -0.868 . . . . 0.22 108.735 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.1 m -64.47 -47.67 78.13 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.415 -0.803 . . . . 1.29 109.074 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -64.09 -34.42 78.0 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.38 -0.825 . . . . 2.2 109.599 179.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.92 -7.14 54.83 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.271 -0.893 . . . . 0.33 109.587 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.4 mt-10 51.11 61.12 3.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.222 -0.924 . . . . 2.34 110.21 179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.435 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 35.0 t -78.61 138.07 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.116 -0.99 . . . . 0.28 108.996 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 38.9 mmtt -123.03 -9.02 8.26 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.431 -0.793 . . . . 2.4 109.546 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -153.3 135.6 14.96 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.064 -1.022 . . . . 0.22 109.66 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.693 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -114.87 150.6 44.38 Favored Pre-proline 0 N--CA 1.5 2.027 0 N-CA-C 108.117 -1.068 . . . . 0.22 108.117 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.4 ' CG ' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.37 146.76 83.57 Favored 'Cis proline' 0 C--N 1.318 -1.054 0 C-N-CA 124.877 -0.885 . . . . 0.2 110.205 -1.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.473 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.84 121.99 42.19 Favored 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 108.429 -0.952 . . . . 0.18 108.429 178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.448 ' CD1' HD21 ' A' ' 97' ' ' LEU . 71.3 m-85 -98.82 115.93 29.9 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.395 -0.965 . . . . 0.15 108.395 179.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -115.89 141.26 48.33 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.988 -1.116 . . . . 1.03 107.988 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 25.5 m-85 -111.17 134.54 52.69 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.49 0.662 . . . . 0.11 110.156 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -130.37 155.12 46.91 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.998 -0.741 . . . . 0.17 108.998 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.6 tttm -154.58 123.18 6.13 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.91 -1.145 . . . . 1.48 107.91 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt 55.74 30.66 16.05 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.41 -0.806 . . . . 1.67 110.064 -179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.63 3.42 90.52 Favored Glycine 0 N--CA 1.493 2.443 0 C-N-CA 119.791 -1.195 . . . . 0.22 110.621 178.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -112.83 145.65 40.27 Favored 'General case' 0 N--CA 1.503 2.198 0 O-C-N 121.248 -1.148 . . . . 2.08 110.319 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 23.0 ttmt -86.88 144.8 26.83 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.364 -0.835 . . . . 1.7 108.75 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.6 m -126.68 -23.74 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.41 -0.806 . . . . 0.26 110.587 -178.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.94 179.34 47.12 Favored Glycine 0 N--CA 1.494 2.514 0 C-N-CA 119.28 -1.438 . . . . 0.18 110.272 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -174.26 158.59 2.99 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.286 -1.126 . . . . 2.04 110.357 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.6 p90 -168.98 132.14 1.34 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.476 -0.765 . . . . 0.14 110.195 178.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.5 p -104.14 -172.95 2.2 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.191 -0.943 . . . . 0.17 108.608 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.1 130.76 5.58 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 109.353 -1.499 . . . . 0.13 109.353 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.539 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -59.27 92.74 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.142 -1.211 . . . . 0.2 110.477 -179.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -139.88 71.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 107.815 -1.18 . . . . 1.15 107.815 178.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.01 -30.51 71.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.514 -0.741 . . . . 1.19 110.294 -178.64 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -66.6 -26.85 67.29 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 120.787 -1.196 . . . . 1.95 108.998 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 45.1 tttm -69.08 -34.14 74.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.486 -0.759 . . . . 2.05 109.405 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.448 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.4 mt -50.92 -37.24 42.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.02 -1.05 . . . . 0.15 108.82 179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -67.23 -57.17 7.19 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.395 -0.815 . . . . 2.15 109.667 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.71 -42.02 92.13 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.494 -0.754 . . . . 0.15 110.509 -179.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 27.5 m -66.84 -44.2 81.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.125 -0.984 . . . . 0.13 110.164 -179.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.3 mt -62.87 -52.75 55.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.12 -0.988 . . . . 0.18 108.974 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -60.1 -16.66 33.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.285 -0.885 . . . . 1.03 109.977 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -77.13 -58.28 3.37 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.131 -0.981 . . . . 2.02 110.484 -179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 29.1 mt -93.04 14.16 18.6 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.301 -0.874 . . . . 0.35 110.693 -178.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.6 p . . . . . 0 N--CA 1.494 1.764 0 O-C-N 120.863 -1.148 . . . . 1.18 109.199 179.22 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.2 p90 . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.564 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.1 OUTLIER -138.49 67.32 1.41 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.451 -0.781 . . . . 0.0 109.537 179.665 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.477 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 37.8 m-85 -119.68 142.83 48.13 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.212 -0.93 . . . . 0.0 108.708 179.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.485 ' NE ' ' O ' ' A' ' 59' ' ' VAL . 13.6 mmm180 -135.84 -109.23 0.21 Allowed 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.516 -0.74 . . . . 0.0 109.635 -179.181 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.693 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -109.59 -168.42 1.33 Allowed 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.274 -0.892 . . . . 0.0 110.525 -179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.09 146.95 11.95 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 CA-C-O 121.717 0.77 . . . . 0.0 112.114 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.0 m -101.16 95.45 6.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.547 ' N ' ' O ' ' A' ' 74' ' ' THR . 4.1 pt-20 -83.3 42.46 0.82 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.064 -1.023 . . . . 0.0 110.479 -178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.653 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.81 -130.11 0.05 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 106.872 -2.491 . . . . 0.0 106.872 177.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.81 20.0 0.09 OUTLIER 'Trans proline' 0 C--N 1.317 -1.107 0 CA-C-N 119.139 1.47 . . . . 0.0 109.05 178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.653 ' H ' ' C ' ' B' ' 9' ' ' GLY . 0.4 OUTLIER -89.01 -31.14 18.24 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.471 -0.768 . . . . 0.0 109.295 -179.706 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 46.0 t60 -155.66 152.26 28.44 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.226 -0.921 . . . . 0.0 109.656 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.353 0 CA-C-O 117.978 -1.457 . . . . 0.0 109.567 -179.952 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.412 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.51 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.312 0.577 . . . . 2.89 109.471 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.568 HG12 ' N ' ' A' ' 3' ' ' LYS . 84.3 t -94.36 164.81 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 121.238 -0.914 . . . . 0.3 109.117 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.568 ' N ' HG12 ' A' ' 2' ' ' VAL . 26.9 tttp -154.99 121.15 5.23 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.169 -0.957 . . . . 1.97 109.553 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.417 ' NE2' ' OE1' ' A' ' 6' ' ' GLU . 31.6 tt0 -89.54 136.51 32.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.245 -0.909 . . . . 0.98 109.579 -179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.9 mm -107.04 113.13 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 N-CA-C 107.606 -1.257 . . . . 0.19 107.606 178.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' OE1' ' NE2' ' A' ' 4' ' ' GLN . 4.1 mm-40 -99.79 -13.32 19.3 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.097 -1.002 . . . . 1.97 108.933 -179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.4 p -154.09 158.78 40.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.226 -0.921 . . . . 0.23 109.554 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.4 tttm -52.36 -22.97 5.16 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.418 -0.801 . . . . 1.9 110.037 -179.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 m -60.93 -51.32 69.79 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.213 -0.93 . . . . 0.25 110.671 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.26 -22.53 64.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.172 -0.955 . . . . 0.2 110.014 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.1 -64.19 1.03 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.913 -1.117 . . . . 0.21 109.791 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -55.75 -46.72 77.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.229 -0.919 . . . . 2.47 109.963 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 72.5 mt-10 -57.94 -35.66 71.42 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.196 -0.94 . . . . 2.1 109.853 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.445 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.96 -46.51 90.44 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.078 -1.014 . . . . 0.2 109.563 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.5 mt -63.26 -44.79 94.14 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.419 -0.8 . . . . 0.62 109.721 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -64.51 -36.8 85.37 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.18 -0.95 . . . . 1.09 109.727 -179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.03 -18.84 52.83 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.167 -0.958 . . . . 0.3 109.776 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -5.94 22.15 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.189 -0.944 . . . . 0.24 109.633 -179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 64.71 -105.68 1.24 Allowed Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.457 -1.457 . . . . 0.28 109.457 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -138.13 0.4 2.13 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.45 -1.03 . . . . 2.21 109.781 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.42 ' N ' ' O ' ' A' ' 109' ' ' HOH . 19.9 mtmm -69.89 172.21 8.11 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.033 -1.042 . . . . 1.9 109.012 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.623 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.34 164.42 16.12 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.383 -0.823 . . . . 0.17 108.992 -179.205 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.623 ' H ' HD23 ' A' ' 22' ' ' LEU . 20.1 t -145.94 105.07 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.164 -0.96 . . . . 0.12 109.469 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.7 t -103.67 133.73 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 O-C-N 121.304 -0.872 . . . . 0.09 109.148 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -110.64 134.07 54.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 N-CA-C 109.233 -0.654 . . . . 0.17 109.233 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -107.87 104.79 14.35 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 109.117 -0.698 . . . . 0.96 109.117 179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.515 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 57.7 m-85 -86.37 82.33 8.02 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 107.736 -1.209 . . . . 0.24 107.736 179.349 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 70.2 m -113.72 147.82 37.54 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 109.443 -0.577 . . . . 1.03 109.443 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.68 124.2 35.66 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.485 -0.931 . . . . 0.26 108.485 179.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 t -65.51 -24.8 67.22 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.37 -0.832 . . . . 0.32 110.478 -178.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 49.2 p-90 -88.79 -13.57 39.12 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.94 -1.1 . . . . 0.44 109.926 -179.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.7 116.92 29.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.433 -0.792 . . . . 0.32 109.723 -179.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.479 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -57.67 -55.47 30.34 Favored Glycine 0 N--CA 1.49 2.271 0 C-N-CA 120.832 -0.699 . . . . 0.36 111.742 -179.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.2 Cg_exo -47.86 -35.23 23.96 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.6 1.533 . . . . 0.44 111.388 -177.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.57 -60.55 2.32 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.049 -1.032 . . . . 0.81 109.194 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -59.65 -18.07 38.84 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.504 -0.748 . . . . 1.92 110.052 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.502 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.6 tmt? -58.77 -24.89 62.45 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.068 -1.02 . . . . 3.13 110.389 -179.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.456 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -96.31 13.82 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 120.873 -1.142 . . . . 0.28 110.149 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.637 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.96 -30.72 2.89 Favored Pre-proline 0 C--N 1.305 -1.351 0 O-C-N 120.585 -1.322 . . . . 1.62 112.164 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.637 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.4 Cg_endo -67.94 7.44 0.6 Allowed 'Trans proline' 0 C--O 1.216 -0.578 0 CA-C-N 119.6 0.893 . . . . 0.25 110.526 -177.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.443 ' H ' ' C ' ' A' ' 39' ' ' LYS . 45.6 m-85 -124.48 -73.7 0.63 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.756 -0.831 . . . . 0.3 108.756 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.8 t80 -43.44 -55.76 3.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.494 -0.754 . . . . 0.13 110.266 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -67.85 -27.33 66.6 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.188 -0.945 . . . . 0.41 109.869 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 46' ' ' SER . 1.4 p -65.13 -44.92 87.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 0.97 110.068 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 65.8 mt -49.15 -14.62 0.09 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.226 -0.921 . . . . 0.5 109.706 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.478 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 68.0 m -57.66 -32.14 67.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.993 -1.067 . . . . 0.51 109.743 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -94.91 -19.57 20.14 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.16 -0.963 . . . . 2.0 110.141 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -91.4 -21.69 20.85 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.954 -1.091 . . . . 2.16 109.584 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -134.2 72.76 1.47 Allowed 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.502 -0.749 . . . . 0.24 109.384 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.8 p -68.59 -6.9 28.26 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.383 -0.823 . . . . 0.17 109.35 179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -96.31 0.92 51.47 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.352 -0.842 . . . . 0.34 109.881 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.402 ' C ' HD13 ' A' ' 53' ' ' ILE . 98.6 t -112.76 146.35 17.57 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 N-CA-C 108.349 -0.982 . . . . 0.12 108.349 179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.402 HD13 ' C ' ' A' ' 52' ' ' VAL . 4.9 mm -100.42 119.42 48.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.47 -0.769 . . . . 0.17 109.538 -179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.571 ' C ' HD12 ' A' ' 55' ' ' LEU . 69.2 m-85 -108.77 130.04 55.38 Favored 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.786 -0.82 . . . . 0.11 108.786 179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -111.9 172.82 6.67 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -142.12 144.12 33.36 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 108.053 -1.091 . . . . 1.31 108.053 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.6 t -141.73 142.53 28.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.111 -0.993 . . . . 0.14 110.858 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 21.4 t70 -99.0 96.47 7.84 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.488 -0.93 . . . . 1.08 108.488 178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.486 HG21 HG21 ' A' ' 74' ' ' THR . 10.3 m -56.59 -3.06 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.324 -0.86 . . . . 0.27 110.833 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 37.7 m-20 -105.05 -46.28 4.31 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.118 -0.989 . . . . 1.11 110.991 -178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.412 ' HB2' ' HE ' ' B' ' 2' ' ' ARG . 0.4 OUTLIER -97.04 -23.56 16.2 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.106 -0.996 . . . . 1.12 110.296 -178.574 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.401 ' C ' ' N ' ' A' ' 64' ' ' ASP . . . -105.32 41.81 1.31 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 121.12 -0.988 . . . . 0.17 108.967 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.427 ' O ' ' OG ' ' A' ' 67' ' ' SER . 35.4 tt0 -54.98 -10.84 0.54 Allowed 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.397 -0.815 . . . . 2.22 109.825 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 62' ' ' ALA . 1.0 OUTLIER -68.9 -43.62 74.87 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.14 -0.975 . . . . 1.11 108.768 179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 6.3 t -74.34 -45.71 45.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 108.302 -0.999 . . . . 0.19 108.302 178.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.79 71.84 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 109.054 -0.721 . . . . 0.22 109.054 179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.427 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 6.6 m -64.0 -54.01 41.05 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.308 -0.87 . . . . 1.29 109.304 -179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -63.2 -33.41 75.42 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.476 -0.765 . . . . 2.2 110.019 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.37 1.2 54.03 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.069 -1.019 . . . . 0.33 109.859 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.409 ' OE2' ' O ' ' A' ' 67' ' ' SER . 15.0 mp0 45.0 50.46 9.11 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.278 -0.889 . . . . 2.34 110.243 179.809 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.34 130.21 36.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.182 -0.949 . . . . 0.28 108.91 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -130.12 7.61 5.07 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.396 -0.815 . . . . 2.4 110.024 -179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.495 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.63 134.27 14.58 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.161 -0.962 . . . . 0.22 108.93 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.574 HG23 ' HE1' ' B' ' 5' ' ' TYR . 23.5 p -119.78 150.24 50.07 Favored Pre-proline 0 N--CA 1.508 2.441 0 O-C-N 121.227 -0.921 . . . . 0.22 108.925 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.456 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.8 Cg_endo -76.88 145.22 80.86 Favored 'Cis proline' 0 N--CA 1.486 1.057 0 C-N-CA 124.893 -0.878 . . . . 0.2 110.758 -2.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.495 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -114.81 122.03 45.09 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 107.7 -1.222 . . . . 0.18 107.7 178.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.439 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.5 m-85 -99.26 121.08 40.58 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.271 -0.893 . . . . 0.15 108.822 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.515 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 10.1 mt-30 -119.62 135.74 54.68 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 107.894 -1.15 . . . . 1.03 107.894 -179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.7 m-85 -109.93 126.57 54.03 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.461 0.648 . . . . 0.11 109.764 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 80.5 m-85 -126.06 156.93 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.601 -0.888 . . . . 0.17 108.601 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.55 126.09 6.84 Favored 'General case' 0 C--N 1.299 -1.607 0 N-CA-C 107.786 -1.19 . . . . 1.48 107.786 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 51.4 mttm 55.05 25.27 6.81 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.311 -0.868 . . . . 1.67 109.951 -179.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.15 6.51 84.48 Favored Glycine 0 N--CA 1.495 2.588 0 C-N-CA 119.909 -1.138 . . . . 0.22 110.347 179.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.0 mt-30 -114.28 146.78 40.01 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.37 -1.076 . . . . 2.08 109.956 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.6 ttpt -85.91 143.88 27.96 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.293 -0.879 . . . . 1.7 109.529 179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.78 -27.26 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.423 -0.798 . . . . 0.26 110.315 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.43 177.99 45.57 Favored Glycine 0 N--CA 1.496 2.68 0 C-N-CA 119.388 -1.387 . . . . 0.18 110.415 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -174.08 154.14 2.22 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.285 -1.127 . . . . 2.04 110.299 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.523 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.0 p90 -169.05 133.11 1.41 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.516 -0.74 . . . . 0.14 109.982 178.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.2 p -105.51 -175.03 2.68 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.136 -0.978 . . . . 0.17 108.44 179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.403 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 98.1 133.83 8.11 Favored Glycine 0 N--CA 1.499 2.844 0 N-CA-C 109.622 -1.391 . . . . 0.13 109.622 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.56 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.24 89.32 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.153 -1.204 . . . . 0.2 110.136 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.403 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.2 t-20 -139.89 72.45 1.4 Allowed 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.466 -0.939 . . . . 1.15 108.466 178.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 1.9 pttm -65.43 -34.09 77.48 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.54 -0.725 . . . . 1.19 110.781 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -64.76 -26.6 68.42 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -68.82 -35.46 77.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.435 -0.79 . . . . 2.05 109.17 179.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.439 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.4 mt -51.13 -36.11 39.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.072 -1.017 . . . . 0.15 108.906 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -64.96 -58.5 5.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.547 -0.72 . . . . 2.15 109.34 -179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.14 -42.26 90.25 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.438 -0.789 . . . . 0.15 110.327 -179.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 22.8 m -67.61 -48.11 67.75 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.156 -0.965 . . . . 0.13 110.31 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.3 mt -62.46 -50.11 81.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.024 -1.048 . . . . 0.18 108.785 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 12.0 t30 -59.41 -17.27 29.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.184 -0.948 . . . . 1.03 109.538 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 25.3 tt0 -77.06 -62.16 1.74 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.255 -0.903 . . . . 2.02 110.009 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 52.6 mt -92.21 21.17 5.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.443 -0.786 . . . . 0.35 110.494 -178.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.3 p . . . . . 0 N--CA 1.493 1.692 0 O-C-N 120.962 -1.086 . . . . 1.18 109.236 179.585 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 24.2 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.57 ' CG ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -118.89 83.36 2.01 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.509 -0.744 . . . . 0.0 109.214 179.899 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.438 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 32.8 m-85 -133.03 146.8 52.06 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.272 -0.892 . . . . 0.0 109.079 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.432 HH11 ' HG2' ' B' ' 4' ' ' ARG . 1.1 tpt180 -147.05 -104.84 0.09 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.401 -0.812 . . . . 0.0 109.329 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.574 ' HE1' HG23 ' A' ' 74' ' ' THR . 3.6 p90 -108.97 -164.89 0.97 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 120.757 -1.214 . . . . 0.0 110.821 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.86 149.98 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.247 -0.908 . . . . 0.0 112.839 -176.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 8.4 m -101.71 95.53 6.49 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.407 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 7.3 pt-20 -84.01 42.66 0.88 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.024 -1.047 . . . . 0.0 110.532 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.08 -133.93 0.05 OUTLIER Glycine 0 N--CA 1.486 1.988 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.29 21.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.322 -0.841 0 CA-C-N 119.154 1.477 . . . . 0.0 109.649 178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -91.87 -21.02 20.85 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.411 -0.806 . . . . 0.0 109.413 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.609 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.8 OUTLIER -62.42 -159.44 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.343 -0.848 . . . . 0.0 109.629 -179.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.609 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.24 0 CA-C-O 118.01 -1.439 . . . . 0.0 109.573 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.42 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.292 0.568 . . . . 2.89 109.498 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.412 ' CG2' ' OG ' ' A' ' 46' ' ' SER . 72.5 t -94.6 153.65 3.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.24 -0.913 . . . . 0.3 109.131 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 69.3 tttt -154.6 122.58 5.91 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 1.97 109.351 179.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -89.23 135.97 33.28 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.325 -0.859 . . . . 0.98 109.447 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -106.03 123.16 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 8.9 mp0 -107.92 -15.2 14.6 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.25 -0.906 . . . . 1.97 109.627 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 77.8 p -152.16 159.23 43.65 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.02 . . . . 0.23 109.695 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -52.32 -30.86 30.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.401 -0.812 . . . . 1.9 109.861 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.1 m -59.53 -44.25 93.25 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.976 -1.078 . . . . 0.25 109.679 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.19 -27.23 64.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.303 -0.873 . . . . 0.2 109.775 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.2 t80 -59.49 -69.0 0.22 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.067 -1.02 . . . . 0.21 110.216 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.8 mt-30 -55.27 -42.04 73.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.131 -0.981 . . . . 2.47 109.61 -179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -58.99 -36.89 75.65 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.14 -0.975 . . . . 2.1 109.474 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.94 -45.34 95.07 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.143 -0.973 . . . . 0.2 109.088 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.404 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 13.6 mt -64.6 -47.8 77.28 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.458 -0.776 . . . . 0.62 109.734 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.04 -37.77 88.63 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.134 -0.979 . . . . 1.09 109.701 -179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.52 -16.53 54.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.207 -0.933 . . . . 0.3 109.616 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.07 -7.39 35.36 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.198 -0.938 . . . . 0.24 109.844 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.96 -111.01 3.42 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.535 -1.426 . . . . 0.28 109.535 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -138.64 4.72 2.37 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.254 -1.145 . . . . 2.21 109.436 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.4 mttp -70.05 168.02 16.38 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 1.9 109.193 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.654 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.34 163.59 12.8 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.045 -1.094 . . . . 0.17 108.045 179.867 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.654 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.2 t -145.26 105.71 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.016 -1.052 . . . . 0.12 109.797 -179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.8 t -101.18 133.42 44.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 N-CA-C 108.284 -1.006 . . . . 0.09 108.284 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.0 t -110.53 134.58 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.636 -0.665 . . . . 0.17 109.827 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -105.75 101.36 10.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.08 -0.711 . . . . 0.96 109.08 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE2' HG11 ' A' ' 57' ' ' VAL . 43.5 m-85 -86.14 79.23 9.19 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 107.566 -1.272 . . . . 0.24 107.566 179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.3 m -113.44 148.61 35.57 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-O 121.415 0.626 . . . . 1.03 109.748 -179.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.475 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.66 124.23 34.91 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.131 -1.063 . . . . 0.26 108.131 179.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.8 t -64.97 -23.11 67.12 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -0.893 . . . . 0.32 110.484 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 56.3 p-90 -89.84 -13.29 36.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.013 -1.054 . . . . 0.44 110.405 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.475 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -93.88 137.78 32.74 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.205 -0.934 . . . . 0.32 109.886 -178.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.16 -59.15 3.19 Favored Glycine 0 N--CA 1.486 1.999 0 C-N-CA 120.739 -0.744 . . . . 0.36 111.355 -179.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.1 Cg_exo -46.1 -43.41 20.53 Favored 'Trans proline' 0 C--N 1.317 -1.079 0 C-N-CA 121.77 1.647 . . . . 0.44 111.766 -177.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.84 -55.19 6.07 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.728 -1.232 . . . . 0.81 109.048 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 21.3 ttpp -60.45 -20.66 60.66 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.413 -0.804 . . . . 1.92 110.225 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.431 ' N ' ' O ' ' A' ' 33' ' ' GLY . 35.6 tpp -59.82 -20.5 57.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.142 -0.974 . . . . 3.13 110.557 -178.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.709 HG22 ' O ' ' A' ' 38' ' ' ILE . 81.8 mt -97.53 11.18 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.103 0 O-C-N 120.992 -1.067 . . . . 0.28 111.686 -178.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.593 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.78 -34.08 9.83 Favored Pre-proline 0 C--N 1.303 -1.425 0 O-C-N 120.02 -1.675 . . . . 1.62 112.63 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -62.52 -11.86 25.24 Favored 'Trans proline' 0 C--N 1.322 -0.863 0 CA-C-N 119.742 0.944 . . . . 0.25 110.803 -176.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -102.76 -68.29 0.84 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.248 -0.908 . . . . 0.3 109.693 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -45.42 -51.31 11.58 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.422 -0.799 . . . . 0.13 110.556 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -68.83 -34.7 75.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.937 -1.102 . . . . 0.41 110.111 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.6 m -60.71 -41.14 94.65 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.943 -1.098 . . . . 0.97 110.153 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 74.0 mt -51.4 -15.6 0.43 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.043 -1.036 . . . . 0.5 109.692 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.412 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 69.2 m -58.15 -31.7 67.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.114 -0.991 . . . . 0.51 109.902 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -94.84 -20.76 19.18 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.273 -0.892 . . . . 2.0 110.272 -179.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -90.34 -21.52 21.98 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.014 -1.054 . . . . 2.16 109.341 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -133.71 68.54 1.49 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.577 -0.702 . . . . 0.24 109.375 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.3 p -67.45 -5.54 15.33 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.286 -0.884 . . . . 0.17 108.915 179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.405 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 24.1 t-20 -95.84 4.0 53.22 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.421 -0.799 . . . . 0.34 109.646 -179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 63.7 t -118.76 149.74 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 N-CA-C 109.212 -0.662 . . . . 0.12 109.212 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.0 mm -101.94 128.56 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.421 -0.8 . . . . 0.17 109.223 -179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.4 m-85 -115.03 132.01 56.74 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.438 -0.788 . . . . 0.11 109.176 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.95 173.89 6.26 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.474 -0.766 . . . . 0.12 109.197 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -143.83 144.89 31.97 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.021 -1.103 . . . . 1.31 108.021 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 27' ' ' PHE . 69.7 t -141.6 139.63 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 121.141 -0.975 . . . . 0.14 110.521 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -99.21 100.44 11.55 Favored 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.204 -1.035 . . . . 1.08 108.204 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.1 m -60.67 -1.77 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.275 -0.891 . . . . 0.27 111.482 -178.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.68 -41.23 3.64 Favored 'General case' 0 N--CA 1.503 2.177 0 O-C-N 121.13 -0.981 . . . . 1.11 111.002 -178.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -93.0 -13.14 29.09 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.025 -1.047 . . . . 1.12 109.581 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 50.45 1.79 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.586 -0.894 . . . . 0.17 108.586 179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 34.7 mt-30 -54.93 -15.23 1.84 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.522 -0.736 . . . . 2.22 109.701 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.3 p30 -70.62 -39.88 73.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.112 -0.992 . . . . 1.11 109.364 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.5 t -73.75 -47.49 43.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.16 -0.963 . . . . 0.19 108.676 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.464 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.46 -36.21 83.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.405 -0.809 . . . . 0.22 109.288 179.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.7 m -63.35 -44.87 93.62 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.23 -0.919 . . . . 1.29 108.968 179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.4 tm-20 -63.59 -44.06 95.12 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.712 -0.847 . . . . 2.2 108.712 179.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 70' ' ' GLU . . . -89.06 10.45 21.64 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.384 -0.822 . . . . 0.33 109.519 179.674 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' N ' ' O ' ' A' ' 66' ' ' ALA . 5.2 pt-20 31.73 56.06 0.3 Allowed 'General case' 0 N--CA 1.504 2.244 0 CA-C-O 121.409 0.623 . . . . 2.34 111.362 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.5 t -79.67 134.32 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.203 -0.936 . . . . 0.28 109.037 179.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.414 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 62.7 mttm -129.66 8.7 5.39 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.47 -0.769 . . . . 2.4 109.861 -179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.556 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.45 135.11 15.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.133 -0.98 . . . . 0.22 108.902 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.519 HG23 ' CE2' ' B' ' 5' ' ' TYR . 70.6 p -121.03 149.53 51.38 Favored Pre-proline 0 N--CA 1.503 2.213 0 O-C-N 121.365 -0.835 . . . . 0.22 109.172 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -78.51 144.17 74.09 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 C-N-CA 124.962 -0.849 . . . . 0.2 110.197 -1.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.556 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -114.27 113.22 24.31 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 107.387 -1.338 . . . . 0.18 107.387 177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.527 ' CD1' HD21 ' A' ' 97' ' ' LEU . 79.1 m-85 -89.68 119.92 30.51 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.215 -0.994 . . . . 0.15 108.734 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 mt-30 -118.92 136.08 54.25 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.925 -1.139 . . . . 1.03 107.925 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.2 m-85 -110.14 127.0 54.65 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.381 0.61 . . . . 0.11 109.568 -178.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -124.98 157.54 35.86 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.752 -0.833 . . . . 0.17 108.752 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -154.8 123.66 6.21 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.429 -1.323 . . . . 1.48 107.429 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 8.9 mtmp? 57.09 27.65 13.71 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.706 -0.621 . . . . 1.67 110.078 -179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.62 5.8 87.94 Favored Glycine 0 N--CA 1.492 2.432 0 C-N-CA 120.025 -1.083 . . . . 0.22 110.427 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -112.98 146.46 39.02 Favored 'General case' 0 N--CA 1.505 2.279 0 O-C-N 121.357 -1.084 . . . . 2.08 110.282 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.0 ttpm? -85.61 139.52 31.35 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 108.766 -0.828 . . . . 1.7 108.766 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.0 m -123.61 -21.46 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.032 0 O-C-N 121.474 -0.766 . . . . 0.26 110.195 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -178.94 176.12 47.77 Favored Glycine 0 N--CA 1.494 2.557 0 C-N-CA 119.498 -1.334 . . . . 0.18 110.397 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.51 159.01 3.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -1.072 . . . . 2.04 110.336 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.541 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.4 p90 -169.0 130.84 1.21 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.466 -0.772 . . . . 0.14 109.811 178.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 p -103.27 -163.73 1.01 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.07 -1.018 . . . . 0.17 108.538 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.48 127.04 1.03 Allowed Glycine 0 N--CA 1.494 2.528 0 N-CA-C 109.19 -1.564 . . . . 0.13 109.19 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.497 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -54.53 94.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -1.16 . . . . 0.2 110.726 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -137.71 73.77 1.45 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.032 -1.099 . . . . 1.15 108.032 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.7 ptpp? -62.2 -35.82 80.05 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.878 -0.514 . . . . 1.19 110.895 -178.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -65.52 -27.09 68.22 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.97 -1.081 . . . . 1.95 109.507 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -69.65 -33.7 72.97 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 2.05 109.759 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.527 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.8 mt -49.82 -36.08 25.26 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.067 -1.021 . . . . 0.15 109.071 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 69.6 tt0 -67.35 -58.24 5.14 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.482 -0.761 . . . . 2.15 110.025 -179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.49 -36.25 77.86 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.405 -0.809 . . . . 0.15 111.273 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.458 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 16.9 m -67.47 -46.76 72.06 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.859 -1.151 . . . . 0.13 110.758 -178.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 68.1 mt -61.25 -52.19 64.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.145 -0.972 . . . . 0.18 109.46 -179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 30.4 t-20 -59.71 -17.88 38.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.199 -0.938 . . . . 1.03 109.745 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -76.4 -59.65 2.68 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.281 -0.887 . . . . 2.02 110.516 -179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.1 mt -92.93 17.37 10.76 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.404 -0.81 . . . . 0.35 110.561 -178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.7 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 120.963 -1.085 . . . . 1.18 109.31 179.296 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.3 t80 . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 121.413 0.625 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.566 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 3.8 mtt-85 -151.02 88.85 1.48 Allowed 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.548 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 40.8 m-85 -134.56 113.29 11.62 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.244 -0.91 . . . . 0.0 109.186 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.591 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -111.97 -81.05 0.59 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.986 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.519 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.3 p90 -130.44 -168.62 2.0 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.186 -0.946 . . . . 0.0 110.666 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.9 t -73.8 148.25 8.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 CA-C-O 122.007 0.908 . . . . 0.0 112.809 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.36 95.08 6.27 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -83.46 46.44 1.15 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.921 -1.112 . . . . 0.0 110.217 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.618 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.01 -130.69 0.08 OUTLIER Glycine 0 N--CA 1.484 1.897 0 N-CA-C 107.144 -2.382 . . . . 0.0 107.144 178.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -66.06 20.41 0.09 OUTLIER 'Trans proline' 0 C--N 1.323 -0.788 0 CA-C-N 119.322 1.561 . . . . 0.0 109.009 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.618 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.1 t -81.1 -51.97 7.9 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.39 -0.819 . . . . 0.0 109.506 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.457 ' ND1' ' N ' ' B' ' 13' ' ' GLY . 4.6 t60 -81.16 155.95 25.94 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.307 -0.871 . . . . 0.0 109.489 180.0 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.457 ' N ' ' ND1' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.014 -1.436 . . . . 0.0 109.559 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.3 mtt . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 121.239 0.542 . . . . 2.89 109.553 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.505 HG12 ' N ' ' A' ' 3' ' ' LYS . 39.8 t -94.39 164.56 2.07 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 121.39 -0.819 . . . . 0.3 108.934 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.505 ' N ' HG12 ' A' ' 2' ' ' VAL . 78.3 tttt -154.28 123.54 6.46 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.019 -1.051 . . . . 1.97 109.468 -179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.3 tt0 -90.65 134.4 34.43 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.365 -0.835 . . . . 0.98 110.087 -179.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.5 mm -106.99 114.11 45.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 N-CA-C 107.724 -1.213 . . . . 0.19 107.724 178.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -101.08 -13.68 18.1 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.962 . . . . 1.97 109.724 -179.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.0 p -153.72 158.76 41.48 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.114 -0.991 . . . . 0.23 109.893 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 27.5 tttp -52.1 -21.36 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.544 -0.722 . . . . 1.9 109.663 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.451 ' O ' ' OE2' ' A' ' 13' ' ' GLU . 21.1 m -61.73 -56.08 23.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.156 -0.965 . . . . 0.25 110.116 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.3 -18.06 64.42 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.2 110.262 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -60.93 -60.85 3.14 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.99 -1.068 . . . . 0.21 110.523 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -60.96 -44.35 97.43 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.016 . . . . 2.47 109.638 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' N ' ' OE1' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -60.77 -32.58 71.9 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.471 -0.768 . . . . 2.1 110.389 -179.513 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.77 -47.34 85.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.853 -1.155 . . . . 0.2 109.121 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.09 -43.55 95.04 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.508 -0.745 . . . . 0.62 109.367 179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -64.71 -40.07 94.73 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 1.09 109.806 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.71 -17.19 54.16 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.112 -0.993 . . . . 0.3 109.85 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.65 -6.61 26.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.142 -0.974 . . . . 0.24 109.679 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.46 18.22 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.365 -1.494 . . . . 0.28 109.365 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -124.18 2.68 8.57 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.553 -0.969 . . . . 2.21 109.627 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.428 ' N ' ' O ' ' A' ' 109' ' ' HOH . 74.7 mttt -69.35 167.05 17.3 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.013 -1.054 . . . . 1.9 108.739 179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -62.96 164.29 8.42 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.196 -1.038 . . . . 0.17 108.196 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.7 t -146.05 106.84 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.957 -1.089 . . . . 0.12 109.525 -179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.456 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.49 134.12 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.644 -0.873 . . . . 0.09 108.644 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -111.15 139.13 36.53 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.626 -0.671 . . . . 0.17 109.821 -179.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -109.58 99.63 8.8 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.632 -0.668 . . . . 0.96 109.248 179.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.0 m-85 -85.41 80.59 9.06 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 107.898 -1.149 . . . . 0.24 107.898 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.2 m -106.48 -163.6 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 1.03 109.633 -179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 124.35 17.38 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 108.573 -0.899 . . . . 0.26 108.573 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 t -64.43 -26.92 68.66 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.415 -0.803 . . . . 0.32 110.77 -178.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.566 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 59.3 p-90 -88.39 -16.54 32.65 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.979 -1.076 . . . . 0.44 110.009 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -96.25 120.12 35.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 0.32 109.809 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -65.03 -52.98 36.58 Favored Glycine 0 N--CA 1.486 1.992 0 O-C-N 121.519 -0.738 . . . . 0.36 111.548 -179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.3 Cg_exo -49.21 -37.04 38.49 Favored 'Trans proline' 0 C--N 1.321 -0.902 0 C-N-CA 121.664 1.576 . . . . 0.44 111.386 -178.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.96 -64.68 1.04 Allowed 'General case' 0 C--N 1.298 -1.659 0 O-C-N 120.884 -1.135 . . . . 0.81 108.993 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.3 ttpp -60.12 -15.04 20.11 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.517 -0.74 . . . . 1.92 110.332 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.48 ' N ' ' O ' ' A' ' 33' ' ' GLY . 2.0 tpt -59.94 -21.51 61.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.081 -1.012 . . . . 3.13 109.839 -179.421 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.555 HG22 ' O ' ' A' ' 38' ' ' ILE . 50.1 mt -96.93 15.07 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.167 -0.958 . . . . 0.28 110.44 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.619 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.53 -31.26 2.93 Favored Pre-proline 0 C--N 1.303 -1.423 0 O-C-N 120.687 -1.258 . . . . 1.62 112.153 179.285 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.74 -5.52 10.58 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 CA-C-N 119.798 0.963 . . . . 0.25 109.799 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 39.1 m-85 -109.72 -78.42 0.59 Allowed 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.832 -0.803 . . . . 0.3 108.832 179.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 94.0 t80 -40.46 -58.56 1.53 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.73 -0.606 . . . . 0.13 111.083 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -66.53 -30.9 71.32 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.053 -1.03 . . . . 0.41 109.939 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.8 t -65.47 -40.48 93.19 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.91 -1.119 . . . . 0.97 110.28 179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 72.6 mt -50.24 -15.93 0.28 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.99 -1.069 . . . . 0.5 109.713 -179.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 9.4 m -57.29 -29.48 63.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.065 -1.022 . . . . 0.51 109.917 -179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -96.73 -21.04 17.81 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.186 -0.946 . . . . 2.0 110.226 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.8 tptm -90.98 -22.19 20.94 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.994 -1.066 . . . . 2.16 109.747 -179.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -133.54 69.78 1.47 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.511 -0.743 . . . . 0.24 109.275 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 86.9 p -67.85 -5.95 19.19 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.465 -0.772 . . . . 0.17 109.243 179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 19.8 t-20 -94.49 3.78 54.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.311 -0.868 . . . . 0.34 109.457 -179.731 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.5 t -121.11 145.38 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 108.701 -0.852 . . . . 0.12 108.701 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.2 mm -97.86 129.01 48.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.242 -0.911 . . . . 0.17 109.422 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.525 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -114.73 130.93 56.91 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.315 -0.866 . . . . 0.11 109.423 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.5 mp -112.61 172.83 6.69 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.959 -0.756 . . . . 0.12 108.959 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 23.2 tt0 -143.89 142.2 30.68 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 107.992 -1.114 . . . . 1.31 107.992 179.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 45.4 t -142.2 136.69 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.121 -0.987 . . . . 0.14 110.774 -178.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 24.0 t70 -96.99 111.45 23.66 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 107.996 -1.113 . . . . 1.08 107.996 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 108' ' ' HOH . 16.8 m -65.33 -12.7 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.27 110.749 -178.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' B' ' 2' ' ' ARG . 10.6 m-20 -97.85 -44.41 6.72 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.013 -1.055 . . . . 1.11 111.021 -178.708 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -91.93 -15.35 28.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.02 -1.05 . . . . 1.12 109.459 -179.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 58' ' ' ASP . . . -117.24 43.05 2.41 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 108.632 -0.877 . . . . 0.17 108.632 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -55.14 -15.35 2.17 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.415 -0.803 . . . . 2.22 109.762 -179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.31 -40.22 74.35 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.256 -0.903 . . . . 1.11 109.002 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.0 t -75.26 -45.77 40.28 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 N-CA-C 108.679 -0.86 . . . . 0.19 108.679 179.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.486 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.28 -32.52 73.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.33 -0.856 . . . . 0.22 108.956 179.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.9 m -64.03 -48.94 74.33 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.355 -0.84 . . . . 1.29 109.271 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -64.08 -38.5 91.3 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.321 -0.862 . . . . 2.2 109.535 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.65 -5.53 58.08 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.212 -0.93 . . . . 0.33 109.697 -179.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.486 ' N ' ' O ' ' A' ' 66' ' ' ALA . 31.2 mt-10 46.66 57.74 5.26 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.299 -0.875 . . . . 2.34 110.284 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.0 t -78.07 132.28 32.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.137 -0.977 . . . . 0.28 108.916 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.37 2.0 8.41 Favored 'General case' 0 N--CA 1.503 2.194 0 O-C-N 121.402 -0.811 . . . . 2.4 110.244 -179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.79 131.33 13.03 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.968 -1.083 . . . . 0.22 109.061 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.645 HG23 ' CE2' ' B' ' 5' ' ' TYR . 46.9 p -116.56 149.72 44.31 Favored Pre-proline 0 N--CA 1.501 2.097 0 O-C-N 121.48 -0.762 . . . . 0.22 109.119 -179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -77.61 145.91 80.78 Favored 'Cis proline' 0 N--CA 1.487 1.091 0 C-N-CA 124.934 -0.861 . . . . 0.2 110.071 -1.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.503 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.0 m -115.96 113.42 23.24 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 107.713 -1.217 . . . . 0.18 107.713 178.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.475 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.1 m-85 -87.56 126.78 35.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.881 -1.137 . . . . 0.15 108.939 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -124.33 133.82 53.34 Favored 'General case' 0 C--N 1.299 -1.596 0 N-CA-C 107.702 -1.221 . . . . 1.03 107.702 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' CD2' HG22 ' A' ' 24' ' ' VAL . 25.3 m-85 -108.22 127.66 54.03 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.49 -0.756 . . . . 0.11 109.619 -178.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -125.69 156.66 38.96 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.714 -0.847 . . . . 0.17 108.714 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -153.86 124.97 7.36 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.558 -1.275 . . . . 1.48 107.558 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.7 mttt 56.64 20.15 4.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.569 -0.707 . . . . 1.67 109.884 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.38 2.51 70.46 Favored Glycine 0 N--CA 1.496 2.67 0 N-CA-C 110.319 -1.112 . . . . 0.22 110.319 179.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -110.35 148.12 32.58 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.258 -1.143 . . . . 2.08 110.057 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -85.01 140.43 31.04 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.376 -0.827 . . . . 1.7 109.274 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 17.6 m -127.98 -3.01 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 O-C-N 121.461 -0.775 . . . . 0.26 110.176 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 164.81 170.74 30.17 Favored Glycine 0 N--CA 1.497 2.752 0 C-N-CA 119.491 -1.338 . . . . 0.18 110.63 179.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.511 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.08 155.52 3.03 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.39 -1.065 . . . . 2.04 110.134 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.547 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.6 p90 -168.58 131.7 1.44 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.274 -0.891 . . . . 0.14 110.439 179.284 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.9 p -101.55 -165.08 1.16 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.134 -0.979 . . . . 0.17 108.875 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 86.13 131.49 2.85 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 109.143 -1.583 . . . . 0.13 109.143 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.543 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -61.13 96.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.219 -1.166 . . . . 0.2 110.837 -179.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.1 t-20 -143.06 77.6 1.57 Allowed 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 108.372 -0.973 . . . . 1.15 108.372 178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.78 -33.59 76.01 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.381 -0.825 . . . . 1.19 110.65 -178.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -65.38 -26.15 67.88 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.891 -1.131 . . . . 1.95 109.179 -179.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmp? -68.38 -36.49 79.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.405 -0.81 . . . . 2.05 109.257 179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.475 HD21 ' CD1' ' A' ' 77' ' ' PHE . 30.5 mt -52.39 -37.04 55.45 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.15 108.775 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -65.85 -58.92 4.49 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.481 -0.762 . . . . 2.15 109.76 -179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.89 -40.54 89.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.821 . . . . 0.15 110.865 -179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.1 m -66.58 -46.85 74.64 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.087 -1.008 . . . . 0.13 110.467 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.2 mt -60.1 -51.95 66.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.114 -0.991 . . . . 0.18 108.853 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 42.2 t-20 -61.18 -16.47 45.13 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.229 -0.919 . . . . 1.03 109.688 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -77.57 -56.2 4.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.263 -0.898 . . . . 2.02 110.342 -179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.516 ' HB2' HD11 ' A' ' 22' ' ' LEU . 22.4 mt -92.84 13.24 21.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.327 -0.858 . . . . 0.35 110.527 -178.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 N--CA 1.489 1.519 0 O-C-N 120.942 -1.098 . . . . 1.18 109.394 179.847 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.566 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 2.5 mtt-85 -140.86 57.15 1.56 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.262 -0.898 . . . . 0.0 109.165 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.41 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.5 m-85 -97.62 159.74 14.74 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.965 -1.084 . . . . 0.0 109.339 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -149.69 -97.89 0.07 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.332 -0.855 . . . . 0.0 109.124 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.645 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -128.2 -166.81 1.67 Allowed 'General case' 0 N--CA 1.504 2.262 0 O-C-N 121.293 -0.879 . . . . 0.0 110.55 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.9 143.18 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.375 -0.828 . . . . 0.0 112.633 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -101.78 94.76 6.0 Favored 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -83.16 46.58 1.14 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.903 -1.123 . . . . 0.0 110.134 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.08 -133.83 0.15 Allowed Glycine 0 N--CA 1.484 1.872 0 N-CA-C 106.703 -2.559 . . . . 0.0 106.703 177.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -68.95 27.73 0.15 Allowed 'Trans proline' 0 C--N 1.322 -0.845 0 CA-C-N 119.325 1.563 . . . . 0.0 109.049 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 8.2 t -89.5 -17.1 29.28 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.379 -0.826 . . . . 0.0 109.64 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.489 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 20.1 t60 -168.35 176.9 5.63 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.15 -0.969 . . . . 0.0 109.609 -179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.489 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.303 0 CA-C-O 117.989 -1.45 . . . . 0.0 109.512 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.436 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.428 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.7 mtp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.435 -0.58 . . . . 2.89 109.435 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.44 HG12 ' N ' ' A' ' 3' ' ' LYS . 91.9 t -94.53 158.63 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.354 -0.841 . . . . 0.3 109.326 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.44 ' N ' HG12 ' A' ' 2' ' ' VAL . 53.4 tttm -154.56 125.48 7.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.161 -0.962 . . . . 1.97 109.079 179.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.2 tt0 -89.39 130.66 35.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.236 -0.915 . . . . 0.98 109.994 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.8 mm -106.08 112.87 41.16 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 N-CA-C 107.768 -1.197 . . . . 0.19 107.768 178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -100.42 -15.12 18.04 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.139 -0.975 . . . . 1.97 109.641 -178.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 p -154.12 159.87 41.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.975 . . . . 0.23 109.698 179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.493 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 26.7 tttp -51.57 -22.7 3.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -0.844 . . . . 1.9 109.293 179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.0 m -60.38 -52.37 65.51 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.267 -0.895 . . . . 0.25 109.869 -179.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.02 -22.7 63.08 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.373 -0.829 . . . . 0.2 109.889 -179.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 80.6 t80 -59.49 -65.74 0.62 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.064 -1.023 . . . . 0.21 109.708 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.9 mm100 -55.04 -45.62 75.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.179 -0.951 . . . . 2.47 109.727 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -58.62 -36.22 73.73 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.303 -0.873 . . . . 2.1 109.973 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.49 86.06 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.935 -1.103 . . . . 0.2 109.409 -179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.3 mt -65.04 -46.85 79.59 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.518 -0.738 . . . . 0.62 110.02 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -63.82 -41.2 97.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.138 -0.976 . . . . 1.09 110.067 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.88 -17.21 53.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.077 -1.014 . . . . 0.3 109.646 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.67 -6.7 27.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.24 109.566 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.96 -133.47 24.73 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.434 -1.466 . . . . 0.28 109.434 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -116.74 6.11 13.22 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.363 -1.081 . . . . 2.21 109.6 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 74.5 mttt -70.66 166.82 19.95 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.062 -1.024 . . . . 1.9 109.252 179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.619 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.38 160.71 15.53 Favored 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 108.494 -0.928 . . . . 0.17 108.494 179.945 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.619 ' H ' HD23 ' A' ' 22' ' ' LEU . 21.6 t -144.61 109.22 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.11 -0.994 . . . . 0.12 109.782 179.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -106.32 133.85 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.831 0 N-CA-C 108.665 -0.865 . . . . 0.09 108.665 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.45 141.95 23.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.431 -0.793 . . . . 0.17 109.869 -178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -111.41 99.89 8.58 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.924 -0.769 . . . . 0.96 108.924 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -85.58 80.04 9.17 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 107.903 -1.147 . . . . 0.24 107.903 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.0 m -113.3 150.01 33.12 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.79 -0.569 . . . . 1.03 109.718 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.39 126.4 37.45 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.568 -0.901 . . . . 0.26 108.568 178.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.2 t -65.98 -25.89 67.31 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.324 -0.86 . . . . 0.32 110.662 -178.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.553 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.5 p-90 -87.7 -10.7 50.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.028 -1.045 . . . . 0.44 109.942 -179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.0 t -97.51 127.52 43.53 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.477 -0.764 . . . . 0.32 109.591 -178.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.516 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.94 -55.83 10.21 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 111.145 -0.782 . . . . 0.36 111.145 -179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.78 -39.64 38.85 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.912 1.742 . . . . 0.44 111.605 -177.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.61 -61.84 1.74 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.675 -1.266 . . . . 0.81 109.243 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -58.98 -20.12 49.64 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.261 -0.899 . . . . 1.92 109.82 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.457 ' N ' ' O ' ' A' ' 33' ' ' GLY . 6.7 ttt -60.37 -18.33 49.64 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.196 -0.94 . . . . 3.13 110.249 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.473 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.0 mt -99.64 8.02 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 121.254 -0.904 . . . . 0.28 110.26 -178.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.75 -31.96 5.4 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 120.648 -1.283 . . . . 1.62 112.453 179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.1 Cg_exo -62.03 -7.71 10.37 Favored 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.757 0.949 . . . . 0.25 109.81 -177.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.3 m-85 -106.28 -74.49 0.65 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 109.032 -0.729 . . . . 0.3 109.032 179.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.4 t80 -44.49 -56.08 4.58 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.754 . . . . 0.13 110.792 -179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -65.75 -32.04 73.36 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.113 -0.992 . . . . 0.41 109.877 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.7 t -64.96 -41.45 95.45 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.856 -1.152 . . . . 0.97 110.049 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 76.0 mt -50.99 -14.64 0.23 Allowed 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.07 -1.019 . . . . 0.5 109.81 -179.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 19.3 m -56.61 -32.37 65.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.038 -1.039 . . . . 0.51 109.926 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -95.09 -17.12 22.12 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.226 -0.921 . . . . 2.0 110.368 -179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.2 tmtt? -91.0 -23.51 20.37 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.123 -0.986 . . . . 2.16 109.187 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 41.5 m-85 -131.5 66.97 1.53 Allowed 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.556 -0.715 . . . . 0.24 109.245 179.61 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 50.0 p -66.68 -1.91 4.32 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.339 -0.851 . . . . 0.17 109.0 179.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.494 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 34.1 t-20 -94.94 -7.38 40.12 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.424 -0.797 . . . . 0.34 109.124 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.4 t -112.65 149.52 15.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.418 -0.801 . . . . 0.12 109.026 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.1 mm -100.37 125.48 54.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 109.052 -0.721 . . . . 0.17 109.052 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.585 ' C ' HD12 ' A' ' 55' ' ' LEU . 77.6 m-85 -109.09 132.57 53.99 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.443 -0.786 . . . . 0.11 108.996 179.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.585 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -113.11 169.56 8.84 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 108.679 -0.86 . . . . 0.12 108.679 -179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -141.01 143.32 34.36 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.729 -1.212 . . . . 1.31 107.729 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 44.8 t -141.38 138.01 32.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.132 -0.98 . . . . 0.14 111.045 -177.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -96.81 96.92 8.9 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 108.049 -1.093 . . . . 1.08 108.049 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.8 m -54.63 -8.9 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 0.27 111.464 -178.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -103.46 -44.07 5.23 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.062 -1.024 . . . . 1.11 110.672 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -92.91 -9.09 41.39 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.167 -0.958 . . . . 1.12 109.323 -179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.15 43.3 3.03 Favored 'General case' 0 N--CA 1.496 1.861 0 N-CA-C 108.708 -0.849 . . . . 0.17 108.708 179.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -54.92 -15.35 1.92 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.416 -0.802 . . . . 2.22 109.669 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.493 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.19 -39.86 74.97 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.021 -1.049 . . . . 1.11 108.913 179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 20.7 t -74.42 -46.06 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.51 -0.922 . . . . 0.19 108.51 178.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.27 -33.96 75.64 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.312 -0.868 . . . . 0.22 108.96 179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.1 m -64.29 -47.91 77.69 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.405 -0.81 . . . . 1.29 109.065 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 25.8 tt0 -64.53 -36.9 85.71 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.407 -0.808 . . . . 2.2 109.811 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.51 -3.36 59.0 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.156 -0.965 . . . . 0.33 110.166 -179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 49.57 55.81 8.8 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.05 -1.031 . . . . 2.34 109.813 179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.5 t -78.5 137.51 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.24 -0.912 . . . . 0.28 109.638 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -128.8 -4.94 5.15 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.577 -0.702 . . . . 2.4 109.465 -179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.562 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.64 136.39 15.28 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.968 -1.082 . . . . 0.22 110.006 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.606 HG23 ' CE2' ' B' ' 5' ' ' TYR . 48.3 p -115.58 150.35 44.55 Favored Pre-proline 0 N--CA 1.499 1.98 0 O-C-N 121.362 -0.836 . . . . 0.22 108.747 178.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.458 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.4 Cg_endo -77.66 143.16 73.38 Favored 'Cis proline' 0 C--N 1.32 -0.965 0 C-N-CA 124.842 -0.899 . . . . 0.2 110.13 -2.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.562 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.27 115.5 28.27 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 108.13 -1.063 . . . . 0.18 108.13 178.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.495 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.7 m-85 -91.45 115.42 28.02 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.378 -0.929 . . . . 0.15 108.568 179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -116.23 136.33 53.1 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.559 -1.274 . . . . 1.03 107.559 179.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.454 ' CZ ' HG21 ' A' ' 100' ' ' THR . 27.9 m-85 -107.75 127.38 53.64 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.596 0.713 . . . . 0.11 109.978 -177.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -121.17 156.97 31.23 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.376 -0.972 . . . . 0.17 108.376 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -155.97 123.52 5.53 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 107.501 -1.296 . . . . 1.48 107.501 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 59.1 mttm 57.89 16.54 3.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.495 -0.753 . . . . 1.67 109.544 -178.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.581 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 96.82 -1.87 61.68 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.424 -1.07 . . . . 0.22 110.424 179.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.581 HE21 ' C ' ' A' ' 83' ' ' GLY . 17.1 mm-40 -110.04 149.91 29.31 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 121.154 -1.203 . . . . 2.08 110.435 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -85.58 143.72 28.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.603 -0.685 . . . . 1.7 109.456 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.27 -21.15 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 O-C-N 121.575 -0.703 . . . . 0.26 110.222 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.94 175.0 45.98 Favored Glycine 0 N--CA 1.494 2.515 0 C-N-CA 119.652 -1.261 . . . . 0.18 110.003 -179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -173.79 154.4 2.41 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.201 -1.176 . . . . 2.04 110.232 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.538 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.0 p90 -169.5 132.09 1.2 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.481 -0.762 . . . . 0.14 109.772 178.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.1 p -104.23 -162.07 0.87 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.205 -0.934 . . . . 0.17 109.1 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.41 133.82 1.56 Allowed Glycine 0 N--CA 1.494 2.504 0 N-CA-C 109.577 -1.409 . . . . 0.13 109.577 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . . . . . . . . . . . -56.71 97.29 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.178 -1.19 . . . . 0.2 110.553 -179.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' ND2' ' H ' ' A' ' 96' ' ' LYS . 0.2 OUTLIER -141.51 72.36 1.38 Allowed 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 108.72 -0.844 . . . . 1.15 108.72 178.219 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.69 -31.15 72.23 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.291 -0.88 . . . . 1.19 110.431 -179.083 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -66.9 -31.29 71.79 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.025 -1.047 . . . . 1.95 109.467 -179.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.551 ' H ' ' ND2' ' A' ' 93' ' ' ASN . 43.4 tttp -67.87 -33.63 75.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.346 -0.846 . . . . 2.05 109.787 -179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.495 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.2 mt -51.46 -36.03 42.39 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.992 -1.068 . . . . 0.15 108.646 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -66.27 -55.74 14.65 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.557 -0.715 . . . . 2.15 109.448 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -60.0 -42.38 94.12 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.532 -0.73 . . . . 0.15 110.946 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.454 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 19.4 m -67.3 -45.97 74.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.923 -1.111 . . . . 0.13 110.44 -178.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 57.6 mt -61.71 -51.39 73.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.084 -1.01 . . . . 0.18 109.037 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -60.01 -18.57 46.99 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.342 -0.849 . . . . 1.03 109.633 -179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -76.44 -61.98 1.77 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.342 -0.849 . . . . 2.02 110.276 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 24.2 mt -91.68 21.61 4.62 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.484 -0.76 . . . . 0.35 110.534 -177.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.492 1.671 0 O-C-N 120.902 -1.124 . . . . 1.18 109.315 179.369 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.2 t80 . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.579 ' CG ' HH11 ' B' ' 2' ' ' ARG . 3.1 mtt-85 -152.03 64.27 0.84 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 0.0 109.322 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.469 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.8 m-85 -101.89 147.72 26.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.932 -1.105 . . . . 0.0 109.751 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -148.45 -105.1 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.385 -0.822 . . . . 0.0 108.79 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.606 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -111.96 -167.68 1.21 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.778 -1.201 . . . . 0.0 110.47 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.402 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -79.34 149.32 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 121.308 -0.87 . . . . 0.0 112.428 -176.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.67 95.61 6.55 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 177.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.414 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 2.7 pt-20 -83.72 47.5 1.3 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.807 -1.183 . . . . 0.0 110.061 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.609 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -74.94 -129.98 0.23 Allowed Glycine 0 N--CA 1.484 1.858 0 N-CA-C 106.851 -2.5 . . . . 0.0 106.851 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -69.72 25.07 0.17 Allowed 'Trans proline' 0 C--N 1.319 -1.004 0 N-CA-C 108.593 -1.349 . . . . 0.0 108.593 178.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.609 ' H ' ' C ' ' B' ' 9' ' ' GLY . 41.9 t -80.56 -15.94 55.41 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.533 -0.73 . . . . 0.0 109.555 -179.395 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.488 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 11.4 t-160 -159.02 -116.08 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.239 -0.913 . . . . 0.0 109.483 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.488 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.323 0 CA-C-O 117.999 -1.445 . . . . 0.0 109.511 -179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.0 mmt . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.32 0.581 . . . . 2.89 109.486 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.551 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.5 t -94.73 165.1 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.223 -0.923 . . . . 0.3 109.524 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.551 ' N ' HG12 ' A' ' 2' ' ' VAL . 74.9 tttt -155.13 130.56 9.74 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.199 -0.938 . . . . 1.97 109.124 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.447 ' NE2' ' OE2' ' A' ' 6' ' ' GLU . 19.3 tt0 -88.69 138.19 31.64 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.106 -0.996 . . . . 0.98 109.752 -179.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.5 mm -119.3 93.02 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.58 -0.896 . . . . 0.19 108.58 179.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.447 ' OE2' ' NE2' ' A' ' 4' ' ' GLN . 58.1 mt-10 -96.72 -1.01 47.36 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.014 -1.054 . . . . 1.97 109.538 -179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 57.5 p -151.85 147.82 27.07 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.975 -1.078 . . . . 0.23 110.184 -179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.439 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 54.3 tttt -52.43 -29.25 23.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.39 -0.819 . . . . 1.9 109.687 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.5 m -60.53 -45.55 93.44 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.034 -1.041 . . . . 0.25 109.557 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.45 -27.45 65.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.309 -0.869 . . . . 0.2 109.61 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.7 t80 -58.85 -65.69 0.62 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.041 -1.037 . . . . 0.21 109.534 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -55.66 -46.34 77.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.394 -0.816 . . . . 2.47 109.818 -179.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 58.7 mt-10 -58.12 -34.49 70.28 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.094 -1.004 . . . . 2.1 109.648 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.66 -47.09 86.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.998 -1.064 . . . . 0.2 109.0 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.7 -44.64 93.05 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.369 -0.832 . . . . 0.62 109.387 179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.08 -37.98 89.42 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.222 -0.924 . . . . 1.09 109.049 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.12 53.38 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.286 -0.884 . . . . 0.3 109.492 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.17 61.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.236 -0.915 . . . . 0.24 109.544 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.25 -109.33 2.8 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.993 -1.243 . . . . 0.28 109.993 179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 9.1 t0 -136.37 -0.46 2.44 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.384 -1.068 . . . . 2.21 109.32 -179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.426 ' N ' ' O ' ' A' ' 109' ' ' HOH . 72.6 mttt -68.47 163.31 23.65 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 120.664 -1.273 . . . . 1.9 108.505 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.715 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -62.24 163.63 8.07 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.115 -1.068 . . . . 0.17 108.115 -179.907 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.715 ' H ' HD23 ' A' ' 22' ' ' LEU . 12.5 t -143.62 108.36 1.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 120.979 -1.076 . . . . 0.12 109.827 -179.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -103.4 133.54 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 N-CA-C 108.642 -0.873 . . . . 0.09 108.642 179.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.7 t -110.28 137.03 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 O-C-N 121.477 -0.764 . . . . 0.17 109.736 -179.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -108.84 104.57 13.85 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.584 -0.698 . . . . 0.96 109.207 179.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.438 ' CE2' HG11 ' A' ' 57' ' ' VAL . 37.5 m-85 -86.86 80.0 8.61 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 107.932 -1.136 . . . . 0.24 107.932 179.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.1 m -114.4 147.74 38.75 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.436 0.636 . . . . 1.03 109.563 -179.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -91.71 123.1 34.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.197 -0.939 . . . . 0.26 108.681 179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 4.8 t -65.93 -21.14 66.41 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.25 -0.906 . . . . 0.32 110.319 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.595 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 56.4 p-90 -88.52 -16.99 31.24 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.006 -1.059 . . . . 0.44 109.915 -179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.4 t -91.49 136.65 32.97 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.25 -0.906 . . . . 0.32 110.209 -178.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.28 -58.17 4.78 Favored Glycine 0 N--CA 1.491 2.313 0 O-C-N 121.679 -0.638 . . . . 0.36 111.535 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.44 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -49.7 -33.38 31.7 Favored 'Trans proline' 0 C--N 1.317 -1.088 0 C-N-CA 121.597 1.532 . . . . 0.44 111.4 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.75 -60.38 2.39 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.835 -1.166 . . . . 0.81 108.841 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -58.69 -21.98 55.99 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.58 -0.7 . . . . 1.92 109.887 179.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 22.1 ttm -60.58 -21.4 62.58 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.201 -0.937 . . . . 3.13 110.533 -178.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.578 HG22 ' O ' ' A' ' 38' ' ' ILE . 54.0 mt -101.08 8.5 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.097 -1.002 . . . . 0.28 110.91 -178.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.589 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.7 -32.44 5.99 Favored Pre-proline 0 C--N 1.306 -1.31 0 C-N-CA 117.923 -1.511 . . . . 1.62 112.709 179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.3 Cg_exo -60.81 -11.61 18.52 Favored 'Trans proline' 0 C--N 1.322 -0.817 0 CA-C-N 119.906 1.002 . . . . 0.25 110.267 -177.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 34.0 m-85 -99.78 -70.3 0.74 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.262 -0.899 . . . . 0.3 109.527 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -45.01 -51.24 10.11 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.263 -0.898 . . . . 0.13 110.658 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.5 t60 -67.97 -33.83 75.39 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.003 -1.061 . . . . 0.41 109.617 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 2.2 t -61.78 -42.76 99.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.933 -1.104 . . . . 0.97 109.786 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 68.4 mt -51.9 -19.6 1.85 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.982 -1.073 . . . . 0.5 109.443 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.7 m -56.85 -32.92 66.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.51 109.275 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -94.64 -16.86 22.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.281 -0.887 . . . . 2.0 109.837 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 54.0 tttm -90.09 -20.94 22.58 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.1 -1.0 . . . . 2.16 108.959 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -134.34 71.14 1.45 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.534 -0.729 . . . . 0.24 109.241 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.3 p -66.89 -4.7 10.04 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.259 -0.9 . . . . 0.17 108.931 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.443 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 5.1 t30 -96.79 1.86 51.24 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.408 -0.807 . . . . 0.34 109.731 -179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 77.1 t -119.04 150.35 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 121.519 -0.738 . . . . 0.12 109.389 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.4 mm -100.66 131.68 47.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.304 -0.872 . . . . 0.17 109.183 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 86.4 m-85 -117.84 132.49 56.43 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.211 -0.931 . . . . 0.11 109.262 179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.1 mp -114.21 174.85 5.74 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.374 -0.829 . . . . 0.12 109.039 -179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 60.3 tt0 -142.69 142.57 32.04 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 108.084 -1.08 . . . . 1.31 108.084 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.438 HG11 ' CE2' ' A' ' 27' ' ' PHE . 44.6 t -139.74 133.59 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 O-C-N 121.109 -0.994 . . . . 0.14 110.447 -178.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -98.72 105.16 17.27 Favored 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.107 -1.071 . . . . 1.08 108.107 178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.6 m -59.33 -4.69 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.413 -0.804 . . . . 0.27 111.171 -178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 53.1 m-20 -108.9 -44.22 4.05 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.216 -0.928 . . . . 1.11 110.83 -179.005 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.427 ' HB2' HH12 ' B' ' 2' ' ' ARG . 1.8 t70 -91.57 -10.7 39.61 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.908 -1.12 . . . . 1.12 109.24 -179.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.28 47.38 2.19 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 108.303 -0.999 . . . . 0.17 108.303 178.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -55.29 -17.45 4.67 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.668 -0.645 . . . . 2.22 109.974 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.439 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 1.5 p-10 -71.54 -38.93 71.0 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.187 -0.946 . . . . 1.11 109.537 -179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -74.14 -48.39 37.73 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.206 -0.934 . . . . 0.19 108.922 179.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.8 -31.03 72.07 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.301 -0.874 . . . . 0.22 109.462 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 10.7 m -64.05 -57.1 10.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.305 -0.872 . . . . 1.29 109.679 -179.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 13.7 tp10 -63.18 -26.6 68.88 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.289 -0.882 . . . . 2.2 109.825 -179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -89.06 -3.16 58.77 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.115 -0.991 . . . . 0.33 109.923 -179.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 47.56 53.09 11.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.126 -0.984 . . . . 2.34 110.08 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.457 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 22.1 t -79.56 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.022 -1.049 . . . . 0.28 109.402 179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.4 mmtp -125.17 -1.83 7.65 Favored 'General case' 0 N--CA 1.502 2.137 0 O-C-N 121.341 -0.85 . . . . 2.4 109.815 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.507 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.56 130.98 12.91 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.019 -1.051 . . . . 0.22 109.418 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.63 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.0 p -114.99 150.63 44.5 Favored Pre-proline 0 N--CA 1.502 2.143 0 N-CA-C 108.26 -1.015 . . . . 0.22 108.26 179.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -76.92 144.07 77.53 Favored 'Cis proline' 0 N--CA 1.484 0.925 0 C-N-CA 124.842 -0.899 . . . . 0.2 110.615 -1.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.507 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -116.03 113.78 23.66 Favored 'General case' 0 N--CA 1.501 2.106 0 N-CA-C 107.757 -1.201 . . . . 0.18 107.757 178.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.504 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.3 m-85 -89.55 122.16 32.45 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.898 -1.126 . . . . 0.15 108.902 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.445 HE22 ' HB1' ' A' ' 69' ' ' ALA . 33.5 mt-30 -119.6 135.99 54.56 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.029 -1.1 . . . . 1.03 108.029 -179.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.0 m-85 -109.65 131.87 54.66 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.68 -0.637 . . . . 0.11 109.967 -178.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -129.08 157.04 42.87 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 108.884 -0.784 . . . . 0.17 108.884 179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -154.05 124.86 7.18 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.601 -1.259 . . . . 1.48 107.601 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 83.2 mttt 54.28 32.73 16.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.106 -0.996 . . . . 1.67 109.77 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 9.69 86.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.005 -1.238 . . . . 0.22 110.005 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.4 ' CA ' HE21 ' A' ' 84' ' ' GLN . 0.9 OUTLIER -114.75 144.07 44.07 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.331 -1.099 . . . . 2.08 110.363 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -85.53 146.66 26.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.939 . . . . 1.7 109.27 179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -129.91 -29.6 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 O-C-N 121.454 -0.779 . . . . 0.26 109.971 -179.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -171.58 178.03 44.1 Favored Glycine 0 N--CA 1.495 2.624 0 C-N-CA 119.5 -1.333 . . . . 0.18 110.477 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 2.9 pp20? -173.6 156.87 3.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.357 -1.084 . . . . 2.04 110.179 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.0 p90 -168.88 134.25 1.64 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.403 -0.811 . . . . 0.14 110.563 179.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.1 p -105.83 -171.33 1.88 Allowed 'General case' 0 N--CA 1.501 2.118 0 O-C-N 121.203 -0.935 . . . . 0.17 108.889 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.426 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 92.88 128.61 4.8 Favored Glycine 0 N--CA 1.5 2.905 0 N-CA-C 109.788 -1.325 . . . . 0.13 109.788 179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.41 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.87 92.39 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.296 -1.12 . . . . 0.2 110.31 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' GLY . 14.5 t-20 -140.14 73.24 1.42 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.452 -0.944 . . . . 1.15 108.452 178.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.481 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.65 -31.73 73.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.511 -0.743 . . . . 1.19 110.28 -179.068 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.517 ' CD ' ' H ' ' A' ' 95' ' ' GLU . 23.6 mp0 -66.86 -29.95 69.99 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 120.898 -1.126 . . . . 1.95 109.124 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.91 -32.38 72.8 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.418 -0.801 . . . . 2.05 109.331 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.504 HD21 ' CD1' ' A' ' 77' ' ' PHE . 29.0 mt -51.38 -35.0 36.77 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.15 108.421 179.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -68.24 -56.77 7.48 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.6 -0.687 . . . . 2.15 109.747 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.5 -40.58 87.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.39 -0.819 . . . . 0.15 110.668 -179.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.5 m -67.0 -45.13 78.54 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.08 -1.013 . . . . 0.13 110.218 -179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.2 mt -61.3 -51.97 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.102 -0.999 . . . . 0.18 109.074 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 37.8 t-20 -62.3 -15.2 46.33 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.16 -0.962 . . . . 1.03 109.781 -179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -76.12 -59.51 2.73 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.172 -0.955 . . . . 2.02 110.294 -179.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.9 mt -93.97 18.49 10.47 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.393 -0.817 . . . . 0.35 110.74 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.1 p . . . . . 0 N--CA 1.492 1.629 0 O-C-N 120.895 -1.128 . . . . 1.18 109.347 179.582 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 23.1 p90 . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.595 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 1.5 mtt-85 -129.12 68.2 1.41 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.36 -0.838 . . . . 0.0 109.244 179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.536 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 36.2 m-85 -125.35 152.84 44.23 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.145 -0.972 . . . . 0.0 109.606 -179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 1.2 ttt180 -150.38 -83.38 0.1 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.083 -1.011 . . . . 0.0 109.771 179.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.63 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.7 p90 -123.25 -168.5 1.77 Allowed 'General case' 0 N--CA 1.508 2.45 0 O-C-N 120.894 -1.129 . . . . 0.0 111.249 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.417 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.3 t -76.22 149.71 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 CA-C-O 121.886 0.851 . . . . 0.0 112.868 -176.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.91 96.95 7.38 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.457 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.0 pt-20 -83.04 46.15 1.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.041 -1.037 . . . . 0.0 110.639 -178.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.61 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.26 -130.24 0.09 OUTLIER Glycine 0 N--CA 1.484 1.9 0 N-CA-C 106.755 -2.538 . . . . 0.0 106.755 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -67.6 22.27 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.335 1.568 . . . . 0.0 109.367 178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.61 ' H ' ' C ' ' B' ' 9' ' ' GLY . 5.0 t -87.08 -18.5 30.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.359 -0.838 . . . . 0.0 109.759 -179.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.605 ' CD2' ' H ' ' B' ' 13' ' ' GLY . 69.0 t60 -149.92 -126.23 0.05 OUTLIER 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.146 -0.971 . . . . 0.0 109.358 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.605 ' H ' ' CD2' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.278 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.2 mtm . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.444 -0.576 . . . . 2.89 109.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 62.1 t -94.57 162.85 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.194 -0.941 . . . . 0.3 109.548 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 14.4 tptm -154.8 122.33 5.71 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.227 -0.92 . . . . 1.97 109.251 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -91.5 134.83 34.31 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.857 . . . . 0.98 110.015 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.0 mm -109.06 109.72 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 N-CA-C 108.063 -1.088 . . . . 0.19 108.063 178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.7 mt-10 -101.02 -7.01 23.66 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.193 -0.942 . . . . 1.97 109.847 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.0 p -152.35 153.58 33.93 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.037 -1.039 . . . . 0.23 109.926 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.437 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 69.4 tttt -52.46 -33.22 43.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.446 -0.784 . . . . 1.9 109.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 54.4 m -59.69 -41.1 89.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.152 -0.968 . . . . 0.25 109.849 -179.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.41 -25.63 63.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.337 -0.852 . . . . 0.2 109.78 -179.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -60.3 -68.31 0.31 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.011 -1.056 . . . . 0.21 110.043 -179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 -54.91 -41.25 70.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.209 -0.932 . . . . 2.47 109.785 -179.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 57.1 mm-40 -59.85 -37.69 80.0 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.084 -1.01 . . . . 2.1 109.504 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.8 -46.18 91.52 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.236 -0.915 . . . . 0.2 109.539 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.5 mt -63.32 -44.7 94.2 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.376 -0.828 . . . . 0.62 109.715 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -63.71 -41.12 98.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.25 -0.906 . . . . 1.09 109.713 -179.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.1 -14.58 58.4 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.129 -0.982 . . . . 0.3 109.732 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.59 -6.97 28.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.119 -0.988 . . . . 0.24 109.847 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.76 -113.81 4.76 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.578 -1.409 . . . . 0.28 109.578 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -139.17 5.15 2.28 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.409 -1.054 . . . . 2.21 109.499 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 76.9 mttt -70.24 170.18 12.2 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.003 -1.061 . . . . 1.9 109.097 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.7 161.51 14.91 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.932 -1.136 . . . . 0.17 107.932 179.71 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.641 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -145.33 106.16 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.927 -1.108 . . . . 0.12 109.652 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.2 t -104.94 130.3 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 108.688 -0.856 . . . . 0.09 108.688 179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.78 140.13 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.55 -0.719 . . . . 0.17 109.591 -179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.8 t0 -110.96 99.27 8.19 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 108.982 -0.747 . . . . 0.96 108.982 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 49.3 m-85 -84.64 82.98 8.18 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 107.807 -1.183 . . . . 0.24 107.807 179.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB3' ' HB1' ' A' ' 35' ' ' ALA . 41.3 m -109.39 -163.24 0.85 Allowed 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 108.985 -0.746 . . . . 1.03 108.985 -179.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.31 125.13 18.26 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.95 -0.759 . . . . 0.26 108.95 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.7 t -65.6 -30.68 71.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.613 -0.68 . . . . 0.32 111.331 -178.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.585 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 50.7 p-90 -86.04 -14.18 45.18 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.748 -1.22 . . . . 0.44 109.884 -179.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -94.76 128.58 41.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.337 -0.852 . . . . 0.32 109.657 -179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -70.62 -55.79 8.14 Favored Glycine 0 N--CA 1.488 2.163 0 O-C-N 121.579 -0.701 . . . . 0.36 111.495 -179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.482 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.6 Cg_exo -48.03 -33.58 20.99 Favored 'Trans proline' 0 C--N 1.321 -0.89 0 C-N-CA 121.72 1.613 . . . . 0.44 111.45 -178.116 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.424 ' HB1' ' HB3' ' A' ' 28' ' ' SER . . . -76.27 -59.75 2.63 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.809 -1.182 . . . . 0.81 108.958 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -60.32 -19.22 54.42 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.464 -0.773 . . . . 1.92 110.258 179.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -59.88 -19.55 52.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.01 . . . . 3.13 110.361 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.434 HD12 ' HG3' ' A' ' 75' ' ' PRO . 4.2 mt -99.45 9.08 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 O-C-N 121.16 -0.962 . . . . 0.28 110.497 -178.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.52 -31.98 4.07 Favored Pre-proline 0 C--N 1.305 -1.358 0 O-C-N 120.374 -1.454 . . . . 1.62 112.516 179.738 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -62.61 -5.0 6.37 Favored 'Trans proline' 0 C--N 1.324 -0.737 0 CA-C-N 119.947 1.017 . . . . 0.25 110.049 -177.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.528 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 45.5 m-85 -112.39 -75.49 0.61 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.218 -0.66 . . . . 0.3 109.218 179.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -43.13 -56.8 3.23 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.52 -0.738 . . . . 0.13 110.551 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -66.94 -32.37 73.57 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.11 -0.994 . . . . 0.41 110.068 -179.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.414 ' C ' ' N ' ' A' ' 46' ' ' SER . 5.5 t -63.18 -40.92 98.9 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.809 -1.182 . . . . 0.97 110.38 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 59.4 mt -50.62 -15.32 0.26 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.992 -1.067 . . . . 0.5 109.532 -179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.414 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.0 m -58.17 -30.77 66.67 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.066 -1.021 . . . . 0.51 109.521 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -96.09 -21.45 17.94 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.272 -0.892 . . . . 2.0 110.156 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -90.43 -21.01 22.12 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.037 -1.039 . . . . 2.16 109.602 -179.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.8 m-85 -134.74 67.6 1.5 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.409 -0.807 . . . . 0.24 108.896 179.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 62.5 p -66.8 -3.01 5.78 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.374 -0.829 . . . . 0.17 109.088 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.0 t-20 -95.29 -1.23 51.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.443 -0.786 . . . . 0.34 109.251 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 72.5 t -115.26 149.01 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 121.633 -0.667 . . . . 0.12 109.24 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -99.96 125.77 53.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.437 -0.789 . . . . 0.17 109.146 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.533 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -112.47 130.96 55.81 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.271 -0.893 . . . . 0.11 108.878 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.533 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.8 mp -112.51 171.58 7.44 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 108.736 -0.838 . . . . 0.12 108.736 -179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -142.82 142.57 31.87 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.836 -1.172 . . . . 1.31 107.836 179.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 39.0 t -141.12 138.28 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.152 -0.967 . . . . 0.14 110.758 -178.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -97.41 105.75 17.95 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.443 -0.947 . . . . 1.08 108.443 178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.1 m -66.94 -4.95 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.376 -0.828 . . . . 0.27 110.905 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.585 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 36.8 m-20 -102.72 -42.83 5.76 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.245 -0.91 . . . . 1.11 110.877 -178.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.21 -25.6 15.23 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.181 -0.949 . . . . 1.12 109.362 -179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -106.29 43.45 1.14 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 108.426 -0.953 . . . . 0.17 108.426 179.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.559 ' NE2' ' NH1' ' B' ' 4' ' ' ARG . 25.6 mt-30 -53.6 -13.28 0.61 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 2.22 110.235 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.437 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.1 p-10 -69.85 -40.68 75.65 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.791 -1.193 . . . . 1.11 109.19 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.6 t -73.37 -48.07 43.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.234 -0.916 . . . . 0.19 108.584 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.84 -38.19 90.17 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.528 -0.732 . . . . 0.22 109.539 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 63' ' ' GLN . 61.8 m -64.1 -43.73 94.47 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.958 . . . . 1.29 109.052 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -63.59 -40.41 96.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.343 -0.848 . . . . 2.2 109.228 179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.83 -6.27 57.47 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.273 -0.892 . . . . 0.33 109.399 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.5 ' N ' ' O ' ' A' ' 66' ' ' ALA . 46.7 mt-10 49.31 71.71 0.36 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.295 -0.878 . . . . 2.34 110.253 179.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.467 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 42.0 t -79.11 135.5 25.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.226 -0.922 . . . . 0.28 108.978 179.147 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -113.64 -12.54 12.82 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.484 -0.76 . . . . 2.4 109.805 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.618 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.78 137.69 15.43 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 120.952 -1.092 . . . . 0.22 109.81 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.733 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.7 p -115.63 151.27 45.99 Favored Pre-proline 0 N--CA 1.502 2.158 0 N-CA-C 108.487 -0.931 . . . . 0.22 108.487 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.434 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -75.73 147.33 87.89 Favored 'Cis proline' 0 N--CA 1.484 0.968 0 C-N-CA 124.651 -0.979 . . . . 0.2 109.878 -1.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -116.08 113.34 23.02 Favored 'General case' 0 N--CA 1.503 2.183 0 N-CA-C 107.996 -1.113 . . . . 0.18 107.996 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.497 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.1 m-85 -89.15 125.1 34.91 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.124 -1.03 . . . . 0.15 108.906 179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -122.16 136.71 54.94 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.895 -1.15 . . . . 1.03 107.895 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 23.4 m-85 -109.91 130.18 55.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.569 -0.707 . . . . 0.11 109.958 -178.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -128.93 157.24 42.17 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.58 -0.896 . . . . 0.17 108.58 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -155.53 122.65 5.45 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.014 -1.106 . . . . 1.48 108.014 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 43.8 mtmt 56.2 22.57 6.22 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.473 -0.767 . . . . 1.67 109.808 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.27 3.55 72.36 Favored Glycine 0 N--CA 1.495 2.611 0 N-CA-C 110.194 -1.162 . . . . 0.22 110.194 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -110.95 144.95 39.22 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.293 -1.122 . . . . 2.08 110.21 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -85.47 139.56 31.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.482 -0.761 . . . . 1.7 109.052 179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 m -127.03 -18.02 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.09 0 O-C-N 121.399 -0.813 . . . . 0.26 110.715 -179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.92 172.69 45.68 Favored Glycine 0 N--CA 1.496 2.7 0 C-N-CA 119.308 -1.425 . . . . 0.18 110.541 -179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -174.21 150.49 1.53 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 2.04 110.195 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.545 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.0 p90 -169.02 132.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.392 -0.818 . . . . 0.14 110.189 179.027 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -101.98 -160.19 0.77 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.064 -1.023 . . . . 0.17 109.066 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 79.4 129.3 0.67 Allowed Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.52 -1.432 . . . . 0.13 109.52 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.57 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.16 93.51 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.236 -1.155 . . . . 0.2 110.205 -179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -137.96 75.53 1.53 Allowed 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 107.819 -1.178 . . . . 1.15 107.819 178.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.528 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.8 ptpt -63.49 -39.36 94.23 Favored 'General case' 0 N--CA 1.492 1.665 0 CA-C-N 115.818 -0.628 . . . . 1.19 111.275 -178.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -64.58 -25.97 68.2 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 120.925 -1.11 . . . . 1.95 109.567 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -68.21 -34.79 76.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.205 -0.935 . . . . 2.05 109.528 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.497 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.8 mt -54.73 -35.96 64.25 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.911 -1.118 . . . . 0.15 108.732 179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -65.7 -58.08 6.55 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.373 -0.829 . . . . 2.15 109.54 -179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.47 -41.92 90.87 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.449 -0.782 . . . . 0.15 110.664 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.2 m -65.81 -45.73 81.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.161 -0.962 . . . . 0.13 110.183 -179.063 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.4 mt -59.48 -53.97 40.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.18 108.822 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -60.64 -17.64 48.49 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.877 . . . . 1.03 109.744 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.1 tp10 -75.9 -60.25 2.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.206 -0.934 . . . . 2.02 110.155 -179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 20.1 mt -92.64 20.74 6.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.467 -0.771 . . . . 0.35 110.416 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 p . . . . . 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.18 109.238 179.473 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.8 p90 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.442 HH11 ' HB3' ' B' ' 2' ' ' ARG . 0.0 OUTLIER -133.59 67.48 1.52 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.402 -0.811 . . . . 0.0 109.455 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -139.26 154.08 47.91 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.257 -0.902 . . . . 0.0 109.395 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.559 ' NH1' ' NE2' ' A' ' 63' ' ' GLN . 7.9 tpt180 -150.28 -79.94 0.12 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.092 -1.005 . . . . 0.0 109.701 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.733 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -128.8 -166.89 1.7 Allowed 'General case' 0 N--CA 1.509 2.501 0 O-C-N 121.013 -1.054 . . . . 0.0 110.525 179.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.55 152.36 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 CA-C-O 122.0 0.905 . . . . 0.0 112.591 -177.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -101.57 95.09 6.22 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 177.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.618 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.16 45.98 1.08 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.144 -0.972 . . . . 0.0 109.78 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.616 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.74 -131.98 0.08 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.991 -2.444 . . . . 0.0 106.991 178.161 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -67.6 24.19 0.12 Allowed 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.251 1.525 . . . . 0.0 109.147 178.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.616 ' H ' ' C ' ' B' ' 9' ' ' GLY . 30.2 t -83.54 -30.84 26.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.54 -0.725 . . . . 0.0 109.58 -179.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -160.82 -68.61 0.07 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.295 -0.878 . . . . 0.0 109.43 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.313 0 CA-C-O 117.998 -1.445 . . . . 0.0 109.569 -179.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 mtt . . . . . 0 N--CA 1.491 1.61 0 N-CA-C 109.467 -0.568 . . . . 2.89 109.467 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.479 HG12 ' N ' ' A' ' 3' ' ' LYS . 76.3 t -94.88 160.38 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.273 -0.892 . . . . 0.3 109.902 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.479 ' N ' HG12 ' A' ' 2' ' ' VAL . 83.4 tttt -155.06 125.97 7.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.262 -0.899 . . . . 1.97 109.375 179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 tt0 -90.13 136.52 33.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.254 -0.904 . . . . 0.98 109.73 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.6 mm -106.3 110.02 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 108.185 -1.042 . . . . 0.19 108.185 178.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -100.87 -9.98 21.11 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.2 -0.938 . . . . 1.97 109.703 -179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.2 p -153.18 152.6 31.43 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.11 -0.994 . . . . 0.23 109.699 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -51.9 -28.0 14.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.32 -0.863 . . . . 1.9 110.021 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 m -59.14 -44.29 92.06 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.119 -0.988 . . . . 0.25 109.692 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.32 -24.56 61.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.369 -0.832 . . . . 0.2 109.952 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.7 t80 -59.33 -68.64 0.26 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.044 -1.035 . . . . 0.21 110.328 -179.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.34 -43.2 71.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.911 . . . . 2.47 109.554 -179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -59.67 -36.73 77.02 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.228 -0.92 . . . . 2.1 110.085 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.52 -47.32 86.69 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.095 -1.003 . . . . 0.2 109.384 -179.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.29 -43.4 94.88 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.468 -0.77 . . . . 0.62 109.645 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -63.76 -40.78 97.54 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.212 -0.93 . . . . 1.09 109.771 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.25 -14.44 59.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.12 -0.988 . . . . 0.3 110.03 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -10.56 56.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.093 -1.004 . . . . 0.24 109.806 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 75.2 -112.3 3.61 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.47 -1.452 . . . . 0.28 109.47 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 42.8 m-20 -139.85 3.77 2.06 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.317 -1.107 . . . . 2.21 109.475 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.1 mttt -69.61 172.68 7.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.018 -1.051 . . . . 1.9 109.032 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.83 161.47 18.15 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.977 -1.12 . . . . 0.17 107.977 179.682 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.3 t -144.87 104.08 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.873 -1.142 . . . . 0.12 109.421 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.429 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.5 t -102.99 128.3 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.359 -0.838 . . . . 0.09 108.937 179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.9 t -105.77 139.72 26.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 121.572 -0.705 . . . . 0.17 109.565 -179.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.3 t0 -112.02 103.49 11.7 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.903 -0.777 . . . . 0.96 108.903 179.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.461 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.5 m-85 -86.06 80.31 8.87 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.3 -1.0 . . . . 0.24 108.3 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.3 m -113.45 149.4 34.28 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.652 -0.655 . . . . 1.03 109.597 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.39 129.26 37.4 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.943 . . . . 0.26 109.048 179.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.8 t -67.15 -25.32 66.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.288 -0.882 . . . . 0.32 110.855 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 54.0 p-90 -88.4 -17.58 30.19 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.842 -1.161 . . . . 0.44 110.351 -179.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -93.96 123.37 37.28 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.214 -0.929 . . . . 0.32 109.941 -179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.87 -53.74 32.43 Favored Glycine 0 N--CA 1.493 2.435 0 CA-C-O 119.426 -0.652 . . . . 0.36 112.002 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -48.32 -36.41 29.95 Favored 'Trans proline' 0 C--N 1.318 -1.039 0 C-N-CA 121.647 1.565 . . . . 0.44 111.33 -178.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.76 -60.99 2.14 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 120.918 -1.114 . . . . 0.81 109.137 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -58.28 -18.92 30.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 1.92 109.96 179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.423 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.9 ttm -58.61 -18.41 29.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.15 -0.969 . . . . 3.13 110.581 -178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 38' ' ' ILE . 67.1 mt -100.39 9.7 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.167 -0.958 . . . . 0.28 110.583 -179.343 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.6 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.74 -32.55 4.39 Favored Pre-proline 0 N--CA 1.487 1.388 0 O-C-N 120.107 -1.621 . . . . 1.62 112.598 179.22 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.6 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -64.09 -6.2 10.87 Favored 'Trans proline' 0 C--N 1.324 -0.762 0 CA-C-N 119.794 0.962 . . . . 0.25 109.758 -178.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.591 ' CD1' ' NZ ' ' A' ' 94' ' ' LYS . 32.6 m-85 -110.52 -75.21 0.63 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.544 -0.723 . . . . 0.3 109.384 179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -43.02 -57.42 2.88 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.427 -0.795 . . . . 0.13 110.67 -179.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -66.82 -31.15 71.59 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.039 -1.038 . . . . 0.41 110.04 -179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.458 ' O ' ' N ' ' A' ' 46' ' ' SER . 3.4 t -64.34 -40.1 95.21 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.822 -1.174 . . . . 0.97 109.938 179.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.5 mt -50.2 -12.87 0.09 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.079 -1.013 . . . . 0.5 109.369 -179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 44' ' ' SER . 20.2 m -58.03 -34.69 70.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.975 -1.078 . . . . 0.51 109.439 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -94.33 -13.17 26.69 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.312 -0.868 . . . . 2.0 110.084 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.3 tptm -91.65 -32.07 15.61 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.121 -0.987 . . . . 2.16 109.455 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 44.5 m-85 -126.38 71.96 1.3 Allowed 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 109.025 -0.732 . . . . 0.24 109.025 179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.5 p -66.08 -2.59 4.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.292 -0.88 . . . . 0.17 108.968 179.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.409 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 35.0 t30 -97.01 -1.99 44.37 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.478 -0.764 . . . . 0.34 109.816 -179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -116.74 148.98 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.508 -0.745 . . . . 0.12 109.586 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mm -100.37 124.21 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 108.993 -0.743 . . . . 0.17 108.993 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.559 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.7 m-85 -109.91 133.0 53.65 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.294 -0.879 . . . . 0.11 108.948 179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.4 mp -115.08 171.87 7.41 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.241 -0.912 . . . . 0.12 108.706 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 73.5 tt0 -141.94 144.24 33.65 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.028 -1.101 . . . . 1.31 108.028 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 46.8 t -141.63 139.26 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 O-C-N 121.17 -0.956 . . . . 0.14 110.507 -178.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 60' ' ' ASP . 8.7 t70 -98.98 101.97 13.54 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.859 -0.793 . . . . 1.08 108.859 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.7 m -61.04 0.43 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.363 -0.836 . . . . 0.27 110.967 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.464 ' OD2' ' NE1' ' A' ' 31' ' ' TRP . 39.3 m-20 -112.7 -41.08 3.88 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.343 -0.848 . . . . 1.11 110.655 -178.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -95.5 -21.18 18.46 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.035 -1.041 . . . . 1.12 109.503 -179.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.48 47.86 1.19 Allowed 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 108.25 -1.019 . . . . 0.17 108.25 179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.479 ' CD ' ' NH1' ' B' ' 4' ' ' ARG . 14.0 mt-30 -54.62 -18.28 4.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.749 -0.594 . . . . 2.22 110.326 -179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.2 p30 -70.82 -39.41 73.06 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 120.917 -1.114 . . . . 1.11 109.606 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 16.4 t -73.44 -47.63 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.149 -0.969 . . . . 0.19 108.836 179.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.16 -34.48 78.17 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.489 -0.757 . . . . 0.22 109.461 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.8 m -63.47 -52.72 60.16 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.315 -0.866 . . . . 1.29 109.525 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -64.75 -30.55 71.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 2.2 110.027 -179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.94 2.99 47.52 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.065 -1.022 . . . . 0.33 109.943 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 47.14 50.3 14.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 2.34 110.541 179.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.46 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 4.0 t -81.39 128.64 38.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.156 -0.965 . . . . 0.28 108.773 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -126.28 -2.13 6.94 Favored 'General case' 0 N--CA 1.502 2.151 0 O-C-N 121.363 -0.835 . . . . 2.4 110.434 -179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.32 124.68 8.21 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 120.759 -1.213 . . . . 0.22 109.427 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.685 HG23 ' CE2' ' B' ' 5' ' ' TYR . 23.7 p -106.24 151.3 40.17 Favored Pre-proline 0 N--CA 1.504 2.226 0 O-C-N 121.322 -0.861 . . . . 0.22 109.185 -179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -76.8 140.13 63.45 Favored 'Cis proline' 0 N--CA 1.484 0.946 0 C-N-CA 124.947 -0.855 . . . . 0.2 110.066 -2.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.463 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.1 m -112.38 111.11 21.73 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 108.056 -1.09 . . . . 0.18 108.056 179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.5 m-85 -89.19 118.14 28.68 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.988 -1.07 . . . . 0.15 109.127 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.3 mt-30 -117.05 135.55 53.63 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.332 -1.358 . . . . 1.03 107.332 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 18.8 m-85 -107.83 128.08 54.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.488 0.661 . . . . 0.11 109.896 -177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -123.8 156.95 35.16 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 108.94 -0.763 . . . . 0.17 108.94 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -155.26 124.35 6.23 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 107.298 -1.371 . . . . 1.48 107.298 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.3 mttt 56.0 32.65 20.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.6 -0.687 . . . . 1.67 109.382 -178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.41 7.19 87.01 Favored Glycine 0 N--CA 1.49 2.284 0 C-N-CA 119.779 -1.201 . . . . 0.22 110.143 179.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -113.03 142.6 45.52 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.375 -1.073 . . . . 2.08 110.64 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 25.2 ttmt -86.62 140.09 30.18 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.36 -0.838 . . . . 1.7 108.947 178.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.2 m -126.27 -17.39 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 121.413 -0.805 . . . . 0.26 110.693 -178.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -177.39 176.56 48.1 Favored Glycine 0 N--CA 1.496 2.638 0 C-N-CA 119.415 -1.374 . . . . 0.18 110.454 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -174.1 156.46 2.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.282 -1.128 . . . . 2.04 110.296 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.1 p90 -168.58 129.97 1.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.354 -0.841 . . . . 0.14 109.982 178.938 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.4 p -102.83 -162.16 0.9 Allowed 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.292 -0.88 . . . . 0.17 109.234 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.422 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 81.55 126.74 0.84 Allowed Glycine 0 N--CA 1.492 2.43 0 N-CA-C 108.964 -1.654 . . . . 0.13 108.964 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -53.88 94.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.091 -1.241 . . . . 0.2 110.043 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.422 ' N ' ' O ' ' A' ' 91' ' ' GLY . 0.2 OUTLIER -138.32 66.65 1.43 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 107.516 -1.29 . . . . 1.15 107.516 178.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.638 ' HZ3' HG23 ' A' ' 38' ' ' ILE . 0.0 OUTLIER -59.25 -34.11 71.83 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.824 -0.548 . . . . 1.19 111.023 -178.777 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -64.58 -26.03 68.23 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.935 -1.103 . . . . 1.95 109.254 -179.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 69.4 tttt -71.05 -36.26 72.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.44 -0.787 . . . . 2.05 110.095 -179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 77' ' ' PHE . 15.4 mt -50.8 -33.29 22.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.914 -1.117 . . . . 0.15 109.012 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -67.38 -57.01 7.37 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.467 -0.893 . . . . 2.15 109.539 179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -61.17 -40.86 95.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 0.15 110.942 -179.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.6 m -64.94 -45.3 86.35 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 120.953 -1.092 . . . . 0.13 109.918 -178.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 47.4 mt -59.63 -53.09 53.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.229 -0.919 . . . . 0.18 108.681 179.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.7 t-20 -61.27 -16.23 43.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.199 -0.938 . . . . 1.03 109.626 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -77.04 -62.38 1.67 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.945 . . . . 2.02 109.934 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.8 mt -91.25 22.62 3.73 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.316 -0.865 . . . . 0.35 110.162 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.037 -1.04 . . . . 1.18 109.295 179.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 40.7 p90 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.533 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 51.8 mtp180 -141.44 71.67 1.37 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.21 -0.931 . . . . 0.0 109.146 179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 m-85 -133.73 156.24 48.31 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.411 -0.806 . . . . 0.0 109.146 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.479 ' NH1' ' CD ' ' A' ' 63' ' ' GLN . 8.7 tpt180 -147.49 -81.59 0.13 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.013 -1.054 . . . . 0.0 109.612 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.685 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.2 p90 -129.95 -167.16 1.77 Allowed 'General case' 0 N--CA 1.507 2.407 0 O-C-N 121.053 -1.029 . . . . 0.0 110.464 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.402 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -73.75 150.58 7.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 CA-C-O 121.938 0.875 . . . . 0.0 112.522 -177.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.5 m -101.12 93.44 5.47 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 4.7 pt-20 -83.79 44.26 0.98 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.021 . . . . 0.0 110.285 -178.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.637 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.73 -130.13 0.05 OUTLIER Glycine 0 N--CA 1.487 2.095 0 N-CA-C 106.979 -2.448 . . . . 0.0 106.979 178.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -65.64 20.8 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.798 0 CA-C-N 119.533 1.667 . . . . 0.0 109.37 178.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.637 ' H ' ' C ' ' B' ' 9' ' ' GLY . 4.3 t -87.83 -29.14 21.18 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.347 -0.846 . . . . 0.0 109.525 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 71.6 t60 -76.57 155.74 33.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.297 -0.877 . . . . 0.0 109.552 -179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.988 -1.451 . . . . 0.0 109.566 179.996 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.6 mpt? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.463 -0.569 . . . . 2.89 109.463 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' LYS . 21.7 t -94.58 163.28 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.243 -0.911 . . . . 0.3 109.268 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 54.6 tttp -154.15 125.31 7.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.215 -0.928 . . . . 1.97 109.402 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.5 tt0 -89.85 136.3 33.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.334 -0.854 . . . . 0.98 109.903 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.6 mm -108.86 107.27 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 N-CA-C 108.206 -1.035 . . . . 0.19 108.206 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -99.57 -8.74 24.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.169 -0.957 . . . . 1.97 109.547 -179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 93.2 p -153.07 156.27 38.42 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.135 -0.978 . . . . 0.23 109.829 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -52.99 -30.15 33.39 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.363 -0.836 . . . . 1.9 110.075 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 86.5 m -60.27 -44.51 95.25 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -0.965 . . . . 0.25 110.313 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.28 -25.14 64.11 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.22 -0.925 . . . . 0.2 109.649 -179.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -60.76 -67.95 0.35 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.957 -1.089 . . . . 0.21 109.94 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -53.55 -44.98 69.7 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.795 . . . . 2.47 109.679 -179.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -58.61 -36.94 74.82 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.184 -0.947 . . . . 2.1 109.845 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.5 -45.93 91.97 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.081 -1.012 . . . . 0.2 109.362 -179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.1 mt -64.14 -46.56 83.58 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.414 -0.804 . . . . 0.62 109.774 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -63.45 -38.71 92.2 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.138 -0.976 . . . . 1.09 109.482 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.54 -16.88 55.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.131 -0.981 . . . . 0.3 109.667 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.47 -5.36 18.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.138 -0.976 . . . . 0.24 109.588 -179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.16 -111.45 3.92 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.453 -1.459 . . . . 0.28 109.453 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 61.5 t0 -139.06 2.49 2.12 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.434 -1.039 . . . . 2.21 109.554 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.43 ' N ' ' O ' ' A' ' 109' ' ' HOH . 83.8 mttt -68.8 171.86 7.28 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.017 . . . . 1.9 109.053 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.8 162.27 19.17 Favored 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 108.351 -0.981 . . . . 0.17 108.351 -179.89 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.571 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.2 t -144.96 107.72 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 120.874 -1.141 . . . . 0.12 109.855 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.416 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.5 t -104.06 132.66 50.04 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.889 0 N-CA-C 108.805 -0.813 . . . . 0.09 108.805 179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -109.2 140.43 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 O-C-N 121.579 -0.701 . . . . 0.17 109.598 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.4 t0 -110.59 101.28 9.96 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 109.247 -0.649 . . . . 0.96 109.247 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.579 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 42.1 m-85 -85.36 80.14 9.24 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.194 -1.039 . . . . 0.24 108.194 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.4 m -114.19 147.96 38.07 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-O 121.228 0.537 . . . . 1.03 109.651 -179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.488 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.59 131.24 37.87 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.194 -0.941 . . . . 0.26 108.853 179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.2 t -67.67 -28.02 67.34 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.311 -0.868 . . . . 0.32 110.655 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.535 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.2 p-90 -87.71 -11.61 47.74 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.909 -1.119 . . . . 0.44 110.023 -179.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.488 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.39 125.29 39.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.246 -0.909 . . . . 0.32 109.864 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -67.81 -54.12 20.04 Favored Glycine 0 N--CA 1.49 2.244 0 CA-C-O 119.491 -0.616 . . . . 0.36 112.299 -179.023 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.445 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.83 -43.85 33.63 Favored 'Trans proline' 0 C--N 1.316 -1.143 0 C-N-CA 121.544 1.496 . . . . 0.44 111.618 -177.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -73.96 -55.85 5.66 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 120.688 -1.257 . . . . 0.81 109.056 -179.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.3 tttm -60.2 -18.23 46.89 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.492 -0.755 . . . . 1.92 109.809 179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.462 ' N ' ' O ' ' A' ' 33' ' ' GLY . 23.0 ttt -62.82 -22.46 66.66 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.197 -0.939 . . . . 3.13 110.466 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.655 HG22 ' O ' ' A' ' 38' ' ' ILE . 65.5 mt -98.12 18.95 2.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.198 -0.939 . . . . 0.28 111.014 -178.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.39 -33.85 3.55 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 120.148 -1.595 . . . . 1.62 113.091 -179.802 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -64.02 -7.71 14.19 Favored 'Trans proline' 0 C--N 1.318 -1.071 0 CA-C-N 119.469 0.846 . . . . 0.25 110.595 -176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.51 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 40.0 m-85 -105.22 -73.87 0.67 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.315 -0.866 . . . . 0.3 109.803 -179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.406 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.6 t80 -41.94 -52.4 4.13 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.463 -0.773 . . . . 0.13 110.742 -179.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.9 t60 -68.73 -34.3 75.37 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.991 -1.068 . . . . 0.41 109.931 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.403 ' C ' ' N ' ' A' ' 46' ' ' SER . 4.2 t -60.64 -44.36 96.49 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.863 -1.148 . . . . 0.97 110.014 -179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.6 mt -50.43 -16.8 0.39 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.978 -1.076 . . . . 0.5 109.214 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.403 ' N ' ' C ' ' A' ' 44' ' ' SER . 20.1 m -57.06 -33.96 67.78 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.364 -0.835 . . . . 0.51 109.629 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -95.14 -18.74 20.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.217 -0.927 . . . . 2.0 110.251 -179.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 3.3 ttmp? -90.54 -20.74 22.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.021 -1.05 . . . . 2.16 109.502 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.7 m-85 -133.9 66.49 1.55 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.456 -0.777 . . . . 0.24 109.297 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 71.2 p -67.68 -3.37 8.92 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.363 -0.836 . . . . 0.17 109.251 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 30.9 t30 -94.37 0.39 55.46 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.395 -0.816 . . . . 0.34 109.46 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.7 t -120.77 150.17 23.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.926 0 N-CA-C 108.872 -0.788 . . . . 0.12 108.872 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 5.9 mm -98.55 132.02 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.191 -0.943 . . . . 0.17 109.659 -179.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.1 m-85 -117.33 131.69 56.75 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.571 -0.706 . . . . 0.11 109.102 179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -114.27 174.98 5.68 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 121.423 -0.798 . . . . 0.12 109.093 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -144.88 146.81 32.19 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 108.247 -1.019 . . . . 1.31 108.247 179.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.5 t -144.03 138.27 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 O-C-N 120.999 -1.063 . . . . 0.14 110.611 -179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.0 t70 -100.03 100.88 11.82 Favored 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 108.665 -0.865 . . . . 1.08 108.665 179.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.412 ' N ' ' O ' ' A' ' 108' ' ' HOH . 25.1 m -59.31 0.68 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.315 -0.866 . . . . 0.27 111.171 -179.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.535 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 14.9 m-20 -116.84 -41.87 3.01 Favored 'General case' 0 N--CA 1.504 2.247 0 O-C-N 121.163 -0.96 . . . . 1.11 110.709 -178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -94.13 -19.5 20.74 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.014 -1.054 . . . . 1.12 109.279 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.36 46.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 108.006 -1.109 . . . . 0.17 108.006 178.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.538 ' OE1' ' NH1' ' B' ' 4' ' ' ARG . 27.3 mt-30 -55.31 -16.46 3.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.619 -0.676 . . . . 2.22 110.533 -179.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -69.21 -36.78 77.62 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.765 -1.209 . . . . 1.11 109.113 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.5 t -73.76 -48.46 39.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 O-C-N 121.217 -0.927 . . . . 0.19 108.72 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -64.27 -36.96 85.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.382 -0.824 . . . . 0.22 109.37 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 75.0 m -63.48 -46.49 85.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.308 -0.87 . . . . 1.29 109.198 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.7 tm-20 -64.55 -38.09 89.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.183 -0.948 . . . . 2.2 109.284 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.98 -6.29 58.08 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.119 -0.988 . . . . 0.33 109.257 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 66' ' ' ALA . 35.3 mt-10 51.61 55.62 9.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.407 -0.808 . . . . 2.34 110.462 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' O ' ' CE2' ' B' ' 5' ' ' TYR . 46.2 t -84.25 124.26 39.64 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.262 -0.898 . . . . 0.28 108.999 178.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 1.4 mptp? -113.37 6.7 17.36 Favored 'General case' 0 N--CA 1.509 2.476 0 O-C-N 121.175 -0.953 . . . . 2.4 110.219 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.55 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -153.02 146.19 24.72 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 120.773 -1.204 . . . . 0.22 109.714 -179.376 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 70.3 p -127.29 148.88 68.04 Favored Pre-proline 0 N--CA 1.506 2.354 0 N-CA-C 108.284 -1.006 . . . . 0.22 108.284 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.528 ' HG3' HD12 ' A' ' 38' ' ' ILE . 12.1 Cg_endo -80.32 139.99 50.74 Favored 'Cis proline' 0 N--CA 1.487 1.113 0 N-CA-C 110.072 -0.78 . . . . 0.2 110.072 -1.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.55 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.6 m -110.58 110.53 21.27 Favored 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 108.157 -1.053 . . . . 0.18 108.157 178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.832 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.3 m-85 -86.98 115.53 24.43 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.995 -1.082 . . . . 0.15 109.206 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.579 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 32.5 mt-30 -114.2 137.01 52.32 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 107.735 -1.209 . . . . 1.03 107.735 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 19.5 m-85 -109.91 126.33 53.76 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-O 121.519 0.676 . . . . 0.11 109.592 -178.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 67.1 m-85 -123.16 156.28 35.36 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.452 -0.944 . . . . 0.17 108.452 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 32.7 tttp -155.82 122.76 5.33 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.385 -1.339 . . . . 1.48 107.385 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 37.4 mtmt 55.01 38.28 30.27 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.433 -0.792 . . . . 1.67 109.238 -178.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.02 6.25 63.75 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 110.352 -1.099 . . . . 0.22 110.352 179.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 mm100 -112.12 145.82 39.12 Favored 'General case' 0 N--CA 1.503 2.199 0 O-C-N 121.312 -1.111 . . . . 2.08 110.541 -179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -86.19 142.62 28.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.27 -0.894 . . . . 1.7 109.279 179.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.6 m -128.9 -9.97 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 121.452 -0.78 . . . . 0.26 110.341 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.75 174.4 38.01 Favored Glycine 0 N--CA 1.494 2.556 0 C-N-CA 119.389 -1.386 . . . . 0.18 110.521 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.437 ' OE2' ' O ' ' A' ' 88' ' ' GLU . 0.0 OUTLIER -173.35 156.69 3.15 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.411 -1.053 . . . . 2.04 110.06 179.903 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.539 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.1 p90 -168.88 131.12 1.27 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.421 -0.799 . . . . 0.14 110.027 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -102.77 -160.98 0.81 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.16 -0.962 . . . . 0.17 109.093 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 82.34 121.07 0.63 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.451 -1.46 . . . . 0.13 109.451 179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.544 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.34 94.7 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.231 -1.158 . . . . 0.2 110.25 -179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.459 ' N ' ' O ' ' A' ' 91' ' ' GLY . 17.8 t-20 -138.38 76.98 1.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 108.129 -1.063 . . . . 1.15 108.129 178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.51 ' NZ ' ' CE1' ' A' ' 41' ' ' PHE . 13.1 ptpt -64.57 -42.55 95.57 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.871 -0.518 . . . . 1.19 111.556 -178.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 66.5 mt-10 -63.93 -25.72 68.27 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.739 -1.226 . . . . 1.95 109.978 -178.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.3 ttmt -70.55 -32.09 69.39 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.307 -0.871 . . . . 2.05 109.432 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.832 HD21 ' CD1' ' A' ' 77' ' ' PHE . 34.1 mt -51.08 -37.54 46.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.997 -1.064 . . . . 0.15 108.805 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.2 tt0 -68.36 -56.33 8.91 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 119.822 -0.751 . . . . 2.15 109.975 -179.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -57.94 -38.16 75.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.327 -0.858 . . . . 0.15 110.453 -179.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 11.9 m -67.68 -45.21 75.84 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.117 -0.989 . . . . 0.13 110.0 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 52.7 mt -61.95 -53.44 47.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.335 -0.853 . . . . 0.18 109.274 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -59.81 -16.25 26.91 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 1.03 109.839 -179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -75.97 -60.18 2.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.125 -0.984 . . . . 2.02 109.944 -179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 37.0 mt -92.89 18.77 8.52 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.398 -0.814 . . . . 0.35 110.414 -179.01 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.493 1.695 0 O-C-N 120.957 -1.089 . . . . 1.18 109.309 179.507 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 44.2 p90 . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.521 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 56.1 mtp180 -136.88 70.64 1.41 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.344 -0.848 . . . . 0.0 109.296 -179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.464 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 38.6 m-85 -130.97 156.18 45.54 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.49 -0.756 . . . . 0.0 109.361 -179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.538 ' NH1' ' OE1' ' A' ' 63' ' ' GLN . 8.3 tpt180 -150.13 -79.71 0.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.053 -1.029 . . . . 0.0 109.417 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' ' O ' ' A' ' 71' ' ' VAL . 4.1 p90 -131.87 -166.59 1.74 Allowed 'General case' 0 N--CA 1.508 2.448 0 O-C-N 121.051 -1.031 . . . . 0.0 110.673 179.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -80.42 150.52 4.79 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.074 0 CA-C-O 122.167 0.984 . . . . 0.0 112.967 -176.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.0 m -102.63 94.35 5.59 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.4 ' CG ' ' HB1' ' A' ' 73' ' ' ALA . 3.2 pt-20 -83.21 49.82 1.63 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.908 -1.12 . . . . 0.0 109.944 -179.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.605 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -76.28 -128.09 0.28 Allowed Glycine 0 N--CA 1.485 1.906 0 N-CA-C 106.835 -2.506 . . . . 0.0 106.835 178.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -68.7 26.64 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 CA-C-N 119.372 1.586 . . . . 0.0 108.946 178.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.605 ' H ' ' C ' ' B' ' 9' ' ' GLY . 14.6 t -81.49 -20.09 40.9 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.315 -0.865 . . . . 0.0 109.271 -179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 50.7 t-80 -159.23 141.34 13.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.387 -0.821 . . . . 0.0 109.506 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 CA-C-O 118.034 -1.425 . . . . 0.0 109.589 179.988 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.412 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.43 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.6 ptm . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.302 -0.629 . . . . 2.89 109.302 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.613 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.6 t -94.75 171.17 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.941 . . . . 0.3 109.743 -179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.613 ' N ' HG12 ' A' ' 2' ' ' VAL . 36.9 tptt -153.99 123.9 6.8 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.321 -0.862 . . . . 1.97 109.002 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -90.3 128.51 36.45 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.186 -0.946 . . . . 0.98 109.861 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.2 mm -108.63 109.22 27.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 N-CA-C 107.871 -1.159 . . . . 0.19 107.871 178.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -100.23 -8.06 23.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.174 -0.954 . . . . 1.97 110.078 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.3 p -152.06 153.45 34.0 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.058 -1.026 . . . . 0.23 109.82 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.412 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 50.7 tttm -52.23 -26.15 11.03 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.373 -0.83 . . . . 1.9 109.784 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.0 m -60.17 -50.08 75.07 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.119 -0.988 . . . . 0.25 110.005 -179.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.74 -21.94 63.42 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.312 -0.867 . . . . 0.2 109.791 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.89 -65.97 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.067 -1.021 . . . . 0.21 109.864 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -54.99 -45.35 75.04 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 2.47 109.733 -179.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.92 -35.79 73.66 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.222 -0.924 . . . . 2.1 109.743 -179.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.3 -48.78 80.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.039 -1.038 . . . . 0.2 109.099 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 10.8 mt -64.55 -39.84 94.49 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.506 -0.746 . . . . 0.62 109.603 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -63.98 -42.86 97.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.292 -0.88 . . . . 1.09 109.756 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -16.04 57.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.114 -0.991 . . . . 0.3 109.613 -179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.76 -8.42 42.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.155 -0.966 . . . . 0.24 109.523 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.07 -129.39 32.12 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 109.161 -1.575 . . . . 0.28 109.161 -179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -116.97 5.89 12.93 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.575 -0.956 . . . . 2.21 109.462 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.415 ' N ' ' O ' ' A' ' 109' ' ' HOH . 45.8 mttp -69.76 167.33 17.38 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.08 -1.013 . . . . 1.9 109.266 179.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 161.47 18.99 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.331 -0.988 . . . . 0.17 108.331 -179.8 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.622 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.0 t -145.09 107.5 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.917 -1.114 . . . . 0.12 109.647 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 2.8 t -105.09 131.73 53.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 108.603 -0.888 . . . . 0.09 108.603 179.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.0 t -109.34 139.57 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.511 -0.743 . . . . 0.17 109.772 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -110.44 102.09 10.74 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 109.164 -0.68 . . . . 0.96 109.164 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -86.1 83.42 7.76 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 107.804 -1.184 . . . . 0.24 107.804 179.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 58.7 m -114.86 152.74 31.69 Favored 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.655 -0.653 . . . . 1.03 109.849 -179.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.464 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -93.4 131.06 38.94 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.559 -0.904 . . . . 0.26 108.559 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.1 t -67.46 -30.84 70.66 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.21 -0.931 . . . . 0.32 111.119 -178.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.54 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 65.9 p-90 -87.64 -5.94 58.48 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 120.937 -1.102 . . . . 0.44 110.651 -178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.464 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -98.17 132.97 43.24 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 0.32 109.691 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.466 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -74.83 -54.19 5.99 Favored Glycine 0 N--CA 1.491 2.363 0 O-C-N 121.628 -0.67 . . . . 0.36 112.019 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -49.5 -39.58 45.3 Favored 'Trans proline' 0 C--N 1.318 -1.03 0 C-N-CA 121.413 1.409 . . . . 0.44 111.603 -178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -74.88 -55.62 5.61 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 120.631 -1.293 . . . . 0.81 109.003 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 58.7 tttm -60.4 -20.57 60.14 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 1.92 110.262 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.1 tpt -60.13 -22.01 62.31 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.177 -0.952 . . . . 3.13 110.556 -179.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.706 HG22 ' O ' ' A' ' 38' ' ' ILE . 80.2 mt -96.61 14.21 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 O-C-N 120.964 -1.085 . . . . 0.28 111.69 -178.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.608 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -67.65 -33.3 5.19 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.042 -1.662 . . . . 1.62 112.924 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.608 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.99 -9.15 18.11 Favored 'Trans proline' 0 C--N 1.318 -1.052 0 CA-C-N 119.69 0.925 . . . . 0.25 110.685 -176.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -106.71 -70.84 0.77 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.433 -0.792 . . . . 0.3 109.68 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -43.69 -53.2 5.97 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.439 -0.788 . . . . 0.13 110.553 -179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.8 t60 -68.43 -34.22 75.6 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.087 -1.008 . . . . 0.41 110.022 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.0 t -60.97 -40.35 93.05 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.883 -1.135 . . . . 0.97 110.302 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 70.2 mt -51.49 -19.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.901 -1.124 . . . . 0.5 109.334 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.7 m -58.36 -28.99 65.63 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.16 -0.963 . . . . 0.51 109.815 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -95.23 -22.97 17.46 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.083 -1.011 . . . . 2.0 110.27 -179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.7 tttp -90.87 -20.2 22.53 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.045 -1.034 . . . . 2.16 109.342 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.2 m-85 -135.49 68.92 1.44 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.479 -0.763 . . . . 0.24 109.374 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 97.9 p -67.65 -5.65 16.75 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.313 -0.867 . . . . 0.17 109.164 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.504 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.6 t30 -94.7 1.52 55.51 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 0.34 109.576 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.79 147.77 17.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 N-CA-C 108.599 -0.889 . . . . 0.12 108.599 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.3 mm -99.77 127.61 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.347 -0.846 . . . . 0.17 109.567 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.569 ' C ' HD12 ' A' ' 55' ' ' LEU . 74.5 m-85 -114.74 132.14 56.54 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.371 -0.831 . . . . 0.11 109.111 179.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.569 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.7 mp -114.47 171.14 7.81 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.432 -0.793 . . . . 0.12 108.883 -179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -143.35 145.63 32.85 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.911 -1.144 . . . . 1.31 107.911 179.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.4 t -138.98 139.18 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 O-C-N 121.086 -1.009 . . . . 0.14 110.375 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HH21 ' B' ' 2' ' ' ARG . 9.9 t70 -97.78 89.71 4.71 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 107.91 -1.144 . . . . 1.08 107.91 178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.674 HG11 ' OH ' ' B' ' 5' ' ' TYR . 27.7 m -53.68 -6.16 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 O-C-N 121.595 -0.691 . . . . 0.27 111.681 -178.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.523 ' O ' ' NE2' ' A' ' 63' ' ' GLN . 46.6 m-20 -104.99 -35.17 7.75 Favored 'General case' 0 N--CA 1.502 2.128 0 O-C-N 121.073 -1.017 . . . . 1.11 110.49 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -100.51 -9.49 22.02 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.123 -0.986 . . . . 1.12 110.07 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -126.17 54.5 1.54 Allowed 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.199 -0.938 . . . . 0.17 109.433 179.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.523 ' NE2' ' O ' ' A' ' 60' ' ' ASP . 3.5 mp0 -54.88 -14.78 1.57 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.3 -0.875 . . . . 2.22 110.379 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.412 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 2.7 p-10 -69.41 -44.84 70.58 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.888 -1.133 . . . . 1.11 109.989 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.3 t -72.94 -44.62 57.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.081 -1.012 . . . . 0.19 108.692 179.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -37.13 86.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.427 -0.796 . . . . 0.22 109.236 179.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 40.0 m -64.5 -47.2 79.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.294 -0.879 . . . . 1.29 109.586 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -63.37 -38.12 89.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.35 -0.844 . . . . 2.2 109.662 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.75 -4.34 58.54 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.242 -0.911 . . . . 0.33 109.801 -179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.7 mt-10 47.66 65.88 1.17 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.197 -0.939 . . . . 2.34 109.866 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -79.15 130.09 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.228 -0.92 . . . . 0.28 109.272 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 16.7 mtpt -125.79 -5.6 6.9 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 121.413 -0.804 . . . . 2.4 109.349 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.724 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.07 129.68 11.51 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 108.131 -1.062 . . . . 0.22 108.131 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 2.4 p -124.69 157.45 65.77 Favored Pre-proline 0 N--CA 1.506 2.346 0 O-C-N 121.361 -0.837 . . . . 0.22 110.04 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -72.93 138.86 57.93 Favored 'Cis proline' 0 N--CA 1.487 1.119 0 O-C-N 122.856 0.924 . . . . 0.2 110.946 0.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -108.23 110.0 21.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 108.077 -1.083 . . . . 0.18 108.077 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.531 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -87.84 118.95 27.71 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.229 -0.989 . . . . 0.15 108.835 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.1 mt-30 -117.2 139.48 50.72 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 107.782 -1.192 . . . . 1.03 107.782 -179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 24.5 m-85 -110.92 133.85 53.04 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.54 -0.725 . . . . 0.11 110.311 -178.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -128.75 156.32 43.72 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.393 -0.965 . . . . 0.17 108.393 179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -155.55 121.54 5.09 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.202 -1.407 . . . . 1.48 107.202 179.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 22.0 mtmt 55.99 33.63 22.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.545 -0.722 . . . . 1.67 109.723 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.27 5.25 87.41 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 120.044 -1.074 . . . . 0.22 110.523 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -112.88 145.37 40.82 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.235 -1.156 . . . . 2.08 110.142 -179.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.9 ttpt -85.54 141.69 29.69 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.236 -0.915 . . . . 1.7 109.338 179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 29.9 m -120.55 -34.28 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.075 0 O-C-N 121.466 -0.771 . . . . 0.26 110.128 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -169.55 -178.17 40.56 Favored Glycine 0 N--CA 1.494 2.528 0 C-N-CA 119.537 -1.316 . . . . 0.18 110.326 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -173.46 157.17 3.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.483 -1.01 . . . . 2.04 110.215 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.548 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.1 p90 -168.67 130.5 1.3 Allowed 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 119.904 -0.718 . . . . 0.14 110.064 179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.3 p -102.7 -159.69 0.74 Allowed 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.255 -0.903 . . . . 0.17 108.917 179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.434 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.58 120.14 0.42 Allowed Glycine 0 N--CA 1.493 2.477 0 N-CA-C 109.05 -1.62 . . . . 0.13 109.05 -179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.492 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -48.43 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.18 -1.188 . . . . 0.2 110.656 -179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.434 ' N ' ' O ' ' A' ' 91' ' ' GLY . 30.3 t-20 -139.34 76.75 1.58 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.131 -1.063 . . . . 1.15 108.131 177.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 3.9 ptpp? -64.79 -40.14 94.76 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.967 -0.56 . . . . 1.19 111.074 -178.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 75.7 mt-10 -65.82 -26.44 67.68 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.057 -1.027 . . . . 1.95 109.974 -179.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 15.5 ttmm -68.1 -33.07 73.84 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.099 -1.0 . . . . 2.05 109.284 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.531 HD21 ' CD1' ' A' ' 77' ' ' PHE . 38.2 mt -50.46 -34.73 25.86 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.052 -1.03 . . . . 0.15 108.52 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -67.31 -56.77 8.41 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.596 -0.69 . . . . 2.15 109.597 -179.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.04 -40.84 86.3 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.412 -0.805 . . . . 0.15 110.548 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 12.3 m -66.91 -47.69 71.0 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.115 -0.991 . . . . 0.13 110.361 -178.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 60.4 mt -61.29 -48.81 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.079 -1.013 . . . . 0.18 108.842 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.414 ' O ' HG12 ' A' ' 105' ' ' VAL . 50.6 t-20 -62.43 -16.84 57.33 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.241 -0.912 . . . . 1.03 109.443 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -78.17 -58.69 3.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.274 -0.891 . . . . 2.02 110.435 -179.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 44.7 mt -91.24 19.07 6.23 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.382 -0.823 . . . . 0.35 110.415 -178.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.414 HG12 ' O ' ' A' ' 102' ' ' ASN . 6.5 p . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.021 -0.99 . . . . 1.18 109.389 179.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 32.8 p90 . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.54 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 56.0 mtp180 -142.39 60.39 1.45 Allowed 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.128 -0.983 . . . . 0.0 109.621 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.48 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 33.6 m-85 -116.51 159.81 21.53 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.264 -0.898 . . . . 0.0 108.867 179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 11.2 tpt180 -150.78 -104.12 0.06 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.976 -1.078 . . . . 0.0 110.649 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.674 ' OH ' HG11 ' A' ' 59' ' ' VAL . 1.2 p90 -109.06 -164.18 0.92 Allowed 'General case' 0 N--CA 1.503 2.21 0 O-C-N 121.077 -1.015 . . . . 0.0 110.398 -179.017 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.04 147.39 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 CA-C-O 121.941 0.876 . . . . 0.0 111.788 -179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.98 95.04 6.32 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.724 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 pt-20 -83.24 46.32 1.12 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.805 -1.184 . . . . 0.0 109.991 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.611 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.3 -130.99 0.13 Allowed Glycine 0 N--CA 1.483 1.804 0 N-CA-C 106.812 -2.515 . . . . 0.0 106.812 178.188 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -69.01 23.73 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.899 0 CA-C-N 119.372 1.586 . . . . 0.0 108.56 177.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.611 ' H ' ' C ' ' B' ' 9' ' ' GLY . 29.5 t -93.26 -11.11 33.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 0.0 109.876 -179.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 69.5 t60 -134.71 123.04 23.05 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.412 -0.805 . . . . 0.0 109.578 -179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.415 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 48.2 mtm . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 121.339 0.59 . . . . 2.89 109.426 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.469 HG12 ' N ' ' A' ' 3' ' ' LYS . 25.8 t -94.22 163.45 2.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.216 -0.927 . . . . 0.3 108.959 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.469 ' N ' HG12 ' A' ' 2' ' ' VAL . 22.7 tptm -155.06 121.81 5.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.072 -1.017 . . . . 1.97 109.16 -179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -91.74 131.73 36.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.426 -0.796 . . . . 0.98 109.621 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.9 mm -107.1 108.87 26.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 N-CA-C 107.821 -1.177 . . . . 0.19 107.821 179.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -100.75 -5.35 26.53 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.162 -0.961 . . . . 1.97 110.209 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 81.9 p -152.03 152.95 33.07 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.008 -1.058 . . . . 0.23 110.076 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 21.2 tttp -52.32 -31.5 33.5 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.499 -0.751 . . . . 1.9 109.713 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.5 m -61.2 -43.86 98.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.154 -0.966 . . . . 0.25 110.294 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.68 -24.39 64.51 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.241 -0.912 . . . . 0.2 110.196 -179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -59.18 -64.81 0.81 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.096 -1.002 . . . . 0.21 109.964 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.2 mm100 -57.2 -44.4 83.62 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.162 -0.961 . . . . 2.47 109.67 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.4 mm-40 -58.2 -36.03 72.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.24 -0.913 . . . . 2.1 110.171 -179.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.62 -47.34 86.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.032 -1.043 . . . . 0.2 109.454 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.405 ' HG ' ' H ' ' A' ' 15' ' ' LEU . 8.7 mt -63.68 -44.41 93.81 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.428 -0.795 . . . . 0.62 109.525 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.41 -36.87 85.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.001 . . . . 1.09 109.322 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.74 -17.88 49.56 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.098 -1.002 . . . . 0.3 109.483 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.02 -6.43 27.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.266 -0.896 . . . . 0.24 109.919 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.79 -112.43 4.09 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.722 -1.351 . . . . 0.28 109.722 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 47.4 t0 -137.86 4.38 2.53 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.286 -1.126 . . . . 2.21 109.463 -179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.2 mttp -71.42 170.17 13.81 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.137 -0.977 . . . . 1.9 109.471 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.632 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.02 164.08 13.49 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.105 -1.072 . . . . 0.17 108.105 179.808 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.632 ' H ' HD23 ' A' ' 22' ' ' LEU . 10.8 t -146.46 109.12 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.931 -1.106 . . . . 0.12 109.809 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 7.1 t -105.13 134.26 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.91 0 N-CA-C 108.41 -0.959 . . . . 0.09 108.41 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.56 140.0 31.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.516 -0.74 . . . . 0.17 109.864 -178.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -110.47 103.34 11.95 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.221 -0.659 . . . . 0.96 109.221 179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.474 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 54.6 m-85 -88.45 79.41 7.67 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.011 -1.107 . . . . 0.24 108.011 179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 25.9 m -114.17 149.68 35.35 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.767 -0.583 . . . . 1.03 109.643 -179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -91.47 129.01 37.52 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.31 -0.868 . . . . 0.26 108.699 179.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.0 t -66.6 -22.86 66.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.222 -0.924 . . . . 0.32 110.688 -179.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.551 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 52.9 p-90 -89.17 -21.73 23.16 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.965 -1.085 . . . . 0.44 110.406 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.7 t -91.01 119.78 31.46 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.108 -0.995 . . . . 0.32 110.017 -178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.492 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.04 -54.57 35.67 Favored Glycine 0 N--CA 1.489 2.181 0 CA-C-O 119.429 -0.651 . . . . 0.36 111.72 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.492 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -48.03 -35.44 25.56 Favored 'Trans proline' 0 C--N 1.32 -0.973 0 C-N-CA 121.58 1.52 . . . . 0.44 111.406 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.05 -63.84 1.3 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.083 -1.01 . . . . 0.81 109.063 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -59.98 -17.49 38.7 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.35 -0.844 . . . . 1.92 109.997 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.486 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 tpt -59.77 -19.59 51.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.142 -0.974 . . . . 3.13 109.997 -179.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.436 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 2.8 mt -99.7 10.58 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.11 -0.994 . . . . 0.28 110.34 -178.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.585 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -65.26 -33.44 7.91 Favored Pre-proline 0 C--N 1.304 -1.39 0 O-C-N 120.714 -1.241 . . . . 1.62 112.167 179.844 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.3 Cg_exo -61.51 -6.54 7.22 Favored 'Trans proline' 0 C--O 1.213 -0.754 0 CA-C-N 120.078 1.064 . . . . 0.25 110.59 -177.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -107.9 -74.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.555 -0.716 . . . . 0.3 109.403 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.2 t80 -45.03 -55.9 5.14 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.299 -0.876 . . . . 0.13 110.707 -179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.7 t60 -66.07 -31.48 72.37 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.049 -1.032 . . . . 0.41 109.89 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.407 ' C ' ' N ' ' A' ' 46' ' ' SER . 2.8 t -64.07 -40.42 96.23 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.924 -1.11 . . . . 0.97 110.189 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 mt -51.57 -12.6 0.18 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.108 -0.995 . . . . 0.5 109.979 -179.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.407 ' N ' ' C ' ' A' ' 44' ' ' SER . 27.8 m -56.44 -38.56 71.78 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.835 -1.165 . . . . 0.51 109.566 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -93.14 -11.18 33.46 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.305 -0.872 . . . . 2.0 109.875 -179.507 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.61 -53.26 4.73 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.3 -1.0 . . . . 2.16 108.3 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -108.19 72.48 0.84 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.342 -0.849 . . . . 0.24 109.789 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 19.4 p -66.7 -1.6 3.99 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.602 -0.888 . . . . 0.17 108.602 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.6 t-20 -95.3 -4.38 45.66 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.459 -0.776 . . . . 0.34 109.541 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 65.2 t -116.75 150.5 18.73 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.071 0 N-CA-C 108.947 -0.76 . . . . 0.12 108.947 179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.3 mm -100.45 132.24 46.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.421 -0.799 . . . . 0.17 109.088 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.58 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.6 m-85 -114.77 134.83 54.79 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.335 -0.853 . . . . 0.11 109.5 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.58 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -115.5 171.36 7.77 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.762 -0.829 . . . . 0.12 108.762 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -144.06 142.49 30.68 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.946 -1.131 . . . . 1.31 107.946 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 68.9 t -138.3 141.16 38.57 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 121.148 -0.97 . . . . 0.14 110.246 -178.631 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 60' ' ' ASP . 9.8 t70 -98.1 93.86 6.51 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.819 -1.178 . . . . 1.08 107.819 178.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.403 HG21 HG21 ' A' ' 74' ' ' THR . 10.5 m -54.35 -3.29 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.426 -0.796 . . . . 0.27 111.47 -178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' H ' ' C ' ' A' ' 58' ' ' ASP . 6.2 m-20 -113.15 -37.35 4.78 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.067 -1.02 . . . . 1.11 111.231 -178.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -95.42 -16.8 22.03 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 120.887 -1.133 . . . . 1.12 109.619 -179.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.81 49.92 1.58 Allowed 'General case' 0 N--CA 1.502 2.13 0 N-CA-C 108.54 -0.911 . . . . 0.17 108.54 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.471 ' CB ' HH21 ' B' ' 4' ' ' ARG . 8.1 pt20 -54.98 -14.5 1.51 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.514 -0.741 . . . . 2.22 110.054 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -70.73 -38.35 73.56 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.927 -1.108 . . . . 1.11 109.405 -179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 22.1 t -74.42 -47.51 39.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.088 -1.007 . . . . 0.19 108.644 179.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.92 -34.85 78.3 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.405 -0.809 . . . . 0.22 109.351 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.3 m -64.31 -50.31 68.33 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.227 -0.92 . . . . 1.29 109.663 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -63.47 -33.27 75.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.251 -0.906 . . . . 2.2 109.803 -179.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -86.93 0.41 55.1 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.094 -1.004 . . . . 0.33 109.538 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 52.1 mm-40 48.95 54.19 11.27 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.122 -0.986 . . . . 2.34 110.157 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.28 129.53 37.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.122 -0.986 . . . . 0.28 109.037 179.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -122.65 -3.58 8.76 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.465 -0.772 . . . . 2.4 109.733 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.445 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.58 141.53 21.18 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.116 -0.99 . . . . 0.22 109.451 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.62 HG23 ' CE2' ' B' ' 5' ' ' TYR . 10.4 p -121.02 150.31 53.03 Favored Pre-proline 0 N--CA 1.502 2.174 0 N-CA-C 108.681 -0.859 . . . . 0.22 108.681 179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -77.25 149.8 90.29 Favored 'Cis proline' 0 N--CA 1.483 0.905 0 C-N-CA 124.749 -0.938 . . . . 0.2 110.127 -2.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.445 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -117.91 124.77 49.09 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 107.855 -1.165 . . . . 0.18 107.855 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.79 ' CD1' HD21 ' A' ' 97' ' ' LEU . 75.3 m-85 -102.35 115.7 31.11 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.269 -1.011 . . . . 0.15 108.269 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.474 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 5.2 mt-30 -116.58 139.96 49.92 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.012 -1.107 . . . . 1.03 108.012 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.1 m-85 -109.54 126.52 53.66 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.48 0.657 . . . . 0.11 110.065 -178.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -123.0 154.78 38.0 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.205 -1.035 . . . . 0.17 108.205 179.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.2 tttm -155.87 123.76 5.67 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.965 -1.124 . . . . 1.48 107.965 -179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 21.5 mtpt 56.84 20.74 5.45 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.726 -0.609 . . . . 1.67 110.088 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.624 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 94.22 -1.48 67.33 Favored Glycine 0 N--CA 1.495 2.586 0 O-C-N 121.074 -1.016 . . . . 0.22 110.579 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.624 HE21 ' C ' ' A' ' 83' ' ' GLY . 15.5 mm-40 -110.79 148.02 33.24 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.112 -1.228 . . . . 2.08 110.56 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? -86.6 139.98 30.29 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.522 -0.918 . . . . 1.7 108.522 178.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 22.4 m -122.34 -21.44 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 O-C-N 121.454 -0.779 . . . . 0.26 110.704 -178.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.74 174.92 47.17 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 119.425 -1.369 . . . . 0.18 110.209 179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -173.75 155.75 2.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -1.14 . . . . 2.04 110.531 -179.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.505 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.5 p90 -169.76 135.06 1.43 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.685 -0.634 . . . . 0.14 109.875 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -107.2 -178.76 3.73 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.341 -0.85 . . . . 0.17 108.898 179.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 100.41 134.0 8.34 Favored Glycine 0 N--CA 1.499 2.888 0 N-CA-C 109.446 -1.462 . . . . 0.13 109.446 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.516 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.75 90.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.169 -1.195 . . . . 0.2 110.261 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -138.82 73.21 1.42 Allowed 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 107.936 -1.135 . . . . 1.15 107.936 178.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.46 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.01 -34.86 78.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.482 -0.761 . . . . 1.19 110.84 -178.565 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -65.38 -25.03 67.39 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.991 -1.068 . . . . 1.95 109.354 -179.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 31.2 ttmt -69.1 -38.12 78.79 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.372 -0.83 . . . . 2.05 109.726 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.79 HD21 ' CD1' ' A' ' 77' ' ' PHE . 42.6 mt -51.23 -36.51 42.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.919 -1.113 . . . . 0.15 109.077 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -66.45 -56.63 10.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.339 -0.851 . . . . 2.15 109.573 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.12 -40.94 86.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.406 -0.809 . . . . 0.15 110.398 -179.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 3.9 m -67.47 -47.41 70.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.137 -0.977 . . . . 0.13 109.818 -179.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 51.3 mt -60.94 -49.4 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.174 -0.954 . . . . 0.18 108.46 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -61.55 -17.71 56.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.21 -0.931 . . . . 1.03 109.62 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -77.2 -60.35 2.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 2.02 109.928 -179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.8 mt -92.11 21.54 5.0 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.492 -0.755 . . . . 0.35 110.307 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 p . . . . . 0 N--CA 1.492 1.656 0 O-C-N 121.025 -1.047 . . . . 1.18 109.197 179.454 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.588 ' CE2' ' CE1' ' B' ' 3' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.717 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.551 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.0 OUTLIER -140.7 89.03 2.23 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.338 -0.851 . . . . 0.0 108.909 -179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.588 ' CE1' ' CE2' ' B' ' 1' ' ' PHE . 43.2 m-85 -99.6 163.52 12.46 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.129 -0.982 . . . . 0.0 109.518 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.471 HH21 ' CB ' ' A' ' 63' ' ' GLN . 5.8 mmt180 -150.33 -101.91 0.07 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.393 -0.817 . . . . 0.0 108.805 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.62 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -113.17 -171.77 1.93 Allowed 'General case' 0 N--CA 1.502 2.17 0 O-C-N 121.068 -1.02 . . . . 0.0 111.002 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.453 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.4 t -64.91 144.78 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.937 0 CA-C-O 121.912 0.863 . . . . 0.0 113.072 -176.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 35.5 m -101.7 93.81 5.52 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 107.848 -1.167 . . . . 0.0 107.848 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.412 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 10.6 pt-20 -85.04 44.7 1.1 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.989 -1.07 . . . . 0.0 110.843 -178.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.655 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.27 -133.46 0.05 OUTLIER Glycine 0 N--CA 1.488 2.107 0 N-CA-C 107.049 -2.42 . . . . 0.0 107.049 178.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -63.36 18.84 0.05 OUTLIER 'Trans proline' 0 C--N 1.323 -0.772 0 CA-C-N 119.23 1.515 . . . . 0.0 109.639 178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.655 ' H ' ' C ' ' B' ' 9' ' ' GLY . 23.3 t -83.74 -25.32 30.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.467 -0.771 . . . . 0.0 109.66 -179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.572 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 0.7 OUTLIER -74.38 -128.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.268 -0.895 . . . . 0.0 109.702 -179.855 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.572 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.33 0 CA-C-O 117.955 -1.47 . . . . 0.0 109.536 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.5 mtt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.251 0.548 . . . . 2.89 109.545 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG12 ' N ' ' A' ' 3' ' ' LYS . 33.0 t -94.71 169.2 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 121.316 -0.865 . . . . 0.3 109.299 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.545 ' N ' HG12 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -152.69 119.77 5.83 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 107.923 -1.139 . . . . 1.97 107.923 179.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -86.95 144.1 27.09 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.974 -1.079 . . . . 0.98 110.362 -179.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.0 mm -111.05 108.64 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 107.884 -1.154 . . . . 0.19 107.884 178.58 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -99.65 -12.56 19.93 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.075 -1.016 . . . . 1.97 109.489 -179.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.6 p -153.55 155.12 35.56 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.234 -0.916 . . . . 0.23 109.631 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 47.7 tttm -51.35 -21.25 2.12 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.321 -0.862 . . . . 1.9 109.436 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.7 m -61.57 -52.9 62.53 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 0.25 110.435 -179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.73 -20.45 63.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.2 110.275 -179.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -59.37 -65.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.059 -1.026 . . . . 0.21 110.19 -179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 28.4 mt-30 -57.37 -45.07 84.83 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.282 -0.886 . . . . 2.47 109.633 -179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -59.0 -34.44 71.86 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.214 -0.929 . . . . 2.1 109.985 -179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.44 -48.38 81.41 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.916 -1.115 . . . . 0.2 109.332 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 8.6 mt -64.74 -45.97 84.23 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.227 -0.921 . . . . 0.62 109.447 179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.9 t0 -63.78 -37.41 87.28 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.201 -0.937 . . . . 1.09 109.466 -179.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.76 -16.93 52.54 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.285 -0.884 . . . . 0.3 109.472 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.6 -6.78 27.64 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 0.24 109.522 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.38 -111.0 3.7 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.742 -1.343 . . . . 0.28 109.742 179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 13.4 t0 -138.1 3.57 2.42 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.391 -1.064 . . . . 2.21 109.349 -179.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 109' ' ' HOH . 76.9 mttt -70.29 169.05 14.58 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.164 -0.96 . . . . 1.9 108.916 179.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.23 162.32 12.2 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.035 -1.098 . . . . 0.17 108.035 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.0 t -144.18 103.97 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.831 -1.168 . . . . 0.12 109.628 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.2 t -102.27 129.92 52.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 N-CA-C 108.563 -0.903 . . . . 0.09 108.563 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.16 141.57 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 121.48 -0.762 . . . . 0.17 109.548 -179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -110.97 99.1 8.05 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 108.957 -0.757 . . . . 0.96 108.957 179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.504 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 52.0 m-85 -84.82 81.41 8.89 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 107.632 -1.248 . . . . 0.24 107.632 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 m -109.89 -163.87 0.89 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 121.563 0.697 . . . . 1.03 109.147 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.53 119.93 13.1 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 108.151 -1.055 . . . . 0.26 108.151 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -63.21 -24.02 67.69 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.468 -0.77 . . . . 0.32 110.565 -178.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 46.7 p-90 -89.64 -14.87 33.96 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.983 -1.073 . . . . 0.44 110.118 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 2.9 t -93.77 133.73 36.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.15 -0.969 . . . . 0.32 109.706 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.448 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -72.77 -57.76 5.21 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 111.337 -0.705 . . . . 0.36 111.337 -179.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 18.5 Cg_exo -49.24 -37.27 39.32 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.779 1.652 . . . . 0.44 111.414 -178.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.46 -62.62 1.56 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 120.857 -1.152 . . . . 0.81 109.069 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 43.7 tttm -59.0 -20.05 49.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.421 -0.799 . . . . 1.92 109.676 179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 1.4 tpt -60.57 -18.04 50.14 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.322 -0.861 . . . . 3.13 109.662 -179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.445 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.6 mt -100.51 10.69 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.289 -0.882 . . . . 0.28 110.412 -178.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.612 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -66.59 -32.3 5.06 Favored Pre-proline 0 C--N 1.305 -1.345 0 O-C-N 120.416 -1.427 . . . . 1.62 112.386 179.81 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.1 Cg_exo -63.07 -5.09 7.17 Favored 'Trans proline' 0 C--O 1.214 -0.704 0 CA-C-N 119.865 0.988 . . . . 0.25 110.29 -177.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.4 m-85 -109.8 -77.51 0.6 Allowed 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.928 -0.767 . . . . 0.3 108.928 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 93.8 t80 -42.44 -56.63 2.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.589 -0.695 . . . . 0.13 110.998 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -65.73 -33.32 75.59 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.103 -0.998 . . . . 0.41 109.688 -179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 14.5 m -64.36 -39.89 94.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.865 -1.147 . . . . 0.97 109.997 179.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 80.9 mt -51.85 -16.54 0.72 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.025 -1.047 . . . . 0.5 109.72 -179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.4 m -57.01 -29.46 63.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.081 -1.012 . . . . 0.51 109.737 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -95.95 -21.4 18.06 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 2.0 110.162 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 26.7 ttmt -90.32 -19.7 23.74 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.053 -1.029 . . . . 2.16 109.41 -179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.15 64.65 1.6 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.39 -0.819 . . . . 0.24 109.209 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 42.3 p -66.9 -4.43 9.41 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.337 -0.852 . . . . 0.17 109.027 179.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 13.9 t30 -95.05 2.31 55.22 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.445 -0.784 . . . . 0.34 109.417 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.7 t -119.0 150.03 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 109.157 -0.683 . . . . 0.12 109.157 179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.4 mm -98.79 122.31 50.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.401 -0.812 . . . . 0.17 108.982 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.558 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.4 m-85 -109.74 129.84 55.58 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.254 -0.904 . . . . 0.11 108.969 179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.558 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.7 169.63 8.76 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.336 -0.852 . . . . 0.12 108.807 -179.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -142.06 140.39 32.56 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.602 -1.259 . . . . 1.31 107.602 179.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.7 t -138.2 136.94 44.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 O-C-N 121.264 -0.898 . . . . 0.14 110.741 -178.19 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.99 107.68 20.26 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 107.645 -1.243 . . . . 1.08 107.645 178.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.417 HG11 ' OH ' ' B' ' 5' ' ' TYR . 23.3 m -65.14 -9.68 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.383 -0.823 . . . . 0.27 111.06 -178.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -101.03 -41.69 6.68 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.013 -1.054 . . . . 1.11 110.704 -179.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.8 -12.48 28.96 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.986 -1.071 . . . . 1.12 109.91 -178.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.31 49.63 1.88 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.311 -0.868 . . . . 0.17 108.836 179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -56.08 -17.01 5.88 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.546 -0.721 . . . . 2.22 109.842 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.4 p30 -70.33 -41.29 73.42 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.094 -1.004 . . . . 1.11 109.433 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 10.7 t -74.18 -45.38 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.185 -0.947 . . . . 0.19 108.674 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.52 -35.27 79.9 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.282 -0.886 . . . . 0.22 108.779 179.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 30.1 m -64.04 -44.79 91.43 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.369 -0.832 . . . . 1.29 109.265 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -63.59 -39.11 93.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.376 -0.827 . . . . 2.2 109.449 179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.34 0.71 55.03 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.186 -0.946 . . . . 0.33 109.909 -179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 68.4 mt-10 47.65 56.21 7.4 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.06 -1.025 . . . . 2.34 109.748 179.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.45 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.9 t -79.52 131.27 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.217 -0.927 . . . . 0.28 109.588 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 27.2 mmtp -128.8 0.96 5.41 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.385 -0.822 . . . . 2.4 109.669 -179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.595 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.0 128.65 10.8 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 120.966 -1.084 . . . . 0.22 108.771 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.666 HG23 ' CE2' ' B' ' 5' ' ' TYR . 11.2 p -114.77 150.43 44.03 Favored Pre-proline 0 N--CA 1.5 2.033 0 N-CA-C 108.733 -0.84 . . . . 0.22 108.733 179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.445 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.5 Cg_endo -77.54 147.47 84.66 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 C-N-CA 124.776 -0.927 . . . . 0.2 109.941 -1.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.509 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -118.56 117.42 28.93 Favored 'General case' 0 N--CA 1.502 2.145 0 N-CA-C 107.938 -1.134 . . . . 0.18 107.938 178.475 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.6 ' CD1' HD21 ' A' ' 97' ' ' LEU . 78.2 m-85 -91.78 121.48 33.45 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.07 -1.019 . . . . 0.15 108.494 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.504 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 9.1 mt-30 -120.05 136.38 54.59 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 107.783 -1.191 . . . . 1.03 107.783 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CZ ' HG21 ' A' ' 100' ' ' THR . 32.3 m-85 -108.97 129.43 55.44 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 121.581 0.705 . . . . 0.11 109.978 -178.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -126.24 156.92 39.52 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.263 -1.014 . . . . 0.17 108.263 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.0 tttp -155.39 120.23 4.79 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.485 -1.302 . . . . 1.48 107.485 -179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 44.6 mtmt 55.97 29.14 13.76 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.446 -0.783 . . . . 1.67 108.909 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.13 7.8 87.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.896 -1.281 . . . . 0.22 109.896 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.6 mm100 -112.85 142.41 45.54 Favored 'General case' 0 N--CA 1.503 2.221 0 O-C-N 121.469 -1.018 . . . . 2.08 110.643 -179.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.3 ttpt -84.77 141.37 30.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.268 -0.895 . . . . 1.7 109.314 179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.34 -20.1 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.426 -0.796 . . . . 0.26 110.452 -179.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.24 172.97 45.53 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 119.346 -1.407 . . . . 0.18 110.435 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 pt-20 -174.22 150.68 1.54 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.447 -1.031 . . . . 2.04 110.044 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.9 p90 -169.09 133.18 1.41 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.373 -0.829 . . . . 0.14 110.48 179.088 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.55 -169.55 1.66 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 120.939 -1.1 . . . . 0.17 108.929 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.13 129.88 3.67 Favored Glycine 0 N--CA 1.495 2.598 0 N-CA-C 109.669 -1.372 . . . . 0.13 109.669 179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.476 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.87 93.12 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.227 -1.16 . . . . 0.2 110.602 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -139.46 76.68 1.58 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.828 -1.175 . . . . 1.15 107.828 178.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.471 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.34 -32.55 74.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.654 -0.654 . . . . 1.19 110.656 -178.671 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.6 mt-10 -65.66 -28.35 69.03 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 120.906 -1.121 . . . . 1.95 109.146 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.7 tttp -68.71 -35.23 76.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.32 -0.863 . . . . 2.05 109.322 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.6 HD21 ' CD1' ' A' ' 77' ' ' PHE . 41.4 mt -52.07 -38.99 59.01 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.042 -1.036 . . . . 0.15 108.823 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.71 -57.63 6.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.578 -0.701 . . . . 2.15 109.785 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.38 -40.32 82.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 0.15 110.494 -179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.438 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 27.2 m -66.78 -45.79 77.36 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.087 -1.008 . . . . 0.13 110.163 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 59.8 mt -61.68 -52.37 61.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.26 -0.9 . . . . 0.18 109.214 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -60.52 -18.09 49.85 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.21 -0.931 . . . . 1.03 109.449 -179.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 23.3 tt0 -77.39 -62.72 1.57 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.367 -0.833 . . . . 2.02 110.202 -179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 27.2 mt -91.33 24.39 2.97 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.558 -0.714 . . . . 0.35 110.437 -178.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 120.937 -1.102 . . . . 1.18 109.165 179.541 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 54.4 p90 . . . . . 0 N--CA 1.491 1.586 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.545 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 90.1 mtt180 -146.68 71.22 1.23 Allowed 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.195 -0.941 . . . . 0.0 109.475 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.5 m-85 -118.65 143.66 46.68 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.536 -0.728 . . . . 0.0 109.208 179.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 12.9 mmm180 -138.65 -105.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.666 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.4 p90 -109.55 -168.39 1.32 Allowed 'General case' 0 N--CA 1.505 2.282 0 O-C-N 121.259 -0.901 . . . . 0.0 110.461 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.67 150.53 6.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 121.266 -0.896 . . . . 0.0 112.57 -176.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 13.9 m -101.4 96.53 7.22 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.595 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.6 pt-20 -83.25 44.76 0.97 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.099 -1.001 . . . . 0.0 110.279 -179.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.622 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.89 -131.43 0.12 Allowed Glycine 0 N--CA 1.483 1.832 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 178.142 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -67.08 23.98 0.11 Allowed 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.273 1.537 . . . . 0.0 109.129 178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.622 ' H ' ' C ' ' B' ' 9' ' ' GLY . 39.6 t -84.99 -50.72 7.24 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.354 -0.842 . . . . 0.0 109.335 -179.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 9.8 t60 -92.23 102.57 15.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.378 -0.827 . . . . 0.0 109.516 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 CA-C-O 117.984 -1.454 . . . . 0.0 109.558 179.919 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.414 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.553 ' SD ' ' N ' ' A' ' 1' ' ' MET . 4.1 mpp? . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.273 -0.639 . . . . 2.89 109.273 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.526 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.9 t -94.52 162.28 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.169 -0.957 . . . . 0.3 109.588 -179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.526 ' N ' HG12 ' A' ' 2' ' ' VAL . 33.6 tttt -155.96 123.32 5.46 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.917 . . . . 1.97 109.224 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 41.3 tt0 -90.45 132.52 35.59 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.279 -0.888 . . . . 0.98 109.645 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.4 mm -112.51 103.5 15.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 N-CA-C 108.548 -0.908 . . . . 0.19 108.548 179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -99.19 -4.46 32.03 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.204 -0.935 . . . . 1.97 109.852 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.3 p -151.18 148.9 28.81 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.112 -0.992 . . . . 0.23 109.96 -179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -52.31 -25.59 9.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.319 -0.863 . . . . 1.9 109.552 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 98.7 m -59.7 -48.92 79.75 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.807 -1.183 . . . . 0.25 109.34 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.83 -23.62 62.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.361 -0.837 . . . . 0.2 109.733 179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -58.28 -66.25 0.52 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.199 -0.938 . . . . 0.21 110.198 -179.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 17.7 mt-30 -56.27 -44.62 79.91 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.056 -1.028 . . . . 2.47 109.669 -179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -58.91 -35.11 72.52 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 2.1 109.804 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.68 -48.68 80.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.932 -1.105 . . . . 0.2 108.898 179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.21 -43.52 94.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.578 -0.702 . . . . 0.62 109.318 179.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.67 -38.2 90.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.85 . . . . 1.09 109.681 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.19 -16.08 55.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.219 -0.926 . . . . 0.3 109.909 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.85 -9.28 50.55 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 0.24 109.889 -179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.63 -112.94 4.76 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.31 -1.516 . . . . 0.28 109.31 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -134.71 2.54 3.18 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.435 -1.038 . . . . 2.21 109.305 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 109' ' ' HOH . 76.3 mttt -70.28 166.87 19.21 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.044 -1.035 . . . . 1.9 108.689 179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.672 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.39 163.36 10.85 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.038 -1.039 . . . . 0.17 108.834 -179.276 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.672 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.2 t -144.6 107.13 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.108 -0.995 . . . . 0.12 109.402 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.38 135.5 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 N-CA-C 108.556 -0.905 . . . . 0.09 108.556 179.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.8 t -112.15 133.44 57.85 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.878 0 O-C-N 121.63 -0.669 . . . . 0.17 109.894 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' CG ' ' HG ' ' A' ' 28' ' ' SER . 9.4 t70 -106.44 102.96 12.31 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.98 -0.748 . . . . 0.96 108.98 179.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 50.5 m-85 -88.45 79.43 7.68 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.603 -1.258 . . . . 0.24 107.603 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.416 ' HG ' ' CG ' ' A' ' 26' ' ' ASP . 67.0 m -113.3 149.27 34.16 Favored 'General case' 0 N--CA 1.497 1.899 0 CA-C-O 121.225 0.536 . . . . 1.03 109.613 -179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.89 129.57 37.82 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.328 -0.858 . . . . 0.26 109.082 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.45 -23.97 65.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.423 -0.798 . . . . 0.32 110.118 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.542 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 53.8 p-90 -89.1 -16.88 30.45 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.061 -1.024 . . . . 0.44 110.176 -179.311 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.419 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.48 124.71 37.66 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.157 -0.965 . . . . 0.32 110.291 -178.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -64.76 -57.75 11.67 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 110.972 -0.851 . . . . 0.36 110.972 179.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.0 Cg_exo -46.18 -36.07 16.19 Favored 'Trans proline' 0 N--CA 1.481 0.789 0 C-N-CA 121.908 1.739 . . . . 0.44 111.359 -178.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.0 -60.31 2.41 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 120.672 -1.267 . . . . 0.81 108.991 179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -59.91 -18.39 44.56 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.489 -0.757 . . . . 1.92 110.029 179.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 12.4 tpt -59.68 -24.77 64.21 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.214 -0.929 . . . . 3.13 110.155 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.662 HG22 ' O ' ' A' ' 38' ' ' ILE . 72.3 mt -96.91 6.93 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.987 0 O-C-N 121.142 -0.974 . . . . 0.28 111.371 -178.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.575 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -62.58 -34.39 14.52 Favored Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 118.194 -1.402 . . . . 1.62 111.64 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.575 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -62.32 -5.9 7.48 Favored 'Trans proline' 0 C--O 1.211 -0.83 0 CA-C-N 120.009 1.039 . . . . 0.25 110.524 -177.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 40.4 m-85 -109.83 -71.33 0.77 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.489 -0.757 . . . . 0.3 108.958 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -46.06 -58.5 3.55 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.488 -0.757 . . . . 0.13 110.733 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -65.24 -30.49 71.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.953 . . . . 0.41 109.714 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.3 m -63.54 -41.17 98.47 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.855 -1.153 . . . . 0.97 109.735 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 75.3 mt -52.01 -16.92 0.85 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.058 -1.026 . . . . 0.5 109.575 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.403 ' OG ' ' CG2' ' A' ' 2' ' ' VAL . 66.6 m -56.93 -31.37 64.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.017 -1.052 . . . . 0.51 109.917 -179.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -94.92 -19.72 20.02 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.127 -0.983 . . . . 2.0 109.906 -179.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -90.94 -21.38 21.38 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.288 -0.883 . . . . 2.16 109.774 -179.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.4 m-85 -134.22 67.71 1.5 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.479 -0.763 . . . . 0.24 109.231 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 83.0 p -68.01 -3.97 11.8 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.413 -0.805 . . . . 0.17 109.322 179.603 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 4.5 t30 -94.94 2.22 55.36 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.245 -0.909 . . . . 0.34 109.719 -179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 80.1 t -119.12 152.99 21.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 N-CA-C 108.811 -0.811 . . . . 0.12 108.811 179.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.9 mm -100.44 128.64 52.27 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 O-C-N 121.306 -0.871 . . . . 0.17 108.911 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.603 ' C ' HD12 ' A' ' 55' ' ' LEU . 65.0 m-85 -114.58 132.9 56.18 Favored 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.407 -0.808 . . . . 0.11 109.144 -179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.603 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -115.31 169.0 9.47 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 109.083 -0.71 . . . . 0.12 109.083 -179.495 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -144.25 141.1 29.64 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 108.196 -1.039 . . . . 1.31 108.196 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 25.6 t -140.15 145.73 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.011 0 O-C-N 121.103 -0.998 . . . . 0.14 110.425 -178.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.53 ' CG ' HH21 ' B' ' 2' ' ' ARG . 19.2 t70 -101.32 100.92 11.48 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.219 -1.03 . . . . 1.08 108.219 178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.4 m -59.09 -3.55 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.246 -0.909 . . . . 0.27 111.287 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.407 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 27.1 m-20 -108.79 -40.94 4.9 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.203 -0.936 . . . . 1.11 111.095 -178.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -96.21 -23.43 16.72 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.891 -1.131 . . . . 1.12 110.036 -179.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.0 46.34 0.98 Allowed 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 108.352 -0.981 . . . . 0.17 108.352 179.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -53.53 -14.05 0.75 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.731 -0.606 . . . . 2.22 109.9 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -71.2 -42.98 68.29 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.062 -1.024 . . . . 1.11 109.316 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 9.8 t -73.19 -43.34 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.143 -0.973 . . . . 0.19 108.696 179.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.429 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -62.53 -35.55 79.77 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.453 -0.943 . . . . 0.22 108.453 178.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.8 m -64.69 -46.98 80.07 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.754 -0.832 . . . . 1.29 108.754 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -63.57 -39.42 94.34 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.388 -0.82 . . . . 2.2 109.35 179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.25 -3.15 58.91 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.139 -0.976 . . . . 0.33 109.603 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 66' ' ' ALA . 52.3 mm-40 47.47 53.01 11.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.873 . . . . 2.34 110.352 179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.96 136.14 24.06 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.228 -0.92 . . . . 0.28 109.413 179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 mttt -129.88 3.86 4.92 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.476 -0.765 . . . . 2.4 109.5 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.5 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.44 136.26 16.27 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.128 -0.982 . . . . 0.22 108.883 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.521 HG23 ' CE2' ' B' ' 5' ' ' TYR . 41.1 p -118.55 150.79 48.76 Favored Pre-proline 0 N--CA 1.504 2.226 0 N-CA-C 108.945 -0.761 . . . . 0.22 108.945 179.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.523 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -77.76 145.92 80.39 Favored 'Cis proline' 0 N--CA 1.482 0.848 0 N-CA-C 109.778 -0.893 . . . . 0.2 109.778 -1.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.5 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.3 m -114.6 112.47 22.96 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 107.513 -1.292 . . . . 0.18 107.513 178.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.451 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.0 m-85 -92.56 113.8 26.17 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.426 -0.91 . . . . 0.15 108.686 179.743 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -115.91 138.68 50.95 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.443 -1.317 . . . . 1.03 107.443 179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 21.3 m-85 -110.11 127.23 54.77 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 121.374 0.607 . . . . 0.11 109.756 -177.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -121.45 157.18 31.14 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.541 -0.911 . . . . 0.17 108.541 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -155.73 123.53 5.65 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.491 -1.3 . . . . 1.48 107.491 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt 57.07 17.81 3.67 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.687 -0.633 . . . . 1.67 109.89 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.609 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 95.72 0.18 62.59 Favored Glycine 0 N--CA 1.497 2.755 0 N-CA-C 110.416 -1.074 . . . . 0.22 110.416 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.609 HE21 ' C ' ' A' ' 83' ' ' GLY . 23.6 mm-40 -111.87 151.1 29.51 Favored 'General case' 0 N--CA 1.505 2.32 0 O-C-N 121.184 -1.186 . . . . 2.08 110.033 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 26.3 ttmt -86.03 140.23 30.46 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.398 -0.814 . . . . 1.7 109.316 179.708 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.5 m -127.87 -7.03 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 121.523 -0.735 . . . . 0.26 110.542 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.93 167.77 35.29 Favored Glycine 0 N--CA 1.497 2.716 0 C-N-CA 119.445 -1.36 . . . . 0.18 110.284 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.95 153.2 2.08 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.248 -1.148 . . . . 2.04 110.604 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.561 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 8.2 p90 -169.66 132.38 1.18 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.713 -0.617 . . . . 0.14 109.603 178.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.7 p -104.23 -162.28 0.88 Allowed 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.015 -1.053 . . . . 0.17 109.183 179.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.14 137.1 1.08 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.325 -1.51 . . . . 0.13 109.325 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.511 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.49 96.56 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.189 -1.183 . . . . 0.2 110.094 -179.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.46 66.66 1.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.868 -1.16 . . . . 1.15 107.868 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 4.7 ptpp? -62.24 -38.94 91.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.816 -0.552 . . . . 1.19 111.262 -178.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -65.58 -27.33 68.35 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.596 -1.315 . . . . 1.95 109.497 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -68.19 -32.77 73.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.305 -0.872 . . . . 2.05 109.344 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.451 HD21 ' CD1' ' A' ' 77' ' ' PHE . 27.9 mt -51.4 -36.88 45.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.029 -1.044 . . . . 0.15 108.687 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 21.8 tp10 -66.34 -59.64 3.51 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.527 -0.733 . . . . 2.15 109.848 -179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.84 -39.47 81.35 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.378 -0.826 . . . . 0.15 110.741 -179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 60.8 m -67.84 -45.28 75.11 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.139 -0.976 . . . . 0.13 110.211 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 56.8 mt -62.55 -51.24 74.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.092 -1.005 . . . . 0.18 109.157 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -60.71 -17.22 46.88 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 1.03 109.634 -179.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -75.95 -61.26 1.99 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.385 -0.822 . . . . 2.02 110.015 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.2 mt -92.9 21.33 5.76 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.424 -0.797 . . . . 0.35 110.391 -178.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.017 -1.052 . . . . 1.18 109.414 179.54 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.6 p90 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.542 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 47.4 mtp180 -142.76 57.77 1.43 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.224 -0.923 . . . . 0.0 109.308 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . . . . . . . . . 44.5 m-85 -118.47 160.24 22.07 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.511 -0.743 . . . . 0.0 109.137 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.606 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -150.54 -86.3 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.098 -1.001 . . . . 0.0 109.408 179.542 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.521 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -125.35 -173.97 2.95 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 121.269 -0.894 . . . . 0.0 110.265 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -73.16 149.72 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.888 0 CA-C-O 122.006 0.908 . . . . 0.0 112.496 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -101.55 95.69 6.63 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -83.89 41.59 0.81 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.03 -1.044 . . . . 0.0 110.361 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.92 -129.4 0.05 OUTLIER Glycine 0 N--CA 1.485 1.915 0 N-CA-C 106.898 -2.481 . . . . 0.0 106.898 178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -66.71 22.67 0.1 Allowed 'Trans proline' 0 C--N 1.324 -0.738 0 CA-C-N 119.307 1.553 . . . . 0.0 109.119 178.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t -101.82 11.39 38.77 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.369 -0.832 . . . . 0.0 110.048 -179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -154.75 123.75 6.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.087 -1.008 . . . . 0.0 109.46 -179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 CA-C-O 117.951 -1.472 . . . . 0.0 109.494 -179.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.416 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.9 mtt . . . . . 0 N--CA 1.489 1.519 0 N-CA-C 109.445 -0.576 . . . . 2.89 109.445 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.618 HG12 ' N ' ' A' ' 3' ' ' LYS . 78.3 t -94.68 168.01 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.262 -0.899 . . . . 0.3 109.41 -179.962 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.618 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.7 tttp -151.92 121.54 6.93 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.234 -0.916 . . . . 1.97 109.073 179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.9 tt0 -88.29 132.04 34.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.326 -0.859 . . . . 0.98 109.709 -179.681 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 mm -102.97 107.46 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 N-CA-C 108.228 -1.027 . . . . 0.19 108.228 179.323 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -99.58 -10.33 22.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.201 -0.937 . . . . 1.97 109.646 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.4 p -153.51 157.49 39.89 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.076 -1.015 . . . . 0.23 109.95 -179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -53.02 -30.38 35.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.421 -0.799 . . . . 1.9 109.916 179.945 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 25.2 m -59.49 -45.1 92.66 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.225 -0.922 . . . . 0.25 110.25 -179.449 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.06 -26.48 64.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 0.2 109.795 -179.528 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.5 t80 -60.02 -69.15 0.23 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.144 -0.973 . . . . 0.21 110.237 -179.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.7 mm100 -54.38 -43.16 71.16 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.224 -0.923 . . . . 2.47 109.603 -179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 84.8 mt-10 -59.0 -36.36 74.8 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.171 -0.956 . . . . 2.1 109.643 -179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 18' ' ' ALA . . . -61.0 -47.63 85.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.032 -1.043 . . . . 0.2 109.013 179.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 9.2 mt -65.18 -44.49 88.27 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.523 -0.735 . . . . 0.62 109.877 179.751 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 43.2 t0 -62.92 -45.73 91.13 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.23 -0.919 . . . . 1.09 109.826 -179.564 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.95 59.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 0.3 109.876 -179.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.402 ' HB2' ' O ' ' A' ' 14' ' ' ALA . . . -68.79 -10.53 57.2 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.084 -1.01 . . . . 0.24 109.649 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.72 -127.61 13.82 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.612 -1.395 . . . . 0.28 109.612 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 46.1 t0 -121.17 2.81 10.4 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.586 -0.949 . . . . 2.21 109.925 -179.75 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 109' ' ' HOH . 46.9 mttp -68.25 169.98 9.5 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 120.902 -1.123 . . . . 1.9 109.367 179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.614 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -66.0 162.43 19.36 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.19 -1.041 . . . . 0.17 108.19 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.614 ' H ' HD23 ' A' ' 22' ' ' LEU . 4.8 t -145.26 102.89 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.981 -1.074 . . . . 0.12 109.111 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.4 HG13 ' CE2' ' A' ' 79' ' ' PHE . 3.1 t -101.42 127.54 54.65 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.485 -0.76 . . . . 0.09 109.069 179.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.0 138.32 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.606 -0.684 . . . . 0.17 109.764 -179.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -108.86 99.46 8.8 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.974 -0.751 . . . . 0.96 108.974 179.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.443 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.6 m-85 -82.96 77.26 9.72 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 107.794 -1.187 . . . . 0.24 107.794 179.574 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -103.98 -166.89 1.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 CA-C-O 121.574 0.702 . . . . 1.03 109.433 -179.337 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -140.42 127.98 21.51 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 108.863 -0.791 . . . . 0.26 108.863 179.735 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.3 t -65.87 -32.6 74.21 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.542 -0.724 . . . . 0.32 111.194 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.557 ' HE1' ' CG ' ' A' ' 60' ' ' ASP . 59.7 p-90 -86.74 -11.05 52.22 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.768 -1.208 . . . . 0.44 110.09 -179.114 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.84 117.38 30.96 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.287 -0.883 . . . . 0.32 109.981 -179.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.465 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -60.63 -55.19 31.32 Favored Glycine 0 N--CA 1.487 2.098 0 C-N-CA 120.865 -0.683 . . . . 0.36 111.419 -179.893 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.465 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 20.1 Cg_exo -49.59 -35.7 38.31 Favored 'Trans proline' 0 C--N 1.318 -1.072 0 C-N-CA 121.814 1.676 . . . . 0.44 111.11 -178.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.34 -62.64 1.59 Allowed 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.951 -1.093 . . . . 0.81 109.055 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.5 ttpp -59.62 -16.93 29.42 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.476 -0.765 . . . . 1.92 110.163 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.437 ' N ' ' O ' ' A' ' 33' ' ' GLY . 4.8 ttt -61.48 -19.37 61.97 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.083 -1.011 . . . . 3.13 110.222 -179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.649 HG22 ' O ' ' A' ' 38' ' ' ILE . 72.2 mt -100.48 13.5 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.963 0 O-C-N 121.244 -0.91 . . . . 0.28 110.718 -178.775 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.601 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -69.51 -32.1 2.96 Favored Pre-proline 0 N--CA 1.486 1.335 0 O-C-N 120.469 -1.394 . . . . 1.62 112.607 -179.985 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.7 Cg_exo -63.79 -4.06 6.64 Favored 'Trans proline' 0 C--O 1.213 -0.743 0 CA-C-N 119.793 0.962 . . . . 0.25 110.268 -178.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.401 ' O ' ' C ' ' A' ' 42' ' ' PHE . 42.0 m-85 -110.9 -79.47 0.58 Allowed 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.404 -0.81 . . . . 0.3 108.907 179.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.401 ' C ' ' O ' ' A' ' 41' ' ' PHE . 84.5 t80 -40.62 -57.12 1.94 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.795 -0.566 . . . . 0.13 110.79 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -67.07 -30.72 70.85 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.081 -1.012 . . . . 0.41 109.834 -179.802 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 40' ' ' PRO . 11.2 m -66.76 -38.62 86.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.889 -1.132 . . . . 0.97 110.284 179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 88.7 mt -49.45 -20.25 0.68 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.935 -1.103 . . . . 0.5 109.772 -179.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.0 m -56.71 -22.94 38.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -0.983 . . . . 0.51 110.105 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -97.07 -26.46 14.98 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.15 -0.969 . . . . 2.0 110.239 -179.47 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 16.7 ttmm -90.13 -17.76 27.06 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.077 -1.014 . . . . 2.16 109.56 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.5 m-85 -134.16 70.19 1.45 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.377 -0.827 . . . . 0.24 109.39 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 57.6 p -68.51 -6.23 24.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.423 -0.798 . . . . 0.17 109.12 179.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.2 3.31 54.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.448 -0.782 . . . . 0.34 110.052 -179.341 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.0 t -118.69 148.54 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.54 -0.725 . . . . 0.12 109.135 179.794 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.419 ' N ' HD13 ' A' ' 53' ' ' ILE . 4.8 mm -99.23 121.73 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.983 -0.747 . . . . 0.17 108.983 179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.497 ' C ' HD12 ' A' ' 55' ' ' LEU . 81.4 m-85 -108.84 128.39 54.86 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.296 -0.878 . . . . 0.11 108.937 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.497 HD12 ' C ' ' A' ' 54' ' ' PHE . 6.7 mp -110.2 170.41 8.1 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.504 -0.747 . . . . 0.12 109.023 -179.536 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -140.82 137.93 33.66 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.634 -1.247 . . . . 1.31 107.634 179.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.6 t -136.69 134.0 48.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.24 -0.913 . . . . 0.14 110.336 -178.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -96.14 110.31 22.61 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.63 -1.248 . . . . 1.08 107.63 178.889 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 17.6 m -66.23 -11.35 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.27 111.346 -178.251 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.557 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 12.1 m-20 -104.76 -38.92 6.51 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.022 -1.049 . . . . 1.11 110.793 -179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.43 ' HB2' HH11 ' B' ' 2' ' ' ARG . 14.8 t70 -93.52 -13.62 27.59 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 120.908 -1.12 . . . . 1.12 109.693 -179.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.46 49.14 1.94 Allowed 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 108.306 -0.998 . . . . 0.17 108.306 178.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -56.11 -16.42 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.583 -0.698 . . . . 2.22 110.755 -179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -69.83 -39.43 76.47 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.853 -1.154 . . . . 1.11 109.304 -179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.9 t -73.8 -47.12 44.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.201 -0.937 . . . . 0.19 108.84 179.381 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.23 -35.86 82.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.346 -0.847 . . . . 0.22 109.333 179.488 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.0 m -62.78 -50.13 72.25 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.273 -0.892 . . . . 1.29 109.26 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -64.54 -32.33 73.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.348 -0.845 . . . . 2.2 109.635 179.81 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.98 0.11 56.93 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.238 -0.913 . . . . 0.33 109.816 -179.605 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 47.41 50.01 15.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 2.34 110.097 179.87 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 21.5 t -80.61 131.94 32.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.241 -0.912 . . . . 0.28 109.064 179.33 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -129.12 6.71 5.41 Favored 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.331 -0.855 . . . . 2.4 109.661 -179.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.67 144.29 24.27 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 108.402 -0.962 . . . . 0.22 108.402 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.497 HG23 ' CE2' ' B' ' 5' ' ' TYR . 32.5 p -131.01 149.12 72.87 Favored Pre-proline 0 N--CA 1.504 2.239 0 N-CA-C 108.546 -0.909 . . . . 0.22 108.546 179.348 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.55 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.4 Cg_endo -79.09 142.69 68.3 Favored 'Cis proline' 0 N--CA 1.487 1.134 0 C-N-CA 124.966 -0.848 . . . . 0.2 110.219 -1.312 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.527 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.4 m -113.01 111.06 21.52 Favored 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 107.862 -1.162 . . . . 0.18 107.862 178.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.803 ' CD1' HD21 ' A' ' 97' ' ' LEU . 88.7 m-85 -86.15 116.0 24.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.822 -1.174 . . . . 0.15 109.541 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.443 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 6.3 mt-30 -115.96 132.12 56.74 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.207 -1.405 . . . . 1.03 107.207 179.325 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.8 m-85 -105.14 127.51 52.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.435 -0.791 . . . . 0.11 109.66 -178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -121.78 155.46 35.24 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.92 -0.77 . . . . 0.17 108.92 -179.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -154.96 123.65 6.11 Favored 'General case' 0 C--N 1.298 -1.654 0 N-CA-C 107.737 -1.208 . . . . 1.48 107.737 -179.842 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 39.6 mtmt 55.95 28.88 13.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.529 -0.732 . . . . 1.67 109.827 -179.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.07 -0.1 89.49 Favored Glycine 0 N--CA 1.493 2.483 0 C-N-CA 120.089 -1.053 . . . . 0.22 110.815 178.89 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -110.98 147.88 33.75 Favored 'General case' 0 N--CA 1.504 2.268 0 O-C-N 121.144 -1.209 . . . . 2.08 110.475 -179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 3.2 ttmp? -87.87 143.84 26.9 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.484 -0.76 . . . . 1.7 109.339 179.413 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.1 m -123.59 -24.0 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.497 -0.752 . . . . 0.26 110.15 -179.667 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -176.29 177.18 47.87 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.586 -1.292 . . . . 0.18 109.975 -179.936 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -173.19 157.21 3.36 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.352 -1.087 . . . . 2.04 110.057 -179.903 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 6.5 p90 -168.76 131.16 1.32 Allowed 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.41 -0.807 . . . . 0.14 110.161 178.958 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.8 p -101.48 -161.16 0.84 Allowed 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.559 -0.904 . . . . 0.17 108.559 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.416 ' N ' ' OE2' ' B' ' 8' ' ' GLU . . . 82.43 126.5 0.98 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.104 -1.598 . . . . 0.13 109.104 179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.526 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.09 96.96 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.156 -1.203 . . . . 0.2 110.891 -179.051 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.7 t-20 -142.73 76.61 1.54 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 107.967 -1.123 . . . . 1.15 107.967 178.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.16 -32.4 73.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.243 -0.911 . . . . 1.19 110.774 -178.56 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.13 -25.23 67.67 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.93 -1.106 . . . . 1.95 109.372 -179.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.5 tttm -70.86 -37.23 73.09 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.3 -0.875 . . . . 2.05 109.852 -179.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.803 HD21 ' CD1' ' A' ' 77' ' ' PHE . 40.5 mt -52.17 -36.03 50.52 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.937 -1.102 . . . . 0.15 108.962 -179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.0 tt0 -66.09 -59.21 4.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.431 -0.793 . . . . 2.15 110.071 -179.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.77 -38.53 82.08 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.279 -0.888 . . . . 0.15 110.676 -179.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 34.4 m -67.22 -45.22 77.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.072 -1.017 . . . . 0.13 110.192 -179.147 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.6 mt -61.04 -53.03 54.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.191 -0.943 . . . . 0.18 109.127 179.987 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -59.19 -18.53 37.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.203 -0.936 . . . . 1.03 109.471 -179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -77.54 -56.56 4.43 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 2.02 110.08 -179.748 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 14.7 mt -92.96 15.47 14.88 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.495 -0.753 . . . . 0.35 110.613 -178.62 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 N--CA 1.49 1.567 0 O-C-N 120.872 -1.143 . . . . 1.18 109.403 179.919 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 50.9 p90 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.508 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 58.9 mtm180 -154.28 74.19 0.95 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.228 -0.92 . . . . 0.0 109.233 179.731 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.552 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.5 m-85 -122.27 152.21 40.3 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.627 -0.67 . . . . 0.0 109.386 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -145.1 -103.58 0.11 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.342 -0.849 . . . . 0.0 109.301 -179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.497 ' CE2' HG23 ' A' ' 74' ' ' THR . 2.6 p90 -109.28 -169.78 1.54 Allowed 'General case' 0 N--CA 1.506 2.35 0 O-C-N 121.177 -0.952 . . . . 0.0 110.973 -179.835 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.63 150.64 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 CA-C-O 122.09 0.948 . . . . 0.0 112.875 -176.778 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.7 m -102.24 96.28 6.87 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 177.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.442 ' OE1' ' O ' ' A' ' 74' ' ' THR . 0.0 OUTLIER -82.88 47.86 1.27 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.191 -0.943 . . . . 0.0 110.131 -179.51 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.598 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -78.16 -125.28 0.35 Allowed Glycine 0 N--CA 1.485 1.931 0 N-CA-C 106.62 -2.592 . . . . 0.0 106.62 177.936 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_endo -67.9 25.67 0.13 Allowed 'Trans proline' 0 CA--C 1.541 0.848 0 CA-C-N 119.495 1.648 . . . . 0.0 109.54 178.167 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.598 ' H ' ' C ' ' B' ' 9' ' ' GLY . 1.4 t -87.52 -24.43 24.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.338 -0.851 . . . . 0.0 109.264 -179.95 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -78.53 143.9 36.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.342 -0.849 . . . . 0.0 109.521 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 CA-C-O 117.996 -1.447 . . . . 0.0 109.523 -179.933 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.6 mtt . . . . . 0 N--CA 1.49 1.542 0 CA-C-O 121.36 0.6 . . . . 2.89 109.449 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.535 HG12 ' N ' ' A' ' 3' ' ' LYS . 95.3 t -94.76 164.12 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.206 -0.934 . . . . 0.3 109.496 -179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.535 ' N ' HG12 ' A' ' 2' ' ' VAL . 37.8 tptt -154.5 125.21 7.06 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.274 -0.891 . . . . 1.97 109.212 179.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -90.26 131.66 35.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.31 -0.869 . . . . 0.98 109.668 -179.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.2 mm -114.32 93.98 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 N-CA-C 108.403 -0.962 . . . . 0.19 108.403 179.34 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -96.63 -1.33 47.03 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.083 -1.011 . . . . 1.97 109.791 -179.365 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 52.0 p -150.99 146.93 26.56 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.167 -0.958 . . . . 0.23 109.813 179.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -51.83 -29.5 19.65 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.34 -0.85 . . . . 1.9 109.831 -179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 22.6 m -59.04 -45.66 90.19 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.094 -1.004 . . . . 0.25 109.799 -179.705 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.13 -26.44 63.95 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.2 109.681 -179.812 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -58.99 -66.81 0.44 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.061 -1.024 . . . . 0.21 109.786 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 77.1 mt-30 -53.65 -46.09 70.43 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.207 -0.933 . . . . 2.47 109.728 -179.671 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.2 mt-10 -58.98 -35.13 72.69 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.152 -0.967 . . . . 2.1 110.022 -179.737 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.53 -46.24 90.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.995 -1.065 . . . . 0.2 109.296 179.916 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.6 mt -64.4 -50.19 68.61 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.453 -0.779 . . . . 0.62 109.717 179.996 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.29 -36.59 84.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.29 -0.881 . . . . 1.09 109.474 -179.822 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.58 -18.66 47.6 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.218 -0.927 . . . . 0.3 109.682 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.8 23.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.292 -0.88 . . . . 0.24 109.73 -179.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.415 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 70.97 -116.11 6.16 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.642 -1.383 . . . . 0.28 109.642 179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.415 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 84.1 m-20 -135.22 4.01 3.16 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.442 -1.034 . . . . 2.21 109.408 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.419 ' N ' ' O ' ' A' ' 109' ' ' HOH . 39.0 mttp -69.8 170.07 11.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.047 -1.033 . . . . 1.9 109.013 179.617 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.5 OUTLIER -65.13 159.89 22.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 107.71 -1.218 . . . . 0.17 107.71 179.574 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.697 ' H ' HD23 ' A' ' 22' ' ' LEU . 16.1 t -143.56 108.35 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 120.865 -1.147 . . . . 0.12 109.374 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.424 HG22 ' CD2' ' A' ' 79' ' ' PHE . 4.0 t -103.95 134.47 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 N-CA-C 108.912 -0.773 . . . . 0.09 108.912 179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.2 t -111.66 136.08 48.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 121.665 -0.647 . . . . 0.17 109.523 -179.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -108.37 101.95 11.1 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 109.017 -0.735 . . . . 0.96 109.017 179.546 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -85.25 77.84 9.92 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 108.041 -1.096 . . . . 0.24 108.041 179.47 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -113.92 146.47 40.02 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 109.16 -0.682 . . . . 1.03 109.16 -179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.56 130.51 36.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.139 -0.975 . . . . 0.26 108.751 179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.8 t -65.88 -24.57 66.88 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.303 -0.873 . . . . 0.32 110.311 -179.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.533 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 58.5 p-90 -88.54 -17.35 30.41 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.082 -1.011 . . . . 0.44 109.888 -179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.82 116.18 28.8 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.281 -0.887 . . . . 0.32 110.135 -178.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.485 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -61.16 -53.14 47.21 Favored Glycine 0 N--CA 1.488 2.123 0 CA-C-O 119.341 -0.699 . . . . 0.36 111.854 -179.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.485 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.7 Cg_exo -48.38 -38.79 35.13 Favored 'Trans proline' 0 C--N 1.32 -0.925 0 C-N-CA 121.534 1.489 . . . . 0.44 111.148 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.4 -59.67 2.64 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 120.727 -1.233 . . . . 0.81 109.015 179.902 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.49 -18.63 52.95 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.518 -0.739 . . . . 1.92 110.295 179.819 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.468 ' N ' ' O ' ' A' ' 33' ' ' GLY . 28.6 ttm -57.93 -19.55 30.87 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.79 -1.194 . . . . 3.13 110.257 -179.098 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.688 HG22 ' O ' ' A' ' 38' ' ' ILE . 77.4 mt -101.5 15.02 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.136 -0.977 . . . . 0.28 110.39 -179.525 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.604 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.75 -32.21 3.43 Favored Pre-proline 0 N--CA 1.487 1.391 0 O-C-N 120.618 -1.301 . . . . 1.62 112.56 179.727 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.6 Cg_exo -63.08 -5.21 7.41 Favored 'Trans proline' 0 C--N 1.323 -0.806 0 CA-C-N 119.883 0.994 . . . . 0.25 110.165 -178.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -110.08 -76.73 0.6 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.475 -0.766 . . . . 0.3 109.203 179.367 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -41.86 -56.97 2.54 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.544 -0.723 . . . . 0.13 110.787 -179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.1 t60 -66.5 -31.52 72.3 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.93 -1.106 . . . . 0.41 110.025 -179.703 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.5 m -64.64 -38.82 92.31 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.818 -1.176 . . . . 0.97 110.039 179.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -50.25 -12.62 0.09 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.926 -1.109 . . . . 0.5 109.776 -179.68 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 44' ' ' SER . 19.4 m -56.76 -37.34 70.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.084 -1.01 . . . . 0.51 109.665 -179.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -94.97 -13.32 25.42 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.232 -0.918 . . . . 2.0 110.283 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -27.5 19.39 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.002 -1.062 . . . . 2.16 109.572 -179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -131.42 72.76 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 109.088 -0.708 . . . . 0.24 109.088 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 98.1 p -67.02 -4.48 9.87 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.353 -0.842 . . . . 0.17 109.215 179.695 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.0 t30 -96.1 -3.17 45.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.359 -0.838 . . . . 0.34 109.829 -179.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.8 t -115.45 150.12 17.49 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 121.452 -0.78 . . . . 0.12 109.603 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.2 mm -100.1 130.48 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.534 -0.729 . . . . 0.17 109.412 -179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.561 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.7 m-85 -115.03 132.53 56.57 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.554 -0.716 . . . . 0.11 109.192 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.2 mp -113.66 171.51 7.53 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 108.743 -0.836 . . . . 0.12 108.743 -179.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -141.68 138.9 32.79 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.688 -1.227 . . . . 1.31 107.688 179.214 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.2 t -138.44 136.9 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.163 -0.961 . . . . 0.14 110.887 -178.335 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -98.78 102.78 14.62 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 108.268 -1.012 . . . . 1.08 108.268 178.955 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG11 ' OH ' ' B' ' 5' ' ' TYR . 16.3 m -61.06 -0.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 0.27 111.56 -178.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 18.0 m-20 -115.18 -37.86 3.98 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 121.102 -0.999 . . . . 1.11 111.053 -178.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -94.96 -14.26 24.57 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.997 -1.064 . . . . 1.12 109.766 -179.191 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.58 52.84 1.6 Allowed 'General case' 0 N--CA 1.501 2.084 0 N-CA-C 108.709 -0.848 . . . . 0.17 108.709 179.312 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -53.93 -19.23 4.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.431 -0.793 . . . . 2.22 110.173 -179.313 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.1 p30 -68.02 -39.57 83.11 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 120.18 -1.575 . . . . 1.11 109.989 -178.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 15.5 t -74.14 -48.27 38.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 120.955 -1.091 . . . . 0.19 108.736 179.608 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.24 -40.22 90.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.458 -0.776 . . . . 0.22 110.336 179.86 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.428 ' HA ' HH22 ' B' ' 4' ' ' ARG . 23.1 t -63.63 -42.19 98.18 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.084 -1.01 . . . . 1.29 109.581 -179.112 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 tm-20 -63.69 -38.81 92.5 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.126 -0.984 . . . . 2.2 109.191 179.579 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.9 0.17 56.19 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.201 -0.937 . . . . 0.33 109.872 -179.738 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' OE2' ' O ' ' A' ' 67' ' ' SER . 22.9 mp0 48.15 56.29 7.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.206 -0.934 . . . . 2.34 110.222 179.772 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 6.9 t -79.14 132.76 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.23 -0.919 . . . . 0.28 108.916 179.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.427 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 9.3 mtmp? -129.77 3.8 4.97 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 121.331 -0.856 . . . . 2.4 110.358 -179.263 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.467 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.85 123.17 7.14 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.975 -1.078 . . . . 0.22 109.457 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.667 HG23 ' CE2' ' B' ' 5' ' ' TYR . 37.5 p -109.47 150.25 40.92 Favored Pre-proline 0 N--CA 1.503 2.196 0 O-C-N 121.322 -0.861 . . . . 0.22 109.068 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -77.41 139.55 58.82 Favored 'Cis proline' 0 N--CA 1.487 1.106 0 C-N-CA 124.894 -0.878 . . . . 0.2 110.421 -1.651 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.467 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 1.9 m -110.44 112.02 23.67 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 107.797 -1.186 . . . . 0.18 107.797 178.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.53 ' CD1' HD21 ' A' ' 97' ' ' LEU . 91.9 m-85 -89.62 119.08 29.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.919 -1.113 . . . . 0.15 109.27 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 29.2 mt-30 -117.0 132.63 56.65 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.37 -1.344 . . . . 1.03 107.37 179.636 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.442 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.8 m-85 -108.76 123.77 49.53 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 121.628 0.727 . . . . 0.11 109.471 -178.234 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -120.86 157.37 29.96 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.54 -0.911 . . . . 0.17 108.54 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -155.65 125.98 6.72 Favored 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 107.855 -1.165 . . . . 1.48 107.855 -179.725 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 58.4 mttm 56.18 26.15 9.97 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.591 -0.693 . . . . 1.67 109.988 -179.154 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.99 3.26 90.56 Favored Glycine 0 N--CA 1.493 2.478 0 N-CA-C 109.947 -1.261 . . . . 0.22 109.947 179.542 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -111.49 148.06 33.98 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.517 -0.99 . . . . 2.08 109.744 -179.73 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.3 ttpm? -86.66 146.03 26.47 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 1.7 109.692 179.805 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 9.5 m -126.91 -29.77 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.084 0 O-C-N 121.497 -0.752 . . . . 0.26 109.844 -179.922 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -172.43 177.91 44.81 Favored Glycine 0 N--CA 1.495 2.595 0 C-N-CA 119.529 -1.32 . . . . 0.18 110.472 -179.796 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.498 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.1 pm0 -173.3 154.52 2.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.364 -1.08 . . . . 2.04 110.164 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.551 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.1 p90 -168.98 131.58 1.28 Allowed 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.353 -0.842 . . . . 0.14 109.924 179.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -102.98 -158.16 0.65 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.231 -0.918 . . . . 0.17 108.895 179.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.428 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 80.9 126.05 0.7 Allowed Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.438 -1.465 . . . . 0.13 109.438 179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.546 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -52.19 94.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.086 -1.244 . . . . 0.2 110.131 -179.475 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 91' ' ' GLY . 15.3 t-20 -139.49 76.59 1.57 Allowed 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.37 -0.974 . . . . 1.15 108.37 178.404 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 6.0 ptpp? -63.99 -41.08 97.62 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.778 -0.576 . . . . 1.19 111.206 -178.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -64.58 -25.85 68.15 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.051 -1.031 . . . . 1.95 109.785 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -69.35 -33.79 73.62 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.192 -0.942 . . . . 2.05 109.405 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.53 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.8 mt -54.77 -35.53 63.9 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 118.68 -1.208 . . . . 0.15 108.583 179.715 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 56.8 tt0 -66.62 -55.96 12.92 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.319 -0.863 . . . . 2.15 109.465 -179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.31 -42.73 92.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.434 -0.791 . . . . 0.15 110.419 -179.516 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 37.2 m -65.81 -46.79 77.33 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.213 -0.929 . . . . 0.13 110.203 -179.185 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 55.8 mt -60.28 -49.67 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.009 -1.057 . . . . 0.18 108.676 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.403 ' O ' HG12 ' A' ' 105' ' ' VAL . 55.8 t30 -62.59 -17.06 59.37 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.214 -0.929 . . . . 1.03 109.183 179.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 49.9 tt0 -79.37 -55.51 5.01 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.328 -0.857 . . . . 2.02 110.457 -179.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . 0.502 ' HB2' HD11 ' A' ' 22' ' ' LEU . 27.2 mt -92.15 14.13 16.99 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.407 -0.808 . . . . 0.35 110.336 -178.331 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 102' ' ' ASN . 7.3 p . . . . . 0 N--CA 1.493 1.676 0 O-C-N 120.962 -1.086 . . . . 1.18 109.284 179.632 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 31.9 p90 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.533 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 57.8 mtp180 -139.78 73.55 1.43 Allowed 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.225 -0.922 . . . . 0.0 109.316 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.468 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 42.2 m-85 -136.39 148.95 48.07 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.295 -0.878 . . . . 0.0 109.281 -179.859 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.428 HH22 ' HA ' ' A' ' 67' ' ' SER . 7.0 ttt180 -143.9 -87.77 0.13 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.146 -0.971 . . . . 0.0 109.734 179.248 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.667 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.5 p90 -116.56 -167.79 1.34 Allowed 'General case' 0 N--CA 1.509 2.521 0 O-C-N 120.843 -1.16 . . . . 0.0 110.187 179.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.1 150.71 4.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.381 -0.825 . . . . 0.0 112.317 -177.437 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -101.59 95.36 6.4 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 177.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.412 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.5 pt-20 -82.51 45.42 0.96 Allowed 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.075 -1.015 . . . . 0.0 109.594 -179.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.608 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.04 -133.99 0.08 OUTLIER Glycine 0 N--CA 1.484 1.877 0 N-CA-C 106.717 -2.553 . . . . 0.0 106.717 178.171 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -68.81 25.38 0.15 Allowed 'Trans proline' 0 C--N 1.323 -0.79 0 CA-C-N 119.2 1.5 . . . . 0.0 108.773 178.396 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.608 ' H ' ' C ' ' B' ' 9' ' ' GLY . 17.2 t -88.04 -53.41 4.74 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.464 -0.772 . . . . 0.0 109.261 -179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.513 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 25.7 t-80 -93.25 -173.19 3.17 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.357 -0.839 . . . . 0.0 109.517 -179.751 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.513 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.275 0 CA-C-O 117.95 -1.472 . . . . 0.0 109.532 179.973 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . 0.402 ' O ' ' N ' ' A' ' 59' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.419 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.8 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 121.287 0.565 . . . . 2.89 109.501 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.596 HG12 ' N ' ' A' ' 3' ' ' LYS . 31.1 t -94.85 172.07 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.27 -0.894 . . . . 0.3 109.722 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.596 ' N ' HG12 ' A' ' 2' ' ' VAL . 76.4 tttt -154.01 124.98 7.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.271 -0.893 . . . . 1.97 109.325 179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -89.03 133.74 34.23 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.251 -0.906 . . . . 0.98 109.654 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.1 mm -105.56 117.01 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 108.162 -1.051 . . . . 0.19 108.162 179.381 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.48 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 11.6 mp0 -102.54 -14.67 16.7 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.156 -0.965 . . . . 1.97 109.508 -179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 8.7 p -152.74 158.63 42.58 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.231 -0.918 . . . . 0.23 109.817 -179.898 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -52.22 -26.71 12.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.466 -0.771 . . . . 1.9 109.703 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.9 m -59.89 -48.61 80.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.195 -0.941 . . . . 0.25 110.018 -179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.48 -24.67 62.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.355 -0.841 . . . . 0.2 109.765 -179.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.7 t80 -59.69 -69.15 0.22 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.072 -1.018 . . . . 0.21 110.039 -179.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -54.23 -43.97 71.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.329 -0.857 . . . . 2.47 109.853 -179.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -58.74 -37.45 76.21 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.236 -0.915 . . . . 2.1 109.743 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.4 -44.52 95.62 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.0 -1.063 . . . . 0.2 109.187 179.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 15.0 mt -64.69 -42.39 95.35 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.415 -0.803 . . . . 0.62 109.589 179.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.9 t0 -63.86 -42.44 97.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.254 -0.904 . . . . 1.09 109.763 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.53 -12.98 60.04 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.146 -0.971 . . . . 0.3 109.552 -179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.08 -5.91 25.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 0.24 109.653 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.25 -110.76 3.59 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.369 -1.492 . . . . 0.28 109.369 -179.886 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -140.14 5.09 2.08 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.335 -1.097 . . . . 2.21 108.98 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 71.1 mttt -69.8 168.61 14.72 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.094 -1.004 . . . . 1.9 108.819 179.419 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.64 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.49 162.52 12.54 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.039 -1.097 . . . . 0.17 108.039 179.693 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.64 ' H ' HD23 ' A' ' 22' ' ' LEU . 8.8 t -145.46 105.13 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 120.907 -1.121 . . . . 0.12 109.379 179.832 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.501 HG22 ' CD2' ' A' ' 79' ' ' PHE . 6.0 t -103.73 126.89 58.19 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.392 -0.817 . . . . 0.09 108.833 179.655 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.4 t -104.59 138.97 26.96 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 121.56 -0.713 . . . . 0.17 109.527 -179.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -111.49 104.99 13.45 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 109.299 -0.63 . . . . 0.96 109.299 179.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.53 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 48.3 m-85 -85.41 81.85 8.56 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.034 -1.099 . . . . 0.24 108.034 179.342 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.5 m -114.53 150.3 35.11 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.785 -0.572 . . . . 1.03 109.636 -179.543 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.497 ' HB1' ' NE1' ' A' ' 31' ' ' TRP . . . -92.46 125.3 37.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.26 108.591 179.102 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.7 t -66.13 -21.27 66.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.2 -0.937 . . . . 0.32 109.96 -179.48 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.523 ' NE1' ' O ' ' B' ' 2' ' ' ARG . 56.9 p-90 -89.4 -17.64 28.4 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.14 -0.975 . . . . 0.44 109.801 -179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.454 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -93.33 125.59 38.02 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.303 -0.873 . . . . 0.32 110.136 -178.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' N ' ' A' ' 37' ' ' MET . . . -63.98 -58.58 10.41 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 111.316 -0.714 . . . . 0.36 111.316 -179.759 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 21.7 Cg_exo -48.26 -34.49 24.75 Favored 'Trans proline' 0 C--N 1.318 -1.066 0 C-N-CA 121.638 1.559 . . . . 0.44 111.275 -178.34 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.5 -63.68 1.32 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.093 -1.005 . . . . 0.81 108.929 179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 45.9 tttm -59.67 -17.55 35.0 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.588 -0.695 . . . . 1.92 110.095 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.461 ' N ' ' O ' ' A' ' 33' ' ' GLY . 19.2 ttt -61.67 -18.71 60.66 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.109 -0.994 . . . . 3.13 110.155 -179.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.519 HD12 ' HG3' ' A' ' 75' ' ' PRO . 29.5 mt -98.15 13.87 4.35 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 O-C-N 121.201 -0.937 . . . . 0.28 110.244 -178.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.609 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.84 -32.05 3.26 Favored Pre-proline 0 N--CA 1.488 1.449 0 O-C-N 120.393 -1.442 . . . . 1.62 112.267 179.416 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.609 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.2 Cg_exo -64.64 -3.26 6.37 Favored 'Trans proline' 0 C--N 1.323 -0.784 0 CA-C-N 119.855 0.984 . . . . 0.25 110.119 -178.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.403 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.2 m-85 -112.47 -81.13 0.59 Allowed 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.519 -0.738 . . . . 0.3 109.173 179.474 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.403 ' C ' ' O ' ' A' ' 41' ' ' PHE . 80.6 t80 -41.44 -55.37 2.83 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.589 -0.694 . . . . 0.13 110.727 -179.482 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 3.9 t60 -68.1 -32.02 72.03 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.854 -1.154 . . . . 0.41 109.675 179.831 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 46' ' ' SER . 6.3 t -64.42 -41.22 96.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.827 -1.17 . . . . 0.97 110.191 -179.98 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.4 mt -49.62 -14.06 0.11 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.885 -1.135 . . . . 0.5 109.494 -179.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 44' ' ' SER . 17.2 m -57.45 -34.65 69.21 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.154 -0.966 . . . . 0.51 109.68 179.871 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -95.05 -17.54 21.79 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.129 -0.982 . . . . 2.0 110.075 -179.526 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 58.2 tttm -89.6 -21.74 22.68 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.064 -1.023 . . . . 2.16 109.093 -179.9 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.7 m-85 -135.75 72.32 1.44 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.567 -0.708 . . . . 0.24 109.142 179.637 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 91.1 p -66.94 -4.27 9.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.258 -0.902 . . . . 0.17 109.174 179.768 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 51' ' ' ASN . 2.7 t30 -96.38 -3.23 44.04 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34 109.818 -179.698 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.5 t -113.95 148.39 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 121.445 -0.784 . . . . 0.12 109.347 179.971 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.8 mm -100.31 129.06 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.43 -0.794 . . . . 0.17 109.553 -179.489 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 76.3 m-85 -116.95 129.48 56.07 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 121.425 -0.797 . . . . 0.11 109.18 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -111.93 175.12 5.56 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.402 -0.811 . . . . 0.12 108.977 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -143.62 146.1 33.0 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 108.204 -1.036 . . . . 1.31 108.204 179.427 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 89.7 t -142.48 138.43 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 121.134 -0.979 . . . . 0.14 110.821 -178.694 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -98.44 104.48 16.51 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.114 -1.069 . . . . 1.08 108.114 178.55 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 23.8 m -60.56 -4.03 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.321 -0.862 . . . . 0.27 111.46 -178.442 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -110.21 -43.04 4.01 Favored 'General case' 0 N--CA 1.503 2.216 0 O-C-N 121.067 -1.02 . . . . 1.11 110.833 -179.108 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -92.34 -12.28 32.78 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.098 -1.002 . . . . 1.12 109.34 -179.245 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.44 45.22 2.63 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 108.764 -0.828 . . . . 0.17 108.764 179.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.682 HE21 HH11 ' B' ' 4' ' ' ARG . 54.3 mt-30 -56.46 -12.98 1.95 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.518 -0.739 . . . . 2.22 110.454 -179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -70.01 -40.41 75.26 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.922 -1.111 . . . . 1.11 109.266 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -73.84 -46.71 45.97 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.907 . . . . 0.19 109.001 179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -62.87 -31.74 72.84 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.333 -0.855 . . . . 0.22 109.078 179.339 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.0 m -64.42 -54.57 30.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.385 -0.822 . . . . 1.29 109.336 179.939 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -63.84 -29.05 70.28 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.332 -0.855 . . . . 2.2 109.599 -179.934 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.89 -5.7 57.82 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.226 -0.921 . . . . 0.33 109.588 -179.857 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 47.25 59.39 4.1 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.327 -0.858 . . . . 2.34 110.2 179.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 21.7 t -78.92 136.6 23.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.145 -0.972 . . . . 0.28 109.061 179.335 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -123.46 -7.77 8.08 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.47 -0.769 . . . . 2.4 109.778 -179.63 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.49 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -154.11 132.47 11.98 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 120.943 -1.098 . . . . 0.22 109.945 179.685 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.73 HG23 ' CE2' ' B' ' 5' ' ' TYR . 2.9 p -110.79 151.37 42.85 Favored Pre-proline 0 N--CA 1.5 2.074 0 N-CA-C 108.278 -1.008 . . . . 0.22 108.278 179.668 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.519 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.0 Cg_endo -76.59 144.38 78.82 Favored 'Cis proline' 0 N--CA 1.484 0.922 0 C-N-CA 124.747 -0.939 . . . . 0.2 110.281 -1.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.439 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.9 122.34 46.0 Favored 'General case' 0 N--CA 1.502 2.163 0 N-CA-C 108.529 -0.915 . . . . 0.18 108.529 179.575 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 76.8 m-85 -98.21 122.73 41.72 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 0.15 109.031 179.488 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.53 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 12.4 mt-30 -120.31 133.35 55.47 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 107.91 -1.144 . . . . 1.03 107.91 -179.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' CD2' HG22 ' A' ' 24' ' ' VAL . 17.4 m-85 -107.68 124.82 50.56 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.602 -0.686 . . . . 0.11 109.346 -178.364 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -124.76 157.42 35.79 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 108.891 -0.781 . . . . 0.17 108.891 -179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 48.8 tttm -153.85 123.19 6.56 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 107.639 -1.245 . . . . 1.48 107.639 179.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 55.72 31.67 17.91 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.432 -0.793 . . . . 1.67 109.284 -178.605 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.59 6.84 88.87 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.285 -1.126 . . . . 0.22 110.285 179.25 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.3 mm100 -112.01 143.52 42.88 Favored 'General case' 0 N--CA 1.506 2.334 0 O-C-N 121.35 -1.088 . . . . 2.08 110.605 -179.366 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -84.31 141.94 30.56 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.329 -0.857 . . . . 1.7 109.58 179.46 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 28.0 m -131.99 -9.48 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.52 -0.737 . . . . 0.26 110.528 -179.616 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 175.05 168.71 36.01 Favored Glycine 0 N--CA 1.498 2.819 0 C-N-CA 119.41 -1.376 . . . . 0.18 110.596 179.923 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.518 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.1 OUTLIER -173.0 152.93 2.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.364 -1.08 . . . . 2.04 110.416 179.959 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 5.4 p90 -169.05 134.07 1.54 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.369 -0.832 . . . . 0.14 110.267 178.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.3 p -103.81 -174.33 2.52 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.074 -1.017 . . . . 0.17 109.168 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.82 132.11 6.29 Favored Glycine 0 N--CA 1.496 2.674 0 N-CA-C 109.382 -1.487 . . . . 0.13 109.382 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.558 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -58.91 94.87 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.162 -1.199 . . . . 0.2 110.137 -179.505 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -139.31 70.54 1.37 Allowed 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 107.822 -1.177 . . . . 1.15 107.822 178.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.447 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -61.77 -33.15 73.57 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.379 -0.826 . . . . 1.19 110.603 -178.511 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 45.8 mm-40 -65.04 -27.03 68.52 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.946 -1.097 . . . . 1.95 109.055 -179.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 17.9 ttmm -71.14 -37.61 72.26 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.546 -0.722 . . . . 2.05 110.063 -179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 16.0 mt -52.28 -36.11 51.99 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.666 -1.271 . . . . 0.15 108.866 -179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -66.91 -54.88 17.77 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.262 -0.899 . . . . 2.15 109.457 -179.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.69 -44.75 93.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.374 -0.829 . . . . 0.15 110.355 -179.652 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 14.2 m -65.51 -44.89 85.58 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.161 -0.962 . . . . 0.13 109.916 -179.226 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 44.3 mt -60.43 -52.88 56.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.124 -0.985 . . . . 0.18 108.764 179.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 36.3 t-20 -61.76 -16.01 45.88 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.266 -0.896 . . . . 1.03 109.808 -179.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 45.8 tt0 -77.22 -59.03 2.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.209 -0.932 . . . . 2.02 110.115 -179.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 23.4 mt -92.04 18.69 7.63 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.443 -0.786 . . . . 0.35 110.246 -178.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--N 1.303 -1.447 0 O-C-N 121.038 -1.039 . . . . 1.18 109.404 179.822 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 60.0 t80 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.523 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 91.7 mtt180 -150.67 60.9 0.94 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.327 -0.858 . . . . 0.0 109.404 179.82 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.498 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 41.7 m-85 -106.07 149.67 26.5 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.882 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.682 HH11 HE21 ' A' ' 63' ' ' GLN . 0.0 OUTLIER -137.3 -84.54 0.33 Allowed 'General case' 0 N--CA 1.501 2.095 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.537 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.73 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.23 -167.22 1.78 Allowed 'General case' 0 N--CA 1.505 2.283 0 O-C-N 121.105 -0.997 . . . . 0.0 110.104 179.016 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -71.51 148.12 10.41 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 121.833 0.825 . . . . 0.0 112.357 -177.055 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 24.1 m -100.89 93.02 5.31 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 107.624 -1.251 . . . . 0.0 107.624 177.316 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.49 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 6.2 pt-20 -83.38 43.26 0.87 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.0 -1.062 . . . . 0.0 110.364 -178.634 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.613 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -68.55 -130.18 0.04 OUTLIER Glycine 0 N--CA 1.486 1.968 0 N-CA-C 106.829 -2.508 . . . . 0.0 106.829 177.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -68.08 24.05 0.13 Allowed 'Trans proline' 0 CA--C 1.54 0.799 0 CA-C-N 119.407 1.604 . . . . 0.0 109.325 178.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.613 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.9 t -91.97 -13.15 31.55 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.758 . . . . 0.0 109.649 -179.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 63.8 t-80 -157.62 129.81 7.17 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 109.653 -179.703 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 CA-C-O 117.986 -1.452 . . . . 0.0 109.572 179.969 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 mtt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.483 -0.562 . . . . 2.89 109.483 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 76.2 t -97.22 154.64 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 121.27 -0.894 . . . . 0.3 109.681 -179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 50.0 tttp -154.24 118.0 4.67 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.368 -0.833 . . . . 1.97 108.886 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.421 ' O ' ' OE2' ' A' ' 6' ' ' GLU . 19.5 tt0 -89.5 134.63 34.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.35 -0.844 . . . . 0.98 109.961 -179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 HG23 ' HB3' ' A' ' 10' ' ' ALA . 14.3 mm -105.09 121.24 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 N-CA-C 107.483 -1.302 . . . . 0.19 107.483 178.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 5.8 mp0 -101.98 -16.89 16.34 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.085 -1.01 . . . . 1.97 109.471 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 60.6 p -153.13 155.58 37.02 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.308 -0.87 . . . . 0.23 109.137 179.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 26.1 ttpt -50.74 -21.77 1.79 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.266 -0.896 . . . . 1.9 109.337 -179.839 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 40.3 m -61.5 -47.46 85.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.118 -0.989 . . . . 0.25 109.31 179.6 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.504 ' HB3' HG23 ' A' ' 5' ' ' ILE . . . -70.85 -22.99 62.24 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.444 -0.785 . . . . 0.2 109.838 -179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -59.34 -65.76 0.62 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.037 -1.04 . . . . 0.21 109.868 -179.73 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 20.5 mm100 -55.27 -45.09 76.15 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.948 . . . . 2.47 109.67 -179.455 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -58.03 -36.17 72.35 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.172 -0.955 . . . . 2.1 109.594 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.512 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -59.76 -45.98 90.58 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.119 -0.988 . . . . 0.2 109.17 179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -65.26 -45.42 84.58 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.446 -0.784 . . . . 0.62 109.92 179.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -63.34 -40.58 97.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.284 -0.885 . . . . 1.09 109.886 -179.482 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -15.38 58.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.065 -1.022 . . . . 0.3 109.516 -179.913 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.97 -7.46 35.48 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.268 -0.895 . . . . 0.24 109.553 179.832 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.08 -110.58 3.5 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.486 -1.445 . . . . 0.28 109.486 -179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -138.67 2.98 2.25 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.436 -1.038 . . . . 2.21 109.52 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.424 ' N ' ' O ' ' A' ' 109' ' ' HOH . 84.4 mttt -70.06 171.71 9.13 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.997 -1.065 . . . . 1.9 109.134 179.591 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.639 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.06 160.5 20.86 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.468 -0.938 . . . . 0.17 108.468 -179.555 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.639 ' H ' HD23 ' A' ' 22' ' ' LEU . 3.7 t -143.38 104.59 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 121.035 -1.04 . . . . 0.12 109.254 179.704 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.19 127.88 55.34 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.325 -0.859 . . . . 0.09 108.799 179.72 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -106.66 135.52 44.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.668 -0.645 . . . . 0.17 109.402 -179.341 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -107.64 101.43 10.74 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.912 -0.773 . . . . 0.96 108.912 179.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -84.82 82.6 8.36 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 107.813 -1.181 . . . . 0.24 107.813 179.662 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.0 m -113.38 149.06 34.62 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.717 -0.615 . . . . 1.03 109.602 -179.456 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -91.0 127.25 36.35 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.517 -0.92 . . . . 0.26 108.517 179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 15.3 t -66.59 -28.46 68.53 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.356 -0.84 . . . . 0.32 111.081 -178.729 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.542 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 62.1 p-90 -87.55 -10.28 52.06 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.887 -1.133 . . . . 0.44 110.218 -179.32 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.9 t -96.48 135.97 37.63 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.219 -0.926 . . . . 0.32 109.532 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.462 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -77.78 -56.9 3.68 Favored Glycine 0 N--CA 1.49 2.264 0 O-C-N 121.501 -0.75 . . . . 0.36 112.035 -178.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 23.4 Cg_exo -46.31 -39.1 21.18 Favored 'Trans proline' 0 C--N 1.319 -1.023 0 C-N-CA 121.673 1.582 . . . . 0.44 111.721 -177.904 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.59 -53.97 7.75 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 120.73 -1.231 . . . . 0.81 108.823 179.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -59.87 -19.85 53.69 Favored 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.624 -0.672 . . . . 1.92 109.791 179.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.504 ' SD ' ' O ' ' A' ' 37' ' ' MET . 0.0 OUTLIER -59.42 -19.15 45.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 3.13 110.504 -179.056 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.3 mt -97.25 12.97 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.053 -1.029 . . . . 0.28 111.112 -178.328 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.621 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.06 -32.98 4.47 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 119.98 -1.7 . . . . 1.62 112.362 179.328 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.621 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 3.1 Cg_exo -66.43 -0.03 3.91 Favored 'Trans proline' 0 C--N 1.319 -0.979 0 CA-C-N 119.571 0.882 . . . . 0.25 110.519 -177.033 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -117.64 -74.29 0.61 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.511 -0.743 . . . . 0.3 109.179 179.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.9 t80 -42.45 -52.57 4.61 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.66 -0.65 . . . . 0.13 110.495 -179.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -68.11 -32.6 73.02 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.012 -1.055 . . . . 0.41 109.72 179.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' C ' ' N ' ' A' ' 46' ' ' SER . 59.7 p -62.37 -44.13 97.18 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.813 -1.179 . . . . 0.97 109.879 -179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -51.33 -15.9 0.46 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.109 -0.994 . . . . 0.5 109.233 179.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.411 ' N ' ' C ' ' A' ' 44' ' ' SER . 28.9 m -57.19 -38.49 73.74 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.272 -0.892 . . . . 0.51 109.698 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.8 mm-40 -94.95 -16.76 22.55 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.12 -0.987 . . . . 2.0 110.473 -179.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -88.91 -19.81 25.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.895 -1.128 . . . . 2.16 109.234 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -134.66 73.15 1.47 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.513 -0.742 . . . . 0.24 109.135 179.518 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 89.1 p -67.46 -5.07 13.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.361 -0.837 . . . . 0.17 109.273 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -96.24 8.32 44.18 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.362 -0.836 . . . . 0.34 109.713 -179.522 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.6 t -125.05 148.42 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 121.547 -0.721 . . . . 0.12 109.454 -179.785 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.0 mm -100.2 129.74 50.45 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.524 -0.735 . . . . 0.17 109.055 -179.994 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.574 ' C ' HD12 ' A' ' 55' ' ' LEU . 79.8 m-85 -116.79 130.34 56.66 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.485 -0.759 . . . . 0.11 109.446 -179.938 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.574 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.4 mp -114.01 171.41 7.62 Favored 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 108.853 -0.795 . . . . 0.12 108.853 -179.631 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -143.42 147.78 35.13 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.893 -1.151 . . . . 1.31 107.893 179.219 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -144.37 144.55 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.919 0 O-C-N 121.0 -1.062 . . . . 0.14 111.114 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -97.57 103.17 15.09 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 107.59 -1.263 . . . . 1.08 107.59 178.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.657 HG21 HG21 ' A' ' 74' ' ' THR . 2.3 m -64.84 -3.02 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.523 -0.736 . . . . 0.27 112.766 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.408 ' OD1' HG23 ' A' ' 59' ' ' VAL . 1.6 m-20 -120.45 -33.28 3.89 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.73 -1.232 . . . . 1.11 110.909 -179.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -95.23 -21.55 18.39 Favored 'General case' 0 N--CA 1.503 2.176 0 O-C-N 120.782 -1.199 . . . . 1.12 108.678 179.174 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -111.03 45.63 1.15 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 107.589 -1.263 . . . . 0.17 107.589 178.287 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.466 ' NE2' ' N ' ' A' ' 64' ' ' ASP . 3.7 pp0? -52.74 -15.12 0.64 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.781 -0.574 . . . . 2.22 110.767 -178.79 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' N ' ' NE2' ' A' ' 63' ' ' GLN . 1.0 OUTLIER -70.02 -38.78 76.0 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.868 -1.145 . . . . 1.11 108.89 179.867 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.2 t -74.65 -47.22 39.61 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.267 -0.896 . . . . 0.19 108.663 179.347 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.453 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.08 -35.48 80.41 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.383 -0.823 . . . . 0.22 109.129 179.33 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 36.5 m -63.49 -46.46 86.01 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.32 -0.862 . . . . 1.29 109.03 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -64.99 -38.42 90.91 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.291 -0.881 . . . . 2.2 109.682 179.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.37 -6.19 56.83 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.211 -0.93 . . . . 0.33 110.132 -179.459 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.453 ' N ' ' O ' ' A' ' 66' ' ' ALA . 65.3 mt-10 48.8 58.29 5.47 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.056 -1.027 . . . . 2.34 110.192 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.452 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 14.6 t -79.27 135.25 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.114 -0.991 . . . . 0.28 109.089 179.344 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 54.4 mttm -127.36 -1.55 6.29 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.374 -0.829 . . . . 2.4 110.063 -179.293 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.464 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.5 125.15 8.99 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.999 -1.063 . . . . 0.22 108.944 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.72 HG23 ' CE2' ' B' ' 5' ' ' TYR . 4.6 p -111.08 152.29 43.61 Favored Pre-proline 0 N--CA 1.499 1.98 0 N-CA-C 108.889 -0.782 . . . . 0.22 108.889 -179.594 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -77.12 143.15 74.53 Favored 'Cis proline' 0 N--CA 1.484 0.943 0 C-N-CA 124.775 -0.927 . . . . 0.2 109.948 -2.095 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.7 m -113.34 109.62 19.0 Favored 'General case' 0 N--CA 1.498 1.963 0 N-CA-C 108.235 -1.024 . . . . 0.18 108.235 178.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.47 ' CD1' HD21 ' A' ' 97' ' ' LEU . 82.1 m-85 -87.02 117.85 26.01 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.916 -1.115 . . . . 0.15 108.778 179.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -115.72 135.15 54.32 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 107.57 -1.27 . . . . 1.03 107.57 179.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 20.3 m-85 -109.95 127.21 54.63 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.617 -0.677 . . . . 0.11 109.706 -178.05 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 75.6 m-85 -125.47 157.98 35.59 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.457 -0.942 . . . . 0.17 108.457 179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -155.0 123.81 6.15 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.95 -1.13 . . . . 1.48 107.95 179.877 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? 56.19 25.39 9.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.591 -0.693 . . . . 1.67 109.228 -179.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.596 ' C ' HE21 ' A' ' 84' ' ' GLN . . . 85.5 4.0 86.09 Favored Glycine 0 N--CA 1.494 2.565 0 N-CA-C 110.132 -1.187 . . . . 0.22 110.132 179.326 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.596 HE21 ' C ' ' A' ' 83' ' ' GLY . 13.8 mm-40 -109.73 145.48 36.52 Favored 'General case' 0 N--CA 1.503 2.218 0 O-C-N 121.286 -1.126 . . . . 2.08 110.137 -179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -86.8 141.21 29.0 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.385 -0.822 . . . . 1.7 109.039 179.435 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 7.4 m -129.06 -20.73 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.486 -0.759 . . . . 0.26 110.323 -179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -173.06 173.15 45.55 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 119.386 -1.388 . . . . 0.18 110.53 -179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -174.05 151.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.42 -1.047 . . . . 2.04 109.802 179.914 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.4 p90 -169.05 133.5 1.46 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.297 -0.877 . . . . 0.14 110.149 179.096 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.5 p -103.56 -163.39 0.98 Allowed 'General case' 0 N--CA 1.499 1.989 0 O-C-N 121.255 -0.903 . . . . 0.17 108.967 179.602 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.91 131.61 2.04 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.361 -1.496 . . . . 0.13 109.361 -179.946 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.495 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -60.53 96.17 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.137 -1.213 . . . . 0.2 110.852 -179.351 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -142.29 78.32 1.62 Allowed 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 107.772 -1.195 . . . . 1.15 107.772 177.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.488 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -64.04 -34.89 79.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.502 -0.749 . . . . 1.19 110.833 -178.494 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -64.8 -25.78 68.06 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 120.879 -1.138 . . . . 1.95 109.23 -179.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 34.9 tttp -68.85 -37.45 79.14 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.252 -0.905 . . . . 2.05 109.404 179.856 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.7 mt -52.46 -35.68 53.08 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.948 -1.095 . . . . 0.15 108.689 179.91 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -67.0 -58.79 4.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.371 -0.83 . . . . 2.15 109.584 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.51 -39.34 83.53 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.305 -0.872 . . . . 0.15 110.628 -179.41 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 28.7 m -66.97 -44.81 79.52 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.049 -1.032 . . . . 0.13 109.938 -179.153 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 45.7 mt -60.99 -52.56 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.18 109.128 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.3 t-20 -60.8 -17.22 48.12 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.112 -0.993 . . . . 1.03 109.407 -179.779 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 20.3 tp10 -77.66 -62.54 1.63 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.357 -0.839 . . . . 2.02 110.3 -179.636 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 35.4 mt -91.59 23.09 3.67 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.518 -0.739 . . . . 0.35 110.617 -178.334 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.491 1.594 0 O-C-N 120.996 -1.065 . . . . 1.18 109.239 179.562 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 39.5 p90 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 16.2 ttp180 -152.86 65.08 0.79 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.046 -1.034 . . . . 0.0 109.577 -179.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.542 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 29.9 m-85 -123.87 162.16 23.86 Favored 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.624 -0.673 . . . . 0.0 109.244 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -150.25 -90.25 0.07 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.082 -1.011 . . . . 0.0 109.549 179.143 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.72 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.9 p90 -121.61 -167.0 1.45 Allowed 'General case' 0 N--CA 1.508 2.443 0 O-C-N 120.837 -1.164 . . . . 0.0 110.334 179.578 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 t -79.48 151.11 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.891 0 O-C-N 121.36 -0.838 . . . . 0.0 112.018 -177.292 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.9 m -101.78 95.42 6.4 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.424 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 1.9 pt-20 -83.43 45.85 1.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.937 -1.102 . . . . 0.0 109.966 -179.637 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.627 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.12 -134.68 0.07 OUTLIER Glycine 0 N--CA 1.484 1.859 0 N-CA-C 106.983 -2.447 . . . . 0.0 106.983 178.155 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -68.76 24.39 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.886 0 CA-C-N 119.212 1.506 . . . . 0.0 108.441 178.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.627 ' H ' ' C ' ' B' ' 9' ' ' GLY . 11.6 t -81.73 -41.98 20.47 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.461 -0.774 . . . . 0.0 109.603 -179.421 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.411 ' ND1' ' C ' ' B' ' 12' ' ' HIS . 0.3 OUTLIER -69.42 94.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.896 . . . . 0.0 109.633 -179.794 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.342 0 CA-C-O 118.033 -1.426 . . . . 0.0 109.552 179.93 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.424 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.1 mtp . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.419 -0.585 . . . . 2.89 109.419 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.514 HG12 ' N ' ' A' ' 3' ' ' LYS . 19.8 t -94.76 168.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.272 -0.892 . . . . 0.3 109.499 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.514 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -153.36 119.36 5.4 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.16 -0.962 . . . . 1.97 108.726 -179.96 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -86.72 139.79 30.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.185 -0.947 . . . . 0.98 109.911 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.0 mm -110.03 119.49 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 N-CA-C 107.961 -1.126 . . . . 0.19 107.961 179.439 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.488 ' N ' ' CD ' ' A' ' 6' ' ' GLU . 6.7 mp0 -105.4 -17.34 14.47 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.264 -0.898 . . . . 1.97 109.705 -179.384 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 58.7 p -151.74 161.39 42.74 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.035 -1.041 . . . . 0.23 110.128 -179.687 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 77.3 tttt -53.01 -32.14 44.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.523 -0.736 . . . . 1.9 109.966 -179.942 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.1 m -59.44 -43.69 93.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.041 -1.037 . . . . 0.25 109.98 -179.471 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.0 64.33 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.855 . . . . 0.2 109.943 -179.718 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 71.4 t80 -59.69 -63.96 1.11 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.092 -1.005 . . . . 0.21 110.04 -179.52 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 66.2 mt-30 -56.54 -45.07 81.39 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.241 -0.912 . . . . 2.47 109.638 -179.441 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -58.7 -35.5 72.74 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.257 -0.902 . . . . 2.1 109.933 -179.879 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.03 -45.39 94.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.074 -1.016 . . . . 0.2 109.682 -179.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.1 mt -62.45 -44.02 97.42 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.336 -0.853 . . . . 0.62 109.649 -179.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -65.1 -38.36 90.48 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.313 -0.867 . . . . 1.09 109.851 -179.797 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -80.62 -19.88 44.46 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.033 -1.042 . . . . 0.3 109.646 -179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.25 -2.9 9.13 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.243 -0.911 . . . . 0.24 109.74 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.2 -136.34 32.39 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.211 -1.556 . . . . 0.28 109.211 -179.864 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 20' ' ' ASP . 3.5 m-20 -116.6 5.65 13.31 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.38 -1.07 . . . . 2.21 109.621 179.87 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.423 ' N ' ' O ' ' A' ' 109' ' ' HOH . 88.0 mttt -70.18 170.92 10.62 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.206 -0.934 . . . . 1.9 109.127 179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.633 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -65.27 161.7 18.91 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 107.855 -1.165 . . . . 0.17 107.855 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.633 ' H ' HD23 ' A' ' 22' ' ' LEU . 5.5 t -145.13 105.94 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.891 -1.131 . . . . 0.12 109.632 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG22 ' CD2' ' A' ' 79' ' ' PHE . 8.7 t -103.41 128.81 56.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.863 0 N-CA-C 108.788 -0.819 . . . . 0.09 108.788 179.462 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.6 t -106.01 139.59 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.598 -0.689 . . . . 0.17 109.649 -178.909 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -109.54 98.42 7.79 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 109.293 -0.632 . . . . 0.96 109.293 179.316 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.411 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 53.0 m-85 -83.42 83.43 7.88 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 107.568 -1.271 . . . . 0.24 107.568 179.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.7 m -110.38 -163.28 0.85 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.514 0.673 . . . . 1.03 109.381 -179.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -139.97 120.26 13.9 Favored 'General case' 0 N--CA 1.493 1.684 0 N-CA-C 108.341 -0.985 . . . . 0.26 108.341 179.728 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.0 t -63.57 -25.02 68.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.561 -0.712 . . . . 0.32 110.934 -178.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.562 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 58.0 p-90 -89.27 -12.79 39.67 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.931 -1.106 . . . . 0.44 110.093 -179.369 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.6 134.33 39.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.278 -0.889 . . . . 0.32 109.776 -178.825 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.446 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -73.65 -55.5 5.97 Favored Glycine 0 N--CA 1.49 2.299 0 C-N-CA 120.809 -0.71 . . . . 0.36 111.492 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.446 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.2 Cg_exo -51.4 -32.83 44.02 Favored 'Trans proline' 0 C--N 1.317 -1.099 0 C-N-CA 121.663 1.575 . . . . 0.44 111.085 -178.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.24 -62.26 1.71 Allowed 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.058 -1.026 . . . . 0.81 108.905 -179.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -59.72 -21.17 60.29 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.467 -0.77 . . . . 1.92 110.03 179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 17.9 ttm -59.61 -18.24 39.79 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.147 -0.97 . . . . 3.13 110.296 -178.843 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.677 HG22 ' O ' ' A' ' 38' ' ' ILE . 95.6 mt -99.45 7.57 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 121.178 -0.951 . . . . 0.28 110.722 -179.277 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.594 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -68.6 -32.2 3.52 Favored Pre-proline 0 C--N 1.307 -1.266 0 C-N-CA 118.429 -1.308 . . . . 1.62 112.519 179.947 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.7 Cg_exo -61.22 -6.05 6.02 Favored 'Trans proline' 0 C--O 1.213 -0.73 0 CA-C-N 119.979 1.028 . . . . 0.25 109.706 -178.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.4 m-85 -110.82 -76.29 0.61 Allowed 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 108.968 -0.753 . . . . 0.3 108.968 179.273 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -42.72 -56.99 2.93 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.531 -0.73 . . . . 0.13 110.726 -179.672 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.4 t60 -66.51 -31.79 72.74 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.007 -1.058 . . . . 0.41 110.013 -179.854 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.427 ' O ' ' N ' ' A' ' 46' ' ' SER . 4.6 t -64.33 -40.82 96.66 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.743 -1.223 . . . . 0.97 110.163 179.851 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.3 mt -50.51 -14.31 0.18 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.886 -1.134 . . . . 0.5 109.469 -179.68 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' O ' ' A' ' 44' ' ' SER . 14.2 m -57.52 -38.0 73.93 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.078 -1.014 . . . . 0.51 109.537 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -93.63 -12.23 29.88 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.227 -0.921 . . . . 2.0 110.054 -179.467 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -51.67 5.69 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.029 -1.1 . . . . 2.16 108.029 -179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 54.8 m-85 -107.34 75.72 1.04 Allowed 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.545 -0.722 . . . . 0.24 109.607 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 77.7 p -66.79 -3.68 7.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.227 -0.921 . . . . 0.17 108.618 179.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -95.77 -0.74 50.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.595 -0.69 . . . . 0.34 109.372 -179.849 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 92.4 t -118.28 147.07 21.99 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-O 121.362 0.601 . . . . 0.12 109.614 -179.503 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.5 mm -99.22 134.72 37.24 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.495 -0.753 . . . . 0.17 109.268 -179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.542 ' C ' HD12 ' A' ' 55' ' ' LEU . 80.3 m-85 -121.62 131.3 54.03 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.507 -0.745 . . . . 0.11 109.237 179.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.542 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.3 mp -112.89 172.71 6.77 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.282 -0.886 . . . . 0.12 108.777 179.993 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 79.3 tt0 -142.79 138.7 30.59 Favored 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.149 -1.056 . . . . 1.31 108.149 179.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.9 t -135.29 136.74 50.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 121.243 -0.91 . . . . 0.14 110.593 -178.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -96.78 100.69 12.22 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.855 -1.165 . . . . 1.08 107.855 178.646 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 29.2 m -60.18 -6.55 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.171 -0.955 . . . . 0.27 110.885 -178.393 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -104.43 -42.31 5.49 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.123 -0.986 . . . . 1.11 110.712 -179.138 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -94.28 -12.43 28.13 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.094 -1.004 . . . . 1.12 109.624 -179.302 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -122.73 48.67 1.74 Allowed 'General case' 0 N--CA 1.502 2.159 0 N-CA-C 108.536 -0.913 . . . . 0.17 108.536 179.093 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.641 ' CG ' HH12 ' B' ' 4' ' ' ARG . 21.6 mt-30 -56.34 -16.47 5.66 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.544 -0.723 . . . . 2.22 110.321 -179.363 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 4.3 p30 -70.49 -39.59 74.1 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.015 -1.053 . . . . 1.11 109.442 -179.765 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 11.2 t -73.9 -46.03 47.6 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.153 -0.967 . . . . 0.19 108.679 179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.07 -35.34 79.91 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.357 -0.839 . . . . 0.22 109.003 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 56.2 m -64.28 -46.8 82.09 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.433 -0.792 . . . . 1.29 109.155 179.824 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 72.5 tt0 -64.18 -38.09 89.8 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.376 -0.827 . . . . 2.2 109.761 179.979 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.54 -3.36 58.99 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.244 -0.91 . . . . 0.33 109.777 -179.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 48.75 59.18 4.57 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.209 -0.932 . . . . 2.34 110.002 179.699 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.444 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 17.2 t -79.22 136.58 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.127 -0.983 . . . . 0.28 109.163 179.516 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.9 mttp -128.04 -4.35 5.67 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.431 -0.793 . . . . 2.4 110.019 -179.453 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.662 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.85 126.8 8.99 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.014 -1.054 . . . . 0.22 109.322 179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.719 HG23 ' CE2' ' B' ' 5' ' ' TYR . 12.6 p -110.76 151.66 43.01 Favored Pre-proline 0 N--CA 1.501 2.097 0 N-CA-C 108.746 -0.835 . . . . 0.22 108.746 -179.901 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.423 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.58 142.77 74.07 Favored 'Cis proline' 0 N--CA 1.485 0.972 0 C-N-CA 124.887 -0.88 . . . . 0.2 110.076 -1.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.17 111.63 21.87 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 107.965 -1.124 . . . . 0.18 107.965 179.039 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.485 ' CD1' HD21 ' A' ' 97' ' ' LEU . 85.7 m-85 -86.99 119.87 27.65 Favored 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.038 -1.065 . . . . 0.15 109.264 -179.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.411 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 41.4 mt-30 -117.05 135.71 53.52 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.575 -1.268 . . . . 1.03 107.575 179.777 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD2' HG22 ' A' ' 24' ' ' VAL . 19.9 m-85 -109.0 127.45 54.09 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 121.496 0.665 . . . . 0.11 109.816 -177.763 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -125.37 156.02 39.41 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 108.516 -0.92 . . . . 0.17 108.516 179.83 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 54.9 tttt -155.1 123.34 5.9 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.169 -1.048 . . . . 1.48 108.169 -179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 25.9 mtpt 54.48 30.61 13.23 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.768 -0.773 . . . . 1.67 110.012 179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.5 3.94 90.52 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 120.074 -1.06 . . . . 0.22 110.48 178.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -112.46 146.25 38.76 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 121.312 -1.111 . . . . 2.08 110.036 -179.771 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 33.1 ttpt -86.18 143.63 27.89 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.361 -0.837 . . . . 1.7 109.246 179.556 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 8.0 m -126.94 -19.51 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.021 0 O-C-N 121.474 -0.766 . . . . 0.26 110.449 -179.283 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 178.58 178.07 47.67 Favored Glycine 0 N--CA 1.495 2.597 0 C-N-CA 119.305 -1.426 . . . . 0.18 110.524 -179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -174.11 154.11 2.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.397 -1.061 . . . . 2.04 110.113 179.919 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.542 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.5 p90 -168.46 131.18 1.43 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.341 -0.85 . . . . 0.14 110.171 178.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 p -102.21 -162.35 0.92 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.246 -0.909 . . . . 0.17 108.96 179.63 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 81.99 129.82 1.21 Allowed Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.075 -1.61 . . . . 0.13 109.075 -179.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.561 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -56.6 96.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.116 -1.226 . . . . 0.2 110.213 -179.201 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -140.23 67.33 1.37 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 107.888 -1.152 . . . . 1.15 107.888 178.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.414 ' HG2' ' H ' ' A' ' 94' ' ' LYS . 12.4 ptpt -58.13 -37.45 74.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.837 -0.539 . . . . 1.19 110.652 -178.797 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.2 mm-40 -64.97 -26.54 68.34 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.155 -0.966 . . . . 1.95 109.611 -179.279 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 36.3 tttm -70.3 -33.39 71.49 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.269 -0.894 . . . . 2.05 109.835 179.977 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.485 HD21 ' CD1' ' A' ' 77' ' ' PHE . 14.5 mt -53.19 -33.88 54.58 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.801 -1.187 . . . . 0.15 108.656 179.869 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -67.36 -55.6 13.13 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.277 -0.889 . . . . 2.15 109.35 179.833 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -43.8 94.46 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.15 110.648 -179.356 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.4 m -65.49 -45.1 84.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.037 -1.039 . . . . 0.13 109.876 -179.113 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 50.1 mt -60.91 -53.23 51.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.18 108.838 179.713 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -60.44 -16.45 36.41 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -0.948 . . . . 1.03 109.593 -179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -76.76 -60.65 2.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.186 -0.946 . . . . 2.02 110.064 -179.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 18.7 mt -92.76 20.79 6.13 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.437 -0.789 . . . . 0.35 110.16 -178.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.023 -1.048 . . . . 1.18 109.317 179.598 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . 0.454 ' CD1' ' C ' ' B' ' 1' ' ' PHE . 11.4 p90 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.562 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 0.2 OUTLIER -115.02 68.26 0.7 Allowed 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.343 -0.848 . . . . 0.0 108.894 179.749 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.513 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.3 m-85 -113.49 156.15 24.06 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.084 -1.01 . . . . 0.0 108.983 179.443 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.641 HH12 ' CG ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -150.23 -92.35 0.07 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.163 -0.96 . . . . 0.0 109.077 179.932 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.719 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -123.42 -167.2 1.57 Allowed 'General case' 0 N--CA 1.506 2.337 0 O-C-N 120.916 -1.115 . . . . 0.0 110.233 179.431 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -75.54 148.98 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 CA-C-O 121.831 0.825 . . . . 0.0 112.154 -177.197 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 4.1 m -100.88 95.59 6.72 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 177.248 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.662 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.4 pt-20 -82.91 43.4 0.85 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.996 -1.065 . . . . 0.0 110.052 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.597 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.59 -132.59 0.07 OUTLIER Glycine 0 N--CA 1.484 1.836 0 N-CA-C 106.464 -2.655 . . . . 0.0 106.464 177.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -68.85 26.51 0.15 Allowed 'Trans proline' 0 C--N 1.321 -0.905 0 CA-C-N 119.328 1.564 . . . . 0.0 109.161 178.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.597 ' H ' ' C ' ' B' ' 9' ' ' GLY . 21.8 t -90.72 -23.46 20.7 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.437 -0.789 . . . . 0.0 109.502 -179.709 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -74.16 131.31 41.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.18 -0.95 . . . . 0.0 109.469 -179.93 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.461 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 179.985 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.423 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 45.1 mmm . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 109.369 -0.604 . . . . 2.89 109.369 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.594 HG12 ' N ' ' A' ' 3' ' ' LYS . 71.2 t -94.68 168.09 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.26 -0.9 . . . . 0.3 109.592 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.594 ' N ' HG12 ' A' ' 2' ' ' VAL . 48.5 tttp -154.29 122.33 5.99 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.181 -0.949 . . . . 1.97 109.199 179.896 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 30.8 tt0 -88.99 139.0 30.9 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.224 -0.922 . . . . 0.98 109.482 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.8 mm -107.96 106.99 21.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 N-CA-C 108.273 -1.01 . . . . 0.19 108.273 179.527 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 -100.1 -6.81 25.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.017 -1.052 . . . . 1.97 109.616 -179.839 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.2 p -152.61 152.08 31.38 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.151 -0.968 . . . . 0.23 109.601 179.935 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 42.8 tttp -52.04 -28.6 17.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.396 -0.815 . . . . 1.9 109.951 -179.758 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.7 m -60.12 -45.13 94.04 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.351 -0.843 . . . . 0.25 110.241 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.64 -25.74 64.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.219 -0.926 . . . . 0.2 110.114 -179.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -59.45 -69.33 0.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.118 -0.989 . . . . 0.21 110.197 -179.41 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -55.73 -41.37 73.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.301 -0.875 . . . . 2.47 109.808 -179.349 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 51.6 mm-40 -58.78 -38.55 78.76 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.223 -0.923 . . . . 2.1 109.848 -179.854 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -60.87 -46.06 92.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.137 -0.977 . . . . 0.2 109.305 179.975 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 10.8 mt -64.38 -45.08 89.26 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.386 -0.821 . . . . 0.62 109.832 179.878 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -63.95 -40.37 96.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 1.09 109.748 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.8 -13.99 59.02 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.181 -0.949 . . . . 0.3 109.734 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.56 -6.92 28.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.175 -0.953 . . . . 0.24 109.809 -179.86 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.88 -111.96 4.14 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.576 -1.409 . . . . 0.28 109.576 -179.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.1 m-20 -138.03 4.32 2.49 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.39 -1.064 . . . . 2.21 109.268 -179.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.4 mttt -71.03 166.44 21.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.305 -0.872 . . . . 1.9 109.153 179.712 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.02 161.37 13.27 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.15 -0.969 . . . . 0.17 108.688 -179.572 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.679 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.0 t -144.0 106.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 120.856 -1.153 . . . . 0.12 109.489 179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.3 t -102.96 132.64 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 N-CA-C 108.108 -1.071 . . . . 0.09 108.108 178.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.5 t -110.26 139.37 33.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 O-C-N 121.548 -0.72 . . . . 0.17 110.002 -178.659 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -109.33 101.89 10.84 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.929 -0.767 . . . . 0.96 108.929 179.328 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE2' HG11 ' A' ' 57' ' ' VAL . 41.1 m-85 -86.35 79.11 9.14 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.708 -1.219 . . . . 0.24 107.708 179.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 57.9 m -113.45 149.56 34.06 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-O 121.324 0.583 . . . . 1.03 109.745 -179.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -92.23 128.48 38.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.287 -0.883 . . . . 0.26 108.73 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.6 t -66.29 -25.17 66.73 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.31 -0.869 . . . . 0.32 110.241 -179.275 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 55.0 p-90 -87.98 -14.34 39.38 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.033 -1.042 . . . . 0.44 109.958 -179.529 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.484 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -95.37 125.88 40.29 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.234 -0.916 . . . . 0.32 109.487 -179.198 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.532 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -67.61 -54.13 20.75 Favored Glycine 0 N--CA 1.489 2.215 0 O-C-N 121.48 -0.762 . . . . 0.36 111.437 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 16.5 Cg_exo -48.51 -32.6 21.21 Favored 'Trans proline' 0 C--N 1.32 -0.926 0 C-N-CA 121.912 1.741 . . . . 0.44 110.88 -178.186 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -77.02 -61.79 1.86 Allowed 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.004 -1.06 . . . . 0.81 109.057 179.959 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.6 ttpm? -59.8 -17.87 39.15 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.537 -0.727 . . . . 1.92 110.033 179.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 8.3 tpt -58.11 -25.75 61.76 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.135 -0.978 . . . . 3.13 110.387 -178.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.664 HG22 ' O ' ' A' ' 38' ' ' ILE . 90.8 mt -97.54 9.03 7.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.924 0 O-C-N 121.123 -0.985 . . . . 0.28 110.819 -179.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.622 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.93 -32.57 6.86 Favored Pre-proline 0 N--CA 1.484 1.264 0 O-C-N 120.425 -1.422 . . . . 1.62 111.846 178.772 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.9 Cg_exo -63.18 -5.24 7.62 Favored 'Trans proline' 0 C--O 1.214 -0.71 0 CA-C-N 119.7 0.929 . . . . 0.25 110.102 -177.505 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -112.37 -71.59 0.75 Allowed 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 108.957 -0.757 . . . . 0.3 108.957 179.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 81.0 t80 -45.69 -56.76 4.86 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.484 -0.76 . . . . 0.13 110.457 -179.688 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.3 t60 -66.59 -31.97 73.01 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.263 -0.898 . . . . 0.41 110.044 -179.63 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.427 ' C ' ' N ' ' A' ' 46' ' ' SER . 7.0 m -64.18 -38.84 92.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.833 -1.167 . . . . 0.97 110.184 -179.747 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 48.9 mt -51.39 -12.76 0.17 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.009 -1.057 . . . . 0.5 109.547 -179.614 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.427 ' N ' ' C ' ' A' ' 44' ' ' SER . 67.1 m -57.92 -32.89 68.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.956 -1.09 . . . . 0.51 109.625 179.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -95.37 -19.45 19.92 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.193 -0.942 . . . . 2.0 110.167 -179.425 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -90.81 -22.16 21.14 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.031 -1.043 . . . . 2.16 109.525 -179.714 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -134.26 68.41 1.48 Allowed 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.479 -0.763 . . . . 0.24 109.292 179.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 84.4 p -67.28 -4.79 11.64 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.427 -0.795 . . . . 0.17 109.164 179.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.5 t-20 -95.51 0.21 52.87 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.825 . . . . 0.34 109.62 -179.774 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 85.4 t -117.17 151.01 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 109.047 -0.723 . . . . 0.12 109.047 179.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.8 mm -101.22 126.5 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.315 -0.866 . . . . 0.17 109.311 -179.371 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.617 ' C ' HD12 ' A' ' 55' ' ' LEU . 67.8 m-85 -112.96 130.87 55.97 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.39 -0.819 . . . . 0.11 109.16 179.736 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.617 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.0 mp -115.17 173.77 6.33 Favored 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.459 -0.775 . . . . 0.12 109.055 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -145.29 141.1 28.28 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.03 -1.1 . . . . 1.31 108.03 179.205 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.408 HG11 ' CE2' ' A' ' 27' ' ' PHE . 76.9 t -137.17 139.44 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 O-C-N 121.2 -0.937 . . . . 0.14 110.443 -178.514 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.544 ' CG ' HH21 ' B' ' 2' ' ' ARG . 7.1 t70 -99.57 108.07 20.38 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 108.089 -1.078 . . . . 1.08 108.089 178.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.407 HG11 ' OH ' ' B' ' 5' ' ' TYR . 33.3 m -68.33 -8.5 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.257 -0.902 . . . . 0.27 111.23 -178.563 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.414 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 7.0 m-20 -104.6 -38.67 6.66 Favored 'General case' 0 N--CA 1.502 2.155 0 O-C-N 120.992 -1.067 . . . . 1.11 110.919 -179.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -95.59 -17.67 21.18 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.008 -1.058 . . . . 1.12 110.131 -178.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -120.56 51.25 1.24 Allowed 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 108.509 -0.923 . . . . 0.17 108.509 179.461 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 52.7 mt-30 -54.26 -15.37 1.54 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.607 -0.683 . . . . 2.22 110.237 -179.505 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 3.3 p30 -70.4 -40.28 74.0 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.905 -1.122 . . . . 1.11 109.53 -179.773 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.1 t -74.09 -47.22 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.222 -0.924 . . . . 0.19 108.729 179.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.404 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.55 -31.21 72.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.415 -0.803 . . . . 0.22 109.352 179.427 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.405 ' O ' ' OE2' ' A' ' 70' ' ' GLU . 15.1 m -63.79 -52.49 60.06 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 1.29 109.288 -179.956 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.9 tm-20 -63.17 -36.23 82.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.31 -0.869 . . . . 2.2 109.466 179.892 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.414 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -87.44 -2.69 58.79 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.29 -0.881 . . . . 0.33 109.582 -179.892 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' OE2' ' O ' ' A' ' 67' ' ' SER . 21.3 mp0 43.98 52.09 6.83 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.379 -0.825 . . . . 2.34 110.083 179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 36.6 t -77.99 129.86 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.162 -0.961 . . . . 0.28 108.944 179.515 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.439 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 83.8 mttt -125.58 5.79 7.55 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 121.531 -0.73 . . . . 2.4 109.68 -179.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -152.69 138.0 17.52 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.112 -0.993 . . . . 0.22 108.806 -179.999 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.482 HG23 ' CE2' ' B' ' 5' ' ' TYR . 65.0 p -123.88 149.7 60.38 Favored Pre-proline 0 N--CA 1.501 2.105 0 N-CA-C 108.865 -0.791 . . . . 0.22 108.865 179.218 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -78.02 144.78 76.88 Favored 'Cis proline' 0 N--CA 1.482 0.835 0 C-N-CA 124.959 -0.851 . . . . 0.2 110.422 -1.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.21 114.74 26.41 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 107.576 -1.268 . . . . 0.18 107.576 178.31 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.719 ' CD1' HD21 ' A' ' 97' ' ' LEU . 84.7 m-85 -90.2 123.93 34.43 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.028 -1.045 . . . . 0.15 108.747 179.808 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.414 HE22 ' HB1' ' A' ' 69' ' ' ALA . 34.0 mt-30 -121.87 136.52 54.93 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.676 -1.231 . . . . 1.03 107.676 -179.832 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.451 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.44 124.22 51.35 Favored 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 121.475 0.655 . . . . 0.11 109.426 -178.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -124.02 155.56 38.06 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.688 -0.856 . . . . 0.17 108.688 -179.873 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 61.2 tttt -155.48 124.36 6.11 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 107.42 -1.326 . . . . 1.48 107.42 -179.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 70.9 mttt 57.96 25.4 12.14 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.704 -0.623 . . . . 1.67 109.821 -178.846 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 6.69 86.56 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 110.219 -1.152 . . . . 0.22 110.219 179.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -114.47 147.93 38.58 Favored 'General case' 0 N--CA 1.503 2.192 0 O-C-N 121.357 -1.084 . . . . 2.08 110.101 -179.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -85.33 141.26 30.16 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.32 -0.863 . . . . 1.7 109.162 179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.6 m -128.31 -18.54 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.452 -0.78 . . . . 0.26 110.221 -179.689 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -175.27 171.79 44.89 Favored Glycine 0 N--CA 1.495 2.626 0 C-N-CA 119.6 -1.286 . . . . 0.18 110.389 179.898 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -174.09 151.93 1.79 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.417 -1.049 . . . . 2.04 110.233 -179.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.549 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.7 p90 -168.97 130.91 1.22 Allowed 'General case' 0 N--CA 1.49 1.535 0 CA-C-O 121.667 0.746 . . . . 0.14 110.316 178.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.2 p -101.27 -162.16 0.91 Allowed 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.035 -1.041 . . . . 0.17 108.685 179.447 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 83.1 128.5 1.32 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 109.249 -1.541 . . . . 0.13 109.249 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.602 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.87 97.26 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.25 -1.147 . . . . 0.2 110.866 -179.157 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 18.4 t-20 -141.06 77.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 107.984 -1.117 . . . . 1.15 107.984 178.23 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 5.9 ptpp? -64.76 -42.66 94.97 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.81 -0.556 . . . . 1.19 111.579 -178.414 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -64.81 -24.97 67.71 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.877 -1.139 . . . . 1.95 110.059 -178.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 26.8 ttmt -68.04 -34.48 76.55 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.052 -1.03 . . . . 2.05 109.497 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.719 HD21 ' CD1' ' A' ' 77' ' ' PHE . 39.4 mt -52.08 -34.44 43.79 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.998 -1.063 . . . . 0.15 109.008 -179.939 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -66.31 -57.74 6.85 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.469 -0.77 . . . . 2.15 109.49 -179.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -58.97 -41.18 86.92 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.343 -0.848 . . . . 0.15 110.546 -179.381 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 12.8 m -66.98 -45.32 78.03 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.193 -0.942 . . . . 0.13 109.973 -179.168 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 34.1 mt -60.51 -52.89 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.153 -0.967 . . . . 0.18 108.79 179.706 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . 0.41 ' OD1' ' O ' ' A' ' 102' ' ' ASN . 23.5 t-20 -60.62 -16.93 43.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.267 -0.896 . . . . 1.03 109.859 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -75.89 -55.99 5.09 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.269 -0.895 . . . . 2.02 110.463 -179.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 28.6 mt -94.38 10.75 33.07 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.329 -0.857 . . . . 0.35 110.872 -178.475 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 N--CA 1.493 1.702 0 O-C-N 120.704 -1.248 . . . . 1.18 109.269 179.721 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 59.1 t80 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.544 HH21 ' CG ' ' A' ' 58' ' ' ASP . 58.5 mtp180 -137.64 56.78 1.75 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.43 -0.794 . . . . 0.0 109.306 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.461 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 43.3 m-85 -106.4 158.38 16.93 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.412 -0.805 . . . . 0.0 109.402 179.781 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.596 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -149.83 -84.23 0.09 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.166 -0.959 . . . . 0.0 108.611 179.624 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.482 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.1 p90 -130.0 -176.11 3.83 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.354 -0.842 . . . . 0.0 110.18 179.446 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 10.3 t -70.38 146.23 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.964 0.888 . . . . 0.0 112.821 -176.99 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.8 m -101.01 95.78 6.81 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -83.15 45.44 1.02 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.063 -1.023 . . . . 0.0 110.188 -178.797 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.624 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.24 -132.63 0.1 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 107.149 -2.38 . . . . 0.0 107.149 177.959 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -66.47 22.92 0.1 OUTLIER 'Trans proline' 0 C--N 1.321 -0.918 0 CA-C-N 118.95 1.375 . . . . 0.0 109.065 178.62 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.624 ' H ' ' C ' ' B' ' 9' ' ' GLY . 19.1 t -84.82 -49.7 8.2 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.431 -0.793 . . . . 0.0 109.34 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -76.44 122.94 25.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.34 -0.85 . . . . 0.0 109.498 -179.992 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.992 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.7 mmm . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.423 -0.584 . . . . 2.89 109.423 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.575 HG12 ' N ' ' A' ' 3' ' ' LYS . 85.3 t -94.58 165.88 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 121.212 -0.93 . . . . 0.3 109.297 -180.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.575 ' N ' HG12 ' A' ' 2' ' ' VAL . 24.2 tptp -155.02 125.55 6.89 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.268 -0.895 . . . . 1.97 109.09 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 -90.73 135.45 33.71 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.425 -0.797 . . . . 0.98 109.792 -179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 11.6 mm -110.16 113.92 45.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 N-CA-C 107.994 -1.113 . . . . 0.19 107.994 178.985 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -103.27 -13.05 16.87 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 1.97 109.657 -178.901 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 29.5 p -152.9 156.99 40.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.173 -0.954 . . . . 0.23 109.91 179.952 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -52.8 -32.62 44.93 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.435 -0.79 . . . . 1.9 110.163 -179.884 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 14.3 m -58.95 -44.24 91.43 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.997 -1.065 . . . . 0.25 109.492 -179.84 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.01 -27.41 64.65 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.263 -0.898 . . . . 0.2 109.448 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 73.5 t80 -59.6 -70.96 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.165 -0.959 . . . . 0.21 109.996 -179.933 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -54.58 -42.56 71.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 2.47 109.709 -179.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 59.1 mm-40 -58.39 -37.76 75.95 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.022 -1.049 . . . . 2.1 109.278 179.803 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.12 -45.74 93.44 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.122 -0.986 . . . . 0.2 108.678 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.8 mt -63.59 -40.47 97.02 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.369 -0.832 . . . . 0.62 109.332 179.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.87 -42.56 97.49 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.113 -0.992 . . . . 1.09 109.383 179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.43 -13.58 59.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.3 109.533 179.89 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.38 -6.33 23.89 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.199 -0.938 . . . . 0.24 109.751 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 69.71 -115.47 6.27 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.515 -1.434 . . . . 0.28 109.515 -179.938 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -136.11 4.88 3.0 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.378 -1.072 . . . . 2.21 109.349 179.94 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 109' ' ' HOH . 13.5 mttp -71.0 169.14 15.55 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.246 -0.909 . . . . 1.9 109.163 179.638 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.662 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.26 162.43 14.74 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.088 -1.079 . . . . 0.17 108.088 179.934 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.662 ' H ' HD23 ' A' ' 22' ' ' LEU . 18.7 t -144.73 109.01 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.826 -1.171 . . . . 0.12 109.397 179.714 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.29 132.43 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 N-CA-C 108.533 -0.914 . . . . 0.09 108.533 179.377 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 5.1 t -112.75 131.34 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.541 -0.724 . . . . 0.17 109.557 -179.291 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -104.76 107.51 18.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.45 -0.781 . . . . 0.96 109.443 179.653 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.501 ' CE1' ' OE1' ' A' ' 78' ' ' GLN . 45.2 m-85 -88.72 81.36 7.04 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.116 -1.068 . . . . 0.24 108.116 179.444 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.8 m -113.72 152.35 30.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.736 -0.602 . . . . 1.03 109.559 -179.548 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.479 ' HB1' ' CD1' ' A' ' 31' ' ' TRP . . . -92.72 123.16 35.8 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.721 -0.844 . . . . 0.26 108.721 179.541 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.42 HG22 ' OD1' ' A' ' 58' ' ' ASP . 7.2 t -65.54 -20.87 66.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.176 -0.952 . . . . 0.32 109.746 -179.632 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.547 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 50.6 p-90 -89.5 -18.15 27.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.231 -0.918 . . . . 0.44 109.934 -179.733 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 1.8 t -92.6 143.97 25.8 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.174 -0.954 . . . . 0.32 110.029 -178.81 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.463 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -83.69 -57.23 2.47 Favored Glycine 0 N--CA 1.486 2.015 0 O-C-N 121.684 -0.635 . . . . 0.36 111.628 -179.268 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 17.3 Cg_exo -47.47 -41.56 29.23 Favored 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.85 1.7 . . . . 0.44 112.031 -177.686 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -75.57 -58.61 3.18 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.816 -1.178 . . . . 0.81 109.02 -179.767 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -59.32 -18.58 39.28 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.553 -0.717 . . . . 1.92 110.232 179.943 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.435 ' N ' ' O ' ' A' ' 33' ' ' GLY . 36.8 ttm -59.43 -18.39 38.85 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.15 -0.969 . . . . 3.13 110.309 -179.189 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.652 HG22 ' O ' ' A' ' 38' ' ' ILE . 67.8 mt -100.35 14.15 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 O-C-N 121.037 -1.039 . . . . 0.28 111.276 -178.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.597 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -64.4 -34.95 12.41 Favored Pre-proline 0 C--N 1.303 -1.451 0 C-N-CA 117.957 -1.497 . . . . 1.62 111.946 178.941 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 6.0 Cg_exo -61.64 -14.81 37.96 Favored 'Trans proline' 0 C--O 1.213 -0.733 0 CA-C-N 119.707 0.931 . . . . 0.25 110.877 -175.215 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -97.8 -69.36 0.76 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.33 -0.856 . . . . 0.3 109.223 179.87 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 89.3 t80 -44.48 -51.55 8.67 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.618 -0.677 . . . . 0.13 110.725 -179.054 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -67.57 -35.28 78.71 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.878 -1.139 . . . . 0.41 109.585 -179.948 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 3.2 m -60.32 -42.71 96.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.017 -1.052 . . . . 0.97 109.624 -179.33 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.3 mt -52.26 -21.72 3.73 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.157 -0.964 . . . . 0.5 109.563 -179.594 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.5 m -57.3 -32.34 66.57 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.07 -1.019 . . . . 0.51 109.592 179.855 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -94.82 -19.49 20.28 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.142 -0.974 . . . . 2.0 110.083 -179.56 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 53.9 tttm -91.28 -20.82 21.48 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.028 -1.045 . . . . 2.16 109.128 179.925 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 36.4 m-85 -133.43 67.95 1.51 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.564 -0.71 . . . . 0.24 109.085 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 68.2 p -67.01 -3.84 8.2 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.465 -0.772 . . . . 0.17 109.243 179.733 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -94.43 -0.52 54.72 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.35 -0.844 . . . . 0.34 109.475 -179.838 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 93.0 t -118.06 149.63 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.539 -0.726 . . . . 0.12 109.189 179.961 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.1 mm -100.43 128.84 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 121.225 -0.922 . . . . 0.17 109.058 -179.296 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.636 ' C ' HD12 ' A' ' 55' ' ' LEU . 84.5 m-85 -114.63 131.8 56.59 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.413 -0.804 . . . . 0.11 109.173 179.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.636 HD12 ' C ' ' A' ' 54' ' ' PHE . 9.5 mp -115.95 175.29 5.61 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.543 -0.723 . . . . 0.12 109.179 -179.288 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -144.07 144.94 31.85 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.417 -0.957 . . . . 1.31 108.417 179.481 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG11 ' CE2' ' A' ' 27' ' ' PHE . 25.4 t -140.26 140.7 34.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 121.2 -0.938 . . . . 0.14 110.147 -178.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.42 ' OD1' HG22 ' A' ' 30' ' ' THR . 8.1 t70 -99.44 100.46 11.5 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.615 -1.254 . . . . 1.08 107.615 178.16 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 19.5 m -56.14 -12.99 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.858 . . . . 0.27 111.217 -178.362 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -100.94 -42.81 6.28 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 120.85 -1.156 . . . . 1.11 111.173 -178.708 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.438 ' CB ' HH21 ' B' ' 2' ' ' ARG . 2.5 t70 -93.1 -10.47 35.88 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.939 -1.101 . . . . 1.12 109.569 -179.206 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -124.82 46.63 2.29 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 108.511 -0.922 . . . . 0.17 108.511 179.366 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -55.82 -14.32 2.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.569 -0.707 . . . . 2.22 109.87 -179.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.509 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 5.5 p30 -70.44 -40.93 73.49 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.121 -0.987 . . . . 1.11 109.618 -179.756 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 12.8 t -74.24 -46.22 45.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.241 -0.912 . . . . 0.19 108.699 179.415 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.81 -32.03 73.4 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.388 -0.82 . . . . 0.22 109.309 179.418 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m -63.72 -52.35 60.9 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.255 -0.903 . . . . 1.29 109.53 -179.85 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -62.82 -34.31 77.05 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.188 -0.945 . . . . 2.2 109.237 179.837 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -87.27 -0.67 57.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.278 -0.889 . . . . 0.33 109.516 179.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 44.99 50.7 9.02 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.296 -0.877 . . . . 2.34 109.911 179.861 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 17.6 t -79.12 129.85 36.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.224 -0.922 . . . . 0.28 109.445 179.857 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.449 ' C ' ' CD2' ' B' ' 5' ' ' TYR . 67.9 mttm -129.93 8.86 5.28 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 121.502 -0.749 . . . . 2.4 109.511 -179.936 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.674 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.04 133.79 14.79 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 108.274 -1.01 . . . . 0.22 108.274 179.948 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.555 HG23 ' CE2' ' B' ' 5' ' ' TYR . 33.8 p -120.38 150.05 51.03 Favored Pre-proline 0 N--CA 1.507 2.424 0 O-C-N 121.205 -0.934 . . . . 0.22 108.96 179.422 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -77.72 147.27 83.75 Favored 'Cis proline' 0 N--CA 1.484 0.949 0 O-C-N 122.714 0.849 . . . . 0.2 110.539 -1.82 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.505 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 4.2 m -117.37 116.49 27.3 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 107.337 -1.357 . . . . 0.18 107.337 178.059 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.628 ' CD1' HD21 ' A' ' 97' ' ' LEU . 77.1 m-85 -93.06 122.08 35.07 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.312 -0.955 . . . . 0.15 108.653 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.501 ' OE1' ' CE1' ' A' ' 27' ' ' PHE . 13.5 mt-30 -119.16 137.4 53.64 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.729 -1.212 . . . . 1.03 107.729 -179.738 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 26.3 m-85 -112.03 128.54 56.22 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.423 0.63 . . . . 0.11 110.04 -178.184 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 82.4 m-85 -127.09 159.85 32.95 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.851 -0.796 . . . . 0.17 108.851 179.792 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.6 tttm -155.11 122.81 5.71 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.748 -1.204 . . . . 1.48 107.748 179.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 31.4 mtmt 57.24 24.44 9.89 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.78 -0.575 . . . . 1.67 110.301 -179.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.4 5.0 76.3 Favored Glycine 0 N--CA 1.494 2.554 0 N-CA-C 110.354 -1.098 . . . . 0.22 110.354 179.11 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 mt-30 -113.4 146.13 40.01 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.303 -1.116 . . . . 2.08 110.236 -179.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -85.98 145.07 27.28 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.455 -0.778 . . . . 1.7 109.363 179.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.6 m -126.54 -15.4 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.51 -0.744 . . . . 0.26 109.762 -179.872 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 169.14 -179.14 41.99 Favored Glycine 0 N--CA 1.496 2.649 0 C-N-CA 119.584 -1.294 . . . . 0.18 110.581 179.68 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.502 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 0.3 OUTLIER -173.2 161.19 4.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.457 -1.025 . . . . 2.04 110.049 179.917 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.534 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 2.8 p90 -169.04 132.52 1.35 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.335 -0.853 . . . . 0.14 110.218 178.755 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 16.2 p -104.58 -170.05 1.71 Allowed 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.225 -0.922 . . . . 0.17 108.759 179.244 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 93' ' ' ASN . . . 93.97 121.37 3.31 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 109.536 -1.426 . . . . 0.13 109.536 179.635 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.548 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -51.44 91.29 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.252 -1.146 . . . . 0.2 110.432 -179.372 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.485 ' N ' ' O ' ' A' ' 91' ' ' GLY . 13.6 t-20 -140.04 78.07 1.64 Allowed 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.119 -1.067 . . . . 1.15 108.119 178.605 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.52 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.91 -34.7 78.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.696 -0.627 . . . . 1.19 110.608 -178.861 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -65.7 -26.07 67.6 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 120.816 -1.177 . . . . 1.95 109.187 -179.608 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.411 ' HB2' ' HZ3' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -67.66 -35.41 78.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.425 -0.797 . . . . 2.05 109.124 179.548 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.628 HD21 ' CD1' ' A' ' 77' ' ' PHE . 44.6 mt -51.87 -37.69 53.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.233 -0.917 . . . . 0.15 108.783 179.758 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -66.37 -57.6 7.1 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.564 -0.71 . . . . 2.15 109.896 -179.277 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.23 -39.64 83.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.247 -0.908 . . . . 0.15 110.477 -179.389 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 7.7 m -67.76 -45.22 75.53 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.074 -1.016 . . . . 0.13 110.29 -179.068 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 54.8 mt -62.22 -52.56 58.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.205 -0.934 . . . . 0.18 109.331 -179.896 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -60.26 -17.9 45.27 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.198 -0.938 . . . . 1.03 109.674 -179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -76.01 -59.41 2.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.306 -0.871 . . . . 2.02 110.476 -179.428 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 30.4 mt -93.69 18.96 9.27 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.348 -0.845 . . . . 0.35 110.794 -178.123 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.412 ' OXT' HG22 ' A' ' 105' ' ' VAL . 8.3 p . . . . . 0 N--CA 1.494 1.728 0 O-C-N 120.941 -1.099 . . . . 1.18 109.303 179.25 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 21.2 t80 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 31' ' ' TRP . 22.8 mtp180 -141.39 52.67 1.54 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.22 -0.925 . . . . 0.0 109.006 -179.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.531 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 39.6 m-85 -103.8 156.23 17.98 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.218 -0.927 . . . . 0.0 109.972 -179.572 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . . . . . . . . . 6.7 mtp180 -150.75 -101.22 0.06 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.208 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.555 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.0 p90 -109.5 -174.59 2.54 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.176 -0.953 . . . . 0.0 110.796 -179.784 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.1 150.29 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-O 122.191 0.996 . . . . 0.0 112.851 -176.935 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 61.3 m -101.05 93.75 5.65 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 177.521 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.674 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 5.0 pt-20 -84.1 44.42 1.01 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.102 -0.999 . . . . 0.0 110.904 -178.645 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.63 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -70.68 -129.98 0.07 OUTLIER Glycine 0 N--CA 1.485 1.923 0 N-CA-C 107.104 -2.398 . . . . 0.0 107.104 177.972 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -64.69 19.88 0.07 OUTLIER 'Trans proline' 0 C--N 1.321 -0.871 0 CA-C-N 119.447 1.623 . . . . 0.0 109.799 178.749 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.63 ' H ' ' C ' ' B' ' 9' ' ' GLY . 7.5 t -82.13 -3.24 54.41 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.328 -0.857 . . . . 0.0 109.617 -179.712 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.501 ' CG ' ' H ' ' B' ' 13' ' ' GLY . 36.9 t-80 -160.2 177.17 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.152 -0.968 . . . . 0.0 109.513 179.932 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.501 ' H ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.492 2.385 0 CA-C-O 118.013 -1.437 . . . . 0.0 109.511 179.981 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.401 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.499 ' SD ' ' O ' ' A' ' 1' ' ' MET . 2.7 ppp? . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.347 0.594 . . . . 2.89 109.458 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.627 HG12 ' N ' ' A' ' 3' ' ' LYS . 44.7 t -96.91 173.23 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.264 -0.898 . . . . 0.3 109.512 -179.838 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.627 ' N ' HG12 ' A' ' 2' ' ' VAL . 44.7 tptt -153.72 122.84 6.49 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.212 -0.93 . . . . 1.97 109.116 179.767 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 22.8 tt0 -90.05 129.4 36.36 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.481 -0.762 . . . . 0.98 109.462 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.3 mm -102.05 120.15 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.291 -1.374 . . . . 0.19 107.291 178.897 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -107.62 -16.76 14.27 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.197 -0.939 . . . . 1.97 109.949 -179.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 59.8 p -152.47 160.15 43.28 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.056 -1.027 . . . . 0.23 109.801 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.418 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 35.0 tttp -52.09 -31.39 30.37 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.439 -0.788 . . . . 1.9 109.639 179.984 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 8.6 m -59.96 -47.25 86.57 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.165 -0.96 . . . . 0.25 110.093 -179.589 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.72 -27.0 65.54 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.317 -0.865 . . . . 0.2 109.662 -179.69 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -60.17 -68.83 0.26 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.247 -0.908 . . . . 0.21 109.838 -179.909 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -53.53 -44.44 69.18 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 2.47 109.749 -179.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 78.9 mt-10 -58.19 -37.0 73.92 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 2.1 109.619 179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -60.65 -45.77 92.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.147 -0.971 . . . . 0.2 109.094 179.801 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.5 -44.95 89.34 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.458 -0.776 . . . . 0.62 109.781 179.857 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 26.0 t0 -62.71 -41.28 99.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.192 -0.943 . . . . 1.09 109.686 -179.614 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.62 -13.6 59.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.18 -0.95 . . . . 0.3 109.467 -179.906 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.58 -5.71 21.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.235 -0.916 . . . . 0.24 109.722 -179.985 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.418 ' O ' ' OD1' ' A' ' 20' ' ' ASP . . . 68.23 -114.1 5.81 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.513 -1.435 . . . . 0.28 109.513 -179.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.418 ' OD1' ' O ' ' A' ' 19' ' ' GLY . 81.2 m-20 -136.55 4.07 2.83 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.265 -1.138 . . . . 2.21 109.447 179.978 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 109' ' ' HOH . 80.5 mttt -69.65 170.09 11.49 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.072 -1.017 . . . . 1.9 108.94 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.43 163.12 13.84 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.172 -1.047 . . . . 0.17 108.172 179.917 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.631 ' H ' HD23 ' A' ' 22' ' ' LEU . 11.3 t -145.42 104.24 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.825 -1.172 . . . . 0.12 109.359 179.723 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.425 HG22 ' CD2' ' A' ' 79' ' ' PHE . 3.7 t -101.61 130.41 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.393 -0.817 . . . . 0.09 108.882 179.713 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.37 133.46 54.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 121.582 -0.699 . . . . 0.17 109.644 -178.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -107.04 102.98 12.29 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.585 -0.697 . . . . 0.96 109.448 179.514 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CE2' HG11 ' A' ' 57' ' ' VAL . 51.0 m-85 -84.87 82.69 8.33 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 107.758 -1.201 . . . . 0.24 107.758 179.099 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.9 m -113.68 148.62 36.01 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.594 -0.692 . . . . 1.03 109.89 -179.114 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' HB3' ' HB2' ' A' ' 32' ' ' CYS . . . -90.89 122.74 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.267 -1.012 . . . . 0.26 108.267 178.976 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.1 t -64.95 -22.33 66.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.286 -0.884 . . . . 0.32 110.414 -178.978 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.604 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 55.5 p-90 -90.34 -14.2 33.6 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.13 -0.981 . . . . 0.44 110.054 -179.4 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 29' ' ' ALA . 2.2 t -94.23 128.56 40.76 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.171 -0.956 . . . . 0.32 110.04 -178.591 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.427 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -66.06 -59.33 7.57 Favored Glycine 0 N--CA 1.49 2.234 0 C-N-CA 120.894 -0.67 . . . . 0.36 111.595 -179.458 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 26.5 Cg_exo -46.11 -37.7 18.28 Favored 'Trans proline' 0 C--N 1.318 -1.031 0 C-N-CA 121.805 1.67 . . . . 0.44 111.941 -178.169 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.4 -55.6 5.39 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.714 -1.241 . . . . 0.81 108.756 179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -60.6 -21.73 62.97 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.655 -0.653 . . . . 1.92 110.045 179.669 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 11.9 tpp -61.44 -18.52 59.3 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.161 -0.962 . . . . 3.13 110.379 -179.324 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.439 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.1 mt -99.56 15.52 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 O-C-N 121.097 -1.002 . . . . 0.28 110.765 -178.457 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -70.77 -33.41 3.01 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.163 -1.586 . . . . 1.62 112.452 179.817 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 5.7 Cg_exo -63.14 -3.59 5.13 Favored 'Trans proline' 0 C--N 1.319 -0.974 0 CA-C-N 119.509 0.86 . . . . 0.25 110.302 -176.708 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.404 ' O ' ' C ' ' A' ' 42' ' ' PHE . 49.0 m-85 -110.46 -79.83 0.58 Allowed 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.45 -0.781 . . . . 0.3 109.08 179.62 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.404 ' C ' ' O ' ' A' ' 41' ' ' PHE . 87.6 t80 -40.9 -54.57 2.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.583 -0.698 . . . . 0.13 111.024 -179.423 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -66.86 -36.83 83.21 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.842 -1.162 . . . . 0.41 110.064 -179.839 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.417 ' C ' ' N ' ' A' ' 46' ' ' SER . 81.8 p -61.34 -38.37 86.66 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.753 -1.217 . . . . 0.97 110.041 -179.642 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 78.4 mt -51.88 -14.3 0.37 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.961 -1.087 . . . . 0.5 109.227 179.966 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.417 ' N ' ' C ' ' A' ' 44' ' ' SER . 37.1 m -57.76 -36.5 72.2 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.176 -0.953 . . . . 0.51 109.636 179.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -94.35 -16.42 23.51 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.21 -0.931 . . . . 2.0 110.166 -179.506 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 13.6 tptm -91.33 -22.83 20.33 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.003 -1.06 . . . . 2.16 109.331 -179.777 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -135.34 66.66 1.51 Allowed 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.415 -0.803 . . . . 0.24 109.151 179.835 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 37.7 p -66.64 -3.03 5.58 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.337 -0.852 . . . . 0.17 109.038 179.698 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 11.7 t30 -93.95 -2.27 53.44 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.423 -0.798 . . . . 0.34 109.263 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 70.1 t -116.64 148.68 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 109.055 -0.72 . . . . 0.12 109.055 179.92 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.0 mm -98.5 125.26 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.414 -0.804 . . . . 0.17 109.338 -179.559 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.524 ' C ' HD12 ' A' ' 55' ' ' LEU . 75.4 m-85 -111.21 129.07 56.07 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.355 -0.841 . . . . 0.11 109.365 179.72 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.524 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.5 mp -111.3 173.73 6.2 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.444 -0.785 . . . . 0.12 109.078 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -144.79 147.94 33.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.307 -0.998 . . . . 1.31 108.307 179.244 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.448 HG11 ' CE2' ' A' ' 27' ' ' PHE . 11.0 t -141.74 142.68 28.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 121.044 -1.035 . . . . 0.14 110.451 -178.799 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' C ' ' H ' ' A' ' 60' ' ' ASP . 10.1 t70 -98.78 90.94 4.86 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 107.969 -1.123 . . . . 1.08 107.969 178.564 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.5 m -52.59 -3.03 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.436 -0.79 . . . . 0.27 111.624 -178.268 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 58' ' ' ASP . 30.3 m-20 -110.04 -40.66 4.67 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 121.034 -1.041 . . . . 1.11 110.982 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -96.61 -19.17 19.23 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.05 -1.031 . . . . 1.12 109.816 -179.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.89 45.52 1.33 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.349 -0.844 . . . . 0.17 108.74 179.172 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -53.25 -13.46 0.53 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.434 -0.791 . . . . 2.22 109.852 -179.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.418 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.9 p-10 -71.13 -41.44 70.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.181 -0.95 . . . . 1.11 109.459 -179.844 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.2 t -74.08 -45.37 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.181 -0.949 . . . . 0.19 108.802 179.649 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.11 -34.14 76.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.22 108.688 179.061 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -64.59 -46.13 84.03 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.415 -0.803 . . . . 1.29 109.075 179.725 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -63.65 -38.48 91.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.387 -0.821 . . . . 2.2 109.349 179.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -88.4 -5.0 58.55 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.246 -0.909 . . . . 0.33 109.874 -179.631 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 49.6 59.19 4.68 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.16 -0.963 . . . . 2.34 109.743 179.806 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.422 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 19.5 t -79.13 137.44 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.28 109.489 179.747 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -130.4 -1.77 4.42 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.452 -0.78 . . . . 2.4 109.791 -179.782 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.639 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.42 127.31 9.61 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.022 -1.049 . . . . 0.22 109.1 179.599 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.706 HG23 ' CE2' ' B' ' 5' ' ' TYR . 3.3 p -111.04 152.02 43.41 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 108.654 -0.869 . . . . 0.22 108.654 -179.994 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.439 ' HG3' HD12 ' A' ' 38' ' ' ILE . 9.6 Cg_endo -77.39 143.98 76.26 Favored 'Cis proline' 0 N--CA 1.485 1.013 0 C-N-CA 124.75 -0.938 . . . . 0.2 109.935 -1.847 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.2 m -114.62 117.94 32.27 Favored 'General case' 0 N--CA 1.501 2.119 0 N-CA-C 108.666 -0.865 . . . . 0.18 108.666 179.566 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.466 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.2 m-85 -93.26 122.68 35.91 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.098 -1.001 . . . . 0.15 108.886 179.368 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -120.19 133.09 55.57 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.804 -1.184 . . . . 1.03 107.804 -179.795 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.44 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 18.1 m-85 -108.64 126.56 53.1 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.609 -0.682 . . . . 0.11 109.716 -178.066 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 74.4 m-85 -124.05 158.79 31.36 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.512 -0.921 . . . . 0.17 108.512 179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 59.5 tttt -154.93 123.46 6.05 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.753 -1.203 . . . . 1.48 107.753 -179.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.583 ' NZ ' ' NE2' ' A' ' 84' ' ' GLN . 7.3 mtmp? 56.01 27.33 11.12 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.527 -0.733 . . . . 1.67 109.882 -179.031 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.32 2.3 87.71 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.165 -1.017 . . . . 0.22 110.625 179.006 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.583 ' NE2' ' NZ ' ' A' ' 82' ' ' LYS . 35.6 mt-30 -109.98 147.48 33.41 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 121.329 -1.1 . . . . 2.08 110.191 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.442 ' NZ ' ' CB ' ' A' ' 85' ' ' LYS . 6.4 ttpm? -86.03 142.46 28.73 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.312 -0.868 . . . . 1.7 109.124 179.672 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 16.4 m -127.35 -17.25 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 O-C-N 121.528 -0.732 . . . . 0.26 110.358 -179.463 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 176.14 174.24 42.49 Favored Glycine 0 N--CA 1.495 2.589 0 C-N-CA 119.455 -1.355 . . . . 0.18 110.351 -179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? -172.9 155.49 3.14 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.388 -1.066 . . . . 2.04 109.937 179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.535 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 4.5 p90 -168.41 133.55 1.73 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.303 -0.873 . . . . 0.14 110.342 179.214 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.4 p -104.07 -171.02 1.86 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 121.198 -0.939 . . . . 0.17 109.03 179.648 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 93.35 128.93 5.06 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.522 -1.431 . . . . 0.13 109.522 179.968 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.528 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -57.89 91.11 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.302 -1.117 . . . . 0.2 110.424 -179.537 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -139.94 77.82 1.63 Allowed 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.665 -1.235 . . . . 1.15 107.665 178.203 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.488 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.97 -33.95 76.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.599 -0.688 . . . . 1.19 110.687 -178.525 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -64.49 -25.61 68.07 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.012 -1.055 . . . . 1.95 109.148 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 27.8 tttm -69.07 -37.6 78.57 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.328 -0.858 . . . . 2.05 109.333 179.996 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.466 HD21 ' CD1' ' A' ' 77' ' ' PHE . 13.8 mt -54.19 -35.6 62.52 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.903 -1.123 . . . . 0.15 108.634 179.871 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -66.1 -58.89 4.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.357 -0.839 . . . . 2.15 109.461 -179.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.0 90.1 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.428 -0.795 . . . . 0.15 110.494 -179.356 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 30.7 m -65.25 -46.76 79.28 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.194 -0.941 . . . . 0.13 109.971 -179.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 46.2 mt -59.95 -52.32 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.183 -0.948 . . . . 0.18 108.88 179.767 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 19.7 t-20 -61.4 -16.48 46.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.199 -0.938 . . . . 1.03 109.614 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -76.9 -60.13 2.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 2.02 109.91 -179.78 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 50.3 mt -91.69 20.57 5.4 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.554 -0.716 . . . . 0.35 110.28 -178.891 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.3 p . . . . . 0 N--CA 1.49 1.557 0 O-C-N 120.976 -1.078 . . . . 1.18 109.247 179.782 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.9 p90 . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.564 ' CG ' HH11 ' B' ' 2' ' ' ARG . 2.8 mtt-85 -152.92 78.99 1.2 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.137 -0.977 . . . . 0.0 109.215 179.215 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.604 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 27.8 m-85 -126.2 148.05 49.53 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.385 -0.822 . . . . 0.0 108.876 179.435 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.595 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -146.36 -86.17 0.11 Allowed 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.081 -1.012 . . . . 0.0 109.263 -179.771 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.706 ' CE2' HG23 ' A' ' 74' ' ' THR . 3.3 p90 -125.13 -170.82 2.23 Favored 'General case' 0 N--CA 1.507 2.382 0 O-C-N 121.062 -1.024 . . . . 0.0 110.48 179.744 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.417 HG23 ' H ' ' B' ' 6' ' ' VAL . 2.5 t -72.33 150.12 8.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.866 0 CA-C-O 121.78 0.8 . . . . 0.0 112.148 -177.431 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 25.0 m -101.15 94.23 5.86 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.72 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.639 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 3.7 pt-20 -83.15 44.71 0.96 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.026 -1.046 . . . . 0.0 110.214 -178.915 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.568 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -72.95 -131.21 0.15 Allowed Glycine 0 N--CA 1.482 1.742 0 N-CA-C 106.582 -2.607 . . . . 0.0 106.582 177.764 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_endo -69.64 30.37 0.18 Allowed 'Trans proline' 0 CA--C 1.542 0.88 0 CA-C-N 119.315 1.557 . . . . 0.0 109.215 178.16 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.568 ' H ' ' C ' ' B' ' 9' ' ' GLY . 10.5 t -94.23 -23.83 17.72 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.293 -0.879 . . . . 0.0 109.832 -179.551 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.443 ' O ' ' O ' ' B' ' 11' ' ' SER . 10.2 t-80 60.81 139.91 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.469 -0.769 . . . . 0.0 109.551 -179.73 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.909 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . 0.417 ' O ' ' N ' ' A' ' 21' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.8 mpt? . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.346 -0.613 . . . . 2.89 109.346 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 3' ' ' LYS . 58.8 t -94.56 159.89 2.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.254 -0.904 . . . . 0.3 109.432 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . 0.467 ' N ' HG12 ' A' ' 2' ' ' VAL . 43.0 tptt -155.56 122.29 5.32 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.151 -0.968 . . . . 1.97 109.26 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.5 tt0 -89.81 134.11 34.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.353 -0.842 . . . . 0.98 108.992 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -107.92 108.6 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.363 -0.977 . . . . 0.19 108.363 179.583 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -100.24 -11.21 20.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.296 -0.878 . . . . 1.97 109.308 -179.549 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.2 p -152.57 153.05 32.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.309 -0.869 . . . . 0.23 109.462 179.748 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . . . . . . . . . 36.5 tttm -52.39 -25.59 10.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.455 -0.778 . . . . 1.9 109.812 -179.936 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 7.4 m -60.2 -47.34 86.37 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.186 -0.946 . . . . 0.25 109.797 -179.753 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.06 -26.21 64.84 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.268 -0.895 . . . . 0.2 109.644 -179.862 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -59.7 -68.73 0.25 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 0.21 109.821 -179.687 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -55.38 -41.39 72.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.299 -0.876 . . . . 2.47 109.849 -179.064 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -59.0 -38.86 80.18 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.085 -1.009 . . . . 2.1 109.601 179.853 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -61.13 -45.28 95.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.201 -0.937 . . . . 0.2 109.497 -179.759 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.4 mt -63.66 -46.66 84.59 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.317 -0.864 . . . . 0.62 110.117 -179.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -64.23 -43.21 95.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.104 -0.997 . . . . 1.09 109.815 -179.189 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.73 -12.8 59.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -0.982 . . . . 0.3 109.917 -179.509 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.11 -8.55 39.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.977 -1.077 . . . . 0.24 109.551 -179.566 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.99 -117.05 6.24 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.669 -1.373 . . . . 0.28 109.669 179.878 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.438 ' OD1' ' O ' ' A' ' 20' ' ' ASP . 8.0 t0 -133.74 4.2 3.58 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.318 -1.107 . . . . 2.21 109.113 -179.818 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.7 mttp -68.57 165.6 18.84 Favored 'General case' 0 N--CA 1.486 1.332 0 O-C-N 120.921 -1.112 . . . . 1.9 108.711 179.295 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.588 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -63.69 157.84 23.07 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.315 -0.994 . . . . 0.17 108.315 179.938 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.588 ' H ' HD23 ' A' ' 22' ' ' LEU . 9.3 t -141.98 107.1 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.149 -0.97 . . . . 0.12 109.329 -179.662 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.4 t -103.62 133.68 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 N-CA-C 108.582 -0.895 . . . . 0.09 108.582 179.237 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.21 133.62 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.577 -0.702 . . . . 0.17 109.529 -178.624 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -104.88 102.26 11.8 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.609 -0.682 . . . . 0.96 109.202 179.258 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.463 ' CE1' ' NE2' ' A' ' 78' ' ' GLN . 44.8 m-85 -86.57 78.96 9.08 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 107.805 -1.183 . . . . 0.24 107.805 179.204 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 m -106.72 -164.47 1.0 Allowed 'General case' 0 N--CA 1.489 1.522 0 CA-C-O 121.532 0.682 . . . . 1.03 109.462 -178.723 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -141.28 122.74 14.99 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.412 -0.959 . . . . 0.26 108.412 179.47 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 t -63.66 -25.11 68.06 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.483 -0.76 . . . . 0.32 110.446 -178.154 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.545 ' CD1' ' O ' ' B' ' 2' ' ' ARG . 45.8 p-90 -88.33 -15.5 35.51 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 0.44 110.011 -179.203 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 1.8 t -95.74 129.08 43.07 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.247 -0.908 . . . . 0.32 109.813 -179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.566 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -71.89 -54.03 8.8 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 111.205 -0.758 . . . . 0.36 111.205 -178.869 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 15.6 Cg_exo -48.54 -34.31 25.99 Favored 'Trans proline' 0 C--N 1.314 -1.287 0 C-N-CA 121.823 1.682 . . . . 0.44 111.156 -178.283 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -78.29 -58.79 3.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.988 -1.07 . . . . 0.81 109.16 179.41 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -58.8 -21.14 55.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.329 -0.857 . . . . 1.92 109.785 179.308 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.484 ' SD ' ' O ' ' A' ' 37' ' ' MET . 1.7 tmt? -58.2 -21.23 46.77 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.322 -0.862 . . . . 3.13 109.946 -178.944 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.518 ' C ' ' HD2' ' A' ' 40' ' ' PRO . 3.3 mt -97.08 2.25 10.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 O-C-N 121.252 -0.905 . . . . 0.28 110.224 -178.812 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 0.0 OUTLIER -61.16 -34.72 18.72 Favored Pre-proline 0 N--CA 1.486 1.347 0 C-N-CA 118.431 -1.308 . . . . 1.62 111.084 -179.483 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 2.5 Cg_endo -63.78 -5.96 9.91 Favored 'Trans proline' 0 C--O 1.212 -0.81 0 CA-C-N 119.691 0.926 . . . . 0.25 110.561 -177.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.446 ' O ' ' HG ' ' A' ' 45' ' ' LEU . 41.9 m-85 -111.1 -73.43 0.68 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 108.848 -0.797 . . . . 0.3 108.848 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -45.48 -56.81 4.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.704 -0.623 . . . . 0.13 110.471 -179.599 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 6.2 t60 -66.9 -31.9 72.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.043 -1.036 . . . . 0.41 110.083 -179.829 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.432 ' C ' ' N ' ' A' ' 46' ' ' SER . 3.5 t -63.99 -39.72 94.76 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.014 -1.054 . . . . 0.97 110.092 179.71 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 41' ' ' PHE . 83.2 mt -50.74 -12.98 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.035 -1.04 . . . . 0.5 109.782 -179.254 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.432 ' N ' ' C ' ' A' ' 44' ' ' SER . 16.4 m -57.78 -36.78 72.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.51 109.636 179.615 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -93.85 -17.16 23.36 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.317 -0.864 . . . . 2.0 110.178 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -90.65 -23.42 20.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.125 -0.984 . . . . 2.16 109.117 179.845 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -135.11 71.8 1.44 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.587 -0.696 . . . . 0.24 109.125 179.465 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 81.2 p -66.84 -3.32 6.57 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.362 -0.836 . . . . 0.17 108.988 179.722 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 51' ' ' ASN . 21.7 t-20 -95.74 -0.07 51.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.516 -0.74 . . . . 0.34 109.514 -179.673 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 95.2 t -114.53 148.66 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 O-C-N 121.239 -0.913 . . . . 0.12 109.6 -179.88 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.3 mm -101.07 123.84 54.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 108.882 -0.784 . . . . 0.17 108.882 179.849 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.59 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.6 m-85 -112.18 132.26 55.0 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.244 -0.91 . . . . 0.11 109.655 -179.563 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD12 ' C ' ' A' ' 54' ' ' PHE . 7.9 mp -114.29 172.08 7.23 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 108.772 -0.825 . . . . 0.12 108.772 -179.654 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -144.23 140.77 29.47 Favored 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 108.345 -0.983 . . . . 1.31 108.345 179.442 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.4 t -139.25 138.62 40.57 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.138 -0.976 . . . . 0.14 110.193 -177.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.47 108.68 21.43 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 107.635 -1.246 . . . . 1.08 107.635 177.441 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 18.1 m -66.14 -10.59 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.137 -0.977 . . . . 0.27 111.107 -177.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' B' ' 4' ' ' ARG . 10.1 m-20 -103.71 -40.34 6.32 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.089 -1.007 . . . . 1.11 110.756 -178.686 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -93.88 -14.39 26.12 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.253 -0.904 . . . . 1.12 109.563 -178.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -125.36 49.28 1.92 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 108.79 -0.818 . . . . 0.17 108.79 178.72 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -55.95 -11.24 0.98 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.432 -0.792 . . . . 2.22 110.19 -179.316 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -69.55 -40.9 76.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.924 -1.11 . . . . 1.11 109.546 -179.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 3.7 t -74.2 -46.34 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.255 -0.903 . . . . 0.19 108.886 179.577 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.02 -28.85 70.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.384 -0.822 . . . . 0.22 109.258 179.325 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.1 m -64.21 -58.29 7.0 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 1.29 109.48 -179.81 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 33.4 tp10 -62.67 -29.82 70.93 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.265 -0.897 . . . . 2.2 109.537 -179.875 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.435 ' HB1' HE22 ' A' ' 78' ' ' GLN . . . -88.18 -5.78 58.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.159 -0.963 . . . . 0.33 109.544 -179.957 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 43.58 52.84 6.05 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.491 -0.756 . . . . 2.34 110.328 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.403 ' CG1' ' OG1' ' A' ' 76' ' ' THR . 17.8 t -77.76 134.79 27.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.22 -0.925 . . . . 0.28 109.156 179.558 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 50.4 mttp -124.66 -0.39 8.06 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.411 -0.806 . . . . 2.4 110.194 -178.956 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.594 ' O ' ' OG1' ' A' ' 76' ' ' THR . . . -151.01 133.93 15.85 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.063 -1.023 . . . . 0.22 109.261 -179.779 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.69 HG23 ' CE2' ' B' ' 5' ' ' TYR . 21.8 p -118.25 150.75 48.27 Favored Pre-proline 0 N--CA 1.5 2.065 0 O-C-N 121.311 -0.868 . . . . 0.22 108.934 179.96 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.412 ' CG ' HD12 ' A' ' 38' ' ' ILE . 10.2 Cg_endo -76.13 145.16 81.69 Favored 'Cis proline' 0 C--N 1.319 -0.995 0 C-N-CA 124.555 -1.019 . . . . 0.2 110.131 -1.849 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.594 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -114.48 116.51 28.96 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 107.693 -1.225 . . . . 0.18 107.693 178.018 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.465 ' CD1' HD21 ' A' ' 97' ' ' LEU . 80.8 m-85 -93.66 116.03 28.51 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 119.363 -0.935 . . . . 0.15 108.603 179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.463 ' NE2' ' CE1' ' A' ' 27' ' ' PHE . 31.8 mt-30 -116.18 139.95 49.8 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.163 -1.421 . . . . 1.03 107.163 179.321 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.436 ' CD1' ' N ' ' A' ' 79' ' ' PHE . 22.1 m-85 -110.06 132.22 54.36 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.55 -0.719 . . . . 0.11 109.856 -176.938 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -126.93 154.94 43.84 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.327 -0.99 . . . . 0.17 108.327 -179.998 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.444 ' HZ2' ' HA ' ' A' ' 22' ' ' LEU . 33.3 tttp -157.02 123.26 4.9 Favored 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.632 -1.247 . . . . 1.48 107.632 -179.642 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.8 mttp 59.23 25.61 14.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.485 -0.76 . . . . 1.67 110.319 -178.713 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.91 3.85 88.98 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.758 -1.337 . . . . 0.22 109.758 179.631 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 28.0 mt-30 -113.35 147.46 37.65 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.293 -1.121 . . . . 2.08 109.701 -179.972 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -86.38 141.93 28.82 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.374 -0.829 . . . . 1.7 109.175 179.812 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 87' ' ' GLY . 27.9 m -118.23 -39.72 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 O-C-N 121.408 -0.808 . . . . 0.26 110.091 -178.927 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.423 ' N ' HG23 ' A' ' 86' ' ' VAL . . . -165.07 -176.99 37.23 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.911 -1.276 . . . . 0.18 109.911 -179.793 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.435 ' N ' ' CD ' ' A' ' 88' ' ' GLU . 1.2 pm0 -172.4 156.28 3.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.287 -1.126 . . . . 2.04 110.147 -179.537 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.554 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.3 p90 -169.05 132.26 1.33 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.496 -0.752 . . . . 0.14 109.385 178.355 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 22.0 p -103.31 -161.23 0.82 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.255 -0.903 . . . . 0.17 108.743 179.892 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.05 137.67 2.56 Favored Glycine 0 N--CA 1.494 2.507 0 N-CA-C 109.492 -1.443 . . . . 0.13 109.492 179.672 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.533 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -65.89 92.21 0.16 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.25 -1.147 . . . . 0.2 110.577 -179.262 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.66 74.82 1.5 Allowed 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 107.888 -1.153 . . . . 1.15 107.888 177.881 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.49 ' H ' ' CD ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -62.73 -34.16 76.61 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.512 -0.743 . . . . 1.19 110.495 -177.946 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -64.5 -26.43 68.43 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.021 -1.049 . . . . 1.95 109.052 -179.533 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 44.8 tttp -67.94 -38.41 82.79 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.411 -0.806 . . . . 2.05 109.428 179.78 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.465 HD21 ' CD1' ' A' ' 77' ' ' PHE . 19.7 mt -51.96 -37.68 53.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.168 -0.958 . . . . 0.15 108.833 179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -65.97 -58.29 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.441 -0.787 . . . . 2.15 109.31 179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.07 -40.95 86.77 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.407 -0.808 . . . . 0.15 110.416 -179.259 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 17.7 m -67.62 -45.55 75.09 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.219 -0.925 . . . . 0.13 110.042 -178.767 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 49.8 mt -61.08 -51.11 76.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.106 -0.996 . . . . 0.18 108.882 179.841 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -61.53 -17.03 53.04 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.206 -0.934 . . . . 1.03 109.488 179.785 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -77.3 -58.98 2.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.887 . . . . 2.02 109.65 -179.919 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 70.9 mt -92.78 20.96 5.97 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.423 -0.798 . . . . 0.35 110.352 -178.576 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 7.6 p . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.077 -1.014 . . . . 1.18 109.209 179.373 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 50.6 t80 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.599 ' CB ' HH11 ' B' ' 2' ' ' ARG . 0.0 OUTLIER -144.92 75.17 1.44 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.384 -0.823 . . . . 0.0 109.104 -179.753 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.478 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.5 m-85 -124.34 119.82 30.35 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.275 -0.891 . . . . 0.0 108.926 179.572 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.57 ' CG ' HH11 ' B' ' 4' ' ' ARG . 0.0 OUTLIER -108.13 -86.13 0.51 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 0.0 109.289 -178.879 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.69 ' CE2' HG23 ' A' ' 74' ' ' THR . 4.2 p90 -128.76 -167.64 1.8 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.959 -1.088 . . . . 0.0 110.208 179.65 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . . . . . . . . . 2.5 t -74.16 146.79 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.255 -0.903 . . . . 0.0 111.934 -176.384 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 3.9 m -100.88 97.11 7.75 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 176.904 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.434 ' HG2' ' HB1' ' A' ' 73' ' ' ALA . 0.9 OUTLIER -83.39 45.45 1.04 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.029 -1.044 . . . . 0.0 109.749 -179.172 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.632 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -69.68 -130.05 0.06 OUTLIER Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.426 -2.27 . . . . 0.0 107.426 177.655 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -63.81 17.79 0.06 OUTLIER 'Trans proline' 0 C--N 1.317 -1.095 0 CA-C-N 118.64 1.22 . . . . 0.0 109.784 178.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.632 ' H ' ' C ' ' B' ' 9' ' ' GLY . 3.2 t -79.32 -30.61 42.87 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.506 -0.746 . . . . 0.0 109.548 -179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.515 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 14.8 t60 -68.19 171.37 7.15 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 109.407 179.898 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.515 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.265 0 CA-C-O 117.97 -1.461 . . . . 0.0 109.495 -179.94 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.7 ttt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.063 -0.717 . . . . 2.89 109.063 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 99.1 t -97.57 151.85 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.17 -0.956 . . . . 0.3 109.802 -179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' LYS . . . . . . . . . . . . . 40.6 tttm -154.39 118.78 4.81 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.314 -0.866 . . . . 1.97 108.921 179.525 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -88.76 135.78 33.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.152 -0.967 . . . . 0.98 109.829 -179.645 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.3 mm -106.69 113.06 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 N-CA-C 107.615 -1.254 . . . . 0.19 107.615 178.857 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 -100.07 -11.01 20.9 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.282 -0.886 . . . . 1.97 109.786 -179.397 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.0 p -154.59 158.02 39.13 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.065 -1.022 . . . . 0.23 109.987 179.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LYS . . . . . 0.436 ' N ' ' OD2' ' A' ' 64' ' ' ASP . 43.0 tttm -52.33 -23.78 6.44 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.446 -0.784 . . . . 1.9 109.697 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 23.0 m -61.95 -51.03 69.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.08 -1.012 . . . . 0.25 110.293 -179.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.99 -21.67 64.13 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.348 -0.845 . . . . 0.2 109.952 -179.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.3 t80 -59.88 -64.27 1.01 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.99 -1.069 . . . . 0.21 109.714 -179.922 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 62.6 mt-30 -55.62 -46.79 77.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.915 . . . . 2.47 109.799 -179.487 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.28 -34.82 70.94 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.273 -0.892 . . . . 2.1 110.142 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.414 ' HB1' HD21 ' A' ' 55' ' ' LEU . . . -61.62 -45.93 91.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.988 -1.07 . . . . 0.2 109.624 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 11.4 mt -64.9 -51.76 60.2 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.54 -0.725 . . . . 0.62 109.646 -179.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -62.28 -35.99 80.72 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.317 -0.864 . . . . 1.09 109.511 -179.671 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.63 -16.08 56.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.228 -0.92 . . . . 0.3 109.458 179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -68.46 -20.64 64.63 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.158 -0.964 . . . . 0.24 109.469 179.947 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 79.45 -107.72 2.6 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.707 -1.357 . . . . 0.28 109.707 179.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -138.1 -2.2 1.88 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.434 -1.039 . . . . 2.21 109.553 -179.591 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 41.2 mttp -67.33 168.06 11.31 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 120.903 -1.123 . . . . 1.9 108.817 179.732 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.636 HD23 ' H ' ' A' ' 23' ' ' VAL . 0.4 OUTLIER -64.41 163.44 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.077 -1.083 . . . . 0.17 108.077 -179.987 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.636 ' H ' HD23 ' A' ' 22' ' ' LEU . 6.4 t -144.39 103.85 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.869 -1.145 . . . . 0.12 109.648 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.433 HG22 ' CD2' ' A' ' 79' ' ' PHE . 5.7 t -102.9 130.87 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 108.78 -0.822 . . . . 0.09 108.78 179.348 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 2.9 t -108.76 135.08 48.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.653 -0.655 . . . . 0.17 109.608 -179.216 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -107.8 101.64 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.783 -0.821 . . . . 0.96 108.783 179.406 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -84.32 80.74 9.11 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 107.884 -1.154 . . . . 0.24 107.884 179.736 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 74.0 m -113.7 152.22 30.78 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.767 -0.583 . . . . 1.03 109.601 -179.453 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -95.61 127.13 41.39 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.287 -0.883 . . . . 0.26 109.275 179.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 9.5 t -67.11 -25.61 66.29 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.382 -0.823 . . . . 0.32 110.64 -179.294 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' TRP . . . . . 0.586 ' CZ3' ' CE2' ' B' ' 3' ' ' PHE . 53.7 p-90 -87.45 -14.83 39.43 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.957 -1.09 . . . . 0.44 109.927 -179.298 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' CYS . . . . . . . . . . . . . 3.2 t -93.34 130.92 38.92 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.913 . . . . 0.32 110.018 -178.946 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.423 ' N ' ' HD2' ' A' ' 34' ' ' PRO . . . -68.9 -59.24 6.1 Favored Glycine 0 N--CA 1.488 2.164 0 C-N-CA 120.875 -0.678 . . . . 0.36 111.48 -179.338 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.423 ' HD2' ' N ' ' A' ' 33' ' ' GLY . 19.9 Cg_exo -48.86 -35.91 32.4 Favored 'Trans proline' 0 C--N 1.316 -1.144 0 C-N-CA 121.795 1.663 . . . . 0.44 111.547 -178.206 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.92 -61.33 2.01 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.81 108.936 179.828 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -59.55 -20.27 54.41 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.561 -0.712 . . . . 1.92 109.986 179.678 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 33' ' ' GLY . 5.1 ttt -62.09 -19.09 62.6 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.206 -0.934 . . . . 3.13 110.341 -179.17 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.466 HD12 ' HG3' ' A' ' 75' ' ' PRO . 3.4 mt -100.28 11.89 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 121.197 -0.94 . . . . 0.28 110.269 -179.076 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.616 ' N ' ' CD ' ' A' ' 40' ' ' PRO . 4.5 ptmm? -71.42 -27.24 1.0 Allowed Pre-proline 0 N--CA 1.487 1.394 0 O-C-N 120.212 -1.555 . . . . 1.62 111.844 179.686 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 39' ' ' LYS . 4.4 Cg_exo -65.23 -4.39 9.12 Favored 'Trans proline' 0 C--O 1.213 -0.742 0 CA-C-N 120.641 1.265 . . . . 0.25 109.452 -177.955 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . 0.408 ' O ' ' C ' ' A' ' 42' ' ' PHE . 37.5 m-85 -107.68 -79.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 108.693 -0.855 . . . . 0.3 108.693 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.408 ' C ' ' O ' ' A' ' 41' ' ' PHE . 92.6 t80 -40.19 -58.13 1.55 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.691 -0.631 . . . . 0.13 111.206 -179.544 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -65.39 -33.59 76.3 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.137 -0.977 . . . . 0.41 110.322 -179.151 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 80.5 p -66.33 -36.81 83.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.633 -1.292 . . . . 0.97 110.409 179.65 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 82.5 mt -50.52 -19.84 0.99 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 120.928 -1.107 . . . . 0.5 109.535 -179.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.7 m -56.94 -21.73 32.34 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.966 -1.083 . . . . 0.51 109.977 -179.699 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -97.22 -26.88 14.78 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.137 -0.977 . . . . 2.0 110.052 -179.672 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 80.9 tttt -90.32 -18.61 25.26 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.046 -1.034 . . . . 2.16 109.412 -179.945 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' TYR . . . . . . . . . . . . . 39.0 m-85 -133.35 62.44 1.66 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.528 -0.732 . . . . 0.24 109.247 -179.998 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 49.9 p -66.72 -3.01 5.67 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.364 -0.835 . . . . 0.17 108.91 179.586 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -95.59 1.11 53.59 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.418 -0.801 . . . . 0.34 109.446 179.899 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 96.1 t -117.73 150.62 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 109.274 -0.639 . . . . 0.12 109.274 179.987 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 7.6 mm -98.89 123.49 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.426 -0.796 . . . . 0.17 109.078 -179.838 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.568 ' C ' HD12 ' A' ' 55' ' ' LEU . 73.3 m-85 -111.24 132.87 54.0 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.357 -0.839 . . . . 0.11 109.141 179.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 54' ' ' PHE . 8.9 mp -114.06 167.3 10.78 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 108.641 -0.874 . . . . 0.12 108.641 179.928 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -140.61 133.97 29.82 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 107.353 -1.351 . . . . 1.31 107.353 179.095 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 63.3 t -132.32 141.43 45.29 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.264 -0.897 . . . . 0.14 110.745 -177.862 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -98.56 101.35 12.75 Favored 'General case' 0 N--CA 1.495 1.781 0 N-CA-C 108.422 -0.955 . . . . 1.08 108.422 178.955 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.411 HG21 HG21 ' A' ' 74' ' ' THR . 16.4 m -61.42 -4.07 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.329 -0.857 . . . . 0.27 111.197 -178.884 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.546 ' CG ' ' HE1' ' A' ' 31' ' ' TRP . 38.3 m-20 -107.58 -41.97 4.9 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.253 -0.905 . . . . 1.11 110.554 -178.663 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -95.11 -21.8 18.29 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.099 -1.0 . . . . 1.12 109.348 -179.301 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -109.73 43.31 1.35 Allowed 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.477 -0.935 . . . . 0.17 108.477 179.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.443 ' NE2' HH12 ' B' ' 4' ' ' ARG . 2.5 pt20 -53.81 -13.19 0.66 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.529 -0.732 . . . . 2.22 110.015 -179.426 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.436 ' OD2' ' N ' ' A' ' 8' ' ' LYS . 3.4 p-10 -70.43 -42.12 71.99 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.992 -1.067 . . . . 1.11 108.981 179.795 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 5.1 t -73.89 -46.02 47.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 108.711 -0.848 . . . . 0.19 108.711 179.547 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.495 ' O ' ' N ' ' A' ' 70' ' ' GLU . . . -63.38 -34.0 76.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.22 108.989 179.045 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 22.4 m -63.63 -48.21 78.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.377 -0.827 . . . . 1.29 108.962 179.748 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -64.94 -36.49 84.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 2.2 109.573 179.712 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -89.34 -7.71 54.75 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.232 -0.917 . . . . 0.33 109.648 -179.803 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 66' ' ' ALA . 39.4 mt-10 47.72 62.97 2.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.274 -0.891 . . . . 2.34 110.323 179.523 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.456 ' CG1' ' OH ' ' B' ' 5' ' ' TYR . 20.5 t -79.0 137.75 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.191 -0.943 . . . . 0.28 108.918 179.12 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.0 mttp -125.26 -4.48 7.34 Favored 'General case' 0 N--CA 1.501 2.076 0 O-C-N 121.407 -0.808 . . . . 2.4 110.085 -179.519 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.654 ' HB1' ' CD ' ' B' ' 8' ' ' GLU . . . -152.55 126.55 9.07 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.91 -1.119 . . . . 0.22 109.349 179.648 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.752 HG23 ' CE2' ' B' ' 5' ' ' TYR . 6.8 p -110.07 151.87 42.75 Favored Pre-proline 0 N--CA 1.5 2.049 0 N-CA-C 108.54 -0.911 . . . . 0.22 108.54 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.466 ' HG3' HD12 ' A' ' 38' ' ' ILE . 10.3 Cg_endo -77.34 143.34 74.56 Favored 'Cis proline' 0 N--CA 1.483 0.875 0 C-N-CA 124.858 -0.892 . . . . 0.2 109.926 -1.982 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 73' ' ' ALA . 2.5 m -113.58 114.7 26.83 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 108.421 -0.955 . . . . 0.18 108.421 179.198 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . 0.496 ' CD1' HD21 ' A' ' 97' ' ' LEU . 83.4 m-85 -89.08 125.57 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.864 -1.147 . . . . 0.15 108.833 179.551 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -122.84 132.23 54.1 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 107.825 -1.176 . . . . 1.03 107.825 -179.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' CZ ' HG21 ' A' ' 100' ' ' THR . 25.7 m-85 -107.09 129.82 54.77 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.59 -0.694 . . . . 0.11 109.911 -178.213 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -129.61 157.29 42.49 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.71 -0.848 . . . . 0.17 108.71 179.757 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 49.3 tttm -155.11 127.01 7.56 Favored 'General case' 0 C--N 1.299 -1.589 0 N-CA-C 107.586 -1.265 . . . . 1.48 107.586 179.894 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 55.6 mttt 56.0 18.97 3.37 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.393 -0.817 . . . . 1.67 109.847 -178.808 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.65 3.08 69.12 Favored Glycine 0 N--CA 1.497 2.737 0 O-C-N 120.836 -1.165 . . . . 0.22 110.447 179.344 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -110.68 147.23 34.77 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.356 -1.085 . . . . 2.08 109.822 -179.932 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 32.6 ttpt -85.51 144.86 27.69 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.335 -0.853 . . . . 1.7 109.384 179.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 5.9 m -129.65 -23.45 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 121.461 -0.775 . . . . 0.26 110.264 -179.45 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -174.22 174.91 46.61 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 119.483 -1.342 . . . . 0.18 110.509 -179.942 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -173.79 153.41 2.2 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.318 -1.107 . . . . 2.04 110.094 179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.531 ' CD1' ' O ' ' A' ' 89' ' ' PHE . 3.7 p90 -168.74 132.26 1.44 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.317 -0.864 . . . . 0.14 110.46 179.079 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.8 p -103.37 -169.17 1.61 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.19 -0.944 . . . . 0.17 109.321 179.84 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 89.66 129.85 3.89 Favored Glycine 0 N--CA 1.496 2.648 0 N-CA-C 109.858 -1.297 . . . . 0.13 109.858 179.872 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' ALA . . . . . 0.487 ' HB2' ' C ' ' B' ' 9' ' ' GLY . . . -55.97 92.97 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.196 -1.179 . . . . 0.2 110.365 -179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -141.13 74.82 1.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 108.109 -1.071 . . . . 1.15 108.109 178.486 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.464 ' HD2' ' H ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -63.23 -34.27 77.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.423 -0.798 . . . . 1.19 110.83 -178.601 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -64.52 -25.74 68.12 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.834 -1.166 . . . . 1.95 109.282 -179.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm -68.54 -35.97 78.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.5 -0.75 . . . . 2.05 109.422 179.824 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' CD1' ' A' ' 77' ' ' PHE . 28.6 mt -51.83 -36.4 47.91 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.167 -0.958 . . . . 0.15 108.958 179.727 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -66.83 -58.17 5.57 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 2.15 109.863 -179.459 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ALA . . . . . . . . . . . . . . . -59.85 -39.1 84.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.36 -0.838 . . . . 0.15 110.844 -179.141 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.437 HG21 ' CZ ' ' A' ' 79' ' ' PHE . 15.9 m -67.18 -47.84 69.76 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.995 -1.065 . . . . 0.13 110.273 -178.905 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 65.8 mt -61.52 -51.09 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.159 -0.963 . . . . 0.18 108.983 179.907 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 15.9 t-20 -59.28 -17.77 31.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.893 . . . . 1.03 109.605 -179.875 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 57.7 tt0 -76.46 -62.22 1.7 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 2.02 110.015 -179.718 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 21.1 mt -92.09 22.38 4.41 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.546 -0.721 . . . . 0.35 110.518 -178.71 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.3 p . . . . . 0 N--CA 1.493 1.721 0 O-C-N 120.884 -1.135 . . . . 1.18 109.226 179.408 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 1' ' ' PHE . . . . . . . . . . . . . 36.3 p90 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.537 ' O ' ' NE1' ' A' ' 31' ' ' TRP . 3.9 mtt-85 -135.25 79.64 1.8 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.35 -0.844 . . . . 0.0 109.278 -179.72 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 3' ' ' PHE . . . . . 0.586 ' CE2' ' CZ3' ' A' ' 31' ' ' TRP . 34.2 m-85 -136.38 153.59 51.07 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.189 -0.944 . . . . 0.0 109.745 -179.707 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 4' ' ' ARG . . . . . 0.443 HH12 ' NE2' ' A' ' 63' ' ' GLN . 7.0 tpt180 -150.47 -79.51 0.12 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.337 -0.852 . . . . 0.0 109.23 179.321 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 5' ' ' TYR . . . . . 0.752 ' CE2' HG23 ' A' ' 74' ' ' THR . 5.1 p90 -131.15 -165.26 1.54 Allowed 'General case' 0 N--CA 1.506 2.359 0 O-C-N 121.099 -1.001 . . . . 0.0 110.471 179.574 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 6' ' ' VAL . . . . . 0.406 ' H ' HG23 ' B' ' 6' ' ' VAL . 2.5 t -80.35 152.54 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.017 0 O-C-N 121.255 -0.903 . . . . 0.0 112.379 -177.157 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 7' ' ' CYS . . . . . . . . . . . . . 7.6 m -102.02 95.61 6.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 177.779 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 8' ' ' GLU . . . . . 0.654 ' CD ' ' HB1' ' A' ' 73' ' ' ALA . 2.9 pt-20 -83.17 46.15 1.09 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.046 -1.033 . . . . 0.0 110.058 -179.511 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 9' ' ' GLY . . . . . 0.612 ' C ' ' H ' ' B' ' 11' ' ' SER . . . -71.81 -131.44 0.11 Allowed Glycine 0 N--CA 1.484 1.871 0 N-CA-C 106.765 -2.534 . . . . 0.0 106.765 177.94 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 10' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.62 25.45 0.12 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 CA-C-N 119.279 1.539 . . . . 0.0 109.276 178.289 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' B' B ' 11' ' ' SER . . . . . 0.612 ' H ' ' C ' ' B' ' 9' ' ' GLY . 20.4 t -84.2 -39.63 19.1 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.386 -179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 12' ' ' HIS . . . . . 0.471 ' CG ' ' N ' ' B' ' 13' ' ' GLY . 10.4 t-160 -170.76 -97.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.364 -179.935 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . 0.471 ' N ' ' CG ' ' B' ' 12' ' ' HIS . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.539 -1.425 . . . . 0.0 109.539 -179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 106' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 107' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 108' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 109' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 110' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 111' ' ' HOH . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_